Citrus Sinensis ID: 008012
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 581 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.987 | 0.568 | 0.369 | 1e-107 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.972 | 0.548 | 0.371 | 1e-104 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.991 | 0.561 | 0.395 | 1e-103 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.963 | 0.571 | 0.355 | 1e-91 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.979 | 0.485 | 0.355 | 4e-90 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.950 | 0.463 | 0.339 | 2e-81 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.963 | 0.447 | 0.323 | 6e-77 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.929 | 0.516 | 0.337 | 9e-76 | |
| Q9LJM4 | 991 | Receptor-like protein kin | no | no | 0.946 | 0.554 | 0.312 | 7e-74 | |
| C0LGX3 | 993 | LRR receptor-like serine/ | no | no | 0.934 | 0.546 | 0.331 | 2e-73 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 389 bits (998), Expect = e-107, Method: Compositional matrix adjust.
Identities = 233/631 (36%), Positives = 356/631 (56%), Gaps = 57/631 (9%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G + LQ + L N L G +P L +L L LSL N+L+G IP + ++T L L L
Sbjct: 381 IGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDL 440
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
++N +P++L ++L + + N L G++ +I ++ L+ LD+S N L G +P+
Sbjct: 441 SNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQD 500
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESL-----------------------DLS 157
I L++L LSL N+ G +P++ G+ +++ESL DLS
Sbjct: 501 IGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEVDLS 560
Query: 158 SNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGP-QRLQ 216
+N+LS IP+ + S L+ N+S N LEG++P +G F N + S N LCG Q
Sbjct: 561 NNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQ 620
Query: 217 VPPCKEDKNKGFKKVALLVLKYIFPPIICVVLIALVF-----IFFLRRR--NRSTKSPDD 269
+ PC KK + + K + + + L+ L+F + +LR+R N+ T +P
Sbjct: 621 LKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTP 680
Query: 270 EELFSLATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKG-ILSDGTTVAIKIFNLQLE 328
L L + SY DL AT+GF+ N++GSG FG+VYK +L++ VA+K+ N+Q
Sbjct: 681 STLEVLH--EKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRR 738
Query: 329 QAFRSFNSECEVLRNVRHRNLIKILSSCCNTN-----FKALVLEFMPNGSLDKWLYSHNY 383
A +SF +ECE L+++RHRNL+K+L++C + + F+AL+ EFMPNGSLD WL+
Sbjct: 739 GAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEV 798
Query: 384 FQ--------DIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDF 435
+ + +RLNI IDVA L+YLH P+ HCDLKPSN+LLD+++ AHVSDF
Sbjct: 799 EEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDF 858
Query: 436 GISKLLGEGD-DSVIQTMTIA----TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRK 490
G+++LL + D +S ++ A TIGY APE+G G S DVYS+GILLLE FT K
Sbjct: 859 GLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGK 918
Query: 491 KPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR---EENFFSARMDCLLSIFHLALDC 547
+PT+E+F G L ++ K +LP + I D ++L F ++CL +F + L C
Sbjct: 919 RPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGF--PVVECLTMVFEVGLRC 976
Query: 548 CAELPDQRLYMKDAATKLKKIRDKFLEDANT 578
C E P RL +L IR++F + + T
Sbjct: 977 CEESPMNRLATSIVVKELISIRERFFKASRT 1007
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 380 bits (976), Expect = e-104, Method: Compositional matrix adjust.
Identities = 235/633 (37%), Positives = 346/633 (54%), Gaps = 68/633 (10%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G + LQ + L N L G +P +L L + L N ++G IP+ ++T L++L L
Sbjct: 389 IGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHL 448
Query: 61 NSNKLTSSIPSALWALEYIL------------------------YVNLSSNYLTGSLTSD 96
NSN IP +L Y+L Y++LS+N+LTG +
Sbjct: 449 NSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEE 508
Query: 97 IQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDL 156
+ +++L+ L S N+LSG +P+ I G + L + GN F G IP+ L+SL+++D
Sbjct: 509 VGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDF 567
Query: 157 SSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQR-L 215
S+NNLS IP+ L +L L+ N+S N+ EG +PT G FRN +A S N +CG R +
Sbjct: 568 SNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREM 627
Query: 216 QVPPCKEDKNKGFKKVALLVLKYIFPPIICVVLIALVFI-------FFLRRR---NRSTK 265
Q+ PC + K+ L V K + IC+ + +L+ I +F++R+ N S
Sbjct: 628 QLKPCIVQASPR-KRKPLSVRKKVVSG-ICIGIASLLLIIIVASLCWFMKRKKKNNASDG 685
Query: 266 SPDDEELFSLATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFN 324
+P D + + SY +L AT F+ NL+GSG FG+V+KG+L + VA+K+ N
Sbjct: 686 NPSDSTTLGMFH-EKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLN 744
Query: 325 LQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN-----TNFKALVLEFMPNGSLDKWLY 379
L A +SF +ECE + +RHRNL+K+++ C + +F+ALV EFMP GSLD WL
Sbjct: 745 LLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQ 804
Query: 380 --------SHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAH 431
H+ ++LNI IDVA ALEYLH PV HCD+KPSNILLD+++ AH
Sbjct: 805 LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAH 864
Query: 432 VSDFGISKLLGEGD-DSVIQTMTIA----TIGYMAPEFGSEGNVSSKCDVYSYGILLLET 486
VSDFG+++LL + D +S + + A TIGY APE+G G S + DVYS+GILLLE
Sbjct: 865 VSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEM 924
Query: 487 FTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALD 546
F+ KKPTDE F G+ NL ++ K S+ G +N + E L + + +
Sbjct: 925 FSGKKPTDESFAGDYNLHSYTK-SILSGCTSSGGSNAIDE---------GLRLVLQVGIK 974
Query: 547 CCAELPDQRLYMKDAATKLKKIRDKFLEDANTL 579
C E P R+ +A +L IR KF T+
Sbjct: 975 CSEEYPRDRMRTDEAVRELISIRSKFFSSKTTI 1007
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 375 bits (963), Expect = e-103, Method: Compositional matrix adjust.
Identities = 240/607 (39%), Positives = 343/607 (56%), Gaps = 31/607 (5%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G + +L+ + L N L G IP L + L L L N GSIP+ L S + L +L L
Sbjct: 421 LGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNL 480
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+NKL SIP L L ++ +N+S N L G L DI +K L+ LD+S N+LSG IP+T
Sbjct: 481 GTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQT 540
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+A L L L GN F GPIP+ G L L LDLS NNLS IP+ + S L+ N+
Sbjct: 541 LANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNL 599
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCGP-QRLQVPPCKED---KNKGFKKVALLVL 236
S N +G +PTEG FRN SA S N LCG LQ+ PC + ++ +K+ + +
Sbjct: 600 SLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICV 659
Query: 237 KYIFPPIICVVLIALVFIFFLRRRNRSTKSPDDEELFSLAT----WRRTSYLDLERATDG 292
+ ++ + L + ++ + R +S ++ ++E S + + + SY +L + T G
Sbjct: 660 SAVMAALLLLCLCVVYLCWY-KLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGG 718
Query: 293 FNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIK 351
F+ NL+GSG FG+V+KG L S VAIK+ NL A +SF +ECE L +RHRNL+K
Sbjct: 719 FSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVK 778
Query: 352 ILSSCCNT-----NFKALVLEFMPNGSLDKWLYSHNYFQ--------DIPDRLNIMIDVA 398
+++ C ++ +F+ALV EFMPNG+LD WL+ + + RLNI IDVA
Sbjct: 779 LVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVA 838
Query: 399 LALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTM-----T 453
AL YLH P+ HCD+KPSNILLD+++ AHVSDFG+++LL + D
Sbjct: 839 SALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGV 898
Query: 454 IATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH 513
TIGY APE+G G+ S DVYS+GI+LLE FT K+PT+++F + L ++ K +L
Sbjct: 899 RGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQK 958
Query: 514 GLP-KIADANLLREENFFSARM-DCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571
I D +LR M +CL +F + + C E P R+ M +A +KL IR+
Sbjct: 959 RQALDITDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRES 1018
Query: 572 FLEDANT 578
F D T
Sbjct: 1019 FFRDEET 1025
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (864), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 222/624 (35%), Positives = 330/624 (52%), Gaps = 64/624 (10%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNS 62
++ +L+ + L++NHL G IP +L + RL L + N L+GSIP +L+ LR L L
Sbjct: 343 KLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYG 402
Query: 63 NKLTSSIPSALWA---LEYI-----------------------LYVNLSSNYLTGSLTSD 96
N L+ ++P +L LE + LY+NLSSN+L+G + +
Sbjct: 403 NHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLE 462
Query: 97 IQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDL 156
+ M +++ +DLS N+LSG IP + L +L+L+ N F +P S G L L+ LD+
Sbjct: 463 LSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDV 522
Query: 157 SSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQ 216
S N L+ IP S S LK N S N L G + +G F + +SF + LCG +
Sbjct: 523 SFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-G 581
Query: 217 VPPCKEDKNKGFKKVALLVLKYIFPPIICVVLIALVFIFFLRRRNR--------STKSPD 268
+ CK+ K+K + ++L I P++C VF + L +R+R + + +
Sbjct: 582 MQACKK-KHKYPSVLLPVLLSLIATPVLC------VFGYPLVQRSRFGKNLTVYAKEEVE 634
Query: 269 DEELFSL--ATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQ 326
DEE + + R SY L AT GFN +L+GSG FG VYKG+L + T VA+K+ + +
Sbjct: 635 DEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPK 694
Query: 327 LEQAFR-SFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ 385
F SF EC++L+ RHRNLI+I+++C F ALVL MPNGSL++ LY Y
Sbjct: 695 TALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSS 754
Query: 386 ---DIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442
D+ +NI DVA + YLHH VVHCDLKPSNILLD+ M A V+DFGIS+L+
Sbjct: 755 KNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQ 814
Query: 443 ------EGDDSV----IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP 492
DDSV + ++GY+APE+G S+ DVYS+G+LLLE + ++P
Sbjct: 815 GVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRP 874
Query: 493 TDEMFTGEMNLKNWVKESLPHGLPKIADANLLR------EENFFSARMDCLLSIFHLALD 546
TD + +L ++K P L I + L R E + +L + L L
Sbjct: 875 TDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLV 934
Query: 547 CCAELPDQRLYMKDAATKLKKIRD 570
C P R M D A ++ ++++
Sbjct: 935 CTQYNPSTRPDMLDVAHEMGRLKE 958
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (852), Expect = 4e-90, Method: Compositional matrix adjust.
Identities = 226/636 (35%), Positives = 346/636 (54%), Gaps = 67/636 (10%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLT------- 53
M M+ L + L++N G IP +L+ L LSLQGNK NGSIP L SL+
Sbjct: 547 MFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDI 606
Query: 54 ---------------SLRELRL----NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLT 94
SL+ ++L ++N LT +IP L LE + ++LS+N +GS+
Sbjct: 607 SDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIP 666
Query: 95 SDIQNMKVLIDLDLSRNQLSGDIPKTI-AGLKDLTNLSLAGNQFQGPIPESFGSLISLES 153
+Q K + LD S+N LSG IP + G+ + +L+L+ N F G IP+SFG++ L S
Sbjct: 667 RSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVS 726
Query: 154 LDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQ 213
LDLSSNNL+ IP+SL LS LK ++ N L+G +P G F+N +A N LCG +
Sbjct: 727 LDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSK 786
Query: 214 RLQVPPCKEDKNKGFKK---VALLVL----------KYIFPPIICVVLIALVFIFFLRRR 260
+ P + K+ F K V L++L + C +
Sbjct: 787 KPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKI-------E 839
Query: 261 NRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAI 320
N S S D L S +R +LE+ATD FN N++GS +VYKG L DGT +A+
Sbjct: 840 NSSESSLPD--LDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAV 897
Query: 321 KIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN-FKALVLEFMPNGSLDKW 377
K+ NL+ ++ + F +E + L ++HRNL+KIL + KALVL FM NG+L+
Sbjct: 898 KVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDT 957
Query: 378 LY-SHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG 436
++ S + +++++ + +A ++YLH G+ P+VHCDLKP+NILLD + VAHVSDFG
Sbjct: 958 IHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFG 1017
Query: 437 ISKLLGEGDDSVIQTMTIA---TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPT 493
+++LG +D T A TIGY+APEF V++K DV+S+GI+++E T+++PT
Sbjct: 1018 TARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPT 1077
Query: 494 --DEMFTGEMNLKNWVKESLPH---GLPKIADANLLREENFFSARMDCLLSIF-HLALDC 547
++ + +M L+ V++S+ + G+ ++ D L ++ S + + + F L L C
Sbjct: 1078 SLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL--GDSIVSLKQEEAIEDFLKLCLFC 1135
Query: 548 CAELPDQRLYMKDAATKLKKIRDK---FLEDANTLR 580
+ P+ R M + T L K+R K F ED N R
Sbjct: 1136 TSSRPEDRPDMNEILTHLMKLRGKANSFREDRNEDR 1171
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 304 bits (778), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 207/609 (33%), Positives = 308/609 (50%), Gaps = 57/609 (9%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G L I L++NHL G IP L +L L L L GN L GSIP + + L+ L L
Sbjct: 600 LGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNL 659
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+N+L IP + L ++ +NL+ N L G + + + N+K L +DLS N LSG++
Sbjct: 660 ANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSE 719
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
++ ++ L L + N+F G IP G+L LE LD+S N LS IP + L +L+ N+
Sbjct: 720 LSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNL 779
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCKEDKNK--GFKKVALLVLKY 238
+ N L GE+P++G ++ S N LCG R+ CK + K +A L+L +
Sbjct: 780 AKNNLRGEVPSDGVCQDPSKALLSGNKELCG--RVVGSDCKIEGTKLRSAWGIAGLMLGF 837
Query: 239 IFPPIICVVLIALVFIFFLRR-----RNRSTKSPD-----------DEELFSLATWRRTS 282
+I VF+F LRR R + P+ D+ L+ L+ R
Sbjct: 838 --------TIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSRE 889
Query: 283 YL-----------------DLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNL 325
L D+ ATD F++ N++G GGFG+VYK L TVA+K +
Sbjct: 890 PLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSE 949
Query: 326 QLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ 385
Q R F +E E L V+H NL+ +L C + K LV E+M NGSLD WL +
Sbjct: 950 AKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGML 1009
Query: 386 DIPD---RLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442
++ D RL I + A L +LHHG ++H D+K SNILLD + V+DFG+++L+
Sbjct: 1010 EVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLI- 1068
Query: 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMF--TGE 500
+S + T+ T GY+ PE+G ++K DVYS+G++LLE T K+PT F +
Sbjct: 1069 SACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEG 1128
Query: 501 MNLKNWVKESLPHGLP-KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMK 559
NL W + + G + D L+ A + L + +A+ C AE P +R M
Sbjct: 1129 GNLVGWAIQKINQGKAVDVIDPLLVS-----VALKNSQLRLLQIAMLCLAETPAKRPNML 1183
Query: 560 DAATKLKKI 568
D LK+I
Sbjct: 1184 DVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 288 bits (738), Expect = 6e-77, Method: Compositional matrix adjust.
Identities = 199/616 (32%), Positives = 306/616 (49%), Gaps = 56/616 (9%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
G++ +L + ++ N L G IP +L K+L + L N L+G IPT L L L EL+L+
Sbjct: 621 GKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLS 680
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
SNK S+P+ +++L IL + L N L GS+ +I N++ L L+L NQLSG +P TI
Sbjct: 681 SNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTI 740
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLES-LDLSSNNLSEGIPKSLVALSHLKQFNV 180
L L L L+ N G IP G L L+S LDLS NN + IP ++ L L+ ++
Sbjct: 741 GKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDL 800
Query: 181 SHNRLEGEIPT------------------EGP----FRNFSAQSFHWNYALCGPQRLQVP 218
SHN+L GE+P EG F + A +F N LCG
Sbjct: 801 SHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGSPLSHCN 860
Query: 219 PCKEDKNKGFKKVALLVLKYIFPPIICVVLIALVFIFFLRRRNRSTKS------------ 266
+ ++++ I + + L+ LV I F ++ + K
Sbjct: 861 RAGSKNQRSLSPKTVVIISAI-SSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNS 919
Query: 267 -PDDEELFSLATWRR-TSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFN 324
LFS + + D+ AT NE ++GSGG G VYK L +G T+A+K
Sbjct: 920 SSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKIL 979
Query: 325 LQLE-QAFRSFNSECEVLRNVRHRNLIKILSSCCNT--NFKALVLEFMPNGSLDKWLYSH 381
+ + + +SFN E + L +RHR+L+K++ C + L+ E+M NGS+ WL+++
Sbjct: 980 WKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHAN 1039
Query: 382 NYFQD-----IPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG 436
+ RL I + +A +EYLH+ P+VH D+K SN+LLD N+ AH+ DFG
Sbjct: 1040 ENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFG 1099
Query: 437 ISKLLGEGDDSVIQ--TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTD 494
++K+L D+ + TM + GY+APE+ + K DVYS GI+L+E T K PT+
Sbjct: 1100 LAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTE 1159
Query: 495 EMFTGEMNLKNWVKESL--PHG---LPKIADANLLREENFFSARMDCLLSIFHLALDCCA 549
MF E ++ WV+ L P G K+ D+ L ++ + + +AL C
Sbjct: 1160 AMFDEETDMVRWVETVLDTPPGSEAREKLIDSEL---KSLLPCEEEAAYQVLEIALQCTK 1216
Query: 550 ELPDQRLYMKDAATKL 565
P +R + A+ L
Sbjct: 1217 SYPQERPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 285 bits (728), Expect = 9e-76, Method: Compositional matrix adjust.
Identities = 197/584 (33%), Positives = 297/584 (50%), Gaps = 44/584 (7%)
Query: 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNK 64
Q+L L++N + G+IP ++ + +L+ L L N++ G +P ++++ + +L+LN N+
Sbjct: 478 QKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNR 537
Query: 65 LTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGL 124
L+ IPS + L + Y++LSSN + + + N+ L ++LSRN L IP+ + L
Sbjct: 538 LSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKL 597
Query: 125 KDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNR 184
L L L+ NQ G I F SL +LE LDLS NNLS IP S + L +VSHN
Sbjct: 598 SQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNN 657
Query: 185 LEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQ--VPPCKEDKNKGFKKVALLVLKYIFPP 242
L+G IP FRN +F N LCG + PC +K K L++ YI P
Sbjct: 658 LQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLII-YILVP 716
Query: 243 IICVVLI----ALVFIFFLRRRNRSTKSPDDE---ELFSLATWR-RTSYLDLERATDGFN 294
II ++I A +FI F +R + + D E E S+ ++ + Y ++ +AT F+
Sbjct: 717 IIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFD 776
Query: 295 ECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAF------RSFNSECEVLRNVRHRN 348
L+G+GG G VYK L + +A+K N + + + F +E L +RHRN
Sbjct: 777 PKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRN 835
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ--DIPDRLNIMIDVALALEYLHH 406
++K+ C + LV E+M GSL K L + + + D R+N++ VA AL Y+HH
Sbjct: 836 VVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHH 895
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGS 466
S +VH D+ NILL E+ A +SDFG +KLL DS + T GY+APE
Sbjct: 896 DRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKP--DSSNWSAVAGTYGYVAPELAY 953
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKPTDEMFT-------GEMNLKNWVKESLPHGLPKIA 519
V+ KCDVYS+G+L LE + P D + T ++LK+ LP P+I
Sbjct: 954 AMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEI- 1012
Query: 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAAT 563
+EE +L I +AL C P R M +T
Sbjct: 1013 -----KEE---------VLEILKVALLCLHSDPQARPTMLSIST 1042
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJM4|IKU2_ARATH Receptor-like protein kinase HAIKU2 OS=Arabidopsis thaliana GN=IKU2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (712), Expect = 7e-74, Method: Compositional matrix adjust.
Identities = 205/657 (31%), Positives = 319/657 (48%), Gaps = 107/657 (16%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G + I +++N L+G IP +C+ + L + N+ G P A +L LR+
Sbjct: 336 LGSWTAFKYIDVSENFLEGQIPPYMCKKGVMTHLLMLQNRFTGQFPESYAKCKTLIRLRV 395
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
++N L+ IPS +W L + +++L+SNY G+LT DI N K L LDLS N+ SG +P
Sbjct: 396 SNNSLSGMIPSGIWGLPNLQFLDLASNYFEGNLTGDIGNAKSLGSLDLSNNRFSGSLPFQ 455
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS------------------ 162
I+G L +++L N+F G +PESFG L L SL L NNLS
Sbjct: 456 ISGANSLVSVNLRMNKFSGIVPESFGKLKELSSLILDQNNLSGAIPKSLGLCTSLVDLNF 515
Query: 163 ------EGIPKSL---------------------VALSHLK--QFNVSHNRLEGEIPTEG 193
E IP+SL V LS LK ++S+N+L G +P
Sbjct: 516 AGNSLSEEIPESLGSLKLLNSLNLSGNKLSGMIPVGLSALKLSLLDLSNNQLTGSVP--- 572
Query: 194 PFRNFSAQSFHWNYALCGPQRLQVPPC------KEDKNKGFKKVALLVLKYIFPPIICVV 247
+ + SF N LC + + PC + K K KV + I
Sbjct: 573 --ESLVSGSFEGNSGLCSSKIRYLRPCPLGKPHSQGKRKHLSKVDMC--------FIVAA 622
Query: 248 LIALVFIF----FLRRRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLLGSGG 303
++AL F+F F RR++ K+ + + ++++R ++ ++E D N++G GG
Sbjct: 623 ILALFFLFSYVIFKIRRDKLNKTVQKKNDWQVSSFRLLNFNEME-IIDEIKSENIIGRGG 681
Query: 304 FGSVYKGILSDGTTVAIKIFNL--QLEQAFRS----------------FNSECEVLRNVR 345
G+VYK L G T+A+K ++FRS F +E L N++
Sbjct: 682 QGNVYKVSLRSGETLAVKHIWCPESSHESFRSSTAMLSDGNNRSNNGEFEAEVATLSNIK 741
Query: 346 HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN--IMIDVALALEY 403
H N++K+ S + K LV E+MPNGSL + L+ Q+I R+ + + A LEY
Sbjct: 742 HINVVKLFCSITCEDSKLLVYEYMPNGSLWEQLHERRGEQEIGWRVRQALALGAAKGLEY 801
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI----ATIGY 459
LHHG PV+H D+K SNILLDE ++DFG++K++ DSV + + T+GY
Sbjct: 802 LHHGLDRPVIHRDVKSSNILLDEEWRPRIADFGLAKIIQA--DSVQRDFSAPLVKGTLGY 859
Query: 460 MAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWV----KESLPHGL 515
+APE+ V+ K DVYS+G++L+E T KKP + F ++ WV KE+ +
Sbjct: 860 IAPEYAYTTKVNEKSDVYSFGVVLMELVTGKKPLETDFGENNDIVMWVWSVSKETNREMM 919
Query: 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572
K+ D ++ E + L + +AL C + P R +MK + L+KI +
Sbjct: 920 MKLIDTSIEDEYK------EDALKVLTIALLCTDKSPQARPFMKSVVSMLEKIEPSY 970
|
Modulates the seed size by negatively regulating the cellularization of syncytial endosperm. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 277 bits (708), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 200/604 (33%), Positives = 301/604 (49%), Gaps = 61/604 (10%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSL-QGNKLNGSIPTCLASLTSLRELRL 60
G L I +ADN L G +P +L L L L N+L GSIP ++ L +L +
Sbjct: 408 GDCHSLNYIRMADNKLSGEVPARFWELP-LTRLELANNNQLQGSIPPSISKARHLSQLEI 466
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
++N + IP L L + ++LS N GS+ S I +K L +++ N L G+IP +
Sbjct: 467 SANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCINKLKNLERVEMQENMLDGEIPSS 526
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
++ +LT L+L+ N+ +G IP G L L LDLS+N L+ IP L+ L L QFNV
Sbjct: 527 VSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPAELLRL-KLNQFNV 585
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCKEDKNKGFKKVALLVLKYIF 240
S N+L G+IP+ G ++ SF N LC P + PC+ + +YI
Sbjct: 586 SDNKLYGKIPS-GFQQDIFRPSFLGNPNLCAPNLDPIRPCRSKRET----------RYIL 634
Query: 241 P-PIICVVLI--ALVFIF------FLRRRNRSTKSPDDEELFSLATWRRTSYLDLERATD 291
P I+C+V + ALV++F F R+ R+ K + ++R + + E
Sbjct: 635 PISILCIVALTGALVWLFIKTKPLFKRKPKRTNK---------ITIFQRVGFTE-EDIYP 684
Query: 292 GFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRS---FNSECEVLRNVRHRN 348
E N++GSGG G VY+ L G T+A+K + Q S F SE E L VRH N
Sbjct: 685 QLTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGETGQKTESESVFRSEVETLGRVRHGN 744
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ-----DIPDRLNIMIDVALALEY 403
++K+L C F+ LV EFM NGSL L+S + D R +I + A L Y
Sbjct: 745 IVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSY 804
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATI----GY 459
LHH P+VH D+K +NILLD M V+DFG++K L D+ + ++++ + GY
Sbjct: 805 LHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGY 864
Query: 460 MAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKE-SLPHGLPKI 518
+APE+G V+ K DVYS+G++LLE T K+P D F ++ + E +L + P
Sbjct: 865 IAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYPSPSA 924
Query: 519 AD--------------ANLLREENFFSAR-MDCLLSIFHLALDCCAELPDQRLYMKDAAT 563
D + L+ + S R + + + +AL C + P R M+
Sbjct: 925 EDGAMNQDSLGNYRDLSKLVDPKMKLSTREYEEIEKVLDVALLCTSSFPINRPTMRKVVE 984
Query: 564 KLKK 567
LK+
Sbjct: 985 LLKE 988
|
Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 581 | ||||||
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.984 | 0.539 | 0.598 | 0.0 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.993 | 0.529 | 0.584 | 0.0 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.974 | 0.520 | 0.579 | 0.0 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.994 | 0.567 | 0.555 | 1e-180 | |
| 449465016 | 1092 | PREDICTED: probable LRR receptor-like se | 0.981 | 0.521 | 0.551 | 1e-178 | |
| 255583725 | 973 | serine-threonine protein kinase, plant-t | 0.987 | 0.589 | 0.562 | 1e-176 | |
| 359485451 | 1454 | PREDICTED: LRR receptor-like serine/thre | 0.979 | 0.391 | 0.546 | 1e-175 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.982 | 0.547 | 0.562 | 1e-174 | |
| 359483677 | 1229 | PREDICTED: LRR receptor-like serine/thre | 0.979 | 0.462 | 0.549 | 1e-174 | |
| 147769371 | 1241 | hypothetical protein VITISV_010511 [Viti | 0.979 | 0.458 | 0.546 | 1e-172 |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 688 bits (1775), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/578 (59%), Positives = 437/578 (75%), Gaps = 6/578 (1%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+GR++ LQ LA N LQG IP ++C L+RL+ L L N +GS+P CL+++TSLREL L
Sbjct: 480 IGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYLLENGFSGSLPACLSNITSLRELYL 539
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
SN+ TS IP+ W+L+ +L +NLS N LTG+L +I N+KV+ +D S NQLSGDIP +
Sbjct: 540 GSNRFTS-IPTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKVVTVIDFSSNQLSGDIPTS 598
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
IA L++L + SL+ N+ QGPIP SFG L+SLE LDLS N+LS IPKSL L HLK FNV
Sbjct: 599 IADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAIPKSLEKLVHLKTFNV 658
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCKE-DKNKGFKKVALLVLKYI 239
S NRL+GEI GPF NFS +SF N ALCGP R+QVPPCK ++ K+ V++YI
Sbjct: 659 SFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQSKRPREFVIRYI 718
Query: 240 FPPIICVVLI-ALVFIFFLRRRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNL 298
P I ++L+ AL I F RR+ K E+ ATWR+ SY +L RAT+GFNE NL
Sbjct: 719 VPAIAFIILVLALAVIIF--RRSHKRKLSTQEDPLPPATWRKISYHELYRATEGFNETNL 776
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
LG+G GSVYKG LSDG +A+K+F+LQLE F+SECEVLR +RHRNL+KI+SSCCN
Sbjct: 777 LGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSCCN 836
Query: 359 TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLK 418
+FKAL+LEF+P+GSL+KWLYSHNY+ DI RLNIMIDVA ALEYLHHG + PVVHCDLK
Sbjct: 837 LDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHGCTRPVVHCDLK 896
Query: 419 PSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYS 478
PSN+L++E+MVAHVSDFGIS+LLGEG D+V QT+T+ATIGYMAPE+G EG VS K DVYS
Sbjct: 897 PSNVLINEDMVAHVSDFGISRLLGEG-DAVTQTLTLATIGYMAPEYGLEGIVSVKGDVYS 955
Query: 479 YGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLL 538
YGI L+ETFTRKKPTD+MF GEM+LKNWVK+SLP + ++ DANLL EE F A+ DC+
Sbjct: 956 YGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLLIEEEHFVAKKDCIT 1015
Query: 539 SIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDA 576
SI +LAL+C A+LP +R+ M+D L+KI+ K+ +D
Sbjct: 1016 SILNLALECSADLPGERICMRDVLPALEKIKLKYKKDV 1053
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 673 bits (1737), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/582 (58%), Positives = 441/582 (75%), Gaps = 5/582 (0%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G ++ LQG+ L N L GSIP +LC L+ L +L L GNKL+GSIPTC ++LTSLR L L
Sbjct: 509 IGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIPTCFSNLTSLRNLFL 568
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
SN+ S+I S LW L+ IL VNL+SNYLTGSL S+I+N++ + +++S+NQLSG+IP +
Sbjct: 569 ASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGEIPIS 628
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
I GL+DL L L+GN+ QGPIP+S G + SLE LDLSSNNLS IPKSL L +LK FNV
Sbjct: 629 IGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYFNV 688
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCKEDKNKGFKKV-ALLVLKYI 239
S N L+GEIP G F NFSAQSF N ALCG RLQV PCK+D ++ + + +VL+Y+
Sbjct: 689 SFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIVLRYV 748
Query: 240 FPPIICVVLIALVFIFFLRRR-NRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNL 298
P I+ V + L F+ L+R R K +++ +L T RR SY +L+ AT+GF E N
Sbjct: 749 LPAIVFAVFV-LAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQLATNGFQESNF 807
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
LG G FGSVYKG LSDGT +A K+FNLQLE+AF+SF++ECEVLRN+RHRNL+KI++SC
Sbjct: 808 LGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCSG 867
Query: 359 TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLK 418
NFKALVLEFMPN SL+KWLYS +YF + RLNIM+DVA LEYLHHG++ P+ HCD+K
Sbjct: 868 PNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPMAHCDIK 927
Query: 419 PSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYS 478
PSN+LL+E+MVA ++DFGISKLLGE + SV+QTMT+ATIGYMAPE+GSEG VS + DVYS
Sbjct: 928 PSNVLLNEDMVAFLADFGISKLLGE-EGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVYS 986
Query: 479 YGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR-EENFFSARMDCL 537
YG+LL+ETFT+KKPTD+MFT +++LK+WV++SL + ++ DANLL EE+ +A+ DC+
Sbjct: 987 YGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLAAKKDCI 1046
Query: 538 LSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDANTL 579
+SI LAL C A+LP R+ MK T L+KI+ KFL D L
Sbjct: 1047 VSILKLALQCSADLPHDRIDMKHVVTTLQKIKTKFLRDIRQL 1088
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 652 bits (1682), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/573 (57%), Positives = 429/573 (74%), Gaps = 7/573 (1%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G++Q+LQG+ L N LQGSIP D+CQL+ L L L N+L+GSIP CL LT LR L L
Sbjct: 513 IGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRHLYL 572
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
SNKL S+IPS LW+L +IL +++SSN+L G L SD+ N+KVL+ +DLSRNQLSG+IP
Sbjct: 573 GSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSN 632
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
I GL+DLT+LSLA N+F+GPI SF +L SLE +DLS N L IPKSL L +LK +V
Sbjct: 633 IGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDV 692
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCKEDKNKGFKKVALLVLKYIF 240
S N L GEIP EGPF NFSA+SF N ALCG RL++PPC+ + ++ L+LKYI
Sbjct: 693 SFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTG-TRWSTTISWLLLKYIL 751
Query: 241 PPIICVVL-IALVFIFFLRRRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLL 299
P I+ +L +AL+F+ + R R R+ P E ATWRR SY ++ +AT+GF+ NLL
Sbjct: 752 PAILSTLLFLALIFV-WTRCRKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNLL 810
Query: 300 GSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT 359
G G GSVY+G LSDG AIK+FNLQ E AF+SF++ECEV+ ++RHRNLIKI+SSC N+
Sbjct: 811 GRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNS 870
Query: 360 --NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
+FKALVLE++PNGSL++WLYSHNY DI RLNIMIDVALA+EYLHHG STPVVHCDL
Sbjct: 871 YIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDL 930
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
KPSNILLDE+ HV DFGI+KLL E ++S+ +T T+ATIGYMAP++ S G V++ DVY
Sbjct: 931 KPSNILLDEDFGGHVGDFGIAKLLRE-EESIRETQTLATIGYMAPKYVSNGIVTTSGDVY 989
Query: 478 SYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR-EENFFSARMDC 536
SYGI+L+ETFTR++PTDE+F+ EM++KNWV + L + ++ DANLLR E+ F A+ C
Sbjct: 990 SYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFMAKKQC 1049
Query: 537 LLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569
+ I LA+DC A+ P++R+ MKD T LKKI+
Sbjct: 1050 ISLILGLAMDCVADSPEERIKMKDVVTTLKKIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 637 bits (1642), Expect = e-180, Method: Compositional matrix adjust.
Identities = 323/581 (55%), Positives = 419/581 (72%), Gaps = 3/581 (0%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G ++++Q + L N+L GSIP D+C +RL ++L N L+G IP+C+ +LTSLR L L
Sbjct: 440 VGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEIPSCIGNLTSLRNLYL 499
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+ N L+S+IP ALW+L+ +L +NL SN+L GSL S + M+ I + LS NQLSG+IP T
Sbjct: 500 HFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGNIPST 559
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
I L++L SL+ N FQG IPE+FG L+SLE LDLS NNLS IPKSL AL +L+ F+V
Sbjct: 560 IGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLEFFSV 619
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCKEDKNKGFKKVALLVLKYIF 240
S N L+GEIP GPF NF+A+SF N LCGP RLQVPPC + K K + L L++
Sbjct: 620 SFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRKDSKTKSRL-LRFSL 678
Query: 241 PPIICVVLIALVFIFFLRRRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLLG 300
P + ++L+ + R R K P E L A RR SYL+L AT+ F+E NLLG
Sbjct: 679 PTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISYLELLHATNEFHESNLLG 738
Query: 301 SGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN 360
G FGSVY+G L DG VA+KIFNLQL++AFRSF++ECE++RN+RHRNL+KI+ SC N +
Sbjct: 739 IGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLD 798
Query: 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPS 420
FKALVLE+MP GSL+KWLYSHNY DI R+NIMIDVA ALEYLHHG+ +PVVHCDLKPS
Sbjct: 799 FKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPS 858
Query: 421 NILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYG 480
N+LLDE+MVAHV DFGI+KLLGE ++S QT T+ATIGYMAPE+G +G VS+K DVYS+G
Sbjct: 859 NVLLDEDMVAHVCDFGIAKLLGE-NESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYSFG 917
Query: 481 ILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMD-CLLS 539
I+L+E TRK+PTDEMF GEM+LK VKESLP + I D+N+L + +S + + C+ S
Sbjct: 918 IMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVKKEHCVTS 977
Query: 540 IFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDANTLR 580
I LAL C E P +R+ M + +LK I+ +FL D+ R
Sbjct: 978 IMELALQCVNESPGERMAMVEILARLKNIKAEFLRDSERRR 1018
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449465016|ref|XP_004150225.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1624), Expect = e-178, Method: Compositional matrix adjust.
Identities = 318/577 (55%), Positives = 430/577 (74%), Gaps = 7/577 (1%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G+++QLQG+ L++N L+G+IP ++CQL+ L+ L L NKL+G+IP C +L++LR L L
Sbjct: 514 IGKLKQLQGLHLSNNSLEGNIPAEICQLENLDELYLANNKLSGAIPECFDNLSALRTLSL 573
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
SN L S++PS+LW+L YIL++NLSSN L GSL +I N++V++D+D+S+NQLSG+IP +
Sbjct: 574 GSNNLNSTMPSSLWSLSYILHLNLSSNSLRGSLPVEIGNLEVVLDIDVSKNQLSGEIPSS 633
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
I GL +L NLSL N+ +G IP+SFG+L++LE LDLSSNNL+ IP+SL LSHL+QFNV
Sbjct: 634 IGGLINLVNLSLLHNELEGSIPDSFGNLVNLEILDLSSNNLTGVIPRSLEKLSHLEQFNV 693
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALC-GPQRLQVPPCKEDKNKGF-KKVALLVLKY 238
S N+LEGEIP GPF NFSAQSF N LC R QV PC ++G +K LV Y
Sbjct: 694 SFNQLEGEIPNGGPFSNFSAQSFISNIGLCSASSRFQVAPCTTKTSQGSGRKTNKLV--Y 751
Query: 239 IFPPIICVVLIALVFIFFLRRRNRSTKSP-DDEELFSLATWRRTSYLDLERATDGFNECN 297
I P I+ +L ++ + F+ R+R + +D L WRRT+Y +L +ATDGF+E N
Sbjct: 752 ILPSILLAMLSLILLLLFMTYRHRKKEQVREDTPLPYQPAWRRTTYQELSQATDGFSESN 811
Query: 298 LLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357
L+G G FGSVYK LSDGT A+KIF+L + A +SF ECE+L N+RHRNL+KI++SC
Sbjct: 812 LIGRGSFGSVYKATLSDGTIAAVKIFDLLTQDANKSFELECEILCNIRHRNLVKIITSCS 871
Query: 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
+ +FKAL+LE+MPNG+LD WLY+H+ ++ +RL+I+IDVALAL+YLH+G+ P+VHCDL
Sbjct: 872 SVDFKALILEYMPNGNLDMWLYNHDCGLNMLERLDIVIDVALALDYLHNGYGKPIVHCDL 931
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
KP+NILLD +MVAH++DFGISKLLG G DS+ QT+T+AT+GYMAPE G +G VS KCDVY
Sbjct: 932 KPNNILLDGDMVAHLTDFGISKLLG-GGDSITQTITLATVGYMAPELGLDGIVSRKCDVY 990
Query: 478 SYGILLLETFTRKKPTDEMFT-GEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDC 536
SYGILL+ETFTRKKPTDEMF+ GEM+L+ WV ++ PH + + D +LL ++ F+ +C
Sbjct: 991 SYGILLMETFTRKKPTDEMFSAGEMSLREWVAKAYPHSINNVVDPDLLNDDKSFNYASEC 1050
Query: 537 LLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573
L SI LAL C AE P++R KD L KI+ L
Sbjct: 1051 LSSIMLLALTCTAESPEKRASSKDVLNSLNKIKAMIL 1087
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583725|ref|XP_002532616.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223527672|gb|EEF29782.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1612), Expect = e-176, Method: Compositional matrix adjust.
Identities = 327/581 (56%), Positives = 423/581 (72%), Gaps = 7/581 (1%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G++++LQ + L N L+G P +LC L+ L LSL N L+GSIP+CL ++ SLR L +
Sbjct: 396 IGKLRKLQALLLDHNKLEGVFPPELCDLQSLAILSLGVNTLSGSIPSCLGNVDSLRNLSM 455
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
NK S+IPS LW LE IL VNLS N L+G+L DI N+KV +DLS NQLSG IP
Sbjct: 456 QMNKFNSTIPSTLWRLENILIVNLSFNSLSGALAVDIGNLKVATIIDLSGNQLSGQIPPG 515
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+ LKDL++LSLA N+F+G IP+SFG ISL+ LDLS+N LS IPK L L +L FNV
Sbjct: 516 LGSLKDLSSLSLADNRFEGSIPQSFGDAISLQFLDLSNNTLSGEIPKYLEILRYLTYFNV 575
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCKEDKNKGFKKVALLVLKY-I 239
S N L+GEIP G F N SAQSF N CG + QV PCK ++G K + L L+Y +
Sbjct: 576 SFNELQGEIPNGGAFTNLSAQSFMGNKGFCGAAKFQVQPCKTRTDQGSKAGSKLALRYGL 635
Query: 240 FPPIICVVLIALVFIFFLRRRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLL 299
+ ++ +A V I F+R R R+ ++ E L LAT R SY +LE+ATD FNE NLL
Sbjct: 636 MATGLTILAVAAVVIIFIRSRKRNRRT--TEGLLPLATLERISYRELEQATDKFNEINLL 693
Query: 300 GSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT 359
G G FGSVYKGI SDG +VA+K+FNLQ E AF+SF+ E EVLR +RHRNL+KI++SC +
Sbjct: 694 GKGSFGSVYKGIFSDGRSVAVKVFNLQAEGAFKSFDVESEVLRMIRHRNLVKIITSCSSV 753
Query: 360 N--FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
N FKALVLEFMPN SL+KWLYS N+F + RLNIM+DVA A+EYLHHG++TP+VHCDL
Sbjct: 754 NIEFKALVLEFMPNHSLEKWLYSPNHFLEFLQRLNIMLDVASAVEYLHHGYTTPIVHCDL 813
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
KP+NILLDENM AHV+DFGI+KLLG+ + S I+T+T+AT+GYMAPE+GSEG VS+ DVY
Sbjct: 814 KPNNILLDENMAAHVTDFGIAKLLGD-ERSFIRTITLATVGYMAPEYGSEGVVSTGGDVY 872
Query: 478 SYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR-EENFFSARMDC 536
S+GIL++ETFT +KPTD+MF EMN+K WV+ESL G+ +IAD NLLR E+ SA+ DC
Sbjct: 873 SFGILMIETFTSRKPTDDMFNEEMNMKQWVQESLAGGVTQIADPNLLRIEDEHLSAKKDC 932
Query: 537 LLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDAN 577
++S+ LAL C A+LP++R ++D + L I+ KFL+ N
Sbjct: 933 IISMMQLALQCSADLPEERPNIRDVLSTLNHIKVKFLKGIN 973
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 621 bits (1601), Expect = e-175, Method: Compositional matrix adjust.
Identities = 314/575 (54%), Positives = 418/575 (72%), Gaps = 6/575 (1%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G++++LQ +G+A N L+GSIP DLC+LK L L L N+L GSIP+CL L LREL L
Sbjct: 883 LGQLKKLQELGIAGNRLRGSIPNDLCRLKNLGYLFLSSNQLTGSIPSCLGYLPPLRELYL 942
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+SN L S+IP +LW L +L +NLSSN+LTG L ++ N+K + LDLS+NQ+SG IP+T
Sbjct: 943 HSNALASNIPPSLWTLRGLLVLNLSSNFLTGHLPPEVGNIKSIRTLDLSKNQVSGHIPRT 1002
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+ L++L +LSL+ N+ QGPIP FG L+SL+ LDLS NNLS IPKSL AL++LK NV
Sbjct: 1003 LGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFLDLSQNNLSGVIPKSLKALTYLKYLNV 1062
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCKEDKNKGFKKVALLVLKYIF 240
S N+L+GEIP GPF NF+A+SF +N ALCG QV C + + L +LKYI
Sbjct: 1063 SFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPHFQVIACDKSTRSRSWRTKLFILKYIL 1122
Query: 241 PPIICVVLIALVFIFFLRRR-NRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLL 299
PP+I ++ + + + ++RRR N +P D L + + S+ L AT+ F E NL+
Sbjct: 1123 PPVISIITLVVFLVLWIRRRKNLEVPTPIDSWL--PGSHEKISHQQLLYATNYFGEDNLI 1180
Query: 300 GSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT 359
G G VYKG+LS+G TVA+K+FNL+ + AFRSF+SECEV++++RHRNL+KI++ C N
Sbjct: 1181 GKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITCCSNL 1240
Query: 360 NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKP 419
+FKALVLE+MP GSLDKWLYSHNYF D+ RLNIMIDVA ALEYLHH + VVHCDLKP
Sbjct: 1241 DFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVVHCDLKP 1300
Query: 420 SNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSY 479
+NILLD++MVAHV DFGI++LL E +S+ QT T+ TIGYMAPE+GS+G VS+K DV+SY
Sbjct: 1301 NNILLDDDMVAHVGDFGIARLLTE-TESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVFSY 1359
Query: 480 GILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF-FSARMDCLL 538
GI+L+E F RKKP DEMF G++ LK+WV ESL + ++ DANLLR E+ F+ ++ CL
Sbjct: 1360 GIMLMEVFARKKPMDEMFNGDLTLKSWV-ESLADSMIEVVDANLLRREDEDFATKLSCLS 1418
Query: 539 SIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573
SI LAL C + P++R+ MKD LKKI+ + L
Sbjct: 1419 SIMALALACTTDSPEERIDMKDVVVGLKKIKIELL 1453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 618 bits (1594), Expect = e-174, Method: Compositional matrix adjust.
Identities = 327/581 (56%), Positives = 428/581 (73%), Gaps = 10/581 (1%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G++Q+L+ L N L+GS PY+LC L+ L L L+ N L+G IP+CL ++ SLR L +
Sbjct: 469 LGKLQELK---LHYNRLEGSFPYELCDLQSLAYLYLEVNALSGQIPSCLGNVNSLRTLSM 525
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
NK +S+IPS LW L IL +NLSSN L+GSL DI N+K + +DLS NQLSG IP +
Sbjct: 526 GMNKFSSTIPSTLWRLADILELNLSSNSLSGSLAVDIGNLKAVTLIDLSGNQLSGHIPSS 585
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
I GLK L NLSLA N+ +G IP+ FG ISL+ LDLS+NNLS IPKSL L +L FNV
Sbjct: 586 IGGLKTLLNLSLAVNRLEGSIPQLFGDAISLQLLDLSNNNLSGEIPKSLEELRYLTYFNV 645
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCKEDKNKGFKKVALLVLKY-I 239
S N L+GEIP F N SA+SF N LCG +LQV PC+ ++G K + L L+Y +
Sbjct: 646 SFNELQGEIPNGRAFINLSAKSFMGNKGLCGAAKLQVQPCETSTHQGSKAASKLALRYGL 705
Query: 240 FPPIICVVLIALVFIFFLRRRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLL 299
+ ++ +A V I F+R R R+ + E L LAT +R SY +LE+ATD FNE NLL
Sbjct: 706 MATGLTILAVAAVAIIFIRSRKRNMRI--TEGLLPLATLKRISYRELEQATDKFNEMNLL 763
Query: 300 GSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC--C 357
G G FGSVYKG SDG++VA+K+FNLQ+E AF+SF+ ECEVLR +RHRNL+KI++SC
Sbjct: 764 GRGSFGSVYKGTFSDGSSVAVKVFNLQVEGAFKSFDVECEVLRMIRHRNLVKIITSCSDI 823
Query: 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
N +FKALVLEFMPN SL+KWL S +F ++ +RLNIM+DVA A+EYLHHG++ P+VHCDL
Sbjct: 824 NIDFKALVLEFMPNYSLEKWLCSPKHFLELLERLNIMLDVASAVEYLHHGYAMPIVHCDL 883
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
KPSNILLDENMVAHV+DFGI+KLLG+ + S IQT+T+AT+GYMAPE+GSEG VS+ D+Y
Sbjct: 884 KPSNILLDENMVAHVTDFGIAKLLGD-EHSFIQTITLATVGYMAPEYGSEGVVSTGGDIY 942
Query: 478 SYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR-EENFFSARMDC 536
S+GILL+ETFTRKKPTD+MF E+++K WV+ES+P G+ +I D +LLR EE FSA+ DC
Sbjct: 943 SFGILLMETFTRKKPTDDMFNEEISMKQWVQESVPGGVTQITDPDLLRIEEQHFSAKKDC 1002
Query: 537 LLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDAN 577
+LS+ +AL C A+LP++R ++D L + KFL+D N
Sbjct: 1003 ILSVMQVALQCSADLPEERPNIRDVLNTLNHTKVKFLKDIN 1043
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 616 bits (1589), Expect = e-174, Method: Compositional matrix adjust.
Identities = 316/575 (54%), Positives = 415/575 (72%), Gaps = 6/575 (1%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+GR+++LQ + + N L+GSIP DLC LK L L L NKL+GSIP+C L +L+EL L
Sbjct: 658 LGRLKKLQKLHIVGNRLRGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALQELFL 717
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+SN L +IP++LW+L +L +NLSSN+LTG+L ++ NMK + LDLS+N +SG IP+
Sbjct: 718 DSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGHIPRK 777
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+ ++L LSL+ N+ QGPIP FG L+SLESLDLS NNLS IPKSL AL +LK NV
Sbjct: 778 MGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNV 837
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCKEDKNKGFKKVALLVLKYIF 240
S N+L+GEIP GPF NF+A+SF +N ALCG QV C ++ K +LKYI
Sbjct: 838 SLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYIL 897
Query: 241 PPIICVVLIALVFIFFLRRR-NRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLL 299
P+ +V + + + ++RRR N +P D L T + S+ L AT+ F E NL+
Sbjct: 898 LPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWL--PGTHEKISHQQLLYATNDFGEDNLI 955
Query: 300 GSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT 359
G G G VYKG+LS+G TVAIK+FNL+ + A RSF+SECEV++ +RHRNL++I++ C N
Sbjct: 956 GKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNL 1015
Query: 360 NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKP 419
+FKALVLE+MPNGSL+KWLYSHNYF D+ RLNIMIDVA ALEYLHH S+ VVHCDLKP
Sbjct: 1016 DFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKP 1075
Query: 420 SNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSY 479
+N+LLD++MVAHV+DFGI+KLL + +S+ QT T+ TIGYMAPE GS+G VS+K DVYSY
Sbjct: 1076 NNVLLDDDMVAHVADFGITKLLTK-TESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSY 1134
Query: 480 GILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF-FSARMDCLL 538
GILL+E F+RKKP DEMFTG++ LK WV ESL + + ++ DANLLR E+ + ++ CL
Sbjct: 1135 GILLMEVFSRKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDANLLRREDEDLATKLSCLS 1193
Query: 539 SIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573
SI LAL C + P++RL MKDA +LKK R K L
Sbjct: 1194 SIMALALACTTDSPEERLNMKDAVVELKKSRMKLL 1228
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147769371|emb|CAN72496.1| hypothetical protein VITISV_010511 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1578), Expect = e-172, Method: Compositional matrix adjust.
Identities = 314/575 (54%), Positives = 412/575 (71%), Gaps = 6/575 (1%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+GR+Q+LQ + +A N ++GSIP DLC LK L L L NKL+GSIP+C L +L+EL L
Sbjct: 670 LGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLHLXSNKLSGSIPSCFGDLPALQELFL 729
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+SN L +IP++LW+L +L +NLSSN+LTG+L ++ NMK + LDLS+N +SG IP+
Sbjct: 730 DSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPRR 789
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+ ++L LSL+ N+ QGPIP FG L+SLESLDLS NNLS IPKSL AL +LK NV
Sbjct: 790 MGEQQNLAKLSLSQNRLQGPIPXEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNV 849
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCKEDKNKGFKKVALLVLKYIF 240
S N+L+GEIP GPF NF+A+SF +N ALCG QV C ++ K +LKYI
Sbjct: 850 SSNKLQGEIPNGGPFXNFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYIL 909
Query: 241 PPIICVVLIALVFIFFLRRR-NRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLL 299
P+ + + + + ++RRR N +P D L T + S+ L AT+ F E NL+
Sbjct: 910 LPVGSTITLVVFIVLWIRRRDNMEIXTPIDSWL--PGTHEKISHQQLLYATNDFGEDNLI 967
Query: 300 GSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT 359
G G G VYKG+LS+G VAIK+FNL+ + A RSF+SECEV++ +RHRNL++I++ C N
Sbjct: 968 GKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNL 1027
Query: 360 NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKP 419
+FKALVL++MPNGSL+KWLYSHNYF D+ RLNIMIDVA ALEYLHH S+ VVHCDLKP
Sbjct: 1028 DFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKP 1087
Query: 420 SNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSY 479
SN+LLD+BMVAHV+DFGI+KLL + +S+ QT T+ TIGYMAPE GS+G VS+K DVYSY
Sbjct: 1088 SNVLLDDBMVAHVTDFGIAKLLTK-TESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSY 1146
Query: 480 GILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF-FSARMDCLL 538
GILL+E F RKKP DEMFTG++ LK WV ESL + + ++ D NLLR E+ + ++ CL
Sbjct: 1147 GILLMEVFARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDEDLATKLSCLS 1205
Query: 539 SIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573
SI LAL C + P++RL MKDA +LKK R K L
Sbjct: 1206 SIMALALACTNDSPEERLDMKDAVVELKKSRMKLL 1240
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 581 | ||||||
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.621 | 0.357 | 0.407 | 8.6e-97 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.617 | 0.355 | 0.413 | 1.1e-92 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.616 | 0.354 | 0.409 | 1.5e-92 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.895 | 0.507 | 0.392 | 5.3e-88 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.982 | 0.486 | 0.346 | 6e-87 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.611 | 0.344 | 0.392 | 3.1e-83 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.648 | 0.367 | 0.376 | 3.1e-61 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.896 | 0.531 | 0.374 | 1.5e-81 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.480 | 0.234 | 0.373 | 1.3e-73 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.554 | 0.282 | 0.321 | 5.3e-70 |
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 712 (255.7 bits), Expect = 8.6e-97, Sum P(2) = 8.6e-97
Identities = 161/395 (40%), Positives = 244/395 (61%)
Query: 212 PQRLQVPPCKEDKNKGFKKVALLVLKYIFPPIICVVLIALVFIFFLRRR-NRSTKS--PD 268
P Q PP + + KKVA+LV I ++ +V+ ++V +F +RR N+ T + P
Sbjct: 624 PCLAQEPPVETKHSSHLKKVAILVSIGI-ALLLLLVIASMVLCWFRKRRKNQQTNNLVPS 682
Query: 269 DEELFSLATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQL 327
E+F + SY DL AT+GF+ N++GSG FG+V+K +L ++ VA+K+ N+Q
Sbjct: 683 KLEIFH----EKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQR 738
Query: 328 EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF-----KALVLEFMPNGSLDKWLYSHN 382
A +SF +ECE L++ RHRNL+K+L++C +T+F +AL+ E++PNGS+D WL+
Sbjct: 739 RGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEE 798
Query: 383 YFQ--------DIPDRLNIMIDVALALEYLH-HGHSTPVVHCDLKPSNILLDENMVAHVS 433
+ + +RLNI+IDVA L+YLH H H P+ HCDLKPSN+LL++++ AHVS
Sbjct: 799 VEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHE-PIAHCDLKPSNVLLEDDLTAHVS 857
Query: 434 DFGISKLLGEGD-DSVIQTMTIA----TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
DFG+++LL + D +S + ++ A TIGY APE+G G S DVYS+G+LLLE FT
Sbjct: 858 DFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFT 917
Query: 489 RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR---EENFFSARMDCLLSIFHLAL 545
K+PTDE+F G + L ++ K +LP + +IAD +L F +A +CL + + L
Sbjct: 918 GKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIGLRVGFRTA--ECLTLVLEVGL 975
Query: 546 DCCAELPDQRLYMKDAATKLKKIRDKFLEDANTLR 580
CC E P RL + A +L IR++F + T R
Sbjct: 976 RCCEEYPTNRLATSEVAKELISIRERFFKTRRTPR 1010
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 701 (251.8 bits), Expect = 1.1e-92, Sum P(2) = 1.1e-92
Identities = 160/387 (41%), Positives = 237/387 (61%)
Query: 216 QVPPCKEDKNKGFKKVALLVLKYIFPPIICVVLIALVFIFFLRRRNRSTKSPDDEELFSL 275
Q PP + KKVA+ V I ++L+ +V + + ++R + K ++ F+L
Sbjct: 628 QAPPVETRHPSLLKKVAIGVSV----GIALLLLLFIVSLSWFKKRKNNQKI-NNSAPFTL 682
Query: 276 ATWR-RTSYLDLERATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRS 333
+ + SY DL ATDGF+ N++GSG FG+V+K +L ++ VA+K+ N+Q A +S
Sbjct: 683 EIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKS 742
Query: 334 FNSECEVLRNVRHRNLIKILSSCCNTNF-----KALVLEFMPNGSLDKWLYS------HN 382
F +ECE L+++RHRNL+K+L++C + +F +AL+ EFMPNGSLDKWL+ H
Sbjct: 743 FMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHR 802
Query: 383 YFQDIP--DRLNIMIDVALALEYLH-HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439
+ + +RLNI IDVA L+YLH H H P+ HCDLKPSNILLD+++ AHVSDFG+++
Sbjct: 803 PSRTLTLLERLNIAIDVASVLDYLHVHCHE-PIAHCDLKPSNILLDDDLTAHVSDFGLAR 861
Query: 440 LLGEGD-DSVIQTMTIA----TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTD 494
LL + D +S ++ A TIGY APE+G G S DVYS+G+L+LE FT K+PT+
Sbjct: 862 LLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTN 921
Query: 495 EMFTGEMNLKNWVKESLPHGLPKIADANLLREE-NFFSARMDCLLSIFHLALDCCAELPD 553
E+F G L ++ K +LP + IAD ++L ++CL I + L CC E P
Sbjct: 922 ELFGGNFTLNSYTKAALPERVLDIADKSILHSGLRVGFPVLECLKGILDVGLRCCEESPL 981
Query: 554 QRLYMKDAATKLKKIRDKFLEDANTLR 580
RL +AA +L IR++F + T R
Sbjct: 982 NRLATSEAAKELISIRERFFKTRRTAR 1008
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 690 (248.0 bits), Expect = 1.5e-92, Sum P(2) = 1.5e-92
Identities = 158/386 (40%), Positives = 233/386 (60%)
Query: 216 QVPPCKEDKNKGFKKVALLVLKYIFPPIICVVLIALVFIFFLRRR--NRSTKSPDDEELF 273
Q P + + KKV + V I ++ ++ +A V + +LR+R N+ T +P L
Sbjct: 627 QAPSVVKKHSSRLKKVVIGVSVGI--TLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLE 684
Query: 274 SLATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFR 332
L + SY DL AT+GF+ N++GSG FG+VYK +L ++ VA+K+ N+Q A +
Sbjct: 685 VLH--EKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMK 742
Query: 333 SFNSECEVLRNVRHRNLIKILSSCCNTNF-----KALVLEFMPNGSLDKWLYS------H 381
SF +ECE L+++RHRNL+K+L++C + +F +AL+ EFMPNGSLD WL+ H
Sbjct: 743 SFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIH 802
Query: 382 NYFQDIP--DRLNIMIDVALALEYLH-HGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438
+ + +RLNI IDVA L+YLH H H P+ HCDLKPSN+LLD+++ AHVSDFG++
Sbjct: 803 RPSRTLTLLERLNIAIDVASVLDYLHVHCHE-PIAHCDLKPSNVLLDDDLTAHVSDFGLA 861
Query: 439 KLLGEGDD-SVIQTMTIA----TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPT 493
+LL + D+ S ++ A TIGY APE+G G S DVYS+GILLLE FT K+PT
Sbjct: 862 RLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPT 921
Query: 494 DEMFTGEMNLKNWVKESLPHGLPKIADANLLREE-NFFSARMDCLLSIFHLALDCCAELP 552
+E+F G L ++ K +LP + I D ++L ++CL +F + L CC E P
Sbjct: 922 NELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVGLRCCEESP 981
Query: 553 DQRLYMKDAATKLKKIRDKFLEDANT 578
RL +L IR++F + + T
Sbjct: 982 MNRLATSIVVKELISIRERFFKASRT 1007
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 879 (314.5 bits), Expect = 5.3e-88, P = 5.3e-88
Identities = 218/556 (39%), Positives = 313/556 (56%)
Query: 1 MGRMQQLQGIGLA-DNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELR 59
+GR++ L GI LA +N+L GSIP + L LN L L NK +G IP L++LT+L L
Sbjct: 420 LGRLKNL-GILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLG 478
Query: 60 LNSNKLTSSIPSALWALEYI-LYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIP 118
L++N L+ IPS L+ ++ + + +N+S N L GS+ +I ++K L++ N+LSG IP
Sbjct: 479 LSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIP 538
Query: 119 KTIAGLKDLTNLSLAGNQFQGPIPESFGXXXXXXXXXXXXXXXXXGIPKSLVALSHLKQF 178
T+ + L L L N G IP + G IP SL ++ L
Sbjct: 539 NTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSL 598
Query: 179 NVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCG--PQRLQVPPCKE--DKNKGFKKVALL 234
N+S N GE+PT G F S S N LCG P L +P C + K F + +
Sbjct: 599 NLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPD-LHLPRCCPLLENRKHFPVLPIS 657
Query: 235 VLKYIFPPIICVVLIALVFIFFLRRRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFN 294
V + L L ++ L ++ TK S+ SY L +ATDGF
Sbjct: 658 VS-------LAAALAILSSLYLLITWHKRTKKGAPSRT-SMKGHPLVSYSQLVKATDGFA 709
Query: 295 ECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILS 354
NLLGSG FGSVYKG L+ VA+K+ L+ +A +SF +ECE LRN+RHRNL+KI++
Sbjct: 710 PTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVT 769
Query: 355 SCCN-----TNFKALVLEFMPNGSLDKWLYSHNYFQ------DIPDRLNIMIDVALALEY 403
C + +FKA+V +FMPNGSL+ W++ Q ++ R+ I++DVA AL+Y
Sbjct: 770 ICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDY 829
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-----IATIG 458
LH PVVHCD+K SN+LLD +MVAHV DFG++++L +G S+IQ T I TIG
Sbjct: 830 LHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGT-SLIQQSTSSMGFIGTIG 888
Query: 459 YMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG-LPK 517
Y APE+G S+ D+YSYGIL+LE T K+PTD F ++ L+ +V+ L HG +
Sbjct: 889 YAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGL-HGRVTD 947
Query: 518 IADANLLRE-ENFFSA 532
+ D L+ + EN+ ++
Sbjct: 948 VVDTKLILDSENWLNS 963
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 869 (311.0 bits), Expect = 6.0e-87, P = 6.0e-87
Identities = 208/600 (34%), Positives = 334/600 (55%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIP-TCLASLTSLR-ELRL 60
+++ L + L N GSIP L L LN+ + N L G+IP LASL +++ L
Sbjct: 573 KLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNF 632
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
++N LT +IP L LE + ++LS+N +GS+ +Q K + LD S+N LSG IP
Sbjct: 633 SNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDE 692
Query: 121 I-AGLKDLTNLSLAGNQFQGPIPESFGXXXXXXXXXXXXXXXXXGIPKSLVALSHLKQFN 179
+ G+ + +L+L+ N F G IP+SFG IP+SL LS LK
Sbjct: 693 VFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLK 752
Query: 180 VSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCK-EDKNKGFKK---VALLV 235
++ N L+G +P G F+N +A N LCG ++ + PC + K+ F K V L++
Sbjct: 753 LASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILII 811
Query: 236 LKYIFPPIICVVLIALVFIFFLRRRNRSTKSPDDE--ELFSLATWRRTSYLDLERATDGF 293
L ++ V+L+ L+ ++ + S + +L S +R +LE+ATD F
Sbjct: 812 LGSA-AALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSF 870
Query: 294 NECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIK 351
N N++GS +VYKG L DGT +A+K+ NL+ ++ + F +E + L ++HRNL+K
Sbjct: 871 NSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVK 930
Query: 352 ILSSCCNTN-FKALVLEFMPNGSLDKWLY-SHNYFQDIPDRLNIMIDVALALEYLHHGHS 409
IL + KALVL FM NG+L+ ++ S + +++++ + +A ++YLH G+
Sbjct: 931 ILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYG 990
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA---TIGYMAPEFGS 466
P+VHCDLKP+NILLD + VAHVSDFG +++LG +D T A TIGY+APEF
Sbjct: 991 FPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAY 1050
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKPT--DEMFTGEMNLKNWVKESLPHG---LPKIADA 521
V++K DV+S+GI+++E T+++PT ++ + +M L+ V++S+ +G + ++ D
Sbjct: 1051 MRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDM 1110
Query: 522 NLLREENFFSARMDCLLSIF-HLALDCCAELPDQRLYMKDAATKLKKIRDK---FLEDAN 577
L ++ S + + + F L L C + P+ R M + T L K+R K F ED N
Sbjct: 1111 EL--GDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLRGKANSFREDRN 1168
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 625 (225.1 bits), Expect = 3.1e-83, Sum P(2) = 3.1e-83
Identities = 153/390 (39%), Positives = 219/390 (56%)
Query: 212 PQRLQVPPCKEDKNKGFKKVALLVLKYIFPPIICVVLIALVFIFFLRRR--NRSTKSPDD 269
P +Q P K KKV + I ++ ++++A + F R++ N S +P D
Sbjct: 631 PCIVQASPRKRKPLSVRKKVVSGICIGI-ASLLLIIIVASLCWFMKRKKKNNASDGNPSD 689
Query: 270 EELFSLATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE 328
+ + SY +L AT F+ NL+GSG FG+V+KG+L + VA+K+ NL
Sbjct: 690 STTLGMFH-EKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKH 748
Query: 329 QAFRSFNSECEVLRNVRHRNLIKILSSCCN-----TNFKALVLEFMPNGSLDKWLY---- 379
A +SF +ECE + +RHRNL+K+++ C + +F+ALV EFMP GSLD WL
Sbjct: 749 GATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDL 808
Query: 380 ----SHNYFQDIPDRLNIMIDVALALEYLH-HGHSTPVVHCDLKPSNILLDENMVAHVSD 434
H+ ++LNI IDVA ALEYLH H H PV HCD+KPSNILLD+++ AHVSD
Sbjct: 809 ERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHD-PVAHCDIKPSNILLDDDLTAHVSD 867
Query: 435 FGISKLLGEGD-DSVIQTMTIA----TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTR 489
FG+++LL + D +S + + A TIGY APE+G G S + DVYS+GILLLE F+
Sbjct: 868 FGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSG 927
Query: 490 KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCA 549
KKPTDE F G+ NL ++ K S+ G +N + E R+ + + + C
Sbjct: 928 KKPTDESFAGDYNLHSYTK-SILSGCTSSGGSNAIDE----GLRL-----VLQVGIKCSE 977
Query: 550 ELPDQRLYMKDAATKLKKIRDKFLEDANTL 579
E P R+ +A +L IR KF T+
Sbjct: 978 EYPRDRMRTDEAVRELISIRSKFFSSKTTI 1007
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 633 (227.9 bits), Expect = 3.1e-61, P = 3.1e-61
Identities = 148/393 (37%), Positives = 220/393 (55%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G + +L+ + L N L G IP L + L L L N GSIP+ L S + L +L L
Sbjct: 421 LGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNL 480
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+NKL SIP L L ++ +N+S N L G L DI +K L+ LD+S N+LSG IP+T
Sbjct: 481 GTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQT 540
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGXXXXXXXXXXXXXXXXXGIPKSLVALSHLKQFNV 180
+A L L L GN F GPIP+ G IP+ + S L+ N+
Sbjct: 541 LANCLSLEFLLLQGNSFVGPIPDIRGLTGLRFLDLSKNNLSGT-IPEYMANFSKLQNLNL 599
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCGP-QRLQVPPCKED---KNKGFKKVALLVL 236
S N +G +PTEG FRN SA S N LCG LQ+ PC + ++ +K+ + +
Sbjct: 600 SLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICV 659
Query: 237 KYIFPPIICVVLIALVFIFFLRRRNRSTKSPDDEE--LFS--LATWRRTSYLDLERATDG 292
+ ++ + L +V++ + + R +S ++ ++E FS + + + SY +L + T G
Sbjct: 660 SAVMAALLLLCL-CVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGG 718
Query: 293 FNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIK 351
F+ NL+GSG FG+V+KG L S VAIK+ NL A +SF +ECE L +RHRNL+K
Sbjct: 719 FSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVK 778
Query: 352 ILSSCCNTNF-----KALVLEFMPNGSLDKWLY 379
+++ C +++F +ALV EFMPNG+LD WL+
Sbjct: 779 LVTICSSSDFEGNDFRALVYEFMPNGNLDMWLH 811
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 818 (293.0 bits), Expect = 1.5e-81, P = 1.5e-81
Identities = 205/547 (37%), Positives = 298/547 (54%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G + +L + ++ N+L GSIP L +L L L GN L+G++P L +L L L
Sbjct: 365 LGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDL 424
Query: 61 NSNKLTSSIPSALWA-LEYI-LYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIP 118
+ N LT +IP + + L + LY+NLSSN+L+G + ++ M +++ +DLS N+LSG IP
Sbjct: 425 SHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIP 484
Query: 119 KTIAGLKDLTNLSLAGNQFQGPIPESFGXXXXXXXXXXXXXXXXXGIPKSLVALSHLKQF 178
+ L +L+L+ N F +P S G IP S S LK
Sbjct: 485 PQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHL 544
Query: 179 NVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCKEDKNKGFKKVAL-LVLK 237
N S N L G + +G F + +SF + LCG + + CK+ K+K + V L ++L
Sbjct: 545 NFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACKK-KHK-YPSVLLPVLLS 601
Query: 238 YIFPPIICVVLIALV--FIFFLRRRNRSTKSPDDEELFSL--ATWRRTSYLDLERATDGF 293
I P++CV LV F + + +DEE + + R SY L AT GF
Sbjct: 602 LIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGF 661
Query: 294 NECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFR-SFNSECEVLRNVRHRNLIKI 352
N +L+GSG FG VYKG+L + T VA+K+ + + F SF EC++L+ RHRNLI+I
Sbjct: 662 NASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRI 721
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ---DIPDRLNIMIDVALALEYLHHGHS 409
+++C F ALVL MPNGSL++ LY Y D+ +NI DVA + YLHH
Sbjct: 722 ITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSP 781
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG-------DDSV----IQTMTIATIG 458
VVHCDLKPSNILLD+ M A V+DFGIS+L+ +G DDSV + ++G
Sbjct: 782 VKVVHCDLKPSNILLDDEMTALVTDFGISRLV-QGVEETVSTDDSVSFGSTDGLLCGSVG 840
Query: 459 YMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518
Y+APE+G S+ DVYS+G+LLLE + ++PTD + +L ++K P L I
Sbjct: 841 YIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGI 900
Query: 519 ADANLLR 525
+ L R
Sbjct: 901 IEQALSR 907
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 463 (168.0 bits), Expect = 1.3e-73, Sum P(2) = 1.3e-73
Identities = 108/289 (37%), Positives = 157/289 (54%)
Query: 285 DLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV 344
D+ ATD F++ N++G GGFG+VYK L TVA+K + Q R F +E E L V
Sbjct: 909 DIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKV 968
Query: 345 RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPD---RLNIMIDVALAL 401
+H NL+ +L C + K LV E+M NGSLD WL + ++ D RL I + A L
Sbjct: 969 KHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGL 1028
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 461
+LHHG ++H D+K SNILLD + V+DFG+++L+ +S + T+ T GY+
Sbjct: 1029 AFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLIS-ACESHVSTVIAGTFGYIP 1087
Query: 462 PEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM--NLKNWVKESLPHGLPKIA 519
PE+G ++K DVYS+G++LLE T K+PT F NL W + + G K
Sbjct: 1088 PEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQG--KAV 1145
Query: 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
D ++ A + L + +A+ C AE P +R M D LK+I
Sbjct: 1146 D--VIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 459 (166.6 bits), Expect = 5.3e-70, Sum P(2) = 5.3e-70
Identities = 110/342 (32%), Positives = 181/342 (52%)
Query: 244 ICVVLIALVFIFFLRRRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNEC----NLL 299
+ VVL+ L + +R R R+ + D EL W+ T + L + D C N++
Sbjct: 734 LTVVLMILGAVAVIRAR-RNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVI 792
Query: 300 GSGGFGSVYKGILSDGTTVAIK-----IFNLQLEQAFR----SFNSECEVLRNVRHRNLI 350
G G G VY+ + +G +A+K + N ++ + SF++E + L +RH+N++
Sbjct: 793 GKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIV 852
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ-DIPDRLNIMIDVALALEYLHHGHS 409
+ L C N N + L+ ++MPNGSL L+ D R I++ A L YLHH
Sbjct: 853 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCL 912
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGN 469
P+VH D+K +NIL+ + +++DFG++KL+ EGD + GY+APE+G
Sbjct: 913 PPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMK 972
Query: 470 VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529
++ K DVYSYG+++LE T K+P D ++L +WV+++ G ++ D+ L R
Sbjct: 973 ITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQN--RGSLEVLDSTL-RSRT- 1028
Query: 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571
A D ++ + AL C PD+R MKD A LK+I+ +
Sbjct: 1029 -EAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLKEIKQE 1069
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00110705 | hypothetical protein (1061 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 581 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-56 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-37 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-34 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-27 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 8e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.003 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.003 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 205 bits (522), Expect = 1e-56
Identities = 152/580 (26%), Positives = 261/580 (45%), Gaps = 44/580 (7%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G + L+ + L DN G +P + +L + L + N L G I + + SL+ L L
Sbjct: 400 LGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL 459
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
NK +P + + + + ++LS N +G++ + ++ L+ L LS N+LSG+IP
Sbjct: 460 ARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDE 518
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
++ K L +L L+ NQ G IP SF + L LDLS N LS IPK+L + L Q N+
Sbjct: 519 LSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQ-VPPCKEDKNKGFKKVALLVLKYI 239
SHN L G +P+ G F +A + N LCG +PPCK + +
Sbjct: 579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK---TPSWWFYITCT 635
Query: 240 FPPIICVVLIALVFIFFLRRRNRSTKSPDDEELFSLATW-------RRTSYLDLERATDG 292
+ + L+A F+F R N K ++E+ TW + + + +
Sbjct: 636 LGAFLVLALVAFGFVFIRGRNNLELKRVENED----GTWELQFFDSKVSKSITINDILSS 691
Query: 293 FNECNLLGSGGFGSVYKG-ILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIK 351
E N++ G G+ YKG + +G +K N + S ++ + ++H N++K
Sbjct: 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVK 747
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
++ C + L+ E++ +L + L + ++ + R I I +A AL +LH S
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWER----RRKIAIGIAKALRFLHCRCSPA 803
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVS 471
VV +L P I++D H+ + LL T + Y+APE +++
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLL------CTDTKCFISSAYVAPETRETKDIT 856
Query: 472 SKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES-----LPHGLPKIADANLLRE 526
K D+Y +G++L+E T K P D F ++ W + L + ++
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916
Query: 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566
+N ++ + +LAL C A P R D L+
Sbjct: 917 QNE-------IVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-48
Identities = 70/199 (35%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSS 355
LGSG FG+VYK G VA+KI + + ++ E +LR + H N+++++ +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHC 415
+ + LV+E+ G L +L + I + + LEYLH S ++H
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLH---SNGIIHR 122
Query: 416 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--FGSEGNVSSK 473
DLKP NILLDEN V ++DFG++K L + S T + T YMAPE G G K
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNG-YGPK 179
Query: 474 CDVYSYGILLLETFTRKKP 492
DV+S G++L E T K P
Sbjct: 180 VDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 5e-47
Identities = 68/191 (35%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFR-SFNSECEVLRNVRHRNLIKILSSC 356
LG GGFG+VY G VAIKI + + E E+L+ + H N++K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCD 416
+ N LV+E+ GSL L + + L I++ + LEYL HS ++H D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRD 117
Query: 417 LKPSNILLDE-NMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-FGSEGNVSSKC 474
LKP NILLD N ++DFG+SKLL + + T YMAPE +G S K
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 475 DVYSYGILLLE 485
D++S G++L E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 1e-46
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 297 NLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFR-SFNSECEVLRNVRHRNLIKILS 354
LG G FG VY G VAIK+ + + R E ++L+ ++H N++++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHSTPVV 413
+ + LV+E+ G L L + + + ALEYLH G +V
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRL-SEDEARFYLRQILSALEYLHSKG----IV 119
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSK 473
H DLKP NILLDE+ ++DFG+++ L G+ T + T YMAPE
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYMAPEVLLGKGYGKA 176
Query: 474 CDVYSYGILLLETFTRKKPTDEMFTGEMNLK 504
D++S G++L E T K P F G+ L
Sbjct: 177 VDIWSLGVILYELLTGKPP----FPGDDQLL 203
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 87/264 (32%), Positives = 125/264 (47%), Gaps = 29/264 (10%)
Query: 299 LGSGGFGSVYKGIL-----SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKI 352
LG G FG VYKG L T VA+K E+ F E +++ + H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
L C +V E+MP G L +L H + D L + + +A +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL---ESKNF 123
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
VH DL N L+ EN+V +SDFG+S+ + E D + I +MAPE +G +S
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 473 KCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531
K DV+S+G+LL E FT ++P + G N + V E L G L R EN
Sbjct: 184 KSDVWSFGVLLWEIFTLGEQP----YPGMSNEE--VLELLEDGYR------LPRPEN--- 228
Query: 532 ARMDCLLSIFHLALDCCAELPDQR 555
C ++ L L C A P+ R
Sbjct: 229 ----CPDELYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 8e-43
Identities = 82/274 (29%), Positives = 121/274 (44%), Gaps = 30/274 (10%)
Query: 299 LGSGGFGSVYKGILSD-----GTTVAIKIFNL-QLEQAFRSFNSECEVLRNVRHRNLIKI 352
LG G FG VYKG L VA+K EQ F E ++R + H N++K+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
L C +V+E+M G L +L + + D L+ + +A +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
+H DL N L+ EN+V +SDFG+S+ L + DD + I +MAPE EG +S
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYRKRGGKLPIRWMAPESLKEGKFTS 182
Query: 473 KCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531
K DV+S+G+LL E FT ++P G+ L+
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQP-------------------YPGMSNEEVLEYLKNGYRLP 223
Query: 532 ARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565
+C ++ L L C AE P+ R + L
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-41
Identities = 83/275 (30%), Positives = 122/275 (44%), Gaps = 31/275 (11%)
Query: 299 LGSGGFGSVYKGILSDG-----TTVAIKIFNL-QLEQAFRSFNSECEVLRNVRHRNLIKI 352
LG G FG VYKG L VA+K EQ F E ++R + H N++K+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWL-YSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
L C +V+E+MP G L +L + + D L+ + +A +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVS 471
+H DL N L+ EN+V +SDFG+S+ L + DD I +MAPE EG +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 472 SKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFF 530
SK DV+S+G+LL E FT ++P G+ L++
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEP-------------------YPGMSNAEVLEYLKKGYRL 223
Query: 531 SARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565
+C ++ L L C AE P+ R + L
Sbjct: 224 PKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 5e-40
Identities = 81/289 (28%), Positives = 123/289 (42%), Gaps = 46/289 (15%)
Query: 297 NLLGSGGFGSVYKGILSDG----TTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIK 351
LG G FG VYKG L T VA+K E+ + F E V++ + H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 352 ILSSCCNTNFK-ALVLEFMPNGSLDKWL------YSHNYFQDIP--DRLNIMIDVALALE 402
+L C LVLE+M G L +L + + D L+ I +A +E
Sbjct: 61 LLG-VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
YL S VH DL N L+ E++V +SDFG+S+ + + D +T I +MAP
Sbjct: 120 YLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 463 EFGSEGNVSSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521
E +G +SK DV+S+G+LL E FT P + E+ L +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-------------LEYLRKG 223
Query: 522 NLLREENFFSARMD----CLLSIFHLALDCCAELPDQRLYMKDAATKLK 566
R+ C ++ L L C P+ R + +L+
Sbjct: 224 Y----------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 297 NLLGSGGFGSVYKGILSD-GTTVAIK--IFNLQLEQAFRSFNSECEVLRNVRHRNLIKIL 353
LLG G FGSVY + D G +A+K + E+ + E +L +++H N+++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 354 SSCCNTNFKAL--VLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALEYLH-HGH 408
S + L LE++ GSL L F +P+ + + L YLH +G
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG- 121
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG 468
+VH D+K +NIL+D + V ++DFG +K LG+ + T +MAPE
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 469 NVSSKCDVYSYGILLLETFTRKKP 492
D++S G ++E T K P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 9e-34
Identities = 79/190 (41%), Positives = 109/190 (57%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+ + L+ + LA N L G IP +L Q+K L + L N L+G IP + LTSL L L
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
N LT IPS+L L+ + Y+ L N L+G + I +++ LI LDLS N LSG+IP+
Sbjct: 244 VYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL 303
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+ L++L L L N F G IP + SL L+ L L SN S IPK+L ++L ++
Sbjct: 304 VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDL 363
Query: 181 SHNRLEGEIP 190
S N L GEIP
Sbjct: 364 STNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 73/190 (38%), Positives = 112/190 (58%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G+M+ L+ I L N+L G IPY++ L LN L L N L G IP+ L +L +L+ L L
Sbjct: 208 LGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFL 267
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
NKL+ IP ++++L+ ++ ++LS N L+G + + ++ L L L N +G IP
Sbjct: 268 YQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVA 327
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+ L L L L N+F G IP++ G +L LDLS+NNL+ IP+ L + +L + +
Sbjct: 328 LTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLIL 387
Query: 181 SHNRLEGEIP 190
N LEGEIP
Sbjct: 388 FSNSLEGEIP 397
|
Length = 968 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 70/216 (32%), Positives = 109/216 (50%), Gaps = 7/216 (3%)
Query: 287 ERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRH 346
ER + F LGSG FG V++G+ + VAIKI + F E + L+ +RH
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 347 RNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYS-HNYFQDIPDRLNIMIDVALALEYLH 405
++LI + + C ++ E M GSL +L S + +++ VA + YL
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFG 465
+S +H DL NIL+ E++V V+DFG+++L+ +D + + + APE
Sbjct: 122 EQNS---IHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAA 176
Query: 466 SEGNVSSKCDVYSYGILLLETFTRKK-PTDEMFTGE 500
S G S+K DV+S+GILL E FT + P M E
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 21/202 (10%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSS-C 356
+G GGFG VYK G VAIK+ L+ ++ +E ++L+ +H N++K S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN------IMIDVALALEYLHHGHST 410
+V+EF GSL L S N L + ++ LEYLH
Sbjct: 68 KKDELW-IVMEFCSGGSLKDLLKSTNQ------TLTESQIAYVCKELLKGLEYLHSNG-- 118
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNV 470
++H D+K +NILL + + DFG+S L + TM + T +MAPE +
Sbjct: 119 -IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR--NTM-VGTPYWMAPEVINGKPY 174
Query: 471 SSKCDVYSYGILLLETFTRKKP 492
K D++S GI +E K P
Sbjct: 175 DYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 15/202 (7%)
Query: 297 NLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKIL 353
+L+G G FG VYKG+ L G VAIK +L+ E+A +S E ++L+N++H N++K +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNI--MIDVALALEYLHHGHSTP 411
S ++ ++LE+ NGSL + + F P+ L + V L YLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPF---PESLVAVYVYQVLQGLAYLH---EQG 119
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEFGSEGNV 470
V+H D+K +NIL ++ V ++DFG++ + +D ++ T +MAPE
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA---TKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 471 SSKCDVYSYGILLLETFTRKKP 492
S+ D++S G ++E T P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-29
Identities = 75/189 (39%), Positives = 106/189 (56%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
G + L+ + L++N L G IP D+ L L L GN L G IP L +LTSL L L
Sbjct: 137 GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLA 196
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
SN+L IP L ++ + ++ L N L+G + +I + L LDL N L+G IP ++
Sbjct: 197 SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVS 181
LK+L L L N+ GPIP S SL L SLDLS N+LS IP+ ++ L +L+ ++
Sbjct: 257 GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLF 316
Query: 182 HNRLEGEIP 190
N G+IP
Sbjct: 317 SNNFTGKIP 325
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 297 NLLGSGGFGSVYKG-ILSDGTTVAIKIFNL-QLEQAFRSF-NSECEVLRNVRHRNLIKIL 353
+G G FG VY SDG +K +L + + R +E ++L+ + H N+IK
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK-- 63
Query: 354 SSCCNTNFKA-----LVLEFMPNGSLDKWLYSHN----YFQDIPDRLNIMIDVALALEYL 404
+F+ +V+E+ G L + + F + L+ + + LAL+YL
Sbjct: 64 ---YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE-EQILDWFVQLCLALKYL 119
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF 464
H ++H D+KP NI L N + + DFGISK+L + +T+ + T Y++PE
Sbjct: 120 HSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTV-VGTPYYLSPEL 174
Query: 465 GSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKN 505
+ K D++S G +L E T K P F GE NL
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGE-NLLE 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 66/196 (33%), Positives = 98/196 (50%), Gaps = 19/196 (9%)
Query: 298 LLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQ-AFRSFNSECEVLRNVRHRNLIKILSSC 356
+G G FG V G G VA+K L+ + A ++F +E V+ +RH NL+++L
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 357 CNTNFKALVLEFMPNGSLDKWLYS----HNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
N +V E+M GSL +L S +L +DV +EYL
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQ---QLGFALDVCEGMEYLE---EKNF 123
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
VH DL N+L+ E++VA VSDFG++K + S Q + + APE E S+
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFST 178
Query: 473 KCDVYSYGILLLETFT 488
K DV+S+GILL E ++
Sbjct: 179 KSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 292 GFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVRH-R 347
+ LG G FG VY D VA+K+ +LE + F E ++L ++ H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 348 NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN--IMIDVALALEYLH 405
N++K+ + LV+E++ GSL+ L + + I+ + ALEYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 406 HGHSTPVVHCDLKPSNILLDEN-MVAHVSDFGISKLLGEGDDSVIQTMT----IATIGYM 460
S ++H D+KP NILLD + V + DFG++KLL + + + T GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 461 APE---FGSEGNVSSKCDVYSYGILLLETFTRKKP 492
APE S SS D++S GI L E T P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 6e-28
Identities = 68/192 (35%), Positives = 99/192 (51%), Gaps = 4/192 (2%)
Query: 298 LLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFR-SFNSECEVLRNVRHRNLIKILSSC 356
+G G FG VYKG+L T VA+K L + F E E+L+ H N++K++ C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCD 416
+V+E +P GSL +L + L + +D A +EYL S +H D
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 417 LKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDV 476
L N L+ EN V +SDFG+S+ G +V + I + APE + G +S+ DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 477 YSYGILLLETFT 488
+SYGILL ETF+
Sbjct: 179 WSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 299 LGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRS-FNSECEVLRNVRHRNLIKILSSC 356
LG G G VYK G A+K ++ ++ FR E + LR+ ++K C
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 357 CNTNFK----ALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALEYLHHGHST 410
+K ++VLE+M GSL L IP+ + I + L+YLH
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRH- 120
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPE-FGSEG 468
++H D+KPSN+L++ ++DFGISK+L D Q T + T+ YM+PE E
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD---QCNTFVGTVTYMSPERIQGE- 175
Query: 469 NVSSKCDVYSYGILLLETFTRKKP 492
+ S D++S G+ LLE K P
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 76/284 (26%), Positives = 118/284 (41%), Gaps = 20/284 (7%)
Query: 297 NLLGSGGFGSVYKG---ILSDGTT--VAIKIFNLQLEQAFRS-FNSECEVLRNVRHRNLI 350
LG G FG V L D T VA+K N E+ RS F E E+LR + H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 351 KILSSCCNTNFKA---LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG 407
K C L++E++P+GSL +L H ++ L + ++YL
Sbjct: 70 K-YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 408 HSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD-SVIQTMTIATIGYMAPEFGS 466
+H DL NIL++ + +SDFG++K+L E D ++ + I + APE
Sbjct: 129 R---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD-ANLLR 525
SS DV+S+G+ L E FT P+ + + G + LL+
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL-----RMIGIAQGQMIVTRLLELLK 240
Query: 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569
E C ++ L C P R D + ++R
Sbjct: 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 77/294 (26%), Positives = 135/294 (45%), Gaps = 51/294 (17%)
Query: 299 LGSGGFGSVYKGIL------SDGTTVAIKIF----NLQLEQAFRSFNSECEVLRNVRHRN 348
LG G FG VYKG L T+VAIK +++Q FR E E++ +++H N
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ---EAELMSDLQHPN 69
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDI---------------PDRLNI 393
++ +L C ++ E++ +G L ++L ++ D+ D L+I
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 394 MIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT 453
I +A +EYL H VH DL N L+ E + +SDFG+S+ + D +Q+ +
Sbjct: 130 AIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 454 IATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH 513
+ + +M PE G +++ D++S+G++L E F+ L+ P+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS------------YGLQ-------PY 227
Query: 514 -GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566
G ++R DC ++ L ++C E+P +R KD T+L+
Sbjct: 228 YGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 85/290 (29%), Positives = 136/290 (46%), Gaps = 45/290 (15%)
Query: 284 LDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRN 343
L+L++ T G ++G G FG+V +G + G VA+K N++ + ++F E V+
Sbjct: 3 LNLQKLTLG----EIIGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTK 55
Query: 344 VRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ-DIPDRLNIMIDVALALE 402
+ H+NL+++L + +V+E M G+L +L + + L +DVA +E
Sbjct: 56 LHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
YL S +VH DL NIL+ E+ VA VSDFG++++ G D+ + + + AP
Sbjct: 115 YLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN-----SKLPVKWTAP 166
Query: 463 EFGSEGNVSSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521
E SSK DV+SYG+LL E F+ + P +M E VKE + G
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKECVEKGY------ 214
Query: 522 NLLREENFFSARMD----CLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567
RM+ C ++ L C P +R KL+K
Sbjct: 215 -----------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 81/290 (27%), Positives = 124/290 (42%), Gaps = 43/290 (14%)
Query: 299 LGSGGFGSVYKGILS------DGTTVAIKIF-NLQLEQAFRSFNSECEVLRNVRHRNLIK 351
LG G FG V+ G D VA+K A + F E E+L N +H N++K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHN---YFQDIPDR----------LNIMIDVA 398
C + +V E+M +G L+K+L SH F PD L I + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 399 LALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG 458
+ YL H VH DL N L+ ++V + DFG+S+ + D + T+ I
Sbjct: 133 SGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 459 YMAPEFGSEGNVSSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPK 517
+M PE +++ DV+S+G++L E FT K+P + E V E + G
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------VIECITQGRLL 243
Query: 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567
R C ++ + L C P QR+ +KD +L+K
Sbjct: 244 Q------RPR-------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 5e-26
Identities = 66/191 (34%), Positives = 100/191 (52%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G ++ LQ + L N L G IP + L++L SL L N L+G IP + L +L L L
Sbjct: 256 LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHL 315
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
SN T IP AL +L + + L SN +G + ++ L LDLS N L+G+IP+
Sbjct: 316 FSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEG 375
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+ +L L L N +G IP+S G+ SL + L N+ S +P L + ++
Sbjct: 376 LCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDI 435
Query: 181 SHNRLEGEIPT 191
S+N L+G I +
Sbjct: 436 SNNNLQGRINS 446
|
Length = 968 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 68/194 (35%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 298 LLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFR-SFNSECEVLRNVRHRNLIKILSSC 356
LLG G FG V+KG L D T VA+K L Q + F SE +L+ H N++K++ C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCD 416
+V+E +P G +L + +D A + YL S +H D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118
Query: 417 LKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATI--GYMAPEFGSEGNVSSKC 474
L N L+ EN V +SDFG+S+ + DD + + + I + APE + G SS+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 475 DVYSYGILLLETFT 488
DV+SYGILL ETF+
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 63/208 (30%), Positives = 90/208 (43%), Gaps = 18/208 (8%)
Query: 299 LGSGGFGSVYK-GILSDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRNLIKILS 354
LG G FG V G A+K+ + + +E +L + H ++K+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHSTPVV 413
+ LVLE+ P G L L F + R ++ LALEYLH G ++
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLHSLG----II 115
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEFGSEGNVSS 472
+ DLKP NILLD + ++DFG++K L +T T T Y+APE
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 473 KCDVYSYGILLLETFTRKKPTDEMFTGE 500
D +S G+LL E T K P F E
Sbjct: 173 AVDWWSLGVLLYEMLTGKPP----FYAE 196
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 64/187 (34%), Positives = 96/187 (51%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+Q+L + L+DN L G IP + QL+ L L L N G IP L SL L+ L+L SN
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
K + IP L + ++LS+N LTG + + + L L L N L G+IPK++
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
+ L + L N F G +P F L + LD+S+NNL I + L+ +++ N
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN 462
Query: 184 RLEGEIP 190
+ G +P
Sbjct: 463 KFFGGLP 469
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 62/194 (31%), Positives = 101/194 (52%), Gaps = 12/194 (6%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRS---FNSECEVLRNVRHRNLIKILSS 355
LG+G FG V+ G + T VA+K L+ S F E ++++ +RH L+++ +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKT----LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYS-HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
C +V E+M GSL +L S +P +++ +A + YL S +H
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIH 126
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKC 474
DL NIL+ EN+V ++DFG+++L+ E D+ + I + APE + G + K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 475 DVYSYGILLLETFT 488
DV+S+GILL E T
Sbjct: 186 DVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRS---FNSECEVLRNVRHRNLIKILSS 355
+GSG FG V+ G + VAIK + + S F E +V+ + H L+++
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIK----TIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHC 415
C + LV EFM +G L +L + L + +DV + YL S+ V+H
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHR 124
Query: 416 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCD 475
DL N L+ EN V VSDFG+++ + + D T T + + +PE S SSK D
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 476 VYSYGILLLETFTR-KKPTDEMFTGEM 501
V+S+G+L+ E F+ K P + E+
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 70/209 (33%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 299 LGSGGFGSVYKGI--LSDGT--TVAIKIF-NLQLEQAFRSFNSECEVLRNVRHRNLIKIL 353
LG G FGSV KG+ + G VA+K + + F E V+ + H +++++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVV 413
C LV+E P G L K+L D + VA+ + YL H V
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVS-DLKELAHQVAMGMAYLESKH---FV 117
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG-----YMAPEFGSEG 468
H DL N+LL A +SDFG+S+ LG G D T G + APE + G
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY----YRATTAGRWPLKWYAPECINYG 173
Query: 469 NVSSKCDVYSYGILLLETFTR-KKPTDEM 496
SSK DV+SYG+ L E F+ KP EM
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 65/187 (34%), Positives = 101/187 (54%), Gaps = 3/187 (1%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLT-SLRELRLNSNK 64
++ I L+ ++ G I + +L + +++L N+L+G IP + + + SLR L L++N
Sbjct: 70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNN 129
Query: 65 LTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGL 124
T SIP L +LS+N L+G + +DI + L LDL N L G IP ++ L
Sbjct: 130 FTGSIPRGSIPNLETL--DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187
Query: 125 KDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNR 184
L L+LA NQ G IP G + SL+ + L NNLS IP + L+ L ++ +N
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNN 247
Query: 185 LEGEIPT 191
L G IP+
Sbjct: 248 LTGPIPS 254
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 62/164 (37%), Positives = 90/164 (54%), Gaps = 3/164 (1%)
Query: 30 RLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEY-ILYVNLSSNY 88
R+ S+ L G ++G I + + L ++ + L++N+L+ IP ++ + Y+NLS+N
Sbjct: 70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNN 129
Query: 89 LTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSL 148
TGS+ ++ L LDLS N LSG+IP I L L L GN G IP S +L
Sbjct: 130 FTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187
Query: 149 ISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE 192
SLE L L+SN L IP+ L + LK + +N L GEIP E
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE 231
|
Length = 968 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 11/203 (5%)
Query: 299 LGSGGFGSVYKGI-LSDGTT----VAIKIF-NLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
LGSG FG+VYKG+ + +G VAIK+ +A + E V+ +V H +++++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
L C ++ L+ + MP G L ++ +H LN + +A + YL +
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---L 130
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
VH DL N+L+ ++DFG++KLL + I +MA E +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 473 KCDVYSYGILLLETFT-RKKPTD 494
K DV+SYG+ + E T KP +
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 297 NLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ--AFRSFNSECEVLRNVRHRNLIKIL 353
N +G G FG VY + L G +A+K +Q + E +VL ++H NL+K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVV 413
+ + +E+ G+L++ L I D I + LE L + HS +V
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV---IQTMTIATIGYMAPEFGSEGNV 470
H D+KP+NI LD N V + DFG + L ++ +Q++ T YMAPE + G
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA-GTPAYMAPEVITGGKG 180
Query: 471 SSK---CDVYSYGILLLETFTRKKPTDEM 496
D++S G ++LE T K+P E+
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 8e-23
Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 299 LGSGGFGSVYKG-ILSDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSC 356
LG+G G V K G +A+K L++ E + E ++L ++ +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALEYLHHGHSTPVVH 414
N ++ +E+M GSLDK L IP+R+ I + V L YLH H ++H
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKE--VQGRIPERILGKIAVAVLKGLTYLHEKHK--IIH 124
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKC 474
D+KPSNIL++ + DFG+S G+ +S+ +T + T YMAPE + S K
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVS---GQLVNSLAKTF-VGTSSYMAPERIQGNDYSVKS 180
Query: 475 DVYSYGILLLETFTRKKP 492
D++S G+ L+E T + P
Sbjct: 181 DIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 78/299 (26%), Positives = 122/299 (40%), Gaps = 60/299 (20%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLE------QAFRSFNSECEVLRNVRHRNLIK 351
+G G +G VYK G VA+K ++ E A R E ++L+ +RH N+++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 352 ---ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH 408
I++S + +V E+M + L L S M + L+YLH
Sbjct: 63 LKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--FGS 466
++H D+K SNIL++ + V ++DFG+++ +S T + T+ Y PE G+
Sbjct: 121 ---ILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPELLLGA 176
Query: 467 EGNVSSKCDVYSYGILLLETFTRK--------------------KPTDEMFTGEMNLKNW 506
+ D++S G +L E F K PTDE + G L +
Sbjct: 177 T-RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235
Query: 507 VKESLPHGLPKIADANLLREENFFSARMD----CLLSIFHLALDCCAELPDQRLYMKDA 561
PK LRE FF +D LL L LD P +R+ A
Sbjct: 236 ENLK-----PKKPYKRRLRE--FFKHLIDPSALDLLDKL-LTLD-----PKKRISADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 69/261 (26%), Positives = 121/261 (46%), Gaps = 36/261 (13%)
Query: 297 NLLGSGGFGSVYKGILS----DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIK 351
++G G FG V +G L VAIK ++ F +E ++ H N+I+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYL-HHGHS 409
+ + ++ E+M NGSLDK+L ++ F + ++ +A ++YL +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVG-QLVGMLRGIASGMKYLSEMNY- 127
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGN 469
VH DL NIL++ N+V VSDFG+S+ L + + + I + APE +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 470 VSSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLRE 526
+S DV+S+GI++ E + ++P +M + + +K ++ G LP
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIK-----AVEDGYRLP---------- 228
Query: 527 ENFFSARMDCLLSIFHLALDC 547
MDC +++ L LDC
Sbjct: 229 -----PPMDCPSALYQLMLDC 244
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 73/263 (27%), Positives = 119/263 (45%), Gaps = 34/263 (12%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
LG+G FG V++G+ ++ T VA+K + F +E ++++ +RH LI++ + C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 359 TNFKALVLEFMPNGSLDKWLYSHNYFQ-DIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
+V E M GSL ++L +P +++ VA + YL + +H DL
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDL 129
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
N+L+ EN + V+DFG+++++ E D + I + APE S K DV+
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 478 SYGILLLETFTRKK-PTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARM-- 534
S+GILL E T + P M E V + + G RM
Sbjct: 189 SFGILLTEIVTYGRMPYPGMTNAE------VLQQVDQGY-----------------RMPC 225
Query: 535 --DCLLSIFHLALDCCAELPDQR 555
C ++ + LDC E PD R
Sbjct: 226 PPGCPKELYDIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 7e-22
Identities = 77/279 (27%), Positives = 127/279 (45%), Gaps = 31/279 (11%)
Query: 298 LLGSGGFGSVYKGILS----DGTTVAIKIFNL-QLEQAFRSFNSECEVLRNVRHRNLIKI 352
++G+G FG V++GIL VAIK E+ + F SE ++ H N+I++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
++ E+M NG+LDK+L H+ + ++ +A ++YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNY 128
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG--YMAPEFGSEGNV 470
VH DL NIL++ N+ VSDFG+S++L E D T + I + APE +
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 471 SSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529
+S DV+S+GI++ E + ++P +M E+ + I D L
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-------------MKAINDGFRL----- 229
Query: 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
A MDC +++ L L C + +R D L K+
Sbjct: 230 -PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 74/261 (28%), Positives = 107/261 (40%), Gaps = 48/261 (18%)
Query: 293 FNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFN---LQLEQAFRSFNSECEVL-RNVRHR 347
F ++G G F +V AIKI + L E+ + E EVL R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 348 NLIKILSSCCNTNFKA-----LVLEFMPNGSLDKWLYSHNYFQ-DIPDRLNIMIDVALAL 401
+IK+ + F+ VLE+ PNG L Y Y D ++ LAL
Sbjct: 63 GIIKLYYT-----FQDEENLYFVLEYAPNGEL--LQYIRKYGSLDEKCTRFYAAEILLAL 115
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD------------DSVI 449
EYLH S ++H DLKP NILLD++M ++DFG +K+L DS I
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 450 QTMTIA------TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG--EM 501
+ T Y++PE +E D+++ G ++ + T K P F G E
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP----FRGSNEY 228
Query: 502 NLKNWVKE---SLPHGLPKIA 519
+ + S P P A
Sbjct: 229 LTFQKILKLEYSFPPNFPPDA 249
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 61/198 (30%), Positives = 101/198 (51%), Gaps = 15/198 (7%)
Query: 297 NLLGSGGFGSVYKGILSD-GTTVAIKIF---NLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
+ LG G +G VY+G+ TVA+K +++E+ F E V++ ++H NL+++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQL 67
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPD--RLNIMIDVALALEYLHHGHST 410
L C ++ EFM G+L +L N Q++ L + ++ A+EYL +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNV 470
+H DL N L+ EN + V+DFG+S+L+ GD I + APE +
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 471 SSKCDVYSYGILLLETFT 488
S K DV+++G+LL E T
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 69/193 (35%), Positives = 96/193 (49%), Gaps = 15/193 (7%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIK-IFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357
+G G FG V G G VA+K I N QAF + E V+ +RH NL+++L
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLA---EASVMTQLRHSNLVQLLGVIV 69
Query: 358 NTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRL-NIMIDVALALEYLHHGHSTPVVHC 415
+V E+M GSL +L S D L +DV A+EYL + VH
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHR 126
Query: 416 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCD 475
DL N+L+ E+ VA VSDFG++K + S Q + + APE E S+K D
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 476 VYSYGILLLETFT 488
V+S+GILL E ++
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRNLIKILS 354
+ G +G V+ S G AIK+ + + +E ++L + ++K+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHSTPVV 413
S LV+E++P G L L + + R + ++ LALEYLH +G ++
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLHSNG----II 115
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKL------LGEGDDSVIQTMTIATIGYMAPEFGSE 467
H DLKP NIL+D N ++DFG+SK+ + DD + T Y+APE
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 468 GNVSSKCDVYSYGILLLETFT 488
S D +S G +L E
Sbjct: 176 QGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-21
Identities = 57/192 (29%), Positives = 96/192 (50%), Gaps = 5/192 (2%)
Query: 299 LGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRS-FNSECEVLRNVRHRNLIKILSSC 356
+G G FG V+ G L +D T VA+K L ++ F E +L+ H N+++++ C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCD 416
+V+E + G +L + + + + ++ + A +EYL H +H D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 417 LKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDV 476
L N L+ E V +SDFG+S+ +G + M + + APE + G SS+ DV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 477 YSYGILLLETFT 488
+S+GILL E F+
Sbjct: 180 WSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNL-----QLEQAFRSFNSECEVLRNVRHRNLIK 351
LLGSG FGSVY+G+ L DG A+K +L ++A + E +L ++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI--DVALALEYLHHGHS 409
L + + + LE +P GSL K L + P+ + + + L LEYLH +
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN- 122
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG---YMAPE-FG 465
VH D+K +NIL+D N V ++DFG++K + E + + G +MAPE
Sbjct: 123 --TVHRDIKGANILVDTNGVVKLADFGMAKQVVE------FSFAKSFKGSPYWMAPEVIA 174
Query: 466 SEGNVSSKCDVYSYGILLLETFTRKKP 492
+G D++S G +LE T K P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 72/223 (32%), Positives = 103/223 (46%), Gaps = 21/223 (9%)
Query: 292 GFNECNLLGSGGFGSVYK-GILSDGTTVAIKIFNLQ-LEQAFR--SFNSECEVLRNVRHR 347
F LG G +GSVYK LSD A+K +L + Q R + N E +L +V H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHP 59
Query: 348 NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD-IPDRL--NIMIDVALALEYL 404
N+I + + N +V+E+ P G L K + + IP++ I I + L+ L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG---YMA 461
H ++H DLK +NILL N + + D GISK+L + M IG YMA
Sbjct: 120 H---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK-------KNMAKTQIGTPHYMA 169
Query: 462 PEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLK 504
PE S K D++S G LL E T P + ++ K
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK 212
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 73/290 (25%), Positives = 122/290 (42%), Gaps = 43/290 (14%)
Query: 299 LGSGGFGSVYKGIL-----SDGTTVAIKIF-NLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
LG FG +YKG L VAIK ++ Q + F E ++ + H N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIP----------------DRLNIMID 396
L ++ E++ G L ++L + D+ D L+I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT 456
+A +EYL S VH DL NIL+ E + +SD G+S+ + D +Q ++
Sbjct: 133 IAAGMEYLS---SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP 516
I +M PE G SS D++S+G++L E F+ L+ + +G
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS------------FGLQPY------YGFS 231
Query: 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566
++R+ DC ++ L +C E P +R KD T+L+
Sbjct: 232 NQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-21
Identities = 65/202 (32%), Positives = 95/202 (47%), Gaps = 9/202 (4%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRS--FNSECEVLRNVRHRNLIKILSSC 356
LGSG FG V+ G VAIK+ E A F E +V+ + H NL+++ C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCD 416
+V E+M NG L +L L++ DV A+EYL S +H D
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125
Query: 417 LKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDV 476
L N L+ E+ V VSDFG+++ + + D T + + PE SSK DV
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLD-DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 477 YSYGILLLETFTRKKPTDEMFT 498
+S+G+L+ E F+ K E F+
Sbjct: 185 WSFGVLMWEVFSEGKMPYERFS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 297 NLLGSGGFGSVYKGILSD-GTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKI 352
++G G FG V D A+K N Q + + R+ +E +L+ + H L+ +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNY-FQDIPDRLNIMIDVALALEYLHHGHSTP 411
S + LV++ + G L ++ S F + + + ++ LALEYLH S
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKF-WICEIVLALEYLH---SKG 120
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVS 471
++H D+KP NILLDE H++DF I+ + + T T T GYMAPE S
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 472 SKCDVYSYGILLLETFTRKKP 492
D +S G+ E K+P
Sbjct: 178 VAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 26/216 (12%)
Query: 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQ------LEQAFRSFNSECEVLRNVRHRNLI 350
+LG G +G+VY G+ + G +A+K L E+ + E ++L++++H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL------NIMIDVALALEYL 404
+ L +C + N ++ +EF+P GS+ L N F +P+ + I+ VA YL
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVA----YL 118
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG----EGDDSVIQTMTIATIGYM 460
H+ VVH D+K +N++L N + + DFG ++ L G S + T +M
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 461 APEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEM 496
APE +E K D++S G + E T K P M
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 12/205 (5%)
Query: 299 LGSGGFGSVYKGIL---SDGTTVAIKIFNLQLEQAFR-SFNSECEVLRNVRHRNLIKILS 354
LGSG FG V KG+ VAIK+ + E++ R E E++ + + +++++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
C LV+E G L+K+L + + + +M V++ ++YL + VH
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVH 118
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT--IGYMAPEFGSEGNVSS 472
DL N+LL A +SDFG+SK LG DDS + + + + APE + SS
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALG-ADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 473 KCDVYSYGILLLETFTR-KKPTDEM 496
+ DV+SYGI + E F+ +KP +M
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 79/284 (27%), Positives = 125/284 (44%), Gaps = 22/284 (7%)
Query: 298 LLGSGGFGSVYK---GILSD--GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
LG G FGSV L D G VA+K + R F E E+L++++H N++K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 353 LSSCCNT---NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS 409
C + N + LV+E++P GSL +L H D L + +EYL S
Sbjct: 71 KGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---S 126
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-VIQTMTIATIGYMAPEFGSEG 468
VH DL NIL++ + DFG++K+L + + ++ + I + APE +E
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 469 NVSSKCDVYSYGILLLETFT---RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525
S DV+S+G++L E FT + F M + + H + LL+
Sbjct: 187 KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI------ELLK 240
Query: 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569
A C I+ + +C P QR + A +++ IR
Sbjct: 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 39/206 (18%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357
+GSG +G VYK ++ G VAIK+ L+ F E +L+ RH N++ S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN----------IMIDVALALEYLHHG 407
+ +V+E+ GSL QDI + + L YLH
Sbjct: 71 RRDKLWIVMEYCGGGSL----------QDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 408 HSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-----IATIGYMAP 462
+H D+K +NILL E+ ++DFG+S L T+ I T +MAP
Sbjct: 121 G---KIHRDIKGANILLTEDGDVKLADFGVSAQLT-------ATIAKRKSFIGTPYWMAP 170
Query: 463 EFGSE---GNVSSKCDVYSYGILLLE 485
E + G KCD+++ GI +E
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 298 LLGSGGFGSVYKGILS----DGTTVAIKIFNL-QLEQAFRSFNSECEVLRNVRHRNLIKI 352
++G+G FG V G L VAIK E+ R F SE ++ H N+I +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
+ +V E+M NGSLD +L H+ + + ++ +A ++YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGY 127
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG--YMAPEFGSEGNV 470
VH DL NIL++ N+V VSDFG+S++L E D T I + APE +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 471 SSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREE 527
+S DV+SYGI++ E + ++P EM + V +++ G LP
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPYWEMSNQD------VIKAIEEGYRLP----------- 229
Query: 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
A MDC ++ L LDC + ++R + + L K+
Sbjct: 230 ----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 62/202 (30%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
LG G +GSVYK I G VAIK+ + E+ + E +L+ ++K S
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN------IMIDVALALEYLHHGHST 410
+V+E+ GS+ + N L I+ LEYLH S
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITN------KTLTEEEIAAILYQTLKGLEYLH---SN 118
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNV 470
+H D+K NILL+E A ++DFG+S L + T+ I T +MAPE E
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK-RNTV-IGTPFWMAPEVIQEIGY 176
Query: 471 SSKCDVYSYGILLLETFTRKKP 492
++K D++S GI +E K P
Sbjct: 177 NNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFN--------SECEVLRNVRHRNL 349
+G G FG+V K SDG + K E + + SE +LR ++H N+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWK------EIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 350 IKILSSCCNTNFKAL--VLEFMPNGSLDKWLYSHNY--FQDIPDR--LNIMIDVALALEY 403
++ + + + L V+E+ G L + L + I + I+ + LAL
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 404 LHHG-HSTPVV-HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 461
H+ V H DLKP+NI LD N + DFG++K+L G DS + T YM+
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMS 178
Query: 462 PEFGSEGNVSSKCDVYSYGILLLETFTRKKP 492
PE + + K D++S G L+ E P
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 22/211 (10%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNL-----QLEQAFRS----FNSECEVLRNVRHR 347
L+GSG FGSVY G+ S G +A+K L + RS E +L+ ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 348 NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG 407
N+++ L S + + + LE++P GS+ L ++ F++ R N + + L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH-- 123
Query: 408 HSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA------TIGYMA 461
+ ++H D+K +NIL+D +SDFGISK L +S+ A ++ +MA
Sbjct: 124 -NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA--NSLSTKTNGARPSLQGSVFWMA 180
Query: 462 PEFGSEGNVSSKCDVYSYGILLLETFTRKKP 492
PE + + + K D++S G L++E T K P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-20
Identities = 60/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
LG G FG V+ G + T VAIK + +F E +V++ +RH L++ L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQ-LYAVVS 71
Query: 359 TNFKALVLEFMPNGSLDKWLY-SHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
+V E+M GSL +L + +P +++ +A + Y+ + VH DL
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 128
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
+ +NIL+ EN+V V+DFG+++L+ + + + Q I + APE G + K DV+
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 187
Query: 478 SYGILLLETFTRKK 491
S+GILL E T+ +
Sbjct: 188 SFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 299 LGSGGFGSVYKGILSD------GTTVAIKIFNLQLEQA----FRSFNSECEVLRNVRHRN 348
LG G FG VY+G+ T VAIK N E A F +E V++ +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSH------NYFQDIPDRLNIM---IDVAL 399
++++L +V+E M G L +L S N P + ++A
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 400 ALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGY 459
+ YL + VH DL N ++ E++ + DFG+++ + E D + + +
Sbjct: 131 GMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 460 MAPEFGSEGNVSSKCDVYSYGILLLETFT 488
MAPE +G ++K DV+S+G++L E T
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-20
Identities = 71/289 (24%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 299 LGSGGFGSVY----KGIL--SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
LG G FG V+ +L D VA+K E A + F E E+L ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDI--------------PDRLNIMIDVA 398
C +V E+M +G L+++L SH I L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 399 LALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG 458
+ YL H VH DL N L+ + +V + DFG+S+ + D + T+ I
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 459 YMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518
+M PE +++ D++S+G++L E FT K + W + S + I
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK------------QPWYQLSNTEAIECI 237
Query: 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567
L C ++ + C P QR+ +KD ++L+
Sbjct: 238 TQGRELERPR------TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 8e-20
Identities = 76/281 (27%), Positives = 124/281 (44%), Gaps = 33/281 (11%)
Query: 298 LLGSGGFGSVYKGILS----DGTTVAIKIFNL-QLEQAFRSFNSECEVLRNVRHRNLIKI 352
++G+G FG V +G L VAIK E+ R F SE ++ H N+I +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI-DVALALEYLHHGHSTP 411
+ ++ EFM NG+LD +L N Q +L M+ +A ++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYLS---EMN 126
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA---TIGYMAPEFGSEG 468
VH DL NIL++ N+V VSDFG+S+ L + T ++ I + APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 469 NVSSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527
+S DV+SYGI++ E + ++P +M ++ N + ++
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-------------------INAIEQD 227
Query: 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
MDC ++ L LDC + + R + L K+
Sbjct: 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 297 NLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQ------LEQAFRSFNSECEVLRNVRHRNL 349
N +G G FG V+K + +D A+K +L E+A E VL + +
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID----EARVLAKLDSSYI 61
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALEYLHHG 407
I+ S + +V+E+ NG L K L + +P+ I + L L +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLH-- 118
Query: 408 HSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE 467
S ++H D+K N+ LD + D G++KLL D++ + T Y++PE +
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELCED 175
Query: 468 GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLK 504
+ K DV++ G++L E T K P D G + LK
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 297 NLLGSGGFGSVYKGI-LSDGTTVAIK-IFNLQLEQAFRSFN----SECEVLRNVRHRNLI 350
LG G + VYK G VAIK I + ++A N E ++L+ ++H N+I
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST 410
+L + + LV EFM L+K + + D + M+ LEYLH S
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SN 121
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--FGSEG 468
++H DLKP+N+L+ + V ++DFG+++ G + T + T Y APE FG+
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSF--GSPNRKMTHQVVTRWYRAPELLFGAR- 178
Query: 469 NVSSKCDVYSYGILLLETFTRK 490
+ D++S G + E R
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 71/283 (25%), Positives = 118/283 (41%), Gaps = 42/283 (14%)
Query: 299 LGSGGFGSVYKG------ILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
LG G FG V+ D VA+K A + F E E+L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSH---------------NYFQDIPDRLNIMIDV 397
C + + +V E+M +G L+K+L +H + L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 398 ALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATI 457
A + YL H VH DL N L+ N++ + DFG+S+ + D + T+ I
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 458 GYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517
+M PE +++ DV+S+G++L E FT K + W + S +
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQLSNTEVIEC 237
Query: 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKD 560
I +L C ++ + L C P QRL +K+
Sbjct: 238 ITQGRVLERPRV------CPKEVYDIMLGCWQREPQQRLNIKE 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 63/213 (29%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 298 LLGSGGFGSVYKGILS--DGTTVAIKIFNLQLEQAFRS----FNSECEVLRNVRHRNLIK 351
+LG G FGSV +G LS DG+ + + + ++L+ S F SE +++ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 352 ILSSCCNTNFKA------LVLEFMPNGSLDKWLYSHNYFQDIPDRLNI------MIDVAL 399
++ C + ++L FM +G L +L +P++L + M+D+AL
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR-LGGLPEKLPLQTLLKFMVDIAL 124
Query: 400 ALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD---DSVIQTMTIAT 456
+EYL + +H DL N +L E+M V+DFG+SK + GD I M +
Sbjct: 125 GMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 180
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFTR 489
++A E ++ +SK DV+++G+ + E TR
Sbjct: 181 --WIAIESLADRVYTSKSDVWAFGVTMWEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 7/201 (3%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
LG+G FG V G VAIK+ + + F E +V+ + H L+++ C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 359 TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLK 418
+V E+M NG L +L H L + DV + YL S +H DL
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLA 127
Query: 419 PSNILLDENMVAHVSDFGISKLLGEGDDSVIQTM-TIATIGYMAPEFGSEGNVSSKCDVY 477
N L+D+ VSDFG+S+ + DD ++ + + + PE SSK DV+
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 478 SYGILLLETFTRKKPTDEMFT 498
++G+L+ E ++ K E F
Sbjct: 186 AFGVLMWEVYSLGKMPYERFN 206
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 49/293 (16%)
Query: 299 LGSGGFGSVYKGIL------SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
LG G FG V+ D VA+K + A + F+ E E+L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPD-----------------RLNIMI 395
C + +V E+M +G L+K+L +H PD L+I
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHG-----PDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 396 DVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA 455
+A + YL H VH DL N L+ EN++ + DFG+S+ + D + T+
Sbjct: 128 QIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 456 TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGL 515
I +M PE +++ DV+S G++L E FT K + W + S +
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------QPWYQLSNNEVI 232
Query: 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
I +L+ C ++ L L C P RL +K+ + L+ +
Sbjct: 233 ECITQGRVLQRPR------TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (218), Expect = 4e-19
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSEC--EV--LRNVRHR 347
+ + LG G +G VYK G VA+K ++L+ S E+ L+ ++H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKK--IRLDNEEEGIPSTALREISLLKELKHP 58
Query: 348 NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALEYLH 405
N++K+L LV E+ +D Y + L +IM + L Y H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE 463
++H DLKP NIL++ + V ++DFG+++ G ++T T + T+ Y APE
Sbjct: 116 SHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG----IPLRTYTHEVVTLWYRAPE 168
Query: 464 --FGSEGNVSSKCDVYSYGILLLETFTRK 490
GS+ + S+ D++S G + E T K
Sbjct: 169 ILLGSK-HYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 6e-19
Identities = 73/279 (26%), Positives = 122/279 (43%), Gaps = 40/279 (14%)
Query: 297 NLLGSGGFGSVYKG----ILSDGT---TVAIKIFNL-QLEQAFRSFNSECEVLRNVRHRN 348
N LGSG FG VY+G IL G+ VA+K +Q + F E ++ N H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIP------DRLNIMIDVALALE 402
++K+L C + +++E M G L +L + P + L+I +DVA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 403 YLHHGHSTPVVHCDLKPSNILLDE-----NMVAHVSDFGISKLLGEGDDSVIQTMTIATI 457
YL H +H DL N L+ E + V + DFG+++ + + D + + +
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 458 GYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517
+MAPE +G +++ DV+S+G+L+ E T + + + N E L H
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQ---QPYPALNNQ-----EVLQH---- 225
Query: 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRL 556
+ +C I+ L +C A+ P +R
Sbjct: 226 ------VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 9e-19
Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 9/218 (4%)
Query: 284 LDLERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLR 342
L+ E D E +LG G +G VY LS +AIK + + + + E +
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 343 NVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALA-L 401
++HRN+++ L S F + +E +P GSL L S + + D +I L
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK--WGPLKDNEQTIIFYTKQIL 118
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDE-NMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460
E L + H +VH D+K N+L++ + V +SDFG SK L G + +T T T+ YM
Sbjct: 119 EGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFT-GTLQYM 176
Query: 461 APEFGSEG--NVSSKCDVYSYGILLLETFTRKKPTDEM 496
APE +G + D++S G ++E T K P E+
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 19/194 (9%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357
+G G G VYK + G VAIK L+ + N E ++++ +H N++ S
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSYL 85
Query: 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN------IMIDVALALEYLHHGHSTP 411
+ +V+E+M GSL + + R+N + +V LEYLH S
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQN------FVRMNEPQIAYVCREVLQGLEYLH---SQN 136
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVS 471
V+H D+K NILL ++ ++DFG + L + + + T +MAPE +
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDYG 194
Query: 472 SKCDVYSYGILLLE 485
K D++S GI+ +E
Sbjct: 195 PKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 9e-19
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILS 354
++G G FG V+ +D V IK ++ + + +EC+VL+ + H N+I+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEY-------LHHG 407
+ +V+E+ P G+L ++ I R N ++D L + LHH
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEY---------IQKRCNSLLDEDTILHFFVQILLALHHV 117
Query: 408 HSTPVVHCDLKPSNILLDEN-MVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGS 466
H+ ++H DLK NILLD++ MV + DFGISK+L + + T Y++PE
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPELCE 174
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKPTD 494
+ K D+++ G +L E + K+ +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQA-FRSFNSECEVLRNVRHRNLIKILSSC 356
+G G VY I L + VAIK +L+ Q E + + H N++K +S
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 357 CNTNFKALVLEFMPNGS-LDKWLYSHNYFQDIPDRLNI---MIDVALALEYLH-HGHSTP 411
+ LV+ ++ GS LD + +Y + D I + +V LEYLH +G
Sbjct: 69 VVGDELWLVMPYLSGGSLLD--IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPEFGSEGN 469
+H D+K NILL E+ ++DFG+S L +G D + + T +MAPE + +
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 470 -VSSKCDVYSYGILLLETFTRKKP 492
K D++S+GI +E T P
Sbjct: 183 GYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 297 NLLGSGGFGSVYKGI-LSDGTTVAIK-IFNL--QLEQAFRSFNSECEVLRNVRHRNLIKI 352
+GSG +G V + G VAIK I N+ L A R E ++LR++RH N+I +
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGL 64
Query: 353 LS---SCCNTNFKAL--VLEFMPNGSLDKWLYSHNYFQDIPDRLN-IMIDVALALEYLHH 406
L +F + V E M L K + S D D + + + L+YLH
Sbjct: 65 LDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTD--DHIQYFLYQILRGLKYLHS 121
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE- 463
+ V+H DLKPSNIL++ N + DFG+++ + D+ +T + T Y APE
Sbjct: 122 AN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP-DEDEKGFLTEYVVTRWYRAPEL 177
Query: 464 FGSEGNVSSKCDVYSYGILLLETFTRK 490
S + D++S G + E TRK
Sbjct: 178 LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNL-QLEQAFRSFNSECEVLRNVRHRNLI 350
F +G G FG VYK I VAIK+ +L + E E + L R +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN------IMIDVALALEYL 404
K S + +++E+ GS L P +L+ I+ +V L LEYL
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLK--------PGKLDETYIAFILREVLLGLEYL 114
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPE 463
H +H D+K +NILL E ++DFG+S G+ ++ + T + T +MAPE
Sbjct: 115 H---EEGKIHRDIKAANILLSEEGDVKLADFGVS---GQLTSTMSKRNTFVGTPFWMAPE 168
Query: 464 FGSEGNVSSKCDVYSYGILLLETFTRKKP 492
+ K D++S GI +E + P
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 37/217 (17%)
Query: 299 LGSGGFGSVYKGIL-SDGTTVAIK------IFNLQLEQAFRSFNSECEVLRNVRHRNLIK 351
LG GGFG V + S T A+K I ++ S E E+L H ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNI--MIDVALALEYLHHGHS 409
+ + + + +++E+ G L L F + R I ++ LA EYLH+
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLHNRG- 113
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEFGSEG 468
+++ DLKP N+LLD N + DFG +K L G +T T T Y+APE
Sbjct: 114 --IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPE----- 162
Query: 469 NVSSK-----CDVYSYGILLLETFTRKKPTDEMFTGE 500
+ +K D +S GILL E T + P F +
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPP----FGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVA---IKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILS 354
+G G F VYK I L DG VA ++IF + +A + E ++L+ + H N+IK L+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD--IPDRL--NIMIDVALALEYLHHGHST 410
S N +VLE G L + + H Q IP+R + + ALE++H S
Sbjct: 70 SFIENNELNIVLELADAGDLSR-MIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SK 125
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT----IATIGYMAPEFGS 466
++H D+KP+N+ + V + D G+ + +T + T YM+PE
Sbjct: 126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS------KTTAAHSLVGTPYYMSPERIH 179
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE-MNL 503
E + K D++S G LL E + P F G+ MNL
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 21/216 (9%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFR----------SFNSECEVLRNVRH 346
L+G G +G VY + ++ G +A+K L A R + SE E L+++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 347 RNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVAL-ALEYLH 405
N+++ L + ++ LE++P GS+ L ++ F+ + + L L YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFE--EQLVRFFTEQVLEGLAYLH 125
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF- 464
S ++H DLK N+L+D + + +SDFGISK + D+ ++ +MAPE
Sbjct: 126 ---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 465 -GSEGNVSSKCDVYSYGILLLETFTRKKP--TDEMF 497
S+K D++S G ++LE F ++P +E
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 72/300 (24%), Positives = 123/300 (41%), Gaps = 51/300 (17%)
Query: 299 LGSGGFGSVYKGI------LSDGTTVAIKIFNLQLEQA-FRSFNSECEVLRNVRHRNLIK 351
LG G FG V K + TTVA+K+ + R SE +L+ V H ++IK
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWL-----------------YSHNYFQDIPDRLNIM 394
+ +C L++E+ GSL +L S L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 395 IDVALA------LEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448
++ A ++YL +VH DL N+L+ E +SDFG+S+ + E D V
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVK 508
++ + +MA E + +++ DV+S+G+LL E T +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------------------LG 226
Query: 509 ESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
+ G+ NLL+ +C +++L L C + PD+R D + +L+K+
Sbjct: 227 GNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 62/223 (27%), Positives = 111/223 (49%), Gaps = 10/223 (4%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
LG G FG V+ G + T VAIK +F E ++++ +RH L+ + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 359 TNFKALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
+V EFM GSL +L + + +P +++ +A + Y+ + +H DL
Sbjct: 73 EPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDL 128
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
+ +NIL+ +N+V ++DFG+++L+ + + + Q I + APE G + K DV+
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 187
Query: 478 SYGILLLETFTRKK-PTDEMFTGEM--NLKNWVKESLPHGLPK 517
S+GILL E T+ + P M E+ ++ + P G P+
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE 230
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 35/263 (13%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
LG+G FG V+ G + T VA+K + SF E ++++ +RH L++ L + +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQ-LYAVVS 71
Query: 359 TNFKALVLEFMPNGSLDKWLYS-HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
+V E+M GSL +L +P+ +++ VA + Y+ + +H DL
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDL 128
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
+ +NIL+ + +V ++DFG+++L+ + + + Q I + APE G + K DV+
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 187
Query: 478 SYGILLLETFTRKK-PTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARM-- 534
S+GILL E T+ + P M E V E + G RM
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNRE------VLEQVERGY-----------------RMPC 224
Query: 535 --DCLLSIFHLALDCCAELPDQR 555
DC +S+ L L C + P++R
Sbjct: 225 PQDCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 69/296 (23%), Positives = 120/296 (40%), Gaps = 55/296 (18%)
Query: 299 LGSGGFGSVYKGILSDGT------TVAIKIFNLQLEQAFRS-FNSECEVLRNVRHRNLIK 351
LG FG VYKG L VAIK + E R F E + ++H N++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDI---------------PDRLNIMID 396
+L +++ + + L ++L + D+ D ++I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT 456
+A +E+L H VVH DL N+L+ + + +SD G+ + + D + ++
Sbjct: 133 IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGL- 515
I +M+PE G S D++SYG++L E F+ +GL
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS------------------------YGLQ 225
Query: 516 PKIADAN-----LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566
P +N ++R DC ++ L L+C E P +R KD ++L+
Sbjct: 226 PYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 291 DGFNECNLLGSGGFGSVYKGILSDGTTV-AIKIFN------LQLEQAFRSFNSECEVLRN 343
+ E + LG G GSV K L + + A+K LQ +Q R E E+ ++
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ-KQILR----ELEINKS 55
Query: 344 VRHRNLIKILSSCCN--TNFKALVLEFMPNGSLD---KWLYSHNYFQDIPDR--LNIMID 396
+ ++K + + ++ + +E+ GSLD K + I ++ I
Sbjct: 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRG--GRIGEKVLGKIAES 113
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT 456
V L YLH S ++H D+KPSNILL + DFG+S GE +S+ T T T
Sbjct: 114 VLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLAGTFT-GT 166
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLE 485
YMAPE S DV+S G+ LLE
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 31/200 (15%)
Query: 299 LGSGGFGSV----YKGILSDGTTVAIKIFNL-------QLEQAFRSFNSECEVLRNVRHR 347
LG+G FG V +KG G A+KI + Q+E +E +L+++RH
Sbjct: 9 LGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHV----LNEKRILQSIRHP 61
Query: 348 NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG 407
L+ + S + + LV+E++P G L L F P V LALEYLH
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRF-PEPVARFYAAQVVLALEYLHSL 120
Query: 408 HSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPE-FG 465
+V+ DLKP N+LLD + ++DFG +K + T T+ T Y+APE
Sbjct: 121 D---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TYTLCGTPEYLAPEIIL 171
Query: 466 SEGNVSSKCDVYSYGILLLE 485
S+G + D ++ GIL+ E
Sbjct: 172 SKGYGKA-VDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 51/194 (26%), Positives = 104/194 (53%), Gaps = 6/194 (3%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
LG+G FG V+ G ++ T VA+K + ++F E +++ ++H L+++ +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 359 TNFKALVLEFMPNGSLDKWLYSHNYFQ-DIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
++ E+M GSL +L S + +P ++ +A + Y+ + +H DL
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDL 129
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
+ +N+L+ E+++ ++DFG+++++ E ++ + I + APE + G+ + K DV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 478 SYGILLLETFTRKK 491
S+GILL E T K
Sbjct: 189 SFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 73/240 (30%), Positives = 108/240 (45%), Gaps = 64/240 (26%)
Query: 280 RTSYLDLERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFR-SFNSE 337
S +LER N +GSG G+VYK I G A+K+ E R E
Sbjct: 70 AKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE 122
Query: 338 CEVLRNVRHRNLIKILSSCCNTNFK-----ALVLEFMPNGSLDKWLYSHNYFQDIPDRLN 392
E+LR+V H N++K C+ F ++LEFM GSL+ + F
Sbjct: 123 IEILRDVNHPNVVK-----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF-------- 169
Query: 393 IMIDVAL----ALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448
+ DVA + YLH H +VH D+KPSN+L++ ++DFG+S++L
Sbjct: 170 -LADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA------ 219
Query: 449 IQTM-----TIATIGYMAPEF-----------GSEGNVSSKCDVYSYGILLLETFTRKKP 492
QTM ++ TI YM+PE G G D++S G+ +LE + + P
Sbjct: 220 -QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAG------DIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 54/191 (28%), Positives = 101/191 (52%), Gaps = 7/191 (3%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
LG+G FG V+ G + T VAIK Q + +F +E +++ ++H L++ L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVR-LYAVVT 71
Query: 359 TNFKALVLEFMPNGSLDKWLYSHNYFQ-DIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
++ E+M NGSL +L + + I +++ +A + ++ + +H DL
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRDL 128
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
+ +NIL+ E + ++DFG+++L+ E ++ + I + APE + G + K DV+
Sbjct: 129 RAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 478 SYGILLLETFT 488
S+GILL E T
Sbjct: 188 SFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 69/282 (24%), Positives = 114/282 (40%), Gaps = 24/282 (8%)
Query: 299 LGSGGFGSVYKGIL------SDGT--TVAIKIFNLQLEQAFRS-FNSECEVLRNVRHRNL 349
LG G FG V L +DGT VA+K + Q S + E +L+ + H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 350 IKILSSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG 407
+K C K L++E++P GSL +L H ++ L + + YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL--NLAQLLLFAQQICEGMAYLHSQ 126
Query: 408 HSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV-IQTMTIATIGYMAPEFGS 466
H +H DL N+LLD + + + DFG++K + EG + ++ + + + A E
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526
E S DV+S+G+ L E T + K+ + I LL
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG-PKQGQMTVVRLI---ELLER 239
Query: 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
+C ++ L +C R + LK++
Sbjct: 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 73/285 (25%), Positives = 107/285 (37%), Gaps = 37/285 (12%)
Query: 298 LLGSGGFGSVYKG----ILSDGTTVAIKIF-NLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
LG G FG V +G VA+K + +L F E ++ ++ H NLI++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 353 LSSCCNTNFKALVLEFMPNGSL-DKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
+V E P GSL D+ I + + +A + YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT-IGYMAPEFGSEGNV 470
+H DL NILL + + DFG+ + L + +D + + + APE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 471 SSKCDVYSYGILLLETFTRKKPTDEMFT-GEMNLKNWVKESLPHGLPKIADANLLREENF 529
S DV+ +G+ L EMFT GE W S L KI D R E
Sbjct: 178 SHASDVWMFGVTLW----------EMFTYGEE---PWAGLSGSQILKKI-DKEGERLER- 222
Query: 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574
C I+++ L C A P R AA +R+ E
Sbjct: 223 ---PEACPQDIYNVMLQCWAHNPADR--PTFAA-----LREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 298 LLGSGGFGSVYKGI-LSDGTT----VAIK-IFNLQLEQAFRSFNSECEVLRNVRHRNLIK 351
LLGSG FG+V+KGI + +G + VAIK I + Q F+ + ++ H +++
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHST 410
+L C + + LV + P GSL + H D LN + +A + YL H
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNV 470
+VH +L NILL + + ++DFG++ LL D + I +MA E G
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 471 SSKCDVYSYGILLLETFT 488
+ + DV+SYG+ + E +
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 298 LLGSGGFGSVYKGILSD-GTTVAIKIFNL-----QLEQAFRSFNSECEVLRNVRHRNLIK 351
LLG G FG VY D G +A+K + ++ + E ++L+N++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD-IPDRLNIMIDVALALEYLHHGHST 410
+ ++ +E+MP GS+ L ++ + + + I LE + + HS
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI-----LEGVEYLHSN 123
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLL------GEGDDSVIQTMTIATIGYMAPEF 464
+VH D+K +NIL D + DFG SK L G G SV T +M+PE
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV-----TGTPYWMSPEV 178
Query: 465 GSEGNVSSKCDVYSYGILLLETFTRKKP 492
S K DV+S G ++E T K P
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQ------LEQAFRSFNSECEVLRNVRHRNLI 350
LG+G F S Y+ + GT +A+K E+ + E ++ + H ++I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI----DVALALEYLHH 406
++L + C + L +E+M GS+ L + F++ ++I + L YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE-----AVIINYTEQLLRGLSYLHE 121
Query: 407 GHSTPVVHCDLKPSNILLDEN-MVAHVSDFGI-----SKLLGEGDDSVIQTMTIATIGYM 460
++H D+K +N+L+D ++DFG +K G G+ Q + TI +M
Sbjct: 122 NQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE---FQGQLLGTIAFM 175
Query: 461 APEFGSEGNVSSKCDVYSYGILLLETFTRKKP 492
APE CDV+S G +++E T K P
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 81/282 (28%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 298 LLGSGGFGSVYKGI-LSDGTT----VAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIK 351
+LGSG FG+VYKGI + +G T VAIKI N +A F E ++ ++ H +L++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
+L C + + LV + MP+G L +++ H LN + +A + YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--- 129
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT-MTIATIGYMAPEFGSEGNV 470
+VH DL N+L+ ++DFG+++LL EGD+ I +MA E
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 471 SSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529
+ + DV+SYG+ + E T KP D + T E+ E LP P I
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ--PPI----------- 235
Query: 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI-RD 570
C + ++ + + C D R K+ A + ++ RD
Sbjct: 236 ------CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 297 NLLGSGGFGSVYKGILS-DGT--TVAIKIFN-LQLEQAFRSFNSECEVLRNV-RHRNLIK 351
+++G G FG V + ++ DG AIK+ E R F E EVL + H N+I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIP---------------DRLNIMID 396
+L +C N + + +E+ P G+L +L + P L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT 456
VA ++YL +H DL N+L+ EN+ + ++DFG+S+ GE + V +TM
Sbjct: 128 VATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR--GE-EVYVKKTMGRLP 181
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLE 485
+ +MA E + ++K DV+S+G+LL E
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWE 210
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-17
Identities = 46/117 (39%), Positives = 64/117 (54%), Gaps = 4/117 (3%)
Query: 106 LDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGI 165
L L L G IP I+ L+ L +++L+GN +G IP S GS+ SLE LDLS N+ + I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 166 PKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHW--NYALCGPQRLQVPPC 220
P+SL L+ L+ N++ N L G +P R SF++ N LCG L C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RAC 537
|
Length = 623 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 80/243 (32%), Positives = 108/243 (44%), Gaps = 45/243 (18%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNL----IKIL 353
LG G +G V K + GT +A+K + + R L I +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-------------EQKRLLMDLDISMR 55
Query: 354 SSCCN---TNFKAL--------VLEFMPNGSLDKWLYSHNYFQD--IPDRL--NIMIDVA 398
S C T + AL +E M + SLDK Y Y + IP+ + I + +
Sbjct: 56 SVDCPYTVTFYGALFREGDVWICMEVM-DTSLDK-FYKKVYDKGLTIPEDILGKIAVSIV 113
Query: 399 LALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG 458
ALEYLH S V+H D+KPSN+L++ N + DFGIS G DSV +T+
Sbjct: 114 KALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS---GYLVDSVAKTIDAGCKP 168
Query: 459 YMAPE-FGSEGNVSS---KCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG 514
YMAPE E N K DV+S GI ++E T + P D T LK V+E P
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQ- 227
Query: 515 LPK 517
LP
Sbjct: 228 LPA 230
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 74/291 (25%), Positives = 123/291 (42%), Gaps = 64/291 (21%)
Query: 298 LLGSGGFGSVYKGILSD------GTTVAIKIFNLQ-LEQAFRSFNSECEVLRNV-RHRNL 349
LG G FG V K +TVA+K+ E+ SE E+++ + +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSH-------NYFQDIP--------DRLNIM 394
I +L C +V+E+ +G+L +L + + P D ++
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 395 IDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI 454
VA +E+L S +H DL N+L+ E+ V ++DFG+++ + D T
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 455 ATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKK------PTDEMFTGEMNLKNWVK 508
+ +MAPE + + + DV+S+G+LL E FT P +E+F
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF----------- 244
Query: 509 ESLPHGLPKIADANLLREENFFSARMD----CLLSIFHLALDCCAELPDQR 555
LL+E RM+ C ++HL DC E+P QR
Sbjct: 245 -------------KLLKE----GYRMEKPQNCTQELYHLMRDCWHEVPSQR 278
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 27/238 (11%)
Query: 298 LLGSGGFGSVYKGILSDG--TTVAIKIFNL----------QLEQAFRSFNSECEVLR-NV 344
LGSG FG VYK + +A+K N+ + +++ SE +++ +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 345 RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYS----HNYFQDIPDRL-NIMIDVAL 399
RH N+++ + + +V++ + L + S F + +R+ NI + + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE--ERIWNIFVQMVL 124
Query: 400 ALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGY 459
AL YLH +VH DL P+NI+L E+ ++DFG++K T + TI Y
Sbjct: 125 ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTILY 179
Query: 460 MAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP--TDEMFTGEMNLKNWVKESLPHGL 515
PE K DV+++G +L + T + P + M + + V E LP G+
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 77/287 (26%), Positives = 125/287 (43%), Gaps = 39/287 (13%)
Query: 299 LGSGGFGSVYKGILSDGTT---VAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKIL 353
LG G FGSV +G L+ + VA+K + + F SE ++ H N+++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 354 SSCCNTNFK------ALVLEFMPNGSLDKWLYSHNYFQDIPDRL------NIMIDVALAL 401
C T ++L FM +G L +L ++ D P L M D+A +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 461
EYL S +H DL N +L+ENM V+DFG+SK + GD + + ++A
Sbjct: 126 EYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 462 PEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521
E ++ ++K DV+S+G+ + E TR + + G N +I D
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTP---YPGVEN-------------SEIYD- 225
Query: 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
LR+ N DCL ++ L C P R + +L+K
Sbjct: 226 -YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFR-SFNSECEVLRNVRHRNLIKILSSC 356
LG+G GSV K + GT +A K+ ++ + + R E +++ R ++ +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALA----LEYLHHGHSTPV 412
N N + +EFM GSLD+ Y + P + I+ +A+A L YL++ H +
Sbjct: 73 LNENNICMCMEFMDCGSLDRI-----YKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--I 125
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
+H D+KPSNIL++ + DFG+S GE +S+ T + T YM+PE G +
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTF-VGTSTYMSPERIQGGKYTV 181
Query: 473 KCDVYSYGILLLETFTRKKPTDE 495
K DV+S GI ++E K P
Sbjct: 182 KSDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 299 LGSGGFGSVYK-GILSDGTTVAIKIFNLQL------EQAFRSFNSECEVLRNVRHRNLIK 351
+G G G V+K G TVA+K L+ QA R E + L+ +H ++K
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR----EIKALQACQHPYVVK 63
Query: 352 ILS-SCCNTNFKALVLEFMPNGSLDKWLYS--HNYFQDIPD----RLNIMIDVALALEYL 404
+L + F LV+E+MP+ L + + +P+ M+ L+ +
Sbjct: 64 LLDVFPHGSGF-VLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRML-----LKGV 112
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE- 463
+ H+ ++H DLKP+N+L+ + V ++DFG+++L E + + + +AT Y APE
Sbjct: 113 AYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY-SHQVATRWYRAPEL 171
Query: 464 -FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500
+G+ D+++ G + E P +F GE
Sbjct: 172 LYGAR-KYDPGVDLWAVGCIFAELL-NGSP---LFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 60/194 (30%), Positives = 91/194 (46%), Gaps = 7/194 (3%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
LGSG FG V+ G VAIK N + + F E +V+ + H L+++ C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 359 TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL-NIMIDVALALEYLHHGHSTPVVHCDL 417
+V EFM NG L +L + D L ++ DV +EYL +H DL
Sbjct: 71 QKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDL 126
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
N L+ V VSDFG+++ + + D+ + + + PE + SSK DV+
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185
Query: 478 SYGILLLETFTRKK 491
S+G+L+ E FT K
Sbjct: 186 SFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 297 NLLGSGGFGSVYKGILS----DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNL 349
LG G FG VY+G+ D + + + L EQ F E ++ H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIP------DRLNIMIDVALALEY 403
++++ + ++LE M G L +L + + P D L DVA +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 404 LHHGHSTPVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460
L H +H D+ N LL VA ++DFG+++ + + I +M
Sbjct: 132 LEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 461 APEFGSEGNVSSKCDVYSYGILLLETFT 488
PE +G +SK DV+S+G+LL E F+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 11/204 (5%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357
LG G FG VYK G A KI ++ E+ F E ++L +H N++ + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
N +++EF G+LD + P + + AL +L HS V+H DL
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL---HSHKVIHRDL 129
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF-----GSEGNVSS 472
K NILL + ++DFG+S + I T +MAPE +
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDY 187
Query: 473 KCDVYSYGILLLETFTRKKPTDEM 496
K D++S GI L+E + P E+
Sbjct: 188 KADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ------AFRSFNSECEVLRNVRHRNLIK 351
+G G +G VYK G VAIK L+ E A R E ++L+ + H N+IK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHST 410
+L + LV EFM + L K + + + + L + H HG
Sbjct: 63 LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--- 118
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--FGSEG 468
++H DLKP N+L++ V ++DFG+++ G T + T Y APE G +G
Sbjct: 119 -ILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 469 NVSSKCDVYSYGILLLETFTRK 490
S+ D++S G + E +R+
Sbjct: 176 -YSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRS-FNSECEVLRNVRH---R 347
+ L+G G +G+VY+G + G VA+KI NL S E +L +R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 348 NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN--IMIDVALALEYLH 405
N+ K S +++E+ GS+ + + I ++ I+ +V +AL+Y+H
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIH 118
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFG 465
V+H D+K +NIL+ + DFG++ LL + S ++ + T +MAPE
Sbjct: 119 K---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFVGTPYWMAPEVI 173
Query: 466 SEGNV-SSKCDVYSYGILLLETFTRKKP 492
+EG +K D++S GI + E T P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 67/228 (29%), Positives = 116/228 (50%), Gaps = 16/228 (7%)
Query: 299 LGSGGFGSVYKGILS---DGTTVAIKIF-NLQLEQAFR-SFNSECEVLRNVRHRNLIKIL 353
LGSG FG+V KG+ TVA+KI N + A + E V++ + + +++++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVV 413
C ++ LV+E G L+K+L + + + + ++ V++ ++YL T V
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEE---TNFV 117
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT--IGYMAPEFGSEGNVS 471
H DL N+LL A +SDFG+SK LG D++ + T + + APE + S
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGA-DENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 472 SKCDVYSYGILLLETFTR-KKPTDEMFTGEMN--LKNWVKESLPHGLP 516
SK DV+S+G+L+ E F+ +KP M E+ +++ + P P
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCP 224
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 21/221 (9%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIK---IFNLQLEQAFRSFNSECEVLRNVRHRNLIKILS 354
+G G F VY+ L DG VA+K IF+L +A E ++L+ + H N+IK +
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD----IPDRL--NIMIDVALALEYLHHGH 408
S N +VLE G L + + +F+ IP++ + + ALE H H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPEKTVWKYFVQLCSALE---HMH 123
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG 468
S V+H D+KP+N+ + V + D G+ + + + T YM+PE E
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHEN 181
Query: 469 NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKE 509
+ K D++S G LL E + P + +MNL + K+
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKK 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 51/286 (17%)
Query: 299 LGSGGFGSVYK----GILS--DGTTVAIKIFNLQLE-QAFRSFNSECEVLRNVRHRNLIK 351
+G G FG V++ G+L T VA+K+ + F E ++ H N++K
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWL--------------------YSHNYFQ-DIPDR 390
+L C L+ E+M G L+++L N ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 391 LNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450
L I VA + YL VH DL N L+ ENMV ++DFG+S+ + D
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRK-KPTDEMFTGEMNLKNWVKE 509
I +M PE +++ DV++YG++L E F+ +P M E+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV-------- 241
Query: 510 SLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQR 555
I +R+ N S +C L +++L C ++LP R
Sbjct: 242 --------IY---YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDR 276
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 67/259 (25%), Positives = 124/259 (47%), Gaps = 27/259 (10%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
LG+G FG V+ + T VA+K + +F +E V++ ++H L+K L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVK-LHAVVT 71
Query: 359 TNFKALVLEFMPNGSLDKWLYS-HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
++ EFM GSL +L S Q +P ++ +A + ++ + +H DL
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDL 128
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
+ +NIL+ ++V ++DFG+++++ E ++ + I + APE + G+ + K DV+
Sbjct: 129 RAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 478 SYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDC 536
S+GILL+E T + P M E V +L G + R EN C
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPE------VIRALERGY------RMPRPEN-------C 228
Query: 537 LLSIFHLALDCCAELPDQR 555
++++ + C P++R
Sbjct: 229 PEELYNIMMRCWKNRPEER 247
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 297 NLLGSGGFGSVYKG-ILSDGTTVAIKIFNLQ---LEQAFRSFNSECEVL-RNVRHRNLIK 351
+++G G FG V K I DG + I ++ + R F E EVL + H N+I
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIP---------------DRLNIMID 396
+L +C + + L +E+ P+G+L +L + P L+ D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT 456
VA ++YL +H DL NIL+ EN VA ++DFG+S+ G+ + V +TM
Sbjct: 133 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVKKTMGRLP 186
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLE 485
+ +MA E + ++ DV+SYG+LL E
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 215
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 297 NLLGSGGFGSVYKGILSDG----TTVAIKIFN--LQLEQAFRSFNSECEVLRNVRHRNLI 350
++G G FG VY G L D A+K N LE+ F E ++++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV-EQFLKEGIIMKDFSHPNVL 59
Query: 351 KILSSCCNTNFKALV-LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS 409
+L C + LV L +M +G L ++ S + + D + + VA +EYL S
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---S 116
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT--IGYMAPEFGSE 467
VH DL N +LDE+ V+DFG+++ + + + + T A + +MA E
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 468 GNVSSKCDVYSYGILLLETFTRKKP 492
++K DV+S+G+LL E TR P
Sbjct: 177 QKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-16
Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 34/267 (12%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIK---IFNLQLEQAFRSFNSECEVLRNVRHRNLIKILS 354
+G G F VY+ L D VA+K IF + +A + E ++L+ + H N+IK L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD----IPDRL--NIMIDVALALEYLHHGH 408
S N +VLE G L + + YF+ IP+R + + A+E H H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMI---KYFKKQKRLIPERTVWKYFVQLCSAVE---HMH 123
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG 468
S V+H D+KP+N+ + V + D G+ + + + T YM+PE E
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHEN 181
Query: 469 NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528
+ K D++S G LL E + P + +MNL SL + + L E
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLF-----SLCQKIEQCDYPPLPTEH- 232
Query: 529 FFSARMDCLLSIFHLALDCCAELPDQR 555
+S ++ L+S+ C PDQR
Sbjct: 233 -YSEKLRELVSM------CIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAF-----RSFNSECEVLRNVRH 346
F + +LGSG FG+VYKG+ + +G V I + +L +A + E V+ +V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 347 RNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--LNIMIDVALALEYL 404
++ ++L C + + L+ + MP G L ++ H +I + LN + +A + YL
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYL 125
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF 464
+VH DL N+L+ ++DFG++KLLG + I +MA E
Sbjct: 126 EERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 465 GSEGNVSSKCDVYSYGILLLETFT-RKKPTD 494
+ + DV+SYG+ + E T KP D
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 58/301 (19%)
Query: 299 LGSGGFGSVYK----GILSD----GTTVAIKIF-NLQLEQAFRSFNSECEVLRNV-RHRN 348
LG G FG V GI D TVA+K+ + E+ SE E+++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSH-----NYFQDI----------PDRLNI 393
+I +L +C +++E+ G+L ++L + Y DI D ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 394 MIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT 453
VA +EYL S +H DL N+L+ EN V ++DFG+++ + D T
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 454 IATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKK------PTDEMFTGEMNLKNWV 507
+ +MAPE + + + DV+S+G+L+ E FT P +E+F
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF---------- 249
Query: 508 KESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567
LL+E + +C ++ + DC +P R K L +
Sbjct: 250 --------------KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295
Query: 568 I 568
I
Sbjct: 296 I 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 26/202 (12%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-------HRNLI 350
LG G FGSVY G VAIK ++++ F S+ EC LR V+ H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSW-EECMNLREVKSLRKLNEHPNIV 61
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALEYLH-HG 407
K+ + V E+M G+L + L + + + +I+ + L ++H HG
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 408 HSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-FGS 466
H DLKP N+L+ V ++DFG+++ E T ++T Y APE
Sbjct: 120 F----FHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTRWYRAPEILLR 172
Query: 467 EGNVSSKCDVYSYGILLLETFT 488
+ SS D+++ G ++ E +T
Sbjct: 173 STSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 76/242 (31%), Positives = 115/242 (47%), Gaps = 28/242 (11%)
Query: 298 LLGSGGFGSVY---KGILSD-GTTVAIKIF---NLQLEQAFRSFNSECEVLRNVRHRNLI 350
+LG G FG V+ K D G A+K+ L++ R+ E ++L V H ++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61
Query: 351 KILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS 409
K L T K L+L+F+ G L L F + D + ++ALAL++LH S
Sbjct: 62 K-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE-EDVKFYLAELALALDHLH---S 116
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPEFGSEG 468
+++ DLKP NILLDE ++DFG+SK E D + + T+ YMAPE +
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 469 NVSSKCDVYSYGILLLETFTRKKPTDEMFTGE-----MNLKNWVKESLPHGLPKIADANL 523
+ D +S+G+L+ E T P F G+ M + K +P L A + L
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLP----FQGKDRKETMTMILKAKLGMPQFLSPEAQS-L 228
Query: 524 LR 525
LR
Sbjct: 229 LR 230
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 297 NLLGSGGFGSVYKGILS-DG--TTVAIKIFN-LQLEQAFRSFNSECEVLRNV-RHRNLIK 351
+++G G FG V K + DG AIK + R F E EVL + H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIP---------------DRLNIMID 396
+L +C + + L +E+ P+G+L +L + P L+ D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT 456
VA ++YL +H DL NIL+ EN VA ++DFG+S+ G+ + V +TM
Sbjct: 121 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVKKTMGRLP 174
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLE 485
+ +MA E + ++ DV+SYG+LL E
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 203
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 73/224 (32%), Positives = 102/224 (45%), Gaps = 42/224 (18%)
Query: 295 ECNLLGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKIL 353
+ +G G FG+V K + GT +A+K RS E E R + +++
Sbjct: 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVK--------RIRSTVDEKEQKRLLMDLDVVMRS 59
Query: 354 SSCCN--TNFKAL--------VLEFMPNGSLDKWLYSHNYF---QDIPDRLNIMIDVAL- 399
S C + AL +E M + SLDK Y + Y IP+ I+ +A+
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELM-DISLDK-FYKYVYEVLKSVIPE--EILGKIAVA 115
Query: 400 ---ALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT 456
AL YL ++H D+KPSNILLD N + DFGIS G+ DS+ +T
Sbjct: 116 TVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKTRDAGC 170
Query: 457 IGYMAPE----FGSEG-NVSSKCDVYSYGILLLETFTRKKPTDE 495
YMAPE +G +V S DV+S GI L E T K P +
Sbjct: 171 RPYMAPERIDPSARDGYDVRS--DVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 65/238 (27%), Positives = 116/238 (48%), Gaps = 39/238 (16%)
Query: 299 LGSGGFGSVY----KGI---LSDGTT--------VAIKIFNLQLEQAFRS-FNSECEVLR 342
LG G FG V+ +G+ L +G VA+K+ + + R+ F E +++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 343 NVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYF------QDIP-----DRL 391
+++ N+I++L C + + ++ E+M NG L+++L +IP + L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 392 NIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451
+ + +A ++YL S VH DL N L+ + ++DFG+S+ L GD IQ
Sbjct: 133 YMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT--RKKP----TDEMF---TGE 500
+ I +MA E G ++ DV+++G+ L E FT +++P +DE TGE
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGE 247
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 74/301 (24%), Positives = 127/301 (42%), Gaps = 58/301 (19%)
Query: 299 LGSGGFGSVYK----GILSDG----TTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRN 348
LG G FG V G+ + T VA+K+ E+ SE E+++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWL---------YSHNYFQ------DIPDRLNI 393
+I +L +C +++E+ G+L ++L Y +N Q D ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 394 MIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT 453
VA +EYL S +H DL N+L+ E+ V ++DFG+++ + D T
Sbjct: 146 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 454 IATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKK------PTDEMFTGEMNLKNWV 507
+ +MAPE + + + DV+S+G+LL E FT P +E+F
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---------- 252
Query: 508 KESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567
LL+E + +C ++ + DC +P QR K L +
Sbjct: 253 --------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298
Query: 568 I 568
I
Sbjct: 299 I 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 64/227 (28%), Positives = 100/227 (44%), Gaps = 21/227 (9%)
Query: 299 LGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357
LG G FG VYK + G A K+ + E+ + E E+L H ++K+L +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
+++EF P G++D + + P I + LE L + HS ++H DL
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVICRQMLEALQYLHSMKIIHRDL 136
Query: 418 KPSNILLDENMVAHVSDFGIS----KLLGEGDDSVIQTMTIATIGYMAPEF-----GSEG 468
K N+LL + ++DFG+S K L D I T +MAPE +
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS------FIGTPYWMAPEVVMCETMKDT 190
Query: 469 NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGL 515
K D++S GI L+E + P E+ + LK + +S P L
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK--IAKSEPPTL 235
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 299 LGSGGFGSVY----KGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLRNVRHRNLI 350
LG+G +G V+ G G A+K+ +Q + +E +VL VR +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 351 KILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS 409
L T+ K L+L+++ G L LY +F + R+ I ++ LAL++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ--- 123
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF--GSE 467
+++ D+K NILLD ++DFG+SK ++ + TI YMAPE G
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAPEVIRGGS 182
Query: 468 GNVSSKCDVYSYGILLLETFTRKKPTDEMFT--GEMN 502
G D +S G+L E T P FT GE N
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASP----FTVDGEQN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 298 LLGSGGFGSVYKGILSD-GTTVAIKI--FNLQLEQAFRSFNS-ECEV--LRNVRHRNLIK 351
LLG G FG VY +D G +A+K F+ + + + N+ ECE+ L+N+ H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 352 ILSSCCNTNFKAL--VLEFMPNGSLDKWLYSHNYF-QDIPDRLNIMIDVALALEYLHHGH 408
+ + L +E MP GS+ L S+ +++ + I LE + + H
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLL------GEGDDSVIQTMTIATIGYMAP 462
S +VH D+K +NIL D + DFG SK L G G SV T +M+P
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-----TGTPYWMSP 178
Query: 463 EFGSEGNVSSKCDVYSYGILLLETFTRKKPTDE 495
E S K D++S G ++E T K P E
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-14
Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 47/226 (20%)
Query: 298 LLGSGGFGSV-YKGILSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILS 354
+LGSG G+V +SDG A+K+ +++ E +E L N +++K
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK--- 95
Query: 355 SCCNTNFK-------------ALVLEFMPNGSLDKWLYSHNYFQDIPDRLN--------- 392
C+ +F ALVL++ G L Q+I R
Sbjct: 96 --CHEDFAKKDPRNPENVLMIALVLDYANAGDLR---------QEIKSRAKTNRTFREHE 144
Query: 393 ---IMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG-DDSV 448
+ I V LA+ HH HS ++H D+K +NILL N + + DFG SK+ D V
Sbjct: 145 AGLLFIQVLLAV---HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201
Query: 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTD 494
+T T Y+APE S K D++S G+LL E T K+P D
Sbjct: 202 GRTFC-GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 11/201 (5%)
Query: 298 LLGSGGFGSVYKGIL----SDGTTVAIKIFNLQLEQAFRS-FNSECEVLRNVRHRNLIKI 352
+G G FG VY+G+ ++ VA+K + R F E ++R H +++K
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK- 71
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
L N +V+E P G L +L + Y D+ + ++ AL YL S
Sbjct: 72 LIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRF 128
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
VH D+ N+L+ + DFG+S+ L E + + I +MAPE + +S
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 473 KCDVYSYGILLLETFTR-KKP 492
DV+ +G+ + E KP
Sbjct: 188 ASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 60/239 (25%), Positives = 110/239 (46%), Gaps = 40/239 (16%)
Query: 299 LGSGGFGSVY----KGIL-------------SDGTTVAIKIFNLQLEQAFRS-FNSECEV 340
LG G FG V+ +G+ + VA+K+ + R+ F E ++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 341 LRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR---------- 390
+ ++ N+I++L+ C ++ ++ E+M NG L+++L H +
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 391 LNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450
+ + +A ++YL S VH DL N L+ +N ++DFG+S+ L GD IQ
Sbjct: 133 IFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT--RKKP----TDEMF---TGE 500
+ I +M+ E G ++ DV+++G+ L E T +++P +DE TGE
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 293 FNECNLLGSGGFGSVYKGILSDGTT---VAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRN 348
F + +G G FG V+KGI D T VAIKI +L+ E E VL
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH 408
+ K S +++E++ GS L + + D I + L+ L + H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF-----DEFQIATMLKEILKGLDYLH 118
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEFGSE 467
S +H D+K +N+LL E ++DFG++ G+ D+ I+ T + T +MAPE +
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 468 GNVSSKCDVYSYGILLLETFTRKKPTDEM 496
SK D++S GI +E + P +M
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 58/191 (30%), Positives = 86/191 (45%), Gaps = 18/191 (9%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLE-QAFRSFNSECEVLRNVRHRNLIKILSSC 356
LG G G+VYK L +A+K+ L + + + SE E+L +I +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALEYLHHGHSTPVVH 414
N ++ EFM GSLD ++ IP+ + I + V L YL S ++H
Sbjct: 69 FVENRISICTEFMDGGSLD-------VYRKIPEHVLGRIAVAVVKGLTYLW---SLKILH 118
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKC 474
D+KPSN+L++ + DFG+S L I + T YMAPE S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 475 DVYSYGILLLE 485
DV+S GI +E
Sbjct: 175 DVWSLGISFME 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNL----QLEQAFRSFNSECEVLRNVR 345
D +G+G FG V+ A+K+ + +L+Q + ++E VL+ V
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE-QHVHNEKRVLKEVS 59
Query: 346 HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH 405
H +I++ + + F +++E++P G L +L + F + ++ ALEYLH
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH 118
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPE- 463
S +V+ DLKP NILLD+ ++DFG +K L +T T+ T Y+APE
Sbjct: 119 ---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCGTPEYLAPEV 169
Query: 464 FGSEGNVSSKCDVYSYGILLLETFTRKKP 492
S+G+ + D ++ GIL+ E P
Sbjct: 170 IQSKGH-NKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 68/228 (29%), Positives = 107/228 (46%), Gaps = 39/228 (17%)
Query: 287 ERATDGFNECNLLGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQ------AFRSFNSECE 339
+R D F+ +G G +G VYK D G VA+K L E+ A R E +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR----EIK 58
Query: 340 VLRNVRHRNLIKILSSCCN----TNFKA------LVLEFMPN---GSLDKWL--YSHNYF 384
+LR + HRN++ + + +FK LV E+M + G L+ L +S ++
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 385 QDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444
+ +L LE L++ H +H D+K SNILL+ ++DFG+++L
Sbjct: 119 KSFMKQL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY-NS 168
Query: 445 DDSVIQTMTIATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK 490
++S T + T+ Y PE G E DV+S G +L E FT+K
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 62/247 (25%), Positives = 109/247 (44%), Gaps = 27/247 (10%)
Query: 295 ECNLLGSGGFGSVY----KGILSDG--TTVAIKIFNLQLEQAFRS-FNSECEVLRNVRHR 347
E LG G FG V+ KGI +G T V +K ++ +S F E ++ R + H+
Sbjct: 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 348 NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD--------IPDRLNIMIDVAL 399
N++++L C ++LE+ G L ++L + + ++ + +AL
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 400 ALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGY 459
+++L + VH DL N L+ VS +SK + + + + +
Sbjct: 129 GMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDV-YNSEYYKLRNALIPLRW 184
Query: 460 MAPEFGSEGNVSSKCDVYSYGILLLETFTR-----KKPTDEMF---TGEMNLKNWVKESL 511
+APE E + S+K DV+S+G+L+ E FT+ +DE L+ V E
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGC 244
Query: 512 PHGLPKI 518
P L K+
Sbjct: 245 PSRLYKL 251
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 26/228 (11%)
Query: 299 LGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQAFRSFN---SECEVLRNVRHRNLIKILS 354
+G GG+G V+ D G VA+K L +E ++L + L+K+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHH-GHSTPVV 413
+ + + L +E++P G L + + R M ++ A++ LH G+ +
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDALHELGY----I 123
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSK 473
H DLKP N L+D + ++DFG+SK + +SV + + YMAPE
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPEVLRGKGYDFT 178
Query: 474 CDVYSYGILLLETFTRKKP-----TDEMFTGEMNLKNWVKESL--PHG 514
D +S G +L E P +E + NLK W KE+L P
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW-KETLQRPVY 222
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 60/162 (37%), Positives = 90/162 (55%), Gaps = 5/162 (3%)
Query: 28 LKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSN 87
L L SL L N+L +I L LT+L L L++N +T P + ++LS N
Sbjct: 92 LLPLPSLDLNLNRLRSNISELLE-LTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDN 150
Query: 88 YLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGS 147
+ SL S ++N+ L +LDLS N LS D+PK ++ L +L NL L+GN+ +P
Sbjct: 151 KIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIEL 207
Query: 148 LISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEI 189
L +LE LDLS+N++ E + SL L +L +S+N+LE
Sbjct: 208 LSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKLEDLP 248
|
Length = 394 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 19/234 (8%)
Query: 287 ERATDGFNECNLLGSGGFGSVY----KGILSDG--TTVAIKIFNLQLEQAFR-SFNSECE 339
E A + LG G FG VY KG++ D T VAIK N R F +E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 340 VLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYS-----HNYFQDIPDRLNIM 394
V++ +++++L +++E M G L +L S N P L M
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 395 I----DVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450
I ++A + YL+ + VH DL N ++ E+ + DFG+++ + E D
Sbjct: 122 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLK 504
+ + +M+PE +G ++ DV+S+G++L E T + + + E L+
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 8e-14
Identities = 74/229 (32%), Positives = 112/229 (48%), Gaps = 56/229 (24%)
Query: 299 LGSGGFGSVYKGILSD---GTTVAIK-IFNLQLEQAFRSFNS--------ECEVLRNVR- 345
LG G +G V+K I D VA+K IF AFR N+ E L+ +
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIF-----DAFR--NATDAQRTFREIMFLQELGD 65
Query: 346 HRNLIKILSSCCNTNFKA-------LVLEFMPNGSLDKWLYS---HNYFQDIPDRLNIMI 395
H N++K+L+ KA LV E+M + L++ N +D+ R IM
Sbjct: 66 HPNIVKLLNV-----IKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMY 114
Query: 396 DVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV---IQTM 452
+ AL+Y+H G+ V+H DLKPSNILL+ + ++DFG+++ L E +++ + T
Sbjct: 115 QLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 453 TIATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG 499
+AT Y APE GS + D++S G +L E KP +F G
Sbjct: 172 YVATRWYRAPEILLGST-RYTKGVDMWSVGCILGEML-LGKP---LFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 15/176 (8%)
Query: 333 SFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSH--------NYF 384
F E ++L + N+ ++L C +++E+M NG L+++L H
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 385 QDIPDR--LNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442
+ + L + +A + YL S VH DL N L+ +N ++DFG+S+ L
Sbjct: 125 KSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT--RKKPTDEM 496
D +Q I +MA E G ++K DV+++G+ L E T R++P + +
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 298 LLGSGGFGSVYKGILSD-GTTVAIK--IFNLQLEQAFRSFNS-ECEV--LRNVRHRNLIK 351
LLG G FG VY +D G +A+K F+ ++ + N+ ECE+ L+N+RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 352 ILSSCCNTNFKALVL--EFMPNGSLDKWLYSHNYF-QDIPDRLNIMIDVALALEYLHHGH 408
+ K L + E+MP GS+ L ++ +++ R I L+ + + H
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI-----LQGVSYLH 123
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG---------Y 459
S +VH D+K +NIL D + DFG SK IQT+ ++ G +
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKR--------IQTICMSGTGIKSVTGTPYW 175
Query: 460 MAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDE 495
M+PE S K DV+S ++E T K P E
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 299 LGSGGFGSVYKG-----ILSDGT-TVAIKIFNLQLEQAFR-SFNSECEVLRNV-RHRNLI 350
LG+G FG V + SD VA+K+ + R + SE +++ ++ H N++
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNY-FQDIPDRLNIMIDVALALEYLHHGHS 409
+L +C ++ E+ G L +L F + D L+ VA + +L S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---S 159
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGN 469
+H DL N+LL + + DFG+++ + + V++ + +MAPE
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219
Query: 470 VSSKCDVYSYGILLLETFT 488
+ + DV+SYGILL E F+
Sbjct: 220 YTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 68/215 (31%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 298 LLGSGGFGSVYKG-ILSDGTTVAIKIFNLQLEQAFRSFNSE--CEVLRNVRHRNLIKILS 354
+GSG G VYK G +A+K Q R+ N E +L ++ + + S
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVK-------QMRRTGNKEENKRILMDLD----VVLKS 70
Query: 355 SCCN----------TNFKALV-LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVAL--AL 401
C T+ + +E M LDK L IP+ + + VA+ AL
Sbjct: 71 HDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKAL 127
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 461
YL H V+H D+KPSNILLD + + DFGIS G DS +T + YMA
Sbjct: 128 HYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKAKTRSAGCAAYMA 182
Query: 462 PEFGSEGNVSSK----CDVYSYGILLLETFTRKKP 492
PE + + K DV+S GI L+E T + P
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357
+G G G+VY I ++ G VAIK NLQ + +E V+R +H N++ L S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
+ +V+E++ GSL + + + + + ALE+LH V+H D+
Sbjct: 87 VGDELWVVMEYLAGGSLTD-VVTETCMDE-GQIAAVCRECLQALEFLHSNQ---VIHRDI 141
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
K NILL + ++DFG + + S TM + T +MAPE + K D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 478 SYGILLLETFTRKKP 492
S GI+ +E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 73/289 (25%), Positives = 127/289 (43%), Gaps = 38/289 (13%)
Query: 298 LLGSGGFGSVYKGIL--SDGT--TVAIKIFNLQLEQA--FRSFNSECEVLRNVRHRNLIK 351
+LG G FGSV + L DG+ VA+K+ + + F E ++ H N+IK
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 352 ILSSCCNTNFKA------LVLEFMPNGSLDKWLYSHNYFQD---IPDR--LNIMIDVALA 400
++ + K ++L FM +G L +L ++ +P + + MID+A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460
+EYL S +H DL N +L+ENM V+DFG+SK + GD + + ++
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 461 APEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520
A E ++ ++ DV+++G+ + E TR + + G N + +
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP---YAGVENSEIY-------------- 225
Query: 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569
N L + N DCL ++ L C + P R + +L+ I
Sbjct: 226 -NYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 299 LGSGGFGSVYKG-ILSDGTTVAIKIFNLQ-----LEQAFRSFNSECEVLRNVRHRNLIKI 352
+G+G FG V G + S T + + L+ EQ F E + R+++H NL++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQ--MKFLEEAQPYRSLQHSNLLQC 60
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDI-PDRLNIM---IDVALALEYLHHGH 408
L C LV+EF P G L +L S + + PD + ++AL L +LH +
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE- 467
+H DL N LL ++ + D+G+S + D V + ++APE E
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 468 -GNV-----SSKCDVYSYGILLLETF 487
GN+ + + +V+S G+ + E F
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 39/217 (17%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ------AFRSFNSECEVLRNVR 345
F + +G G +G VYK G VA+K L E A R E +L+ +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELN 57
Query: 346 HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIM-IDVALALEYL 404
H N++K+L N LV EF+ + L K++ D + I + L YL
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM----------DASPLSGIPLPLIKSYL 106
Query: 405 H---HG----HSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IA 455
G HS V+H DLKP N+L++ ++DFG+++ G ++T T +
Sbjct: 107 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVV 162
Query: 456 TIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK 490
T+ Y APE G + S+ D++S G + E TR+
Sbjct: 163 TLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 53/235 (22%)
Query: 291 DGFNECNLLGSGGFGSVYKGIL----SDGTTVAIKIFN----LQLEQAFRSFNSECEVLR 342
D F ++G G FG V+ L G A+K+ ++ Q +E ++L
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQI-AHVRAERDILA 56
Query: 343 NVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALE 402
+ ++K+ S + LV+E+MP G L L + F + R I ++ LAL+
Sbjct: 57 DADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALD 115
Query: 403 YLHH-GHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDS------------ 447
+H G +H D+KP NIL+D + H+ +DFG+ K + + D
Sbjct: 116 SVHKLGF----IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 448 ---------------VIQTMTIATIGYMAPEF--GSEGNVSSKCDVYSYGILLLE 485
V T+ T Y+APE G+ + CD +S G++L E
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE--CDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 32/208 (15%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ------AFRSFNSECEVLRNVRHRNLIK 351
+G G +G VYKG G VA+K L+ E+ A R E +L+ ++H N++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIVC 63
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHH----- 406
+ + L+ EF+ S+D Y +P +D L YL+
Sbjct: 64 LQDVLMQESRLYLIFEFL---SMD----LKKYLDSLPK--GQYMDAELVKSYLYQILQGI 114
Query: 407 --GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE- 463
HS V+H DLKP N+L+D V ++DFG+++ G + T + T+ Y APE
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI--PVRVYTHEVVTLWYRAPEV 172
Query: 464 -FGSEGNVSSKCDVYSYGILLLETFTRK 490
GS S+ D++S G + E T+K
Sbjct: 173 LLGSP-RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 74/301 (24%), Positives = 129/301 (42%), Gaps = 58/301 (19%)
Query: 299 LGSGGFGSVYK----GILSD----GTTVAIKIF-NLQLEQAFRSFNSECEVLRNV-RHRN 348
LG G FG V + GI TVA+K+ + ++ SE E+++ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSH-----NYFQDI----------PDRLNI 393
+I +L C +++E+ G+L ++L + +Y DI D ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 394 MIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT 453
VA +EYL S +H DL N+L+ E+ V ++DFG+++ + + D +
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 454 IATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKK------PTDEMFTGEMNLKNWV 507
+ +MAPE + + + DV+S+GIL+ E FT P +E+F
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF---------- 246
Query: 508 KESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567
LLRE + +C ++ L +C +P QR K L K
Sbjct: 247 --------------KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292
Query: 568 I 568
+
Sbjct: 293 V 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 73/301 (24%), Positives = 130/301 (43%), Gaps = 58/301 (19%)
Query: 299 LGSGGFGSVYK----GILSD----GTTVAIKIF-NLQLEQAFRSFNSECEVLRNV-RHRN 348
LG G FG V GI D TVA+K+ + ++ SE E+++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSH-----NYFQD---IP-------DRLNI 393
+I +L +C +++E+ G+L ++L + +Y D +P D ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 394 MIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT 453
VA +EYL S +H DL N+L+ E+ V ++DFG+++ + D T
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 454 IATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKK------PTDEMFTGEMNLKNWV 507
+ +MAPE + + + DV+S+G+LL E FT P +E+F
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF---------- 246
Query: 508 KESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567
LL+E + +C ++ + +C +P QR K L +
Sbjct: 247 --------------KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDR 292
Query: 568 I 568
+
Sbjct: 293 V 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-13
Identities = 38/103 (36%), Positives = 58/103 (56%), Gaps = 1/103 (0%)
Query: 82 VNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPI 141
+ L + L G + +DI ++ L ++LS N + G+IP ++ + L L L+ N F G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 142 PESFGSLISLESLDLSSNNLSEGIPKSLVA-LSHLKQFNVSHN 183
PES G L SL L+L+ N+LS +P +L L H FN + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 13/208 (6%)
Query: 293 FNECNLLGSGGFGSVYKGILSDGTT---VAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRN 348
F + +G G FG V+KGI D T VAIKI +L+ E E VL
Sbjct: 6 FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH 408
+ K S +++E++ GS L D I+ ++ L+YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPL--DETQIATILREILKGLDYLH--- 118
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG 468
S +H D+K +N+LL E+ ++DFG++ L D + + + T +MAPE +
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 469 NVSSKCDVYSYGILLLETFTRKKPTDEM 496
SK D++S GI +E + P E+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 69/229 (30%), Positives = 104/229 (45%), Gaps = 25/229 (10%)
Query: 293 FNECNLLGSGGFGSVY----KGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLRNV 344
F +LG+G +G V+ G A+K+ +Q + +E VL +V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 345 RHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEY 403
R + L T K L+L+++ G + LY + F + R ++ LALE+
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEH 120
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK-LLGEGDDSVIQTMTI-ATIGYMA 461
LH +V+ D+K NILLD ++DFG+SK L E + +T + TI YMA
Sbjct: 121 LH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE---RTYSFCGTIEYMA 174
Query: 462 PE-FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFT--GEMNLKNWV 507
PE +G D +S GIL+ E T P FT GE N ++ V
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASP----FTLEGERNTQSEV 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 31/281 (11%)
Query: 298 LLGSGGFGSVYKGI-LSDGTT----VAIKIFNLQLE-QAFRSFNSECEVLRNVRHRNLIK 351
+LGSG FG+VYKGI + DG VAIK+ +A + E V+ V + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
+L C + + LV + MP G L ++ + D LN + +A + YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL---EEVR 129
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVS 471
+VH DL N+L+ ++DFG+++LL + I +MA E +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 472 SKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFF 530
+ DV+SYG+ + E T KP D G+P +LL +
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYD-------------------GIPAREIPDLLEKGERL 230
Query: 531 SARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI-RD 570
C + ++ + + C + R ++ + ++ RD
Sbjct: 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 54/201 (26%), Positives = 81/201 (40%), Gaps = 15/201 (7%)
Query: 299 LGSGGFGSVYKGILSD-GTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRNLIKILS 354
LG GGFG V + G A K + L+ + + +E ++L V I L+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59
Query: 355 SCCNTNFK-ALVLEFMPNGSLDKWLYSHNY--FQDIPDRLNIMIDVALALEYLHHGHSTP 411
T LV+ M G L +Y+ F + + + LE+LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPE-ARAIFYAAQIICGLEHLHQRR--- 115
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVS 471
+V+ DLKP N+LLD++ +SD G++ L G T GYMAPE
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---KGRAGTPGYMAPEVLQGEVYD 172
Query: 472 SKCDVYSYGILLLETFTRKKP 492
D ++ G L E + P
Sbjct: 173 FSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-13
Identities = 32/76 (42%), Positives = 44/76 (57%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+ +++ LQ I L+ N ++G+IP L + L L L N NGSIP L LTSLR L L
Sbjct: 438 ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497
Query: 61 NSNKLTSSIPSALWAL 76
N N L+ +P+AL
Sbjct: 498 NGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 285 DLERAT--DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVL 341
DL R + F +GSG +G VYK ++ G AIK+ L+ + F E ++
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMM 60
Query: 342 RNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALA- 400
++ +H N++ S + + +EF GSL QDI + + +A
Sbjct: 61 KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL----------QDIYHVTGPLSESQIAY 110
Query: 401 -----LEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA 455
L+ L++ HS +H D+K +NILL +N ++DFG+S + + I
Sbjct: 111 VSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIG 168
Query: 456 TIGYMAPEFGS---EGNVSSKCDVYSYGILLLETFTRKKP 492
T +MAPE + +G + CD+++ GI +E + P
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 7e-13
Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 298 LLGSGGFGSVYKGILSD-GTTVAIKIFNLQLE-----QAFRSFNSECEVLRNVRHRNLIK 351
LLG G FG VY D G +A K E + + E ++L+N++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 352 ILSSCCNTNFKALV--LEFMPNGSLDKWLYSHNYF-QDIPDRLNIMIDVALALEYLHHGH 408
+ K L +E+MP GS+ L ++ + + + I LE + + H
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI-----LEGMSYLH 123
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLL------GEGDDSVIQTMTIATIGYMAP 462
S +VH D+K +NIL D + DFG SK L G G SV T +M+P
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV-----TGTPYWMSP 178
Query: 463 EFGSEGNVSSKCDVYSYGILLLETFTRKKPTDE 495
E S K DV+S G ++E T K P E
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-13
Identities = 54/186 (29%), Positives = 84/186 (45%), Gaps = 16/186 (8%)
Query: 315 GTTVAIKIF---NLQLEQAFRSFNSECEVLRNVRHRNLIKILSS-CCNTNFKALVLEFMP 370
G VAIK+ + E F E + + H N++ +L S V E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL---DEN 427
+L + L + + +M+ V L+ L H+ +VH DLKP NI++
Sbjct: 63 GRTLREVLAADGALPAG-ETGRLMLQV---LDALACAHNQGIVHRDLKPQNIMVSQTGVR 118
Query: 428 MVAHVSDFGISKLLGEGDDSVIQTMTIAT--IG---YMAPEFGSEGNVSSKCDVYSYGIL 482
A V DFGI LL D+ + T+T T +G Y APE V+ D+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 483 LLETFT 488
LE T
Sbjct: 179 FLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 28/203 (13%)
Query: 318 VAIKIFNLQLEQAFRS-FNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDK 376
VA+KI + R+ F E ++L ++ N+I++L C + + ++ E+M NG L++
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 377 WLYSHNYFQ------------------DIPDRLNIMIDVALALEYLHHGHSTPVVHCDLK 418
+L SH+ L++ + +A ++YL S VH DL
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165
Query: 419 PSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYS 478
N L+ EN+ ++DFG+S+ L GD IQ + I +MA E G ++ DV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 479 YGILLLETFT--RKKP----TDE 495
+G+ L E +++P TDE
Sbjct: 226 FGVTLWEILMLCKEQPYGELTDE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 299 LGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQA-FRSFNSECEVLRNVRHRNLIKILSSC 356
LG G +GSVYK + G T+A+K L+L+++ F E ++L ++ +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALEYLHHGHSTPVVH 414
+ +E+M GSLDK + IP+ + I V L++L H+ ++H
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIH 126
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS-- 472
D+KP+N+L++ N + DFG+S G S+ +T I YMAPE G +
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKT-NIGCQSYMAPERIKSGGPNQNP 182
Query: 473 ----KCDVYSYGILLLE 485
+ DV+S G+ +LE
Sbjct: 183 TYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 39/215 (18%)
Query: 297 NLLGSGGFGSVYKGI-LSDGTTVAIKI---FNLQL--EQAFRSFNSECEVLRNVRHRNLI 350
+ +G G +G V G VAIK F Q ++ R E ++LR +H N+I
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENII 66
Query: 351 KIL-----SSCCNTNFKALVLEFMPNGSLDKWLYSHN-------YFQDIPDRLNIMIDVA 398
IL S + N +V E M L K + + + YF + +
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYF---------LYQIL 116
Query: 399 LALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL-LGEGDDSVIQTMTIATI 457
L+Y+H S V+H DLKPSN+LL+ N + DFG++++ E D + T +AT
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 458 GYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK 490
Y APE S+G + D++S G +L E + +
Sbjct: 174 WYRAPEIMLNSKG-YTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 298 LLGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKI--- 352
++G G +G VYK G VAIKI ++ ++ E +LR H N+
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYGA 71
Query: 353 ---LSSCCNTNFKALVLEFMPNGS---LDKWLYSHNYFQDIPDRL--NIMIDVALALEYL 404
+ N + LV+E GS L K L + + + I+ + L YL
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG--KRLKEEWIAYILRETLRGLAYL 129
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVS--DFGISKLLGEGDDSVIQTMT-IATIGYMA 461
H V+H D+K NILL +N A V DFG+S L D ++ + T I T +MA
Sbjct: 130 HENK---VIHRDIKGQNILLTKN--AEVKLVDFGVSAQL---DSTLGRRNTFIGTPYWMA 181
Query: 462 PEFGS-----EGNVSSKCDVYSYGILLLETFTRKKPTDEM 496
PE + + + ++ DV+S GI +E K P +M
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 34/207 (16%)
Query: 298 LLGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQ-------AFRSFNSECEVLRNVRHRNL 349
L+G G +G V K + G VAIK F L+ E A R E +L+ +RH NL
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMR----EIRMLKQLRHENL 62
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN------IMIDVALALEY 403
+ ++ LV EF+ + LD + P+ L+ + + +E+
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDD-------LEKYPNGLDESRVRKYLFQILRGIEF 115
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 463
H S ++H D+KP NIL+ ++ V + DFG ++ L + + T +AT Y APE
Sbjct: 116 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPE 170
Query: 464 FGSEGNVS--SKCDVYSYGILLLETFT 488
G+ D+++ G L+ E T
Sbjct: 171 L-LVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 293 FNECNLLGSGGFGSVYKGILSDGT-TVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLI 350
F + +G G FG VYKGI + VAIKI +L+ E E VL +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 351 KILSSCCNTNFKALVLEFMPNGS----LDKWLYSHNYFQDIPDRLNIMIDVALALEYLHH 406
+ S +++E++ GS L Y I+ ++ L+YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA------TILREILKGLDYLH- 118
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEFG 465
S +H D+K +N+LL E ++DFG++ G+ D+ I+ T + T +MAPE
Sbjct: 119 --SERKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 466 SEGNVSSKCDVYSYGILLLETFTRKKPTDEM 496
+ K D++S GI +E + P ++
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 299 LGSGGFGSVY--KGILSDGTTVAIKIFNLQLEQAFRSFNSECEV--LRNVRHRNLIKILS 354
+G G FG +Y K SD IK +L S+ EV L ++H N++ +
Sbjct: 8 IGEGSFGKIYLAKA-KSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR-LNIMIDVALALEYLHHGHSTPVV 413
S +V+E+ G L K + D+ L+ + ++L L+ H H ++
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK---HIHDRKIL 123
Query: 414 HCDLKPSNILLDEN-MVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
H D+K NI L +N MVA + DFGI++ L D + + T Y++PE ++
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEICQNRPYNN 181
Query: 473 KCDVYSYGILLLETFTRKKP 492
K D++S G +L E T K P
Sbjct: 182 KTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 35/85 (41%), Positives = 53/85 (62%)
Query: 9 GIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSS 68
G+GL + L+G IP D+ +L+ L S++L GN + G+IP L S+TSL L L+ N S
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 69 IPSALWALEYILYVNLSSNYLTGSL 93
IP +L L + +NL+ N L+G +
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 299 LGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357
LG G FG VYK + G A K+ + + E+ + E ++L + H N++K+L +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
N +++EF G++D + P I + LE L++ H ++H DL
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEP---QIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPEF-----GSEGNV 470
K NIL + ++DFG+S + IQ I T +MAPE +
Sbjct: 130 KAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 471 SSKCDVYSYGILLLETFTRKKPTDEM 496
K DV+S GI L+E + P E+
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 13/210 (6%)
Query: 287 ERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRS-FNSECEVLRNV 344
E D F + + LG+G G V+K G +A K+ +L+++ A R+ E +VL
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 345 RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALE 402
++ + + ++ +E M GSLD+ L IP+++ + I V L
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLT 117
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
YL H ++H D+KPSNIL++ + DFG+S G+ DS+ + + T YM+P
Sbjct: 118 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSP 171
Query: 463 EFGSEGNVSSKCDVYSYGILLLETFTRKKP 492
E + S + D++S G+ L+E + P
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 19/222 (8%)
Query: 299 LGSGGFGSVYKGILSD------GTTVAIKIFNLQLEQAFR-SFNSECEVLRNVRHRNLIK 351
LG G FG VY+G D T VA+K N R F +E V++ ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYS-----HNYFQDIPDRLNIMI----DVALALE 402
+L +V+E M +G L +L S N P L MI ++A +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
YL+ + VH DL N ++ + + DFG+++ + E D + + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 463 EFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLK 504
E +G ++ D++S+G++L E + + + + E LK
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 299 LGSGGFGS--VYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILS 354
LG G FG +Y+ D + V K NL E+ R +E +L ++H N+I +
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNI--MIDVALALEYLHHGHSTPV 412
+ N + +E+ G+L + Q + + + + + A+ Y+H +
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGI 122
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
+H D+K NI L + + + DFGISK+LG + S+ +T+ + T YM+PE +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETV-VGTPYYMSPELCQGVKYNF 180
Query: 473 KCDVYSYGILLLETFTRKK 491
K D+++ G +L E T K+
Sbjct: 181 KSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 67/232 (28%), Positives = 102/232 (43%), Gaps = 41/232 (17%)
Query: 298 LLGSGGFGSVYKGILSDGTTVAIKIFNLQ-LEQAFRSFN--------SECEVLRNVRHRN 348
+LG GG+G V++ G KIF ++ L++A N +E +L V+H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTG-KIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVA--------LA 400
++ ++ + L+LE++ G L L F M D A LA
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIF---------MEDTACFYLSEISLA 112
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460
LE+LH +++ DLKP NILLD ++DFG+ K + +V T TI YM
Sbjct: 113 LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFC-GTIEYM 167
Query: 461 APEFGSEGNVSSKCDVYSYGILLLETFT---------RKKPTDEMFTGEMNL 503
APE D +S G L+ + T RKK D++ G++NL
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 43/222 (19%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQA------FRSFNSECEVLRNVR 345
+ E +G G +G+VYK L+ G VA+K + L + R E +L+ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR----EIALLKQLE 56
Query: 346 ---HRNLIKILSSCCNTNFK-----ALVLEFMPNGSLDKWLYSHNYFQDIPDR------- 390
H N++++L C LV E + D+ L Y P
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-----DQDL--ATYLSKCPKPGLPPETI 109
Query: 391 LNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450
++M + +++LH S +VH DLKP NIL+ + ++DFG++++ +
Sbjct: 110 KDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMAL 163
Query: 451 TMTIATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK 490
T + T+ Y APE S + D++S G + E F R+
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYA--TPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 6e-12
Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 8/195 (4%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357
+G G G+VY I ++ G VAIK NLQ + +E V+R ++ N++ L S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
+ +V+E++ GSL + + D I L+ L HS V+H D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDI 141
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
K NILL + ++DFG + + S TM + T +MAPE + K D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 478 SYGILLLETFTRKKP 492
S GI+ +E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 55/229 (24%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAF-------RSFNSECEVLRNVRHRNLI 350
+GSG +G V I G VAIK ++ AF R+ E ++LR+ +H N+I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTLR-ELKILRHFKHDNII 67
Query: 351 KILSSCCNTNFKA---------LVLEFMPNGSLDKWLYSH--------NYFQDIPDRLNI 393
I + +V++ M + L ++S YF
Sbjct: 68 AIRDI-----LRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYF--------- 112
Query: 394 MIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT 453
+ + L+Y+H S V+H DLKPSN+L++E+ + DFG+++ L MT
Sbjct: 113 LYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169
Query: 454 --IATIGYMAPEFG-SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG 499
+AT Y APE S ++ D++S G + E R+ ++F G
Sbjct: 170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR----QLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 13/210 (6%)
Query: 287 ERATDGFNECNLLGSGGFGSVYK-GILSDGTTVAIKIFNLQLEQAFRS-FNSECEVLRNV 344
E D F + LG+G G V K G +A K+ +L+++ A R+ E +VL
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 345 RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALE 402
++ + + ++ +E M GSLD+ L + IP+ + + I V L
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLA 117
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
YL H ++H D+KPSNIL++ + DFG+S G+ DS+ + + T YM+P
Sbjct: 118 YLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSP 171
Query: 463 EFGSEGNVSSKCDVYSYGILLLETFTRKKP 492
E + S + D++S G+ L+E + P
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 38/256 (14%)
Query: 299 LGSGGFGSVYKG--ILSDGTTVAIKIFNLQLEQAFRSFNS--ECEVLRNVR---HRNLIK 351
+G G +G V+K + + G VA+K +Q + ++ E VLR++ H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 352 ILSSCCNTNFK-----ALVLEFMPNGSLDKWLYSHNYFQDIPDR-------LNIMIDVAL 399
+ C + LV E +D+ L + Y +P+ ++M +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFE-----HVDQDLTT--YLDKVPEPGVPTETIKDMMFQLLR 121
Query: 400 ALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGY 459
L++LH S VVH DLKP NIL+ + ++DFG++++ + T + T+ Y
Sbjct: 122 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWY 175
Query: 460 MAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519
APE + + ++ D++S G + E F R+KP +F G ++ K GLP
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP---LFRGSSDVDQLGKILDVIGLPGEE 231
Query: 520 D--ANLLREENFFSAR 533
D ++ F ++
Sbjct: 232 DWPRDVALPRQAFHSK 247
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 53/233 (22%), Positives = 92/233 (39%), Gaps = 39/233 (16%)
Query: 297 NLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNS--------------ECEVL 341
LG G +G V K G VAIK + + + E +++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 342 RNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALAL 401
++H N++ ++ +F LV++ M L K + + I++ + L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTE-SQVKCILLQILNGL 132
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE-------GDDSVIQ---- 450
LH +H DL P+NI ++ + ++DFG+++ G D +Q
Sbjct: 133 NVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 451 -TMTIATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500
T + T+ Y APE G+E D++S G + E T K +F GE
Sbjct: 190 MTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKP----LFPGE 237
|
Length = 335 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 293 FNECNLLGSGGFGSVY---KGILSD-GTTVAIKIFN----LQLEQAFRSFNSECEVLRNV 344
F +LG+G +G V+ K D G A+K+ +Q + +E +VL ++
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 345 RHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI-DVALALE 402
R + L T+ K L+L+++ G L L F++ + I ++ LALE
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALE 119
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMA 461
+LH +++ D+K NILLD N ++DFG+SK E D V + + TI YMA
Sbjct: 120 HLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE--DEVERAYSFCGTIEYMA 174
Query: 462 PEF--GSEGNVSSKCDVYSYGILLLETFTRKKP 492
P+ G +G D +S G+L+ E T P
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 62/206 (30%), Positives = 88/206 (42%), Gaps = 19/206 (9%)
Query: 299 LGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFN---SECEVLRNVRHRNLIKILS 354
+G G FG+VY VAIK + +Q+ + E L+ +RH N I+
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNY-FQDIPDRLNIMIDVALALEYLHHGHSTPVV 413
+ LV+E+ GS L H Q+ + I AL+ L + HS +
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDILEVHKKPLQE----VEIAAICHGALQGLAYLHSHERI 137
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF---GSEGNV 470
H D+K NILL E ++DFG + L+ + V T +MAPE EG
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEGQY 191
Query: 471 SSKCDVYSYGILLLETFTRKKPTDEM 496
K DV+S GI +E RK P M
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 15/198 (7%)
Query: 298 LLGSGGFGSVYKGILSD-GTTVAIKIF--NLQLEQAFRSFNSECEVLRNVRHRNLIKILS 354
++G G +G V K G VAIK F + E ++ E +VLR +RH N++ +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALA---LEYLHHGHSTP 411
+ LV E++ L+ + P L + L+ + + HS
Sbjct: 68 AFRRKGRLYLVFEYVERTLLE-------LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-FGSEGNV 470
++H D+KP NIL+ E+ V + DFG ++ L S + T +AT Y APE + N
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPELLVGDTNY 179
Query: 471 SSKCDVYSYGILLLETFT 488
DV++ G ++ E
Sbjct: 180 GKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 34/232 (14%)
Query: 297 NLLGSGGFGSV----YKGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLRNVRHRN 348
LG+G FG V +KG G AIK L+++Q + E +L + H
Sbjct: 24 ETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQV-QHVAQEKSILMELSHPF 79
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYF-QDIPDRLNIMIDVALALEYLHHG 407
++ ++ S + N +LEF+ G L L F D+ + ++ LA EYLH
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA--ELVLAFEYLH-- 135
Query: 408 HSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPEFGS 466
S +++ DLKP N+LLD V+DFG +K + + +T T+ T Y+APE
Sbjct: 136 -SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPEVIQ 188
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKP---------TDEMFTGEMNLKNWVKE 509
D ++ G+LL E P +++ G + NW
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240
|
Length = 329 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 2e-11
Identities = 52/195 (26%), Positives = 89/195 (45%), Gaps = 8/195 (4%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357
+G G G+VY + ++ G VAI+ NLQ + +E V+R ++ N++ L S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
+ +V+E++ GSL + + D I L+ L HS V+H D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 142
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
K NILL + ++DFG + ++ + T +MAPE + K D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 478 SYGILLLETFTRKKP 492
S GI+ +E + P
Sbjct: 201 SLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 299 LGSGGFGSV----YKGILSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKI 352
+G G +G V ++ +DG IK NL+ + ++ E ++L ++H N++
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 353 LSSCCNTN-FKALVLEFMPNGSLDKWLYSHNYFQDIPDR--LNIMIDVALALEYLHHGHS 409
S + +V+ F G L L + +P+ + + +A+AL+YLH H
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKH- 122
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGN 469
++H DLK N+ L + V D GI+++L D + + I T YM+PE S
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKP 178
Query: 470 VSSKCDVYSYGILLLETFTRK 490
+ K DV++ G + E T K
Sbjct: 179 YNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRS-FNSECEVLRNVRHRN 348
D F + LG+G G V K + G +A K+ +L+++ A R+ E +VL
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALEYLHH 406
++ + + ++ +E M GSLD+ L IP+ + I I V L YL
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLRE 117
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF-- 464
H ++H D+KPSNIL++ + DFG+S G+ DS+ + + T YM+PE
Sbjct: 118 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQ 171
Query: 465 GSEGNVSSKCDVYSYGILLLE 485
G+ V S D++S G+ L+E
Sbjct: 172 GTHYTVQS--DIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 45/223 (20%)
Query: 281 TSYLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNS--E 337
TSYL+LE+ LG G + +VYKGI +G VA+K+ +++ E+ F + E
Sbjct: 5 TSYLNLEK----------LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIRE 53
Query: 338 CEVLRNVRHRNLIKILSSCCNTNFKALVLEFM-----------PNGSLDKWLYSHNYFQD 386
+L+ ++H N++ + V E+M P G L+ +N
Sbjct: 54 ASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNV--- 105
Query: 387 IPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446
RL M + L Y+H H ++H DLKP N+L+ ++DFG+++ +
Sbjct: 106 ---RL-FMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIP 156
Query: 447 SVIQTMTIATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETF 487
S + + T+ Y P+ G+ + SS D++ G + +E
Sbjct: 157 SQTYSSEVVTLWYRPPDVLLGAT-DYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 46/173 (26%), Positives = 89/173 (51%), Gaps = 7/173 (4%)
Query: 313 SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNG 372
S G VA+K +L+ +Q +E ++R+ +H N++++ SS + +V+EF+ G
Sbjct: 42 STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG 101
Query: 373 SLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHV 432
+L + +H + + + V AL +LH + V+H D+K +ILL + +
Sbjct: 102 ALTD-IVTHTRMNE-EQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKL 156
Query: 433 SDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLE 485
SDFG + + + + + T +MAPE S ++ D++S GI+++E
Sbjct: 157 SDFGFCAQVSK--EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-11
Identities = 71/244 (29%), Positives = 119/244 (48%), Gaps = 37/244 (15%)
Query: 259 RRNRSTKSPDDEELFSLATWRRTSYLDLERATD-GFNECNLLGSGGFGSVYKGILSDGT- 316
R + + D++E + D+ R+ + + N++G+G FG VY+ I D +
Sbjct: 40 RSHNNNAGEDEDE-------EKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSE 92
Query: 317 TVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKI----LSSCCNTN----FKALVLEF 368
VAIK ++ Q + N E +++N+ H N+I + + C N F +V+EF
Sbjct: 93 KVAIK----KVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEF 148
Query: 369 MPNGSLDKWL--YSHNYFQDIPDRLNIMIDVAL--ALEYLHHGHSTPVVHCDLKPSNILL 424
+P ++ K++ Y+ N +P L + L AL Y+H S + H DLKP N+L+
Sbjct: 149 IPQ-TVHKYMKHYARNN-HALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLI 203
Query: 425 DENM-VAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--FGSEGNVSSKCDVYSYGI 481
D N + DFG +K L G SV I + Y APE G+ N ++ D++S G
Sbjct: 204 DPNTHTLKLCDFGSAKNLLAGQRSV---SYICSRFYRAPELMLGAT-NYTTHIDLWSLGC 259
Query: 482 LLLE 485
++ E
Sbjct: 260 IIAE 263
|
Length = 440 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 32/209 (15%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357
+GSG +G VYK L G A+KI L+ F E +++ +H N++ S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALA------LEYLHHGHSTP 411
+ + +E+ GSL QDI + ++ +A L+ L + HS
Sbjct: 77 SREKLWICMEYCGGGSL----------QDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-----IATIGYMAPEFGS 466
+H D+K +NILL +N ++DFG++ + T+ I T +MAPE +
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAA-------KITATIAKRKSFIGTPYWMAPEVAA 179
Query: 467 ---EGNVSSKCDVYSYGILLLETFTRKKP 492
G + CD+++ GI +E + P
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 298 LLGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSS- 355
++G GGFG VY +D G A+K + + R + E L + R ++ ++S+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETLA-LNERIMLSLVSTG 54
Query: 356 ------CCNTNFKA-----LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYL 404
C F +L+ M G L L H F + R ++ L LE
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLE-- 111
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF 464
H H+ VV+ DLKP+NILLDE+ +SD G++ + ++ T GYMAPE
Sbjct: 112 -HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEV 166
Query: 465 GSEGNV-SSKCDVYSYGILLLETFTRKKP 492
+G S D +S G +L + P
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 75/314 (23%), Positives = 129/314 (41%), Gaps = 65/314 (20%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ------AFRSFNSECEVLRN 343
D + + +G G +G VYK + G VA+K L++++ A R E +L+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQM 56
Query: 344 VRHRNLIKILSSCCNTNFKA------LVLEFMPNGSLDKWLYSH--NYFQDIPDRL--NI 393
+ I L + K LV E++ + L K++ S+ + +P + +
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 394 MIDVALALEYLH-HGHSTPVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSVIQT 451
M + + + H HG V+H DLKP N+L+D + + ++D G+ + S T
Sbjct: 116 MYQLLKGVAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--T 169
Query: 452 MTIATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK------------------- 490
I T+ Y APE GS + S+ D++S G + E ++
Sbjct: 170 HEIVTLWYRAPEVLLGST-HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228
Query: 491 -KPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCA 549
PT++++ G L++W H P+ +L R S LL L D
Sbjct: 229 GTPTEQVWPGVSKLRDW------HEFPQWKPQDLSRAVPDLSPEGLDLLQKM-LRYD--- 278
Query: 550 ELPDQRLYMKDAAT 563
P +R+ K A T
Sbjct: 279 --PAKRISAKAALT 290
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 23/235 (9%)
Query: 291 DGFNECNLLGSGGFGSVYKGILSDGTT---VAIKIFN---LQLEQAFRSFNSECEVLRNV 344
F+ +L+G G FG V ++ + T A+K+ L ++ F E ++L
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 345 RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYL 404
+ ++ + + + LV+E+ P G L L N ++D D +A + +
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAI 115
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF 464
H H VH D+KP N+L+D ++DFG + L + V + + T Y+APE
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAPEV 174
Query: 465 GSEGNVSSK------CDVYSYGILLLETFTRKKPTDE-----MFTGEMNLKNWVK 508
+ N K CD +S G++ E + P E + MN + ++K
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 1/119 (0%)
Query: 58 LRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDI 117
L L++ L IP+ + L ++ +NLS N + G++ + ++ L LDLS N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 118 PKTIAGLKDLTNLSLAGNQFQGPIPESFGS-LISLESLDLSSNNLSEGIPKSLVALSHL 175
P+++ L L L+L GN G +P + G L+ S + + N GIP HL
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHL 541
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 58/158 (36%), Positives = 91/158 (57%), Gaps = 7/158 (4%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS 71
L+DN ++ S+P L L L +L L N L+ +P L++L++L L L+ NK+ S +P
Sbjct: 147 LSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI-SDLPP 203
Query: 72 ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLS 131
+ L + ++LS+N + L+S + N+K L L+LS N+L D+P++I L +L L
Sbjct: 204 EIELLSALEELDLSNNSIIELLSS-LSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLD 261
Query: 132 LAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSL 169
L+ NQ S GSL +L LDLS N+LS +P
Sbjct: 262 LSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIA 297
|
Length = 394 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 66/246 (26%), Positives = 101/246 (41%), Gaps = 32/246 (13%)
Query: 260 RNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTT-- 317
R K P+ +LF D E G +E +G G FG+VY ++ T
Sbjct: 1 RKGVVKDPEIADLFYKD--------DPEEIFVGLHE---IGHGSFGAVY--FATNSHTNE 47
Query: 318 -VAIKIFNL---QLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGS 373
VA+K + Q + ++ E + L+ ++H N I+ + LV+E+ +
Sbjct: 48 VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSA 107
Query: 374 LDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVS 433
D Q++ I AL+ L + HS ++H D+K NILL E ++
Sbjct: 108 SDLLEVHKKPLQEV----EIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLA 163
Query: 434 DFGISKLLGEGDDSVIQTMTIATIGYMAPEF---GSEGNVSSKCDVYSYGILLLETFTRK 490
DFG + + V T +MAPE EG K DV+S GI +E RK
Sbjct: 164 DFGSASKSSPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 217
Query: 491 KPTDEM 496
P M
Sbjct: 218 PPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 57/227 (25%), Positives = 110/227 (48%), Gaps = 17/227 (7%)
Query: 299 LGSGGFGSV-YKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357
+G G G V + S G VA+K +L+ +Q +E ++R+ +H N++++ +S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
+ +V+EF+ G+L + +H + + + V AL LH + V+H D+
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHTRMNE-EQIAAVCLAVLKALSVLH---AQGVIHRDI 142
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
K +ILL + +SDFG + + + + + T +MAPE S + D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 478 SYGILLLETFTRKKPTDEMFTGEMNLK--NWVKESLPHGLPKIADAN 522
S GI+++E + P + E LK ++++LP PK+ + +
Sbjct: 201 SLGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLP---PKLKNLH 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 32/246 (13%)
Query: 260 RNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTT-- 317
R S K P+ ELF ++ D E+ F + +G G FG+VY D T
Sbjct: 5 RAGSLKDPEIAELF----FKE----DPEKL---FTDLREIGHGSFGAVY--FARDVRTNE 51
Query: 318 -VAIKIFNLQLEQA---FRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGS 373
VAIK + +Q+ ++ E + L+ ++H N I+ + LV+E+ +
Sbjct: 52 VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSA 111
Query: 374 LDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVS 433
D Q++ I AL+ L + HS ++H D+K NILL E ++
Sbjct: 112 SDLLEVHKKPLQEV----EIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLA 167
Query: 434 DFGISKLLGEGDDSVIQTMTIATIGYMAPEF---GSEGNVSSKCDVYSYGILLLETFTRK 490
DFG + + + V T +MAPE EG K DV+S GI +E RK
Sbjct: 168 DFGSASIASPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221
Query: 491 KPTDEM 496
P M
Sbjct: 222 PPLFNM 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357
+G G G+V+ I ++ G VAIK NLQ + +E V++ +++ N++ L S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
+ +V+E++ GSL + + D I L+ L H+ V+H D+
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHANQVIHRDI 141
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
K N+LL + ++DFG + + S TM + T +MAPE + K D++
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 478 SYGILLLETFTRKKP 492
S GI+ +E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNL---QLEQAFRSFNSECEVLRNVRHRN 348
F++ +G G FG+VY + + VAIK + Q + ++ E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH 408
I+ + LV+E+ + D Q++ I AL+ L + H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV----EIAAVTHGALQGLAYLH 132
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF---G 465
S ++H D+K NILL E + + DFG + ++ + V T +MAPE
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAM 186
Query: 466 SEGNVSSKCDVYSYGILLLETFTRKKPTDEM 496
EG K DV+S GI +E RK P M
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 34/212 (16%)
Query: 298 LLGSGGFGSVYKGILSD-GTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRNLIKIL 353
++G GGFG VY +D G A+K + ++++Q E L + R ++ ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--------ETLA-LNERIMLSLV 51
Query: 354 SS-------CCNTNFK-----ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALAL 401
S+ C + F + +L+ M G L L H F + R ++ L L
Sbjct: 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGL 110
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 461
E H H+ VV+ DLKP+NILLDE+ +SD G++ + ++ T GYMA
Sbjct: 111 E---HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMA 163
Query: 462 PEFGSEGNV-SSKCDVYSYGILLLETFTRKKP 492
PE +G S D +S G +L + P
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 64/282 (22%), Positives = 113/282 (40%), Gaps = 38/282 (13%)
Query: 299 LGSGGFGSVY------KGILSDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIK 351
LG G FG V +G + G VA+K + E E+LRN+ H N++K
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 352 ILSSCCNT--NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS 409
C N L++EF+P+GSL ++L + ++ +L + + ++YL S
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL---GS 127
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD-SVIQTMTIATIGYMAPEFGSEG 468
VH DL N+L++ + DFG++K + + ++ + + + APE +
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 469 NVSSKCDVYSYGILLLETFT----RKKPTDEMFT------GEMNLKNWVKESLPHGLPKI 518
DV+S+G+ L E T P G+M + V+
Sbjct: 188 KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR---------- 237
Query: 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKD 560
+L E +C ++ L C P +R ++
Sbjct: 238 ----VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQN 275
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 52/210 (24%), Positives = 104/210 (49%), Gaps = 16/210 (7%)
Query: 315 GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSL 374
G VA+K +L+ +Q +E ++R+ H N++ + +S + +V+EF+ G+L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 375 DKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSD 434
+ +H + + + V AL YLH + V+H D+K +ILL + +SD
Sbjct: 107 TD-IVTHTRMNE-EQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSD 161
Query: 435 FGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTD 494
FG + + + + + T +MAPE S ++ D++S GI+++E + P
Sbjct: 162 FGFCAQVSK--EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP-- 217
Query: 495 EMFTGEMNLKNW--VKESLPHGLPKIADAN 522
+ E L+ ++++LP P++ D++
Sbjct: 218 --YFNEPPLQAMRRIRDNLP---PRVKDSH 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 299 LGSGGFGSVYKGILSDGTTVA-IKIFNLQL-----EQAFRSFNSECEVLRNVRHRNLIKI 352
+G+G FG V G G + A + + L+ EQ F E + R + H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL--LFLQEVQPYRELNHPNVLQC 60
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYS---HNYFQDIPDRLNIMI-DVALALEYLHHGH 408
L C + LVLEF P G L +L S D L M +VA L +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE----F 464
+H DL N L ++ + D+G++ D + + + ++APE
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 465 GSE---GNVSSKCDVYSYGILLLETFT 488
G + + + K +++S G+ + E FT
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 25/204 (12%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ------AFRSFNSECEVLRNVRHRNLIK 351
+G G +G VYK G VA+K L+ E A R E +L+ + H N+++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL-NIMIDVALALEYLHHGHST 410
+L + N LV EF+ + L K++ S P + + + + + Y H S
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SH 118
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE--FGS 466
V+H DLKP N+L+D ++DFG+++ G ++T T + T+ Y APE GS
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFG----VPVRTYTHEVVTLWYRAPEILLGS 174
Query: 467 EGNVSSKCDVYSYGILLLETFTRK 490
S+ D++S G + E R+
Sbjct: 175 R-QYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 293 FNECNLLGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQAFRSFNS--ECEVLRNVRHRNL 349
F + N +G G +G VY+ + G VA+K + E+ +S E +L N+RH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 350 IKILSSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG 407
+++ + + LV+E+ L L + +M+ + L+YLH
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 408 HSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--FG 465
++H DLK SN+LL + ++DFG+++ G + T + T+ Y APE G
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYRAPELLLG 182
Query: 466 SEGNVSSKCDVYSYGILLLETFTRK 490
++ D+++ G +L E K
Sbjct: 183 CT-TYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 50/194 (25%), Positives = 90/194 (46%), Gaps = 11/194 (5%)
Query: 298 LLGSGGFGSVYKGILS----DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKI 352
+LG+G FG + +G L VAI ++ R F +E L H N++++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
N +V E+M NG+LD +L H + ++ +A ++YL
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGY 128
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG-YMAPEFGSEGNVS 471
VH L +L++ ++V +S F +L + +++ TM+ + + APE + S
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 472 SKCDVYSYGILLLE 485
S DV+S+GI++ E
Sbjct: 187 SASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 59/229 (25%)
Query: 291 DGFNECNLLGSGGFGSVYKGILSD-GTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRH 346
D + + +GSG +G V + G VAIK + A R++ E +L+++ H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDH 73
Query: 347 RNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDI--------PDRLNIMIDVA 398
N+I +L F P SL+ FQD+ D NI+
Sbjct: 74 ENVIGLLDV------------FTPASSLED-------FQDVYLVTHLMGADLNNIVKCQK 114
Query: 399 L--------------ALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444
L L+Y+H S ++H DLKPSNI ++E+ + DFG+++ +
Sbjct: 115 LSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD- 170
Query: 445 DDSVIQTMT--IATIGYMAPE-FGSEGNVSSKCDVYSYGILLLETFTRK 490
MT +AT Y APE + + + D++S G ++ E T K
Sbjct: 171 ------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 298 LLGSGGFGSVYKGIL----SDGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLI 350
LLG G FG V IL + G A+KI ++ + +E VL+N RH L
Sbjct: 2 LLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIM-IDVALALEYLHHGHS 409
+ S + V+E++ G L L F + DR ++ AL+YLH G
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSE--DRTRFYGAEIVSALDYLHSGK- 115
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGN 469
+V+ DLK N++LD++ ++DFG+ K G D + ++T T Y+APE + +
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFC-GTPEYLAPEVLEDND 171
Query: 470 VSSKCDVYSYGILLLETFTRKKP 492
D + G+++ E + P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 299 LGSGGFGSVYKGILSDGTTVA---------IKIFNLQLEQAFRSFNSECEVLRNVRHRNL 349
LG G FG+VY ++ D VA I + L + ++ N E ++L + H +
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAI 64
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDI---PDRLNIMIDVALALEYLHH 406
+K +S + ++ E+ LD L + I + L + Y+H
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL-GEGDDSVIQTMTIATIGYMAPEFG 465
++H DLK NI L N++ + DFG+S+LL G D + T T YM+PE
Sbjct: 125 RR---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCD---LATTFTGTPYYMSPEAL 177
Query: 466 SEGNVSSKCDVYSYGILLLE 485
SK D++S G +L E
Sbjct: 178 KHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 31/240 (12%)
Query: 285 DLERATDGFNECNLLGSGGFGSV----YKGILSDGTTVAIKIFNLQLEQAFRS----FNS 336
DL + + ++G G FG V +K S A+K+ + + E RS F
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLS-KFEMIKRSDSAFFWE 92
Query: 337 ECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN--IM 394
E +++ ++++ + + + +V+E+MP G L + NY D+P++
Sbjct: 93 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWARFYT 148
Query: 395 IDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI 454
+V LAL+ +H S +H D+KP N+LLD++ ++DFG + + + V +
Sbjct: 149 AEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAV 204
Query: 455 ATIGYMAPEF----GSEGNVSSKCDVYSYGILLLETFTRKKP--TDEM---FTGEMNLKN 505
T Y++PE G +G +CD +S G+ L E P D + ++ MN KN
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 264
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 64/240 (26%), Positives = 105/240 (43%), Gaps = 31/240 (12%)
Query: 285 DLERATDGFNECNLLGSGGFGSVYKGILSDGTTV-AIKIFNLQLEQAFRS----FNSECE 339
L + F+ ++G G FG V V A+K+ + + E RS F E +
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEERD 95
Query: 340 VLRNVRHRNLIKILSSCC---NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIM-- 394
++ H N I+ + + +V+E+MP G L + NY DIP++
Sbjct: 96 IMA---HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DIPEKWARFYT 148
Query: 395 IDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI 454
+V LAL+ +H S +H D+KP N+LLD++ ++DFG + + V +
Sbjct: 149 AEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA-NGMVRCDTAV 204
Query: 455 ATIGYMAPEF----GSEGNVSSKCDVYSYGILLLETFTRKKP-TDEMFTGE----MNLKN 505
T Y++PE G +G +CD +S G+ L E P + G M+ KN
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN 264
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 291 DGFNECNLLGSGGFGSVYKGILSDGTTV-AIKIFNLQLEQAFRS----FNSECEVLRNVR 345
+ F ++G G FG V L + V A+KI N + E R+ F E +VL N
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN-KWEMLKRAETACFREERDVLVNGD 59
Query: 346 HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD-IPDRLN--IMIDVALALE 402
++ + + + + N LV+++ G L L + F+D +P+ + + ++ +A++
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVIAID 116
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
+H H VH D+KP NIL+D N ++DFG L E D +V ++ + T Y++P
Sbjct: 117 SVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISP 172
Query: 463 EF-----GSEGNVSSKCDVYSYGILLLETFTRKKP 492
E +G +CD +S G+ + E + P
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 17/208 (8%)
Query: 293 FNECNLLGSGGFGSVYK-GILSDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRN 348
F + +LG GGFG V + + G A K ++ + +E ++L V R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIM--IDVALALEYLHH 406
++ + + + LVL M G L +Y H + + ++ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPEF 464
+V+ DLKP NILLD++ +SD G++ + EG QT+ + T+GYMAPE
Sbjct: 121 ER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-----QTIKGRVGTVGYMAPEV 172
Query: 465 GSEGNVSSKCDVYSYGILLLETFTRKKP 492
+ D ++ G LL E + P
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 291 DGFNECNLLGSGGFGSVYKGILSDGT--TVAIKIFN----LQLEQAFRSFNSECEVLRNV 344
+ FN LG+G FG V + VAIK F ++ +Q F SE ++L +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYI 88
Query: 345 RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIM--IDVALALE 402
H + + S + ++ LVLEF+ G +L + F P+ + + L E
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRF---PNDVGCFYAAQIVLIFE 145
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG---Y 459
YL S +V+ DLKP N+LLD++ ++DFG +K V+ T T G Y
Sbjct: 146 YLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--------VVDTRTYTLCGTPEY 194
Query: 460 MAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP 492
+APE D ++ GI + E P
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 49/184 (26%), Positives = 89/184 (48%), Gaps = 19/184 (10%)
Query: 315 GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSL 374
G VA+K+ +L+ +Q +E ++R+ +H+N++++ S +++EF+ G+L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 375 DKWLYSHNYFQDIPDRLN------IMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM 428
+ RLN + V AL YLH S V+H D+K +ILL +
Sbjct: 106 T------DIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDG 154
Query: 429 VAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
+SDFG + + D + + T +MAPE S ++ D++S GI+++E
Sbjct: 155 RVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD 212
Query: 489 RKKP 492
+ P
Sbjct: 213 GEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 33/141 (23%), Positives = 60/141 (42%), Gaps = 9/141 (6%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNL--QLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
+ K T VA+K NL ++ + E R ++H N++ ++S
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALEYLHHGHSTPVVH 414
+ +V M GS + L +H + + +P+ I+ DV AL+Y+H +H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIH 124
Query: 415 CDLKPSNILLDENMVAHVSDF 435
+K S+ILL + +S
Sbjct: 125 RSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 63/229 (27%), Positives = 92/229 (40%), Gaps = 43/229 (18%)
Query: 293 FNECNLLGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQAFRSFN---SECEVLRNVRHRN 348
F + LLG G G V+ L G A+K+ + + +E E+L + H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWL--YSHNYFQDIPDRLNIMIDVALALEYLH- 405
L + +S + LV+++ P G L + L + R +V LALEYLH
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHL 121
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSVIQTM----------- 452
G +V+ DLKP NILL E+ H+ SDF +SK V + +
Sbjct: 122 LG----IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 453 ----TIATIG------------YMAPEFGSEGNVSSKCDVYSYGILLLE 485
T + Y+APE S S D ++ GILL E
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 286 LERATDGFNECNLLGSGGFGSV----YKGILSDGTTVAIKIFNLQLEQAFRS----FNSE 337
L+ + ++ ++G G FG V +K S A+K+ + + E RS F E
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLS-KFEMIKRSDSAFFWEE 93
Query: 338 CEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN--IMI 395
+++ ++++ + + + +V+E+MP G L + NY D+P++
Sbjct: 94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTA 149
Query: 396 DVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA 455
+V LAL+ +H S ++H D+KP N+LLD++ ++DFG + E T +
Sbjct: 150 EVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVG 205
Query: 456 TIGYMAPEF----GSEGNVSSKCDVYSYGILLLETFTRKKP 492
T Y++PE G +G +CD +S G+ L E P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEV-----LRNVRHRNLIKI 352
+G G +G+VYK G VA+K +Q + ++ EV L H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 353 LSSCCNTNFK-----ALVLEFMPNGSLDKWLYSHNYFQDIP------DRL-NIMIDVALA 400
+ C + LV E +D+ L + Y +P + + ++M
Sbjct: 68 MDVCATSRTDRETKVTLVFE-----HVDQDLRT--YLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460
L++LH + +VH DLKP NIL+ ++DFG++++ + T + T+ Y
Sbjct: 121 LDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYR 174
Query: 461 APEFGSEGNVSSKCDVYSYGILLLETFTRK 490
APE + ++ D++S G + E F RK
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 291 DGFNECNLLGSGGFGSVYKGILSDGTTV-AIKIFNLQLEQAFRS----FNSECEVLRNVR 345
D F ++G G FG V + + A+KI N + E R+ F E VL N
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-KWEMLKRAETACFREERNVLVNGD 59
Query: 346 HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD-IPDRLN--IMIDVALALE 402
+ + + + + N+ LV+++ G L L + F+D +P+ + + ++ LA+
Sbjct: 60 CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIAEMVLAIH 116
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
+H H VH D+KP N+LLD N ++DFG S L D +V ++ + T Y++P
Sbjct: 117 SIHQLH---YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISP 172
Query: 463 EF-----GSEGNVSSKCDVYSYGILLLETFTRKKP 492
E G +CD +S G+ + E + P
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 299 LGSGGFGSVYK-GILSDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRNLIKILS 354
LG GGFG V + + G A K N L+ + + E +L V R ++ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNY----FQDIPDRLNIMIDVALALEYLHHGHST 410
+ LV+ M G L +Y+ + F + P + LE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPE-PRACFYTAQIISGLEHLHQRR-- 117
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT---IATIGYMAPEF--G 465
+++ DLKP N+LLD + +SD G++ L +G Q+ T T G+MAPE G
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-----QSKTKGYAGTPGFMAPELLQG 171
Query: 466 SEGNVSSKCDVYSYGILLLETFTRKKP 492
E + S D ++ G+ L E + P
Sbjct: 172 EEYDFS--VDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 10/104 (9%)
Query: 400 ALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATI 457
L+Y+H S V+H DLKP N+L++ + + DFG+++ E MT +AT
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 458 GYMAPEFG-SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500
Y APE S + + DV+S G +L E RK +F G+
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP----VFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 54/191 (28%), Positives = 81/191 (42%), Gaps = 41/191 (21%)
Query: 300 GSGGFGSVYKGILSDGTT---VAIKIFNLQLEQ-------AFRSFNSECEVLRNVRHRNL 349
G G +G VYK +G AIK F EQ A R E +LR ++H N+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR----EIALLRELKHENV 64
Query: 350 IKILSSCCNTNFKA--LVLEFMPN--GSLDKWLYSHNYFQDIPDRLNIMIDVAL--ALEY 403
+ ++ K+ L+ ++ + + K+ IP M+ L L
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVS-IPPS---MVKSLLWQILNG 120
Query: 404 LHHGHSTPVVHCDLKPSNILL----DENMVAHVSDFGIS-------KLLGEGDDSVIQTM 452
+H+ HS V+H DLKP+NIL+ E V + D G++ K L + D V+
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV--- 177
Query: 453 TIATIGYMAPE 463
TI Y APE
Sbjct: 178 ---TIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 52/227 (22%), Positives = 97/227 (42%), Gaps = 25/227 (11%)
Query: 306 SVYKGILSDGTTVAIKIF---NLQLEQAFRSFNSECEVLRNVRHRNLIKI----LSSCCN 358
S+YKGI + V I+ F + + +E + LR + N++KI + +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 359 TNFKALVLEFMPNGSLDKWLYSHNYFQDIP--DRLNIMIDVALALEYLHHGHSTPVVHCD 416
+L+LE+ G L + L + +D+ +L++ ID L L+ + P + +
Sbjct: 94 LPRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148
Query: 417 LKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE--GNVSSKC 474
L + L+ EN + G+ K+L S + + Y + + ++ + K
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKIL-----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKD 203
Query: 475 DVYSYGILLLETFTRKKPTDEMFTGE---MNLKNWVKESLPHGLPKI 518
D+YS G++L E FT K P + + T E + + LP P
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLE 250
|
Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 51/221 (23%), Positives = 93/221 (42%), Gaps = 25/221 (11%)
Query: 302 GGFGSVY--KGILSDGTTVAIKIF---NLQLEQAFRSFNSECEVLRNVRHR-NLIKILSS 355
G FGSVY K + G AIK+ ++ + + +E ++ + K+ S
Sbjct: 7 GAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHC 415
+ ++ LV+E++ G + + + + + +V L +E LH ++H
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---QRGIIHR 121
Query: 416 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSK-C 474
D+KP N+L+D+ ++DFG+S+ + + T Y+APE G K
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPET-ILGVGDDKMS 174
Query: 475 DVYSYGILLLETFTRKKP-----TDEMFTG-EMNLKNWVKE 509
D +S G ++ E P D +F NW +E
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEE 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 9/204 (4%)
Query: 293 FNECNLLGSGGFGSVYK-GILSDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRN 348
F + +LG GGFG V + + G A K ++ + +E ++L V +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH 408
++ + + + LVL M G L +Y N + + A L L H
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG 468
V+ DLKP NILLD+ +SD G++ + EG+ I+ + T+GYMAPE +
Sbjct: 120 RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRG-RVGTVGYMAPEVLNNQ 176
Query: 469 NVSSKCDVYSYGILLLETFTRKKP 492
+ D + G L+ E + P
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 25/204 (12%)
Query: 299 LGSGGFGSVYKGIL----SDGTTVAIKIFNL------QLEQAFRSFNSECEVLRNVRHRN 348
+G G FG K IL DG IK N+ + E++ + E VL N++H N
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRK----EVAVLSNMKHPN 60
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR-LNIMIDVALALEYLHHG 407
+++ S +V+++ G L K + + D+ L+ + + LAL+ H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK---HV 117
Query: 408 HSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEFGS 466
H ++H D+K NI L ++ + DFGI+++L + +V T I T Y++PE
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIGTPYYLSPEICE 174
Query: 467 EGNVSSKCDVYSYGILLLETFTRK 490
++K D+++ G +L E T K
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 32/224 (14%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLI 350
F L+G+G +G VYKG + G AIK+ ++ ++ E +L+ HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 351 KILSSCCNTNFKA------LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALA---- 400
+ N LV+EF GS+ + + + N + + +A
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--------TKGNTLKEEWIAYICR 118
Query: 401 --LEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-IATI 457
L L H H V+H D+K N+LL EN + DFG+S L D +V + T I T
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTP 175
Query: 458 GYMAPEF-----GSEGNVSSKCDVYSYGILLLETFTRKKPTDEM 496
+MAPE + K D++S GI +E P +M
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ-----AFRSFNSECEVLRNVRHRNLIKI 352
LG G + +VYKG + G VA+K +L E+ A R E +++ ++H N+++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR----EISLMKELKHENIVR- 62
Query: 353 LSSCCNTNFK-ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
L +T K LV E+M + L K++ +H + L L+ + H
Sbjct: 63 LHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL-LKGIAFCHENR 120
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE--FGSE 467
V+H DLKP N+L+++ ++DFG+++ G + T + + T+ Y AP+ GS
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFG----IPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 468 GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMN 502
S+ D++S G ++ E T + +F G N
Sbjct: 177 -TYSTSIDIWSVGCIMAEMITGRP----LFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 297 NLLGSGGFGSVYKGILSDGTT-----VAIK--IFNLQLEQAFRSFNSECEVLRNVRHRNL 349
+LL G FG ++ GIL D V +K + Q E +L + H+N+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYGLSHQNI 70
Query: 350 IKILSSCCNTNFKALVLE-FMPNGSLDKWLY-----SHNYFQDIPDR--LNIMIDVALAL 401
+ IL C VL +M G+L +L N Q + + +++ I +A +
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 461
YLH V+H D+ N ++DE + ++D +S+ L D + + +MA
Sbjct: 131 SYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187
Query: 462 PEFGSEGNVSSKCDVYSYGILLLETFT 488
E SS DV+S+G+LL E T
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460
L+YLH ++H D+KP N+L++ N V + DFG+++ + E D+S T + T Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYR 171
Query: 461 APEF--GSEGNVSSKCDVYSYGILLLETFTRK 490
APE GS + +S D++S G + E R+
Sbjct: 172 APEILMGSR-HYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 298 LLGSGGFGSVYKGIL----SDGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLI 350
LLG G FG V IL + G A+KI ++ + +E VL+N RH L
Sbjct: 2 LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIM-IDVALALEYLHHGHS 409
+ + + V+E+ G L L F + +R ++ ALEYLH S
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE--ERARFYGAEIVSALEYLH---S 113
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGN 469
VV+ D+K N++LD++ ++DFG+ K G D + ++T T Y+APE + +
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GTPEYLAPEVLEDND 171
Query: 470 VSSKCDVYSYGILLLETFTRKKP 492
D + G+++ E + P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 65/212 (30%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 298 LLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-----EQAFRSFNSECEVL-RNVRHRNLI 350
++G G FG V DG A+K+ ++ EQ + +E VL +NV+H L+
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ--KHIMAERNVLLKNVKHPFLV 59
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST 410
+ S T VL+F+ G L L F + R ++A AL YLH S
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SI 115
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPEFGSEGN 469
+V+ DLKP NILLD ++DFG+ K EG T T T Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 470 VSSKCDVYSYGILLLETFTRKKPTDEMFTGEM 501
+ D + G +L E P EM
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 52/174 (29%), Positives = 79/174 (45%), Gaps = 19/174 (10%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEV-------LRNVRHRNLI 350
+G G FG V +DG A+K+ ++A + + L+NV+H L+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQ---KKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST 410
+ S + VL+++ G L L F + R ++A AL YLH S
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SL 115
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPE 463
+++ DLKP NILLD ++DFG+ K EG + T T T Y+APE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 36/101 (35%), Positives = 59/101 (58%), Gaps = 4/101 (3%)
Query: 99 NMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPES-FGSLISLESLDLS 157
N ++ +DLS +SG I I L + ++L+ NQ GPIP+ F + SL L+LS
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 158 SNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRN 197
+NN + IP+ ++ +L+ ++S+N L GEIP + G F +
Sbjct: 127 NNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSS 165
|
Length = 968 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 30/234 (12%)
Query: 299 LGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKI----- 352
LG G G V+ + SD VA+K L Q+ + E +++R + H N++K+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 353 ---------LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEY 403
+ S N +V E+M L + + RL M + L+Y
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLAN-VLEQGPLSEEHARL-FMYQLLRGLKY 129
Query: 404 LHHGHSTPVVHCDLKPSNILLD-ENMVAHVSDFGISKLLG-EGDDSVIQTMTIATIGYMA 461
+H S V+H DLKP+N+ ++ E++V + DFG+++++ + + T Y +
Sbjct: 130 IH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 462 PEFG-SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG--EMNLKNWVKESLP 512
P S N + D+++ G + E T K +F G E+ + ES+P
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAGAHELEQMQLILESVP 236
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 49/207 (23%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFN----SECEVLRNVRHRNLIKIL 353
+G G FG V+K VA+K + +E F E ++L+ ++H N++ ++
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 354 SSCCN-----TNFKA---LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH 405
C +K LV EF + L L + N + + +M + L Y+H
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK--LLGEGDDSVIQTMTIATIGYMAPE 463
++H D+K +NIL+ ++ + ++DFG+++ L + T + T+ Y PE
Sbjct: 137 ---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 464 -FGSEGNVSSKCDVYSYGILLLETFTR 489
E + D++ G ++ E +TR
Sbjct: 194 LLLGERDYGPPIDMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 55/228 (24%), Positives = 105/228 (46%), Gaps = 34/228 (14%)
Query: 288 RATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ--------AFRSFNSEC 338
R+ D + + N + G +G VY+ G VA+K L++E+ + R N
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREIN--- 56
Query: 339 EVLRNVRHRNLIKILSSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMID 396
+L ++H N++ + +N +V+E++ + L + + + +M+
Sbjct: 57 -ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQ 114
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--I 454
+ + +LH ++H DLK SN+LL+ + + DFG+++ G S ++ T +
Sbjct: 115 LLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG----SPLKPYTQLV 167
Query: 455 ATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500
T+ Y APE G S+ D++S G + E KKP +F G+
Sbjct: 168 VTLWYRAPELLLG-AKEYSTAIDMWSVGCIFAE-LLTKKP---LFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 293 FNECNLLGSGGFGSVYKGILSD-GTTVAIKIF--NLQLEQAFRSFNSECEVLRNVRHRNL 349
F ++G G +G V K + VAIK F + + E+ + E ++LR ++ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS 409
+++ + LV E++ L+ L P+++ I ++ +H H
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYI--YQLIKAIHWCHK 118
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGN 469
+VH D+KP N+L+ N V + DFG ++ L EG ++ T +AT Y +PE
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLLGAP 177
Query: 470 VSSKCDVYSYGILLLE------TFTRKKPTDEMFT 498
D++S G +L E F + D++FT
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT 456
VA +E+L S +H DL NILL EN V + DFG+++ + + D V +
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
+ +MAPE + +++ DV+S+G+LL E F+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 23/175 (13%)
Query: 299 LGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQ-------AFRSFNSECEVLRNVRHRNLI 350
+G G +G V+K + G VAIK F ++ E A R E +L+ ++H NL+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALR----EIRMLKQLKHPNLV 63
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALEYLHHGH 408
++ LV E+ + L++ L + + +P+ L I+ A+ + H
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNP--RGVPEHLIKKIIWQTLQAVNFCH--- 117
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 463
+H D+KP NIL+ + + DFG +++L D T +AT Y APE
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 291 DGFNECNLLGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQAFRS----FNSECEVLRNVR 345
D F ++G G FG V + + G A+KI N + E R+ F E +VL N
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN-KWEMLKRAETACFREERDVLVNGD 59
Query: 346 HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD-IPDRLN--IMIDVALALE 402
R + + + + N LV+++ G L L + F+D +P+ + + ++ LA++
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAID 116
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
+H VH D+KP N+LLD+N ++DFG S L D +V + + T Y++P
Sbjct: 117 SVHQLG---YVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISP 172
Query: 463 EF-----GSEGNVSSKCDVYSYGILLLETFTRKKP 492
E +G +CD +S G+ + E + P
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 7/201 (3%)
Query: 21 IPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYIL 80
+P L +L L+ LS G L +L L L LN N+L S+I L L +
Sbjct: 62 LPSSLSRLLSLDLLSPSGISSLDGSEN-LLNLLPLPSLDLNLNRLRSNISELL-ELTNLT 119
Query: 81 YVNLSSNYLTGSLTSDIQNMKVLID-LDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQG 139
++L +N +T + I +K + LDLS N++ +P + L +L NL L+ N
Sbjct: 120 SLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD 177
Query: 140 PIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFS 199
+P+ +L +L +LDLS N +S+ +P + LS L++ ++S+N + + + +N S
Sbjct: 178 -LPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSIIELLSSLSNLKNLS 235
Query: 200 AQSFHWNYALCGPQRLQVPPC 220
N P+ +
Sbjct: 236 GLELSNNKLEDLPESIGNLSN 256
|
Length = 394 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 299 LGSGGFGSVYKGILSD---GTTVAIKIFNLQLEQAFRSFNS----ECEVLRNVRHRNLIK 351
+G G +G VYK D T+A+K ++LEQ S E +L+ ++H N+++
Sbjct: 10 IGEGTYGVVYKA--RDRVTNETIALK--KIRLEQEDEGVPSTAIREISLLKEMQHGNIVR 65
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVAL--ALEYLHHGHS 409
+ + LV E++ + L K + S F P +I L L + + HS
Sbjct: 66 LQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPR----LIKTYLYQILRGIAYCHS 120
Query: 410 TPVVHCDLKPSNILLDENMVA-HVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE--F 464
V+H DLKP N+L+D A ++DFG+++ G ++T T + T+ Y APE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG----IPVRTFTHEVVTLWYRAPEILL 176
Query: 465 GSEGNVSSKCDVYSYGILLLETFTRK 490
GS + S+ D++S G + E +K
Sbjct: 177 GSR-HYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 20/203 (9%)
Query: 299 LGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQ---AFRSFNSECEVLRNVRHRNLIK--- 351
+G G +G V S+ VAIK + A R+ E ++LR++ H N+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 352 ILSSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVAL-ALEYLHHGH 408
I+ F +V E M + L + + S D D + L L+Y+H
Sbjct: 72 IMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSD--DHCQYFLYQLLRGLKYIH--- 125
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-FGSE 467
S V+H DLKPSN+LL+ N + DFG+++ E D T + T Y APE +
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNC 183
Query: 468 GNVSSKCDVYSYGILLLETFTRK 490
++ DV+S G + E RK
Sbjct: 184 SEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 15/166 (9%)
Query: 332 RSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDI---- 387
++ E ++L+ + HR +I ++ + K+ V MP Y + F +
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPK-------YKCDLFTYVDRSG 180
Query: 388 PDRLNIMIDVALAL-EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446
P L I + L E L + H ++H D+K NI LDE A + DFG + L D
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240
Query: 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP 492
+ T+ +PE + +K D++S G++L E +
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 21/227 (9%)
Query: 285 DLERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRN 343
L TD + +G G +G VYK DG+ A+KI + + +E +L++
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQS 74
Query: 344 V-RHRNLIKIL-----SSCCNTNFKALVLEFMPNGS---LDKWLYSHNYFQDIPDRLNIM 394
+ H N++K + LVLE GS L K L D I+
Sbjct: 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134
Query: 395 IDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI 454
L L++LH+ ++H D+K +NILL + DFG+S L + + ++
Sbjct: 135 YGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST--RLRRNTSV 189
Query: 455 ATIGYMAPEFGS-----EGNVSSKCDVYSYGILLLETFTRKKPTDEM 496
T +MAPE + + + ++CDV+S GI +E P +M
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 15/207 (7%)
Query: 293 FNECNLLGSGGFGSVYK-GILSDGTTVAIKIFNLQLEQAFR------SFNSECEVLRNVR 345
F +LG GGFG V + + G A K L+ ++ + + N E ++L V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALN-EKQILEKVN 58
Query: 346 HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH 405
R ++ + + + LVL M G L + +N D + A L
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLK--FHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFG 465
H +V+ DLKP NILLD+ +SD G++ + EG+ I+ + T+GYMAPE
Sbjct: 117 DLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRG-RVGTVGYMAPEVV 173
Query: 466 SEGNVSSKCDVYSYGILLLETFTRKKP 492
+ D + G L+ E K P
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 336 SECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKW----LYSHNYFQDIPDRL 391
SE L H ++K + + L++E+ G L+K L H FQ+ L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 392 NIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV--- 448
+ + LAL+ +H S ++H DLK +NI L + + DFG SK + DSV
Sbjct: 174 -LFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSK---QYSDSVSLD 226
Query: 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP 492
+ + T Y+APE S K D++S G++L E T +P
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 59/192 (30%), Positives = 83/192 (43%), Gaps = 31/192 (16%)
Query: 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI-DVALALEYLHHGHSTPVVHCDLKPSNI 422
LV ++M G L L F + DR I ++ LALE+LH +V+ DLKP NI
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSE--DRAKFYIAELVLALEHLHKYD---IVYRDLKPENI 127
Query: 423 LLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-FGSEGNVSSKCDVYSYGI 481
LLD + DFG+SK D+ T T Y+APE E + D +S G+
Sbjct: 128 LLDATGHIALCDFGLSK-ANLTDNKTTNTFC-GTTEYLAPEVLLDEKGYTKHVDFWSLGV 185
Query: 482 LLLETFTRKKP-----TDEMFT----GEMNL---------KNWVKESL----PHGLPKIA 519
L+ E P T +M+ G++ + +VK L H L
Sbjct: 186 LVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHR 245
Query: 520 DANLLREENFFS 531
DA L+E FF+
Sbjct: 246 DAVELKEHPFFA 257
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 48/200 (24%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQA--FRSFNSECEVLRNVRHR 347
D + + LG G + +VYKG +G VA+K+ LQ E+ F + E +L+ ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 348 NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNI-MIDVALALEYLHH 406
N++ + LV E++ + L +++ H P+ + + + + L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLH-PENVKLFLFQLLRGLSYIHQ 121
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGS 466
+ ++H DLKP N+L+ + ++DFG+++ + S + + T+ Y P+
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 467 EGNVSSKC-DVYSYGILLLE 485
S C D++ G + +E
Sbjct: 177 GSTEYSTCLDMWGVGCIFVE 196
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT 456
VA +E+L S +H DL NILL EN V + DFG+++ + + D V +
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
+ +MAPE + +++ DV+S+G+LL E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 39/219 (17%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNL 349
D + + +GSG +G+V + G VAIK + +R F SE R R L
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK-------KLYRPFQSELFAKRAYRELRL 67
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIP-----------------DRLN 392
+K + + N L+ F P+ SLD++ H+++ +P DR+
Sbjct: 68 LKHMK---HENVIGLLDVFTPDLSLDRF---HDFYLVMPFMGTDLGKLMKHEKLSEDRIQ 121
Query: 393 IMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTM 452
+ V L+ L + H+ ++H DLKP N+ ++E+ + DFG+++ + D + T
Sbjct: 122 FL--VYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEM--TG 174
Query: 453 TIATIGYMAPE-FGSEGNVSSKCDVYSYGILLLETFTRK 490
+ T Y APE + + + D++S G ++ E T K
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 3/103 (2%)
Query: 386 DIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445
D D L+ VA + +L S +H DL NILL + + DFG+++ +
Sbjct: 212 DTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268
Query: 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
+ V++ + +MAPE + + DV+SYGILL E F+
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLI 350
F ++G+G +G VYKG + G AIK+ ++ E E +L+ HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIA 76
Query: 351 KIL------SSCCNTNFKALVLEFMPNGSLDKWLYSH--NYFQDIPDRLN-IMIDVALAL 401
S + + LV+EF GS+ + + N ++ D + I ++ L
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE--DWIAYICREILRGL 134
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-IATIGYM 460
+LH V+H D+K N+LL EN + DFG+S L D +V + T I T +M
Sbjct: 135 AHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWM 188
Query: 461 APE-FGSEGNVSS----KCDVYSYGILLLETFTRKKPTDEM 496
APE + N + + D++S GI +E P +M
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 64/226 (28%), Positives = 95/226 (42%), Gaps = 40/226 (17%)
Query: 293 FNECNLLGSGGFGSV----YKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLR------ 342
F +LG G FG V YK G AIK L++ E E L
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYK---KTGELYAIKA----LKKGDIIARDEVESLMCEKRIF 53
Query: 343 ----NVRHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDV 397
+ RH L+ L +C T V+E+ G L ++ H P + V
Sbjct: 54 ETANSERHPFLVN-LFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACV 110
Query: 398 ALALEYLH-HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL-LGEGDDSVIQTMTI- 454
L L+YLH + +V+ DLK N+LLD ++DFG+ K +G GD +T T
Sbjct: 111 VLGLQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD----RTSTFC 162
Query: 455 ATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500
T ++APE +E + + D + G+L+ E + P F G+
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 389 DRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448
D L+ VA +E+L S VH DL N+LL + + + DFG+++ + + V
Sbjct: 238 DLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYV 294
Query: 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
+ T + +MAPE + ++ DV+SYGILL E F+
Sbjct: 295 SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 298 LLGSGGFGSVYKGIL----SDGTTVAIKIFNLQLEQAFRSFN---SECEVLRNVRHRNLI 350
LLG G FG V IL + G A+KI ++ A +E VL+N RH L
Sbjct: 2 LLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIM-IDVALALEYLHHGHS 409
+ S + V+E+ G L L F + DR ++ AL+YLH +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE--DRARFYGAEIVSALDYLHSEKN 116
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGN 469
VV+ DLK N++LD++ ++DFG+ K G D + ++T T Y+APE + +
Sbjct: 117 --VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GTPEYLAPEVLEDND 172
Query: 470 VSSKCDVYSYGILLLETFTRKKP 492
D + G+++ E + P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 30/78 (38%), Positives = 48/78 (61%), Gaps = 6/78 (7%)
Query: 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHSTPVVHCDLKPSNI 422
LV+E++ G + L+ + YF D + + +VALAL+YLH HG ++H DLKP N+
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYF-DEEMAVKYISEVALALDYLHRHG----IIHRDLKPDNM 135
Query: 423 LLDENMVAHVSDFGISKL 440
L+ ++DFG+SK+
Sbjct: 136 LISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 45/212 (21%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSF------NSECEVLRNVRHRNLIKI 352
+GSG +GSV T +++ +L + F+S E +L++++H N+I +
Sbjct: 25 VGSGAYGSVCAAF---DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 81
Query: 353 LSSCCNTNFKALVLEFMPNGSL----DKWLYSHNYFQDI----------PDRLNIMI-DV 397
L F P SL D +L +H D+ D + +I +
Sbjct: 82 LDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 129
Query: 398 ALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATI 457
L+Y+H S ++H DLKPSN+ ++E+ + DFG+++ DD + T +AT
Sbjct: 130 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATR 181
Query: 458 GYMAPEFG-SEGNVSSKCDVYSYGILLLETFT 488
Y APE + + + D++S G ++ E T
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 298 LLGSGGFGSVYKGIL----SDGTTVAIKIFN----LQLEQAFRSFNSECEVLRNVRHRNL 349
LLG G FG V IL + G A+KI + ++ + +E VL+N RH L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFL 57
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIM-IDVALALEYLHHGH 408
+ S + V+E+ G L L F + DR ++ AL YLH
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE--DRARFYGAEIVSALGYLH--- 112
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPEFGSE 467
S VV+ DLK N++LD++ ++DFG+ K EG T T Y+APE +
Sbjct: 113 SCDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 468 GNVSSKCDVYSYGILLLETFTRKKP 492
+ D + G+++ E + P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 48/142 (33%), Positives = 63/142 (44%), Gaps = 8/142 (5%)
Query: 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNIL 423
LVL F+ G L L F R ++ ALE LH V++ DLKP NIL
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLH---KFNVIYRDLKPENIL 125
Query: 424 LDENMVAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPEFGSEGNVSSKCDVYSYGIL 482
LD + DFG+ KL + DD +T T T Y+APE + D ++ G+L
Sbjct: 126 LDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVL 182
Query: 483 LLETFTRKKPTDEMFTGEMNLK 504
L E T P + EM K
Sbjct: 183 LYEMLTGLPPFYDENVNEMYRK 204
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 59/246 (23%), Positives = 97/246 (39%), Gaps = 57/246 (23%)
Query: 291 DGFNECNLLGSGGFGSV-YKGILSDGTTVAIKIFNLQLEQAFRS-----FNSECEVLRNV 344
+ F+ ++G G FG V G A+K L + F+ +E +VL
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLAES 58
Query: 345 RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYL 404
++ + S + + L++EF+P G L L ++ F + R M + LA+E +
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAV 117
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS------------KLLGEGD------- 445
H +H D+KP NIL+D +SDFG+S + L +G
Sbjct: 118 H---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 446 -------DSVIQTM-------------------TIATIGYMAPEFGSEGNVSSKCDVYSY 479
DS+ TM T+ T Y+APE + +CD +S
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 480 GILLLE 485
G ++ E
Sbjct: 235 GAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 298 LLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECE-VLRNV-----RHRNLIK 351
+LG G FG V+ L GT I L+ + + EC V + V H L
Sbjct: 2 MLGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
+ + V+E++ G L + S + F D+P ++ L++LH S
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF-DLPRATFYAAEIICGLQFLH---SKG 116
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISK--LLGEGDDSVIQTMTIATIGYMAPEFGSEGN 469
+V+ DLK NILLD + ++DFG+ K +LG+ T Y+APE
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF----CGTPDYIAPEILLGQK 172
Query: 470 VSSKCDVYSYGILLLETFTRKKP 492
++ D +S+G+LL E + P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 50/223 (22%)
Query: 290 TDGFNECNLLGSGGFGSV--YKGILSDGTTVAIK-IFN-----LQLEQAFRSFNSECEVL 341
T+ + + +G G FG V + L+ G VAIK I + ++ +R E ++L
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYR----ELKLL 63
Query: 342 RNVRHRNLIKI----LSSCCNTNFKALVLEFMPNGSLDKWLYSH-------NYFQDIPDR 390
+++RH N+I + +S + F V E + L + L S YF
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYF---VTELLGT-DLHRLLTSRPLEKQFIQYF------ 113
Query: 391 LNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450
+ + L+Y+H S VVH DLKPSNIL++EN + DFG++++ D +
Sbjct: 114 ---LYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQM- 162
Query: 451 TMTIATIGYMAPEF---GSEGNVSSKCDVYSYGILLLETFTRK 490
T ++T Y APE + +V + D++S G + E K
Sbjct: 163 TGYVSTRYYRAPEIMLTWQKYDV--EVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 29/203 (14%)
Query: 299 LGSGGFGSVYKG--ILSDGTTVAIKIFNLQLEQ-----AFRSFNSECEVLRNVRHRNLIK 351
LG G + +VYKG L+D VA+K L+ E+ A R E +L++++H N++
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVT 68
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG---- 407
+ LV E+ LDK L Y D + +N M +V L L L G
Sbjct: 69 LHDIIHTEKSLTLVFEY-----LDKDL--KQYLDDCGNSIN-MHNVKLFLFQLLRGLNYC 120
Query: 408 HSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--FG 465
H V+H DLKP N+L++E ++DFG+++ + + + + T+ Y P+ G
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLG 178
Query: 466 SEGNVSSKCDVYSYGILLLETFT 488
S + S++ D++ G + E T
Sbjct: 179 ST-DYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 56/194 (28%), Positives = 87/194 (44%), Gaps = 13/194 (6%)
Query: 298 LLGSGGFGSVYKGIL-SDGTTVAIKIFN----LQLEQAFRSFNSECEVLRNVRHRNLIKI 352
++G G FG V SDG+ A+K+ L+ ++ +L+N++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
S VL+++ G L L F + R +VA A+ YLH S +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SLNI 117
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPEFGSEGNVS 471
++ DLKP NILLD ++DFG+ K EG + T T T Y+APE +
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 472 SKCDVYSYGILLLE 485
D + G +L E
Sbjct: 175 RTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 62/284 (21%), Positives = 118/284 (41%), Gaps = 55/284 (19%)
Query: 299 LGSGGFGSVYKGIL---SDG--------TTVAIKIFNLQLEQAFRSFNSECEVLRNVRHR 347
LG G F ++YKG+L SD +V +K+ + +F ++ + H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61
Query: 348 NLIKILSSC-CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHH 406
+L+K+ C + N +V E++ G LD +L+ + +L++ +A AL YL
Sbjct: 62 HLVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL-- 117
Query: 407 GHSTPVVHCDLKPSNILL-----DENMV--AHVSDFGISKLLGEGDDSVIQTMTIATIGY 459
+VH ++ NIL+ +E V +SD GI + ++ V + I +
Sbjct: 118 -EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------IPW 170
Query: 460 MAPEF--GSEGNVSSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLP 516
+APE + +++ D +S+G LLE + ++P + + E + LP +P
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP--MP 228
Query: 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKD 560
A+ + +L C P +R +
Sbjct: 229 DCAE-------------------LANLINQCWTYDPTKRPSFRA 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 37/212 (17%)
Query: 324 NLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN-TNFKALVLEFMPNGSLDKWLYSHN 382
N+ +++ R F ++ R R L+K C N N +L+ F P SL++
Sbjct: 44 NVAIKKLSRPFQNQTHAKRAYRELVLMK----CVNHKNIISLLNVFTPQKSLEE------ 93
Query: 383 YFQDIPDRLNIM-------IDVAL---ALEYL--------HHGHSTPVVHCDLKPSNILL 424
FQD+ + +M I + L + YL H HS ++H DLKPSNI++
Sbjct: 94 -FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 152
Query: 425 DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLL 484
+ + DFG+++ G S + T + T Y APE D++S G ++
Sbjct: 153 KSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 485 ETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP 516
E K +F G + W K G P
Sbjct: 210 EMVRHKI----LFPGRDYIDQWNKVIEQLGTP 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 298 LLGSGGFGSVYKGILSDGTTV-AIKIFNLQLEQAFRSFNSEC-----EVLRNVRHRNLIK 351
+LG G FG V L V AIK+ L+ + + + +C +L +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 352 ILSSCCNTNFKAL-VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHS 409
L C T + V+E++ G L + F + R +V LAL +LH HG
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRHG-- 116
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPEFGSEG 468
V++ DLK NILLD ++DFG+ K EG + + T T T Y+APE E
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 469 NVSSKCDVYSYGILLLETFTRKKP-----TDEMFTGEMN 502
D ++ G+L+ E + P D++F ++
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 59/237 (24%)
Query: 299 LGSGGFGSV---YKGILSDGTTVAIKIFNLQLEQAF-------RSFNSECEVLRNVRHRN 348
+GSG G V Y + G VAIK +L + F R++ E +++ V H+N
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIK----KLSRPFQNVTHAKRAYR-ELVLMKLVNHKN 76
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKW--------LYSHNYFQDIP-----DRLNIMI 395
+I +L+ F P SL+++ L N Q I +R++ ++
Sbjct: 77 IIGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLL 124
Query: 396 DVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA 455
L + H HS ++H DLKPSNI++ + + DFG+++ G S + T +
Sbjct: 125 YQMLC--GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVV 179
Query: 456 TIGYMAPE----FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVK 508
T Y APE G + NV D++S G ++ E +F G ++ W K
Sbjct: 180 TRYYRAPEVILGMGYKENV----DIWSVGCIMGEMIRGTV----LFPGTDHIDQWNK 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 30/87 (34%), Positives = 43/87 (49%), Gaps = 3/87 (3%)
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFG 465
H HS +V+ D+KP N+LLD+ +SD G++ L +G T T GYMAPE
Sbjct: 110 HLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEIL 166
Query: 466 SEGNVSSKCDVYSYGILLLETFTRKKP 492
E S D ++ G + E + P
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT 456
VA +E+L S +H DL NILL EN V + DFG+++ + + D V +
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
+ +MAPE + + + DV+S+G+LL E F+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 65/232 (28%), Positives = 95/232 (40%), Gaps = 49/232 (21%)
Query: 299 LGSGGFGSV---YKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSS 355
+GSG G V Y IL VAIK + R F ++ R R L+K
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLS-------RPFQNQTHAKRAYRELVLMK---- 78
Query: 356 CCN-TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIM-------IDVALALE---YL 404
C N N L+ F P SL++ FQD+ + +M I + L E YL
Sbjct: 79 CVNHKNIIGLLNVFTPQKSLEE-------FQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 405 --------HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT 456
H HS ++H DLKPSNI++ + + DFG+++ G S + T + T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 188
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVK 508
Y APE D++S G ++ E +F G ++ W K
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 15/207 (7%)
Query: 293 FNECNLLGSGGFGSVYK-GILSDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRN 348
F +LG GGFG V + + G A K ++ + +E +L V R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHG 407
++ + + + LVL M G L +Y+ N D + ++ LE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 408 HSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTM--TIATIGYMAPEFG 465
+V+ DLKP NILLD+ +SD G++ + EG +T+ + T+GYMAPE
Sbjct: 122 R---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-----ETVRGRVGTVGYMAPEVI 173
Query: 466 SEGNVSSKCDVYSYGILLLETFTRKKP 492
+ + D + G L+ E + P
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 28/225 (12%)
Query: 293 FNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSEC-----EVLRNVRH 346
FN +LG G FG V AIKI L+ + + + EC VL
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQDK 59
Query: 347 RNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH 405
+ L SC T + V+E++ G L + F++ P + ++++ L +LH
Sbjct: 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE-PQAVFYAAEISVGLFFLH 118
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATI----GYMA 461
+++ DLK N++LD ++DFG+ K + ++ +T T Y+A
Sbjct: 119 R---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK------EHMVDGVTTRTFCGTPDYIA 169
Query: 462 PEFGSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMFTGEM 501
PE + D ++YG+LL E + P DE+F M
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 44/204 (21%), Positives = 89/204 (43%), Gaps = 24/204 (11%)
Query: 337 ECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMID 396
E +L+NV H ++I++ + + +VL P+ S D + Y + +P ++I+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI-- 454
+ LE L + H+ ++H D+K NI +++ + D G ++ V+ +
Sbjct: 164 KQI-LEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF------PVVAPAFLGL 216
Query: 455 -ATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKK---------PTDEMFTGEMNLK 504
T+ APE + +SK D++S GI+L E P + + + +L
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276
Query: 505 NWVK--ESLPHGLPKIADANLLRE 526
+ + P P+ + L+R
Sbjct: 277 KIISTLKVHPEEFPRDPGSRLVRG 300
|
Length = 357 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 3e-07
Identities = 20/59 (33%), Positives = 32/59 (54%)
Query: 127 LTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRL 185
L +L L+ N+ +F L +L+ LDLS NNL+ P++ L L+ ++S N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 57/240 (23%), Positives = 93/240 (38%), Gaps = 43/240 (17%)
Query: 291 DGFNECNLLGSGGFGSVYKGILSD-GTTVAIKIFN----LQLEQAFRSFNSECEVLRNVR 345
D F ++G G FG V D G A+KI L+ EQ +E ++L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQV-AHIRAERDILVEAD 59
Query: 346 HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH 405
++K+ S + L++EF+P G + L + + + I + LA++ +H
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH 118
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG--------------DDSVIQT 451
+H D+KP N+LLD +SDFG+ L + D Q
Sbjct: 119 Q---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 452 M-------------------TIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP 492
M T+ T Y+APE + + CD +S G+++ E P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 20/196 (10%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ------AFRSFNSECEVLRNVRHRNLIK 351
+G G +G+V+K VA+K L + A R E +L+ ++H+N+++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 63
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
+ + LV E+ + L K+ S N D + M + L+ L HS
Sbjct: 64 LYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQL---LKGLAFCHSHN 119
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--FGSEGN 469
V+H DLKP N+L+++N ++DFG+++ G + + T+ Y P+ FG++
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKL- 176
Query: 470 VSSKCDVYSYGILLLE 485
S+ D++S G + E
Sbjct: 177 YSTSIDMWSAGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 11/209 (5%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFN----LQLEQAFRSFNSECEVLRNVRHRNLIKI 352
++G G FG V ++ A+K+ L+ ++ + +L+NV+H L+ +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
S + VL+++ G L L F + R ++A AL YLH S +
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLNI 117
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
V+ DLKP NILLD ++DFG+ K E + + + T Y+APE +
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT--STFCGTPEYLAPEVLHKQPYDR 175
Query: 473 KCDVYSYGILLLETFTRKKPTDEMFTGEM 501
D + G +L E P T EM
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 32/227 (14%)
Query: 293 FNECNLLGSGGFGSVYKGILSD--GTT--VAIKIFNLQLEQAFRSFNSECEVLRNVRHRN 348
FN +LG G FG V +L++ GT AIKI L+ + + + EC + V R
Sbjct: 2 FNFLMVLGKGSFGKV---MLAERKGTDELYAIKI--LKKDVVIQDDDVECTM---VEKRV 53
Query: 349 L--------IKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVAL 399
L + L SC T + V+E++ G L + F++ P + ++A+
Sbjct: 54 LALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKE-PHAVFYAAEIAI 112
Query: 400 ALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGY 459
L +LH S +++ DLK N++LD ++DFG+ K D V T Y
Sbjct: 113 GLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDY 167
Query: 460 MAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMFTGEM 501
+APE + D +++G+LL E + P DE+F M
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 35/218 (16%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ------AFRSFNSECEVLRNVRHRNLIK 351
LG G FG VYK + G VA+K + E+ A R E ++L+ ++H N++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71
Query: 352 ILS-----SCCNTNFKALVLEFMP--NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYL 404
++ + + V P + L L + + M+ + + YL
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYL 131
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL-----------GEGDDSVIQTMT 453
H H ++H D+K +NIL+D + ++DFG+++ G G T
Sbjct: 132 HENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY--TNL 186
Query: 454 IATIGYMAPEF-GSEGNVSSKCDVYSYGILLLETFTRK 490
+ T Y PE E ++ D++ G + E FTR+
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 56/240 (23%), Positives = 93/240 (38%), Gaps = 43/240 (17%)
Query: 291 DGFNECNLLGSGGFGSVYKGILSD-GTTVAIKIFN----LQLEQAFRSFNSECEVLRNVR 345
+ F ++G G FG V D G A+KI L+ EQ +E ++L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQV-GHIRAERDILVEAD 59
Query: 346 HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH 405
++K+ S + L++EF+P G + L + + + I + LA++ +H
Sbjct: 60 SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH 118
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG--------------DDSVIQT 451
+H D+KP N+LLD +SDFG+ L + D Q
Sbjct: 119 Q---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 452 M-------------------TIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP 492
M T+ T Y+APE + + CD +S G+++ E P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 34/209 (16%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFN--LQLE----QAFRSFNSECEVLRNVRHRNLI 350
+GSG +GSV I G VAIK + Q E +A+R E +L++++H N+I
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQHENVI 77
Query: 351 KIL----SSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYL 404
+L S+ F+ LV+ +M L K + H +D + V L L
Sbjct: 78 GLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQK-IMGHPLSED-----KVQYLVYQMLCGL 130
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAP 462
+ HS ++H DLKP N+ ++E+ + DFG+++ MT + T Y AP
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAP 183
Query: 463 E-FGSEGNVSSKCDVYSYGILLLETFTRK 490
E + + + D++S G ++ E T K
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSSC 356
+G G +G V+K + +G+ A+KI + + +E +L+ + H N++K
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 357 CNTNFKA-----LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVAL---ALEYLHHGH 408
+ K LVLE GS+ + F +R+ I + AL L H H
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGS-- 466
+H D+K +NILL + DFG+S L + + ++ T +MAPE +
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 467 ---EGNVSSKCDVYSYGILLLE 485
+ ++CDV+S GI +E
Sbjct: 200 QQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIK----IFNLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
++G G +G V I G VAIK +F + A R E ++LR +RH ++++I
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILR-EIKLLRLLRHPDIVEI 64
Query: 353 LSSCCNTN---FKAL--VLEFMPN------GSLDKWLYSHNYFQDIPDRLNIMIDVALAL 401
+ FK + V E M + + D H+ F + + AL
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQF--------FLYQLLRAL 116
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL-LGEGDDSVIQTMTIATIGYM 460
+Y+H + V H DLKP NIL + + + DFG++++ + ++ T +AT Y
Sbjct: 117 KYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 461 APEF-GS-EGNVSSKCDVYSYGILLLETFTRK 490
APE GS + D++S G + E T K
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 54/236 (22%), Positives = 83/236 (35%), Gaps = 68/236 (28%)
Query: 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL 424
V++++P G + L F++ R I ++ A+E +H +H D+KP NIL+
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILI 134
Query: 425 DENMVAHVSDFGI---------SKLLGEGDDSVIQTMT---------------------- 453
D + ++DFG+ SK +GD +M
Sbjct: 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKR 194
Query: 454 ----------IATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNL 503
+ T Y+APE + CD +S G++L E + P E L
Sbjct: 195 QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQL 254
Query: 504 K--NWVKE-SLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRL 556
K NW +P A L RE I L CC + RL
Sbjct: 255 KVINWETTLHIPS------QAKLSRE---------ASDLILRL---CCG--AEDRL 290
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 33/208 (15%)
Query: 299 LGSGGFGSVYKGILSDGTT---VAIKIFNLQLEQAFRSF------NSECEVLRNVRHRNL 349
+GSG +GSV D VA+K +L + F+S E +L++++H N+
Sbjct: 23 VGSGAYGSVCSAY--DTRLRQKVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 350 IKIL------SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEY 403
I +L +S N N LV M L+ + Q + D ++ + L
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK----CQKLSDE-HVQFLIYQLLRG 130
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 463
L + HS ++H DLKPSN+ ++E+ + DFG+++ + DD + T +AT Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEM--TGYVATRWYRAPE 185
Query: 464 FG-SEGNVSSKCDVYSYGILLLETFTRK 490
+ + + D++S G ++ E K
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 3/100 (3%)
Query: 389 DRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448
D + VA +E+L S VH DL N+L+ E + + DFG+++ + + +
Sbjct: 240 DLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYI 296
Query: 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
+ T + +MAPE ++ DV+S+GILL E FT
Sbjct: 297 SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 47/187 (25%), Positives = 84/187 (44%), Gaps = 37/187 (19%)
Query: 337 ECEVLRNVRHRNLIKILSSCCNTNFKAL--VLEFMPNGSLDKWLYS-HNYFQDIPDR--L 391
E V+R ++H+N+++ + N + L ++EF G L + + + F I + +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 392 NIMIDVALALEYLHHGHSTP----VVHCDLKPSNILLDENM-----------------VA 430
+I + AL Y H+ P V+H DLKP NI L + +A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 431 HVSDFGISKLLGEGDDSVIQTMTIATIG---YMAPE--FGSEGNVSSKCDVYSYGILLLE 485
+ DFG+SK +G I++M + +G Y +PE + K D+++ G ++ E
Sbjct: 182 KIGDFGLSKNIG------IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235
Query: 486 TFTRKKP 492
+ K P
Sbjct: 236 LCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 19/195 (9%)
Query: 299 LGSGGFGSVYKG--ILSDGTTVAIKIFNLQLEQ-AFRSFNSECEVLRNVRHRNLIKILSS 355
LG G + +V+KG L++ VA+K L+ E+ A + E +L++++H N++ +
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHNYFQD---IPDRLNIMIDVALALEYLHHGHSTPV 412
LV E+ LDK L Y D I N+ I + L L + H V
Sbjct: 73 VHTDKSLTLVFEY-----LDKDL--KQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV 125
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--FGSEGNV 470
+H DLKP N+L++E ++DFG+++ + + + + T+ Y P+ GS
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSS-EY 182
Query: 471 SSKCDVYSYGILLLE 485
S++ D++ G + E
Sbjct: 183 STQIDMWGVGCIFFE 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 35/114 (30%), Positives = 54/114 (47%), Gaps = 14/114 (12%)
Query: 396 DVALALEYLH-HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI 454
++ L L++LH G +++ DLK N+LLD ++DFG+ K EG + T T
Sbjct: 104 EIVLGLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTF 156
Query: 455 -ATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMFTGEMN 502
T Y+APE S D ++ G+LL E + P DE+F +
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 7/105 (6%)
Query: 386 DIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445
D+ D L VA +++L S +H D+ N+LL + VA + DFG+++ +
Sbjct: 210 DLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 446 DSVIQTMTIATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFT 488
+ V++ + +MAPE F V S DV+SYGILL E F+
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVYTVQS--DVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 40/242 (16%)
Query: 305 GSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN-TNFKA 363
GS +GI+ + I N+ +++ R F ++ R R L+K C N N +
Sbjct: 30 GSGAQGIVCAAFDTVLGI-NVAVKKLSRPFQNQTHAKRAYRELVLLK----CVNHKNIIS 84
Query: 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALA-----------LEYL-------- 404
L+ F P SL++ FQD+ + +M D L + YL
Sbjct: 85 LLNVFTPQKSLEE-------FQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLCGI 136
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF 464
H HS ++H DLKPSNI++ + + DFG+++ + + T + T Y APE
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEV 193
Query: 465 GSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524
D++S G ++ E +F G ++ W K G P N L
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVK----GSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249
Query: 525 RE 526
+
Sbjct: 250 QP 251
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 28/221 (12%)
Query: 299 LGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQ-----AFRSFNSECEVLRNVRHRNLIKI 352
LG G + +V+KG VA+K L+ E+ A R E +L+N++H N++ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTL 68
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
LV E++ + L ++L + + + M + L Y H +
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKI 124
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--FGSEGNV 470
+H DLKP N+L++E ++DFG+++ + + + + T+ Y P+ GS
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGST-EY 181
Query: 471 SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESL 511
S+ D++ G +L E T + MF G VKE L
Sbjct: 182 STPIDMWGVGCILYEMATGRP----MFPGST-----VKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 40/209 (19%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFN-----SECEVLRNVR-HRNLIK 351
+G G F V K G AIK +++ F+S E + LR + H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 352 ILSSCCN--TNFKALVLEFMPNGSLDKWLYSH--NYFQDIPDR--LNIMIDVALALEYLH 405
++ + T ALV E M D LY + +P++ + M + +L+++H
Sbjct: 63 LIEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 406 -HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ----TMTIATIGYM 460
+G + H D+KP NIL+ ++++ ++DFG + + T I+T Y
Sbjct: 118 RNG----IFHRDIKPENILIKDDIL-KLADFGSCR-------GIYSKPPYTEYISTRWYR 165
Query: 461 APE-FGSEGNVSSKCDVYSYGILLLETFT 488
APE ++G K D+++ G + E +
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 48/201 (23%), Positives = 83/201 (41%), Gaps = 14/201 (6%)
Query: 299 LGSGGFGSVYKGI---LSDG-----TTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLI 350
LG G F ++KGI + D T V +K+ + SF ++ + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST 410
C + +V E++ GSLD +L + +I +L + +A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL---EDK 119
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT--IGYMAPEFGSEG 468
+ H ++ N+LL + KL G + I I ++ PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENP 179
Query: 469 -NVSSKCDVYSYGILLLETFT 488
N+S D +S+G L E F+
Sbjct: 180 QNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 40/122 (32%), Positives = 54/122 (44%), Gaps = 19/122 (15%)
Query: 387 IPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG--ISKLLGEG 444
+ L+I + +EY+H S V+H DLKP NILL + D+G I K L E
Sbjct: 112 VGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEE 168
Query: 445 DDSVIQ---------TMTI-----ATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRK 490
D I +MTI T YMAPE S D+Y+ G++L + T
Sbjct: 169 DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228
Query: 491 KP 492
P
Sbjct: 229 FP 230
|
Length = 932 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 298 LLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSEC-----EVLRNVRHRNLIK 351
+LG G FG V L G A+K+ L+ + + + EC +L R+ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 352 ILSSCCNTNFKAL-VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST 410
L C T + V+EF+ G L + F + R ++ AL +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH---DK 115
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPEFGSEGN 469
+++ DLK N+LLD ++DFG+ K EG + T T T Y+APE E
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 470 VSSKCDVYSYGILLLETFTRKKP-----TDEMFTGEMN 502
D ++ G+LL E P D++F +N
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 67/295 (22%), Positives = 119/295 (40%), Gaps = 54/295 (18%)
Query: 299 LGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQ-----AFRSFNSECEVLRNVRHRNLIKI 352
LG G + +VYKG G VA+K L+ E+ A R E +L++++H N++ +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLKDLKHANIVTL 68
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
LV E++ + L +++ + + + + L Y H V
Sbjct: 69 HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---V 124
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV-IQTMT--IATIGYMAPE--FGSE 467
+H DLKP N+L+ E ++DFG+++ SV +T + + T+ Y P+ GS
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARA-----KSVPSKTYSNEVVTLWYRPPDVLLGST 179
Query: 468 GNVSSKCDVYSYGILLLETFTRK---------------------KPTDEMFTGEMNLKNW 506
S+ D++ G + E T + PT+E + G + +
Sbjct: 180 -EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238
Query: 507 VKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDA 561
S P P+ L+ R+D + LAL P +R+ +A
Sbjct: 239 KPYSFPFYPPR----PLINHAP----RLDRIPHGEELALKFLQYEPKKRISAAEA 285
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 28/225 (12%)
Query: 293 FNECNLLGSGGFGSVYKGILSD--GTT--VAIKIFNLQLEQAFRSFNSEC-----EVLRN 343
FN +LG G FG V +L++ GT AIKI L+ + + + EC VL
Sbjct: 2 FNFLMVLGKGSFGKV---MLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLAL 56
Query: 344 VRHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALE 402
+ L SC T + V+E++ G L + F++ P + ++A+ L
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE-PHAVFYAAEIAIGLF 115
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMA 461
+LH S +++ DLK N++LD ++DFG+ K G + T T T Y+A
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIA 169
Query: 462 PEFGSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMFTGEM 501
PE + D +++G+LL E + P DE+F M
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 50/212 (23%), Positives = 84/212 (39%), Gaps = 26/212 (12%)
Query: 293 FNECNLLGSGGFGS--VYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLI 350
+N ++G G FG + + + SD +I + A E +L ++H N++
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR----------LNIMIDVALA 400
S +V+E+ G L Q I + L + + L
Sbjct: 62 AFKESFEADGHLYIVMEYCDGGDL---------MQKIKLQRGKLFPEDTILQWFVQMCLG 112
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460
++ H H V+H D+K NI L +N + DFG ++LL + T Y+
Sbjct: 113 VQ---HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYACTYVGTPYYV 167
Query: 461 APEFGSEGNVSSKCDVYSYGILLLETFTRKKP 492
PE ++K D++S G +L E T K P
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 28/161 (17%)
Query: 298 LLGSGGFGSVYK-GILSDGT---TVAIKIFNLQLEQAFRS---FNSECEV--------LR 342
L+G GGFG VY+ SD KI NL+ E +N+ ++ +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78
Query: 343 NVRHRNLIKILSSC-----CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDV 397
N+ H I C C ++ ++LE + + K ++ ++ NIM D+
Sbjct: 79 NIDHLG-IPKYYGCGSFKRCRMYYRFILLEKLVENT--KEIFKRIKCKNKKLIKNIMKDM 135
Query: 398 ALALEYLH-HGHSTPVVHCDLKPSNILLDENMVAHVSDFGI 437
LEY+H HG S H D+KP NI++D N ++ D+GI
Sbjct: 136 LTTLEYIHEHGIS----HGDIKPENIMVDGNNRGYIIDYGI 172
|
Length = 294 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 2e-05
Identities = 28/59 (47%), Positives = 33/59 (55%)
Query: 103 LIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNL 161
L LDLS N+L+ GL +L L L+GN PE+F L SL SLDLS NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 52/239 (21%)
Query: 291 DGFNECNLLGSGGFGSV--YKGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLRNV 344
D F ++G G FG V + + G A+K L+ EQ +E ++L
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDT-GHIYAMKKLRKSEMLEKEQVAH-VRAERDILAEA 58
Query: 345 RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYL 404
+ ++K+ S + N+ L++E++P G + L + F + R I + LA++ +
Sbjct: 59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSI 117
Query: 405 H-HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK-----------------LLGEGDD 446
H G+ +H D+KP N+LLD +SDFG+ L D
Sbjct: 118 HKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 447 SVIQTM-------------------TIATIGYMAPE-FGSEGNVSSKCDVYSYGILLLE 485
+ + M T+ T Y+APE F G + +CD +S G+++ E
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYE 231
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 39/146 (26%), Positives = 69/146 (47%), Gaps = 13/146 (8%)
Query: 353 LSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLN--IMIDVALALEYLHHGHS 409
L SC T + LV+E++ G L ++ + +P+ ++ +AL +LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE--- 114
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKL-LGEGDDSVIQTMTIATIGYMAPEFGSEG 468
+++ DLK N+LLD + ++D+G+ K LG GD + + T Y+APE
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRGE 171
Query: 469 NVSSKCDVYSYGILLLETFTRKKPTD 494
D ++ G+L+ E + P D
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 14/109 (12%)
Query: 396 DVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK--LLGEGDDSVIQTMT 453
++ L++LH +++ DLK N+LLD++ ++DFG+ K + GEG S
Sbjct: 104 EIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF---- 156
Query: 454 IATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMF 497
T Y+APE + D +S+G+LL E + P DE+F
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 42/163 (25%), Positives = 66/163 (40%), Gaps = 26/163 (15%)
Query: 336 SECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLY-SHNYFQDIPDRLNIM 394
+E +LR + H ++I++ + F L+L P D + Y + I D L I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 395 IDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS---------KLLGEGD 445
V A++YLH ++H D+K NI ++ + DFG + K G
Sbjct: 189 RSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA- 244
Query: 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
TI APE + D++S GI+L E T
Sbjct: 245 ---------GTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 34/147 (23%), Positives = 63/147 (42%), Gaps = 19/147 (12%)
Query: 295 ECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLI--KI 352
LL G VY + + +KI + + A R E +L+ + + L K+
Sbjct: 2 SIKLLKGGLTNRVYL-LGTKDEDYVLKINPSREKGADR--EREVAILQLLARKGLPVPKV 58
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP- 411
L+S + + L++E++ +LD+ ++ +I +A E L H P
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLA---ELLAKLHQLPL 107
Query: 412 --VVHCDLKPSNILLDENMVAHVSDFG 436
+ H DL P NIL+D+ + + D+
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 62/276 (22%), Positives = 103/276 (37%), Gaps = 61/276 (22%)
Query: 299 LGSGGFGSVYKGILSD---------GTTVAIKIFNLQLEQAFR----SFNSECEVLRNVR 345
LG G +Y GIL+ IK+ L+ + R +F ++R V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 346 HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH 405
H++++ + C +V EF+ G LD +++ + P + + +A AL YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL- 121
Query: 406 HGHSTPVVHCDLKPSNILLDENMV-------AHVSDFGISKLLGEGDDSVIQTMTIATIG 458
+VH ++ NILL + +SD GI + + + + I
Sbjct: 122 --EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV------LSRQECVERIP 173
Query: 459 YMAPE-FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517
++APE N+S D +S+G L E + GE+ LK
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEI---------CYNGEIPLK------------- 211
Query: 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPD 553
D L +E F+ + L C EL D
Sbjct: 212 --DKTLAEKERFYEGQ-------CMLVTPSCKELAD 238
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 13/163 (7%)
Query: 336 SECEVLRNVRHRNLIKILSSCCNTNFKAL-VLEFMPNGSLDKWLYSHNYFQDIPDRLN-- 392
+E V + + L SC T + V+E++ G L ++ + +P+
Sbjct: 44 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARF 100
Query: 393 IMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL-LGEGDDSVIQT 451
+++LAL YLH +++ DLK N+LLD ++D+G+ K L GD + +
Sbjct: 101 YSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---S 154
Query: 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTD 494
T Y+APE + D ++ G+L+ E + P D
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 16/100 (16%)
Query: 399 LALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL--------LGEGDDSV-- 448
LALEYLH + +VH DLKP N+L+ ++DFG+SK+ L EG
Sbjct: 112 LALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 449 ---IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLE 485
+ T Y+APE D ++ GI+L E
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 10/107 (9%)
Query: 396 DVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA 455
++ L++LH S +++ DLK N++LD + ++DFG+ K GD+ +
Sbjct: 104 EIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA--STFCG 158
Query: 456 TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMF 497
T Y+APE + D +S+G+LL E + P DE+F
Sbjct: 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 19/149 (12%)
Query: 353 LSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI--DVALALEYLHHGHS 409
L SC T + V+EF+ G L ++ + +P+ +++LAL +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHERG- 116
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKL-LGEGDDSVIQTMTI-ATIGYMAPEF--G 465
+++ DLK N+LLD ++D+G+ K + GD T T T Y+APE G
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIAPEILRG 170
Query: 466 SEGNVSSKCDVYSYGILLLETFTRKKPTD 494
+ S D ++ G+L+ E + P D
Sbjct: 171 EDYGFS--VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 45/205 (21%), Positives = 87/205 (42%), Gaps = 21/205 (10%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRN------VRHRNLIKI 352
+G+G FG V + T VA + ++ +A S + E L+ ++H N+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVV--VKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL---NIMIDVALALEYLHHGHS 409
L C LV E+ G L +L + + L + ++A + ++H +
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN- 119
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE-- 467
+H DL N L ++ V D+GI + D + + ++APE E
Sbjct: 120 --FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 468 -GNVSSK----CDVYSYGILLLETF 487
G ++++ +V++ G+ L E F
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALEYLHHGHSTPVVHCDLKPSN 421
LVL+ G L W + + IP+ ++ +AL+ LH +V DL P+N
Sbjct: 62 LVLQHAEGGKL--WSHISKFLN-IPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNN 115
Query: 422 ILLDENMVAHVSDFG-ISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYG 480
ILLD+ ++ F S++ D ++ M Y APE G + CD +S G
Sbjct: 116 ILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEVGGISEETEACDWWSLG 169
Query: 481 ILLLETFTRKKPTDEMFTG-----EMNLKNWVKE 509
+L E T K + +G +N+ WV E
Sbjct: 170 AILFELLTGKTLVECHPSGINTHTTLNIPEWVSE 203
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 4e-04
Identities = 21/60 (35%), Positives = 28/60 (46%)
Query: 30 RLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYL 89
L SL L N+L L +L+ L L+ N LTS P A L + ++LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 56/265 (21%), Positives = 98/265 (36%), Gaps = 55/265 (20%)
Query: 293 FNECNLLGSGGFGSVYKGILSD-GTTVAIKIF---NLQLEQAFRSFNSECEVLRNVRHRN 348
F + LG G FG V D A+K ++ L +E ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH 408
++++ S + + V++++P G + L F + R I ++ A+E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVH--- 118
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGI---------SKLLGEGD----DSVIQTMT-- 453
+H D+KP NIL+D + ++DFG+ SK GD DS+ +
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 454 ------------------------------IATIGYMAPEFGSEGNVSSKCDVYSYGILL 483
+ T Y+APE + CD +S G++L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 484 LETFTRKKP--TDEMFTGEMNLKNW 506
E + P +M + NW
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 40/148 (27%), Positives = 62/148 (41%), Gaps = 37/148 (25%)
Query: 5 QQLQGIGLADNHLQGS-IPY------DLCQLKRLNSLSLQGNKLN----GSIPTCLASLT 53
+ L+ + LA+N + + I C L+ L+ L N L ++ LASL
Sbjct: 165 RDLKELNLANNGIGDAGIRALAEGLKANCNLEVLD---LNNNGLTDEGASALAETLASLK 221
Query: 54 SLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQL 113
SL L L N LT + +AL + L+ +I L+ L LS N +
Sbjct: 222 SLEVLNLGDNNLTDAGAAAL---------------ASALLSPNIS----LLTLSLSCNDI 262
Query: 114 SGDIPKTIAGL----KDLTNLSLAGNQF 137
+ D K +A + + L L L GN+F
Sbjct: 263 TDDGAKDLAEVLAEKESLLELDLRGNKF 290
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 64/278 (23%), Positives = 108/278 (38%), Gaps = 59/278 (21%)
Query: 293 FNECNLLGSGGFGSVYKGILSD-GTTVAIKIFN----LQLEQAFRSFNSECEVLRNVRHR 347
F + LG G FG V D A+K L Q +E ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQV-AHVKAERDILAEADNE 61
Query: 348 NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG 407
++K+ S + + V++++P G + L F ++ R I ++ LA+E +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH-- 118
Query: 408 HSTPVVHCDLKPSNILLDENMVAHVSDFGI---------SKLLGEGD----DSV------ 448
+H D+KP NIL+D + ++DFG+ SK +G DS+
Sbjct: 119 -KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 449 -----------IQTMT---------------IATIGYMAPEFGSEGNVSSKCDVYSYGIL 482
++T+ + T Y+APE + CD +S G++
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 483 LLETFTRKKPTDEMFTGEMNLK--NWVKESLPHGLPKI 518
L E + P E LK NW E+ H P++
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINW--ENTLHIPPQV 273
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.002
Identities = 20/60 (33%), Positives = 29/60 (48%)
Query: 54 SLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQL 113
+L+ L L++N+LT A L + ++LS N LT + L LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.003
Identities = 20/60 (33%), Positives = 26/60 (43%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKL 65
L+ + L++N L L L L L GN L P + L SLR L L+ N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 49/204 (24%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 315 GTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNG 372
GT V ++I +L+ E+ ++ +E + RH N++ + ++ ++ FM G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 373 SLDKWLYSHNYFQDIPDRLN-IMIDVAL--ALEYLHHGHSTPVVHCDLKPSNILLDENMV 429
S + L YF P+ ++ +I L AL L++ H +H ++K S+IL+ + +
Sbjct: 85 SANSLL--KTYF---PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL 139
Query: 430 AHVSDFGISKLL-----GEGDDSV--IQTMTIATIGYMAPEFGSEG--NVSSKCDVYSYG 480
+S G+S L G+ V + + + +++PE + + K D+YS G
Sbjct: 140 VSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVG 197
Query: 481 ILLLETFTRKKPTDEMFTGEMNLK 504
I E T + P +M +M L+
Sbjct: 198 ITACELATGRVPFQDMLRTQMLLQ 221
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 299 LGSGGFGSVYKGILSDGT---TVAIKIFNLQLEQAFRSFNS--ECEVLRNVRHRNLIKIL 353
+G G +G VYK DG A+K Q+E S ++ E +LR ++H N+I +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALK----QIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 354 SSCCNTNFKALVLEFMPNGSLDKW----LYSHNYFQDIPDRL-NIMIDVAL--ALEYLHH 406
+ + + + L F D W + + P +L M+ L L+ +H+
Sbjct: 65 KVFLSHSDRKVWLLF-DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 407 GHSTPVVHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSVIQTMT-----IATI 457
H+ V+H DLKP+NIL+ E ++D G ++L +S ++ + + T
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF----NSPLKPLADLDPVVVTF 179
Query: 458 GYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK 490
Y APE G+ + + D+++ G + E T +
Sbjct: 180 WYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 52/186 (27%), Positives = 73/186 (39%), Gaps = 29/186 (15%)
Query: 30 RLNSLSLQGNKLNGSIPTCLASLT---SLRELRLNSNKLTSSI-----------PSALWA 75
L L L N L L SL SL+EL+LN+N L P AL
Sbjct: 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141
Query: 76 LEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGD-IPKTIAGLKDLTNL---S 131
L +L N +L ++ + L +L+L+ N + I GLK NL
Sbjct: 142 L--VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLD 199
Query: 132 LAGNQFQ----GPIPESFGSLISLESLDLSSNNLSE-GIPKSLVALSH----LKQFNVSH 182
L N + E+ SL SLE L+L NNL++ G AL L ++S
Sbjct: 200 LNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSC 259
Query: 183 NRLEGE 188
N + +
Sbjct: 260 NDITDD 265
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 581 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.88 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.87 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.83 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.63 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.63 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.62 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.6 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.59 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.59 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.56 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.55 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.48 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.37 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.36 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.36 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.33 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.3 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.28 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.16 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.15 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.13 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.09 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.09 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.08 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.06 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.05 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.04 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.02 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.93 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.88 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.8 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.77 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.76 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.72 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.68 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.68 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.67 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-70 Score=625.86 Aligned_cols=548 Identities=28% Similarity=0.453 Sum_probs=407.8
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
.+++|+.|+|++|++++.+|..|..+++|++|+|++|.|++..+..+..+++|+.|+|++|++.+.+|..+ ..++|+.|
T Consensus 402 ~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L 480 (968)
T PLN00113 402 ACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENL 480 (968)
T ss_pred CCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEE
Confidence 45666677777777766666667777777777777777776666666667777777777777766666544 45778888
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
++++|++++..|..+.++++|++|+|++|.+.+.+|..+.++++|+.|+|++|.+++.+|..|..+++|+.|+|++|+++
T Consensus 481 ~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 560 (968)
T PLN00113 481 DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS 560 (968)
T ss_pred ECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCccc
Confidence 88888888888888999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCCC-CCCCCCCCcccccccchheeeeeeeecc
Q 008012 163 EGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQ-RLQVPPCKEDKNKGFKKVALLVLKYIFP 241 (581)
Q Consensus 163 ~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~-~~~~p~c~~~~~~~~~~~~~~~~~~~~~ 241 (581)
+.+|..+..+++|+.|++++|++.+.+|..+.+..+....+.+|+..|++. +...|+|..... ...+..+ +++
T Consensus 561 ~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~---~~~~~~~---~~~ 634 (968)
T PLN00113 561 GEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK---TPSWWFY---ITC 634 (968)
T ss_pred ccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc---cceeeee---hhH
Confidence 999999999999999999999999999998888888888899999999865 335678854211 1111111 212
Q ss_pred chhhHHHHHHHH-HH-HHHHhccCCCCCCchhhhhh--hcc--ccchhhhHHHhhcCCCcCCeecccccccEEEEEe-CC
Q 008012 242 PIICVVLIALVF-IF-FLRRRNRSTKSPDDEELFSL--ATW--RRTSYLDLERATDGFNECNLLGSGGFGSVYKGIL-SD 314 (581)
Q Consensus 242 ~~~~~~~~~~~~-~~-~~~rr~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~-~~ 314 (581)
++++++++++++ ++ +++++++......+...... ... ........+.....|...+.||+|+||.||+|.. .+
T Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~ 714 (968)
T PLN00113 635 TLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKN 714 (968)
T ss_pred HHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCC
Confidence 222222222222 22 22222211111100000000 000 0011123334445688889999999999999996 47
Q ss_pred CcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHH
Q 008012 315 GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIM 394 (581)
Q Consensus 315 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~ 394 (581)
+..||+|.++..... ...|++.+++++||||+++++++.+.+..++||||+++|+|.++++. +++..+.+++
T Consensus 715 ~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~ 786 (968)
T PLN00113 715 GMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIA 786 (968)
T ss_pred CcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHH
Confidence 899999988654321 23468899999999999999999999999999999999999999963 6889999999
Q ss_pred HHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccc
Q 008012 395 IDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKC 474 (581)
Q Consensus 395 ~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 474 (581)
.|+++||+|||..++.+|+||||||+||+++.++.+++. ||....... .....++..|+|||++.+..++.++
T Consensus 787 ~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~s 859 (968)
T PLN00113 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKS 859 (968)
T ss_pred HHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCccc
Confidence 999999999997667899999999999999998888775 665443211 1223578999999999999999999
Q ss_pred cHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC-CCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCC
Q 008012 475 DVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG-LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPD 553 (581)
Q Consensus 475 Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 553 (581)
|||||||++|||+||+.||+..........+|........ ...+.|+.+.... ....+...++.+++.+||+.||+
T Consensus 860 Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~ 936 (968)
T PLN00113 860 DIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV---SVNQNEIVEVMNLALHCTATDPT 936 (968)
T ss_pred chhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC---CccHHHHHHHHHHHHhhCcCCch
Confidence 9999999999999999999765555556666665443322 2333344332211 11223455788999999999999
Q ss_pred CCCCHHHHHHHHHHhHHHHHhh
Q 008012 554 QRLYMKDAATKLKKIRDKFLED 575 (581)
Q Consensus 554 ~Rps~~evl~~L~~~~~~~~~~ 575 (581)
+||||+|+++.|+++.......
T Consensus 937 ~RPt~~evl~~L~~~~~~~~~~ 958 (968)
T PLN00113 937 ARPCANDVLKTLESASRSSSSC 958 (968)
T ss_pred hCcCHHHHHHHHHHhhcccccc
Confidence 9999999999999987755444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=379.77 Aligned_cols=255 Identities=25% Similarity=0.353 Sum_probs=216.0
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC-eeeEEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN-FKALVL 366 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 366 (581)
.++.+.++.||+|..|+||++.++ +++.+|+|++.... +...+++.+|+++++..+||+||.+||.|.... ..+++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 345556789999999999999976 88999999995553 455678999999999999999999999999988 599999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|||++|+|++++...+. +++....+|+.++++||.|||+ +++|+||||||+|||++..|.|||||||.+..+...
T Consensus 158 EYMDgGSLd~~~k~~g~-i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGR-IPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred hhcCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999999987644 7899999999999999999995 589999999999999999999999999999876433
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
......||..|||||.+.+..|+.++||||||++++|+++|+.||...........+.+........+...+.
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~----- 305 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG----- 305 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-----
Confidence 3456789999999999999999999999999999999999999998753434444444444333222221111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+++++.+++..||++||.+|||++|+++|
T Consensus 306 --------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 --------EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred --------cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 366789999999999999999999999987
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=399.21 Aligned_cols=289 Identities=42% Similarity=0.681 Sum_probs=246.2
Q ss_pred ccccchhhhHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeee
Q 008012 277 TWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356 (581)
Q Consensus 277 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 356 (581)
..+.+++.+++.++++|...+.||+|+||.||+|...+|+.||||.+..........|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999998899999988776533134599999999999999999999999
Q ss_pred ecCC-eeeEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEee
Q 008012 357 CNTN-FKALVLEFMPNGSLDKWLYSHNY-FQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSD 434 (581)
Q Consensus 357 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~D 434 (581)
.+.+ +.+||+|||++|+|.+++..... .++|..+++|+.++|+||+|||+.+...|+||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999997765 789999999999999999999987777899999999999999999999999
Q ss_pred ccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccc-cccccHHHHHHhhCCC
Q 008012 435 FGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMF-TGEMNLKNWVKESLPH 513 (581)
Q Consensus 435 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~-~~~~~~~~~~~~~~~~ 513 (581)
||+|+..... .........||.+|+|||+...+..+.|+|||||||++.|++||+.|.+... ..+..+..|.......
T Consensus 221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999654321 1111111179999999999999999999999999999999999999887643 3455688887666655
Q ss_pred -CCCccccccchh-hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 514 -GLPKIADANLLR-EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 514 -~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
.+.+++|+.+.. ..... +....+..+..+|++.+|++||+|.||++.|+.+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~~----~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDE----KEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cchhheeCCCccCCCCChH----HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 588899998763 22111 445568899999999999999999999999966543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=378.77 Aligned_cols=254 Identities=27% Similarity=0.362 Sum_probs=211.6
Q ss_pred hhcCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccchH-------HHHHHHHHHHHHHHhcCCCccceEeeeeecCC
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLE-------QAFRSFNSECEVLRNVRHRNLIKILSSCCNTN 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 360 (581)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++++... .....+.+|+++|++++||+||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678899999999999999999 45899999999976531 12234679999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC---CcEEEeeccC
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN---MVAHVSDFGI 437 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~---~~~kl~Dfg~ 437 (581)
..|+||||++||+|.+++-.++. +.+.....++.|++.|+.||| +.||+||||||+|||+..+ ..+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999999987765 677888999999999999999 9999999999999999765 7899999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCCCC---ccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVS---SKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG 514 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 514 (581)
|+..+. .......+||+.|.|||++.++.++ .++|+||+||++|-+++|.+||.+...+.....+..+..+...
T Consensus 326 AK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 326 AKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred hhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 998753 2345667899999999998876433 4789999999999999999999886544332233222222111
Q ss_pred CCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 515 LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+.+++++..++|.+||..||++|||++|+++|
T Consensus 403 ---------------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 403 ---------------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ---------------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 13345677889999999999999999999999987
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-49 Score=388.42 Aligned_cols=262 Identities=31% Similarity=0.476 Sum_probs=218.6
Q ss_pred hcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC-eeeEEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN-FKALVL 366 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 366 (581)
..+..+.+.+|+|+||+||+|.+.....||||++.... ....+.|.+|+.++.+++|||||+++|++.+.. ..++||
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 34445556799999999999999844449999998754 222668999999999999999999999999887 799999
Q ss_pred eccCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCCCCeEecCCC-cEEEeeccCceecCC
Q 008012 367 EFMPNGSLDKWLYS-HNYFQDIPDRLNIMIDVALALEYLHHGHSTP-VVHCDLKPSNILLDENM-VAHVSDFGISKLLGE 443 (581)
Q Consensus 367 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~ 443 (581)
||+++|+|.+++.. ....+++..++.++.|||+|+.||| +.+ ||||||||+|||++.++ ++||+|||+++....
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999998 4667899999999999999999999 788 99999999999999997 999999999987643
Q ss_pred CCCcceeeccccCccccCCCCCC--CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGS--EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
.. ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... .......+....+..++.
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~---- 269 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPK---- 269 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCc----
Confidence 22 2233468999999999999 66999999999999999999999999988644 222222222332222222
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
.+++.+..+|.+||+.||++||++.+++..|+.+...+..
T Consensus 270 -------------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 270 -------------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -------------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 2567788999999999999999999999999999887764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-49 Score=389.77 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=213.6
Q ss_pred cCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
..|...+.||+|||+.||.++. .+|+.||+|++.+.. ....+.+.+|+++.+.++|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 789999999997753 456678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|+|+.++|..+++ .++.+++.++..++.||+.||.||| +++|+|||||..|+|++++.+|||+|||+|..+..++.
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999988 4455899999999999999999999 89999999999999999999999999999999864433
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.....+|||.|.|||++.....+..+||||+|||||-|+.|++||+.. .+.+.........
T Consensus 174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~vkety~~Ik~~~------------ 234 (592)
T KOG0575|consen 174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TVKETYNKIKLNE------------ 234 (592)
T ss_pred --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hHHHHHHHHHhcC------------
Confidence 345678999999999999999999999999999999999999999863 1222222211111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+...+.+..+||.++|+.||.+|||+++|+.|
T Consensus 235 ---Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 ---YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11112344567799999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=356.96 Aligned_cols=257 Identities=25% Similarity=0.351 Sum_probs=211.5
Q ss_pred hcCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeee-eecCCe-eeE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSS-CCNTNF-KAL 364 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~-~~l 364 (581)
..+|.+.++||+|+||.||++. ..+|..||.|.++-. +....+....|+.++++++|||||+++++ +.++.. .++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3468888999999999999999 558999999988754 35566788999999999999999999994 444444 899
Q ss_pred EEeccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 365 VLEFMPNGSLDKWLY---SHNYFQDIPDRLNIMIDVALALEYLHHGHSTP--VVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 365 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
|||||.+|+|.+.++ +.++.++++.+|+++.|++.||.++|... .. |+||||||.||+++.+|.|||+|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999987 45667899999999999999999999422 44 8999999999999999999999999999
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
.+... .......+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+. ++.+.........++.+.
T Consensus 177 ~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 177 FLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred Hhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHHcCCCCCCc
Confidence 88543 33445678999999999999999999999999999999999999999874 444443333333333222
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
+ .-++..+..+|..|+..||+.||+...++..++.
T Consensus 250 ~-------------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 D-------------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred H-------------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 2 2456778899999999999999996655555444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=367.45 Aligned_cols=201 Identities=30% Similarity=0.516 Sum_probs=183.9
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
..++|...+.||+|+||+||+|+++ ++..||||.+.+. .....+.+..|+.+++.++|||||++++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4578999999999999999999965 7899999999777 566677889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC------CcEEEeeccCce
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN------MVAHVSDFGISK 439 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~------~~~kl~Dfg~a~ 439 (581)
||||.||+|.+|++..+. +++..+..++.|||.||++|| +++||||||||+|||++.. -.+||+|||+|+
T Consensus 88 MEyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999999998865 789999999999999999999 8999999999999999864 568999999999
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEM 496 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~ 496 (581)
.+.+.. .....+|++.|||||++...+|+.|+|+||+|+++|+|++|++||+..
T Consensus 164 ~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 886432 345678999999999999999999999999999999999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=385.10 Aligned_cols=262 Identities=29% Similarity=0.485 Sum_probs=219.6
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
++...+.+..++.||+|.||.||.|.++....||+|.++... ...+.|.+|+++|++++|++||+++++|..++.++||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 333444556678999999999999999877799999998753 2235788999999999999999999999998899999
Q ss_pred EeccCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 366 LEFMPNGSLDKWLYS-HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+.|+|.+|++. .+..+...+.+.++.|||+|++||+ ++++|||||.++||||+++..+||+|||+|+...++
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 999999999999997 5667889999999999999999999 999999999999999999999999999999955433
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
.........-+..|.|||.+..+.++.|||||||||+||||+| |+.||..+...+ +.+.+.
T Consensus 357 -~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--v~~~le--------------- 418 (468)
T KOG0197|consen 357 -EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--VLELLE--------------- 418 (468)
T ss_pred -ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--HHHHHh---------------
Confidence 2333333445778999999999999999999999999999999 889987643221 122222
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
.+...+.+..||+.++++|..||+.+|++|||++.+...|+.+...
T Consensus 419 --~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 419 --RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred --ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 2223455668999999999999999999999999998888887653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=347.59 Aligned_cols=261 Identities=22% Similarity=0.278 Sum_probs=212.0
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
+.|+...++|+|+||.||+++.+ +|+.||||.+... ++...+-..+|++++++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 57889999999999999999966 8999999998544 24455667899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
||+. ++.+-++......+...+.+++.|++.|+.|+| +++++||||||+|||++.+|.+||||||+|+.+....+
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd- 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD- 156 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence 9987 666667776666888999999999999999999 99999999999999999999999999999998864332
Q ss_pred ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC------------
Q 008012 448 VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG------------ 514 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~------------ 514 (581)
..+..+.|..|+|||.+.+ .+|+..+||||+||++.||++|.+-|.+. .+.+....+......-
T Consensus 157 -~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~--SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 157 -NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR--SDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc--chHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 3466789999999998877 79999999999999999999999988763 2222222233222211
Q ss_pred ------CCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 515 ------LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 515 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+|+..++.-. ...-...+.-+.++++.|++.||++|++.+|++.|
T Consensus 234 ~F~Gv~lP~~~~~epL-----e~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPL-----ERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccch-----hhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 2222222211 12223445578899999999999999999999876
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=350.92 Aligned_cols=248 Identities=27% Similarity=0.345 Sum_probs=208.0
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
...++|++.+.||+|+||.||+++.+ +++.+|+|++++.. ....+...+|..++.+++||+||+++-.|.+.+..|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 34678999999999999999999954 79999999998764 345678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+|+||+.||.|..++++.+. +++..+.-++..|+.||.||| ++||+||||||+|||+|.+|+++|+|||+|+..-.
T Consensus 102 lVld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999999998776 688888889999999999999 99999999999999999999999999999985433
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---CCcccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---LPKIAD 520 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 520 (581)
.. ......+||+.|||||++.+..|+.++|.||+|+++|||++|.+||... +...++....... .+..
T Consensus 178 ~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~~~I~~~k~~~~p~~-- 248 (357)
T KOG0598|consen 178 DG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMYDKILKGKLPLPPGY-- 248 (357)
T ss_pred CC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHHHHHhcCcCCCCCcc--
Confidence 22 2334578999999999999999999999999999999999999999873 2222333222221 1111
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCC----CHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRL----YMKDAAT 563 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~evl~ 563 (581)
.+.+..+++.+++..||++|. ++.+|.+
T Consensus 249 ---------------ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 249 ---------------LSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred ---------------CCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 234567999999999999996 4555443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=386.48 Aligned_cols=265 Identities=29% Similarity=0.479 Sum_probs=225.6
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccchHH-HHHHHHHHHHHHHhcCCCccceEeeeeec
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQLEQ-AFRSFNSECEVLRNVRHRNLIKILSSCCN 358 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 358 (581)
.+....+....+.||+|.||.||+|+.. +...||||.++..... ...+|++|++++..++|||||+++|+|..
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3344556677789999999999999842 4567999999887654 78899999999999999999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHHhhC---------C----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSH---------N----YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD 425 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~---------~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~ 425 (581)
++..++|+|||..|||.+|+... + ..++..+.+.|+.|||.|+.||- ++.+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceec
Confidence 99999999999999999999843 1 22678899999999999999999 78899999999999999
Q ss_pred CCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHH
Q 008012 426 ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLK 504 (581)
Q Consensus 426 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~ 504 (581)
++..|||+|||+++.+...+.........-+.+|||||.+..++||.+||||||||+|||+++ |+.||.+....+ ..
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--VI 715 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--VI 715 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--HH
Confidence 999999999999998766665555555566889999999999999999999999999999999 999998854432 12
Q ss_pred HHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 505 NWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
+.+.. +...+.+++||.++++||..||+.+|++||+++||-..|+......
T Consensus 716 e~i~~-----------------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 716 ECIRA-----------------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHc-----------------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 22221 2224566789999999999999999999999999999999876543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=362.33 Aligned_cols=268 Identities=25% Similarity=0.274 Sum_probs=215.7
Q ss_pred HhhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHH-HHHHHHHHHHHHHhcC-CCccceEeeeeecCC-eee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQ-AFRSFNSECEVLRNVR-HRNLIKILSSCCNTN-FKA 363 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~ 363 (581)
...++|.++++||.|.||.||+|+. .+|+.||||.++..... +...-.||+..+++++ ||||+++.+++.+.+ ..+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3467899999999999999999994 48999999999876433 2234568999999997 999999999999988 999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+|||||+. +|++++..++..+++..+..|+.||++||+|+| ++|+.|||+||+|||+..+..+||+|||+|+.+..
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999966 999999999999999999999999999999999 99999999999999999999999999999997643
Q ss_pred CCCcceeeccccCccccCCCCC-CCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFG-SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
....+.++.|..|+|||++ +.+-|+.+.||||+|||++|+.+-++-|.+. .+.+....+.+.+.....+.....
T Consensus 163 ---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~--sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 163 ---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA--SEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC--cHHHHHHHHHHHhCCCccccchhH
Confidence 3345677899999999964 6678999999999999999999999988763 333333333444333222111110
Q ss_pred --chhh----------hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 523 --LLRE----------ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 523 --~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+... .+...-...++.+..++|.+|+.+||++||||+|++++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0000 01111122367788899999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=362.03 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=213.7
Q ss_pred HHhhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCe
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNF 361 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 361 (581)
.....+|.+.+.||+|+|++|++|+. ++++.+|||++.+.- +...+.+.+|-.+|.+| .||.|+++|-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44567899999999999999999995 489999999997663 33345678899999999 89999999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
+|+|+||+++|+|.++|.+.+. +++.....++.+|+.||+||| ++|||||||||+|||+|++++++|+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999999998876 788899999999999999999 999999999999999999999999999999987
Q ss_pred CCCCCc---------c--eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 008012 442 GEGDDS---------V--IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES 510 (581)
Q Consensus 442 ~~~~~~---------~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~ 510 (581)
.+.... . .....+||..|.+||++.....++.+|+|+|||++|+|+.|++||.+. .....+..++.-.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~-NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA-NEYLIFQKIQALD 303 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc-cHHHHHHHHHHhc
Confidence 543221 1 124578999999999999999999999999999999999999999873 2222222222211
Q ss_pred CCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 511 LPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+ .-+...++.+.+|+.+.|..||.+|+|++||.+|
T Consensus 304 y-------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 304 Y-------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred c-------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1 1112334567899999999999999999999887
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=354.38 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=208.8
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC--eeeEEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN--FKALVL 366 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 366 (581)
..+|...+.||+|+||+||++... +|+..|||.+........+.+.+|+.+|++++|||||+++|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 455778899999999999999965 58999999987764333677899999999999999999999855544 689999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-CCcEEEeeccCceecCC-C
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE-NMVAHVSDFGISKLLGE-G 444 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~-~ 444 (581)
||+++|+|.+++.+.+..+++..+..++.||++||+||| ++||+||||||+|||++. ++.+||+|||++..... .
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999999987656899999999999999999999 999999999999999999 79999999999987653 1
Q ss_pred CCcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
..........||+.|||||++.++ ....++||||+||++.||+||++||...... .............+.+.
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~---~~~~~~ig~~~~~P~ip---- 245 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE---AEALLLIGREDSLPEIP---- 245 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch---HHHHHHHhccCCCCCCC----
Confidence 112223456899999999999863 3345999999999999999999999874111 11111111111122111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
..++++..+++.+|+..||++||||+++++|--...
T Consensus 246 ----------~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 246 ----------DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred ----------cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 124556789999999999999999999999865443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=365.39 Aligned_cols=270 Identities=24% Similarity=0.405 Sum_probs=222.4
Q ss_pred chhhhHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeec
Q 008012 281 TSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358 (581)
Q Consensus 281 ~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 358 (581)
.+..++++..++..+...||+|.||+||+|.|. ..||||+++... .+..+.|++|+..+++-+|.||+-+.|+|..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 344677788888999999999999999999986 469999997663 5578899999999999999999999999998
Q ss_pred CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
+.. .||+.||+|.+|+.+++.....+++.+.+.|++||++|+.||| .++|||||||..||++.+++.|||+|||++
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccce
Confidence 887 9999999999999999988788999999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCC---CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCC
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSE---GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGL 515 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 515 (581)
..-..-..........|...|||||+++. .+|++.+||||||+|+|||+||..||.....+.. +...-...+
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-----ifmVGrG~l 610 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-----IFMVGRGYL 610 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-----EEEeccccc
Confidence 76432222223344567889999998764 4789999999999999999999999984322211 111000000
Q ss_pred CccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
.........+|++++.+|+..||..++++||.+.+|+..|+.+...
T Consensus 611 ----------~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 611 ----------MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ----------CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 0011223357888999999999999999999999999988887653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=360.87 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=215.7
Q ss_pred hcCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
...|....+||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+..|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3568888999999999999999 458899999999888766677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
|+||+|.+.+.... +++.++..|++++++||+||| .+||+|||||.+|||++.+|.+||+|||+|..+.....
T Consensus 352 m~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred cCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 99999999998665 789999999999999999999 99999999999999999999999999999998765433
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
......||+.|||||+.....|++++||||||++++||+-|++||-.. ........+... +.+.
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE--~PlrAlyLIa~n---g~P~----------- 488 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATN---GTPK----------- 488 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC--ChHHHHHHHhhc---CCCC-----------
Confidence 456778999999999999999999999999999999999999998641 111111122221 1222
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+...+..+.+++.+||..||++|++|.|+++|
T Consensus 489 -lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 -LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 22234566789999999999999999999999987
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=342.51 Aligned_cols=264 Identities=23% Similarity=0.298 Sum_probs=215.1
Q ss_pred HhhcCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
...++|+..+.||.|..++||+|+ ...++.||||++..+. ....+.+.+|+..|+.++||||++++..|..+...|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 346789999999999999999999 5578999999998774 34468899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 366 LEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
|+||.+|++.+.+... ...+++..+..|++++++||.||| .+|.||||||+.||||+++|.|||+|||.+..+-..
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999999854 344899999999999999999999 899999999999999999999999999988766443
Q ss_pred CCcc-ee-eccccCccccCCCCCCC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 445 DDSV-IQ-TMTIATIGYMAPEFGSE--GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 445 ~~~~-~~-~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
+... .. ....|++.|||||++.. ..|+.|+||||||++..||.+|..||....+-..-+.. +....+...
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-----Lqn~pp~~~- 253 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-----LQNDPPTLL- 253 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-----hcCCCCCcc-
Confidence 3222 22 45689999999998544 47999999999999999999999999875443322221 222211111
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.... ........+..+.+++..||.+||++|||+++++++
T Consensus 254 t~~~----~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGL----DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccC----ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0000 112233455679999999999999999999999987
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=323.77 Aligned_cols=266 Identities=24% Similarity=0.343 Sum_probs=212.2
Q ss_pred cCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccchH--HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLE--QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
++|...+++|+|.||.||+|+ .++|+.||||.++.... .......+|+..++.++|+||+.++++|.+.+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 568888999999999999999 45899999999976632 223467899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
||+. +|...++.....++...+..++.++++|++||| ++.|+||||||.|+|++++|.+||+|||+|+.++.....
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9966 999999999888999999999999999999999 899999999999999999999999999999998765443
Q ss_pred ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC----CCccc---
Q 008012 448 VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG----LPKIA--- 519 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~--- 519 (581)
.+..+.|..|+|||.+.| ..|+..+||||.|||+.||+.|.+-|.+. .+.+....+-..+... +++..
T Consensus 158 --~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~--sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 158 --QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD--SDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred --cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC--chHHHHHHHHHHcCCCCcccCccccccc
Confidence 334478999999997766 57999999999999999999999877652 2222222333333221 11111
Q ss_pred cccchhhh---hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 DANLLREE---NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 ~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
|....... +.......++....+|+.+|+..||.+|+|++|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11000000 0001122355677999999999999999999999886
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=352.42 Aligned_cols=269 Identities=26% Similarity=0.297 Sum_probs=215.7
Q ss_pred hhcCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecC--Ceee
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT--NFKA 363 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 363 (581)
..+.|+.+++||+|.||.||+|+ ..+|+.||+|.++.+. +.......+|+.+|++++||||+++.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34567888899999999999999 5589999999987764 44456678999999999999999999988776 6899
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
||+|||+. +|..++...+..+++.++..++.|++.||+|+| .+||+|||||.+|||||.+|.+||+|||+|+++..
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99999987 999999988888999999999999999999999 99999999999999999999999999999998865
Q ss_pred CCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc--
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD-- 520 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 520 (581)
.. ....+..+.|..|+|||++.+ ..|+.++|+||.||||.||++|++.|.+. .+......+.........+.+.
T Consensus 271 ~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~--tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 271 SG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR--TEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred CC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc--cHHHHHHHHHHHhCCCChhccccc
Confidence 43 233567788999999998776 57999999999999999999999998873 2222222333222211111111
Q ss_pred ---------ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ---------ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+.-.-.....+.....+....+|+..+|..||.+|.||.++++.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00000111122344567778899999999999999999998864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=353.15 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=208.2
Q ss_pred HhhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccc----hH-HHHHHHHHHHHHHHhcC-CCccceEeeeeecCC
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQ----LE-QAFRSFNSECEVLRNVR-HRNLIKILSSCCNTN 360 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 360 (581)
...++|.+.+.||+|+||.|+.|.. .+++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567899999999999999999985 47899999987664 12 33456778999999998 999999999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC-CcEEEeeccCce
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN-MVAHVSDFGISK 439 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~ 439 (581)
..++||||+.||+|.+++.+ ...+.+.++..+++|+++|++|+| ++||+||||||+||+++.+ +.+||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999999 445788999999999999999999 9999999999999999999 999999999999
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCCCC-CC-ccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC--CC
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSEGN-VS-SKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH--GL 515 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--~~ 515 (581)
... .........+|++.|+|||++.+.. |+ .++||||+||++|.|++|+.||++. +........... .+
T Consensus 170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----~~~~l~~ki~~~~~~~ 242 (370)
T KOG0583|consen 170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-----NVPNLYRKIRKGEFKI 242 (370)
T ss_pred ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcCCccC
Confidence 773 1222345678999999999999977 75 7899999999999999999999872 111222211111 12
Q ss_pred CccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+.... +.++..++.+|+..||.+|+|+.+++++
T Consensus 243 p~~~~----------------S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 243 PSYLL----------------SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred CCCcC----------------CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 22221 3467799999999999999999999954
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=352.12 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=214.7
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+. .+.+.+.+.+|++++++++||||+.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57889999999999999999966 7899999999765 35667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+.| +|..++...+. ++++.+..++.|+++||.||| +.+|.|||+||.||+++.++.+|+||||+|+.++. .+
T Consensus 82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT 154 (808)
T ss_pred hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence 9977 99999988765 789999999999999999999 99999999999999999999999999999998754 44
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
...+...||+.|||||+..+..|+..+|.||+||++||+++|++||... .+.+.++....+....
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v~~---------- 219 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPVKP---------- 219 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCCCC----------
Confidence 5567778999999999999999999999999999999999999999762 3334444333222111
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+...+..+.+++...|.+||.+|.|..+++.|
T Consensus 220 -----p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 220 -----PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -----cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11345568899999999999999999999887
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=355.43 Aligned_cols=262 Identities=26% Similarity=0.406 Sum_probs=207.5
Q ss_pred HhhcCCCcCCeecccccccEEEEEe------CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeecC
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGIL------SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNT 359 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 359 (581)
...++|++.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.+++++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3457899999999999999999973 235689999987543 33456789999999999 899999999988764
Q ss_pred -CeeeEEEeccCCCCHHHHHhhCC--------------------------------------------------------
Q 008012 360 -NFKALVLEFMPNGSLDKWLYSHN-------------------------------------------------------- 382 (581)
Q Consensus 360 -~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------------------------- 382 (581)
+..++||||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 46889999999999999997532
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCc
Q 008012 383 -----YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATI 457 (581)
Q Consensus 383 -----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~ 457 (581)
..+++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||+++...............++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 23667788999999999999999 8999999999999999999999999999998654332222223345668
Q ss_pred cccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHH
Q 008012 458 GYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDC 536 (581)
Q Consensus 458 ~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (581)
.|+|||++.+..++.++|||||||++|||++ |..||......+ .+...+....... .+..+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~~~~~~-----------------~~~~~ 302 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKDGTRMR-----------------APENA 302 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHhcCCCCC-----------------CCCCC
Confidence 8999999999899999999999999999997 999997632221 1111111111000 01133
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 537 LLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 537 ~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
++.+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4568899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=345.63 Aligned_cols=250 Identities=27% Similarity=0.375 Sum_probs=212.2
Q ss_pred hcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
...|+..+.||+|.||.||+|.+ ++++.||+|++..+. ....+.+++|+.++.+++++||.++|+.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 34677889999999999999995 489999999998774 4566889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
||.||++.+.+..... +++..+.-++++++.|+.||| ..+.+|||||+.||++..+|.+||+|||.+..+.....
T Consensus 92 y~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~- 166 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK- 166 (467)
T ss_pred HhcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence 9999999999986654 377788889999999999999 89999999999999999999999999999987754332
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
......||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+ +.+...+-...++ ..+.
T Consensus 167 -rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--mrvlflIpk~~PP----~L~~------ 233 (467)
T KOG0201|consen 167 -RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--MRVLFLIPKSAPP----RLDG------ 233 (467)
T ss_pred -ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--ceEEEeccCCCCC----cccc------
Confidence 33667899999999999999999999999999999999999999987544 2221111111111 1111
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+++.+.+++..||++||+.||+|.++++|
T Consensus 234 -------~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 -------DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -------ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 455678899999999999999999999987
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=317.03 Aligned_cols=238 Identities=25% Similarity=0.337 Sum_probs=203.4
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|++++.||.|+||.|.+++.+ +|..+|+|++++.. ....+...+|..+++.+.||+++++++.+.+.+..++
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 3467899999999999999999965 78999999998774 3456778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||++||.|..++++.++ ++++.+.-++.||+.||+||| +.+|++||+||+|||+|.+|.+||+|||+|+.....
T Consensus 122 vmeyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999999998765 688999999999999999999 999999999999999999999999999999987422
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
+...+||+.|+|||++....|+.++|-|||||++|||+.|.+||.+... ...+..++.... .+|..+
T Consensus 198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~v--~fP~~f----- 264 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGKV--KFPSYF----- 264 (355)
T ss_pred -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCcc--cCCccc-----
Confidence 4567899999999999999999999999999999999999999987433 111222221111 133322
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCC
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQR 555 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 555 (581)
+..+.+|+.+.++.|-.+|
T Consensus 265 ------------s~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 265 ------------SSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ------------CHHHHHHHHHHHhhhhHhh
Confidence 3357799999999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=350.93 Aligned_cols=249 Identities=23% Similarity=0.321 Sum_probs=212.6
Q ss_pred hcCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
.+-|..++.||.|+.|.|-+|+ ..+|+.+|||++.+.. ......+.+|+-+|+.+.|||++++|+++++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 4568889999999999999999 4599999999997662 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
.||++||-|.+++-.++. +++.++.+++.||+.|+.|+| ..+|+|||+||+|+|+|..+.+||+|||+|..-.++.
T Consensus 91 lEyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999999998876 677888899999999999999 8899999999999999999999999999998754332
Q ss_pred CcceeeccccCccccCCCCCCCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVS-SKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
.....+|++.|.|||++.+.+|. .++||||.|||||.|+||+.||++ .++...........
T Consensus 167 ---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLlKV~~G~---------- 228 (786)
T KOG0588|consen 167 ---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLLKVQRGV---------- 228 (786)
T ss_pred ---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHHHHHcCc----------
Confidence 23456899999999999999884 689999999999999999999985 23444333332221
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
+..+..++.+.++|+++|+..||++|.|++||++|-
T Consensus 229 -----f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 229 -----FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -----ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 222335566788999999999999999999999984
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=340.23 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=208.2
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
+...++|+.++.||+|+||.||+|+-+ +|..+|+|++++.. ..+.+.++.|-.+|...++|.||++|-.|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 346689999999999999999999944 89999999998764 45667889999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
||||||++||++..+|...+. +++..+..++.+++-|+..+| +.|+|||||||+|+|||..|++||+|||++..+.
T Consensus 217 YLiMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999999998775 788899999999999999999 8999999999999999999999999999996431
Q ss_pred C----------------------CCCc----c-------------------eeeccccCccccCCCCCCCCCCCccccHH
Q 008012 443 E----------------------GDDS----V-------------------IQTMTIATIGYMAPEFGSEGNVSSKCDVY 477 (581)
Q Consensus 443 ~----------------------~~~~----~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 477 (581)
. .+.. . .....+|||.|+|||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0000 0 00124699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC
Q 008012 478 SYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLY 557 (581)
Q Consensus 478 slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 557 (581)
|||||+|||+.|.+||......+. ...++.-...-..+. ...++++..+||.+|+. ||++|..
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T-~rkI~nwr~~l~fP~---------------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQET-YRKIVNWRETLKFPE---------------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhhhccCCC---------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999987533322 222211111111111 11234568899999999 9999985
Q ss_pred ---HHHHHHH
Q 008012 558 ---MKDAATK 564 (581)
Q Consensus 558 ---~~evl~~ 564 (581)
++||.+|
T Consensus 436 ~~G~~EIK~H 445 (550)
T KOG0605|consen 436 SKGAEEIKKH 445 (550)
T ss_pred cccHHHHhcC
Confidence 6666554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=363.91 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=221.9
Q ss_pred CCCcCCeecccccccEEEEEeC----CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 292 GFNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
...+.++||.|.||.||+|+.+ ....||||.++... +.....|..|+.||-+++||||+++.|+.......++|+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3466789999999999999965 24579999998875 556778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|||++|+|+.|++.+...+++-+...++++|+.|++||- ++++|||||.++|||++.+..+|++|||+++.+.++..
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 999999999999988877999999999999999999999 99999999999999999999999999999998855442
Q ss_pred cceeecccc--CccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 447 SVIQTMTIA--TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 447 ~~~~~~~~~--~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
...+...| +.+|.|||.+...+++.+|||||||++|||.++ |..||.++...+ .++..
T Consensus 787 -~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-----VIkaI------------- 847 (996)
T KOG0196|consen 787 -AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-----VIKAI------------- 847 (996)
T ss_pred -ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-----HHHHH-------------
Confidence 22233333 568999999999999999999999999999888 999998764332 12111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
++....+.+++||..|.+||..||++|-.+||.+.||+..|+++..+
T Consensus 848 -e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 848 -EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred -HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 12234567789999999999999999999999999999999998654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=343.68 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=208.5
Q ss_pred hcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
.+....++-||+|+.|.||+|+.+ ++.||||.++.-. ..+++.|++|+||||+.+.|+|.....+|||||||
T Consensus 123 Fe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred HHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence 333444567999999999999987 7999999765332 24788999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce
Q 008012 370 PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI 449 (581)
Q Consensus 370 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 449 (581)
..|-|...++..+. +.......|..+||.|+.||| .+.|||||||.-||||+.+..|||+|||-++..... ..
T Consensus 195 a~GqL~~VLka~~~-itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---ST 267 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRP-ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---ST 267 (904)
T ss_pred ccccHHHHHhccCc-cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hh
Confidence 99999999987765 566788899999999999999 899999999999999999999999999999876432 22
Q ss_pred eeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 450 QTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 450 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
.-...||..|||||+++..+.++|+||||||||||||+||..||.+...... +... + ...+ .
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----IwGV---G-----sNsL-----~ 329 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----IWGV---G-----SNSL-----H 329 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----EEec---c-----CCcc-----c
Confidence 3456899999999999999999999999999999999999999976422211 0000 0 0000 1
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
.+-+..||+.+.-|+++||+-.|..||++.+++.||+-+..+..
T Consensus 330 LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 330 LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 23455788899999999999999999999999999987766554
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.20 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=207.6
Q ss_pred hhcCCCcCCeecccccccEEEEEe------CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCC
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL------SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTN 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 360 (581)
..++|++.+.||+|+||.||+|.+ .++..||+|+++... ....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 356799999999999999999973 246689999987543 33456788999999999 8999999999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCC----------------------------------------------------------
Q 008012 361 FKALVLEFMPNGSLDKWLYSHN---------------------------------------------------------- 382 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------- 382 (581)
..++||||+++|+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999987432
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 383 ----------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 383 ----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 13677889999999999999999 89999999999999999999999999999987643332
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
........++..|+|||++.+..++.++|||||||++|||++ |..||...... ......+........+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~--------- 339 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYRMLSP--------- 339 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCccCCCC---------
Confidence 222223345678999999999999999999999999999998 88898764222 2222333222111111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
...+.++.+++.+||+.||++|||+.|+++.|++.
T Consensus 340 --------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 --------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11245688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=310.52 Aligned_cols=265 Identities=22% Similarity=0.269 Sum_probs=213.7
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecC----
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT---- 359 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 359 (581)
++....++|++.+.+|+|||+.||+++ ..++..+|+|.+.....+..+..++|++..++++|||+++++++...+
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 455667899999999999999999999 568999999999888877788999999999999999999999987443
Q ss_pred -CeeeEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeEecCCCcEEEe
Q 008012 360 -NFKALVLEFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHSTP--VVHCDLKPSNILLDENMVAHVS 433 (581)
Q Consensus 360 -~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dikp~Nill~~~~~~kl~ 433 (581)
...|++++|+..|+|.+.++. .+...++.+++.|+.+|++||++|| +.. ++||||||.||++++++.++|.
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEE
Confidence 358999999999999999984 3557899999999999999999999 565 9999999999999999999999
Q ss_pred eccCceecCCCCCc-------ceeeccccCccccCCCCCC---CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccH
Q 008012 434 DFGISKLLGEGDDS-------VIQTMTIATIGYMAPEFGS---EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNL 503 (581)
Q Consensus 434 Dfg~a~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~ 503 (581)
|||.+....-.-.. ........|..|+|||.+. +...++++|||||||++|+|+.|..||+.......++
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 99999754211000 0112335789999999765 4567889999999999999999999998755433332
Q ss_pred HHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 504 KNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
.-.+.. +.+ ..+....+++.+.++|+.|++.||.+||++.+++.+++.+
T Consensus 252 aLAv~n-----------~q~-----s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 ALAVQN-----------AQI-----SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred EEeeec-----------ccc-----ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 211111 000 0011112567789999999999999999999999998875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=337.11 Aligned_cols=265 Identities=25% Similarity=0.403 Sum_probs=223.0
Q ss_pred hhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHH-HHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQ-AFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
..+...+.++||+|-||.|.++....+..||||.++..+.. ....|.+|+++|.+++||||++++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 34567888999999999999999887899999999988644 45789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCC-CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 368 FMPNGSLDKWLYSHNYFQ-DIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~-~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||++|+|.+|+.++..+. +.+...+|+.||++|++||. +.++||||+.++|+|++.++++||+|||+++-+..++.
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999999885443 55667789999999999999 89999999999999999999999999999997766666
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh--CCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT--RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
........-+.+|||||.+.-++++.++|||+||+++||+++ ...||.+..+++. .+-..+..+.+-..
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v--ven~~~~~~~~~~~------- 763 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV--VENAGEFFRDQGRQ------- 763 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH--HHhhhhhcCCCCcc-------
Confidence 666666677899999999999999999999999999999887 7789887543321 11111222211111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
...+.+.-|+.+++++|.+||+.|-++||+++++..+|++.
T Consensus 764 ---~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 ---VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12234556889999999999999999999999999998864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=346.38 Aligned_cols=262 Identities=24% Similarity=0.401 Sum_probs=209.0
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeec
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCN 358 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 358 (581)
....++|++.+.||+|+||.||+|... ++..||+|+++... ......+.+|+++++.+ +|+||+++++++..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 344568999999999999999998842 34579999997543 34456788999999999 89999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHHhhCC--------------------------------------------------------
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSHN-------------------------------------------------------- 382 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------------------------- 382 (581)
.+..++||||+++|+|.+++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999999986421
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce
Q 008012 383 -------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI 449 (581)
Q Consensus 383 -------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 449 (581)
..+++..+++++.||+.||+||| ++||+||||||+||++++++.+||+|||++...........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 23577888999999999999999 89999999999999999999999999999986643322222
Q ss_pred eeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 450 QTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 450 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....... .....+........+.
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~~~~~----------- 338 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQMSRPD----------- 338 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCccCCC-----------
Confidence 223345678999999988899999999999999999997 999997643222 2222222211111111
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
..++++.+++.+||+.||++|||+.++++.|+++.
T Consensus 339 ------~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 ------FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 12456889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=333.63 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=200.7
Q ss_pred CeecccccccEEEEEeCCCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeec----CCeeeEEEecc
Q 008012 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCN----TNFKALVLEFM 369 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~ 369 (581)
..||+|+++.||+|.. +|+.||+|.++... ....+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 48999999997653 2235678899999999999999999999876 34688999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce
Q 008012 370 PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI 449 (581)
Q Consensus 370 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 449 (581)
++|+|.+++.+.. .+++.....++.|++.||.|||+ ..+++||||||+||++++++.+||+|||++.......
T Consensus 105 ~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---- 177 (283)
T PHA02988 105 TRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---- 177 (283)
T ss_pred CCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence 9999999998754 47889999999999999999993 2589999999999999999999999999998653221
Q ss_pred eeccccCccccCCCCCCC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 450 QTMTIATIGYMAPEFGSE--GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 450 ~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ......+........
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~~~------------ 243 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-EIYDLIINKNNSLKL------------ 243 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhcCCCCCC------------
Confidence 23457899999999876 68999999999999999999999999764211 111111111111110
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
+..+++.+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 244 -----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 244 -----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 11346678999999999999999999999999998754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=370.73 Aligned_cols=263 Identities=28% Similarity=0.450 Sum_probs=220.7
Q ss_pred hcCCCcCCeecccccccEEEEEeC--CCc----EEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS--DGT----TVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
....+..+.||+|.||.||.|... +|. .||+|.++.. +.+....|.+|..+|++++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 455667788999999999999954 343 4899988765 456778999999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeecc
Q 008012 363 ALVLEFMPNGSLDKWLYSH------NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
++++|||+||+|..||++. ...+...+.+.++.|||+|+.||+ ++++|||||..+|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999977 667889999999999999999999 8889999999999999999999999999
Q ss_pred CceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCC
Q 008012 437 ISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGL 515 (581)
Q Consensus 437 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 515 (581)
+|+.+...+.........-+..|||||.+..+.++.|+|||||||++||++| |..||.+....+ .+..+...
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-v~~~~~~g------ 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-VLLDVLEG------ 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-HHHHHHhC------
Confidence 9996654444333333244578999999999999999999999999999999 899987742221 11111111
Q ss_pred CccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
...+.+..||+.++++|..||+.+|++||++..+++.+.++.+....
T Consensus 921 ------------gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 921 ------------GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred ------------CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 12345568999999999999999999999999999999888776553
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=339.96 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=215.0
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe-eeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF-KALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv 365 (581)
.++|..++.+|+|+||.++.++.+ ++..+++|.+.... ....+...+|+.++++++|||||.+.+.|..++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 467999999999999999999965 78899999987653 3444578899999999999999999999998887 9999
Q ss_pred EeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 366 LEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
|+||+||++.+.+.+.+ ..++++.+..|+.|++.|+.||| +..|+|||||+.|||++.++.|||+|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998665 77899999999999999999999 889999999999999999999999999999988654
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
. .......||+.|+.||++.+.+|+.|+|||||||++|||++-+++|... +....+.........
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~ki~~~~~~-------- 224 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILKINRGLYS-------- 224 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHHHhhccCC--------
Confidence 3 2345678999999999999999999999999999999999999999873 233333333222111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+.+..++.++..+|..|+..+|+.||++.+++.+
T Consensus 225 ------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 ------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1223455678899999999999999999999987
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=337.04 Aligned_cols=262 Identities=26% Similarity=0.399 Sum_probs=204.7
Q ss_pred hcCCCcCCeecccccccEEEEEeC-----------------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccce
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-----------------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIK 351 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~ 351 (581)
.++|++.+.||+|+||.||+|.++ ++..||+|++.... ......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 467899999999999999999753 23469999987653 334567899999999999999999
Q ss_pred EeeeeecCCeeeEEEeccCCCCHHHHHhhCC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 008012 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHN------------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVV 413 (581)
Q Consensus 352 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~ 413 (581)
+++++.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||+||| +.||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 9999999999999999999999999986432 23577888999999999999999 89999
Q ss_pred ecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh--CCC
Q 008012 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT--RKK 491 (581)
Q Consensus 414 H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t--g~~ 491 (581)
||||||+||+++.++.+||+|||++................++..|+|||++.++.++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999987644333222333455788999999888899999999999999999987 567
Q ss_pred CCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 492 PTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 492 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
||...... .....+............ ...+..++..+.+++.+||+.||++|||+.||.+.|+
T Consensus 241 p~~~~~~~--~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDE--QVIENAGEFFRDQGRQVY----------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHH--HHHHHHHHHhhhcccccc----------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 77653221 111212111111100000 0011234567889999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=323.23 Aligned_cols=273 Identities=24% Similarity=0.268 Sum_probs=215.1
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEecc--chHHHHHHHHHHHHHHHhcCCCccceEeeeeec---
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNL--QLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN--- 358 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 358 (581)
+...+...|...+.||+|+||.|+.|..+ +|+.||||.+.. ......++..+|+.+++.++|+||+.+++.+..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 44556677777899999999999999965 899999999873 345566788899999999999999999999865
Q ss_pred --CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeecc
Q 008012 359 --TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 359 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
-+..|+|+|+| +.+|.+.++.+.. ++...+..++.|++.||+|+| +.+|+|||+||.|++++.+..+||+|||
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccc
Confidence 34789999999 5599999987654 688899999999999999999 9999999999999999999999999999
Q ss_pred CceecCCCCCcceeeccccCccccCCCCC-CCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCC
Q 008012 437 ISKLLGEGDDSVIQTMTIATIGYMAPEFG-SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGL 515 (581)
Q Consensus 437 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 515 (581)
+|+...........+....|..|+|||++ ....|+.+.||||.|||+.||++|++-|.+ .+.......+.+..+..-
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG--~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG--KDYVHQLQLILELLGTPS 248 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC--CchHHHHHHHHHhcCCCC
Confidence 99988644333344667889999999965 557899999999999999999999999876 333333344444443321
Q ss_pred Ccccc----ccchh---------hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 516 PKIAD----ANLLR---------EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 516 ~~~~~----~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
++... ..... ..+.........+...+|+.+||..||.+|+|++|+++|
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111 00000 001112223456678899999999999999999999987
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=345.17 Aligned_cols=265 Identities=28% Similarity=0.422 Sum_probs=218.5
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeC--CC---cEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeee
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILS--DG---TTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~--~~---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 357 (581)
++...++....++||+|+||.||+|..+ ++ ..||+|..+.. .......+.+|+++|++++|||||++||++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 4444566666799999999999999965 22 23899999863 3566788999999999999999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccC
Q 008012 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGI 437 (581)
Q Consensus 358 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 437 (581)
.....++|||+|.||+|.+++++.+..++..++..++.+.|.||+||| +++++||||..+|+|++.++.+||+|||+
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccc
Confidence 999999999999999999999998877899999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHH-HhhCCCCC
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWV-KESLPHGL 515 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~-~~~~~~~~ 515 (581)
+..-. ..........-+..|+|||.+..+.|+.++|||||||++||+++ |..||.+.... ....++ ....+...
T Consensus 309 s~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 309 SRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNGYRMPI 384 (474)
T ss_pred ccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcCccCCC
Confidence 87532 11111112245688999999999999999999999999999999 88999875332 233333 33333222
Q ss_pred CccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
+. ..|..+..++.+||..+|++||||.++.+.++.+......
T Consensus 385 ~~-----------------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 385 PS-----------------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CC-----------------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 22 3456788999999999999999999999999999876553
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=325.01 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=211.5
Q ss_pred hhcCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
...+|++.+.||+|.||.|-+|. ...|+.||||.++++ +++..-.+.+|+++|..++||||+.+|++|+..+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 34678999999999999999999 468999999999776 35566678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||..+|.|++|+.+.+. +++.++..+++||.+|+.|+| .++++|||||.+|||+|.++.+||+|||++..+...
T Consensus 131 vMEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999999998776 788999999999999999999 899999999999999999999999999999887533
Q ss_pred CCcceeeccccCccccCCCCCCCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNV-SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
. .....+|++-|.+||+..+.+| ++.+|-|||||++|-|+.|..||++. +....+.+.....+.+-.
T Consensus 207 k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQIs~GaYrEP~---- 274 (668)
T KOG0611|consen 207 K---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQISRGAYREPE---- 274 (668)
T ss_pred c---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHhhcccccCCC----
Confidence 2 3456789999999999999988 57899999999999999999999873 222333332222111110
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
-|....-||+.||..+|++|.|+.+|..|.
T Consensus 275 ------------~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 275 ------------TPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 112244699999999999999999999885
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=332.57 Aligned_cols=251 Identities=23% Similarity=0.297 Sum_probs=202.8
Q ss_pred CCCcCCeecccccccEEEEEe-CCCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 292 GFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++|++|+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999995 479999999987543 2233467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 368 FMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999999888653 335788999999999999999999 8999999999999999999999999999998753322
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... .... +..........
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~-~~~~~~~~~~~--------- 223 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREE-VDRRVKEDQEE--------- 223 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHH-HHHHhhccccc---------
Confidence 1234468999999999999999999999999999999999999997642211 1111 11111111000
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLY-----MKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 564 (581)
.+...+..+.+|+.+||+.||++||+ ++++++|
T Consensus 224 -----~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 224 -----YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -----CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 11123456889999999999999997 8899886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=338.71 Aligned_cols=267 Identities=23% Similarity=0.284 Sum_probs=207.8
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.++|++.+.||+|+||.||++..+ ++..+|+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999965 78899999987653 3445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++++|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 999999999998654 36889999999999999999993 2469999999999999999999999999987653221
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---CCc-c-----
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---LPK-I----- 518 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~-~----- 518 (581)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..... ..+...+....... ... .
T Consensus 159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA--KELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhcccccccccCCccccCcccc
Confidence 2334689999999999999999999999999999999999999965321 11221111110000 000 0
Q ss_pred ----------ccc--cc---------hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 519 ----------ADA--NL---------LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 519 ----------~~~--~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
.+. .. ............++.++.++|.+||..||++|||++|+++|-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000 00 000000000113566799999999999999999999999985
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=334.90 Aligned_cols=267 Identities=21% Similarity=0.297 Sum_probs=204.5
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.++|++.+.||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 357999999999999999999965 78999999987543 2223467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++ +|.+++...+..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 9975 999999877666788999999999999999999 89999999999999999999999999999976532221
Q ss_pred ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC----CCcccccc
Q 008012 448 VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG----LPKIADAN 522 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 522 (581)
......+++.|+|||++.+ ..++.++||||+||++|+|++|++||......+ .+. .+....... .+.+.+..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELH-LIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHHHHhCCCChHHhhccccch
Confidence 1233467899999998765 568999999999999999999999997632211 111 111111111 11111000
Q ss_pred -----chh---hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 523 -----LLR---EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 523 -----~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
... ..+........+.+..+++.+||..||.+|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 000011112345668899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=337.58 Aligned_cols=269 Identities=20% Similarity=0.285 Sum_probs=203.8
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH-HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE-QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.++|++.+.||+|+||.||+|..+ +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 578999999999999999999965 789999999875432 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|++ ++|.+++......+++..+..++.|++.||+||| +.||+||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-- 157 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence 995 5888888876666788999999999999999999 8999999999999999999999999999997543222
Q ss_pred ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---CCcc-----
Q 008012 448 VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---LPKI----- 518 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~----- 518 (581)
.......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||....+....+........... .+..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 11234567899999998765 45888999999999999999999999864322222222111100000 0000
Q ss_pred ccc-cch----hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 ADA-NLL----REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ~~~-~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.++ ... ............+..+.+++.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000 000 0000000111134567899999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.14 Aligned_cols=246 Identities=24% Similarity=0.302 Sum_probs=203.4
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999965 78999999987543 234456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++++|.+++...+. +++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGR-FSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred eCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 99999999999987653 688899999999999999999 8999999999999999999999999999998653221
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+.+.... ..++
T Consensus 156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~-~~~~---------- 218 (291)
T cd05612 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GIYEKILAGK-LEFP---------- 218 (291)
T ss_pred ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC-cCCC----------
Confidence 2346899999999999989999999999999999999999999763211 1111111110 0111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLY-----MKDAATKL 565 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~L 565 (581)
...+..+.+++.+||+.||.+||+ ++|+++|-
T Consensus 219 -------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 219 -------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred -------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 112345789999999999999995 99998873
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=331.39 Aligned_cols=257 Identities=28% Similarity=0.517 Sum_probs=209.5
Q ss_pred hcCCCcCCeecccccccEEEEEeCC------CcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSD------GTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
.++|++.+.||+|+||.||+|.... ...|++|.++... ......+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 3578899999999999999998542 2579999987543 34456789999999999999999999999998999
Q ss_pred eEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC
Q 008012 363 ALVLEFMPNGSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN 427 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~ 427 (581)
+++|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCC
Confidence 99999999999999997542 34678889999999999999999 8999999999999999999
Q ss_pred CcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHH
Q 008012 428 MVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNW 506 (581)
Q Consensus 428 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~ 506 (581)
+.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~~ 238 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIEM 238 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence 9999999999986543332223334456788999999988899999999999999999998 99998764221 12222
Q ss_pred HHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 507 VKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
+...... ..+..++.++.+++.+||+.||++||+++||+++|+++
T Consensus 239 i~~~~~~-----------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 IRSRQLL-----------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHcCCcC-----------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 2211111 11234567899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=329.11 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=207.3
Q ss_pred hcCCCcCCeecccccccEEEEEeC----CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..+|++.+.||+|+||.||+|.++ .+..||+|.++... ......+.+|+..+++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457889999999999999999753 46789999987653 3344678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+++|+|.+++......+++..++.++.|++.||+||| +.|++||||||+||+++.++.++++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999876666889999999999999999999 899999999999999999999999999987653221
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
. ........++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .....+.+....
T Consensus 161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~~~---------- 227 (266)
T cd05064 161 A-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVEDGFRL---------- 227 (266)
T ss_pred c-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCCCC----------
Confidence 1 111112234678999999999999999999999999999775 99999764221 122222211110
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
+.+..++..+.+++.+||+.+|++||+++|+.+.|+++
T Consensus 228 -------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01123556788999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=341.71 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=205.9
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999965 68999999997653 234457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++++|.+++...+ .+++..+..++.|++.||.||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999997654 3688899999999999999999 89999999999999999999999999999986533
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhC-CCCCCccccccchh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESL-PHGLPKIADANLLR 525 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 525 (581)
......|++.|+|||++.+..++.++|||||||++|||++|+.||......+ .... +.... ....+...++
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~-i~~~~~~~~~~~~~~~---- 225 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWEN-LKYWKETLQRPVYDDP---- 225 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHH-HHhccccccCCCCCcc----
Confidence 2234568999999999999999999999999999999999999997632211 1111 11100 0001111110
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...++.++.+++.+||..+|++||+++|++++
T Consensus 226 -------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 -------RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -------ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 02345678899999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=314.91 Aligned_cols=268 Identities=21% Similarity=0.292 Sum_probs=210.3
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHH--HHHHHHHHHHHHHhcCCCccceEeeeeec--CCeee
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQ--AFRSFNSECEVLRNVRHRNLIKILSSCCN--TNFKA 363 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 363 (581)
..++|+.++.|++|+||.||+|+++ +++.||+|.++.+.+. -.-...+|+.++.+.+|||||.+-.+... -+..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 4467888999999999999999966 8999999999876422 12346789999999999999999988754 45799
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+|||||+. +|...+.....++...++..++.|+++|++||| ...|+||||||+|+|++..|.+||+|||+|+.++.
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99999987 999999988888899999999999999999999 88999999999999999999999999999998865
Q ss_pred CCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC----CCcc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG----LPKI 518 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~ 518 (581)
... ..+..+.|..|+|||.+.+ ..|+.+.|+||+|||+.||+++++-|.+. .+.+....+-...... ++.+
T Consensus 230 p~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~--sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 230 PLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK--SEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred Ccc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC--chHHHHHHHHHHhCCCccccCCCc
Confidence 532 3456678999999997766 57999999999999999999999998773 3333333333222211 1111
Q ss_pred ccccchh-----hh--hhhhHHH---HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 ADANLLR-----EE--NFFSARM---DCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ~~~~~~~-----~~--~~~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....... .. +...... ..++.-++|+..++..||++|.||+|.++|
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111110 00 0011100 134677899999999999999999999876
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=328.65 Aligned_cols=258 Identities=26% Similarity=0.372 Sum_probs=201.8
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH--------------HHHHHHHHHHHHHHhcCCCccce
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE--------------QAFRSFNSECEVLRNVRHRNLIK 351 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~ 351 (581)
....++|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 455688999999999999999999955 899999999965421 12357889999999999999999
Q ss_pred EeeeeecC--CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc
Q 008012 352 ILSSCCNT--NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV 429 (581)
Q Consensus 352 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~ 429 (581)
++++..+. +..|||+|||..|.+.. .......+++.++++++++++.||+||| ..||+||||||+|+|++++|+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCc
Confidence 99999774 58999999999887643 2222223788999999999999999999 899999999999999999999
Q ss_pred EEEeeccCceecCCCCC---cceeeccccCccccCCCCCCCCC----CCccccHHHHHHHHHHHHhCCCCCCcccccccc
Q 008012 430 AHVSDFGISKLLGEGDD---SVIQTMTIATIGYMAPEFGSEGN----VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMN 502 (581)
Q Consensus 430 ~kl~Dfg~a~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~ 502 (581)
|||+|||.+.....+.. ........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||.+.+. ..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--~~ 326 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--LE 326 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--HH
Confidence 99999999987632211 11223368999999999877632 35689999999999999999999976321 11
Q ss_pred HH-HHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 503 LK-NWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 503 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
+. .++.+.+ .++ ...+....+.+||.+||.+||++|.+..+|..|..-
T Consensus 327 l~~KIvn~pL--~fP---------------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 327 LFDKIVNDPL--EFP---------------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HHHHHhcCcc--cCC---------------CcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 11 1111111 011 111334568899999999999999999999888653
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=340.11 Aligned_cols=246 Identities=24% Similarity=0.276 Sum_probs=203.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 467899999999999999999965 78999999997653 23446788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+++++|.+++...+. +++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGR-FPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EcCCCCChHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999999999987653 688888999999999999999 8999999999999999999999999999998764322
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ..++.
T Consensus 173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~~-~~~p~-------- 236 (329)
T PTZ00263 173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FRIYEKILAGR-LKFPN-------- 236 (329)
T ss_pred -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HHHHHHHhcCC-cCCCC--------
Confidence 234689999999999999999999999999999999999999965321 11111111110 01111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLY-----MKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 564 (581)
.++..+.+++.+||+.||++||+ ++++++|
T Consensus 237 ---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 237 ---------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 12345779999999999999997 6888876
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=337.58 Aligned_cols=242 Identities=24% Similarity=0.270 Sum_probs=198.2
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNG 372 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 372 (581)
+.||+|+||.||+|..+ +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 78999999997653 334456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeec
Q 008012 373 SLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTM 452 (581)
Q Consensus 373 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 452 (581)
+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence 9999998654 4688999999999999999999 8999999999999999999999999999987532211 11234
Q ss_pred cccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhH
Q 008012 453 TIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSA 532 (581)
Q Consensus 453 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (581)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... ...++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~~~~~-~~~~p---------------- 215 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILME-EIRFP---------------- 215 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--HHHHHHHHcC-CCCCC----------------
Confidence 5689999999999999999999999999999999999999975311 1111111110 00011
Q ss_pred HHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 533 RMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 533 ~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
..++.++.+++.+||+.||++|| ++.++++|
T Consensus 216 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 -RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred -CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 12345688999999999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=310.45 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=208.0
Q ss_pred hhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
..+.|++.+.||+|.|+.||++.. .+|+.+|+|+++.. .....+.+.+|+++.+.++||||+++.+.+......|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788889999999999999984 48999999988654 244667899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec---CCCcEEEeeccCceecC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD---ENMVAHVSDFGISKLLG 442 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a~~~~ 442 (581)
+|+|.|++|..-|-++ ...++..+-..++||++||.|+| .+||+|||+||+|+++. ..--+||+|||+|..+.
T Consensus 89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999997766544 33577888899999999999999 89999999999999995 34479999999999886
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
.+ .......|||+|||||+++..+|+..+|||+.||++|-|+.|.+||.+. +..++.+-+...... ++
T Consensus 165 ~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~--~~~rlye~I~~g~yd-~~------ 232 (355)
T KOG0033|consen 165 DG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYEQIKAGAYD-YP------ 232 (355)
T ss_pred Cc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc--cHHHHHHHHhccccC-CC------
Confidence 32 2345678999999999999999999999999999999999999999873 222222222221111 00
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
.+.+..++++..+|+++||..||++|.|+.|+++|=
T Consensus 233 -------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 233 -------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred -------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 012234456788999999999999999999998763
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=323.91 Aligned_cols=257 Identities=26% Similarity=0.442 Sum_probs=210.2
Q ss_pred hcCCCcCCeecccccccEEEEEeC----CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
.++|++.+.||+|+||.||+|.++ +...||+|.++... ......+.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357899999999999999999964 24579999987553 3445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+++++|.+++......+++..++.++.|++.|++||| +++|+||||||+||++++++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999876667899999999999999999999 899999999999999999999999999999877522
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
..........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .....+.......
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~--------- 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGYRLP--------- 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCCC---------
Confidence 22222222344678999999998899999999999999999998 99998653211 1222222111110
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
.+..++..+.+++.+||+.+|++||++.|++++|+++
T Consensus 229 --------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 --------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0113455688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=328.35 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=211.6
Q ss_pred hcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357889999999999999999842 35668999988766666678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEE
Q 008012 364 LVLEFMPNGSLDKWLYSHN------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAH 431 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~k 431 (581)
+||||+++++|.+++...+ ..+++..++.++.|++.||+||| ++|++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence 9999999999999997543 24788999999999999999999 89999999999999999999999
Q ss_pred EeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhh
Q 008012 432 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKES 510 (581)
Q Consensus 432 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 510 (581)
|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....+...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~i~~~ 238 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQG 238 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC
Confidence 999999986643332222233445778999999998899999999999999999999 999986542211 11111111
Q ss_pred CCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 511 LPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
..... ...++.++.+++.+||+.||.+|||+.|+.+.|+++...
T Consensus 239 ---~~~~~--------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 239 ---RVLQR--------------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ---CcCCC--------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11100 012345688999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=300.94 Aligned_cols=251 Identities=25% Similarity=0.297 Sum_probs=211.6
Q ss_pred hhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|++.+.||+|-||.||+|+. +++-.||+|++.+.. .+...++.+|+++-..++||||+++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 457899999999999999999994 478899999997653 3345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 365 VLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
++||.++|.+...++.. ...+++.....+..|+|.||.|+| .++|+||||||+|+|++..+.+||+|||.+..-.
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 99999999999999954 344788999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
.......+||..|.|||+..+..++..+|+|++|++.||++.|.+||..... ...+..+.+-.. .++
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI~k~~~--~~p------- 242 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRIRKVDL--KFP------- 242 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHHHHccc--cCC-------
Confidence 2334567899999999999999999999999999999999999999987542 122222211111 011
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
..++....++|.+|+.++|.+|.+..|+++|-.
T Consensus 243 ----------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 243 ----------STISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ----------cccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 233456779999999999999999999998743
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=319.75 Aligned_cols=276 Identities=25% Similarity=0.372 Sum_probs=222.3
Q ss_pred chhhhHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhc--CCCccceEeeeeec
Q 008012 281 TSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV--RHRNLIKILSSCCN 358 (581)
Q Consensus 281 ~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~ 358 (581)
.+....+.++.+...++.||+|.||.||+|.|+ |+.||||++...++ +.+.+|.++++.+ +|+||+.+++.-..
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 445556677888999999999999999999998 89999999987765 4677899999887 99999999987654
Q ss_pred CC----eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCceecCCCCCCeEecCCCc
Q 008012 359 TN----FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHH-----GHSTPVVHCDLKPSNILLDENMV 429 (581)
Q Consensus 359 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-----~~~~~i~H~dikp~Nill~~~~~ 429 (581)
++ ..|||++|.+.|||.||+.+.. ++.+..++++..+|.||+|||. +.+..|+|||||+.|||+..++.
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 33 6799999999999999999854 6889999999999999999993 56788999999999999999999
Q ss_pred EEEeeccCceecCCCCC--cceeeccccCccccCCCCCCCCC----C--CccccHHHHHHHHHHHHhC----------CC
Q 008012 430 AHVSDFGISKLLGEGDD--SVIQTMTIATIGYMAPEFGSEGN----V--SSKCDVYSYGILLLETFTR----------KK 491 (581)
Q Consensus 430 ~kl~Dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~----~--~~~~Dv~slG~vl~el~tg----------~~ 491 (581)
+.|+|+|+|.......+ .......+||.+|||||++...- + -..+||||||.|+||+... +.
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 99999999987755432 22345678999999999886642 1 2368999999999999873 47
Q ss_pred CCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 492 PTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 492 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
||.+..+.+.++.+.-+-..-..+....+.. .....+...+.++|+.||..+|.-|.|+-.+.+.|.++.+
T Consensus 435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnr--------W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNR--------WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CcccCCCCCCCHHHHhcceeecccCCCCCcc--------cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 9988877777777654433322222222222 2223455668899999999999999999999999988864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=330.85 Aligned_cols=267 Identities=20% Similarity=0.215 Sum_probs=203.7
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999975 78899999987542 2334577889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|++++.+..+. .....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 155 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN- 155 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence 99987665544 33445788999999999999999999 89999999999999999999999999999987643221
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC-------------
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG------------- 514 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~------------- 514 (581)
.......|+..|+|||++.+..++.++|||||||++|||++|++||....... .... +.......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFT-IQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhhCCCCHHHHHhhhccch
Confidence 11233468999999999988899999999999999999999999997632211 1111 11110000
Q ss_pred CCccccccchh-hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 515 LPKIADANLLR-EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 515 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
......+.... ..........++..+.+++.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000 000001112356779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=328.70 Aligned_cols=255 Identities=29% Similarity=0.463 Sum_probs=207.2
Q ss_pred hcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccchHH-HHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQLEQ-AFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
.++|.+.+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 456888999999999999999853 3578999998765433 457899999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc
Q 008012 363 ALVLEFMPNGSLDKWLYSHN-------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV 429 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~ 429 (581)
++||||+++++|.+++...+ ..+++..+..++.|++.|++||| +.|++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 99999999999999997542 33678889999999999999999 899999999999999999999
Q ss_pred EEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 008012 430 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVK 508 (581)
Q Consensus 430 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~ 508 (581)
++|+|||.+................++..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~~~ 238 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECIT 238 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH
Confidence 99999999986543322222233445788999999999999999999999999999998 99998653221 1222222
Q ss_pred hhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 509 ESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
....... ...++..+.+++.+||..||++||++.|+++.|+
T Consensus 239 ~~~~~~~-----------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 QGRLLQR-----------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred cCCcCCC-----------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111100 1123456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=322.56 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=203.5
Q ss_pred cCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccC
Q 008012 291 DGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMP 370 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 370 (581)
++|++.+.||+|+||.||+|.++++..+|+|.+..... ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 46888899999999999999988788999998865432 23568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCccee
Q 008012 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 450 (581)
+|+|.+++......+++..++.++.|++.||+||| +.|++||||||+||++++++.+||+|||.+........ ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence 99999999865556789999999999999999999 89999999999999999999999999999886532221 111
Q ss_pred eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+........+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~------------ 224 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFRLYRPK------------ 224 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCCCCCCC------------
Confidence 22235568999999988889999999999999999999 8999865321 11222222211110010
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
..+..+.+++.+||..+|++||+++++++.|
T Consensus 225 -----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 -----LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -----CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1234578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=326.35 Aligned_cols=257 Identities=30% Similarity=0.500 Sum_probs=213.0
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
+...+|++.+.||.|+||.||+|..++++.+++|++..........+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45678999999999999999999988899999999987766556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 368 FMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|+++++|.+++.+. +..+++..++.++.|++.||+||| +.|++|+||+|+||++++++.+||+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999864 345789999999999999999999 89999999999999999999999999999976533221
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
......++..|+|||...+..++.++||||||+++|+|++ |+.||..... ......+.......
T Consensus 160 --~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~----------- 224 (261)
T cd05148 160 --LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQITAGYRMP----------- 224 (261)
T ss_pred --cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHHhCCcCC-----------
Confidence 1223345678999999888899999999999999999998 8999865321 11112222111111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
.+..+++.+.++|.+||..||++|||++++++.|+.+
T Consensus 225 ------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 225 ------CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1123455688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=332.44 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=208.7
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCc----EEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGT----TVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
..+|+..+.||+|+||.||+|.+. +++ .||+|+++... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356999999999999999999854 343 48999987543 34556788999999999999999999998764 567
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+|+||+++|+|.+++.+....+++..++.++.||+.||+||| +.||+||||||+||++++++.+||+|||++.....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999999987666888999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
...........++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+........
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~------- 232 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGERLPQ------- 232 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCCCCCCC-------
Confidence 333222222334678999999999999999999999999999998 99998763211 12222221111110
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
+..++..+.+++.+||..+|++||++.+++..+.++..+.
T Consensus 233 ----------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 233 ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1123446789999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.51 Aligned_cols=252 Identities=21% Similarity=0.232 Sum_probs=206.2
Q ss_pred cCCCcCCeecccccccEEEEEeC-C-CcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-D-GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
..|.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34889999999999999999854 4 678999987766666566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 369 MPNGSLDKWLYSH---NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 369 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
+++|+|.+++... ...+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+|||++..+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988642 345788899999999999999999 8999999999999999999999999999998765433
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+..........
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~~~~-------- 290 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYGKYDP-------- 290 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCC--------
Confidence 22223445689999999999999999999999999999999999999975321 12222211111110
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+..++..+.++|.+||..||++||++.+++.+
T Consensus 291 ------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 ------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 011234568899999999999999999999764
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=320.43 Aligned_cols=248 Identities=26% Similarity=0.434 Sum_probs=199.9
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCH
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSL 374 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 374 (581)
+.||+|+||.||+|..+ +++.||+|.+.... .+....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999965 78999999876543 34456789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccc
Q 008012 375 DKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI 454 (581)
Q Consensus 375 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 454 (581)
.+++......+++..++.++.|+++||+||| +.|++||||||+||+++.++.+||+|||.+................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999876666789999999999999999999 8999999999999999999999999999987653221111111122
Q ss_pred cCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHH
Q 008012 455 ATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSAR 533 (581)
Q Consensus 455 ~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (581)
.+..|+|||.+.++.++.++||||||+++|||++ |..||...... .....+....+... +
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~-----------------~ 218 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQGVRLPC-----------------P 218 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCCCCC-----------------c
Confidence 3457999999998899999999999999999998 88888653221 11111111111111 1
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 534 MDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 534 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
..++..+.+++.+||..+|++|||++++++.|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 123456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=327.85 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=211.5
Q ss_pred cCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
.+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999742 355689999877766666788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc
Q 008012 365 VLEFMPNGSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV 429 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~ 429 (581)
||||+++++|.+++.... ..+++..++.++.||+.|++||| ++|++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 999999999999997542 23688999999999999999999 899999999999999999999
Q ss_pred EEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 008012 430 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVK 508 (581)
Q Consensus 430 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~ 508 (581)
++|+|||++................++..|+|||.+.+..++.++||||||+++|||+| |+.||....... ..+.+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~ 239 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECIT 239 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHh
Confidence 99999999986543332222334456788999999998899999999999999999999 999986642211 111111
Q ss_pred hhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 509 ESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
.. ..... ...++..+.+++.+||..||++|||++++++.|+++.+.
T Consensus 240 ~~---~~~~~--------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 240 QG---RVLER--------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CC---CCCCC--------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11 11110 112345688999999999999999999999999999664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=329.21 Aligned_cols=249 Identities=33% Similarity=0.536 Sum_probs=197.7
Q ss_pred cCCeecccccccEEEEEeC-----CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 295 ECNLLGSGGFGSVYKGILS-----DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 295 ~~~~lg~G~~~~v~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+.+.||.|.||.||+|.+. .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999965 36789999996543 34578899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 369 MPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 369 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
+++|+|.+++... ...+++..++.|+.||++||+||| +.+++|+||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999987 566899999999999999999999 789999999999999999999999999999877433333
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
...........|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.+.....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~~~~~~~~------------ 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKLKQGQRLP------------ 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHHHTTEETT------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccce------------
Confidence 33344557789999999988889999999999999999999 7889876411 22222222211111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
.+..++..+.+++.+||+.||++|||+.++++.|
T Consensus 226 -----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1123456788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=323.64 Aligned_cols=256 Identities=22% Similarity=0.422 Sum_probs=208.9
Q ss_pred hhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
..++|++.++||+|++|.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 4568999999999999999999988888999998875432 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 369 MPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 369 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
+++++|.+++... ....++..++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||.+.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999754 345788899999999999999999 899999999999999999999999999999876432211
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
......++..|+|||+..+..++.++|||||||++|+|+| |+.||...... .....+.......
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~------------ 224 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYRMP------------ 224 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCCC------------
Confidence 1222345678999999988889999999999999999998 99998753211 1222222111100
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
....++.++.+++.+||..+|++||+++++.+.|+++
T Consensus 225 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 -----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0112345688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.76 Aligned_cols=242 Identities=24% Similarity=0.272 Sum_probs=197.5
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNG 372 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 372 (581)
+.||+|+||.||++... +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 78999999997653 334456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeec
Q 008012 373 SLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTM 452 (581)
Q Consensus 373 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 452 (581)
+|..++.... .+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence 9999887654 4788999999999999999999 8999999999999999999999999999987532211 11233
Q ss_pred cccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhH
Q 008012 453 TIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSA 532 (581)
Q Consensus 453 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (581)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ..++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~~~~~~--~~~p---------------- 215 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEE--IRFP---------------- 215 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCC--CCCC----------------
Confidence 46899999999999999999999999999999999999999753211 1111111100 0011
Q ss_pred HHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 533 RMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 533 ~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
..+++.+.+++.+||+.||++|| ++.++++|
T Consensus 216 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 -RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred -CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 12345678999999999999998 89998876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=333.08 Aligned_cols=267 Identities=22% Similarity=0.251 Sum_probs=205.3
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
..++|++.+.||+|+||.||++... ++..+|+|++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3578999999999999999999966 78899999887653 344567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++++|.+++...+. +++..+..++.|++.||.|||+ ..+++||||||+||++++++.+||+|||++.......
T Consensus 83 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 83 EHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred ecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 99999999999986543 6888999999999999999993 3479999999999999999999999999987553221
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc-cccch-
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA-DANLL- 524 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~- 524 (581)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||...... .....+............ .+...
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK--ELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh--HHHHHhcCcccCCccccccCcccCC
Confidence 22346889999999999889999999999999999999999999753211 111111100000000000 00000
Q ss_pred ----------------------h----hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 525 ----------------------R----EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 525 ----------------------~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
. ...........+.++.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0 000000000134578899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=348.50 Aligned_cols=261 Identities=23% Similarity=0.293 Sum_probs=210.8
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCCC-cEEEEEEeccchHHHHHHHHHHHHHHHhcC-CCccceEeee-eec------
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSDG-TTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSS-CCN------ 358 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~~------ 358 (581)
....++++.+.|.+|||+.||+|....+ ..||+|++-..++...+.+.+|+++|++|+ |+|||.++|. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 4455678889999999999999996644 999999998888888999999999999995 9999999993 221
Q ss_pred CCeeeEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccC
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGI 437 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 437 (581)
.-++.|.||||+||.|-+++..+ ...+++.++++|+.|+++|+++||.. ..+|||||||.+|||++.++..||||||.
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 12578999999999999999843 33389999999999999999999943 46699999999999999999999999999
Q ss_pred ceecCCCCCcc-------eeeccccCccccCCCC---CCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHH
Q 008012 438 SKLLGEGDDSV-------IQTMTIATIGYMAPEF---GSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWV 507 (581)
Q Consensus 438 a~~~~~~~~~~-------~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~ 507 (581)
|.......... ..-...-|+.|+|||+ +.+..+++|+|||||||+||-|+....||+....-
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------- 264 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------- 264 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------
Confidence 97543222111 0012246899999995 56788999999999999999999999999873111
Q ss_pred HhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 508 KESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
.|.+.. ..++....++..+.+||+.||+.||++||++-||+.++.++..+
T Consensus 265 ---------aIlng~-----Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 ---------AILNGN-----YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ---------eEEecc-----ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 111111 11222245677899999999999999999999999999988754
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=333.11 Aligned_cols=261 Identities=25% Similarity=0.406 Sum_probs=207.0
Q ss_pred hhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeec-C
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCN-T 359 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~ 359 (581)
..++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.+++++ +|+||+++++++.. .
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4568999999999999999999632 35789999987543 33446678899999999 89999999998865 4
Q ss_pred CeeeEEEeccCCCCHHHHHhhCC---------------------------------------------------------
Q 008012 360 NFKALVLEFMPNGSLDKWLYSHN--------------------------------------------------------- 382 (581)
Q Consensus 360 ~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------------- 382 (581)
...+++|||+++++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 56889999999999999986421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccc
Q 008012 383 ---YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGY 459 (581)
Q Consensus 383 ---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y 459 (581)
..+++..+..++.||+.||+||| +.||+||||||+||++++++.++|+|||++..+.............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 24688899999999999999999 899999999999999999999999999999876433322223334567789
Q ss_pred cCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHH
Q 008012 460 MAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLL 538 (581)
Q Consensus 460 ~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (581)
+|||++.+..++.++|||||||++|||++ |..||......+ .+...+........ +..++.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~-----------------~~~~~~ 303 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTRMRA-----------------PEYATP 303 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCCCCC-----------------CccCCH
Confidence 99999999999999999999999999998 999987532221 12222211111100 112345
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 539 SIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 539 ~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
++.+++.+||+.+|++||++.|++++|+++..
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 68899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=325.86 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=204.6
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN 360 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 360 (581)
...++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999998753 35679999986542 334456889999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEE
Q 008012 361 FKALVLEFMPNGSLDKWLYSHN---------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAH 431 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~k 431 (581)
..++||||+++++|.+++.+.. ...++..+..++.|++.||+||| +.|++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEE
Confidence 9999999999999999997532 22467788999999999999999 89999999999999999999999
Q ss_pred EeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhh
Q 008012 432 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKES 510 (581)
Q Consensus 432 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 510 (581)
|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||..... ......+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~ 237 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVLRFVMEG 237 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcC
Confidence 999999876543322222222345778999999998899999999999999999999 7888865321 1112211111
Q ss_pred CCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 511 LPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
..... +..++..+.+++.+||+.||++|||+.|++++|+
T Consensus 238 ---~~~~~--------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 238 ---GLLDK--------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ---CcCCC--------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11110 1123456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=337.99 Aligned_cols=262 Identities=24% Similarity=0.394 Sum_probs=208.8
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcC-CCccceEeeeeec
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVR-HRNLIKILSSCCN 358 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 358 (581)
....++|++.+.||+|+||.||+|... .+..||+|+++... ....+.+.+|+++++++. ||||+++++++.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 344678999999999999999999853 23469999997543 344567899999999995 9999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHHhhCC--------------------------------------------------------
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSHN-------------------------------------------------------- 382 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------------------------- 382 (581)
.+..++||||+++|+|.+++.+..
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 999999999999999999886421
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeE
Q 008012 383 ---------------------------------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNIL 423 (581)
Q Consensus 383 ---------------------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nil 423 (581)
..+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEE
Confidence 13567788899999999999999 899999999999999
Q ss_pred ecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCcccccccc
Q 008012 424 LDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMN 502 (581)
Q Consensus 424 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~ 502 (581)
+++++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.....+..
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~- 348 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST- 348 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-
Confidence 99999999999999987643322222233456788999999988899999999999999999997 9999876422211
Q ss_pred HHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 503 LKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
....+...... ..+..++..+.+++.+||..||++|||+.++.+.|+++.
T Consensus 349 ~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 FYNKIKSGYRM-----------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHhcCCCC-----------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11111111100 011234567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=320.77 Aligned_cols=258 Identities=23% Similarity=0.312 Sum_probs=209.3
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||.||+|+.. +++.||+|.++.. .......+.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999964 7899999987542 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 367 EFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 367 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
||+++++|.+++.. ....+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998863 2344688899999999999999999 89999999999999999999999999999987643
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ..+.........+..
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~----- 228 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---FSLCQKIEQCDYPPL----- 228 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH---HHHHHHHhcCCCCCC-----
Confidence 221 1123457889999999988889999999999999999999999986532221 222221111111111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
....++..+.+++.+||..+|++||++.++++.+++++
T Consensus 229 --------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 --------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 01234566889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=320.74 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=207.7
Q ss_pred hhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
..++|++.+.||+|++|.||+|...+++.||+|.++.... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 4567999999999999999999987788899999876432 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 369 MPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 369 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
+++++|.+++.... ..+++..+..++.|++.|+.||| +.|++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 99999999997653 45789999999999999999999 89999999999999999999999999999987652211
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
........+..|+|||+..+..++.++||||||+++|||++ |+.||...... .....+.......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~------------ 224 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVDQGYRMP------------ 224 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCCC------------
Confidence 11111223457999999998899999999999999999999 99998753211 1111121111100
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
....++..+.+++.+||+.+|++||+++++++.|+++
T Consensus 225 -----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 225 -----CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -----CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0112345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=338.00 Aligned_cols=245 Identities=23% Similarity=0.293 Sum_probs=204.9
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCe
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNF 361 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 361 (581)
....++|...++||+|+||.|+++..+ +++.+|||++++.. .++.+..+.|.+++... +||.++.++.+|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 445688999999999999999999966 78999999999874 56677888999999888 59999999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
+|+||||+.||++..+. +...+++..+.-++..|+.||+||| ++||||||||.+|||+|.+|.+||+|||+++.-
T Consensus 444 l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999999944333 3344799999999999999999999 899999999999999999999999999999864
Q ss_pred CCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
-.. ...+++.+||+.|+|||++.+..|+.++|-|||||+||||+.|..||.+.. .+..+..++.+..
T Consensus 519 m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd-Eee~FdsI~~d~~---------- 585 (694)
T KOG0694|consen 519 MGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD-EEEVFDSIVNDEV---------- 585 (694)
T ss_pred CCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhcCCC----------
Confidence 322 224567899999999999999999999999999999999999999998732 2222222222211
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYM 558 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 558 (581)
..+..++.+..+++++++.++|++|..+
T Consensus 586 ---------~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 ---------RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1122345678899999999999999965
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=335.58 Aligned_cols=247 Identities=23% Similarity=0.286 Sum_probs=202.5
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-C-CcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-D-GTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
..++|++.+.||+|+||.||+|..+ + +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 4567999999999999999999854 3 3689999986542 234457889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+++|+|.+++..... +++..+..++.|++.||.||| +.||+||||||+|||++.++.+||+|||++.....
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKR-FPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999987653 788999999999999999999 89999999999999999999999999999987642
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ..++
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~i~~~~-~~~p------- 248 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--LLIYQKILEGI-IYFP------- 248 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--HHHHHHHhcCC-CCCC-------
Confidence 2 1234689999999999988899999999999999999999999975321 11111111110 0011
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
...+..+.+++.+|++.||++|+ +++++++|
T Consensus 249 ----------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 ----------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11234567999999999999995 89999887
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=320.15 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=204.5
Q ss_pred cCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccC
Q 008012 291 DGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMP 370 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 370 (581)
++|++.+.||+|+||.||.|.+.++..+|+|.+..... ....+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 46888999999999999999987677799998875432 23568899999999999999999999998889999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCccee
Q 008012 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 450 (581)
+++|.+++......+++..++.++.||+.||+||| +.|++|+||||+||++++++.+||+|||.+........ ...
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence 99999999876556899999999999999999999 89999999999999999999999999999886543221 111
Q ss_pred eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
....++..|+|||...+..++.++||||||+++|+|++ |+.||...... .....+........+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~------------- 223 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLRLYRP------------- 223 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcCCCCCCC-------------
Confidence 22345678999999988889999999999999999999 99998753221 111222111111101
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 224 ----~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 ----HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 012356889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=319.80 Aligned_cols=262 Identities=24% Similarity=0.300 Sum_probs=200.0
Q ss_pred cCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC-----eeeE
Q 008012 291 DGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN-----FKAL 364 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l 364 (581)
-.|+..+++|+|+||.||+|.. .+++.||||..-.+.. .-.+|+++|+.++|||||++.-+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4577789999999999999994 4689999998765532 2346999999999999999998875432 3458
Q ss_pred EEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC-CcEEEeeccCcee
Q 008012 365 VLEFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN-MVAHVSDFGISKL 440 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~~ 440 (581)
|||||+. +|.++++. .+..++...+.-++.||++||+||| +.||+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999987 99999984 3555777888899999999999999 8999999999999999955 9999999999999
Q ss_pred cCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc--
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK-- 517 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-- 517 (581)
+..+... .....+..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+. ++...+..+++-.-.+.-.+
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHhCCCCHHHHh
Confidence 8655543 45578999999997766 57999999999999999999999999873 33333444333221111000
Q ss_pred --------cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 --------IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+.+....-..-.....+++..+|+.+++..+|.+|.++.|++.|
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00011111000000123456778999999999999999999999876
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=303.38 Aligned_cols=254 Identities=26% Similarity=0.350 Sum_probs=211.5
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--------HHHHHHHHHHHHHHHhc-CCCccceEeeeee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--------EQAFRSFNSECEVLRNV-RHRNLIKILSSCC 357 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 357 (581)
.....|.-.+.+|.|..++|.++..+ +|..+|+|++.... ....+.-.+|+.+++++ .||+|+.+.++|.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 44567888899999999999998854 88999999885432 34456677899999999 7999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccC
Q 008012 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGI 437 (581)
Q Consensus 358 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 437 (581)
.+...++|+|.|+.|.|.+++.+.-. ++++...+|+.|+.+|++||| .++|+|||+||+|||++++.++||+|||+
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~Vt-lSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVT-LSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhee-ecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccce
Confidence 99999999999999999999987654 688999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCC------CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSE------GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESL 511 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 511 (581)
|+.+.++.. ....+||++|.|||.+.. ..|+..+|+||+||+||-++.|.+||.. ...+.+...+.+..
T Consensus 170 a~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH--RkQmlMLR~ImeGk 244 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH--RKQMLMLRMIMEGK 244 (411)
T ss_pred eeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH--HHHHHHHHHHHhcc
Confidence 998866543 356689999999997653 3688899999999999999999999975 22232333332221
Q ss_pred CCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 512 PHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.. + ..+.+.+++....+||.+||+.||.+|.|++|+++|
T Consensus 245 yq----F----------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 245 YQ----F----------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cc----c----------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11 0 123455667778899999999999999999999987
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=321.10 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=206.0
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCc----EEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGT----TVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.++|++.+.||+|+||.||+|.+. +++ .+++|.+.... ......+..|+..+++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 357888999999999999999964 444 47788775442 3344677888889999999999999998754 4578
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+++||+++|+|.+++......+++..+..++.||+.||+||| +++++||||||+||++++++.+||+|||.+.....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999999877667899999999999999999999 89999999999999999999999999999987644
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
...........++..|+|||.+.++.++.++||||||+++|||++ |+.||..... ....+.+........+
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~------ 233 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEKGERLAQP------ 233 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCcCCCC------
Confidence 333222334456778999999988899999999999999999998 9999876422 1122222211111111
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
..++..+.+++.+||..||++|||+.|+++.|..+..
T Consensus 234 -----------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 234 -----------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -----------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1133457789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=333.76 Aligned_cols=242 Identities=24% Similarity=0.278 Sum_probs=198.0
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNG 372 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 372 (581)
+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999965 78999999997653 334567888999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeec
Q 008012 373 SLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTM 452 (581)
Q Consensus 373 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 452 (581)
+|.+++.... .+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT 154 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence 9999887654 4788999999999999999999 8999999999999999999999999999987532211 11234
Q ss_pred cccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhH
Q 008012 453 TIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSA 532 (581)
Q Consensus 453 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (581)
..|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ............ . .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~-~--------------~ 214 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEDI-K--------------F 214 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccCCc-c--------------C
Confidence 5689999999999998999999999999999999999999975311 111111111110 0 0
Q ss_pred HHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 533 RMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 533 ~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
+..++..+.+++.+||..||++|| ++.|+++|
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112345678999999999999997 89999887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=336.53 Aligned_cols=266 Identities=22% Similarity=0.288 Sum_probs=199.2
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecC-----Ceee
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT-----NFKA 363 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 363 (581)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999965 78999999987432 23345688999999999999999999987543 2579
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||++ ++|.+++..... +++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD-LTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhccc-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 689998876543 788999999999999999999 89999999999999999999999999999986532
Q ss_pred CCC-cceeeccccCccccCCCCCCC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 444 GDD-SVIQTMTIATIGYMAPEFGSE--GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 444 ~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
... ........|+..|+|||++.+ ..++.++|||||||++|||++|++||..... ......+.............
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHH
Confidence 221 112234568999999998765 6789999999999999999999999965321 11111111111111000000
Q ss_pred ----cc-------chh--hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ----AN-------LLR--EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ----~~-------~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.. +.. ..........++..+.+++.+||+.||++|||++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 000 000001111245668899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=331.89 Aligned_cols=240 Identities=25% Similarity=0.258 Sum_probs=195.7
Q ss_pred ecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCH
Q 008012 299 LGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSL 374 (581)
Q Consensus 299 lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 374 (581)
||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 68899999987542 33456778899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccc
Q 008012 375 DKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI 454 (581)
Q Consensus 375 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 454 (581)
.+++...+ .+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||++....... .......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC 154 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence 99998754 3788999999999999999999 8999999999999999999999999999997542221 1223456
Q ss_pred cCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHH
Q 008012 455 ATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARM 534 (581)
Q Consensus 455 ~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (581)
|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.......... . .+.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~~~-~--------------~~~ 214 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQEPL-R--------------FPD 214 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCCC-C--------------CCC
Confidence 8999999999999999999999999999999999999997532 1222222211110 0 011
Q ss_pred HHHHHHHHHHHhccCcCCCCCCC---HHHHHHH
Q 008012 535 DCLLSIFHLALDCCAELPDQRLY---MKDAATK 564 (581)
Q Consensus 535 ~~~~~l~~li~~cl~~dP~~Rps---~~evl~~ 564 (581)
.+++.+.+++.+||..||++||+ +.|++.|
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 23456789999999999999985 6777665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=323.19 Aligned_cols=255 Identities=28% Similarity=0.455 Sum_probs=204.9
Q ss_pred cCCCcCCeecccccccEEEEEe-----CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 291 DGFNECNLLGSGGFGSVYKGIL-----SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
++|++.+.||+|+||.||+|.. .++..|++|.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5688889999999999999984 256789999987543 3444678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHN----------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM 428 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~ 428 (581)
||||+++++|.+++.... ..+++..+..++.|++.||+||| +++++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 999999999999986321 23678888999999999999999 89999999999999999999
Q ss_pred cEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 008012 429 VAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWV 507 (581)
Q Consensus 429 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~ 507 (581)
.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||..... ....+.+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence 999999999986643332222333445678999999988889999999999999999999 9999865321 1222222
Q ss_pred HhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 508 KESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
....... .+..++..+.+++.+||+.||++||++.++.++|++
T Consensus 240 ~~~~~~~-----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQLLP-----------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCcCC-----------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 2111110 111244568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.80 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=205.0
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999965 78999999997653 234566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++|+|.+++.+....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999887666899999999999999999999 89999999999999999999999999999987643322
Q ss_pred cceeeccccCccccCCCCCC------CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 447 SVIQTMTIATIGYMAPEFGS------EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
. ......|++.|+|||++. +..++.++|||||||++|||++|+.||...... ..+....... .....
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~i~~~~---~~~~~-- 230 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-KTYNNIMNFQ---RFLKF-- 230 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-HHHHHHHcCC---CccCC--
Confidence 2 233456899999999876 456789999999999999999999999753221 1111111100 00000
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+....++..+.+++.+|+. +|++|||++++++|
T Consensus 231 ----------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 231 ----------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ----------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0011234568899999998 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=335.64 Aligned_cols=264 Identities=22% Similarity=0.230 Sum_probs=201.5
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
...+|++.+.||+|+||.||+|... +++.||+|.... ..+.+|++++++++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3467999999999999999999964 789999997432 346789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
++. ++|..++.... .+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||++........
T Consensus 164 ~~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 164 RYK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred cCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 995 68988887654 3688999999999999999999 89999999999999999999999999999975432211
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccc------ccccHHHHHHhhCC--CCCCccc
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFT------GEMNLKNWVKESLP--HGLPKIA 519 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~------~~~~~~~~~~~~~~--~~~~~~~ 519 (581)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+...+..... ...+...
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 112345689999999999999999999999999999999999988754211 11111111111110 0000000
Q ss_pred cccch--------------hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 DANLL--------------REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 ~~~~~--------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+. ...+........+.++.+++.+||+.||++|||++|++++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 0001112223456789999999999999999999999975
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=312.93 Aligned_cols=271 Identities=24% Similarity=0.313 Sum_probs=209.2
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH--HHHHHHHHHHHHHHhcCCCc-cceEeeeeecCC-----
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE--QAFRSFNSECEVLRNVRHRN-LIKILSSCCNTN----- 360 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~----- 360 (581)
...|..+++||+|+||+||+|+.+ +|+.||+|.++.+.. .......+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 455777788999999999999954 899999999987643 23456689999999999999 999999998876
Q ss_pred -eeeEEEeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeecc
Q 008012 361 -FKALVLEFMPNGSLDKWLYSHN---YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 361 -~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
..++|+||++. +|..++.... ...+...+..++.||+.||+||| +++|+||||||.||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 78999999955 9999999765 34677889999999999999999 9999999999999999999999999999
Q ss_pred CceecCCCCCcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC--
Q 008012 437 ISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH-- 513 (581)
Q Consensus 437 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-- 513 (581)
+|+...-+.. ..+...+|..|+|||++.+. .|+...||||+|||++||+++++-|.+..+ .+....+-+....
T Consensus 166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPN 241 (323)
T ss_pred hHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCC
Confidence 9996653322 24566789999999988776 799999999999999999999998877433 2222222222211
Q ss_pred --CCCccc---ccc--chh---hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHHh
Q 008012 514 --GLPKIA---DAN--LLR---EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK--LKKI 568 (581)
Q Consensus 514 --~~~~~~---~~~--~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~ 568 (581)
.++.+. +-. ... ................+++.+|++.+|.+|.|++.+++| ++.+
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 122111 111 000 001111111222467899999999999999999999998 5544
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=334.23 Aligned_cols=249 Identities=26% Similarity=0.356 Sum_probs=196.5
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.++|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 345677889999999999999965 78999999986543 3445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++++|.+. ...++..+..++.||+.||+||| +.||+||||||+||++++++.+||+|||++..+.....
T Consensus 153 ~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 153 FMDGGSLEGT-----HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred cCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 9999998653 22466788899999999999999 89999999999999999999999999999987643221
Q ss_pred ceeeccccCccccCCCCCCC-----CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 448 VIQTMTIATIGYMAPEFGSE-----GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
......|+..|+|||++.. ...+.++|||||||++|||++|+.||..... .................
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~----- 295 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCAICMSQPPE----- 295 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHHHhccCCCC-----
Confidence 1234568999999998743 2345689999999999999999999974221 12222221111100000
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....++.++.++|.+||+.||++|||+.|+++|
T Consensus 296 ---------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 ---------APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011345568899999999999999999999987
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=319.86 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=206.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
..+|++.+.||+|++|.||+|..+ +++.||+|.+.... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 456888899999999999999965 68899999987553 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 369 MPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 369 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
+++++|.+++... ...+++..++.++.|+++||+||| +.|++||||||+||++++++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~- 159 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 159 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence 9999999999754 345788999999999999999999 89999999999999999999999999999987643221
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+.......
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~------------ 225 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKGYRME------------ 225 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCCCC------------
Confidence 11112234567999999988899999999999999999998 9999865311 11111111111110
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
.+..++..+.+++.+||..||++|||+.++++.|+.+
T Consensus 226 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 -----RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1113456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=340.15 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=199.4
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.|+.++.||+|+||+||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999954 78999999997643 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++|+|.+++.+... +++..+..++.||+.||+||| +.||+||||||+||+++.++++||+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999999987654 688888999999999999999 899999999999999999999999999997643110000
Q ss_pred ---------------------------------------------ceeeccccCccccCCCCCCCCCCCccccHHHHHHH
Q 008012 448 ---------------------------------------------VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGIL 482 (581)
Q Consensus 448 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~v 482 (581)
.......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123468999999999988899999999999999
Q ss_pred HHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHh--ccCcCCCCCCCHHH
Q 008012 483 LLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALD--CCAELPDQRLYMKD 560 (581)
Q Consensus 483 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~Rps~~e 560 (581)
+|||++|+.||......+. ....+........+ ....+++++.+++.+ |+..+|..||+++|
T Consensus 238 l~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~---------------~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTET-QLKVINWENTLHIP---------------PQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred HHHHHhCCCCCcCCCHHHH-HHHHHccccccCCC---------------CCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 9999999999976322111 11111100000011 111234567789988 55666667999999
Q ss_pred HHHH
Q 008012 561 AATK 564 (581)
Q Consensus 561 vl~~ 564 (581)
+++|
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=317.44 Aligned_cols=266 Identities=24% Similarity=0.365 Sum_probs=206.8
Q ss_pred hcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhc--CCCccceEeeeeecCC----eee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV--RHRNLIKILSSCCNTN----FKA 363 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~----~~~ 363 (581)
.......+.+|+|+||.||+|... ++.||||++.... .+.|+.|-++++.. +|+||+++++.-...+ .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345566788999999999999986 6999999998554 45788888888775 8999999999876555 889
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc------CCCCCceecCCCCCCeEecCCCcEEEeeccC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHH------GHSTPVVHCDLKPSNILLDENMVAHVSDFGI 437 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~------~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 437 (581)
||++|.+.|+|.+|+..+. .+|....+++..+++||+|||+ +|+.+|+|||||++|||+..|++..|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999999875 5999999999999999999996 4678899999999999999999999999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCC-CC-----ccccHHHHHHHHHHHHhCCCCC------------Cccccc
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGN-VS-----SKCDVYSYGILLLETFTRKKPT------------DEMFTG 499 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-----~~~Dv~slG~vl~el~tg~~Pf------------~~~~~~ 499 (581)
|..+.++.........+||.+|||||++.+.. +. .+.||||+|.|+|||++...-+ +.....
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 99987665555555678999999999987742 22 3689999999999999965433 211111
Q ss_pred c---ccHHHHH-HhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 500 E---MNLKNWV-KESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 500 ~---~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
. ..+.+.+ .+..++.+++..-. -.....+.+.+..||+.||+.|.|+.=+.+++.++..-.+
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~------------h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRK------------HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhc------------CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1 1122222 12222222221111 1234568899999999999999999999999988865443
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.84 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=205.9
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999965 79999999997653 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC-
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD- 445 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~- 445 (581)
||+++++|.+++.+. ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999876 44788999999999999999999 8999999999999999999999999999998664332
Q ss_pred --------------------------CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Q 008012 446 --------------------------DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG 499 (581)
Q Consensus 446 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~ 499 (581)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001223456899999999999999999999999999999999999999764211
Q ss_pred cccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-HHHHHHH
Q 008012 500 EMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLY-MKDAATK 564 (581)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~ 564 (581)
..............++. ...+++.+.++|.+|+. ||++||+ ++|+++|
T Consensus 237 -~~~~~i~~~~~~~~~p~---------------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 -ETYNKIINWKESLRFPP---------------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -HHHHHHhccCCcccCCC---------------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111111000000110 01135668899999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=347.02 Aligned_cols=258 Identities=24% Similarity=0.312 Sum_probs=207.8
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC-
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN- 360 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 360 (581)
+.+...++|++.+.||+|+||+||+|... +++.||+|++... .......+.+|+.++..++|+||+++++.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 33445679999999999999999999954 7999999998654 2445567889999999999999999988765432
Q ss_pred -------eeeEEEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcE
Q 008012 361 -------FKALVLEFMPNGSLDKWLYSH---NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVA 430 (581)
Q Consensus 361 -------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~ 430 (581)
..++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCE
Confidence 367999999999999999743 345788999999999999999999 8999999999999999999999
Q ss_pred EEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 008012 431 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES 510 (581)
Q Consensus 431 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~ 510 (581)
||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||... .....+...
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~~~~~~ 257 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEEVMHKT 257 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHH
Confidence 999999998764332222234457899999999999999999999999999999999999999753 122222222
Q ss_pred CCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 511 LPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....... .+..+++++.+++.+||+.||++||++.+++++
T Consensus 258 ~~~~~~~--------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGRYDP--------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCCCCC--------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 2111111 011345568899999999999999999999876
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=324.05 Aligned_cols=269 Identities=27% Similarity=0.415 Sum_probs=206.4
Q ss_pred cCCCcCCeecccccccEEEEEe-----CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeec--CCeee
Q 008012 291 DGFNECNLLGSGGFGSVYKGIL-----SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN--TNFKA 363 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 363 (581)
.+|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788999999999999999974 2578999999987766666788999999999999999999998754 34688
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+++++|.+++.+....+++..++.++.|++.||+||| ++|++||||||+||++++++.+||+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999876666899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCcce-eeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVI-QTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
...... .....++..|+|||+..+..++.++||||||+++|||++|..|+..... .....+...... ......
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~~---~~~~~~ 234 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGNDKQG---QMIVYH 234 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhccccccc---ccchHH
Confidence 322211 1112234569999999888999999999999999999999877543211 000000000000 000000
Q ss_pred c---hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 523 L---LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 523 ~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
+ .......+....++..+.+++.+||..+|++|||+.|+++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0 000000111224556789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=320.56 Aligned_cols=260 Identities=24% Similarity=0.401 Sum_probs=208.0
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCc----EEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGT----TVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.++|++.+.||+|+||.||+|.+. +++ .||+|+++... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 467889999999999999999853 444 48999987543 34456788999999999999999999998754 568
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+++||+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999876666899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
...........++..|+|||...+..++.++|||||||++|||++ |..||..... .....++........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~------- 232 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGERLPQ------- 232 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCcCCC-------
Confidence 322222222335678999999988899999999999999999998 8999865321 122222222111110
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
+..++..+.+++.+||..||++||++.++++.|+++..+.
T Consensus 233 ----------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 233 ----------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1123456889999999999999999999999998875543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=325.09 Aligned_cols=266 Identities=24% Similarity=0.305 Sum_probs=197.8
Q ss_pred cCCCcCCeecccccccEEEEEeC--CCcEEEEEEeccch--HHHHHHHHHHHHHHHhc---CCCccceEeeeee-----c
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS--DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNV---RHRNLIKILSSCC-----N 358 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~ 358 (581)
++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999863 46889999886542 22223456677777766 6999999999885 2
Q ss_pred CCeeeEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccC
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGI 437 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 437 (581)
....++||||++ ++|.+++... ...+++..+..++.|++.||.||| +.||+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 5999998754 334788999999999999999999 89999999999999999999999999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC---C
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH---G 514 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~ 514 (581)
+...... .......|++.|+|||.+.+..++.++|||||||++|||++|++||...... ..+...+...... .
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhh
Confidence 9876432 1223456899999999998889999999999999999999999999764221 1222222111100 0
Q ss_pred CCccc---cccchh--hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 515 LPKIA---DANLLR--EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 515 ~~~~~---~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+... ...... .........+++..+.+++.+||+.||++|||+.|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00000 000000 000001112355678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.58 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=206.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
..+|...++||+|+||.||++... ++..+++|.+..........+.+|++++++++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356788899999999999999632 46689999988766666678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc
Q 008012 364 LVLEFMPNGSLDKWLYSHN--------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV 429 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~ 429 (581)
++|||+++++|.+++.... ..+++..++.++.|++.|++||| +.|++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence 9999999999999998643 24688999999999999999999 899999999999999999999
Q ss_pred EEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 008012 430 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVK 508 (581)
Q Consensus 430 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~ 508 (581)
+||+|||++................+++.|+|||...+..++.++|||||||++|||++ |.+||...... .....+.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~ 238 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EAIECIT 238 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HHHHHHH
Confidence 99999999976543222122223345678999999998899999999999999999998 99998653221 1111111
Q ss_pred hhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 509 ESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
...... .+..++..+.+++.+||+.||++||+++||.+.|+
T Consensus 239 ~~~~~~-----------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 QGRELE-----------------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCccCC-----------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111100 01134456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=324.92 Aligned_cols=262 Identities=28% Similarity=0.449 Sum_probs=209.4
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeee
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCC 357 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 357 (581)
++...++|++.+.||+|+||.||++... +...+|+|.+.... ......+.+|+++++++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4455678999999999999999999854 23679999987642 34456788999999999 8999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCe
Q 008012 358 NTNFKALVLEFMPNGSLDKWLYSH---------------NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNI 422 (581)
Q Consensus 358 ~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Ni 422 (581)
..+..+++|||+++++|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeE
Confidence 999999999999999999999742 235788899999999999999999 89999999999999
Q ss_pred EecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccc
Q 008012 423 LLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEM 501 (581)
Q Consensus 423 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~ 501 (581)
++++++.+||+|||.+..+.............++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 241 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 241 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence 999999999999999987644332222222335678999999988899999999999999999998 99998653211
Q ss_pred cHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 502 NLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
.....+....... .+..++..+.+++.+||..||++|||+.|+++.|+++.
T Consensus 242 ~~~~~~~~~~~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ELFKLLKEGYRME-----------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHcCCcCC-----------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111111000 01123456889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=337.35 Aligned_cols=253 Identities=21% Similarity=0.348 Sum_probs=202.1
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999965 78999999997643 334456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.||+||||||+|||++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999998765 3788999999999999999999 89999999999999999999999999999876532110
Q ss_pred cc------------------------------------eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCC
Q 008012 447 SV------------------------------------IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRK 490 (581)
Q Consensus 447 ~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~ 490 (581)
.. ......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 011235899999999999999999999999999999999999
Q ss_pred CCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC---HHHHHHH
Q 008012 491 KPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLY---MKDAATK 564 (581)
Q Consensus 491 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~ 564 (581)
.||......+ .... +... ...+.. +....+++.+.++|.+|+. +|.+|++ +.|+++|
T Consensus 237 ~Pf~~~~~~~-~~~~-i~~~-~~~~~~-------------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQE-TYRK-IINW-KETLQF-------------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHH-HHHH-HHcC-CCccCC-------------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9997632211 1111 1110 000000 0001234567799999996 9999998 9999886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=314.59 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=213.7
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCC
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
|.++++||+|+||.||+|.++ +|+.+|+|.+..+. ..+.+..|+.++++++.|++|++||.|......|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 556789999999999999955 89999999877653 457788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
|+..+.++.+++.+++.++..+++.-+.||+||| ...-+|||||..|||++.+|.+||+|||.|-.+.. ......
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN 187 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN 187 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence 9999999999899999999999999999999999 78899999999999999999999999999976642 233456
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
...||+.|||||++..-.|..++||||||++..||..|++||.+..+-...+ ..+.. ..+.+.
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------MIPT~-----------PPPTF~ 250 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------MIPTK-----------PPPTFK 250 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------eccCC-----------CCCCCC
Confidence 6789999999999999999999999999999999999999998754322110 01111 112334
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.++..+.++.+++++||.++|++|-|+-++++|
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 556778889999999999999999999999987
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=321.89 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=204.0
Q ss_pred hhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 361 (581)
..++|.+.+.||+|++|.||+|.+. .+..|++|.+.... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567899999999999999999964 35779999886543 3344578899999999999999999999998889
Q ss_pred eeEEEeccCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC---cEEE
Q 008012 362 KALVLEFMPNGSLDKWLYSHN------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM---VAHV 432 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~---~~kl 432 (581)
.++||||+++++|.+++...+ ..+++..+..++.||+.||+||| +.+++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999998653 24788999999999999999999 89999999999999998654 6999
Q ss_pred eeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhC
Q 008012 433 SDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESL 511 (581)
Q Consensus 433 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~ 511 (581)
+|||++.................+..|+|||++.+..++.++|||||||++|||++ |..||...... .....+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~ 238 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEFVTGGG 238 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCC
Confidence 99999987633222111222234568999999988899999999999999999997 99998753221 1222222111
Q ss_pred CCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 512 PHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
... .+..++..+.+++.+||+.+|++|||+.+|+++|+
T Consensus 239 ~~~-----------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 RLD-----------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCC-----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 110 01123456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=325.39 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=208.2
Q ss_pred hhcCCCcCCeecccccccEEEEEeC--------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeec
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS--------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCN 358 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 358 (581)
..++|.+.+.||+|+||.||+|... ++..+|+|.++... ......+.+|+++++++ +||||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3468999999999999999999752 23569999997653 34456788899999999 79999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeE
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNIL 423 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nil 423 (581)
.+..++||||+++++|.+++.... ..+++.+++.++.|++.||+||| +.|++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheE
Confidence 999999999999999999998642 24688899999999999999999 899999999999999
Q ss_pred ecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCcccccccc
Q 008012 424 LDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMN 502 (581)
Q Consensus 424 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~ 502 (581)
++.++.+||+|||.+................++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~ 250 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 250 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HH
Confidence 99999999999999876543221111222234568999999988889999999999999999998 8888865311 11
Q ss_pred HHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 503 LKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
....+....... .+..++.++.+++.+||..+|++|||+.++++.|+++...
T Consensus 251 ~~~~~~~~~~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 251 LFKLLKEGHRMD-----------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHcCCCCC-----------------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 222221111100 1113445788999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=321.87 Aligned_cols=257 Identities=27% Similarity=0.414 Sum_probs=206.4
Q ss_pred CCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 292 GFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
+|++.+.||+|+||.||+|... ....+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788899999999999999853 23578999887553 3445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 008012 365 VLEFMPNGSLDKWLYSHN-----------------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSN 421 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~N 421 (581)
||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 999999999999987421 23678889999999999999999 8999999999999
Q ss_pred eEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCcccccc
Q 008012 422 ILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGE 500 (581)
Q Consensus 422 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~ 500 (581)
|++++++.+||+|||++................++..|+|||...+..++.++||||||+++|||++ |..||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999986543332222233345678999999888889999999999999999999 9999865321
Q ss_pred ccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 501 MNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
..+.+.+....... .+..++.++.+++.+||+.+|++||+++|+++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFNLLKTGYRME-----------------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHhCCCCCC-----------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 12222222211111 011334568899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=327.86 Aligned_cols=262 Identities=24% Similarity=0.399 Sum_probs=220.5
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC---CC--cEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeec
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS---DG--TTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~---~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 358 (581)
+.+...+..+..++||.|.||.||+|.+. .| -.||||..+.+. .+..+.|.+|..+|+.++||||++++|+|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 34444555667788999999999999953 23 358999988753 4557899999999999999999999999976
Q ss_pred CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
. ..|+|||.++-|-|..|++.+...++......++.||+.||+||| +.++|||||..+|||+.+...|||+|||++
T Consensus 463 ~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 463 Q-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred c-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchh
Confidence 5 579999999999999999998888899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
+.+....... .+...-+..|||||.+.-..++.+||||.|||.+||++. |..||......+...
T Consensus 539 R~~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------------- 603 (974)
T KOG4257|consen 539 RYLEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------------- 603 (974)
T ss_pred hhccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE--------------
Confidence 9886544332 233344678999999999999999999999999999998 999998754332210
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
-.+.+...+.+..||+.++.|+.+||..||.+||++.|+...|..+..
T Consensus 604 -----~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 -----HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -----EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 012233456677899999999999999999999999999999988876
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=333.76 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=198.3
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||+||+|... +++.||+|+++... ......+.+|+.++.+++||+|+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999965 78999999997643 233456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++|+|.+++.+.+ .+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999998754 4788999999999999999999 89999999999999999999999999999875432110
Q ss_pred c---------------------------------ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCC
Q 008012 447 S---------------------------------VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPT 493 (581)
Q Consensus 447 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf 493 (581)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012346899999999999999999999999999999999999999
Q ss_pred CccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccC--cCCCCCCCHHHHHHH
Q 008012 494 DEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCA--ELPDQRLYMKDAATK 564 (581)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~Rps~~evl~~ 564 (581)
...... ..............++. ...+++++.+++.+++. .++..||+++|+++|
T Consensus 237 ~~~~~~-~~~~~i~~~~~~~~~p~---------------~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQ-ETYKKVMNWKETLIFPP---------------EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHH-HHHHHHHcCcCcccCCC---------------cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 753211 11111111000000111 00123456678877554 233456899999988
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=316.21 Aligned_cols=251 Identities=27% Similarity=0.380 Sum_probs=203.4
Q ss_pred cCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccC
Q 008012 291 DGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMP 370 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 370 (581)
.+|++.+.||+|+||.||+|.++++..+|+|++..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 45888999999999999999988778899999865422 12467789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCccee
Q 008012 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 450 (581)
+++|.+++......+++..++.++.|++.||+||| +.|++||||||+||++++++.+||+|||.+......... ..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~ 158 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SS 158 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc-cc
Confidence 99999999876656899999999999999999999 899999999999999999999999999999865422111 11
Q ss_pred eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .....+........
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~-------------- 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAGYRLYR-------------- 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHcCCcCCC--------------
Confidence 12223457999999998899999999999999999999 89998753221 11111211111100
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
+..++.++.+++.+||..+|++|||+.|+++.|
T Consensus 223 ---~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 ---PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 112456788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.18 Aligned_cols=243 Identities=24% Similarity=0.315 Sum_probs=196.6
Q ss_pred CCeecccccccEEEEEe----CCCcEEEEEEeccch----HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 296 CNLLGSGGFGSVYKGIL----SDGTTVAIKIFNLQL----EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
++.||+|+||.||++.. .+++.||+|+++... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36899999999999985 257899999987642 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++++|.+++...+. +.+..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 81 YLSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCCchHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 9999999999987654 677888889999999999999 89999999999999999999999999999875432221
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ...+........ .
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~~~~~~~~-~---------- 218 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTIDKILKGKL-N---------- 218 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCC-C----------
Confidence 12334689999999999998899999999999999999999999976321 111111111110 0
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
.+..+++.+.+++.+||+.||++|| ++.+++++
T Consensus 219 ----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 ----LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ----CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 0112345678999999999999999 88888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=332.64 Aligned_cols=242 Identities=24% Similarity=0.271 Sum_probs=197.0
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNG 372 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 372 (581)
+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999954 78999999997653 234456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 373 SLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS-TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 373 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
+|.+++.... .+++..+..++.||+.||+||| + .||+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK 154 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence 9999887654 4788999999999999999999 6 7999999999999999999999999999875422211 123
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+... ...++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--~~~~~~i~~~-~~~~p--------------- 216 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILME-EIRFP--------------- 216 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--HHHHHHHhcC-CCCCC---------------
Confidence 34689999999999999999999999999999999999999965321 1111111110 00111
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
..+++++.+++.+||+.||++|+ ++.++++|
T Consensus 217 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 --RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 12345678999999999999997 89999877
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=330.85 Aligned_cols=252 Identities=23% Similarity=0.272 Sum_probs=199.9
Q ss_pred CCCcCCeecccccccEEEEEe----CCCcEEEEEEeccch----HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCee
Q 008012 292 GFNECNLLGSGGFGSVYKGIL----SDGTTVAIKIFNLQL----EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 362 (581)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+.+++.+ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999885 268899999987542 23345678899999999 599999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+++|+|.+++..... +++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN-FSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999999976543 788999999999999999999 8999999999999999999999999999998653
Q ss_pred CCCCcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
..... ......|+..|+|||++.+. .++.++|||||||++|||++|+.||....... ............. +.
T Consensus 157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~-~~---- 229 (332)
T cd05614 157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVSRRILKCD-PP---- 229 (332)
T ss_pred ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHHHHHhcCC-CC----
Confidence 32221 12345689999999988765 47889999999999999999999997532211 1111111111100 00
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
.+..++..+.+++.+||+.||++|| +++++++|
T Consensus 230 ----------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 230 ----------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0012345678999999999999999 77888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=327.62 Aligned_cols=247 Identities=23% Similarity=0.280 Sum_probs=198.7
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCC-CccceEeeeeecCCeeeEEE
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRH-RNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 366 (581)
+|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+..|.+++..+.| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999965 67899999997653 3345677889999999965 56888999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++|+|.+++..... +++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 99999999999976553 688899999999999999999 89999999999999999999999999999875322111
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
......|++.|+|||++.+..++.++||||+||++|||+||+.||...... .....+.... ..++
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~~~-~~~~---------- 221 (324)
T cd05587 157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIMEHN-VSYP---------- 221 (324)
T ss_pred --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCC-CCCC----------
Confidence 223456899999999999999999999999999999999999999753211 1111111111 0111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCH-----HHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYM-----KDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 564 (581)
..++.++.+++.+||..||++|++. +++++|
T Consensus 222 -------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 222 -------KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1234467899999999999999986 666655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.98 Aligned_cols=245 Identities=22% Similarity=0.287 Sum_probs=196.0
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHH---HhcCCCccceEeeeeecCCeeeEE
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVL---RNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|.+++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999965 78999999997653 23345666776665 456799999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+++++|..++... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 9999999999888653 4789999999999999999999 8999999999999999999999999999987532211
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+..... ..+
T Consensus 156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~~~-~~p--------- 221 (324)
T cd05589 156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVFDSIVNDEV-RYP--------- 221 (324)
T ss_pred --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC-CCC---------
Confidence 1223456899999999999999999999999999999999999999753211 11111111100 011
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
..++..+.+++.+||+.||++|| ++.+++++
T Consensus 222 --------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 222 --------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 12345678999999999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=316.70 Aligned_cols=254 Identities=27% Similarity=0.465 Sum_probs=202.4
Q ss_pred CCcCCeecccccccEEEEEeC----CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe-----
Q 008012 293 FNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF----- 361 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 361 (581)
|.+.+.||+|+||.||+|... .+..||+|.++... ......+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999854 24779999987542 3445678999999999999999999998866543
Q ss_pred -eeEEEeccCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeec
Q 008012 362 -KALVLEFMPNGSLDKWLYSH-----NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDF 435 (581)
Q Consensus 362 -~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 435 (581)
.+++|||+++++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 78999999999999998642 235788999999999999999999 899999999999999999999999999
Q ss_pred cCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCC
Q 008012 436 GISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHG 514 (581)
Q Consensus 436 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 514 (581)
|.++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ....+.+.......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~ 235 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLRHGNRLK 235 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCC
Confidence 99987643332222222345678999999988899999999999999999999 8899865322 12222222111111
Q ss_pred CCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 515 LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
. +..++..+.+++.+||+.||++|||+.|++++|+++
T Consensus 236 ~-----------------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 236 Q-----------------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C-----------------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 113455788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=335.56 Aligned_cols=257 Identities=19% Similarity=0.276 Sum_probs=204.5
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF 361 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 361 (581)
.....++|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3445678999999999999999999965 78999999997542 2334557789999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
.++||||+++|+|.+++.... +++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||++...
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999999987643 678888999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCcceeeccccCccccCCCCCCCC----CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSEG----NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
..... .......|++.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+...........++.
T Consensus 193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~ 270 (370)
T cd05596 193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMDHKNSLTFPD 270 (370)
T ss_pred cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-HHHHHHHHcCCCcCCCCC
Confidence 43221 122345689999999987653 478899999999999999999999976321 111111111100000110
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQ--RLYMKDAATK 564 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 564 (581)
...++.++.++|.+||..+|++ |||++|+++|
T Consensus 271 ---------------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 271 ---------------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---------------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1123456889999999999988 9999999887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=323.43 Aligned_cols=263 Identities=26% Similarity=0.425 Sum_probs=210.2
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC--------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeee
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS--------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSC 356 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 356 (581)
....++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 345678899999999999999999731 34579999987543 34456789999999999 899999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 008012 357 CNTNFKALVLEFMPNGSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSN 421 (581)
Q Consensus 357 ~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~N 421 (581)
...+..++||||+++++|.+++.... ..+++..+..++.||+.||+||| ++|++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccce
Confidence 99999999999999999999998642 23677889999999999999999 8999999999999
Q ss_pred eEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCcccccc
Q 008012 422 ILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGE 500 (581)
Q Consensus 422 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~ 500 (581)
|++++++.+||+|||.+................++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-- 245 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 245 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--
Confidence 9999999999999999987644332222233345678999999988889999999999999999998 7888865311
Q ss_pred ccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 501 MNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
......+....... .+..++..+.+++.+||+.+|++|||+.|+++.|+++..-
T Consensus 246 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 EELFKLLKEGHRMD-----------------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHcCCcCC-----------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11111111111100 0123456788999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=320.09 Aligned_cols=261 Identities=24% Similarity=0.368 Sum_probs=211.3
Q ss_pred hhcCCCcCCeecccccccEEEEEeCC-----CcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeec-CCe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILSD-----GTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCN-TNF 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 361 (581)
..++|++.+.||+|+||.||+|.... +..|++|.+... .......+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999999764 688999988754 34455778899999999999999999998766 567
Q ss_pred eeEEEeccCCCCHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEee
Q 008012 362 KALVLEFMPNGSLDKWLYSHN-------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSD 434 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~D 434 (581)
.++++||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence 899999999999999997532 34789999999999999999999 89999999999999999999999999
Q ss_pred ccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 008012 435 FGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPH 513 (581)
Q Consensus 435 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 513 (581)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||.... ......++......
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~ 238 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYLKDGYRL 238 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHHHcCCCC
Confidence 999986543332222223345778999999988889999999999999999999 999997531 12222222221110
Q ss_pred CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 514 GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
. ....+++.+.+++.+||..||++|||+.++++.|+.+.++
T Consensus 239 ~-----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 239 A-----------------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred C-----------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0 0112455788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=321.82 Aligned_cols=260 Identities=23% Similarity=0.377 Sum_probs=209.0
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeecC
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNT 359 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 359 (581)
...++|.+.+.||+|+||.||+|... ++..||+|.++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44567999999999999999999741 35579999987653 34456789999999999 799999999999999
Q ss_pred CeeeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 360 NFKALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 360 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
+..++||||+++++|.+++.... ..+++.++..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999998643 34799999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
................++..|+|||.+.+..++.++||||+||++|||++ |..||......+ .....+........+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~- 266 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEGYRMAQP- 266 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcCCcCCCC-
Confidence 86643332222223345778999999998899999999999999999998 999987642221 122222211111000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
...+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 267 ----------------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 267 ----------------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----------------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=311.01 Aligned_cols=255 Identities=25% Similarity=0.332 Sum_probs=207.9
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..+.|+.++.||.|.-|+||++..+ ++..+|+|++.++. .+...+.+.|-+||+.++||.+..+|+.|+.+...|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 3456777889999999999999966 56899999998874 3445677889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 365 VLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
|||||+||+|....+++ +..+++..+.-++..++-||+||| ..|||+|||||+||||.++|++-|+||.++.....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999999865 566899999999999999999999 99999999999999999999999999998753210
Q ss_pred ---------------------------------CCC---------------------cceeeccccCccccCCCCCCCCC
Q 008012 444 ---------------------------------GDD---------------------SVIQTMTIATIGYMAPEFGSEGN 469 (581)
Q Consensus 444 ---------------------------------~~~---------------------~~~~~~~~~~~~y~aPE~~~~~~ 469 (581)
... .......+||-.|.|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 00112346899999999999999
Q ss_pred CCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccC
Q 008012 470 VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCA 549 (581)
Q Consensus 470 ~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 549 (581)
.+.++|.|+|||++|||+.|..||.+....+ .+...+.+... ++. ....+..+.+||++.|.
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~NIv~~~l~--Fp~---------------~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRNIVGQPLK--FPE---------------EPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHHHhcCCCc--CCC---------------CCcchhHHHHHHHHHhc
Confidence 9999999999999999999999998753332 23333322211 111 11344568899999999
Q ss_pred cCCCCCCC----HHHHHHH
Q 008012 550 ELPDQRLY----MKDAATK 564 (581)
Q Consensus 550 ~dP~~Rps----~~evl~~ 564 (581)
+||.+|.. |.||.+|
T Consensus 374 KdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred cChhhhhccccchHHhhcC
Confidence 99999998 7787765
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=336.63 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=199.3
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++++.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999954 78999999986542 334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999998654 4688889999999999999999 89999999999999999999999999999864321100
Q ss_pred c-----------c----------------------------------eeeccccCccccCCCCCCCCCCCccccHHHHHH
Q 008012 447 S-----------V----------------------------------IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGI 481 (581)
Q Consensus 447 ~-----------~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 481 (581)
. . ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0 001246899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCC---CCH
Q 008012 482 LLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQR---LYM 558 (581)
Q Consensus 482 vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~ 558 (581)
++|||++|..||...... ..+...........++. ...++.++.+++.+|+. +|.+| +++
T Consensus 237 il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~---------------~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 237 IMFECLIGWPPFCSENSH-ETYRKIINWRETLYFPD---------------DIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred hhhhhhcCCCCCCCCCHH-HHHHHHHccCCccCCCC---------------CCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 999999999999753221 11111111000000110 01234567899999997 67765 599
Q ss_pred HHHHHH
Q 008012 559 KDAATK 564 (581)
Q Consensus 559 ~evl~~ 564 (581)
.|+++|
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=324.92 Aligned_cols=258 Identities=24% Similarity=0.323 Sum_probs=207.4
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEecc--chHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCee
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNL--QLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 362 (581)
+......|++.++||+||.+.||++...+.+.+|+|.+.. .+.+....|.+|+..|.++ .|.+|+++|+|-..++..
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3445577999999999999999999988788888886643 3567778899999999999 599999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
|+||||-+ .+|..++.+.....+.-.++.+..|++.|+.+.| .+||||.||||.|+++- .|.+||+|||.|..+.
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 99999864 4999999987655443378889999999999999 89999999999999995 5699999999999988
Q ss_pred CCCCcceeeccccCccccCCCCCCCC-----------CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEG-----------NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESL 511 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 511 (581)
.+.........+||+.||+||.+... +.+.++||||+|||+|+|+.|++||.........+.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~------- 583 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLH------- 583 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHH-------
Confidence 77777778888999999999976543 256789999999999999999999986422211111
Q ss_pred CCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 512 PHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+.++.-.-+.+..+. ..++.++|+.||..||.+|||+.|+++|
T Consensus 584 -----aI~~P~~~Iefp~~~~----~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 584 -----AITDPNHEIEFPDIPE----NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----hhcCCCccccccCCCC----chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1222211111111111 1127899999999999999999999986
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=319.66 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=204.8
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCc--EEEEEEeccc-hHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGT--TVAIKIFNLQ-LEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 365 (581)
++|++.+.||+|+||.||+|..+ ++. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57899999999999999999865 333 4788888743 334456788999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcE
Q 008012 366 LEFMPNGSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVA 430 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~ 430 (581)
|||+++++|.+++.... ..+++..++.++.|++.||+||| ++||+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999997532 24678899999999999999999 8999999999999999999999
Q ss_pred EEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHh
Q 008012 431 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKE 509 (581)
Q Consensus 431 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~ 509 (581)
||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||...... .....+..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--~~~~~~~~ 233 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQ 233 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhc
Confidence 99999998643211 11111223557999999988889999999999999999998 99999753221 11111111
Q ss_pred hCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 510 SLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
..... .+..++..+.+++.+||+.+|.+|||++++++.|+.+..+..
T Consensus 234 ~~~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 234 GYRME-----------------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred CCCCC-----------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 10000 011244568899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=319.56 Aligned_cols=245 Identities=24% Similarity=0.301 Sum_probs=196.8
Q ss_pred ecccccccEEEEEeC-CCcEEEEEEeccchH---HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCH
Q 008012 299 LGSGGFGSVYKGILS-DGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSL 374 (581)
Q Consensus 299 lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 374 (581)
||+|+||+||++..+ +++.||+|.+..... ...+.+..|++++++++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999965 789999999875432 2335677899999999999999999999999999999999999999
Q ss_pred HHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 375 DKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 375 ~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+||++++++.++|+|||.+..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 988753 3345789999999999999999999 89999999999999999999999999999986643322 123
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...... ............... .
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~---------------~ 219 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRILNDSV---------------T 219 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc-hhHHHHHHhhcccCC---------------C
Confidence 346899999999999999999999999999999999999999753221 111111111111100 0
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
.+..++..+.+++.+||+.||++|| +++++++|
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1123456688999999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=320.41 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=202.7
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999964 78999999987543 2223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 368 FMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|+++|+|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999988754 345789999999999999999999 89999999999999999999999999999987532221
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||..... ....... ..........
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~-~~~~~~~-~~~~~~~~~~--------- 223 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-KVKREEV-ERRVKEDQEE--------- 223 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch-hhHHHHH-HHHhhhcccc---------
Confidence 1234688999999999988999999999999999999999999976321 1111111 1111111000
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
.+..++..+.+++.+||..||++|| ++++++++
T Consensus 224 -----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 224 -----YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -----cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0112455688999999999999999 89899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=325.84 Aligned_cols=242 Identities=22% Similarity=0.277 Sum_probs=192.7
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|... +++.||+|+++... ....+....|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 68899999997653 23344556677777655 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 99999997655 4788999999999999999999 8999999999999999999999999999998643222 2223
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ..++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~~-~~~~--------------- 216 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--DELFDSILNDR-PHFP--------------- 216 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCC-CCCC---------------
Confidence 45689999999999998999999999999999999999999976322 11111111110 0111
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCCCHH-HHHHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRLYMK-DAATK 564 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 564 (581)
..++.++.+++.+||+.||++||++. +++++
T Consensus 217 --~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 217 --RWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred --CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 12334577999999999999999875 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=321.85 Aligned_cols=255 Identities=24% Similarity=0.411 Sum_probs=204.5
Q ss_pred cCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.+|++.+.||+|+||.||+|... ++..||+|+++... ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45778889999999999999853 25789999997654 233467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC
Q 008012 364 LVLEFMPNGSLDKWLYSH---------------NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM 428 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~ 428 (581)
+++||+++++|.+++... ...+++..++.++.|++.||+||| ++||+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence 999999999999998632 123677888999999999999999 89999999999999999999
Q ss_pred cEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 008012 429 VAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWV 507 (581)
Q Consensus 429 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~ 507 (581)
.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||..... ....+.+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~i 239 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVIEMI 239 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence 999999999886543332222334456788999999988889999999999999999998 8888865322 1122222
Q ss_pred HhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 508 KESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
... .... .+.+++..+.+++.+||+.+|++||++++|++.|+.
T Consensus 240 ~~~---~~~~--------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 RNR---QVLP--------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HcC---CcCC--------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 211 1110 112456678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.08 Aligned_cols=242 Identities=21% Similarity=0.252 Sum_probs=195.4
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|..+ +++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 68999999987643 23445677888888877 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
|+|.+++.... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS 154 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence 99999988664 3788999999999999999999 8999999999999999999999999999987542221 1223
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||..... .............
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~--------------- 214 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDEVV--------------- 214 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcCCCC---------------
Confidence 45689999999999999999999999999999999999999976321 1111111111100
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCCCH------HHHHHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRLYM------KDAATK 564 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~ 564 (581)
.+..++..+.+++.+||+.||++||++ +++++|
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 001134567899999999999999998 666665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=316.50 Aligned_cols=258 Identities=23% Similarity=0.334 Sum_probs=208.7
Q ss_pred cCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|++|.||+|.. .+++.+++|.+... .......+.+|+++++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788899999999999999995 48999999987653 2334467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 367 EFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 367 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
||+++++|.+++.. ....+++..++.++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998874 2345788999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
... ......++..|+|||...+..++.++||||||+++|+|++|..||.............+... ..+..
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~----- 228 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---DYPPL----- 228 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC---CCCCC-----
Confidence 221 12234588899999999888899999999999999999999999865322211111111111 11100
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
....++..+.+++.+||..||++|||+.+|++.++++.
T Consensus 229 --------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 --------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 01134567889999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=320.15 Aligned_cols=261 Identities=22% Similarity=0.359 Sum_probs=205.8
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecC
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT 359 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 359 (581)
+...++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++||||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 345688999999999999999999743 24579999886443 23345678899999999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcE
Q 008012 360 NFKALVLEFMPNGSLDKWLYSHN---------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVA 430 (581)
Q Consensus 360 ~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~ 430 (581)
+..++||||+++|+|.+++.... ...++..+..++.|++.||.||| +++|+||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcE
Confidence 99999999999999999997532 23466788899999999999999 8999999999999999999999
Q ss_pred EEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHh
Q 008012 431 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKE 509 (581)
Q Consensus 431 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~ 509 (581)
+|+|||++................++..|+|||.+.++.++.++|||||||++|||++ |..||...... .....+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~- 235 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLKFVM- 235 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH-
Confidence 9999999886543222222222345678999999998899999999999999999999 78888653211 1111111
Q ss_pred hCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 510 SLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
...... .+..++..+.+++.+||+.||++|||+.++++.|++..
T Consensus 236 --~~~~~~--------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 --DGGYLD--------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred --cCCCCC--------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111110 01123457889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=316.81 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=206.8
Q ss_pred cCCCcCCeecccccccEEEEEeC-CC---cEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DG---TTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
.+|++.+.||+|+||.||+|..+ ++ ..||+|.+... .......+..|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45788899999999999999964 33 36999998765 344567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+++++|.+++......+++..++.++.|++.||+||| +.|++|+||||+||+++.++.+||+|||.+.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999876666899999999999999999999 8999999999999999999999999999987664322
Q ss_pred Ccceeec-cc--cCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 446 DSVIQTM-TI--ATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 446 ~~~~~~~-~~--~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
....... .. .+..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~~~~~~-------- 230 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIEQDYRL-------- 230 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCCcC--------
Confidence 2111111 11 2457999999998999999999999999999887 9999875322 1222222211110
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
+.+.+++..+.+++.+||..+|++||++.+++..|+++
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 ---------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01123456688999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=318.60 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=203.3
Q ss_pred hcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999999996 47899999999765544456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|.+++.... .+++..+..++.|++.||+||| +.||+||||+|+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06646 88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-- 161 (267)
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence 99999999987654 4688999999999999999999 89999999999999999999999999999986632211
Q ss_pred eeeccccCccccCCCCCC---CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 449 IQTMTIATIGYMAPEFGS---EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
......++..|+|||.+. ...++.++|||||||++|||++|+.||........ ...+...... .+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~--~~~~------- 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSNFQ--PPKL------- 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCCCC--CCCC-------
Confidence 122345788999999874 34578899999999999999999999865321111 0000000000 0000
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
......+..+.+++.+||..+|++|||++++++++
T Consensus 232 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 -----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00112345788999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=325.59 Aligned_cols=267 Identities=18% Similarity=0.285 Sum_probs=204.0
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.++|.+.+.||+|+||.||+|+.+ +++.||+|.++... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 367999999999999999999965 78899999987543 2223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++ +|.+++...+..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 9975 899988877666788999999999999999999 89999999999999999999999999999976532221
Q ss_pred ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC----CCcccccc
Q 008012 448 VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG----LPKIADAN 522 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 522 (581)
......++..|+|||++.+ ..++.++|||||||++|+|+||++||...... .....+....... .+.+....
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE--DELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhhcchh
Confidence 1223457889999998755 56889999999999999999999999763221 1111111111111 00000000
Q ss_pred ------chh--hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 523 ------LLR--EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 523 ------~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
... ..........++.++.+++.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000 000011112356678899999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=327.07 Aligned_cols=248 Identities=20% Similarity=0.280 Sum_probs=196.9
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|..+ +++.||+|+++... ......+.+|..+++++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 78999999998653 23445688899999999 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
|+|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccc
Confidence 99999887654 4789999999999999999999 89999999999999999999999999999874321111 123
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG---EMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||+..... ......+...........
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 223 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR----------- 223 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-----------
Confidence 456899999999999999999999999999999999999999642111 111112221111111000
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCC------HHHHHHH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLY------MKDAATK 564 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~evl~~ 564 (581)
.+..++.++.+++.+||+.||++||+ ++++++|
T Consensus 224 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 ---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 01123456789999999999999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=312.63 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=205.4
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+|++.+.||+|++|.||+|..+ +++.|++|.+... .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999965 7899999998653 244556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 369 MPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 369 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
+++++|.+++... ...+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999875 456788999999999999999999 89999999999999999999999999999987643322
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
......++..|+|||+..+..++.++||||||+++|+|++|+.||..... ......+.. ...+.+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~---~~~~~~--------- 221 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILKIIR---GVFPPV--------- 221 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHc---CCCCCC---------
Confidence 12334578899999999998999999999999999999999999975421 111111111 111111
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...++..+.+++.+||+.+|++||++.+++++
T Consensus 222 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 -----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 01234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=315.37 Aligned_cols=254 Identities=26% Similarity=0.457 Sum_probs=204.2
Q ss_pred hhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
..++|++.+.||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|++++++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3567999999999999999999988888999999876432 2356889999999999999999999875 4567899999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 369 MPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 369 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
+++++|.+++.+. ...+++..++.++.|++.||+||| +.+++||||||+||++++++.++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999999864 344789999999999999999999 889999999999999999999999999999876432211
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
......++..|+|||...+..++.++||||||+++|+|++ |..||..... ......+........
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~----------- 224 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQVERGYRMPC----------- 224 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCCC-----------
Confidence 1122235667999999888889999999999999999999 8999865321 112222211111100
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
+...+..+.+++.+||..+|++|||+.++.+.|++
T Consensus 225 ------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 ------PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ------CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11334568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=313.93 Aligned_cols=258 Identities=25% Similarity=0.357 Sum_probs=210.1
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|++|.||+|... +|+.||+|.++.. .....+.+.+|++++++++|++++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999966 8999999988643 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 367 EFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 367 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
||+++++|.+++.. ....+++..++.++.|++.||+||| +.|++||||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999864 2344788999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ....+..........+...
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~---- 229 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEKCDYPPLP---- 229 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhcCCCCCCC----
Confidence 221 1223457889999999988889999999999999999999999986532 2222222211111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
...++..+.++|.+||..+|++|||+.+|++.|+++.
T Consensus 230 ---------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ---------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1134556889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=315.40 Aligned_cols=254 Identities=27% Similarity=0.451 Sum_probs=198.9
Q ss_pred CCcCCeecccccccEEEEEeCC-Cc--EEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecC------Ce
Q 008012 293 FNECNLLGSGGFGSVYKGILSD-GT--TVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT------NF 361 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 361 (581)
|.+.+.||+|+||.||+|.+.+ +. .||+|.++.. .....+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999999653 33 6899988654 244567788999999999999999999987432 25
Q ss_pred eeEEEeccCCCCHHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeecc
Q 008012 362 KALVLEFMPNGSLDKWLYS-----HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
.+++|||+++|+|.+++.. ....+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999998852 2234688999999999999999999 8999999999999999999999999999
Q ss_pred CceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCC
Q 008012 437 ISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGL 515 (581)
Q Consensus 437 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 515 (581)
++................++..|+|||...+..++.++||||||+++|||++ |+.||..... ......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~--- 232 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLRQGNR--- 232 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcCCC---
Confidence 9987643322111223345678999999999899999999999999999999 8899865322 111121211110
Q ss_pred CccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
.. ....++..+.+++.+||..||++|||+.++++.|+++
T Consensus 233 ~~--------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LK--------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC--------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 0112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=326.92 Aligned_cols=248 Identities=20% Similarity=0.276 Sum_probs=196.0
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|..+ +++.||+|+++... ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 78899999997642 33445678899988887 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
|+|..++.... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence 99999887654 4788999999999999999999 89999999999999999999999999999875322111 123
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG---EMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
...|+..|+|||++.+..++.++|||||||++|||++|+.||...... ......++..........
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----------- 223 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----------- 223 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC-----------
Confidence 456899999999999999999999999999999999999999642111 111112221111111000
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCC------HHHHHHH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLY------MKDAATK 564 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~evl~~ 564 (581)
.+..++..+.+++.+||+.||++||+ +.++++|
T Consensus 224 ---~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 ---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ---CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 01123456789999999999999998 4677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=337.30 Aligned_cols=252 Identities=20% Similarity=0.300 Sum_probs=198.3
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.|++++.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999964 78999999997653 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC-
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD- 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~- 446 (581)
|+++|+|.+++.+.+ .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999998754 3688888999999999999999 89999999999999999999999999999753311000
Q ss_pred --------------------------------------------cceeeccccCccccCCCCCCCCCCCccccHHHHHHH
Q 008012 447 --------------------------------------------SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGIL 482 (581)
Q Consensus 447 --------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~v 482 (581)
........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000112368999999999999999999999999999
Q ss_pred HHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC---HH
Q 008012 483 LLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLY---MK 559 (581)
Q Consensus 483 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~ 559 (581)
+|||++|++||......+ ..............+ .....++++.+++.+|+ .+|++|++ ++
T Consensus 238 l~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~p---------------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLE-TQMKVINWQTSLHIP---------------PQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred HHHHHhCCCCCCCCCHHH-HHHHHHccCCCcCCC---------------CcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 999999999997632211 111111100000011 01123455778888876 59999997 88
Q ss_pred HHHHH
Q 008012 560 DAATK 564 (581)
Q Consensus 560 evl~~ 564 (581)
|+++|
T Consensus 301 ei~~h 305 (382)
T cd05625 301 EIKAH 305 (382)
T ss_pred HHhcC
Confidence 88876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=331.76 Aligned_cols=262 Identities=19% Similarity=0.268 Sum_probs=205.8
Q ss_pred hhhhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeee
Q 008012 282 SYLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCC 357 (581)
Q Consensus 282 ~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 357 (581)
...++....++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 35566677799999999999999999999965 78999999986532 233456788999999999999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccC
Q 008012 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGI 437 (581)
Q Consensus 358 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 437 (581)
+.+..++||||+++|+|.+++.... +++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999999997653 688888999999999999999 89999999999999999999999999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCC----CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEG----NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH 513 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 513 (581)
+........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.......
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~ 266 (371)
T cd05622 189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMNHKNSL 266 (371)
T ss_pred eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCcc
Confidence 987643221 122345699999999987653 378899999999999999999999975321 11111111110000
Q ss_pred CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHHH
Q 008012 514 GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQ--RLYMKDAATKL 565 (581)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~L 565 (581)
.++ ....++..+.++|.+|+..++.+ ||+++|+++|.
T Consensus 267 ~~~---------------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 267 TFP---------------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCC---------------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 011 11134456789999999844433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=328.29 Aligned_cols=242 Identities=23% Similarity=0.268 Sum_probs=196.0
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|+.+ +++.||+|++.... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 68899999997653 23445677889998876 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
++|..++..... +++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (321)
T cd05591 81 GDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT 154 (321)
T ss_pred CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence 999999876543 688899999999999999999 89999999999999999999999999999875432221 123
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...... ............ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~~~~i~~~~~~---~----------- 215 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDDVL---Y----------- 215 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCCCC---C-----------
Confidence 456899999999999989999999999999999999999999763211 111111111100 0
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCC-------CHHHHHHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRL-------YMKDAATK 564 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rp-------s~~evl~~ 564 (581)
+..++.++.+++.+||+.||++|| +++++++|
T Consensus 216 -p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 -PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 011234678999999999999999 88888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=313.72 Aligned_cols=254 Identities=27% Similarity=0.457 Sum_probs=204.5
Q ss_pred hcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
.++|++.++||+|+||.||+|.+.++..||+|.++.... ..+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 467999999999999999999987667899999875432 2346889999999999999999999874 45679999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 370 PNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 370 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
++++|.+++.+. ...+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 999999999864 345788999999999999999999 899999999999999999999999999999876433221
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
......++..|+|||+..+..++.++||||||+++|+|+| |..||....... ....+..... .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~~--~------------ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYR--M------------ 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HHHHHhcCCC--C------------
Confidence 1223346678999999988899999999999999999999 888887542211 1111111000 0
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
.....++..+.+++.+|++.||++||+++++++.|+..
T Consensus 223 ---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 01123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=323.79 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=213.7
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH---HHHHHHHHHHHHHHhcC-CCccceEeeeeecCCee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFK 362 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 362 (581)
.....|++.+.||+|.||.||+++.+ +|+.+|+|++.+... .....+.+|+++|+++. ||||+.++++|++.+..
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34567899999999999999999966 699999999977643 24468899999999997 99999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC----CCcEEEeeccCc
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE----NMVAHVSDFGIS 438 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~----~~~~kl~Dfg~a 438 (581)
++|||++.||.|.+.+... . +++..+..++.|++.+++||| +.||+|||+||+|+|+.. ++.+|++|||++
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 9999999999999999877 3 899999999999999999999 899999999999999963 358999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||........ ........+ .+
T Consensus 187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-~~~i~~~~~-----~f 257 (382)
T KOG0032|consen 187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-FLAILRGDF-----DF 257 (382)
T ss_pred eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-HHHHHcCCC-----CC
Confidence 98765 3345677899999999999999999999999999999999999999987533222 222221111 11
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
. .+.+..++..+.++|..|+..||.+|+|+.++++|
T Consensus 258 ~----------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 258 T----------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred C----------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1 12233456678899999999999999999999997
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=339.07 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=199.6
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
.+|++++.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999954 78999999987543 233456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++|+|.+++.+.+ .+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|..+.....
T Consensus 81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999998765 3688888999999999999999 89999999999999999999999999999753311000
Q ss_pred -----------------------------------------cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHH
Q 008012 447 -----------------------------------------SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLE 485 (581)
Q Consensus 447 -----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~e 485 (581)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112468999999999999999999999999999999
Q ss_pred HHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCC---CHHHHH
Q 008012 486 TFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRL---YMKDAA 562 (581)
Q Consensus 486 l~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~evl 562 (581)
|++|+.||......+ ....+.. ...... . +....++..+.+++.+|+ .+|++|+ ++.|++
T Consensus 237 ll~G~~Pf~~~~~~~--~~~~i~~-~~~~~~-~------------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 237 MLVGQPPFLADTPAE--TQLKVIN-WETTLH-I------------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred hhhCCCCCCCCCHHH--HHHHHhc-cCcccc-C------------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 999999997642211 1111110 000000 0 001123455778888876 5999999 899999
Q ss_pred HH
Q 008012 563 TK 564 (581)
Q Consensus 563 ~~ 564 (581)
+|
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 87
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=315.31 Aligned_cols=258 Identities=23% Similarity=0.380 Sum_probs=208.0
Q ss_pred hcCCCcCCeecccccccEEEEEeCC----CcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSD----GTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
.++|.+.+.||+|+||.||+|.+.+ ...|++|...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568889999999999999998542 3468999887664 4556788999999999999999999998875 45789
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+++++|.+++......+++..++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999999876666799999999999999999999 899999999999999999999999999999876433
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
.. .......++..|+|||.+....++.++||||||+++||+++ |..||...... .....+.......
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~~~~--------- 228 (270)
T cd05056 161 SY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRIENGERLP--------- 228 (270)
T ss_pred cc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCcCC---------
Confidence 21 11222334568999999888889999999999999999996 99999764222 1111111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
.+..++..+.+++.+|+..+|++|||+.++++.|++++.+
T Consensus 229 --------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 229 --------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1123456788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.85 Aligned_cols=258 Identities=19% Similarity=0.283 Sum_probs=203.6
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN 360 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 360 (581)
.+....++|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34455688999999999999999999965 68899999986532 233456788999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..++||||+++|+|.+++.... +++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~~--~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999999999997653 688899999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCccccCCCCCCCC----CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCC
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSEG----NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP 516 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 516 (581)
...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...............++
T Consensus 192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~~~p 269 (370)
T cd05621 192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-VGTYSKIMDHKNSLNFP 269 (370)
T ss_pred cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCcccCCC
Confidence 643221 122345699999999987654 378899999999999999999999975321 11112211111100111
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 008012 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQ--RLYMKDAATK 564 (581)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 564 (581)
.....+..+.+++.+|+..++.+ |+++.|+++|
T Consensus 270 ---------------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 270 ---------------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---------------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11123456778999999865544 8999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=322.81 Aligned_cols=264 Identities=25% Similarity=0.413 Sum_probs=209.1
Q ss_pred hhcCCCcCCeecccccccEEEEEeC--------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeec
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS--------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCN 358 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 358 (581)
..++|.+.+.||+|+||.||+|... ....+|+|.++... ......+.+|+++++++ +||||+++++++.+
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3467889999999999999999742 24579999987543 34456788999999999 69999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeE
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNIL 423 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nil 423 (581)
.+..++||||+++|+|.+++.... ..+++.++..++.|++.||+||| ++|++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEE
Confidence 999999999999999999997532 34688889999999999999999 899999999999999
Q ss_pred ecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCcccccccc
Q 008012 424 LDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMN 502 (581)
Q Consensus 424 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~ 502 (581)
++.++.+||+|||.++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~ 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--EE 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--HH
Confidence 99999999999999986543222111122234567999999988899999999999999999999 8899865321 11
Q ss_pred HHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 503 LKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
....+...... . .+..++.++.+++.+||..+|++|||+.|+++.|+++.....+
T Consensus 245 ~~~~~~~~~~~---~--------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 245 LFKLLREGHRM---D--------------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred HHHHHHcCCCC---C--------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 22222111100 0 0113345688999999999999999999999999998765544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=324.36 Aligned_cols=242 Identities=22% Similarity=0.273 Sum_probs=193.7
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|..+ +|+.||+|+++... .........|..++... +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 78999999997653 23345567788888765 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
|+|.+++.... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence 99999987654 3688899999999999999999 8999999999999999999999999999987532211 1223
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
...|+..|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+.... ..++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~~-~~~~~-------------- 217 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVDT-PHYPR-------------- 217 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC-CCCCC--------------
Confidence 45689999999999999999999999999999999999999975321 11111111111 01111
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCCCHH-HHHHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRLYMK-DAATK 564 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 564 (581)
.++.++.+++.+||+.||++||++. ++++|
T Consensus 218 ---~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 218 ---WITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred ---CCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 1234677999999999999999985 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=330.09 Aligned_cols=263 Identities=24% Similarity=0.349 Sum_probs=208.3
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcC-CCccceEeeeee
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVR-HRNLIKILSSCC 357 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 357 (581)
++...++|.+.+.||+|+||.||+|.+. .+..||+|+++... ....+.+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4455667889999999999999999853 34689999997653 333457889999999997 999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHHhhCC-------------------------------------------------------
Q 008012 358 NTNFKALVLEFMPNGSLDKWLYSHN------------------------------------------------------- 382 (581)
Q Consensus 358 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------- 382 (581)
..+..++||||+++|+|.+++.+.+
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999997432
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 008012 383 ------------------------------------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPS 420 (581)
Q Consensus 383 ------------------------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~ 420 (581)
..+++..++.++.|++.||+||| +.+++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence 12466678889999999999999 899999999999
Q ss_pred CeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccc
Q 008012 421 NILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTG 499 (581)
Q Consensus 421 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~ 499 (581)
||++++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986533222122223356788999999988889999999999999999998 88998653221
Q ss_pred cccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 500 EMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
+ .....+........ +..++.++.+++.+||..+|++||+++|+++.|+++.
T Consensus 349 ~-~~~~~~~~~~~~~~-----------------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 E-QFYNAIKRGYRMAK-----------------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H-HHHHHHHcCCCCCC-----------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 11111111111100 1123457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=311.85 Aligned_cols=250 Identities=30% Similarity=0.473 Sum_probs=207.2
Q ss_pred hcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
.++|++.+.||.|++|.||+|... |+.||+|.++.... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 467899999999999999999976 78999999987654 4567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 370 PNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 370 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
++++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999998654 35799999999999999999999 89999999999999999999999999999986532211
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
....+..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+........
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~------------ 220 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHVEKGYRMEA------------ 220 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhcCCCCCC------------
Confidence 2234567999999988899999999999999999997 9999865321 112222211111100
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
+..+++.+.+++.+||..+|++|||++|+++.|+.+
T Consensus 221 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 -----PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -----ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 112356788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=314.07 Aligned_cols=257 Identities=30% Similarity=0.481 Sum_probs=207.5
Q ss_pred hcCCCcCCeecccccccEEEEEeC-C---CcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-D---GTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
.++|++.+.||+|+||.||+|... + +..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357888999999999999999853 2 3479999887543 3445678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+++++|.+++......+++.+++.++.|++.|++||| +.+++||||||+||+++.++.++|+|||++..+...
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999877666799999999999999999999 899999999999999999999999999999876443
Q ss_pred CCccee-eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 445 DDSVIQ-TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 445 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
...... ....++..|+|||.+.+..++.++||||||+++||+++ |..||...... .....+.+... .+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~~--~~------ 229 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGYR--LP------ 229 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCCc--CC------
Confidence 221111 11223567999999998899999999999999999887 99998763221 12222221111 00
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
....++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 230 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 ---------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0113455688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=325.59 Aligned_cols=247 Identities=23% Similarity=0.274 Sum_probs=198.8
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEE
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999965 67899999997653 23344567788888887 6899999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++|+|.+++...+. +++..+..++.||+.||+||| +.||+||||||+||++++++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred cCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 99999999999876544 788999999999999999999 8999999999999999999999999999997543221
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.......|++.|+|||++.+..++.++|||||||++|||+||+.||..... ......+..... .++
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~~~~~-~~p---------- 221 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIMEHNV-AYP---------- 221 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC-CCC----------
Confidence 122345689999999999999999999999999999999999999976322 112222211110 011
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCH-----HHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYM-----KDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 564 (581)
...+.++.+++.+|++.||++|++. .++.+|
T Consensus 222 -------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 222 -------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -------CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 1234567899999999999999985 566554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=311.88 Aligned_cols=248 Identities=26% Similarity=0.454 Sum_probs=198.3
Q ss_pred eecccccccEEEEEeC---CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCC
Q 008012 298 LLGSGGFGSVYKGILS---DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGS 373 (581)
Q Consensus 298 ~lg~G~~~~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 373 (581)
.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 45679999987653 334467899999999999999999999875 456899999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce-eec
Q 008012 374 LDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI-QTM 452 (581)
Q Consensus 374 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~ 452 (581)
|.+++......+++..++.++.|++.||+||| ++|++||||||+||+++.++.+||+|||.+........... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999876666899999999999999999999 89999999999999999999999999999986543322111 111
Q ss_pred cccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 453 TIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 453 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
..++..|+|||.+.+..++.++|||||||++||+++ |..||...... .....+........
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~---------------- 219 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQGKRLDC---------------- 219 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCCCCCC----------------
Confidence 223568999999888889999999999999999996 99999764221 12222221111111
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
+..+++++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 220 -~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 -PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 113456788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=319.00 Aligned_cols=266 Identities=23% Similarity=0.410 Sum_probs=204.5
Q ss_pred cCC-CcCCeecccccccEEEEEe-----CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecC--Ce
Q 008012 291 DGF-NECNLLGSGGFGSVYKGIL-----SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT--NF 361 (581)
Q Consensus 291 ~~y-~~~~~lg~G~~~~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 361 (581)
++| .+.+.||+|+||+||++.. .++..||+|+++... ......+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 8889999999999988652 367889999987653 33456788999999999999999999987653 46
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
.++||||+++++|.+++.... +++..++.++.|++.||.||| +.+|+||||||+||++++++.++|+|||++...
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 889999999999999997653 799999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCcc-eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC----CCC
Q 008012 442 GEGDDSV-IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH----GLP 516 (581)
Q Consensus 442 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~----~~~ 516 (581)
....... ......++..|+|||...+..++.++||||||+++|||+||..||...... +.......... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhcccccccchhhhh
Confidence 4332211 112234566799999998889999999999999999999999998653221 11111000000 000
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
...+... ..+.+..++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 235 ~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGM-----RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCC-----CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000000 01112345678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=314.34 Aligned_cols=257 Identities=28% Similarity=0.498 Sum_probs=207.3
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CC---cEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DG---TTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
.++|+..+.||+|+||.||+|..+ ++ ..+++|.++... ....+.+.+|++++++++|||++++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999965 33 379999987552 3445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+++++|.+++......+++..+..++.|++.|++||| +.|++||||||+||++++++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999876666899999999999999999999 899999999999999999999999999999866432
Q ss_pred CCccee-eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 445 DDSVIQ-TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 445 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
...... .....+..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+.... ..+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~i~~~~--~~~------ 230 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAINDGF--RLP------ 230 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhcCC--CCC------
Confidence 221111 11223457999999988889999999999999999998 9999865322 11222221111 111
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
...+++.++.+++.+||..+|++||++.+|++.|+++
T Consensus 231 ---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 ---------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1113456688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=314.43 Aligned_cols=255 Identities=24% Similarity=0.406 Sum_probs=206.2
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
...++|++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++||||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 44678999999999999999999988889999999876543 2357889999999999999999999874 456899999
Q ss_pred ccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 368 FMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|+++++|.+++... +..+++..+..++.|++.||+||| +.|++||||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999998753 345788999999999999999999 89999999999999999999999999999987642221
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+........
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~---------- 224 (260)
T cd05067 158 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERGYRMPR---------- 224 (260)
T ss_pred -ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcCCCCCC----------
Confidence 11223345678999999988899999999999999999999 99999753221 12222221111110
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
+..++.++.+++.+||..+|++|||++++.+.|+.
T Consensus 225 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 -------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=325.73 Aligned_cols=261 Identities=27% Similarity=0.416 Sum_probs=204.5
Q ss_pred hhcCCCcCCeecccccccEEEEEe------CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeecC-
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL------SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNT- 359 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~- 359 (581)
..++|++.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 356899999999999999999973 257889999997643 33456788999999999 689999999988654
Q ss_pred CeeeEEEeccCCCCHHHHHhhCC---------------------------------------------------------
Q 008012 360 NFKALVLEFMPNGSLDKWLYSHN--------------------------------------------------------- 382 (581)
Q Consensus 360 ~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------------- 382 (581)
...++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 46789999999999999987431
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeecc
Q 008012 383 ---------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT 453 (581)
Q Consensus 383 ---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 453 (581)
..+++..+..++.|+++||+||| ++||+||||||+||+++.++.+||+|||++...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 13567788899999999999999 899999999999999999999999999999865333222222233
Q ss_pred ccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhH
Q 008012 454 IATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSA 532 (581)
Q Consensus 454 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (581)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .....+........+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~--------------- 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRMRAPD--------------- 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccCCCCCCC---------------
Confidence 45678999999988899999999999999999997 999986532221 1111111111111111
Q ss_pred HHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 533 RMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 533 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
..++++.+++.+||+.||++|||+.|++++|+.+.+
T Consensus 306 --~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 --YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 123457899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=312.02 Aligned_cols=252 Identities=24% Similarity=0.308 Sum_probs=203.1
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-----HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-----EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
++|.+.+.||+|++|.||+|... +++.|++|.+.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999954 78999999886432 2234578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
|+||+++++|.+++...+. +++..+..++.|++.||+||| +.|++||||+|+||+++.++.++|+|||.+......
T Consensus 82 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999999999986543 678889999999999999999 899999999999999999999999999999865432
Q ss_pred CCcce-eeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 445 DDSVI-QTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 445 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
..... .....++..|+|||++.+..++.++||||||+++|||++|+.||..... ...............
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~------ 227 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIATQPTNPQ------ 227 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHHHHhccCCCCC------
Confidence 21111 1234577899999999998899999999999999999999999865311 111111111111000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+..++..+.+++.+||..+|++|||+.|++++
T Consensus 228 --------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 --------LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --------CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011234568899999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=320.12 Aligned_cols=262 Identities=25% Similarity=0.382 Sum_probs=202.5
Q ss_pred hcCCCcCCeecccccccEEEEEeCC---------------CcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSD---------------GTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKIL 353 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~ 353 (581)
.++|++.+.||+|+||.||++.... ...||+|.++... ......+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4679999999999999999987532 2358999987653 34456789999999999999999999
Q ss_pred eeeecCCeeeEEEeccCCCCHHHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCe
Q 008012 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHN-----------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNI 422 (581)
Q Consensus 354 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Ni 422 (581)
+++...+..++||||+++++|.+++.... ...++..++.++.|++.||+||| +.+++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence 99999999999999999999999997532 23578889999999999999999 89999999999999
Q ss_pred EecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh--CCCCCCcccccc
Q 008012 423 LLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT--RKKPTDEMFTGE 500 (581)
Q Consensus 423 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t--g~~Pf~~~~~~~ 500 (581)
++++++.+||+|||++................++..|+|||...++.++.++|||||||++|+|++ |..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~- 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE- 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence 999999999999999976543322222233345678999999988899999999999999999998 66777653221
Q ss_pred ccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 501 MNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
.....+............. .....++..+.+++.+||..||++|||+++|++.|+
T Consensus 240 -~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 -QVIENTGEFFRNQGRQIYL----------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHHhhhhccccccC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111000000000 001123457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=318.14 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=205.9
Q ss_pred hhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 361 (581)
..++|++.+.||+|+||.||+|..+ ++..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 3568899999999999999999864 24689999987553 3445678899999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEE
Q 008012 362 KALVLEFMPNGSLDKWLYSHN---------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHV 432 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl 432 (581)
.++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEE
Confidence 999999999999999997432 23577889999999999999999 899999999999999999999999
Q ss_pred eeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhC
Q 008012 433 SDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESL 511 (581)
Q Consensus 433 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~ 511 (581)
+|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |..||..... ......+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~ 238 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFVIDGG 238 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHHhcCC
Confidence 99999986543332222233456788999999988889999999999999999998 9999865321 12222222111
Q ss_pred CCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 512 PHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
....+ ..++..+.+++.+||..+|++|||+.++++.|+
T Consensus 239 ~~~~~-----------------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 HLDLP-----------------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCC-----------------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11111 123457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=315.76 Aligned_cols=246 Identities=22% Similarity=0.300 Sum_probs=195.1
Q ss_pred ecccccccEEEEEeC-CCcEEEEEEeccchH---HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCH
Q 008012 299 LGSGGFGSVYKGILS-DGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSL 374 (581)
Q Consensus 299 lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 374 (581)
||+|+||.||++..+ +|+.||+|.+..... .....+..|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999965 799999999865321 2233456799999999999999999999999999999999999999
Q ss_pred HHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeecc
Q 008012 375 DKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT 453 (581)
Q Consensus 375 ~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 453 (581)
.+++.... ...++..+..++.|++.||+||| +.||+||||||+||++++++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 99886543 34788899999999999999999 8999999999999999999999999999998764322 22345
Q ss_pred ccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHH
Q 008012 454 IATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSAR 533 (581)
Q Consensus 454 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (581)
.++..|+|||++.+..++.++||||+||++|||++|+.||...... ................. ..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~--------------~~ 219 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDEVKF--------------EH 219 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhcccccc--------------cc
Confidence 6889999999998888999999999999999999999999753221 11122222211111100 00
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 534 MDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 534 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
..++.++.+++.+||+.||++||++.|+++.+
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 12345688999999999999999997665433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=311.48 Aligned_cols=247 Identities=27% Similarity=0.415 Sum_probs=198.0
Q ss_pred eecccccccEEEEEe---CCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCC
Q 008012 298 LLGSGGFGSVYKGIL---SDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNG 372 (581)
Q Consensus 298 ~lg~G~~~~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 372 (581)
.||+|+||.||+|.+ +++..+|+|+++... ....+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999974 367889999986543 334567889999999999999999999875 45678999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce-ee
Q 008012 373 SLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI-QT 451 (581)
Q Consensus 373 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~ 451 (581)
+|.+++.... .+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||.+........... ..
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999997654 4788999999999999999999 89999999999999999999999999999987643332211 11
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFF 530 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (581)
...++..|+|||.+....++.++|||||||++|||++ |+.||..... ......+........
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~~~~~~~--------------- 219 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESGERMEC--------------- 219 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCCCCC---------------
Confidence 2234578999999888889999999999999999998 9999976322 122222222111111
Q ss_pred hHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 531 SARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 531 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
+..++.++.++|.+||+.||++||++++|.+.|+.+
T Consensus 220 --~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 --PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 113456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=330.46 Aligned_cols=264 Identities=25% Similarity=0.283 Sum_probs=204.4
Q ss_pred hhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-C-----CccceEeeeeecCCe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-H-----RNLIKILSSCCNTNF 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~ 361 (581)
...+|++.+.||+|+||.|.+|.+ ++++.||||+++.... ...+-..|+.+|..++ | -|+|+++++|...++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 334899999999999999999995 4899999999987743 3455677999999996 4 389999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC--CCcEEEeeccCc
Q 008012 362 KALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE--NMVAHVSDFGIS 438 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a 438 (581)
.|||+|.+. .+|.++++.+. ..++...+..++.||+.||.+|| +.+|||+||||+|||+.+ ...+|++|||.|
T Consensus 263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 999999994 59999999653 44789999999999999999999 899999999999999974 348999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc-
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK- 517 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~- 517 (581)
+.....- ...+.+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+. .+.+....+.+......+.
T Consensus 339 c~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~--ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 339 CFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD--NEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC--CHHHHHHHHHHHhCCCCHHH
Confidence 9764332 2557789999999999999999999999999999999998888763 2222233333222111000
Q ss_pred ---------cccc----------cc-----------------hhh--hh-hh----hHHH-HHHHHHHHHHHhccCcCCC
Q 008012 518 ---------IADA----------NL-----------------LRE--EN-FF----SARM-DCLLSIFHLALDCCAELPD 553 (581)
Q Consensus 518 ---------~~~~----------~~-----------------~~~--~~-~~----~~~~-~~~~~l~~li~~cl~~dP~ 553 (581)
.++. .. ... .+ .. .... .....+.+++++||.+||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 1111 00 000 00 00 0001 2235688999999999999
Q ss_pred CCCCHHHHHHH
Q 008012 554 QRLYMKDAATK 564 (581)
Q Consensus 554 ~Rps~~evl~~ 564 (581)
+|+|+.|+++|
T Consensus 492 ~R~tp~qal~H 502 (586)
T KOG0667|consen 492 ERITPAQALNH 502 (586)
T ss_pred hcCCHHHHhcC
Confidence 99999999987
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=312.91 Aligned_cols=248 Identities=31% Similarity=0.507 Sum_probs=205.2
Q ss_pred CeecccccccEEEEEeC-C---CcEEEEEEeccchHH-HHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-D---GTTVAIKIFNLQLEQ-AFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|... . +..|++|.+...... ..+.+.+|++.++.++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999965 3 889999999876433 367889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 372 GSLDKWLYSH--------NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 372 ~~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
++|.+++... ...+++..++.++.|++.||+||| +.+++||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999876 466899999999999999999999 89999999999999999999999999999987754
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
...........++..|+|||...+..++.++||||+|+++|+|++ |..||.... .......+......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~--------- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--NEEVLEYLRKGYRL--------- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCC---------
Confidence 432222334557889999999888889999999999999999999 699997642 11222222211100
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
..+..++.++.+++.+||..+|++|||+.|++++|+
T Consensus 227 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 --------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111233567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=316.03 Aligned_cols=260 Identities=23% Similarity=0.394 Sum_probs=205.3
Q ss_pred CCCcCCeecccccccEEEEEe-----CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecC--Ceee
Q 008012 292 GFNECNLLGSGGFGSVYKGIL-----SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT--NFKA 363 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 363 (581)
-|++++.||+|+||.||++.. .++..||+|.++... ......+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 468889999999999999973 257889999987553 34456789999999999999999999998775 5688
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+++++|.+++.+....+++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+|||++..+..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999999876656799999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCcc-eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccc----------cccHHHHHHhhCC
Q 008012 444 GDDSV-IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG----------EMNLKNWVKESLP 512 (581)
Q Consensus 444 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~----------~~~~~~~~~~~~~ 512 (581)
..... ......++..|+|||++.+..++.++||||||+++|||++++.|+...... +......+.....
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 32211 122345677899999988888999999999999999999988765332110 0011111110000
Q ss_pred CCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 513 HGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
. ...+....++..+.+++.+||+.+|++|||++++++.++++
T Consensus 242 ~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 242 G--------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred C--------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0 00011123566799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=314.30 Aligned_cols=258 Identities=25% Similarity=0.432 Sum_probs=208.8
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCc----EEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGT----TVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.++|++.+.||+|+||.||+|..+ +|+ .+|+|.+.... ......+.+|+..+++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 367888999999999999999854 333 58999887654 3445678899999999999999999999887 7889
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+++|+|.+++......+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||.+.....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999887666899999999999999999999 89999999999999999999999999999987653
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
...........++..|+|||......++.++||||||+++||+++ |+.||..... ......+........+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~------ 233 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLEKGERLPQP------ 233 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhCCCCCCCC------
Confidence 332222222234568999999888899999999999999999999 9999976422 1222222221111111
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
..++..+.+++.+||..||++||++.++++.|+++.+
T Consensus 234 -----------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 234 -----------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -----------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1123457799999999999999999999999998855
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=348.84 Aligned_cols=261 Identities=21% Similarity=0.302 Sum_probs=206.0
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.++||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999965 68999999987542 334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeecc
Q 008012 367 EFMPNGSLDKWLYSH----------NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 367 e~~~~~~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
||++|++|.+++... ....++..++.++.||++||+||| +.||+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998742 123456778899999999999999 8999999999999999999999999999
Q ss_pred CceecCCCCC----------------cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc
Q 008012 437 ISKLLGEGDD----------------SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500 (581)
Q Consensus 437 ~a~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~ 500 (581)
++........ ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 001122468999999999999999999999999999999999999997532111
Q ss_pred ccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-CHHHHHHHHHHhHHH
Q 008012 501 MNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRL-YMKDAATKLKKIRDK 571 (581)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~~~~~ 571 (581)
... ...... + .......++++.+.+++.+|+..||++|| +++++++.|+.....
T Consensus 239 i~~----~~~i~~-------P------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISY----RDVILS-------P------IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhh----hhhccC-------h------hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 100 000000 0 00011124556788999999999999996 667777778776553
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=322.10 Aligned_cols=242 Identities=25% Similarity=0.335 Sum_probs=193.7
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|... +++.||+|+++... .........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 68899999997653 23345566788888765 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
|+|.+++.... .+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence 99999998653 3688899999999999999999 89999999999999999999999999999875422211 223
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
...|+..|+|||++.+..++.++||||+||++|||++|+.||..... ......+....+ .++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i~~~~~-~~~~-------------- 217 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSIRMDNP-CYPR-------------- 217 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC-CCCc--------------
Confidence 45689999999999998999999999999999999999999976321 111111111110 1111
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCCCHH-HHHHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRLYMK-DAATK 564 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 564 (581)
.++.++.+++.+||+.||++||++. ++.++
T Consensus 218 ---~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 218 ---WLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred ---cCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 1234577999999999999999997 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=323.38 Aligned_cols=242 Identities=23% Similarity=0.280 Sum_probs=196.5
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|..+ +++.||+|+++... ......+.+|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 68899999998653 23445677899999888 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
++|.+++.+.+ .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++........ ...
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS 154 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence 99999988664 4789999999999999999999 89999999999999999999999999999875322111 123
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
...|+..|+|||++.+..++.++|||||||++|+|++|+.||..... ......+..... ..+
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~~~i~~~~~-~~~--------------- 216 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQSILEDEV-RYP--------------- 216 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHHHHHHcCCC-CCC---------------
Confidence 34689999999999999999999999999999999999999975321 111111111100 011
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCCCH-----HHHHHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRLYM-----KDAATK 564 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 564 (581)
..++..+.++|.+||..||++|||+ .+++++
T Consensus 217 --~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 --RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred --CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1234567899999999999999999 888775
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=320.22 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=205.9
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
...+|++.+.||+|++|.||+|... +++.|++|.+........+.+.+|+.+++.++||||+++++.+......++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 4468999999999999999999954 789999999877655555778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++++|.+++... .+++.++..++.|++.||+||| +.||+||||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred ccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 99999999998754 3688899999999999999999 89999999999999999999999999999876533221
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .+.. ......+...
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~-~~~~~~~~~~-------- 237 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYL-IATNGTPELQ-------- 237 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHH-HhcCCCCCCC--------
Confidence 1223468889999999988889999999999999999999999997532211 1111 1111111100
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+...+..+.+++.+||..+|++|||+.|++++
T Consensus 238 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 ----NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ----CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 012344568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=308.87 Aligned_cols=247 Identities=30% Similarity=0.477 Sum_probs=200.2
Q ss_pred CeecccccccEEEEEeCCCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCHH
Q 008012 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLD 375 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 375 (581)
+.||+|+||.||+|...++..+|+|.++... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998788999999987653 333457889999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeecccc
Q 008012 376 KWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA 455 (581)
Q Consensus 376 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 455 (581)
+++......+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++........ .......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 999876666789999999999999999999 89999999999999999999999999999875432211 11112234
Q ss_pred CccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHH
Q 008012 456 TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARM 534 (581)
Q Consensus 456 ~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (581)
+..|+|||+..+..++.++||||||+++|++++ |..||...... .....+........ +.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~-----------------~~ 217 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEKGYRMSC-----------------PQ 217 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCCCCC-----------------CC
Confidence 567999999998899999999999999999998 99998753221 11111111111000 11
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 535 DCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 535 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
.++..+.+++.+||..+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=309.90 Aligned_cols=248 Identities=33% Similarity=0.516 Sum_probs=201.7
Q ss_pred CeecccccccEEEEEeCCCcEEEEEEeccchH-HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCHH
Q 008012 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQLE-QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLD 375 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 375 (581)
++||+|++|.||+|...+++.|++|.+..... .....+.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999976699999999876543 35567899999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeecccc
Q 008012 376 KWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA 455 (581)
Q Consensus 376 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 455 (581)
+++.......++..+..++.+++.|++||| +.+++||||+|+||+++.++.++|+|||.+.................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999876656788999999999999999999 89999999999999999999999999999986542221111122234
Q ss_pred CccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHH
Q 008012 456 TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARM 534 (581)
Q Consensus 456 ~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (581)
+..|+|||.+.++.++.++||||||+++|||+| |..||..... ......+....... .+.
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~~~~~~~~~-----------------~~~ 218 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRERIESGYRMP-----------------APQ 218 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHHHhcCCCCC-----------------CCc
Confidence 567999999988899999999999999999999 8888865322 11222221111100 111
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 535 DCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 535 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
.++..+.+++.+||..+|++|||+.|+++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 33457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=312.71 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=208.3
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
.++|++.+.||+|++|.||+|... +++.+++|++........+.+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367899999999999999999964 6789999999877655667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|.+++......+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 9999999999877556889999999999999999999 89999999999999999999999999999876543211
Q ss_pred eeeccccCccccCCCCCCCC---CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 449 IQTMTIATIGYMAPEFGSEG---NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
......++..|+|||...+. .++.++||||||+++|+|++|+.||........ ........... ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~~~~~-------~~--- 225 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKSNFPP-------PK--- 225 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCCC-------cc---
Confidence 12334678899999998776 889999999999999999999999976322111 11111110000 00
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.......+.++.+++.+||..+|++|||+++++.+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 ----LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ----ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01112345678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=311.59 Aligned_cols=249 Identities=28% Similarity=0.406 Sum_probs=201.8
Q ss_pred hcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeee-cCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC-NTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~ 368 (581)
..+|.+.+.||+|+||.||++... |..|++|.++.... .+.+.+|+.++++++|++++++++++. ..+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 357899999999999999999875 78899999875532 357889999999999999999999764 45678999999
Q ss_pred cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 369 MPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 369 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
+++++|.+++.+.. ..+++..++.++.|++.||+||| +.|++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999998654 34788999999999999999999 8999999999999999999999999999988653222
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
....++..|+|||+..+..++.++|||||||++|+|++ |+.||.... .......+........
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~~~----------- 220 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGYKMDA----------- 220 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCCCCCC-----------
Confidence 12234568999999988899999999999999999998 999986521 1112222211111110
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
...++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 221 ------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 ------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 113456788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=318.98 Aligned_cols=261 Identities=28% Similarity=0.437 Sum_probs=204.9
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCc--EEEEEEeccc-hHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGT--TVAIKIFNLQ-LEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 364 (581)
.++|++.+.||+|+||.||+|.++ ++. .+++|.++.. .......+.+|++++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357889999999999999999964 454 4577776543 234456788999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc
Q 008012 365 VLEFMPNGSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV 429 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~ 429 (581)
||||+++++|.+++...+ ..+++.+++.++.|++.|++||| ++|++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 999999999999997542 24688899999999999999999 899999999999999999999
Q ss_pred EEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 008012 430 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVK 508 (581)
Q Consensus 430 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~ 508 (581)
+||+|||++...... .......++..|+|||.+.+..++.++|||||||++|||+| |..||...... +...
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~ 234 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYE 234 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----HHHH
Confidence 999999998642111 11112234567999999888889999999999999999998 99998653211 1111
Q ss_pred hhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHhh
Q 008012 509 ESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLED 575 (581)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 575 (581)
.. +..... ..+..++..+.+++.+||+.+|++||+++++++.|+++...-.+.
T Consensus 235 ~~-~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 235 KL-PQGYRL-------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred HH-hcCCcC-------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 11 111000 001123456789999999999999999999999999887655433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.75 Aligned_cols=253 Identities=24% Similarity=0.324 Sum_probs=205.7
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
.+.|++.+.||+|+||.||+|... +++.+++|.+........+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467999999999999999999965 6899999999877766778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|..++.+....+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||.+....... .
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~ 165 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--Q 165 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--c
Confidence 9999999988766666899999999999999999999 8999999999999999999999999999987543221 1
Q ss_pred eeeccccCccccCCCCCC-----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 449 IQTMTIATIGYMAPEFGS-----EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
......++..|+|||++. ...++.++|||||||++|||++|+.||..... ............+....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~--- 237 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSEPPTLSQ--- 237 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHHHhcCCCccCCC---
Confidence 123345788999999874 34578899999999999999999999865321 11111111111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...++.++.+++.+||..+|++||+++|++++
T Consensus 238 ---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 238 ---------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ---------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11234467899999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=318.73 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=206.3
Q ss_pred hcCCCcCCeecccccccEEEEEeCC-----------------CcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccce
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSD-----------------GTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIK 351 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~ 351 (581)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4679999999999999999988542 2458999987653 345567899999999999999999
Q ss_pred EeeeeecCCeeeEEEeccCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 008012 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHN----------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSN 421 (581)
Q Consensus 352 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~N 421 (581)
+++++...+..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 9999999999999999999999999997654 25789999999999999999999 8999999999999
Q ss_pred eEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh--CCCCCCccccc
Q 008012 422 ILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT--RKKPTDEMFTG 499 (581)
Q Consensus 422 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t--g~~Pf~~~~~~ 499 (581)
|+++.++.++|+|||.+................++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986543332223334456778999999888889999999999999999998 67787653211
Q ss_pred cccHHHHHHhhCCC-CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 500 EMNLKNWVKESLPH-GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 500 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
. ........... ...... ..+..++.++.+++.+||+.||++|||+.|+++.|+
T Consensus 241 ~--~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q--VIENAGHFFRDDGRQIYL-----------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H--HHHHHHhccccccccccC-----------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 11111111000 000000 011124467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=311.84 Aligned_cols=257 Identities=26% Similarity=0.331 Sum_probs=203.5
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
++...+.+.....||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445566666679999999999999954 688899999887766666789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-CCcEEEeeccCceec
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQ--DIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE-NMVAHVSDFGISKLL 441 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~--~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~ 441 (581)
|+||+++++|.+++....... ++..+..++.||+.||+||| +.||+||||||+||+++. ++.++|+|||.+...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999998654434 77888899999999999999 899999999999999976 679999999998765
Q ss_pred CCCCCcceeeccccCccccCCCCCCCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSEG--NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
..... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||............ .. .....+.
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~--~~-~~~~~~~-- 232 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK--VG-MFKIHPE-- 232 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh--hh-hhccCCC--
Confidence 43221 12233578899999987654 3788999999999999999999998753221111100 00 0000000
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+..+++++.+++.+||+.+|++|||+.|++++
T Consensus 233 ------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 233 ------------IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------------CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 011234568899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=311.81 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=203.4
Q ss_pred hcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
.++|++.+.||+|++|.||+|..+++..+|+|.+..... ..+.+.+|++++++++|||++++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 467889999999999999999987777899998765432 2356888999999999999999999875 45678999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 370 PNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 370 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
++++|.+++... ...+++..+..++.|++.||+||| +.|++|+||||+||++++++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 999999999764 344788999999999999999999 899999999999999999999999999999876432211
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
......++..|+|||...+..++.++||||||+++|+|++ |+.||...... .....+.......
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~------------- 223 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERGYRMP------------- 223 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCC-------------
Confidence 1122345678999999988899999999999999999999 89998764222 1112221111110
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
.+...+..+.+++.+||..||++||+++++++.|++
T Consensus 224 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 ----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=313.40 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=207.9
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
...++|++.+.||+|++|.||+|..++++.||+|.+..... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 45678999999999999999999988788999999875432 23568899999999999999999999998889999999
Q ss_pred ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 368 FMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|+++++|.+++.+.. ..+++..+..++.|++.|++||| +.+++|+||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999998653 45789999999999999999999 88999999999999999999999999999987643211
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
........+..|+|||.+.+..++.++||||+|+++|+|++ |+.||...... .....+........
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~~---------- 225 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQVERGYRMPR---------- 225 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCC----------
Confidence 11122234568999999998899999999999999999999 99998653211 11111111111110
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
+..++.++.+++.+||..+|++||+++++.+.|+.
T Consensus 226 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 -------PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11224568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=328.45 Aligned_cols=266 Identities=20% Similarity=0.201 Sum_probs=199.1
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC----
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN---- 360 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 360 (581)
...++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34688999999999999999999964 7899999998654 2334456789999999999999999999986543
Q ss_pred --eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 361 --FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 361 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999965 67666643 2678889999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
...... .......+++.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+..... .........
T Consensus 171 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~-~~~~~~~~~-~~~~~~~~~ 245 (359)
T cd07876 171 RTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH-IDQWNKVIE-QLGTPSAEF 245 (359)
T ss_pred cccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH-hcCCCcHHH
Confidence 754322 122344688999999999999999999999999999999999999976321 111111111 110000000
Q ss_pred ccc------------------cchhhh------hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 519 ADA------------------NLLREE------NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 519 ~~~------------------~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
.+. ...... .........+..+.+++.+||..||++|||++|+++|-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000 000000 00000112345688999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=310.36 Aligned_cols=249 Identities=21% Similarity=0.284 Sum_probs=203.4
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
+|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++||||+++++.+.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999965 7899999998643 2344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 370 PNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 370 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
++++|.+++... ...+++..++.++.|++.||.||| +.|++|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 999999998753 445788999999999999999999 89999999999999999999999999999986643221
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
......++..|+|||++.+..++.++|+||||+++|+|++|+.||.... ................
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~---------- 220 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKVCQGSYKPL---------- 220 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHHhcCCCCCC----------
Confidence 1233468889999999998899999999999999999999999997531 1111111111111110
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+..++..+.+++.+||+.||++|||+.+++..
T Consensus 221 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ----PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01234457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=316.16 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=202.3
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCC
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677789999999999999965 6788999998776666667889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
++|..++.+....+++..+..++.|+++||+||| +.|++||||||+||+++.++.+||+|||++....... ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence 9999988765566899999999999999999999 8999999999999999999999999999987653221 1123
Q ss_pred ccccCccccCCCCCC-----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 452 MTIATIGYMAPEFGS-----EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
...++..|+|||++. +..++.++|||||||++|+|++|++||....... ........ .. +...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~-~~---~~~~------- 229 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKS-EP---PTLA------- 229 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhc-CC---CCCC-------
Confidence 346888999999873 4567889999999999999999999987632111 11111111 10 0000
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+..++.++.++|.+||+.||++||++.+++++
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 -----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011234568899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=330.88 Aligned_cols=265 Identities=22% Similarity=0.281 Sum_probs=199.9
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC-----eee
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN-----FKA 363 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 363 (581)
+|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999964 7999999998653 2334467889999999999999999999998776 789
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+. ++|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 58888876544 4788999999999999999999 89999999999999999999999999999986543
Q ss_pred CCCcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
... .......++..|+|||++.+. .++.++||||+||++|||++|+.||...... .....+...............
T Consensus 156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 156 DES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred Ccc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCCHHHHHHh
Confidence 221 122334678899999988764 5789999999999999999999999763221 111111111111100000000
Q ss_pred -------chh-------hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 523 -------LLR-------EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 523 -------~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+.. ...........++++.+++.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 000000111235678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=317.16 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=205.1
Q ss_pred hcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999853 46789999987653 34456788999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 008012 363 ALVLEFMPNGSLDKWLYSHN---------------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSN 421 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~N 421 (581)
++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 99999999999999997432 23577888999999999999999 8999999999999
Q ss_pred eEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCcccccc
Q 008012 422 ILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGE 500 (581)
Q Consensus 422 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~ 500 (581)
|++++++.++|+|||.+.................+..|+|||...+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999876543322111222344677999999888899999999999999999998 8888865322
Q ss_pred ccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 501 MNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
.+............ .+..++.++.+++.+||+.||++|||+.|+++.|++
T Consensus 239 ---~~~~~~~~~~~~~~--------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ---EEVIYYVRDGNVLS--------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HHHHHHHhcCCCCC--------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 12222111111110 011245678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=323.60 Aligned_cols=254 Identities=23% Similarity=0.277 Sum_probs=200.1
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|..+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999965 78999999997532 233456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++|+|.+++.+....+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999876666889999999999999999999 89999999999999999999999999999976543222
Q ss_pred cceeeccccCccccCCCCCCC-----CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC-CCcccc
Q 008012 447 SVIQTMTIATIGYMAPEFGSE-----GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG-LPKIAD 520 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 520 (581)
.......|++.|+|||++.. ..++.++|||||||++|+|++|+.||..... .+......... ...+.
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~~~~- 230 (331)
T cd05597 158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKEHFQFP- 230 (331)
T ss_pred -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCCcccCC-
Confidence 11223468999999998763 4578899999999999999999999975321 11111111100 00000
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCC--CCCCHHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPD--QRLYMKDAATK 564 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~Rps~~evl~~ 564 (581)
.....++..+.+++.+|+..+++ .||++.++++|
T Consensus 231 ----------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 231 ----------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ----------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00112455678899998865443 38899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=315.52 Aligned_cols=253 Identities=26% Similarity=0.356 Sum_probs=207.2
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
.++|++.+.||.|++|.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999964 7899999999877666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|.+++.+.+..+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 9999999999877667899999999999999999999 89999999999999999999999999998875532221
Q ss_pred eeeccccCccccCCCCCC-----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 449 IQTMTIATIGYMAPEFGS-----EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
......++..|+|||.+. ...++.++||||||+++|+|++|+.||...... ..... ......+..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~----~~~~~~~~~----- 228 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLK----ILKSEPPTL----- 228 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHH----HhcCCCCCc-----
Confidence 223346888999999864 345778999999999999999999999763211 11111 111111110
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+..++..+.+++.+||+.+|++||++.+++++
T Consensus 229 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 -------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0112344568899999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=320.67 Aligned_cols=267 Identities=19% Similarity=0.267 Sum_probs=204.1
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.++|++.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 367999999999999999999965 78999999986543 2223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|++ ++|.+++......+++..+..++.|++.||+||| +.||+|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 997 5999999876666889999999999999999999 89999999999999999999999999999976432221
Q ss_pred ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC----CCcccccc
Q 008012 448 VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG----LPKIADAN 522 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 522 (581)
......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...... .....+....... .+...+..
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhccc
Confidence 1223456889999998765 45788999999999999999999999753221 1111111111111 11111100
Q ss_pred chhh--hh------hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 523 LLRE--EN------FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 523 ~~~~--~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.... .+ .......+++.+.++|.+|++.||.+|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 00 001122356678899999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=322.76 Aligned_cols=237 Identities=26% Similarity=0.295 Sum_probs=188.8
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHH-HHHhcCCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECE-VLRNVRHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999965 79999999997643 222334445544 56778999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
|+|.+++.... .+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS 154 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence 99999998654 4788899999999999999999 8999999999999999999999999999987532211 1223
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
...|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+...........
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~--------------- 214 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNILNKPLR--------------- 214 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcCCCC---------------
Confidence 4468999999999999999999999999999999999999997531 11222221111100
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCCCHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRLYMK 559 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ 559 (581)
.....+..+.+++.+||+.||++||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0012245678999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.07 Aligned_cols=264 Identities=25% Similarity=0.395 Sum_probs=208.6
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC--------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS--------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCC 357 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 357 (581)
....+|++.+.||+|+||.||+|... ++..||+|.++... ....+.+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 33457899999999999999999742 12368999887543 34456788999999999 8999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCe
Q 008012 358 NTNFKALVLEFMPNGSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNI 422 (581)
Q Consensus 358 ~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Ni 422 (581)
..+..+++|||+++|+|.+++.+.. ..+++.++..++.|++.||+||| ++|++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceE
Confidence 9999999999999999999997532 23677888999999999999999 89999999999999
Q ss_pred EecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccc
Q 008012 423 LLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEM 501 (581)
Q Consensus 423 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~ 501 (581)
+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... .
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~ 243 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--E 243 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--H
Confidence 999999999999999987643322222222334567999999999999999999999999999998 8888865321 1
Q ss_pred cHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 502 NLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
.....+........ +..++..+.+++.+||+.+|++|||+.|++++|+++.....
T Consensus 244 ~~~~~~~~~~~~~~-----------------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 244 ELFKLLKEGHRMDK-----------------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHHHHHcCCCCCC-----------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 11111111111000 11234568899999999999999999999999999985443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=317.32 Aligned_cols=263 Identities=24% Similarity=0.392 Sum_probs=203.3
Q ss_pred hcCCCcCCeecccccccEEEEEeC-----------------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccce
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-----------------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIK 351 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~ 351 (581)
.++|++.+.||+|+||.||++... ++..||+|++.... ......+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998532 24468999987653 344567899999999999999999
Q ss_pred EeeeeecCCeeeEEEeccCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 008012 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHN----------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSN 421 (581)
Q Consensus 352 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~N 421 (581)
+++++...+..++||||+++++|.+++.... ..+++.++..++.|++.||+||| +.|++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence 9999999999999999999999999998642 23567789999999999999999 8999999999999
Q ss_pred eEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh--CCCCCCccccc
Q 008012 422 ILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT--RKKPTDEMFTG 499 (581)
Q Consensus 422 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t--g~~Pf~~~~~~ 499 (581)
|++++++.++|+|||++..+.............++..|+|||...++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999986543322222223344678999998888889999999999999999998 77888653221
Q ss_pred cccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 500 EMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
+ ................ ..+.+..++..+.+++.+||+.||++||++.||.+.|++
T Consensus 241 ~--~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 Q--VIENTGEFFRDQGRQV----------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H--HHHHHHHHHhhccccc----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1111111000000000 001112345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=314.38 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=203.2
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
.++|++.+.||+|+||.||+|... +++.||+|+++.........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999954 7899999998876555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|.+++...+ .+++.+++.++.|++.|+.||| +.|++|+||||+||+++.++.++|+|||.+....... .
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06645 88 CGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--A 161 (267)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--c
Confidence 99999999987655 4788999999999999999999 8899999999999999999999999999987653221 1
Q ss_pred eeeccccCccccCCCCCC---CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 449 IQTMTIATIGYMAPEFGS---EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
......|+..|+|||++. ...++.++|||||||++|+|++|+.||........ .......... .+...+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~--~~~~~~----- 233 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNFQ--PPKLKD----- 233 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCCC--CCcccc-----
Confidence 223446889999999864 45688999999999999999999999865322111 1111111000 000000
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...++..+.+++.+||..+|++|||+++++++
T Consensus 234 -------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 -------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -------cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 01234457899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=312.48 Aligned_cols=250 Identities=24% Similarity=0.302 Sum_probs=200.5
Q ss_pred cCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 291 DGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
++|++.+.||+|+||.||+|.. .+++.||+|++... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4688899999999999999995 47899999998655 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|..+. ..++..+..++.|++.||+||| +.||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 9999997652 3577888999999999999999 8999999999999999999999999999998654322
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccccc--HHHHHHhhCCCCCCccccccchhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMN--LKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||......... .............+..
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 220 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL-------- 220 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC--------
Confidence 23346889999999999889999999999999999999999999764322211 1111111100000000
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
.....+.++.+++.+||+.+|++||+++|++++-
T Consensus 221 -----~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 221 -----PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred -----CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 0012334678999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=317.59 Aligned_cols=267 Identities=23% Similarity=0.272 Sum_probs=205.4
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999965 78889999987553 33456688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|.+++...+ .+++..+..++.|+++||.|||+ ..+++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 99999999998664 46889999999999999999993 2689999999999999999999999999987553221
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc-c---------
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK-I--------- 518 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~--------- 518 (581)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ......+........... .
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCC
Confidence 233467899999999988889999999999999999999999986532 112222211110000000 0
Q ss_pred ccccc------h----hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 519 ADANL------L----REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 519 ~~~~~------~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
.+... . ...........++.++.+++.+||..+|++|||+.|++++--
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000 0 000000001124567899999999999999999999999843
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=309.92 Aligned_cols=255 Identities=23% Similarity=0.425 Sum_probs=206.6
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
...++|++.+.||+|+||.||+|...++..+++|.+.... ...+.+.+|++++++++|+||+++++++.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4567899999999999999999997777889999887543 234678899999999999999999999887 77899999
Q ss_pred ccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 368 FMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|+++++|.+++.+. ....++..+..++.|++.||+||| +.|++|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999864 345688899999999999999999 88999999999999999999999999999986643221
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
.......++..|+|||++.+..++.++|+|||||++|++++ |+.||..... ......+.......
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~~----------- 223 (260)
T cd05073 158 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYRMP----------- 223 (260)
T ss_pred -ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCCCC-----------
Confidence 11222345677999999988889999999999999999999 9999875321 12222222211110
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
.....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 224 ------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=335.36 Aligned_cols=264 Identities=23% Similarity=0.269 Sum_probs=194.7
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecC--------
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT-------- 359 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-------- 359 (581)
...+|++.+.||+|+||.||+|... +++.||+|.+..... ...+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999964 789999998865432 335799999999999999999876432
Q ss_pred CeeeEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC-cEEEeec
Q 008012 360 NFKALVLEFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM-VAHVSDF 435 (581)
Q Consensus 360 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Df 435 (581)
...++||||+++ ++.+++.. ....+++..++.++.||+.||+||| ++||+||||||+||+++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999975 77777653 3455789999999999999999999 89999999999999998654 7999999
Q ss_pred cCceecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC
Q 008012 436 GISKLLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG 514 (581)
Q Consensus 436 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 514 (581)
|+|+.+..... .....|++.|+|||++.+ ..++.++|||||||++|||++|.+||...... ..+...+...-...
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCC
Confidence 99986643222 223467999999998765 46899999999999999999999999764221 12222221110000
Q ss_pred ----------CCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 515 ----------LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 515 ----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+.-+......-....+...+.++.+||.+||..||++|||+.|+++|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000000000000000112345678899999999999999999999977
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=330.66 Aligned_cols=266 Identities=19% Similarity=0.200 Sum_probs=203.2
Q ss_pred hhcCCCcCCeecccccccEEEEEeC---CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS---DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
...+|++.+.||+|+||.||++... .+..|++|.+.... ...+|++++++++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3467999999999999999999743 46789999886542 345799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
||++. ++|.+++... ..+++..++.++.||+.||.||| +.||+||||||+||+++.++.++|+|||++.......
T Consensus 165 ~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 165 MPKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred ehhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 99995 5898888543 45799999999999999999999 8999999999999999999999999999998765443
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--ccHHHHHHhhCCC--CCCccccc
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE--MNLKNWVKESLPH--GLPKIADA 521 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~~--~~~~~~~~ 521 (581)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+...+...... .++.....
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 3333345578999999999999999999999999999999999999997643221 1122222111100 01100000
Q ss_pred cchhhh-------------hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 NLLREE-------------NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ~~~~~~-------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+.... +........+.++.++|.+||..||++|||+.|++.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 0000011234568899999999999999999999987
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=332.40 Aligned_cols=265 Identities=17% Similarity=0.200 Sum_probs=202.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
..+|.+.+.||+|+||.||+|... +++.||+|.... ..+.+|++++++++|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999965 688999996432 2356799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+. ++|.+++......+++..++.++.|++.||.||| ++||+||||||+|||++.++.+||+|||+++.........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 95 6999998876666899999999999999999999 8999999999999999999999999999998764332222
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccc------cccHHHHHHhhCC--CCCCcccc
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG------EMNLKNWVKESLP--HGLPKIAD 520 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~------~~~~~~~~~~~~~--~~~~~~~~ 520 (581)
......||..|+|||++.+..++.++|||||||++|||++|..|+...... ...+...+..... ..++....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 223456899999999999999999999999999999999988765332111 1112222222111 11111111
Q ss_pred ccchhhh--------------hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ANLLREE--------------NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+.... ..+.........+.+||.+||+.||++|||+.|+++|
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1000000 0001111234568899999999999999999999986
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=310.26 Aligned_cols=252 Identities=24% Similarity=0.383 Sum_probs=202.4
Q ss_pred CCCcCCeecccccccEEEEEeCCCcEEEEEEeccch------HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 292 GFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL------EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 588899999999999999998789999999886432 23345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+++++|.+++.+... +++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFGP-LPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 999999999999986543 688899999999999999999 8999999999999999999999999999987653211
Q ss_pred C----cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 446 D----SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 446 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
. ........++..|+|||+..+..++.++||||||+++|+|++|+.||....... .... +... ....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~-~~~~-~~~~~~~--- 230 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFY-IGAH-RGLMPRL--- 230 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHH-hhhc-cCCCCCC---
Confidence 1 111223457889999999999889999999999999999999999997532111 1111 1110 0011111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+..++.++.+++.+||+.+|++||++.|++++
T Consensus 231 -----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 231 -----------PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -----------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11234567899999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=308.46 Aligned_cols=248 Identities=30% Similarity=0.469 Sum_probs=199.1
Q ss_pred CeecccccccEEEEEeC-C---CcEEEEEEeccchH-HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-D---GTTVAIKIFNLQLE-QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
++||+|+||.||+|.+. . +..+|+|.+..... ...+.+.+|+++++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999853 2 36899999876543 34567889999999999999999999876 4567999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce-e
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI-Q 450 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~ 450 (581)
++|.+++.... .+++..+..++.|++.||+||| ..+++|+||||+||+++.++.+||+|||.+........... .
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999998765 4789999999999999999999 88999999999999999999999999999987644332211 1
Q ss_pred eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
....++..|+|||...+..++.++||||||+++|+|++ |..||..... ......+.......
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~--------------- 218 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERLP--------------- 218 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcCC---------------
Confidence 11223467999999998899999999999999999998 9999976422 22223332221111
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
.+..++..+.+++.+||..+|++||++.++++.|+++
T Consensus 219 --~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 --RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1112445788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=310.59 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=207.2
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
++|++.+.||+|++|.||+|... +++.+++|.+..... .+.+.+|++++++++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 67999999999999999999976 588999999876643 578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce
Q 008012 370 PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI 449 (581)
Q Consensus 370 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 449 (581)
++++|.+++......+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 999999999877777899999999999999999999 88999999999999999999999999999987643321 1
Q ss_pred eeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 450 QTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 450 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||........ . ..........
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----~-~~~~~~~~~~------------ 218 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----I-FMIPNKPPPT------------ 218 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----h-hhhccCCCCC------------
Confidence 2334578899999999888999999999999999999999999875322111 0 0000000000
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
......++..+.+++.+||+.||++|||++|++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 01112345568899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=314.88 Aligned_cols=261 Identities=26% Similarity=0.408 Sum_probs=208.8
Q ss_pred cCCCcCCeecccccccEEEEEeC-----CCcEEEEEEeccchHH-HHHHHHHHHHHHHhcCCCccceEeeeeec--CCee
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-----DGTTVAIKIFNLQLEQ-AFRSFNSECEVLRNVRHRNLIKILSSCCN--TNFK 362 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 362 (581)
+.|++.+.||+|+||.||+|.+. ++..+|+|++...... ..+.+.+|+++++++.||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999853 4788999999766443 56789999999999999999999999877 5578
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+++++|.+++......+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999877666899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCcce-eeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccccc----------HHHHHHhhC
Q 008012 443 EGDDSVI-QTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMN----------LKNWVKESL 511 (581)
Q Consensus 443 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~----------~~~~~~~~~ 511 (581)
....... .....++..|+|||...+..++.++||||||+++|||++|+.|+......... ...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 3322211 11234456799999998889999999999999999999999998653222111 111110000
Q ss_pred CCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 512 PHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
. . .....+..++.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 241 ~-~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 E-G-------------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred c-C-------------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0 0 00111223556789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=324.61 Aligned_cols=238 Identities=26% Similarity=0.303 Sum_probs=192.9
Q ss_pred CeecccccccEEEEEe----CCCcEEEEEEeccchH--HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccC
Q 008012 297 NLLGSGGFGSVYKGIL----SDGTTVAIKIFNLQLE--QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMP 370 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 370 (581)
+.||+|+||.||++.. .+|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 3689999999976532 233457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCccee
Q 008012 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 450 (581)
+++|.+++.+.. .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++....... ...
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA 155 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence 999999997654 4789999999999999999999 8999999999999999999999999999988653321 122
Q ss_pred eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhh
Q 008012 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFF 530 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (581)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ............ .
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~i~~~~~-~------------- 216 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTMILKAKL-G------------- 216 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHHHHcCCC-C-------------
Confidence 345689999999999988899999999999999999999999975321 111111111110 0
Q ss_pred hHHHHHHHHHHHHHHhccCcCCCCCCCHHH
Q 008012 531 SARMDCLLSIFHLALDCCAELPDQRLYMKD 560 (581)
Q Consensus 531 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 560 (581)
.+..++..+.+++.+||+.||++||++.+
T Consensus 217 -~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 -MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 01123456789999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=320.15 Aligned_cols=248 Identities=20% Similarity=0.278 Sum_probs=196.4
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.++ +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 68899999998653 33456688999999998 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
++|..++...+ .+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTS 154 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--cee
Confidence 99999887654 3789999999999999999999 89999999999999999999999999999875322111 223
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHhhCCCCCCccccccchhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE-MNLKNWVKESLPHGLPKIADANLLREENFF 530 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (581)
...|++.|+|||++.+..++.++|||||||++|||++|+.||....... ......+..........
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------- 221 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR------------- 221 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC-------------
Confidence 4568999999999999999999999999999999999999996532211 11111111111111000
Q ss_pred hHHHHHHHHHHHHHHhccCcCCCCCCCH------HHHHHH
Q 008012 531 SARMDCLLSIFHLALDCCAELPDQRLYM------KDAATK 564 (581)
Q Consensus 531 ~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~ 564 (581)
.+...+..+.+++.+||+.||++|+++ +++++|
T Consensus 222 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 222 -IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 011233457799999999999999985 566665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.53 Aligned_cols=241 Identities=23% Similarity=0.274 Sum_probs=194.3
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcC-CCccceEeeeeecCCeeeEEE
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 366 (581)
+|+..+.||+|+||.||+|... +++.||+|++.... ....+.+..|..+++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999965 78999999997653 233456778899998885 678889999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++|+|.+++..... +++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 Ey~~~g~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 99999999999976544 788999999999999999999 8999999999999999999999999999987543221
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+..... ..+
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~i~~~~~-~~p---------- 221 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELFQSIMEHNV-SYP---------- 221 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC-CCC----------
Confidence 112344689999999999988999999999999999999999999976322 111111111110 011
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYM 558 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 558 (581)
..++.++.+++.+||+.+|++|++.
T Consensus 222 -------~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 -------KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -------ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1234467799999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=329.06 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=199.2
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||.||+|..+ +++.||+|+++... ......+.+|+.++.+++||+|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999965 78999999997543 234567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++|+|.+++.+.+. +++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999999986544 688999999999999999999 89999999999999999999999999999875432110
Q ss_pred c---------------------------------ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCC
Q 008012 447 S---------------------------------VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPT 493 (581)
Q Consensus 447 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf 493 (581)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011346899999999999999999999999999999999999999
Q ss_pred CccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC---HHHHHHH
Q 008012 494 DEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLY---MKDAATK 564 (581)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~ 564 (581)
....... .............++. ...++.++.++|.+|+. ||++|++ +.|+++|
T Consensus 237 ~~~~~~~-~~~~i~~~~~~~~~p~---------------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQE-TYRKVMNWKETLVFPP---------------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHH-HHHHHHcCCCceecCC---------------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 7632211 1111110000000000 01133457788988774 9999985 6777776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=326.83 Aligned_cols=244 Identities=26% Similarity=0.363 Sum_probs=203.7
Q ss_pred eecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCHHH
Q 008012 298 LLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDK 376 (581)
Q Consensus 298 ~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 376 (581)
+||+|.||+||-|++. +...+|||-+...+....+-+..|+.+.++++|.|||+++|.+..+++.-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 5899999999999965 677899999988777777889999999999999999999999999999999999999999999
Q ss_pred HHhhCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec-CCCcEEEeeccCceecCCCCCcceeecc
Q 008012 377 WLYSHNYFQ--DIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSVIQTMT 453 (581)
Q Consensus 377 ~l~~~~~~~--~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 453 (581)
+++..=.++ .+.++-.+.+||++||.||| +..|||||||-+|||++ -.|.+||+|||-++.+.. -...+...
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 999764444 67788889999999999999 78899999999999996 689999999999987642 33345567
Q ss_pred ccCccccCCCCCCCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 454 IATIGYMAPEFGSEG--NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 454 ~~~~~y~aPE~~~~~--~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
.||..|||||++..+ .|+.++|||||||++.||.||++||.+.......+.+. ++.+. . -+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-------GmyKv-H---------P~ 799 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-------GMYKV-H---------PP 799 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-------cceec-C---------CC
Confidence 799999999998775 68999999999999999999999998754433222111 10000 0 02
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRLYMKDAAT 563 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 563 (581)
.+.+.+.+..++|.+|+.+||.+||+|+++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 23456677889999999999999999999975
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=322.07 Aligned_cols=240 Identities=26% Similarity=0.287 Sum_probs=189.0
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHH-HHHHhcCCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSEC-EVLRNVRHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|... +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 67889999997543 12223344444 456778999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
++|.+++..... +.+..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~L~~~~~~~~~-~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~ 154 (325)
T cd05602 81 GELFYHLQRERC-FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS 154 (325)
T ss_pred CcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence 999999987544 677888889999999999999 89999999999999999999999999999875422211 223
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
...|++.|+|||++.+..++.++|||||||++|+|++|++||...... +...........
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~~~--------------- 214 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMYDNILNKPLQ--------------- 214 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----HHHHHHHhCCcC---------------
Confidence 456899999999999999999999999999999999999999753211 111111111100
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCCCHHHHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRLYMKDAA 562 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 562 (581)
....++..+.+++.+||+.||.+||++.+.+
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 0012345678999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=308.70 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=201.1
Q ss_pred CeecccccccEEEEEeCC--C--cEEEEEEeccchH-HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILSD--G--TTVAIKIFNLQLE-QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998642 3 3689999987765 566789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc-e
Q 008012 372 GSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV-I 449 (581)
Q Consensus 372 ~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~ 449 (581)
++|.+++.+.. ..+++..++.++.|++.||+||| +.|++|+||||+||+++.++.+||+|||++..+....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998765 46799999999999999999999 8999999999999999999999999999998775432221 1
Q ss_pred eeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 450 QTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 450 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ ....+... ....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~-~~~~------------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKE-GERL------------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhc-CCcC-------------
Confidence 123456788999999988899999999999999999999 999986532211 11111110 0000
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
..+..++..+.+++.+||..+|++|||+.++++.|.
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 --ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001123456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=307.04 Aligned_cols=239 Identities=23% Similarity=0.361 Sum_probs=191.4
Q ss_pred CeecccccccEEEEEeCC-------------CcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 297 NLLGSGGFGSVYKGILSD-------------GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
+.||+|+||.||+|+..+ ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999987766556667889999999999999999999999988999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc-------EEEeecc
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV-------AHVSDFG 436 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~-------~kl~Dfg 436 (581)
+||||+++++|..++......+++..++.++.||++||+||| +++|+||||||+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998876666899999999999999999999 899999999999999986654 8999999
Q ss_pred CceecCCCCCcceeeccccCccccCCCCCC-CCCCCccccHHHHHHHHHHHH-hCCCCCCccccccccHHHHHHhhCCCC
Q 008012 437 ISKLLGEGDDSVIQTMTIATIGYMAPEFGS-EGNVSSKCDVYSYGILLLETF-TRKKPTDEMFTGEMNLKNWVKESLPHG 514 (581)
Q Consensus 437 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el~-tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 514 (581)
.+...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+ ....... .
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~----~ 225 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERFYEG----Q 225 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHHHhc----C
Confidence 98754321 2335778899999876 467899999999999999998 5888876532111 1111110 0
Q ss_pred CCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 515 LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
. ... ...+..+.++|.+||+.||++||++.++++++
T Consensus 226 ~-~~~--------------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 C-MLV--------------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred c-cCC--------------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 000 01234678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=307.92 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=195.7
Q ss_pred CeecccccccEEEEEeC----CCcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeee-cCCeeeEEEeccC
Q 008012 297 NLLGSGGFGSVYKGILS----DGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCC-NTNFKALVLEFMP 370 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~ 370 (581)
+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999988543 3445567889999999999999999999775 4556889999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc--
Q 008012 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV-- 448 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 448 (581)
+++|.+++.......++..+..++.|+++||+||| +.+++||||||+||++++++.+||+|||++..........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999876655678888999999999999999 8999999999999999999999999999997653221111
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhC-CCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
......++..|+|||.+.+..++.++|||||||++|||++| .+||.... .......+.......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~~~~~------------- 222 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYLLQGRRLL------------- 222 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCCCCC-------------
Confidence 11123456789999999888999999999999999999995 55665421 111111111110000
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
.+..++..+.+++.+||..+|++||++.|+++.|+++..
T Consensus 223 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 223 ----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 011234568899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=322.52 Aligned_cols=262 Identities=26% Similarity=0.395 Sum_probs=217.4
Q ss_pred hhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 284 LDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 284 ~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
+.++.-..+.....+||-|.||.||.|.|+ -.-.||||.++.+ .-..+.|..|+.+|+.++|||+|+++|+|......
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 455555667778899999999999999987 4567999998765 34567899999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 363 ALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
|||+|||..|+|.+|+++-+ ...+....+.++.||++|++||. .+++|||||..+|+|+.++..||++|||+++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999653 33565667889999999999999 899999999999999999999999999999988
Q ss_pred CCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
..+..+. .....-...|.|||-+....++.|+|||+|||+|||+.| |..||... ++.+.. +
T Consensus 416 tgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSqVY-~----------- 477 (1157)
T KOG4278|consen 416 TGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVY-G----------- 477 (1157)
T ss_pred cCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHHH-H-----------
Confidence 6443322 222233677999999999999999999999999999999 88888663 122211 1
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
+++.......++.|++.+++||+.||+++|.+||++.|+-+.++.+.
T Consensus 478 --LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 478 --LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred --HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 12222334556789999999999999999999999999999988764
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=323.12 Aligned_cols=255 Identities=21% Similarity=0.271 Sum_probs=200.8
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||.||+++.+ +++.||+|++.... ......+.+|..++..++|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999965 78899999987532 233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++|+|.+++.+....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999876556788999999999999999999 89999999999999999999999999999987643222
Q ss_pred cceeeccccCccccCCCCCCC-----CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 447 SVIQTMTIATIGYMAPEFGSE-----GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
.......|++.|+|||++.+ +.++.++|||||||++|+|++|+.||...... ..............++..
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~--- 232 (331)
T cd05624 158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHEERFQFPSH--- 232 (331)
T ss_pred -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-HHHHHHHcCCCcccCCCc---
Confidence 12233568999999998765 46788999999999999999999999753211 111111110000001110
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQ--RLYMKDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 564 (581)
..+++..+.+++.+|+..++++ |++++++++|
T Consensus 233 -----------~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 233 -----------ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -----------cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1123456889999999876554 5688988876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=314.75 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=206.8
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCc----EEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGT----TVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.++|+..+.||+|+||.||+|.+. +++ .||+|.+.... ......+.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 457888899999999999999854 444 57889886543 33344688999999999999999999998654 467
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+++||+++|+|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999999877666788999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
...........++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .....++........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~------- 232 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGERLPQ------- 232 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCCCCC-------
Confidence 332222223345678999999998899999999999999999998 8999865321 222233322111100
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
+..++..+.+++.+||..+|++||+++++++.|+++..+.
T Consensus 233 ----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 233 ----------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0123346789999999999999999999999999886553
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=311.40 Aligned_cols=254 Identities=24% Similarity=0.310 Sum_probs=208.3
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
++|+..+.||+|++|.||+|..+ +++.+++|.+.... ......+.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46888899999999999999966 78999999987653 34556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS-TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
+++++|.+++......+++..+..++.|++.|++||| + .|++|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999999999876566788999999999999999999 7 9999999999999999999999999999876532211
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+.+........+...
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 225 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP-------- 225 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCC--------
Confidence 125678899999999888999999999999999999999999976432222233333222211111100
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...++..+.++|.+||..||++|||+.+++++
T Consensus 226 -----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 -----SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -----hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 01145668899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=309.47 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=191.4
Q ss_pred CeecccccccEEEEEeC---CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCC
Q 008012 297 NLLGSGGFGSVYKGILS---DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNG 372 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 372 (581)
+.||+|+||.||+|... ++..+++|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999854 34679999887653 233457888999999999999999999999999999999999999
Q ss_pred CHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 373 SLDKWLYSHN----YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 373 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+|.+++.... ...++..+..++.|++.|++||| +.+++|+||||+||+++.++.+||+|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 23466778889999999999999 8999999999999999999999999999997543322222
Q ss_pred eeeccccCccccCCCCCCCC-------CCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 449 IQTMTIATIGYMAPEFGSEG-------NVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~-------~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+. ....+.. ......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~----~~~~~~~ 232 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVRE----QQLKLPK 232 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHhhc----ccCCCCC
Confidence 22234567889999987542 35789999999999999996 9999976422211 1111111 1111111
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
+... ...++.+.+++..|| .+|++|||++||++.|+
T Consensus 233 ~~~~---------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PRLK---------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CccC---------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1110 112345778999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=322.35 Aligned_cols=255 Identities=22% Similarity=0.263 Sum_probs=200.4
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||.||++..+ +++.+|+|++.... ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999965 67889999986532 233445788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++|+|.+++.+....+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999876566888999999999999999999 89999999999999999999999999999976533221
Q ss_pred cceeeccccCccccCCCCCC-----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 447 SVIQTMTIATIGYMAPEFGS-----EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
.......|++.|+|||++. ...++.++|||||||++|||++|+.||.... ..+...............
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~~~p- 230 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHKERFQFP- 230 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-----HHHHHHHHhCCCccccCC-
Confidence 2223456899999999875 3468899999999999999999999997531 111111111110000000
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQ--RLYMKDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 564 (581)
.....++..+.+++.+|+..++++ |++++|+++|
T Consensus 231 ---------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 231 ---------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 001234566889999988655444 7899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=307.60 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=203.7
Q ss_pred cCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccC
Q 008012 291 DGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMP 370 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 370 (581)
.+|++.+.||+|+||.||+|.+.++..+|+|.+...... ...+.+|++++++++||+++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 468888999999999999999877889999988754321 2467889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCccee
Q 008012 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 450 (581)
+++|.+++......++++.++.++.|++.|++||| +.+++|+||||+||+++.++.++|+|||.+........ ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-ccc
Confidence 99999999876666788999999999999999999 88999999999999999999999999999986543221 111
Q ss_pred eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
....++..|+|||...++.++.++||||||+++|||++ |+.||...... ...+.+....... .+.
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~-----~~~------- 224 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINAGFRLY-----KPR------- 224 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhCCCCCC-----CCC-------
Confidence 22335678999999988899999999999999999998 99998753211 1111111111100 010
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
..+..+.+++.+||..+|++|||+.|++++|+
T Consensus 225 -----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 -----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=314.69 Aligned_cols=253 Identities=32% Similarity=0.446 Sum_probs=201.5
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHH--HHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAF--RSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
|++++.||+|+||+||++... +++.+|+|++........ ....+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 667899999999999999966 677899999987754322 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce
Q 008012 370 PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI 449 (581)
Q Consensus 370 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 449 (581)
++++|.+++.... .+++..++.++.|+++||.+|| +.+++|+||||+||+++.++.++|+|||.+.... .....
T Consensus 81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNEN 154 (260)
T ss_dssp TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSE
T ss_pred ccccccccccccc-cccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccccc
Confidence 9999999998433 3689999999999999999999 8899999999999999999999999999998652 22223
Q ss_pred eeccccCccccCCCCCC-CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 450 QTMTIATIGYMAPEFGS-EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 450 ~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
.....++..|+|||+.. +..++.++||||+|+++|+|++|..||.... ..+....+......... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~--~~~~~~~~~~~~~~~~~--------~--- 221 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN--SDDQLEIIEKILKRPLP--------S--- 221 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS--HHHHHHHHHHHHHTHHH--------H---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc--chhhhhhhhhccccccc--------c---
Confidence 44567899999999988 8889999999999999999999999998641 11111111111100000 0
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...........+.+++.+||+.||++|||+.+++++
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 222 SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000112678999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=315.95 Aligned_cols=253 Identities=24% Similarity=0.318 Sum_probs=206.5
Q ss_pred HhhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
....+|++.+.||+|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 3457899999999999999999995 479999999997665455567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++++|.+++.+. .+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||.+........
T Consensus 96 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 96 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999999998754 3688899999999999999999 89999999999999999999999999999986543321
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........... ......+..
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~~~~~-------- 235 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNGTPEL-------- 235 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCCCCCC--------
Confidence 12334678899999999888899999999999999999999999965322111000 000000000
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+...+..+.+++.+||..+|++||++++++++
T Consensus 236 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 ----QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0112344567899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=325.53 Aligned_cols=265 Identities=20% Similarity=0.212 Sum_probs=199.4
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecC-----
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT----- 359 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 359 (581)
...++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35678999999999999999999954 7899999998754 233456778899999999999999999988643
Q ss_pred -CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 360 -NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 360 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
...++||||+++ ++.+.+.. .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999965 67776653 3678889999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
...... .......++..|+|||++.+..++.++|||||||++|+|++|+.||...... ......+... ....+..
T Consensus 167 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~-~~~~~~~ 241 (355)
T cd07874 167 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQL-GTPCPEF 241 (355)
T ss_pred ccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh-CCCCHHH
Confidence 865322 1223456899999999999989999999999999999999999999753211 1111111110 0000000
Q ss_pred ---------------------ccccchhhh---hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 ---------------------ADANLLREE---NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ---------------------~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+...... .........+..+.+++.+||..||++|||+.|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 0000011234567899999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=311.70 Aligned_cols=251 Identities=24% Similarity=0.290 Sum_probs=201.1
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++|++|+.+++++...+..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677789999999999999964 78999999986543 2233457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 368 FMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|+++++|.+++... ...+++..+..++.|++.||.||| ++||+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999999988754 335899999999999999999999 89999999999999999999999999999976532211
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.....|+..|+|||++.+..++.++|+||||+++|+|++|+.||....... .... +..........+
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~-~~~~~~~~~~~~-------- 224 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREE-VDRRVLETEEVY-------- 224 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhhhcccccc--------
Confidence 123468999999999988899999999999999999999999997632211 1111 111111110000
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLY-----MKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 564 (581)
...++..+.+++.+||+.||++||+ +.+++++
T Consensus 225 ------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 225 ------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 1123456789999999999999999 7788776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=315.66 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=205.6
Q ss_pred hcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
..+|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35699999999999999999985 47899999998765544556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|.+++... .+++.++..++.|++.|++||| +.|++||||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 170 (296)
T cd06655 98 LAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-- 170 (296)
T ss_pred cCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence 9999999998754 3689999999999999999999 89999999999999999999999999999886543321
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||........ . ..+..... +..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~-~~~~~~~~---~~~---------- 235 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L-YLIATNGT---PEL---------- 235 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHhcCC---ccc----------
Confidence 12234678899999999988899999999999999999999999976322111 1 11111110 000
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+..++..+.++|.+||..||++|||+.+++++
T Consensus 236 --~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 --QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred --CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0112345568899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=309.52 Aligned_cols=239 Identities=24% Similarity=0.330 Sum_probs=190.5
Q ss_pred eecccccccEEEEEeCC-------------------------CcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceE
Q 008012 298 LLGSGGFGSVYKGILSD-------------------------GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKI 352 (581)
Q Consensus 298 ~lg~G~~~~v~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 352 (581)
.||+|+||.||+|.... ...|++|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 23589999876655555678889999999999999999
Q ss_pred eeeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC----
Q 008012 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM---- 428 (581)
Q Consensus 353 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~---- 428 (581)
++++.+.+..++||||+++++|..++......+++..+..++.||+.||+||| +++|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999876666889999999999999999999 89999999999999997543
Q ss_pred ---cEEEeeccCceecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHH-hCCCCCCccccccccH
Q 008012 429 ---VAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETF-TRKKPTDEMFTGEMNL 503 (581)
Q Consensus 429 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~-tg~~Pf~~~~~~~~~~ 503 (581)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+ .
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~ 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--K 230 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--H
Confidence 4899999987643211 22346788999998765 56899999999999999995 6999987642221 1
Q ss_pred HHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 504 KNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
........ ..+. .....+.++|.+||+.+|++|||+.++++.|+
T Consensus 231 ~~~~~~~~--~~~~-----------------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERFYEKKH--RLPE-----------------PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHhcc--CCCC-----------------CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111111 0110 11235789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=309.64 Aligned_cols=249 Identities=25% Similarity=0.341 Sum_probs=205.1
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
++|++.+.||.|++|.||+|... +++.|++|.+.... ......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999965 78999999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|.+++... .+++..++.++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||.+....... .
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S 153 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence 9999999999865 5789999999999999999999 8999999999999999999999999999998775332 1
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
......++..|+|||.+.+..++.++||||||+++|+|+||+.||...... .....+...... .....
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~---~~~~~------- 221 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RVLFLIPKNNPP---SLEGN------- 221 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HHHHHhhhcCCC---CCccc-------
Confidence 223446788999999999888999999999999999999999999753211 111111111111 10000
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.++..+.+++.+||..+|++|||+++++++
T Consensus 222 ------~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 ------KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ------ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 134568899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.06 Aligned_cols=238 Identities=26% Similarity=0.314 Sum_probs=188.8
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHH-HHHhcCCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECE-VLRNVRHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999965 78999999997652 223344555554 46778999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
|+|..++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT 154 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence 99999887654 4788999999999999999999 89999999999999999999999999999875322111 123
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+........... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~~~~~~~~--~~----------- 216 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----AEMYDNILHKPLV--LR----------- 216 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----HHHHHHHHcCCcc--CC-----------
Confidence 45689999999999999999999999999999999999999975321 1111111111100 00
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCCCHHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRLYMKD 560 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rps~~e 560 (581)
...+..+.+++.+|+..+|++||++.+
T Consensus 217 --~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 217 --PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred --CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 112345779999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=311.33 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=201.1
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|++++.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999965 78999999986542 2233457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 368 FMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999999986533 34788999999999999999999 89999999999999999999999999999876532221
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.....|+..|+|||++.+..++.++||||+|+++|+|++|+.||....... .... ...... ....
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~-~~~~~~-~~~~--------- 222 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREE-VERLVK-EVQE--------- 222 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHH-HHhhhh-hhhh---------
Confidence 123468999999999999999999999999999999999999997632211 1111 111000 0000
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLY-----MKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 564 (581)
.....++..+.+++.+||+.||++||| ++|+++|
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 ----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 001123456789999999999999999 8899885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=319.16 Aligned_cols=237 Identities=24% Similarity=0.293 Sum_probs=187.4
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHH-HHHhcCCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECE-VLRNVRHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|+.. +++.||+|++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 78999999987543 222334555554 67888999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
++|..++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS 154 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence 99999887654 3678888899999999999999 8999999999999999999999999999987532211 1223
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
...|++.|+|||++.+..++.++|||||||++|||++|+.||.... ............. .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~-~~------------- 215 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNILHKPL-QL------------- 215 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHhcCCC-CC-------------
Confidence 4568999999999999899999999999999999999999997631 1112221111110 00
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCCCHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRLYMK 559 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ 559 (581)
+...+..+.+++.+||+.||++||++.
T Consensus 216 -~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 -PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 011234577999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=311.10 Aligned_cols=250 Identities=21% Similarity=0.301 Sum_probs=210.8
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
+++-|...+.||+|.|+.|-+|++- +|+.||||++.+.. .-....+.+|++.|+.++|||||++|++.......|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 4567888899999999999999954 89999999998764 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec-CCCcEEEeeccCceecCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~ 444 (581)
+|.-++|+|.+||.++...+.+..+.+++.||+.|+.|+| +.-+|||||||+||.+- .-|-|||.|||++..+.++
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999999999888999999999999999999999 55599999999998875 6789999999999887655
Q ss_pred CCcceeeccccCccccCCCCCCCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVS-SKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
.. ....+|+..|-|||++.+..|+ +++||||||||+|.|++|++||+...+.+. + . -++|-.+
T Consensus 173 ~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-L-T-----------mImDCKY 236 (864)
T KOG4717|consen 173 KK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-L-T-----------MIMDCKY 236 (864)
T ss_pred ch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-h-h-----------hhhcccc
Confidence 43 3556899999999999999887 578999999999999999999987544332 1 1 1112111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.-+...+.+..+||.+||..||.+|.+.+||..+
T Consensus 237 -------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 237 -------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 1122445667799999999999999999999764
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=314.50 Aligned_cols=265 Identities=23% Similarity=0.287 Sum_probs=196.1
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhc---CCCccceEeeeeec-----CC
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNV---RHRNLIKILSSCCN-----TN 360 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~ 360 (581)
+|++.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999965 78999999987542 11123455677777665 79999999998764 34
Q ss_pred eeeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 361 FKALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
..++||||+++ +|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57999999975 8988887643 34789999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC---CCCC
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLP---HGLP 516 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~ 516 (581)
...... ......++..|+|||++.+..++.++||||+||++|+|++|++||...... ..+......... ...+
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCc
Confidence 664322 123346788999999998889999999999999999999999999653221 112222111100 0000
Q ss_pred ccc---cccchh--hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 517 KIA---DANLLR--EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 517 ~~~---~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
... ...... ..........++..+.+++.+||+.||++|||+.|++.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 000000 000011112355678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=317.44 Aligned_cols=267 Identities=21% Similarity=0.266 Sum_probs=199.9
Q ss_pred cCCeeccc--ccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 295 ECNLLGSG--GFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 295 ~~~~lg~G--~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
++++||+| +|++||++..+ +|+.||+|.++... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 67899999954 89999999997652 344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 370 PNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 370 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
++++|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999754 334788999999999999999999 8999999999999999999999999998654432111100
Q ss_pred -----eeeccccCccccCCCCCCC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 449 -----IQTMTIATIGYMAPEFGSE--GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 449 -----~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ...... ...+...+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~----~~~~~~~~~ 233 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLN----GTVPCLLDT 233 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhc----CCccccccc
Confidence 1122346778999998876 4688999999999999999999999976432211 111111 111100000
Q ss_pred -------------------cchh------------hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHHh
Q 008012 522 -------------------NLLR------------EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK--LKKI 568 (581)
Q Consensus 522 -------------------~~~~------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~ 568 (581)
.... .....+....+++.+.+++.+||+.||++|||++|++++ ++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0000 000011122346678999999999999999999999985 4444
Q ss_pred H
Q 008012 569 R 569 (581)
Q Consensus 569 ~ 569 (581)
+
T Consensus 314 ~ 314 (327)
T cd08227 314 K 314 (327)
T ss_pred c
Confidence 4
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=303.70 Aligned_cols=250 Identities=23% Similarity=0.307 Sum_probs=206.0
Q ss_pred CCCcCCeecccccccEEEEEe-CCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 292 GFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+|+..+.||.|+||.||.++. .+++.+++|.+.... ......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999994 478999999886542 44556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 369 MPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 369 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
+++++|.+++.+. ...+++..+..++.|++.|++||| +.|++|+||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999865 445789999999999999999999 89999999999999999999999999999987643321
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
......++..|+|||...+..++.++||||||+++|||++|..||.... ..+.............
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~~~~~~--------- 221 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVVKIVQGNYTPV--------- 221 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCCCCCC---------
Confidence 2234468899999999988889999999999999999999999986531 1122222211111111
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
...++.++.+++.+||..+|++||+++++++++
T Consensus 222 -----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 -----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -----ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 013345688999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=311.23 Aligned_cols=252 Identities=24% Similarity=0.327 Sum_probs=201.7
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46889999999999999999965 7899999988754 334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 369 MPNGSLDKWLYSH--NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 369 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
+++++|.+++... ...+++..+..++.|++.||.|||+ +.+|+|+||||+||+++.++.++|+|||.+..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999998764 2357899999999999999999994 3699999999999999999999999999987653221
Q ss_pred cceeeccccCccccCCCCCCCC------CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 447 SVIQTMTIATIGYMAPEFGSEG------NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
.....++..|+|||.+.+. .++.++|||||||++|+|++|+.||...... .....+........+.
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~--- 229 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQLSAIVDGDPPT--- 229 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHHHHHhhcCCCC---
Confidence 2234578899999987554 3478999999999999999999999653211 1111111111111011
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+.+++.++.++|.+||..+|++||++++++++
T Consensus 230 -----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 -----------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 011245668899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=309.74 Aligned_cols=248 Identities=27% Similarity=0.469 Sum_probs=198.1
Q ss_pred CeecccccccEEEEEeCC-------CcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 297 NLLGSGGFGSVYKGILSD-------GTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+.||+|+||.||+|+.++ ++.+++|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886543 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC-----cEEEeeccC
Q 008012 369 MPNGSLDKWLYSH------NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM-----VAHVSDFGI 437 (581)
Q Consensus 369 ~~~~~L~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~-----~~kl~Dfg~ 437 (581)
+++++|.+++... ...+++..+..++.|++.||+||| +.+++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999742 234688999999999999999999 89999999999999999877 899999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCC
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLP 516 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 516 (581)
+................++..|+|||.+.++.++.++|||||||++|||++ |+.||..... ......+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~~--- 232 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVTAGGRL--- 232 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHhcCCcc---
Confidence 976543322222223345678999999999999999999999999999998 9999865321 1122221111000
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
.....++..+.+++.+||..+|++||+++++++.|+
T Consensus 233 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 233 --------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 011234567889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.77 Aligned_cols=267 Identities=22% Similarity=0.250 Sum_probs=195.5
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCC------CccceEeeeee
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRH------RNLIKILSSCC 357 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~ 357 (581)
++....++|++.+.||+|+||.||+|... +++.||||+++... ........|+++++.++| .+++.+++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 44556789999999999999999999964 68899999986542 223445667888777754 45888998887
Q ss_pred cC-CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeEecCCC-------
Q 008012 358 NT-NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS-TPVVHCDLKPSNILLDENM------- 428 (581)
Q Consensus 358 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dikp~Nill~~~~------- 428 (581)
.. ++.++|||++ +++|.+++.+.+ .+++..+..++.||+.||+||| + .||+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccccccc
Confidence 64 5789999988 778999887664 4788999999999999999999 6 5999999999999998665
Q ss_pred ---------cEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Q 008012 429 ---------VAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG 499 (581)
Q Consensus 429 ---------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~ 499 (581)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~- 350 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN- 350 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-
Confidence 499999998864321 12345789999999999999999999999999999999999999976322
Q ss_pred cccHHHHHHhhCCCCCCcc----------------------ccccchhhhhhh--hHHHHHHHHHHHHHHhccCcCCCCC
Q 008012 500 EMNLKNWVKESLPHGLPKI----------------------ADANLLREENFF--SARMDCLLSIFHLALDCCAELPDQR 555 (581)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~R 555 (581)
......+..........+ .++......... .......+.+.+||.+||+.||++|
T Consensus 351 -~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 351 -LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred -HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 111111111111000000 000000000000 0000113457899999999999999
Q ss_pred CCHHHHHHH
Q 008012 556 LYMKDAATK 564 (581)
Q Consensus 556 ps~~evl~~ 564 (581)
||++|+++|
T Consensus 430 ~ta~e~L~H 438 (467)
T PTZ00284 430 LNARQMTTH 438 (467)
T ss_pred CCHHHHhcC
Confidence 999999986
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=321.09 Aligned_cols=267 Identities=21% Similarity=0.257 Sum_probs=200.0
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecC--
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT-- 359 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 359 (581)
......++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 34456789999999999999999999954 78899999987543 23345677899999999999999999987543
Q ss_pred ----CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeec
Q 008012 360 ----NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDF 435 (581)
Q Consensus 360 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 435 (581)
...+++++++ +++|.+++... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCC
Confidence 3578999988 77998887643 3788999999999999999999 899999999999999999999999999
Q ss_pred cCceecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC
Q 008012 436 GISKLLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG 514 (581)
Q Consensus 436 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 514 (581)
|++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+..+. ......
T Consensus 163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~-~~~~~~ 235 (343)
T cd07878 163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-IDQLKRIM-EVVGTP 235 (343)
T ss_pred ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHH-HHhCCC
Confidence 999865432 123468999999998876 5789999999999999999999999965311 11111111 111110
Q ss_pred CCccccc----c---chhhh---h---hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 515 LPKIADA----N---LLREE---N---FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 515 ~~~~~~~----~---~~~~~---~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+..... . ..... + .........+.+.+++.+||..||++|||+.|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0 00000 0 000011233457899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=306.46 Aligned_cols=248 Identities=29% Similarity=0.443 Sum_probs=195.5
Q ss_pred CeecccccccEEEEEeC-CCc--EEEEEEeccc-hHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGT--TVAIKIFNLQ-LEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|..+ ++. .+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999965 443 4688888753 234456788999999999 899999999999999999999999999
Q ss_pred CCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeecc
Q 008012 372 GSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 372 ~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
++|.+++.... ..+++..+..++.|++.|++||| +.|++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999997542 23678899999999999999999 8999999999999999999999999999
Q ss_pred CceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCC
Q 008012 437 ISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGL 515 (581)
Q Consensus 437 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 515 (581)
++..... .........+..|+|||++.+..++.++||||||+++|||++ |..||..... ............
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~~~~~~~ 229 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEKLPQGYR 229 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HHHHHHHhCCCC
Confidence 9863211 111112233567999999988889999999999999999997 9999865321 111111111000
Q ss_pred CccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
.. .+..++.++.+++.+||+.+|.+|||+.++++.|+++.
T Consensus 230 ~~--------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 LE--------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC--------------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 01123456889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=319.17 Aligned_cols=245 Identities=27% Similarity=0.361 Sum_probs=204.4
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
|+-++.||.|+||.||-|++. +.+.||||.+.-. +.+...++..|+.++++++|||++.+-|+|......|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 455678999999999999954 7899999998643 334456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
|- |+-.+++.-..+++-+.++..|+.+.+.||+||| +.+.||||||..|||+++.|.|||+|||.|....+.
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---- 179 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---- 179 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence 95 5999999988888899999999999999999999 999999999999999999999999999999876543
Q ss_pred eeeccccCccccCCCCC---CCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 449 IQTMTIATIGYMAPEFG---SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
...+|||.|||||++ ..+.|+-++||||||++..||...++|+..+. .+....-+..+-.+.+.
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--AMSALYHIAQNesPtLq--------- 246 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESPTLQ--------- 246 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch--HHHHHHHHHhcCCCCCC---------
Confidence 346799999999965 45789999999999999999999999976541 12222222222222211
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
..+.++.+.+++..||++-|.+|||.+++++|-
T Consensus 247 -------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 247 -------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred -------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 124566789999999999999999999998873
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=307.68 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=200.8
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---------HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---------EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF 361 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 361 (581)
+|.+.+.||+|++|.||+|... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999964 68899999886432 1233578899999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
.++||||+++++|.+++...+ .+++..+..++.|++.||+||| +.|++||||+|+||++++++.++|+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999998764 3688899999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCc----ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 442 GEGDDS----VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 442 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
...... .......++..|+|||.+.+..++.++||||+||++|+|++|+.||..... .... ........+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~-~~~~~~~~~~ 231 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQAI-FKIGENASPE 231 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HHHH-HHHhccCCCc
Confidence 422111 111223578899999999988899999999999999999999999976321 1111 1110000000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+..++..+.+++.+||+.||++||++.|++++
T Consensus 232 --------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 232 --------------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred --------------CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 011234568899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=324.20 Aligned_cols=265 Identities=19% Similarity=0.213 Sum_probs=199.5
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecC-----
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT----- 359 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 359 (581)
...++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 34678999999999999999999955 78999999987542 33445678899999999999999999987543
Q ss_pred -CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 360 -NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 360 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
...++||||+++ +|.+++... +++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHhc---CCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999965 777777542 678889999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
....... ......++..|+|||++.+..++.++|||||||++|+|++|+.||..... ...+...+. ......+..
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~~~~-~~~~~~~~~ 248 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIE-QLGTPCPEF 248 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH-hcCCCCHHH
Confidence 8653221 22344689999999999999999999999999999999999999976321 111111111 111110000
Q ss_pred ccc---c------------------chhhh---hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 ADA---N------------------LLREE---NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ~~~---~------------------~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
... . +.... ............+.+++.+||..||++|||+.|+++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 0 00000 0000001123467899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=310.37 Aligned_cols=266 Identities=21% Similarity=0.271 Sum_probs=205.3
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+|++.+.||+|++|.||+|... +|+.|++|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999965 78999999987653 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+ +++|.+++......+++.+++.++.||+.||+||| +.|++|+||||+||+++.++.++|+|||.+........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 99999999876667899999999999999999999 89999999999999999999999999999987643322 1
Q ss_pred eeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC----CCccccc--
Q 008012 449 IQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG----LPKIADA-- 521 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-- 521 (581)
......++..|+|||.+.+. .++.++||||+|+++|||++|.+||....+ ...+ ..+....... .+...+.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQL-AIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHH-HHHHHHcCCCChHHHhhccCcch
Confidence 12334688899999987654 468999999999999999999888765321 1111 1111111110 0000000
Q ss_pred ----cchhhh--hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 ----NLLREE--NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ----~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...... .......+.+..+.+++.+||..+|++|||++++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 0001112345778999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=306.17 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=204.3
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
..|+..+.||.|+||.||+|... +++.||+|++.... ......+.+|+.+++++.||||+++++++.+.+..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45778899999999999999965 68899999987543 44567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|.+++... .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06640 84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence 9999999998754 3688889999999999999999 89999999999999999999999999999976643221
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
......++..|+|||++.+..++.++|+|||||++|||++|+.||........ ...+... ..+
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~---~~~------------ 219 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--LFLIPKN---NPP------------ 219 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--hhhhhcC---CCC------------
Confidence 12334578889999999888899999999999999999999999876422111 1101000 000
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.....++..+.+++.+||+.+|++||++.+++++
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 --TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1112356678899999999999999999999888
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=303.01 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=201.7
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeec-CCeeeEEEe
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCN-TNFKALVLE 367 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 367 (581)
+|++.+.||+|++|.||++..+ +++.||+|.+.... ....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999999965 67899999986542 3445678899999999999999999998764 446789999
Q ss_pred ccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 368 FMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|+++++|.+++... ...+++.+++.++.|++.|+++|| +.|++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999864 345789999999999999999999 89999999999999999999999999999987643221
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
......+++.|+|||+..+..++.++||||+|+++|+|++|+.||..... ............+..
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~-------- 222 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIEGKLPPM-------- 222 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcCCCCC--------
Confidence 22334678899999999999999999999999999999999999875321 111111111111110
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+...++.+.+++.+||+.||++|||+.+++++
T Consensus 223 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 ------PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ------ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=310.71 Aligned_cols=253 Identities=24% Similarity=0.313 Sum_probs=200.1
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecC------
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNT------ 359 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------ 359 (581)
.+.+.|++.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678999999999999999999954 788999999875532 235678899999999 799999999998653
Q ss_pred CeeeEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 360 NFKALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 360 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
...++||||+++++|.+++... ...+++..+..++.|++.|++||| +++|+|+||||+||++++++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4689999999999999999864 345788999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCC-----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGS-----EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH 513 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 513 (581)
....... .......|+..|+|||++. +..++.++|||||||++|||++|+.||...... ....... ..
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~~~~-~~ 231 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFLIP-RN 231 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHHHHh-cC
Confidence 8653321 1223456889999999875 346788999999999999999999999653211 1111100 00
Q ss_pred CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 514 GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...... ...++..+.+++.+||..||.+|||+.|++++
T Consensus 232 ~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 PAPRLK-------------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCC-------------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000100 11234568899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=321.14 Aligned_cols=263 Identities=20% Similarity=0.240 Sum_probs=197.7
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++...+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999965 6789999985443 23468999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
++. ++|.+++......+++..+..|+.||+.||+||| ++||+||||||+||+++.++.+||+|||.+.......
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 995 5899998877667899999999999999999999 8999999999999999999999999999997542211
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCC-Ccccccc--------ccHHHHHHhh--CCCCCC
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPT-DEMFTGE--------MNLKNWVKES--LPHGLP 516 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf-~~~~~~~--------~~~~~~~~~~--~~~~~~ 516 (581)
......|+..|+|||++.+..++.++|||||||++|||+++..|+ ....... ..+...+... .+..++
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 123346899999999999999999999999999999999965554 3321110 0111111110 011111
Q ss_pred ccccccchhhh---------h----hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 517 KIADANLLREE---------N----FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 517 ~~~~~~~~~~~---------~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
........... + .......++..+.++|.+||+.||++|||+.|+++|
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00000000000 0 000112345567789999999999999999999986
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=314.18 Aligned_cols=267 Identities=22% Similarity=0.260 Sum_probs=201.2
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+|++.+.||+|++|.||+|... +|+.||+|.++... ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4888899999999999999965 78999999986542 22234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
++ ++|.+++......+++..++.++.||++||.||| +++++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence 96 4888888766666899999999999999999999 89999999999999999999999999999986543221
Q ss_pred eeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC------CCccccc
Q 008012 449 IQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG------LPKIADA 521 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 521 (581)
......++..|+|||++.+. .++.++|||||||++|+|+||+.||....+....+........... .....+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12234578899999987664 4789999999999999999999986543222222221111100000 0000000
Q ss_pred ----cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 ----NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..............++.++.+++.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000011122356778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=307.15 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=190.0
Q ss_pred CeecccccccEEEEEeC---CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCC
Q 008012 297 NLLGSGGFGSVYKGILS---DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNG 372 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 372 (581)
+.||+|+||.||+|... ....+++|.+.... ......+.+|++.++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 36899999999999743 34578888876543 334467889999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 373 SLDKWLYSHNY----FQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 373 ~L~~~l~~~~~----~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+|.+++..... ..++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999986432 2357788899999999999999 8999999999999999999999999999987543222111
Q ss_pred eeeccccCccccCCCCCC-------CCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 449 IQTMTIATIGYMAPEFGS-------EGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
......++..|+|||+.. ...++.++|||||||++|||++ |..||...... ..+...+.... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~~----~~~~~ 232 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-QVLKQVVREQD----IKLPK 232 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHHHHHhhccC----ccCCC
Confidence 122334567899999754 3456889999999999999999 78888653221 11222111111 11111
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
+.+ ...++..+.+++..|| .||++|||++||++.|.
T Consensus 233 ~~~---------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 233 PQL---------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred Ccc---------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111 1123456778999999 59999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=312.33 Aligned_cols=266 Identities=24% Similarity=0.310 Sum_probs=200.0
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+|++.+.||+|++|.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5888999999999999999965 78999999986542 22235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 369 MPNGSLDKWLYSHN--YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 369 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
++ ++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 58988887532 45789999999999999999999 8999999999999999999999999999997653322
Q ss_pred cceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---C---Cccc
Q 008012 447 SVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---L---PKIA 519 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~---~~~~ 519 (581)
.......+++.|+|||++.+. .++.++|||||||++|+|+||++||....... ............. . ....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhhH
Confidence 112334568899999987654 57889999999999999999999997532211 1111111100000 0 0000
Q ss_pred cc--cc--hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 DA--NL--LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 ~~--~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+. .. ............+++++.++|.+||..||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00 00 00000001112356778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.37 Aligned_cols=260 Identities=21% Similarity=0.288 Sum_probs=202.5
Q ss_pred hhhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeec-
Q 008012 283 YLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCN- 358 (581)
Q Consensus 283 ~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 358 (581)
+.+.....++|++++.||+|+||.||+|... ++..||+|++... .......+..|+.++++++||||++++++|.+
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3445556789999999999999999999965 6788999998654 23445678899999999999999999998854
Q ss_pred -CCeeeEEEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCceecCCCCCCeEecC----
Q 008012 359 -TNFKALVLEFMPNGSLDKWLYSH---NYFQDIPDRLNIMIDVALALEYLHHGH----STPVVHCDLKPSNILLDE---- 426 (581)
Q Consensus 359 -~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~----~~~i~H~dikp~Nill~~---- 426 (581)
...+|+||||+++++|.+++... ...+++..++.|+.||+.||+|||+.. ..+|+||||||+|||++.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 45789999999999999999753 345799999999999999999999421 146999999999999964
Q ss_pred -------------CCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCC--CCCCccccHHHHHHHHHHHHhCCC
Q 008012 427 -------------NMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE--GNVSSKCDVYSYGILLLETFTRKK 491 (581)
Q Consensus 427 -------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~ 491 (581)
.+.+||+|||++..+.... ......|++.|+|||++.+ ..++.++|||||||++|||+||+.
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 2358999999998654322 1234568999999998754 458899999999999999999999
Q ss_pred CCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 492 PTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 492 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
||.... ....++....... ... ....+..+.+||..||..+|++||++.|++.+
T Consensus 242 PF~~~~----~~~qli~~lk~~p--~lp-------------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 242 PFHKAN----NFSQLISELKRGP--DLP-------------IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCCcCC----cHHHHHHHHhcCC--CCC-------------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 996532 2222222211110 000 01124568899999999999999999999864
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=324.47 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=209.8
Q ss_pred CCcCCeecccccccEEEEEeC--CC--cEEEEEEeccchHH-HHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 293 FNECNLLGSGGFGSVYKGILS--DG--TTVAIKIFNLQLEQ-AFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
....++||+|.||.|++|.|. +| ..||||.++..... ....|.+|+.+|.+|+|||++++||+..+ ....+|||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 345578999999999999976 33 45899999877543 67899999999999999999999999887 66789999
Q ss_pred ccCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 368 FMPNGSLDKWLYS-HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
.+++|+|.+.+++ ....+-......++.|||.|+.||. +++.||||+..+|+++-....|||+|||+.+.++.+++
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999997 4555777888999999999999999 89999999999999999999999999999999987766
Q ss_pred ccee-eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 447 SVIQ-TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 447 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
.+.. ....-...|+|||.++...++.++|||+|||++|||+| |+.||-+... ..+.+.+.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~qIL~~iD---------------- 329 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--IQILKNID---------------- 329 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--HHHHHhcc----------------
Confidence 5533 33345678999999999999999999999999999999 8899876321 11111111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
+....+.+..|++.++++++.||..+|++|||+..|.+.+-
T Consensus 330 -~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 330 -AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred -ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 11223455679999999999999999999999999985543
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=311.10 Aligned_cols=261 Identities=22% Similarity=0.319 Sum_probs=203.8
Q ss_pred hhhhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeee--
Q 008012 282 SYLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCC-- 357 (581)
Q Consensus 282 ~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-- 357 (581)
.+..+....++|++.+.||+|+||.||+|... +++.+|+|++..... ....+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34566778899999999999999999999965 688999998865322 235677899999999 7999999999874
Q ss_pred ---cCCeeeEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEE
Q 008012 358 ---NTNFKALVLEFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAH 431 (581)
Q Consensus 358 ---~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~k 431 (581)
.++..++||||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||++++++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEE
Confidence 34578999999999999998863 2345788899999999999999999 89999999999999999999999
Q ss_pred EeeccCceecCCCCCcceeeccccCccccCCCCCCC-----CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHH
Q 008012 432 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE-----GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNW 506 (581)
Q Consensus 432 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~ 506 (581)
|+|||++........ ......|+..|+|||++.. ..++.++||||+||++|||++|+.||...... ...
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----~~~ 238 (286)
T cd06638 165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----RAL 238 (286)
T ss_pred EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----HHH
Confidence 999999986643221 1233468899999998753 45788999999999999999999998753211 111
Q ss_pred HHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 507 VKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
.. ......+...++ ..++..+.+++.+||+.||++|||+.|++++.
T Consensus 239 ~~-~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 FK-IPRNPPPTLHQP------------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hh-ccccCCCcccCC------------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11 000000111111 11234688999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.24 Aligned_cols=250 Identities=32% Similarity=0.529 Sum_probs=202.7
Q ss_pred CCcCCeecccccccEEEEEeC-C----CcEEEEEEeccchHH-HHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 293 FNECNLLGSGGFGSVYKGILS-D----GTTVAIKIFNLQLEQ-AFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
+++.+.||.|+||.||++... . +..||+|++...... ....+..|+++++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 457789999999999999965 3 388999999766432 5678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYF-QDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
||+++++|.+++...... +++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||.+.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999865544 799999999999999999999 8999999999999999999999999999998765432
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
... .....++..|+|||...+..++.++||||+|+++|+|++ |.+||... ......+.+........
T Consensus 158 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~~--------- 225 (258)
T smart00219 158 YYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--SNEEVLEYLKKGYRLPK--------- 225 (258)
T ss_pred ccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCCCC---------
Confidence 221 112336789999999888889999999999999999998 78888652 11111222211111100
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
...++.++.+++.+||..||++|||+.|+++.|
T Consensus 226 --------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 --------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 112456788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=310.12 Aligned_cols=266 Identities=21% Similarity=0.249 Sum_probs=202.7
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
++|++.+.||+|++|.||+|..+ +++.||+|++.... ....+.+.+|++++++++|||++++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47899999999999999999976 68999999886442 2233567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++++|..++.... .+++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 999988887766543 4789999999999999999999 89999999999999999999999999999987644322
Q ss_pred ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCC----------
Q 008012 448 VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP---------- 516 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------- 516 (581)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+ ...... .......+
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIR-KTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH-HHhCCCChHHhhhccccc
Confidence 1223457889999998765 567899999999999999999999997643221 111111 11000000
Q ss_pred ---ccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 517 ---KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 517 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....+...............+..+.+++.+||+.+|++|||+.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000000011122346778899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=308.02 Aligned_cols=239 Identities=25% Similarity=0.379 Sum_probs=190.7
Q ss_pred CeecccccccEEEEEeC-C-------CcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 297 NLLGSGGFGSVYKGILS-D-------GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+.||+|+||.||+|..+ . ...+++|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999854 2 234888888766555567788999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc--------EEEeeccCcee
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV--------AHVSDFGISKL 440 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~--------~kl~Dfg~a~~ 440 (581)
+++|+|.+++...+..+++..++.++.||+.||+||| ++||+||||||+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999877666899999999999999999999 899999999999999987664 69999998875
Q ss_pred cCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCC-CCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRK-KPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
.... ....++..|+|||++.+ ..++.++||||||+++|||++|. .||...... ........ ...++.
T Consensus 158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~--~~~~~~- 226 (258)
T cd05078 158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKLQFYED--RHQLPA- 226 (258)
T ss_pred cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHHHHHHc--cccCCC-
Confidence 4321 23457888999998876 45789999999999999999985 555432111 11111111 011111
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
....++.+++.+||+.||++|||++++++.|
T Consensus 227 ----------------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 227 ----------------PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ----------------CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1124578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=309.65 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=201.7
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34666788999999999999865 68899999987543 34456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|.+++... .+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06642 84 LGGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred cCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence 9999999988653 4688899999999999999999 89999999999999999999999999999976543221
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
......++..|+|||.+.+..++.++|||||||++|||++|+.||....... ....+....... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~--------~----- 221 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIPKNSPPT--------L----- 221 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhhcCCCCC--------C-----
Confidence 1223457889999999998899999999999999999999999987532211 111111111000 0
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...++..+.+++.+||+.+|++||++.+++++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11234568899999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=310.10 Aligned_cols=258 Identities=23% Similarity=0.295 Sum_probs=207.0
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.++|++.+.||+|+||+||++... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 467888999999999999999965 68899999886543 3445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++++|.+++.+.+ .+++..+..++.+++.||.|||+ ..+++||||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 84 FMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred cCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 999999999987654 47889999999999999999994 3689999999999999999999999999987542211
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccc------cHHHHHHhhCCCCCCccccc
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM------NLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 521 (581)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||........ ....+.........+.+
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 233 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL--- 233 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC---
Confidence 1234688999999998888999999999999999999999999986432210 11112222111110100
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
....++..+.+++.+||+.||++|||++|++++..-
T Consensus 234 ----------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 234 ----------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred ----------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 011245678899999999999999999999987533
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=316.71 Aligned_cols=195 Identities=23% Similarity=0.281 Sum_probs=160.1
Q ss_pred CCeecccccccEEEEEeC---CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeec--CCeeeEEEeccC
Q 008012 296 CNLLGSGGFGSVYKGILS---DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN--TNFKALVLEFMP 370 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 370 (581)
.++||+|+||.||+|..+ +++.||+|.+..... ...+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 568899999875432 2346789999999999999999998854 456889999985
Q ss_pred CCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe----cCCCcEEEeeccCc
Q 008012 371 NGSLDKWLYSH--------NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL----DENMVAHVSDFGIS 438 (581)
Q Consensus 371 ~~~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill----~~~~~~kl~Dfg~a 438 (581)
+ +|.+++... ...+++..+..++.||+.||+||| +.||+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 888887632 224788899999999999999999 8999999999999999 45679999999999
Q ss_pred eecCCCCCc-ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCcc
Q 008012 439 KLLGEGDDS-VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEM 496 (581)
Q Consensus 439 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~ 496 (581)
......... .......+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876432211 12234568999999998876 45899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=302.50 Aligned_cols=248 Identities=29% Similarity=0.386 Sum_probs=202.3
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-----HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-----EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999976 78999999886543 33556789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
+||+++++|.+++.+.. .+++..+..++.|++.|++||| +.|++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999998664 3688999999999999999999 8999999999999999999999999999988754322
Q ss_pred CcceeeccccCccccCCCCCCCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGN-VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
......++..|+|||.+.... ++.++|+||||+++|+|++|+.||..... .............+.+
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~------ 223 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFKIGRSKELPPI------ 223 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHHHHhcccCCCc------
Confidence 223456888999999887766 89999999999999999999999976431 1111111110111111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+..++..+.+++.+||..+|++||++.+++++
T Consensus 224 --------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 224 --------PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11234567899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=319.70 Aligned_cols=252 Identities=25% Similarity=0.326 Sum_probs=210.8
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
+-|+++..||.|+||.||+|..+ ++-..|.|++........+.|.-|++++..++||+||++++.|...+.+|+..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34667788999999999999966 56667899999888889999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce
Q 008012 370 PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI 449 (581)
Q Consensus 370 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 449 (581)
.||-+...+-.-+..+.+.++..+++|++.||.||| +.+|||||||..|||++-+|.++|+|||.+.... .....
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQK 186 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhh
Confidence 999999999888888999999999999999999999 8999999999999999999999999999886432 22234
Q ss_pred eeccccCccccCCCCC-----CCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 450 QTMTIATIGYMAPEFG-----SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 450 ~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
....+||++|||||+. ...+|+.++||||||++|.||..+.+|-... +....+-.......+.+.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-----npMRVllKiaKSePPTLl----- 256 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIAKSEPPTLL----- 256 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-----chHHHHHHHhhcCCCccc-----
Confidence 5567899999999965 4568999999999999999999999996553 111222211111122222
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+...+..+.+++.+||.+||..||++.++++|
T Consensus 257 -------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 -------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 223445568899999999999999999999986
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=306.16 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=200.4
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch----------HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL----------EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN 360 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 360 (581)
+|...+.||+|++|.||+|... +++.+|+|.++... ....+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999854 78999999886421 112356788999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..++||||+++++|.+++.+.+ .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||.+..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999998764 4788899999999999999999 89999999999999999999999999999976
Q ss_pred cCCCCCcceeeccccCccccCCCCCCCCC--CCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSEGN--VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
..............++..|+|||.+.... ++.++|+||||+++|++++|..||..... ..... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~-~~~~~~~~~~ 232 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMF-KLGNKRSAPP 232 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHH-HhhccccCCc
Confidence 53322111223345788999999877654 78999999999999999999999864211 11111 1111110000
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.... ....++..+.+++.+||..+|++|||+++++++
T Consensus 233 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IPPD---------VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcc---------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0110 111345678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=304.26 Aligned_cols=257 Identities=26% Similarity=0.346 Sum_probs=206.9
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
++|++.+.||.|++|.||+|... ++..+++|++.... ......+.+|++.++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999954 78899999986542 33567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 369 MPNGSLDKWLYSHN--YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 369 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
+++++|.+++.... ..+++..+..++.|++.|++||| +.|++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999998642 35788999999999999999999 89999999999999999999999999999987654332
Q ss_pred cc--eeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 447 SV--IQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 447 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
.. ......++..|+|||++... .++.++|+||||+++|+|++|+.||...... ..+....... +..+....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~-~~~~~~~~---- 231 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQND-PPSLETGA---- 231 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCC-CCCcCCcc----
Confidence 21 22334688899999988776 7899999999999999999999999764221 1122221111 11011000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....++..+.+++.+||..||++|||+.++++|
T Consensus 232 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 232 --------DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred --------ccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 012345678899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=303.29 Aligned_cols=251 Identities=23% Similarity=0.286 Sum_probs=197.1
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-----HHHHHHHHHHHHHHHhcCCCccceEeeeeec--CCee
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-----EQAFRSFNSECEVLRNVRHRNLIKILSSCCN--TNFK 362 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 362 (581)
.+|+..+.||+|+||.||+|... ++..|++|.+.... ......+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36889999999999999999964 68999999886432 2345678899999999999999999998865 3578
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++++||+++++|.+++..... +++..++.++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 899999999999999986543 688899999999999999999 8999999999999999999999999999987653
Q ss_pred CCCCc-ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 443 EGDDS-VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 443 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
..... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... .. +........ .+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----~~-~~~~~~~~~----~~ 228 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----AA-IFKIATQPT----NP 228 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----HH-HHHHhcCCC----CC
Confidence 21111 1112345788999999999888999999999999999999999999753211 11 111111100 00
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+ +..+++.+.+++ +||..+|++||+++|+++|
T Consensus 229 ~~---------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 229 QL---------PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CC---------chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 00 112334566777 6888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=302.40 Aligned_cols=237 Identities=24% Similarity=0.410 Sum_probs=190.7
Q ss_pred CeecccccccEEEEEeCC-C----------cEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 297 NLLGSGGFGSVYKGILSD-G----------TTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
+.||+|+||.||+|...+ + ..+++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 469999999999999763 3 25788877655433 5778899999999999999999999888 778999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC-------cEEEeeccCc
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM-------VAHVSDFGIS 438 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~-------~~kl~Dfg~a 438 (581)
|||+++++|.+++......+++..+..++.||+.||+||| +.||+||||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999877656889999999999999999999 89999999999999999887 7999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCCC--CCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCC
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSEG--NVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGL 515 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 515 (581)
..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||..... .....+.... ...
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~~~~~~~--~~~ 225 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQDQ--HRL 225 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--hhHHHHHhcC--CCC
Confidence 86533 1233467789999998776 78999999999999999999 5777765421 1111111110 000
Q ss_pred CccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
+. + ....+.+++.+||..+|++|||+.++++.|
T Consensus 226 ~~---~--------------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 226 PM---P--------------DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CC---C--------------CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00 0 014578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=319.09 Aligned_cols=241 Identities=22% Similarity=0.228 Sum_probs=188.5
Q ss_pred ecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc---CCCccceEeeeeecCCeeeEEEeccCC
Q 008012 299 LGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV---RHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 299 lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
||+|+||.||+|+.+ +++.||+|++.... .........|..++... +||+|+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 78999999986543 22333455677777665 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
|+|.+++...+ .+++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~ 154 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN 154 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence 99999987654 3788999999999999999999 89999999999999999999999999999875422221 123
Q ss_pred ccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFF 530 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (581)
...|+..|+|||++.+. .++.++|||||||++|+|++|+.||..... .+.......... .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~~-~~~~---------- 218 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNIAFGKV-RFPK---------- 218 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHHHcCCC-CCCC----------
Confidence 45689999999988654 589999999999999999999999975321 111221111110 0000
Q ss_pred hHHHHHHHHHHHHHHhccCcCCCCCC----CHHHHHHH
Q 008012 531 SARMDCLLSIFHLALDCCAELPDQRL----YMKDAATK 564 (581)
Q Consensus 531 ~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~evl~~ 564 (581)
..++..+.+++.+||+.||++|| ++.++++|
T Consensus 219 ---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 219 ---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 11344677999999999999998 56777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=302.01 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=204.1
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+|++.+.||+|+||.+|.+... +++.|++|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999954 78999999986542 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 369 MPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 369 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
+++++|.+++... ....++..++.++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999999764 334688999999999999999999 89999999999999999999999999999986643221
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
......++..|+|||+..+..++.++|+|||||++|+|++|+.||.... ..+.+........+..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~~~~~~--------- 221 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKIIRGSYPPV--------- 221 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHHHHHhcCCCCCC---------
Confidence 1223457888999999988889999999999999999999999986531 1222222221111111
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+..++.++.++|.+||+.+|++||++.+|+++
T Consensus 222 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 -----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -----cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=310.14 Aligned_cols=269 Identities=21% Similarity=0.303 Sum_probs=200.1
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH-HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE-QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
+.++|.+.+.||+|+||.||+|... +++.|++|++..... .....+.+|+++++.++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999854 789999999865432 22235678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+. +++.+++.......++..+..++.|++.||+||| +.||+|+||||+||+++.++.++|+|||++........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9995 6888877765555678888999999999999999 88999999999999999999999999999876432221
Q ss_pred cceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC----------C
Q 008012 447 SVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG----------L 515 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~----------~ 515 (581)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....+....+.+... ..... .
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT-VLGVPTEDTWPGVSKL 235 (291)
T ss_pred --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHH-HcCCCChhhhhhhhhc
Confidence 12233568899999988653 5788999999999999999999999764322111111111 00000 0
Q ss_pred Cccccccc----hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 516 PKIADANL----LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 516 ~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+....... .............+..+.+++.+|+..||++|||++|++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000 00000000001124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=302.47 Aligned_cols=246 Identities=30% Similarity=0.494 Sum_probs=199.2
Q ss_pred cCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccC
Q 008012 291 DGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMP 370 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 370 (581)
++|++.+.||+|+||.||++.. +++.||+|.++.... ...+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5689999999999999999975 478899999876533 35788999999999999999999998654 4799999999
Q ss_pred CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce
Q 008012 371 NGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI 449 (581)
Q Consensus 371 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 449 (581)
+++|.+++.... ..+++..++.++.|++.|+.||| +.|++||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999998653 34788999999999999999999 8999999999999999999999999999987643221
Q ss_pred eeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 450 QTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 450 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
.....+..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .....+.......
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~-------------- 217 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKECVEKGYRME-------------- 217 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhCCCCCC--------------
Confidence 12234567999999988899999999999999999998 99998753221 1112111111000
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
....++..+.+++.+||+.+|++||+++++++.|++
T Consensus 218 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 ---PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011345678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=306.61 Aligned_cols=254 Identities=23% Similarity=0.390 Sum_probs=203.8
Q ss_pred cCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccchHH-HHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQLEQ-AFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
++|++.+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999954 3567999988765433 4567899999999999999999999999989999
Q ss_pred EEEeccCCCCHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeec
Q 008012 364 LVLEFMPNGSLDKWLYSHN--------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDF 435 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 435 (581)
+||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999998544 14789999999999999999999 899999999999999999999999999
Q ss_pred cCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCC
Q 008012 436 GISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHG 514 (581)
Q Consensus 436 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 514 (581)
|++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ........ ..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~~---~~ 235 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQA---GK 235 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHHc---CC
Confidence 9987543221 112223345778999999888889999999999999999999 88888653221 11111111 11
Q ss_pred CCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 515 LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
.... ....++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 236 ~~~~-------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LELP-------------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCC-------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1100 01124457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=301.93 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=203.7
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeec--CCeeeEEE
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCN--TNFKALVL 366 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 366 (581)
+|++.+.||.|+||.||+|... +++.||+|.+... .....+.+..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5888999999999999999954 7899999998643 24445678899999999999999999998754 45679999
Q ss_pred eccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 367 EFMPNGSLDKWLYSH---NYFQDIPDRLNIMIDVALALEYLHHGH--STPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 367 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
||+++++|.+++... ...+++..++.++.|++.||.|||..+ +.+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999753 456789999999999999999999543 678999999999999999999999999999876
Q ss_pred CCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.... .....+.+.... .+.
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~---~~~---- 229 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEGK---FRR---- 229 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcCC---CCC----
Confidence 43321 1233468899999999998889999999999999999999999997632 111222221111 111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+...+..+.+++.+|+..+|++||++.+|+++
T Consensus 230 ----------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 ----------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=310.11 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=201.1
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccC
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMP 370 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 370 (581)
.|.....||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++||||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444567999999999999964 789999999876655566778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCccee
Q 008012 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 450 (581)
+++|.+++... .+++.++..++.||+.||+||| +++|+||||||+||++++++.++|+|||++........ ..
T Consensus 103 ~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 175 (292)
T cd06658 103 GGALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KR 175 (292)
T ss_pred CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cC
Confidence 99999988653 3688999999999999999999 89999999999999999999999999999875532221 12
Q ss_pred eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhh
Q 008012 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFF 530 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (581)
....++..|+|||...+..++.++||||||+++|||++|+.||...... .....+....+.....
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~------------- 240 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRDNLPPRVKD------------- 240 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCcccc-------------
Confidence 3346789999999998888999999999999999999999998753211 1111111111111110
Q ss_pred hHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 531 SARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 531 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....+..+.+++.+||..||++|||++|++++
T Consensus 241 --~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 --SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234467899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=300.48 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=202.2
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+|+..+.||+|++|.||+|... +++.+|+|.+.... ......+.+|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999964 78999999986542 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC-CcEEEeeccCceecCCCCC
Q 008012 369 MPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN-MVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 369 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~~~~~~~~ 446 (581)
+++++|.+++.+. +..+++..+..++.|++.|++||| +.|++|+||+|+||+++++ +.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999865 344788999999999999999999 8999999999999999854 5689999999987643322
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ................
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~------- 222 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKIMSGTFAPIS------- 222 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHHHhcCCCCCC-------
Confidence 2234578899999999988899999999999999999999999865321 1111111111111111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..++..+.+++.+||..+|++|||+.|++++
T Consensus 223 -------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 -------DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -------CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=308.66 Aligned_cols=265 Identities=25% Similarity=0.308 Sum_probs=202.4
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH-----HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE-----QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
+|++.+.||+|++|.||+|... +++.|++|.+..... .....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999965 789999999976532 2344577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+ +++|.+++......+++..++.++.||++||+||| ++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 88999999876546899999999999999999999 8999999999999999999999999999998764432
Q ss_pred CcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC----------
Q 008012 446 DSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---------- 514 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---------- 514 (581)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|.+||..... ...+.... ......
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 157 RK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIF-EALGTPTEENWPGVTS 232 (298)
T ss_pred cc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHH-HHcCCCchhhhhhccc
Confidence 21 223356788999998754 4678999999999999999999888765321 11111111 111000
Q ss_pred CCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 515 LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
......................+..+.++|.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000011112345678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=306.90 Aligned_cols=250 Identities=27% Similarity=0.333 Sum_probs=195.0
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHH-HHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEV-LRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
++|++.+.||+|+||.||+|..+ +|+.||+|.++... ......+..|+.. ++..+||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999965 79999999987653 2223445556665 566689999999999999999999999
Q ss_pred ccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 368 FMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHST-PVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 368 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
|++ ++|.+++.. ....+++..++.++.|++.||+||| ++ +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 588888764 2345789999999999999999999 66 999999999999999999999999999886532
Q ss_pred CCCcceeeccccCccccCCCCCCC----CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSE----GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
.. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.........+...... ..+.+.
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~ 229 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE----PSPQLP 229 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc----CCCCCC
Confidence 21 1223457889999998765 456889999999999999999999996532221112221111 111110
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
. ..++.++.+++.+||..+|++||++++++++
T Consensus 230 ~-------------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 230 A-------------EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred c-------------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 1245678899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=306.46 Aligned_cols=260 Identities=23% Similarity=0.288 Sum_probs=204.4
Q ss_pred chhhhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeec
Q 008012 281 TSYLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCN 358 (581)
Q Consensus 281 ~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 358 (581)
.+..++....+.|++.+.||+|+||.||+|... +++.+|+|++..... ....+..|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 345566667789999999999999999999964 789999999876543 335688899999999 79999999999853
Q ss_pred ------CCeeeEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEE
Q 008012 359 ------TNFKALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAH 431 (581)
Q Consensus 359 ------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~k 431 (581)
.+..+++|||+++|+|.+++... ...+++..++.++.|++.|++||| +.+++|+||+|+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 45789999999999999999864 344678888999999999999999 89999999999999999999999
Q ss_pred EeeccCceecCCCCCcceeeccccCccccCCCCCC-----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHH
Q 008012 432 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGS-----EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNW 506 (581)
Q Consensus 432 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~ 506 (581)
|+|||++........ ......++..|+|||.+. +..++.++|||||||++|||++|+.||........ .
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~----~ 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA----L 235 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh----h
Confidence 999999875532211 123346888999999875 34678899999999999999999999965322111 1
Q ss_pred HHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 507 VKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
. ......... .....++..+.++|.+||+.||.+|||+.|++++
T Consensus 236 ~-~~~~~~~~~-------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 F-LIPRNPPPK-------------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred h-hHhhCCCCC-------------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 000000000 0112345678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=303.17 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=199.5
Q ss_pred CCcCCeecccccccEEEEEeC----CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC------
Q 008012 293 FNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN------ 360 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 360 (581)
|.+.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 667889999999999999853 4688999998764 2344567889999999999999999999886532
Q ss_pred eeeEEEeccCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeec
Q 008012 361 FKALVLEFMPNGSLDKWLYSH-----NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDF 435 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 435 (581)
..++++||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999999887532 123688889999999999999999 899999999999999999999999999
Q ss_pred cCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCC
Q 008012 436 GISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHG 514 (581)
Q Consensus 436 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 514 (581)
|.+................++..|++||.+.+..++.++||||||+++|+|++ |++||..... ......+.......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~ 235 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGNRLK 235 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCCcCC
Confidence 99986543322222223345678999999988889999999999999999999 8899865322 11222222111000
Q ss_pred CCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 515 LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
. ...++..+.+++.+||..+|++|||+.|+++.|+++
T Consensus 236 ~-----------------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 Q-----------------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C-----------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 012345688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=300.19 Aligned_cols=252 Identities=24% Similarity=0.322 Sum_probs=208.6
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH-HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE-QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
++|++.+.||+|++|.||+|... +++.|++|.+..... .....+.+|++.+++++|+|++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36889999999999999999966 699999999877643 4557889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS-TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
+++++|.+++... ..+++..++.++.|+++|++||| + .+++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999876 34789999999999999999999 8 99999999999999999999999999999876433222
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....+..........+..
T Consensus 157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~--------- 223 (264)
T cd06623 157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDGPPPSL--------- 223 (264)
T ss_pred --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcCCCCCC---------
Confidence 1234578899999999998999999999999999999999999976432 122222222221111111
Q ss_pred hhhhHHHH-HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 528 NFFSARMD-CLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 528 ~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
... ++..+.+++.+||..+|++|||+.|++++
T Consensus 224 -----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 -----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011 45678899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=301.81 Aligned_cols=252 Identities=19% Similarity=0.315 Sum_probs=187.9
Q ss_pred CeecccccccEEEEEeCCC---cEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCC
Q 008012 297 NLLGSGGFGSVYKGILSDG---TTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNG 372 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 372 (581)
+.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999985433 346677665443 344568899999999999999999999999999999999999999
Q ss_pred CHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce
Q 008012 373 SLDKWLYSHN---YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI 449 (581)
Q Consensus 373 ~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 449 (581)
+|.+++.+.. ...++..+..++.||+.||+||| +.+++||||||+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999998542 23466778899999999999999 89999999999999999999999999999864322111112
Q ss_pred eeccccCccccCCCCCCC-------CCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 450 QTMTIATIGYMAPEFGSE-------GNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 450 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... ...+....... .....++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~----~~~~~~~ 232 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKDQ----QVKLFKP 232 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhhc----ccccCCC
Confidence 234457889999998743 245789999999999999997 5678754321 11112211111 1111111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
.+. ...++.+.+++..|| .+|++||+++||++.|.
T Consensus 233 ~~~---------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 QLE---------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccC---------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 113345778999999 67999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=303.76 Aligned_cols=256 Identities=24% Similarity=0.257 Sum_probs=202.1
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecC--CeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT--NFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 366 (581)
++|+..+.||.|++|.||+|... +++.+|+|.+.... ......+.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999975 68999999987543 34456789999999999999999999988653 4789999
Q ss_pred eccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 367 EFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 367 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
||+++++|.+++.. ....+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988763 3445788899999999999999999 89999999999999999999999999999875532
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHhhCCCCCCcccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG---EMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 520 (581)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ......++.......+.....
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 21 12345788899999999889999999999999999999999999764221 112222222111111111000
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.....++.+.+++.+||+.+|++|||+.|++++
T Consensus 234 -----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 234 -----------NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -----------CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 001234568899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=319.06 Aligned_cols=245 Identities=27% Similarity=0.427 Sum_probs=204.8
Q ss_pred cCCeecccccccEEEEEeC-CCcEEEEEEecc----chHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe--eeEEEe
Q 008012 295 ECNLLGSGGFGSVYKGILS-DGTTVAIKIFNL----QLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF--KALVLE 367 (581)
Q Consensus 295 ~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~e 367 (581)
....||+|+|-+||+|.+. +|..||=-.++. ..+...++|..|+.+|+.|+||||+++|+++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3468999999999999965 677765322222 135567899999999999999999999999987654 779999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec-CCCcEEEeeccCceecCCCCC
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
.+..|+|..|..+.+. .+.+.+..|++||++||.|||.+ ..+|+|||||-+||||+ ..|.|||+|+|+|.......
T Consensus 124 L~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred cccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 9999999999998876 68899999999999999999965 58999999999999998 45899999999999864332
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
....+|||.|||||++. ..|.+.+||||||+.+.||+|+..||.........+...+....|..+..+.|+
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP----- 271 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP----- 271 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH-----
Confidence 23478999999999987 689999999999999999999999998876655555555555555556555554
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
++.++|.+|+.. .++|||+.|++++
T Consensus 272 ------------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 272 ------------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ------------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 467999999999 8999999999875
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=306.30 Aligned_cols=260 Identities=24% Similarity=0.310 Sum_probs=203.5
Q ss_pred hhhhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecC
Q 008012 282 SYLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNT 359 (581)
Q Consensus 282 ~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 359 (581)
...++....++|++.+.||+|+||.||+|..+ +++.+|+|++..... ....+.+|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34556667899999999999999999999964 789999999865422 235677899999999 899999999998653
Q ss_pred -----CeeeEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEE
Q 008012 360 -----NFKALVLEFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAH 431 (581)
Q Consensus 360 -----~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~k 431 (581)
+..++||||+++++|.+++.. ....+++..++.++.|++.||+||| +.+++||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence 358999999999999998863 3445788999999999999999999 89999999999999999999999
Q ss_pred EeeccCceecCCCCCcceeeccccCccccCCCCCCCC-----CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHH
Q 008012 432 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG-----NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNW 506 (581)
Q Consensus 432 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~ 506 (581)
|+|||.+........ ......++..|+|||.+... .++.++|||||||++|||++|+.||...... .....
T Consensus 169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~- 244 (291)
T cd06639 169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFK- 244 (291)
T ss_pred Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHH-
Confidence 999999886543221 12234578899999987543 3688999999999999999999999764221 11111
Q ss_pred HHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 507 VKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
......+...+ +...+..+.++|.+||+.+|++||++.|++++
T Consensus 245 ---~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 ---IPRNPPPTLLH------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ---HhcCCCCCCCc------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111111111 11233468899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=301.87 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=202.4
Q ss_pred CCCcCCeecccccccEEEEEe-CCCcEEEEEEeccch------HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 292 GFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQL------EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
+|+..+.||+|++|.||+|.. .+++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999995 578999999986532 2245678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC-cEEEeeccCceecCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM-VAHVSDFGISKLLGE 443 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~ 443 (581)
||||+++++|.+++.+.+ .+++..+..++.|++.||+||| +.|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999997654 4688999999999999999999 89999999999999998775 699999999987643
Q ss_pred CCCc--ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 444 GDDS--VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 444 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
.... .......++..|+|||.+.+..++.++||||+|+++|+|++|..||..... ......+..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~---- 230 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH--SNHLALIFKIASATTAP---- 230 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--cchHHHHHHHhccCCCC----
Confidence 2111 112234578899999999888899999999999999999999999964321 11111111111100000
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+...+..+.+++.+||..+|++||++.|++++
T Consensus 231 ---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 231 ---------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ---------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0112344568899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=308.27 Aligned_cols=254 Identities=21% Similarity=0.247 Sum_probs=199.0
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||.||++... +++.|++|.+.... ......+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46889999999999999999965 68899999987653 234457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++++|.+++...+ .+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999997664 4788899999999999999999 89999999999999999999999999998864211000
Q ss_pred -------------cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 008012 447 -------------SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH 513 (581)
Q Consensus 447 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 513 (581)
........++..|+|||.+.+..++.++||||||+++|||++|+.||..... .++.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~~~~~~~ 231 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFGQVISD 231 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhc
Confidence 0011123567889999999888899999999999999999999999965321 1222211111
Q ss_pred CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 514 GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
....... ...++..+.+++.+||+.||++||++.++.+.|
T Consensus 232 ~~~~~~~------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 232 DIEWPEG------------DEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred ccCCCCc------------cccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 1000000 012455688999999999999999854444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=300.39 Aligned_cols=252 Identities=22% Similarity=0.363 Sum_probs=201.5
Q ss_pred CCCcCCeecccccccEEEEEeCC--CcEEEEEEeccc----------hHHHHHHHHHHHHHHHh-cCCCccceEeeeeec
Q 008012 292 GFNECNLLGSGGFGSVYKGILSD--GTTVAIKIFNLQ----------LEQAFRSFNSECEVLRN-VRHRNLIKILSSCCN 358 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 358 (581)
+|++.+.||+|+||.||+|..+. ++.+|+|.+... .......+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999653 788999987532 23344567788888876 699999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeec
Q 008012 359 TNFKALVLEFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDF 435 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 435 (581)
.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ ..+++|+||+|+||++++++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998853 34457889999999999999999993 368999999999999999999999999
Q ss_pred cCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCC
Q 008012 436 GISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGL 515 (581)
Q Consensus 436 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 515 (581)
|.+....... ......++..|+|||...+..++.++||||||+++|+|++|+.||.... .............
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~~~~~~~~~~~~~ 230 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----MLSLATKIVEAVY 230 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----HHHHHHHHhhccC
Confidence 9998754332 2334568889999999998889999999999999999999999986521 1111111111111
Q ss_pred CccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
..... ..++..+.+++.+||+.||++||++.|+.++++
T Consensus 231 ~~~~~-------------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EPLPE-------------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcCCc-------------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11000 123456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=305.66 Aligned_cols=245 Identities=27% Similarity=0.322 Sum_probs=202.2
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999965 68999999987543 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999998764 4788999999999999999999 899999999999999999999999999999876433
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+... ...++.
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~-~~~~~~--------- 219 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--PIQIYEKILEG-KVRFPS--------- 219 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcC-CccCCc---------
Confidence 233457899999999888889999999999999999999999997532 11111111110 001111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
..+..+.+++.+||..||++|+ +++|++++
T Consensus 220 --------~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 220 --------FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred --------cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1234678999999999999999 78888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=303.60 Aligned_cols=254 Identities=26% Similarity=0.331 Sum_probs=202.0
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCC-----
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTN----- 360 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~----- 360 (581)
...++|++.+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+++++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999965 688999999876543 336788999999999 7999999999986544
Q ss_pred -eeeEEEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeecc
Q 008012 361 -FKALVLEFMPNGSLDKWLYSH---NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 361 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
..++||||+++++|.+++... +..+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 589999999999999998753 356789999999999999999999 8999999999999999999999999999
Q ss_pred CceecCCCCCcceeeccccCccccCCCCCCC-----CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 008012 437 ISKLLGEGDDSVIQTMTIATIGYMAPEFGSE-----GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESL 511 (581)
Q Consensus 437 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 511 (581)
.+....... .......++..|+|||++.. ..++.++||||||+++|+|++|+.||...... ..... ..
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~----~~ 231 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFK----IP 231 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHH----hh
Confidence 998654322 12234468889999997653 35678999999999999999999999753211 11111 11
Q ss_pred CCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 512 PHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....+.. .....++..+.+++.+||..||++|||+.|++++
T Consensus 232 ~~~~~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 RNPPPTL------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ccCCCCC------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111 1112345678899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=301.18 Aligned_cols=251 Identities=22% Similarity=0.251 Sum_probs=197.9
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc-----hHHHHHHHHHHHHHHHhcCCCccceEeeeeecC--Cee
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ-----LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT--NFK 362 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 362 (581)
.+|++.+.||+|+||.||.|... ++..|++|.+... .....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999965 6899999987532 123456788999999999999999999988763 467
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+++++|.+++..... +++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 899999999999999986543 678889999999999999999 8999999999999999999999999999988653
Q ss_pred CCCCc-ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 443 EGDDS-VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 443 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
..... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||..... .... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~-~~~~~~~~~~---- 228 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAAI-FKIATQPTNP---- 228 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHHH-HHHhcCCCCC----
Confidence 22111 111233578899999999888899999999999999999999999975311 1111 1111111000
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+...+..+.+++.+|+. +|++||+++|++++
T Consensus 229 ---------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 229 ---------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0111334567789999995 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=308.37 Aligned_cols=268 Identities=21% Similarity=0.301 Sum_probs=200.7
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH-HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE-QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.++|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 468999999999999999999965 789999999865432 122346789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++ +|.+++......+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 9975 999999876667889999999999999999999 89999999999999999999999999999875432111
Q ss_pred ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC----CCcccc--
Q 008012 448 VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG----LPKIAD-- 520 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~-- 520 (581)
......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.........+.... ...... .+...+
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIF-RVLGTPTEETWPGVSSNP 236 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHH-HhcCCCChhhhhhhhhcc
Confidence 1122346788999998765 4588999999999999999999999975432111111111 111100 000000
Q ss_pred ----ccc--hhhhhhhhHHHHH--HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ----ANL--LREENFFSARMDC--LLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ----~~~--~~~~~~~~~~~~~--~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
... ............. ...+.+++.+||+.+|++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 0000000000111 2567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=301.12 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=204.1
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH--HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE--QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+|.+.+.||+|++|.||+|... +++.|++|.++.... ...+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999954 789999999876543 3667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|.+++.... ..++..+..++.|++.|++||| +.|++|+||+|+||++++++.+||+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999998754 3688899999999999999999 8999999999999999999999999999998764433211
Q ss_pred e--eeccccCccccCCCCCCCCC---CCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 449 I--QTMTIATIGYMAPEFGSEGN---VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 449 ~--~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
. .....++..|+|||++.+.. ++.++||||||+++|++++|+.||...... ......+.......++.
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~------ 229 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGAGHKPPIPD------ 229 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhcCCCCCCCc------
Confidence 1 11345788999999988766 889999999999999999999999753211 11111111111111111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...++..+.+++.+||+.+|++|||+.|++.+
T Consensus 230 ---------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 230 ---------SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred ---------ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11234567899999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=307.31 Aligned_cols=252 Identities=25% Similarity=0.332 Sum_probs=205.6
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
..++|.+.+.||+|+||.||++... ++..|++|.+........+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 3478999999999999999999854 788999999876554555678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++++|.+++.+.. +++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 97 YLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred cCCCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999999997643 578899999999999999999 89999999999999999999999999998876543322
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
......+++.|+|||.+.+..++.++||||||+++|++++|+.||........ ... +. ....+.
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~-~~---~~~~~~---------- 234 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL-IA---TNGTPE---------- 234 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eee-hh---cCCCCC----------
Confidence 12334688899999999888899999999999999999999999975322111 000 00 000000
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.......+..+.+++.+||..+|++||++.+++.|
T Consensus 235 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112344568899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.40 Aligned_cols=255 Identities=28% Similarity=0.443 Sum_probs=216.8
Q ss_pred CcCCeecccccccEEEEEe-CCC----cEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 294 NECNLLGSGGFGSVYKGIL-SDG----TTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 294 ~~~~~lg~G~~~~v~~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
...++||+|+||+||+|.+ ..| -+||+|++... ..+....+..|+-+|.+++|||++++++++..+. ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 4457899999999999995 344 35788988654 3455678999999999999999999999998776 889999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|++.|+|.+|++.++..+..+..+.|..|||+|+.||| +++++||||..+|||+.+-..+|+.|||+++....+...
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999998888888999999999999999999 899999999999999999999999999999998776665
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.......-.+.|||=|.+....|+.++|||||||++||++| |..|++.....+. +.+.+.
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-------------------~dlle~ 915 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-------------------PDLLEK 915 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-------------------hHHHhc
Confidence 54444455778999999999999999999999999999999 9999887533221 112222
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
+...+.+..|+.+++-++.+||..|++.||+++++...+.++..+
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 333556677889999999999999999999999999998887543
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=307.93 Aligned_cols=267 Identities=24% Similarity=0.284 Sum_probs=202.2
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
++|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999975 68999999886542 2234568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++++|.++..... .+++..++.++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 999999888776543 3789999999999999999999 89999999999999999999999999999987643321
Q ss_pred ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHh--hCCCCCCccc-----
Q 008012 448 VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKE--SLPHGLPKIA----- 519 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~----- 519 (581)
......++..|+|||++.+ ..++.++||||||+++|||++|++||...... ......... ..........
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccchH
Confidence 1223457889999998765 45788999999999999999999998653211 111111100 0000000000
Q ss_pred -----cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 -----DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 -----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+..............++..+.+++.+||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000001111122456779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=309.01 Aligned_cols=194 Identities=23% Similarity=0.289 Sum_probs=159.0
Q ss_pred CeecccccccEEEEEeC---CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeec--CCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS---DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN--TNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 371 (581)
.+||+|+||.||+|..+ ++..||+|.+..... ...+.+|++++++++||||+++++++.. ....++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 58999999999999964 457899998875432 2356789999999999999999998854 5578999999865
Q ss_pred CCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe----cCCCcEEEeeccCce
Q 008012 372 GSLDKWLYSH--------NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL----DENMVAHVSDFGISK 439 (581)
Q Consensus 372 ~~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill----~~~~~~kl~Dfg~a~ 439 (581)
+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||++.
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 888877522 224678889999999999999999 8999999999999999 466799999999998
Q ss_pred ecCCCCCc-ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCcc
Q 008012 440 LLGEGDDS-VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEM 496 (581)
Q Consensus 440 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~ 496 (581)
........ .......++..|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76433221 11233467899999998876 45899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=307.80 Aligned_cols=248 Identities=22% Similarity=0.300 Sum_probs=199.8
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCC
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
|+....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444557999999999999964 7899999998765444456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
++|.+++... .+++..++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++........ ...
T Consensus 103 ~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 175 (297)
T cd06659 103 GALTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK 175 (297)
T ss_pred CCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence 9999987653 3688999999999999999999 89999999999999999999999999999875533221 123
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+........ .
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~---------------~ 238 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPPKL---------------K 238 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCCCc---------------c
Confidence 35688999999999888999999999999999999999999875321 111111111110000 0
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.....+..+.+++.+||..+|++||++++++++
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 011234567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=303.76 Aligned_cols=248 Identities=26% Similarity=0.334 Sum_probs=199.9
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
...|+..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356889999999999999999965 7899999988643 234446788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||++ |++.+++......+++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99997 5788877765556899999999999999999999 899999999999999999999999999998765322
Q ss_pred CcceeeccccCccccCCCCCC---CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 446 DSVIQTMTIATIGYMAPEFGS---EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
....++..|+|||++. ...++.++||||||+++|||+||+.||...... ...........+..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~---- 234 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQNDSPTL---- 234 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHHHHHhcCCCCCC----
Confidence 2345788999999864 456889999999999999999999998653211 11111111111110
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
....++..+.+++.+||..+|++||++.+++.+.
T Consensus 235 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 235 ---------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ---------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0113456788999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=295.81 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=207.6
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccC
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMP 370 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 370 (581)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|++++++++||+++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4788899999999999999975 789999999987765566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCccee
Q 008012 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 450 (581)
+++|.+++......+++..+..++.|++.||++|| ..|++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999877556899999999999999999999 89999999999999999999999999999987654332 2
Q ss_pred eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhh
Q 008012 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFF 530 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (581)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....... ...+...+.
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~---~~~~~~~~~--------- 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--ALFKIAT---NGPPGLRNP--------- 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHh---cCCCCcCcc---------
Confidence 34567889999999988889999999999999999999999987532111 1111111 111111111
Q ss_pred hHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 531 SARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 531 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..++..+.+++.+||..||++|||+.|++++
T Consensus 221 ---~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 ---EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ---cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1124568899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=301.76 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=200.4
Q ss_pred CCCcCCeecccccccEEEEEe-CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhcC---CCccceEeeeeecCCeeeEEE
Q 008012 292 GFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVR---HRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~ 366 (581)
.|+..+.||+|+||.||+|.. .+++.|++|.+.... ......+.+|+.++++++ |||++++++++...+..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 478889999999999999995 478999999987542 344567888999999996 999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++++|.+++... .+++..++.++.|++.||.||| +.|++|+||+|+||++++++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998764 4788999999999999999999 89999999999999999999999999999987654331
Q ss_pred cceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 447 SVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ..+........+....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~----- 224 (277)
T cd06917 157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLIPKSKPPRLED----- 224 (277)
T ss_pred --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhccccCCCCCCCc-----
Confidence 1233468889999998765 45789999999999999999999999753211 1111110001111100
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+.++.+++.+||+.||++||++.|++++
T Consensus 225 --------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 --------NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0134568899999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=287.66 Aligned_cols=253 Identities=22% Similarity=0.266 Sum_probs=201.8
Q ss_pred hhcCCCcC-CeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeec----CCe
Q 008012 289 ATDGFNEC-NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCN----TNF 361 (581)
Q Consensus 289 ~~~~y~~~-~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~ 361 (581)
++++|++. ++||-|-.|.|-.+..+ +|+.+|+|++... ....+|++..-.. .|||||.++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 44566554 56899999999999865 8999999988644 3456788876666 69999999999864 346
Q ss_pred eeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec---CCCcEEEeeccC
Q 008012 362 KALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD---ENMVAHVSDFGI 437 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~ 437 (581)
..+|||.|+||.|...+++++ ..+++.++..|+.||..|++||| +.+|.||||||+|+|.+ .+..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence 679999999999999999764 45799999999999999999999 99999999999999997 455899999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
|+.-.. ........-|+.|.|||++...+|+..+|+||+||++|-|++|.+||........ ..-++.....+.-.
T Consensus 211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--spgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKRRIRTGQYE 285 (400)
T ss_pred ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC--ChhHHhHhhccCcc
Confidence 986432 2233456789999999999999999999999999999999999999987533211 11111111111111
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+ ..+.+...++...++|+.+|..+|.+|.|+.|+++|
T Consensus 286 F----------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 286 F----------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred C----------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1 134566788899999999999999999999999876
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=301.67 Aligned_cols=249 Identities=22% Similarity=0.275 Sum_probs=201.3
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccC
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMP 370 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 370 (581)
.|...+.||+|++|.||++... +++.+++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3555679999999999999954 789999999876655555678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCccee
Q 008012 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 450 (581)
+++|.+++... .+++..+..++.|++.||+||| +.|++||||+|+||+++.++.++|+|||.+....... ...
T Consensus 100 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~ 172 (285)
T cd06648 100 GGALTDIVTHT--RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRR 172 (285)
T ss_pred CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccc
Confidence 99999999873 4688999999999999999999 8999999999999999999999999999887553221 112
Q ss_pred eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhh
Q 008012 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFF 530 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (581)
....++..|+|||...+..++.++||||||+++|+|++|+.||..... ............+....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~---------- 237 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKRIRDNLPPKLKN---------- 237 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHHhcCCCCCcc----------
Confidence 334688999999999888899999999999999999999999865211 11111111111011000
Q ss_pred hHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 531 SARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 531 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...++..+.+++.+||..+|++|||+.+++++
T Consensus 238 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 238 --LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred --cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 11234568899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=301.81 Aligned_cols=248 Identities=26% Similarity=0.302 Sum_probs=203.2
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
+|++.+.||.|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++.+.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999965 68999999997543 2456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++++|.+++... ..+++..+..++.|+++||.||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999876 35788999999999999999999 8999999999999999999999999999988664332
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
......++..|+|||...+..++.++|+||||+++|+|++|+.||...... .......... ....
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~-~~~~----------- 219 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQE-TADV----------- 219 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhc-cccc-----------
Confidence 123446788999999998888999999999999999999999999764321 1111111111 0000
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCH--HHHHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYM--KDAAT 563 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~--~evl~ 563 (581)
..+...+..+.++|.+||..||.+||++ +|+++
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 220 ---LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ---cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 0111234678899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=309.08 Aligned_cols=253 Identities=27% Similarity=0.341 Sum_probs=203.4
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH---HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|+..+.||+|++|.||+|... +++.||+|.+..... ...+.+..|+++++.++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999965 589999999976532 34567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 367 EFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 367 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
||+.+++|.+++... +..+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999999854 345788999999999999999999 8999999999999999999999999999987653221
Q ss_pred Ccc---------------------------eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Q 008012 446 DSV---------------------------IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFT 498 (581)
Q Consensus 446 ~~~---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~ 498 (581)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 100 11123578889999999988899999999999999999999999975322
Q ss_pred ccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC----HHHHHHH
Q 008012 499 GEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLY----MKDAATK 564 (581)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~evl~~ 564 (581)
. ..+........ ..+ .....+..+.+++.+||..||++||| ++|++++
T Consensus 238 ~-~~~~~~~~~~~--~~~---------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 D-ETFSNILKKEV--TFP---------------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred H-HHHHHHhcCCc--cCC---------------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 1 11111111000 000 00114567889999999999999999 8888775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=298.79 Aligned_cols=247 Identities=25% Similarity=0.364 Sum_probs=201.6
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
-|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4778889999999999999864 78999999986443 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce
Q 008012 370 PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI 449 (581)
Q Consensus 370 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 449 (581)
++++|.+++... .+++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06641 85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--h
Confidence 999999998754 3688999999999999999999 89999999999999999999999999999876543221 1
Q ss_pred eeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 450 QTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 450 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
.....++..|+|||.+.+..++.++|+|||||++|+|++|..||...... .....+... ..+. .+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~---~~~~-~~--------- 222 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLIPKN---NPPT-LE--------- 222 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHHhcC---CCCC-CC---------
Confidence 22345788999999998888999999999999999999999998753211 111111111 1110 00
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..++..+.+++.+||+.+|++||++.+++++
T Consensus 223 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 ----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1234568899999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=282.62 Aligned_cols=251 Identities=25% Similarity=0.274 Sum_probs=203.6
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEEec
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+.+.+..||+|+.|.||+++.+ +|...|||.+.... .++.+++...++++..- ++|.||+.+|+|..+..+++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3455677999999999999955 78999999997764 45667888888888777 499999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
|. ..+..++..-..++++..+-++...+++||.||.+ +++|+|||+||+|||+|+.|.+||||||.+-.+.+. .
T Consensus 173 Ms-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---k 246 (391)
T KOG0983|consen 173 MS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---K 246 (391)
T ss_pred HH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc---c
Confidence 84 36677777666668888888999999999999998 889999999999999999999999999999876433 3
Q ss_pred eeeccccCccccCCCCCCC---CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 449 IQTMTIATIGYMAPEFGSE---GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
..+...|-+.|||||.+.. ..|+.++||||||++++||.||+.||.....+-..+.. +....++.++
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk-vln~ePP~L~--------- 316 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK-VLNEEPPLLP--------- 316 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH-HHhcCCCCCC---------
Confidence 3455678999999998764 47888999999999999999999999875333322222 2223222221
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+..++.+.+++..||.+|+.+||...++++|
T Consensus 317 ------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 ------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 122356678899999999999999999999986
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=295.94 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=207.3
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecC--CeeeEEE
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT--NFKALVL 366 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 366 (581)
+|...+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++||||+++++.+.+. +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999966 78999999987664 24567889999999999999999999999888 8899999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++++|.+++.... .+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999998765 5789999999999999999999 89999999999999999999999999999987754432
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC-CCCCccccccchh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLP-HGLPKIADANLLR 525 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 525 (581)
........++..|+|||...+..++.++||||||+++|+|++|..||..... .......... ...+.
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~-------- 224 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYKIGSSGEPPE-------- 224 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHhccccCCCcC--------
Confidence 1123345688899999999888899999999999999999999999976431 1111111110 11111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+...+..+.+++.+|+..+|++||++.|++++
T Consensus 225 ------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 225 ------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111235678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=302.91 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=208.3
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
...+.|+..+.||+|++|.||+|..+ ++..|++|++..... ..+.+.+|++.+++++|+|++++++.+...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45677999999999999999999976 789999999987654 4567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++++|.+++......+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999999987656899999999999999999999 89999999999999999999999999998875533221
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ....... . ...+...
T Consensus 172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~-~---~~~~~~~------- 237 (286)
T cd06614 172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLIT-T---KGIPPLK------- 237 (286)
T ss_pred --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-h---cCCCCCc-------
Confidence 112335778999999998888999999999999999999999998653211 1111111 1 1111111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....++..+.+++.+||+.+|.+|||+.+++++
T Consensus 238 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 -----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -----chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 112245678899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=304.24 Aligned_cols=267 Identities=21% Similarity=0.261 Sum_probs=201.6
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH--HHHHHHHHHHHHHHhcCCCccceEeeeeecC--CeeeE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE--QAFRSFNSECEVLRNVRHRNLIKILSSCCNT--NFKAL 364 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 364 (581)
.++|++.+.||+|++|.||+|..+ +++.+++|.++.... .....+.+|++++++++||||+++++++... +..++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357999999999999999999976 688999999875432 2233567899999999999999999998877 88999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+++ +|.+++......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||.+......
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999975 999999876666899999999999999999999 899999999999999999999999999999876543
Q ss_pred CCcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---------
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG--------- 514 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~--------- 514 (581)
.. ......++..|+|||.+.+. .++.++||||+|+++|+|++|++||...... ...... .......
T Consensus 160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKI-FKLLGTPTEKIWPGFS 235 (293)
T ss_pred cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHH-HHHhCCCchHHHHHhh
Confidence 21 12334578889999987654 4688999999999999999999999763221 111111 1111100
Q ss_pred -CCccccccchhhh--hhhhHHHH--HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 515 -LPKIADANLLREE--NFFSARMD--CLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 515 -~~~~~~~~~~~~~--~~~~~~~~--~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
++........... ........ .++.+.++|.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000000000 00000011 35678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=304.46 Aligned_cols=267 Identities=22% Similarity=0.261 Sum_probs=202.5
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
++|++.+.||+|++|.||+|..+ +++.|++|.++... ......+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46889999999999999999965 68899999987542 3334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|++++.+..+.... ..+++..++.++.||+.||.||| +.+++|+||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 99987666655443 44788999999999999999999 88999999999999999999999999999987654332
Q ss_pred ceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC---CCCccc--cc
Q 008012 448 VIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH---GLPKIA--DA 521 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~--~~ 521 (581)
.......++..|+|||++.+. .++.++||||||+++|+|++|++||...... ............ ...... +.
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhcccCc
Confidence 122334678889999998887 8899999999999999999999999753211 111111110000 000000 00
Q ss_pred cchh--------hhh-hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 NLLR--------EEN-FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ~~~~--------~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.... ... ....+..++.++.++|++||..+|++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000 000 000111246789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=299.66 Aligned_cols=261 Identities=20% Similarity=0.227 Sum_probs=196.9
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcC-CCccceEeeeeecC--CeeeEEEe
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVR-HRNLIKILSSCCNT--NFKALVLE 367 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e 367 (581)
|++.+.||+|+||.||+|... +++.||+|.++... ........+|+.+++++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677889999999999999954 78999999987542 122233457889999985 99999999999887 88999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|++ +++.+++......+++..++.++.|++.||+||| +.|++||||+|+||+++. +.+||+|||.+........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 997 4888888876566899999999999999999999 899999999999999999 9999999999986643222
Q ss_pred ceeeccccCccccCCCCCC-CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCC----------
Q 008012 448 VIQTMTIATIGYMAPEFGS-EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP---------- 516 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------- 516 (581)
.....++..|+|||.+. +..++.++||||+||++|||++|.+||..... ................
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 12345788999999654 45678899999999999999999999965321 1111122111111100
Q ss_pred --ccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 517 --KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 517 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....+.... .........++..+.++|.+||+.+|++|||+++++++
T Consensus 231 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKG-TGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCccccc-ccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 00011123457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=296.52 Aligned_cols=249 Identities=21% Similarity=0.245 Sum_probs=196.5
Q ss_pred hHHHhhcCCCcCCee--cccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCC
Q 008012 285 DLERATDGFNECNLL--GSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTN 360 (581)
Q Consensus 285 ~~~~~~~~y~~~~~l--g~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 360 (581)
+.....++|++.+.+ |+|+||.||++..+ +++.+|+|.+....... .|+.....+ +||||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 344455678888887 99999999999954 78899999987542211 122222223 7999999999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC-cEEEeeccCce
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM-VAHVSDFGISK 439 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~ 439 (581)
..++||||+++++|.+++.... .++++.+..++.|+++||.||| +.|++||||||+||+++.++ .++|+|||.+.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 9999999999999999998765 5799999999999999999999 89999999999999999988 99999999988
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
..... ....++..|+|||++.+..++.++||||+|+++|+|++|+.||............+.... ....
T Consensus 159 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~---- 227 (267)
T PHA03390 159 IIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKL---- 227 (267)
T ss_pred ecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccC----
Confidence 65422 123578899999999998999999999999999999999999985433332333332221 1110
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-HHHHHHH
Q 008012 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLY-MKDAATK 564 (581)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~ 564 (581)
.....++..+.+++.+||+.+|.+||+ ++|+++|
T Consensus 228 -----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 228 -----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 011134567889999999999999996 6998864
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=305.93 Aligned_cols=268 Identities=23% Similarity=0.270 Sum_probs=201.3
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH--HHHHHHHHHHHHHHhcCCCccceEeeeeecC--Ceee
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE--QAFRSFNSECEVLRNVRHRNLIKILSSCCNT--NFKA 363 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 363 (581)
..++|++.+.||+|+||.||+|..+ +|+.||+|.++.... .....+.+|++++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3578999999999999999999965 799999999875432 1123456799999999999999999998754 5689
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+.+ +|.+++......+++..+..++.|++.||+||| +.|++||||||+||++++++.+||+|||.+.....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 99999965 899988876666899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc---
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA--- 519 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 519 (581)
.... .....++..|+|||.+.+ ..++.++||||+||++|||++|++||..... ......+............
T Consensus 161 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCChhhchhh
Confidence 3211 122345778999998765 5678999999999999999999999975321 1111212221111100000
Q ss_pred -cc------cchhhh--hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 -DA------NLLREE--NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 -~~------~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+. ...... .........++.+.++|.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 000000 0000111235678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.56 Aligned_cols=264 Identities=23% Similarity=0.294 Sum_probs=204.5
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH--HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE--QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
|++.+.||+|++|.||+|... +++.+++|.+..... .....+.+|++++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 677889999999999999965 789999999876532 24567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce
Q 008012 370 PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI 449 (581)
Q Consensus 370 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 449 (581)
++ ++.+++......+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 75 899888876566899999999999999999999 8999999999999999999999999999998765433 11
Q ss_pred eeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCC----cccc----
Q 008012 450 QTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP----KIAD---- 520 (581)
Q Consensus 450 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~---- 520 (581)
.....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||..... ......+.+......+ ...+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 2234578889999988776 789999999999999999999999865321 1111111111111100 0000
Q ss_pred --ccchh--hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 --ANLLR--EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 --~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..... ..........++.++.++|.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000 000011223467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=303.76 Aligned_cols=265 Identities=23% Similarity=0.295 Sum_probs=199.4
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+|+.++.||.|++|.||+|..+ +++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4888999999999999999965 78999999887543 22335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 369 MPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 369 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
+. ++|.+++... ...+++..+..++.|++.||+||| +.+++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 96 5899888753 345788999999999999999999 899999999999999999999999999998765432211
Q ss_pred ceeeccccCccccCCCCCCCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc-----c
Q 008012 448 VIQTMTIATIGYMAPEFGSEGN-VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD-----A 521 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 521 (581)
.....++..|+|||.+.+.. ++.++||||||+++|+|+||+.||...... ....+.+...... ...... +
T Consensus 157 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (284)
T cd07860 157 --YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTP-DEVVWPGVTSLP 232 (284)
T ss_pred --cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCC-ChhhhhhhhHHH
Confidence 22335678899999876644 688999999999999999999999753211 1122222111100 000000 0
Q ss_pred ----cchh--hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 ----NLLR--EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ----~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.... ..........++..+.++|.+||+.||++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000 000001112245668899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=302.67 Aligned_cols=247 Identities=25% Similarity=0.334 Sum_probs=199.3
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.|+..+.||+|+||.||+|... ++..||+|.+... ..+....+.+|++++++++|||++++++++.+.+..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3777889999999999999954 7899999998643 23444678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++ ++.+.+......+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 9975 888888766666899999999999999999999 899999999999999999999999999998754322
Q ss_pred ceeeccccCccccCCCCC---CCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 448 VIQTMTIATIGYMAPEFG---SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
....++..|+|||++ .++.++.++|||||||++|||++|+.||...... .....+.....+ ..
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~----~~------ 244 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESP----TL------ 244 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccCC----CC------
Confidence 234578899999986 3457889999999999999999999998653111 111111111110 00
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
....++..+.+++.+||+.+|++||++.+++++..
T Consensus 245 -------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 245 -------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 01123456889999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=310.74 Aligned_cols=264 Identities=21% Similarity=0.220 Sum_probs=199.9
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecC-----
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT----- 359 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 359 (581)
...++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35688999999999999999999965 7999999998643 233445677899999999999999999988543
Q ss_pred -CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 360 -NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 360 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
...++||||+.+ +|.+.+... ++...+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 357999999964 888887654 688899999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc-
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK- 517 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~- 517 (581)
........ .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... .......+ ........+
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~-~~~~~~~~~~ 240 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNKII-EQLGTPSDEF 240 (353)
T ss_pred eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHH-HhcCCCCHHH
Confidence 87543221 2234578899999999999999999999999999999999999965311 11111111 111000000
Q ss_pred -------------------------cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 -------------------------IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 -------------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
........ ..........+..+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFP-PDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccC-cccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 00000011245668899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=340.20 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=207.6
Q ss_pred HHhhcCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
....-+|.....||.|.||.||.|. ..+|+..|+|-++..+ ......+.+|..++..++|||+|++||+-.+.+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3455678888999999999999999 5589999999887654 334456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
|.||||++|+|.+.+...+. .++.....+..|++.|++||| ++|||||||||+||+++.+|.+|++|||.|..+..
T Consensus 1311 IFMEyC~~GsLa~ll~~gri-~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRI-EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHhccCcHHHHHHhcch-hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999999876554 466666778999999999999 89999999999999999999999999999998765
Q ss_pred CCCcc--eeeccccCccccCCCCCCCC---CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 444 GDDSV--IQTMTIATIGYMAPEFGSEG---NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 444 ~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
..... .-....||+.|||||++.+. ...-+.||||+|||+.||+||+.||..... +......+.....+.+|.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-e~aIMy~V~~gh~Pq~P~- 1464 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-EWAIMYHVAAGHKPQIPE- 1464 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-hhHHHhHHhccCCCCCch-
Confidence 42111 12345799999999988764 356689999999999999999999987533 222222222222222222
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+.+-.+++..||..||++|.++.|++++
T Consensus 1465 ----------------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1465 ----------------RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----------------hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 245567799999999999999999998876
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=298.38 Aligned_cols=242 Identities=23% Similarity=0.274 Sum_probs=187.8
Q ss_pred eecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHh---cCCCccceEeeeeecCCeeeEEEeccC
Q 008012 298 LLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRN---VRHRNLIKILSSCCNTNFKALVLEFMP 370 (581)
Q Consensus 298 ~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~---l~h~~iv~~~~~~~~~~~~~lv~e~~~ 370 (581)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..+++. .+||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 68999999886542 1222233444444433 479999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCccee
Q 008012 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 450 (581)
+++|.+++...+. +++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++....... .
T Consensus 81 ~~~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 152 (279)
T cd05633 81 GGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (279)
T ss_pred CCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence 9999999876554 789999999999999999999 8999999999999999999999999999987653221 1
Q ss_pred eccccCccccCCCCCC-CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 451 TMTIATIGYMAPEFGS-EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
....|+..|+|||... +..++.++||||+||++|+|++|..||........ .. +....... . .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~-~~~~~~~~-~----~-------- 216 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HE-IDRMTLTV-N----V-------- 216 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HH-HHHHhhcC-C----c--------
Confidence 2346899999999876 45688999999999999999999999976422211 11 11111000 0 0
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
..+..++.++.+++.+||+.||++|| |++|+++|
T Consensus 217 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 -ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 01113455788999999999999999 69999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=295.14 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=202.2
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+|++.+.||+|+||.||+|..+ +|..+|+|.+.... ....+.+.+|++++++++|+||+++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999965 68899999986642 23345778999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC-cEEEeeccCceecCCCCC
Q 008012 369 MPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM-VAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 369 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 446 (581)
+++++|.+++.... ..+++..+..++.|+++||+||| +.+++|+||||+||++++++ .++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999997643 34688999999999999999999 89999999999999999875 569999999986643221
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
......|+..|+|||+..+..++.++|+||||+++|+|++|..||.... ..+.+............
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~------- 223 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGYFAPIS------- 223 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcccCCCCC-------
Confidence 1223458889999999888889999999999999999999999986532 22222222222111111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+..+.+++.+||..+|++|||+.|++++
T Consensus 224 -------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 -------PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -------CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1223468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=292.48 Aligned_cols=249 Identities=26% Similarity=0.381 Sum_probs=206.4
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+|++.+.||+|++|.||++... ++..+++|++.... ......+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999965 78999999987653 24556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 369 MPNGSLDKWLYSH---NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 369 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
+++++|.+++... +..+++..+..++.+++.||.||| +.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999865 366899999999999999999999 8899999999999999999999999999998764432
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
.......+++.|+|||...+..++.++|+||+|+++|+|++|+.||.... ..+.............
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~------- 223 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQYPPI------- 223 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCCCCCC-------
Confidence 12233467889999999888889999999999999999999999986532 1122222111111111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+..++..+.+++.+||..+|++|||+.|++++
T Consensus 224 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 -------PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.98 Aligned_cols=271 Identities=24% Similarity=0.278 Sum_probs=203.4
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC---
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN--- 360 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 360 (581)
+...++|++.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 356788999999999999999999975 68999999987543 222346778999999999999999999987654
Q ss_pred -------eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEe
Q 008012 361 -------FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVS 433 (581)
Q Consensus 361 -------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~ 433 (581)
..++|+||+++ ++.+++......+++..+..++.|++.||+||| +.||+|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 788877766556899999999999999999999 8999999999999999999999999
Q ss_pred eccCceecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 008012 434 DFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLP 512 (581)
Q Consensus 434 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 512 (581)
|||.+........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||.... ....+.. +.....
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~-~~~~~~~-~~~~~~ 235 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ-ELAQLEL-ISRLCG 235 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHH-HHHHhC
Confidence 9999987643322 11122345778999997754 457889999999999999999999997532 1111111 222111
Q ss_pred CC----CCccccccchh--------hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 513 HG----LPKIADANLLR--------EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 513 ~~----~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.. .+.+....... ..........++..+.+++.+||..||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 11111100000 000011112346778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.38 Aligned_cols=272 Identities=16% Similarity=0.156 Sum_probs=192.2
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC--CCcEEEEEE--------------ecc---chHHHHHHHHHHHHHHHhcCCCc
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS--DGTTVAIKI--------------FNL---QLEQAFRSFNSECEVLRNVRHRN 348 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~--~~~~vavK~--------------~~~---~~~~~~~~~~~e~~~l~~l~h~~ 348 (581)
...++|++++.||+|+||.||++..+ ++..++.|. +.+ ........+.+|+.++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998753 222222221 110 11223456889999999999999
Q ss_pred cceEeeeeecCCeeeEEEeccCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe
Q 008012 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHN----YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL 424 (581)
Q Consensus 349 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill 424 (581)
|+++++++.+.+..++|+|++. +++.+++.... .......+..++.||+.||+||| ++||+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 9999999999999999999985 57888776432 12345667889999999999999 8999999999999999
Q ss_pred cCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCC-CCccccc-ccc
Q 008012 425 DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP-TDEMFTG-EMN 502 (581)
Q Consensus 425 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~P-f~~~~~~-~~~ 502 (581)
+.++.+||+|||++..+..... .......|+..|+|||++.+..++.++|||||||++|||++|..+ |...... ...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999987643322 122345689999999999999999999999999999999998754 4322111 112
Q ss_pred HHHHHHhhC--CCCCCccc-------cc-cchh---hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 503 LKNWVKESL--PHGLPKIA-------DA-NLLR---EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 503 ~~~~~~~~~--~~~~~~~~-------~~-~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+.+.+.... ...+++.. +. .+.. .....-.....+..+.+++.+||..||++|||+.|++++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 222221110 00011100 00 0000 000001111244567889999999999999999999986
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=293.81 Aligned_cols=247 Identities=28% Similarity=0.350 Sum_probs=203.5
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+|++.+.||+|++|.||++..+ +++.+++|.+.... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5788999999999999999855 78899999987642 33456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 369 MPNGSLDKWLYSH---NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 369 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
+++++|.+++.+. +..+++..++.++.|++.||+||| +.|++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998752 345788999999999999999999 899999999999999999999999999999876443
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..... ..+...+.. ...+..
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~---~~~~~~------- 221 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--QDLRYKVQR---GKYPPI------- 221 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhc---CCCCCC-------
Confidence 12234578899999999998999999999999999999999999975321 111111111 111111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...++..+.+++.+||..+|++||++.|++++
T Consensus 222 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 -------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -------chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11344568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=298.82 Aligned_cols=245 Identities=22% Similarity=0.303 Sum_probs=199.4
Q ss_pred CCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCH
Q 008012 296 CNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSL 374 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 374 (581)
...||+|+||.||++..+ +++.||+|.+..........+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999864 7899999998765555566789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccc
Q 008012 375 DKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI 454 (581)
Q Consensus 375 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 454 (581)
.+++... .+++..+..++.|++.|++||| +.|++||||+|+||+++.++.++|+|||.+....... .......
T Consensus 105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 177 (292)
T cd06657 105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV 177 (292)
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence 9987543 3688999999999999999999 8999999999999999999999999999987653321 1123345
Q ss_pred cCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHH
Q 008012 455 ATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARM 534 (581)
Q Consensus 455 ~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (581)
++..|+|||...+..++.++|+||+|+++|+|++|..||... ........+....+..+.. ..
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~---------------~~ 240 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPKLKN---------------LH 240 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhhCCcccCC---------------cc
Confidence 788999999988888999999999999999999999998652 1111222222222211111 11
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 535 DCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 535 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.++..+.+++.+||..+|.+||++.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 234467899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=308.39 Aligned_cols=273 Identities=23% Similarity=0.288 Sum_probs=201.4
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecC-----Ce
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT-----NF 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 361 (581)
..++|++.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.++++++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999954 78999999986432 33445678899999999999999999987544 35
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
.++|+||+++ ++.+++... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++...
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 7999999965 888877543 4788999999999999999999 899999999999999999999999999999865
Q ss_pred CCCCCcc-eeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc--
Q 008012 442 GEGDDSV-IQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK-- 517 (581)
Q Consensus 442 ~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-- 517 (581)
....... ......++..|+|||.+.+ ..++.++||||+||++|+|++|++||..... ......+.........+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHHH
Confidence 4322111 1123467889999997644 5688999999999999999999999965311 11111111111111000
Q ss_pred --cccccch---------hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHHhH
Q 008012 518 --IADANLL---------REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK--LKKIR 569 (581)
Q Consensus 518 --~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~~ 569 (581)
+.+.... ...+........+.++.+++.+||+.||++|||+.|++++ ++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000000 0000001112345678899999999999999999999998 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.69 Aligned_cols=270 Identities=19% Similarity=0.275 Sum_probs=198.3
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC-----
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN----- 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 360 (581)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3467999999999999999999965 78999999886542 222335668999999999999999999986644
Q ss_pred ---eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccC
Q 008012 361 ---FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGI 437 (581)
Q Consensus 361 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 437 (581)
..++||||+.+ +|.+++......+++.+++.++.|++.||+||| ++|++|+||||+||+++.++.+||+|||.
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999964 888888876656899999999999999999999 88999999999999999999999999999
Q ss_pred ceecCCCCCc--ceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC--
Q 008012 438 SKLLGEGDDS--VIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLP-- 512 (581)
Q Consensus 438 a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-- 512 (581)
+......... .......++..|+|||.+.+. .++.++||||||+++|||++|++||..... ......+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--~~~~~~~~~~~~~~ 243 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--QHQLTLISQLCGSI 243 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCC
Confidence 9866432211 112234567889999987654 478899999999999999999999875321 111111111111
Q ss_pred -CC-CCccccccchh------hhh-hhh---HHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 513 -HG-LPKIADANLLR------EEN-FFS---ARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 513 -~~-~~~~~~~~~~~------~~~-~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.. .+...+..... ... ... ........+.++|.+||..||++|||++|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 10 11100000000 000 000 000123457799999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.41 Aligned_cols=269 Identities=20% Similarity=0.246 Sum_probs=198.4
Q ss_pred CCCcCCeecccccccEEEEEeC---CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecC--Ceee
Q 008012 292 GFNECNLLGSGGFGSVYKGILS---DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT--NFKA 363 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 363 (581)
+|++.+.||+|++|.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999964 47999999998743 33345678899999999999999999999888 7899
Q ss_pred EEEeccCCCCHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC----CCcEEEeec
Q 008012 364 LVLEFMPNGSLDKWLYSH----NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE----NMVAHVSDF 435 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~----~~~~kl~Df 435 (581)
+||||+++ ++.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 777776532 225788999999999999999999 899999999999999999 999999999
Q ss_pred cCceecCCCCC-cceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCcccccc--------ccHHH
Q 008012 436 GISKLLGEGDD-SVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE--------MNLKN 505 (581)
Q Consensus 436 g~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~--------~~~~~ 505 (581)
|++........ ........++..|+|||++.+ ..++.++||||||+++|+|++|++||....... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 112233457888999997765 457899999999999999999999997643322 01111
Q ss_pred HHHhhCCCC---------CCcccc---ccchhhhh------hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 506 WVKESLPHG---------LPKIAD---ANLLREEN------FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 506 ~~~~~~~~~---------~~~~~~---~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+....... .+.... ........ ........+..+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111000000 000000 00000000 000001345578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=292.89 Aligned_cols=242 Identities=28% Similarity=0.331 Sum_probs=196.4
Q ss_pred ecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCH
Q 008012 299 LGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSL 374 (581)
Q Consensus 299 lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 374 (581)
||.|++|.||+|... +++.|++|++.... ....+.+.+|+.+++.++||||+++++.+.+.+..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999965 68999999987543 23446789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccc
Q 008012 375 DKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI 454 (581)
Q Consensus 375 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 454 (581)
.+++.+... +++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~~~-l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhcCC-CCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 999987543 688899999999999999999 8999999999999999999999999999998764332 122346
Q ss_pred cCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHh-hCCCCCCccccccchhhhhhhhHH
Q 008012 455 ATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKE-SLPHGLPKIADANLLREENFFSAR 533 (581)
Q Consensus 455 ~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 533 (581)
++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....+.......+.. ......+
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------------- 216 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP----------------- 216 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC-----------------
Confidence 7889999999888889999999999999999999999997643211111111110 0000011
Q ss_pred HHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 008012 534 MDCLLSIFHLALDCCAELPDQRLY-----MKDAATK 564 (581)
Q Consensus 534 ~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 564 (581)
...+..+.+++.+||..+|++||+ ++|++++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 112456889999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=301.10 Aligned_cols=267 Identities=22% Similarity=0.260 Sum_probs=197.5
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH--HHHHHHHHHHHHHHhc-CCCccceEeeeeecCCe-----
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE--QAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNF----- 361 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~----- 361 (581)
++|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.+++.+ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46899999999999999999965 789999998865432 2235678899999999 46999999999877655
Q ss_pred eeEEEeccCCCCHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-CCcEEEeecc
Q 008012 362 KALVLEFMPNGSLDKWLYSH----NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE-NMVAHVSDFG 436 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg 436 (581)
.++||||+++ +|.+++... ...+++..++.++.||+.||+||| +++|+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 898888743 234789999999999999999999 899999999999999998 8999999999
Q ss_pred CceecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC-
Q 008012 437 ISKLLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG- 514 (581)
Q Consensus 437 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~- 514 (581)
.+..+...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....... .............
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhCCCCh
Confidence 99865322211 123356788999997755 467899999999999999999999997532111 1111111100000
Q ss_pred --CCccccccchhh------hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 515 --LPKIADANLLRE------ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 515 --~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+...+...... ..........+.++.++|.+||..||++||+++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000 00011112356778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=297.90 Aligned_cols=265 Identities=23% Similarity=0.290 Sum_probs=201.9
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecC--CeeeEEEe
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT--NFKALVLE 367 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 367 (581)
|++.+.||+|++|.||+|... +++.+|+|.+.... ......+.+|++++++++|||++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999966 68999999998663 33345688899999999999999999999887 88999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++ +|.+++......+++..++.++.|++.||+||| +.|++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 9975 899988876556899999999999999999999 88999999999999999999999999999987654332
Q ss_pred ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC----CCCccccc-
Q 008012 448 VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH----GLPKIADA- 521 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~- 521 (581)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...... +...... ..+...+.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEK-IFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH-HHHHhCCCchhhccccccch
Confidence 11233456788999997654 4678999999999999999999999976322 111111 1111110 01111000
Q ss_pred ---cchhh----hhhhhHHHH-HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 ---NLLRE----ENFFSARMD-CLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ---~~~~~----~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..... ......... ++..+.+++.+||..+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 000011111 36788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=305.92 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=208.8
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
.....|.+...||+|.|+.|.+|+.. ++..||+|.+.+.. ....+.+.+|+++|+.++|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34577999999999999999999954 89999999998764 3344568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+.+|.+.+++.+++...+ ..+..++.|+.+|++||| +++|+|||||++||+++.+..+||+|||++..+..+
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999999999887545 888999999999999999 899999999999999999999999999999988633
Q ss_pred CCcceeeccccCccccCCCCCCCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNV-SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
. .....+|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||++..-.+. -++.+
T Consensus 209 ~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----------------r~rvl 268 (596)
T KOG0586|consen 209 L---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----------------RPRVL 268 (596)
T ss_pred c---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----------------cchhe
Confidence 2 3456789999999999998776 5799999999999999999999986322111 11111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
.... ..+.-.+.+..++|++++..+|.+|+++++++++-
T Consensus 269 ~gk~---rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 269 RGKY---RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred eeee---cccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 1110 00011122355899999999999999999999874
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.05 Aligned_cols=254 Identities=25% Similarity=0.309 Sum_probs=196.5
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcC-CCccceEeeeeecCCeeeEEEe
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 367 (581)
++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++...+..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35666788999999999999965 78999999987543 344567889999999995 9999999999999999999999
Q ss_pred ccCCCCHHHHHh---h-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 368 FMPNGSLDKWLY---S-HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 368 ~~~~~~L~~~l~---~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
|++. ++.++.. . ....+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 6555432 2 23457889999999999999999993 35999999999999999999999999999976532
Q ss_pred CCCcceeeccccCccccCCCCCCCC---CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEG---NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||.... .....+........+....
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGDPPILSN 233 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCCCCcCCC
Confidence 221 1233578899999988776 68999999999999999999999997532 1111222221111111100
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.....++.++.+++.+||+.||++|||+++++++
T Consensus 234 ----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 234 ----------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0012355678899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=289.12 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=204.2
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH--HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE--QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+|++.+.||+|++|.||++... +++.|++|.+..... .....+.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5788999999999999999865 688999999976643 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|.+++.... .+++..++.++.|++.|+.||| +.|++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 99999999998763 4789999999999999999999 899999999999999999999999999999877543321
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ........ ....+..
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~~---------- 219 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIV-QDDHPPL---------- 219 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHh-ccCCCCC----------
Confidence 2334578899999998888889999999999999999999999875321 11111111 1111111
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+..++..+.+++.+||..+|++|||+.+++.+
T Consensus 220 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 220 ----PEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 01234567899999999999999999999863
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=295.50 Aligned_cols=244 Identities=23% Similarity=0.277 Sum_probs=194.3
Q ss_pred ecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCH
Q 008012 299 LGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSL 374 (581)
Q Consensus 299 lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 374 (581)
||+|+||+||+|... +|+.||+|.+.... ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999855 78999999986542 22344567899999999999999999999999999999999999999
Q ss_pred HHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeecc
Q 008012 375 DKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT 453 (581)
Q Consensus 375 ~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 453 (581)
.+++.... ..+++..+..++.|++.||.||| +.|++||||+|+||++++++.++|+|||.+....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence 99998654 35789999999999999999999 8999999999999999999999999999987653311 12334
Q ss_pred ccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHH
Q 008012 454 IATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSAR 533 (581)
Q Consensus 454 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (581)
.++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .............. . ..+
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~-~--------------~~~ 218 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEMA-V--------------EYP 218 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhcccccc-c--------------cCC
Confidence 5788999999988888999999999999999999999999753221 11111111111000 0 001
Q ss_pred HHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 534 MDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 534 ~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
...++.+.+++.+||+.||++|| ++.++++|
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 12345688999999999999999 77777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=298.40 Aligned_cols=266 Identities=21% Similarity=0.293 Sum_probs=201.0
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH-HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE-QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
+|++.+.||.|++|.||+|+.. +|+.||+|.++.... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999975 789999999876532 22356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 370 PNGSLDKWLYSHN--YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 370 ~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
++ +|.+++.... ..+++..+..++.|++.||+||| +.|++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8999887654 45789999999999999999999 89999999999999999999999999999975532211
Q ss_pred ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC---------CCCc
Q 008012 448 VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH---------GLPK 517 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~~ 517 (581)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ............. ..+.
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1123456888999998765 45788999999999999999999999764221 1111111111000 0000
Q ss_pred cccccch-hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IADANLL-REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....... ...........++..+.+++.+|++.||++||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 0000011112346778899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=299.11 Aligned_cols=265 Identities=24% Similarity=0.303 Sum_probs=199.6
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
|++.+.||.|++|.||+|..+ +|..||+|++.... ......+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678899999999999999965 79999999987553 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 370 PNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 370 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+ ++|.+++.... ..+++..++.++.|++.||+||| +.+++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 5 68999987654 35789999999999999999999 88999999999999999999999999999976532221
Q ss_pred eeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---------CCcc
Q 008012 449 IQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---------LPKI 518 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---------~~~~ 518 (581)
......++..|+|||++.+. .++.++||||||+++|+|++|++||...... .............. .++.
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 11233568899999987654 5788999999999999999999999753221 11112111110000 0000
Q ss_pred ccccc-hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 ADANL-LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..... .............+..+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 00000001122345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.35 Aligned_cols=269 Identities=21% Similarity=0.273 Sum_probs=201.8
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeec----CCee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCN----TNFK 362 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 362 (581)
.++|++.+.||+|++|.||+|..+ +++.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999955 79999999987542 2334567789999999999999999998753 3468
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+. ++|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999995 589998876544 789999999999999999999 8999999999999999999999999999997654
Q ss_pred CCCCc--ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 443 EGDDS--VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 443 ~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
..... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+............
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCCChhHhh
Confidence 32211 11123467889999998765 46889999999999999999999999653211 111111111111111110
Q ss_pred c----ccchh---------hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 520 D----ANLLR---------EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 520 ~----~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
+ ..+.. ...........+.++.+++.+||+.+|++|||+++++.+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0 00000 0000011123467799999999999999999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=279.84 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=203.8
Q ss_pred CeecccccccEEEEE-eCCCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEEeccCCCCH
Q 008012 297 NLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEFMPNGSL 374 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 374 (581)
+.||+|+|+.|--+. ..+|..+|||++.+.......++.+|++++.+. .|+||++++++|++++..|+|||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999999888 678999999999998877888999999999999 699999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC---cEEEeeccCceecCCCC-----C
Q 008012 375 DKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM---VAHVSDFGISKLLGEGD-----D 446 (581)
Q Consensus 375 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~---~~kl~Dfg~a~~~~~~~-----~ 446 (581)
..+|+++.. +++.++.++..+|+.||.+|| .+||.|||+||+|||..+.. -+|||||.++.-+.... .
T Consensus 164 LshI~~~~~-F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 164 LSHIQKRKH-FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred HHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 999998765 688999999999999999999 89999999999999997554 58999998876443211 1
Q ss_pred cceeeccccCccccCCCCCC-----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccc---------cHHHHHHhhCC
Q 008012 447 SVIQTMTIATIGYMAPEFGS-----EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM---------NLKNWVKESLP 512 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~---------~~~~~~~~~~~ 512 (581)
+.......|+..|||||+.. ...|+.++|.||||||+|-|++|.+||.+.-..+- .=.+..-+...
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 22234567889999999532 34688999999999999999999999976432111 00111112222
Q ss_pred CCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 513 HGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
++.-++.| ..+..++.+..+++...+..|+.+|.++.+++.|
T Consensus 320 EGkYeFPd----------kdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 320 EGKYEFPD----------KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred ccCCcCCh----------hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 22222222 2345677788899999999999999999999874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=326.25 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=197.9
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeee-------
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCC------- 357 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------- 357 (581)
.+...+|+..+.||+||||.||+++.+ ||+.+|||.+.... ......+.+|+..+.+++|||||++|..+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 356788999999999999999999987 99999999997663 445677899999999999999999873210
Q ss_pred ----------------------------------------------------c-------------------C-------
Q 008012 358 ----------------------------------------------------N-------------------T------- 359 (581)
Q Consensus 358 ----------------------------------------------------~-------------------~------- 359 (581)
. +
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0 0
Q ss_pred ----------------------------------CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh
Q 008012 360 ----------------------------------NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH 405 (581)
Q Consensus 360 ----------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH 405 (581)
...||=||||+...+.+++.++.........|+++++|++||+|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1247889999997888777766543356788999999999999999
Q ss_pred cCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC----------------CCCCcceeeccccCccccCCCCCCCC-
Q 008012 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG----------------EGDDSVIQTMTIATIGYMAPEFGSEG- 468 (581)
Q Consensus 406 ~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~~~~~y~aPE~~~~~- 468 (581)
++|||||||||.||++++++.|||+|||+|+... .+......+..+||.-|+|||++.+.
T Consensus 715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 8999999999999999999999999999998721 01122244567899999999988765
Q ss_pred --CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc---ccccchhhhhhhhHHHHHHHHHHHH
Q 008012 469 --NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI---ADANLLREENFFSARMDCLLSIFHL 543 (581)
Q Consensus 469 --~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~l 543 (581)
.|+.|+|+||+|||++||+. ||... +.....+.......++.. .++... .=..+
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----MERa~iL~~LR~g~iP~~~~f~~~~~~--------------~e~sl 850 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTS----MERASILTNLRKGSIPEPADFFDPEHP--------------EEASL 850 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCch----HHHHHHHHhcccCCCCCCcccccccch--------------HHHHH
Confidence 49999999999999999996 56553 233333333333333333 332221 23479
Q ss_pred HHhccCcCCCCCCCHHHHHHH
Q 008012 544 ALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 544 i~~cl~~dP~~Rps~~evl~~ 564 (581)
|+.|++.||.+||||.|++..
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhhc
Confidence 999999999999999999863
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=300.04 Aligned_cols=264 Identities=21% Similarity=0.214 Sum_probs=194.0
Q ss_pred cCCeecccccccEEEEEeCCCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCC
Q 008012 295 ECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNG 372 (581)
Q Consensus 295 ~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 372 (581)
+.+.+|.|+++.||++.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 334444444544444444 6899999998765 3455678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc----
Q 008012 373 SLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS---- 447 (581)
Q Consensus 373 ~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---- 447 (581)
+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||.+.........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999864 345788899999999999999999 899999999999999999999999999988765322211
Q ss_pred -ceeeccccCccccCCCCCCC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCC-----Cc--
Q 008012 448 -VIQTMTIATIGYMAPEFGSE--GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGL-----PK-- 517 (581)
Q Consensus 448 -~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~-----~~-- 517 (581)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.+....+..+ +.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhhc
Confidence 11123356778999998765 3588999999999999999999999976422211 1111111110000 00
Q ss_pred ---------cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 ---------IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+... ............+.++.+++.+||..||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 241 DSMSQSRSSNEHPNN-RDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CCcCcccccccccch-hhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 0001111223445678899999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=301.95 Aligned_cols=265 Identities=21% Similarity=0.281 Sum_probs=195.0
Q ss_pred Ceeccc--ccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSG--GFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G--~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
..||+| +||+||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 89999999964 79999999987542 34457889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc--
Q 008012 372 GSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV-- 448 (581)
Q Consensus 372 ~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 448 (581)
+++.+++.... ..+++..+..++.|++.||+||| +.|++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999988643 34788899999999999999999 8999999999999999999999999998654332111110
Q ss_pred ---eeeccccCccccCCCCCCCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCC-------
Q 008012 449 ---IQTMTIATIGYMAPEFGSEG--NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP------- 516 (581)
Q Consensus 449 ---~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~------- 516 (581)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||........ ..............
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccchh
Confidence 01112345679999998763 578999999999999999999999976432211 11111100000000
Q ss_pred --c-----------cccc--------cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 517 --K-----------IADA--------NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 517 --~-----------~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
. +.+. ......-..+....++..+.+++.+||..||++|||++|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0 0000 00000001122335677899999999999999999999999773
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=297.99 Aligned_cols=266 Identities=21% Similarity=0.270 Sum_probs=198.0
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
++|++.+.||+|++|.||+|..+ +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999965 78999999886542 2234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-CCcEEEeeccCceecCCCC
Q 008012 368 FMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE-NMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~ 445 (581)
|++ +++.+++.... ...++..+..++.||+.||+||| +++++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 48888876543 33578888899999999999999 899999999999999985 5679999999997653321
Q ss_pred CcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc----
Q 008012 446 DSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD---- 520 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 520 (581)
. ......++..|+|||.+.+ ..++.++||||+|+++|+|+||++||...... ........ ..........+
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFR-ILGTPNEETWPGVTS 233 (294)
T ss_pred c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-HhCCCChhhcccccc
Confidence 1 1223456889999998765 46789999999999999999999999753221 11111111 11111111000
Q ss_pred ---cc--ch--hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ---AN--LL--REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ---~~--~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.. .. ............++++.+++.+|++.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 0000001112345668899999999999999999999975
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.32 Aligned_cols=251 Identities=22% Similarity=0.250 Sum_probs=199.1
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc-----hHHHHHHHHHHHHHHHhcCCCccceEeeeeecC--Cee
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ-----LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT--NFK 362 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 362 (581)
.+|++.+.||+|++|.||+|... ++..|++|.+... .......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999964 7899999987532 234456788999999999999999999998764 468
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+++++|.+++..... +++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 899999999999999986544 688899999999999999999 8999999999999999999999999999998653
Q ss_pred CCCCc-ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 443 EGDDS-VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 443 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
..... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||..... .... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-~~~~~~~~~~~~-- 230 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAI-FKIATQPTKPML-- 230 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHH-HHHHcCCCCCCC--
Confidence 21111 111234578899999999888899999999999999999999999975311 1111 111111111111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+...++.+.+++.+||. +|.+||++.++++|
T Consensus 231 -----------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 231 -----------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -----------CcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11234568899999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=299.41 Aligned_cols=255 Identities=24% Similarity=0.269 Sum_probs=198.5
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 365 (581)
..++|++.+.||+|++|.||+|..+ +++.||+|.++... ......+..|+.++.+. .||||+++++++.+....++|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 4577899999999999999999976 58999999997543 23345566777777777 599999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||++ +++.+++......+++..+..++.|++.|++|||+ ..||+||||+|+||++++++.+||+|||.+..+....
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 99985 47888777655568899999999999999999993 2599999999999999999999999999987653322
Q ss_pred CcceeeccccCccccCCCCCCCCC----CCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGN----VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
. .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.........+...... ..+....
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~- 241 (296)
T cd06618 170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE----EPPSLPP- 241 (296)
T ss_pred c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC----CCCCCCC-
Confidence 1 12335778899999887553 7889999999999999999999996532211111111111 1111100
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
...++.++.+++.+||+.||++||++++++++-
T Consensus 242 -----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 242 -----------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -----------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 012345688999999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=283.59 Aligned_cols=251 Identities=23% Similarity=0.250 Sum_probs=207.3
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
...++|..+++||+|.||.|-+++-+ +++.+|+|+++++. .++...-..|-++++..+||.+..+--.|...++.|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 35678999999999999999999955 89999999999874 455666778999999999999999988999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||..||.|.-++.+.+. +++....-+-..|+.||.||| +++||.||+|.+|.|+|.+|++||.|||+++.--
T Consensus 245 FVMeyanGGeLf~HLsrer~-FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERV-FSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEEEccCceEeeehhhhhc-ccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc-
Confidence 99999999999998887654 577777789999999999999 8999999999999999999999999999998421
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
.........+||+.|.|||++....|+.++|.|.+||++|||++|+.||... +...+.+.+....
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~--dh~kLFeLIl~ed------------ 384 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK--DHEKLFELILMED------------ 384 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc--chhHHHHHHHhhh------------
Confidence 2223345678999999999999999999999999999999999999999873 2223333322110
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
..-+...+++...|+...|.+||.+|. .+.||.+|
T Consensus 385 ------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 385 ------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 011123445677899999999999997 45566554
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=289.31 Aligned_cols=241 Identities=21% Similarity=0.263 Sum_probs=187.4
Q ss_pred CeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHH-hcCCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLR-NVRHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|... +++.||+|++.... ......+..|..++. ..+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999964 68999999987543 122234455555544 44899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||.+..... ..
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999997654 3688999999999999999999 89999999999999999999999999999875432 12
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
...++..|+|||.+.+..++.++||||||+++|+|++|..||...... .....+..... ..+. .
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~-~~~~-------------~ 215 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--AVFDNILSRRI-NWPE-------------E 215 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhccc-CCCC-------------c
Confidence 345788999999988888899999999999999999999999753221 11111111000 0000 0
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRLYMKDAAT 563 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 563 (581)
....++..+.+++.+||..+|++||++.++.+
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 11134567889999999999999997754433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=295.10 Aligned_cols=244 Identities=26% Similarity=0.344 Sum_probs=195.8
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
|...+.||+|+||.||+|... +++.|++|.+... .......+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999964 7899999998643 233445788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+. +++.+++......+++.++..++.|++.|++||| +.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 5888888766666899999999999999999999 89999999999999999999999999998864321
Q ss_pred eeeccccCccccCCCCCC---CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 449 IQTMTIATIGYMAPEFGS---EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
.....++..|+|||++. ...++.++|||||||++|+|++|..||...... ..... .. ....+....
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-~~~~~-~~---~~~~~~~~~----- 242 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYH-IA---QNDSPTLQS----- 242 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHH-HH---hcCCCCCCc-----
Confidence 12345788999999874 456888999999999999999999998653211 11111 11 111111111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..++..+.+++.+||+.+|++||++.+++++
T Consensus 243 --------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 --------NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223457899999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=297.45 Aligned_cols=261 Identities=20% Similarity=0.209 Sum_probs=187.7
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-C---CcEEEEEEeccchHHH-----------HHHHHHHHHHHHhcCCCccceE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-D---GTTVAIKIFNLQLEQA-----------FRSFNSECEVLRNVRHRNLIKI 352 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~---~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~iv~~ 352 (581)
...++|.+.+.||+|+||.||+|... + +..+|+|+........ ......+...+..+.|++++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 34578999999999999999999965 3 4567777643322110 0112233445566789999999
Q ss_pred eeeeecCC----eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC
Q 008012 353 LSSCCNTN----FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM 428 (581)
Q Consensus 353 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~ 428 (581)
++++.... ..++++|++.. ++.+.+.... ..++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence 98765443 44788888743 6777665443 2467888999999999999999 89999999999999999999
Q ss_pred cEEEeeccCceecCCCCCc-----ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccH
Q 008012 429 VAHVSDFGISKLLGEGDDS-----VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNL 503 (581)
Q Consensus 429 ~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~ 503 (581)
.++|+|||+|+.+...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||........ .
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~ 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-L 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-H
Confidence 9999999999876432211 112234689999999999999999999999999999999999999986522211 1
Q ss_pred HHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 504 KNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
...........+. ... .....+++.+.+++..||..+|++||+++++.+.+
T Consensus 243 ~~~~~~~~~~~~~---~~~--------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLH---EGK--------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhh---hhh--------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111100000000 000 01123456788999999999999999999999875
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=303.76 Aligned_cols=272 Identities=24% Similarity=0.280 Sum_probs=201.7
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhc-CCCccceEeeeeecC--Cee
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNT--NFK 362 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~ 362 (581)
..++|++.+.||+|+||.||+|... +++.+|+|.+... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999965 6889999988542 223345677899999999 999999999988653 368
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||++ ++|.+++... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||.+....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 4999988765 5688889999999999999999 8999999999999999999999999999998664
Q ss_pred CCCCc---ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCC--
Q 008012 443 EGDDS---VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP-- 516 (581)
Q Consensus 443 ~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-- 516 (581)
..... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .... +.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~-~~~~~~~~~~~~ 236 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEK-IIEVIGPPSAED 236 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHH-HHHHhCCCCHHH
Confidence 33221 12233467889999997654 567889999999999999999999996532211 1111 1111100000
Q ss_pred ----------ccccccch-hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHHh
Q 008012 517 ----------KIADANLL-REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK--LKKI 568 (581)
Q Consensus 517 ----------~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~ 568 (581)
...+.... ...........++.++.++|.+||+.||++|||+.+++++ ++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00000000 0000011112256778999999999999999999999987 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.72 Aligned_cols=272 Identities=25% Similarity=0.341 Sum_probs=204.1
Q ss_pred CCCcCCeecccccccEEEEE-eCCCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecC------Ceee
Q 008012 292 GFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT------NFKA 363 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~ 363 (581)
-|...+.||+|+||.||+++ .++|+.||||.++... ....+...+|++++++++|||||+++++-.+. +...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 45566789999999999999 4589999999998753 33456788999999999999999999986543 3678
Q ss_pred EEEeccCCCCHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec--CCC--cEEEeeccC
Q 008012 364 LVLEFMPNGSLDKWLYS--HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD--ENM--VAHVSDFGI 437 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~--~~~--~~kl~Dfg~ 437 (581)
+|||||.||||...+.+ +...+++.+.+.++.+++.||.||| +.||+||||||.||++- .+| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999984 3455899999999999999999999 89999999999999984 323 589999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCC-CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHh---hCCC
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGS-EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKE---SLPH 513 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~---~~~~ 513 (581)
|+.++++. .....+||..|.+||++. .+.|+..+|.|||||++|+++||..||....... +..+.... ..+.
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk-~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK-NNKEIMWHIITKKPS 246 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc-ccchhhhhhhccCCC
Confidence 99875443 456778999999999988 4899999999999999999999999997643332 11111111 1111
Q ss_pred CCCccccccchhh------hh-hhhHHHHHHHHHHHHHHhccCcCCCCCC--CHHHHHHHHHHhHH
Q 008012 514 GLPKIADANLLRE------EN-FFSARMDCLLSIFHLALDCCAELPDQRL--YMKDAATKLKKIRD 570 (581)
Q Consensus 514 ~~~~~~~~~~~~~------~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rp--s~~evl~~L~~~~~ 570 (581)
...........+. .+ ...........+...+..+|..+|++|. ...+....+..+..
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1111111110000 00 0011112233456788888999999999 77777776666653
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.52 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=198.1
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
..|+..+.||+|++|.||+|... +++.+++|.+... .......+.+|+++++.++|+|++++++++...+..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777789999999999999965 6889999988642 2344456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+. |++.+++......+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9996 5888887765566789999999999999999999 899999999999999999999999999998865432
Q ss_pred cceeeccccCccccCCCCCC---CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 447 SVIQTMTIATIGYMAPEFGS---EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
....++..|+|||.+. ...++.++|||||||++|+|++|+.||...... .....+.. ...+..
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~----~~~~~~----- 234 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQ----NESPAL----- 234 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhh----cCCCCc-----
Confidence 2335788999999764 456788999999999999999999998653111 11111111 111110
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
....++..+.++|.+||..+|++||++++++++-.
T Consensus 235 --------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 235 --------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred --------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 01134456889999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=290.32 Aligned_cols=242 Identities=24% Similarity=0.319 Sum_probs=186.9
Q ss_pred eecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHH---HHHHhcCCCccceEeeeeecCCeeeEEEeccC
Q 008012 298 LLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSEC---EVLRNVRHRNLIKILSSCCNTNFKALVLEFMP 370 (581)
Q Consensus 298 ~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 370 (581)
.||+|+||.||+|... +++.||+|.+.... ......+..|. +.++...||+|+.+++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999954 68999999986542 11112233333 34445579999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCccee
Q 008012 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 450 (581)
|++|.+++...+ .+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~ 152 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence 999999887654 4789999999999999999999 8999999999999999999999999999987653221 1
Q ss_pred eccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 451 TMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||.....................++
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------- 219 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP------------- 219 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCC-------------
Confidence 234689999999988754 689999999999999999999999976422111110000000000111
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
..++.++.+++.+|+..+|++|| ++.+++++
T Consensus 220 ----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 ----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 12345688999999999999999 99999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=303.81 Aligned_cols=272 Identities=24% Similarity=0.269 Sum_probs=203.7
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecC-----C
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT-----N 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 360 (581)
+.++|.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3567999999999999999999954 7899999998653 223345677899999999999999999987644 3
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..++|+||+. ++|.+++...+ .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 5799999995 68999887654 4789999999999999999999 89999999999999999999999999999986
Q ss_pred cCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC----C
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG----L 515 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~----~ 515 (581)
..... .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||..... ......+....... .
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCChHHh
Confidence 64322 11233457889999997654 4688999999999999999999999965311 11111111111100 0
Q ss_pred Cccccccchh---------hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHHhH
Q 008012 516 PKIADANLLR---------EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK--LKKIR 569 (581)
Q Consensus 516 ~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~~ 569 (581)
..+.+..... ..........+++++.+++.+||+.+|++|||++|++++ ++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0000000000 000011123466778999999999999999999999998 66554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=302.27 Aligned_cols=273 Identities=24% Similarity=0.280 Sum_probs=208.0
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC-----eee
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN-----FKA 363 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 363 (581)
+|++.+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999965 58999999987653 344567889999999999999999999987765 789
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||++ ++|.+++.... .+++..++.++.|++.||+||| +.||+||||||+||+++.++.++|+|||.+.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999997 48999887655 5789999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCc-ceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc---
Q 008012 444 GDDS-VIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI--- 518 (581)
Q Consensus 444 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 518 (581)
.... .......++..|+|||.+.+. .++.++||||||+++|+|++|++||...... .....+...........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCChhHhhh
Confidence 3210 112334578899999998887 8899999999999999999999999764221 11111111111110000
Q ss_pred -ccccchh---------hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHHhHHH
Q 008012 519 -ADANLLR---------EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK--LKKIRDK 571 (581)
Q Consensus 519 -~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~~~~ 571 (581)
....... ...........+..+.+++.+||+.+|++|||+.+++++ ++..+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0000000 000011112356778999999999999999999999987 6655543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=294.25 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=203.6
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcC-CCccceEeeeeecCCeeeEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 365 (581)
++|.+.+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999965 79999999987632 333467889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+++++|.+++.+.+ .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999998765 4799999999999999999999 8999999999999999999999999999998764332
Q ss_pred Cc------------------ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHH
Q 008012 446 DS------------------VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWV 507 (581)
Q Consensus 446 ~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~ 507 (581)
.. .......++..|+|||...+..++.++||||||+++|++++|+.||..... ...+.. +
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~-~ 234 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-YLTFQK-I 234 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-HHHHHH-H
Confidence 11 122234578899999998888899999999999999999999999976421 111111 1
Q ss_pred HhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCH----HHHHHH
Q 008012 508 KESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYM----KDAATK 564 (581)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~evl~~ 564 (581)
... ...++ ...++.+.+++.+||+.+|++|||+ +++++|
T Consensus 235 ~~~-~~~~~-----------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 235 LKL-EYSFP-----------------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred Hhc-CCCCC-----------------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 110 00011 1224567899999999999999999 887764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=285.81 Aligned_cols=267 Identities=22% Similarity=0.333 Sum_probs=222.4
Q ss_pred hhHHHhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeee
Q 008012 284 LDLERATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSC 356 (581)
Q Consensus 284 ~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 356 (581)
.++.....+++....+.+|.||.||.|.+. +.+.|.+|.++... +-....+..|.-.+..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 445556677888889999999999999654 34567788776653 44567788999999999999999999987
Q ss_pred ec-CCeeeEEEeccCCCCHHHHHh-----hC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC
Q 008012 357 CN-TNFKALVLEFMPNGSLDKWLY-----SH--NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM 428 (581)
Q Consensus 357 ~~-~~~~~lv~e~~~~~~L~~~l~-----~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~ 428 (581)
.. .+..+++++++.-|+|..|+. +. .+..+..+...++.|++.|++||| ++||+|.||..+|++||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence 54 567889999999999999998 22 223455667789999999999999 99999999999999999999
Q ss_pred cEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 008012 429 VAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWV 507 (581)
Q Consensus 429 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~ 507 (581)
++||+|=.+++.+-+.+..........+..||+||.+....|+.++|||||||++|||+| |+.||.+..+- .+..++
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf--Em~~yl 511 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--EMEHYL 511 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH--HHHHHH
Confidence 999999999998888777776667777889999999999999999999999999999999 99998764222 222332
Q ss_pred HhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 508 KESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
++ +....++.+||++++.+|.-||..+|++||+++|+..-|.++..+.
T Consensus 512 kd-----------------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 512 KD-----------------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred hc-----------------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 22 2334566789999999999999999999999999999999987765
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=292.47 Aligned_cols=244 Identities=25% Similarity=0.316 Sum_probs=195.2
Q ss_pred ecccccccEEEEEeC-CCcEEEEEEeccchH---HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCH
Q 008012 299 LGSGGFGSVYKGILS-DGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSL 374 (581)
Q Consensus 299 lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 374 (581)
||+|+||.||++... +|+.+++|++..... ...+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 599999999876532 4556788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC------cc
Q 008012 375 DKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD------SV 448 (581)
Q Consensus 375 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~ 448 (581)
.+++.+.+ .+++..++.++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99998765 4789999999999999999999 89999999999999999999999999999876433211 11
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
......++..|+|||...+..++.++||||||+++|++++|+.||..... ..............
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~----------- 220 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQNILNGKIEW----------- 220 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCCcCC-----------
Confidence 22334578899999998888899999999999999999999999975321 11111111111000
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+.....+..+.+++.+||+.+|++|||+.++.+.
T Consensus 221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~ 254 (265)
T cd05579 221 --PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI 254 (265)
T ss_pred --CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence 0000125568899999999999999999444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=291.20 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=198.7
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhc---CCCccceEeeeeecCCe-----
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNV---RHRNLIKILSSCCNTNF----- 361 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~----- 361 (581)
|++.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677889999999999999976 58999999997542 22234566788877766 59999999999987776
Q ss_pred eeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 362 KALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
.+++|||+++ +|.+++.... ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 8999887643 35789999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---CCc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---LPK 517 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~ 517 (581)
...... .....++..|+|||.+.+..++.++|||||||++|+|++|++||..... ......+........ .+.
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCC
Confidence 643321 1223468889999999988999999999999999999999999876322 222222222111100 000
Q ss_pred cc---cccchh--hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IA---DANLLR--EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~---~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.. ...... .........+.+..+.+++.+||..||++||+++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 000000 000111223456778899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.56 Aligned_cols=268 Identities=21% Similarity=0.265 Sum_probs=198.2
Q ss_pred hcCCCc-CCeecccccccEEEEEeC-CCcEEEEEEeccchHHH--------------HHHHHHHHHHHHhcCCCccceEe
Q 008012 290 TDGFNE-CNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQA--------------FRSFNSECEVLRNVRHRNLIKIL 353 (581)
Q Consensus 290 ~~~y~~-~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~iv~~~ 353 (581)
.++|.. .+.||+|+||.||+|..+ +++.||+|.+....... ...+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456764 467999999999999965 78999999986542211 12467899999999999999999
Q ss_pred eeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEe
Q 008012 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVS 433 (581)
Q Consensus 354 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~ 433 (581)
+++...+..++||||++ ++|.+++.... .+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence 99999999999999996 59999887644 3788999999999999999999 8999999999999999999999999
Q ss_pred eccCceecCCCC------------CcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCcccccc
Q 008012 434 DFGISKLLGEGD------------DSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500 (581)
Q Consensus 434 Dfg~a~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~ 500 (581)
|||.+....... .........++..|+|||.+.+. .++.++|||||||++|+|++|++||......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~- 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI- 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 999998664111 01111223467889999988764 4689999999999999999999999764221
Q ss_pred ccHHHHHHhhCCCC----CCcccccc-c-----hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 501 MNLKNWVKESLPHG----LPKIADAN-L-----LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 501 ~~~~~~~~~~~~~~----~~~~~~~~-~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+.. +....... ++...+.. . ............++..+.+++.+||+.+|++|||++|++.+
T Consensus 241 ~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 DQLGR-IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHH-HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11111 11111111 00000000 0 00000011112345678899999999999999999999975
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.43 Aligned_cols=267 Identities=24% Similarity=0.278 Sum_probs=200.7
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeec-CC
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCN-TN 360 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 360 (581)
++....++|++.+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34557889999999999999999999955 89999999875432 2334567789999999999999999999865 56
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..++|+||+ +++|.+++.... +++..+..++.|+++||+||| +.+|+||||+|+||++++++.++|+|||.+..
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 789999998 568988886543 577888899999999999999 89999999999999999999999999999875
Q ss_pred cCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
..... ....++..|+|||.+.+ ..++.++||||||+++|+|++|++||..... ......+.+.......+..
T Consensus 158 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 158 QDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred cCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHH
Confidence 43211 22356788999998765 5789999999999999999999999965321 1111111111111100000
Q ss_pred c----cc-------c--hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 D----AN-------L--LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 ~----~~-------~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
. .. . ....+.......++..+.++|.+||..+|++|||+++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00 0 00000011112345778999999999999999999999887
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=298.08 Aligned_cols=270 Identities=21% Similarity=0.246 Sum_probs=197.7
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH--HHHHHHHHHHHHHHhcCCCccceEeeeeecCC------
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE--QAFRSFNSECEVLRNVRHRNLIKILSSCCNTN------ 360 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 360 (581)
.++|++.+.||+|++|.||+|..+ +++.+|+|.+..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999965 789999998865421 12235678999999999999999999875433
Q ss_pred --eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 361 --FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 361 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
..++||||+.+ ++.+.+......+++..+..++.|+++||+||| +.|++|+||||+||++++++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 46999999965 788887766666899999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcc---------eeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 008012 439 KLLGEGDDSV---------IQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVK 508 (581)
Q Consensus 439 ~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~ 508 (581)
.......... ......++..|+|||.+.+ ..++.++|||||||++|||++|++||...... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 7654322111 1122356788999997765 45889999999999999999999999753221 11111111
Q ss_pred hhCCC---------CCCccccccchhhh--hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 509 ESLPH---------GLPKIADANLLREE--NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 509 ~~~~~---------~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..... .++...+....... ..........+.+.+++.+||..||++|||+.|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 10000 00000000000000 0001112234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=290.32 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=198.6
Q ss_pred CCCcCCeecccccccEEEEEe----CCCcEEEEEEeccchH----HHHHHHHHHHHHHHhc-CCCccceEeeeeecCCee
Q 008012 292 GFNECNLLGSGGFGSVYKGIL----SDGTTVAIKIFNLQLE----QAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 362 (581)
+|++.+.||+|+||.||.|.. .+|+.||+|++..... ...+.+.+|+++++++ +|++|+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999985 3689999999875432 2345678899999999 699999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.|++||||+|+||+++.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999998654 3678889999999999999999 8999999999999999999999999999998654
Q ss_pred CCCCcceeeccccCccccCCCCCCCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEG--NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
.... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ......+........ +..
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~-~~~-- 231 (290)
T cd05613 157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE-PPY-- 231 (290)
T ss_pred cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC-CCC--
Confidence 3221 112234578899999987653 467899999999999999999999864211 112222222211111 000
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
+..++..+.+++.+||..||++|| ++.+++++
T Consensus 232 ------------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 232 ------------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ------------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 112345678999999999999997 78888776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.42 Aligned_cols=265 Identities=27% Similarity=0.423 Sum_probs=215.7
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC----C----CcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEee
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS----D----GTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILS 354 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 354 (581)
.++...++..+.+.+|+|.||.|++|... . ...||||.++... ..+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34555566677779999999999999833 1 4579999987653 35667899999999999 6999999999
Q ss_pred eeecCCeeeEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCC
Q 008012 355 SCCNTNFKALVLEFMPNGSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKP 419 (581)
Q Consensus 355 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp 419 (581)
+|...+..++|+||+..|+|.++++..+ ..++..+.+.++.|||.|++||+ +.+++|||+..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence 9999999999999999999999999776 34788899999999999999999 89999999999
Q ss_pred CCeEecCCCcEEEeeccCceecCCCCCcceeecc-ccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccc
Q 008012 420 SNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMF 497 (581)
Q Consensus 420 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~ 497 (581)
+|||++++..+||+|||+|+.....+........ .-+..|||||.+....|+.+||||||||++||++| |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999976544333212111 13456999999999999999999999999999999 889987632
Q ss_pred cccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 498 TGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
....+.+++.+.. ....+..|+++++++|+.||+.+|++||++.|+.+.++....
T Consensus 527 -~~~~l~~~l~~G~-----------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 -PTEELLEFLKEGN-----------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred -cHHHHHHHHhcCC-----------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1122222333222 233445677889999999999999999999999999998643
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=297.90 Aligned_cols=270 Identities=21% Similarity=0.263 Sum_probs=202.0
Q ss_pred hhhhHHHhhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeec
Q 008012 282 SYLDLERATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358 (581)
Q Consensus 282 ~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 358 (581)
...++....++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456777889999999999999999999985 478999999987542 2334567889999999999999999998754
Q ss_pred C------CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEE
Q 008012 359 T------NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHV 432 (581)
Q Consensus 359 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl 432 (581)
. ...+++++++ +++|.+++... .+++..++.++.|++.||+||| +.||+||||||+||++++++.+||
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEE
Confidence 3 3467888887 77998888654 3688999999999999999999 899999999999999999999999
Q ss_pred eeccCceecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 008012 433 SDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESL 511 (581)
Q Consensus 433 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 511 (581)
+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ...+.......
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~- 234 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLV- 234 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHh-
Confidence 999998764321 123457889999998765 5688899999999999999999999965321 11111111111
Q ss_pred CCCCCcc----cccc---chhh------hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 512 PHGLPKI----ADAN---LLRE------ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 512 ~~~~~~~----~~~~---~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....+.. .+.. .... ..........+..+.++|.+|++.||++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 1000000 0000 0000 00000011235568899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=290.58 Aligned_cols=264 Identities=25% Similarity=0.288 Sum_probs=201.0
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
|+..+.||+|++|.||+|... +++.+++|++.... ....+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567789999999999999965 69999999998653 333456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce
Q 008012 370 PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI 449 (581)
Q Consensus 370 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 449 (581)
+ ++|.+++.+....+++..+..++.|++.||+||| +.||+||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 7 5999999877556899999999999999999999 88999999999999999999999999999987643221 1
Q ss_pred eeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCC-------cc--c
Q 008012 450 QTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP-------KI--A 519 (581)
Q Consensus 450 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------~~--~ 519 (581)
.....++..|+|||.+.+. .++.++||||||+++|||++|++||...... ..+.... ........ .. .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIF-QILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHH-HHhCCCcHHHHHhhcccccc
Confidence 2233457789999988766 8899999999999999999999998653211 1111111 11000000 00 0
Q ss_pred cccchh--hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 DANLLR--EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 ~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+..... ...........+..+.+++.+||..||++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000 000001111235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=289.24 Aligned_cols=263 Identities=22% Similarity=0.246 Sum_probs=197.0
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH-HHHHHHHHHHHHHHhcC-CCccceEeeeeecCCeeeEEEecc
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE-QAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
|++.+.||+|++|.||+|... +++.|++|.+..... .......+|+..+++++ |||++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677899999999999999975 688999999865532 22234557999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 370 PNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 370 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 779999888654 45799999999999999999999 89999999999999999999999999999986643221
Q ss_pred eeeccccCccccCCCCCC-CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc----------
Q 008012 449 IQTMTIATIGYMAPEFGS-EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK---------- 517 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---------- 517 (581)
.....++..|+|||++. +..++.++|+||||+++|+|++|++||....... .... +..........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYK-ICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHH-HHHhcCCCChhhhhhHhhhhc
Confidence 22345788999999774 4567899999999999999999999986532111 1111 11100000000
Q ss_pred cccccchhhh--hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IADANLLREE--NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+....... .........+..+.+++.+||..||++|||++|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000 0000011124668899999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=290.58 Aligned_cols=254 Identities=23% Similarity=0.290 Sum_probs=198.1
Q ss_pred CCCcCCeecccccccEEEEEeC----CCcEEEEEEeccch----HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCee
Q 008012 292 GFNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQL----EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 362 (581)
+|++.+.||+|++|.||++... +++.||+|+++... ....+.+.+|+++++++ +||+|+++++.+...+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999998842 57889999987542 23345678999999999 699999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+++++|.+++.... .+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999987654 4688899999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcceeeccccCccccCCCCCCCCC--CCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGN--VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
..... ......++..|+|||...+.. .+.++||||||+++|+|++|..||..... ............... ..
T Consensus 157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~--- 230 (288)
T cd05583 157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKSK-PP--- 230 (288)
T ss_pred ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHccC-CC---
Confidence 33211 122345788999999877654 78899999999999999999999864211 111112111111110 00
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
.+..++..+.+++.+||+.||++|||+.++.+.|+
T Consensus 231 -----------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 231 -----------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred -----------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 01123456789999999999999999877765543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.56 Aligned_cols=267 Identities=21% Similarity=0.268 Sum_probs=196.8
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecC---------
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT--------- 359 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------- 359 (581)
..+|++.+.||.|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999964 7899999998766555557788999999999999999999876543
Q ss_pred -----CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec-CCCcEEEe
Q 008012 360 -----NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD-ENMVAHVS 433 (581)
Q Consensus 360 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl~ 433 (581)
...++||||++ ++|.+++... .+++..++.++.||++||+||| +.|++||||||+||+++ +++.++|+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 5898888654 3688999999999999999999 89999999999999997 45678999
Q ss_pred eccCceecCCCCCc-ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 008012 434 DFGISKLLGEGDDS-VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESL 511 (581)
Q Consensus 434 Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 511 (581)
|||.+......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ....... ..
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~-~~ 235 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILE-SV 235 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-hc
Confidence 99999865322111 11123357889999997544 568889999999999999999999997542211 1111111 11
Q ss_pred CCCCC----cc---ccccch-----hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 512 PHGLP----KI---ADANLL-----REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 512 ~~~~~----~~---~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+.... .. ...... ...+........+.++.+++.+||..||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 10000 00 000000 0000001112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.85 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=214.8
Q ss_pred chhhhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeee
Q 008012 281 TSYLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSC 356 (581)
Q Consensus 281 ~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 356 (581)
....+++...++|++++.||+|+||.|..++.+ +++.||+|++++-. ......|..|-++|..-+.+-|+.++-.|
T Consensus 65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 65 KKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 345567778899999999999999999999965 78999999997742 34456789999999999999999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeecc
Q 008012 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 357 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
.+..+.|+|||||+||+|-.++.+.. .++++.+.-++..|+-||..+| +.|+|||||||+|||+|..|++||+|||
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccch
Confidence 99999999999999999999999888 6899999999999999999999 9999999999999999999999999999
Q ss_pred CceecCCCCCcceeeccccCccccCCCCCC----C-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 008012 437 ISKLLGEGDDSVIQTMTIATIGYMAPEFGS----E-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESL 511 (581)
Q Consensus 437 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 511 (581)
.|-.+..+ ........+|||.|.+||++. + +.|+..+|.||+||++|||+.|..||+.. .+...+....
T Consensus 221 sClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIM 294 (1317)
T ss_pred hHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHh
Confidence 99877543 344556778999999999764 3 57999999999999999999999999863 2222222211
Q ss_pred CC----CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC---HHHHHHH
Q 008012 512 PH----GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLY---MKDAATK 564 (581)
Q Consensus 512 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~ 564 (581)
.. .+|+ ..+++....+||.+.+. +|+.|.. ++++..|
T Consensus 295 ~hk~~l~FP~---------------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 295 NHKESLSFPD---------------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred chhhhcCCCc---------------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 11 1221 12355678899998876 6888887 8888776
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=297.90 Aligned_cols=266 Identities=21% Similarity=0.264 Sum_probs=200.5
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC-
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN- 360 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 360 (581)
.++...++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++||||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 44556789999999999999999999854 79999999986432 333456789999999999999999999886543
Q ss_pred -----eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeec
Q 008012 361 -----FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDF 435 (581)
Q Consensus 361 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 435 (581)
..++||||+ +++|.+++... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.++|+||
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 77999888653 4788999999999999999999 899999999999999999999999999
Q ss_pred cCceecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC
Q 008012 436 GISKLLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG 514 (581)
Q Consensus 436 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 514 (581)
|++...... .....++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||...... .......... ..
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~-~~- 234 (343)
T cd07880 163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVT-GT- 234 (343)
T ss_pred ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc-CC-
Confidence 999865322 123356889999998765 45889999999999999999999999753211 1111111100 00
Q ss_pred CCccccccch--------h------hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 515 LPKIADANLL--------R------EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 515 ~~~~~~~~~~--------~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+......+. . ..........++..+.+++.+|++.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0 000001112355678899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.63 Aligned_cols=265 Identities=22% Similarity=0.272 Sum_probs=200.5
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe--
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF-- 361 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 361 (581)
....++|++.+.||+|++|.||+|... +++.||+|++... .......+.+|+.++++++|||++++++++...+.
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 345778999999999999999999965 6889999998653 23334567789999999999999999998866554
Q ss_pred ----eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccC
Q 008012 362 ----KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGI 437 (581)
Q Consensus 362 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 437 (581)
.++|+||+ +++|.+++... .+++..+..++.|++.||+||| +.||+||||+|+||++++++.++|+|||+
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 66999988763 4789999999999999999999 89999999999999999999999999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCC
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP 516 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 516 (581)
+...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ...+.. +........+
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~-i~~~~~~~~~ 237 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKR-IMNLVGTPDE 237 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH-HHHhcCCCCH
Confidence 9865332 123357888999998755 4678899999999999999999999975321 111111 1111111111
Q ss_pred ccccccc-------------hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 517 KIADANL-------------LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 517 ~~~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....... .............+.++.+++.+||..||++|||+.||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 1000000 00000001112246778999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=298.62 Aligned_cols=270 Identities=23% Similarity=0.281 Sum_probs=199.5
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecC-----
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT----- 359 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 359 (581)
...++|.+.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 44578999999999999999999964 78999999986532 22335678899999999999999999998654
Q ss_pred -CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 360 -NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 360 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
...++|+||+.. ++.++.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred CceEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 246899999964 7776652 24688999999999999999999 899999999999999999999999999998
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
....... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+.. +....+...+.
T Consensus 165 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-~~~~~~-~~~~~~~~~~~ 237 (342)
T cd07879 165 RHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQ-ILKVTGVPGPE 237 (342)
T ss_pred cCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH-HHHhcCCCCHH
Confidence 7643211 23356788999998766 4688999999999999999999999975321 111111 11111100000
Q ss_pred cc----cccch---------hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHHhHHH
Q 008012 518 IA----DANLL---------REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK--LKKIRDK 571 (581)
Q Consensus 518 ~~----~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~~~~ 571 (581)
.. +.... ............+..+.+++.+||+.||++||+++|++.| ++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 00 00000 0000000111244568899999999999999999999977 7776543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=277.32 Aligned_cols=251 Identities=24% Similarity=0.280 Sum_probs=197.0
Q ss_pred cCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEEeccCC
Q 008012 295 ECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 295 ~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
-...||.|+||+|++...+ +|+..|||.++... ..+..++..|.+...+- ++|+||++||.+..++..|+-||.|+
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 3457999999999999965 89999999998764 35667888888876655 79999999999999999999999995
Q ss_pred CCHHHHHh----hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 372 GSLDKWLY----SHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 372 ~~L~~~l~----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
.|+..+.. -....+++...-.|+...+.||.||-+ ...|+|||+||+|||++..|.+||||||.+-.+. ++
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv---~S 221 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV---DS 221 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH---HH
Confidence 47765544 224457888888899999999999987 7889999999999999999999999999987653 34
Q ss_pred ceeeccccCccccCCCCCCC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 448 VIQTMTIATIGYMAPEFGSE--GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
...+...|-..|||||.+.. ..|+.+|||||||++|||+.||+.||..... ..+.+........+.+...
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~gdpp~l~~~---- 293 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVIGDPPILLFD---- 293 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHcCCCCeecCc----
Confidence 44566678899999997754 3588999999999999999999999876432 2222222222222221111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
......+.++..+|.-|+.+|-..||..+++.++
T Consensus 294 -----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 -----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1123456678899999999999999999998764
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=285.31 Aligned_cols=248 Identities=21% Similarity=0.264 Sum_probs=195.4
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc-----hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ-----LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
+|.+.+.||+|+||.||++... .+..+++|+++.. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999999865 4455666665432 122334567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 366 LEFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
|||+++++|.+++.. ....+++..++.++.|++.||.||| +.|++|+||+|+||++++ +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998874 3445789999999999999999999 899999999999999975 579999999998764
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
.... ......++..|+|||...+..++.++|+||||+++|+|++|..||.... .............+..
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~~---- 225 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIVEGPTPSL---- 225 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHcCCCCCC----
Confidence 3222 1223457889999999888888999999999999999999999986421 1122222111111110
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+..++.++.++|.+||..+|++||++.|++++
T Consensus 226 ----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 226 ----------PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ----------cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 12345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=286.65 Aligned_cols=254 Identities=24% Similarity=0.302 Sum_probs=206.1
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..+.|+.-++||+||||.||-++.+ +|+-+|.|.+.+.. ........+|-.++++++.+.||.+--.|...+..|+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 4467888899999999999999844 89999999886653 2333456789999999999999999989999999999
Q ss_pred EEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 365 VLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
|+..|.||+|.-+|...+ ..++++.+.-++.+|+.||++|| ..+||+||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999888654 45799999999999999999999 89999999999999999999999999999998865
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
+.. ....+||.+|||||++.+..|+...|-||+||++|||+.|+.||........ ..+ +|..+
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-~eE-------------vdrr~ 402 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-REE-------------VDRRT 402 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-HHH-------------HHHHH
Confidence 443 3345899999999999999999999999999999999999999976322211 111 11111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLY-----MKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 564 (581)
.... ...+...+++..++.+..|.+||++|.. +++|.+|
T Consensus 403 ~~~~--~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 403 LEDP--EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred hcch--hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 1111 1112355677889999999999999974 4455544
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=272.87 Aligned_cols=272 Identities=21% Similarity=0.259 Sum_probs=199.1
Q ss_pred hcCCCcCCeecccccccEEEEEeC---C--CcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeec-CCe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS---D--GTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCN-TNF 361 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~---~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 361 (581)
...|+.+..||+|.||.||+|..+ + ...+|+|.++.+. ........+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 357999999999999999999633 2 2368999987663 2223456789999999999999999999877 778
Q ss_pred eeEEEeccCCCCHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC----CcEEEe
Q 008012 362 KALVLEFMPNGSLDKWLYSH----NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN----MVAHVS 433 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~----~~~kl~ 433 (581)
+++++||.+. +|.+.|+-+ ...++...+..|+.||+.|+.||| +.=|+||||||.|||+..+ |+|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence 9999999977 999988732 345688899999999999999999 6779999999999999877 899999
Q ss_pred eccCceecCCCCCcc-eeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccc-----cc--cHH
Q 008012 434 DFGISKLLGEGDDSV-IQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTG-----EM--NLK 504 (581)
Q Consensus 434 Dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~-----~~--~~~ 504 (581)
|||+++.+...-... .....+.|..|+|||.+.+ ..|+++.||||.|||+.||+|-++-|...... .. +..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999875433222 3344567999999998776 47999999999999999999999888653211 00 111
Q ss_pred HHHHhhCCCC----CCcccc---c-----cchhhh-------hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 505 NWVKESLPHG----LPKIAD---A-----NLLREE-------NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 505 ~~~~~~~~~~----~~~~~~---~-----~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
..+-+..... ++.+.. - .+.... ........-++..++|+.++|..||.+|.|+++++++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1122221111 111100 0 000000 00011111223477999999999999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.21 Aligned_cols=242 Identities=24% Similarity=0.258 Sum_probs=199.2
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
..++|+....+|.|+|+.|-.+... +++..++|++.... ....+|+.++... +||||+++.+++.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3578888899999999999999854 78999999997762 2334577777776 7999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe-cCCCcEEEeeccCceecCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL-DENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill-~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|.+.|+-+.+.+...... ...+..|+.+|+.|+.||| ++|++|||+||+|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~~--~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEF--CSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hhccccHHHHHHHhcchh--HHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 999999888888766542 2677789999999999999 8999999999999999 58999999999999876433
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
....+-|..|.|||++....|++++|+||||++||+|++|+.||.....+ .+...........
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i~~~~~s--------- 532 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRIQMPKFS--------- 532 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhhcCCccc---------
Confidence 22345688999999999999999999999999999999999999875443 1222222111111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
..+++...+|+.+||+.||.+||+|+++..|=
T Consensus 533 --------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 533 --------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred --------cccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 34566788999999999999999999998764
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.95 Aligned_cols=266 Identities=23% Similarity=0.255 Sum_probs=193.8
Q ss_pred CCCcCCeecccccccEEEEEeC-C--CcEEEEEEeccch--HHHHHHHHHHHHHHHhc-CCCccceEeeeeec----CCe
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-D--GTTVAIKIFNLQL--EQAFRSFNSECEVLRNV-RHRNLIKILSSCCN----TNF 361 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~ 361 (581)
+|++.+.||+|+||.||++... + +..||+|.+.... ......+.+|+++++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999965 4 7889999886532 22345678899999999 59999999987543 245
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
.++++||+. ++|.+++.... .+++..++.++.||+.||+||| +.|++||||||+||+++.++.+||+|||.+...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788999985 58999887544 4788999999999999999999 899999999999999999999999999999866
Q ss_pred CCCCCc--ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc-
Q 008012 442 GEGDDS--VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK- 517 (581)
Q Consensus 442 ~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~- 517 (581)
...... .......|+..|+|||...+ ..++.++||||+|+++|+|++|++||..... ...+.. +.........+
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-~~~~~~-~~~~~~~~~~~~ 233 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-VDQLNQ-ILQVLGTPDEET 233 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-HHHHHH-HHHHhCCCCHHH
Confidence 432211 11223468899999997655 5689999999999999999999999875321 111111 11111000000
Q ss_pred ---cccccc---------hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 ---IADANL---------LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ---~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+.+... ............++..+.+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 00000000111234678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=278.36 Aligned_cols=239 Identities=27% Similarity=0.304 Sum_probs=194.7
Q ss_pred ecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCH
Q 008012 299 LGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSL 374 (581)
Q Consensus 299 lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 374 (581)
||+|+||.||++... +++.+++|++.... ......+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 68999999987653 23456788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccc
Q 008012 375 DKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI 454 (581)
Q Consensus 375 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 454 (581)
.+++.... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+....... .......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC 154 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence 99998764 3788999999999999999999 8999999999999999999999999999998764332 1223456
Q ss_pred cCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHH
Q 008012 455 ATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARM 534 (581)
Q Consensus 455 ~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (581)
++..|+|||...+...+.++|+||||+++|++++|+.||..... ............ ..+.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~---------------~~~~ 214 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKDPL---------------RFPE 214 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCCC---------------CCCC
Confidence 78899999999888889999999999999999999999965321 111111111110 0011
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCH---HHHHH
Q 008012 535 DCLLSIFHLALDCCAELPDQRLYM---KDAAT 563 (581)
Q Consensus 535 ~~~~~l~~li~~cl~~dP~~Rps~---~evl~ 563 (581)
..+..+.+++.+||..||++||++ +++++
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 124567899999999999999999 55544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=279.41 Aligned_cols=264 Identities=23% Similarity=0.262 Sum_probs=202.4
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-C-C----ccceEeeeeecCC
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-H-R----NLIKILSSCCNTN 360 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~iv~~~~~~~~~~ 360 (581)
....+|.++..+|+|.||.|-.+.+. .+..||+|+++.-. ...+..+-|+++++++. + | -++.+.+||...+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 34789999999999999999999854 68999999987543 34456778999999993 2 2 3788889999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-------------
Q 008012 361 FKALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE------------- 426 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~------------- 426 (581)
+.|+|+|.+ |.|+.+++..++ .+++...+..++.|+++++++|| +.+++|-||||+||++.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999988 779999999753 45789999999999999999999 899999999999999932
Q ss_pred -------CCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Q 008012 427 -------NMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG 499 (581)
Q Consensus 427 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~ 499 (581)
+..++++|||.|.+-.+.. +..+.|..|+|||++.+-.++.++||||+||||+|++||...|+...+.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 3368999999998754332 4557899999999999999999999999999999999999998764321
Q ss_pred cccHHHHHHhhCCCCCCccc-ccc-----------------chh-------hh----hhhhHHHHHHHHHHHHHHhccCc
Q 008012 500 EMNLKNWVKESLPHGLPKIA-DAN-----------------LLR-------EE----NFFSARMDCLLSIFHLALDCCAE 550 (581)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~-~~~-----------------~~~-------~~----~~~~~~~~~~~~l~~li~~cl~~ 550 (581)
+ .+ ..+..... ++|.-+ ... ..+ .. ...........+|.+|+++||..
T Consensus 316 E-HL-aMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 316 E-HL-AMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred H-HH-HHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 1 11 22222221 111110 000 000 00 00111122345699999999999
Q ss_pred CCCCCCCHHHHHHH
Q 008012 551 LPDQRLYMKDAATK 564 (581)
Q Consensus 551 dP~~Rps~~evl~~ 564 (581)
||.+|+|+.|++.|
T Consensus 393 DP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 393 DPARRITLREALSH 406 (415)
T ss_pred CccccccHHHHhcC
Confidence 99999999999876
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=280.95 Aligned_cols=245 Identities=24% Similarity=0.273 Sum_probs=200.8
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCe
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNF 361 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 361 (581)
..-..+|..+.+||+|+||.|-+|..+ +.+.+|||+++++. .+..+.-..|-+++..- +-|.+++++.+|..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 445678999999999999999999966 67889999998874 23334455677777766 67899999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
+|+||||+.||+|--.+++-++ +.+..+.-++..||-||-+|| ++||++||||.+|||++.+|++||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999999999998776 466778889999999999999 999999999999999999999999999999853
Q ss_pred CCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
-- ....+....||+.|+|||++...+|+.++|.||+||+||||+.|++||++. ++..+.+.+.++.-
T Consensus 501 i~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe--DE~elF~aI~ehnv--------- 567 (683)
T KOG0696|consen 501 IF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDELFQAIMEHNV--------- 567 (683)
T ss_pred cc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHHccC---------
Confidence 22 222345678999999999999999999999999999999999999999873 33344444433321
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLY 557 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 557 (581)
..+...+.+...+.+..+.+.|.+|..
T Consensus 568 ---------syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 568 ---------SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ---------cCcccccHHHHHHHHHHhhcCCccccC
Confidence 111234456778999999999999974
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=314.07 Aligned_cols=146 Identities=27% Similarity=0.435 Sum_probs=132.3
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
.++|.+.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999966 78999999987542 34456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
|||+++++|.+++...+ .+++..++.++.||+.||+||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997654 3688899999999999999999 8899999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=246.21 Aligned_cols=267 Identities=22% Similarity=0.246 Sum_probs=203.9
Q ss_pred cCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.+|...++||+|.||+||+|+ +.+++.||+|.++.++ +.......+|+-+++.++|.|||+++++...+...-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 356677899999999999999 5589999999987764 3334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
||.. +|..+...-+..++.+.+..++.|+++||.++| ++++.|||+||.|.+|+.+|++|++|||+++-++-.-
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv-- 155 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-- 155 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence 9955 999999887777899999999999999999999 8999999999999999999999999999998765322
Q ss_pred ceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhC---CCCC---Cccc
Q 008012 448 VIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESL---PHGL---PKIA 519 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~---~~~~---~~~~ 519 (581)
...+....|..|++|.++.+. -|+...|+||.||++.|+.. |++.|.+. +-...+..+....- ...+ ....
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-cHHHHHHHHHHHhCCCccccCCccccCC
Confidence 233455779999999988775 58899999999999999998 55556542 22222333222111 1111 1122
Q ss_pred cccchhhhhhhhHHHH----HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 DANLLREENFFSARMD----CLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 ~~~~~~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
|-.....++....+.+ ....-.+++++.+.-+|.+|.++++++++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2211111111111222 22234589999999999999999998875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=268.02 Aligned_cols=270 Identities=19% Similarity=0.278 Sum_probs=203.0
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeec--------
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCN-------- 358 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 358 (581)
.+.|+...+||+|.||.||+|+.+ +|+.||+|.+-.+. ........+|+++++.++|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 356777789999999999999954 78889988764332 2223456789999999999999999988743
Q ss_pred CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
....|+||.+|+. +|...+......++..++.+++.++..||.|+| ...|+|||+||+|+||+.+|.+||+|||++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 3358999999977 999999988777899999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCC--cceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC--
Q 008012 439 KLLGEGDD--SVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH-- 513 (581)
Q Consensus 439 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-- 513 (581)
+.+...+. ....+..+.|..|++||.+.+ ..|+++.|||+.|||+.||+||.+-+.+.. +......+......
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt--eqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT--EQQQLHLISQLCGSIT 249 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh--HHHHHHHHHHHhccCC
Confidence 76643332 223455677999999996655 689999999999999999999999887632 22222333322211
Q ss_pred --CCCccccccchhhh-------hhhhHHHHH------HHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 514 --GLPKIADANLLREE-------NFFSARMDC------LLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 514 --~~~~~~~~~~~~~~-------~~~~~~~~~------~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
.++....-.+.... .......+. .++..+|+.+++..||.+|+++++++.|-
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 12221111111000 000111111 23577999999999999999999999874
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=275.63 Aligned_cols=219 Identities=21% Similarity=0.179 Sum_probs=176.3
Q ss_pred cccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCHHHHHhh
Q 008012 302 GGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYS 380 (581)
Q Consensus 302 G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 380 (581)
|.+|.||++.+. +++.+|+|.+..... ..+|...+....||||+++++++.+.+..++||||+++++|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999965 789999999976532 23455555566799999999999999999999999999999999976
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCcccc
Q 008012 381 HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460 (581)
Q Consensus 381 ~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~ 460 (581)
... +++..+..++.|+++||+||| +.|++||||||+||+++.++.++++|||.+....... ....++..|+
T Consensus 79 ~~~-l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~ 149 (237)
T cd05576 79 FLN-IPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYC 149 (237)
T ss_pred hcC-CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcccc
Confidence 543 788999999999999999999 8999999999999999999999999999886553321 2234567799
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHH
Q 008012 461 APEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSI 540 (581)
Q Consensus 461 aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 540 (581)
|||...+..++.++||||+|+++|||++|+.|+....... .......++ ..++..+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~~~~~~~~~-----------------~~~~~~~ 205 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------NTHTTLNIP-----------------EWVSEEA 205 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------ccccccCCc-----------------ccCCHHH
Confidence 9999988889999999999999999999998875421110 000000001 1234567
Q ss_pred HHHHHhccCcCCCCCCCH
Q 008012 541 FHLALDCCAELPDQRLYM 558 (581)
Q Consensus 541 ~~li~~cl~~dP~~Rps~ 558 (581)
.+++.+|++.||++||++
T Consensus 206 ~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 206 RSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHccCCHHHhcCC
Confidence 899999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=288.94 Aligned_cols=244 Identities=22% Similarity=0.351 Sum_probs=200.7
Q ss_pred CeecccccccEEEEE-eCCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCC
Q 008012 297 NLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGS 373 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 373 (581)
+.||+|.||+||-|+ .++|+.||||++.+.. ......+.+|+.+++.++||.||.+...|+..+..++|||.+.|.=
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 689999999999999 4589999999997653 3344788999999999999999999999999999999999996644
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC---CcEEEeeccCceecCCCCCccee
Q 008012 374 LDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN---MVAHVSDFGISKLLGEGDDSVIQ 450 (581)
Q Consensus 374 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~ 450 (581)
|.-.+......+++....-+..||+.||.||| .++|+|+||||+|||+.+. .++||||||+|+.+++. ...
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---sFR 723 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---SFR 723 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchh---hhh
Confidence 55555555666888888889999999999999 8999999999999999643 48999999999998643 345
Q ss_pred eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhh
Q 008012 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFF 530 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 530 (581)
....||+.|.|||+++++.|...-|+||.|||+|--++|..||.+. .+..+.++...-- ...
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdIndQIQNAaFM--------------yPp 785 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDINDQIQNAAFM--------------YPP 785 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchhHHhhccccc--------------cCC
Confidence 6778999999999999999999999999999999999999999763 1222222211100 001
Q ss_pred hHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 531 SARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 531 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+.+++....+||...|+..-.+|-|.++-+.|
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 2345666778899999999999999999887766
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=283.85 Aligned_cols=250 Identities=24% Similarity=0.318 Sum_probs=206.7
Q ss_pred cCCCcCCeecccccccEEEEEeCCC-cEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILSDG-TTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
.++..+..||-||||.|-++..+.. ..+|+|++++. +....+.+..|-.+|...+.|.||++|..|.+...+|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 4566777899999999999997633 34899988765 3556678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|-|-||.++..+.+++. ++..+..-++..+++|++||| ++|||+|||||+|.+++.+|-+||.|||+|+.++.+..
T Consensus 500 EaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 99999999999998776 677888889999999999999 99999999999999999999999999999999876554
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
+...+||+.|.|||++.++..+.++|.||||+++|||++|.+||... +.+.....+-... .
T Consensus 576 ---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~--dpmktYn~ILkGi----d---------- 636 (732)
T KOG0614|consen 576 ---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV--DPMKTYNLILKGI----D---------- 636 (732)
T ss_pred ---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC--chHHHHHHHHhhh----h----------
Confidence 45678999999999999999999999999999999999999999873 2222222221111 1
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLY-----MKDAATKL 565 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~L 565 (581)
....+..++....++|++.+..+|.+|.. +.+|.+|-
T Consensus 637 --~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 637 --KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred --hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 11122334455779999999999999985 66776663
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=279.17 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=201.5
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccch-------HHHHHHHHHHHHHHHhcCCCccceEeeee
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL-------EQAFRSFNSECEVLRNVRHRNLIKILSSC 356 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 356 (581)
+-....++|-.+.+||+|||+.||+|. ....+.||+|+-.... +...+...+|.++.+.++||.||++|+++
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 334455778889999999999999999 4568999999864432 22334577899999999999999999998
Q ss_pred e-cCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec---CCCcEEE
Q 008012 357 C-NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD---ENMVAHV 432 (581)
Q Consensus 357 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~---~~~~~kl 432 (581)
. +.+.+|-|+|||+|.+|.-|+..+.. ++++++..|+.||+.||.||.+. +.+|||-||||.|||+- ..|.+||
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 5 45678999999999999988877654 78999999999999999999964 57899999999999995 4578999
Q ss_pred eeccCceecCCCCCc-----ceeeccccCccccCCCCCCC----CCCCccccHHHHHHHHHHHHhCCCCCCccccccccH
Q 008012 433 SDFGISKLLGEGDDS-----VIQTMTIATIGYMAPEFGSE----GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNL 503 (581)
Q Consensus 433 ~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~ 503 (581)
.|||+++.++.+... ..+....||..|.+||.+.- .+++.|+||||+|||+|.++.|+.||........
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-- 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-- 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--
Confidence 999999988654432 23445679999999996543 3578899999999999999999999986433222
Q ss_pred HHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 008012 504 KNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAAT 563 (581)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 563 (581)
++.+.. ++.+ ....++.....+.+...+|++||.+--++|....++..
T Consensus 693 --ILqeNT------IlkA----tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 --ILQENT------ILKA----TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --HHhhhc------hhcc----eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111110 0000 00011122234456779999999999999988777654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=293.67 Aligned_cols=259 Identities=23% Similarity=0.277 Sum_probs=210.4
Q ss_pred hhhHHHhhcCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeec--
Q 008012 283 YLDLERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCN-- 358 (581)
Q Consensus 283 ~~~~~~~~~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-- 358 (581)
+..+..-++.|++.+.||.|.+|.||+++ .++++.+|+|+.....+. .+.+..|.++++.. .|||++.+|++|.-
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 33444556789999999999999999999 458999999998776432 35677899999998 79999999999853
Q ss_pred ---CCeeeEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEee
Q 008012 359 ---TNFKALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSD 434 (581)
Q Consensus 359 ---~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~D 434 (581)
++.+|||||||.+||..+++... +..+.|+.+..|++.++.|+.+|| ...++|||||-.|||++.++.|||+|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEee
Confidence 56899999999999999999843 556889999999999999999999 78899999999999999999999999
Q ss_pred ccCceecCCCCCcceeeccccCccccCCCCCCCC-----CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 008012 435 FGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG-----NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKE 509 (581)
Q Consensus 435 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~ 509 (581)
||.+..++.. ........||+.|||||++... .|+.++|+||||++..||.-|.+|+.++.+... . -.
T Consensus 167 FGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra----L-F~ 239 (953)
T KOG0587|consen 167 FGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA----L-FL 239 (953)
T ss_pred eeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh----h-cc
Confidence 9999876432 2334567899999999987543 577799999999999999999999877543211 1 00
Q ss_pred hCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 510 SLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+.. .+....+...++++.++|..||.+|.++||++.++++|
T Consensus 240 IpRNP------------PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 240 IPRNP------------PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCCC------------CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111 11223345667789999999999999999999999876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=247.65 Aligned_cols=220 Identities=29% Similarity=0.348 Sum_probs=182.7
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCee
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 362 (581)
++...++...+..||+|++|.|-+.++ .+|...|+|.++... .+..++..+|+++..+. .+|.+|.+||........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 455566677778899999999988884 489999999997764 44556788899987766 799999999999999999
Q ss_pred eEEEeccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 363 ALVLEFMPNGSLDKWLY---SHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
++.||.|+ .||..+-. +.+...++..+-+|+..+.+||.|||+ +..++|||+||+|||++.+|++|+||||.+-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999995 48877665 456668889999999999999999997 7899999999999999999999999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCC----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGS----EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESL 511 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 511 (581)
.+.+ +...+...|-..|+|||.+. ...|+.++||||||+++.||.+++.||+.....-..+.+.+.+..
T Consensus 198 ~L~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 198 YLVD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred eehh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence 7642 33334456788999999764 347899999999999999999999999887666666666555443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.18 Aligned_cols=264 Identities=22% Similarity=0.235 Sum_probs=170.4
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-C----CcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeee------ee
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-D----GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSS------CC 357 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~ 357 (581)
..++|++.+.||+|+||.||+|... + +..||+|.+...... +....| .++...+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999965 5 789999987654321 111111 1112122222222211 23
Q ss_pred cCCeeeEEEeccCCCCHHHHHhhCCCCC-------------------CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCC
Q 008012 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQ-------------------DIPDRLNIMIDVALALEYLHHGHSTPVVHCDLK 418 (581)
Q Consensus 358 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dik 418 (581)
.....++||||+++++|.+++....... ....+..++.||+.||+||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 5667899999999999999987543211 12345679999999999999 8999999999
Q ss_pred CCCeEecC-CCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCC----------------------CCCcccc
Q 008012 419 PSNILLDE-NMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG----------------------NVSSKCD 475 (581)
Q Consensus 419 p~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~D 475 (581)
|+|||++. ++.+||+|||+|..+..... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 68999999999986543222 223345788999999954322 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCC---ccccccchhh-hhhhhHHHHHHHHHHHHHHhccCcC
Q 008012 476 VYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP---KIADANLLRE-ENFFSARMDCLLSIFHLALDCCAEL 551 (581)
Q Consensus 476 v~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~d 551 (581)
||||||++|||+++..|++... ..+...+... ..... ....+....+ ...............+|+.+||+.|
T Consensus 362 VwSlGviL~el~~~~~~~~~~~---~~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNL---IQFNRQLKRN-DYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHH---HHHHHHHHhc-CCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 9999999999999776654310 0111111110 00000 0000000000 0000000011234568999999999
Q ss_pred CCCCCCHHHHHHH
Q 008012 552 PDQRLYMKDAATK 564 (581)
Q Consensus 552 P~~Rps~~evl~~ 564 (581)
|++|||++|+++|
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999987
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=292.52 Aligned_cols=245 Identities=28% Similarity=0.404 Sum_probs=192.2
Q ss_pred CCcCCeeccccccc-EEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEEeccC
Q 008012 293 FNECNLLGSGGFGS-VYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEFMP 370 (581)
Q Consensus 293 y~~~~~lg~G~~~~-v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 370 (581)
|.-.+.+|.|+.|+ ||+|... |+.||||++-.+. .....+|++.++.- +|||||++|+.-.++...|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 33346689999986 7999986 8999999876543 34667899999998 69999999999999999999999996
Q ss_pred CCCHHHHHhhCCCCC---CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-----CCcEEEeeccCceecC
Q 008012 371 NGSLDKWLYSHNYFQ---DIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE-----NMVAHVSDFGISKLLG 442 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~---~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~-----~~~~kl~Dfg~a~~~~ 442 (581)
. +|.+++....... .....+.+..|+++||++|| +.+||||||||.||||+. ..+++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 9999998742111 11345788999999999999 899999999999999975 2589999999999886
Q ss_pred CCCCcc-eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhC-CCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 443 EGDDSV-IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 443 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
.+..+. ......||.+|+|||++....-+.++||||+||++|+.++| .+||.+....+.+... .... +..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~---~~~~--L~~--- 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT---GNYT--LVH--- 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc---Cccc--eee---
Confidence 655433 23456799999999999998888999999999999999995 9999875444332221 1100 000
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.....++ +..+||.+|++++|..||+|.+|+.|
T Consensus 735 ---------L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 ---------LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ---------eccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0011112 56799999999999999999999876
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=262.83 Aligned_cols=239 Identities=27% Similarity=0.363 Sum_probs=194.5
Q ss_pred ccccEEEEEeC-CCcEEEEEEeccchHHH-HHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCHHHHHhh
Q 008012 303 GFGSVYKGILS-DGTTVAIKIFNLQLEQA-FRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYS 380 (581)
Q Consensus 303 ~~~~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 380 (581)
+||.||+|... +++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 58999999997765433 67899999999999999999999999999999999999999999999986
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCcccc
Q 008012 381 HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460 (581)
Q Consensus 381 ~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~ 460 (581)
... +++..++.++.+++.++.+|| +.+++|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 554 788999999999999999999 8899999999999999999999999999998765432 223446788999
Q ss_pred CCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHH
Q 008012 461 APEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSI 540 (581)
Q Consensus 461 aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 540 (581)
|||...+..++.++||||+|+++|++++|..||...... ....+......... ... ...++.++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~~----~~~-----------~~~~~~~~ 217 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGKPKPPF----PPP-----------EWKISPEA 217 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCC----ccc-----------cccCCHHH
Confidence 999988888999999999999999999999998653111 11112111111100 000 00034568
Q ss_pred HHHHHhccCcCCCCCCCHHHHHHH
Q 008012 541 FHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 541 ~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+++.+||..+|++||++.+++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhhC
Confidence 899999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=277.25 Aligned_cols=218 Identities=22% Similarity=0.385 Sum_probs=183.9
Q ss_pred chhhhHHHhh---cCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEe
Q 008012 281 TSYLDLERAT---DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKIL 353 (581)
Q Consensus 281 ~~~~~~~~~~---~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~ 353 (581)
..|..++++. .-|..++.||-|+||.|.+++ ..+...+|.|.+++.+ ......++.|-+||..-+.+-||++|
T Consensus 616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 3455555543 447788999999999999998 4567789999998764 45566788999999999999999999
Q ss_pred eeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEe
Q 008012 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVS 433 (581)
Q Consensus 354 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~ 433 (581)
-.|.+.+.+|+||+|++||++-.++.+.+- +++..+.-++..+..|+++.| ++|+|||||||+|||||.+|++||.
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeee
Confidence 999999999999999999999999988775 677888888999999999999 9999999999999999999999999
Q ss_pred eccCceecCC---------CCCc-------------------------------ceeeccccCccccCCCCCCCCCCCcc
Q 008012 434 DFGISKLLGE---------GDDS-------------------------------VIQTMTIATIGYMAPEFGSEGNVSSK 473 (581)
Q Consensus 434 Dfg~a~~~~~---------~~~~-------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 473 (581)
|||+|.-+.. ++-. ......+||+.|+|||++....|+..
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~ 851 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL 851 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence 9999964311 0000 00112368999999999999999999
Q ss_pred ccHHHHHHHHHHHHhCCCCCCcccccccc
Q 008012 474 CDVYSYGILLLETFTRKKPTDEMFTGEMN 502 (581)
Q Consensus 474 ~Dv~slG~vl~el~tg~~Pf~~~~~~~~~ 502 (581)
+|.||.|||||||+.|++||......+..
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCcce
Confidence 99999999999999999999887666543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=247.45 Aligned_cols=264 Identities=20% Similarity=0.296 Sum_probs=200.6
Q ss_pred HhhcCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-CCccceEeeeeecC--Ceee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSSCCNT--NFKA 363 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~ 363 (581)
...++|++++++|+|.++.||.|. ..+.+.++||++++-.. +.+.+|+.+++.+. ||||+++++...++ ....
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 456889999999999999999999 55789999999986533 57889999999996 99999999998765 4678
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-CCcEEEeeccCceecC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE-NMVAHVSDFGISKLLG 442 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~ 442 (581)
+|+||+.+.+....... ++...+..++.+++.||.|+| ++||.|||+||.|+++|. .-.++|+|+|+|.++.
T Consensus 112 LiFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hHhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99999999887765543 455678889999999999999 999999999999999994 5579999999999987
Q ss_pred CCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhh-----------
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES----------- 510 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~----------- 510 (581)
++.+. .....+..|.-||.+-. ..|+..-|+|||||++..|+..+.||....+...++..+.+-.
T Consensus 185 p~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 66543 34567888999997765 4678899999999999999999999865444333333322110
Q ss_pred ----CCCCCCccccccchhhhhh---hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 511 ----LPHGLPKIADANLLREENF---FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 511 ----~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+.+.+.+++.......-.. ....--..++..+++.+.|..|..+||||+|+++|
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1111111111110000000 00011134678899999999999999999999987
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=256.75 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=201.8
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCe
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNF 361 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 361 (581)
....++|...+.||+|+|+.|-+++.+ +.+-+|+|+++++. .+...-.+.|-.+..+. +||.+|.+..+|.....
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 344578999999999999999999954 78899999998763 34445677788888887 79999999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
.++|.||++||+|--+++++++ ++++.+.-+...|.-||.||| ++||+.||+|.+|||+|..|++||.|+|+++.-
T Consensus 326 lffvieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999999888877665 788888889999999999999 999999999999999999999999999999853
Q ss_pred CCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccc--cccccHHHHHHhhCCCCCCccc
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMF--TGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
-.+.+ .++..+||+.|.|||++++..|+..+|.|++||+++||+.|+.||+-.. ..+.+..++.-+...+.
T Consensus 402 l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek----- 474 (593)
T KOG0695|consen 402 LGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK----- 474 (593)
T ss_pred CCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-----
Confidence 22222 3466789999999999999999999999999999999999999997532 23333333333322111
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC
Q 008012 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLY 557 (581)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 557 (581)
.+ ..+...+.....+++.-|++||.+|..
T Consensus 475 --qi-------riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 475 --QI-------RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --cc-------cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 00 011122233557889999999999863
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=279.48 Aligned_cols=258 Identities=21% Similarity=0.248 Sum_probs=181.1
Q ss_pred hhcCCCcCCeecccccccEEEEEe-----------------CCCcEEEEEEeccchHHHHHH--------------HHHH
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-----------------SDGTTVAIKIFNLQLEQAFRS--------------FNSE 337 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e 337 (581)
..++|++.++||+|+||.||+|.. .+++.||||.+........+. ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 235689999987543322222 3346
Q ss_pred HHHHHhcCCCcc-----ceEeeeeec--------CCeeeEEEeccCCCCHHHHHhhCC----------------------
Q 008012 338 CEVLRNVRHRNL-----IKILSSCCN--------TNFKALVLEFMPNGSLDKWLYSHN---------------------- 382 (581)
Q Consensus 338 ~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~---------------------- 382 (581)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777765543 667777643 356899999999999999987421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccC
Q 008012 383 -YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 461 (581)
Q Consensus 383 -~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~a 461 (581)
...++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........ .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 12356778899999999999999 88999999999999999999999999999976533221 11122234789999
Q ss_pred CCCCCCCC--------------------C--CccccHHHHHHHHHHHHhCCC-CCCcccccc-------ccHHHHHHhhC
Q 008012 462 PEFGSEGN--------------------V--SSKCDVYSYGILLLETFTRKK-PTDEMFTGE-------MNLKNWVKESL 511 (581)
Q Consensus 462 PE~~~~~~--------------------~--~~~~Dv~slG~vl~el~tg~~-Pf~~~~~~~-------~~~~~~~~~~~ 511 (581)
||.+.... + ..+.||||+||++|+|++|.. ||.....-. .....|... .
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-~ 457 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-K 457 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-c
Confidence 99765432 1 124799999999999999875 665321111 111111110 0
Q ss_pred CCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCC---CCCCCHHHHHHH
Q 008012 512 PHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELP---DQRLYMKDAATK 564 (581)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~evl~~ 564 (581)
... ...+.....++...+++.+|+..+| .+|+|++|+++|
T Consensus 458 ~~~-------------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 GQK-------------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccC-------------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000 0011122345668899999999866 689999999987
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=258.86 Aligned_cols=264 Identities=19% Similarity=0.196 Sum_probs=196.9
Q ss_pred cCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-----C---CccceEeeeeec---
Q 008012 291 DGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-----H---RNLIKILSSCCN--- 358 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~~--- 358 (581)
++|.+.++||.|.|++||+|.+ .+.+.||+|+.+.. ....+....|+.+|++++ | .+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 7899999999999999999994 47899999998765 344567788999999993 2 479999999965
Q ss_pred -CCeeeEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC---------
Q 008012 359 -TNFKALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN--------- 427 (581)
Q Consensus 359 -~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~--------- 427 (581)
+.++|||+|++ |.+|..+|... -+.++...+.+|++||+.||.|||+ +.||||-||||+|||+..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeeccccchhhhhh
Confidence 45899999999 77999998854 3447999999999999999999998 7799999999999999000
Q ss_pred --------------------------------------------------------------------------------
Q 008012 428 -------------------------------------------------------------------------------- 427 (581)
Q Consensus 428 -------------------------------------------------------------------------------- 427 (581)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------------------------------------------------------------CcE
Q 008012 428 -----------------------------------------------------------------------------MVA 430 (581)
Q Consensus 428 -----------------------------------------------------------------------------~~~ 430 (581)
.++
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 025
Q ss_pred EEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccc-----cccccHHH
Q 008012 431 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMF-----TGEMNLKN 505 (581)
Q Consensus 431 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~-----~~~~~~~~ 505 (581)
||+|||-|+.... ..+..+.|..|+|||++.+..|++.+||||++|++|||+||...|+... .++..++.
T Consensus 394 KIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 394 KIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred EEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 6666666654321 1234456888999999999999999999999999999999999887532 12222332
Q ss_pred HHHhhCCCC----------CCcccccc----------chhhh----hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHH
Q 008012 506 WVKESLPHG----------LPKIADAN----------LLREE----NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDA 561 (581)
Q Consensus 506 ~~~~~~~~~----------~~~~~~~~----------~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 561 (581)
++ +.+..- ..++++.. .+.-. ..+.-+.+...++.+++.-||+.+|++||||.+.
T Consensus 469 i~-ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 469 IM-ELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HH-HHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 22 211110 11111110 00000 1122234567789999999999999999999999
Q ss_pred HHH
Q 008012 562 ATK 564 (581)
Q Consensus 562 l~~ 564 (581)
++|
T Consensus 548 l~h 550 (590)
T KOG1290|consen 548 LKH 550 (590)
T ss_pred hcC
Confidence 976
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=248.20 Aligned_cols=265 Identities=22% Similarity=0.297 Sum_probs=195.4
Q ss_pred CcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC-----eeeEE
Q 008012 294 NECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN-----FKALV 365 (581)
Q Consensus 294 ~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv 365 (581)
+--+.||.|+||.||.+++. +|+.|++|.+..-- -...+++-+|+.++..++|.|++..++...... +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34478999999999999965 89999999886442 233467889999999999999999988765432 56788
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
+|.|. .+|...|-... .++.+.+.-+..||++||+||| +.+|.||||||.|.+++++..+||||||+++..+..+
T Consensus 136 TELmQ-SDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHH-hhhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 89884 47877776544 3677888889999999999999 9999999999999999999999999999999764433
Q ss_pred CcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc--
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN-- 522 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 522 (581)
....+....|..|+|||++.+. .|+.+.||||.||++.|++..+..|... +.....+.+.+.......+.+...
T Consensus 211 -~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq--~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 211 -RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA--GPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred -hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc--ChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 3334556788999999988874 7999999999999999999999888753 223333344333322111110000
Q ss_pred -----chhhh---------hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 523 -----LLREE---------NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 523 -----~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
+++.. .....+...-.+...+...++..||++|.+..+++.++.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 00000 001111122234568899999999999999999988753
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=261.49 Aligned_cols=273 Identities=21% Similarity=0.218 Sum_probs=210.2
Q ss_pred chhhhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcC------CCccceEe
Q 008012 281 TSYLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR------HRNLIKIL 353 (581)
Q Consensus 281 ~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~ 353 (581)
+.+.--+....+|.+....|+|-|++|..|.+. .|+.||||++..... ..+.=+.|+++|++|. --|+++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 444555667789999999999999999999954 688999999987643 2344567999999994 34899999
Q ss_pred eeeecCCeeeEEEeccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-CCcE
Q 008012 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNY--FQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE-NMVA 430 (581)
Q Consensus 354 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~-~~~~ 430 (581)
..|...+++|||+|-+ ..+|.+.+.+.+. .+....+..++.|+.-||..|- ..||+|.||||+|||+++ ...+
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCccee
Confidence 9999999999999988 4599999997643 4677899999999999999999 899999999999999985 4578
Q ss_pred EEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHH---
Q 008012 431 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWV--- 507 (581)
Q Consensus 431 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~--- 507 (581)
||||||.|........ +.+..+..|.|||++.|.+|+...|+||.||+|||++||+..|.+.....+ ..+.
T Consensus 577 KLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M--Lrl~me~ 650 (752)
T KOG0670|consen 577 KLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM--LRLFMEL 650 (752)
T ss_pred eeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH--HHHHHHh
Confidence 9999999998765443 344567889999999999999999999999999999999998877543322 1111
Q ss_pred ---------------HhhCCCCCCc---cccc---------------------cchhhhhhhhHHHHHHHHHHHHHHhcc
Q 008012 508 ---------------KESLPHGLPK---IADA---------------------NLLREENFFSARMDCLLSIFHLALDCC 548 (581)
Q Consensus 508 ---------------~~~~~~~~~~---~~~~---------------------~~~~~~~~~~~~~~~~~~l~~li~~cl 548 (581)
.+++...+.- -.|+ .+.+..............+.+|+.+|+
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 1111111000 0000 000000111223446678999999999
Q ss_pred CcCCCCCCCHHHHHHH
Q 008012 549 AELPDQRLYMKDAATK 564 (581)
Q Consensus 549 ~~dP~~Rps~~evl~~ 564 (581)
..||++|.|..++++|
T Consensus 731 ~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 731 ILDPEKRITVNQALKH 746 (752)
T ss_pred ccChhhcCCHHHHhcC
Confidence 9999999999999876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=262.14 Aligned_cols=197 Identities=24% Similarity=0.373 Sum_probs=171.3
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH---H-----HHHHHHHHHHHHHhcC---CCccceEeeeeec
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE---Q-----AFRSFNSECEVLRNVR---HRNLIKILSSCCN 358 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~---~-----~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~ 358 (581)
.+|+.++.+|.|+||.|++|.++ +...|+||.+.++.- . ....+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 56999999999999999999976 566799999877631 1 1223557999999996 9999999999999
Q ss_pred CCeeeEEEecc-CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccC
Q 008012 359 TNFKALVLEFM-PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGI 437 (581)
Q Consensus 359 ~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 437 (581)
++.+|++||-. +|-+|.++|..+.. +++.++..|+.|++.|+++|| +.||+|||||-+||.++.+|-+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence 99999999984 56699999986654 788999999999999999999 89999999999999999999999999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCCC-CccccHHHHHHHHHHHHhCCCCCCc
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNV-SSKCDVYSYGILLLETFTRKKPTDE 495 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~Pf~~ 495 (581)
|.+...+. .....||..|.|||++.+.+| +..-|||++|+++|.++....||..
T Consensus 717 aa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 98765433 355689999999999999887 4568999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=236.75 Aligned_cols=211 Identities=34% Similarity=0.513 Sum_probs=184.6
Q ss_pred ecccccccEEEEEeC-CCcEEEEEEeccchHH-HHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCHHH
Q 008012 299 LGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQ-AFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDK 376 (581)
Q Consensus 299 lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 376 (581)
||+|++|.||++... +++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999965 4899999999876542 34678899999999999999999999999899999999999999999
Q ss_pred HHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-CCcEEEeeccCceecCCCCCcceeecccc
Q 008012 377 WLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE-NMVAHVSDFGISKLLGEGDDSVIQTMTIA 455 (581)
Q Consensus 377 ~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 455 (581)
++.......++..++.++.++++++++|| +.|++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 99876445788999999999999999999 889999999999999999 89999999999987643321 1233457
Q ss_pred CccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHH
Q 008012 456 TIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARM 534 (581)
Q Consensus 456 ~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (581)
...|++||..... .++.++|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8889999988877 888999999999999999
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 535 DCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 535 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
..+.+++.+|+..+|++||++.++++++
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1366899999999999999999998763
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=269.17 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=209.2
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
-.++|+.++.+|+|.||.||+++++ +++..|+|+++.+..+....+++|+-+++..+||||+.+++.+...+..|+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3578999999999999999999965 899999999999988888889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
||.||+|++.-+-.+. +++.++....+..++|++||| +.|-+|||||-.||++++.|.+|+.|||.+..++. .-
T Consensus 93 ycgggslQdiy~~Tgp-lselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGP-LSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI 166 (829)
T ss_pred ecCCCcccceeeeccc-chhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh--hh
Confidence 9999999997665543 688888999999999999999 99999999999999999999999999999876642 22
Q ss_pred ceeeccccCccccCCCC---CCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 448 VIQTMTIATIGYMAPEF---GSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
.......||+.|||||+ -+.+.|...+|||++|++..|+-.-++|..+.... . .-+....-....+...|+.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r-~l~LmTkS~~qpp~lkDk~-- 241 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--R-ALFLMTKSGFQPPTLKDKT-- 241 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--H-HHHHhhccCCCCCcccCCc--
Confidence 23456789999999995 35678999999999999999999988885442221 1 1111111122223333332
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+.+-++++.|+.++|++||+++.++.|
T Consensus 242 ----------kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 242 ----------KWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ----------cchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 223457799999999999999999988764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=241.05 Aligned_cols=257 Identities=22% Similarity=0.264 Sum_probs=194.7
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC------
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN------ 360 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 360 (581)
..+|.-.+.+|.|.- .|..|.+. .++.||+|...... ....++..+|..++..+.|+||++++.+|....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777788899888 66666644 68999999875442 233456778999999999999999999986543
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..|+|||+|.. +|.+.+.-. ++-+.+..|..|++.|++||| +.||+||||||+||++..+..+||.|||+|..
T Consensus 95 e~y~v~e~m~~-nl~~vi~~e---lDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILME---LDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHHh---cchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence 67999999954 999888732 466788999999999999999 99999999999999999999999999999986
Q ss_pred cCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhh--CCCCCCcc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES--LPHGLPKI 518 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~ 518 (581)
-.. ....+....+..|.|||++.+..+.+.+||||+||++.||++|+.-|.+ ...+.+|.+-. ....-+.+
T Consensus 168 e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g----~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 168 EDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG----KDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred cCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC----chHHHHHHHHHHHhcCCCHHH
Confidence 432 2345667889999999999998899999999999999999999988763 33444443211 11110010
Q ss_pred c---------------------------cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 A---------------------------DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ~---------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
. |..+... .+...--...+.+++.+||..||++|.|++++++|
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~---~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVV---LEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCccccccc---ccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 0000000 00000112346799999999999999999999987
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=234.07 Aligned_cols=253 Identities=21% Similarity=0.266 Sum_probs=194.3
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeee-eecCCeeeE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSS-CCNTNFKAL 364 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~~~l 364 (581)
...+.|.+.+.+|+|.||.+-++.++ +.+.+++|.+..... ..+.|.+|...--.+ .|.||+.-|++ |...+.+++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 45678999999999999999999965 788999999877643 346788888877777 58999998875 677788899
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec--CCCcEEEeeccCceecC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD--ENMVAHVSDFGISKLLG 442 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~--~~~~~kl~Dfg~a~~~~ 442 (581)
++||++.|+|..-+...+ +.+.....++.|+++|+.||| ++++||||||.+||||- +..++||||||.....+
T Consensus 100 ~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999999999888755 577888999999999999999 99999999999999994 45599999999988653
Q ss_pred CCCCcceeeccccCccccCCCCCCCC-----CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC--CC
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEG-----NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH--GL 515 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--~~ 515 (581)
..-. ..--+..|.|||..... ...+.+|||+||+++|.++||+.||+.....+..+.+|..-.... .+
T Consensus 175 ~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 175 TTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred ceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 2211 12235679999954332 356789999999999999999999987655555555554322211 12
Q ss_pred CccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
|+.+. ..++.+..+.++-+..+|++|--..++.+..
T Consensus 250 P~~F~--------------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 250 PKKFN--------------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred chhhc--------------ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 22111 2344577899999999999995555554443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=232.27 Aligned_cols=199 Identities=27% Similarity=0.426 Sum_probs=173.9
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHH-HHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccC
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQ-AFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMP 370 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 370 (581)
|++.+.||+|++|.||++... +++.+++|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 567789999999999999976 4899999999876544 56788999999999999999999999999899999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCccee
Q 008012 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 450 (581)
+++|.+++.......++..+..++.+++.++.+|| +.+++|+||+|.||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 99999999876543688999999999999999999 789999999999999999999999999999877543210 12
Q ss_pred eccccCccccCCCCC-CCCCCCccccHHHHHHHHHHHHhCCCCCCc
Q 008012 451 TMTIATIGYMAPEFG-SEGNVSSKCDVYSYGILLLETFTRKKPTDE 495 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~ 495 (581)
....++..|++||.. ....++.++|||+||+++|+|++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 334577889999988 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=241.84 Aligned_cols=270 Identities=23% Similarity=0.285 Sum_probs=204.3
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeC----CCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCC
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTN 360 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 360 (581)
+......|..+++||.|.|++||++... ..+.||+|.+...+. ..++.+|++++..+ .+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4456678999999999999999999833 478899998876643 25688999999999 6999999999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec-CCCcEEEeeccCce
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD-ENMVAHVSDFGISK 439 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~ 439 (581)
...+|+||++.....++...- +..++..+++.++.||+++| ..|||||||||.|++.+ ..++-.|+|||+|.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~l----~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRSL----SLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHhcC----CHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence 999999999999988888653 57889999999999999999 99999999999999998 56788999999998
Q ss_pred ecCCC------------------------------------------CCcceeeccccCccccCCCCCCC-CCCCccccH
Q 008012 440 LLGEG------------------------------------------DDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDV 476 (581)
Q Consensus 440 ~~~~~------------------------------------------~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 476 (581)
..... ..........||++|+|||++.. ...++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 21100 00011123468999999997755 567889999
Q ss_pred HHHHHHHHHHHhCCCCCCccccccccHHHHHHhh----------CCCC--CCc------cccc-----cch-hhhh----
Q 008012 477 YSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES----------LPHG--LPK------IADA-----NLL-REEN---- 528 (581)
Q Consensus 477 ~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~----------~~~~--~~~------~~~~-----~~~-~~~~---- 528 (581)
||.|||+..+++++.||....++-..+.+.+.-. .+.. +.+ +.+. .+. +...
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999987666655555544211 1111 000 0000 000 0000
Q ss_pred ---hhhHHHH-HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 529 ---FFSARMD-CLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 529 ---~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
......+ .+..+++++.+|++.||.+|.|++|+++|
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0011112 33478899999999999999999999987
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=216.03 Aligned_cols=171 Identities=20% Similarity=0.172 Sum_probs=132.5
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
|+|.+++...+..+++..++.++.|++.||+||| +.+ ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999877777899999999999999999999 566 999999999999999 99998764321
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
..|++.|+|||++.+..++.++|||||||++|||+||+.||.........+..+........... . .
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~---------~ 130 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD---R---------S 130 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc---c---------c
Confidence 25789999999999999999999999999999999999999764332222333322221111000 0 0
Q ss_pred HHHHHHH--HHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 532 ARMDCLL--SIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 532 ~~~~~~~--~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
....... .+.+++.+||..+|++||++.|+++++..+..+.
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 1112222 5889999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=265.46 Aligned_cols=197 Identities=18% Similarity=0.232 Sum_probs=139.6
Q ss_pred hcCC-CccceEeeee-------ecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 008012 343 NVRH-RNLIKILSSC-------CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414 (581)
Q Consensus 343 ~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H 414 (581)
.++| +||++++++| ...+..+.++||+ +++|.+++......+++.+++.++.||++||.||| ++||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 3445 5777888876 2234567888987 55999999876666899999999999999999999 899999
Q ss_pred cCCCCCCeEecCCCc-------------------EEEeeccCceecCCCCC--------------cceeeccccCccccC
Q 008012 415 CDLKPSNILLDENMV-------------------AHVSDFGISKLLGEGDD--------------SVIQTMTIATIGYMA 461 (581)
Q Consensus 415 ~dikp~Nill~~~~~-------------------~kl~Dfg~a~~~~~~~~--------------~~~~~~~~~~~~y~a 461 (581)
|||||+|||++..+. +|++|||+++....... ........||+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999965444 55555555543210000 000112357888999
Q ss_pred CCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHH
Q 008012 462 PEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIF 541 (581)
Q Consensus 462 PE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 541 (581)
||++.+..++.++|||||||++|||++|.+|+..... ..........+.. . ........
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~~~~~--------~----------~~~~~~~~ 242 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRVLPPQ--------I----------LLNWPKEA 242 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhhcChh--------h----------hhcCHHHH
Confidence 9999999999999999999999999999988653211 1111111111000 0 01122355
Q ss_pred HHHHhccCcCCCCCCCHHHHHHH
Q 008012 542 HLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 542 ~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+++.+||+++|.+||++.|++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 78899999999999999999876
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=258.56 Aligned_cols=207 Identities=33% Similarity=0.520 Sum_probs=158.1
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
++|+.|++++|++++.+|..+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++.+|..+..+++|+.|++
T Consensus 380 ~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 459 (968)
T PLN00113 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL 459 (968)
T ss_pred CCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEEC
Confidence 34444444444444445555555556666666666666555666666666666666666666666666666666666666
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEG 164 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~ 164 (581)
++|++.+..|..+ ..++|+.|++++|++++..|..+.++++|+.|+|++|++++.+|..+..+++|++|+|++|.+++.
T Consensus 460 ~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 538 (968)
T PLN00113 460 ARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538 (968)
T ss_pred cCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCccccc
Confidence 6666665555544 347788888888898888898999999999999999999999999999999999999999999999
Q ss_pred CchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCccccccccccccCC
Q 008012 165 IPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNYALCGP 212 (581)
Q Consensus 165 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~ 212 (581)
.|..+..+++|+.|+|++|++++.+|.. ..+..+..+++.+|+..+.-
T Consensus 539 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~ 587 (968)
T PLN00113 539 IPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL 587 (968)
T ss_pred CChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeC
Confidence 9999999999999999999999988875 66788999999999877643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=215.49 Aligned_cols=169 Identities=21% Similarity=0.231 Sum_probs=132.3
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC--CCcEEEEEEeccc-----hHHHHHHHHHHHHHHHhcCCCccce-Eeeee
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS--DGTTVAIKIFNLQ-----LEQAFRSFNSECEVLRNVRHRNLIK-ILSSC 356 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~ 356 (581)
......++|++.+.||+|+||+||+|..+ +++.||||++... .....+.+.+|++++++++|+|+++ ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 34556788999999999999999999864 5777899986533 2234567899999999999999985 4432
Q ss_pred ecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCCeEecCCCcEEEeec
Q 008012 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL-KPSNILLDENMVAHVSDF 435 (581)
Q Consensus 357 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~di-kp~Nill~~~~~~kl~Df 435 (581)
+..++||||++|++|.. .... . ...++.|+++||.||| ++||+|||| ||+||+++.++.+||+||
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-ARPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hCcc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 45799999999999963 2111 1 1468899999999999 899999999 999999999999999999
Q ss_pred cCceecCCCCCcce------eeccccCccccCCCCCCCC
Q 008012 436 GISKLLGEGDDSVI------QTMTIATIGYMAPEFGSEG 468 (581)
Q Consensus 436 g~a~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~ 468 (581)
|+|+.+........ -....+++.|+|||.+...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99997754332111 1244678889999987654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-25 Score=200.79 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=191.5
Q ss_pred CCCcCCeecccccccEEEEEeCCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 292 GFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
+.....+|.+...|..|+|+++ |..+++|+++... ....+.|..|.-.++-+.||||..+++.|..+.+..++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 3455678899999999999997 7778889886553 334467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 370 PNGSLDKWLYSHNY-FQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 370 ~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+.|+|+..+++... ..+..++.+++.++++|++|||.. +.-|----+++..|++|++.+++|+- +-+++ +.
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf------sf 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF------SF 341 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee------ee
Confidence 99999999997643 356778999999999999999952 22244456899999999999887741 11111 11
Q ss_pred eeeccccCccccCCCCCCCCCCC---ccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVS---SKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~---~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
......-.+.|++||.++.++-+ .++|+|||++++||+.|...||.+..+-+....-. -+.+...++
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-leglrv~ip--------- 411 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-LEGLRVHIP--------- 411 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-hccccccCC---------
Confidence 12233457899999988876544 47999999999999999999998865444322221 111111111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
...+..+.+||.-|+..||.+||.++.|+-.|+++.
T Consensus 412 --------pgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 412 --------PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred --------CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 234456779999999999999999999999988764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=209.61 Aligned_cols=261 Identities=19% Similarity=0.185 Sum_probs=197.2
Q ss_pred CCCcCCeecccccccEEEEEeCC--CcEEEEEEeccchHHHHHHHHHHHHHHHhcC----CCccceEeeee-ecCCeeeE
Q 008012 292 GFNECNLLGSGGFGSVYKGILSD--GTTVAIKIFNLQLEQAFRSFNSECEVLRNVR----HRNLIKILSSC-CNTNFKAL 364 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~l 364 (581)
+|.+.+.||+|+||.||.|.... ...+|+|+...........+..|..++..+. .+++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999654 3578999876653222226778889988886 36899999998 47778999
Q ss_pred EEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC-----CcEEEeeccCc
Q 008012 365 VLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN-----MVAHVSDFGIS 438 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~-----~~~kl~Dfg~a 438 (581)
||+.+ |.+|.++..... ..++..++..|+.|++.+|+++| +.|++||||||+|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 889999886554 67899999999999999999999 9999999999999999854 46999999999
Q ss_pred e--ecCCCCC----cc-e-eeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 008012 439 K--LLGEGDD----SV-I-QTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES 510 (581)
Q Consensus 439 ~--~~~~~~~----~~-~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~ 510 (581)
+ .+..... .. . .....||..|+++....+...+.+.|+||++.++.|++.|..||........ ........
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence 8 3221111 01 1 2234599999999999999999999999999999999999999966432211 11111111
Q ss_pred CCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 511 LPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
....... .....+..+.++...+-..+...+|....+.+.+++....
T Consensus 254 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 RKLLTDR--------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hhhcccc--------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 1100000 0011234456666666678999999999999998877655
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=230.86 Aligned_cols=255 Identities=20% Similarity=0.192 Sum_probs=193.0
Q ss_pred CcCCeecccccccEEEEEeC-CCcEEEEEEec----c-chHH-HHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 294 NECNLLGSGGFGSVYKGILS-DGTTVAIKIFN----L-QLEQ-AFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 294 ~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~----~-~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
.....+|.|++|.|+.+... .....+.|.+. . .... ....+..|+-+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999988877633 34444555432 2 1222 2223667888888889999998888777766666669
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|||++ +|..++.... ++...++..++.|+..|++|+| +.||.|||+|++|++++.+|.+||+|||.+..+..+.+
T Consensus 401 E~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 9999998763 3677888899999999999999 99999999999999999999999999999987755444
Q ss_pred c--ceeeccccCccccCCCCCCCCCCCc-cccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 447 S--VIQTMTIATIGYMAPEFGSEGNVSS-KCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 447 ~--~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
. .......|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......+..+.+ ...... .
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---~~~~~~--------~ 544 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---NNYSDQ--------R 544 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---hccccc--------c
Confidence 3 4556678999999999999999987 589999999999999999999764433332200 000000 0
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.............+..-..+|.+||+.||.+|.|+++|++.
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 11112223344567778899999999999999999999863
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=188.62 Aligned_cols=265 Identities=15% Similarity=0.162 Sum_probs=209.6
Q ss_pred hhcCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
..-.|.+.++||+|+||.++.|+ .-+++.||||.-...++ ..++..|.+.++.| ..++|..+|-+...+-+-.||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 44579999999999999999999 44799999997654432 24677899999999 5799999998888888889999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC-----CcEEEeeccCceec
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN-----MVAHVSDFGISKLL 441 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~-----~~~kl~Dfg~a~~~ 441 (581)
|.+ |.+|.|+..--+..++.+++..+|.|++.-++|+| ++..|.|||||+|+||... ..+.++|||+|+.+
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 998 88999999877777999999999999999999999 8899999999999999743 46899999999987
Q ss_pred CCCCCcc-----eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHhhCCCCC
Q 008012 442 GEGDDSV-----IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMN-LKNWVKESLPHGL 515 (581)
Q Consensus 442 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~-~~~~~~~~~~~~~ 515 (581)
.+..... ......||..||+-....+.+-+.+-|+=|+|-++...+.|..||.+...+... -.+.+.+..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K---- 255 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK---- 255 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc----
Confidence 6544322 223446999999999999999999999999999999999999999986433211 111111111
Q ss_pred CccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
+..+....+...|.++..-+.-.-+.+-.+-|..+=+...+..+.+..
T Consensus 256 ---------r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 256 ---------RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred ---------ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 111223445567778888888777888889999888777777766554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=185.20 Aligned_cols=262 Identities=17% Similarity=0.179 Sum_probs=198.7
Q ss_pred HhhcCCCcCCeecccccccEEEEE-eCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-CCccceEeeeeecCCeeeEE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 365 (581)
...+.|.++++||+|+||.+|.|. ..+|+.||||+-...... ..+..|..+.+.++ ...|..+..+..+.++-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 456789999999999999999999 668999999987655433 35778999999996 46777777788888889999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec---CCCcEEEeeccCceecC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD---ENMVAHVSDFGISKLLG 442 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a~~~~ 442 (581)
|+.. |.+|.++..--...++.++++-++-|++.-++|+| .++++||||||+|+|.. ....+.++|||+|+.+.
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9998 88999998855556899999999999999999999 89999999999999996 34579999999998764
Q ss_pred CCCCc-----ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHhhCCCCCC
Q 008012 443 EGDDS-----VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM-NLKNWVKESLPHGLP 516 (581)
Q Consensus 443 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~ 516 (581)
+.... .......||..|.+-....+...+.+.|+=|+|.++...-.|..||++...... .-.+.+.+.....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~-- 243 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST-- 243 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC--
Confidence 43221 122345689999998888888888999999999999999999999988643221 1111222211110
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
+....+...|.++.-.+.-|-..--++-|...=+.+.+.-+
T Consensus 244 -----------~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 244 -----------PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred -----------CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 11223344566677777777777777777766555554444
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-22 Score=200.47 Aligned_cols=258 Identities=29% Similarity=0.384 Sum_probs=200.4
Q ss_pred CCcCCeecccccccEEEEEeCCCcEEEEEEeccchHH---HHHHHHHHHHHHHhcCCC-ccceEeeeeecCCeeeEEEec
Q 008012 293 FNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQ---AFRSFNSECEVLRNVRHR-NLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~ 368 (581)
|.+.+.||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++++.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999976 78899998766432 467899999999999888 799999999777778999999
Q ss_pred cCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC-cEEEeeccCceecCCCC
Q 008012 369 MPNGSLDKWLYSHN--YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM-VAHVSDFGISKLLGEGD 445 (581)
Q Consensus 369 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~ 445 (581)
+.++++.+++.... ...+......++.|++.++.|+| +.+++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997777654 25788999999999999999999 89999999999999999888 79999999998664433
Q ss_pred Ccc----eeeccccCccccCCCCCCC---CCCCccccHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHhhCCCCCC
Q 008012 446 DSV----IQTMTIATIGYMAPEFGSE---GNVSSKCDVYSYGILLLETFTRKKPTDEMFTG--EMNLKNWVKESLPHGLP 516 (581)
Q Consensus 446 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~ 516 (581)
... ......++..|+|||...+ ..++...|+||+|++++++++|..||...... .......+.........
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 221 2456689999999998887 57889999999999999999999997654321 11222222222211000
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
........ ......+.+++..|+..+|..|.++.+....
T Consensus 237 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSPSNP---------ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCcccc---------chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 1222457789999999999999999988775
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-23 Score=189.24 Aligned_cols=172 Identities=13% Similarity=0.129 Sum_probs=134.3
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHH---HHHH------HHHHHHHHHhcCCCccceEeeeeec
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQ---AFRS------FNSECEVLRNVRHRNLIKILSSCCN 358 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~---~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~ 358 (581)
...++|+..+.+|.|+||.||++.. ++..+|+|+++..... .... +.+|++.+.++.||+|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999766 5778999999755322 1122 6899999999999999999988654
Q ss_pred C--------CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcE
Q 008012 359 T--------NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVA 430 (581)
Q Consensus 359 ~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~ 430 (581)
. +..++||||++|.+|.++.. .+. ....+++.++..+| ..|++|||+||+||+++.++ +
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-E
Confidence 3 35789999999999988732 222 34669999999999 89999999999999999988 9
Q ss_pred EEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHH
Q 008012 431 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETF 487 (581)
Q Consensus 431 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~ 487 (581)
+|+|||........... ..+.....+..++|+||||+++....
T Consensus 174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988754221110 01334445667999999999876654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-23 Score=219.97 Aligned_cols=245 Identities=24% Similarity=0.259 Sum_probs=180.2
Q ss_pred CCCcCCeecccccccEEEEEeCCCcEEEEEEeccch-HHHHHHH---HHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 292 GFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL-EQAFRSF---NSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~-~~~~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
+|...+.+|++.|=.|.+|++..|. |+||++-+.. .-..+.+ ..|++ ...+++||++++.-+.......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6778899999999999999988777 9999986654 2222333 33444 455599999999988888888899999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC--CC-
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG--EG- 444 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~--~~- 444 (581)
|+.. +|+|.+..+. ++...+.+-|+.|++.||..+| ..||+|||||.+||||+.-+-+.|+||..-+... ++
T Consensus 102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9966 9999987654 4566777779999999999999 8999999999999999999999999998665431 11
Q ss_pred --CCcceeeccccCccccCCCCCCCC----------C-CCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhh
Q 008012 445 --DDSVIQTMTIATIGYMAPEFGSEG----------N-VSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKES 510 (581)
Q Consensus 445 --~~~~~~~~~~~~~~y~aPE~~~~~----------~-~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 510 (581)
+..........-.+|.|||.+... . .+++.||||+||+++||++ |++||.-. ++..+-...
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~ 251 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN 251 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC
Confidence 112233333455679999955331 2 5678999999999999999 78888531 111110000
Q ss_pred C--CC-CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 511 L--PH-GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 511 ~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
. ++ -+..+.| ..+.+++..|++.||++|.+|++.++.-
T Consensus 252 ~~~~e~~Le~Ied-----------------~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 252 ADDPEQLLEKIED-----------------VSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ccCHHHHHHhCcC-----------------ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 0 00 0111111 1467999999999999999999999874
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-24 Score=211.94 Aligned_cols=158 Identities=23% Similarity=0.259 Sum_probs=75.3
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
.++++|+|++|.|+.+.-+.|.++.+|..|.|+.|+|+...+.+|.+|++|+.|+|..|+|+....-.|.+|++|+.|.|
T Consensus 173 ~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlkl 252 (873)
T KOG4194|consen 173 VNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKL 252 (873)
T ss_pred CCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhh
Confidence 35666666666666555556666666666666666666555555666666666666666655322333444444444444
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
..|+|+.....+|-.|.++++|+|+.|+++..-..++.+|++|+.|+||+|.|..+.++...-.++|++|+|++|+|+
T Consensus 253 qrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~ 330 (873)
T KOG4194|consen 253 QRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT 330 (873)
T ss_pred hhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccc
Confidence 444444333333434444444444444443333333333333333333333333333333333333333333333333
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-23 Score=208.05 Aligned_cols=213 Identities=23% Similarity=0.267 Sum_probs=132.7
Q ss_pred CCCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCc
Q 008012 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYIL 80 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 80 (581)
|..+.+|..|.|++|+|+...+..|++|++|+.|+|..|+|+...--.|.+|++|+.|.|..|.|...-.+.|..+.+++
T Consensus 193 F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme 272 (873)
T KOG4194|consen 193 FDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKME 272 (873)
T ss_pred ccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccc
Confidence 34455666666666666655555566666666666666666644355566666666666666666655566666666666
Q ss_pred EEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccc
Q 008012 81 YVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNN 160 (581)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~ 160 (581)
+|+|..|+++..-..++-+++.|+.|+||+|.|....++.++-.++|+.|+|++|+|+...+.+|..+..|++|+|++|.
T Consensus 273 ~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Ns 352 (873)
T KOG4194|consen 273 HLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNS 352 (873)
T ss_pred eeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccc
Confidence 66666666664444555666666666666666665666666666666666666666666666666666666666666666
Q ss_pred cCCCCchhhhcccccCeeEccCCCCCCCCCCC----CCCcCCccccccccccccCCC
Q 008012 161 LSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE----GPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 161 l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~----~~~~~~~~~~~~~n~~~c~~~ 213 (581)
++.+-...|.++.+|+.|||.+|.++..+.+. ..++.+..+.+.||.....++
T Consensus 353 i~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~k 409 (873)
T KOG4194|consen 353 IDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPK 409 (873)
T ss_pred hHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecch
Confidence 66555556666666666666666666555442 335556666666665555444
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.6e-25 Score=185.21 Aligned_cols=182 Identities=27% Similarity=0.473 Sum_probs=153.5
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
++.+.+.|-|++|+++ .+|..+.++.+|++|++++|+|+ .+|.+++.++.|+.|+++.|++. ..|.+|+++|.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 5677888999999998 78888999999999999999999 78889999999999999999997 889999999999999
Q ss_pred ecccCcCC-CCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeecccccc
Q 008012 83 NLSSNYLT-GSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNL 161 (581)
Q Consensus 83 ~l~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l 161 (581)
+|.+|++. ..+|..|-.++.|+-|+|++|.+. .+|..++++++|+.|.+.+|.+- ..|..++.+..|++|++.+|++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 99999886 467888888999999999999998 78888999999999999999888 6888899999999999999999
Q ss_pred CCCCchhhhccc---ccCeeEccCCCCCCCCC
Q 008012 162 SEGIPKSLVALS---HLKQFNVSHNRLEGEIP 190 (581)
Q Consensus 162 ~~~~~~~~~~l~---~L~~l~l~~n~l~~~~~ 190 (581)
+. +|..++.+. +=+.+.+.+|++-..+.
T Consensus 186 ~v-lppel~~l~l~~~k~v~r~E~NPwv~pIa 216 (264)
T KOG0617|consen 186 TV-LPPELANLDLVGNKQVMRMEENPWVNPIA 216 (264)
T ss_pred ee-cChhhhhhhhhhhHHHHhhhhCCCCChHH
Confidence 75 666666543 23456667777655443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-22 Score=181.05 Aligned_cols=139 Identities=17% Similarity=0.162 Sum_probs=109.0
Q ss_pred CCeecccccccEEEEEeCCCcEEEEEEeccchHH--H------------------------HHHHHHHHHHHHhcCCCcc
Q 008012 296 CNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQ--A------------------------FRSFNSECEVLRNVRHRNL 349 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~i 349 (581)
.+.||+|++|.||+|...+|+.||+|+++..... . .....+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999999764211 0 1123459999999987776
Q ss_pred ceEeeeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceecCCCCCCeEecCCC
Q 008012 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYL-HHGHSTPVVHCDLKPSNILLDENM 428 (581)
Q Consensus 350 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~i~H~dikp~Nill~~~~ 428 (581)
.....+.. ...++||||++|+++....... ..++...+..++.|++.+|.++ | +.||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence 44333222 2238999999998776554333 3478889999999999999999 6 78999999999999998 47
Q ss_pred cEEEeeccCceec
Q 008012 429 VAHVSDFGISKLL 441 (581)
Q Consensus 429 ~~kl~Dfg~a~~~ 441 (581)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999865
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=185.64 Aligned_cols=198 Identities=23% Similarity=0.269 Sum_probs=142.2
Q ss_pred CCCccceEeeeeec---------------------------CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHH
Q 008012 345 RHRNLIKILSSCCN---------------------------TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDV 397 (581)
Q Consensus 345 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i 397 (581)
+|||||++.++|.+ +...|+||..++. +|.+++..+.. +.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~--s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHR--SYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCC--chHHHHHHHHHH
Confidence 59999999887643 2256899999866 99999987653 556677799999
Q ss_pred HHHHHHHhcCCCCCceecCCCCCCeEec--CCC--cEEEeeccCceecCCC----CCcceeeccccCccccCCCCCCCCC
Q 008012 398 ALALEYLHHGHSTPVVHCDLKPSNILLD--ENM--VAHVSDFGISKLLGEG----DDSVIQTMTIATIGYMAPEFGSEGN 469 (581)
Q Consensus 398 ~~~L~~LH~~~~~~i~H~dikp~Nill~--~~~--~~kl~Dfg~a~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~ 469 (581)
++|+.||| .+||.|||+|++|||+. +|+ .+.++|||++---+.. ......-...|...-||||+....+
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 89999999999999994 333 6789999987532110 1111223346788899999866532
Q ss_pred C------CccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHH
Q 008012 470 V------SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHL 543 (581)
Q Consensus 470 ~------~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 543 (581)
- -.|+|.|+.|.+.||+++...||........+...+-... ++. .+..+++.+.++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q----LPa--------------lp~~vpp~~rql 489 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ----LPA--------------LPSRVPPVARQL 489 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh----CCC--------------CcccCChHHHHH
Confidence 1 2489999999999999999999987322222222211111 111 123466678899
Q ss_pred HHhccCcCCCCCCCHHHHHHHHH
Q 008012 544 ALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 544 i~~cl~~dP~~Rps~~evl~~L~ 566 (581)
+...|+.||.+|++..-+...|.
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHH
Confidence 99999999999999876665543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=197.20 Aligned_cols=220 Identities=25% Similarity=0.342 Sum_probs=168.0
Q ss_pred HHhcCCCccceEeeeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 008012 341 LRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPS 420 (581)
Q Consensus 341 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~ 420 (581)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.......++.....+.++|+.||+|+|+ +....|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence 356789999999999999999999999999999999999887778999999999999999999994 333399999999
Q ss_pred CeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCC-------CCCccccHHHHHHHHHHHHhCCCCC
Q 008012 421 NILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG-------NVSSKCDVYSYGILLLETFTRKKPT 493 (581)
Q Consensus 421 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Dv~slG~vl~el~tg~~Pf 493 (581)
|++++....+||+|||+....................-|.|||.+... ..+.++||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998876431111222233356679999987764 1466799999999999999999999
Q ss_pred CccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 494 DEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
+........ .+.+..... .-....-+.+.. ..+.++.+..++.+||..+|++||+++++-..++.+...
T Consensus 159 ~~~~~~~~~-~eii~~~~~-~~~~~~rP~i~~-------~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDP-DEIILRVKK-GGSNPFRPSIEL-------LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCCh-HHHHHHHHh-cCCCCcCcchhh-------hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 875444432 233322111 101111111111 113444688999999999999999999999988877653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=186.90 Aligned_cols=230 Identities=20% Similarity=0.268 Sum_probs=148.6
Q ss_pred CCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcC----------CCccceEeeeee-
Q 008012 293 FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVR----------HRNLIKILSSCC- 357 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~----------h~~iv~~~~~~~- 357 (581)
+...+.||.|+++.||.+++. +++.+|+|++.... ....+.+++|.-....+. |-.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999976 79999999885432 334566666665554432 112222222211
Q ss_pred --------c---CC-----eeeEEEeccCCCCHHHHHhh---CCC---CCCHHHHHHHHHHHHHHHHHHhcCCCCCceec
Q 008012 358 --------N---TN-----FKALVLEFMPNGSLDKWLYS---HNY---FQDIPDRLNIMIDVALALEYLHHGHSTPVVHC 415 (581)
Q Consensus 358 --------~---~~-----~~~lv~e~~~~~~L~~~l~~---~~~---~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~ 415 (581)
. .. ..+++|+-+ .++|.+++.. ... ......+..+..|+++.+++|| ..|++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence 1 11 236788887 4588887662 211 1234556778899999999999 8999999
Q ss_pred CCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCC--------CCCCccccHHHHHHHHHHHH
Q 008012 416 DLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE--------GNVSSKCDVYSYGILLLETF 487 (581)
Q Consensus 416 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~vl~el~ 487 (581)
||+|+|++++.+|.++|+||+.....+. .. .....+..|.|||.... ..++.+.|.|++|+++|.|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~---~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT---RY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE---EE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc---ee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999998775432 11 11345678999996533 35788999999999999999
Q ss_pred hCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCC
Q 008012 488 TRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQR 555 (581)
Q Consensus 488 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 555 (581)
+|..||+.......... .+..+.+.|+.+..||..+|+.+|++|
T Consensus 245 C~~lPf~~~~~~~~~~~------------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW------------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG------------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc------------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999986432211100 122333678889999999999999988
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-23 Score=196.25 Aligned_cols=219 Identities=24% Similarity=0.291 Sum_probs=175.3
Q ss_pred CCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccC-CcccCCCCc-------------
Q 008012 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNS-NKLTSSIPS------------- 71 (581)
Q Consensus 6 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~------------- 71 (581)
.-..++|..|+|+.+.|+.|+.+++|++||||+|.|+.+-|++|.++.+|.+|.+.+ |+|++...+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 356789999999988888999999999999999999988899999999988886665 888854333
Q ss_pred -----------ccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCC--------------------------
Q 008012 72 -----------ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLS-------------------------- 114 (581)
Q Consensus 72 -----------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~-------------------------- 114 (581)
.|+.+++|..|.+.+|.+.......|..+..++.+++..|.+-
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 4556667777777777776444446777777777777777621
Q ss_pred -----------------------------------CCCc-ccccCcccccceeccccccccccCccccCccccceeeccc
Q 008012 115 -----------------------------------GDIP-KTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSS 158 (581)
Q Consensus 115 -----------------------------------~~~~-~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~ 158 (581)
...| ..|..|++|++|+|++|.|+.+-+.+|.+...|++|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 0111 1256788999999999999999999999999999999999
Q ss_pred cccCCCCchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCccccccccccccC------------CCCCCCCCCCccc
Q 008012 159 NNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNYALCG------------PQRLQVPPCKEDK 224 (581)
Q Consensus 159 N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~------------~~~~~~p~c~~~~ 224 (581)
|+|..+-...|.++..|+.|+|.+|+|++..|.. ..+..+..+++..|||.|+ ......|+|+.+.
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~ 386 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPG 386 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCc
Confidence 9998777788999999999999999999988876 7788899999999999998 2244567887653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=173.16 Aligned_cols=140 Identities=19% Similarity=0.183 Sum_probs=110.9
Q ss_pred CCeecccccccEEEEEeCCCcEEEEEEeccchHH--------------------------HHHHHHHHHHHHHhcCCCcc
Q 008012 296 CNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQ--------------------------AFRSFNSECEVLRNVRHRNL 349 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~~i 349 (581)
.+.||+|++|.||+|...+|+.||||+++..... ......+|.+.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998764210 01234679999999999887
Q ss_pred ceEeeeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeEecCCC
Q 008012 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS-TPVVHCDLKPSNILLDENM 428 (581)
Q Consensus 350 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dikp~Nill~~~~ 428 (581)
.....+... ..++||||++|+++....... ...+......++.|++.++.++| . .||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CC
Confidence 544443332 248999999988654432222 23577889999999999999999 6 9999999999999998 88
Q ss_pred cEEEeeccCceecC
Q 008012 429 VAHVSDFGISKLLG 442 (581)
Q Consensus 429 ~~kl~Dfg~a~~~~ 442 (581)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=169.60 Aligned_cols=187 Identities=17% Similarity=0.088 Sum_probs=139.9
Q ss_pred CcCCeecccccccEEEEEeCCCcEEEEEEeccchHH----HHHHHHHHHHHHHhcC-CCccceEeeeeecCCeeeEEEec
Q 008012 294 NECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQ----AFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 294 ~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
.+...|++|+||+||.+.. ++.+++.+.+...... ....+.+|+++++++. |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998877 5788887777655321 1225789999999994 5889999886 346899999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL-KPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~di-kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
++|.+|.+.... ....++.|++.+|+++| +.||+|||| ||+||+++.++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998764321 11357889999999999 899999999 799999999999999999999865433211
Q ss_pred ----c-------eeeccccCccccCCCCCCC-CCCC-ccccHHHHHHHHHHHHhCCCCCCcc
Q 008012 448 ----V-------IQTMTIATIGYMAPEFGSE-GNVS-SKCDVYSYGILLLETFTRKKPTDEM 496 (581)
Q Consensus 448 ----~-------~~~~~~~~~~y~aPE~~~~-~~~~-~~~Dv~slG~vl~el~tg~~Pf~~~ 496 (581)
. .......++.|++|+...- ...+ .+.+.++-|.-+|.++|+..|+...
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0111234666777773221 1223 5678999999999999999987653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-23 Score=173.99 Aligned_cols=181 Identities=27% Similarity=0.419 Sum_probs=161.3
Q ss_pred cccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccC
Q 008012 24 DLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVL 103 (581)
Q Consensus 24 ~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 103 (581)
.+.++.+.+.|.||+|+|+ .+|..++.+.+|+.|++.+|+|+ .+|..++++++|+.|+++-|++. ..|..|+.+|.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 3556889999999999999 77888999999999999999998 88999999999999999999999 899999999999
Q ss_pred cEEeCCCCcCCC-CCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccC
Q 008012 104 IDLDLSRNQLSG-DIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSH 182 (581)
Q Consensus 104 ~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~ 182 (581)
+.|||+.|.+.+ .+|..|..++.|+.|+|++|.|. .+|..++.+++|+.|.+..|.+-. +|..++.++.|+.|...+
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~-lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLS-LPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhh-CcHHHHHHHHHHHHhccc
Confidence 999999999863 78889999999999999999999 899999999999999999999974 999999999999999999
Q ss_pred CCCCCCCCCCCCCcCC---ccccccccccc
Q 008012 183 NRLEGEIPTEGPFRNF---SAQSFHWNYAL 209 (581)
Q Consensus 183 n~l~~~~~~~~~~~~~---~~~~~~~n~~~ 209 (581)
|+++..+|+.+.+..+ +...+..|||.
T Consensus 183 nrl~vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 183 NRLTVLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred ceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 9999888876443322 33444556654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-21 Score=208.33 Aligned_cols=258 Identities=20% Similarity=0.216 Sum_probs=192.1
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcC---CCccceEeeeeecCCe
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR---HRNLIKILSSCCNTNF 361 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~ 361 (581)
+.+...+.|.+.+.||+|+||+||.|...+|+.||+|+-+.....+ |.--.+++.+|+ -+.|+.+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 4455667899999999999999999997779999999987765431 111233444444 3456666666777788
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec-------CCCcEEEee
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD-------ENMVAHVSD 434 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~-------~~~~~kl~D 434 (581)
-++|+||.+.|+|.+++.. ....++.-++.+..|++..+++|| ..+||||||||+|+|+. +...++|+|
T Consensus 769 S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred ceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 8999999999999999984 444788899999999999999999 89999999999999994 344699999
Q ss_pred ccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC
Q 008012 435 FGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG 514 (581)
Q Consensus 435 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 514 (581)
||.+..+.--.+........+|..+-.+|+..|..++..+|-|.++.+++-|+.|+.-- ...+.. | .....
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~g~~----~---~~~~~ 915 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VKNGSS----W---MVKTN 915 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hcCCcc----e---ecccc
Confidence 99998765444444556678899999999999999999999999999999999997531 000000 0 00001
Q ss_pred CCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 515 LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
++...+.. ...+++..+|+.|=..=|...++...+++......+
T Consensus 916 ~~Ry~~~~----------------~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~ 959 (974)
T KOG1166|consen 916 FPRYWKRD----------------MWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFT 959 (974)
T ss_pred chhhhhHH----------------HHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence 12222221 133566667776666667888888888887766554
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-22 Score=199.92 Aligned_cols=178 Identities=29% Similarity=0.467 Sum_probs=114.2
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
++..|+.|||++|+++ ..|..+-.-+++-+|+||+|+|..+.-..|-+|+.|-.|||++|++. .+|.....+..|++|
T Consensus 101 ~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL 178 (1255)
T KOG0444|consen 101 RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTL 178 (1255)
T ss_pred ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhh
Confidence 5667778888888887 67777777778888888888887655556677777777777777776 556666666666666
Q ss_pred ecccCcCC-------------------------CCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceecccccc
Q 008012 83 NLSSNYLT-------------------------GSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQF 137 (581)
Q Consensus 83 ~l~~n~l~-------------------------~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i 137 (581)
.|++|.+. ..+|..+..+.+|..+|+|.|.+. .+|+.+-++.+|..|+||+|+|
T Consensus 179 ~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~i 257 (1255)
T KOG0444|consen 179 KLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKI 257 (1255)
T ss_pred hcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCce
Confidence 66666432 123334444556666666666666 5666666666666666666666
Q ss_pred ccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCC
Q 008012 138 QGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRL 185 (581)
Q Consensus 138 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l 185 (581)
+ .+....+.+.+|++|+||.|+++ .+|+.+.+++.|+.|.+.+|++
T Consensus 258 t-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL 303 (1255)
T KOG0444|consen 258 T-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKL 303 (1255)
T ss_pred e-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcc
Confidence 6 33444445555566666666654 3555555555555555555543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-22 Score=198.81 Aligned_cols=207 Identities=25% Similarity=0.343 Sum_probs=147.8
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCccc----------------
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLT---------------- 66 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~---------------- 66 (581)
+.+++-.|+|++|+|.++....|-+|..|-+||||+|++. .+|.....|.+|++|+|++|.+.
T Consensus 124 ~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vL 202 (1255)
T KOG0444|consen 124 YAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVL 202 (1255)
T ss_pred hhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhh
Confidence 3467788999999998766677888899999999999998 67888888888888888888754
Q ss_pred ---------CCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceecccccc
Q 008012 67 ---------SSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQF 137 (581)
Q Consensus 67 ---------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i 137 (581)
..+|..+..+.+|..++|++|++. .+|+.+-++++|+.|+||+|.|+ .+.-..+...+|+.|+||.|++
T Consensus 203 hms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQL 280 (1255)
T KOG0444|consen 203 HMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQL 280 (1255)
T ss_pred hcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchh
Confidence 235667777788888888888888 78888888888888888888887 4444555566777777777777
Q ss_pred ccccCccccCccccceeeccccccC------------------------CCCchhhhcccccCeeEccCCCCCCCCCCCC
Q 008012 138 QGPIPESFGSLISLESLDLSSNNLS------------------------EGIPKSLVALSHLKQFNVSHNRLEGEIPTEG 193 (581)
Q Consensus 138 ~~~~~~~~~~l~~L~~L~l~~N~l~------------------------~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~ 193 (581)
+ .+|..+..+++|+.|.+.+|+++ ...|+.++.+..|+.|.|+.|++-+.+....
T Consensus 281 t-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLiTLPeaIH 359 (1255)
T KOG0444|consen 281 T-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLITLPEAIH 359 (1255)
T ss_pred c-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhcccccceeechhhhh
Confidence 7 56666666666666666666554 1345555555566666666666554444445
Q ss_pred CCcCCccccccccccccCCC
Q 008012 194 PFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 194 ~~~~~~~~~~~~n~~~c~~~ 213 (581)
-+..+..+++..||...-||
T Consensus 360 lL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 360 LLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred hcCCcceeeccCCcCccCCC
Confidence 56666667777776554443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=163.81 Aligned_cols=137 Identities=18% Similarity=0.265 Sum_probs=106.9
Q ss_pred CCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhc-----CCCccceEeeeeecCC---e-ee
Q 008012 293 FNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-----RHRNLIKILSSCCNTN---F-KA 363 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~-~~ 363 (581)
+.-.+.||+|+||.||. ...++.. +||++........+.+.+|+++++.+ .||||++++|++.+.. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34457899999999996 2224444 79988765444456789999999999 5799999999998763 3 33
Q ss_pred EEEec--cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCceecCCCCCCeEecC----CCcEEEeecc
Q 008012 364 LVLEF--MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALAL-EYLHHGHSTPVVHCDLKPSNILLDE----NMVAHVSDFG 436 (581)
Q Consensus 364 lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L-~~LH~~~~~~i~H~dikp~Nill~~----~~~~kl~Dfg 436 (581)
+|+|| +++++|.+++.+.. +++. ..++.|++.++ +||| +.+|+||||||+||+++. ++.++|+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 55799999997642 4444 35678888777 9999 899999999999999974 3489999954
Q ss_pred Cc
Q 008012 437 IS 438 (581)
Q Consensus 437 ~a 438 (581)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-20 Score=190.51 Aligned_cols=224 Identities=25% Similarity=0.269 Sum_probs=176.9
Q ss_pred ecccccccEEEEEe----CCCcEEEEEEeccchH--HHHHHHHHHHHHHHhcC-CCccceEeeeeecCCeeeEEEeccCC
Q 008012 299 LGSGGFGSVYKGIL----SDGTTVAIKIFNLQLE--QAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 299 lg~G~~~~v~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+|+|+||.|++++- ..|..+|.|+.++... ........|..++...+ ||.++++.-.+..+...+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 78999999998762 2467788888765531 11125567888888996 99999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
|.+...+.+... +++.........++-+++++| +.+|+|||+|++||+++.+|++++.|||.++..-....
T Consensus 82 g~lft~l~~~~~-f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----- 152 (612)
T KOG0603|consen 82 GDLFTRLSKEVM-FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----- 152 (612)
T ss_pred chhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----
Confidence 999998877655 455666678888999999999 99999999999999999999999999999986543322
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhh
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 531 (581)
.+||..|||||+.. ....++|.||||++++||+||..||.. .....+.+.. ..
T Consensus 153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~-------------------~~ 205 (612)
T KOG0603|consen 153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAE-------------------LE 205 (612)
T ss_pred -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhc-------------------cC
Confidence 17899999999988 567799999999999999999999976 1111111101 11
Q ss_pred HHHHHHHHHHHHHHhccCcCCCCCCCH
Q 008012 532 ARMDCLLSIFHLALDCCAELPDQRLYM 558 (581)
Q Consensus 532 ~~~~~~~~l~~li~~cl~~dP~~Rps~ 558 (581)
.+.+......+++..++..+|..|.-.
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 223445567789999999999999855
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.1e-22 Score=187.28 Aligned_cols=198 Identities=25% Similarity=0.383 Sum_probs=140.5
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
++..|++|++++|.+. .+|+.++.+..|+.|+..+|+|+ ..|+.+.++.+|..|++.+|+++...|. .-+++.|++|
T Consensus 112 s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~-~i~m~~L~~l 188 (565)
T KOG0472|consen 112 SLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPEN-HIAMKRLKHL 188 (565)
T ss_pred hhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHH-HHHHHHHHhc
Confidence 3445566666666665 55556666666666666666666 4566666666666666666666633333 3336777777
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCcc-ccCccccceeecccccc
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPES-FGSLISLESLDLSSNNL 161 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~-~~~l~~L~~L~l~~N~l 161 (581)
++..|-++ .+|..++.+..|.-|||..|+|. .+| .|.+++.|+.|+++.|+|. .+|.. ...+++|..|||..|++
T Consensus 189 d~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNkl 264 (565)
T KOG0472|consen 189 DCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKL 264 (565)
T ss_pred ccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeecccccc
Confidence 77777777 66677777777777777777777 566 6777778888888888887 44444 44788888888888888
Q ss_pred CCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccc
Q 008012 162 SEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYAL 209 (581)
Q Consensus 162 ~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~ 209 (581)
+. .|+.+..+.+|..||+++|.+++.+++.+.+ .+..+.+.|||..
T Consensus 265 ke-~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 265 KE-VPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLR 310 (565)
T ss_pred cc-CchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCchH
Confidence 74 8888888888888888888888888777777 7888888888654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.5e-18 Score=159.38 Aligned_cols=134 Identities=19% Similarity=0.302 Sum_probs=113.8
Q ss_pred CeecccccccEEEEEeCCCcEEEEEEeccch--------HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--------EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+.||+|++|.||+|.. +|..+++|+..... ......+.+|++++..+.|+++.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 57889999865432 11234678899999999999988777777777788999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
++|++|.+++.... . .+..++.+++.+|.++| +.+++|||++|+||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986542 1 77889999999999999 89999999999999999 78999999998864
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-20 Score=178.69 Aligned_cols=187 Identities=24% Similarity=0.302 Sum_probs=154.8
Q ss_pred CCCCCCCcEEEeecCcccccCCccccCCCCCCEEEccC-CcccccCCccccCCCCCCEEEc-------------------
Q 008012 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQG-NKLNGSIPTCLASLTSLRELRL------------------- 60 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~l~~L~~L~L------------------- 60 (581)
|+.+++|++|||++|+|+.+-|++|.++++|..|-+.+ |+|+.+..+.|.+|..|+.|.+
T Consensus 87 F~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l 166 (498)
T KOG4237|consen 87 FKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSL 166 (498)
T ss_pred ccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhc
Confidence 67899999999999999999999999999998877766 9999776666666655555544
Q ss_pred -----cCCcccCCCCcccccCCCCcEEecccCcCC---------------------------------------------
Q 008012 61 -----NSNKLTSSIPSALWALEYILYVNLSSNYLT--------------------------------------------- 90 (581)
Q Consensus 61 -----~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~--------------------------------------------- 90 (581)
..|.+...--..|..+.+++.+.+..|.+-
T Consensus 167 ~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c 246 (498)
T KOG4237|consen 167 SLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLC 246 (498)
T ss_pred chhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhh
Confidence 445444222236778888888888777510
Q ss_pred ----------------CCCC-ccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccce
Q 008012 91 ----------------GSLT-SDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLES 153 (581)
Q Consensus 91 ----------------~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~ 153 (581)
+..| ..|..+++|+.|+|++|.|+++-+.+|.++.+++.|+|..|+|..+....|.++..|+.
T Consensus 247 ~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~t 326 (498)
T KOG4237|consen 247 SLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKT 326 (498)
T ss_pred hHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhcccccee
Confidence 0001 13566899999999999999999999999999999999999999888888999999999
Q ss_pred eeccccccCCCCchhhhcccccCeeEccCCCCCC
Q 008012 154 LDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEG 187 (581)
Q Consensus 154 L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~ 187 (581)
|+|++|+|+...|.+|..+.+|.+|.|-.|++.+
T Consensus 327 L~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 327 LSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred eeecCCeeEEEecccccccceeeeeehccCcccC
Confidence 9999999999999999999999999999999876
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=163.77 Aligned_cols=143 Identities=19% Similarity=0.146 Sum_probs=112.4
Q ss_pred hcCCCcCCeecccccccEEEEE--eCCCcEEEEEEeccchH------------------------HHHHHHHHHHHHHHh
Q 008012 290 TDGFNECNLLGSGGFGSVYKGI--LSDGTTVAIKIFNLQLE------------------------QAFRSFNSECEVLRN 343 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~--~~~~~~vavK~~~~~~~------------------------~~~~~~~~e~~~l~~ 343 (581)
...|.+.+.||+|++|.||+|. ..+|+.||+|+++.... .....+.+|++.+++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458889999999999999998 45899999999875321 011346789999999
Q ss_pred cCC--CccceEeeeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCCC
Q 008012 344 VRH--RNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP-VVHCDLKPS 420 (581)
Q Consensus 344 l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-i~H~dikp~ 420 (581)
+.+ ..+.+++++ ...++||||++|.++........ ..+..+...++.|++.++++|| +.| ++||||||+
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~ 178 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEY 178 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChh
Confidence 965 334444543 23489999999988876553332 3455667889999999999999 899 999999999
Q ss_pred CeEecCCCcEEEeeccCceec
Q 008012 421 NILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 421 Nill~~~~~~kl~Dfg~a~~~ 441 (581)
||+++ ++.++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=154.49 Aligned_cols=138 Identities=20% Similarity=0.201 Sum_probs=110.1
Q ss_pred cCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchH----------------------HHHHHHHHHHHHHHhcCCC-
Q 008012 291 DGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLE----------------------QAFRSFNSECEVLRNVRHR- 347 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~- 347 (581)
.-|.+.+.||+|+||.||++..++|+.||||+++.... .......+|..++..+.++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 34888899999999999999988899999998764320 0112367789999999776
Q ss_pred -ccceEeeeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC
Q 008012 348 -NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE 426 (581)
Q Consensus 348 -~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~ 426 (581)
.+...++. ...++||||++|++|...... .....++.+++.++.++| ..|++||||||+||++++
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcC
Confidence 44444442 345899999999998765421 345678899999999999 899999999999999999
Q ss_pred CCcEEEeeccCceecC
Q 008012 427 NMVAHVSDFGISKLLG 442 (581)
Q Consensus 427 ~~~~kl~Dfg~a~~~~ 442 (581)
++.++|+|||.+....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 9999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=3e-17 Score=175.47 Aligned_cols=139 Identities=20% Similarity=0.239 Sum_probs=113.1
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccc--------hHHHHHHHHHHHHHHHhcCCCccceEeeeeecC
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQ--------LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT 359 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 359 (581)
.....|...+.||+|+||.||+|.+.+ ..+++|+.... .....+.+.+|+++++.++|++++..+.++.+.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 334556778999999999999998763 34444432211 112235688999999999999999888777777
Q ss_pred CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 360 NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 360 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
...++||||++|++|.+++. ....++.+++.+|.+|| +.|++||||||+||++ +++.++|+|||+++
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 77899999999999999875 34679999999999999 8999999999999999 67799999999987
Q ss_pred e
Q 008012 440 L 440 (581)
Q Consensus 440 ~ 440 (581)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.3e-17 Score=152.48 Aligned_cols=130 Identities=22% Similarity=0.301 Sum_probs=106.8
Q ss_pred eecccccccEEEEEeCCCcEEEEEEeccch--------HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 298 LLGSGGFGSVYKGILSDGTTVAIKIFNLQL--------EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 298 ~lg~G~~~~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
.||+|++|.||+|.+ ++..|++|+..... ......+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 47889999864321 112356788999999998887665555555666778999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 370 PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 370 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
+|++|.+++..... .++.+++.+|.+|| +.|++|||++|+||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998754321 78999999999999 89999999999999999 88999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-18 Score=171.46 Aligned_cols=174 Identities=23% Similarity=0.400 Sum_probs=130.1
Q ss_pred eeeEEEeccCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 361 FKALVLEFMPNGSLDKWLYSH--NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
+.|+.|++|...+|.+|+... ....++.....++.|++.|+.| ++.+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999743 3446778889999999999998 67999999999999999999999999999
Q ss_pred eecCCCC----CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCC
Q 008012 439 KLLGEGD----DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPH 513 (581)
Q Consensus 439 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 513 (581)
....... .....+...||..||+||.+.+..|+.++||||||++++|+++ =..+|+.. ....+....
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~--------~t~~d~r~g 475 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI--------ATLTDIRDG 475 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH--------HhhhhhhcC
Confidence 8765443 2234556689999999999999999999999999999999998 22222211 111111111
Q ss_pred CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHH
Q 008012 514 GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAA 562 (581)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 562 (581)
.++ +.... +.| .=..|+.+++.+.|.+||++.+..
T Consensus 476 ~ip----~~~~~---------d~p-~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 476 IIP----PEFLQ---------DYP-EEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred CCC----hHHhh---------cCc-HHHHHHHHhcCCCcccCchHHHHh
Confidence 122 11111 111 123799999999999999555443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-20 Score=177.44 Aligned_cols=203 Identities=24% Similarity=0.374 Sum_probs=157.1
Q ss_pred CCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEe
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 83 (581)
+..++.|+.+.|+++ .+|..+.++.+|..|++++|.+. ..|+.++.+..|+.|+..+|+++ +.|..+.++.+|..++
T Consensus 90 l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~ 166 (565)
T KOG0472|consen 90 LEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLD 166 (565)
T ss_pred HHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhh
Confidence 334555556666665 56666666666666777777666 55666667777777777777776 6677777777778888
Q ss_pred cccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCC
Q 008012 84 LSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 163 (581)
+.+|++....|+.+ +++.|++||..+|.++ .+|+.++++.+|+.|+|..|+|. ..| .|.++..|++|+++.|.|.
T Consensus 167 ~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~- 241 (565)
T KOG0472|consen 167 LEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE- 241 (565)
T ss_pred ccccchhhCCHHHH-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-
Confidence 88888774444444 4888999999999988 89999999999999999999999 566 8999999999999999997
Q ss_pred CCchhhh-cccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCCCC
Q 008012 164 GIPKSLV-ALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQR 214 (581)
Q Consensus 164 ~~~~~~~-~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~ 214 (581)
.+|.+.. .+++|..|||..|+++..+.+...++++..+++++|..+.-+..
T Consensus 242 ~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is~Lp~s 293 (565)
T KOG0472|consen 242 MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDISSLPYS 293 (565)
T ss_pred hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccccCCcc
Confidence 4666655 89999999999999996555557788899999999876666554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.5e-18 Score=179.75 Aligned_cols=212 Identities=25% Similarity=0.265 Sum_probs=147.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
..+|+.++.|..|+||.||.++++ +.+.+|+|+ +++. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee------------------
Confidence 467899999999999999999976 577888854 3221 11111 22233344433
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC--
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD-- 446 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-- 446 (581)
|+-...+...+. ++... +.+++||| +.||+|||+||+|.+|+.-|++|+.|||+++.......
T Consensus 136 ---gDc~tllk~~g~-lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP-LPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ---chhhhhcccCCC-Ccchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 344444443332 22222 78999999 89999999999999999999999999999875321110
Q ss_pred -----------cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCC
Q 008012 447 -----------SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGL 515 (581)
Q Consensus 447 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 515 (581)
.......+||+.|.|||++....|+..+|.|++|+++||.+.|+.||..... +.-+...+.+....
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~visd~i~w-- 277 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIEW-- 277 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhhhhhhhccc--
Confidence 0112234799999999999999999999999999999999999999987522 22333443332211
Q ss_pred CccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHH
Q 008012 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMK 559 (581)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 559 (581)
++- | ...+.+..+++.+.|+.+|..|--..
T Consensus 278 pE~-d-------------ea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 278 PEE-D-------------EALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ccc-C-------------cCCCHHHHHHHHHHHHhChHhhcccc
Confidence 111 1 12345688999999999999997443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.2e-18 Score=179.74 Aligned_cols=257 Identities=21% Similarity=0.254 Sum_probs=199.5
Q ss_pred hcCCCcCCeecccccccEEEEEeC--CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcC-CCccceEeeeeecCCeeeE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS--DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 364 (581)
...|...+.||+|+|+.|-.+... ....+|+|.+.... .........|..+-+.+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 557888889999999999888753 34456666664442 334455666888877776 9999999999999999999
Q ss_pred EEeccCCCCHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC-cEEEeeccCceecC
Q 008012 365 VLEFMPNGSLDKWL-YSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM-VAHVSDFGISKLLG 442 (581)
Q Consensus 365 v~e~~~~~~L~~~l-~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~ 442 (581)
+++|..|+++.+.+ .......+......++.|+..++.|+|. ..++.|+||||+|.+++..+ ..+++|||+|..+.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999988 5443245667778899999999999995 68899999999999999999 99999999999887
Q ss_pred C-CCCcceeecccc-CccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 443 E-GDDSVIQTMTIA-TIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 443 ~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
. .+.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..||+........+..|........
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 251 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT----- 251 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc-----
Confidence 6 455555556678 9999999988874 5577899999999999999999999876555544444443321100
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 008012 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAAT 563 (581)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 563 (581)
...+........+++.+++..+|..|.+.+++..
T Consensus 252 ----------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 252 ----------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ----------cCccccCChhhhhcccccccCCchhccccccccc
Confidence 0111223344668999999999999999988754
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.1e-18 Score=178.96 Aligned_cols=201 Identities=31% Similarity=0.405 Sum_probs=152.4
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccc----------------------cCCccccCCCCCCEEEccC
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNG----------------------SIPTCLASLTSLRELRLNS 62 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~----------------------~~~~~~~~l~~L~~L~L~~ 62 (581)
.+|++++++.|+++ .+|+.++.+.+|+.|+..+|+|+. -+|.....+..|++|+|..
T Consensus 241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~ 319 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQS 319 (1081)
T ss_pred ccceeeecchhhhh-cchHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehh
Confidence 35667777777776 455666667777777776666652 2455666678888888888
Q ss_pred CcccCCCCccc--------------------------ccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCC
Q 008012 63 NKLTSSIPSAL--------------------------WALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGD 116 (581)
Q Consensus 63 N~l~~~~~~~~--------------------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 116 (581)
|+|. .+|..+ ...+.|+.|++.+|.+++.....+.+.++|+.|+|++|++...
T Consensus 320 N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f 398 (1081)
T KOG0618|consen 320 NNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF 398 (1081)
T ss_pred cccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence 8887 334322 1234577778888888877767778888999999999999844
Q ss_pred CcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCC-CCCCCCC
Q 008012 117 IPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGE-IPTEGPF 195 (581)
Q Consensus 117 ~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~-~~~~~~~ 195 (581)
....+.+++.|+.|+||+|.++ .+|..+.+++.|++|...+|++.. +| .+..++.|+.+|++.|+++-. +|...+.
T Consensus 399 pas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~-fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~ 475 (1081)
T KOG0618|consen 399 PASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLS-FP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS 475 (1081)
T ss_pred CHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceee-ch-hhhhcCcceEEecccchhhhhhhhhhCCC
Confidence 4456788899999999999998 688888899999999999999974 78 888999999999999998753 3444566
Q ss_pred cCCcccccccccccc
Q 008012 196 RNFSAQSFHWNYALC 210 (581)
Q Consensus 196 ~~~~~~~~~~n~~~c 210 (581)
+.++.+++.||.|.-
T Consensus 476 p~LkyLdlSGN~~l~ 490 (1081)
T KOG0618|consen 476 PNLKYLDLSGNTRLV 490 (1081)
T ss_pred cccceeeccCCcccc
Confidence 899999999999743
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.9e-16 Score=143.06 Aligned_cols=136 Identities=22% Similarity=0.258 Sum_probs=98.6
Q ss_pred CCeecccccccEEEEEeCCCcEEEEEEeccchHH--HHHH----------------------HHHHHHHHHhcCCC--cc
Q 008012 296 CNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQ--AFRS----------------------FNSECEVLRNVRHR--NL 349 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~--~i 349 (581)
.+.||+|+||+||+|...+++.||||+++..... .... ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999878999999998754211 1111 13566666666433 24
Q ss_pred ceEeeeeecCCeeeEEEeccCCCCHHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeEecCC
Q 008012 350 IKILSSCCNTNFKALVLEFMPNGSLDK-WLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS-TPVVHCDLKPSNILLDEN 427 (581)
Q Consensus 350 v~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dikp~Nill~~~ 427 (581)
.+.+++ ...++||||++++++.. .+..... . ..+..++.+++.++.++| . .+|+|+||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~--~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL--L-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhh--c-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence 444443 23589999999854321 1111110 1 567889999999999999 7 9999999999999999 8
Q ss_pred CcEEEeeccCceecC
Q 008012 428 MVAHVSDFGISKLLG 442 (581)
Q Consensus 428 ~~~kl~Dfg~a~~~~ 442 (581)
+.++++|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.8e-16 Score=136.43 Aligned_cols=135 Identities=23% Similarity=0.270 Sum_probs=114.8
Q ss_pred cCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCC--CccceEeeeeecCCeeeEEEeccCCC
Q 008012 295 ECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRH--RNLIKILSSCCNTNFKALVLEFMPNG 372 (581)
Q Consensus 295 ~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~ 372 (581)
+++.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.+++ .++.+++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999864 7899999876543 4578889999999976 58999999888888899999999988
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 373 SLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 373 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
.+..+ +......++.+++++++++|..+..+++|+|++|+||+++..+.++++|||.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 4456678899999999999954446899999999999999989999999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1e-15 Score=165.99 Aligned_cols=160 Identities=27% Similarity=0.490 Sum_probs=92.6
Q ss_pred CCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecc
Q 008012 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85 (581)
Q Consensus 6 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 85 (581)
+|+.|+|++|+|+ .+|..+. ++|++|+|++|.|+ .+|..+. .+|+.|+|++|+++ .+|..+. .+|+.|+++
T Consensus 200 ~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 200 QITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred CCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 4677777777776 4555444 46777777777777 3454443 35777777777776 4455443 367777777
Q ss_pred cCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCC
Q 008012 86 SNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGI 165 (581)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 165 (581)
+|+|+ .+|..+. ++|+.|++++|+|+ .+|..+. ++|+.|++++|+++. +|..+ .++|+.|++++|.+++ +
T Consensus 271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-L 340 (754)
T PRK15370 271 HNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETL--PPGLKTLEAGENALTS-L 340 (754)
T ss_pred CCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-CCccc--cccceeccccCCcccc-C
Confidence 77777 4455443 46777777777776 3444332 355666666666653 33322 1355555555555554 3
Q ss_pred chhhhcccccCeeEccCCCCC
Q 008012 166 PKSLVALSHLKQFNVSHNRLE 186 (581)
Q Consensus 166 ~~~~~~l~~L~~l~l~~n~l~ 186 (581)
|..+. ++|+.|++++|+|+
T Consensus 341 P~~l~--~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 341 PASLP--PELQVLDVSKNQIT 359 (754)
T ss_pred Chhhc--CcccEEECCCCCCC
Confidence 43332 45555555555555
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=8e-16 Score=165.77 Aligned_cols=33 Identities=30% Similarity=0.521 Sum_probs=18.4
Q ss_pred CCcEEEeecCcccccCCccccCCCCCCEEEccCCccc
Q 008012 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLN 42 (581)
Q Consensus 6 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~ 42 (581)
+|+.|+|++|+|+ .+|.. +++|++|+|++|+|+
T Consensus 223 ~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt 255 (788)
T PRK15387 223 HITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT 255 (788)
T ss_pred CCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC
Confidence 4566666666665 34431 355666666666665
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=5e-16 Score=168.38 Aligned_cols=182 Identities=24% Similarity=0.395 Sum_probs=130.5
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
++|++|+|++|+++ .+|..+. ++|+.|+|++|.|+ .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|++
T Consensus 220 ~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~L 290 (754)
T PRK15370 220 GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSV 290 (754)
T ss_pred cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEEC
Confidence 57999999999998 5676665 58999999999999 5676654 58999999999998 5666553 58999999
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEG 164 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~ 164 (581)
++|+|+. +|..+. ++|+.|++++|.++ .+|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+.
T Consensus 291 s~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~- 360 (754)
T PRK15370 291 YDNSIRT-LPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV- 360 (754)
T ss_pred CCCcccc-Ccccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-
Confidence 9999984 554443 46888888888887 4555442 578888888888874 555443 578888888888864
Q ss_pred CchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccc
Q 008012 165 IPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYAL 209 (581)
Q Consensus 165 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~ 209 (581)
+|..+. ++|+.|++++|+++..++... ..+..+++.+|...
T Consensus 361 LP~~lp--~~L~~LdLs~N~Lt~LP~~l~--~sL~~LdLs~N~L~ 401 (754)
T PRK15370 361 LPETLP--PTITTLDVSRNALTNLPENLP--AALQIMQASRNNLV 401 (754)
T ss_pred CChhhc--CCcCEEECCCCcCCCCCHhHH--HHHHHHhhccCCcc
Confidence 565543 577888888888774433221 23555566666544
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.6e-15 Score=140.99 Aligned_cols=134 Identities=17% Similarity=0.197 Sum_probs=105.1
Q ss_pred Ceec-ccccccEEEEEeCCCcEEEEEEeccch-------------HHHHHHHHHHHHHHHhcCCCcc--ceEeeeeecCC
Q 008012 297 NLLG-SGGFGSVYKGILSDGTTVAIKIFNLQL-------------EQAFRSFNSECEVLRNVRHRNL--IKILSSCCNTN 360 (581)
Q Consensus 297 ~~lg-~G~~~~v~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~ 360 (581)
..|| .||.|+||.+... +..++||.+.... ......+.+|++++.++.|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999999875 7889999885421 1223467889999999988774 66776643322
Q ss_pred ----eeeEEEeccCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeec
Q 008012 361 ----FKALVLEFMPN-GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDF 435 (581)
Q Consensus 361 ----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 435 (581)
..++|||+++| .+|.+++.... ++.. .+.+++.++.+|| +.||+||||||+|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAP--LSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCC--CCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 23599999997 69998886532 3332 3678999999999 899999999999999999889999999
Q ss_pred cCcee
Q 008012 436 GISKL 440 (581)
Q Consensus 436 g~a~~ 440 (581)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98875
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.4e-17 Score=174.12 Aligned_cols=210 Identities=23% Similarity=0.285 Sum_probs=159.6
Q ss_pred CCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccC----------------
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTS---------------- 67 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~---------------- 67 (581)
-+.|+.|+.+.|.++...+... -.+|+++++++|+++ .+|+.+..+.+|+.|+.++|+|+.
T Consensus 218 g~~l~~L~a~~n~l~~~~~~p~--p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~ 294 (1081)
T KOG0618|consen 218 GPSLTALYADHNPLTTLDVHPV--PLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLVALPLRISRITSLVSLSA 294 (1081)
T ss_pred CcchheeeeccCcceeeccccc--cccceeeecchhhhh-cchHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHh
Confidence 3678999999999985444323 389999999999999 567999999999999999999872
Q ss_pred ------CCCcccccCCCCcEEecccCcCCCCCCcccc-------------------------CCccCcEEeCCCCcCCCC
Q 008012 68 ------SIPSALWALEYILYVNLSSNYLTGSLTSDIQ-------------------------NMKVLIDLDLSRNQLSGD 116 (581)
Q Consensus 68 ------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-------------------------~l~~L~~L~l~~N~l~~~ 116 (581)
-+|.....+..|++|+|..|+|...++..+. .++.|+.|++.+|.+++.
T Consensus 295 ~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~ 374 (1081)
T KOG0618|consen 295 AYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDS 374 (1081)
T ss_pred hhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccccc
Confidence 1344445567777777777777633221111 123467777777777766
Q ss_pred CcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCc
Q 008012 117 IPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFR 196 (581)
Q Consensus 117 ~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~ 196 (581)
.-+.+.++.+|+.|+|++|++.......+.++..|+.|+||+|+++. +|..+..+..|++|...+|++. ..|....+.
T Consensus 375 c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~ 452 (1081)
T KOG0618|consen 375 CFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQLL-SFPELAQLP 452 (1081)
T ss_pred chhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCcee-echhhhhcC
Confidence 66667788899999999999985555668889999999999999975 8888999999999999999988 455778888
Q ss_pred CCccccccccccccCCCCCCCC
Q 008012 197 NFSAQSFHWNYALCGPQRLQVP 218 (581)
Q Consensus 197 ~~~~~~~~~n~~~c~~~~~~~p 218 (581)
.++.++++.|...-..-+...|
T Consensus 453 qL~~lDlS~N~L~~~~l~~~~p 474 (1081)
T KOG0618|consen 453 QLKVLDLSCNNLSEVTLPEALP 474 (1081)
T ss_pred cceEEecccchhhhhhhhhhCC
Confidence 9999999988766555444444
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.5e-15 Score=162.01 Aligned_cols=186 Identities=24% Similarity=0.273 Sum_probs=118.2
Q ss_pred CCCCcEEEeecCcccccCCccccCC-----------------CCCCEEEccCCcccccCCccccCCCCCCEEEccCCccc
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQL-----------------KRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLT 66 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l-----------------~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 66 (581)
.++|++|+|++|+|+. +|..+.+| .+|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+
T Consensus 241 p~~Lk~LdLs~N~Lts-LP~lp~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~ 315 (788)
T PRK15387 241 PPELRTLEVSGNQLTS-LPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLA 315 (788)
T ss_pred CCCCcEEEecCCccCc-ccCcccccceeeccCCchhhhhhchhhcCEEECcCCccc-cccc---cccccceeECCCCccc
Confidence 5677788888887773 44322111 23445555555555 2332 2356777777777776
Q ss_pred CCCCcccc-------------c----CCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccc
Q 008012 67 SSIPSALW-------------A----LEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTN 129 (581)
Q Consensus 67 ~~~~~~~~-------------~----l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 129 (581)
+ +|..+. . ..+|+.|+|++|+|++ +|.. ..+|+.|++++|+|+ .+|.. ..+|+.
T Consensus 316 ~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~ 386 (788)
T PRK15387 316 S-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKE 386 (788)
T ss_pred c-CCCCcccccccccccCccccccccccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---ccccce
Confidence 4 232111 1 1368888888888884 4432 256777788888887 45543 356888
Q ss_pred eeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccc
Q 008012 130 LSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYAL 209 (581)
Q Consensus 130 L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~ 209 (581)
|+|++|+|++ +|.. .++|+.|++++|+++. +|... .+|+.|++++|+++..+.....+..+..+++.+|++.
T Consensus 387 LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 387 LIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred EEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCcccccChHHhhccCCCeEECCCCCCC
Confidence 8888888884 4432 3578888888888875 55432 4577788888888844333466777788888888776
Q ss_pred cC
Q 008012 210 CG 211 (581)
Q Consensus 210 c~ 211 (581)
..
T Consensus 459 ~~ 460 (788)
T PRK15387 459 ER 460 (788)
T ss_pred ch
Confidence 44
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.59 E-value=6e-17 Score=162.69 Aligned_cols=206 Identities=25% Similarity=0.264 Sum_probs=127.8
Q ss_pred CCCCCcEEEeecCcccc------cCCccccCCCCCCEEEccCCcccccCCccccCCCC---CCEEEccCCcccC----CC
Q 008012 3 RMQQLQGIGLADNHLQG------SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTS---LRELRLNSNKLTS----SI 69 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~------~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~ 69 (581)
..++|++|+++++.+.+ .++..+..+++|+.|++++|.+....+..+..+.+ |+.|++++|++++ .+
T Consensus 49 ~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l 128 (319)
T cd00116 49 PQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLL 128 (319)
T ss_pred hCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHH
Confidence 45667788888777662 23345666778888888888877555555555554 8888888887763 22
Q ss_pred CcccccC-CCCcEEecccCcCCCC----CCccccCCccCcEEeCCCCcCCCC----CcccccCcccccceeccccccccc
Q 008012 70 PSALWAL-EYILYVNLSSNYLTGS----LTSDIQNMKVLIDLDLSRNQLSGD----IPKTIAGLKDLTNLSLAGNQFQGP 140 (581)
Q Consensus 70 ~~~~~~l-~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~i~~~ 140 (581)
...+..+ ++|+.|++++|.+++. .+..+..+++|++|++++|.+++. ++..+..+++|+.|+|++|.+++.
T Consensus 129 ~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 208 (319)
T cd00116 129 AKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE 208 (319)
T ss_pred HHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChH
Confidence 2344555 7788888888887732 223455667788888888877632 223344556788888888877643
Q ss_pred c----CccccCccccceeeccccccCCCCchhhhc-----ccccCeeEccCCCCCCCC-----CCCCCCcCCcccccccc
Q 008012 141 I----PESFGSLISLESLDLSSNNLSEGIPKSLVA-----LSHLKQFNVSHNRLEGEI-----PTEGPFRNFSAQSFHWN 206 (581)
Q Consensus 141 ~----~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~l~l~~n~l~~~~-----~~~~~~~~~~~~~~~~n 206 (581)
. ...+..+++|+.|++++|.+++.....+.. .+.|+.|++++|.++..- .....+..+..+++.+|
T Consensus 209 ~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N 288 (319)
T cd00116 209 GASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGN 288 (319)
T ss_pred HHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCC
Confidence 2 234556677888888888776533333322 267788888888776210 11122345666666665
Q ss_pred cc
Q 008012 207 YA 208 (581)
Q Consensus 207 ~~ 208 (581)
..
T Consensus 289 ~l 290 (319)
T cd00116 289 KF 290 (319)
T ss_pred CC
Confidence 43
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.1e-17 Score=161.49 Aligned_cols=176 Identities=30% Similarity=0.493 Sum_probs=161.9
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
..-..+||+.|++. .+|..++.+..|+.|.|..|.|. .+|.++.++..|+.|||+.|++. .+|..++.|+ |+.|-+
T Consensus 75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~ 150 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIV 150 (722)
T ss_pred cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEE
Confidence 34567899999998 89999999999999999999999 78999999999999999999998 8899999998 999999
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEG 164 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~ 164 (581)
++|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|..+..| .|..||++.|+++.
T Consensus 151 sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis~- 225 (722)
T KOG0532|consen 151 SNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKISY- 225 (722)
T ss_pred ecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCceee-
Confidence 999999 78888999999999999999999 78999999999999999999999 577777744 78899999999985
Q ss_pred CchhhhcccccCeeEccCCCCCCCC
Q 008012 165 IPKSLVALSHLKQFNVSHNRLEGEI 189 (581)
Q Consensus 165 ~~~~~~~l~~L~~l~l~~n~l~~~~ 189 (581)
+|..|..|+.|++|-|.+|+++..+
T Consensus 226 iPv~fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 226 LPVDFRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred cchhhhhhhhheeeeeccCCCCCCh
Confidence 9999999999999999999999433
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.4e-16 Score=158.33 Aligned_cols=206 Identities=27% Similarity=0.326 Sum_probs=150.1
Q ss_pred CCCCCcEEEeecCcccc----cCCccccCCCCCCEEEccCCcccc------cCCccccCCCCCCEEEccCCcccCCCCcc
Q 008012 3 RMQQLQGIGLADNHLQG----SIPYDLCQLKRLNSLSLQGNKLNG------SIPTCLASLTSLRELRLNSNKLTSSIPSA 72 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~n~i~~------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 72 (581)
.+.+|++|+|+++.++. .++..+...++|+.|++++|.+.. .++..+..+++|+.|+|++|.+.+..+..
T Consensus 21 ~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~ 100 (319)
T cd00116 21 KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGV 100 (319)
T ss_pred HHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHH
Confidence 45678999999999853 255667778889999999998872 23456778889999999999998666666
Q ss_pred cccCCC---CcEEecccCcCCC----CCCccccCC-ccCcEEeCCCCcCCCC----CcccccCcccccceeccccccccc
Q 008012 73 LWALEY---ILYVNLSSNYLTG----SLTSDIQNM-KVLIDLDLSRNQLSGD----IPKTIAGLKDLTNLSLAGNQFQGP 140 (581)
Q Consensus 73 ~~~l~~---L~~L~l~~n~l~~----~~~~~~~~l-~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~i~~~ 140 (581)
+..+.+ |++|++++|.+++ .+...+..+ ++|+.|++++|.+++. ++..+..+++|+.|++++|.+++.
T Consensus 101 ~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 180 (319)
T cd00116 101 LESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDA 180 (319)
T ss_pred HHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchH
Confidence 666665 9999999999873 222345566 8999999999998842 334566778899999999998842
Q ss_pred ----cCccccCccccceeeccccccCCCC----chhhhcccccCeeEccCCCCCCCCCCC------CCCcCCcccccccc
Q 008012 141 ----IPESFGSLISLESLDLSSNNLSEGI----PKSLVALSHLKQFNVSHNRLEGEIPTE------GPFRNFSAQSFHWN 206 (581)
Q Consensus 141 ----~~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~l~l~~n~l~~~~~~~------~~~~~~~~~~~~~n 206 (581)
++..+..+++|+.|++++|.+++.. ...+..+++|+.|++++|+++...... .....+..+.+.+|
T Consensus 181 ~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n 260 (319)
T cd00116 181 GIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCN 260 (319)
T ss_pred HHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCC
Confidence 2334555679999999999987543 334566788999999999987521110 11356777777766
Q ss_pred cc
Q 008012 207 YA 208 (581)
Q Consensus 207 ~~ 208 (581)
..
T Consensus 261 ~i 262 (319)
T cd00116 261 DI 262 (319)
T ss_pred CC
Confidence 44
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.5e-14 Score=164.54 Aligned_cols=197 Identities=22% Similarity=0.297 Sum_probs=108.7
Q ss_pred CCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCC--
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYI-- 79 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-- 79 (581)
..+++|+.|+|++|...+.+| .++.+++|++|+|++|..-..+|..+.++++|+.|+|++|.....+|..+ ++++|
T Consensus 631 ~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~ 708 (1153)
T PLN03210 631 HSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYR 708 (1153)
T ss_pred ccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCE
Confidence 346667777777654333444 36666777777776665444566666666666666666643222444332 33444
Q ss_pred -------------------cEEecccCcCCCCCCccc------------------------------cCCccCcEEeCCC
Q 008012 80 -------------------LYVNLSSNYLTGSLTSDI------------------------------QNMKVLIDLDLSR 110 (581)
Q Consensus 80 -------------------~~L~l~~n~l~~~~~~~~------------------------------~~l~~L~~L~l~~ 110 (581)
++|++++|.++ .+|..+ ..+++|+.|+|++
T Consensus 709 L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~ 787 (1153)
T PLN03210 709 LNLSGCSRLKSFPDISTNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSD 787 (1153)
T ss_pred EeCCCCCCccccccccCCcCeeecCCCccc-cccccccccccccccccccchhhccccccccchhhhhccccchheeCCC
Confidence 44444444443 222211 1124677888888
Q ss_pred CcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCC
Q 008012 111 NQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIP 190 (581)
Q Consensus 111 N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 190 (581)
|.....+|..++++++|+.|+|++|..-..+|..+ ++++|+.|+|++|.....+|.. .++|+.|+|++|.++..+.
T Consensus 788 n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~~iP~ 863 (1153)
T PLN03210 788 IPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIEEVPW 863 (1153)
T ss_pred CCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCccChH
Confidence 87666788888888888888888874333556544 4566666666665433333322 2345555555555553222
Q ss_pred CCCCCcCCccccccc
Q 008012 191 TEGPFRNFSAQSFHW 205 (581)
Q Consensus 191 ~~~~~~~~~~~~~~~ 205 (581)
....+..+..+.+.+
T Consensus 864 si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 864 WIEKFSNLSFLDMNG 878 (1153)
T ss_pred HHhcCCCCCEEECCC
Confidence 223444444444433
|
syringae 6; Provisional |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=4e-14 Score=146.26 Aligned_cols=145 Identities=21% Similarity=0.249 Sum_probs=102.8
Q ss_pred cCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHH---------------------------------------
Q 008012 291 DGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAF--------------------------------------- 331 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~--------------------------------------- 331 (581)
..|+ .+.||.|++|.||+|+.++|+.||||+.+.......
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3444 368999999999999999999999999865421100
Q ss_pred -HHHHHHHHHHHhcC----CCccceEeeee-ecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH-HHHHH
Q 008012 332 -RSFNSECEVLRNVR----HRNLIKILSSC-CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVAL-ALEYL 404 (581)
Q Consensus 332 -~~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~-~L~~L 404 (581)
-.+.+|++.+.++. +.+-+.+-.++ ...+..++||||++|++|.++........ ....++.+++. .+..+
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH
Confidence 02445666555552 22223322232 22345789999999999988775332112 23456666666 46788
Q ss_pred hcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 405 H~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
| ..|++|+|++|.||+++.+++++++|||++..++
T Consensus 274 ~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 274 L---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred H---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 8999999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.1e-14 Score=157.26 Aligned_cols=119 Identities=37% Similarity=0.619 Sum_probs=104.8
Q ss_pred cCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEcc
Q 008012 102 VLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVS 181 (581)
Q Consensus 102 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 181 (581)
.++.|+|++|.+.+.+|..+..+++|+.|+|++|.|++.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCC--CCCcCCccccccccccccCCCCCCCCCCCc
Q 008012 182 HNRLEGEIPTE--GPFRNFSAQSFHWNYALCGPQRLQVPPCKE 222 (581)
Q Consensus 182 ~n~l~~~~~~~--~~~~~~~~~~~~~n~~~c~~~~~~~p~c~~ 222 (581)
+|++++.+|.. ..+..+..+.+.+|+..|+.+. .++|..
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~~ 539 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACGP 539 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCcc
Confidence 99999999875 2223455678899999998664 467854
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.7e-14 Score=163.48 Aligned_cols=195 Identities=21% Similarity=0.253 Sum_probs=117.2
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
.+|++|+|.+|+|. .++..+..+++|++|+|++|.....+|. ++.+++|++|+|++|.....+|..+..+++|+.|++
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 45666666666665 4555666666677777766543324443 566667777777666544466666667777777777
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccc-------------------
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESF------------------- 145 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~------------------- 145 (581)
++|..-..+|..+ ++++|+.|++++|......|.. .++|+.|+|++|.++. +|..+
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~~l~~L~~L~l~~~~~~~l~ 763 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNLRLENLDELILCEMKSEKLW 763 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccccccccccccccccchhhcc
Confidence 6654222444433 4566666666665443333322 2455566666666552 33211
Q ss_pred -----------cCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCcccccccc
Q 008012 146 -----------GSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWN 206 (581)
Q Consensus 146 -----------~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n 206 (581)
...++|+.|+|++|.....+|..+..+++|+.|++++|..-..+|....+..+..+.+.++
T Consensus 764 ~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c 835 (1153)
T PLN03210 764 ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGC 835 (1153)
T ss_pred ccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCC
Confidence 1134677778888776667788888888888888888753335555545666666666654
|
syringae 6; Provisional |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.9e-14 Score=133.16 Aligned_cols=205 Identities=18% Similarity=0.249 Sum_probs=142.1
Q ss_pred HHHHHhcCCCccceEeeeeecC-----CeeeEEEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 008012 338 CEVLRNVRHRNLIKILSSCCNT-----NFKALVLEFMPNGSLDKWLYSH---NYFQDIPDRLNIMIDVALALEYLHHGHS 409 (581)
Q Consensus 338 ~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~ 409 (581)
..-+-++.|.|||+++.|+.+. ....+++|||..|++.+++++. ...+......+|+.||..||.|||. ++
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 3445556799999999998654 3578999999999999999843 3446777888999999999999995 47
Q ss_pred CCceecCCCCCCeEecCCCcEEEeeccCceecC--CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHH
Q 008012 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLG--EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETF 487 (581)
Q Consensus 410 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~--~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~ 487 (581)
..|+|+++..+-|++..+|-+|++----..... ............+-++|.|||.-.....+.++|||+||+...||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 899999999999999999988875321111000 000111122335678999999988888888999999999999999
Q ss_pred hCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 488 TRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 488 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
.|..--....... ....-+.. .+....+. + =..++.+|++..|..||+|.+++.|.
T Consensus 277 ilEiq~tnseS~~-~~ee~ia~----~i~~len~-l----------------qr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSESKV-EVEENIAN----VIIGLENG-L----------------QRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCccee-ehhhhhhh----heeeccCc-c----------------ccCcCcccccCCCCCCcchhhhhcCc
Confidence 9875422111110 00000000 00000010 0 11688999999999999999998874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.8e-14 Score=143.18 Aligned_cols=249 Identities=21% Similarity=0.206 Sum_probs=186.9
Q ss_pred cCCCcCCeecc--cccccEEEEEe--C-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCee
Q 008012 291 DGFNECNLLGS--GGFGSVYKGIL--S-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 291 ~~y~~~~~lg~--G~~~~v~~~~~--~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 362 (581)
..+.+.+.+|. |.+|.+|.+.. . ++..+|+|.-+... ......=.+|+....++ .|++.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566778999 99999999986 3 78889999743332 22223344677777777 599999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCceecCCCCCCeEecCC-CcEEEeeccC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVAL----ALEYLHHGHSTPVVHCDLKPSNILLDEN-MVAHVSDFGI 437 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~----~L~~LH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~ 437 (581)
++-+|++ +.+|.++.......++....+....+..+ |+.++| ..+++|-|+||+||+...+ ...+++|||+
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence 9999999 47999999888777888999999999999 999999 8999999999999999999 8999999999
Q ss_pred ceecCCCCCcce---eeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccc-cccccHHHHHHhhCCC
Q 008012 438 SKLLGEGDDSVI---QTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMF-TGEMNLKNWVKESLPH 513 (581)
Q Consensus 438 a~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~-~~~~~~~~~~~~~~~~ 513 (581)
...++....... .....|...|++||...+ -++.++|||++|.++.+..++..+..... .....+..+.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------ 342 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------ 342 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc------
Confidence 998876553221 122367888999998665 78899999999999999999876643321 1111111100
Q ss_pred CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 514 GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
++. +.......++...+..|++.+|-.|++++.+..+
T Consensus 343 -ip~-------------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 343 -IPL-------------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred -Cch-------------hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 000 1111122345568999999999999998877653
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.2e-14 Score=147.14 Aligned_cols=180 Identities=34% Similarity=0.574 Sum_probs=115.2
Q ss_pred CCCCcEEEeecCcccccCCccccCCC-CCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQLK-RLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
++.++.|++.+|+++ .++.....++ +|+.|++++|.|. .+|..+..+++|+.|++++|+++ .+|.....+++|+.|
T Consensus 115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L 191 (394)
T COG4886 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL 191 (394)
T ss_pred ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence 345667777777776 4555555553 6777777777777 44455667777777777777776 445544466677777
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
++++|+++ .+|.....+..|++|.+++|.+. ..+..+.++.++..|.+++|++. ..+..++.+++|++|++++|.++
T Consensus 192 ~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 192 DLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred eccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc
Confidence 77777776 45544444455777777777544 35555666677777777777666 23556666667777777777776
Q ss_pred CCCchhhhcccccCeeEccCCCCCCCCCC
Q 008012 163 EGIPKSLVALSHLKQFNVSHNRLEGEIPT 191 (581)
Q Consensus 163 ~~~~~~~~~l~~L~~l~l~~n~l~~~~~~ 191 (581)
...+ +..+.+++.|++++|.+...++.
T Consensus 269 ~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 269 SISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred cccc--ccccCccCEEeccCccccccchh
Confidence 5333 66667777777777776655444
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.4e-12 Score=133.68 Aligned_cols=167 Identities=16% Similarity=0.188 Sum_probs=131.2
Q ss_pred eCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHH
Q 008012 312 LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL 391 (581)
Q Consensus 312 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 391 (581)
..++.+|.|..++.......+...+-++.++.++||+|+++++.+...+..|+|+|.+. .|..++.+.+ .....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence 34788899998877765555677888999999999999999999999999999999974 6777777654 35566
Q ss_pred HHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCC
Q 008012 392 NIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVS 471 (581)
Q Consensus 392 ~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 471 (581)
..+.||+.||.|||+ +.+++|++|.-+.|+++..|..||++|.++........ ......--..|..|+......
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence 688999999999986 78999999999999999999999999998865432221 111222333466666543322
Q ss_pred ccccHHHHHHHHHHHHhCC
Q 008012 472 SKCDVYSYGILLLETFTRK 490 (581)
Q Consensus 472 ~~~Dv~slG~vl~el~tg~ 490 (581)
-..|.|.|||++||++.|.
T Consensus 182 ~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhhHHHHHHHHhCcc
Confidence 3569999999999999993
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.4e-13 Score=139.90 Aligned_cols=148 Identities=18% Similarity=0.225 Sum_probs=97.0
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeCC-CcEEEEEEeccchHH----------------------------------HH
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQ----------------------------------AF 331 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~ 331 (581)
+.....|+. +.||+|++|.||+|+.++ |+.||||+.++.... ..
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 344566777 799999999999999876 999999999754211 11
Q ss_pred HH------HHHHHHHHHhcC----CCccceEeeeeec-CCeeeEEEeccCCCCHHHHHh--hCCCCCCHHHHHHHHHHHH
Q 008012 332 RS------FNSECEVLRNVR----HRNLIKILSSCCN-TNFKALVLEFMPNGSLDKWLY--SHNYFQDIPDRLNIMIDVA 398 (581)
Q Consensus 332 ~~------~~~e~~~l~~l~----h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~~i~ 398 (581)
+. +.+|+..+.+++ +...+.+-.++.+ ....++||||++|+++.++.. ..+ .+.. .++...+
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~---~la~~~v 269 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMK---LLAERGV 269 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHH---HHHHHHH
Confidence 11 333444444442 3333333333322 345679999999999987532 222 1211 2222222
Q ss_pred HH-HHHHhcCCCCCceecCCCCCCeEecCCC----cEEEeeccCceecCC
Q 008012 399 LA-LEYLHHGHSTPVVHCDLKPSNILLDENM----VAHVSDFGISKLLGE 443 (581)
Q Consensus 399 ~~-L~~LH~~~~~~i~H~dikp~Nill~~~~----~~kl~Dfg~a~~~~~ 443 (581)
.. +..+. ..|++|+|+||.||+++.++ +++++|||++..+.+
T Consensus 270 ~~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 22 23344 68999999999999999888 999999999987754
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.1e-15 Score=148.08 Aligned_cols=194 Identities=26% Similarity=0.398 Sum_probs=168.4
Q ss_pred EEEeecCcccccCCc-cc-cCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEeccc
Q 008012 9 GIGLADNHLQGSIPY-DL-CQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSS 86 (581)
Q Consensus 9 ~L~l~~n~l~~~~~~-~~-~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 86 (581)
+|.|++-++. .+|. .+ -.+..-...||+.|++. .+|..+..+..|+.|.|++|.|. .+|..+.++..|.+|+|+.
T Consensus 54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS 130 (722)
T ss_pred ccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence 4566776776 4442 22 33456677999999999 88999999999999999999999 8899999999999999999
Q ss_pred CcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCc
Q 008012 87 NYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIP 166 (581)
Q Consensus 87 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 166 (581)
|+++ .+|..++.|+ |+.|-+++|+++ .+|+.++.+..|..||.+.|+|. .+|..++++.+|+.|.+..|++.. +|
T Consensus 131 NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp 205 (722)
T KOG0532|consen 131 NQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LP 205 (722)
T ss_pred chhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CC
Confidence 9999 7787777654 999999999999 89999999999999999999999 688889999999999999999986 78
Q ss_pred hhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccC
Q 008012 167 KSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCG 211 (581)
Q Consensus 167 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~ 211 (581)
..+..| .|..||++.|+++..+-.+..+..++.+.+.+||....
T Consensus 206 ~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 206 EELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred HHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCCCC
Confidence 888855 58899999999997777788999999999999976544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.6e-12 Score=117.62 Aligned_cols=128 Identities=21% Similarity=0.208 Sum_probs=96.2
Q ss_pred CCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCcc-ceEeeeeecCCeeeEEEeccCCCCH
Q 008012 296 CNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNL-IKILSSCCNTNFKALVLEFMPNGSL 374 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L 374 (581)
++.++.|.++.||+++.. ++.+++|+...... ....+.+|+.+++.+.+.++ .+++.+. .+..++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357899999999999876 78899999765532 12346789999999865444 3455443 2345799999999887
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----ceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 375 DKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP-----VVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 375 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-----i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
.+. . .....++.+++++|+.|| ..+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~-----~----~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE-----D----FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-----c----ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 643 0 112346789999999999 666 59999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.1e-13 Score=119.95 Aligned_cols=138 Identities=28% Similarity=0.361 Sum_probs=47.8
Q ss_pred eecCcccccCCccccCCCCCCEEEccCCcccccCCcccc-CCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCC
Q 008012 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLA-SLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLT 90 (581)
Q Consensus 12 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~ 90 (581)
|..+.|. ..+ .+.+..+++.|+|++|.|+.+ +.++ .+++|+.|+|++|+|+. +. .+..++.|++|++++|+|+
T Consensus 4 lt~~~i~-~~~-~~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 4 LTANMIE-QIA-QYNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp ------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred ccccccc-ccc-ccccccccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC
Confidence 4445554 222 344556788888888888843 3455 57888888888888873 33 4777888888888888888
Q ss_pred CCCCccc-cCCccCcEEeCCCCcCCCC-CcccccCcccccceeccccccccccC---ccccCccccceeec
Q 008012 91 GSLTSDI-QNMKVLIDLDLSRNQLSGD-IPKTIAGLKDLTNLSLAGNQFQGPIP---ESFGSLISLESLDL 156 (581)
Q Consensus 91 ~~~~~~~-~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~i~~~~~---~~~~~l~~L~~L~l 156 (581)
. +.+.+ ..+++|++|++++|+|... .-..+..+++|+.|+|.+|+++.... ..+..+|+|+.||-
T Consensus 78 ~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 78 S-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred c-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 4 43344 4678888888888888642 12456778888889999998874311 23567888888873
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.2e-13 Score=138.09 Aligned_cols=195 Identities=33% Similarity=0.492 Sum_probs=162.2
Q ss_pred EEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCC-CCCEEEccCCcccCCCCcccccCCCCcEEecccC
Q 008012 9 GIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLT-SLRELRLNSNKLTSSIPSALWALEYILYVNLSSN 87 (581)
Q Consensus 9 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n 87 (581)
.+++++|.+. .....+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 5888888885 34455666789999999999999 5666666774 9999999999998 66778999999999999999
Q ss_pred cCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCch
Q 008012 88 YLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPK 167 (581)
Q Consensus 88 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 167 (581)
+++ .++.....+++|+.|++++|+++ .+|.....+..|+.|.+++|++. ..+..+..+.++..|.+.+|++.. .+.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence 999 66665658899999999999999 67777677778999999999655 466778889999999999999975 578
Q ss_pred hhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccC
Q 008012 168 SLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCG 211 (581)
Q Consensus 168 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~ 211 (581)
.+..+++++.|++++|+++. ++....+..+..+.+.+|...-.
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~-i~~~~~~~~l~~L~~s~n~~~~~ 292 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISS-ISSLGSLTNLRELDLSGNSLSNA 292 (394)
T ss_pred hhccccccceeccccccccc-cccccccCccCEEeccCcccccc
Confidence 88999999999999999994 44477778888888887754433
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.1e-13 Score=119.95 Aligned_cols=126 Identities=30% Similarity=0.407 Sum_probs=40.6
Q ss_pred ccCCCCCCEEEccCCcccCCCCcccc-cCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccc-cCccc
Q 008012 49 LASLTSLRELRLNSNKLTSSIPSALW-ALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI-AGLKD 126 (581)
Q Consensus 49 ~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l~~ 126 (581)
+.+...+++|+|.+|+|+ .+. .++ .+.+|+.|+|++|.|+. +. .+..+++|++|++++|+|+. +.+.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 444556777777777776 332 343 46677777777777773 32 46667777777777777773 33334 35677
Q ss_pred ccceeccccccccccC-ccccCccccceeeccccccCCCC---chhhhcccccCeeE
Q 008012 127 LTNLSLAGNQFQGPIP-ESFGSLISLESLDLSSNNLSEGI---PKSLVALSHLKQFN 179 (581)
Q Consensus 127 L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~---~~~~~~l~~L~~l~ 179 (581)
|+.|+|++|+|....- ..+..+++|+.|+|.+|+++... ...+..+|+|+.||
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 7777777777764222 44566777777777777776421 12245567777665
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.8e-14 Score=128.51 Aligned_cols=132 Identities=28% Similarity=0.325 Sum_probs=94.2
Q ss_pred CCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCccccccee
Q 008012 52 LTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLS 131 (581)
Q Consensus 52 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 131 (581)
+..|++|||++|.|+ .+..+..-+|.++.|++++|.|. .+.+ +..+++|+.||||+|.++ .+-.+-..+-+++.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 446778888888887 66667777778888888888877 3333 777788888888888877 4555556677778888
Q ss_pred ccccccccccCccccCccccceeeccccccCCCC-chhhhcccccCeeEccCCCCCCCC
Q 008012 132 LAGNQFQGPIPESFGSLISLESLDLSSNNLSEGI-PKSLVALSHLKQFNVSHNRLEGEI 189 (581)
Q Consensus 132 l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~n~l~~~~ 189 (581)
|++|.|... ..+..+-+|..||+++|+|.... ...++++|+|+.+.|.+|++.+.+
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 888877632 34666677778888888876532 245777888888888888877544
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.1e-14 Score=128.80 Aligned_cols=133 Identities=26% Similarity=0.352 Sum_probs=97.4
Q ss_pred ccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCc
Q 008012 25 LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLI 104 (581)
Q Consensus 25 ~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 104 (581)
......|+.||||+|.|+ .+.++..-+|.++.|++++|+|+ .. +.+..+++|+.|+|++|.++ .+..+=.++-+.+
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TV-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK 355 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-ee-hhhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence 334567778888888887 56667777778888888888887 33 33777888888888888877 4445556677788
Q ss_pred EEeCCCCcCCCCCcccccCcccccceecccccccccc-CccccCccccceeeccccccCC
Q 008012 105 DLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPI-PESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 105 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~-~~~~~~l~~L~~L~l~~N~l~~ 163 (581)
.|.|++|.|.. -+.+..+-+|..||+++|+|.... -..++++|.|+.|.|.+|.+.+
T Consensus 356 tL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 356 TLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred eeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 88888888762 245667777888888888886432 2568888999999999998876
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.9e-11 Score=110.77 Aligned_cols=137 Identities=18% Similarity=0.176 Sum_probs=99.8
Q ss_pred CCeecccccccEEEEEeCC-------CcEEEEEEeccch------H----------------HHHHHH----HHHHHHHH
Q 008012 296 CNLLGSGGFGSVYKGILSD-------GTTVAIKIFNLQL------E----------------QAFRSF----NSECEVLR 342 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~~-------~~~vavK~~~~~~------~----------------~~~~~~----~~e~~~l~ 342 (581)
...||.|--+.||.|...+ +..+|||+++... . .....+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998543 4799999875321 0 011222 38999999
Q ss_pred hcC--CCccceEeeeeecCCeeeEEEeccCCCCHHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceecCCC
Q 008012 343 NVR--HRNLIKILSSCCNTNFKALVLEFMPNGSLDK-WLYSHNYFQDIPDRLNIMIDVALALEYL-HHGHSTPVVHCDLK 418 (581)
Q Consensus 343 ~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~i~H~dik 418 (581)
++. .-++...+++ ...++||||+.+..+.. .+.+. ..+.++...+..+++.++..| | ..|++|||++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 994 3456666654 45689999997654422 22221 234456677889999999999 7 8899999999
Q ss_pred CCCeEecCCCcEEEeeccCceecC
Q 008012 419 PSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 419 p~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
+.||+++ ++.+.++|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999888654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.33 E-value=3e-12 Score=138.55 Aligned_cols=114 Identities=35% Similarity=0.548 Sum_probs=104.6
Q ss_pred CCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeecc
Q 008012 78 YILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLS 157 (581)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~ 157 (581)
.++.|+|++|.+.+.+|..++.+++|+.|+|++|.+.+.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCchhhhcc-cccCeeEccCCCCCCCCCC
Q 008012 158 SNNLSEGIPKSLVAL-SHLKQFNVSHNRLEGEIPT 191 (581)
Q Consensus 158 ~N~l~~~~~~~~~~l-~~L~~l~l~~n~l~~~~~~ 191 (581)
+|.+++.+|..+..+ .++..+++.+|...+..|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence 999999999988764 4678899999986654443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3e-11 Score=105.26 Aligned_cols=131 Identities=20% Similarity=0.266 Sum_probs=101.6
Q ss_pred CeecccccccEEEEEeCCCcEEEEEEeccch--------HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--------EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
..+++|+-+.+|.+.+. |.++++|.-.+.. .-...+-.+|+.++.+++--.|...+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999875 5567777542221 11234577899999999655555555555677778899999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
++|..|.+++.... ..++..+-.-+.-|| ..||+|+|+.++||++..++ +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~~--------~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEAR--------PDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcc--------hHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999887652 456777778888999 89999999999999997764 99999999975
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.4e-10 Score=112.53 Aligned_cols=269 Identities=12% Similarity=0.082 Sum_probs=175.5
Q ss_pred CcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeee------eecC-CeeeEE
Q 008012 294 NECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSS------CCNT-NFKALV 365 (581)
Q Consensus 294 ~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~------~~~~-~~~~lv 365 (581)
...+.||+|+-+.+|-.-- -...+.|++......... +-+..|... .||-+-.-+.| ..+. ....+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3457899999999996532 233567888766432222 223444444 56654432222 1122 236688
Q ss_pred EeccCCC-CHHHHHh-----hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 366 LEFMPNG-SLDKWLY-----SHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 366 ~e~~~~~-~L~~~l~-----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
|+.+++. ....+.. +.-....|...++.++.++.+.+.|| ..|.+-||++++|+|+++++.|.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccccee
Confidence 8888765 2333332 12234589999999999999999999 8999999999999999999999999976554
Q ss_pred ecCCCCCcceeeccccCccccCCCCCC-----CCCCCccccHHHHHHHHHHHHhC-CCCCCcccccc---ccHHHHHHhh
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGS-----EGNVSSKCDVYSYGILLLETFTR-KKPTDEMFTGE---MNLKNWVKES 510 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg-~~Pf~~~~~~~---~~~~~~~~~~ 510 (581)
.. ..........|...|.+||.-. +..-+...|-|.||+++++++.| ++||.+..... ..+..-+...
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 43 2223345668999999999543 34556789999999999999996 99998753221 1111111110
Q ss_pred CCCCCCccccccc-hhhhhhhhHHHHHHHHHHHHHHhccCcC--CCCCCCHHHHHHHHHHhHHHHHhhc
Q 008012 511 LPHGLPKIADANL-LREENFFSARMDCLLSIFHLALDCCAEL--PDQRLYMKDAATKLKKIRDKFLEDA 576 (581)
Q Consensus 511 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~Rps~~evl~~L~~~~~~~~~~~ 576 (581)
. +..-.+... ....+......-.++.+..+..+|+... +.-|||++..+..|.+++++...|.
T Consensus 243 ~---f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 243 R---FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCT 308 (637)
T ss_pred e---eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence 0 000000000 0011222334456677889999999653 5689999999999999999988764
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.1e-13 Score=130.08 Aligned_cols=182 Identities=23% Similarity=0.251 Sum_probs=139.6
Q ss_pred CCCCCcEEEeecCcccccCC--ccccCCCCCCEEEccCCccccc--CCccccCCCCCCEEEccCCcccCCCCcc-cccCC
Q 008012 3 RMQQLQGIGLADNHLQGSIP--YDLCQLKRLNSLSLQGNKLNGS--IPTCLASLTSLRELRLNSNKLTSSIPSA-LWALE 77 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~--~~~~~l~~L~~L~l~~n~i~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~ 77 (581)
++.+|+++.|.+..+. ..+ +....|++++.||||.|-+... +......|++|+.|+|+.|++..-..+. -..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 5778999999999887 444 4678899999999999998843 3455678999999999999987322221 23578
Q ss_pred CCcEEecccCcCCCC-CCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccC--ccccCcccccee
Q 008012 78 YILYVNLSSNYLTGS-LTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIP--ESFGSLISLESL 154 (581)
Q Consensus 78 ~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~--~~~~~l~~L~~L 154 (581)
+|+.|.|+.|+|+.. +......+|+|+.|+|+.|............+..|+.|||++|++.. .+ ...+.++.|..|
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhh
Confidence 999999999999821 11234567999999999995332444445668899999999999974 33 456789999999
Q ss_pred eccccccCCC-Cchh-----hhcccccCeeEccCCCCC
Q 008012 155 DLSSNNLSEG-IPKS-----LVALSHLKQFNVSHNRLE 186 (581)
Q Consensus 155 ~l~~N~l~~~-~~~~-----~~~l~~L~~l~l~~n~l~ 186 (581)
+++.+.+..+ .|+. ...+++|+.|++..|++.
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 9999998863 3333 456889999999999986
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.6e-12 Score=130.64 Aligned_cols=252 Identities=20% Similarity=0.141 Sum_probs=178.7
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEe--CCCcEEEEEEeccchHHH--HHHHHHHHHHHHhc-CCCccceEeeeeecCC
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGIL--SDGTTVAIKIFNLQLEQA--FRSFNSECEVLRNV-RHRNLIKILSSCCNTN 360 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~--~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 360 (581)
-.....+|..+..||.|.|+.|+.... .++..+++|......... ...-..|+.+...+ .|.++++.+..+...+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 334567899999999999999999873 367888999775543221 12234567777776 5899999888888777
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC-CcEEEeeccCce
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN-MVAHVSDFGISK 439 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~ 439 (581)
..|+--|||+++++...+.. ...+++..++.+..|++.++.++| ++.++|+|++|+||++..+ +..+++|||.+.
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccc
Confidence 88899999999988776632 223567788999999999999999 9999999999999999876 788999999886
Q ss_pred ecCCCCCcceeeccccCccc-cCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 440 LLGEGDDSVIQTMTIATIGY-MAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
.+.- ........+..| .+|+......+..+.|+||||..+.+..+|..--... .. . ..+.... ++
T Consensus 416 ~~~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~~---~-~~i~~~~---~p-- 481 (524)
T KOG0601|consen 416 RLAF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-VQ---S-LTIRSGD---TP-- 481 (524)
T ss_pred ccce----ecccccccccccccchhhccccccccccccccccccccccccCcccCccc-cc---c-eeeeccc---cc--
Confidence 4211 111112233344 3666667778889999999999999999987532210 00 0 0000000 00
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
........+..+.+.+..+++..||.+.++..+..-.
T Consensus 482 -------------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 482 -------------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -------------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0011124566888899999999999999887765543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=7.3e-11 Score=102.23 Aligned_cols=142 Identities=20% Similarity=0.259 Sum_probs=107.9
Q ss_pred cCCeecccccccEEEEEeCCCcEEEEEEeccc--------hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 295 ECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQ--------LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 295 ~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
....+.+|+-+.|+++.+. |+.++||.-... ..-...+..+|++.+.++.--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999986 788888743221 1123456788999999986545554444556666678999
Q ss_pred eccCC-CCHHHHHhhCCCCCCHHHH-HHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC---cEEEeeccCcee
Q 008012 367 EFMPN-GSLDKWLYSHNYFQDIPDR-LNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM---VAHVSDFGISKL 440 (581)
Q Consensus 367 e~~~~-~~L~~~l~~~~~~~~~~~~-~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~---~~kl~Dfg~a~~ 440 (581)
||++| .++.+++.........+.. ...+..|-+.+.-|| ..+|+||||..+||++.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 4788888865433333444 788999999999999 89999999999999997554 458999999874
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.27 E-value=8e-13 Score=128.15 Aligned_cols=183 Identities=25% Similarity=0.335 Sum_probs=137.1
Q ss_pred CCCCCcEEEeecCcccccCC--ccccCCCCCCEEEccCCcccccCCcc-ccCCCCCCEEEccCCcccCC-CCcccccCCC
Q 008012 3 RMQQLQGIGLADNHLQGSIP--YDLCQLKRLNSLSLQGNKLNGSIPTC-LASLTSLRELRLNSNKLTSS-IPSALWALEY 78 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~--~~~~~l~~L~~L~l~~n~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~ 78 (581)
.+++++.|||+.|-+....+ .....||+|+.|+|+.|++.....+. -..+++|+.|.|+.|.|+.. +-.....+|+
T Consensus 144 ~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPs 223 (505)
T KOG3207|consen 144 ILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPS 223 (505)
T ss_pred hCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCc
Confidence 58999999999998885433 45677899999999999998332222 23578999999999999832 2234567899
Q ss_pred CcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCc--ccccCcccccceeccccccccc-cCcc-----ccCccc
Q 008012 79 ILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIP--KTIAGLKDLTNLSLAGNQFQGP-IPES-----FGSLIS 150 (581)
Q Consensus 79 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L~l~~N~i~~~-~~~~-----~~~l~~ 150 (581)
|+.|+|..|............+..|++|||++|.+. ..+ ...+.++.|..|+++.+.|.++ .|+. ...+++
T Consensus 224 l~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~k 302 (505)
T KOG3207|consen 224 LEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPK 302 (505)
T ss_pred HHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhccccc
Confidence 999999999633233444566799999999999987 344 4578899999999999999763 2333 356899
Q ss_pred cceeeccccccCCCCc--hhhhcccccCeeEccCCCCCC
Q 008012 151 LESLDLSSNNLSEGIP--KSLVALSHLKQFNVSHNRLEG 187 (581)
Q Consensus 151 L~~L~l~~N~l~~~~~--~~~~~l~~L~~l~l~~n~l~~ 187 (581)
|++|+++.|+|.+ .+ ..+..+++|+.|....|.++.
T Consensus 303 L~~L~i~~N~I~~-w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 303 LEYLNISENNIRD-WRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred ceeeecccCcccc-ccccchhhccchhhhhhcccccccc
Confidence 9999999999964 22 234456677777777777663
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.2e-10 Score=110.35 Aligned_cols=142 Identities=20% Similarity=0.206 Sum_probs=109.6
Q ss_pred CeecccccccEEEEEeCCCcEEEEEEeccchH-HHHHHHHHHHHHHHhcCC--CccceEeeeeecC---CeeeEEEeccC
Q 008012 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQLE-QAFRSFNSECEVLRNVRH--RNLIKILSSCCNT---NFKALVLEFMP 370 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~~~lv~e~~~ 370 (581)
+.++.|.++.+|++...+|+.+++|+...... .....+.+|+++++.+.+ ..+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999977678999999765432 134567899999999965 3456777776654 25689999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 008012 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG------------------------------------------- 407 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~------------------------------------------- 407 (581)
|.++.+.+.. ...+......++.+++++|.+||+.
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888775532 2356677778888899999888842
Q ss_pred ----------CCCCceecCCCCCCeEecC--CCcEEEeeccCcee
Q 008012 408 ----------HSTPVVHCDLKPSNILLDE--NMVAHVSDFGISKL 440 (581)
Q Consensus 408 ----------~~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~ 440 (581)
....++|+|++|.||+++. ++.+.++||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0256799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.6e-12 Score=130.64 Aligned_cols=174 Identities=29% Similarity=0.377 Sum_probs=97.2
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
.+++|+.|+|.+|+|..+ ...+..+++|++|+|++|.|+.+ ..+..++.|+.|++++|.|+. ...+..++.|+.+
T Consensus 93 ~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~~l 167 (414)
T KOG0531|consen 93 KLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLISD--ISGLESLKSLKLL 167 (414)
T ss_pred cccceeeeeccccchhhc-ccchhhhhcchheeccccccccc--cchhhccchhhheeccCcchh--ccCCccchhhhcc
Confidence 455666666666666532 22255566666666666666643 225555556666666666652 2334446666666
Q ss_pred ecccCcCCCCCC-ccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccc--cceeecccc
Q 008012 83 NLSSNYLTGSLT-SDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLIS--LESLDLSSN 159 (581)
Q Consensus 83 ~l~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~--L~~L~l~~N 159 (581)
++++|.+....+ . ...+..|+.+++.+|.+. ....+..+..+..+++..|.++...+ +..+.. |+.+++++|
T Consensus 168 ~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n 242 (414)
T KOG0531|consen 168 DLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGN 242 (414)
T ss_pred cCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccC
Confidence 666666653322 1 355566666666666665 22334445555555666666653322 222222 677777777
Q ss_pred ccCCCCchhhhcccccCeeEccCCCCCC
Q 008012 160 NLSEGIPKSLVALSHLKQFNVSHNRLEG 187 (581)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~l~l~~n~l~~ 187 (581)
.+.. .+..+..++.+..|++.+|++..
T Consensus 243 ~i~~-~~~~~~~~~~l~~l~~~~n~~~~ 269 (414)
T KOG0531|consen 243 RISR-SPEGLENLKNLPVLDLSSNRISN 269 (414)
T ss_pred cccc-ccccccccccccccchhhccccc
Confidence 7764 33455666777777777776653
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.7e-12 Score=119.09 Aligned_cols=163 Identities=20% Similarity=0.208 Sum_probs=114.1
Q ss_pred ccCCCCCCEEEccCCcccccCCcc----ccCCCCCCEEEccCCcccCCC-------------CcccccCCCCcEEecccC
Q 008012 25 LCQLKRLNSLSLQGNKLNGSIPTC----LASLTSLRELRLNSNKLTSSI-------------PSALWALEYILYVNLSSN 87 (581)
Q Consensus 25 ~~~l~~L~~L~l~~n~i~~~~~~~----~~~l~~L~~L~L~~N~l~~~~-------------~~~~~~l~~L~~L~l~~n 87 (581)
+..+++|++||||+|.+...-+.. +++++.|+.|.|.+|.+...- .+...+-++|+.+..++|
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rN 167 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRN 167 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecc
Confidence 344568888888888887443333 456788888888888876211 112345678888888888
Q ss_pred cCCCCCC----ccccCCccCcEEeCCCCcCCCC----CcccccCcccccceecccccccc----ccCccccCccccceee
Q 008012 88 YLTGSLT----SDIQNMKVLIDLDLSRNQLSGD----IPKTIAGLKDLTNLSLAGNQFQG----PIPESFGSLISLESLD 155 (581)
Q Consensus 88 ~l~~~~~----~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~i~~----~~~~~~~~l~~L~~L~ 155 (581)
++..... ..|..++.|+.+.++.|.|... +-..|..+++|++|||.+|-|+. .....+..++.|+.|+
T Consensus 168 rlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~ 247 (382)
T KOG1909|consen 168 RLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELN 247 (382)
T ss_pred ccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeec
Confidence 8874333 3556778888888888887532 22356778888888888888864 2335577788888888
Q ss_pred ccccccCCCCchhh-----hcccccCeeEccCCCCCC
Q 008012 156 LSSNNLSEGIPKSL-----VALSHLKQFNVSHNRLEG 187 (581)
Q Consensus 156 l~~N~l~~~~~~~~-----~~l~~L~~l~l~~n~l~~ 187 (581)
+++|.+.......+ ...++|+.|.|.+|.++-
T Consensus 248 l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~ 284 (382)
T KOG1909|consen 248 LGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITR 284 (382)
T ss_pred ccccccccccHHHHHHHHhccCCCCceeccCcchhHH
Confidence 88888876544333 236788888888888864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.7e-12 Score=133.38 Aligned_cols=252 Identities=23% Similarity=0.259 Sum_probs=172.2
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
+...+++.+.+-+.+|.++.++.+.-. .|...+.|+..... ....+....+-.+.-..++|.++...-.+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 356678888899999999999988733 44344444433221 11112222233333333456666665555667788
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
+++++|..+++|...++..+. .+.+........+..++++|| ...+.|+|++|.|.+...++..++.|||.....+
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred chhhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999999987663 344555667777889999999 7779999999999999999999999998443221
Q ss_pred CC-----------------------------CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCC
Q 008012 443 EG-----------------------------DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPT 493 (581)
Q Consensus 443 ~~-----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf 493 (581)
.. ++........+|+.|.+||...+......+|.|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0001123446899999999999999999999999999999999999999
Q ss_pred CccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHH
Q 008012 494 DEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMK 559 (581)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 559 (581)
....... .+ +.....-....+ .+...+....+++...+..+|.+|..|.
T Consensus 1036 na~tpq~-~f-----~ni~~~~~~~p~-----------g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQ-IF-----ENILNRDIPWPE-----------GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhh-hh-----hccccCCCCCCC-----------CccccChhhhhhhhhhhccCchhccCcc
Confidence 8743321 11 111111011111 1122334567899999999999998776
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.4e-11 Score=86.20 Aligned_cols=61 Identities=31% Similarity=0.512 Sum_probs=37.5
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcc
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKL 65 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l 65 (581)
|+|++|+|++|+|+.+.++.|.++++|++|++++|.|+...+++|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566666666666655445666666666666666666655556666666666666666654
|
... |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.4e-11 Score=127.57 Aligned_cols=192 Identities=29% Similarity=0.372 Sum_probs=128.2
Q ss_pred CCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEe
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 83 (581)
+..++.+++..|.|.. +-..+..+.+|+.|++.+|+|.. +...+..+++|++|+|++|.|+.. ..+..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--cchhhccchhhhe
Confidence 4566777788888873 34457778888888888888884 333377788888888888888744 3366677788888
Q ss_pred cccCcCCCCCCccccCCccCcEEeCCCCcCCCCCccc-ccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 84 LSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT-IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
+++|.|+. + ..+..++.|+.+++++|++...-+ . ...+.+|+.+++++|.+..+ ..+..+..+..+++..|.++
T Consensus 147 l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 147 LSGNLISD-I-SGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred eccCcchh-c-cCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccce
Confidence 88888883 2 245668888888888888874332 2 47778888888888888732 44555566666688888887
Q ss_pred CCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCcccccc
Q 008012 163 EGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFH 204 (581)
Q Consensus 163 ~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~ 204 (581)
...+.....+.+|+.+++++|++.-.......+..+..++..
T Consensus 222 ~~~~l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~ 263 (414)
T KOG0531|consen 222 KLEGLNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLS 263 (414)
T ss_pred eccCcccchhHHHHHHhcccCccccccccccccccccccchh
Confidence 543322111113788888888887332232333334433333
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.7e-09 Score=97.78 Aligned_cols=126 Identities=22% Similarity=0.262 Sum_probs=84.9
Q ss_pred cEEEEEeCCCcEEEEEEeccch--------------------------HHHHHHHHHHHHHHHhcCCC--ccceEeeeee
Q 008012 306 SVYKGILSDGTTVAIKIFNLQL--------------------------EQAFRSFNSECEVLRNVRHR--NLIKILSSCC 357 (581)
Q Consensus 306 ~v~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~ 357 (581)
.||.|...+|..+|+|+.+... ........+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998889999999875321 11234567899999999654 466666553
Q ss_pred cCCeeeEEEeccC--CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCceecCCCCCCeEecCCCcEEEee
Q 008012 358 NTNFKALVLEFMP--NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEY-LHHGHSTPVVHCDLKPSNILLDENMVAHVSD 434 (581)
Q Consensus 358 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~-LH~~~~~~i~H~dikp~Nill~~~~~~kl~D 434 (581)
..++||||++ |..+..+....- +.+....++.+++..+.. +| ..|++|||+.+.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~---~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDL---SPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGG---GGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhccc---cchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 3479999998 655555433221 123456678888885555 57 8999999999999999887 999999
Q ss_pred ccCceecC
Q 008012 435 FGISKLLG 442 (581)
Q Consensus 435 fg~a~~~~ 442 (581)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.1e-10 Score=85.25 Aligned_cols=61 Identities=39% Similarity=0.539 Sum_probs=43.4
Q ss_pred CCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcC
Q 008012 29 KRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYL 89 (581)
Q Consensus 29 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l 89 (581)
++|++|++++|+|+.+.+++|.++++|++|+|++|+|+...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4667777777777766666777777777777777777766666777777777777777764
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.4e-09 Score=103.86 Aligned_cols=214 Identities=17% Similarity=0.162 Sum_probs=150.1
Q ss_pred ccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeee----cCCeeeEEEeccCC-CCHHH
Q 008012 303 GFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC----NTNFKALVLEFMPN-GSLDK 376 (581)
Q Consensus 303 ~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~-~~L~~ 376 (581)
-..+.|++... ||..|++|+++............-+++++++.|+|+|++.+++. .+...++|++|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34678999854 89999999995544333333445688999999999999999876 34478899999886 36666
Q ss_pred HHhh--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 377 WLYS--------------HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 377 ~l~~--------------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
+--. .+...++..+|.++.|+..||.++| +.|...+-+.|.+|+++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 4431 2344578899999999999999999 8999999999999999999999999888777654
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHH-HHhhCCCCCCccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNW-VKESLPHGLPKIADA 521 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 521 (581)
.+.. |-+. --.+-|.=.||.++..|.||..--.. .+ ...+. ..
T Consensus 445 ~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~---~d-~~~~s~~~------------- 488 (655)
T KOG3741|consen 445 EDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTENSNR---TD-STQSSHLT------------- 488 (655)
T ss_pred CCCC----------------cchh---HHhhhhHHHHHHHHHHHhhccccccc---cc-chHHHHHH-------------
Confidence 3321 1111 12367999999999999999643111 00 00000 00
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
.....++.++.+++.-....++++ -++.+++.++
T Consensus 489 ---------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 489 ---------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ---------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 011234555667777777777776 4667766553
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=8.8e-12 Score=117.84 Aligned_cols=184 Identities=24% Similarity=0.274 Sum_probs=142.4
Q ss_pred CCCCCcEEEeecCcccccCCcc----ccCCCCCCEEEccCCcccccCC-------------ccccCCCCCCEEEccCCcc
Q 008012 3 RMQQLQGIGLADNHLQGSIPYD----LCQLKRLNSLSLQGNKLNGSIP-------------TCLASLTSLRELRLNSNKL 65 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~----~~~l~~L~~L~l~~n~i~~~~~-------------~~~~~l~~L~~L~L~~N~l 65 (581)
..++|++|+||+|-+....+.. ++++..|+.|+|.+|.+...-. .....-++|+++..+.|++
T Consensus 90 ~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrl 169 (382)
T KOG1909|consen 90 GCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRL 169 (382)
T ss_pred cCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccc
Confidence 3468999999999988555544 5667999999999999983322 2234567899999999999
Q ss_pred cCC----CCcccccCCCCcEEecccCcCCC----CCCccccCCccCcEEeCCCCcCCCCC----cccccCcccccceecc
Q 008012 66 TSS----IPSALWALEYILYVNLSSNYLTG----SLTSDIQNMKVLIDLDLSRNQLSGDI----PKTIAGLKDLTNLSLA 133 (581)
Q Consensus 66 ~~~----~~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~ 133 (581)
... +...|...+.|+.+.++.|.|.. .+..+|..|++|+.|||.+|-++... ...+..+++|+.|+++
T Consensus 170 en~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~ 249 (382)
T KOG1909|consen 170 ENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLG 249 (382)
T ss_pred ccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccc
Confidence 743 23467788999999999999873 22346789999999999999997432 3456778899999999
Q ss_pred ccccccccCccc-----cCccccceeeccccccCCC----CchhhhcccccCeeEccCCCCC
Q 008012 134 GNQFQGPIPESF-----GSLISLESLDLSSNNLSEG----IPKSLVALSHLKQFNVSHNRLE 186 (581)
Q Consensus 134 ~N~i~~~~~~~~-----~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~n~l~ 186 (581)
+|.++......| ...|+|+.|.+.+|.|+.. +...+...+.|..|+|++|.+.
T Consensus 250 dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 250 DCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 999975443332 2478999999999999852 2334556789999999999984
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.9e-09 Score=98.65 Aligned_cols=140 Identities=14% Similarity=0.096 Sum_probs=99.1
Q ss_pred CeecccccccEEEEEeCCCcEEEEEEeccchHH-HHH----------HHHHHHHHHHhcCC--CccceEeeeeec-----
Q 008012 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQ-AFR----------SFNSECEVLRNVRH--RNLIKILSSCCN----- 358 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~e~~~l~~l~h--~~iv~~~~~~~~----- 358 (581)
+.+-......|+++... |+.+.||......-. ..+ .+.+|...+.++.. -.+.+.+++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 34444444456676664 789999977543311 111 36789998888832 223344444432
Q ss_pred CCeeeEEEeccCCC-CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-------CCc
Q 008012 359 TNFKALVLEFMPNG-SLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE-------NMV 429 (581)
Q Consensus 359 ~~~~~lv~e~~~~~-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~-------~~~ 429 (581)
....++|||++++. +|.+++... ....+......++.+++..+..|| ..||+|+|+++.|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23568999999886 899988632 223455677789999999999999 899999999999999975 468
Q ss_pred EEEeeccCcee
Q 008012 430 AHVSDFGISKL 440 (581)
Q Consensus 430 ~kl~Dfg~a~~ 440 (581)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998763
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.2e-11 Score=126.97 Aligned_cols=174 Identities=29% Similarity=0.317 Sum_probs=113.0
Q ss_pred CCCCCcEEEeecCcccccCCccccCC-CCCCEEEccCCcccccCCcccc----------CCCCCCEEEccCCcccCCCCc
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQL-KRLNSLSLQGNKLNGSIPTCLA----------SLTSLRELRLNSNKLTSSIPS 71 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~i~~~~~~~~~----------~l~~L~~L~L~~N~l~~~~~~ 71 (581)
-|+.|++|.|.++.|.. . ..+..+ ..|+.|..++ .+. .+.+.|+ .+..|.+.+.++|++. ....
T Consensus 107 pF~sLr~LElrg~~L~~-~-~GL~~lr~qLe~LIC~~-Sl~-Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~mD~ 181 (1096)
T KOG1859|consen 107 PFRSLRVLELRGCDLST-A-KGLQELRHQLEKLICHN-SLD-ALRHVFASCGGDISNSPVWNKLATASFSYNRLV-LMDE 181 (1096)
T ss_pred cccceeeEEecCcchhh-h-hhhHHHHHhhhhhhhhc-cHH-HHHHHHHHhccccccchhhhhHhhhhcchhhHH-hHHH
Confidence 35667777777777663 1 122222 3444544433 221 0111111 1235777778888887 6667
Q ss_pred ccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcc-cccCcccccceeccccccccccCccccCccc
Q 008012 72 ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPK-TIAGLKDLTNLSLAGNQFQGPIPESFGSLIS 150 (581)
Q Consensus 72 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~ 150 (581)
++.-++.|+.|+|++|+++... .+..|+.|++|||+.|.++ .+|. ...++. |+.|+|++|-++.. ..+.++.+
T Consensus 182 SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~Lks 255 (1096)
T KOG1859|consen 182 SLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLKS 255 (1096)
T ss_pred HHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hhHHhhhh
Confidence 7788888888888888887422 6778888888888888888 4443 233444 88888888888733 45677888
Q ss_pred cceeeccccccCCC-CchhhhcccccCeeEccCCCCCC
Q 008012 151 LESLDLSSNNLSEG-IPKSLVALSHLKQFNVSHNRLEG 187 (581)
Q Consensus 151 L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~n~l~~ 187 (581)
|+.||+++|-|.+- --..+..+..|..|.|.||++.+
T Consensus 256 L~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 256 LYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred hhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 88888888887752 12335667788888888888876
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.3e-10 Score=116.20 Aligned_cols=153 Identities=16% Similarity=0.194 Sum_probs=106.2
Q ss_pred HHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce-------eeccccCccccCCCCC
Q 008012 393 IMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI-------QTMTIATIGYMAPEFG 465 (581)
Q Consensus 393 i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~~~~~y~aPE~~ 465 (581)
=+.+++.|+.|+|+ +.++||++|.|++|.++.++..||+.|+++....++..... .........|.|||++
T Consensus 104 nl~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 34455699999997 89999999999999999999999999999876544222111 1112345679999999
Q ss_pred CCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHH
Q 008012 466 SEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLA 544 (581)
Q Consensus 466 ~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 544 (581)
.+...+.++|+||+|+++|.+.. |+.-+... .. ...... ...... ........++|.++.+-+
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~-~~-~~~~~~--~~~~~~------------~~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAAN-GG-LLSYSF--SRNLLN------------AGAFGYSNNLPSELRESL 245 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhcc-CC-cchhhh--hhcccc------------cccccccccCcHHHHHHH
Confidence 99888999999999999999995 44444321 11 111110 000000 001111245677899999
Q ss_pred HhccCcCCCCCCCHHHHHH
Q 008012 545 LDCCAELPDQRLYMKDAAT 563 (581)
Q Consensus 545 ~~cl~~dP~~Rps~~evl~ 563 (581)
.+++..++..||++.++..
T Consensus 246 ~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHhcCCcccCcchhhhhc
Confidence 9999999999997776653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.6e-08 Score=93.82 Aligned_cols=136 Identities=23% Similarity=0.222 Sum_probs=100.1
Q ss_pred CCcCCeecccccccEEEEEeCCCcEEEEEEeccch----------------------HHHHHHHHHHHHHHHhcCCC--c
Q 008012 293 FNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL----------------------EQAFRSFNSECEVLRNVRHR--N 348 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--~ 348 (581)
+.+...||-|--|.||.|....|.++|||.=+... .-.....++|.++|+++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45668999999999999999999999999643211 01223467899999999544 6
Q ss_pred cceEeeeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC
Q 008012 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM 428 (581)
Q Consensus 349 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~ 428 (581)
+.+.+++ +...+||||++|-.|...- ++.+..-.++..|++-+.-+- ..||+|||+++-||+++++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence 6666655 3457999999987665422 123344455666666666555 58899999999999999999
Q ss_pred cEEEeeccCceec
Q 008012 429 VAHVSDFGISKLL 441 (581)
Q Consensus 429 ~~kl~Dfg~a~~~ 441 (581)
.+.++||--+...
T Consensus 240 ~~~vIDwPQ~v~~ 252 (304)
T COG0478 240 DIVVIDWPQAVPI 252 (304)
T ss_pred CEEEEeCcccccC
Confidence 9999999766544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.1e-08 Score=102.22 Aligned_cols=148 Identities=19% Similarity=0.207 Sum_probs=98.0
Q ss_pred hhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHH--------------------------------------
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQA-------------------------------------- 330 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~-------------------------------------- 330 (581)
....|+. +.|+.++-|.||+|+.++|+.||||+.++.....
T Consensus 124 ~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l 202 (517)
T COG0661 124 LFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL 202 (517)
T ss_pred HHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence 3344553 6899999999999999999999999986542110
Q ss_pred --HHHHHHHHHHHHhcC-----CCccceEeeeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHH-HH
Q 008012 331 --FRSFNSECEVLRNVR-----HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALA-LE 402 (581)
Q Consensus 331 --~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~-L~ 402 (581)
.-++.+|+..+.+++ .|.+.-..=++.-.+...++|||++|-.+.+.........+.+. ++..++++ +.
T Consensus 203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~ 279 (517)
T COG0661 203 REELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLR 279 (517)
T ss_pred HHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHH
Confidence 002344555555542 23222111122334566899999999999888543223345333 33333333 23
Q ss_pred HHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 403 ~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
.+- ..|++|.|.+|.||+++.+|++.+.|||+...+++
T Consensus 280 q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 280 QLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 333 57899999999999999999999999999987644
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.1e-10 Score=116.73 Aligned_cols=131 Identities=21% Similarity=0.222 Sum_probs=106.8
Q ss_pred CCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeec
Q 008012 77 EYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDL 156 (581)
Q Consensus 77 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l 156 (581)
-+|.+.++++|.+. .....+.-++.|+.|+|++|+++.. ..+..|++|+.|||++|.++.+.--...++ +|..|.|
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhh-hheeeee
Confidence 36888999999999 7778888899999999999999843 378999999999999999994333334444 4999999
Q ss_pred cccccCCCCchhhhcccccCeeEccCCCCCCCCCC--CCCCcCCccccccccccccCCC
Q 008012 157 SSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPT--EGPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 157 ~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~--~~~~~~~~~~~~~~n~~~c~~~ 213 (581)
.+|-++.. ..+.++.+|..|||++|-|.+...- ...+..+..+.+.|||..|.+.
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 99999752 3477899999999999998864432 2566778889999999999853
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.7e-09 Score=100.13 Aligned_cols=185 Identities=21% Similarity=0.259 Sum_probs=100.2
Q ss_pred CCcEEEeecCcccccCCc-cc-cCCCCCCEEEccCCccccc--CCccccCCCCCCEEEccCCcccCCCCcccccCCCCcE
Q 008012 6 QLQGIGLADNHLQGSIPY-DL-CQLKRLNSLSLQGNKLNGS--IPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILY 81 (581)
Q Consensus 6 ~L~~L~l~~n~l~~~~~~-~~-~~l~~L~~L~l~~n~i~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 81 (581)
.+..|.|.++.|..+..- .| .....++.|||.+|.|+.. +...+.++|.|++|+|++|.+.+.+......+.+|+.
T Consensus 46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~ 125 (418)
T KOG2982|consen 46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRV 125 (418)
T ss_pred chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEE
Confidence 344555556555533221 11 2235666666666666632 2334556666666666666666333222234556666
Q ss_pred EecccCcCCC-CCCccccCCccCcEEeCCCCcCCCCCcc--c----------c-----------------cCccccccee
Q 008012 82 VNLSSNYLTG-SLTSDIQNMKVLIDLDLSRNQLSGDIPK--T----------I-----------------AGLKDLTNLS 131 (581)
Q Consensus 82 L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~--~----------~-----------------~~l~~L~~L~ 131 (581)
|-|.+..+.= .....+..+|.+++|++|.|.+....-+ . + .-++++..+-
T Consensus 126 lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~ 205 (418)
T KOG2982|consen 126 LVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVF 205 (418)
T ss_pred EEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchhee
Confidence 6666665541 2223345566666666666643210000 0 0 1134445555
Q ss_pred ccccccccccC-ccccCccccceeeccccccCC-CCchhhhcccccCeeEccCCCCCCCCC
Q 008012 132 LAGNQFQGPIP-ESFGSLISLESLDLSSNNLSE-GIPKSLVALSHLKQFNVSHNRLEGEIP 190 (581)
Q Consensus 132 l~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~l~l~~n~l~~~~~ 190 (581)
+..|+|..... +.+..++.+..|+|+.|+|.. .--+.+.++++|..|.+.+|++.....
T Consensus 206 v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~ 266 (418)
T KOG2982|consen 206 VCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLR 266 (418)
T ss_pred eecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccccccc
Confidence 55555543222 334556777788888888864 223567788888888888888764443
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.9e-10 Score=92.45 Aligned_cols=104 Identities=22% Similarity=0.231 Sum_probs=45.3
Q ss_pred CEEEccCCcccccCCcccc---CCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeC
Q 008012 32 NSLSLQGNKLNGSIPTCLA---SLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDL 108 (581)
Q Consensus 32 ~~L~l~~n~i~~~~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 108 (581)
..|+|+.++|. -++++.. ....|+..+|++|.+.+..++.-..++.++.|+|++|+|+ .+|.++..++.|+.|++
T Consensus 30 h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl 107 (177)
T KOG4579|consen 30 HFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNL 107 (177)
T ss_pred hhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhccc
Confidence 34555555544 2233322 2233444455555554222222223334445555555544 34444444444554555
Q ss_pred CCCcCCCCCcccccCcccccceeccccccc
Q 008012 109 SRNQLSGDIPKTIAGLKDLTNLSLAGNQFQ 138 (581)
Q Consensus 109 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~ 138 (581)
+.|.+. ..|..+..|.+|-.|+..+|.+.
T Consensus 108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 108 RFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred ccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 444444 34444444444444444444443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.2e-07 Score=88.30 Aligned_cols=106 Identities=22% Similarity=0.235 Sum_probs=82.8
Q ss_pred HHHHHHHHHHHhcC--CCccceEeeeeecC----CeeeEEEeccCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 008012 332 RSFNSECEVLRNVR--HRNLIKILSSCCNT----NFKALVLEFMPNG-SLDKWLYSHNYFQDIPDRLNIMIDVALALEYL 404 (581)
Q Consensus 332 ~~~~~e~~~l~~l~--h~~iv~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~L 404 (581)
....+|...+.++. .-.+.+.+++.... ...++|+|++++. +|.+++..... .+......++.+++..++-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 35677888887773 22344555555442 2458999999884 89999886433 45667788999999999999
Q ss_pred hcCCCCCceecCCCCCCeEecCCC---cEEEeeccCceec
Q 008012 405 HHGHSTPVVHCDLKPSNILLDENM---VAHVSDFGISKLL 441 (581)
Q Consensus 405 H~~~~~~i~H~dikp~Nill~~~~---~~kl~Dfg~a~~~ 441 (581)
| ..||+|+|+++.|||++.++ .+.++||+-+...
T Consensus 135 H---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 H---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred H---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9 89999999999999999877 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.1e-07 Score=82.76 Aligned_cols=137 Identities=20% Similarity=0.145 Sum_probs=99.9
Q ss_pred ecccccccEEEEEeCCCcEEEEEEeccch------HHHHHHHHHHHHHHHhcCC--CccceEeeeee--cC--CeeeEEE
Q 008012 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQL------EQAFRSFNSECEVLRNVRH--RNLIKILSSCC--NT--NFKALVL 366 (581)
Q Consensus 299 lg~G~~~~v~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~--~~--~~~~lv~ 366 (581)
-|+||-+.|+..... |..+-+|.-.... +.....|.+|...++++.. -.+.+...... .+ -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467899999998876 4578888754221 1233578899999999842 22444442211 11 2457999
Q ss_pred eccCC-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc--EEEeeccCce
Q 008012 367 EFMPN-GSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV--AHVSDFGISK 439 (581)
Q Consensus 367 e~~~~-~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~--~kl~Dfg~a~ 439 (581)
|-++| .+|.+++.+.. ...+......+..+++.+++-|| ..|+.|+|+.+.||+++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98754 48988886542 23567778899999999999999 899999999999999986666 9999997665
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1e-09 Score=90.06 Aligned_cols=137 Identities=20% Similarity=0.214 Sum_probs=104.9
Q ss_pred CCcEEEeecCcccccCCcc---ccCCCCCCEEEccCCcccccCCccccC-CCCCCEEEccCCcccCCCCcccccCCCCcE
Q 008012 6 QLQGIGLADNHLQGSIPYD---LCQLKRLNSLSLQGNKLNGSIPTCLAS-LTSLRELRLNSNKLTSSIPSALWALEYILY 81 (581)
Q Consensus 6 ~L~~L~l~~n~l~~~~~~~---~~~l~~L~~L~l~~n~i~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 81 (581)
.+..++|++|+|- -+++. +.....|+..+|++|.+.. .|..|.. .+.+++|+|.+|.|+ .+|..+..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 4567899999875 45544 4555778888999999994 5655554 568999999999998 77888999999999
Q ss_pred EecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccC
Q 008012 82 VNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGS 147 (581)
Q Consensus 82 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~ 147 (581)
|+++.|.+. ..|..+..+.+|-.|+..+|.+. .+|-.+-.-+.+-..++.++++.+.-+..+..
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa 168 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQA 168 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccccc
Confidence 999999999 77777877999999999999988 55555433334444556777777665554433
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.8e-07 Score=85.35 Aligned_cols=138 Identities=14% Similarity=0.131 Sum_probs=94.2
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHH---------HHHHHHHHHhcC---CCccceEeee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRS---------FNSECEVLRNVR---HRNLIKILSS 355 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~---h~~iv~~~~~ 355 (581)
....+|.+.+.+.......|.+.... |+.+++|..+.......+. ..+++....+++ ......++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 35678888888888887878777765 7999999887654322222 233444444443 2333333332
Q ss_pred e-----ecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcE
Q 008012 356 C-----CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVA 430 (581)
Q Consensus 356 ~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~ 430 (581)
. .-....+++|||++|..|.+... +++ .++..+.+++.-+| +.|+.|||.+|.|++++++ .+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cE
Confidence 2 22345578999999988766432 111 35567788899999 8999999999999999865 49
Q ss_pred EEeeccCce
Q 008012 431 HVSDFGISK 439 (581)
Q Consensus 431 kl~Dfg~a~ 439 (581)
+++||+...
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 581 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-36 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-16 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-16 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-06 | ||
| 3a79_B | 562 | Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len | 9e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 1e-88
Identities = 104/313 (33%), Positives = 150/313 (47%), Gaps = 13/313 (4%)
Query: 259 RRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTV 318
+ S R +DLE AT+ F+ L+G G FG VYKG+L DG V
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 319 AIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWL 378
A+K + Q F +E E L RH +L+ ++ C N L+ ++M NG+L + L
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 379 YSHNYFQDIPD---RLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDF 435
Y + RL I I A L YLH ++H D+K NILLDEN V ++DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF 183
Query: 436 GISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDE 495
GISK E D + + T+ T+GY+ PE+ +G ++ K DVYS+G++L E + +
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 496 MF-TGEMNLKNWVKESLPHG-LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPD 553
+NL W ES +G L +I D NL + R + L A+ C A +
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNL--ADKI---RPESLRKFGDTAVKCLALSSE 298
Query: 554 QRLYMKDAATKLK 566
R M D KL+
Sbjct: 299 DRPSMGDVLWKLE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 2e-86
Identities = 107/312 (34%), Positives = 159/312 (50%), Gaps = 15/312 (4%)
Query: 263 STKSPDDEELFSLATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKI 322
+ +D E+ L +R S +L+ A+D F+ N+LG GGFG VYKG L+DGT VA+K
Sbjct: 3 DVPAEEDPEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR 61
Query: 323 FNLQLEQAF-RSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSH 381
+ Q F +E E++ HRNL+++ C + LV +M NGS+ L
Sbjct: 62 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 121
Query: 382 NYFQ---DIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438
Q D P R I + A L YLH ++H D+K +NILLDE A V DFG++
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181
Query: 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFT 498
KL+ D+ + T TIG++APE+ S G S K DV+ YG++LLE T ++ D
Sbjct: 182 KLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 499 GE---MNLKNWVKESLPHG-LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQ 554
+ L +WVK L L + D +L + N+ ++ L+ + AL C P +
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDL--QGNYKDEEVEQLIQV---ALLCTQSSPME 295
Query: 555 RLYMKDAATKLK 566
R M + L+
Sbjct: 296 RPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 1e-77
Identities = 86/316 (27%), Positives = 151/316 (47%), Gaps = 27/316 (8%)
Query: 268 DDEELFSLATWRRT-SYLDLERATDGFNE------CNLLGSGGFGSVYKGILSDGTTVAI 320
+++ L T + S+ +L+ T+ F+E N +G GGFG VYKG + + TTVA+
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 321 K----IFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDK 376
K + ++ E+ + F+ E +V+ +H NL+++L + + LV +MPNGSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 377 WLYSHNYFQ--DIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSD 434
L + R I A + +LH +H D+K +NILLDE A +SD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISD 176
Query: 435 FGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTD 494
FG+++ + +V+ + + T YMAPE G ++ K D+YS+G++LLE T D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 495 EMFTGEMNLKNWVKESL--PHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELP 552
E L + +E + D + + + +++ +A C E
Sbjct: 236 EHR-EPQLLLDIKEEIEDEEKTIEDYIDKKM---NDA---DSTSVEAMYSVASQCLHEKK 288
Query: 553 DQRLYMKDAATKLKKI 568
++R +K L+++
Sbjct: 289 NKRPDIKKVQQLLQEM 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 7e-76
Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 6/220 (2%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
++ QL + + ++ G+IP L Q+K L +L N L+G++P ++SL +L + +
Sbjct: 98 AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157
Query: 62 SNKLTSSIPSALWALEYIL-YVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
N+++ +IP + + + + +S N LTG + N+ L +DLSRN L GD
Sbjct: 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVL 216
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
K+ + LA N + G +L LDL +N + +P+ L L L NV
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPC 220
S N L GEIP G + F ++ N LCG +P C
Sbjct: 276 SFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS---PLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 44/165 (26%), Positives = 69/165 (41%), Gaps = 4/165 (2%)
Query: 32 NSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKL--TSSIPSALWALEYILYVNLSS-NY 88
+ G + + L L+ L IPS+L L Y+ ++ + N
Sbjct: 29 PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88
Query: 89 LTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSL 148
L G + I + L L ++ +SG IP ++ +K L L + N G +P S SL
Sbjct: 89 LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148
Query: 149 ISLESLDLSSNNLSEGIPKSLVALSHLKQF-NVSHNRLEGEIPTE 192
+L + N +S IP S + S L +S NRL G+IP
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 25/87 (28%), Positives = 38/87 (43%), Gaps = 2/87 (2%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
G + Q I LA N L + + K LN L L+ N++ G++P L L L L +
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSN 87
+ N L IP L+ ++N
Sbjct: 276 SFNNLCGEIPQ-GGNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 23/70 (32%), Positives = 35/70 (50%), Gaps = 1/70 (1%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G + L G+ L +N + G++P L QLK L+SL++ N L G IP +L
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAY 298
Query: 61 NSNKLTSSIP 70
+NK P
Sbjct: 299 ANNKCLCGSP 308
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 4e-64
Identities = 60/308 (19%), Positives = 117/308 (37%), Gaps = 27/308 (8%)
Query: 282 SYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVL 341
+L + + G FG V+K L VA+KIF +Q +Q+++ E L
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYSL 72
Query: 342 RNVRHRNLIKILSSCCNTNFKA----LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDV 397
++H N+++ + + L+ F GSL +L + +I +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETM 130
Query: 398 ALALEYLH------HGHSTP-VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450
A L YLH P + H D+K N+LL N+ A ++DFG++ G +
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 451 TMTIATIGYMAPE-----FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG-EMNLK 504
+ T YMAPE + + + D+Y+ G++L E +R D + +
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 505 NWVKESLP-HGLPKIADANLLR---EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKD 560
+ + + ++ R + + + + +C + RL
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK--HAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 561 AATKLKKI 568
++ ++
Sbjct: 309 VGERITQM 316
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 1e-63
Identities = 73/248 (29%), Positives = 105/248 (42%), Gaps = 22/248 (8%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSI--------------- 45
+GR++ L + L++N G+IP +L + L L L N NG+I
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANF 569
Query: 46 -----PTCLASLTSLRELRL--NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQ 98
+ + +E N + L L N++S G +
Sbjct: 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD 629
Query: 99 NMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSS 158
N ++ LD+S N LSG IPK I + L L+L N G IP+ G L L LDLSS
Sbjct: 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS 689
Query: 159 NNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVP 218
N L IP+++ AL+ L + ++S+N L G IP G F F F N LCG +
Sbjct: 690 NKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCD 749
Query: 219 PCKEDKNK 226
P D
Sbjct: 750 PSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-50
Identities = 63/190 (33%), Positives = 96/190 (50%), Gaps = 2/190 (1%)
Query: 5 QQLQGIGLADNHLQGSIPYDLCQ--LKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNS 62
L + L+ N+ G I +LCQ L L LQ N G IP L++ + L L L+
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427
Query: 63 NKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIA 122
N L+ +IPS+L +L + + L N L G + ++ +K L L L N L+G+IP ++
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
Query: 123 GLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSH 182
+L +SL+ N+ G IP+ G L +L L LS+N+ S IP L L +++
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547
Query: 183 NRLEGEIPTE 192
N G IP
Sbjct: 548 NLFNGTIPAA 557
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-48
Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 7/194 (3%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+L+ + ++ N + G + + + L L + N + IP L ++L+ L +
Sbjct: 174 SDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDI 230
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+ NKL+ A+ + +N+SSN G + +K L L L+ N+ +G+IP
Sbjct: 231 SGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDF 288
Query: 121 IAG-LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPK-SLVALSHLKQF 178
++G LT L L+GN F G +P FGS LESL LSSNN S +P +L+ + LK
Sbjct: 289 LSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVL 348
Query: 179 NVSHNRLEGEIPTE 192
++S N GE+P
Sbjct: 349 DLSFNEFSGELPES 362
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-48
Identities = 67/189 (35%), Positives = 97/189 (51%), Gaps = 4/189 (2%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
LQ + L +N G IP L L SL L N L+G+IP+ L SL+ LR+L+L N
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
L IP L ++ + + L N LTG + S + N L + LS N+L+G+IPK I
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
L++L L L+ N F G IP G SL LDL++N + IP ++ S ++ N
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAAN 568
Query: 184 RLEGEIPTE 192
+ G+
Sbjct: 569 FIAGKRYVY 577
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-44
Identities = 57/214 (26%), Positives = 85/214 (39%), Gaps = 22/214 (10%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+ +L + L+ N+L G+IP L L +L L L N L G IP L + +L L L
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+ N LT IPS L + +++LS+N LTG + I ++ L L LS N SG+IP
Sbjct: 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE 533
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSN--------------------- 159
+ + L L L N F G IP + + + +
Sbjct: 534 LGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNL 593
Query: 160 -NLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE 192
+ L LS N++ G
Sbjct: 594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-44
Identities = 47/197 (23%), Positives = 82/197 (41%), Gaps = 11/197 (5%)
Query: 2 GRMQQLQGIGLADNHLQGSIP--YDLCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLREL 58
L + L+ N L G + L L L++ N L+ L SL L
Sbjct: 97 KCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVL 156
Query: 59 RLNSNKLTSSIPSALWA---LEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSG 115
L++N ++ + + ++ +S N ++G + D+ L LD+S N S
Sbjct: 157 DLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFST 214
Query: 116 DIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHL 175
IP + L +L ++GN+ G + + L+ L++SSN IP L L
Sbjct: 215 GIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSL 271
Query: 176 KQFNVSHNRLEGEIPTE 192
+ +++ N+ GEIP
Sbjct: 272 QYLSLAENKFTGEIPDF 288
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-43
Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPT--CLASLTSLRELR 59
+ L+ + L+++H+ GS+ L SL L N L+G + T L S + L+ L
Sbjct: 74 LSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLN 132
Query: 60 LNSNKLTSSIP-SALWALEYILYVNLSSNYLTGSLTSDIQ---NMKVLIDLDLSRNQLSG 115
++SN L S L + ++LS+N ++G+ L L +S N++SG
Sbjct: 133 VSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISG 192
Query: 116 DIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHL 175
D+ ++ +L L ++ N F IP G +L+ LD+S N LS +++ + L
Sbjct: 193 DVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTEL 249
Query: 176 KQFNVSHNRLEGEIPTE 192
K N+S N+ G IP
Sbjct: 250 KLLNISSNQFVGPIPPL 266
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-39
Identities = 58/193 (30%), Positives = 89/193 (46%), Gaps = 12/193 (6%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKL 65
L L N ++ L L L SL L + +NGS+ SL L L+ N L
Sbjct: 56 DLSSKPL--NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSL 112
Query: 66 TSSIPSA--LWALEYILYVNLSSNYLTGSL-TSDIQNMKVLIDLDLSRNQLSGDIPKTIA 122
+ + + L + + ++N+SSN L S + L LDLS N +SG
Sbjct: 113 SGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWV 172
Query: 123 ---GLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFN 179
G +L +L+++GN+ G + ++LE LD+SSNN S GIP L S L+ +
Sbjct: 173 LSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLD 229
Query: 180 VSHNRLEGEIPTE 192
+S N+L G+
Sbjct: 230 ISGNKLSGDFSRA 242
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 41/174 (23%), Positives = 74/174 (42%), Gaps = 12/174 (6%)
Query: 26 CQLKRLNSLSLQGNKLN---GSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82
C+ ++ S+ L LN ++ + L SLT L L L+++ + S+ + +
Sbjct: 47 CRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSL 105
Query: 83 NLSSNYLTGSLTSD--IQNMKVLIDLDLSRNQLSGDIPKTI-AGLKDLTNLSLAGNQFQG 139
+LS N L+G +T+ + + L L++S N L + L L L L+ N G
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165
Query: 140 PIPESF---GSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIP 190
+ L+ L +S N +S + + +L+ +VS N IP
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP 217
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 6e-10
Identities = 19/74 (25%), Positives = 33/74 (44%), Gaps = 3/74 (4%)
Query: 126 DLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRL 185
DL++ L + S SL LESL LS+++++ + + L ++S N L
Sbjct: 56 DLSSKPLNV--GFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSL 112
Query: 186 EGEIPTEGPFRNFS 199
G + T + S
Sbjct: 113 SGPVTTLTSLGSCS 126
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 13/51 (25%), Positives = 27/51 (52%), Gaps = 3/51 (5%)
Query: 150 SLESLDLSSNNLSEG---IPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRN 197
+ S+DLSS L+ G + SL++L+ L+ +S++ + G + +
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSAS 101
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 4e-63
Identities = 77/288 (26%), Positives = 134/288 (46%), Gaps = 45/288 (15%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQ-------LEQAFRSFNSECEVLRNVRHRNLI 350
+G GGFG V+KG + D + VAIK L + + F+ F E ++ N+ H N++
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST 410
K+ N +V+EF+P G L L + +L +M+D+AL +EY+ + +
Sbjct: 87 KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNP 143
Query: 411 PVVHCDLKPSNILLDE-----NMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE 463
P+VH DL+ NI L + A V+DFG+S+ + +++ + +MAPE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-------SVHSVSGLLGNFQWMAPE 196
Query: 464 --FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGL-PKIAD 520
E + + K D YS+ ++L T + P DE G++ N ++E GL P I +
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE---EGLRPTIPE 253
Query: 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
DC + ++ C + P +R + +L ++
Sbjct: 254 --------------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 3e-62
Identities = 75/279 (26%), Positives = 114/279 (40%), Gaps = 34/279 (12%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
+G G FG V K VAIK + E+ ++F E L V H N++K+ +C N
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 359 TNFKALVLEFMPNGSLDKWLYSHNYFQDIP--DRLNIMIDVALALEYLHHGHSTPVVHCD 416
LV+E+ GSL L+ ++ + + + YLH ++H D
Sbjct: 73 PV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 417 LKPSNILLDENM-VAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPEFGSEGNVSSK 473
LKP N+LL V + DFG + + MT + +MAPE N S K
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQ-------THMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 474 CDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSAR 533
CDV+S+GI+L E TR+KP DE+ + V P +
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---RPPLIK------------- 227
Query: 534 MDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572
+ I L C ++ P QR M++ + + F
Sbjct: 228 -NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 1e-61
Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 28/284 (9%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
+G+G FG+V++ G+ VA+KI Q + F E +++ +RH N++ + +
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIP--DRLNIMIDVALALEYLHHGHSTPVVH 414
++V E++ GSL + L+ + + RL++ DVA + YLH+ + P+VH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKC 474
+LK N+L+D+ V DFG+S+L + + T +MAPE + + K
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 475 DVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGL-PKIADANLLREENFFSAR 533
DVYS+G++L E T ++P +N V +I
Sbjct: 221 DVYSFGVILWELATLQQPWG-----NLNPAQVVAAVGFKCKRLEIPR------------- 262
Query: 534 MDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDAN 577
+ + + C P +R L+ + + N
Sbjct: 263 -NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-59
Identities = 68/284 (23%), Positives = 107/284 (37%), Gaps = 41/284 (14%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQ----AFRSFNSECEVLRNVRHRNLIKILS 354
+G GGFG VY+ G VA+K ++ + E ++ ++H N+I +
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
C LV+EF G L++ L +N + +A + YLH P++H
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 415 CDLKPSNILLDE--------NMVAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEFG 465
DLK SNIL+ + N + ++DFG+++ M+ A +MAPE
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-----KMSAAGAYAWMAPEVI 186
Query: 466 SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGL-PKIADANLL 524
S DV+SYG+LL E T + P + + + L I
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-----AYGVAMNKLALPIPS---- 237
Query: 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
C L DC P R + +L I
Sbjct: 238 ----------TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 6e-59
Identities = 69/275 (25%), Positives = 122/275 (44%), Gaps = 25/275 (9%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSC 356
+GSG FG+VYKG VA+K+ N+ Q ++F +E VLR RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCD 416
A+V ++ SL L++ ++ ++I A ++YLH + ++H D
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 417 LKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE---FGSEGNVSSK 473
LK +NI L E+ + DFG++ S +I +MAPE S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 474 CDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSAR 533
DVY++GI+L E T + P + + ++ + SL L K+ R
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV--------------R 251
Query: 534 MDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
+C + L +C + D+R +++++
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 4e-58
Identities = 63/285 (22%), Positives = 110/285 (38%), Gaps = 43/285 (15%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSC 356
L G ++KG G + +K+ ++ + R FN EC LR H N++ +L +C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 357 CNTNFK--ALVLEFMPNGSLDKWLYSHNYFQ-DIPDRLNIMIDVALALEYLHHGHSTPVV 413
+ L+ +MP GSL L+ F D + +D+A + +LH +
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIP 135
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF---GSEGNV 470
L ++++DE+M A +S + S + ++APE E
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 471 SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFF 530
D++S+ +LL E TR+ P ++ E+ + K+A L
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADLSNMEIGM-------------KVALEGL------- 228
Query: 531 SARM----DCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571
R + L C E P +R L+K++DK
Sbjct: 229 --RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 9e-58
Identities = 67/291 (23%), Positives = 114/291 (39%), Gaps = 33/291 (11%)
Query: 299 LGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357
LG G FG K G + +K E+ R+F E +V+R + H N++K +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
+ E++ G+L + S + R++ D+A + YL HS ++H DL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HSMNIIHRDL 134
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGD------------DSVIQTMTIATIGYMAPEFG 465
N L+ EN V+DFG+++L+ + D + + +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 466 SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525
+ + K DV+S+GI+L E R + M+ V+ L P
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP--------- 245
Query: 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDA 576
+C S F + + CC P++R L+ +R
Sbjct: 246 --------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 190 bits (483), Expect = 1e-55
Identities = 74/320 (23%), Positives = 123/320 (38%), Gaps = 38/320 (11%)
Query: 281 TSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEV 340
+ + D L+G G +G+VYKG L D VA+K+F+ Q +F +E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 341 --LRNVRHRNLIKILSSCCNTNFKA-----LVLEFMPNGSLDKWLYSHNYFQDIPDRLNI 393
+ + H N+ + + LV+E+ PNGSL K+L H D +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS--DWVSSCRL 116
Query: 394 MIDVALALEYLH-----HGHSTP-VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447
V L YLH H P + H DL N+L+ + +SDFG+S L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 448 VIQTMTIA------TIGYMAPE-------FGSEGNVSSKCDVYSYGILLLETFTRKK--- 491
A TI YMAPE + + D+Y+ G++ E F R
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 492 PTDEMFTGEMNLKNWVKESLP-HGLPKIADANLLREE--NFFSARMDCLLSIFHLALDCC 548
P + + +M + V + + R + + + S+ DC
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 549 AELPDQRLYMKDAATKLKKI 568
+ + RL + A ++ ++
Sbjct: 297 DQDAEARLTAQXAEERMAEL 316
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 5e-54
Identities = 55/289 (19%), Positives = 105/289 (36%), Gaps = 38/289 (13%)
Query: 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILS 354
L+G G FG VY G VAI++ +++ E ++F E R RH N++ +
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
+C + A++ +L + D+ I ++ + YL H+ ++H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILH 153
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT-MTIA--TIGYMAPE-------- 463
DLK N+ D V ++DFG+ + G + + I + ++APE
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 464 -FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522
+ S DV++ G + E R+ P +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--------------PAEAIIWQMGTG 258
Query: 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571
+ +++ I + L C A ++R L+K+ +
Sbjct: 259 MKPNL----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-53
Identities = 66/295 (22%), Positives = 110/295 (37%), Gaps = 27/295 (9%)
Query: 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEV--LRNVRHRNLIKILS 354
+G G +G V+ G G VA+K+F S+ E E+ +RH N++ ++
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 355 SCCNTNFK----ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH----- 405
+ L+ ++ NGSL +L S D L + L +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTL--DAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA--TIGYMAPE 463
+ H DLK NIL+ +N ++D G++ + V T YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 464 -FGSEGNVSS-----KCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLP-HGLP 516
N + D+YS+G++L E R + ++ + V +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 517 KIADANLLR-EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570
+I LR + +CL + L +C A P RL L K+ +
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-52
Identities = 67/302 (22%), Positives = 120/302 (39%), Gaps = 45/302 (14%)
Query: 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEV--LRNVRHRNLIKILS 354
+G G +G V++G G VA+KIF+ + E+ S+ E E+ +RH N++ ++
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69
Query: 355 SCCNTNFKA----LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH----- 405
S + + L+ + GSL +L D L I++ +A L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA--TIGYMAPE 463
+ H DLK NIL+ +N ++D G++ + + + + T YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 464 ------FGSEGNVSSKCDVYSYGILLLETFTR----------KKPTDEMFTGEMNLKNWV 507
+ + D++++G++L E R K P ++ + + ++
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 508 KESLPHGL-PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566
K P I + L S+ L +C + P RL L
Sbjct: 248 KVVCVDQQRPNIPNRWFSDP---------TLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 567 KI 568
KI
Sbjct: 299 KI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 7e-50
Identities = 65/302 (21%), Positives = 118/302 (39%), Gaps = 45/302 (14%)
Query: 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEV--LRNVRHRNLIKILS 354
+G G FG V++G G VA+KIF+ + E+ S+ E E+ +RH N++ ++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 103
Query: 355 SCCNTNFKA----LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH----- 405
+ N LV ++ +GSL +L + Y + + + + A L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA--TIGYMAPE 463
+ H DLK NIL+ +N ++D G++ D++ T YMAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 464 -FGSEGNVSS-----KCDVYSYGILLLETFTR----------KKPTDEMFTGEMNLKNWV 507
N+ + D+Y+ G++ E R + P ++ + +++
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 508 KESLPHGL-PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566
K L P I + E L + + +C RL L
Sbjct: 282 KVVCEQKLRPNIPNRWQSCE---------ALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 567 KI 568
++
Sbjct: 333 QL 334
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-43
Identities = 74/280 (26%), Positives = 119/280 (42%), Gaps = 33/280 (11%)
Query: 299 LGSGGFGSVYKGIL-SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSC 356
+G G FG V+ G L +D T VA+K L F E +L+ H N+++++ C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCD 416
+V+E + G +L + + L ++ D A +EYL S +H D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRD 238
Query: 417 LKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDV 476
L N L+ E V +SDFG+S+ +G + + + + APE + G SS+ DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 477 YSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMD 535
+S+GILL ETF+ P + + +E + G R+
Sbjct: 299 WSFGILLWETFSLGASPYPNLSNQQ------TREFVEKGG-----------------RLP 335
Query: 536 ----CLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571
C ++F L C A P QR +L+ IR +
Sbjct: 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 26/288 (9%)
Query: 299 LGSGGFGSVYKGIL-----SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKIL 353
LG G FGSV + G VA+K E+ R F E E+L++++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 354 SSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
C + + L++E++P GSL +L H D L + +EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 134
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-VIQTMTIATIGYMAPEFGSEGNV 470
+H DL NIL++ + DFG++K+L + + ++ + I + APE +E
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 471 SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR--EEN 528
S DV+S+G++L E FT + + M + + ++ +L+ + N
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG----NDKQ--GQMIVFHLIELLKNN 248
Query: 529 FFSARM----DCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572
R+ C I+ + +C +QR +D A ++ +IRD
Sbjct: 249 G---RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 26/288 (9%)
Query: 299 LGSGGFGSVYKGIL-----SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKIL 353
LG G FGSV + G VA+K E+ R F E E+L++++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 354 SSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
C + + L++E++P GSL +L H D L + +EYL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 165
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-VIQTMTIATIGYMAPEFGSEGNV 470
+H DL NIL++ + DFG++K+L + + ++ + I + APE +E
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225
Query: 471 SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR--EEN 528
S DV+S+G++L E FT + + M + + ++ +L+ + N
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG----NDKQ--GQMIVFHLIELLKNN 279
Query: 529 FFSARM----DCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572
R+ C I+ + +C +QR +D A ++ +IRD+
Sbjct: 280 G---RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 68/266 (25%), Positives = 108/266 (40%), Gaps = 34/266 (12%)
Query: 299 LGSGGFGSVYKGILSDG-----TTVAIKIFNL-QLEQAFRSFNSECEVLRNVRHRNLIKI 352
LGSG FG+VYKG+ VAIK +A + E V+ +V + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
L C T+ L+ + MP G L ++ H LN + +A + YL +
Sbjct: 83 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---L 138
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
VH DL N+L+ ++DFG++KLLG + I +MA E +
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 473 KCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREENF 529
+ DV+SYG+ + E T KP D + E + L G LP+
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERLPQ------------ 240
Query: 530 FSARMDCLLSIFHLALDCCAELPDQR 555
C + ++ + C D R
Sbjct: 241 ---PPICTIDVYMIMRKCWMIDADSR 263
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 7e-39
Identities = 59/274 (21%), Positives = 106/274 (38%), Gaps = 32/274 (11%)
Query: 299 LGSGGFGSVYKGIL-----SDGTTVAIKIF-NLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
LG G FG V + G VA+K E E+LRN+ H N++K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 353 LSSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST 410
C L++EF+P+GSL ++L + ++ +L + + ++YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ-- 146
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-VIQTMTIATIGYMAPEFGSEGN 469
VH DL N+L++ + DFG++K + + ++ + + + APE +
Sbjct: 147 -YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205
Query: 470 VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP--KIADANLLR-- 525
DV+S+G+ L E T + + G ++ L+
Sbjct: 206 FYIASDVWSFGVTLHELLTY---------CDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256
Query: 526 EENFFSARM----DCLLSIFHLALDCCAELPDQR 555
+E R+ +C ++ L C P R
Sbjct: 257 KEGK---RLPCPPNCPDEVYQLMRKCWEFQPSNR 287
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-39
Identities = 66/268 (24%), Positives = 113/268 (42%), Gaps = 39/268 (14%)
Query: 299 LGSGGFGSVYKGIL---SDGTTVAIKIF--NLQLEQAFRSFNSECEVLRNVRHRNLIKIL 353
LGSG FG+V KG TVA+KI +E V++ + + +++++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVV 413
C ++ LV+E G L+K+L + + + + + ++ V++ ++YL + V
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYLQQNRHVK-DKNIIELVHQVSMGMKYLEESN---FV 139
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT---IGYMAPEFGSEGNV 470
H DL N+LL A +SDFG+SK L ++ + + APE +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYYKF 197
Query: 471 SSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREE 527
SSK DV+S+G+L+ E F+ +KP M E V L G +
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMGC---------- 241
Query: 528 NFFSARMDCLLSIFHLALDCCAELPDQR 555
C ++ L C + R
Sbjct: 242 -----PAGCPREMYDLMNLCWTYDVENR 264
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-38
Identities = 71/272 (26%), Positives = 109/272 (40%), Gaps = 29/272 (10%)
Query: 299 LGSGGFGSVYKGIL-----SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKIL 353
LG G FGSV + G VA+K R F E ++L+ + ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 354 SSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
++ LV+E++P+G L +L H D L + +EYL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--- 147
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-VIQTMTIATIGYMAPEFGSEGNV 470
VH DL NIL++ ++DFG++KLL D V++ + I + APE S+
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 471 SSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR--EE 527
S + DV+S+G++L E FT K + + A + LL EE
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKS--------CSPSAEFLRMMGCERDVPALSRLLELLEE 259
Query: 528 NFFSARM----DCLLSIFHLALDCCAELPDQR 555
R+ C + L C A P R
Sbjct: 260 GQ---RLPAPPACPAEVHELMKLCWAPSPQDR 288
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-38
Identities = 42/208 (20%), Positives = 77/208 (37%), Gaps = 11/208 (5%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNG--SIPTCLASLTSLRELR 59
++ + I L+ N + L L L+ L S P+ L +L L
Sbjct: 427 RGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD 486
Query: 60 LNSNKLTSSIPSALWALEYILYVNLSSNYLT--------GSLTSDIQNMKVLIDLDLSRN 111
L++N + + L LE + ++L N L G ++ + L L+L N
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546
Query: 112 QLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSL-V 170
+ L +L + L N F + +SL+SL+L N ++ K
Sbjct: 547 GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP 606
Query: 171 ALSHLKQFNVSHNRLEGEIPTEGPFRNF 198
A +L + ++ N + + F N+
Sbjct: 607 AFRNLTELDMRFNPFDCTCESIAWFVNW 634
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-36
Identities = 45/195 (23%), Positives = 87/195 (44%), Gaps = 5/195 (2%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
R QL + + N + P +L L L+LQ N+L+ A T+L EL L
Sbjct: 46 TRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
SN + + + ++ ++LS N L+ + ++ L +L LS N++ + +
Sbjct: 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165
Query: 122 AGLKD--LTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSL---VALSHLK 176
+ L L L+ NQ + P F ++ L L L++ L + + L +A + ++
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225
Query: 177 QFNVSHNRLEGEIPT 191
++S+++L T
Sbjct: 226 NLSLSNSQLSTTSNT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-34
Identities = 41/211 (19%), Positives = 83/211 (39%), Gaps = 14/211 (6%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIP---TCLASLTSLRELRLNS 62
L+ + L+ N ++ P + RL L L +L S+ + TS+R L L++
Sbjct: 172 SLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231
Query: 63 NKLTSSIPSALWALEY--ILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
++L+++ + L++ + ++LS N L + L L N + +
Sbjct: 232 SQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS 291
Query: 121 IAGLKDLTNLSLAGN---------QFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVA 171
+ GL ++ L+L + SF L LE L++ N++
Sbjct: 292 LHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTG 351
Query: 172 LSHLKQFNVSHNRLEGEIPTEGPFRNFSAQS 202
L +LK ++S++ T F + +
Sbjct: 352 LINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-34
Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 18/214 (8%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDL--CQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELR 59
+++ LQ + L++N +Q +L L L L N++ P C ++ L L
Sbjct: 142 VQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLF 201
Query: 60 LNSNKLTSSIPSAL---WALEYILYVNLSSNYLTGSLTSDIQNMKV--LIDLDLSRNQLS 114
LN+ +L S+ L A I ++LS++ L+ + + +K L LDLS N L+
Sbjct: 202 LNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN 261
Query: 115 GDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSN---------NLSEGI 165
+ A L L L N Q S L ++ L+L + +L +
Sbjct: 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321
Query: 166 PKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFS 199
S L L+ N+ N + G F
Sbjct: 322 DFSFQWLKCLEHLNMEDNDIPGIKS--NMFTGLI 353
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-33
Identities = 41/190 (21%), Positives = 69/190 (36%), Gaps = 7/190 (3%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS 71
+ L +P DL + L+L N+L + L L + N ++ P
Sbjct: 11 CSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE 67
Query: 72 ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLS 131
L + +NL N L+ L +L L N + K+L L
Sbjct: 68 LCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD 127
Query: 132 LAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPK--SLVALSHLKQFNVSHNRLEGEI 189
L+ N + L +L+ L LS+N + + + A S LK+ +S N+++
Sbjct: 128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFS 187
Query: 190 PTEGPFRNFS 199
P G F
Sbjct: 188 P--GCFHAIG 195
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-32
Identities = 39/212 (18%), Positives = 82/212 (38%), Gaps = 14/212 (6%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGN---------KLNGSIPTCLASL 52
+ QL+ L N++Q + L L + L+L+ + L L
Sbjct: 269 AWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL 328
Query: 53 TSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLT-GSLTSDI---QNMKVLIDLDL 108
L L + N + + L + Y++LS+++ + +LT++ L L+L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 109 SRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIP-ESFGSLISLESLDLSSNNLSEGIPK 167
++N++S + L L L L N+ + + + L ++ + LS N +
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN 448
Query: 168 SLVALSHLKQFNVSHNRLEGEIPTEGPFRNFS 199
S + L++ + L+ + PF+
Sbjct: 449 SFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 41/204 (20%), Positives = 66/204 (32%), Gaps = 11/204 (5%)
Query: 2 GRMQQLQGIGLADNHLQG--SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELR 59
+ LQ + L L+ S P L+ L L L N + L L L L
Sbjct: 451 ALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILD 510
Query: 60 LNSNKLTS--------SIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRN 111
L N L L L ++ +NL SN +++ L +DL N
Sbjct: 511 LQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLN 570
Query: 112 QLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFG-SLISLESLDLSSNNLSEGIPKSLV 170
L+ L +L+L N + FG + +L LD+ N
Sbjct: 571 NLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAW 630
Query: 171 ALSHLKQFNVSHNRLEGEIPTEGP 194
++ + + + + L P
Sbjct: 631 FVNWINETHTNIPELSSHYLCNTP 654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 34/138 (24%), Positives = 54/138 (39%), Gaps = 3/138 (2%)
Query: 53 TSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQ 112
S + KLT +P L I +NL+ N L ++ L LD+ N
Sbjct: 4 VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 113 LSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVAL 172
+S P+ L L L+L N+ ++F +L L L SN++ + V
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 173 SHLKQFNVSHNRLEGEIP 190
+L ++SHN L
Sbjct: 121 KNLITLDLSHNGLSSTKL 138
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 15/234 (6%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNL--QLEQAFRSFNSECEVLRNVRHRNLIKILS 354
+G G F +VYKG+ VA + + F E E+L+ ++H N+++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 355 SCCNTNFKA----LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST 410
S +T LV E M +G+L +L I + + L++LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM-KIKVLRSWCRQILKGLQFLH-TRTP 150
Query: 411 PVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGN 469
P++H DLK NI + + D G++ L S + + I T +MAPE E
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAV-IGTPEFMAPEMYEEK- 205
Query: 470 VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523
DVY++G+ +LE T + P E + P K+A +
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 72/266 (27%), Positives = 120/266 (45%), Gaps = 35/266 (13%)
Query: 296 CNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSS 355
LG G FG V+ G + T VAIK +F E +V++ +RH L+++ +
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
+V E+M GSL +L + +P +++ +A + Y+ + VH
Sbjct: 248 VSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 303
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKC 474
DL+ +NIL+ EN+V V+DFG+++L+ + + + Q I + APE G + K
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKS 362
Query: 475 DVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSAR 533
DV+S+GILL E T+ + P M E V + + G R
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGY-----------------R 399
Query: 534 M----DCLLSIFHLALDCCAELPDQR 555
M +C S+ L C + P++R
Sbjct: 400 MPCPPECPESLHDLMCQCWRKEPEER 425
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 65/267 (24%), Positives = 109/267 (40%), Gaps = 37/267 (13%)
Query: 299 LGSGGFGSVYKGILSDG---TTVAIKIF-NLQLEQAFRSFNSECEVLRNVRHRNLIKILS 354
LG G FGSV +G+ VAIK+ + E +++ + + +++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
C LV+E G L K+L + + ++ V++ ++YL + VH
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVH 133
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT---IGYMAPEFGSEGNVS 471
DL N+LL A +SDFG+SK LG D T A + + APE + S
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECINFRKFS 191
Query: 472 SKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREEN 528
S+ DV+SYG+ + E + +KP +M E V + G +
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMEC----------- 234
Query: 529 FFSARMDCLLSIFHLALDCCAELPDQR 555
+C ++ L DC + R
Sbjct: 235 ----PPECPPELYALMSDCWIYKWEDR 257
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-38
Identities = 72/266 (27%), Positives = 120/266 (45%), Gaps = 35/266 (13%)
Query: 296 CNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSS 355
LG G FG V+ G + T VAIK +F E +V++ +RH L+++ +
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
+V E+M GSL +L + +P +++ +A + Y+ + VH
Sbjct: 331 VSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKC 474
DL+ +NIL+ EN+V V+DFG+++L+ + + + Q I + APE G + K
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKS 445
Query: 475 DVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSAR 533
DV+S+GILL E T+ + P M E V + + G R
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGY-----------------R 482
Query: 534 M----DCLLSIFHLALDCCAELPDQR 555
M +C S+ L C + P++R
Sbjct: 483 MPCPPECPESLHDLMCQCWRKEPEER 508
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 66/271 (24%), Positives = 102/271 (37%), Gaps = 41/271 (15%)
Query: 299 LGSGGFGSVYKGIL----SDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRNLIK 351
LG G FG V +G +VA+K L +A F E + ++ HRNLI+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
+ K +V E P GSL L H + + VA + YL
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--- 141
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT---IGYMAPEFGSEG 468
+H DL N+LL + + DFG+ + L + DD M + APE
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWCAPESLKTR 199
Query: 469 NVSSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESL-PHG--LPKIADANLL 524
S D + +G+ L E FT ++P + + + + G LP+
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGERLPR------- 246
Query: 525 REENFFSARMDCLLSIFHLALDCCAELPDQR 555
DC I+++ + C A P+ R
Sbjct: 247 --------PEDCPQDIYNVMVQCWAHKPEDR 269
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-38
Identities = 76/275 (27%), Positives = 113/275 (41%), Gaps = 33/275 (12%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIF--NLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
+GSG FG V+ G + VAIK E+ F E EV+ + H L+++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVC 72
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCD 416
LV EFM +G L +L + L + +DV + YL V+H D
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 129
Query: 417 LKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDV 476
L N L+ EN V VSDFG+++ + D T T + + +PE S SSK DV
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 477 YSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREENFFSAR 533
+S+G+L+ E F+ K P + E V E + G L K
Sbjct: 189 WSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTGFRLYK---------------P 227
Query: 534 MDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
++ + C E P+ R +L +I
Sbjct: 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-38
Identities = 64/264 (24%), Positives = 124/264 (46%), Gaps = 31/264 (11%)
Query: 296 CNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSS 355
LG+G FG V+ + T VA+K + +F +E V++ ++H L+K L +
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK-LHA 250
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHNY-FQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
++ EFM GSL +L S Q +P ++ +A + ++ + +H
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKC 474
DL+ +NIL+ ++V ++DFG+++++ + + + + I + APE + G+ + K
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKS 366
Query: 475 DVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREENFFS 531
DV+S+GILL+E T + P M E V +L G +P+
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPE------VIRALERGYRMPR-------------- 406
Query: 532 ARMDCLLSIFHLALDCCAELPDQR 555
+C ++++ + C P++R
Sbjct: 407 -PENCPEELYNIMMRCWKNRPEER 429
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-38
Identities = 34/214 (15%), Positives = 71/214 (33%), Gaps = 27/214 (12%)
Query: 1 MGRMQQLQGIGLADNHLQG-------SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLT 53
+ + I + N + + + ++S++L N+++ ++ +
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
Query: 54 SLRELRLNSNKLTS-------SIPSALWALEYILYVNLSSNYLTGSLTSDIQ--NMKVLI 104
L + L N LT + ++L N LT L+ D + + L+
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLV 516
Query: 105 DLDLSRNQLSGDIPKTIAGLKDLT------NLSLAGNQFQGPIPESFGSLISLESLDLSS 158
+DLS N S P L GN+ PE SL L + S
Sbjct: 517 GIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGS 575
Query: 159 NNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE 192
N++ + + + ++ ++ N +
Sbjct: 576 NDIR-KVNEKI--TPNISVLDIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-38
Identities = 41/214 (19%), Positives = 86/214 (40%), Gaps = 18/214 (8%)
Query: 2 GRMQQLQGIGLADNHLQ-GSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+++Q I + N+L+ + L ++K+L L N+L G +P S L L L
Sbjct: 302 PVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNL 360
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTG-SLTSDIQNMKVLIDLDLSRNQLSG---- 115
N++T + E + ++ + N L D +++ V+ +D S N++
Sbjct: 361 AYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGK 420
Query: 116 ---DIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE-------GI 165
+ T ++++++L+ NQ E F + L S++L N L+E
Sbjct: 421 NFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDE 480
Query: 166 PKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFS 199
++ L ++ N+L + +
Sbjct: 481 NENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLP 513
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-34
Identities = 28/224 (12%), Positives = 72/224 (32%), Gaps = 26/224 (11%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNG----SIPTCLASLTSLR 56
+ ++ G+ L G +P + QL L L+L + P +++ S
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 57 ELRLNSNKLTSSIPSALWALEY--ILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLS 114
+ + + ++ ++ ++S+ S+ + + N ++
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 115 GDIPKTIAGLKDLTNLSLAGNQFQGP-------------------IPESFGSLISLESLD 155
+ K + L L + + F + +L L ++
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255
Query: 156 LSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFS 199
+ + +P L AL ++ NV+ NR + ++ +
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-31
Identities = 34/199 (17%), Positives = 66/199 (33%), Gaps = 18/199 (9%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNG-------SIPTCLASLTS 54
+ + I L++N + L+S++L GN L +
Sbjct: 430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYL 489
Query: 55 LRELRLNSNKLTSSIPS-ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDL------D 107
L + L NKLT L Y++ ++LS N + + N L D
Sbjct: 490 LTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRD 548
Query: 108 LSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPK 167
N+ + P+ I LT L + N + + E ++ LD+ N
Sbjct: 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLS 605
Query: 168 SLVALSHLKQFNVSHNRLE 186
+ + + +++ +
Sbjct: 606 YVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-29
Identities = 25/225 (11%), Positives = 64/225 (28%), Gaps = 35/225 (15%)
Query: 2 GRMQQLQGIGLADNHLQG----SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLA--SLTSL 55
G++ +L+ + L + + P + + + L
Sbjct: 102 GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDL 161
Query: 56 RELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSG 115
+ +NS+ SI + + SN +T ++ + + L + +
Sbjct: 162 IKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVA 220
Query: 116 D-------------------IPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDL 156
+ LKDLT++ + +P +L ++ +++
Sbjct: 221 ENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINV 280
Query: 157 SSNNLSEG--------IPKSLVALSHLKQFNVSHNRL-EGEIPTE 192
+ N G ++ + +N L + T
Sbjct: 281 ACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETS 325
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 28/176 (15%), Positives = 46/176 (26%), Gaps = 18/176 (10%)
Query: 2 GRMQQLQGIGLADNHLQG-------SIPYDLCQLKRLNSLSLQGNKLNGSIPT-CLASLT 53
L I L N L + L S+ L+ NKL +L
Sbjct: 454 STGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLP 513
Query: 54 SLRELRLNSNKLTSSIP------SALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLD 107
L + L+ N + P S L + N I L L
Sbjct: 514 YLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572
Query: 108 LSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163
+ N + + + I +++ L + N I L + +
Sbjct: 573 IGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQD 625
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 11/66 (16%), Positives = 23/66 (34%)
Query: 129 NLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGE 188
N + + + S S + L L S +P ++ L+ L+ + + +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 189 IPTEGP 194
GP
Sbjct: 121 ERLFGP 126
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-38
Identities = 42/200 (21%), Positives = 75/200 (37%), Gaps = 5/200 (2%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRL 60
L+ + L+ N + + + L++L L Q + L SL +L L +
Sbjct: 370 FGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPK 119
+ + L + + ++ N + DI ++ L LDLS+ QL P
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
Query: 120 TIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVAL-SHLKQF 178
L L L+++ N F + L SL+ LD S N++ + L S L
Sbjct: 489 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 548
Query: 179 NVSHNRLEGEIPTEGPFRNF 198
N++ N + F +
Sbjct: 549 NLTQNDFACTCEHQ-SFLQW 567
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-36
Identities = 40/184 (21%), Positives = 69/184 (37%), Gaps = 6/184 (3%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS 71
L+ N L+ Y L L L ++ SL+ L L L N + S
Sbjct: 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 94
Query: 72 ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQL-SGDIPKTIAGLKDLTNL 130
A L + + L I ++K L +L+++ N + S +P+ + L +L +L
Sbjct: 95 AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154
Query: 131 SLAGNQFQGPIPESFGSLISLE----SLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
L+ N+ Q L + SLDLS N ++ I L + + +N
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDS 213
Query: 187 GEIP 190
+
Sbjct: 214 LNVM 217
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-34
Identities = 43/202 (21%), Positives = 77/202 (38%), Gaps = 7/202 (3%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+LQ + L+ +Q L L++L L GN + + L+SL++L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTG-SLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
L S + L+ + +N++ N + L N+ L LDLS N++
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
Query: 121 IAGLKDLTN----LSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPK-SLVALSHL 175
+ L + L L+ N P +F + L L L +N S + K + L+ L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGL 227
Query: 176 KQFNVSHNRLEGEIPTEGPFRN 197
+ + E E ++
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKS 249
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-28
Identities = 30/169 (17%), Positives = 65/169 (38%), Gaps = 5/169 (2%)
Query: 25 LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84
+ + + + IP L S + L L+ N L + ++ + ++L
Sbjct: 4 VEVVPNI-TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPES 144
S + Q++ L L L+ N + +GL L L
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 145 FGSLISLESLDLSSNNLSEG-IPKSLVALSHLKQFNVSHNRLEGEIPTE 192
G L +L+ L+++ N + +P+ L++L+ ++S N+++ T+
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 35/203 (17%), Positives = 70/203 (34%), Gaps = 17/203 (8%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRL----NSLSLQGNKLNGSIPTCLASLTSLR 56
+ L+ + L+ N +Q DL L ++ SL L N +N P + L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLH 203
Query: 57 ELRLNSNKLTSSIPS-ALWALEYILYVNLSSNYLTGS---LTSDIQNMKVLIDLDLSRNQ 112
+L L +N + ++ + L + L D ++ L +L + +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 113 LS------GDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIP 166
L+ DI L ++++ SL + S+ + L+L + +
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPT 321
Query: 167 KSLVALSHLKQFNVSHNRLEGEI 189
L +L L + E+
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEV 344
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-38
Identities = 69/278 (24%), Positives = 112/278 (40%), Gaps = 33/278 (11%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIF--NLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
LGSG FG V G VA+K+ E F E + + + H L+K C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ---EAQTMMKLSHPKLVKFYGVC 72
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCD 416
+V E++ NG L +L SH + L + DV + +L +H D
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRD 129
Query: 417 LKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDV 476
L N L+D ++ VSDFG+++ + + + + APE SSK DV
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP-VKWSAPEVFHYFKYSSKSDV 188
Query: 477 YSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREENFFSAR 533
+++GIL+ E F+ K P D E V + G L +
Sbjct: 189 WAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQGHRLYR---------------P 227
Query: 534 MDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571
+I+ + C ELP++R + + ++ +R+K
Sbjct: 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 37/291 (12%)
Query: 299 LGSGGFGSVYKGIL----SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKIL 353
+G+G FG V G L +VAIK + E+ R F E ++ H N+I++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVV 413
+ +V E+M NGSLD +L H+ + + ++ +A ++YL V
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YV 169
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTM-TIATIGYMAPEFGSEGNVSS 472
H DL NIL++ N+V VSDFG+ ++L + ++ T I + +PE + +S
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 473 KCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREENF 529
DV+SYGI+L E + ++P EM + V +++ G LP
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPP------------ 271
Query: 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDANTLR 580
MDC +++ L LDC + + R + + L DK + + +L+
Sbjct: 272 ---PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL----DKLIRNPGSLK 315
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 65/293 (22%), Positives = 120/293 (40%), Gaps = 41/293 (13%)
Query: 297 NLLGSGGFGSVYKGILSDG----TTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIK 351
++G G FG VY G L D A+K N F +E ++++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 352 ILSSCCNTNFKAL-VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST 410
+L C + L VL +M +G L ++ + + + D + + VA +++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-- 212
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT--IGYMAPEFGSEG 468
VH DL N +LDE V+DFG+++ + + + + T A + +MA E
Sbjct: 213 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 469 NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM---NLKNW-VKESLPHG--LPKIADAN 522
++K DV+S+G+LL E TR G ++ + + L G L +
Sbjct: 272 KFTTKSDVWSFGVLLWELMTR---------GAPPYPDVNTFDITVYLLQGRRLLQ----- 317
Query: 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLED 575
C ++ + L C + R + +++ I F+ +
Sbjct: 318 ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 67/293 (22%), Positives = 121/293 (41%), Gaps = 41/293 (13%)
Query: 297 NLLGSGGFGSVYKGILSDG----TTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIK 351
++G G FG VY G L D A+K N F +E ++++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 352 ILSSCCNTNFKAL-VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST 410
+L C + L VL +M +G L ++ + + + D + + VA ++YL S
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 147
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT--IGYMAPEFGSEG 468
VH DL N +LDE V+DFG+++ + + + + T A + +MA E
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 469 NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM---NLKNW-VKESLPHG--LPKIADAN 522
++K DV+S+G+LL E TR G ++ + + L G L +
Sbjct: 208 KFTTKSDVWSFGVLLWELMTR---------GAPPYPDVNTFDITVYLLQGRRLLQ----- 253
Query: 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLED 575
C ++ + L C + R + +++ I F+ +
Sbjct: 254 ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 71/289 (24%), Positives = 119/289 (41%), Gaps = 30/289 (10%)
Query: 299 LGSGGFGSVYKGIL-----SDGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLI 350
LG G FG V G VA+K L+ Q + E ++LR + H ++I
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 351 KILSSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH 408
K C + + LV+E++P GSL +L H+ + L + + YLH H
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH 154
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-VIQTMTIATIGYMAPEFGSE 467
+H DL N+LLD + + + DFG++K + EG + ++ + + + APE E
Sbjct: 155 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 468 GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527
DV+S+G+ L E T + T + L + G + L E
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-----IGIAQGQMTVLRLTELLER 266
Query: 528 NFFSARM----DCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572
R+ C ++HL +C R ++ LK + +K+
Sbjct: 267 GE---RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 63/266 (23%), Positives = 112/266 (42%), Gaps = 34/266 (12%)
Query: 299 LGSGGFGSVYKGILSDG-----TTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKI 352
LGSG FG+V+KG+ V IK+ + Q+F++ + ++ H +++++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
L C + LV +++P GSL + H LN + +A + YL +
Sbjct: 81 LG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---M 136
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
VH +L N+LL V+DFG++ LL D ++ + I +MA E G +
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH 196
Query: 473 KCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREENF 529
+ DV+SYG+ + E T +P + E V + L G L +
Sbjct: 197 QSDVWSYGVTVWELMTFGAEPYAGLRLAE------VPDLLEKGERLAQ------------ 238
Query: 530 FSARMDCLLSIFHLALDCCAELPDQR 555
C + ++ + + C + R
Sbjct: 239 ---PQICTIDVYMVMVKCWMIDENIR 261
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 81/291 (27%), Positives = 122/291 (41%), Gaps = 37/291 (12%)
Query: 299 LGSGGFGSVYKGIL----SDGTTVAIKIFNL-QLEQAFRSFNSECEVLRNVRHRNLIKIL 353
+GSG G V G L VAIK E+ R F SE ++ H N+I++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVV 413
+V E+M NGSLD +L +H+ I + ++ V + YL V
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YV 173
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTM-TIATIGYMAPEFGSEGNVSS 472
H DL N+L+D N+V VSDFG+S++L + D+ T I + APE + SS
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233
Query: 473 KCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREENF 529
DV+S+G+++ E ++P M + V S+ G LP
Sbjct: 234 ASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISSVEEGYRLPA------------ 275
Query: 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDANTLR 580
M C ++ L LDC + QR + L D + +LR
Sbjct: 276 ---PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL----DALIRSPESLR 319
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 68/266 (25%), Positives = 108/266 (40%), Gaps = 34/266 (12%)
Query: 299 LGSGGFGSVYKGILSDG-----TTVAIKIFNL-QLEQAFRSFNSECEVLRNVRHRNLIKI 352
LGSG FG+VYKG+ VAIK +A + E V+ +V + ++ +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR- 81
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
L C T+ L+ + MP G L ++ H LN + +A + YL +
Sbjct: 82 LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---L 138
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
VH DL N+L+ ++DFG++KLLG + I +MA E +
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 473 KCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREENF 529
+ DV+SYG+ + E T KP D + E + L G LP+
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERLPQ------------ 240
Query: 530 FSARMDCLLSIFHLALDCCAELPDQR 555
C + ++ + + C D R
Sbjct: 241 ---PPICTIDVYMIMVKCWMIDADSR 263
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 23/243 (9%)
Query: 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNL--IKI 352
+GSGG V++ + AIK NL+ Q S+ +E L ++ + I++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHSTP 411
+ +V+E N L+ WL D +R + ++ A+ +H HG
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 128
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-------- 463
+VH DLKP+N L+ + M+ + DFGI+ + SV++ + T+ YM PE
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 464 ---FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520
S+ +S K DV+S G +L K P ++ L + + P I +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 247
Query: 521 ANL 523
+L
Sbjct: 248 KDL 250
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-37
Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 23/243 (9%)
Query: 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNL--IKI 352
+GSGG V++ + AIK NL+ Q S+ +E L ++ + I++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHSTP 411
+ +V+E N L+ WL D +R + ++ A+ +H HG
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 147
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-------- 463
+VH DLKP+N L+ + M+ + DFGI+ + SV++ + T+ YM PE
Sbjct: 148 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 464 ---FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520
S+ +S K DV+S G +L K P ++ L + + P I +
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 266
Query: 521 ANL 523
+L
Sbjct: 267 KDL 269
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-37
Identities = 65/278 (23%), Positives = 111/278 (39%), Gaps = 33/278 (11%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIF--NLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
LG+G FG V G VAIK+ E F E +V+ N+ H L+++ C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE---EAKVMMNLSHEKLVQLYGVC 88
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCD 416
++ E+M NG L +L + L + DV A+EYL +H D
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRD 145
Query: 417 LKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDV 476
L N L+++ V VSDFG+S+ + + + + + + PE SSK D+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-VRWSPPEVLMYSKFSSKSDI 204
Query: 477 YSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREENFFSAR 533
+++G+L+ E ++ K P + E E + G L +
Sbjct: 205 WAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---------------P 243
Query: 534 MDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571
++ + C E D+R K + + + D+
Sbjct: 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-37
Identities = 69/280 (24%), Positives = 112/280 (40%), Gaps = 35/280 (12%)
Query: 296 CNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILS 354
+ LG G +G VY+G+ TVA+K + F E V++ ++H NL+++L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLG 283
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVV 413
C ++ EFM G+L +L N L + ++ A+EYL + +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 340
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSK 473
H +L N L+ EN + V+DFG+S+L+ GD I + APE + S K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 474 CDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSA 532
DV+++G+LL E T P + + V E L
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDY----------------- 436
Query: 533 RM----DCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
RM C ++ L C P R + + +
Sbjct: 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-37
Identities = 64/267 (23%), Positives = 109/267 (40%), Gaps = 37/267 (13%)
Query: 299 LGSGGFGSVYKGILSDG---TTVAIKIF-NLQLEQAFRSFNSECEVLRNVRHRNLIKILS 354
LG G FGSV +G+ VAIK+ + E +++ + + +++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
C LV+E G L K+L + + ++ V++ ++YL + VH
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVH 459
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT---IGYMAPEFGSEGNVS 471
+L N+LL A +SDFG+SK LG D T A + + APE + S
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECINFRKFS 517
Query: 472 SKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREEN 528
S+ DV+SYG+ + E + +KP +M E V + G +
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMEC----------- 560
Query: 529 FFSARMDCLLSIFHLALDCCAELPDQR 555
+C ++ L DC + R
Sbjct: 561 ----PPECPPELYALMSDCWIYKWEDR 583
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 60/243 (24%), Positives = 104/243 (42%), Gaps = 23/243 (9%)
Query: 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNL--IKI 352
+GSGG V++ + AIK NL+ Q S+ +E L ++ + I++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHSTP 411
+ +V+E N L+ WL D +R + ++ A+ +H HG
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 175
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-------- 463
+VH DLKP+N L+ + M+ + DFGI+ + SV++ + + YM PE
Sbjct: 176 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 464 ---FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520
S+ +S K DV+S G +L K P ++ L + + P I +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 294
Query: 521 ANL 523
+L
Sbjct: 295 KDL 297
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 79/292 (27%), Positives = 135/292 (46%), Gaps = 38/292 (13%)
Query: 299 LGSGGFGSVYKGILSDGT-----TVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKI 352
+G+G FG VYKG+L + VAIK E+ F E ++ H N+I++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
++ E+M NG+LDK+L + + + ++ +A ++YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---Y 168
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTM-TIATIGYMAPEFGSEGNVS 471
VH DL NIL++ N+V VSDFG+S++L + ++ T I + APE S +
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228
Query: 472 SKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREEN 528
S DV+S+GI++ E T ++P E+ E V +++ G LP
Sbjct: 229 SASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGFRLPT----------- 271
Query: 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDANTLR 580
MDC +I+ L + C + +R D + L DK + ++L+
Sbjct: 272 ----PMDCPSAIYQLMMQCWQQERARRPKFADIVSIL----DKLIRAPDSLK 315
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 31/225 (13%)
Query: 288 RATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRH 346
R F E +LG G FG V K D AIK E+ + SE +L ++ H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNH 61
Query: 347 RNLIKILSSCCNTNFKA-------------LVLEFMPNGSLDKWLYSHNYFQDIPDRLNI 393
+ +++ ++ + +E+ NG+L ++S N Q + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 394 MIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT 453
+ AL Y+H ++H DLKP NI +DE+ + DFG++K + D +
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 454 IAT---------IG---YMAPE-FGSEGNVSSKCDVYSYGILLLE 485
IG Y+A E G+ + K D+YS GI+ E
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 59/265 (22%), Positives = 101/265 (38%), Gaps = 34/265 (12%)
Query: 299 LGSGGFGSVYKGILSDG----TTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKIL 353
+G G FG V++GI VAIK + F E +R H +++K++
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVV 413
+++E G L +L Y D+ + ++ AL YL V
Sbjct: 83 GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 138
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSK 473
H D+ N+L+ N + DFG+S+ + E + I +MAPE + +S
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 474 CDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREENFF 530
DV+ +G+ + E KP + + V + +G LP
Sbjct: 198 SDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPM------------- 238
Query: 531 SARMDCLLSIFHLALDCCAELPDQR 555
+C +++ L C A P +R
Sbjct: 239 --PPNCPPTLYSLMTKCWAYDPSRR 261
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-36
Identities = 67/293 (22%), Positives = 121/293 (41%), Gaps = 41/293 (13%)
Query: 297 NLLGSGGFGSVYKGILSDG----TTVAIKIFN-LQLEQAFRSFNSECEVLRNVRHRNLIK 351
++G G FG VY G D AIK + + Q +F E ++R + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 352 ILSSCCNTN-FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST 410
++ ++L +M +G L +++ S + D ++ + VA +EYL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQ 143
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT--IGYMAPEFGSEG 468
VH DL N +LDE+ V+DFG+++ + + + +Q A + + A E
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203
Query: 469 NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM---NLKNW-VKESLPHG--LPKIADAN 522
++K DV+S+G+LL E TR G ++ + + L G LP+
Sbjct: 204 RFTTKSDVWSFGVLLWELLTR---------GAPPYRHIDPFDLTHFLAQGRRLPQ----- 249
Query: 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLED 575
C S++ + C P R + ++++I L D
Sbjct: 250 ----------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-36
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 30/229 (13%)
Query: 287 ERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR 345
+R F E L+GSGGFG V+K DG T IK E+A R E + L +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62
Query: 346 HRNLIKILSSCCNTNFKA----------------LVLEFMPNGSLDKWLYSHN--YFQDI 387
H N++ ++ + +EF G+L++W+ D
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL-DK 121
Query: 388 PDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447
L + + ++Y+H S +++ DLKPSNI L + + DFG+ L
Sbjct: 122 VLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK- 177
Query: 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEM 496
+T + T+ YM+PE S + + D+Y+ G++L E E
Sbjct: 178 --RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 224
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 63/261 (24%), Positives = 122/261 (46%), Gaps = 31/261 (11%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
LG+G FG V+ G + T VA+K +F +E +++ ++H+ L++ L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR-LYAVVT 78
Query: 359 TNFKALVLEFMPNGSLDKWLYSHNYFQ-DIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417
++ E+M NGSL +L + + + I L++ +A + ++ + +H DL
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVY 477
+ +NIL+ + + ++DFG+++L+ + + + + I + APE + G + K DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 194
Query: 478 SYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREENFFSARM 534
S+GILL E T + P M E V ++L G + +
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYRMVR---------------PD 233
Query: 535 DCLLSIFHLALDCCAELPDQR 555
+C ++ L C E P+ R
Sbjct: 234 NCPEELYQLMRLCWKERPEDR 254
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-35
Identities = 71/264 (26%), Positives = 113/264 (42%), Gaps = 41/264 (15%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
+G G FG V G G VA+K ++ + ++F +E V+ +RH NL+++L
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 359 TNFKA-LVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCD 416
+V E+M GSL +L S L +DV A+EYL + VH D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 314
Query: 417 LKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDV 476
L N+L+ E+ VA VSDFG++K + S Q + + APE E S+K DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 477 YSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARM- 534
+S+GILL E ++ + P + + V + G +M
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGY-----------------KMD 406
Query: 535 ---DCLLSIFHLALDCCAELPDQR 555
C +++ + +C R
Sbjct: 407 APDGCPPAVYDVMKNCWHLDAATR 430
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 17/223 (7%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIK---IFNLQLEQAFRSFNSECEVLRNVRH 346
F +G G F VY+ L DG VA+K IF+L +A E ++L+ + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 347 RNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSH-NYFQDIPDR--LNIMIDVALALEY 403
N+IK +S N +VLE G L + + + IP+R + + ALE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 463
+H V+H D+KP+N+ + V + D G+ + + ++ + T YM+PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSL-VGTPYYMSPE 206
Query: 464 FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE-MNLKN 505
E + K D++S G LL E + P F G+ MNL +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYS 245
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 8e-35
Identities = 72/300 (24%), Positives = 125/300 (41%), Gaps = 53/300 (17%)
Query: 299 LGSGGFGSVYKGILSDG----TTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKI 352
LG G FGSV +G L VA+K L ++ F SE +++ H N+I++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 353 LSSCCNTNFKA-----LVLEFMPNGSLDKWLYSHNYFQD-----IPDRLNIMIDVALALE 402
L C + + ++L FM G L +L + L M+D+AL +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
YL + + +H DL N +L ++M V+DFG+SK + GD + + ++A
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 463 EFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM---NLKNW-VKESLPHGLPKI 518
E ++ +SK DV+++G+ + E TR G ++N + + L HG
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATR---------GMTPYPGVQNHEMYDYLLHG---- 265
Query: 519 ADANLLREENFFSARMD----CLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574
R+ CL ++ + C P R +L+K+ + +
Sbjct: 266 -------------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 9e-35
Identities = 69/266 (25%), Positives = 109/266 (40%), Gaps = 39/266 (14%)
Query: 299 LGSGGFGSVYKGILSDGTT-VAIKIF--NLQLEQAFRSFNSECEVLRNVRHRNLIKILSS 355
LG G +G VY+G+ + VA+K + + F E V++ ++H NL+++L
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGV 77
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHNYFQ-DIPDRLNIMIDVALALEYLHHGHSTPVVH 414
C ++ EFM G+L +L N + L + ++ A+EYL +H
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKC 474
DL N L+ EN + V+DFG+S+L+ GD I + APE + S K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 475 DVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSAR 533
DV+++G+LL E T P + + V E L R
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDY-----------------R 230
Query: 534 M----DCLLSIFHLALDCCAELPDQR 555
M C ++ L C P R
Sbjct: 231 MERPEGCPEKVYELMRACWQWNPSDR 256
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 29/224 (12%)
Query: 288 RATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNL-QLEQAFRSFNSECEVLRNVR 345
R F LG GGFG V++ D AIK L E A E + L +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 346 HRNLIKILSSCCNTNFKA------------LVLEFMPNGSLDKWLYSHNYFQDIPDR--L 391
H +++ ++ N + ++ +L W+ ++ L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 392 NIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD----- 446
+I + +A A+E+LH ++H DLKPSNI + V V DFG+ + + ++
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 447 --SVIQTMTIATIG---YMAPEFGSEGNVSSKCDVYSYGILLLE 485
+G YM+PE + S K D++S G++L E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 56/265 (21%), Positives = 103/265 (38%), Gaps = 34/265 (12%)
Query: 299 LGSGGFGSVYKGIL----SDGTTVAIKIFNL-QLEQAFRSFNSECEVLRNVRHRNLIKIL 353
LG G FG VY+G+ + VA+K F SE +++N+ H +++K++
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVV 413
+++E P G L +L + + + + + A+ YL + V
Sbjct: 80 GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CV 135
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSK 473
H D+ NIL+ + DFG+S+ + + D + I +M+PE + ++
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRFTTA 194
Query: 474 CDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREENFF 530
DV+ + + + E + K+P + + V L G LPK
Sbjct: 195 SDVWMFAVCMWEILSFGKQPFFWLENKD------VIGVLEKGDRLPK------------- 235
Query: 531 SARMDCLLSIFHLALDCCAELPDQR 555
C ++ L C P R
Sbjct: 236 --PDLCPPVLYTLMTRCWDYDPSDR 258
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
+LG G +G VY G LS+ +AIK + + + + E + ++++H+N+++ L S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR----LNIMIDVALALEYLHHGHSTPV 412
F + +E +P GSL L + + + D + L+YL H +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIGFYTKQILEGLKYL---HDNQI 143
Query: 413 VHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--FGSEGN 469
VH D+K N+L++ + V +SDFG SK L G + +T T T+ YMAPE
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFT-GTLQYMAPEIIDKGPRG 201
Query: 470 VSSKCDVYSYGILLLETFTRKKP 492
D++S G ++E T K P
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPP 224
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 293 FNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNV-RHRNLI 350
F ++LG G G++ + D VA+K + A R E ++LR H N+I
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR----EVQLLRESDEHPNVI 81
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST 410
+ + + F+ + +E +L +++ ++ + + ++ L +LH S
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137
Query: 411 PVVHCDLKPSNILLDE-----NMVAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPE- 463
+VH DLKP NIL+ + A +SDFG+ K L G S + + T G++APE
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 464 --FGSEGNVSSKCDVYSYGILLLETFTRKKP 492
+ N + D++S G + +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-34
Identities = 61/265 (23%), Positives = 102/265 (38%), Gaps = 34/265 (12%)
Query: 299 LGSGGFGSVYKGILSDG----TTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKIL 353
+G G FG V++GI VAIK + F E +R H +++K L
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK-L 456
Query: 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVV 413
N +++E G L +L + D+ + ++ AL YL S V
Sbjct: 457 IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL---ESKRFV 513
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSK 473
H D+ N+L+ N + DFG+S+ + E + I +MAPE + +S
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 474 CDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREENFF 530
DV+ +G+ + E KP + + V + +G LP
Sbjct: 573 SDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPM------------- 613
Query: 531 SARMDCLLSIFHLALDCCAELPDQR 555
+C +++ L C A P +R
Sbjct: 614 --PPNCPPTLYSLMTKCWAYDPSRR 636
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-34
Identities = 34/227 (14%), Positives = 77/227 (33%), Gaps = 24/227 (10%)
Query: 1 MGRMQQLQGIGLADNHLQG-----SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSL 55
+ + + + N + S D + ++++L N++ A+ + +
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI 699
Query: 56 RELRLNSNKLTS-------SIPSALWALEYILYVNLSSNYLTG-SLTSDIQNMKVLIDLD 107
+ L++N +TS + ++L N LT S + L ++D
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMD 759
Query: 108 LSRNQLSGDIPKTIAGLKDLT------NLSLAGNQFQGPIPESFGSLISLESLDLSSNNL 161
+S N S P L GN+ P + SL L + SN++
Sbjct: 760 VSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818
Query: 162 SEGIPKSLVALSHLKQFNVSHNRL-EGEIPTEGPFRNFSAQSFHWNY 207
+ + + L L +++ N ++ + P+ ++
Sbjct: 819 RK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 4e-31
Identities = 46/215 (21%), Positives = 78/215 (36%), Gaps = 27/215 (12%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQ-LKRLNSLSLQGNKLNGSIPTC--LASLTSLRE 57
G +L + L N ++ IP D C ++ L NKL IP S+ +
Sbjct: 591 FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGS 648
Query: 58 LRLNSNKLTSSIPSALWALEYIL-----YVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQ 112
+ + NK+ S + +++ V LS N + T + + LS N
Sbjct: 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708
Query: 113 LS-------GDIPKTIAGLKDLTNLSLAGNQFQGPIPES--FGSLISLESLDLSSNNLSE 163
++ LT + L N+ + + +L L ++D+S N S
Sbjct: 709 MTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS 767
Query: 164 GIPKSLVALSHLKQFNVSH------NRLEGEIPTE 192
P + S LK F + H NR+ + PT
Sbjct: 768 -FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-30
Identities = 38/207 (18%), Positives = 74/207 (35%), Gaps = 20/207 (9%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
R+ +LQ I A++ + K + ++L L ++ L
Sbjct: 445 QRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTG---------SLTSDIQNMKVLIDLDLSRNQ 112
+ + +P L+ L + +N++ N L D + + N
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN 559
Query: 113 LSG-DIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVA 171
L ++ + L L N+ + E+FG+ + L L L N + E IP+ A
Sbjct: 560 LEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEE-IPEDFCA 616
Query: 172 -LSHLKQFNVSHNRLEGEIPTEGPFRN 197
++ SHN+L+ IP ++
Sbjct: 617 FTDQVEGLGFSHNKLK-YIPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-30
Identities = 35/206 (16%), Positives = 69/206 (33%), Gaps = 20/206 (9%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNG---------SIPTCLASL 52
++ L + L + +P L L L SL++ N+ + +
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTG 547
Query: 53 TSLRELRLNSNKLTSSIPSA-LWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRN 111
++ + N L SA L + + ++ N + L L DL L N
Sbjct: 548 PKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HL-EAFGTNVKLTDLKLDYN 605
Query: 112 QLSGDIPKTI-AGLKDLTNLSLAGNQFQG-PIPESFGSLISLESLDLSSNNLSE-----G 164
Q+ IP+ A + L + N+ + P + S+ + S+D S N +
Sbjct: 606 QIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNIS 664
Query: 165 IPKSLVALSHLKQFNVSHNRLEGEIP 190
+ +S+N ++
Sbjct: 665 CSMDDYKGINASTVTLSYNEIQKFPT 690
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-29
Identities = 37/198 (18%), Positives = 62/198 (31%), Gaps = 15/198 (7%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTS---- 67
+ LK L + L +P L L L+ L + N+ S
Sbjct: 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL 533
Query: 68 -----SIPSALWALEYILYVNLSSNYLTGSLTS-DIQNMKVLIDLDLSRNQLSGDIPKTI 121
+ I + N L S +Q M L LD N++ +
Sbjct: 534 KADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAF 591
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPK--SLVALSHLKQFN 179
LT+L L NQ + + +E L S N L IP + ++ + +
Sbjct: 592 GTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVD 650
Query: 180 VSHNRLEGEIPTEGPFRN 197
S+N++ E +
Sbjct: 651 FSYNKIGSEGRNISCSMD 668
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 33/222 (14%), Positives = 69/222 (31%), Gaps = 26/222 (11%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+ ++ G+ LA +G +P + QL L LS + S +
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
Query: 61 NSNKLTSSIPS-ALWALEYILYVNLSSNYLT-----GSLTSDIQNMKVLIDLDLSRNQLS 114
+++ L + + +L + + + D + + N+++
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT 438
Query: 115 GDIPKTIAGLKDLTNLSLAGNQFQGP-------------------IPESFGSLISLESLD 155
I K I L L + A + F S+ +L L ++
Sbjct: 439 F-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497
Query: 156 LSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRN 197
L + +P L L L+ N++ NR + +
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 30/230 (13%), Positives = 71/230 (30%), Gaps = 36/230 (15%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTC-LASLTSLRELRL 60
G++ +L+ + + S + + + +++ L L L
Sbjct: 344 GQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDL 403
Query: 61 NSNKLTS-----SIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSG 115
+ + I + +N +T ++ IQ + L + + + +
Sbjct: 404 LQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTY 462
Query: 116 -------------------DIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDL 156
+ + + LKDLT++ L +P+ L L+SL++
Sbjct: 463 DNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNI 522
Query: 157 SSNNLS---------EGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRN 197
+ N + ++ F + +N LE E P +
Sbjct: 523 ACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQK 571
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 8e-22
Identities = 31/207 (14%), Positives = 54/207 (26%), Gaps = 34/207 (16%)
Query: 15 NHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALW 74
+ DL R+ LSL G G +P + LT L+ L ++ T S
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 75 ALEYILYVNLSSNYLTGSLTSD-IQNMKVLIDLDLSRNQLSG------------------ 115
+ + + + L DL ++ ++
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
Query: 116 ----------DIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGI 165
I K I L L + A + F + E + E
Sbjct: 429 QIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENE 483
Query: 166 PKSLVALSHLKQFNVSHNRLEGEIPTE 192
S L L + + ++P
Sbjct: 484 ELSWSNLKDLTDVELYNCPNMTQLPDF 510
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 26/194 (13%), Positives = 54/194 (27%), Gaps = 3/194 (1%)
Query: 27 QLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSS 86
+L + ++ +Q + I A L + + S + N
Sbjct: 250 KLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSL-NWNFNKEL 308
Query: 87 NYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFG 146
+ D+ N + L L+ G +P I L +L LS +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 147 SLISLESLDLSSNNLSEGIPK-SLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHW 205
++ + + + + K L L ++ + + P P + S S
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-RNPEMKPIKKDSRISLKD 427
Query: 206 NYALCGPQRLQVPP 219
R+
Sbjct: 428 TQIGNLTNRITFIS 441
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 70/264 (26%), Positives = 111/264 (42%), Gaps = 37/264 (14%)
Query: 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
+G G FG V G G VA+K ++ + ++F +E V+ +RH NL+++L
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 357 C-NTNFKALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
+V E+M GSL +L S L +DV A+EYL VH
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKC 474
DL N+L+ E+ VA VSDFG++K + S Q + + APE E S+K
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 475 DVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHG--LPKIADANLLREENFFS 531
DV+S+GILL E ++ + P + + V + G +
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDA-------------- 235
Query: 532 ARMDCLLSIFHLALDCCAELPDQR 555
C +++ + +C R
Sbjct: 236 -PDGCPPAVYEVMKNCWHLDAAMR 258
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 64/293 (21%), Positives = 120/293 (40%), Gaps = 50/293 (17%)
Query: 299 LGSGGFGSVYKGILSDG----TTVAIKIF--NLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
LG G FGSV + L VA+K+ ++ F E ++ H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 353 LSSCCNTNFKA------LVLEFMPNGSLDKWLYSHNYFQD-----IPDRLNIMIDVALAL 401
+ + K ++L FM +G L +L + ++ + + M+D+A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 461
EYL + +H DL N +L E+M V+DFG+S+ + GD + + ++A
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 462 PEFGSEGNVSSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNW-VKESLPHGLPKIA 519
E ++ + DV+++G+ + E TR + P + G ++N + L G
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTP----YAG---IENAEIYNYLIGG----- 255
Query: 520 DANLLREENFFSARMD----CLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
R+ C+ ++ L C + P QR +L+ I
Sbjct: 256 ------------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 45/240 (18%), Positives = 81/240 (33%), Gaps = 14/240 (5%)
Query: 258 RRRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGI-LSDGT 316
+ R +D E L + + +G G FG V++ G
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84
Query: 317 TVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDK 376
A+K L+ E + ++ + + + + +E + GSL +
Sbjct: 85 QCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139
Query: 377 WLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN-MVAHVSDF 435
+ + L + LEYLH + ++H D+K N+LL + A + DF
Sbjct: 140 LIKQMGCLPE-DRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDF 195
Query: 436 GISKLLGEGDDSVIQTMTIATIG---YMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP 492
G + L G +MAPE +K D++S ++L P
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 48/200 (24%), Positives = 88/200 (44%), Gaps = 11/200 (5%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILS 354
+G G FG DG IK N+ + E VL N++H N+++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--LNIMIDVALALEYLHHGHSTPV 412
S +V+++ G L K + + + L+ + + LAL+++H +
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---I 146
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
+H D+K NI L ++ + DFGI+++L + + I T Y++PE ++
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARAC-IGTPYYLSPEICENKPYNN 204
Query: 473 KCDVYSYGILLLETFTRKKP 492
K D+++ G +L E T K
Sbjct: 205 KSDIWALGCVLYELCTLKHA 224
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 16/213 (7%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILS 354
+G+G +G K SDG + K + E + SE +LR ++H N+++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 355 SCCNTNFKAL--VLEFMPNGSLDKWLYSHNYFQD-IPDR--LNIMIDVALALEYLHHGHS 409
+ L V+E+ G L + + + + L +M + LAL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 410 TP--VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE 467
V+H DLKP+N+ LD + DFG++++L D S +T + T YM+PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTF-VGTPYYMSPEQMNR 190
Query: 468 GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500
+ + K D++S G LL E P FT
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP----FTAF 219
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-33
Identities = 49/212 (23%), Positives = 84/212 (39%), Gaps = 27/212 (12%)
Query: 299 LGSGGFGSVYKGIL--------SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLI 350
LG G F ++KG+ T V +K+ + SF ++ + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST 410
C + LV EF+ GSLD +L + +I +L + +A A+ +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT-- 133
Query: 411 PVVHCDLKPSNILLD--------ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
++H ++ NILL +SD GIS + D + I ++ P
Sbjct: 134 -LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPP 186
Query: 463 EFGSEGNV-SSKCDVYSYGILLLETFTR-KKP 492
E + D +S+G L E + KP
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFN-LQLEQAFRSFNSECEVLRNVRHRNLIKILS- 354
+LG G +V++G G AIK+FN + + E EVL+ + H+N++K+ +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 355 -SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--LNIMIDVALALEYLHHGHSTP 411
T K L++EF P GSL L + +P+ L ++ DV + +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 412 VVHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE---- 463
+VH ++KP NI+ D V ++DFG ++ L DD ++ T Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHPDMYER 189
Query: 464 ----FGSEGNVSSKCDVYSYGILL 483
+ + D++S G+
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTF 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 299 LGSGGFGSVYKGILSDG------TTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
LG G FG V+ + VA+K E A + F E E+L ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD--------------IPDRLNIMIDVA 398
C +V E+M +G L+++L SH + L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 399 LALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG 458
+ YL H VH DL N L+ + +V + DFG+S+ + D + T+ I
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 459 YMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
+M PE +++ DV+S+G++L E FT
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFN-LQLEQAFRSFNSECEVLRNVRHRNLIKILS- 354
+LG G +V++G G AIK+FN + + E EVL+ + H+N++K+ +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 355 -SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--LNIMIDVALALEYLH-HGHST 410
T K L++EF P GSL L + +P+ L ++ DV + +L +G
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 411 PVVHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--- 463
+VH ++KP NI+ D V ++DFG ++ L DD ++ T Y+ P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHPDMYE 188
Query: 464 -----FGSEGNVSSKCDVYSYGILL 483
+ + D++S G+
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 23/214 (10%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
LG GGF V L DG A+K +Q E ++ R H N++++++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 357 CNTNFKA----LVLEFMPNGSL----DKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH 408
L+L F G+L ++ N+ + L +++ + LE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE-DQILWLLLGICRGLEAIH--- 151
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA-------TIGYMA 461
+ H DLKP+NILL + + D G + Q +T+ TI Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 462 PE---FGSEGNVSSKCDVYSYGILLLETFTRKKP 492
PE S + + DV+S G +L + P
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 66/305 (21%), Positives = 116/305 (38%), Gaps = 53/305 (17%)
Query: 299 LGSGGFGSVYKGILSDG------TTVAIKIFN-LQLEQAFRSFNSECEVLRNVRHRNLIK 351
LG G FG VY+G +S VA+K + EQ F E ++ H+N+++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIP------DRLNIMIDVALALEYLH 405
+ + + +++E M G L +L P D L++ D+A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 406 HGHSTPVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
H +H D+ N LL VA + DFG+++ + + + +M P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 463 EFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM---NLKNW-VKESLPHG--LP 516
E EG +SK D +S+G+LL E F+ G M + N V E + G +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYMPYPSKSNQEVLEFVTSGGRMD 265
Query: 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDA 576
+C ++ + C P+ R ++ + +D
Sbjct: 266 PP---------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI----EYCTQDP 306
Query: 577 NTLRL 581
+ +
Sbjct: 307 DVINT 311
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 299 LGSGGFGSVYKGILSDG------TTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIK 351
LG G FG VY+G+ T VAIK N + F +E V++ ++++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ---------DIPDRLNIMIDVALALE 402
+L +++E M G L +L S + + + ++A +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
YL+ + VH DL N ++ E+ + DFG+++ + E D + + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 463 EFGSEGNVSSKCDVYSYGILLLETFTR 489
E +G ++ DV+S+G++L E T
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATL 236
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 38/182 (20%), Positives = 65/182 (35%), Gaps = 3/182 (1%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLNSNK 64
L+ + L+ N + + L+ L L Q + L SL L L ++
Sbjct: 377 SLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTN 435
Query: 65 LTSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAG 123
L + + ++ N + S++ N L LDLS+ QL
Sbjct: 436 TKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDT 495
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
L L L+++ N + L SL +LD S N + L FN+++N
Sbjct: 496 LHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
Query: 184 RL 185
+
Sbjct: 556 SV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-30
Identities = 37/193 (19%), Positives = 64/193 (33%), Gaps = 7/193 (3%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS 71
L+ N L+ Y L L L ++ L L L L N + S P
Sbjct: 39 LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG 98
Query: 72 ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSG-DIPKTIAGLKDLTNL 130
+ L + + L + I + L L+++ N + +P + L +L ++
Sbjct: 99 SFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHV 158
Query: 131 SLAGNQFQGPIPESFGSL----ISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
L+ N Q L SLD+S N + I L + + N
Sbjct: 159 DLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNS 217
Query: 187 GEIPTEGPFRNFS 199
I + +N +
Sbjct: 218 SNIM-KTCLQNLA 229
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 42/192 (21%), Positives = 67/192 (34%), Gaps = 5/192 (2%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLK--RLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ L + L+ N L S L L L L N + L L+ L
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQ 407
Query: 62 SNKLTSSIPSALWA-LEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPK- 119
+ L + + LE +LY+++S + L L ++ N +
Sbjct: 408 HSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
Query: 120 TIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFN 179
A +LT L L+ Q + F +L L+ L++S NNL L L +
Sbjct: 468 VFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLD 527
Query: 180 VSHNRLEGEIPT 191
S NR+E
Sbjct: 528 CSFNRIETSKGI 539
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-28
Identities = 45/199 (22%), Positives = 75/199 (37%), Gaps = 7/199 (3%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+LQ + L+ ++ L L++L L GN + P + LTSL L
Sbjct: 53 SNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTG-SLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
KL S + L + +N++ N++ L + N+ L+ +DLS N +
Sbjct: 113 ETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND 172
Query: 121 IAGLKDLTN----LSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPK-SLVALSHL 175
+ L++ L ++ N I + I L L L N S I K L L+ L
Sbjct: 173 LQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGL 231
Query: 176 KQFNVSHNRLEGEIPTEGP 194
+ + E E
Sbjct: 232 HVHRLILGEFKDERNLEIF 250
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-26
Identities = 32/170 (18%), Positives = 71/170 (41%), Gaps = 5/170 (2%)
Query: 19 GSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEY 78
GS+ + + + + KL+ +P + +S + + L+ N L +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 79 ILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQ 138
+ +++LS + + L +L L+ N + P + +GL L NL +
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 139 GPIPESFGSLISLESLDLSSNNLSE-GIPKSLVALSHLKQFNVSHNRLEG 187
G LI+L+ L+++ N + +P L++L ++S+N ++
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 26/160 (16%), Positives = 55/160 (34%), Gaps = 25/160 (15%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTC-LASLTSLRELRLNS 62
+++L + ++ + + L LN+L + GN + + A+ T+L L L+
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482
Query: 63 NKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIA 122
+L + L L++S N L
Sbjct: 483 CQLEQISWGVF------------------------DTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 123 GLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162
L L+ L + N+ + SL +L++N+++
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 9e-19
Identities = 36/199 (18%), Positives = 65/199 (32%), Gaps = 19/199 (9%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLN----SLSLQGNKLNGSIPTCLASLTSLR 56
+ L + L+ N++Q DL L+ SL + N ++ + L
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLH 207
Query: 57 ELRLNSNKLTSSIPS-ALWALEYILYVNLSSNYLTGSLTSDIQNMKVL--------IDLD 107
EL L N +S+I L L + L +I ++ +
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 108 LSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPK 167
L+ D L +++ +SLAG + E +SL + L +
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTL 325
Query: 168 SLVALSHLKQFNVSHNRLE 186
L LK ++ N+
Sbjct: 326 D---LPFLKSLTLTMNKGS 341
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 18/86 (20%), Positives = 33/86 (38%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
L + L+ L+ L RL L++ N L + L SL L +
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529
Query: 62 SNKLTSSIPSALWALEYILYVNLSSN 87
N++ +S + + + NL++N
Sbjct: 530 FNRIETSKGILQHFPKSLAFFNLTNN 555
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 299 LGSGGFGSVYKGIL------SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
LG G FG V+ D VA+K A + F E E+L N++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD---------------IPDRLNIMIDV 397
C + + +V E+M +G L+K+L +H + L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 398 ALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATI 457
A + YL H VH DL N L+ N++ + DFG+S+ + D + T+ I
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 458 GYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
+M PE +++ DV+S+G++L E FT
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 67/305 (21%), Positives = 116/305 (38%), Gaps = 53/305 (17%)
Query: 299 LGSGGFGSVYKGILSDG------TTVAIKIFN-LQLEQAFRSFNSECEVLRNVRHRNLIK 351
LG G FG VY+G +S VA+K + EQ F E ++ H+N+++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIP------DRLNIMIDVALALEYLH 405
+ + + ++LE M G L +L P D L++ D+A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 406 HGHSTPVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
H +H D+ N LL VA + DFG+++ + + + +M P
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 463 EFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM---NLKNW-VKESLPHG--LP 516
E EG +SK D +S+G+LL E F+ G M + N V E + G +
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYMPYPSKSNQEVLEFVTSGGRMD 306
Query: 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDA 576
+C ++ + C P+ R ++ + +D
Sbjct: 307 PP---------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI----EYCTQDP 347
Query: 577 NTLRL 581
+ +
Sbjct: 348 DVINT 352
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 49/209 (23%), Positives = 77/209 (36%), Gaps = 12/209 (5%)
Query: 288 RATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNV 344
F + LG G +G V+K DG A+K + +E V
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 345 -RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEY 403
+H +++ + L E SL + + + D LAL +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 463
LH +VH D+KP+NI L + DFG+ LG + YMAPE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQ-EGDPRYMAPE 226
Query: 464 FGSEGNVSSKCDVYSYGILLLETFTRKKP 492
+G+ + DV+S G+ +LE +
Sbjct: 227 L-LQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-31
Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 39/240 (16%)
Query: 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLR-NVRHRNLIKILSS 355
+LG G G+V G VA+K + E ++L + H N+I+ S
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRYYCS 77
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHNYFQDI------PDRLNIMIDVALALEYLH-HGH 408
F + LE N +L + S N + + ++++ +A + +LH
Sbjct: 78 ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK- 135
Query: 409 STPVVHCDLKPSNILLD-------------ENMVAHVSDFGISKLLGEGDDSVIQTMTIA 455
++H DLKP NIL+ EN+ +SDFG+ K L G S +
Sbjct: 136 ---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 456 --TIGYMAPE-------FGSEGNVSSKCDVYSYGILLLETFTRKK-PTDEMFTGEMNLKN 505
T G+ APE ++ ++ D++S G + ++ K P + ++ E N+
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 78/308 (25%), Positives = 124/308 (40%), Gaps = 60/308 (19%)
Query: 297 NLLGSGGFGSVYKGILSDG---TTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIK 351
+++G G FG V K + AIK + R F E EVL + H N+I
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIP---------------DRLNIMID 396
+L +C + + L +E+ P+G+L +L + P L+ D
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT 456
VA ++YL +H DL NIL+ EN VA ++DFG+S+ + V +TM
Sbjct: 151 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM---NLKNW-VKESLP 512
+ +MA E + ++ DV+SYG+LL E + G + + E LP
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL---------GGTPYCGMTCAELYEKLP 255
Query: 513 HG--LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570
G L K ++C ++ L C E P +R L +
Sbjct: 256 QGYRLEK---------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL----N 296
Query: 571 KFLEDANT 578
+ LE+ T
Sbjct: 297 RMLEERKT 304
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 44/188 (23%), Positives = 77/188 (40%), Gaps = 5/188 (2%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIP-TCLASLTSLRELRLNS 62
+ LQ + L+ N + +L L L +L + +L L+ L L+
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSH 434
Query: 63 NKLTSSIPSALWALEYILYVNLSSNYLTG---SLTSDIQNMKVLIDLDLSRNQLSGDIPK 119
+ L S L + ++NL N+ T+ +Q + L L LS LS
Sbjct: 435 SLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494
Query: 120 TIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFN 179
LK + ++ L+ N+ E+ L + L+L+SN++S +P L LS + N
Sbjct: 495 AFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTIN 553
Query: 180 VSHNRLEG 187
+ N L+
Sbjct: 554 LRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-30
Identities = 42/194 (21%), Positives = 73/194 (37%), Gaps = 7/194 (3%)
Query: 4 MQQLQGIGLADNHLQGS--IPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
++ L+ + L+ + ++ S L L L SL+L N+ L L L
Sbjct: 349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408
Query: 62 SNKLTSSIP-SALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+L S L + +NLS + L S + L L+L N +
Sbjct: 409 FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQK 468
Query: 121 IAGLKDLTN---LSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQ 177
L+ L L L+ +F SL + +DLS N L+ ++L L +
Sbjct: 469 TNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-Y 527
Query: 178 FNVSHNRLEGEIPT 191
N++ N + +P+
Sbjct: 528 LNLASNHISIILPS 541
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-30
Identities = 48/203 (23%), Positives = 82/203 (40%), Gaps = 9/203 (4%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLNS 62
+ L+ + L+ N + L LS++GN + T CL +L +LREL L+
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359
Query: 63 NKLTSS--IPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+ + +S L L ++ +NLS N T + L LDL+ +L ++
Sbjct: 360 DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419
Query: 121 I-AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGI---PKSLVALSHLK 176
L L L+L+ + + F L +L+ L+L N+ +G SL L L+
Sbjct: 420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479
Query: 177 QFNVSHNRLEGEIPTEGPFRNFS 199
+S L F +
Sbjct: 480 ILVLSFCDLSSIDQ--HAFTSLK 500
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-28
Identities = 35/198 (17%), Positives = 62/198 (31%), Gaps = 5/198 (2%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS 71
+ L IP L L N L T + L +L L L ++
Sbjct: 19 CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75
Query: 72 ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLS 131
+ + + L++N L + + K L L + +S + K L +L
Sbjct: 76 TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135
Query: 132 LAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQ--FNVSHNRLEGEI 189
L N L+ LD +N + + + +L N++ N + G
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIE 195
Query: 190 PTEGPFRNFSAQSFHWNY 207
P F + +F
Sbjct: 196 PGAFDSAVFQSLNFGGTQ 213
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-28
Identities = 40/208 (19%), Positives = 67/208 (32%), Gaps = 7/208 (3%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
R+ L + L + RL++L L N L T L+ +L+ L
Sbjct: 54 SRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
++S L + + + L SN+++ + L LD N + + +
Sbjct: 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173
Query: 122 AGLKDLTN--LSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLV--ALSHLKQ 177
+ L+ TN L+L GN G I +SL+ I K L + L
Sbjct: 174 SSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWL 232
Query: 178 FNVSHNRLEGEIPTEGPFRNFSAQSFHW 205
E + F S
Sbjct: 233 GTFEDMDDED--ISPAVFEGLCEMSVES 258
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 42/197 (21%), Positives = 72/197 (36%), Gaps = 7/197 (3%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLA--SLTSLRELRLNSN 63
+ L N + I SL+ G + I L ++ SL
Sbjct: 180 TNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 64 KLTSSIPSALWALE--YILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
P+ L + +NL +Y ++ L +LDL+ LS ++P +
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGL 297
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGI-PKSLVALSHLKQFNV 180
GL L L L+ N+F+ S + SL L + N + L L +L++ ++
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357
Query: 181 SHNRLEGEIPTEGPFRN 197
SH+ +E RN
Sbjct: 358 SHDDIETSDCCNLQLRN 374
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-20
Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 4/141 (2%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTC---LASLTSLREL 58
+ L+ + L+ + L S L L L+LQGN L +L L L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481
Query: 59 RLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIP 118
L+ L+S A +L+ + +V+LS N LT S + ++K + L+L+ N +S +P
Sbjct: 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILP 540
Query: 119 KTIAGLKDLTNLSLAGNQFQG 139
+ L ++L N
Sbjct: 541 SLLPILSQQRTINLRQNPLDC 561
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 25/212 (11%)
Query: 299 LGSGGFGSVYKGILSDG------TTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIK 351
LG FG VYKG L VAIK + F E + ++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD---------------IPDRLNIMID 396
+L +++ + +G L ++L + D PD ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT 456
+A +EYL H VVH DL N+L+ + + +SD G+ + + D + ++
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
I +MAPE G S D++SYG++L E F+
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 298 LLGSGGFGSVYKG---ILSDGTTVAIKIFNLQL--EQAFRS-FNSECEVLRNVRHRNLIK 351
L+G GG G VY+ + VA+K+ + L + FR+ E ++ +++
Sbjct: 41 LVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR-LNIMIDVALALEYLHHGHST 410
I + + + L L P R + I+ + AL+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLA--PPRAVAIVRQIGSALDAAHAAG-- 154
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT-MTIATIGYMAPEFGSEGN 469
H D+KP NIL+ + A++ DFGI+ D+ + Q T+ T+ YMAPE SE +
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 470 VSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500
+ + D+Y+ +L E T P + G+
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 47/201 (23%), Positives = 80/201 (39%), Gaps = 13/201 (6%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
R+ LQ + + L +P + Q L +L+L N L ++P +ASL LREL +
Sbjct: 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157
Query: 61 NS-NKLTS--------SIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRN 111
+ +LT L + + L + SL + I N++ L L + +
Sbjct: 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216
Query: 112 QLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVA 171
LS + I L L L L G P FG L+ L L + +P +
Sbjct: 217 PLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHR 275
Query: 172 LSHLKQFNVSHNRLEGEIPTE 192
L+ L++ ++ +P+
Sbjct: 276 LTQLEKLDLRGCVNLSRLPSL 296
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 43/196 (21%), Positives = 78/196 (39%), Gaps = 14/196 (7%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQG-NKL--------NGSIPTCLAS 51
M + L+ + LA N L+ ++P + L RL LS++ +L +
Sbjct: 123 MQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181
Query: 52 LTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRN 111
L +L+ LRL + S +P+++ L+ + + + ++ L+ +L I ++ L +LDL
Sbjct: 182 LVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGC 239
Query: 112 QLSGDIPKTIAGLKDLTNLSLAG-NQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLV 170
+ P G L L L + +P L LE LDL +P +
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298
Query: 171 ALSHLKQFNVSHNRLE 186
L V +
Sbjct: 299 QLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 33/176 (18%), Positives = 73/176 (41%), Gaps = 14/176 (7%)
Query: 26 CQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85
+L L+ L P L+ L+ + +++ L +P + + + L+
Sbjct: 78 ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLA 135
Query: 86 SNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIA---------GLKDLTNLSLAGNQ 136
N L +L + I ++ L +L + ++P+ +A GL +L +L L
Sbjct: 136 RNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTG 194
Query: 137 FQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE 192
+ +P S +L +L+SL + ++ LS + ++ L L++ ++ P
Sbjct: 195 IRS-LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPI 248
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 31/159 (19%), Positives = 60/159 (37%), Gaps = 7/159 (4%)
Query: 18 QGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALE 77
+ L L SL L+ + S+P +A+L +L+ L++ ++ L++ + A+ L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLP 229
Query: 78 YILYVNLSSNYLTGSLTSDIQNMKVLIDLDLS-RNQLSGDIPKTIAGLKDLTNLSLAGNQ 136
+ ++L + L L L + L +P I L L L L G
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCV 288
Query: 137 FQGPIPESFGSLISLESLDLSSN---NLSEGIPKSLVAL 172
+P L + + + + L + P + A
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 27/176 (15%), Positives = 57/176 (32%), Gaps = 10/176 (5%)
Query: 19 GSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEY 78
GS + +L QG+ L+ N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNN 57
Query: 79 ILYVNLSSNYLTGSLTSDIQNMKV--LIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQ 136
+ L + +++ + L+L L P L L ++++
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 137 FQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE 192
+P++ LE+L L+ N L +P S+ +L+ L++ ++ E+P
Sbjct: 116 LME-LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEP 169
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 298 LLGSGGFGSVYKG---ILSDGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIK 351
LG GG +VY IL VAIK + E+ + F E + H+N++
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
++ + LV+E++ +L +++ SH + +N + +++ H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL-SVDTAINFTNQILDGIKHAHDMR--- 131
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT-MTIATIGYMAPEFGSEGNV 470
+VH D+KP NIL+D N + DFGI+K L + S+ QT + T+ Y +PE
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 471 SSKCDVYSYGILLLETFTRKKPTDEMFTGE 500
D+YS GI+L E + P F GE
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 69/266 (25%), Positives = 116/266 (43%), Gaps = 13/266 (4%)
Query: 291 DGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSF-NSECEVLRNVRHRN 348
D F + + LG+G G V+K G +A K+ +L+++ A R+ E +VL
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALEYLHH 406
++ + + ++ +E M GSLD+ L IP+++ + I V L YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGS 466
H ++H D+KPSNIL++ + DFG+S G+ DS+ + + T YM+PE
Sbjct: 150 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQ 203
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526
+ S + D++S G+ L+E + P E+ L + R
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 527 ENFFSARMDCLLSIFHLALDCCAELP 552
N F ++IF L E P
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPP 289
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-29
Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 23/223 (10%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFR-SFNSECEVLRNVRHRNLIKIL--- 353
LG+GGFG V + I G VAIK +L R + E ++++ + H N++
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 354 ---SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--LNIMIDVALALEYLHHGH 408
+ L +E+ G L K+L + + ++ D++ AL YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 409 STPVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFG 465
++H DLKP NI+L + ++ + D G +K L + + T+ Y+APE
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAPELL 195
Query: 466 SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVK 508
+ + D +S+G L E T +P F W
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRP----FLPNWQPVQWHG 234
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 21/214 (9%)
Query: 285 DLERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL-EQAFRSFNSECEV-L 341
+ + + +G G +GSV K + G +A+K + E+ + + +V +
Sbjct: 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVM 75
Query: 342 RNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN------IMI 395
R+ +++ + + +E M + S DK+ + + D + I +
Sbjct: 76 RSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEILGKITL 132
Query: 396 DVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA 455
AL +L ++H D+KPSNILLD + + DFGIS G+ DS+ +T
Sbjct: 133 ATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAG 187
Query: 456 TIGYMAPE----FGSEGNVSSKCDVYSYGILLLE 485
YMAPE S + DV+S GI L E
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 298 LLGSGGFGSVYKG---ILSDGTTVAIKIFNLQL--EQAFRS-FNSECEVLRNVRHRNLIK 351
+LG GG V+ VA+K+ L + +F F E + + H ++
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 352 IL------SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH 405
+ + + +V+E++ +L +++ + ++ D AL + H
Sbjct: 77 VYDTGEAETPAGPLPY--IVMEYVDGVTLRDIVHTEGPM-TPKRAIEVIADACQALNFSH 133
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT-MTIATIGYMAPEF 464
++H D+KP+NI++ V DFGI++ + + +SV QT I T Y++PE
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 465 GSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500
+V ++ DVYS G +L E T + P FTG+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 65/309 (21%), Positives = 116/309 (37%), Gaps = 63/309 (20%)
Query: 299 LGSGGFGSVYKGILSDG------TTVAIKIFN-LQLEQAFRSFNSECEVLRNVRHRNLIK 351
+G G FG V++ T VA+K+ F E ++ + N++K
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDI-----------------------P 388
+L C L+ E+M G L+++L S +
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 389 DRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448
++L I VA + YL VH DL N L+ ENMV ++DFG+S+ + D
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVK 508
I +M PE +++ DV++YG++L E F+ G
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY---------GLQ------- 275
Query: 509 ESLPHGLPKIADANLLREENFFSA--RMD----CLLSIFHLALDCCAELPDQRLYMKDAA 562
P+ +A ++ + + C L +++L C ++LP R
Sbjct: 276 ---PY--YGMAHEEVIY---YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 327
Query: 563 TKLKKIRDK 571
L+++ ++
Sbjct: 328 RILQRMCER 336
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-29
Identities = 43/216 (19%), Positives = 80/216 (37%), Gaps = 36/216 (16%)
Query: 298 LLGSGGFGSVYKG---ILSDGTTVAIKIFNLQLEQAFRS-FNSECEVLRNVRHRNLIKIL 353
+ GG G +Y + +G V +K + ++ +E + L V H ++++I
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 354 -------SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH- 405
+ +V+E++ SL + + + + ++++ AL YLH
Sbjct: 146 NFVEHTDRHGDPVGY--IVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHS 200
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT-MTIATIGYMAPEF 464
G +V+ DLKP NI+L E + + D G + T G+ APE
Sbjct: 201 IG----LVYNDLKPENIMLTEEQLK-LIDLGAVSRIN-------SFGYLYGTPGFQAPEI 248
Query: 465 GSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500
+ D+Y+ G L G
Sbjct: 249 -VRTGPTVATDIYTVGRTLAALTLDLPT----RNGR 279
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 61/287 (21%), Positives = 102/287 (35%), Gaps = 55/287 (19%)
Query: 299 LGSGGFGSVYKGILSD------GTTVAIKIFNLQ-LEQAFRSFNSECEVLRNV-RHRNLI 350
LG+G FG V + TVA+K+ + SE +VL + H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSH-----------------NYFQDIPDRLNI 393
+L +C ++ E+ G L +L D+ D L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 394 MIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT 453
VA + +L S +H DL NILL + + DFG+++ + + V++
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 454 IATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLP 512
+ +MAPE + + DV+SYGI L E F+ P M + +
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIK 262
Query: 513 HGLPKIADANLLREENFFSARMD----CLLSIFHLALDCCAELPDQR 555
G RM ++ + C P +R
Sbjct: 263 EG-----------------FRMLSPEHAPAEMYDIMKTCWDADPLKR 292
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 50/231 (21%), Positives = 86/231 (37%), Gaps = 29/231 (12%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSS 355
+L GGF VY+ + G A+K E+ R+ E ++ + H N+++ S+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 356 CC-------NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--LNIMIDVALALEYLHH 406
+ L+L + G L ++L + L I A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA----------T 456
P++H DLK N+LL + DFG + + D A T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 457 IGYMAPE---FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLK 504
Y PE S + K D+++ G +L R+ P F L+
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKLR 260
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 43/247 (17%), Positives = 78/247 (31%), Gaps = 24/247 (9%)
Query: 284 LDLERATDGFNECNLLGSGGFGSVYKGILSD------GTTVAIKIFNLQLEQAFRSFNSE 337
+ + + +LLG G F VY+ D +K+ F
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 338 CEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWL--YSHNYFQDIPDRL--NI 393
E L+ +K S+ N LV E G+L + Y + + +P L +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 394 MIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAH-----------VSDFGISKLLG 442
+ + +E + H ++H D+KP N +L + + D G S +
Sbjct: 178 AMRMLYMIEQV---HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMN 502
I T T G+ E S + + D + + + GE
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294
Query: 503 LKNWVKE 509
+ +
Sbjct: 295 PEGLFRR 301
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 43/186 (23%), Positives = 88/186 (47%), Gaps = 14/186 (7%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ L + L N ++ P L L L+ + N++ P +A++T L L++
Sbjct: 174 ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIG 229
Query: 62 SNKLTSSIP-SALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+NK+T P + L L ++ + +N ++ + ++++ L L++ NQ+S
Sbjct: 230 NNKITDLSPLANLSQLTWL---EIGTNQISDI--NAVKDLTKLKMLNVGSNQISD--ISV 282
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+ L L +L L NQ E G L +L +L LS N++++ P L +LS + +
Sbjct: 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340
Query: 181 SHNRLE 186
++ ++
Sbjct: 341 ANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 49/189 (25%), Positives = 84/189 (44%), Gaps = 12/189 (6%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
M L + + ++ ++ P + L L SLSL N++ P LASLTSL
Sbjct: 152 SNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAY 207
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
N++T P + + + + + +N +T S + N+ L L++ NQ+S DI +
Sbjct: 208 VNQITDITP--VANMTRLNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQIS-DIN-AV 261
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVS 181
L L L++ NQ +L L SL L++N L + + L++L +S
Sbjct: 262 KDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS 319
Query: 182 HNRLEGEIP 190
N + P
Sbjct: 320 QNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 10/162 (6%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ L N + P + + RLNSL + NK+ P LA+L+ L L +
Sbjct: 196 ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIG 251
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
+N+++ +A+ L + +N+ SN ++ S + N+ L L L+ NQL + + I
Sbjct: 252 TNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVI 307
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163
GL +LT L L+ N P SL ++S D ++ + +
Sbjct: 308 GGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIKK 347
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 52/190 (27%), Positives = 90/190 (47%), Gaps = 13/190 (6%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+ + L+ + L N + P L L +L +L + NK+ + + L +LT+LREL L
Sbjct: 62 IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYL 117
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
N + ++ P L L + +NL +N+ L S + NM L L ++ +++ P
Sbjct: 118 NEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP-- 172
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
IA L DL +LSL NQ + P SL SL N +++ P + ++ L +
Sbjct: 173 IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228
Query: 181 SHNRLEGEIP 190
+N++ P
Sbjct: 229 GNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 44/189 (23%), Positives = 86/189 (45%), Gaps = 13/189 (6%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
++ + + +A + SI + L L L+L GN++ P L++L L L +
Sbjct: 41 EELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIG 96
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
+NK+T SAL L + + L+ + ++ S + N+ + L+L N D+ +
Sbjct: 97 TNKITD--ISALQNLTNLRELYLNEDNISDI--SPLANLTKMYSLNLGANHNLSDL-SPL 151
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVS 181
+ + L L++ ++ + P +L L SL L+ N + + P L +L+ L F
Sbjct: 152 SNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAY 207
Query: 182 HNRLEGEIP 190
N++ P
Sbjct: 208 VNQITDITP 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 39/186 (20%), Positives = 83/186 (44%), Gaps = 13/186 (6%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ L+ + L ++++ P L L ++ SL+L N + L+++T L L +
Sbjct: 107 QNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVT 163
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
+K+ P + L + ++L+ N + S + ++ L NQ++ P +
Sbjct: 164 ESKVKDVTP--IANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITDITP--V 217
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVS 181
A + L +L + N+ P +L L L++ +N +S+ ++ L+ LK NV
Sbjct: 218 ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVG 273
Query: 182 HNRLEG 187
N++
Sbjct: 274 SNQISD 279
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 3e-22
Identities = 34/184 (18%), Positives = 69/184 (37%), Gaps = 13/184 (7%)
Query: 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLT 66
+ + P L LQ + + L S+ +L + K+
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 67 SSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKD 126
S + L + Y+NL+ N +T S + N+ L +L + N+++ + L +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDI--SPLSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 127 LTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
L L L + P +L + SL+L +N+ L ++ L V+ ++++
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVK 168
Query: 187 GEIP 190
P
Sbjct: 169 DVTP 172
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 68/286 (23%), Positives = 109/286 (38%), Gaps = 54/286 (18%)
Query: 299 LGSGGFGSVYKGIL------SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLI 350
LG G FG V + + TVA+K+ R+ SE ++L ++ H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 351 KILSSCCNTNFKALV-LEFMPNGSLDKWLYSH---------------NYFQDIPDRLNIM 394
+L +C +V +EF G+L +L S F + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 395 IDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI 454
VA +E+L +H DL NILL E V + DFG+++ + + D V +
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 455 ATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPH 513
+ +MAPE + + + DV+S+G+LL E F+ P + E L
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKE 266
Query: 514 GLPKIADANLLREENFFSARMD----CLLSIFHLALDCCAELPDQR 555
G RM ++ LDC P QR
Sbjct: 267 G-----------------TRMRAPDYTTPEMYQTMLDCWHGEPSQR 295
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 33/220 (15%)
Query: 299 LGSGGFGSVYKGILSDG------TTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIK 351
LG G FG V K TTVA+K+ R SE VL+ V H ++IK
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD-----------------------IP 388
+ +C L++E+ GSL +L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 389 DRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448
D ++ ++ ++YL +VH DL NIL+ E +SDFG+S+ + E D V
Sbjct: 151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
++ + +MA E + +++ DV+S+G+LL E T
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 59/257 (22%), Positives = 107/257 (41%), Gaps = 28/257 (10%)
Query: 257 LRRRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGILSD-- 314
+R R + + D L ++ + E D LG G FG V
Sbjct: 47 VRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGID 106
Query: 315 ------GTTVAIKIFN-LQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVL 366
TVA+K+ E+ SE E+++ + +H+N+I +L +C +++
Sbjct: 107 KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 166
Query: 367 EFMPNGSLDKWLYSH---------------NYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
E+ G+L ++L + D ++ +A +EYL
Sbjct: 167 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--- 223
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVS 471
+H DL N+L+ EN V ++DFG+++ + D T + +MAPE + +
Sbjct: 224 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 283
Query: 472 SKCDVYSYGILLLETFT 488
+ DV+S+G+L+ E FT
Sbjct: 284 HQSDVWSFGVLMWEIFT 300
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 26/276 (9%), Positives = 61/276 (22%), Gaps = 49/276 (17%)
Query: 258 RRRNRSTKSPDDEELFSLATWRRTSYLDLERATDG----FNECNLLGSGGFGSVYKGI-L 312
R + E + W + + ++ L G V+ +
Sbjct: 25 CREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDV 84
Query: 313 SDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA------ 363
A+K+F + + + +
Sbjct: 85 ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144
Query: 364 --------------------LVLEFM-----PNGSLDKWLYSHNYFQDIPDRLNIMIDVA 398
L++ S ++Y + I + +
Sbjct: 145 QPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLI 204
Query: 399 LALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG 458
L +VH P N+ + + + D +G + +
Sbjct: 205 RLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVT 256
Query: 459 YMAPEF--GSEGNVSSKCDVYSYGILLLETFTRKKP 492
Y EF S + + + G+ + + P
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 52/233 (22%), Positives = 95/233 (40%), Gaps = 37/233 (15%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFN---LQLEQAFRSFNS--------------ECEVL 341
L G F + D A+K + L+ ++ F N+ E +++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 342 RNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL-------NIM 394
++++ + N + ++ E+M N S+ K+ I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 395 IDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI 454
V + Y+H+ + + H D+KPSNIL+D+N +SDFG S+ + D I+ +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKG-SR 211
Query: 455 ATIGYMAPEF--GSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKN 505
T +M PEF +K D++S GI L F P F+ +++L
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVE 260
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 299 LGSGGFGSVYKGILSD--------GTTVAIKIFN-LQLEQAFRSFNSECEVLRNV-RHRN 348
LG G FG V TVA+K+ E+ SE E+++ + +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSH---------------NYFQDIPDRLNI 393
+I +L +C +++E+ G+L ++L + D ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 394 MIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT 453
+A +EYL +H DL N+L+ EN V ++DFG+++ + D T
Sbjct: 163 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 454 IATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
+ +MAPE + + + DV+S+G+L+ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 48/213 (22%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 297 NLLGSGGFGSVYKGILSD------GTTVAIKIFNLQ-LEQAFRSFNSECEVLRNV-RHRN 348
LG+G FG V + VA+K+ + SE +++ ++ +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD-------------IPDRLNIMI 395
++ +L +C + ++ E+ G L +L + + D L+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 396 DVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA 455
VA + +L + +H D+ N+LL VA + DFG+++ + + +++
Sbjct: 172 QVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 456 TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
+ +MAPE + + + DV+SYGILL E F+
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 286 LERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL-EQAFRSFNSECEV-LR 342
+E D LG G +G V K + G +A+K + Q + + ++ +R
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 343 NVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD--IPDRL--NIMIDVA 398
V + + + +E M + SLDK Y + IP+ + I + +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELM-DTSLDK-FYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 399 LALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG 458
ALE+LH S V+H D+KPSN+L++ + DFGIS G D V + +
Sbjct: 120 KALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGCKP 174
Query: 459 YMAPE----FGSEGNVSSKCDVYSYGILLLE 485
YMAPE ++ S K D++S GI ++E
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 8e-28
Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 12/193 (6%)
Query: 297 NLLGSGGFGSVYKGI-LSDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRNLIKI 352
LG G FG+VY +A+K+ L+ E E+ ++RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
+ L+LE+ P G++ + L + F + + ++A AL Y H V
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKR---V 130
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
+H D+KP N+LL ++DFG S S + T+ Y+ PE
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLC-GTLDYLPPEMIEGRMHDE 186
Query: 473 KCDVYSYGILLLE 485
K D++S G+L E
Sbjct: 187 KVDLWSLGVLCYE 199
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 41/289 (14%), Positives = 80/289 (27%), Gaps = 56/289 (19%)
Query: 258 RRRNRSTKSPDDEELFSLATWRRTSYLDLERATDG----FNECNLLGSGGFGSVYKGI-L 312
R + +S D L S + W +E +LG + +
Sbjct: 42 RTTSEYMQSAADS-LVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQ 100
Query: 313 SDGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE-- 367
G + + + A + E LR +R K F +++
Sbjct: 101 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160
Query: 368 ----FMPNGSLDKWLYSHNYFQDIPD--------------------------RLNIMIDV 397
+ ++ ++ + F P RL + + V
Sbjct: 161 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 220
Query: 398 ALALEYLH-HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT 456
L LH +G +VH L+P +I+LD+ ++ F G A
Sbjct: 221 IRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-SAVSPIGRGFAP 275
Query: 457 IGYMAPEF-----GSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500
A ++ D ++ G+ + + P T +
Sbjct: 276 PETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NTDD 320
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 47/191 (24%), Positives = 80/191 (41%), Gaps = 12/191 (6%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRNLIKIL 353
LG GGF ++ A KI L + E + R++ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG-F 80
Query: 354 SSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
N +VLE SL + + R + + L +YLH V
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---V 136
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
+H DLK N+ L+E++ + DFG++ + E D + + T Y+APE S+ S
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLC-GTPNYIAPEVLSKKGHSF 194
Query: 473 KCDVYSYGILL 483
+ DV+S G ++
Sbjct: 195 EVDVWSIGCIM 205
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 299 LGSGGFGSVYKGIL--------SDGTTVAIKIFN-LQLEQAFRSFNSECEVLRNV-RHRN 348
LG G FG V + T VA+K+ E+ SE E+++ + +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD---------------IPDRLNI 393
+I +L +C +++E+ G+L ++L + D ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 394 MIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT 453
VA +EYL +H DL N+L+ E+ V ++DFG+++ + D T
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 454 IATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
+ +MAPE + + + DV+S+G+LL E FT
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 57/224 (25%), Positives = 88/224 (39%), Gaps = 41/224 (18%)
Query: 299 LGSGGFGSVYKGILSDG------TTVAIKIFNLQL-----EQAFRSFNSECEVLRNV-RH 346
LGSG FG V VA+K L + SE +++ + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVK----MLKEKADSSEREALMSELKMMTQLGSH 108
Query: 347 RNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSH----------------------NYF 384
N++ +L +C + L+ E+ G L +L S
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 385 QDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444
D L VA +E+L VH DL N+L+ V + DFG+++ +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT 488
+ V++ + +MAPE EG + K DV+SYGILL E F+
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 63/252 (25%), Positives = 109/252 (43%), Gaps = 34/252 (13%)
Query: 257 LRRRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNL---------LGSGGFGSV 307
+ + R + + E SL+ + + DL L LGSG G V
Sbjct: 92 VGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEV 151
Query: 308 YKGI-LSDGTTVAIKIFN--------LQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
VAI+I + + + +E E+L+ + H +IK + + +
Sbjct: 152 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFD 210
Query: 359 TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHSTPVVHCDL 417
+VLE M G L + + ++ + LA++YLH +G ++H DL
Sbjct: 211 AEDYYIVLELMEGGELFDKVVGNKRLKE-ATCKLYFYQMLLAVQYLHENG----IIHRDL 265
Query: 418 KPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE---FGSEGNVS 471
KP N+LL +E+ + ++DFG SK+LGE S+++T+ T Y+APE +
Sbjct: 266 KPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTL-CGTPTYLAPEVLVSVGTAGYN 322
Query: 472 SKCDVYSYGILL 483
D +S G++L
Sbjct: 323 RAVDCWSLGVIL 334
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 32/227 (14%)
Query: 280 RTSYLDLERATDGFNE----CNLLGSGGFGSVYKGI-LSDGTTVAIKIFN---------L 325
R + L +T GF E +LG G V + I A+KI +
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 326 QLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYF 384
++++ + E ++LR V H N+I++ + F LV + M G L +L
Sbjct: 62 EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 385 QDIPDRLNIMIDVALALEYLH-HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443
+ + IM + + LH +VH DLKP NILLD++M ++DFG S L
Sbjct: 122 SE-KETRKIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 444 GDDSVIQTMTIA-TIGYMAPE------FGSEGNVSSKCDVYSYGILL 483
G+ + + T Y+APE + + D++S G+++
Sbjct: 177 GE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-27
Identities = 41/199 (20%), Positives = 77/199 (38%), Gaps = 5/199 (2%)
Query: 4 MQQLQGIGLADNHLQ--GSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ L+ + L+ N L G L L L N + ++ + L L L
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQ 404
Query: 62 SNKLTSSIP-SALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+ L S +L ++Y+++S + + + L L ++ N +
Sbjct: 405 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
Query: 121 I-AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFN 179
I L++LT L L+ Q + P +F SL SL+ L+++SN L L+ L++
Sbjct: 465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIW 524
Query: 180 VSHNRLEGEIPTEGPFRNF 198
+ N + P +
Sbjct: 525 LHTNPWDCSCPRIDYLSRW 543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-25
Identities = 41/200 (20%), Positives = 73/200 (36%), Gaps = 7/200 (3%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS 71
L+ N L+ Y L L L ++ SL+ L L L N + S
Sbjct: 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 94
Query: 72 ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQL-SGDIPKTIAGLKDLTNL 130
A L + + L I ++K L +L+++ N + S +P+ + L +L +L
Sbjct: 95 AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154
Query: 131 SLAGNQFQGPIPESFGSLISLE----SLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
L+ N+ Q L + SLDLS N ++ I L + + +N
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDS 213
Query: 187 GEIPTEGPFRNFSAQSFHWN 206
+ + + + H
Sbjct: 214 LNVM-KTCIQGLAGLEVHRL 232
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 42/174 (24%), Positives = 67/174 (38%), Gaps = 7/174 (4%)
Query: 31 LNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLT 90
+L L N L S L+ L L+ ++ + A +L ++ + L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 91 GSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQ-GPIPESFGSLI 149
+ L L L+ I LK L L++A N Q +PE F +L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 150 SLESLDLSSNNLSEGIPKSLVALSHLKQF----NVSHNRLEGEIPTEGPFRNFS 199
+LE LDLSSN + L L + ++S N + I G F+
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ-PGAFKEIR 201
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 41/192 (21%), Positives = 71/192 (36%), Gaps = 7/192 (3%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+LQ + L+ +Q L L++L L GN + + L+SL++L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLT-GSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
L S + L+ + +N++ N + L N+ L LDLS N++
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
Query: 121 IAGLKDLTN----LSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPK-SLVALSHL 175
+ L + L L+ N I I L L L +N S + K + L+ L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL 227
Query: 176 KQFNVSHNRLEG 187
+ +
Sbjct: 228 EVHRLVLGEFRN 239
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 29/156 (18%), Positives = 60/156 (38%), Gaps = 4/156 (2%)
Query: 32 NSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTG 91
+ IP L S + L L+ N L + ++ + ++LS +
Sbjct: 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 92 SLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISL 151
Q++ L L L+ N + +GL L L G L +L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 152 ESLDLSSNNLSE-GIPKSLVALSHLKQFNVSHNRLE 186
+ L+++ N + +P+ L++L+ ++S N+++
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 17/78 (21%), Positives = 33/78 (42%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
++ L + L+ L+ P L L L++ N+L LTSL+++ L+
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLH 526
Query: 62 SNKLTSSIPSALWALEYI 79
+N S P + ++
Sbjct: 527 TNPWDCSCPRIDYLSRWL 544
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 37/195 (18%), Positives = 76/195 (38%), Gaps = 12/195 (6%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+ + + D+ L+ ++ + L L GN L+ LA T L L L+SN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
L L +L + ++L++NY+ ++ + L + N +S + +
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR-- 118
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE-GIPKSLVALSHLKQFNVSH 182
+ N+ LA N+ G ++ LDL N + + + L+ N+ +
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 183 NRLEGEIPTEGPFRN 197
N + ++ + F
Sbjct: 179 NFIY-DVKGQVVFAK 192
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 30/186 (16%), Positives = 72/186 (38%), Gaps = 9/186 (4%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
++ + A+N++ + + ++ L NK+ + ++ L L
Sbjct: 96 LVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152
Query: 62 SNKLTS-SIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
N++ + + + + + ++NL N++ + + L LDLS N+L+ +
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPE 209
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+T +SL N+ I ++ +LE DL N G + + + V
Sbjct: 210 FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTV 267
Query: 181 SHNRLE 186
+ ++
Sbjct: 268 AKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 29/143 (20%), Positives = 58/143 (40%), Gaps = 10/143 (6%)
Query: 44 SIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVL 103
+I + + ++ + L ++ S + + ++LS N L+ +D+ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 104 IDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163
L+LS N L + + L L L L N Q S+E+L ++NN+S
Sbjct: 61 ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 164 GIPKSLVALSHLKQFNVSHNRLE 186
+ S K +++N++
Sbjct: 114 -VSCS--RGQGKKNIYLANNKIT 133
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 47/191 (24%), Positives = 80/191 (41%), Gaps = 12/191 (6%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRNLIKIL 353
LG GGF ++ A KI L + E + R++ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG-F 106
Query: 354 SSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
N +VLE SL + + R + + L +YLH V
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---V 162
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
+H DLK N+ L+E++ + DFG++ + E D + + T Y+APE S+ S
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLC-GTPNYIAPEVLSKKGHSF 220
Query: 473 KCDVYSYGILL 483
+ DV+S G ++
Sbjct: 221 EVDVWSIGCIM 231
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 10/195 (5%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIK 351
+ +G G G V G VA+K+ +L+ +Q +E ++R+ +H N+++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
+ S +++EF+ G+L + S + + V AL YLH +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNE-EQIATVCEAVLQALAYLH---AQG 161
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEFGSEGNV 470
V+H D+K +ILL + +SDFG + V + + + T +MAPE S
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 471 SSKCDVYSYGILLLE 485
+++ D++S GI+++E
Sbjct: 219 ATEVDIWSLGIMVIE 233
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 14/197 (7%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIK 351
+ +G G G+VY + ++ G VAI+ NLQ + +E V+R ++ N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQD--IPDRLNIMIDVALALEYLHHGHS 409
L S + +V+E++ GSL + + + I + + ALE+LH S
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIA---AVCRECLQALEFLH---S 134
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEFGSEG 468
V+H D+K NILL + ++DFG + + T + T +MAPE +
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 469 NVSSKCDVYSYGILLLE 485
K D++S GI+ +E
Sbjct: 192 AYGPKVDIWSLGIMAIE 208
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 31/250 (12%), Positives = 77/250 (30%), Gaps = 60/250 (24%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLE---------------------------- 328
+LG + + G + + +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 329 QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM----PNGSLDKWLYSHNYF 384
+ F +++++ + + +I++ + + + + + L SH+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 385 QDIPD---RLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441
RL + + V L LHH +VH L+P +I+LD+ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 442 GEGDDSVIQTMTIATIGYMAPEF-----------GSEGNVSSKCDVYSYGILLLETFTRK 490
G + ++ + G+ PE ++ D ++ G+++ +
Sbjct: 257 GA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 491 KPTDEMFTGE 500
P T +
Sbjct: 311 LP----ITKD 316
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 27/202 (13%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFN--------LQLEQAFRSFNSECEVLRNVRHRNL 349
LGSG G V VAIKI + + + +E E+L+ + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGH 408
IKI + + +VLE M G L + + ++ + LA++YLH +G
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKE-ATCKLYFYQMLLAVQYLHENG- 134
Query: 409 STPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPE- 463
++H DLKP N+LL +E+ + ++DFG SK+LGE T+ T Y+APE
Sbjct: 135 ---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEV 187
Query: 464 --FGSEGNVSSKCDVYSYGILL 483
+ D +S G++L
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVIL 209
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRNLIKIL 353
LLG G F VY+ + G VAIK+ + + + +E ++ ++H ++++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE-L 76
Query: 354 SSCCNTNFKA-LVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTP 411
+ + LVLE NG ++++L + F + R + M + + YLH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSHG--- 132
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVS 471
++H DL SN+LL NM ++DFG++ L + T+ T Y++PE +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQL-KMPHEKHYTLC-GTPNYISPEIATRSAHG 190
Query: 472 SKCDVYSYGILL 483
+ DV+S G +
Sbjct: 191 LESDVWSLGCMF 202
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQL-EQAFRSFNSECEVL-RNVRHRNLIKILSS 355
+GSG G V+K G +A+K ++ + + +V+ ++ +++ +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALEYLHHGHSTPVV 413
+ +E M +K IP+R+ + + + AL YL H V+
Sbjct: 93 FITNTDVFIAMELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG--VI 147
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-----FGSEG 468
H D+KPSNILLDE + DFGIS G D + + YMAPE ++
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 469 NVSSKCDVYSYGILLLE 485
+ + DV+S GI L+E
Sbjct: 205 DYDIRADVWSLGISLVE 221
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 42/227 (18%), Positives = 88/227 (38%), Gaps = 26/227 (11%)
Query: 288 RATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNV 344
R T F+E +GSG FGSV+K + DG AIK L ++ E +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 345 -RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHN-YFQDIPDR--LNIMIDVALA 400
+H ++++ S+ + + E+ GSL + + + ++++ V
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ---------- 450
L Y+H +VH D+KPSNI + + + + + + + +
Sbjct: 128 LRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 451 TMTIATIG---YMAPEF--GSEGNVSSKCDVYSYGILLLETFTRKKP 492
+ G ++A E + + K D+++ + ++ +
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTH-LPKADIFALALTVVCAAGAEPL 230
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 5e-26
Identities = 60/289 (20%), Positives = 96/289 (33%), Gaps = 74/289 (25%)
Query: 288 RATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNL-QLEQAFRSFNSECEVLRNVR 345
R F +G GGFG V++ D AIK L E A E + L +
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 346 HRNLIKILSSCCNTNFKALVLE-------------------------------------- 367
H +++ ++ T + E
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 368 ---FMPNGSLDKWLY------------------SHNYFQDIPDRLNIMIDVALALEYLHH 406
+ S +LY ++ L+I I +A A+E+LH
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD----------SVIQTMTIAT 456
++H DLKPSNI + V V DFG+ + + ++ T + T
Sbjct: 183 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKN 505
YM+PE N S K D++S G++L E E +++N
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRN 288
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 36/204 (17%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
+LGSG F V+ G A+K S +E VL+ ++H N++ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--------LNIMIDVALALEYLH-HG 407
+T LV++ + G L F I +R ++ V A++YLH +G
Sbjct: 76 ESTTHYYLVMQLVSGGEL---------FDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 408 HSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPE 463
+VH DLKP N+L +EN ++DFG+SK+ G T T GY+APE
Sbjct: 127 ----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVAPE 177
Query: 464 FGSEGNVSSKCDVYSYG----ILL 483
++ S D +S G ILL
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILL 201
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-26
Identities = 43/185 (23%), Positives = 75/185 (40%), Gaps = 4/185 (2%)
Query: 4 MQQLQGIGLADNHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLN 61
+ L+ + + DN L I + L L L+L+ L SIPT L+ L L LRL
Sbjct: 127 LYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLR 184
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
+ + + L + + +S ++T + L L ++ L+ +
Sbjct: 185 HLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAV 244
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVS 181
L L L+L+ N L+ L+ + L L+ P + L++L+ NVS
Sbjct: 245 RHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304
Query: 182 HNRLE 186
N+L
Sbjct: 305 GNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 42/199 (21%), Positives = 71/199 (35%), Gaps = 3/199 (1%)
Query: 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLT 66
+ + L N ++ + L L L N ++ P +L +LR L L SN+L
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK 93
Query: 67 SSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAGLK 125
L + +++S N + L + Q++ L L++ N L + +GL
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLN 152
Query: 126 DLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRL 185
L L+L E+ L L L L N++ S L LK +SH
Sbjct: 153 SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212
Query: 186 EGEIPTEGPFRNFSAQSFH 204
+ + S
Sbjct: 213 LDTMT-PNCLYGLNLTSLS 230
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 39/183 (21%), Positives = 73/183 (39%), Gaps = 2/183 (1%)
Query: 4 MQQLQGIGLADNHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNS 62
+ L+ + L +L SIP + L L L L L+ +N L L+ L ++
Sbjct: 151 LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 63 NKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIA 122
++ + ++++ LT ++++ L L+LS N +S +
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLH 269
Query: 123 GLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSH 182
L L + L G Q P +F L L L++S N L+ ++ +L+ +
Sbjct: 270 ELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDS 329
Query: 183 NRL 185
N L
Sbjct: 330 NPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 41/168 (24%), Positives = 67/168 (39%), Gaps = 4/168 (2%)
Query: 20 SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYI 79
++P + L L N++ AS L EL LN N +++ P A L +
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 80 LYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQ 138
+ L SN L + + + L LD+S N++ + L +L +L + N
Sbjct: 83 RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141
Query: 139 GPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
+F L SLE L L NL+ ++L L L + H +
Sbjct: 142 YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN 189
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 37/161 (22%), Positives = 65/161 (40%), Gaps = 26/161 (16%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTC-LASLTSLRELRLN 61
R+ +L+ + ++ ++ + L SLS+ L ++P + L LR L L+
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLS 256
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
N +++ S L + L ++ L QL+ P
Sbjct: 257 YNPISTIEGSML------------------------HELLRLQEIQLVGGQLAVVEPYAF 292
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162
GL L L+++GNQ F S+ +LE+L L SN L+
Sbjct: 293 RGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 39/195 (20%), Positives = 76/195 (38%), Gaps = 12/195 (6%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+ + + D+ L+ ++ + L L GN L+ LA T L L L+SN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
L L +L + ++L++NY+ ++ + L + N +S + +
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR-- 118
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVA-LSHLKQFNVSH 182
+ N+ LA N+ G ++ LDL N + L A L+ N+ +
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 183 NRLEGEIPTEGPFRN 197
N + ++ + F
Sbjct: 179 NFIY-DVKGQVVFAK 192
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 41/186 (22%), Positives = 77/186 (41%), Gaps = 13/186 (6%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
++ + L+ N L DL +L L+L N L ++ L SL++LR L LN
Sbjct: 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
+N + L I ++ ++N ++ S Q ++ L+ N+++
Sbjct: 89 NNYVQE-----LLVGPSIETLHAANNNISRVSCSRGQG---KKNIYLANNKITMLRDLDE 140
Query: 122 AGLKDLTNLSLAGNQFQG-PIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+ L L N+ E S +LE L+L N + + + + + LK ++
Sbjct: 141 GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDL 198
Query: 181 SHNRLE 186
S N+L
Sbjct: 199 SSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 2e-22
Identities = 37/187 (19%), Positives = 73/187 (39%), Gaps = 8/187 (4%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNG-SIPTCLASLTSLRELRL 60
R Q + I LA+N + D R+ L L+ N+++ + AS +L L L
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
N + + + + ++LSSN L + + Q+ + + L N+L I K
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 121 IAGLKDLTNLSLAGNQFQ-GPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFN 179
+ ++L + L GN F G + + F ++++ + G + + +
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE--CTVPTLGH 290
Query: 180 VSHNRLE 186
E
Sbjct: 291 YGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 29/143 (20%), Positives = 58/143 (40%), Gaps = 10/143 (6%)
Query: 44 SIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVL 103
+I + + ++ + L ++ S + + ++LS N L+ +D+ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 104 IDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163
L+LS N L + + L L L L N Q S+E+L ++NN+S
Sbjct: 61 ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 164 GIPKSLVALSHLKQFNVSHNRLE 186
+ S K +++N++
Sbjct: 114 -VSCS--RGQGKKNIYLANNKIT 133
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 23/191 (12%), Positives = 49/191 (25%), Gaps = 7/191 (3%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+L+ + L+ N L + + + +SL+ NKL I L +L L N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
++ + ++ + + + V
Sbjct: 248 GFHCGTLRDFFSKNQRVQ-TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306
Query: 124 LKDLTNLSLAGNQFQG----PIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFN 179
L L A QG + + +D I + +
Sbjct: 307 LIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLE 366
Query: 180 VSHNRLEGEIP 190
L+ ++
Sbjct: 367 QKKKALDEQVS 377
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 25/212 (11%), Positives = 57/212 (26%), Gaps = 29/212 (13%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLN-GSIPTCLASLTSLRELRL 60
+ I L +N L I L + L L+GN + G++ + ++ +
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK 269
Query: 61 NSNKLTSSIPSALWALEYILYVN------LSSNYLTG--------------------SLT 94
+ K + + + + L + + L
Sbjct: 270 QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLE 329
Query: 95 SDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESL 154
+ +N ++D + Q I + + L + + L+
Sbjct: 330 CERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGT 389
Query: 155 DLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
+ E + + S L+ R E
Sbjct: 390 LQQAVGQIE-LQHATEEQSPLQLLRAIVKRYE 420
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 55/192 (28%), Positives = 86/192 (44%), Gaps = 12/192 (6%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRNLIKIL 353
LG G FG+VY + +A+K+ L+ E E E+ ++RH N++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVV 413
+ + L+LEF P G L K L H F + M ++A AL Y H V+
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHERK---VI 136
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSK 473
H D+KP N+L+ ++DFG S +TM T+ Y+ PE K
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHA---PSLRRRTMC-GTLDYLPPEMIEGKTHDEK 192
Query: 474 CDVYSYGILLLE 485
D++ G+L E
Sbjct: 193 VDLWCAGVLCYE 204
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 64/252 (25%), Positives = 107/252 (42%), Gaps = 35/252 (13%)
Query: 258 RRRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNE----CNLLGSGGFGSVYKGI-L 312
+ + P E + L A F + +++G G V + +
Sbjct: 57 EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR 116
Query: 313 SDGTTVAIKIFNL--------QLEQAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKA 363
+ G A+KI + QLE+ + E +LR V H ++I ++ S +++F
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176
Query: 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHSTPVVHCDLKPSNI 422
LV + M G L +L + + +IM + A+ +LH + +VH DLKP NI
Sbjct: 177 LVFDLMRKGELFDYLTEKVALSE-KETRSIMRSLLEAVSFLHANN----IVHRDLKPENI 231
Query: 423 LLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPE------FGSEGNVSSKCD 475
LLD+NM +SDFG S L G+ + + T GY+APE + + D
Sbjct: 232 LLDDNMQIRLSDFGFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 476 VYSYG----ILL 483
+++ G LL
Sbjct: 288 LWACGVILFTLL 299
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 25/206 (12%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIK 351
+ LG G FG VYK G A K+ + E+ + E E+L H ++K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN------IMIDVALALEYLH 405
+L + + +++EF P G++D ++ L + + AL +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVD------AIMLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPE- 463
++H DLK N+L+ ++DFG+S + ++ + + I T +MAPE
Sbjct: 135 SKR---IIHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQKRDSFIGTPYWMAPEV 188
Query: 464 ----FGSEGNVSSKCDVYSYGILLLE 485
+ K D++S GI L+E
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIE 214
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 42/199 (21%), Positives = 76/199 (38%), Gaps = 18/199 (9%)
Query: 300 GSGGFGSVYKGI-LSDGTTVAIKIFNL--QLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
G +V G V ++ NL + E V + H N++ ++
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 357 CNTNFKALVLEFMPNGSL-DKWLYSHNYFQDIPDRL--NIMIDVALALEYLHHGHSTPVV 413
N +V FM GS D L ++ + + I+ V AL+Y+HH V
Sbjct: 96 IADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YV 150
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDD--SVIQTMTIATIG---YMAPEFGSEG 468
H +K S+IL+ + ++S + + V+ ++ +++PE +
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN 210
Query: 469 NV--SSKCDVYSYGILLLE 485
+K D+YS GI E
Sbjct: 211 LQGYDAKSDIYSVGITACE 229
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 54/192 (28%), Positives = 84/192 (43%), Gaps = 15/192 (7%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRNLIKILS 354
LG G FG V G A+K+ + ++ + S E ++L+ + H N++K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
+ + LV E G L + S F + D I+ V + Y+H +VH
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSE-VDAARIIRQVLSGITYMHKNK---IVH 149
Query: 415 CDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVS 471
DLKP N+LL ++ + DFG+S I T Y+APE G
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEV-LHGTYD 205
Query: 472 SKCDVYSYGILL 483
KCDV+S G++L
Sbjct: 206 EKCDVWSTGVIL 217
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNL-QLEQAFRSFNSECEVLRNVRHRNLI 350
F + +G G FG V+KGI VAIKI +L + E E VL +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDI--PDRLN------IMIDVALALE 402
K S +++E++ GS D+ P L+ I+ ++ L+
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSA----------LDLLEPGPLDETQIATILREILKGLD 133
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMA 461
YLH S +H D+K +N+LL E+ ++DFG++ L D+ I+ T + T +MA
Sbjct: 134 YLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTFVGTPFWMA 187
Query: 462 PEFGSEGNVSSKCDVYSYGILLLETFTRKKP 492
PE + SK D++S GI +E + P
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 57/198 (28%), Positives = 85/198 (42%), Gaps = 24/198 (12%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFN--LQLEQAFRSFNSECEVLRNVRHRNLIKILSS 355
LG G FG V K A+K+ N + + E E+L+ + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHSTPVVH 414
+++ +V E G L + F + D I+ V + Y+H H +VH
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMHKHN----IVH 144
Query: 415 CDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIA--TIGYMAPEFGSEGN 469
DLKP NILL +++ + DFG+S + M T Y+APE G
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-----TKMKDRIGTAYYIAPEV-LRGT 198
Query: 470 VSSKCDVYSYG----ILL 483
KCDV+S G ILL
Sbjct: 199 YDEKCDVWSAGVILYILL 216
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 22/201 (10%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIK 351
F+ LG G +GSVYK I G VAIK + E + E +++ +++K
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN------IMIDVALALEYLH 405
S +V+E+ GS+ + + L I+ LEYLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDII------RLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPEF 464
+H D+K NILL+ A ++DFG++ L D++ + T I T +MAPE
Sbjct: 143 ---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTVIGTPFWMAPEV 196
Query: 465 GSEGNVSSKCDVYSYGILLLE 485
E + D++S GI +E
Sbjct: 197 IQEIGYNCVADIWSLGITAIE 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 50/194 (25%), Positives = 84/194 (43%), Gaps = 18/194 (9%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357
+G G +G V + A K + F E E+++++ H N+I++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHSTPVVHCD 416
+ LV+E G L + + F++ D IM DV A+ Y H V H D
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRE-SDAARIMKDVLSAVAYCHKLN----VAHRD 131
Query: 417 LKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSK 473
LKP N L + + DFG++ G +++T + T Y++P+ EG +
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTK-VGTPYYVSPQV-LEGLYGPE 187
Query: 474 CDVYSYG----ILL 483
CD +S G +LL
Sbjct: 188 CDEWSAGVMMYVLL 201
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 53/191 (27%), Positives = 81/191 (42%), Gaps = 14/191 (7%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSS 355
LGSG +G V AIKI + E VL+ + H N++K+
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHC 415
+ LV+E G L + F + D I+ V + YLH + +VH
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNE-VDAAVIIKQVLSGVTYLHKHN---IVHR 160
Query: 416 DLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
DLKP N+LL +++ + + DFG+S + + T Y+APE
Sbjct: 161 DLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEV-LRKKYDE 216
Query: 473 KCDVYSYGILL 483
KCDV+S G++L
Sbjct: 217 KCDVWSIGVIL 227
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 30/199 (15%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSS 355
LG G FG V K A+K+ N + + E E+L+ + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--------LNIMIDVALALEYLHHG 407
+++ +V E G L F +I R I+ V + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGEL---------FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 408 HSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF 464
+ +VH DLKP NILL +++ + DFG+S + ++ I T Y+APE
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDR-IGTAYYIAPEV 194
Query: 465 GSEGNVSSKCDVYSYGILL 483
G KCDV+S G++L
Sbjct: 195 -LRGTYDEKCDVWSAGVIL 212
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 25/204 (12%)
Query: 297 NLLGSGGFGSVYKGI-LSDGTTVAIKI-------------FNLQLEQAFRSFNSECEVLR 342
LGSG +G V + + AIK+ N +E+ +E +L+
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 343 NVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALE 402
++ H N+IK+ + + LV EF G L + + + + F + D NIM + +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDE-CDAANIMKQILSGIC 160
Query: 403 YLHHGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGY 459
YLH + +VH D+KP NILL + + + DFG+S + + T Y
Sbjct: 161 YLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYY 214
Query: 460 MAPEFGSEGNVSSKCDVYSYGILL 483
+APE + + KCDV+S G+++
Sbjct: 215 IAPEV-LKKKYNEKCDVWSCGVIM 237
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 18/201 (8%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNL-QLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
+GSG V VAIK NL + + + E + + H N++ +S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 357 CNTNFKALVLEFMPNGSL-DKWLYSHNYFQDIPDRLN------IMIDVALALEYLHHGHS 409
+ LV++ + GS+ D + + L+ I+ +V LEYLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG- 141
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ----TMTIATIGYMAPEFG 465
+H D+K NILL E+ ++DFG+S L G D T + T +MAPE
Sbjct: 142 --QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF-VGTPCWMAPEVM 198
Query: 466 SEGNV-SSKCDVYSYGILLLE 485
+ K D++S+GI +E
Sbjct: 199 EQVRGYDFKADIWSFGITAIE 219
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 35/203 (17%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFN-LQLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
LGSG FG V+ S G IK N + + +E EVL+++ H N+IKI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL------------NIMIDVALALEYL 404
+ + +V+E G L + I +M + AL Y
Sbjct: 90 EDYHNMYIVMETCEGGEL---------LERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 405 H-HGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460
H VVH DLKP NIL + + DFG+++L + T T YM
Sbjct: 141 HSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYM 193
Query: 461 APEFGSEGNVSSKCDVYSYGILL 483
APE + +V+ KCD++S G+++
Sbjct: 194 APEV-FKRDVTFKCDIWSAGVVM 215
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 37/205 (18%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSS 355
LG G F V + + + G A KI N + + F+ E + R ++H N++++ S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--------LNIMIDVALALEYLH-H 406
+F LV + + G L F+DI R + + + ++ Y H +
Sbjct: 74 IQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 407 GHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAP 462
G +VH +LKP N+LL + ++DFG++ + + + A T GY++P
Sbjct: 125 G----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGYLSP 176
Query: 463 EFGSEGNVSSKCDVYSYG----ILL 483
E + S D+++ G ILL
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILL 201
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ L I ++N L P L L +L + + N++ P LA+LT+L L L
Sbjct: 65 EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 120
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTG--------SLT-----------SDIQNMKV 102
+N++T P L L + + LSSN ++ SL + N+
Sbjct: 121 NNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTT 178
Query: 103 LIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162
L LD+S N++S +A L +L +L NQ P G L +L+ L L+ N L
Sbjct: 179 LERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK 234
Query: 163 EGIPKSLVALSHLKQFNVSHNRLEGEIP 190
+ +L +L++L ++++N++ P
Sbjct: 235 D--IGTLASLTNLTDLDLANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 15/190 (7%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+ + LQ + N + P L L L L + NK+ S + LA LT+L L
Sbjct: 152 LSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKV--SDISVLAKLTNLESLIA 206
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+N+++ P L L + ++L+ N L + ++ L DLDL+ NQ+S P
Sbjct: 207 TNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP-- 260
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
++GL LT L L NQ P L +L +L+L+ N L + + L +L +
Sbjct: 261 LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTL 316
Query: 181 SHNRLEGEIP 190
N + P
Sbjct: 317 YFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 38/207 (18%), Positives = 80/207 (38%), Gaps = 33/207 (15%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+ + L ++ ++ L ++ +L + + L +L ++ ++N
Sbjct: 23 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 78
Query: 64 KLTSSIP-SALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIA 122
+LT P L L I +++N + + + N+ L L L NQ++ +
Sbjct: 79 QLTDITPLKNLTKLVDI---LMNNNQIADI--TPLANLTNLTGLTLFNNQITD--IDPLK 131
Query: 123 GLKDLTNLSLAGNQFQGPIP-------------------ESFGSLISLESLDLSSNNLSE 163
L +L L L+ N + +L +LE LD+SSN +S+
Sbjct: 132 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 191
Query: 164 GIPKSLVALSHLKQFNVSHNRLEGEIP 190
L L++L+ ++N++ P
Sbjct: 192 --ISVLAKLTNLESLIATNNQISDITP 216
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 35/185 (18%), Positives = 72/185 (38%), Gaps = 12/185 (6%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ +L + L N + P L L L +L L N+L P +++L +L L L
Sbjct: 262 SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLY 317
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
N ++ P + +L + + +N ++ S + N+ + L NQ+S P +
Sbjct: 318 FNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--L 371
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVS 181
A L +T L L + ++ ++ + L P ++ + +++
Sbjct: 372 ANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDIT 429
Query: 182 HNRLE 186
N
Sbjct: 430 WNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-19
Identities = 39/175 (22%), Positives = 75/175 (42%), Gaps = 14/175 (8%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS 71
D + L L + ++ L + L+ + + S
Sbjct: 9 TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--ID 62
Query: 72 ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLS 131
+ L + +N S+N LT + ++N+ L+D+ ++ NQ++ P +A L +LT L+
Sbjct: 63 GVEYLNNLTQINFSNNQLTDI--TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118
Query: 132 LAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
L NQ P +L +L L+LSSN +S+ +L L+ L+Q + + +
Sbjct: 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD 169
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 15/96 (15%), Positives = 36/96 (37%), Gaps = 6/96 (6%)
Query: 95 SDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESL 154
+ + L + ++ + L +T L + + L +L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73
Query: 155 DLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIP 190
+ S+N L++ P L L+ L +++N++ P
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 15/141 (10%), Positives = 36/141 (25%), Gaps = 29/141 (20%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ + + N + P L L R+ L L + A+++ ++
Sbjct: 350 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNV 407
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
+ L + + I + + D++ N S +
Sbjct: 408 TGALIA--------------------------PATISDGGSYTEPDITWNLPS-YTNEVS 440
Query: 122 AGLKDLTNLSLAGNQFQGPIP 142
+ F G +
Sbjct: 441 YTFSQPVTIGKGTTTFSGTVT 461
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 47/223 (21%), Positives = 76/223 (34%), Gaps = 18/223 (8%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ L ++ N L L + L N +N + L L+L
Sbjct: 183 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQ 234
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
N LT + L ++ V+LS N L + M+ L L +S N+L +
Sbjct: 235 HNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYG 291
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVS 181
+ L L L+ N + + LE+L L N++ + S LK +S
Sbjct: 292 QPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVT-LKLS--THHTLKNLTLS 347
Query: 182 HNRLEGEIPTEGPFRNFSAQSFHWN--YALCGPQRLQVPPCKE 222
HN + FRN + + + Q CKE
Sbjct: 348 HNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKE 389
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 36/197 (18%), Positives = 75/197 (38%), Gaps = 14/197 (7%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+Q++ + L D ++ Y + L + N + P ++ L L L
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKT 120
N L+S + +++S+N L + D Q L +L LS N+L+ +
Sbjct: 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD-- 181
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
++ + L + +++ N + I++E LD S N+++ + L +
Sbjct: 182 LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGP--VNVELTILKL 233
Query: 181 SHNRLEGEIPTEGPFRN 197
HN L + +
Sbjct: 234 QHNNLT-DTAWLLNYPG 249
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 42/183 (22%), Positives = 74/183 (40%), Gaps = 7/183 (3%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKL 65
+ + ++ L ++ + + + L S + L LN ++
Sbjct: 22 VFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 81
Query: 66 TSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTI-AG 123
A I + + N + L + QN+ +L L L RN LS +P+ I
Sbjct: 82 EEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 139
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
LT LS++ N + ++F + SL++L LSSN L+ + S + L NVS+N
Sbjct: 140 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDLS--LIPSLFHANVSYN 196
Query: 184 RLE 186
L
Sbjct: 197 LLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 9e-22
Identities = 49/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 4 MQQLQGIGLADNHLQGSIPYDL-CQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNS 62
+ L + L N L S+P + +L +LS+ N L + TSL+ L+L+S
Sbjct: 116 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSS 174
Query: 63 NKLTSSIPSALWALEYILYVNLSSNYLT-----GSLTS-DIQNMKV----------LIDL 106
N+LT S + +L + N+S N L+ ++ D + + L L
Sbjct: 175 NRLTHVDLSLIPSLFHA---NVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTIL 231
Query: 107 DLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIP 166
L N L+ D + L + L+ N+ + + F + LE L +S+N L +
Sbjct: 232 KLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LN 288
Query: 167 KSLVALSHLKQFNVSHNRLE 186
+ LK ++SHN L
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 36/185 (19%), Positives = 73/185 (39%), Gaps = 12/185 (6%)
Query: 3 RMQQLQGIGLADNHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ + + ++ ++ +P L +++ L+L ++ A ++++L +
Sbjct: 43 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 101
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKT 120
N + P + + + L N L+ SL I N L L +S N L T
Sbjct: 102 FNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT 160
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
L NL L+ N+ + + SL ++S N LS +L +++ +
Sbjct: 161 FQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDA 212
Query: 181 SHNRL 185
SHN +
Sbjct: 213 SHNSI 217
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 29/180 (16%), Positives = 58/180 (32%), Gaps = 5/180 (2%)
Query: 20 SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYI 79
I +L + + + +L + + + ++ + + L + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 80 LYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQG 139
+NL+ + T + L + N + P + LT L L N
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 140 PIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFS 199
F + L +L +S+NNL + A + L+ +S NRL T
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-----THVDLSLIP 186
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 18/136 (13%), Positives = 39/136 (28%), Gaps = 2/136 (1%)
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
I S L V++ + + + + + +
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVS 181
+ + L+L Q + +F +++ L + N + P + L +
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125
Query: 182 HNRLEGEIPTEGPFRN 197
N L +P G F N
Sbjct: 126 RNDLS-SLP-RGIFHN 139
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 41/183 (22%), Positives = 71/183 (38%), Gaps = 2/183 (1%)
Query: 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLT 66
++ + L+ N + DL L L L+ +++N SL SL L L+ N L+
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 67 SSIPSALWALEYILYVNLSSNYLTG-SLTSDIQNMKVLIDLDLSRNQLSGDIPK-TIAGL 124
S S L + Y+NL N +TS N+ L L + + +I + AGL
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147
Query: 125 KDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNR 184
L L + + +S S+ + L L + + + LS ++ +
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207
Query: 185 LEG 187
L
Sbjct: 208 LAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-20
Identities = 67/384 (17%), Positives = 128/384 (33%), Gaps = 32/384 (8%)
Query: 31 LNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLT 90
+ SIP+ L +++ L L+ NK+T L A + + L S+ +
Sbjct: 7 SGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 91 GSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQG-PIPESFGSLI 149
++ L LDLS N LS L L L+L GN +Q + F +L
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123
Query: 150 SLESLDLSSNNLSEGIPK-SLVALSHLKQFNVSHNRLEGEIPTE--GPFRNFSAQSFHWN 206
+L++L + + I + L+ L + + L ++ R+ + H +
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLS 182
Query: 207 YALCGPQRLQVPPCKEDKNKGFKKVALLVLKY-IFPPIICVVLIALVFIFFLRRRNRSTK 265
+ + D + + L F V + L R
Sbjct: 183 ------ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236
Query: 266 SPDDEELFSLATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGT---TVAIKI 322
EL L L+L F++C L G G F ++S+ TV I+
Sbjct: 237 DESFNELLKL----LRYILELSEVE--FDDCTLNGLGDFNPSESDVVSELGKVETVTIRR 290
Query: 323 FNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLY-SH 381
++ F ++ +L V+ + + + + + ++L S
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRIT----VENSKVFLVPCSFSQHLKS---LEFLDLSE 343
Query: 382 NYFQDIPDRLNIMIDVALALEYLH 405
N + + + +L+ L
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLV 367
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 38/188 (20%), Positives = 70/188 (37%), Gaps = 15/188 (7%)
Query: 3 RMQQLQGIGLADNHLQGSIPYD---LCQLKRLNSLSLQGNKLN--GSIPTCLASLTSLRE 57
++ L+ + L++N + + L +L L N L L +L +L
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391
Query: 58 LRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDI 117
L ++ N +P + E + ++NLSS + + + I L LD+S N L
Sbjct: 392 LDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQT--LEVLDVSNNNLD-SF 446
Query: 118 PKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQ 177
L L L ++ N+ + S L + +S N L L+ L++
Sbjct: 447 S---LFLPRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQK 501
Query: 178 FNVSHNRL 185
+ N
Sbjct: 502 IWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 35/241 (14%), Positives = 73/241 (30%), Gaps = 45/241 (18%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+ L + + L+ L ++ ++ L+L ++ + L+S+R L L
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 64 KLTS----------------------------------SIPSALWALEYILYVNLSSNYL 89
L + + L + + + + N L
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL 266
Query: 90 TGSLTSDIQNMK--------VLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPI 141
S+ + + L + + L D+ + L+ + +++ ++
Sbjct: 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVP 326
Query: 142 PESFGSLISLESLDLSSNNLSEGIPKSLVA---LSHLKQFNVSHNRLEGEIPTEGPFRNF 198
L SLE LDLS N + E K+ L+ +S N L T
Sbjct: 327 CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386
Query: 199 S 199
Sbjct: 387 K 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 33/188 (17%), Positives = 68/188 (36%), Gaps = 5/188 (2%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNS 62
LQ + L + + L L L L N L+ + L+SL+ L L
Sbjct: 48 ACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMG 107
Query: 63 NKLTS-SIPSALWALEYILYVNLSSNYLTGSL-TSDIQNMKVLIDLDLSRNQLSGDIPKT 120
N + + S L + + + + + D + L +L++ L ++
Sbjct: 108 NPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS 167
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE---GIPKSLVALSHLKQ 177
+ ++D+ +L+L ++ + L S+ L+L NL+ S +K+
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227
Query: 178 FNVSHNRL 185
+ L
Sbjct: 228 LAFRGSVL 235
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 8e-19
Identities = 39/190 (20%), Positives = 72/190 (37%), Gaps = 18/190 (9%)
Query: 21 IPYDLCQLKRLNSLSLQGNKLNG---------SIPTCLASL--TSLRELRLNSNKLTSSI 69
+ L + L+ + LNG + + L + ++R L + L +
Sbjct: 243 LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDL 302
Query: 70 PSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT---IAGLKD 126
+ LE + + + ++ + S Q++K L LDLS N + + K
Sbjct: 303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362
Query: 127 LTNLSLAGNQFQ--GPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNR 184
L L L+ N + E +L +L SLD+S N +P S ++ N+S
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTG 421
Query: 185 LEGEIPTEGP 194
+ + T P
Sbjct: 422 IR-VVKTCIP 430
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 41/162 (25%), Positives = 68/162 (41%), Gaps = 12/162 (7%)
Query: 2 GRMQQLQGIGLADNHLQ--GSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELR 59
G LQ + L+ NHL+ L LK L SL + N + +P +R L
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLN 416
Query: 60 LNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPK 119
L+S + LE + ++S+N L S + + L +L +SRN+L +P
Sbjct: 417 LSSTGIRVVKTCIPQTLEVL---DVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLPD 468
Query: 120 TIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNL 161
+ L + ++ NQ + F L SL+ + L +N
Sbjct: 469 A-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 28/203 (13%), Positives = 64/203 (31%), Gaps = 19/203 (9%)
Query: 2 GRMQQLQGIGLADNHLQGSIPY-DLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+ LQ + + + I D L LN L ++ L L S+ + L L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLS------ 114
+ ++ + L + Y+ L L S + +V + + S
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 115 -GDIPKTIAGLKDLTNLSLAGNQFQG-----------PIPESFGSLISLESLDLSSNNLS 162
++ K + + +L+ + G +++ L + L
Sbjct: 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 163 EGIPKSLVALSHLKQFNVSHNRL 185
+ L +K+ V ++++
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKV 322
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 23/131 (17%), Positives = 46/131 (35%), Gaps = 22/131 (16%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCL-------------- 49
++ L + ++ N +P +++ L+L + + TC+
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNL 443
Query: 50 ----ASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLID 105
L L+EL ++ NKL + +P A +L + +S N L + L
Sbjct: 444 DSFSLFLPRLQELYISRNKLKT-LPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQK 501
Query: 106 LDLSRNQLSGD 116
+ L N
Sbjct: 502 IWLHTNPWDCS 512
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 17/77 (22%), Positives = 36/77 (46%), Gaps = 2/77 (2%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNS 62
+ +LQ + ++ N L+ ++P D L + + N+L LTSL+++ L++
Sbjct: 449 FLPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506
Query: 63 NKLTSSIPSALWALEYI 79
N S P + ++
Sbjct: 507 NPWDCSCPRIDYLSRWL 523
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 7/197 (3%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKL 65
+ + L +N +Q L+ L L L N + L +L L L N+L
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124
Query: 66 TSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSR-NQLSGDIPKTIAG 123
T+ A L + + L +N + S+ S + L LDL +LS G
Sbjct: 125 TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
L +L L+LA + IP + LI L+ LDLS N+LS P S L HL++ + +
Sbjct: 184 LSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241
Query: 184 RLEGEIPTEGPFRNFSA 200
+++ I F N +
Sbjct: 242 QIQ-VIE-RNAFDNLQS 256
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 48/188 (25%), Positives = 86/188 (45%), Gaps = 9/188 (4%)
Query: 3 RMQQLQGIGLADNHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRL 60
++ L+ + L+ NH++ +I L LN+L L N+L +IP L+ L+EL L
Sbjct: 86 HLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWL 143
Query: 61 NSNKLTSSIPSALWALEYILYVNLSS-NYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIP 118
+N + S A + + ++L L+ ++ + + L L+L+ L +IP
Sbjct: 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP 201
Query: 119 KTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQF 178
+ L L L L+GN P SF L+ L+ L + + + + L L +
Sbjct: 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260
Query: 179 NVSHNRLE 186
N++HN L
Sbjct: 261 NLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 7e-20
Identities = 55/183 (30%), Positives = 85/183 (46%), Gaps = 7/183 (3%)
Query: 4 MQQLQGIGLADNHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRL- 60
+ L + L DN L +IP L +L L L+ N + SIP+ + SLR L L
Sbjct: 111 LANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLG 168
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+L+ A L + Y+NL+ L ++ + L +LDLS N LS P +
Sbjct: 169 ELKRLSYISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLSAIRPGS 226
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
GL L L + +Q Q +F +L SL ++L+ NNL+ L HL++ ++
Sbjct: 227 FQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHL 286
Query: 181 SHN 183
HN
Sbjct: 287 HHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 5/160 (3%)
Query: 4 MQQLQGIGLADNHLQGSIPYDL-CQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLN 61
+ +L+ + L +N ++ SIP ++ L L L K I L++LR L L
Sbjct: 135 LSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
L IP L L + ++LS N+L+ Q + L L + ++Q+
Sbjct: 194 MCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAF 251
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNL 161
L+ L ++LA N + F L LE + L N
Sbjct: 252 DNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 36/164 (21%), Positives = 67/164 (40%), Gaps = 7/164 (4%)
Query: 30 RLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYL 89
+ + + L +P + T+ R L L+ N++ ++ L ++ + LS N++
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 90 TGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSL 148
++ + L L+L N+L+ L L L L N + +F +
Sbjct: 101 R-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRI 159
Query: 149 ISLESLDLSSNNLSEGIPK-SLVALSHLKQFNVSHNRLEGEIPT 191
SL LDL I + + LS+L+ N++ L EIP
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN 202
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 31/138 (22%), Positives = 57/138 (41%), Gaps = 5/138 (3%)
Query: 3 RMQQLQGIGLAD-NHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
R+ L+ + L + L I L L L+L L IP L L L EL L
Sbjct: 158 RIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDL 214
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+ N L++ P + L ++ + + + + + N++ L++++L+ N L+
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDL 274
Query: 121 IAGLKDLTNLSLAGNQFQ 138
L L + L N +
Sbjct: 275 FTPLHHLERIHLHHNPWN 292
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 32/199 (16%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSSC 356
LG G F K + A+KI + ++E + E L+ H N++K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN--------IMIDVALALEYLH-HG 407
+ LV+E + G L F+ I + + IM + A+ ++H G
Sbjct: 76 HDQLHTFLVMELLNGGEL---------FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 408 HSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF 464
VVH DLKP N+L ++N+ + DFG ++L D+ ++T T+ Y APE
Sbjct: 127 ----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTP-CFTLHYAAPEL 180
Query: 465 GSEGNVSSKCDVYSYGILL 483
++ CD++S G++L
Sbjct: 181 LNQNGYDESCDLWSLGVIL 199
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 57/210 (27%), Positives = 85/210 (40%), Gaps = 37/210 (17%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSS 355
+LG G V I L A+KI Q E E+L + HRN+++++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN--------IMIDVALALEYLH-H 406
+ LV E M GS+ I R + ++ DVA AL++LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSI---------LSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 407 GHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDD-SVIQTMTIATI----G 458
G + H DLKP NIL ++ + DF + + D S I T + T
Sbjct: 131 G----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 459 YMAPE-----FGSEGNVSSKCDVYSYGILL 483
YMAPE +CD++S G++L
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 52/235 (22%), Positives = 90/235 (38%), Gaps = 17/235 (7%)
Query: 258 RRRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNE----CNLLGSGGFGSVYKGI-L 312
+ + + + W++ +E D + LG+G FG V++
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179
Query: 313 SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNG 372
+ G A K E + E + + +RH L+ + + + N ++ EFM G
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239
Query: 373 SL-DKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHSTPVVHCDLKPSNILLDENMVA 430
L +K HN + + + M V L ++H + VH DLKP NI+
Sbjct: 240 ELFEKVADEHNKMSE-DEAVEYMRQVCKGLCHMHENN----YVHLDLKPENIMFTTKRSN 294
Query: 431 HV--SDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILL 483
+ DFG++ L +T T + APE V D++S G+L
Sbjct: 295 ELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 57/243 (23%), Positives = 92/243 (37%), Gaps = 41/243 (16%)
Query: 258 RRRNRSTKSPDDEELFSLATWR--RTSYLDLERATDGFNECNLLGSGGFGSVYKGI-LSD 314
S D ++ L + DL +G G FG+VY + +
Sbjct: 29 MPAGGRAGSLKDPDVAELFFKDDPEKLFSDLRE----------IGHGSFGAVYFARDVRN 78
Query: 315 GTTVAIKIFNLQLEQA---FRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPN 371
VAIK + +Q+ ++ E L+ +RH N I+ + LV+E+
Sbjct: 79 SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 138
Query: 372 GSLDKWLYSHNYFQDIPDRLN------IMIDVALALEYLHHGHSTPVVHCDLKPSNILLD 425
+ D + L + L YLH S ++H D+K NILL
Sbjct: 139 SASD-------LLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLS 188
Query: 426 ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE---FGSEGNVSSKCDVYSYGIL 482
E + + DFG + ++ + + + T +MAPE EG K DV+S GI
Sbjct: 189 EPGLVKLGDFGSASIMAPAN-----SF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 242
Query: 483 LLE 485
+E
Sbjct: 243 CIE 245
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 48/180 (26%), Positives = 69/180 (38%), Gaps = 3/180 (1%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIP-TCLASLTSLRELRLNSNK 64
L + L N L L L L L N S+ L L L L+
Sbjct: 57 NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116
Query: 65 LTSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAG 123
L P L + Y+ L N L +L D +++ L L L N++S + G
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
L L L L N+ P +F L L +L L +NNLS ++L L L+ ++ N
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 44/183 (24%), Positives = 65/183 (35%), Gaps = 5/183 (2%)
Query: 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLT 66
Q I L N + + L L L N L L L +L L+ N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 67 SSIPS-ALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTI-AG 123
S+ L + ++L L L + + + L L L N L +P
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD 151
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
L +LT+L L GN+ +F L SL+ L L N ++ P + L L + N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 184 RLE 186
L
Sbjct: 212 NLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 8/174 (4%)
Query: 26 CQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85
C + + S L ++P + + + + L+ N+++ ++ A + + L
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 86 SNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPK-TIAGLKDLTNLSLAGNQFQGPIPE 143
SN L + + + +L LDLS N + T GL L L L Q P
Sbjct: 65 SNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG 123
Query: 144 SFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRN 197
F L +L+ L L N L + L +L + NR+ +P E FR
Sbjct: 124 LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVP-ERAFRG 175
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 34/138 (24%), Positives = 57/138 (41%), Gaps = 6/138 (4%)
Query: 4 MQQLQGIGLADNHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLN 61
+ +L + L LQ + L L L LQ N L ++P L +L L L+
Sbjct: 104 LGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLH 161
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKT 120
N+++S A L + + L N + + +++ L+ L L N LS +
Sbjct: 162 GNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEA 220
Query: 121 IAGLKDLTNLSLAGNQFQ 138
+A L+ L L L N +
Sbjct: 221 LAPLRALQYLRLNDNPWV 238
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 53/237 (22%), Positives = 85/237 (35%), Gaps = 56/237 (23%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQL-----EQAFRSFNSECEVLRNVRHRNLIKI 352
+G G +G V I AIKI N + +E +++ + H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 353 LSSCCNTNFKALVLEFMPNGSL-DKWLYSHNYFQDIPDRL-------------------- 391
+ + LV+E G L DK +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 392 ------------------NIMIDVALALEYLH-HGHSTPVVHCDLKPSNILL--DENMVA 430
NIM + AL YLH G + H D+KP N L +++
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTNKSFEI 209
Query: 431 HVSDFGISKLLGEGDDSVIQTMTIA--TIGYMAPE--FGSEGNVSSKCDVYSYGILL 483
+ DFG+SK + ++ MT T ++APE + + KCD +S G+LL
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 55/242 (22%), Positives = 93/242 (38%), Gaps = 33/242 (13%)
Query: 259 RRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNE----CNLLGSGGFGSVYKGI-LS 313
R +D + F W++ +E + LGSG FG V++ + +
Sbjct: 15 RGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKA 74
Query: 314 DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGS 373
G K N + +E ++ + H LI + + + L+LEF+ G
Sbjct: 75 TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134
Query: 374 LDKWLYSHNYFQDIPDR---------LNIMIDVALALEYLH-HGHSTPVVHCDLKPSNIL 423
L F I +N M L+++H H +VH D+KP NI+
Sbjct: 135 L---------FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS----IVHLDIKPENIM 181
Query: 424 LDENMVAHV--SDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGI 481
+ + V DFG++ L + I +T AT + APE V D+++ G+
Sbjct: 182 CETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238
Query: 482 LL 483
L
Sbjct: 239 LG 240
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 37/208 (17%)
Query: 296 CNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKI 352
LG G F V + + + G A KI N + + F+ E + R ++H N++++
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--------LNIMIDVALALEYL 404
S +F LV + + G L F+DI R + + + ++ Y
Sbjct: 94 HDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 405 H-HGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIA-TIGY 459
H +G +VH +LKP N+LL + ++DFG++ + + + A T GY
Sbjct: 145 HSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGY 196
Query: 460 MAPEFGSEGNVSSKCDVYSYG----ILL 483
++PE + S D+++ G ILL
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILL 224
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 49/188 (26%), Positives = 84/188 (44%), Gaps = 9/188 (4%)
Query: 3 RMQQLQGIGLADNHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRL 60
+ L+ + L N ++ I L LN+L L N L IP+ L+ LREL L
Sbjct: 97 HLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWL 154
Query: 61 NSNKLTSSIPSALWALEYILYVNLSS-NYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIP 118
+N + S A + ++ ++L L ++ + + L L+L + D+P
Sbjct: 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP 212
Query: 119 KTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQF 178
+ L L L ++GN F P SF L SL+ L + ++ +S + L+ L +
Sbjct: 213 -NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271
Query: 179 NVSHNRLE 186
N++HN L
Sbjct: 272 NLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 49/197 (24%), Positives = 79/197 (40%), Gaps = 7/197 (3%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKL 65
+ + L +N++Q L L L L N + L SL L L N L
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135
Query: 66 TSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSR-NQLSGDIPKTIAG 123
T A L + + L +N + S+ S + L+ LDL +L G
Sbjct: 136 TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
L +L L+L + +P + L+ LE L++S N+ E P S LS LK+ V ++
Sbjct: 195 LFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252
Query: 184 RLEGEIPTEGPFRNFSA 200
++ I F ++
Sbjct: 253 QVS-LIE-RNAFDGLAS 267
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 50/183 (27%), Positives = 77/183 (42%), Gaps = 7/183 (3%)
Query: 4 MQQLQGIGLADNHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRL- 60
+ L + L DN L IP L +L L L+ N + SIP+ + SL L L
Sbjct: 122 LASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLG 179
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
KL A L + Y+NL + + ++ + L +L++S N P +
Sbjct: 180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DM-PNLTPLVGLEELEMSGNHFPEIRPGS 237
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
GL L L + +Q +F L SL L+L+ NNLS L +L + ++
Sbjct: 238 FHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHL 297
Query: 181 SHN 183
HN
Sbjct: 298 HHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 42/189 (22%), Positives = 70/189 (37%), Gaps = 12/189 (6%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS 71
L +P + L+L N + L L L+L N +
Sbjct: 61 CTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVG 117
Query: 72 ALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTI-AGLKDLTN 129
A L + + L N+LT + S + + L +L L N + IP + L
Sbjct: 118 AFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMR 175
Query: 130 LSLAG-NQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGE 188
L L + + +F L +L+ L+L N+ + +P +L L L++ +S N E
Sbjct: 176 LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFP-E 232
Query: 189 IPTEGPFRN 197
I G F
Sbjct: 233 IR-PGSFHG 240
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 7e-17
Identities = 37/160 (23%), Positives = 60/160 (37%), Gaps = 5/160 (3%)
Query: 4 MQQLQGIGLADNHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLN 61
+ +L+ + L +N ++ SIP ++ L L L K I L +L+ L L
Sbjct: 146 LSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
+ +P L L + + +S N+ + L L + +Q+S
Sbjct: 205 MCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAF 262
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNL 161
GL L L+LA N + F L L L L N
Sbjct: 263 DGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 28/137 (20%), Positives = 53/137 (38%), Gaps = 5/137 (3%)
Query: 4 MQQLQGIGLAD-NHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ L + L + L+ I L L L+L + +P L L L EL ++
Sbjct: 170 VPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMS 226
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
N P + L + + + ++ ++ + + L++L+L+ N LS
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLF 286
Query: 122 AGLKDLTNLSLAGNQFQ 138
L+ L L L N +
Sbjct: 287 TPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 25/95 (26%), Positives = 40/95 (42%), Gaps = 5/95 (5%)
Query: 106 LDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGI 165
+ +R LS ++P+ I + L+L N Q ++F L LE L L N++ +
Sbjct: 59 VVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIE 115
Query: 166 PKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSA 200
+ L+ L + N L IP G F S
Sbjct: 116 VGAFNGLASLNTLELFDNWLT-VIP-SGAFEYLSK 148
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 20/85 (23%), Positives = 35/85 (41%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNS 62
+ L+ + ++ NH P L L L + ++++ L SL EL L
Sbjct: 216 PLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAH 275
Query: 63 NKLTSSIPSALWALEYILYVNLSSN 87
N L+S L Y++ ++L N
Sbjct: 276 NNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 5/183 (2%)
Query: 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLN--GSIPTCLASLTSLRELRLNSNK 64
+ L N LQ +L +L LSL N L+ G TSL+ L L+ N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 65 LTSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAG 123
+ ++ S LE + +++ + L + +++ LI LD+S G
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148
Query: 124 LKDLTNLSLAGNQFQGPIPE-SFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSH 182
L L L +AGN FQ F L +L LDLS L + P + +LS L+ N+SH
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 208
Query: 183 NRL 185
N
Sbjct: 209 NNF 211
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 43/189 (22%), Positives = 77/189 (40%), Gaps = 7/189 (3%)
Query: 3 RMQQLQGIGLADNHL--QGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
++ QL + L+ N L +G L L L N + ++ + L L L
Sbjct: 50 KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 108
Query: 61 NSNKLTSSIP-SALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIP 118
+ L S +L ++Y+++S + + I + L L ++ N +
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFL 167
Query: 119 KTI-AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQ 177
I L++LT L L+ Q + P +F SL SL+ L++S NN L+ L+
Sbjct: 168 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227
Query: 178 FNVSHNRLE 186
+ S N +
Sbjct: 228 LDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 43/188 (22%), Positives = 79/188 (42%), Gaps = 10/188 (5%)
Query: 14 DNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLT--SSIPS 71
L S+P + L L+ NKL LT L +L L+SN L+
Sbjct: 16 SKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72
Query: 72 ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI-AGLKDLTNL 130
+ + + Y++LS N + +++S+ ++ L LD + L ++ L++L L
Sbjct: 73 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 131
Query: 131 SLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGI-PKSLVALSHLKQFNVSHNRLEGEI 189
++ + F L SLE L ++ N+ E P L +L ++S +LE ++
Sbjct: 132 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QL 190
Query: 190 PTEGPFRN 197
F +
Sbjct: 191 S-PTAFNS 197
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 29/163 (17%), Positives = 62/163 (38%), Gaps = 5/163 (3%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQ-LKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNS 62
++QL+ + ++L+ + + L+ L L + + L+SL L++
Sbjct: 100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 159
Query: 63 NKLTSSIPSALWA-LEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKT 120
N + ++ L + +++LS L L+ ++ L L++S N
Sbjct: 160 NSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 218
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLI-SLESLDLSSNNLS 162
L L L + N + SL L+L+ N+ +
Sbjct: 219 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 23/82 (28%), Positives = 33/82 (40%), Gaps = 5/82 (6%)
Query: 106 LDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEG- 164
+ + L+ +P I T L L N+ Q F L L L LSSN LS
Sbjct: 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 165 -IPKSLVALSHLKQFNVSHNRL 185
+S + LK ++S N +
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGV 90
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 18/87 (20%), Positives = 33/87 (37%), Gaps = 3/87 (3%)
Query: 3 RMQQLQGIGLADNHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
++ L + L+ L+ + L L L++ N L SL+ L +
Sbjct: 173 ELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 231
Query: 62 SNKLTSSIPSALWALEYIL-YVNLSSN 87
N + +S L L ++NL+ N
Sbjct: 232 LNHIMTSKKQELQHFPSSLAFLNLTQN 258
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 66/244 (27%), Positives = 100/244 (40%), Gaps = 31/244 (12%)
Query: 274 SLATWRRTSYLDLERATD---GFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ 329
S + R +DL D F L+G+G +G VYKG + G AIK+ ++
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GD 62
Query: 330 AFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKA------LVLEFMPNGSLDKWLYSHN 382
E +L+ HRN+ + N LV+EF GS+ L +
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNT 121
Query: 383 YFQDIPDRL--NIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440
+ + I ++ L +LH V+H D+K N+LL EN + DFG+S
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 441 LGEGDDSVIQTMTIATIG---YMAPE-----FGSEGNVSSKCDVYSYGILLLETFTRKKP 492
L D +V + T IG +MAPE + K D++S GI +E P
Sbjct: 179 L---DRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
Query: 493 TDEM 496
+M
Sbjct: 234 LCDM 237
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 5e-23
Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 33/227 (14%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQ-----LEQAFRSFNSECEVLRNVRHRNLIK 351
LG G +G V + VA+KI +++ E + E + + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 352 ILSSCCNTNFKALVLEFMPNGSL-DKWLY--------SHNYFQDIPDRLNIMIDVALALE 402
N + L LE+ G L D+ + +F + + +
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-------MA---GVV 119
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
YLH + H D+KP N+LLDE +SDFG++ + + + T+ Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 463 E-FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVK 508
E + DV+S GI+L + P D+ +W +
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 50/226 (22%), Positives = 86/226 (38%), Gaps = 41/226 (18%)
Query: 284 LDLERATDGFNE----CNLLGSGGFGSVYKGI-LSDGTTVAIKI-----FNLQLEQAFRS 333
LD+ F + C ++G G F V + I G A+KI F +
Sbjct: 13 LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 334 FNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN- 392
E + ++H +++++L + + +V EFM L +I R +
Sbjct: 73 LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADA 123
Query: 393 -----------IMIDVALALEYLH-HGHSTPVVHCDLKPSNILL---DENMVAHVSDFGI 437
M + AL Y H + ++H D+KP +LL + + + FG+
Sbjct: 124 GFVYSEAVASHYMRQILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGV 179
Query: 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILL 483
+ LGE V + T +MAPE DV+ G++L
Sbjct: 180 AIQLGE-SGLVAGGR-VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 40/220 (18%), Positives = 82/220 (37%), Gaps = 27/220 (12%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+ +L+ + L+ N L+ +P + K L L + N++ + L + + L +N
Sbjct: 99 LVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 155
Query: 64 KLTSSI--PSALWALEYILYVNLSSNYLT----GSLTSDIQNMKVLIDLDLSRNQLSGDI 117
L SS A ++ + Y+ ++ +T G S L +L L N+++
Sbjct: 156 PLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS-------LTELHLDGNKITKVD 208
Query: 118 PKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQ 177
++ GL +L L L+ N S + L L L++N L + +P L +++
Sbjct: 209 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQV 267
Query: 178 FNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQV 217
+ +N + + F
Sbjct: 268 VYLHNNNI----------SAIGSNDFCPPGYNTKKASYSG 297
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 35/204 (17%), Positives = 71/204 (34%), Gaps = 12/204 (5%)
Query: 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSI--PTCLASLTSLRELRLNS 62
+ LQ + + +N + L ++ + L N L S + L +R+
Sbjct: 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 180
Query: 63 NKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIA 122
+T+ +L + +L N +T + ++ + L L LS N +S ++A
Sbjct: 181 TNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 237
Query: 123 GLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE------GIPKSLVALSHLK 176
L L L N+ +P ++ + L +NN+S P +
Sbjct: 238 NTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 296
Query: 177 QFNVSHNRLEGEIPTEGPFRNFSA 200
++ N ++ FR
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYV 320
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 8e-21
Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLT 66
+ L +N + D LK L++L L NK++ P A L L L L+ N+L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 67 --------------------SSIPSALWA-LEYILYVNLSSNYLTGSLTSD--IQNMKVL 103
+ + +++ L ++ V L +N L S + Q MK L
Sbjct: 114 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 173
Query: 104 IDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163
+ ++ ++ IP+ + LT L L GN+ S L +L L LS N++S
Sbjct: 174 SYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 230
Query: 164 GIPKSLVALSHLKQFNVSHNRLEGEIP 190
SL HL++ ++++N+L ++P
Sbjct: 231 VDNGSLANTPHLRELHLNNNKLV-KVP 256
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 41/191 (21%), Positives = 75/191 (39%), Gaps = 14/191 (7%)
Query: 4 MQQLQGIGLADNHLQGS-IPYDLCQ-LKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ Q+ + L N L+ S I Q +K+L+ + + + +IP SL EL L+
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLD 200
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
NK+T ++L L + + LS N ++ + N L +L L+ N+L +P +
Sbjct: 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 122 AGLKDLTNLSLAGNQFQG------PIPESFGSLISLESLDLSSNNLSEGI--PKSLVALS 173
A K + + L N P S + L SN + P + +
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319
Query: 174 HLKQFNVSHNR 184
+ + +
Sbjct: 320 VRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 33/167 (19%), Positives = 62/167 (37%), Gaps = 11/167 (6%)
Query: 31 LNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLT 90
L + L +P L L L +NK+T L+ + + L +N ++
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 91 GSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLI 149
++ + L L LS+NQL ++P+ + K L L + N+ F L
Sbjct: 90 -KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145
Query: 150 SLESLDLSSNNLSEGI--PKSLVALSHLKQFNVSHNRLEGEIPTEGP 194
+ ++L +N L + + L ++ + IP P
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP 191
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 34/144 (23%), Positives = 60/144 (41%), Gaps = 6/144 (4%)
Query: 54 SLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQL 113
LR ++ + L +P L ++L +N +T D +N+K L L L N++
Sbjct: 32 HLRVVQCSDLGLEK-VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 114 SGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALS 173
S P A L L L L+ NQ + +PE +L+ L + N +++ L+
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKE-LPE--KMPKTLQELRVHENEITKVRKSVFNGLN 145
Query: 174 HLKQFNVSHNRLEGEIPTEGPFRN 197
+ + N L+ G F+
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQG 169
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 34/200 (17%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVL-RNVRHRNLIKILSSC 356
+G G + + I + A+KI + E E+L R +H N+I +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDVY 85
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLN--------IMIDVALALEYLH-HG 407
+ + +V E M G L I + ++ + +EYLH G
Sbjct: 86 DDGKYVYVVTELMKGGEL---------LDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 408 HSTPVVHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 463
VVH DLKPSNIL + DFG +K L ++ ++ T T ++APE
Sbjct: 137 ----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTP-CYTANFVAPE 190
Query: 464 FGSEGNVSSKCDVYSYGILL 483
+ CD++S G+LL
Sbjct: 191 VLERQGYDAACDIWSLGVLL 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 37/204 (18%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFN-LQLEQAFRSFNSECEVLRNVRHRNLIKILSS 355
LG G VY+ A+K+ ++ R+ E VL + H N+IK+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT---EIGVLLRLSHPNIIKLKEI 116
Query: 356 CCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--------LNIMIDVALALEYLH-H 406
+LVLE + G L F I ++ + + + A+ YLH +
Sbjct: 117 FETPTEISLVLELVTGGEL---------FDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 407 GHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 463
G +VH DLKP N+L + ++DFG+SK++ +++T+ T GY APE
Sbjct: 168 G----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTV-CGTPGYCAPE 220
Query: 464 FGSEGNVSSKCDVYSYG----ILL 483
+ D++S G ILL
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILL 244
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 44/209 (21%), Positives = 72/209 (34%), Gaps = 16/209 (7%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ L ++ N L L + L N +N + L L+L
Sbjct: 189 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQ 240
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
N LT + L ++ V+LS N L + M+ L L +S N+L +
Sbjct: 241 HNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYG 297
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVS 181
+ L L L+ N + + LE+L L N++ + S LK +S
Sbjct: 298 QPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVT-LKLS--THHTLKNLTLS 353
Query: 182 HNRLEGEIPTEGPFRNFSAQSFHWNYALC 210
HN + FRN + + C
Sbjct: 354 HNDWD-CNSLRALFRNVARPAVDDADQHC 381
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 2e-21
Identities = 49/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 4 MQQLQGIGLADNHLQGSIPYDL-CQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNS 62
+ L + L N L S+P + +L +LS+ N L + TSL+ L+L+S
Sbjct: 122 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSS 180
Query: 63 NKLTSSIPSALWALEYILYVNLSSNYLT-----GSLTS-DIQNMKV----------LIDL 106
N+LT S + +L + N+S N L+ ++ D + + L L
Sbjct: 181 NRLTHVDLSLIPSLFHA---NVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTIL 237
Query: 107 DLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIP 166
L N L+ D + L + L+ N+ + + F + LE L +S+N L +
Sbjct: 238 KLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LN 294
Query: 167 KSLVALSHLKQFNVSHNRLE 186
+ LK ++SHN L
Sbjct: 295 LYGQPIPTLKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 8e-21
Identities = 36/186 (19%), Positives = 73/186 (39%), Gaps = 12/186 (6%)
Query: 3 RMQQLQGIGLADNHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ + + ++ ++ +P L +++ L+L ++ A ++++L +
Sbjct: 49 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 107
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKT 120
N + P + + + L N L+ SL I N L L +S N L T
Sbjct: 108 FNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT 166
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
L NL L+ N+ + + SL ++S N LS +L +++ +
Sbjct: 167 FQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDA 218
Query: 181 SHNRLE 186
SHN +
Sbjct: 219 SHNSIN 224
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 1e-20
Identities = 42/182 (23%), Positives = 74/182 (40%), Gaps = 7/182 (3%)
Query: 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLT 66
+ + ++ L ++ + + + L S + L LN ++
Sbjct: 29 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 88
Query: 67 SSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTI-AGL 124
A I + + N + L + QN+ +L L L RN LS +P+ I
Sbjct: 89 EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNT 146
Query: 125 KDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNR 184
LT LS++ N + ++F + SL++L LSSN L+ + S + L NVS+N
Sbjct: 147 PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDLS--LIPSLFHANVSYNL 203
Query: 185 LE 186
L
Sbjct: 204 LS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 4e-20
Identities = 36/197 (18%), Positives = 75/197 (38%), Gaps = 14/197 (7%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+Q++ + L D ++ Y + L + N + P ++ L L L
Sbjct: 72 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKT 120
N L+S + +++S+N L + D Q L +L LS N+L+ +
Sbjct: 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD-- 187
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
++ + L + +++ N + I++E LD S N+++ + L +
Sbjct: 188 LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGP--VNVELTILKL 239
Query: 181 SHNRLEGEIPTEGPFRN 197
HN L + +
Sbjct: 240 QHNNLT-DTAWLLNYPG 255
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 1e-17
Identities = 27/168 (16%), Positives = 58/168 (34%), Gaps = 2/168 (1%)
Query: 20 SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYI 79
I +L + + + +L + + + ++ + + L + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 80 LYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQ 138
+NL+ + + + + L + N + P + LT L L N
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 139 GPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
F + L +L +S+NNL + A + L+ +S NRL
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 18/131 (13%), Positives = 39/131 (29%), Gaps = 2/131 (1%)
Query: 67 SSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKD 126
I S L V++ + + + + + + +
Sbjct: 17 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76
Query: 127 LTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
+ L+L Q + +F +++ L + N + P + L + N L
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 187 GEIPTEGPFRN 197
+P G F N
Sbjct: 137 -SLP-RGIFHN 145
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 14/109 (12%), Positives = 36/109 (33%), Gaps = 2/109 (1%)
Query: 92 SLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISL 151
+ S++Q V D+ + L + ++ + + S +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 152 ESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSA 200
E L+L+ + E + +++ + N + +P F+N
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLP-PHVFQNVPL 124
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 34/207 (16%)
Query: 296 CNLLGSGGFGSVYKGI-LSDGTTVAIKIFN--LQLEQAFRSFNSECEVLRNVRHRNLIKI 352
LG G F V + + + G A I N + + E + R ++H N++++
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--------LNIMIDVALALEYL 404
S L+ + + G L F+DI R + + + A+ +
Sbjct: 76 HDSISEEGHHYLIFDLVTGGEL---------FEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 405 H-HGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460
H G VVH +LKP N+LL + ++DFG++ + EG+ T GY+
Sbjct: 127 HQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGF-AGTPGYL 180
Query: 461 APEFGSEGNVSSKCDVYSYG----ILL 483
+PE + D+++ G ILL
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILL 207
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 52/206 (25%), Positives = 79/206 (38%), Gaps = 16/206 (7%)
Query: 12 LADNHLQG--SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSI 69
+A +P L +RL L N + + L L+ L L S +I
Sbjct: 8 IAFYRFCNLTQVPQVLNTTERLL---LSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 70 -PSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDI--PKTIAGLKD 126
A L + ++L S+ + Q + L +L L LS + LK
Sbjct: 65 DKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA 124
Query: 127 LTNLSLAGNQFQG-PIPESFGSLISLESLDLSSNNLSEGIPKSLVALS--HLKQFNVSHN 183
LT L L+ NQ + + SFG L SL+S+D SSN + L L L F+++ N
Sbjct: 125 LTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAAN 184
Query: 184 RLEGEIPTE-----GPFRNFSAQSFH 204
L + + PFRN +
Sbjct: 185 SLYSRVSVDWGKCMNPFRNMVLEILD 210
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 8e-22
Identities = 43/196 (21%), Positives = 79/196 (40%), Gaps = 12/196 (6%)
Query: 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSI-PTCLASLTSLRELRLNSNKL 65
+ + L+ N+++ L++L L L +I +L +LR L L S+K+
Sbjct: 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85
Query: 66 TSSIPSALWALEYILYVNLSSNYLTGSLTSD--IQNMKVLIDLDLSRNQLSG-DIPKTIA 122
P A L ++ + L L+ ++ D +N+K L LDLS+NQ+ + +
Sbjct: 86 YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG 145
Query: 123 GLKDLTNLSLAGNQFQGPIPESFGSL--ISLESLDLSSNNLSEGIPKSLVALS------H 174
L L ++ + NQ L +L L++N+L +
Sbjct: 146 KLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMV 205
Query: 175 LKQFNVSHNRLEGEIP 190
L+ +VS N +I
Sbjct: 206 LEILDVSGNGWTVDIT 221
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-21
Identities = 46/207 (22%), Positives = 75/207 (36%), Gaps = 28/207 (13%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+ LQ + L+ N L + L ++ + LQ N + L L+ L L N
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDN 372
Query: 64 KLT------------------SSIPSALWALEYILYVNLSSNYLTG-SLTSDIQNMKVLI 104
LT ++P I +LS N L + + + L
Sbjct: 373 ALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLI---HLSENRLENLDILYFLLRVPHLQ 429
Query: 105 DLDLSRNQLSG-DIPKTIAGLKDLTNLSLAGNQFQGPI-----PESFGSLISLESLDLSS 158
L L++N+ S +T + L L L N Q + F L L+ L L+
Sbjct: 430 ILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNH 489
Query: 159 NNLSEGIPKSLVALSHLKQFNVSHNRL 185
N L+ P L+ L+ +++ NRL
Sbjct: 490 NYLNSLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 8e-21
Identities = 46/208 (22%), Positives = 78/208 (37%), Gaps = 24/208 (11%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQ-LKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
++QLQ + L + +I + + L L L L +K+ P L L ELRL
Sbjct: 46 FLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLY 105
Query: 62 SNKLTSSI--PSALWALEYILYVNLSSNYLTG-SLTSDIQNMKVLIDLDLSRNQLSGDIP 118
L+ ++ L+ + ++LS N + L + L +D S NQ+
Sbjct: 106 FCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCE 165
Query: 119 KTIAGL--KDLTNLSLAGNQFQGPIPESFGSL------ISLESLDLSSNNLSEGIPK--- 167
+ L K L+ SLA N + +G + LE LD+S N + I
Sbjct: 166 HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFS 225
Query: 168 ---------SLVALSHLKQFNVSHNRLE 186
SL+ H+ + ++
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIK 253
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-20
Identities = 43/206 (20%), Positives = 74/206 (35%), Gaps = 22/206 (10%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQL--KRLNSLSLQGNKLNGSIPTCLASL------T 53
G++ L+ I + N + ++L L K L+ SL N L +
Sbjct: 145 GKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNM 204
Query: 54 SLRELRLNSNKLTSSIPSA------------LWALEYILYVNLSSNYLTGSLTSDIQNMK 101
L L ++ N T I L +I+ + + + +
Sbjct: 205 VLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLA 264
Query: 102 V--LIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSN 159
+ LDLS + + LKDL L+LA N+ E+F L +L+ L+LS N
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 160 NLSEGIPKSLVALSHLKQFNVSHNRL 185
L E + L + ++ N +
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHI 350
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-20
Identities = 36/177 (20%), Positives = 65/177 (36%), Gaps = 7/177 (3%)
Query: 11 GLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASL--TSLRELRLNSNKLTSS 68
G N + S + L + + + A L +S+R L L+ + S
Sbjct: 222 GNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSL 281
Query: 69 IPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLT 128
L+ + +NL+ N + + L L+LS N L GL +
Sbjct: 282 NSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA 341
Query: 129 NLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRL 185
+ L N ++F L L++LDL N L+ ++ + + +S N+L
Sbjct: 342 YIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL 393
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-20
Identities = 40/198 (20%), Positives = 70/198 (35%), Gaps = 11/198 (5%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
++ L+ + LA N + L L L+L N L + L + + L N
Sbjct: 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
+ LE + ++L N LT I + + D+ LS N+L +
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLT- 402
Query: 124 LKDLTNLSLAGNQFQG-PIPESFGSLISLESLDLSSNNLSEGIPKSLVA-LSHLKQFNVS 181
+ L+ N+ + I + L+ L L+ N S + L+Q +
Sbjct: 403 ---ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLG 459
Query: 182 HNRLEGEIPTEGPFRNFS 199
N L+ TE + F
Sbjct: 460 ENMLQLAWETELCWDVFE 477
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-17
Identities = 51/234 (21%), Positives = 84/234 (35%), Gaps = 36/234 (15%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+ ++ I L NH+ L++L +L L+ N L T + + S+ ++ L+ N
Sbjct: 337 LPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGN 391
Query: 64 KLTS---------------------SIPSALWALEYILYVNLSSNYLTG-SLTSDIQNMK 101
KL + I L + ++ + L+ N + S
Sbjct: 392 KLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENP 451
Query: 102 VLIDLDLSRNQLSGDIPKTI-----AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDL 156
L L L N L + GL L L L N P F L +L L L
Sbjct: 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSL 511
Query: 157 SSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALC 210
+SN L+ L ++L+ ++S N+L P F + S N +C
Sbjct: 512 NSNRLTVLSHNDL--PANLEILDISRNQL--LAPNPDVFVSLSVLDITHNKFIC 561
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 35/209 (16%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIK 351
++ +LG G FG V+K + G +A KI + + +E V+ + H NLI+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR---------LNIMIDVALALE 402
+ + + N LV+E++ G L F I D + M + +
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGEL---------FDRIIDESYNLTELDTILFMKQICEGIR 201
Query: 403 YLH-HGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG 458
++H ++H DLKP NIL D + + DFG+++ + ++ T
Sbjct: 202 HMHQMY----ILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPRE--KLKVN-FGTPE 253
Query: 459 YMAPEFGSEGNVSSKCDVYSYG----ILL 483
++APE + VS D++S G +LL
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 44/211 (20%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFN--------LQLEQAFRSFNSECEVLRNVRHRN 348
LLG G +G V + + A+KI + E ++LR +RH+N
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK----EIQLLRRLRHKN 67
Query: 349 LIKILSSCCNTNFKA--LVLEFMPNGSLDKWLY----------SHNYFQDIPDRLNIMID 396
+I+++ N + +V+E+ G + +H YF + ID
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL-------ID 120
Query: 397 VALALEYLH-HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG-DDSVIQTMTI 454
LEYLH G +VH D+KP N+LL +S G+++ L D +T +
Sbjct: 121 ---GLEYLHSQG----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQ 172
Query: 455 ATIGYMAPEF--GSEGNVSSKCDVYSYGILL 483
+ + PE G + K D++S G+ L
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 53/228 (23%), Positives = 91/228 (39%), Gaps = 35/228 (15%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQ-----LEQAFRSFNSECEVLRNVRHRNLIK 351
LG G +G V + VA+KI +++ E + E + + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 352 ILSSCCNTNFKALVLEFMPNGSL-DKWLY--------SHNYFQDIPDRLNIMIDVALALE 402
N + L LE+ G L D+ + +F + + +
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-------MA---GVV 119
Query: 403 YLH-HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 461
YLH G + H D+KP N+LLDE +SDFG++ + + + T+ Y+A
Sbjct: 120 YLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 462 PE-FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVK 508
PE + DV+S GI+L + P D+ +W +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-22
Identities = 47/190 (24%), Positives = 77/190 (40%), Gaps = 10/190 (5%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNS 62
+Q L + L +N + L++L L + N L IP L +SL ELR++
Sbjct: 76 GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHD 132
Query: 63 NKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDI--QNMKVLIDLDLSRNQLSGDIPKT 120
N++ L + + + N L S +K L L +S +L+ IPK
Sbjct: 133 NRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLT-GIPKD 190
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+ + L L L N+ Q E L L L N + SL L L++ ++
Sbjct: 191 L--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL 248
Query: 181 SHNRLEGEIP 190
+N+L +P
Sbjct: 249 DNNKLS-RVP 257
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 40/204 (19%), Positives = 76/204 (37%), Gaps = 15/204 (7%)
Query: 5 QQLQGIGLADNHLQGSIPYDLCQ-LKRLNSLSLQGNKL-NGSIPTCLASLTSLRELRLNS 62
L + + DN ++ +P + L+ +N + + GN L N L LR++
Sbjct: 123 SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE 181
Query: 63 NKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIA 122
KLT L + +L N + D+ L L L NQ+ +++
Sbjct: 182 AKLTGIPKDLPETLNEL---HLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238
Query: 123 GLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIP-------KSLVALSHL 175
L L L L N+ +P L L+ + L +NN+++ + V ++
Sbjct: 239 FLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITK-VGVNDFCPVGFGVKRAYY 296
Query: 176 KQFNVSHNRLEGEIPTEGPFRNFS 199
++ +N + FR +
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVT 320
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 32/163 (19%), Positives = 65/163 (39%), Gaps = 14/163 (8%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLNSNK 64
+L + +++ L IP DL + LN L L NK+ +I L + L L L N+
Sbjct: 173 KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQ 228
Query: 65 LTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGL 124
+ +L L + ++L +N L+ + + + ++K+L + L N ++ +
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPV 287
Query: 125 KD------LTNLSLAGNQFQGPI--PESFGSLISLESLDLSSN 159
+SL N P +F + ++ +
Sbjct: 288 GFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 40/200 (20%), Positives = 80/200 (40%), Gaps = 20/200 (10%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKL 65
L+ + +D L+ ++P ++ L LQ N ++ L L L L +NK+
Sbjct: 34 HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 66 TSSIPSALWALEYILYVNLSSNYLT----GSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
+ A L + + +S N+L +S L++L + N++
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSS-------LVELRIHDNRIRKVPKGVF 143
Query: 122 AGLKDLTNLSLAGNQFQ-GPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+GL+++ + + GN + + L L +S L+ IPK L L + ++
Sbjct: 144 SGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL--PETLNELHL 200
Query: 181 SHNRLEGEIPTEGPFRNFSA 200
HN+++ I +S
Sbjct: 201 DHNKIQ-AIE-LEDLLRYSK 218
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 25/137 (18%), Positives = 44/137 (32%), Gaps = 23/137 (16%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQ-LKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
R +L +GL N ++ I L L L L NKL+ +P L L L+ + L+
Sbjct: 215 RYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDI--PK 119
+N +T + + + + L N + P
Sbjct: 273 TNNIT-KVGVNDFC-------PVGFGVKRAYYNG----------ISLFNNPVPYWEVQPA 314
Query: 120 TIAGLKDLTNLSLAGNQ 136
T + D + +
Sbjct: 315 TFRCVTDRLAIQFGNYK 331
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-22
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 44/207 (21%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVL-RNVRHRNLIKILSS 355
+LG G G V + G A+K+ +A + E + + +++ IL
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDV 90
Query: 356 CCNTNFKA----LVLEFMPNGSLDKWLYSHNYFQDIPDRLN----------IMIDVALAL 401
N + +++E M G L F I +R + IM D+ A+
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL---------FSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 402 EYLH-HGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIA-T 456
++LH H + H D+KP N+L +++ V ++DFG +K + T T
Sbjct: 142 QFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-----ALQTPCYT 192
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILL 483
Y+APE CD++S G+++
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 47/206 (22%), Positives = 75/206 (36%), Gaps = 38/206 (18%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFN------LQLEQAFRSFNSECEVLRNVRHRNLIK 351
LGSG F V K S G A K + E +LR V H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--------LNIMIDVALALEY 403
+ N L+LE + G L F + + + + + + Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGEL---------FDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 404 LHHGHSTPVVHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSVIQTMTIA--TI 457
LH + H DLKP NI+L + DFG++ + +G T
Sbjct: 131 LHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-----VEFKNIFGTP 182
Query: 458 GYMAPEFGSEGNVSSKCDVYSYGILL 483
++APE + + + D++S G++
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 34/204 (16%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFN------LQLEQAFRSFNSECEVLRNVRHRNLIK 351
LGSG F V K S G A K + + E +LR V H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--------LNIMIDVALALEY 403
+ N L+LE + G L F + + + + + + Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGEL---------FDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 404 LHHGHSTPVVHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGY 459
LH + + H DLKP NI+L + DFG++ + +G + + T +
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNI-FGTPEF 184
Query: 460 MAPEFGSEGNVSSKCDVYSYGILL 483
+APE + + + D++S G++
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 51/227 (22%), Positives = 93/227 (40%), Gaps = 57/227 (25%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFN----LQLEQAFRSFNS---------------- 336
+G G +G V +D T A+K+ + ++ R
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 337 ------ECEVLRNVRHRNLIK---ILSSCCNTNFKALVLEFMPNGSLDKWLY-------- 379
E +L+ + H N++K +L + +V E + G + +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 380 SHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439
+ YFQD+ +EYLH+ ++H D+KPSN+L+ E+ ++DFG+S
Sbjct: 139 ARFYFQDL----------IKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 440 LLGEGDDSVIQTMTIATIGYMAPEF--GSEGNVS-SKCDVYSYGILL 483
+G D+++ T+ T +MAPE + S DV++ G+ L
Sbjct: 186 EF-KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 48/205 (23%), Positives = 79/205 (38%), Gaps = 36/205 (17%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFN------LQLEQAFRSFNSECEVLRNVRHRNLIK 351
LGSG F V K G A K + + E +LR +RH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--------LNIMIDVALALEY 403
+ N L+LE + G L F + ++ + + + Y
Sbjct: 73 LHDIFENKTDVVLILELVSGGEL---------FDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 404 LH-HGHSTPVVHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG 458
LH + H DLKP NI+L N + DFGI+ + G+ + + T
Sbjct: 124 LHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNI-FGTPE 176
Query: 459 YMAPEFGSEGNVSSKCDVYSYGILL 483
++APE + + + D++S G++
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 46/210 (21%), Positives = 83/210 (39%), Gaps = 30/210 (14%)
Query: 287 ERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR 345
+ + + LG G FG V++ + S T K ++ E +L R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIAR 59
Query: 346 HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR---------LNIMID 396
HRN++ + S + ++ EF+ + F+ I ++ +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDI---------FERINTSAFELNEREIVSYVHQ 110
Query: 397 VALALEYLH-HGHSTPVVHCDLKPSNILL--DENMVAHVSDFGISKLLGEGDDSVIQTMT 453
V AL++LH H + H D++P NI+ + + +FG ++ L GD +
Sbjct: 111 VCEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLL 163
Query: 454 IATIGYMAPEFGSEGNVSSKCDVYSYGILL 483
Y APE VS+ D++S G L+
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 51/209 (24%), Positives = 80/209 (38%), Gaps = 44/209 (21%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFN------------LQLEQAFRSFNSECEVLRNVR 345
LGSG FG V+ + V +K +L + E +L V
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL----EIAILSRVE 87
Query: 346 HRNLIKILSSCCNTNFKALVLEFMPNGS-LDKWLYSH---------NYFQDIPDRLNIMI 395
H N+IK+L N F LV+E +G L ++ H F+ +
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL-------- 139
Query: 396 DVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA 455
A+ YL ++H D+K NI++ E+ + DFG + L G + T
Sbjct: 140 --VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYT-FCG 191
Query: 456 TIGYMAPE-FGSEGNVSSKCDVYSYGILL 483
TI Y APE + +++S G+ L
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 48/202 (23%), Positives = 76/202 (37%), Gaps = 36/202 (17%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRNLIKIL 353
+GSG FG VA+K E R E R++RH N+++
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82
Query: 354 SSCCNTNFKALVLEFMPNGSLDKWLYSH---------NYFQDIPDRLNIMIDVALALEYL 404
A+++E+ G L + + + +FQ + + + Y
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL-------LS---GVSYC 132
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAH--VSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
H + H DLK N LLD + + DFG SK S ++ T+ T Y+AP
Sbjct: 133 HSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKS-TVGTPAYIAP 186
Query: 463 E-FGSEGNVSSKCDVYSYGILL 483
E + DV+S G+ L
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTL 208
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 48/203 (23%), Positives = 81/203 (39%), Gaps = 34/203 (16%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFN--LQLEQAFRSFNSECEVLRNVRHR-NLIKILS 354
LG G F V + I S G A K + + E VL + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRL----------NIMIDVALALEYL 404
NT+ L+LE+ G + F L ++ + + YL
Sbjct: 97 VYENTSEIILILEYAAGGEI---------FSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 405 H-HGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460
H + +VH DLKP NILL + DFG+S+ +G ++ + + T Y+
Sbjct: 148 HQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREI-MGTPEYL 200
Query: 461 APEFGSEGNVSSKCDVYSYGILL 483
APE + +++ D+++ GI+
Sbjct: 201 APEILNYDPITTATDMWNIGIIA 223
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 45/207 (21%), Positives = 76/207 (36%), Gaps = 40/207 (19%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFN------LQLEQAFRSFNSECEVLRNVRHRNLIK 351
LGSG F V K S G A K + + E +L+ ++H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDR--------LNIMIDVALALEY 403
+ N L+LE + G L F + ++ + + + Y
Sbjct: 79 LHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 404 LH-HGHSTPVVHCDLKPSNILL----DENMVAHVSDFGISKLLGEGDDSVIQTMTIA--T 456
LH + H DLKP NI+L + DFG++ + G T
Sbjct: 130 LHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-----NEFKNIFGT 180
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILL 483
++APE + + + D++S G++
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 38/204 (18%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQ-------LEQAFRSFNSECEVLRNVRHRNL 349
LG G FG V G G VA+KI N Q + + R E + L+ RH ++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQNLKLFRHPHI 73
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSH---------NYFQDIPDRLNIMIDVALA 400
IK+ +V+E++ G L ++ H FQ I + A
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI-------LS---A 123
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460
++Y H VVH DLKP N+LLD +M A ++DFG+S + D ++T + + Y
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRT-SCGSPNYA 177
Query: 461 APE-FGSEGNVSSKCDVYSYGILL 483
APE + D++S G++L
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVIL 201
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 1e-20
Identities = 50/235 (21%), Positives = 83/235 (35%), Gaps = 37/235 (15%)
Query: 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNK 64
Q+ + + N L S+P L+ L+ N+L+ ++P SL+ L +++N+
Sbjct: 80 PQITVLEITQNALI-SLPELPASLEYLD---ACDNRLS-TLP---ELPASLKHLDVDNNQ 131
Query: 65 LTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLI-----------------DLD 107
LT +P LEYI N +N LT L +++VL LD
Sbjct: 132 LTM-LPELPALLEYI---NADNNQLT-MLPELPTSLEVLSVRNNQLTFLPELPESLEALD 186
Query: 108 LSRNQLSGDIPKTIAGLKDLTN----LSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163
+S N L +P N+ IPE+ SL ++ L N LS
Sbjct: 187 VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSS 244
Query: 164 GIPKSLVALSHLKQFNVSHNRLEGEIPTEG-PFRNFSAQSFHWNYALCGPQRLQV 217
I +SL + ++ + R + W Q+
Sbjct: 245 RIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQI 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 3e-18
Identities = 40/181 (22%), Positives = 74/181 (40%), Gaps = 30/181 (16%)
Query: 12 LADNHLQG---SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTS- 67
N + G + ++ N+ + CL + EL+LN L+S
Sbjct: 17 SFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLSSL 74
Query: 68 --SIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLK 125
++P + L ++ N L SL +++ LD N+LS +P+ A LK
Sbjct: 75 PDNLPPQITVL------EITQNALI-SLPELPASLEY---LDACDNRLS-TLPELPASLK 123
Query: 126 DLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRL 185
+L + NQ +PE LE ++ +N L+ +P+ + L+ +V +N+L
Sbjct: 124 ---HLDVDNNQLTM-LPELPA---LLEYINADNNQLTM-LPEL---PTSLEVLSVRNNQL 172
Query: 186 E 186
Sbjct: 173 T 173
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 18/98 (18%), Positives = 33/98 (33%), Gaps = 9/98 (9%)
Query: 98 QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAG---NQFQGPIPESFGSLISLESL 154
N + + N +SG + +L G N+ + E + L
Sbjct: 7 INNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSEL 64
Query: 155 DLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE 192
L+ NLS +P +L + ++ N L +P
Sbjct: 65 QLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLPEL 98
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-20
Identities = 45/199 (22%), Positives = 82/199 (41%), Gaps = 8/199 (4%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
++ L + + Y +N + + C + ++ L ++N
Sbjct: 275 LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLT--GSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
LT ++ L + + L N L + MK L LD+S+N +S D K
Sbjct: 335 LLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD 394
Query: 122 -AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+ K L +L+++ N I ++ LDL SN + IPK +V L L++ NV
Sbjct: 395 CSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNV 451
Query: 181 SHNRLEGEIPTEGPFRNFS 199
+ N+L+ +P +G F +
Sbjct: 452 ASNQLK-SVP-DGIFDRLT 468
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 7e-18
Identities = 39/164 (23%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTC---LASLTSLREL 58
++ + ++N L ++ + L L +L LQ N+L + + SL++L
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQL 379
Query: 59 RLNSNKLTSSIPSALWA-LEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDI 117
++ N ++ + + +L +N+SSN LT ++ + + LDL N++ I
Sbjct: 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SI 436
Query: 118 PKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNL 161
PK + L+ L L++A NQ + F L SL+ + L +N
Sbjct: 437 PKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 7e-17
Identities = 33/184 (17%), Positives = 67/184 (36%), Gaps = 5/184 (2%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKL 65
+ + L Y LK L+ + + +++ +
Sbjct: 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT 312
Query: 66 TSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLS--GDIPKTIAG 123
+ L+++ S+N LT ++ + ++ L L L NQL I +
Sbjct: 313 RMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQ 372
Query: 124 LKDLTNLSLAGNQFQ-GPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSH 182
+K L L ++ N SL SL++SSN L++ I + L +K ++
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHS 430
Query: 183 NRLE 186
N+++
Sbjct: 431 NKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 61/391 (15%), Positives = 120/391 (30%), Gaps = 60/391 (15%)
Query: 20 SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYI 79
+P DL ++ L++ N ++ + + SL+ LR L ++ N++ S
Sbjct: 14 HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVF------ 65
Query: 80 LYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQG 139
+ + L LDLS N+L I +L +L L+ N F
Sbjct: 66 ------------------KFNQELEYLDLSHNKLVK-IS--CHPTVNLKHLDLSFNAFDA 104
Query: 140 -PIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNF 198
PI + FG++ L+ L LS+ +L + + L+ K V + EG ++F
Sbjct: 105 LPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEG-LQDF 163
Query: 199 SAQSFHWNYALCGPQRLQVPPCKEDKNKGFKKVALLVLKYIFPPIICVVLI-------AL 251
+ +S H + P + + K + L +K + C +
Sbjct: 164 NTESLHIVF----PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219
Query: 252 VFIFFLRRRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGI 311
+ L N T + L Y + S+
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279
Query: 312 LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN--TNFKALVLEF- 368
+ + + + F + N ++N + C + + F L
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMN-----IKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334
Query: 369 ----MPNGSLDKW-----LY-SHNYFQDIPD 389
+ L N +++
Sbjct: 335 LLTDTVFENCGHLTELETLILQMNQLKELSK 365
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 34/192 (17%), Positives = 64/192 (33%), Gaps = 6/192 (3%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS 71
++ N++ D+ L +L L + N++ + L L L+ NKL
Sbjct: 28 ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH 87
Query: 72 ALWALEYILYVNLSSNYLTG-SLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNL 130
L+++ +LS N + + NM L L LS L IA L L
Sbjct: 88 PTVNLKHL---DLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVL 144
Query: 131 SLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIP 190
+ G + E L + L + ++ +S N+ + ++ +
Sbjct: 145 LVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLE 202
Query: 191 TEGPFRNFSAQS 202
S +
Sbjct: 203 DNKCSYFLSILA 214
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 35/142 (24%), Positives = 62/142 (43%), Gaps = 10/142 (7%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYD---LCQLKRLNSLSLQGNKLNGSIPTCL-ASLTSLRE 57
G + +L+ + L N L+ + Q+K L L + N ++ + SL
Sbjct: 345 GHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403
Query: 58 LRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDI 117
L ++SN LT +I L +L L SN + S+ + ++ L +L+++ NQL +
Sbjct: 404 LNMSSNILTDTIFRCLPPRIKVLD--LHSNKIK-SIPKQVVKLEALQELNVASNQLK-SV 459
Query: 118 PKTI-AGLKDLTNLSLAGNQFQ 138
P I L L + L N +
Sbjct: 460 PDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 33/121 (27%), Positives = 47/121 (38%), Gaps = 13/121 (10%)
Query: 80 LYVNLSSNYLT---GSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQ 136
V+ S N L L+ L++S+N +S I L L L ++ N+
Sbjct: 3 FLVDRSKNGLIHVPKDLSQKTTI------LNISQNYISELWTSDILSLSKLRILIISHNR 56
Query: 137 FQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFR 196
Q F LE LDLS N L + V L HL ++S N + +P F
Sbjct: 57 IQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHL---DLSFNAFD-ALPICKEFG 112
Query: 197 N 197
N
Sbjct: 113 N 113
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 24/181 (13%), Positives = 56/181 (30%), Gaps = 7/181 (3%)
Query: 24 DLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83
++ + N S + L S +L + N I +W + Y +
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR-ILQLVWHTT-VWYFS 253
Query: 84 LSSNYLTGSLTSDI-----QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQ 138
+S+ L G L ++K L + + ++ + + +
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313
Query: 139 GPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNF 198
+ LD S+N L++ + ++ L+ L+ + N+L+
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQM 373
Query: 199 S 199
Sbjct: 374 K 374
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 32/213 (15%), Positives = 80/213 (37%), Gaps = 22/213 (10%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTC--LASLTSLRELRL 60
Q+L+ + L+ N L I L L L N + ++P C +++ L+ L L
Sbjct: 67 FNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGL 122
Query: 61 NSNKLTSSIPSALWALEYI-LYVNLSSNYLTGSLTSDIQN--MKVLIDLDLSRNQLSGDI 117
++ L S + L + + L Y +Q+ + L + + + +
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFIL 182
Query: 118 PKTIAGLKDLTNLSLAGNQFQGPIPESFGSL-----------ISLESLDLSSNNLSEGIP 166
++ + +L ++ L ++L +++ + N+ +
Sbjct: 183 DVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL- 241
Query: 167 KSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFS 199
LV + + F++S+ +L+G++ + +
Sbjct: 242 -QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 33/241 (13%), Positives = 65/241 (26%), Gaps = 50/241 (20%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
G M QL+ +GL+ HL+ S + L L + G L L+
Sbjct: 112 GNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLH 169
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKV------------------- 102
T+ + + NL + + L + + +
Sbjct: 170 IVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNN 229
Query: 103 -------------------LIDLDLSRNQLSGDIPKTIA-----GLKDLTNLSLAGNQFQ 138
+ +S +L G + LK L+ + + F
Sbjct: 230 IETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG 289
Query: 139 GPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNF 198
P + ++ + + + +S + S+N L T+ F N
Sbjct: 290 FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLL-----TDTVFENC 344
Query: 199 S 199
Sbjct: 345 G 345
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 43/205 (20%), Positives = 77/205 (37%), Gaps = 33/205 (16%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASL------------- 52
LQ ++L +P + +K ++ + P
Sbjct: 12 FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD 70
Query: 53 TSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQ 112
EL LN+ L+ S+P LE + S N LT L Q++K L+ + +
Sbjct: 71 RQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKA 125
Query: 113 LSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVAL 172
LS P L L ++ NQ + +PE + L+ +D+ +N+L + +P +L
Sbjct: 126 LSDLPPL-------LEYLGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLKK-LPDLPPSL 175
Query: 173 SHLKQFNVSHNRLEGEIPTEGPFRN 197
+ +N+LE E+P
Sbjct: 176 EFI---AAGNNQLE-ELPELQNLPF 196
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 39/204 (19%), Positives = 73/204 (35%), Gaps = 33/204 (16%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTC--------------- 48
L+ + + N L +P LK L + L+ P
Sbjct: 90 PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPE 148
Query: 49 LASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDL 108
L + + L+ + +++N L +P +LE+I +N L L ++QN+ L +
Sbjct: 149 LQNSSFLKIIDVDNNSLKK-LPDLPPSLEFI---AAGNNQLE-EL-PELQNLPFLTAIYA 202
Query: 109 SRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKS 168
N L +P L+ ++ N + +L L ++ +N L +P
Sbjct: 203 DNNSLK-KLPDLPLSLE---SIVAGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPDL 255
Query: 169 LVALSHLKQFNVSHNRLEGEIPTE 192
L+ NV N L ++P
Sbjct: 256 ---PPSLEALNVRDNYLT-DLPEL 275
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 9e-18
Identities = 48/208 (23%), Positives = 82/208 (39%), Gaps = 42/208 (20%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+ + L I +N L+ ++P L+ LN ++ N L +P SLT L
Sbjct: 233 LQNLPFLTTIYADNNLLK-TLPDLPPSLEALN---VRDNYLT-DLPELPQSLTFLDVSEN 287
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+ L+ P+ + Y+N SSN + SL +++ L++S N+L ++P
Sbjct: 288 IFSGLSELPPN-------LYYLNASSNEIR-SLCDLPPSLEE---LNVSNNKLI-ELPAL 335
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVAL-------- 172
L+ L + N +PE +L+ L + N L E P ++
Sbjct: 336 PPRLE---RLIASFNHLAE-VPELPQ---NLKQLHVEYNPLRE-FPDIPESVEDLRMNSH 387
Query: 173 --------SHLKQFNVSHNRLEGEIPTE 192
+LKQ +V N L E P
Sbjct: 388 LAEVPELPQNLKQLHVETNPLR-EFPDI 414
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 40/209 (19%), Positives = 73/209 (34%), Gaps = 43/209 (20%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKL-------------NGSIPTCLASL 52
L+ + + DN+L +P L L+ + L + I +
Sbjct: 258 SLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLP 316
Query: 53 TSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQ 112
SL EL +++NKL +P+ LE + S N+L + QN+K L + N
Sbjct: 317 PSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLA-EVPELPQNLKQL---HVEYNP 368
Query: 113 LSGDIPKTIAGLKD----------------LTNLSLAGNQFQGPIPESFGSLISLESLDL 156
L + P ++D L L + N + P+ S+ E L +
Sbjct: 369 LR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE-FPDIPESV---EDLRM 423
Query: 157 SSNNLSEGIPKSLVALSHLKQFNVSHNRL 185
+S + + + L+ H+
Sbjct: 424 NSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 29/161 (18%), Positives = 57/161 (35%), Gaps = 21/161 (13%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
L+ + +++N L +P +L+RL N L +P +L++L +
Sbjct: 314 DLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVP---ELPQNLKQLHVE 365
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
N L P ++E +L N + QN+K L + N L + P
Sbjct: 366 YNPLRE-FPDIPESVE-----DLRMNSHLAEVPELPQNLKQL---HVETNPLR-EFPDIP 415
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162
+ +L + + P + + LE ++
Sbjct: 416 ESV---EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 33/161 (20%), Positives = 59/161 (36%), Gaps = 27/161 (16%)
Query: 50 ASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKV------- 102
S T L+E +S+ LT +P ++ + + + +
Sbjct: 8 VSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66
Query: 103 ------LIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDL 156
+L+L+ LS +P+ L +L + N +PE SL SL +
Sbjct: 67 DCLDRQAHELELNNLGLS-SLPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNN 121
Query: 157 SSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRN 197
+ LS+ +P L L VS+N+LE ++P
Sbjct: 122 NLKALSD-LPPLLEYL------GVSNNQLE-KLPELQNSSF 154
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 48/206 (23%), Positives = 80/206 (38%), Gaps = 43/206 (20%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSC 356
LG G G V + A+K+ +A R E E+ + ++++I+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124
Query: 357 CNTNFKA----LVLEFMPNGSLDKWLYSHNYFQDIPDRLN----------IMIDVALALE 402
N +V+E + G L F I DR + IM + A++
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 403 YLH-HGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIA-TI 457
YLH + H D+KP N+L N + ++DFG +K + T T
Sbjct: 176 YLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTP 227
Query: 458 GYMAPEFGSEGNVSSKCDVYSYGILL 483
Y+APE CD++S G+++
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-20
Identities = 30/159 (18%), Positives = 60/159 (37%), Gaps = 7/159 (4%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
M L I LA+ ++ + + L++ P ++ L++L LR+
Sbjct: 43 MNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGK 98
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
+TS L L + +++S + S+ + I + + +DLS N DI +
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKT 157
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162
L +L +L++ + L L S +
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIG 194
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 30/163 (18%), Positives = 65/163 (39%), Gaps = 9/163 (5%)
Query: 27 QLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIP-SALWALEYILYVNLS 85
Q+ L ++L + + T + ++++L +N+ T+ P S L LE + +
Sbjct: 42 QMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNPISGLSNLERL---RIM 96
Query: 86 SNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESF 145
+T ++ + L LD+S + I I L + ++ L+ N I
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPL 155
Query: 146 GSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGE 188
+L L+SL++ + + + + L Q + G+
Sbjct: 156 KTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 31/159 (19%), Positives = 60/159 (37%), Gaps = 8/159 (5%)
Query: 27 QLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSS 86
K + L + A + SL + L + +T + + I + +++
Sbjct: 21 TFKAYLNGLLGQSSTANITE---AQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINN 75
Query: 87 NYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFG 146
+ T + I + L L + ++ D ++GL LT L ++ + I
Sbjct: 76 IHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 147 SLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRL 185
+L + S+DLS N I L L LK N+ + +
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 6e-10
Identities = 21/112 (18%), Positives = 46/112 (41%), Gaps = 6/112 (5%)
Query: 83 NLSSNYLTGSLTSDIQ--NMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGP 140
+ L S T++I M L + L+ ++ D+ I ++ +L++
Sbjct: 24 AYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNY 81
Query: 141 IPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE 192
L +LE L + +++ +L L+ L ++SH+ + I T+
Sbjct: 82 --NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 49/219 (22%), Positives = 93/219 (42%), Gaps = 23/219 (10%)
Query: 287 ERATDGFNECNLLGSGGFGSVYKGILSD-GTTVAIK-IFNLQLEQAFRSFNSECEVLRNV 344
+ D F + G G FG+V G G +VAIK + R + L +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNREL-QIMQDLAVL 76
Query: 345 RHRNLIKIL-------SSCCNTNFKALVLEFMPNGSLDKWLYSHNYF-QDIPDRL--NIM 394
H N++++ + +V+E++P+ +L + ++ P L +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 395 IDVALALEYLHHGHSTPVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSVIQTMT 453
+ ++ LH S V H D+KP N+L++ + + DFG +K L + +
Sbjct: 136 FQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VAY 191
Query: 454 IATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK 490
I + Y APE FG++ + ++ D++S G + E +
Sbjct: 192 ICSRYYRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGE 229
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 51/202 (25%), Positives = 84/202 (41%), Gaps = 37/202 (18%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFN------LQLEQAFRSFNSECEVLRNVRHRNLIK 351
+G G F V + G VAIKI + L++ FR E +++ + H N++K
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSH---------NYFQDIPDRLNIMIDVALALE 402
+ L++E+ G + +L +H + F+ I A++
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI----------VSAVQ 128
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
Y H +VH DLK N+LLD +M ++DFG S + Y AP
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDA-FCGAPPYAAP 182
Query: 463 E-FGSEGNVSSKCDVYSYGILL 483
E F + + DV+S G++L
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVIL 204
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 7e-20
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 38/204 (18%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQ-------LEQAFRSFNSECEVLRNVRHRNL 349
LG G FG V G G VA+KI N Q + + R E + L+ RH ++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR----EIQNLKLFRHPHI 78
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSH---------NYFQDIPDRLNIMIDVALA 400
IK+ + +V+E++ G L ++ + FQ I +
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI-------LS---G 128
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460
++Y H VVH DLKP N+LLD +M A ++DFG+S + D ++T + + Y
Sbjct: 129 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRT-SCGSPNYA 182
Query: 461 APE-FGSEGNVSSKCDVYSYGILL 483
APE + D++S G++L
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVIL 206
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 7e-20
Identities = 47/179 (26%), Positives = 72/179 (40%), Gaps = 8/179 (4%)
Query: 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLT 66
+ L++N L L RL L+L +L + +L L L L+ N+L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ 90
Query: 67 SSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTI-AGL 124
S +P L + +++S N LT SL + + L +L L N+L +P +
Sbjct: 91 S-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 125 KDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
L LSLA N L +L++L L N+L IPK L + N
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 41/170 (24%), Positives = 63/170 (37%), Gaps = 14/170 (8%)
Query: 31 LNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLT 90
++ L ++P L L L+ N L + + L + +NL LT
Sbjct: 12 HLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 91 GSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLIS 150
+ VL LDLS NQL +P L LT L ++ N+ + L
Sbjct: 69 KLQVDG--TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125
Query: 151 LESLDLSSNNLS---EGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRN 197
L+ L L N L G+ L L ++++N L E+P G
Sbjct: 126 LQELYLKGNELKTLPPGLLTPTPKLEKL---SLANNNLT-ELP-AGLLNG 170
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 1e-19
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 35/206 (16%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
LQ + ++DN L S+P +L +L N+L S+P + L+EL ++ N
Sbjct: 140 PPGLQELSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLP---MLPSGLQELSVSDN 191
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLI-----------------DL 106
+L S +P+ L + +N LT SL + +K LI +L
Sbjct: 192 QLAS-LPTLPSELYKL---WAYNNRLT-SLPALPSGLKELIVSGNRLTSLPVLPSELKEL 246
Query: 107 DLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIP 166
+S N+L+ +P +GL +LS+ NQ +PES L S +++L N LSE
Sbjct: 247 MVSGNRLT-SLPMLPSGL---LSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTL 301
Query: 167 KSLVALSHLKQFNVSHNRLEGEIPTE 192
++L ++ ++ R + +
Sbjct: 302 QALREITSAPGYSGPIIRFDMAGASA 327
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 47/186 (25%), Positives = 71/186 (38%), Gaps = 25/186 (13%)
Query: 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNK 64
+ + + DN+L S+P +L+ L + GN+L S+P L L
Sbjct: 61 AHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQLT-SLPVLPPGLLELSIFSNPLTH 115
Query: 65 LTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGL 124
L ++PS L L + N LT SL L +L +S NQL+ +P A
Sbjct: 116 LP-ALPSGLCKL------WIFGNQLT-SLPVLPPG---LQELSVSDNQLA-SLP---ALP 160
Query: 125 KDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNR 184
+L L NQ +P L+ L +S N L+ +P L L +N
Sbjct: 161 SELCKLWAYNNQLTS-LPMLPS---GLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTS 215
Query: 185 LEGEIP 190
L
Sbjct: 216 LPALPS 221
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-18
Identities = 38/167 (22%), Positives = 59/167 (35%), Gaps = 24/167 (14%)
Query: 26 CQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85
C L++ + L ++P CL + L + N LT S+P+ L + +S
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTL---EVS 89
Query: 86 SNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESF 145
N LT SL + L L L L + GNQ +P
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLTS-LPVLP 140
Query: 146 GSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE 192
L+ L +S N L+ +P L L +N+L +P
Sbjct: 141 P---GLQELSVSDNQLAS-LPALPSELCKL---WAYNNQLT-SLPML 179
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 18/202 (8%)
Query: 293 FNECNLLGSGGFGSVY----KGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLRNV 344
F +LG G F +V + AIKI ++ + E +V+ +
Sbjct: 32 FKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKENKV-PYVTRERDVMSRL 87
Query: 345 RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYL 404
H +K+ + + L + NG L K++ F + R ++ ALEYL
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYL 146
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMAPE 463
H ++H DLKP NILL+E+M ++DFG +K+L + + T Y++PE
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPE 202
Query: 464 FGSEGNVSSKCDVYSYGILLLE 485
+E + D+++ G ++ +
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQ 224
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 281 TSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEV 340
+ E+ + C ++G+G FG V++ L + VAIK R E ++
Sbjct: 30 SDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQI 85
Query: 341 LRNVRHRNLIKIL----SSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYF-QDIPDRL-- 391
+R V+H N++ + S+ + LVLE++P ++ + + Q +P L
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIK 144
Query: 392 NIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM-VAHVSDFGISKLLGEGDDSVIQ 450
M + +L Y+H S + H D+KP N+LLD V + DFG +K+L G +
Sbjct: 145 LYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-----E 196
Query: 451 TMT--IATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK 490
I + Y APE FG+ N ++ D++S G ++ E +
Sbjct: 197 PNVSYICSRYYRAPELIFGAT-NYTTNIDIWSTGCVMAELMQGQ 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 29/213 (13%)
Query: 293 FNECNLLGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIK 351
+ + ++G+G FG VY+ L D G VAIK R E +++R + H N+++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 352 IL----SSCCNTNFKAL--VLEFMPNGSLDKWLYSHNYF-QDIPDRL--NIMIDVALALE 402
+ SS + L VL+++P ++ + ++ Q +P M + +L
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENM-VAHVSDFGISKLLGEGDDSVIQTMT--IATIGY 459
Y+H S + H D+KP N+LLD + V + DFG +K L G + I + Y
Sbjct: 171 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-----EPNVSYICSRYY 222
Query: 460 MAPE--FGSEGNVSSKCDVYSYGILLLETFTRK 490
APE FG+ + +S DV+S G +L E +
Sbjct: 223 RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 254
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 51/221 (23%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ------AFRSFNSECEVLRN 343
+ + +G G +G+V+K VA+K L + A R E +L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57
Query: 344 VRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEY 403
++H+N++++ + LV EF L K+ S N D + + + L +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMA 461
H + V+H DLKP N+L++ N +++FG+++ G ++ + + T+ Y
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG----IPVRCYSAEVVTLWYRP 169
Query: 462 PE--FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500
P+ FG++ S+ D++S G + E +P +F G
Sbjct: 170 PDVLFGAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 56/257 (21%), Positives = 101/257 (39%), Gaps = 43/257 (16%)
Query: 287 ERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQ------AFRSFNSECEV 340
+ + + + +G G +G VYK S G VA+K L E A R E +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISL 72
Query: 341 LRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALA 400
L+ + H N++ ++ + LV EFM L K L + + +
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIG 458
+ + H ++H DLKP N+L++ + ++DFG+++ G +++ T + T+
Sbjct: 132 VAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG----IPVRSYTHEVVTLW 184
Query: 459 YMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK--------------------KPTDEM 496
Y AP+ GS+ S+ D++S G + E T K P
Sbjct: 185 YRAPDVLMGSK-KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243
Query: 497 FTGEMNLKNWVKESLPH 513
+ L W + +
Sbjct: 244 WPQVQELPLWKQRTFQV 260
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 45/219 (20%), Positives = 83/219 (37%), Gaps = 7/219 (3%)
Query: 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLNSNKL 65
++ + L++N + DL + L +L L N +N +I +SL SL L L+ N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 66 TSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIP-KTIAG 123
++ S L + ++NL N + + ++ L L + I K AG
Sbjct: 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG 172
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
L L L + + Q P+S S+ ++ L L + + S ++ +
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT 232
Query: 184 RLEGEIPTE---GPFRNFSAQSFHWNYALCGPQRLQVPP 219
L+ +E G + + N + QV
Sbjct: 233 DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMK 271
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 39/195 (20%), Positives = 77/195 (39%), Gaps = 14/195 (7%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDL-CQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRL 60
R LQ + L N + +I D L L L L N L ++ + L+SL L L
Sbjct: 74 RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNL 131
Query: 61 NSNKLTSSIPSALWA-LEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIP 118
N + ++L++ L + + + + + + L +L++ + L P
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191
Query: 119 KTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNL--------SEGIPKSLV 170
K++ ++++++L L Q + S+E L+L +L S G SL+
Sbjct: 192 KSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLI 251
Query: 171 ALSHLKQFNVSHNRL 185
+ ++ L
Sbjct: 252 KKFTFRNVKITDESL 266
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 33/189 (17%), Positives = 64/189 (33%), Gaps = 13/189 (6%)
Query: 6 QLQGIGLADNHLQGSIPYDL-CQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLNSN 63
L + L N + L L +L L + I A LT L EL ++++
Sbjct: 125 SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI-- 121
L S P +L +++ + ++ L L + + L+L L +
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST 244
Query: 122 ------AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVA-LSH 174
N+ + + + + L L+ S N L +P + L+
Sbjct: 245 GETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTS 302
Query: 175 LKQFNVSHN 183
L++ + N
Sbjct: 303 LQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 28/169 (16%), Positives = 60/169 (35%), Gaps = 12/169 (7%)
Query: 3 RMQQLQGIGLADNHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ +LQ + + + I L L L + + L P L S+ ++ L L+
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQ--------NMKVLIDLDLSRNQL 113
+ + + + + L L S++ ++ ++ L
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266
Query: 114 SGDIPKTIAGLKDLTNLSLAGNQFQGPIPES-FGSLISLESLDLSSNNL 161
+ K + + L L + NQ + +P+ F L SL+ + L +N
Sbjct: 267 F-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 41/170 (24%), Positives = 76/170 (44%), Gaps = 8/170 (4%)
Query: 20 SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYI 79
SIP L + + SL L N++ + L +L+ L L SN + + + +L +
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 80 LYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIA--GLKDLTNLSLAGNQ 136
+++LS NYL+ +L+S + + L L+L N + +T L L L +
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160
Query: 137 FQGPIPE-SFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRL 185
I F L LE L++ +++L PKSL ++ ++ + +
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 28/146 (19%), Positives = 56/146 (38%), Gaps = 13/146 (8%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLN 61
+ L+ + + + LQ P L ++ ++ L L + + + +S+ L L
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELR 230
Query: 62 SNKLT----SSIPS----ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQL 113
L S + + +L V ++ L + + + L++L+ SRNQL
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
Query: 114 SGDIPKTI-AGLKDLTNLSLAGNQFQ 138
+P I L L + L N +
Sbjct: 290 KS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 18/79 (22%), Positives = 37/79 (46%), Gaps = 3/79 (3%)
Query: 107 DLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIP 166
S L+ IP + + + +L L+ N+ ++L++L L+SN ++
Sbjct: 37 KGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93
Query: 167 KSLVALSHLKQFNVSHNRL 185
S +L L+ ++S+N L
Sbjct: 94 DSFSSLGSLEHLDLSYNYL 112
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 69/275 (25%), Positives = 104/275 (37%), Gaps = 35/275 (12%)
Query: 266 SPDDEELFSLATWRRTSYLDLERAT---DGFNECNLLGSGGFGSVYKGILSD-GTTVAIK 321
+P + L S+ R + LER + F + +LG GGFG V + G A K
Sbjct: 156 APFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACK 215
Query: 322 IFN---LQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKW 377
++ + +E ++L V R ++ L+ T LVL M G L
Sbjct: 216 KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFH 274
Query: 378 LYSHNYFQDIPDRLNIMI-DVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHV--SD 434
+Y R ++ LE LH +V+ DLKP NILLD++ H+ SD
Sbjct: 275 IYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDH--GHIRISD 329
Query: 435 FGISKLLGEGDDSVIQTMTIA-TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT----- 488
G++ + EG T+GYMAPE + D ++ G LL E
Sbjct: 330 LGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385
Query: 489 ----RKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519
+K +E+ V E A
Sbjct: 386 QQRKKKIKREEVERLVKE----VPEEYSERFSPQA 416
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 34/197 (17%), Positives = 56/197 (28%), Gaps = 17/197 (8%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDL----CQLKRLNSLSLQGNKLNGSIPTCLASLTSLREL 58
L + L + + L LS+ + +L L
Sbjct: 119 TGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178
Query: 59 RLNSNKLTSSI-------PSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRN 111
L+ N P L+ + N +G ++ L LDLS N
Sbjct: 179 DLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHN 238
Query: 112 QLSGDIPKTI-AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLV 170
L L +L+L+ + +P+ + L LDLS N L P
Sbjct: 239 SLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLDR-NPSPD- 293
Query: 171 ALSHLKQFNVSHNRLEG 187
L + ++ N
Sbjct: 294 ELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 35/176 (19%), Positives = 62/176 (35%), Gaps = 14/176 (7%)
Query: 25 LCQLKRLNSLSLQGNKLNGSIPTCLASLT--SLRELRLNSNKLTSSIPSAL----WALEY 78
+ + L L+L+ ++ G+ P L T L L L + + W
Sbjct: 91 VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150
Query: 79 ILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIA----GLKDLTNLSLAG 134
+ ++++ + ++ L LDLS N G+ A L L+L
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
Query: 135 NQFQ---GPIPESFGSLISLESLDLSSNNLSEGIPKSL-VALSHLKQFNVSHNRLE 186
+ G + + L+ LDLS N+L + S L N+S L+
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 42/200 (21%), Positives = 67/200 (33%), Gaps = 21/200 (10%)
Query: 4 MQQLQGIGLADNHLQGSIPYDL--CQLKRLNSLSLQGNKLNG------SIPTCLASLTSL 55
+ LQ + L + + G+ P L LN L+L+ + L L
Sbjct: 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWL--KPGL 151
Query: 56 RELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSL----TSDIQNMKVLIDLDLSRN 111
+ L + + + + ++LS N G L L L
Sbjct: 152 KVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNA 211
Query: 112 Q---LSGDIPKTIAGLKDLTNLSLAGNQFQG-PIPESFGSLISLESLDLSSNNLSEGIPK 167
SG A L L L+ N + S L SL+LS L + +PK
Sbjct: 212 GMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPK 270
Query: 168 SLVALSHLKQFNVSHNRLEG 187
L + L ++S+NRL+
Sbjct: 271 GL--PAKLSVLDLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 32/198 (16%), Positives = 66/198 (33%), Gaps = 16/198 (8%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLA---SLTSLRELRLNSNKLTSS 68
D D+ + L L+++ ++ I ++ L+EL L + ++T +
Sbjct: 51 RVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGT 110
Query: 69 IPSAL--WALEYILYVNLSSNYLTG--SLTSDIQN--MKVLIDLDLSRNQLSGDIPKTIA 122
P L + +NL + + +++Q L L +++ + +
Sbjct: 111 APPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVR 170
Query: 123 GLKDLTNLSLAGNQFQGPIPES----FGSLISLESLDLSSNN---LSEGIPKSLVALSHL 175
L+ L L+ N G +L+ L L + S A L
Sbjct: 171 VFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQL 230
Query: 176 KQFNVSHNRLEGEIPTEG 193
+ ++SHN L
Sbjct: 231 QGLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 35/149 (23%), Positives = 53/149 (35%), Gaps = 15/149 (10%)
Query: 1 MGRMQQLQGIGLADNHLQGSI-------PYDLCQLKRLNSLSLQGNKLNGSIPTCLASLT 53
+ L + L+DN G P L+ L + +G A+
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228
Query: 54 SLRELRLNSNKLTSSIPSALWA-LEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRN 111
L+ L L+ N L + + + +NLS L + + + V LDLS N
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSV---LDLSYN 284
Query: 112 QLSGDIPKTIAGLKDLTNLSLAGNQFQGP 140
+L P L + NLSL GN F
Sbjct: 285 RLDR-NPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 18/143 (12%), Positives = 46/143 (32%), Gaps = 10/143 (6%)
Query: 57 ELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSD---IQNMKVLIDLDLSRNQL 113
R+++ + +L + + + + + + + + L +L L ++
Sbjct: 49 LKRVDTEADLGQFTDIIKSLS-LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEV 107
Query: 114 SGDIPKTIAGL--KDLTNLSLAGNQFQGPIPE----SFGSLISLESLDLSSNNLSEGIPK 167
+G P + DL L+L + L+ L ++ + +
Sbjct: 108 TGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCE 167
Query: 168 SLVALSHLKQFNVSHNRLEGEIP 190
+ L ++S N GE
Sbjct: 168 QVRVFPALSTLDLSDNPELGERG 190
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 3e-19
Identities = 70/285 (24%), Positives = 114/285 (40%), Gaps = 41/285 (14%)
Query: 265 KSPDDEELFSLATWRRTSYLDLERAT----DGFNECNLLGSGGFGSVYKGILSD-GTTVA 319
+ + S R + ++E + F+ ++G GGFG VY +D G A
Sbjct: 159 GDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYA 218
Query: 320 IKIFN---LQLEQAFRSFNSECEVL---RNVRHRNLIKILSSCCNTNFKA-LVLEFMPNG 372
+K + ++++Q +E +L ++ +S +T K +L+ M G
Sbjct: 219 MKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC-MSYAFHTPDKLSFILDLMNGG 277
Query: 373 SLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHV 432
L L H F + R ++ L LE++H + VV+ DLKP+NILLDE+ HV
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAA-EIILGLEHMH---NRFVVYRDLKPANILLDEH--GHV 331
Query: 433 --SDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEFGSEGNVSSKC-DVYSYGILLLETFT 488
SD G++ + + T GYMAPE +G D +S G +L +
Sbjct: 332 RISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386
Query: 489 --------RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525
+ K E+ M L LP +LL
Sbjct: 387 GHSPFRQHKTKDKHEID--RMTLTM--AVELPDSFSPEL-RSLLE 426
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 59/212 (27%), Positives = 81/212 (38%), Gaps = 48/212 (22%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFN----------LQLEQAFRSFNSECEVLRNVRH 346
LLGSGGFGSVY GI +SD VAIK + E +L+ V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLKKVSS 105
Query: 347 R--NLIKILSSCCNTNFKALVLEF-MPNGSLDKWLYSH---------NYFQDIPDRLNIM 394
+I++L + L+LE P L ++ ++F +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV------- 158
Query: 395 IDVALALEYLH-HGHSTPVVHCDLKPSNILLDEN-MVAHVSDFGISKLLGEGDDSVIQTM 452
A+ + H G V+H D+K NIL+D N + DFG LL D+V
Sbjct: 159 ---LEAVRHCHNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD- 207
Query: 453 TIATIGYMAPE-FGSEGNVSSKCDVYSYGILL 483
T Y PE V+S GILL
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 36/218 (16%)
Query: 293 FNECNLLGSGGFGSVY----KGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLRNV 344
F +G G FG V A+K N ++ + R+ E ++++ +
Sbjct: 17 FEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEV-RNVFKELQIMQGL 72
Query: 345 RHRNLIKILSSCCNTNFKA-----LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI-DVA 398
H L+ + S F+ +V++ + G L L + +F++ + + + I ++
Sbjct: 73 EHPFLVNLWYS-----FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE--ETVKLFICELV 125
Query: 399 LALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA-TI 457
+AL+YL + ++H D+KP NILLDE+ H++DF I+ +L Q T+A T
Sbjct: 126 MALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMAGTK 178
Query: 458 GYMAPE-FGSEGNV--SSKCDVYSYGILLLETFTRKKP 492
YMAPE F S S D +S G+ E ++P
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 59/201 (29%), Positives = 80/201 (39%), Gaps = 24/201 (11%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFN-------LQLEQAFRSFNSECEVLRNVR---- 345
LLG GGFG+V+ G L+D VAIK+ L + E +L V
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP-LEVALLWKVGAGGG 96
Query: 346 HRNLIKILSSCCNTNFKALVLEF-MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYL 404
H +I++L LVLE +P L ++ + P R V A+++
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHC 155
Query: 405 HHGHSTPVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 463
H VVH D+K NIL+D A + DFG LL D T Y PE
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTD-FDGTRVYSPPE 208
Query: 464 -FGSEGNVSSKCDVYSYGILL 483
+ V+S GILL
Sbjct: 209 WISRHQYHALPATVWSLGILL 229
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 39/204 (19%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQ-------LEQAFRSFNSECEVLRNVRHRNL 349
LG G FG V VA+K + Q + R E L+ +RH ++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER----EISYLKLLRHPHI 71
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSH---------NYFQDIPDRLNIMIDVALA 400
IK+ +V+E+ G L ++ +FQ I I A
Sbjct: 72 IKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI-------IC---A 120
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460
+EY H +VH DLKP N+LLD+N+ ++DFG+S + D + ++T + + Y
Sbjct: 121 IEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKT-SCGSPNYA 174
Query: 461 APE-FGSEGNVSSKCDVYSYGILL 483
APE + + DV+S GI+L
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVL 198
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 54/237 (22%), Positives = 100/237 (42%), Gaps = 35/237 (14%)
Query: 293 FNECNLLGSGGFGSVY----KGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLRNV 344
+ ++G G FG V K A+K+ + ++ + F E +++
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFA 126
Query: 345 RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIP-DRLNIMI-DVALALE 402
++++ + + + +V+E+MP G L + D+P +V LAL+
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDL----VNLMSNYDVPEKWARFYTAEVVLALD 182
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSVIQTMTIATIGYM 460
+H S +H D+KP N+LLD++ H+ +DFG + + T + T Y+
Sbjct: 183 AIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYI 236
Query: 461 APEF----GSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMFTGEMNLKNWVK 508
+PE G +G +CD +S G+ L E P ++ MN KN +
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 293
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 3e-18
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 291 DGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQ------AFRSFNSECEVLRNV 344
+ ++ +G G +G VYK + G T A+K L+ E R E +L+ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKEL 57
Query: 345 RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYL 404
+H N++K+ LV E + L K L + + ++ + + Y
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAP 462
H V+H DLKP N+L++ ++DFG+++ G ++ T I T+ Y AP
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG----IPVRKYTHEIVTLWYRAP 169
Query: 463 E--FGSEGNVSSKCDVYSYGILLLETFTRK 490
+ GS+ S+ D++S G + E
Sbjct: 170 DVLMGSK-KYSTTIDIWSVGCIFAEMVNGT 198
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 67/278 (24%), Positives = 107/278 (38%), Gaps = 36/278 (12%)
Query: 265 KSPDDEELFSLATWRRTSYLDLERAT---DGFNECNLLGSGGFGSVYKGILSD-GTTVAI 320
++P E L SL R + LE D F + +LG GGFG V+ + G A
Sbjct: 156 QAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYAC 215
Query: 321 KIFN---LQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDK 376
K N L+ + ++ E ++L V R ++ L+ T LV+ M G +
Sbjct: 216 KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LAYAFETKTDLCLVMTIMNGGDIRY 274
Query: 377 WLYSHNYFQDI--PDRLNIMI-DVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHV- 432
+Y+ + R + LE+LH +++ DLKP N+LLD++ +V
Sbjct: 275 HIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDD--GNVR 329
Query: 433 -SDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-- 488
SD G++ L G T A T G+MAPE D ++ G+ L E
Sbjct: 330 ISDLGLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
Query: 489 -------RKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519
K E+ + + P +
Sbjct: 387 GPFRARGEKVENKELKQRVLE----QAVTYPDKFSPAS 420
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 42/184 (22%), Positives = 85/184 (46%), Gaps = 16/184 (8%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+ + + + +I + L L L L+ N++ + L +LT + EL L+ N
Sbjct: 40 LDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGN 95
Query: 64 KLTS-SIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIA 122
L + S + L +++ + +L+S +T + + + L L L NQ++ +I +A
Sbjct: 96 PLKNVSAIAGLQSIKTL---DLTSTQITD--VTPLAGLSNLQVLYLDLNQIT-NIS-PLA 148
Query: 123 GLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSH 182
GL +L LS+ Q +L L +L N +S+ I L +L +L + ++ +
Sbjct: 149 GLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKN 204
Query: 183 NRLE 186
N++
Sbjct: 205 NQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 32/162 (19%), Positives = 69/162 (42%), Gaps = 12/162 (7%)
Query: 25 LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84
L ++ + + ++ A L + L +T+ + L ++ + L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70
Query: 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPES 144
N +T + ++N+ + +L+LS N L ++ IAGL+ + L L Q P
Sbjct: 71 KDNQITD--LAPLKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDLTSTQITDVTP-- 124
Query: 145 FGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
L +L+ L L N ++ I L L++L+ ++ + ++
Sbjct: 125 LAGLSNLQVLYLDLNQITN-IS-PLAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 37/180 (20%), Positives = 84/180 (46%), Gaps = 15/180 (8%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+ ++ + L+ N L+ ++ + L+ + +L L ++ P LA L++L+ L L+ N
Sbjct: 84 LTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLN 139
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
++T+ S L L + Y+++ + ++ + + N+ L L N++S DI +A
Sbjct: 140 QITNI--SPLAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNKIS-DISP-LAS 193
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
L +L + L NQ + +L + L++ ++ + + ++L NV
Sbjct: 194 LPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITN---QPVFYNNNLVVPNVVKG 248
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 32/158 (20%), Positives = 65/158 (41%), Gaps = 10/158 (6%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+Q ++ + L + P L L L L L N++ P LA LT+L+ L + +
Sbjct: 106 LQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNA 161
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
+++ + L L + + N ++ S + ++ LI++ L NQ+S D+ +A
Sbjct: 162 QVSDL--TPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQIS-DVS-PLAN 215
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNL 161
+L ++L +L+ + S
Sbjct: 216 TSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 19/92 (20%), Positives = 37/92 (40%), Gaps = 6/92 (6%)
Query: 95 SDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESL 154
+ I + ++ ++ + A L +T LS G E L +L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGL 68
Query: 155 DLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
+L N +++ P L L+ + + +S N L+
Sbjct: 69 ELKDNQITDLAP--LKNLTKITELELSGNPLK 98
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 45/189 (23%), Positives = 70/189 (37%), Gaps = 20/189 (10%)
Query: 26 CQLKRLNS-----------LSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALW 74
C L L N L S L+ L L+ ++ + A
Sbjct: 14 CMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73
Query: 75 ALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLA 133
+L ++ + L+ N + SL + L L L+ I LK L L++A
Sbjct: 74 SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 134 GNQFQG-PIPESFGSLISLESLDLSSNNL---SEGIPKSLVALSHLK-QFNVSHNRLEGE 188
N Q +PE F +L +LE LDLSSN + + L + L ++S N +
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-F 191
Query: 189 IPTEGPFRN 197
I G F+
Sbjct: 192 IQ-PGAFKE 199
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 44/192 (22%), Positives = 75/192 (39%), Gaps = 24/192 (12%)
Query: 6 QLQGIGLADNHLQGSIPYDLC-QLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLNSN 63
+LQ + L+ +Q +I L L++L L GN + S+ + L+SL++L
Sbjct: 53 ELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVET 110
Query: 64 KLTS------SIPSALWALEYILYVNLSSNYLTGSLTSD--IQNMKVLIDLDLSRNQLSG 115
L S L L N++ N + S N+ L LDLS N++
Sbjct: 111 NLASLENFPIGHLKTLKEL------NVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 116 DIPKTIAGLKDLT----NLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVA 171
+ L + +L L+ N P +F + L+ L L +N L
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDR 222
Query: 172 LSHLKQFNVSHN 183
L+ L++ + N
Sbjct: 223 LTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 26/90 (28%), Positives = 40/90 (44%), Gaps = 7/90 (7%)
Query: 3 RMQQLQGIGLADNHLQGSIPYD----LCQLKRLN-SLSLQGNKLNGSIPTCLASLTSLRE 57
+ L+ + L+ N +Q SI L Q+ LN SL L N +N I L+E
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKE 204
Query: 58 LRLNSNKLTSSIPSALWALEYILYVNLSSN 87
L L++N+L S L + + L +N
Sbjct: 205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 8/191 (4%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS 71
+ + S +N L + C S +S L N T S+
Sbjct: 312 VKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQ 371
Query: 72 ALWALEYILYVNLSSNYLTG-SLTSDI-QNMKVLIDLDLSRNQL-SGDIPKTIAGLKDLT 128
L+ + + L N L + + +NM L LD+S N L S +T A + +
Sbjct: 372 GCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431
Query: 129 NLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGE 188
L+L+ N G + ++ LDL +N + IPK + L L++ NV+ N+L+
Sbjct: 432 VLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-S 487
Query: 189 IPTEGPFRNFS 199
+P +G F +
Sbjct: 488 VP-DGVFDRLT 497
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 48/164 (29%), Positives = 67/164 (40%), Gaps = 10/164 (6%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ N S+ LKRL +L LQ N L + ++ L
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETL 408
Query: 62 SNKLTSSIPSALWAL----EYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGD 116
L S A E IL +NLSSN LTGS+ + +KVL DL N++
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVL---DLHNNRIM-S 464
Query: 117 IPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNN 160
IPK + L+ L L++A NQ + F L SL+ + L N
Sbjct: 465 IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 34/142 (23%), Positives = 62/142 (43%), Gaps = 10/142 (7%)
Query: 2 GRMQQLQGIGLADNHLQGSIP---YDLCQLKRLNSLSLQGNKLNGSIPTCLASL-TSLRE 57
+++LQ + L N L+ + + L +L + N LN + S+
Sbjct: 374 STLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432
Query: 58 LRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDI 117
L L+SN LT S+ L +L L +N + S+ D+ +++ L +L+++ NQL +
Sbjct: 433 LNLSSNMLTGSVFRCLPPKVKVLD--LHNNRIM-SIPKDVTHLQALQELNVASNQLK-SV 488
Query: 118 PK-TIAGLKDLTNLSLAGNQFQ 138
P L L + L N +
Sbjct: 489 PDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 55/344 (15%), Positives = 105/344 (30%), Gaps = 65/344 (18%)
Query: 26 CQLKRLNS-----------LSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSA-- 72
+ L LSL N ++ ++ L+ LR LRL+ N++ S+
Sbjct: 38 YSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVF 96
Query: 73 --LWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNL 130
LEY LD+S N+L I + L +L
Sbjct: 97 LFNQDLEY---------------------------LDVSHNRLQN-IS--CCPMASLRHL 126
Query: 131 SLAGNQFQG-PIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEI 189
L+ N F P+ + FG+L L L LS+ + L+ ++HL + + + I
Sbjct: 127 DLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183
Query: 190 PTEGPFRNFSAQSFHWNYALCGPQRLQVPPC----KEDKNKGFKKVALLVLKYIFPPIIC 245
G + + + + P L + + L
Sbjct: 184 K-GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL 242
Query: 246 VVLIALVFIFFLRRRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLLGSGGFG 305
L + + ++ T +LF R YL++ +
Sbjct: 243 SELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN-------LTITERIDRE 295
Query: 306 SVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNL 349
S+ ++ I +++ + S + V + + L
Sbjct: 296 E---FTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 31/123 (25%), Positives = 50/123 (40%), Gaps = 13/123 (10%)
Query: 80 LYVNLSSNYLT---GSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQ 136
V+ S+ LT L + L LS+N +S I+ L +L L L+ N+
Sbjct: 34 SMVDYSNRNLTHVPKDLPPRTKA------LSLSQNSISELRMPDISFLSELRVLRLSHNR 87
Query: 137 FQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFR 196
+ F LE LD+S N L I ++ L+ ++S N + +P F
Sbjct: 88 IRSLDFHVFLFNQDLEYLDVSHNRLQN-ISCC--PMASLRHLDLSFNDFD-VLPVCKEFG 143
Query: 197 NFS 199
N +
Sbjct: 144 NLT 146
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 36/203 (17%), Positives = 70/203 (34%), Gaps = 18/203 (8%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTC--LASLTSLRELRL 60
Q L+ + ++ N LQ +I + L L L N + +P C +LT L L L
Sbjct: 98 FNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGL 153
Query: 61 NSNKLTSSIPSALWALE-YILYVNLSSNYLTGSLTSDIQNMKVLI-DLDLSRNQLS---- 114
++ K + L + ++L S ++ G T +Q + L N L
Sbjct: 154 SAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQV 213
Query: 115 GDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPK-----SL 169
+ L+ L+N+ L Q + L+++ ++
Sbjct: 214 NMSVNALGHLQ-LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272
Query: 170 VALSHLKQFNVSHNRLEGEIPTE 192
++ N+ + + I E
Sbjct: 273 FWPRPVEYLNIYNLTITERIDRE 295
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 25/174 (14%), Positives = 50/174 (28%), Gaps = 15/174 (8%)
Query: 28 LKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWA----------LE 77
+ L L L KLN L + S +T W
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276
Query: 78 YILYVNLSSNYLTG-----SLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSL 132
+ Y+N+ + +T T +K L+ + + ++ L
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336
Query: 133 AGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
+ + S S L+ + N ++ + + L L+ + N L+
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 29/240 (12%), Positives = 65/240 (27%), Gaps = 50/240 (20%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLK-RLNSLSLQGNKLNGSIPTCLASLT------- 53
G + +L +GL+ + + L L L + G L
Sbjct: 143 GNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLV 202
Query: 54 ---------------------SLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGS 92
L ++LN + +N++ ++ +
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262
Query: 93 LTSDIQNMKV-----LIDLDLSRNQLSGDIPKTIAG-----LKDLTNLSLAGNQFQGPIP 142
++ + + L++ ++ I + LK L + F
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 143 ESFGSLISLESLDLSSNN---LSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFS 199
+ + LS ++ + P S + + L N + N T+ F+ S
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFL---NFTQNVF-----TDSVFQGCS 374
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 284 LDLERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFR-SFNS----E 337
LD++ + + + LG G F +VYK + VAIK L + N E
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 338 CEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDV 397
++L+ + H N+I +L + + + +LV +FM L+ + ++ M+
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 398 ALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IA 455
LEYLH ++H DLKP+N+LLDEN V ++DFG++K G S + T +
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG----SPNRAYTHQVV 174
Query: 456 TIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK 490
T Y APE FG+ D+++ G +L E R
Sbjct: 175 TRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRV 210
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 63/256 (24%), Positives = 110/256 (42%), Gaps = 36/256 (14%)
Query: 293 FNECNLLGSGGFGSVY----KGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLRNV 344
F ++G G FG V K A+KI N L+ + F E +VL N
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETAC-FREERDVLVNG 131
Query: 345 RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEY 403
+ + + + + N LV+++ G L L + + R + ++ +A++
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDS 190
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSVIQTMTIATIGYMA 461
+H VH D+KP NIL+D N H+ +DFG L E D +V ++ + T Y++
Sbjct: 191 VH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLME-DGTVQSSVAVGTPDYIS 244
Query: 462 PE-----FGSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMFTGEMNLKNWVKESL 511
PE G +G +CD +S G+ + E + P E + MN K +
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ--F 302
Query: 512 PHGLPKIADA--NLLR 525
P + +++ +L+R
Sbjct: 303 PTQVTDVSENAKDLIR 318
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 85.2 bits (210), Expect = 1e-17
Identities = 35/162 (21%), Positives = 67/162 (41%), Gaps = 12/162 (7%)
Query: 25 LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84
+L+ + ++ L S+ ++ N++ + S + L + + L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFL 72
Query: 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPES 144
+ N LT + N+K L L L N++ D+ ++ LK L +LSL N
Sbjct: 73 NGNKLTD--IKPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS--DING 126
Query: 145 FGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
L LESL L +N +++ L L+ L ++ N++
Sbjct: 127 LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.0 bits (194), Expect = 1e-15
Identities = 45/183 (24%), Positives = 86/183 (46%), Gaps = 12/183 (6%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
++ L + L +N ++ + L LK+L SLSL+ N ++ I L L L L L +N
Sbjct: 86 LKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNN 141
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
K+T + L L + ++L N ++ + + + L +L LS+N +S D+ + +AG
Sbjct: 142 KITD--ITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DL-RALAG 195
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
LK+L L L + +L+ ++ + +L P+ + ++ NV +
Sbjct: 196 LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWH 253
Query: 184 RLE 186
E
Sbjct: 254 LPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 7e-07
Identities = 14/92 (15%), Positives = 34/92 (36%), Gaps = 6/92 (6%)
Query: 95 SDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESL 154
I +L + ++ + L + + + + + L ++ L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--SVQGIQYLPNVTKL 70
Query: 155 DLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
L+ N L++ I K L L +L + N+++
Sbjct: 71 FLNGNKLTD-I-KPLTNLKNLGWLFLDENKIK 100
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 42/221 (19%), Positives = 78/221 (35%), Gaps = 21/221 (9%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQ-LKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRL 60
R+Q LQ + + I + + L L L L N+ + T L +L L L
Sbjct: 52 RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTL 110
Query: 61 NSNKLTSSI--PSALWALEYILYVNLSSNYLTGSLTSDI--QNMKVLIDLDLSRNQLSGD 116
L ++ + L + + L N + + NM+ LDL+ N++
Sbjct: 111 TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFNKVKSI 169
Query: 117 IPKTIAGL--KDLTNLSLAGNQ--------FQGPIPESFGSLISLESLDLSSNNLSEGIP 166
+ + K T L L+ + S+ +LDLS N E +
Sbjct: 170 CEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA 229
Query: 167 K---SLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFH 204
K +A + ++ +S++ G F++ +F
Sbjct: 230 KRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 4/133 (3%)
Query: 31 LNSLSLQGNKLNGSIP-TCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYL 89
+ + L +K+ ++ + + T L +L L N++ +A W L ++L +NLS N+L
Sbjct: 277 VKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335
Query: 90 TGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSL 148
S+ S + +N+ L LDLS N + ++ GL +L L+L NQ + F L
Sbjct: 336 G-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL 394
Query: 149 ISLESLDLSSNNL 161
SL+ + L +N
Sbjct: 395 TSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 36/228 (15%), Positives = 71/228 (31%), Gaps = 15/228 (6%)
Query: 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLNSNKL 65
+ + L+ N + +L+ L L ++ I L+SL L+L+ N+
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 66 TSSIPSALWALEYILYVNLSSNYLTGS-LTSDI-QNMKVLIDLDLSRNQLSGDIPKTI-A 122
A L + + L+ L G+ L+ + + + L L L N + P +
Sbjct: 92 LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151
Query: 123 GLKDLTNLSLAGNQFQGPIPESFGSLIS--LESLDLSSNNL--------SEGIPKSLVAL 172
++ L L N+ + E + L LSS L +
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 173 SHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPC 220
+ + ++S N + E + F +
Sbjct: 212 TSITTLDLSGNGFK-ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGH 258
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 41/214 (19%), Positives = 81/214 (37%), Gaps = 21/214 (9%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELR--- 59
R+ + + + L + + + +L L GN S+ + +++
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 60 ----------LNSNKLTSSIPSALWALEY--ILYVNLSSNYLTGSLTSDI-QNMKVLIDL 106
LE + +LS + + +L + + L L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQL 304
Query: 107 DLSRNQLSGDIPKTI-AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGI 165
L++N+++ I GL L L+L+ N F +L LE LDLS N++
Sbjct: 305 TLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALG 363
Query: 166 PKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFS 199
+S + L +LK+ + N+L+ +P +G F +
Sbjct: 364 DQSFLGLPNLKELALDTNQLK-SVP-DGIFDRLT 395
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 20/74 (27%), Positives = 38/74 (51%), Gaps = 4/74 (5%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQ-LKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRL 60
+ +L+ + L+ NH++ ++ L L L+L N+L S+P LTSL+++ L
Sbjct: 345 NLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWL 402
Query: 61 NSNKLTSSIPSALW 74
++N S P +
Sbjct: 403 HTNPWDCSCPRIDY 416
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 12/62 (19%), Positives = 21/62 (33%), Gaps = 1/62 (1%)
Query: 126 DLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPK-SLVALSHLKQFNVSHNR 184
+ + L+ N SF L L+ L + I + LS L + +N+
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 185 LE 186
Sbjct: 91 FL 92
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 62/301 (20%), Positives = 121/301 (40%), Gaps = 53/301 (17%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ-----AFRSFNSECEVLRNV 344
+ + + + LG G + +VYKG VA+K L+ E+ A R E +L+++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 345 RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYL 404
+H N++ + LV E++ L ++L ++ + + + L Y
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 405 HHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAP 462
H V+H DLKP N+L++E ++DFG+++ +T + T+ Y P
Sbjct: 117 HRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS----IPTKTYDNEVVTLWYRPP 169
Query: 463 E--FGSEGNVSSKCDVYSYGILLLETFTRK--------------------KPTDEMFTGE 500
+ GS + S++ D++ G + E T + PT+E + G
Sbjct: 170 DILLGST-DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228
Query: 501 MNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKD 560
++ + + + P + LL + LL+ L + R+ +D
Sbjct: 229 LSNEEFKTYNYPKYRAE----ALLSHAPRLDSDGADLLTKL-LQFE-----GRNRISAED 278
Query: 561 A 561
A
Sbjct: 279 A 279
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 54/180 (30%), Positives = 81/180 (45%), Gaps = 33/180 (18%)
Query: 6 QLQGIGLADNHLQGSIPYDLC-QLKRLNSLSLQGNKLNGSIPTCL-ASLTSLRELRLNSN 63
+L+ + L DN LQ ++P + +LK L +L + NKL ++P + L +L ELRL+ N
Sbjct: 62 KLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRN 119
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI-A 122
+L S +P ++ SLT L L L N+L +PK +
Sbjct: 120 QLKS-LPPRVFD----------------SLTK-------LTYLSLGYNELQ-SLPKGVFD 154
Query: 123 GLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNL---SEGIPKSLVALSHLKQFN 179
L L L L NQ + +F L L++L L +N L EG SL L L+
Sbjct: 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 7e-17
Identities = 61/198 (30%), Positives = 88/198 (44%), Gaps = 27/198 (13%)
Query: 26 CQLKRLNS-----------LSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTS---SIPS 71
C K+L + L LQ NKL+ LT LR L LN NKL + I
Sbjct: 23 CSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFK 82
Query: 72 ALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTI-AGLKDLTN 129
L LE + ++ N L +L + + L +L L RNQL +P + L LT
Sbjct: 83 ELKNLE---TLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTY 137
Query: 130 LSLAGNQFQGPIPE-SFGSLISLESLDLSSNNLSEGIPKSLVA-LSHLKQFNVSHNRLEG 187
LSL N+ Q +P+ F L SL+ L L +N L +P+ L+ LK + +N+L+
Sbjct: 138 LSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLK- 194
Query: 188 EIPTEGPFRNFSAQSFHW 205
+P EG F +
Sbjct: 195 RVP-EGAFDSLEKLKMLQ 211
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 64/315 (20%), Positives = 121/315 (38%), Gaps = 60/315 (19%)
Query: 288 RATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNS----ECEVLR 342
+ + +G G FG V+K G VA+K + +E F E ++L+
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQ 71
Query: 343 NVRHRNLIKIL------SSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIM 394
++H N++ ++ +S N + LV +F + L L + + + +M
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVM 130
Query: 395 IDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT- 453
+ L Y+H ++H D+K +N+L+ + V ++DFG+++ +S T
Sbjct: 131 QMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 454 -IATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK-------------------- 490
+ T+ Y PE G + D++ G ++ E +TR
Sbjct: 188 RVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246
Query: 491 KPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDC----LLSIFHLALD 546
T E++ N + + K L G +++ + D L+ L LD
Sbjct: 247 SITPEVWPNVDNYELYEKLELVKGQK-----RKVKDR-LKAYVRDPYALDLIDKL-LVLD 299
Query: 547 CCAELPDQRLYMKDA 561
P QR+ DA
Sbjct: 300 -----PAQRIDSDDA 309
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 43/185 (23%), Positives = 74/185 (40%), Gaps = 20/185 (10%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
++ L + N++ ++ DL Q L L+ NKL ++ + LT L L +
Sbjct: 61 EKLTGLTKLICTSNNIT-TL--DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCD 114
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
+NKLT S L Y+ N + N LT D+ + L +LD N+ + +
Sbjct: 115 TNKLTKLDVSQNPLLTYL---NCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--V 166
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVS 181
LT L + N+ L L+ +NN+++ + L L + S
Sbjct: 167 TPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK-LD--LNQNIQLTFLDCS 220
Query: 182 HNRLE 186
N+L
Sbjct: 221 SNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 41/186 (22%), Positives = 69/186 (37%), Gaps = 20/186 (10%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+ + +L + N L D+ Q L L+ N L I ++ T L EL
Sbjct: 102 VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDC 155
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+ NK + + + + ++ S N +T D+ K+L L+ N ++ +
Sbjct: 156 HLNKKITKLD--VTPQTQLTTLDCSFNKIT---ELDVSQNKLLNRLNCDTNNIT-KLD-- 207
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+ LT L + N+ I L L D S N L+E + S LS L +
Sbjct: 208 LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTE-LDVS--TLSKLTTLHC 261
Query: 181 SHNRLE 186
L
Sbjct: 262 IQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 33/185 (17%), Positives = 60/185 (32%), Gaps = 20/185 (10%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ + L + N++ + DL Q +L L NKL I + LT L +
Sbjct: 188 SQNKLLNRLNCDTNNIT-KL--DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCS 241
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
N LT S L L + + L D+ + LI + ++ +
Sbjct: 242 VNPLTELDVSTLSKLTTL---HCIQTDLL---EIDLTHNTQLIYFQAEGCRKIKELD--V 293
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVS 181
L L L L L++ L+E + + + LK +
Sbjct: 294 THNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCV 347
Query: 182 HNRLE 186
+ ++
Sbjct: 348 NAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 39/182 (21%), Positives = 62/182 (34%), Gaps = 20/182 (10%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
QL + + N + D+ Q K LN L+ N + + L L L +SN
Sbjct: 169 QTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSN 222
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
KLT + L L Y + S N LT D+ + L L + L +I +
Sbjct: 223 KLTEIDVTPLTQLTYF---DCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EID--LTH 273
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
L G + + L LD + ++E L L +++
Sbjct: 274 NTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITE---LDLSQNPKLVYLYLNNT 328
Query: 184 RL 185
L
Sbjct: 329 EL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 38/175 (21%), Positives = 62/175 (35%), Gaps = 16/175 (9%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS 71
A +Q + QL L SL + + + + LT L +L SN +T+ S
Sbjct: 25 AAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITTLDLS 82
Query: 72 ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLS 131
L Y+ SN LT D+ + L L+ N+L+ ++ LT L+
Sbjct: 83 QNTNLTYL---ACDSNKLT---NLDVTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLN 133
Query: 132 LAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
A N L LD N + + + L + S N++
Sbjct: 134 CARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 44/185 (23%), Positives = 69/185 (37%), Gaps = 20/185 (10%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ L + N L ++ + L +L L+ NKL + ++ L L
Sbjct: 82 SQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCA 135
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
N LT S L + + N L D+ L LD S N+++ ++ +
Sbjct: 136 RNTLTEIDVSHNTQLTEL---DCHLNKKITKL--DVTPQTQLTTLDCSFNKIT-ELD--V 187
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVS 181
+ K L L+ N I L LD SSN L+E I + L+ L F+ S
Sbjct: 188 SQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCS 241
Query: 182 HNRLE 186
N L
Sbjct: 242 VNPLT 246
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 31/173 (17%), Positives = 58/173 (33%), Gaps = 24/173 (13%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
+ +L + L I DL +L +G + + + T L L
Sbjct: 251 STLSKLTTLHCIQTDLL-EI--DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQ 305
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
+ +T S L Y+ L++ LT L D+ + L L + D ++
Sbjct: 306 AAGITELDLSQNPKLVYL---YLNNTELT-EL--DVSHNTKLKSLSCVNAHIQ-DFS-SV 357
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSH 174
+ L N A Q I++ L++N+L+ + L+
Sbjct: 358 GKIPALNNNFEAEGQ-----------TITMPKETLTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 27/160 (16%), Positives = 60/160 (37%), Gaps = 14/160 (8%)
Query: 31 LNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLT 90
S ++ + L +L L +++ +T + + L + + +SN +T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT 77
Query: 91 GSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLIS 150
+L D+ L L N+L+ ++ + L LT L+ N+
Sbjct: 78 -TL--DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPL 128
Query: 151 LESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIP 190
L L+ + N L+E + + L + + N+ ++
Sbjct: 129 LTYLNCARNTLTE---IDVSHNTQLTELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 17/130 (13%), Positives = 40/130 (30%), Gaps = 8/130 (6%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61
QL + + + DL Q +L L L +L + ++ T L+ L
Sbjct: 294 THNTQLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCV 347
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
+ + S++ + + + + N + I + G+
Sbjct: 348 NAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIE 405
Query: 122 AGLKDLTNLS 131
G + + +
Sbjct: 406 PGDGGVYDQA 415
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 57/257 (22%), Positives = 96/257 (37%), Gaps = 52/257 (20%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIK-IFN-LQLEQAFRSFNS---------ECEVLRNVRHR 347
+ SG +G+V G+ S+G VAIK +FN + + + E +L + H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 348 NLIKIL---SSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLN-IMIDVALAL 401
N++ + LV E M L + ++ P + M + L L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS-PQHIQYFMYHILLGL 147
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGY 459
LH VVH DL P NILL +N + DF +++ + T + Y
Sbjct: 148 HVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-----KTHYVTHRWY 199
Query: 460 MAPE-FGSEGNVSSKCDVYSYGILLLETFTRK--------------------KPTDE--M 496
APE + D++S G ++ E F RK P E +
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV 259
Query: 497 FTGEMNLKNWVKESLPH 513
+ +++++ SL +
Sbjct: 260 MFSSPSARDYLRNSLSN 276
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 77/314 (24%), Positives = 127/314 (40%), Gaps = 68/314 (21%)
Query: 288 RATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ------AFRSFNSECEV 340
+ D + LG G +G VYK I TVAIK L+ E+ A R E +
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSL 86
Query: 341 LRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALA 400
L+ ++HRN+I++ S + + L+ E+ N L K++ + + + + +
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDV-SMRVIKSFLYQLING 144
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAH-----VSDFGISKLLGEGDDSVIQTMT-- 453
+ + H +H DLKP N+LL + + + DFG+++ G I+ T
Sbjct: 145 VNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG----IPIRQFTHE 197
Query: 454 IATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK--------------------K 491
I T+ Y PE GS + S+ D++S + E +
Sbjct: 198 IITLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256
Query: 492 PTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDC----LLSIFHLALDC 547
P D + G L +W K+S P K L R A +D LL+ L +D
Sbjct: 257 PDDTTWPGVTALPDW-KQSFPKFRGK----TLKRV---LGALLDDEGLDLLTAM-LEMD- 306
Query: 548 CAELPDQRLYMKDA 561
P +R+ K+A
Sbjct: 307 ----PVKRISAKNA 316
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 51/251 (20%), Positives = 86/251 (34%), Gaps = 46/251 (18%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ------AFRSFNSECEVLRNVRHRNLIK 351
+G G +G V+K G VAIK F + A R E +L+ ++H NL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVN 66
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH-HGHST 410
+L LV E+ + ++ L + +I A+ + H H
Sbjct: 67 LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--- 122
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE--FGS 466
+H D+KP NIL+ ++ V + DFG ++LL +AT Y +PE G
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFARLLT----GPSDYYDDEVATRWYRSPELLVGD 177
Query: 467 EGNVSSKCDVYSYGILLLETFTRK--------------------KPTDEMFTGEMNLKNW 506
DV++ G + E + + +
Sbjct: 178 T-QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 507 VKESLPHGLPK 517
+P
Sbjct: 237 SGVKIPDPEDM 247
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 289 ATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ-----AFRSFNSECEVLR 342
++ F + LG+G + +VYKG+ + G VA+K L E+ A R E +++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMK 58
Query: 343 NVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ-----DIPDRLNIMIDV 397
++H N++++ N LV EFM N L K++ S ++ +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 398 ALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IA 455
L + H ++H DLKP N+L+++ + DFG+++ G + T + +
Sbjct: 118 LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG----IPVNTFSSEVV 170
Query: 456 TIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK 490
T+ Y AP+ GS S+ D++S G +L E T K
Sbjct: 171 TLWYRAPDVLMGSR-TYSTSIDIWSCGCILAEMITGK 206
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 56/261 (21%), Positives = 96/261 (36%), Gaps = 44/261 (16%)
Query: 288 RATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ------AFRSFNSECEV 340
++ + + L+G G +G V K G VAIK F + A R E ++
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKL 77
Query: 341 LRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALA 400
L+ +RH NL+ +L C LV EF+ + ++ L D + +
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIING 136
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIG 458
+ + H + ++H D+KP NIL+ ++ V + DFG ++ L + + +AT
Sbjct: 137 IGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA----APGEVYDDEVATRW 189
Query: 459 YMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK--------------------KPTDEM 496
Y APE G DV++ G L+ E F +
Sbjct: 190 YRAPELLVGDV-KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248
Query: 497 FTGEMNLKNWVKESLPHGLPK 517
+ LP +
Sbjct: 249 QELFNKNPVFAGVRLPEIKER 269
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 35/162 (21%), Positives = 67/162 (41%), Gaps = 12/162 (7%)
Query: 25 LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84
+L+ + ++ L S+ ++ N++ + S + L + + L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFL 75
Query: 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPES 144
+ N LT + N+K L L L N++ D+ ++ LK L +LSL N
Sbjct: 76 NGNKLTD--IKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS--DING 129
Query: 145 FGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
L LESL L +N +++ L L+ L ++ N++
Sbjct: 130 LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 46/182 (25%), Positives = 85/182 (46%), Gaps = 14/182 (7%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+ + I ++ ++ S+ + L + L L GNKL I LA+L +L L L+ N
Sbjct: 45 LNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDEN 100
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
K+ S+L L+ + ++L N ++ + + + ++ L L L N+++ DI ++
Sbjct: 101 KVKDL--SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT-DI-TVLSR 154
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
L L LSL NQ L L++L LS N++S+ ++L L +L +
Sbjct: 155 LTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQ 210
Query: 184 RL 185
Sbjct: 211 EC 212
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 45/183 (24%), Positives = 86/183 (46%), Gaps = 12/183 (6%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
++ L + L +N ++ + L LK+L SLSL+ N ++ I L L L L L +N
Sbjct: 89 LKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNN 144
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
K+T + L L + ++L N ++ + + + L +L LS+N +S D+ + +AG
Sbjct: 145 KITD--ITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DL-RALAG 198
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
LK+L L L + +L+ ++ + +L P+ + ++ NV +
Sbjct: 199 LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWH 256
Query: 184 RLE 186
E
Sbjct: 257 LPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 13/92 (14%), Positives = 33/92 (35%), Gaps = 6/92 (6%)
Query: 95 SDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESL 154
I +L + ++ + L + + + + + L ++ L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--SVQGIQYLPNVTKL 73
Query: 155 DLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
L+ N L++ P L L +L + N+++
Sbjct: 74 FLNGNKLTDIKP--LANLKNLGWLFLDENKVK 103
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 54/256 (21%), Positives = 101/256 (39%), Gaps = 53/256 (20%)
Query: 286 LERATDGFNECNLLGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQAFRSFNSECEVLRNV 344
LE ++ ++ LG+G FG V + + G A+K ++ Q R N E ++++ +
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK----KVLQDPRYKNRELDIMKVL 57
Query: 345 RHRNLIKILS---SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALAL 401
H N+IK++ + + K N K +N+ + + + + + +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 402 EY----------------------------------LHHGHSTPVVHCDLKPSNILLD-E 426
EY + HS + H D+KP N+L++ +
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177
Query: 427 NMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE--FGSEGNVSSKCDVYSYGILLL 484
+ + DFG +K L + S I + Y APE G+ + D++S G +
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGAT-EYTPSIDLWSIGCVFG 233
Query: 485 ETFTRKKPTDEMFTGE 500
E KP +F+GE
Sbjct: 234 ELILG-KP---LFSGE 245
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 291 DGFNECNLLGSGGFGSVY----KGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLR 342
D F+ LG+G FG V K G A+KI + ++L+Q +E +L+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQI-EHTLNEKRILQ 96
Query: 343 NVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALE 402
V L+K+ S + + +V+E++ G + L F + R + L E
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFE 155
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTI-ATIGYMA 461
YLH +++ DLKP N+L+D+ V+DFG +K + +T T+ T +A
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALA 206
Query: 462 PEFGSEGNVSSKCDVYSYGILLLE 485
PE + D ++ G+L+ E
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYE 230
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 24/221 (10%)
Query: 291 DGFNECNLLGSGGFGSVY----KGILSDGTTVAIKIF---NLQLEQAFRSFNSECEVLRN 343
+ F LLG G FG V K G A+KI + + +E VL+N
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 344 VRHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI-DVALAL 401
RH L L T+ + V+E+ G L L F + DR ++ AL
Sbjct: 205 SRHPFLTA-LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE--DRARFYGAEIVSAL 261
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 461
+YLH + VV+ DLK N++LD++ ++DFG+ K G D + ++T T Y+A
Sbjct: 262 DYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTF-CGTPEYLA 317
Query: 462 PEFGSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMF 497
PE + + D + G+++ E + P +++F
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 61/239 (25%), Positives = 101/239 (42%), Gaps = 36/239 (15%)
Query: 291 DGFNECNLLGSGGFGSVY----KGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLR 342
D F ++G G F V K G A+KI N L+ + F E +VL
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEV-SCFREERDVLV 116
Query: 343 NVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIP-DRLNIMI-DVALA 400
N R + ++ + + N+ LV+E+ G L L + + IP + + ++ +A
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLS--KFGERIPAEMARFYLAEIVMA 174
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSVIQTMTIATIG 458
++ +H VH D+KP NILLD H+ +DFG L D +V + + T
Sbjct: 175 IDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRA-DGTVRSLVAVGTPD 228
Query: 459 YMAPE-FGSEGNVSSK------CDVYSYGILLLETFTRKKP-----TDEMFTGEMNLKN 505
Y++PE + G CD ++ G+ E F + P T E + ++ K
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE 287
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 31/204 (15%), Positives = 53/204 (25%), Gaps = 43/204 (21%)
Query: 298 LLGSGGFGSVYKGILSD---GTTVAIKIFNLQL--EQAFRS-FNSECEVLRNVRHRNLIK 351
G ++ + D VA+ + Q S L + + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 352 ILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
+L +V E++ GSL + + + M +A A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG--- 149
Query: 412 VVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVS 471
V PS + VS G L A M +
Sbjct: 150 VALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPD-------AN 180
Query: 472 SKCDVYSYGILLLETFTRKKPTDE 495
+ D+ G L + P E
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPE 204
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 37/210 (17%)
Query: 299 LGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQAFRSFNS------ECEVLRNVRHRNLIK 351
+GSG G V + VAIK +L + F++ E +++ V H+N+I
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 88
Query: 352 IL----SSCCNTNFKA--LVLEFMPNGSLDKWLY---SHNYFQDIPDRLNIMIDVALALE 402
+L F+ +V+E M +L + + H ++ + ++
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMS------YLLYQMLCGIK 141
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYM 460
+LH S ++H DLKPSNI++ + + DFG+++ G MT + T Y
Sbjct: 142 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-----MTPYVVTRYYR 193
Query: 461 APEFGSEGNVSSKCDVYSYGILLLETFTRK 490
APE D++S G ++ E
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 31/226 (13%)
Query: 291 DGFNECNLLGSGGFGSVY---KGILSD-GTTVAIKIFN----LQLEQAFRSFNSECEVLR 342
+ F +LG GG+G V+ K ++ G A+K+ ++ + +E +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 343 NVRHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI-DVALA 400
V+H ++ L T K L+LE++ G L L F + D + ++++A
Sbjct: 77 EVKHPFIVD-LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME--DTACFYLAEISMA 133
Query: 401 LEYLH-HGHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSVIQTMTIA-T 456
L +LH G +++ DLKP NI+L+ HV +DFG+ K T T T
Sbjct: 134 LGHLHQKG----IIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV---THTFCGT 184
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMF 497
I YMAPE + D +S G L+ + T P +
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 39/210 (18%)
Query: 293 FNECNLLGSGGFGSVY----KGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLRNV 344
F LG+G FG V+ + +G A+K+ ++L+Q + N E +L V
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSIV 63
Query: 345 RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI-DVALALEY 403
H +I++ + + ++++++ G L L F + +V LALEY
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN--PVAKFYAAEVCLALEY 121
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSVIQTMTI-ATIGYM 460
LH +++ DLKP NILLD+N H+ +DFG +K + + T T+ T Y+
Sbjct: 122 LHSKD---IIYRDLKPENILLDKN--GHIKITDFGFAKYVPD------VTYTLCGTPDYI 170
Query: 461 APEFGSEGNVSSK-----CDVYSYGILLLE 485
APE VS+K D +S+GIL+ E
Sbjct: 171 APEV-----VSTKPYNKSIDWWSFGILIYE 195
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 56/263 (21%), Positives = 101/263 (38%), Gaps = 48/263 (18%)
Query: 285 DLERATDGFNECNL-LGSGGFGSVYKGILSDGTT---VAIKIFNLQLEQAFRSFNSECEV 340
+ ER D F +G G +G VYK DG A+K Q+E S ++ E+
Sbjct: 14 ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK----QIEGTGISMSACREI 69
Query: 341 --LRNVRHRNLIKILSSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMID 396
LR ++H N+I + + + L+ ++ D W + ++ + +
Sbjct: 70 ALLRELKHPNVISLQKVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLP 126
Query: 397 VAL----------ALEYLHHGHSTPVVHCDLKPSNILLDENMVAH----VSDFGISKLLG 442
+ + YLH V+H DLKP+NIL+ ++D G ++L
Sbjct: 127 RGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
Query: 443 EGDDSVIQTMT-----IATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRKKPTDE 495
S ++ + + T Y APE G+ + + D+++ G + E T +P
Sbjct: 184 ----SPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTS-EP--- 234
Query: 496 MFTGEMNLKNWVKESLPHGLPKI 518
+F L +I
Sbjct: 235 IFHCRQEDIKTSNPYHHDQLDRI 257
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 33/135 (24%), Positives = 58/135 (42%), Gaps = 3/135 (2%)
Query: 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVV 413
S ++ + + F + + VA +E+L S +
Sbjct: 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCI 215
Query: 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSK 473
H DL NILL E V + DFG+++ + + D V + + +MAPE + + +
Sbjct: 216 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 275
Query: 474 CDVYSYGILLLETFT 488
DV+S+G+LL E F+
Sbjct: 276 SDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 32/150 (21%), Positives = 55/150 (36%), Gaps = 17/150 (11%)
Query: 299 LGSGGFGSVYKGIL------SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLI 350
LG G FG V + + TVA+K+ R+ SE ++L ++ H N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 351 KILSSCCNTNFKALV-LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS 409
+L +C +V +EF G+L +L S R + +
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK--------RNEFVPYKTKGARFRQGKDY 141
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISK 439
+ DLK + + + S F K
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 15/163 (9%)
Query: 32 NSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTS----SIPSALWALEYILYVNLSSN 87
N LS +L ++P L S T L L+ N L+ P+ L L + LS N
Sbjct: 21 NILSCSKQQLP-NVPQSLPSYT--ALLDLSHNNLSRLRAEWTPTRLTNLHSL---LLSHN 74
Query: 88 YLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFG 146
+L ++S+ + L LDLS N L + L+ L L L N +F
Sbjct: 75 HLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFE 133
Query: 147 SLISLESLDLSSNNLS---EGIPKSLVALSHLKQFNVSHNRLE 186
+ L+ L LS N +S + K L L ++S N+L+
Sbjct: 134 DMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 14/160 (8%)
Query: 12 LADNHLQGSIP--YDLCQLKRLNSLSLQGNKLNGSIPTC-LASLTSLRELRLNSNKLTSS 68
L+ N+L + + +L L+SL L N LN I + + +LR L L+SN L +
Sbjct: 46 LSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTL 103
Query: 69 IPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIP----KTIAG 123
L+ + + L +N++ + + ++M L L LS+NQ+S P K
Sbjct: 104 DEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNK 161
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISL--ESLDLSSNNL 161
L L L L+ N+ + L + L L +N L
Sbjct: 162 LPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 9/92 (9%)
Query: 3 RMQQLQGIGLADNHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIP----TCLASLTSLRE 57
+Q L+ + L +NH+ + + + +L L L N+++ P L L
Sbjct: 110 DLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLML 167
Query: 58 LRLNSNKLTSSIPSALWALEYI--LYVNLSSN 87
L L+SNKL + L L + L +N
Sbjct: 168 LDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 48/207 (23%), Positives = 82/207 (39%), Gaps = 31/207 (14%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNS------ECEVLRNVRHRNLIK 351
+GSG G V VAIK +L + F++ E +++ V H+N+I
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 352 IL----SSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH 405
+L F+ LV+E M + ++ + +++LH
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSY-LLYQMLCGIKHLH 181
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE 463
++H DLKPSNI++ + + DFG+++ G MT + T Y APE
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-----MMTPYVVTRYYRAPE 233
Query: 464 FGSEGNVSSKCDVYSYGILLLETFTRK 490
D++S G ++ E K
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 40/211 (18%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIK----IFNLQLE--QAFRSFNSECEVLRNVRHRNLIK 351
+GSG +GSV I G VAIK F ++ +A+R E +L++++H N+I
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 87
Query: 352 IL----SSCCNTNFKA--LVLEFMPNGSLDKWLY---SHNYFQDIPDRLNIMIDVALALE 402
+L + NF LV+ FM L K + S Q ++ + L+
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQ------YLVYQMLKGLK 140
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYM 460
Y+H S VVH DLKP N+ ++E+ + DFG+++ MT + T Y
Sbjct: 141 YIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYR 190
Query: 461 APE-FGSEGNVSSKCDVYSYGILLLETFTRK 490
APE S + + D++S G ++ E T K
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIK-IFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKIL-- 353
+G G +G V + VAIK I + R+ E ++L RH N+I I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 354 -SSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST 410
+ K +V + M L K L + + + + + L+Y+H S
Sbjct: 94 IRAPTIEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICY-FLYQILRGLKYIH---SA 147
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE-FGSE 467
V+H DLKPSN+LL+ + DFG++++ + D +T +AT Y APE +
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 468 GNVSSKCDVYSYGILLLETFTRK 490
+ D++S G +L E + +
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 33/229 (14%)
Query: 293 FNECNLLGSGGFGSVY---KGILSD-GTTVAIKIFN----LQLEQAFRSFNSECEVLRNV 344
F +LG+G +G V+ K D G A+K+ +Q + +E +VL ++
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 345 RHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI-DVALALE 402
R + L T K L+L+++ G L L F + + I + ++ LALE
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE--HEVQIYVGEIVLALE 173
Query: 403 YLH-HGHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSVIQTMTIATIGY 459
+LH G +++ D+K NILLD N HV +DFG+SK + TI Y
Sbjct: 174 HLHKLG----IIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDF-CGTIEY 226
Query: 460 MAPE--FGSEGNVSSKCDVYSYGILLLE---------TFTRKKPTDEMF 497
MAP+ G + D +S G+L+ E K E+
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 291 DGFNECNLLGSGGFGSVY----KGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLR 342
F +LG G FG V+ A+K+ ++ E ++L
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV--RTKMERDILV 81
Query: 343 NVRHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI-DVALA 400
V H ++K L T K L+L+F+ G L L F + + + + ++ALA
Sbjct: 82 EVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE--EDVKFYLAELALA 138
Query: 401 LEYLH-HGHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSVIQTMTI-AT 456
L++LH G +++ DLKP NILLDE H+ +DFG+SK + + + T
Sbjct: 139 LDHLHSLG----IIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSFCGT 189
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMF 497
+ YMAPE + + D +S+G+L+ E T P E
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 35/226 (15%)
Query: 291 DGFNECNLLGSGGFGSV----YKGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLR 342
+ F+ LLG G FG V K G A+KI + ++ +E VL+
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQ 60
Query: 343 NVRHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI-DVALA 400
N RH L L T+ + V+E+ G L L F + +R ++ A
Sbjct: 61 NTRHPFLTA-LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE--ERARFYGAEIVSA 117
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKL-LGEGDDSVIQTMTI-AT 456
LEYLH S VV+ D+K N++LD++ H+ +DFG+ K + +G T T
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGA----TMKTFCGT 168
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMF 497
Y+APE + + D + G+++ E + P + +F
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIK---IFNLQLE--QAFRSFNSECEVLRNVRHRNLIKI 352
LG G +G V G VAIK F+ L + R E ++L++ +H N+I I
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74
Query: 353 L---SSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG 407
NF ++ E M L + + S D + + A++ LH
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQT-DLHR-VISTQMLSDDHIQY-FIYQTLRAVKVLH-- 129
Query: 408 HSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT------MT--IATIGY 459
+ V+H DLKPSN+L++ N V DFG+++++ E + M +AT Y
Sbjct: 130 -GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 460 MAPE-FGSEGNVSSKCDVYSYGILLLETFTRK 490
APE + S DV+S G +L E F R+
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 46/221 (20%)
Query: 299 LGSGGFGSVYKGILSD-GTTVAIK--IF-NLQLEQ-AFRSFNSECEVLRNVRHRNLIKIL 353
LG GG G V+ + +D VAIK + + Q + A R E +++R + H N++K+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74
Query: 354 ------------SSCCNTNFKA--LVLEFMPNGSLDKWLYSHN-------YFQDIPDRLN 392
T + +V E+M L L F
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLF-------- 125
Query: 393 IMIDVALALEYLHHGHSTPVVHCDLKPSNILLD-ENMVAHVSDFGISKLLG-EGDDSVIQ 450
M + L+Y+H S V+H DLKP+N+ ++ E++V + DFG+++++
Sbjct: 126 -MYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 451 TMTIATIGYMAPE-FGSEGNVSSKCDVYSYGILLLETFTRK 490
+ + T Y +P S N + D+++ G + E T K
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 30/222 (13%)
Query: 288 RATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ-AFRSFNSEC--EV--- 340
AT + +G G +G+VYK G VA+K + EV
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 341 --LRNVRHRNLIKILSSCCNTNFKA-----LVLEFMPNGSLDKWLYSHN-YFQDIPDRLN 392
L H N+++++ C + LV E + L +L +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 393 IMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTM 452
+M L++LH +VH DLKP NIL+ ++DFG++++ +
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS-----YQMAL 176
Query: 453 T--IATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK 490
T + T+ Y APE S ++ D++S G + E F RK
Sbjct: 177 TPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRK 216
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 37/210 (17%)
Query: 299 LGSGGFGSVYKGILSD-GTTVAIKIFNLQLE------QAFRSFNSECEVLRNVRHRNLIK 351
+GSG +GSV + G VA+K + + + +R E +L++++H N+I
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 352 IL----SSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDI-PDRLN-IMIDVALALEY 403
+L + F LV M L+ + Q + D + ++ + L+Y
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKC----QKLTDDHVQFLIYQILRGLKY 147
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMA 461
+H S ++H DLKPSN+ ++E+ + DFG+++ MT +AT Y A
Sbjct: 148 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATRWYRA 197
Query: 462 PE-FGSEGNVSSKCDVYSYGILLLETFTRK 490
PE + + + D++S G ++ E T +
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 34/217 (15%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQ-AFRSFNSECEVLRNVR-HRNLIKILSS 355
LG G + V++ I +++ V +KI ++ R E ++L N+R N+I +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99
Query: 356 CCNTNFK--ALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMIDVALALEYLHHGHSTP 411
+ + ALV E + N +Q + D M ++ AL+Y H S
Sbjct: 100 VKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALDYCH---SMG 150
Query: 412 VVHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPE--FGS 466
++H D+KP N+++D E+ + D+G L E Q +A+ + PE
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWG----LAEFYHPG-QEYNVRVASRYFKGPELLVDY 205
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNL 503
+ D++S G +L RK+P F G N
Sbjct: 206 Q-MYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNY 238
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 34/128 (26%), Positives = 61/128 (47%), Gaps = 7/128 (5%)
Query: 53 TSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRN 111
++ E+RL N + P A + + ++LS+N ++ L D Q ++ L L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 112 QLSGDIPKTI-AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS---EGIPK 167
+++ ++PK++ GL L L L N+ ++F L +L L L N L +G
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 168 SLVALSHL 175
L A+ +
Sbjct: 150 PLRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 33/128 (25%), Positives = 54/128 (42%), Gaps = 4/128 (3%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLNSNKLTSSIP 70
L N ++ P K+L + L N+++ + L SL L L NK+T
Sbjct: 39 LEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPK 97
Query: 71 SALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTN 129
S L + + L++N + L D Q++ L L L N+L T + L+ +
Sbjct: 98 SLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQT 156
Query: 130 LSLAGNQF 137
+ LA N F
Sbjct: 157 MHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 23/95 (24%), Positives = 43/95 (45%), Gaps = 8/95 (8%)
Query: 106 LDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE-- 163
+ L +N + P + K L + L+ NQ P++F L SL SL L N ++E
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELP 96
Query: 164 -GIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRN 197
+ + L +L L ++ N++ + F++
Sbjct: 97 KSLFEGLFSLQLL---LLNANKIN-CLR-VDAFQD 126
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 40/226 (17%)
Query: 288 RATDGFNECNLLGSGGFGSVYKG--ILSDGTTVAIKIFNLQLEQ------AFRSFNSECE 339
RA + +G G +G V+K + + G VA+K +Q + R E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------E 61
Query: 340 V-----LRNVRHRNLIKILSSCCNTNFKA-----LVLEFMPNGSLDKWLYSH-NYFQDIP 388
V L H N++++ C + LV E + L +L
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 389 DRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448
++M + L++LH VVH DLKP NIL+ + ++DFG++++
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS-----F 172
Query: 449 IQTMT--IATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK 490
+T + T+ Y APE S ++ D++S G + E F RK
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRK 216
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 37/187 (19%), Positives = 78/187 (41%), Gaps = 21/187 (11%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIK-IFNLQLEQ-----AFRSFNSECEVLRNVRHRNLIK 351
+G+G +G V + + VAIK I + + R E +L + H +++K
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVK 116
Query: 352 ---ILSSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHH 406
I+ F +VLE + K + Y ++ + ++ ++ + ++Y+H
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH- 173
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGS 466
S ++H DLKP+N L++++ V DFG+++ + ++ Q M
Sbjct: 174 --SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 467 EGNVSSK 473
+
Sbjct: 232 HTKNLKR 238
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 44/205 (21%), Positives = 74/205 (36%), Gaps = 62/205 (30%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVL-RNVRHRNLIKILSSC 356
LG G G V + A+K+ +A R E E+ R + ++++I+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80
Query: 357 CNTNFKA----LVLEFMPNGSLDKWLYSHNYFQDIPDRLN----------IMIDVALALE 402
N +V+E + G L F I DR + IM + A++
Sbjct: 81 ENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 403 YLH-HGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG 458
YLH + H D+KP N+L N + ++DFG
Sbjct: 132 YLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------- 166
Query: 459 YMAPEFGSEGNVSSKCDVYSYGILL 483
A E + CD++S G+++
Sbjct: 167 --AKET-TGEKYDKSCDMWSLGVIM 188
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 7e-14
Identities = 65/257 (25%), Positives = 109/257 (42%), Gaps = 33/257 (12%)
Query: 259 RRNRSTKSPDDEELFSLATWRRTSYLDLERATDGFNECNLLGSGGFGSV----YKGILSD 314
+ + TK+P+++ +++ + D + TD FN +LG G FG V KG
Sbjct: 310 KIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD-FNFLMVLGKGSFGKVMLSERKG---T 365
Query: 315 GTTVAIKIFN----LQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA-LVLEFM 369
A+KI +Q + E VL + L SC T + V+E++
Sbjct: 366 DELYAVKILKKDVVIQDDDV-ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 424
Query: 370 PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV 429
G L + F P + ++A+ L +L S +++ DLK N++LD
Sbjct: 425 NGGDLMYHIQQVGRF-KEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE-- 478
Query: 430 AHV--SDFGISKL-LGEGDDSVIQTMTIA-TIGYMAPEFGSEGNVSSKCDVYSYGILLLE 485
H+ +DFG+ K + +G T T T Y+APE + D +++G+LL E
Sbjct: 479 GHIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 534
Query: 486 TFTRKKP-----TDEMF 497
+ P DE+F
Sbjct: 535 MLAGQAPFEGEDEDELF 551
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 7e-14
Identities = 30/164 (18%), Positives = 68/164 (41%), Gaps = 17/164 (10%)
Query: 25 LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84
L +L + + L+ ++ +++ + S + + + ++L
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHL 70
Query: 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKD--LTNLSLAGNQFQGPIP 142
S N ++ S ++++ L +L ++RN+L + G+ L+ L L N+ +
Sbjct: 71 SHNQISD--LSPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELRD--T 121
Query: 143 ESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
+S L +LE L + +N L L LS L+ ++ N +
Sbjct: 122 DSLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 38/180 (21%), Positives = 69/180 (38%), Gaps = 16/180 (8%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+ +Q ++++Q S+ + L L L N+++ + + L LT L EL +N N
Sbjct: 40 LSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRN 95
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
+L + L + L +N L T + ++K L L + N+L I +
Sbjct: 96 RLKNLNGIPSACLSRL---FLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIV-MLGF 148
Query: 124 LKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
L L L L GN+ L + +DL+ + + L N +
Sbjct: 149 LSKLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKCVN---EPVKYQPELYITNTVKD 203
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 30/161 (18%), Positives = 57/161 (35%), Gaps = 13/161 (8%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+ +L+ + + N L+ L RL L N+L L L +L L + +N
Sbjct: 84 LTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNEL--RDTDSLIHLKNLEILSIRNN 138
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
KL S L L + ++L N +T + + +K + +DL+ + + P
Sbjct: 139 KLKS--IVMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCV-NEPVKY-- 191
Query: 124 LKDLTNLSLAGNQFQGPI-PESFGSLISLESLDLSSNNLSE 163
+L + + I P + S +
Sbjct: 192 QPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVY 232
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 18/92 (19%), Positives = 39/92 (42%), Gaps = 6/92 (6%)
Query: 95 SDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESL 154
+ + +L + ++ D+ + L + N + + Q +L+ L
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DL-VSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKEL 68
Query: 155 DLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
LS N +S+ L L+ L++ +V+ NRL+
Sbjct: 69 HLSHNQISD--LSPLKDLTKLEELSVNRNRLK 98
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 47/215 (21%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNS------ECEVLRNVRHRNLIK 351
+GSG +G+V + G VAIK +L + F+S E +L+++RH N+I
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIK----KLYRPFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 352 IL----SSCCNTNFKA--LVLEFMPNGSLDKWLYS-------HNYFQDIPDRLNIMIDVA 398
+L +F LV+ FM L K + + + +
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFL---------VYQML 138
Query: 399 LALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IAT 456
L Y+H + ++H DLKP N+ ++E+ + DFG+++ MT + T
Sbjct: 139 KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QADSEMTGYVVT 188
Query: 457 IGYMAPE-FGSEGNVSSKCDVYSYGILLLETFTRK 490
Y APE + + D++S G ++ E T K
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 40/198 (20%), Positives = 78/198 (39%), Gaps = 43/198 (21%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIK-IFNLQLEQAFRSFNS------ECEVLRNVRHRNLI 350
+G G +G VY + VAIK + F E +L ++ +I
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNR-----MFEDLIDCKRILREITILNRLKSDYII 88
Query: 351 KILSSCCNTNFKA-----LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH 405
++ + +VLE + L K + + + + I+ ++ L ++H
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH 146
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS------------------KLLGEGDDS 447
+ ++H DLKP+N LL+++ V DFG++ + G + +
Sbjct: 147 ---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 448 VIQTMT--IATIGYMAPE 463
+ + +T + T Y APE
Sbjct: 204 LKKQLTSHVVTRWYRAPE 221
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 2e-13
Identities = 94/590 (15%), Positives = 170/590 (28%), Gaps = 191/590 (32%)
Query: 25 LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84
L +L+ ++ + G + GS T +A S K+ + I ++NL
Sbjct: 144 LLELRPAKNVLIDG--VLGSGKTWVALDV------CLSYKVQCKMDFK------IFWLNL 189
Query: 85 SSNYLTGSLTSDIQNMKVLIDLDL-SRNQLSGDIPKTIAGLKDLTNLSLAGNQFQ----- 138
+ ++ +Q + ID + SR+ S +I I ++ L ++
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249
Query: 139 ------GPIPESFG----------------SLISLESLDLSSNNLSEGI--PKSLVALSH 174
+F L + + +S ++ S + + L
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL- 308
Query: 175 LKQFNVSHNRLEGEIPTEGPF---------RNFSAQSFHWNYALCGPQRLQVPPCKEDKN 225
K + L E+ T P R+ A +W + C DK
Sbjct: 309 -KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC------------DKL 355
Query: 226 KGFKKVALLVLKYIFPPIICVVLIALVFIFFLRRRNRSTKSPDD----EELFSLATWRRT 281
+ +L VL+ P + L +F P L SL W
Sbjct: 356 TTIIESSLNVLE---PAEYRKMFDRL-SVF-----------PPSAHIPTILLSL-IWFDV 399
Query: 282 SYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVL 341
D+ + ++ +L+ S I ++ LE + E
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTI------------SIPSIYLE-----LKVKLENE 442
Query: 342 RNVRHRNLI---KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVA 398
+ HR+++ I + + + L+ YF
Sbjct: 443 YAL-HRSIVDHYNIPKTFDSDDLIPPYLD--------------QYF-------------- 473
Query: 399 LALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIG 458
Y H GH H LK NI E M + F + D ++ I
Sbjct: 474 ----YSHIGH-----H--LK--NIEHPERM----TLF--RMVF--LDFRFLEQ-KIRHDS 511
Query: 459 YMAPEFGSEGNVSSKCDVY-SYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517
GS N + Y Y P E ++ LPK
Sbjct: 512 TAWNASGSILNTLQQLKFYKPY-------ICDNDPKYERLV----------NAILDFLPK 554
Query: 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567
I EEN ++ LL +AL + + ++A ++++
Sbjct: 555 I-------EENLICSKYTDLL---RIAL-----MAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 1e-06
Identities = 93/593 (15%), Positives = 162/593 (27%), Gaps = 194/593 (32%)
Query: 58 LRLNSNKLTSSI------PSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRN 111
LR+N L S I PS + YI + L +D Q V ++SR
Sbjct: 87 LRINYKFLMSPIKTEQRQPS-MMTRMYIEQRD--------RLYNDNQ---VFAKYNVSRL 134
Query: 112 QLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVA 171
Q + + + L+ N+ + G G G K+ VA
Sbjct: 135 QPYLKLRQALLELRPAKNVLIDG--VLG-----SG--------------------KTWVA 167
Query: 172 LSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCKEDKNKGFKKV 231
L + V +++ +I W L + C +
Sbjct: 168 LDVCLSYKV-QCKMDFKI--------------FW---------LNLKNCNSPE------- 196
Query: 232 ALLVLKYIFPPIICVVLIALVFIFFLRRRNRSTKSPDDEELFSLATWRRTSYLDLERATD 291
VL+ +L L++ +RS S + + L +
Sbjct: 197 --TVLE---------MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP--- 242
Query: 292 GFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIK 351
+ C LL +L + V +A+ +FN C++L R + +
Sbjct: 243 -YENC-LL-----------VLLN---VQNA-------KAWNAFNLSCKILLTTRFKQVTD 279
Query: 352 ILSSCCNTNFKALVLEFMPNG-----SLD---KWLYSHNYFQDIPDRLNIMIDVALAL-- 401
LS + L+ K+L QD+P + L++
Sbjct: 280 FLS---AATTTHISLDHHSMTLTPDEVKSLLLKYL--DCRPQDLPREVLTTNPRRLSIIA 334
Query: 402 EYLHHGHST----PVVHCD-----LKPS-NILLDENMVAHVSDFGISKLLGEGDDSVIQT 451
E + G +T V+CD ++ S N+L + + I T
Sbjct: 335 ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP-----PSAHIPT 389
Query: 452 MTIATIGYMAPEFGSEGNVSSKCDVYS----------YGILLLETFTRKKPTDEMFTGEM 501
+ ++ I + V +K YS I + + K +E +
Sbjct: 390 ILLSLI-WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENE---YAL 445
Query: 502 NLK-----NWVKESLPHGLPKIAD------------ANLLREENFFSARMDCLLS----- 539
+ N K L N+ E RM L
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRM-VFLDFRFLE 504
Query: 540 --IFHLALDCCAE------LPDQRLYMK----DAATKLKKIRD--KFLEDANT 578
I H + A L + Y + + + FL
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEE 557
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 57/208 (27%), Positives = 82/208 (39%), Gaps = 34/208 (16%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIF-NLQ--LEQAFRSFNSECEVLRNVRHR------ 347
++G G FG V K VA+K+ N + QA E +L ++R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE----EIRILEHLRKQDKDNTM 159
Query: 348 NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYS---HNYFQDIPDRL--NIMIDVALALE 402
N+I +L + N + E L LY N FQ L + L+
Sbjct: 160 NVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAH--VSDFGISKLLGEGDDSVIQTMTIATIGYM 460
LH ++HCDLKP NILL + + V DFG S + + IQ+ Y
Sbjct: 215 ALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YR 266
Query: 461 APEFGSEGNVSSKCDVYSYGILLLETFT 488
APE D++S G +L E T
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLT 294
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 62/223 (27%), Positives = 91/223 (40%), Gaps = 32/223 (14%)
Query: 293 FNECNLLGSGGFGSV----YKGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVL-RN 343
F +LG G FG V +K AIK L + E VL
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDV-ECTMVEKRVLSLA 74
Query: 344 VRHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALE 402
H L + T V+E++ G L + S + F D+ ++ L L+
Sbjct: 75 WEHPFLTH-MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQ 132
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSVIQTMTI-ATIGY 459
+LH S +V+ DLK NILLD++ H+ +DFG+ K GD T T T Y
Sbjct: 133 FLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---TNTFCGTPDY 184
Query: 460 MAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMF 497
+APE + D +S+G+LL E + P +E+F
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 32/184 (17%), Positives = 70/184 (38%), Gaps = 10/184 (5%)
Query: 4 MQQLQGIGLADNHLQGSIPYDL-CQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLN 61
+ + I ++ + + L ++ + ++ + I L L L+ L +
Sbjct: 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113
Query: 62 SNKLTSSIP--SALWALEYILYVNLSSNYLTGSLTSDI-QNM-KVLIDLDLSRNQLSGDI 117
+ L P + +++ + + ++ N S+ + Q + + L L N +
Sbjct: 114 NTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQ 172
Query: 118 PKTIAGLKDLTNLSLAGNQFQGPIPE-SFGSLIS-LESLDLSSNNLSEGIPKSLVALSHL 175
G K L + L N++ I + +FG + S LD+S +++ K L L L
Sbjct: 173 GYAFNGTK-LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKEL 231
Query: 176 KQFN 179
N
Sbjct: 232 IARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 24/161 (14%), Positives = 60/161 (37%), Gaps = 10/161 (6%)
Query: 31 LNSLSLQGNKLNGSIPT-CLASLTSLRELRLNSNKLTSSIPS-ALWALEYILYVNLSSNY 88
+L L L +IP+ ++L ++ + ++ + + S + + L + ++ + +
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 89 LTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIA--GLKDLTNLSLAGNQFQGPIPE-S 144
+ D + + +L L + L P L + N + IP +
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 145 FGSLIS-LESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNR 184
F L + +L L +N + + + L ++ N+
Sbjct: 151 FQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNK 190
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 21/158 (13%), Positives = 51/158 (32%), Gaps = 14/158 (8%)
Query: 53 TSLRELRLNSNKLTS--SIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSR 110
+ R+ + S+P + L L +L + N+ + + +S
Sbjct: 11 HQEEDFRVTCKDIQRIPSLPPSTQTL------KLIETHLRTIPSHAFSNLPNISRIYVSI 64
Query: 111 N-QLSGDIPKTIAGLKDLTNLSLAGNQFQGPIP-ESFGSLISLESLDLSSNNLSEGIP-- 166
+ L + L +T++ + + I ++ L L+ L + + L P
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDL 123
Query: 167 KSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFH 204
+ + ++ N IP F+ ++
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIP-VNAFQGLCNETLT 160
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 40/192 (20%), Positives = 69/192 (35%), Gaps = 7/192 (3%)
Query: 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRL-NSNK 64
+ L+ L + + N + I ++L L E+R+ +N
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 65 LTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIP-KTIAG 123
L P A L + Y+ +S+ + + + LD+ N I + G
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151
Query: 124 L-KDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPK-SLVALSHLKQFNVS 181
L + L L N Q I S + L+ L+LS NN E +P S ++S
Sbjct: 152 LSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 210
Query: 182 HNRLEGEIPTEG 193
R+ +P+ G
Sbjct: 211 RTRIH-SLPSYG 221
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 26/201 (12%), Positives = 65/201 (32%), Gaps = 10/201 (4%)
Query: 4 MQQLQGIGLADNHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLN 61
L+ I ++ N + I D L +L+ + ++ I +L +L+ L ++
Sbjct: 53 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 112
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSD-IQNMKV-LIDLDLSRNQLSGDIPK 119
+ + + +++ N ++ + + + L L++N +
Sbjct: 113 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNS 172
Query: 120 TIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFN 179
G + N + + F LD+S + L L L+ +
Sbjct: 173 AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS 232
Query: 180 VSHNRLEGEIPTEGPFRNFSA 200
+ + ++P A
Sbjct: 233 TYNLK---KLP---TLEKLVA 247
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 33/163 (20%), Positives = 60/163 (36%), Gaps = 8/163 (4%)
Query: 32 NSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTG 91
Q +K+ IP+ L + ELR KL A + + +S N +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 92 SLTSDI-QNMKVLIDLDLSR-NQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLI 149
+ +D+ N+ L ++ + + N L P+ L +L L ++ + +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 128
Query: 150 SLESLDLSSNNLSEGIP-KSLVALSH-LKQFNVSHNRLEGEIP 190
LD+ N I S V LS ++ N ++ EI
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIH 170
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 37/177 (20%), Positives = 59/177 (33%), Gaps = 14/177 (7%)
Query: 14 DNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIP--- 70
++ + IP DL + L KL + L ++ ++ N + I
Sbjct: 18 ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 74
Query: 71 -SALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLT 128
S L L I +N L + + QN+ L L +S +
Sbjct: 75 FSNLPKLHEIRIEK--ANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV 131
Query: 129 NLSLAGNQFQGPIPE-SFGSL-ISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183
L + N I SF L L L+ N + E I S + L + N+S N
Sbjct: 132 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDN 187
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 22/176 (12%), Positives = 54/176 (30%), Gaps = 11/176 (6%)
Query: 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSL-QGNKLNGSIPTCLASLTSLRELRL 60
G + + L N +Q I +L+ L+L N L + L +
Sbjct: 151 GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRN-QLSGDIPK 119
+ ++ S L L+ + + + +L + + L++ L+
Sbjct: 210 SRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL----EKLVALMEASLTYPSHCCAFAN- 264
Query: 120 TIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHL 175
+ ++ L N+ + + + L+ +N S + +
Sbjct: 265 ---WRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYSRGFDMTYTEF 317
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 4e-13
Identities = 37/188 (19%), Positives = 72/188 (38%), Gaps = 13/188 (6%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLR--EL 58
+ ++LQ + + +I + L L + L ++ +R L
Sbjct: 368 LESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST-----LKAVDPMRAAYL 422
Query: 59 RLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIP 118
+K + ++L+ LT L ++ + ++ LDLS N+L +P
Sbjct: 423 DDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VL-CHLEQLLLVTHLDLSHNRLR-ALP 479
Query: 119 KTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE-GIPKSLVALSHLKQ 177
+A L+ L L + N + + +L L+ L L +N L + + LV+ L
Sbjct: 480 PALAALRCLEVLQASDNALE--NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 537
Query: 178 FNVSHNRL 185
N+ N L
Sbjct: 538 LNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.2 bits (171), Expect = 8e-13
Identities = 38/179 (21%), Positives = 60/179 (33%), Gaps = 9/179 (5%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNS 62
M+ L + LQ R L +K +R L L
Sbjct: 391 LMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAH 450
Query: 63 NKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIA 122
LT L L + +++LS N L +L + ++ L L S N L ++ +A
Sbjct: 451 KDLTV--LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VA 505
Query: 123 GLKDLTNLSLAGNQFQG-PIPESFGSLISLESLDLSSNNLSEG---IPKSLVALSHLKQ 177
L L L L N+ Q + S L L+L N+L + + L +
Sbjct: 506 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 40/195 (20%), Positives = 71/195 (36%), Gaps = 31/195 (15%)
Query: 15 NHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALW 74
D ++L L K + + L S L+EL + +I +
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMR 393
Query: 75 ALEYILYVNLSSNYLTGSLTSDIQNMKVLID---------------------LDLSRNQL 113
AL+ +LY + Y + D L D L L+ L
Sbjct: 394 ALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453
Query: 114 SGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS--EGIPKSLVA 171
+ + + L +T+L L+ N+ + +P + +L LE L S N L +G+
Sbjct: 454 T--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVDGVAN---- 506
Query: 172 LSHLKQFNVSHNRLE 186
L L++ + +NRL+
Sbjct: 507 LPRLQELLLCNNRLQ 521
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 49/230 (21%), Positives = 87/230 (37%), Gaps = 44/230 (19%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIF-NLQ--LEQAFRSFNSECEVLRNVR-------- 345
LG G F +V+ + + T VA+KI + E A E ++L+ V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLLQRVNDADNTKED 81
Query: 346 ---HRNLIKILSS--CCNTNFK--ALVLEFMPNGSLDKWLYSHNYFQDIPDRL--NIMID 396
+++K+L N +V E + +L + + + IP I
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQ 139
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILLDENMVAH------VSDFGISKLLGEGDDSVIQ 450
+ L L+Y+H ++H D+KP N+L++ ++D G + E + IQ
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500
T Y +PE D++S L+ E T +F +
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDF----LFEPD 238
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 6e-13
Identities = 41/230 (17%), Positives = 68/230 (29%), Gaps = 58/230 (25%)
Query: 289 ATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKI--------FNLQLEQAFRSFNSECEV 340
T+ C +G G FG V++ I D T VAIKI N ++ F E +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 341 LRNV---------RHRNLIKILSSCC------------------------------NTNF 361
+ + R I + S C +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 362 KALVLEFMPNG-SLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPS 420
+VLEF G L++ + +I+ + +L H DL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWG 191
Query: 421 NILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNV 470
N+LL + + + K + ++ I Y +G V
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTIPSCGLQ----VSIIDYTLSRLERDGIV 237
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 34/226 (15%)
Query: 291 DGFNECNLLGSGGFGSVY----KGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVL- 341
F+ ++G G FG V K + A+K+ L+ ++ + SE VL
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEE-KHIMSERNVLL 93
Query: 342 RNVRHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI-DVAL 399
+NV+H L+ L T K VL+++ G L L F + R ++A
Sbjct: 94 KNVKHPFLVG-LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE--PRARFYAAEIAS 150
Query: 400 ALEYLHHGHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSVIQTMTI-AT 456
AL YLH S +V+ DLKP NILLD H+ +DFG+ K E + + T T T
Sbjct: 151 ALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTFCGT 202
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMF 497
Y+APE + D + G +L E P T EM+
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 37/147 (25%), Positives = 64/147 (43%), Gaps = 14/147 (9%)
Query: 26 CQLKRLNS-----------LSLQGNKLNGSIPT-CLASLTSLRELRLNSNKLTSSIPSAL 73
C ++LN L L N+ T L LR++ ++NK+T A
Sbjct: 18 CSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAF 77
Query: 74 WALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSL 132
+ + L+SN L ++ + + ++ L L L N+++ + GL + LSL
Sbjct: 78 EGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL 136
Query: 133 AGNQFQGPIPESFGSLISLESLDLSSN 159
NQ P +F +L SL +L+L +N
Sbjct: 137 YDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 60/225 (26%), Positives = 89/225 (39%), Gaps = 32/225 (14%)
Query: 291 DGFNECNLLGSGGFGSVY----KGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLR 342
D F +LG G FG V K G A+K+ LQ + +E +L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDV-ECTMTEKRILS 78
Query: 343 NVRHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALAL 401
R+ + L C T + V+EF+ G L + F + R ++ AL
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISAL 137
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKL-LGEGDDSVIQTMTI-ATI 457
+LH +++ DLK N+LLD H +DFG+ K + G T T T
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGV----TTATFCGTP 188
Query: 458 GYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMF 497
Y+APE E D ++ G+LL E P D++F
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 34/224 (15%)
Query: 293 FNECNLLGSGGFGSV----YKGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLRNV 344
FN +LG G FG V KG A+KI +Q + E VL
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDV-ECTMVEKRVLALP 77
Query: 345 RHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI-DVALALE 402
+ L SC T + V+E++ G L + F++ ++A+ L
Sbjct: 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE--PHAVFYAAEIAIGLF 135
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKL-LGEGDDSVIQTMTI-ATIG 458
+L S +++ DLK N++LD H+ +DFG+ K + +G T T T
Sbjct: 136 FLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGV----TTKTFCGTPD 186
Query: 459 YMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP-----TDEMF 497
Y+APE + D +++G+LL E + P DE+F
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 42/223 (18%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIK-IFN-----LQLEQAFRSFNSECEVLRNVR-HRNLI 350
LG G +G V+K I G VA+K IF+ ++ FR E +L + H N++
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIV 72
Query: 351 KILSSCCNTNFKA--LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH 408
+L+ N + LV ++M L + + N + + + ++ + ++YLH
Sbjct: 73 NLLNVLRADNDRDVYLVFDYMET-DLHAVIRA-NILEPVHKQY-VVYQLIKVIKYLH--- 126
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFG-----------------ISKLLGEGDDSVIQT 451
S ++H D+KPSNILL+ V+DFG E D
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 452 MT--IATIGYMAPE--FGSEGNVSSKCDVYSYGILLLETFTRK 490
+T +AT Y APE GS + D++S G +L E K
Sbjct: 187 LTDYVATRWYRAPEILLGST-KYTKGIDMWSLGCILGEILCGK 228
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 20/155 (12%)
Query: 26 CQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85
CQ K L+S +P+ + + T +L L S L + + L + ++NL
Sbjct: 21 CQGKSLDS-----------VPSGIPADT--EKLDLQSTGLATLSDATFRGLTKLTWLNLD 67
Query: 86 SNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPES 144
N L +L++ + ++ L L L+ NQL+ L L L L GNQ + +P
Sbjct: 68 YNQLQ-TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSG 125
Query: 145 -FGSLISLESLDLSSNNLS---EGIPKSLVALSHL 175
F L L+ L L++N L G L L L
Sbjct: 126 VFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTL 160
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 44/160 (27%), Positives = 62/160 (38%), Gaps = 24/160 (15%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLNSNKLTS--- 67
L L L +L L+L N+L ++ LT L L L +N+L S
Sbjct: 42 LQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLASLPL 100
Query: 68 SIPSALWALEYILYVNLSSNYLTG-------SLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+ L L+ + L N L LT L +L L+ NQL IP
Sbjct: 101 GVFDHLTQLDKL---YLGGNQLKSLPSGVFDRLTK-------LKELRLNTNQLQ-SIPAG 149
Query: 121 I-AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSN 159
L +L LSL+ NQ Q +F L L+++ L N
Sbjct: 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 27/83 (32%), Positives = 36/83 (43%), Gaps = 6/83 (7%)
Query: 106 LDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS--- 162
LDL L+ T GL LT L+L NQ Q F L L +L L++N L+
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLP 99
Query: 163 EGIPKSLVALSHLKQFNVSHNRL 185
G+ L L L + N+L
Sbjct: 100 LGVFDHLTQLDKL---YLGGNQL 119
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 45/148 (30%), Positives = 64/148 (43%), Gaps = 26/148 (17%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDL-CQLKRLNSLSLQGNKLNGSIPTCL-ASLTSLRELRL 60
+ +L + L N LQ ++ + L L +L L N+L S+P + LT L +L L
Sbjct: 57 GLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYL 114
Query: 61 NSNKLTSSIPSA----LWALEYILYVNLSSNYLTG-------SLTSDIQNMKVLIDLDLS 109
N+L S +PS L L+ L L++N L LT+ L L LS
Sbjct: 115 GGNQLKS-LPSGVFDRLTKLKE-LR--LNTNQLQSIPAGAFDKLTN-------LQTLSLS 163
Query: 110 RNQLSGDIPKTIAGLKDLTNLSLAGNQF 137
NQL L L ++L GNQF
Sbjct: 164 TNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 57/209 (27%), Positives = 83/209 (39%), Gaps = 32/209 (15%)
Query: 297 NLLGSGGFGSVYKGI-LSDGTTVAIKIF-NLQ--LEQAFRSFNSECEVLRNVRHR----- 347
+L+G G FG V K + VAIKI N + L QA E +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI----EVRLLELMNKHDTEMK 115
Query: 348 -NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYS---HNYFQDIPDRL--NIMIDVALAL 401
++ + N LV E L LY + F+ + L + AL
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 402 EYLHHGHSTPVVHCDLKPSNILL--DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGY 459
+L + ++HCDLKP NILL + + DFG S LG+ IQ+ Y
Sbjct: 171 LFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----Y 224
Query: 460 MAPEFGSEGNVSSKCDVYSYGILLLETFT 488
+PE D++S G +L+E T
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 48/209 (22%), Positives = 82/209 (39%), Gaps = 29/209 (13%)
Query: 291 DGFNECNLLGSGGFGSVY----KGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLR 342
F+ ++G G + V K A+++ E +E V
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDI-DWVQTEKHVFE 107
Query: 343 NVRHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI-DVALA 400
+ + L SC T + V+E++ G L + + + +++LA
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE--EHARFYSAEISLA 165
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKL-LGEGDDSVIQTMTI-AT 456
L YLH +++ DLK N+LLD H+ +D+G+ K L GD T T T
Sbjct: 166 LNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGD----TTSTFCGT 216
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLE 485
Y+APE + D ++ G+L+ E
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFE 245
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 53/247 (21%), Positives = 93/247 (37%), Gaps = 33/247 (13%)
Query: 291 DGFNECNLLGSGGFGSVY----KGILSDGTTVAIKIFN----LQLEQAFRSFNSECEVLR 342
F+ ++G G + V K A+K+ E +E V
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDI-DWVQTEKHVFE 64
Query: 343 NVRHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI-DVALA 400
+ + L SC T + V+E++ G L + + + +++LA
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE--EHARFYSAEISLA 122
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHV--SDFGISKL-LGEGDDSVIQTMTI-AT 456
L YLH +++ DLK N+LLD H+ +D+G+ K L GD T T T
Sbjct: 123 LNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGD----TTSTFCGT 173
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP 516
Y+APE + D ++ G+L+ E + P F + N + + +
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP----FDIVGSSDNPDQNTEDYLFQ 229
Query: 517 KIADANL 523
I + +
Sbjct: 230 VILEKQI 236
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 41/158 (25%), Positives = 61/158 (38%), Gaps = 19/158 (12%)
Query: 26 CQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85
C+ KR S+ IPT + + L L+ N++T P +L + + L
Sbjct: 26 CRSKRHASVP-------AGIPT------NAQILYLHDNQITKLEPGVFDSLINLKELYLG 72
Query: 86 SNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPES 144
SN L +L + ++ L LDL NQL+ L L L + N+ +P
Sbjct: 73 SNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRG 130
Query: 145 FGSLISLESLDLSSNNLS---EGIPKSLVALSHLKQFN 179
L L L L N L G L +L+H F
Sbjct: 131 IERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 43/149 (28%), Positives = 63/149 (42%), Gaps = 27/149 (18%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCL-ASLTSLRELRLNSNKLTSSIP 70
L DN + P L L L L N+L ++P + SLT L L L +N+LT +P
Sbjct: 47 LHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLP 104
Query: 71 SALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNL 130
SA++ L L +L + N+L+ +P+ I L LT+L
Sbjct: 105 SAVF----------------DRLVH-------LKELFMCCNKLTE-LPRGIERLTHLTHL 140
Query: 131 SLAGNQFQGPIPESFGSLISLESLDLSSN 159
+L NQ + +F L SL L N
Sbjct: 141 ALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 2e-10
Identities = 23/105 (21%), Positives = 44/105 (41%), Gaps = 3/105 (2%)
Query: 82 VNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPK-TIAGLKDLTNLSLAGNQFQGP 140
+ + + SL + + L +L + Q + + GL +L NL++ + +
Sbjct: 13 LRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 141 IPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRL 185
P++F L L+LS N L + V L++ +S N L
Sbjct: 72 APDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 1e-09
Identities = 21/123 (17%), Positives = 40/123 (32%), Gaps = 24/123 (19%)
Query: 39 NKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQ 98
L +L EL + + + + D++
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLEL-----------------------RDLR 53
Query: 99 NMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSS 158
+ L +L + ++ L P L+ L+L+ N + ++ L SL+ L LS
Sbjct: 54 GLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSG 112
Query: 159 NNL 161
N L
Sbjct: 113 NPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 24/95 (25%), Positives = 36/95 (37%), Gaps = 2/95 (2%)
Query: 20 SIPYDLCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLNSNKLTSSIPSALWALEY 78
+ L + L L ++ + + L L LR L + + L P A
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 79 ILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQL 113
+ +NLS N L SL+ L +L LS N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 19/88 (21%), Positives = 32/88 (36%), Gaps = 2/88 (2%)
Query: 4 MQQLQGIGLADNHLQGSIP-YDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNS 62
+ L + + + + DL L L +L++ + L P L L L+
Sbjct: 30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89
Query: 63 NKLTSSIPSALWALEYILYVNLSSNYLT 90
N L S + L + + LS N L
Sbjct: 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 37/151 (24%), Positives = 67/151 (44%), Gaps = 19/151 (12%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLI-KILSSC 356
+G G FG + G L VAIK+ ++ + E + + + I ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 357 CNTNFKALVLEFMPNG-SL-DKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
+ A+VLE + G SL D + F + L I I + +EY+H S +++
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTF-SLKTVLMIAIQLISRMEYVH---SKNLIY 128
Query: 415 CDLKPSNILL------DENMVAHVSDFGISK 439
D+KP N L+ + ++ H+ DF ++K
Sbjct: 129 RDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 31/181 (17%), Positives = 60/181 (33%), Gaps = 28/181 (15%)
Query: 25 LCQLKRLNSLSLQGNKLNG----SIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYIL 80
L + +L+++ L N + L+ T L L L++N L P A + L
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG---PQAGAKIARAL 146
Query: 81 YVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGD----IPKTIAGLKDLTNLSLAGNQ 136
+ + L + RN+L KT + L + + N
Sbjct: 147 QELAVNKKAKNAPP--------LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNG 198
Query: 137 F-----QGPIPESFGSLISLESLDLSSNNLS----EGIPKSLVALSHLKQFNVSHNRLEG 187
+ + E L+ LDL N + + +L + +L++ ++ L
Sbjct: 199 IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 258
Query: 188 E 188
Sbjct: 259 R 259
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 27/197 (13%), Positives = 57/197 (28%), Gaps = 39/197 (19%)
Query: 31 LNSLSLQGNKLNG----SIPTCLASLTSLRELRLNSNKLT----SSIPSALWALEYILYV 82
+ SL+ + + S+ L S++E+ L+ N + + + + + +
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 83 NLSSNYL----------TGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGL----KDLT 128
S + L + L + LS N + + L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 129 NLSLAGNQF-------------QGPIPESFGSLISLESLDLSSNNLSEG----IPKSLVA 171
+L L N + + + + L S+ N L G K+ +
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 172 LSHLKQFNVSHNRLEGE 188
L + N + E
Sbjct: 186 HRLLHTVKMVQNGIRPE 202
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 34/224 (15%), Positives = 65/224 (29%), Gaps = 41/224 (18%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQL----KRLNSLSLQGNKL-------------NGSI 45
+ +L + L+DN + L L L L N L ++
Sbjct: 92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAV 151
Query: 46 PTCLASLTSLRELRLNSNKLT----SSIPSALWALEYILYVNLSSNYLT-----GSLTSD 96
+ LR + N+L + + V + N + L
Sbjct: 152 NKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG 211
Query: 97 IQNMKVLIDLDLSRNQLSGD----IPKTIAGLKDLTNLSLAGNQFQGP----IPESF--G 146
+ + L LDL N + + + +L L L + ++F
Sbjct: 212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271
Query: 147 SLISLESLDLSSNNLS----EGIPKSL-VALSHLKQFNVSHNRL 185
I L++L L N + + + + L ++ NR
Sbjct: 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 31/151 (20%), Positives = 55/151 (36%), Gaps = 23/151 (15%)
Query: 5 QQLQGIGLADNHL-----QGSIPYDLCQLKRLNSLSLQGNKLNG----SIPTCLASLTSL 55
+ L + + N + + + L + L L LQ N ++ L S +L
Sbjct: 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 246
Query: 56 RELRLNSNKLTS----SIPSALWALE--YILYVNLSSNYLTGSLTSDI-----QNMKVLI 104
REL LN L++ ++ A LE + + L N + + + M L+
Sbjct: 247 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 306
Query: 105 DLDLSRNQLS--GDIPKTIA-GLKDLTNLSL 132
L+L+ N+ S D+ I L
Sbjct: 307 FLELNGNRFSEEDDVVDEIREVFSTRGRGEL 337
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 43/209 (20%), Positives = 78/209 (37%), Gaps = 28/209 (13%)
Query: 5 QQLQGIGLADNHLQGSIPYDLCQ-LKRLNSLSLQGNKLN----GSIPTCLASLTSLRELR 59
+Q + + L + +L L++ + L L I + L +L EL
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 60 LNSNKLTSSIPSAL-WALEY----ILYVNLSSNYLT----GSLTSDIQNMKVLIDLDLSR 110
L SN+L + L+ I ++L + LT G L+S ++ + L +L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 111 NQLSGDIPKTIA-GLKD----LTNLSLAGNQFQGPIPESFGSLI----SLESLDLSSNNL 161
N L + + GL D L L L E S++ + L +S+N++
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 162 S-EGIPKSLVALSH----LKQFNVSHNRL 185
+ G+ L L+ + +
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGV 211
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 45/219 (20%), Positives = 84/219 (38%), Gaps = 38/219 (17%)
Query: 5 QQLQGIGLADNHLQGSIPYDLCQ-LK----RLNSLSLQGNKLN----GSIPTCLASLTSL 55
+ + +++N + + LCQ LK +L +L L+ + + +AS SL
Sbjct: 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASL 229
Query: 56 RELRLNSNKLTSS-----IPSALWALEYILYVNLSSNYLT----GSLTSDIQNMKVLIDL 106
REL L SNKL P L + + + +T G L ++ + L +L
Sbjct: 230 RELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKEL 289
Query: 107 DLSRNQLSGDIPKTIA-GLKD----LTNLSLAGNQFQGPIPESFGSLI----SLESLDLS 157
L+ N+L + + + L + L +L + F F S++ L L +S
Sbjct: 290 SLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQIS 349
Query: 158 SNN--------LSEGIPKSLVALSHLKQFNVSHNRLEGE 188
+N L +G+ + L L ++ +
Sbjct: 350 NNRLEDAGVRELCQGLGQPGSVLRVL---WLADCDVSDS 385
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 47/216 (21%), Positives = 75/216 (34%), Gaps = 32/216 (14%)
Query: 5 QQLQGIGLADNHLQGS-----IPYDLCQLKRLNSLSLQGNKLN----GSIPTCLASLTSL 55
L+ + L N L P L RL +L + + G + L + SL
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL 286
Query: 56 RELRLNSNKLTSSIPSALW-ALEY----ILYVNLSSNYLTG----SLTSDIQNMKVLIDL 106
+EL L N+L L L + + + S T +S + + L++L
Sbjct: 287 KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL 346
Query: 107 DLSRNQLSGDIPKTIA-GLKD----LTNLSLAGNQFQ----GPIPESFGSLISLESLDLS 157
+S N+L + + GL L L LA + + + SL LDLS
Sbjct: 347 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLS 406
Query: 158 SNNLSEGIPKSLVAL-----SHLKQFNVSHNRLEGE 188
+N L + LV L+Q + E
Sbjct: 407 NNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 48/217 (22%), Positives = 80/217 (36%), Gaps = 32/217 (14%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQ-LK----RLNSLSLQGNKLN----GSIPTCLASLTS 54
L + L N L + + Q L+ ++ LSLQ L G + + L +L +
Sbjct: 55 NPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPT 114
Query: 55 LRELRLNSNKLTSS----IPSALWALEYIL-YVNLSSNYLT----GSLTSDIQNMKVLID 105
L+EL L+ N L + + L + L + L L+ L S ++ +
Sbjct: 115 LQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKE 174
Query: 106 LDLSRNQLSGDIPKTIA-GLKD----LTNLSLAGNQFQ----GPIPESFGSLISLESLDL 156
L +S N ++ + + GLKD L L L + S SL L L
Sbjct: 175 LTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELAL 234
Query: 157 SSNNLS-EGIPKSLVALSH----LKQFNVSHNRLEGE 188
SN L G+ + L H L+ + + +
Sbjct: 235 GSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAK 271
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 39/171 (22%), Positives = 58/171 (33%), Gaps = 23/171 (13%)
Query: 25 LCQLKRLNSLSLQGNKLNGSIPTCLASL-----TSLRELRLNSNKLTS----SIPSALWA 75
L + L LSL GN+L L L L + S T+ S L
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 339
Query: 76 LEYILYVNLSSNYLTGSLTSDI-----QNMKVLIDLDLSRNQLS----GDIPKTIAGLKD 126
++L + +S+N L + ++ Q VL L L+ +S + T+
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 399
Query: 127 LTNLSLAGNQFQGPIPESFGSLI-----SLESLDLSSNNLSEGIPKSLVAL 172
L L L+ N + LE L L SE + L AL
Sbjct: 400 LRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 450
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 51/236 (21%), Positives = 81/236 (34%), Gaps = 68/236 (28%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIF-NLQ--LEQAFRSFNSECEVLRNVRHR-----N 348
+G G FG V + + A+K+ N++ A E ++L+ +++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDDINNNN 97
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYS---HNYFQDIPDRL--NIMIDVALALEY 403
++K + L+ E L LY N + I++ AL Y
Sbjct: 98 IVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHVS-------------------------DFGIS 438
L + H DLKP NILLD+ DFG +
Sbjct: 153 LRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSEGNV------SSKCDVYSYGILLLETFT 488
+ S+I T Y APE V D++S+G +L E +T
Sbjct: 210 TFKSDYHGSIINTRQ-----YRAPE------VILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 51/227 (22%), Positives = 80/227 (35%), Gaps = 54/227 (23%)
Query: 298 LLGSGGFGSVYKGI--LSDGTTVAIKIF-NLQ--LEQAFRSFNSECEVLRNVRHR----- 347
LG G FG V + + + VA+KI N+ E A E VL+ ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL----EINVLKKIKEKDKENK 81
Query: 348 -NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYS---HNYFQDIPDRL--NIMIDVALAL 401
+ + + E L K + N FQ P ++ + AL
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI------------ 449
+LH + H DLKP NIL + + + S ++ I
Sbjct: 137 RFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 450 QTMT--IATIGYMAPEFGSEGNV------SSKCDVYSYGILLLETFT 488
+ T +AT Y PE V + CDV+S G +L E +
Sbjct: 194 EHHTTIVATRHYRPPE------VILELGWAQPCDVWSIGCILFEYYR 234
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 39/148 (26%), Positives = 59/148 (39%), Gaps = 42/148 (28%)
Query: 26 CQLKRLNS-----------LSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALW 74
C K L L L GN+ +P L++ L + L++N+++
Sbjct: 17 CSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-------- 67
Query: 75 ALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTI-AGLKDLTNLSL 132
+L++ NM L+ L LS N+L IP GLK L LSL
Sbjct: 68 -----------------TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSL 109
Query: 133 AGNQFQGPIPE-SFGSLISLESLDLSSN 159
GN +PE +F L +L L + +N
Sbjct: 110 HGNDISV-VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 9/95 (9%)
Query: 106 LDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS--- 162
L L NQ + +PK ++ K LT + L+ N+ +SF ++ L +L LS N L
Sbjct: 36 LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIP 94
Query: 163 EGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRN 197
L +L L ++ N + +P EG F +
Sbjct: 95 PRTFDGLKSLRLL---SLHGNDIS-VVP-EGAFND 124
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 47/155 (30%), Positives = 68/155 (43%), Gaps = 13/155 (8%)
Query: 27 QLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS--ALWALEYILYVNL 84
+L ++ + + + S+ + L ++R L L NKL I + L L Y + L
Sbjct: 39 ELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLHD-ISALKELTNLTY---LIL 92
Query: 85 SSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPE 143
+ N L SL + + + L +L L NQL L +LT L+LA NQ Q
Sbjct: 93 TGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKG 151
Query: 144 SFGSLISLESLDLSSNNLS---EGIPKSLVALSHL 175
F L +L LDLS N L EG+ L L L
Sbjct: 152 VFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL 186
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 51/167 (30%), Positives = 72/167 (43%), Gaps = 28/167 (16%)
Query: 6 QLQGIGLADNHLQGSIP-YDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNK 64
++ + L N L I +L L L L GN+L LT+L+EL L N+
Sbjct: 64 NVRYLALGGNKLH-DISALK--ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQ 120
Query: 65 LTSSIPSALWALEYILYVNLSSNYLTG-------SLTSDIQNMKVLIDLDLSRNQLSGDI 117
L S L + Y+NL+ N L LT+ L +LDLS NQL +
Sbjct: 121 LQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTN-------LTELDLSYNQLQS-L 172
Query: 118 PKTIAGLKD----LTNLSLAGNQFQGPIPE-SFGSLISLESLDLSSN 159
P G+ D L +L L NQ + +P+ F L SL+ + L N
Sbjct: 173 P---EGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 34/167 (20%), Positives = 55/167 (32%), Gaps = 33/167 (19%)
Query: 26 CQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85
+ L +T + L I + +
Sbjct: 5 VSTPIKQIFPDD-------AFA------ETIKANLKKKSVTDA--VTQNELNSIDQIIAN 49
Query: 86 SNYLTGSLTSDIQNMKVLIDLDLSRNQLSG----DIPKTIAGLKDLTNLSLAGNQFQGPI 141
++ + IQ + + L L N+L L +LT L L GNQ Q
Sbjct: 50 NSDIKSV--QGIQYLPNVRYLALGGNKLHDISALK------ELTNLTYLILTGNQLQSLP 101
Query: 142 PESFGSLISLESLDLSSNNLS---EGIPKSLVALSHLKQFNVSHNRL 185
F L +L+ L L N L +G+ L L++L N++HN+L
Sbjct: 102 NGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL---NLAHNQL 145
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 36/128 (28%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 21 IPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLT--SSIPSALWALEY 78
+ L LK L+L N + I + L+ + +LR L L N + ++ + LE
Sbjct: 40 MDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIKKIENLDAVADTLEE 97
Query: 79 ILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLS--GDIPKTIAGLKDLTNLSLAGNQ 136
+ +S N + SL S I+ + L L +S N+++ G+I +A L L +L LAGN
Sbjct: 98 L---WISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNP 151
Query: 137 FQGPIPES 144
E+
Sbjct: 152 LYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-09
Identities = 31/166 (18%), Positives = 55/166 (33%), Gaps = 31/166 (18%)
Query: 33 SLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGS 92
L + + L++L + + L L++N +
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEK------------------------- 62
Query: 93 LTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLE 152
S + M+ L L L RN + I A L L ++ NQ L++L
Sbjct: 63 -ISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLR 118
Query: 153 SLDLSSNNLSE-GIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRN 197
L +S+N ++ G L AL L+ ++ N L +
Sbjct: 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 33/151 (21%), Positives = 59/151 (39%), Gaps = 19/151 (12%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLI-KILSSC 356
+G G FG +++G L + VAIK + + E + + I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 357 CNTNFKALVLEFMPNG-SL-DKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
LV++ + G SL D F + + ++ +H +V+
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKF-SVKTVAMAAKQMLARVQSIH---EKSLVY 129
Query: 415 CDLKPSNILL------DENMVAHVSDFGISK 439
D+KP N L+ + NM+ +V DFG+ K
Sbjct: 130 RDIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 54/232 (23%), Positives = 82/232 (35%), Gaps = 64/232 (27%)
Query: 298 LLGSGGFGSVYKGI--LSDGTTVAIKIF-NLQ--LEQAFRSFNSECEVLRNVRHR----- 347
LG G FG V + I + G VA+KI N+ E A SE +VL ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAAR----SEIQVLEHLNTTDPNST 76
Query: 348 -NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYS---HNYFQDIPDRL--NIMIDVALAL 401
+++L + +V E L Y N F + + ++
Sbjct: 77 FRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVS-------------------DFGISKLLG 442
+LH + H DLKP NIL ++ DFG +
Sbjct: 132 NFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 443 EGDDSVIQTMTIATIGYMAPEFGSEGNV------SSKCDVYSYGILLLETFT 488
E +++ T Y APE V S CDV+S G +L+E +
Sbjct: 189 EHHSTLVSTRH-----YRAPE------VILALGWSQPCDVWSIGCILIEYYL 229
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 36/165 (21%), Positives = 67/165 (40%), Gaps = 30/165 (18%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIF--------NLQLEQAFRSFNSECEVLRNVRHRN 348
+GSGGFG +Y + A + L E F ++ + ++ R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 349 LIKIL----------SSCCNTNFKALVLEFMPNG-SLDKWLYSHNYFQDIPDRLNIMIDV 397
+ L + +++ +V+E + G L K + F L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTF-KKSTVLQLGIRM 160
Query: 398 ALALEYLHHGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISK 439
LEY+H VH D+K +N+LL + + V +++D+G+S
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 17/149 (11%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLI-KILSSC 356
+GSG FG +Y G ++ G VAIK+ ++ + + E ++ + ++ I I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 357 CNTNFKALVLEFMPNG-SL-DKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
++ +V+E + G SL D + + F + L + + +EY+H S +H
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKF-SLKTVLLLADQMISRIEYIH---SKNFIH 128
Query: 415 CDLKPSNILL----DENMVAHVSDFGISK 439
D+KP N L+ N+V ++ DFG++K
Sbjct: 129 RDVKPDNFLMGLGKKGNLV-YIIDFGLAK 156
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 33/176 (18%), Positives = 66/176 (37%), Gaps = 49/176 (27%)
Query: 298 LLGSGGFGSVYKGILSDGTTVAIKIFN-----------LQLEQAFRSFNSECEVLRNVRH 346
+G GGFG +Y ++ +V L E F ++ E ++
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 347 RNLIKIL----------SSCCNTNFKALVLEFMPNG-SLDKWLYSHNYFQDIPDRLNI-- 393
+K L +++ ++++ G L K ++ R +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK------IYEANAKRFSRKT 153
Query: 394 -------MIDVALALEYLHHGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISK 439
++D+ LEY+H VH D+K SN+LL + + V ++ D+G++
Sbjct: 154 VLQLSLRILDI---LEYIHEHE---YVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 8e-09
Identities = 33/110 (30%), Positives = 50/110 (45%), Gaps = 5/110 (4%)
Query: 53 TSLRELRLNSNKLTSSIPSALW-ALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSR 110
EL LN N+L L+ L +++ + L N LT + + + + +L L
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGE 87
Query: 111 NQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPE-SFGSLISLESLDLSSN 159
N++ K GL L L+L NQ + SF L SL SL+L+SN
Sbjct: 88 NKIKEISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 25/93 (26%), Positives = 38/93 (40%), Gaps = 3/93 (3%)
Query: 106 LDLSRNQLSGDIPKTI-AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEG 164
L L+ N+L + L L L L NQ G P +F ++ L L N + E
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEI 93
Query: 165 IPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRN 197
K + L LK N+ N++ + G F +
Sbjct: 94 SNKMFLGLHQLKTLNLYDNQISC-VM-PGSFEH 124
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-08
Identities = 29/131 (22%), Positives = 51/131 (38%), Gaps = 28/131 (21%)
Query: 31 LNSLSLQGNKLN-GSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYL 89
+ L L ++ N G + L L + LTS
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS---------------------- 56
Query: 90 TGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGP-IPESFGSL 148
+++ + L L+LS N++SG + +LT+L+L+GN+ + E L
Sbjct: 57 ----IANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKL 112
Query: 149 ISLESLDLSSN 159
+L+SLDL +
Sbjct: 113 ENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-05
Identities = 19/81 (23%), Positives = 34/81 (41%), Gaps = 7/81 (8%)
Query: 106 LDLSRNQLS--GDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163
L L+ ++PK L L L L+ N+ G + +L L+LS N + +
Sbjct: 47 LSTINVGLTSIANLPK----LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD 102
Query: 164 -GIPKSLVALSHLKQFNVSHN 183
+ L L +LK ++ +
Sbjct: 103 LSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 8e-05
Identities = 20/83 (24%), Positives = 35/83 (42%), Gaps = 3/83 (3%)
Query: 104 IDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163
+ LD SR+ G + ++L LS + L L+ L+LS N +S
Sbjct: 22 LVLDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELSDNRVSG 78
Query: 164 GIPKSLVALSHLKQFNVSHNRLE 186
G+ +L N+S N+++
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 23/117 (19%), Positives = 43/117 (36%), Gaps = 25/117 (21%)
Query: 19 GSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEY 78
G + + + L LS L SI L L L++L L+ N+++ +
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 79 ILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGN 135
+ ++NLS N + D+ ++ L L++L +L L
Sbjct: 90 LTHLNLSGNKI-----KDLSTIEPL------------------KKLENLKSLDLFNC 123
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 46/157 (29%), Positives = 61/157 (38%), Gaps = 35/157 (22%)
Query: 26 CQLKRLNS-----------LSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALW 74
C + S L L+ N L LTSL +L L NKL S
Sbjct: 14 CYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN 73
Query: 75 ALEYILYVNLSSNYLTG-------SLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG---- 123
L + Y+NLS+N L LT L +L L+ NQL +P G
Sbjct: 74 KLTSLTYLNLSTNQLQSLPNGVFDKLTQ-------LKELALNTNQLQS-LP---DGVFDK 122
Query: 124 LKDLTNLSLAGNQFQGPIPE-SFGSLISLESLDLSSN 159
L L +L L NQ + +P+ F L SL+ + L N
Sbjct: 123 LTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 36/139 (25%), Positives = 59/139 (42%), Gaps = 6/139 (4%)
Query: 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121
++ +S+P+ + A L L +N L + L L L N+L
Sbjct: 15 YSQGRTSVPTGIPAQTTYLD--LETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72
Query: 122 AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLV-ALSHLKQFNV 180
L LT L+L+ NQ Q F L L+ L L++N L +P + L+ LK +
Sbjct: 73 NKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRL 131
Query: 181 SHNRLEGEIPTEGPFRNFS 199
N+L+ +P +G F +
Sbjct: 132 YQNQLKS-VP-DGVFDRLT 148
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.0 bits (131), Expect = 3e-08
Identities = 33/175 (18%), Positives = 61/175 (34%), Gaps = 34/175 (19%)
Query: 28 LKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSN 87
L + L+ K ++ +L+ L + S L S+ +
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDI-------------- 213
Query: 88 YLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI-------AGLKDLTNLSLAGNQFQGP 140
L SD+ N++ L L + D + +L L + + Q
Sbjct: 214 -----LGSDLPNLEKL-VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNV 267
Query: 141 IPESFGS---LISLESLDLSSNNLS----EGIPKSLVALSHLKQFNVSHNRLEGE 188
+ E F L LE++D+S+ L+ + + + HLK N+ +N L E
Sbjct: 268 VVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 3e-05
Identities = 23/143 (16%), Positives = 54/143 (37%), Gaps = 14/143 (9%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASL------TSLR 56
+ ++ GL D+ ++ + DL L++L + L +L+
Sbjct: 196 KSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLK 255
Query: 57 ELRLNSNKLTSSIPSALWA---LEYILYVNLSSNYLTGS----LTSDIQNMKVLIDLDLS 109
L + + + + L + +++S+ LT L + +K L +++
Sbjct: 256 WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMK 315
Query: 110 RNQLSGDIPKTIA-GLKDLTNLS 131
N LS ++ K + L ++S
Sbjct: 316 YNYLSDEMKKELQKSLPMKIDVS 338
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 35/218 (16%), Positives = 71/218 (32%), Gaps = 31/218 (14%)
Query: 6 QLQGIGLADNHLQGSIPYDLCQ-LKRLN----SLSLQGNKLNGSIPTCLASL-----TSL 55
+ + L N + Q L SL+L+GN L L + ++
Sbjct: 110 TITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANV 169
Query: 56 RELRLNSNKLTSS----IPSALWAL-EYILYVNLSSNYLTGSLTSDI-----QNMKVLID 105
L L N L S + L ++ + ++LS+N L +++ ++
Sbjct: 170 NSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVS 229
Query: 106 LDLSRNQLSGDIPKTIAGLKD----LTNLSLAGNQFQGP-------IPESFGSLISLESL 154
L+L N L G + + LKD L + L + + + +F ++ + +
Sbjct: 230 LNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILV 289
Query: 155 DLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE 192
D + + + L L +
Sbjct: 290 DKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIF 327
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 37/165 (22%), Positives = 55/165 (33%), Gaps = 31/165 (18%)
Query: 49 LASLTSLRELRLNSNKLTSSIPSALW-ALE----YILYVNLSSNYLTGSLTSDI-----Q 98
+ + L L+ N L S L A + +NLS N L + ++
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 99 NMKVLIDLDLSRNQLSGDIPKTIA-GLKD----LTNLSLAGNQFQGPIPESFGSLI---- 149
+ L+LS N LS + L +T L L N F F
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 150 -SLESLDLSSNNLSEGIPKSLVALS--------HLKQFNVSHNRL 185
S+ SL+L N+L KS L ++ N+ N L
Sbjct: 138 ASITSLNLRGNDLGI---KSSDELIQILAAIPANVNSLNLRGNNL 179
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 35/148 (23%), Positives = 66/148 (44%), Gaps = 15/148 (10%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLI-KILSSC 356
+GSG FG +Y G + VAIK+ ++ E ++ R ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 357 CNTNFKALVLEFMPNG-SLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHC 415
++ LV++ + G SL+ + + L + + +E++H S +H
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHR 127
Query: 416 DLKPSNILL----DENMVAHVSDFGISK 439
D+KP N L+ N V ++ DFG++K
Sbjct: 128 DIKPDNFLMGLGRRANQV-YIIDFGLAK 154
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 26/113 (23%), Positives = 45/113 (39%), Gaps = 6/113 (5%)
Query: 25 LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84
R L L+G K+ I A+L + + N++ L + + +
Sbjct: 15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLV 71
Query: 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLS--GDIPKTIAGLKDLTNLSLAGN 135
++N + Q + L +L L+ N L GD+ +A LK LT L + N
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 26/118 (22%), Positives = 44/118 (37%), Gaps = 8/118 (6%)
Query: 49 LASLTSLRELRLNSNKLTS--SIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDL 106
+ REL L K+ ++ + L + I + S N + L ++ L L
Sbjct: 15 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAI---DFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 107 DLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGP-IPESFGSLISLESLDLSSNNLSE 163
++ N++ L DLT L L N + SL SL L + N ++
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 127
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 24/131 (18%), Positives = 49/131 (37%), Gaps = 14/131 (10%)
Query: 58 LRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLID----LDLSRNQL 113
++L + + + + ++L + I+N+ +D +D S N++
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEI 54
Query: 114 SGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE-GIPKSLVAL 172
+ L+ L L + N+ +L L L L++N+L E G L +L
Sbjct: 55 R-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASL 112
Query: 173 SHLKQFNVSHN 183
L + N
Sbjct: 113 KSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 21/107 (19%), Positives = 43/107 (40%), Gaps = 9/107 (8%)
Query: 82 VNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPI 141
V L++ + + + N +LDL ++ I A L + + N+ I
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE----I 54
Query: 142 P--ESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
+ F L L++L +++N + AL L + +++N L
Sbjct: 55 RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 28/166 (16%), Positives = 54/166 (32%), Gaps = 31/166 (18%)
Query: 299 LGSGGFGSVYKGI---------LSDGTTVAIKI----FNLQLEQAFRSFNSECEVLRNVR 345
G +Y+ ++K+ L EQ F ++ + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 346 HRNLIKIL-------SSCCNTNFKALVLEFMPNG-SL-DKWLYSHNYFQDIPDRLNIMID 396
+L ++ LVL + G SL S + L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISK 439
+ ALE+LH VH ++ NI + D++ V ++ +G +
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 37/146 (25%), Positives = 53/146 (36%), Gaps = 37/146 (25%)
Query: 26 CQLKRLNS-----------LSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALW 74
C K L S L L+ NKL LT L +L L+ N++ S +P ++
Sbjct: 14 CNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVF 72
Query: 75 ALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI-AGLKDLTNLSLA 133
LT L L L N+L +P + L L L+L
Sbjct: 73 ----------------DKLTK-------LTILYLHENKLQS-LPNGVFDKLTQLKELALD 108
Query: 134 GNQFQGPIPESFGSLISLESLDLSSN 159
NQ + F L SL+ + L +N
Sbjct: 109 TNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 7e-05
Identities = 29/95 (30%), Positives = 42/95 (44%), Gaps = 4/95 (4%)
Query: 106 LDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGI 165
L+L N+L L LT LSL+ NQ Q F L L L L N L +
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS-L 91
Query: 166 PKSLV-ALSHLKQFNVSHNRLEGEIPTEGPFRNFS 199
P + L+ LK+ + N+L+ +P +G F +
Sbjct: 92 PNGVFDKLTQLKELALDTNQLKS-VP-DGIFDRLT 124
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 3e-07
Identities = 29/111 (26%), Positives = 54/111 (48%), Gaps = 4/111 (3%)
Query: 51 SLTSLRELRLNSNKLT-SSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLS 109
+ ++REL L++ K I + +++L + L S++ + L L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS--VSNLPKLPKLKKLELS 79
Query: 110 RNQLSGDIPKTIAGLKDLTNLSLAGNQFQGP-IPESFGSLISLESLDLSSN 159
N++ G + L +LT+L+L+GN+ + E L L+SLDL +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 22/83 (26%), Positives = 35/83 (42%), Gaps = 3/83 (3%)
Query: 104 IDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163
+ LD ++ G I A +L LSL + L L+ L+LS N +
Sbjct: 29 LVLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFG 85
Query: 164 GIPKSLVALSHLKQFNVSHNRLE 186
G+ L +L N+S N+L+
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 7e-05
Identities = 33/148 (22%), Positives = 49/148 (33%), Gaps = 28/148 (18%)
Query: 19 GSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEY 78
G I + L LSL L S+ + L L L++L L+ N++ + L
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 79 ILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGN--- 135
+ ++NLS N L DI ++ L L+ L +L L
Sbjct: 97 LTHLNLSGNKL-----KDISTLEPL------------------KKLECLKSLDLFNCEVT 133
Query: 136 QFQGPIPESFGSLISLESLDLSSNNLSE 163
F L L LD E
Sbjct: 134 NLNDYRESVFKLLPQLTYLDGYDREDQE 161
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 21/82 (25%), Positives = 33/82 (40%), Gaps = 3/82 (3%)
Query: 103 LIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162
L L L L + + L L L L+ N+ G + L +L L+LS N L
Sbjct: 51 LEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
Query: 163 E-GIPKSLVALSHLKQFNVSHN 183
+ + L L LK ++ +
Sbjct: 109 DISTLEPLKKLECLKSLDLFNC 130
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 51/258 (19%), Positives = 82/258 (31%), Gaps = 82/258 (31%)
Query: 299 LGSGGFGSVYKGI-LSDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRHRNLIKILS 354
LG G F +V+ + VA+K+ E A E +L++VR+ +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD----EIRLLKSVRNSDPNDPNR 100
Query: 355 SCC------------NTNFKALVLEFMPNG-SLDKWLYSHNYFQDIPDRL--NIMIDVAL 399
N +V E + G L KW+ NY Q +P I+ V
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQ 157
Query: 400 ALEYLHHGHSTPVVHCDLKPSNILL----------------------------------- 424
L+YLH ++H D+KP NILL
Sbjct: 158 GLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 425 --------------DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNV 470
E + ++D G + + + IQT Y + E
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGY 270
Query: 471 SSKCDVYSYGILLLETFT 488
++ D++S + E T
Sbjct: 271 NTPADIWSTACMAFELAT 288
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 33/153 (21%), Positives = 54/153 (35%), Gaps = 18/153 (11%)
Query: 29 KRLNSLSLQGNKLNGSIPTCLAS-LTSLRELRLNSNKLT----SSIPSALWALEYIL-YV 82
L+ ++L +L+ + L R+L L N L + L + + +
Sbjct: 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTL 160
Query: 83 NLSSNYLTGS----LTSDIQNMKVLIDLDLSRNQLSGDIPKTIA-GLKD---LTNLSLAG 134
LS+N LT + L + + L L L + + +A L L L++A
Sbjct: 161 RLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAY 220
Query: 135 NQFQGPIPESFGSLI----SLESLDLSSNNLSE 163
N + SLE L L N LS
Sbjct: 221 NGAGDTAALALARAAREHPSLELLHLYFNELSS 253
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 27/150 (18%), Positives = 51/150 (34%), Gaps = 29/150 (19%)
Query: 49 LASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDL 108
L+SLR+L L ++T P + +L L +++L
Sbjct: 68 AEVLSSLRQLNLAGVRMT---PVKCTVVAAVLGS----------------GRHALDEVNL 108
Query: 109 SRNQLSGDIPKTIA-GLKDLTNLSLAGNQFQGPIPESFGSLI-----SLESLDLSSNNLS 162
+ QL +T+ L L N + L+ + +L LS+N L+
Sbjct: 109 ASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLT 168
Query: 163 EG----IPKSLVALSHLKQFNVSHNRLEGE 188
+ + L + + ++ H L E
Sbjct: 169 AAGVAVLMEGLAGNTSVTHLSLLHTGLGDE 198
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 46/184 (25%), Positives = 72/184 (39%), Gaps = 10/184 (5%)
Query: 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKL--NGSIPTCLASLTSLRELRL 60
+ +LQ + L L I L + L L+L G ++ T L+S + L EL L
Sbjct: 116 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL 175
Query: 61 NS-NKLTSSIPSALWA--LEYILYVNLS--SNYLT-GSLTSDIQNMKVLIDLDLSR-NQL 113
+ T A E I +NLS L L++ ++ L+ LDLS L
Sbjct: 176 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVML 235
Query: 114 SGDIPKTIAGLKDLTNLSLAGNQFQGPI-PESFGSLISLESLDLSSNNLSEGIPKSLVAL 172
D + L L +LSL+ P G + +L++L + + AL
Sbjct: 236 KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEAL 295
Query: 173 SHLK 176
HL+
Sbjct: 296 PHLQ 299
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 30/171 (17%), Positives = 68/171 (39%), Gaps = 10/171 (5%)
Query: 25 LCQLKRLNSLSLQGNKLN-GSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83
R+ + L + + ++ L+ + L+ L L +L+ I + L ++ +N
Sbjct: 89 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148
Query: 84 LSS-NYLT-GSLTSDIQNMKVLIDLDLSR-NQLSGDIPKTIA--GLKDLTNLSLAGNQFQ 138
LS + + +L + + + L +L+LS + + + +T L+L+G +
Sbjct: 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 208
Query: 139 ---GPIPESFGSLISLESLDLSS-NNLSEGIPKSLVALSHLKQFNVSHNRL 185
+ +L LDLS L + L++L+ ++S
Sbjct: 209 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD 259
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 19/99 (19%), Positives = 44/99 (44%), Gaps = 13/99 (13%)
Query: 99 NMKVLIDLDLSR-NQLSGDIPKTIA-GLKD---LTNLSLAGNQFQGPIPESFGSLI---- 149
N L +++L+ + K A LK + S+ G + P+ + ++
Sbjct: 34 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNN 93
Query: 150 SLESLDLSSNNLS-EG---IPKSLVALSHLKQFNVSHNR 184
+L+SL++ SN +S G + ++L + + L + + +
Sbjct: 94 TLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQS 132
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 581 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.94 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.94 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.94 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.93 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.93 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.93 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.93 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.93 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.92 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.92 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.92 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.92 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.92 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.92 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.92 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.92 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.92 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.91 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.91 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.91 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.9 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.9 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.9 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.9 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.89 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.89 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.89 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.89 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.89 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.89 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.89 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.88 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.88 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.88 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.87 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.87 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.87 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.87 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.87 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.87 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.86 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.86 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.86 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.86 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.86 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.85 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.85 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.85 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.85 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.84 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.84 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.84 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.83 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.83 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.83 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.82 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.81 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.81 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.81 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.81 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.8 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.8 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.79 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.78 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.77 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.76 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.75 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.75 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.75 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.75 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.73 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.73 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.73 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.72 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.72 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.68 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.68 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.66 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.62 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.6 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.6 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.57 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.55 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.49 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.49 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.48 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.45 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.44 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.43 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.43 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.41 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.33 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.03 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.77 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.77 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.74 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.74 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.73 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.68 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.66 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.65 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.62 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.58 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.52 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.47 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.32 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.11 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.1 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.1 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.08 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.9 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.81 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.75 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.66 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.66 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.62 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.61 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.6 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.56 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.54 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.47 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.44 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.36 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.25 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.21 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.17 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.06 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.9 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.35 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.41 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 91.2 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 90.66 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 88.72 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.51 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.95 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-57 Score=442.22 Aligned_cols=267 Identities=26% Similarity=0.418 Sum_probs=213.5
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
++...+++++.++||+|+||+||+|+++ ..||||+++.. ..+..+.|.+|++++++++|||||++++++.+ +..+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 4455678999999999999999999975 36999998654 34556789999999999999999999998864 5689
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+|||||++|+|.+++......+++.++..|+.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999999887777899999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCcceeeccccCccccCCCCCCC---CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC-CCCccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSE---GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH-GLPKIA 519 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~ 519 (581)
...........||+.|||||++.+ +.|+.++|||||||++|||+||+.||...... ......+...... .++.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-~~~~~~~~~~~~~p~~~~-- 261 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-DQIIFMVGRGYASPDLSK-- 261 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHHHTTCCCCCSTT--
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-HHHHHHHhcCCCCCCccc--
Confidence 443334455689999999998753 46899999999999999999999999764222 2222222222111 1111
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
.+.++++.+.+||.+||+.||++|||++||+++|+.++..++
T Consensus 262 ------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 262 ------------LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp ------------SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred ------------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 112456778999999999999999999999999998876543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-57 Score=443.08 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=218.3
Q ss_pred hcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.++|.+.+.||+|+||.||+|++. +++.||||+++.......+.|.+|++++++++|||||+++|+|.+.+..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 357888899999999999999853 47889999998877777788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEE
Q 008012 364 LVLEFMPNGSLDKWLYSHN------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAH 431 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~k 431 (581)
+|||||++|+|.+++.+.+ ..+++.+++.|+.||++||+||| +++|+||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence 9999999999999998642 45899999999999999999999 89999999999999999999999
Q ss_pred EeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhh
Q 008012 432 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKES 510 (581)
Q Consensus 432 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 510 (581)
|+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||+| |+.||...... .+...+...
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~~ 246 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECITQG 246 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHHT
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC
Confidence 999999987654433333344568999999999999999999999999999999999 89999874322 222333322
Q ss_pred CCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 511 LPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
..... +..+++++.+||.+||+.||++|||++||.+.|+++.+.
T Consensus 247 ~~~~~-----------------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 247 RVLQR-----------------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CCCCC-----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC-----------------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 21111 124566789999999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=444.17 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=210.6
Q ss_pred cCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
++|.+.++||+|+||.||+|+++ +++.||||+++.......+.|.+|++++++++|||||+++|+|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56777889999999999999864 478899999988777777889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcE
Q 008012 365 VLEFMPNGSLDKWLYSHN--------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVA 430 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~ 430 (581)
|||||++|+|.+++.+.. ..+++.+++.|+.||++||+||| +++|+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 999999999999998542 34789999999999999999999 8999999999999999999999
Q ss_pred EEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHh
Q 008012 431 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKE 509 (581)
Q Consensus 431 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~ 509 (581)
||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||...... .....+..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~ 275 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDCITQ 275 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc
Confidence 9999999987755444444455679999999999999999999999999999999999 89999864322 22233333
Q ss_pred hCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 510 SLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
...... +..+++++.+||.+||+.||++|||++||+++|+.+.+
T Consensus 276 g~~~~~-----------------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 276 GRELER-----------------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp TCCCCC-----------------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCC-----------------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 221111 12456678999999999999999999999999999865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-56 Score=437.49 Aligned_cols=256 Identities=25% Similarity=0.420 Sum_probs=212.7
Q ss_pred cCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.++++.++||+|+||.||+|.+. +++.||||+++... ....+.|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 44567789999999999999863 46889999997543 334567999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC
Q 008012 364 LVLEFMPNGSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM 428 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~ 428 (581)
+|||||++|+|.+++.... ..+++..++.|+.||++||+||| +++|+||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence 9999999999999997532 34789999999999999999999 89999999999999999999
Q ss_pred cEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 008012 429 VAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWV 507 (581)
Q Consensus 429 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~ 507 (581)
.+||+|||+|+.....+.........||+.|+|||++.++.|+.++|||||||++|||+| |+.||..... ..+...+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~~~i 260 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVVEMI 260 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHHHHH
Confidence 999999999987654443333455679999999999999999999999999999999999 8999986432 2233333
Q ss_pred HhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 508 KESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
....... .+.+|++.+.+||.+||+.||++|||++||+++|+++
T Consensus 261 ~~~~~~~-----------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 RNRQVLP-----------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HTTCCCC-----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HcCCCCC-----------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 3221111 1224667789999999999999999999999999865
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=437.70 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=205.1
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
.++|++++.||+|+||.||+|+.. +|+.||||+++.. .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 478999999999999999999965 7999999999754 3455678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 367 EFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 367 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+||+|.+++... +..+++..++.|+.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 999999999999855 345688999999999999999999 899999999999999999999999999999876321
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
........||+.|+|||++.+..|+.++|||||||++|||+||++||...... ..+........ +..
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i~~~~~----~~~------- 245 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-NLVLKIISGSF----PPV------- 245 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCC----CCC-------
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHcCCC----CCC-------
Confidence 11234457999999999999999999999999999999999999999763211 11122222111 111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+..+++++.+||.+||..||++|||++|+++|
T Consensus 246 -------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 -------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11245568899999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-55 Score=435.50 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=212.8
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
+.|++.++||+|+||.||+|+++ +|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56899999999999999999965 79999999997665444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce
Q 008012 370 PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI 449 (581)
Q Consensus 370 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 449 (581)
+||+|.+++.+. .+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 226 (346)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence 999999999864 3799999999999999999999 89999999999999999999999999999998754322 2
Q ss_pred eeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 450 QTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 450 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
.....||+.|+|||++.+..|+.++|||||||++|||++|++||... ........+....+..++
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~~~~~~------------- 291 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPRLK------------- 291 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSSCCCCS-------------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCCCCCCC-------------
Confidence 34568999999999999999999999999999999999999999763 222223333333222211
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....+++++.+||.+||..||++|||++|+++|
T Consensus 292 --~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp --CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112345678899999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-55 Score=427.84 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=211.6
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||+||+|+.+ +|+.||+|++.+.. ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999965 89999999997653 233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|||+||+|.+++.+.+. +++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~~~~-l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999987654 799999999999999999999 89999999999999999999999999999998765444
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.......+||+.|+|||++.+..|+.++||||+||++|||+||++||.... ...+...+.... ..+++
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~-~~~p~--------- 255 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EGLIFAKIIKLE-YDFPE--------- 255 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTC-CCCCT---------
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCC-CCCCc---------
Confidence 444556789999999999999999999999999999999999999997632 122222222211 11111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+++++.+||.+||..||++|||++|++.+
T Consensus 256 --------~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 256 --------KFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp --------TCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred --------ccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 234567899999999999999999997554
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-55 Score=432.45 Aligned_cols=259 Identities=19% Similarity=0.223 Sum_probs=212.2
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
..+.|++.++||+|+||.||+|+++ +|+.||||+++.+.. ..+|+.++++++|||||++++++.+.+..|+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3456888899999999999999965 799999999976532 2469999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC-cEEEeeccCceecCCCCC
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM-VAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 446 (581)
||+||+|.+++.+.+. +++..+..++.||+.||+||| ++||+||||||+|||++.++ ++||+|||+|+.+.....
T Consensus 131 y~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred ccCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999987654 799999999999999999999 89999999999999999887 699999999998754322
Q ss_pred cc---eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 447 SV---IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 447 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
.. ......||+.|||||++.+..|+.++|||||||++|||+||++||....... ......... + ..
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~-~-~~-------- 275 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEP-P-PI-------- 275 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSC-C-GG--------
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCC-C-Cc--------
Confidence 11 2233579999999999999999999999999999999999999998743332 222222211 0 00
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
...+..+++.+.++|.+||..||++|||+.|++++|..+..+..
T Consensus 276 ------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 276 ------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp ------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 01122456678899999999999999999999999988876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-54 Score=416.78 Aligned_cols=245 Identities=24% Similarity=0.367 Sum_probs=199.2
Q ss_pred CcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeec----CCeeeEEE
Q 008012 294 NECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCN----TNFKALVL 366 (581)
Q Consensus 294 ~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~ 366 (581)
++.++||+|+||.||+|.+. +++.||+|++... .....+.+.+|++++++++|||||++++++.+ .+..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999965 7899999999654 34456789999999999999999999999865 34689999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeEecC-CCcEEEeeccCceecCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP--VVHCDLKPSNILLDE-NMVAHVSDFGISKLLGE 443 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~ 443 (581)
|||+||+|.+++.+.+ .+++..+..++.||+.||+||| +++ |+||||||+|||++. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999998754 4799999999999999999999 777 999999999999984 79999999999986432
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
. ......||+.|||||++.+ .|+.++|||||||++|||+||++||..... .............+...+
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~~i~~~~~~~~~~--- 252 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSGVKPASFD--- 252 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTTCCCGGGG---
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----HHHHHHHHHcCCCCCCCC---
Confidence 2 2345689999999998875 699999999999999999999999975322 222222222111111111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+++++.+||.+||..||++|||++|+++|
T Consensus 253 ----------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 ----------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1234568899999999999999999999876
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-54 Score=436.91 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=213.1
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
.+.|++.+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+.+|++++|||||+++++|.+.+..|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999965 7999999999766544456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
|+||+|.+++.... +++..+..++.||+.||+||| ++||+||||||+|||++.+|.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~~~--l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-- 302 (423)
T 4fie_A 230 LEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-- 302 (423)
T ss_dssp CTTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred CCCCcHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence 99999999997653 799999999999999999999 89999999999999999999999999999998754322
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
.....+||+.|||||++.+..|+.++|||||||++|||++|++||... ........+....+..+..
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~~~~~~~----------- 369 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPRLKN----------- 369 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCCCCSC-----------
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCCCCCCcc-----------
Confidence 234568999999999999999999999999999999999999999763 2222233333332222111
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+++++.+||.+||..||++|||++|+++|
T Consensus 370 ----~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 370 ----LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp ----TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11345578899999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-54 Score=430.04 Aligned_cols=268 Identities=26% Similarity=0.380 Sum_probs=222.6
Q ss_pred hhhHHHhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCC-CccceEee
Q 008012 283 YLDLERATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRH-RNLIKILS 354 (581)
Q Consensus 283 ~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~iv~~~~ 354 (581)
...++...++|++.+.||+|+||.||+|.+. +++.||||.++... ....+.+.+|++++.+++| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 3456677789999999999999999999854 23579999997653 4456789999999999965 99999999
Q ss_pred eeecC-CeeeEEEeccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCC
Q 008012 355 SCCNT-NFKALVLEFMPNGSLDKWLYSH---------------NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLK 418 (581)
Q Consensus 355 ~~~~~-~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dik 418 (581)
+|... +..++|||||++|+|.+++++. ...+++..+..++.|||+||+||| +++|+|||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccC
Confidence 98664 5789999999999999999853 234789999999999999999999 8999999999
Q ss_pred CCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccc
Q 008012 419 PSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMF 497 (581)
Q Consensus 419 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~ 497 (581)
|+|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999998765555445556679999999999999999999999999999999998 999997643
Q ss_pred cccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 498 TGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
.. ..+...+........+ ..+++++.++|.+||+.||++|||++||+++|+++.+.
T Consensus 293 ~~-~~~~~~i~~g~~~~~p-----------------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 293 ID-EEFCRRLKEGTRMRAP-----------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CS-HHHHHHHHHTCCCCCC-----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH-HHHHHHHHcCCCCCCC-----------------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 22 2233334333222222 23456788999999999999999999999999998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=411.16 Aligned_cols=246 Identities=25% Similarity=0.385 Sum_probs=193.6
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||.||+|... +|+.||+|+++... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999964 79999999997543 233467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+ +|+|.+++.+.+. +++..+..++.||+.||+||| ++||+||||||+|||+++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~~-l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDK-MSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp ECC-CEEHHHHHHHSCS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 999 6799999987654 799999999999999999999 8999999999999999999999999999998764322
Q ss_pred cceeeccccCccccCCCCCCCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNV-SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... ...+...+..... .++.
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--~~~~~~~i~~~~~-~~p~-------- 233 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--IPVLFKNISNGVY-TLPK-------- 233 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCC-CCCT--------
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCC-CCCC--------
Confidence 2345679999999999988876 579999999999999999999997632 1122222222111 1111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+++++.+||.+||+.||++|||++|+++|
T Consensus 234 ---------~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 234 ---------FLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---------TSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---------CCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 234567899999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=413.51 Aligned_cols=270 Identities=21% Similarity=0.306 Sum_probs=204.9
Q ss_pred hcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC----eeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN----FKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 365 (581)
..+|.+.++||+|+||+||+|++. |+.||||+++...... .....|+..+.+++|||||++++++.+.+ ..++|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 346778899999999999999985 8999999997664332 23345666677889999999999997654 57999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG-----HSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
||||++|+|.+++.... ++++.+.+++.|++.||+|||+. +..+|+||||||+|||++.++++||+|||+|+.
T Consensus 80 ~Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999998754 68999999999999999999932 123999999999999999999999999999987
Q ss_pred cCCCCCcc--eeeccccCccccCCCCCCCC------CCCccccHHHHHHHHHHHHhCCCCCCcccc----------cccc
Q 008012 441 LGEGDDSV--IQTMTIATIGYMAPEFGSEG------NVSSKCDVYSYGILLLETFTRKKPTDEMFT----------GEMN 502 (581)
Q Consensus 441 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~----------~~~~ 502 (581)
........ ......||+.|+|||++.+. .++.++|||||||++|||+||++||..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 75443321 22345799999999988654 467899999999999999999887654222 1122
Q ss_pred HHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 503 LKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
.............. +.+ +......++++.+.+||.+||+.||++||||.||++.|+++.++
T Consensus 238 ~~~~~~~~~~~~~r----p~~----p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 VEEMRKVVCEQKLR----PNI----PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTTSCCC----CCC----CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcccCC----CCC----CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 22222222211111 111 11112235667889999999999999999999999999998653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=415.04 Aligned_cols=248 Identities=25% Similarity=0.300 Sum_probs=198.2
Q ss_pred cCCCcCCeecccccccEEEEEeC----CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
++|++++.||+|+||+||+|+.. +++.||+|+++... ......+.+|++++++++|||||++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 57899999996542 1122357789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
|||||+||+|.+++.+.+. +++.++..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM-FTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999999987654 799999999999999999999 899999999999999999999999999999865332
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
.. ......||+.|+|||++.+..|+.++||||+||++|||+||++||..... ......+..... .++
T Consensus 180 ~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~~-~~p-------- 246 (304)
T 3ubd_A 180 EK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--KETMTMILKAKL-GMP-------- 246 (304)
T ss_dssp -C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC-CCC--------
T ss_pred Cc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--HHHHHHHHcCCC-CCC--------
Confidence 22 23456799999999999999999999999999999999999999976322 122222222111 111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCH-----HHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYM-----KDAATK 564 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 564 (581)
..+++++.+||.+||+.||++|||+ +|+++|
T Consensus 247 ---------~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 247 ---------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp ---------TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred ---------CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 1234568899999999999999985 677765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=405.52 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=191.8
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC--------
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN-------- 360 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------- 360 (581)
++|++++.||+|+||.||+|+.+ +|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999965 79999999997543 445567899999999999999999999986544
Q ss_pred ----eeeEEEeccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEee
Q 008012 361 ----FKALVLEFMPNGSLDKWLYSHNY--FQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSD 434 (581)
Q Consensus 361 ----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~D 434 (581)
..|+|||||++|+|.+++..... ..++..++.++.||++||+||| ++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999986543 2355678899999999999999 89999999999999999999999999
Q ss_pred ccCceecCCCCCc----------ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHH
Q 008012 435 FGISKLLGEGDDS----------VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLK 504 (581)
Q Consensus 435 fg~a~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~ 504 (581)
||+|+.+...... ...+...||+.|||||++.+..|+.++|||||||++|||++ ||.... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ERV 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HHH
Confidence 9999876543221 11234579999999999999999999999999999999996 775421 111
Q ss_pred HHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 505 NWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+........+ +...+.++.+.+||.+||+.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~p--------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 235 RTLTDVRNLKFP--------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHHTTCCC--------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhcCCCC--------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112211111111 1122334556789999999999999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=404.52 Aligned_cols=268 Identities=22% Similarity=0.261 Sum_probs=205.5
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeec------CC
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCN------TN 360 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 360 (581)
.++|++++.||+|+||.||+|.+. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999965 89999999997542 3445678899999999999999999998754 35
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..|+|||||+ |+|.+++.+.+ .+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 7899999996 68999998655 4899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCC--CcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 441 LGEGD--DSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 441 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
+.... .........||+.|+|||++.+. .++.++||||+||++|||++|++||.+.. .......+..........
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~--~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--YVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHHHHHHHHHHHCCCCGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC--HHHHHHHHHHhcCCCChH
Confidence 64322 12233456899999999987775 56999999999999999999999997632 222222222221111111
Q ss_pred cccc----cchhh---------hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IADA----NLLRE---------ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~~~----~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.... ..... .+.......+++++.+||.+||..||++|||++|+++|
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1000 00000 00001112345678899999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=400.91 Aligned_cols=271 Identities=17% Similarity=0.234 Sum_probs=204.1
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC----CCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecC
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNT 359 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 359 (581)
.+....++|++.+.||+|+||+||+|+.+ +++.||+|.+...... ..+.+|+++++.+ +||||+++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~--~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP--IRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH--HHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH--HHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 34456789999999999999999999853 5788999998665432 4678899999999 699999999999999
Q ss_pred CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC-CcEEEeeccCc
Q 008012 360 NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN-MVAHVSDFGIS 438 (581)
Q Consensus 360 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a 438 (581)
++.|+||||++||+|.+++. .+++.++..++.||+.||+||| ++||+||||||+|||++.+ +.+||+|||+|
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999999984 3789999999999999999999 8999999999999999876 79999999999
Q ss_pred eecCCCCCc--------------------------ceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCC
Q 008012 439 KLLGEGDDS--------------------------VIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKK 491 (581)
Q Consensus 439 ~~~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~ 491 (581)
+........ .......||+.|+|||++.+. .|+.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 865432211 112334799999999988775 58999999999999999999999
Q ss_pred CCCccccccccHHHHHHhh-----------CC------CCCCccc------------------cccchhhhhhhhHHHHH
Q 008012 492 PTDEMFTGEMNLKNWVKES-----------LP------HGLPKIA------------------DANLLREENFFSARMDC 536 (581)
Q Consensus 492 Pf~~~~~~~~~~~~~~~~~-----------~~------~~~~~~~------------------~~~~~~~~~~~~~~~~~ 536 (581)
||....+....+.....-. .. ...+... .................
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 9965433222222211100 00 0000000 00000000001112235
Q ss_pred HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 537 LLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 537 ~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
++++.+|+.+||..||++|||++|+++|
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 6678899999999999999999999876
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=414.18 Aligned_cols=253 Identities=22% Similarity=0.255 Sum_probs=213.7
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
.++|++.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+++|+.++|||||++++++.+.+..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999965 8999999999877666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC--CcEEEeeccCceecCCCCC
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN--MVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~--~~~kl~Dfg~a~~~~~~~~ 446 (581)
|+||+|.+++.+....+++.++..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 9999999999876666899999999999999999999 8999999999999999854 899999999999875432
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
......||+.|+|||++.+..|+.++||||+||++|||++|++||...... .....+..... .++.
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~i~~~~~-~~~~--------- 377 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKSCDW-NMDD--------- 377 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTCC-CCCS---------
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHhCCC-CCCc---------
Confidence 234557999999999999999999999999999999999999999763221 11122221111 1111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.....+++.+.+||.+||..||++|||+.|+++|
T Consensus 378 ----~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 378 ----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112345668899999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=408.95 Aligned_cols=249 Identities=23% Similarity=0.305 Sum_probs=203.4
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch------HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL------EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 361 (581)
..++|++++.||+|+||.||+|+.+ +|+.||+|++++.. .........++.+++.++|||||+++++|.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 3478999999999999999999965 79999999997543 1122233345667777899999999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
.|+|||||+||+|.+++.+.+. +++..+..++.||+.||+||| ++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~-l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999999987654 799999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhh--CCCCCCcc
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES--LPHGLPKI 518 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~ 518 (581)
.... ....+||+.|+|||++.+ ..|+.++||||+||++|||++|++||...... ......... ....++.
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--~~~~i~~~i~~~~~~~p~- 415 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTMAVELPD- 415 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--CHHHHHHHHHHCCCCCCT-
T ss_pred CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhhcCCCCCCCc-
Confidence 5432 234589999999999864 57999999999999999999999999763222 122222211 1111111
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLY-----MKDAATK 564 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 564 (581)
.+++++.+||.+||..||++|++ ++||++|
T Consensus 416 ----------------~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 416 ----------------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ----------------TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ----------------cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 23456889999999999999998 6888776
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=377.75 Aligned_cols=284 Identities=36% Similarity=0.572 Sum_probs=233.8
Q ss_pred ccchhhhHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeec
Q 008012 279 RRTSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358 (581)
Q Consensus 279 ~~~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 358 (581)
.+.++.++....++|++.+.||+|+||.||+|..++++.||+|++........+.+.+|++++++++||||+++++++.+
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 34556677788999999999999999999999988899999999887665566789999999999999999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeec
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSHN---YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDF 435 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 435 (581)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999997543 34789999999999999999999 899999999999999999999999999
Q ss_pred cCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHhh-CCC
Q 008012 436 GISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE-MNLKNWVKES-LPH 513 (581)
Q Consensus 436 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~-~~~~~~~~~~-~~~ 513 (581)
|++................|++.|+|||++.+..++.++||||||+++|||++|+.||....... .....|.... ...
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 99987654333333344568999999999988899999999999999999999999997654332 2333333222 222
Q ss_pred CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 514 GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
.+....++.... ....+++..+.+++.+||+.||++|||++|++++|+.+.+
T Consensus 264 ~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 264 QLEQIVDPNLAD-----KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCCSSSSSSCTT-----CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHHHhcChhhcc-----ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 233444433322 1224677889999999999999999999999999998864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=373.55 Aligned_cols=261 Identities=25% Similarity=0.413 Sum_probs=220.2
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467889999999999999999965 7999999998777777778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|.+++......+++.+++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++..........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999999987777899999999999999999999 8999999999999999999999999999998764332211
Q ss_pred ------------eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccc----cHHHHHHhhCC
Q 008012 449 ------------IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM----NLKNWVKESLP 512 (581)
Q Consensus 449 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~----~~~~~~~~~~~ 512 (581)
......||+.|+|||++.+..++.++||||||+++|||++|..||........ ..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~- 244 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC- 244 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTC-
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccC-
Confidence 11145689999999999999999999999999999999999999876433221 1111111111
Q ss_pred CCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 513 HGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
+..+++.+.+++.+||+.||++|||+.|+++.|++++.....
T Consensus 245 --------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 245 --------------------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp --------------------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred --------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 123445688999999999999999999999999999887654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=377.06 Aligned_cols=264 Identities=26% Similarity=0.418 Sum_probs=218.5
Q ss_pred hhcCCCcCCeecccccccEEEEEeC--------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeec
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS--------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCN 358 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 358 (581)
..++|++.+.||+|+||.||+|.+. ++..||+|+++... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4578999999999999999999852 35679999997653 44567899999999999 89999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeE
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNIL 423 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nil 423 (581)
.+..++||||+++|+|.+++.... ..+++..++.++.||+.||+||| ++||+||||||+||+
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEE
Confidence 999999999999999999998653 24688999999999999999999 899999999999999
Q ss_pred ecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCcccccccc
Q 008012 424 LDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMN 502 (581)
Q Consensus 424 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~ 502 (581)
++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ..
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~--~~ 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EE 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GG
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--HH
Confidence 99999999999999997754433333334467889999999999999999999999999999999 9999976422 22
Q ss_pred HHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 503 LKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
....+........ +..++..+.++|.+||+.||++|||+.|++++|+++......
T Consensus 314 ~~~~~~~~~~~~~-----------------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 314 LFKLLKEGHRMDK-----------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp HHHHHHTTCCCCC-----------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHhcCCCCCC-----------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 2233322221111 113456788999999999999999999999999999876543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=372.97 Aligned_cols=287 Identities=36% Similarity=0.551 Sum_probs=233.1
Q ss_pred hhccccchhhhHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHH-HHHHHHHHHHHHHhcCCCccceEe
Q 008012 275 LATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQ-AFRSFNSECEVLRNVRHRNLIKIL 353 (581)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~ 353 (581)
......+++.++....++|++.+.||+|+||.||+|..++++.||+|++...... ....+.+|++++++++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 3456778899999999999999999999999999999888999999999765422 223688999999999999999999
Q ss_pred eeeecCCeeeEEEeccCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcE
Q 008012 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHN---YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVA 430 (581)
Q Consensus 354 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~ 430 (581)
+++.+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+..||+||||||+||+++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999998643 347899999999999999999994322399999999999999999999
Q ss_pred EEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcc---ccccccHHHHH
Q 008012 431 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEM---FTGEMNLKNWV 507 (581)
Q Consensus 431 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~---~~~~~~~~~~~ 507 (581)
||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||... .........++
T Consensus 174 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 9999999987653332 2334456999999999998889999999999999999999999999632 12333455555
Q ss_pred HhhCCCC-CCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 508 KESLPHG-LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 508 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
....... .....+..... ....+.+..+.+++.+||+.||++|||++|++++|+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQG-----NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTT-----SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHhhchhhhhhcChhhcc-----ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 4443332 33333333222 1234567789999999999999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=366.17 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=211.0
Q ss_pred hhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
..++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 457899999999999999999995 4799999999976654445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++++|.+++.... +++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 98 YLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CCTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 999999999998763 689999999999999999999 89999999999999999999999999999987654332
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... +........
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~-~~~~~~~~~------------ 236 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYL-IATNGTPEL------------ 236 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHH-HHHHCSCCC------------
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHhCCCCCC------------
Confidence 2344579999999999999999999999999999999999999997632211 1111 111111110
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+..++..+.+++.+||+.||++|||++|++++
T Consensus 237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 ---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1112345668899999999999999999999885
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=370.54 Aligned_cols=271 Identities=22% Similarity=0.312 Sum_probs=214.7
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC----e
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN----F 361 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~ 361 (581)
+....++|++.+.||+|+||.||+|++. ++.||||++...... .....+|+.++++++||||+++++++.... .
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3445678999999999999999999986 799999999766433 345566999999999999999999998744 4
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CceecCCCCCCeEecCCCcEE
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST----------PVVHCDLKPSNILLDENMVAH 431 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~----------~i~H~dikp~Nill~~~~~~k 431 (581)
.++||||+++|+|.+++.... +++..++.++.|++.||+||| +. ||+||||||+||+++.++.+|
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 699999999999999998754 789999999999999999999 77 999999999999999999999
Q ss_pred EeeccCceecCCCCCcceeeccccCccccCCCCCCC-----CCCCccccHHHHHHHHHHHHhCCCCCCccccccc-----
Q 008012 432 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE-----GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM----- 501 (581)
Q Consensus 432 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~----- 501 (581)
|+|||++................||+.|+|||++.+ ..++.++|||||||++|||+||+.||........
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999988765443333444678999999998876 3556789999999999999999999976433211
Q ss_pred ------cHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 502 ------NLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 502 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
....+............... ......++..+.++|.+||+.||++|||+.|+++.|+++.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRD--------YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCG--------GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccc--------cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111111111111111 112234567799999999999999999999999999999764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=364.87 Aligned_cols=272 Identities=25% Similarity=0.367 Sum_probs=208.4
Q ss_pred chhhhHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeec
Q 008012 281 TSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358 (581)
Q Consensus 281 ~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 358 (581)
....++....++|++.+.||+|+||.||+|... ++.||+|++.... ....+.+.+|++++++++||||+++++++.+
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 334455566788999999999999999999874 8899999987653 4455778999999999999999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeEecCCCcEEEee
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSHNY--FQDIPDRLNIMIDVALALEYLHHGHSTP--VVHCDLKPSNILLDENMVAHVSD 434 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dikp~Nill~~~~~~kl~D 434 (581)
.+..++||||+++++|.+++..... .+++..++.++.|++.||+||| +.| |+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECC
Confidence 9999999999999999999986542 3788999999999999999999 888 99999999999999999999999
Q ss_pred ccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhh-CCC
Q 008012 435 FGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES-LPH 513 (581)
Q Consensus 435 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~-~~~ 513 (581)
||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+... ...
T Consensus 183 fg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~~~~~~~ 258 (309)
T 3p86_A 183 FGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVGFKCKRL 258 (309)
T ss_dssp CC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHHHSCCCC
T ss_pred CCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCC
Confidence 99998643221 2234457899999999999999999999999999999999999999764221 111111111 111
Q ss_pred CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHhhcc
Q 008012 514 GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDAN 577 (581)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~ 577 (581)
..+ ..+++.+.++|.+||+.||++|||++|+++.|+.+.+....+.+
T Consensus 259 ~~~-----------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 259 EIP-----------------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp CCC-----------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred CCC-----------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 111 13445688999999999999999999999999999877655543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=380.72 Aligned_cols=265 Identities=27% Similarity=0.418 Sum_probs=218.7
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
+....++|++.+.||+|+||.||+|.+. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3445678999999999999999999976 78999999987653 344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+++|+|.+++...+..+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999999877666899999999999999999999 89999999999999999999999999999986533
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
...........++..|+|||++.+..++.++|||||||++|||+| |..||...... .....+........
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~------- 336 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKGGRLPC------- 336 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTTCCCCC-------
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCC-------
Confidence 221111122335778999999988899999999999999999998 99999764221 22222222211111
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
+..+++.+.++|.+||+.||++|||++++++.|++++++.
T Consensus 337 ----------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 337 ----------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 1234567889999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=368.45 Aligned_cols=265 Identities=28% Similarity=0.411 Sum_probs=215.6
Q ss_pred hhcCCCcCCeecccccccEEEEEeC----CCcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
..++|++.+.||+|+||.||+|.+. .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3567899999999999999999964 3456999999765 3445678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+++++|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999999877667899999999999999999999 89999999999999999999999999999997754
Q ss_pred CCCcc-eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 444 GDDSV-IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 444 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+........
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~~~~~------ 275 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSVEEGYRLPA------ 275 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCCCCC------
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCCCCC------
Confidence 33222 2233356778999999998899999999999999999999 99999764222 22222222211111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHhh
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLED 575 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 575 (581)
+..++..+.+++.+||..||++|||+.|+++.|+++.+...+.
T Consensus 276 -----------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 276 -----------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp -----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred -----------CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 1234567889999999999999999999999999998765443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=356.98 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=215.2
Q ss_pred hhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
..++|++.+.||+|+||.||+|.+.+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 35678999999999999999999888899999999765322 25688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 162 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 162 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-cc
Confidence 9999999999887777899999999999999999999 8999999999999999999999999999998653321 11
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||...... .....+........+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~~~~----------- 229 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRLYKP----------- 229 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCCCCC-----------
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCccCCCC-----------
Confidence 2233456778999999998899999999999999999999 99999763221 222222222111111
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
..+++.+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 230 ------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 230 ------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11245688999999999999999999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=368.36 Aligned_cols=275 Identities=26% Similarity=0.421 Sum_probs=213.1
Q ss_pred hhcCCCcCCeecccccccEEEEEe-----CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeec--CCe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-----SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN--TNF 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 361 (581)
..++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++.. ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 357899999999999999999984 2689999999988777777889999999999999999999999865 356
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
.++||||+++++|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++...
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 89999999999999999987766899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCc-ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 442 GEGDDS-VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 442 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
...... .......++..|+|||.+.+..++.++||||||+++|||+||..||...... ...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------FMRMIGNDKQGQMIV 238 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH------HHHHHCTTCCTHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH------HHhhhcCccccchhH
Confidence 543322 1223345777899999999899999999999999999999999998653211 000000000000000
Q ss_pred ccc---hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 521 ANL---LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 521 ~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
... .......+.+..+++.+.+++.+||+.||++|||++|+++.|+++++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 000 0000011112345678999999999999999999999999999998765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=364.96 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=209.4
Q ss_pred HHhhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
....++|++.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 34467899999999999999999996 48999999999765 3455677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+++++|.+++...+. +++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EEEECCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999999987654 789999999999999999999 89999999999999999999999999999986643
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVS-SKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
... .....||+.|+|||++.+..+. .++||||+||++|+|++|+.||..... ......+..... .++.
T Consensus 167 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~-~~p~----- 235 (328)
T 3fe3_A 167 GGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--KELRERVLRGKY-RIPF----- 235 (328)
T ss_dssp SCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC-CCCT-----
T ss_pred CCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC-CCCC-----
Confidence 322 3445799999999998887765 799999999999999999999976321 112222211111 1111
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+++.+.+++.+||..||++|||++|+++|
T Consensus 236 ------------~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 236 ------------YMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------------TSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------------CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 234567899999999999999999999886
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=356.01 Aligned_cols=282 Identities=30% Similarity=0.467 Sum_probs=227.8
Q ss_pred ccccchhhhHHHhhcCCCcC------CeecccccccEEEEEeCCCcEEEEEEeccc----hHHHHHHHHHHHHHHHhcCC
Q 008012 277 TWRRTSYLDLERATDGFNEC------NLLGSGGFGSVYKGILSDGTTVAIKIFNLQ----LEQAFRSFNSECEVLRNVRH 346 (581)
Q Consensus 277 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~~~v~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h 346 (581)
....+++.++..++++|... +.||+|+||.||+|.. +++.||+|++... .....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45667888999999888877 8999999999999997 4889999998653 23445678999999999999
Q ss_pred CccceEeeeeecCCeeeEEEeccCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe
Q 008012 347 RNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSH--NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL 424 (581)
Q Consensus 347 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill 424 (581)
|||+++++++.+.+..++||||+++++|.+++... ...+++..++.++.|++.||+||| +.||+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence 99999999999999999999999999999999743 345799999999999999999999 8999999999999999
Q ss_pred cCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHH
Q 008012 425 DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLK 504 (581)
Q Consensus 425 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~ 504 (581)
+.++.+||+|||++................|++.|+|||.+.+ .++.++||||||+++|+|++|+.||....... ...
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~ 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLL 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHH
Confidence 9999999999999987755443333445578999999998765 58999999999999999999999998643322 222
Q ss_pred HHHHhhC--CCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 505 NWVKESL--PHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 505 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
.+..... ...+....+..+. .....++..+.+++.+||+.||++|||+.+++++|+++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMN------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCS------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHhhhhhhhhhhhcccccc------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2222111 1111222222111 1223567789999999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=370.91 Aligned_cols=270 Identities=26% Similarity=0.394 Sum_probs=221.3
Q ss_pred chhhhHHHhhcCCCcCCeecccccccEEEEEe------CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceE
Q 008012 281 TSYLDLERATDGFNECNLLGSGGFGSVYKGIL------SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKI 352 (581)
Q Consensus 281 ~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~ 352 (581)
+....++...++|++.+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34456667789999999999999999999983 256889999997653 44557799999999999 79999999
Q ss_pred eeeeecCC-eeeEEEeccCCCCHHHHHhhCCC------------------------------------------------
Q 008012 353 LSSCCNTN-FKALVLEFMPNGSLDKWLYSHNY------------------------------------------------ 383 (581)
Q Consensus 353 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------ 383 (581)
++++.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99988755 48999999999999999986532
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 384 -----------------FQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 384 -----------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
.+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 2788999999999999999999 89999999999999999999999999999987755444
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
........+|+.|+|||++.+..++.++|||||||++|||+| |+.||....... .....+........+.
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~-------- 319 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRMRAPD-------- 319 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTCCCCCCT--------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHHHHcCCCCCCCC--------
Confidence 444556678999999999988999999999999999999998 999997643222 2223333322222211
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
.+++.+.+++.+||+.||++|||++|++++|+++...
T Consensus 320 ---------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 320 ---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp ---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 2345688999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=356.91 Aligned_cols=260 Identities=27% Similarity=0.384 Sum_probs=215.4
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
...++|++.+.||+|+||.||+|..+++..||+|+++..... .+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 346789999999999999999999888889999999765422 2568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++++|.+++...+..+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 159 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY- 159 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-
Confidence 99999999999877666899999999999999999999 89999999999999999999999999999987654322
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... .....+........+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~---------- 227 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--EVVLKVSQGHRLYRP---------- 227 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCCCCCC----------
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--HHHHHHHcCCCCCCC----------
Confidence 22334456778999999988899999999999999999999 99999763222 111111111111111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
..+++.+.+++.+||+.||++|||+.|++++|++++++
T Consensus 228 -------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 228 -------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11234688999999999999999999999999998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=377.71 Aligned_cols=265 Identities=21% Similarity=0.257 Sum_probs=214.9
Q ss_pred chhhhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHH---HHHHHHHHHHHHHhcCCCccceEeeee
Q 008012 281 TSYLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQ---AFRSFNSECEVLRNVRHRNLIKILSSC 356 (581)
Q Consensus 281 ~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~ 356 (581)
..+.+++...++|++.+.||+|+||.||+|+.+ +++.||+|+++..... ....+.+|..++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345667777899999999999999999999976 6889999999764321 123488899999999999999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeecc
Q 008012 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 357 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
.+.+..++||||+++|+|.+++.+....+++..++.++.||+.||+||| +.||+||||||+|||++.++.+||+|||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999999986666899999999999999999999 8999999999999999999999999999
Q ss_pred CceecCCCCCcceeeccccCccccCCCCCC-----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 008012 437 ISKLLGEGDDSVIQTMTIATIGYMAPEFGS-----EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESL 511 (581)
Q Consensus 437 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 511 (581)
+|+....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ......+....
T Consensus 221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~ 298 (437)
T 4aw2_A 221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHKE 298 (437)
T ss_dssp TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHH
T ss_pred hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhhccc
Confidence 9987643322 2234457999999999886 567899999999999999999999999763221 11222221111
Q ss_pred CCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 008012 512 PHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQ--RLYMKDAATK 564 (581)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 564 (581)
...++... ..+++.+.+||.+||..+|++ ||+++|+++|
T Consensus 299 ~~~~p~~~--------------~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 299 RFQFPTQV--------------TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HCCCCSSC--------------CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccCCccc--------------ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11111110 123456889999999998888 9999999886
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=363.48 Aligned_cols=254 Identities=19% Similarity=0.259 Sum_probs=212.2
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
..++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc-cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 4578999999999999999999965 789999999876543 34568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC--CCcEEEeeccCceecCCCC
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE--NMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~~~~~~ 445 (581)
|+++++|.+++......+++..++.++.||+.||+||| +.||+||||||+||+++. ++.+||+|||++.......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999999877667899999999999999999999 899999999999999987 7899999999998875432
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+...... .+
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~-~~--------- 223 (321)
T 1tki_A 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNAEYT-FD--------- 223 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCCC-CC---------
T ss_pred ---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHcCCCC-CC---------
Confidence 234457899999999999988999999999999999999999999763221 111111111110 00
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
......++.++.+++.+||..||++|||+.|+++|-
T Consensus 224 ----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 224 ----EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp ----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ----hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 011224566788999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=360.23 Aligned_cols=272 Identities=21% Similarity=0.296 Sum_probs=211.9
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchH--HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLE--QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.+...++|++.+.||+|+||.||+|...+++.||+|++..... .....+.+|++++++++||||+++++++.+.+..+
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 3456788999999999999999999988899999999975532 23467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+++ +|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99999975 899998887777899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---CCccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---LPKIA 519 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~ 519 (581)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .............. .+...
T Consensus 172 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 172 PVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-DQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp CCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT-THHHHHHHHHCCCCTTTSGGGT
T ss_pred Ccc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHHCCCChHHhhhhh
Confidence 322 2334568999999998776 56899999999999999999999999864332 22222222211111 11111
Q ss_pred cccc--------hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 DANL--------LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 ~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+... ............+++++.++|.+||..||++|||++|+++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1000 00001111222345678899999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=369.38 Aligned_cols=269 Identities=26% Similarity=0.420 Sum_probs=218.4
Q ss_pred hhHHHhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeee
Q 008012 284 LDLERATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSC 356 (581)
Q Consensus 284 ~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 356 (581)
..+....++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345556789999999999999999999964 34889999997653 44567899999999999999999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 008012 357 CNTNFKALVLEFMPNGSLDKWLYSHN-----------------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVV 413 (581)
Q Consensus 357 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~ 413 (581)
.+.+..++||||+++++|.+++.... ..+++.+++.++.||++||+||| ++||+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 99999999999999999999998642 45789999999999999999999 89999
Q ss_pred ecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCC
Q 008012 414 HCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKP 492 (581)
Q Consensus 414 H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~P 492 (581)
||||||+||+++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999987644332233345567899999999988899999999999999999999 9999
Q ss_pred CCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 493 TDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 493 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
|...... .....+........+ ..++..+.+++.+||+.||++|||+.+++++|+++.+++
T Consensus 277 ~~~~~~~--~~~~~~~~~~~~~~~-----------------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 277 YYGMAHE--EVIYYVRDGNILACP-----------------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTTSCHH--HHHHHHHTTCCCCCC-----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCCChH--HHHHHHhCCCcCCCC-----------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 9763221 122222221111111 134557889999999999999999999999999998776
Q ss_pred Hh
Q 008012 573 LE 574 (581)
Q Consensus 573 ~~ 574 (581)
.+
T Consensus 338 ~~ 339 (343)
T 1luf_A 338 EG 339 (343)
T ss_dssp --
T ss_pred hh
Confidence 54
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=358.04 Aligned_cols=265 Identities=25% Similarity=0.375 Sum_probs=215.8
Q ss_pred hhhHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 283 YLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 283 ~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
+..++...++|++.+.||+|+||.||+|.+.++..||+|+++..... .+.+.+|++++++++||||+++++++.+.+..
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 34455667889999999999999999999888889999999765322 25688999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+++++|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999999999999876666899999999999999999999 8999999999999999999999999999998654
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
... ........+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... .....+........+.
T Consensus 172 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~---- 244 (283)
T 3gen_A 172 DDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLYRPH---- 244 (283)
T ss_dssp CHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCCCCCCT----
T ss_pred ccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhcccCCCCCC----
Confidence 321 111223356788999999988899999999999999999998 99999764221 2222222221111111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
.+++.+.+++.+||+.||++|||++|++++|+++.++
T Consensus 245 -------------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 245 -------------LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -------------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1234688999999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=370.12 Aligned_cols=265 Identities=27% Similarity=0.410 Sum_probs=219.7
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC--------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeee
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS--------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSC 356 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 356 (581)
+...++|.+.+.||+|+||.||+|.+. ++..||+|+++... ....+.+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344578999999999999999999852 23579999997653 44567889999999999 999999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 008012 357 CNTNFKALVLEFMPNGSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSN 421 (581)
Q Consensus 357 ~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~N 421 (581)
.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||+||| +.||+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcce
Confidence 99999999999999999999998654 34799999999999999999999 8899999999999
Q ss_pred eEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCcccccc
Q 008012 422 ILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGE 500 (581)
Q Consensus 422 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~ 500 (581)
|+++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-- 299 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 299 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999987755443333444567889999999999999999999999999999999 9999976321
Q ss_pred ccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 501 MNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
......+........+ ..++..+.+++.+||+.||++|||++|++++|+++.....
T Consensus 300 ~~~~~~~~~~~~~~~~-----------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 300 EELFKLLKEGHRMDKP-----------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HHHHHHHHTTCCCCCC-----------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHcCCCCCCC-----------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 2222223222211111 1234568899999999999999999999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=362.06 Aligned_cols=265 Identities=28% Similarity=0.417 Sum_probs=219.6
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEe------CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeee
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGIL------SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCC 357 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 357 (581)
.++...++|.+.+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|++++++++||||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 3344567899999999999999999985 245889999997653 455678899999999999999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHHhhCCC-----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 008012 358 NTNFKALVLEFMPNGSLDKWLYSHNY-----------------------FQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414 (581)
Q Consensus 358 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H 414 (581)
+.+..++||||+++++|.+++..... .+++..++.++.||+.||+||| +.||+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcc
Confidence 99999999999999999999986532 3688999999999999999999 899999
Q ss_pred cCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCC
Q 008012 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPT 493 (581)
Q Consensus 415 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf 493 (581)
|||||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987755443333344567889999999988899999999999999999999 99999
Q ss_pred CccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 494 DEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
..... ......+........+ ..+++.+.+++.+||+.||++|||+.|++++|+++..+
T Consensus 254 ~~~~~--~~~~~~~~~~~~~~~~-----------------~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 254 PGIPP--ERLFNLLKTGHRMERP-----------------DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TTCCG--GGHHHHHHTTCCCCCC-----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCH--HHHHHHhhcCCcCCCC-----------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 76432 2233333322211111 13445688999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=369.28 Aligned_cols=262 Identities=28% Similarity=0.456 Sum_probs=205.2
Q ss_pred hhcCCCcCCeecccccccEEEEEeC----CCcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
..++|++.+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3468999999999999999999864 5778999999765 3445678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+++++|.+++...+..+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999999987777899999999999999999999 89999999999999999999999999999987653
Q ss_pred CCCcc-eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 444 GDDSV-IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 444 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+.......
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~~i~~~~~~~------- 270 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEGYRLP------- 270 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHHHHHTTEECC-------
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCC-------
Confidence 32211 1122245678999999998999999999999999999998 99999764221 1222222211100
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
.+..++..+.+++.+||+.||++||++.|+++.|+++....
T Consensus 271 ----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 271 ----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ----------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ----------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 11234567889999999999999999999999999997654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=371.32 Aligned_cols=263 Identities=23% Similarity=0.343 Sum_probs=214.7
Q ss_pred hcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
.++|++.+.||+|+||.||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467899999999999999999943 4678999999654 344456788999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC---cEEEe
Q 008012 363 ALVLEFMPNGSLDKWLYSHN------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM---VAHVS 433 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~---~~kl~ 433 (581)
++||||+++|+|.+++.... ..+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999998643 34789999999999999999999 89999999999999999554 59999
Q ss_pred eccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCC
Q 008012 434 DFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLP 512 (581)
Q Consensus 434 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~ 512 (581)
|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ......+.....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~~i~~~~~ 304 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGGR 304 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC
Confidence 9999986533332233345567899999999988899999999999999999998 9999976322 222222222211
Q ss_pred CCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 513 HGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
... +..++..+.+++.+||+.||++|||+.|++++|+.+......
T Consensus 305 ~~~-----------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 305 MDP-----------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp CCC-----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred CCC-----------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 111 113445688999999999999999999999999998876543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=364.14 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=208.2
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999966 89999999986553 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++++|.+++..... +++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||++..+......
T Consensus 86 ~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTTTB-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999999876544 789999999999999999999 899999999999999999999999999999876443333
Q ss_pred ceeeccccCccccCCCCCCCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNV-SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............+.......
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 228 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------- 228 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS-------------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC-------------
Confidence 33345679999999999877765 7789999999999999999999976543333333322211110
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.....++..+.+++.+||..||++|||++|++++
T Consensus 229 ----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1112345567899999999999999999999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=365.13 Aligned_cols=270 Identities=24% Similarity=0.363 Sum_probs=217.5
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEe------CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeee
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGIL------SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSC 356 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 356 (581)
+++...++|++.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3455678899999999999999999995 246689999997653 33456789999999999 899999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHHhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 008012 357 CNTNFKALVLEFMPNGSLDKWLYSHNY----------------------FQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414 (581)
Q Consensus 357 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H 414 (581)
...+..++||||+++|+|.+++..... .+++..++.++.||+.||+||| +.||+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence 999999999999999999999986543 2688999999999999999999 899999
Q ss_pred cCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCC
Q 008012 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPT 493 (581)
Q Consensus 415 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf 493 (581)
|||||+||+++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|+| |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999987755444444455667889999999988899999999999999999998 99999
Q ss_pred CccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 494 DEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
...... ......+........+ ..+++.+.+++.+||+.||++|||+.|++++|+.+.+...
T Consensus 276 ~~~~~~-~~~~~~~~~~~~~~~~-----------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 276 PGIPVD-ANFYKLIQNGFKMDQP-----------------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TTCCCS-HHHHHHHHTTCCCCCC-----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred ccCCcH-HHHHHHHhcCCCCCCC-----------------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 764322 2233333332221111 1234568899999999999999999999999999988766
Q ss_pred hh
Q 008012 574 ED 575 (581)
Q Consensus 574 ~~ 575 (581)
+.
T Consensus 338 ~~ 339 (344)
T 1rjb_A 338 EA 339 (344)
T ss_dssp --
T ss_pred HH
Confidence 54
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=353.94 Aligned_cols=264 Identities=23% Similarity=0.364 Sum_probs=206.0
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeC----CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN 360 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 360 (581)
.+...++|++.+.||+|+||.||+|.+. .+..||+|+++... ....+.+.+|+.++++++||||+++++++. .+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 4455678999999999999999999964 24579999987643 445678999999999999999999999984 56
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..++||||+++++|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccc
Confidence 789999999999999999987767899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
...... .......+++.|+|||++.+..++.++||||||+++|||++ |..||...... .....+........+
T Consensus 166 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~~~~~~~~~--- 239 (281)
T 1mp8_A 166 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERLPMP--- 239 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCCCCC---
T ss_pred cCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHHcCCCCCCC---
Confidence 643321 12233456788999999988899999999999999999997 99999764322 222222222111111
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
..+++.+.+++.+||+.||++|||+.|++++|+++.++..
T Consensus 240 --------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 240 --------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp --------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1345678899999999999999999999999999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=359.06 Aligned_cols=249 Identities=24% Similarity=0.271 Sum_probs=207.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
.++|++.+.||+|+||.||+|+.+ +|+.||+|+++... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467999999999999999999965 79999999997653 22345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||++||+|.+++...+ .+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999998654 3789999999999999999999 8999999999999999999999999999998643222
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ..++
T Consensus 160 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~-~~~p--------- 225 (337)
T 1o6l_A 160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILMEE-IRFP--------- 225 (337)
T ss_dssp C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC-CCCC---------
T ss_pred C--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHHHHHHcCC-CCCC---------
Confidence 1 23445789999999999999999999999999999999999999976321 11222221111 1111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
..+++++.++|.+||+.||++|| +++|+++|
T Consensus 226 --------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 226 --------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 12345688999999999999999 89999887
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=358.46 Aligned_cols=266 Identities=24% Similarity=0.359 Sum_probs=221.2
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEe------CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeee
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGIL------SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCC 357 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 357 (581)
++...++|++.+.||+|+||.||+|.+ .+++.||+|+++... ....+.+.+|+++++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 344567899999999999999999984 257889999997653 34557899999999999 9999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHHhhCCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 008012 358 NTNFKALVLEFMPNGSLDKWLYSHNY-----------------FQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPS 420 (581)
Q Consensus 358 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~ 420 (581)
+.+..++||||+++|+|.+++..... .+++..++.++.|++.||+||| +.||+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccc
Confidence 99999999999999999999986543 3789999999999999999999 899999999999
Q ss_pred CeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccc
Q 008012 421 NILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTG 499 (581)
Q Consensus 421 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~ 499 (581)
||+++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|+| |+.||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999988765544444445567889999999988899999999999999999999 99999764322
Q ss_pred cccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 500 EMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
......+........+ ..++..+.+++.+||+.||++|||+.|++++|+++..+.
T Consensus 255 -~~~~~~~~~~~~~~~~-----------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 255 -SKFYKMIKEGFRMLSP-----------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp -HHHHHHHHHTCCCCCC-----------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -hHHHHHhccCCCCCCc-----------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 2233333332221111 123456889999999999999999999999999987654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=359.04 Aligned_cols=260 Identities=21% Similarity=0.276 Sum_probs=213.1
Q ss_pred chhhhHHHhhcC----------CCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCcc
Q 008012 281 TSYLDLERATDG----------FNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNL 349 (581)
Q Consensus 281 ~~~~~~~~~~~~----------y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i 349 (581)
+++.+++.+.+. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni 104 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc
Confidence 455555555433 667789999999999999976 799999999976655555678899999999999999
Q ss_pred ceEeeeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc
Q 008012 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV 429 (581)
Q Consensus 350 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~ 429 (581)
+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.
T Consensus 105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~ 179 (321)
T 2c30_A 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGR 179 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCC
T ss_pred ceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCc
Confidence 99999999999999999999999999998754 4799999999999999999999 899999999999999999999
Q ss_pred EEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 008012 430 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKE 509 (581)
Q Consensus 430 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~ 509 (581)
+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..
T Consensus 180 ~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~~~~ 255 (321)
T 2c30_A 180 VKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRD 255 (321)
T ss_dssp EEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHH
T ss_pred EEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhc
Confidence 99999999987654322 22445799999999999999999999999999999999999999976321 112222222
Q ss_pred hCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 510 SLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....... ....+++.+.+++.+||..||++|||++|++++
T Consensus 256 ~~~~~~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 256 SPPPKLK---------------NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp SSCCCCT---------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCcC---------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2111110 112344568899999999999999999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=364.20 Aligned_cols=253 Identities=20% Similarity=0.251 Sum_probs=208.8
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHH------HHHHHHHHHHHHHhcCCCccceEeeeeecCCe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQ------AFRSFNSECEVLRNVRHRNLIKILSSCCNTNF 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 361 (581)
..+.|++.+.||+|+||.||+|..+ +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4578999999999999999999966 7999999999765321 24578899999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC----cEEEeeccC
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM----VAHVSDFGI 437 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~----~~kl~Dfg~ 437 (581)
.++||||++||+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||+++.++ .+||+|||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 999999999999999997654 4799999999999999999999 89999999999999998776 799999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...... .....+..... .++
T Consensus 166 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--~~~~~i~~~~~-~~~- 238 (361)
T 2yab_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANITAVSY-DFD- 238 (361)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTCC-CCC-
T ss_pred ceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCC-CCC-
Confidence 987754322 23457999999999999999999999999999999999999999763211 11111111110 000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
......++..+.++|.+||..||++|||+.|+++|
T Consensus 239 ------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 239 ------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp ------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01122345678899999999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=352.06 Aligned_cols=267 Identities=25% Similarity=0.369 Sum_probs=209.9
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHh--cCCCccceEeeeeec----CCe
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRN--VRHRNLIKILSSCCN----TNF 361 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~----~~~ 361 (581)
...++|++.+.||+|+||.||+|.. +++.||||++..... ..+.+|.+++.. ++||||+++++++.. ...
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 3467899999999999999999998 589999999976543 345567777776 799999999998654 346
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCCeEecCCCcEEEeecc
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG-----HSTPVVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
.++||||+++|+|.+++... .+++..++.++.|++.||+|||.. ++.+|+||||||+||+++.++.+||+|||
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 89999999999999999654 478999999999999999999932 25789999999999999999999999999
Q ss_pred CceecCCCCCcc--eeeccccCccccCCCCCCCC------CCCccccHHHHHHHHHHHHhC----------CCCCCcccc
Q 008012 437 ISKLLGEGDDSV--IQTMTIATIGYMAPEFGSEG------NVSSKCDVYSYGILLLETFTR----------KKPTDEMFT 498 (581)
Q Consensus 437 ~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~vl~el~tg----------~~Pf~~~~~ 498 (581)
++.......... ......||+.|+|||++.+. .++.++|||||||++|||+|| +.||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 998765433221 12234789999999988776 455799999999999999999 888877655
Q ss_pred ccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 499 GEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
....................... ......++..+.+++.+||+.||++|||++|+++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQRPNIPN--------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCG--------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcchhhhhHHHhccCCCCCCCh--------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 54444444333222211111111 111235677899999999999999999999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=356.81 Aligned_cols=264 Identities=22% Similarity=0.373 Sum_probs=211.1
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 4578999999999999999999965 7899999998543 34556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+++++|.+++...+ .+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 89 v~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 999999999999998765 3789999999999999999999 899999999999999999999999999999866432
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
.. .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ..........+...
T Consensus 165 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~~~----- 233 (294)
T 4eqm_A 165 SL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-----IAIKHIQDSVPNVT----- 233 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-----HHHHHHSSCCCCHH-----
T ss_pred cc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhhccCCCcc-----
Confidence 21 22334568999999999999999999999999999999999999997642211 11111111111110
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-CHHHHHHHHHHhHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRL-YMKDAATKLKKIRDKF 572 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~~~~~~ 572 (581)
.....++++.+.+++.+||+.||++|| +++++.+.|+++..+.
T Consensus 234 -----~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 234 -----TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp -----HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred -----hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 011123566788999999999999999 8999999998876443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=369.83 Aligned_cols=255 Identities=20% Similarity=0.285 Sum_probs=208.7
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
...++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 45678999999999999999999965 79999999987543 3455678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec---CCCcEEEeeccCceec
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD---ENMVAHVSDFGISKLL 441 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a~~~ 441 (581)
||||+++|+|.+++...+. +++..+..++.||+.||+||| +.||+||||||+||+++ .++.+||+|||++...
T Consensus 88 v~E~~~gg~L~~~i~~~~~-~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EECCCBCCBHHHHHHHCSC-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999999987654 799999999999999999999 89999999999999998 4678999999999876
Q ss_pred CCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
..... ......||+.|+|||++.+..++.++||||+||++|+|++|.+||.... .......+....... +.
T Consensus 164 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~~-~~---- 234 (444)
T 3soa_A 164 EGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--QHRLYQQIKAGAYDF-PS---- 234 (444)
T ss_dssp CTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTCCCC-CT----
T ss_pred cCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHhCCCCC-Cc----
Confidence 43322 2234579999999999999999999999999999999999999997632 122222222211111 00
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+....+++.+.++|.+||+.||++|||+.|+++|
T Consensus 235 ---------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 235 ---------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0111345678899999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=364.86 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=211.6
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
..++|++.+.||+|+||.||+|... +++.||+|++..........+.+|++++++++||||+++++++.+.+..++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 3568999999999999999999965 789999999987765556688999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC--CCcEEEeeccCceecCCCC
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE--NMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~~~~~~ 445 (581)
|+++|+|.+++......+++..++.++.||+.||+||| +.||+||||||+||+++. ++.+||+|||++.......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999999877666899999999999999999999 899999999999999974 5789999999999775432
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... .+.
T Consensus 206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~~~~~-~~~-------- 271 (387)
T 1kob_A 206 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDWE-FDE-------- 271 (387)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHHCCCC-CCS--------
T ss_pred c---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCC-CCc--------
Confidence 2 2345799999999999999999999999999999999999999976321 1111112111110 000
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.....+++.+.++|.+||..||++|||+.|++++
T Consensus 272 -----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 -----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0011345568899999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=355.40 Aligned_cols=264 Identities=27% Similarity=0.424 Sum_probs=202.9
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
..+...++|++.+.||+|+||.||+|... ..||+|+++.. .....+.+.+|++++++++||||+++++++ ..+..
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 34556788999999999999999999865 35999998654 345567899999999999999999999965 45668
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+++++|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999999877777899999999999999999999 8999999999999999999999999999998664
Q ss_pred CCCCcceeeccccCccccCCCCCC---CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC-CCCCcc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGS---EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLP-HGLPKI 518 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~ 518 (581)
............|++.|+|||++. +..++.++||||||+++|+|++|+.||....... .....+..... ......
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 250 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMVGRGSLSPDLSKV 250 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHHHHTSCCCCTTSS
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHhcccccCcchhhc
Confidence 433333334557899999999876 6678899999999999999999999997643322 22222222211 111111
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
...+++.+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 251 --------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 251 --------------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --------------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1134567889999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=359.65 Aligned_cols=259 Identities=25% Similarity=0.426 Sum_probs=206.7
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcE----EEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTT----VAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467899999999999999999954 4444 5888775443 334567899999999999999999999998765 78
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+|+||+++|+|.+++......+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999999987777899999999999999999999 88999999999999999999999999999988765
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
...........+|..|+|||++.+..++.++|||||||++|||+| |+.||..... ......+........+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~~~~~------ 241 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP------ 241 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCCCCCC------
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--HHHHHHHHcCCCCCCC------
Confidence 544444445567889999999999999999999999999999999 9999976422 2333333332211111
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
..++..+.+++.+||+.||++|||+.|++++|+++...
T Consensus 242 -----------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 242 -----------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -----------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 12345688999999999999999999999999988654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=360.89 Aligned_cols=267 Identities=23% Similarity=0.409 Sum_probs=199.8
Q ss_pred hhHHHhhcCCCcCCeecccccccEEEEEeC-CCc---EEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeee
Q 008012 284 LDLERATDGFNECNLLGSGGFGSVYKGILS-DGT---TVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCC 357 (581)
Q Consensus 284 ~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 357 (581)
.++....++|++.+.||+|+||.||+|.+. +++ .||+|+++.. .....+.+.+|++++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 344556788999999999999999999965 332 7999999765 3345678999999999999999999999998
Q ss_pred cCCee------eEEEeccCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC
Q 008012 358 NTNFK------ALVLEFMPNGSLDKWLYSH-----NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE 426 (581)
Q Consensus 358 ~~~~~------~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~ 426 (581)
..+.. ++||||+++++|.+++... ...+++..++.++.|++.||+||| +.||+||||||+||+++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcC
Confidence 76654 9999999999999999743 224789999999999999999999 899999999999999999
Q ss_pred CCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHH
Q 008012 427 NMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKN 505 (581)
Q Consensus 427 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~ 505 (581)
++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~ 250 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYN 250 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHH
Confidence 99999999999987654443333444567889999999999899999999999999999999 99999764322 2222
Q ss_pred HHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 506 WVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
.+........ +..++..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 251 ~~~~~~~~~~-----------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 251 YLIGGNRLKQ-----------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHHTTCCCCC-----------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHhcCCCCCC-----------------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 2222111111 1123456889999999999999999999999999987643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=360.89 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=206.5
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHH-----HHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQ-----AFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.++|++.+.||+|+||.||+|..+ +++.||+|++...... ..+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999965 7999999998654311 2467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc---EEEeeccC
Q 008012 364 LVLEFMPNGSLDKWLYSH---NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV---AHVSDFGI 437 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~---~kl~Dfg~ 437 (581)
+||||+++++|.+++... +..+++..++.++.||+.||+||| ++||+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888643 345789999999999999999999 899999999999999986554 99999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ............. ..
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~i~~~~~~--~~- 252 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYK--MN- 252 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHHHHHHTCCC--CC-
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHHHHHcCCCC--CC-
Confidence 987754322 2334579999999999999999999999999999999999999997631 1111111111110 00
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
......++..+.++|.+||..||++|||+.|+++|
T Consensus 253 ------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 253 ------------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp ------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01112345678899999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=352.41 Aligned_cols=268 Identities=21% Similarity=0.259 Sum_probs=207.6
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999965 78999999997543 3344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++ ++.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 9976 777777766666899999999999999999999 88999999999999999999999999999987643322
Q ss_pred ceeeccccCccccCCCCCCCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---CCccccc--
Q 008012 448 VIQTMTIATIGYMAPEFGSEGN-VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---LPKIADA-- 521 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-- 521 (581)
......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.........+........... .+.....
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 234457899999999887765 899999999999999999998886543333223333322221111 1000000
Q ss_pred -----cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 -----NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 -----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..............++..+.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000011112355678899999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=361.33 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=209.3
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
...++|++.+.||+|+||.||+|..+ +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34578999999999999999999965 7899999999754 24455778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC---CcEEEeeccCceec
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN---MVAHVSDFGISKLL 441 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~---~~~kl~Dfg~a~~~ 441 (581)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.+ +.+||+|||++...
T Consensus 106 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 999999999999997654 4789999999999999999999 8999999999999999864 45999999999876
Q ss_pred CCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|++||..... ......+...... .+.
T Consensus 182 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~-~~~---- 251 (362)
T 2bdw_A 182 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYD-YPS---- 251 (362)
T ss_dssp TTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCC-CCT----
T ss_pred cCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCCCC-CCc----
Confidence 53322 2345799999999999999999999999999999999999999976321 1222222221111 000
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.....+++.+.++|.+||..||++|||+.|+++|
T Consensus 252 ---------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 252 ---------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ---------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1112345678899999999999999999999887
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=358.04 Aligned_cols=266 Identities=26% Similarity=0.429 Sum_probs=218.1
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC--------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeee
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS--------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSC 356 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 356 (581)
....++|++.+.||+|+||.||+|.+. +++.||+|+++... ....+.+.+|+++++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 345688999999999999999999863 46789999997653 44567889999999999 899999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHHhhCCC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCC
Q 008012 357 CNTNFKALVLEFMPNGSLDKWLYSHNY---------------FQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSN 421 (581)
Q Consensus 357 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~N 421 (581)
.+.+..++||||+++++|.+++..... .+++..++.++.||+.||+||| +.||+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccce
Confidence 999999999999999999999986532 3788999999999999999999 8999999999999
Q ss_pred eEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCcccccc
Q 008012 422 ILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGE 500 (581)
Q Consensus 422 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~ 500 (581)
|+++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-- 265 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 265 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--
Confidence 9999999999999999987754433333344457889999999988889999999999999999999 9999976321
Q ss_pred ccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 501 MNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
......+........+ ..++..+.+++.+||+.||++|||+.|++++|+++......
T Consensus 266 ~~~~~~~~~~~~~~~~-----------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 266 EELFKLLKEGHRMDKP-----------------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHHHHHHTCCCCCC-----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhcCCCCCCC-----------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1222222222211111 13445688999999999999999999999999999876543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=359.10 Aligned_cols=269 Identities=23% Similarity=0.375 Sum_probs=221.5
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC-CC-----cEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeee
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS-DG-----TTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSC 356 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 356 (581)
.++...++|++.+.||+|+||.||+|... ++ ..||+|++.... ....+.+.+|+++++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45566789999999999999999999964 23 479999997653 34557789999999999 899999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeE
Q 008012 357 CNTNFKALVLEFMPNGSLDKWLYSH-------------NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNIL 423 (581)
Q Consensus 357 ~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nil 423 (581)
.+.+..++||||+++|+|.+++... ...+++..++.++.|++.||+||| +.||+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEE
Confidence 9999999999999999999999853 234688999999999999999999 889999999999999
Q ss_pred ecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCcccccccc
Q 008012 424 LDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMN 502 (581)
Q Consensus 424 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~ 502 (581)
++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||+| |..||...... ..
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~ 275 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SK 275 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-HH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-HH
Confidence 99999999999999987654444334445567889999999988899999999999999999999 99999764322 22
Q ss_pred HHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 503 LKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
....+........+. .++..+.+++.+||+.||++|||+.|++++|+++..+...
T Consensus 276 ~~~~~~~~~~~~~~~-----------------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 330 (333)
T 2i1m_A 276 FYKLVKDGYQMAQPA-----------------FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR 330 (333)
T ss_dssp HHHHHHHTCCCCCCT-----------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCC-----------------CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence 333333332221111 2245688999999999999999999999999998876554
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=352.04 Aligned_cols=273 Identities=25% Similarity=0.376 Sum_probs=212.8
Q ss_pred hhhhHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhc--CCCccceEeeeeecC
Q 008012 282 SYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV--RHRNLIKILSSCCNT 359 (581)
Q Consensus 282 ~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~ 359 (581)
+........++|++.+.||+|+||.||+|+.. ++.||+|++..... ....+|.+++... +||||+++++++...
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 33444566789999999999999999999986 89999999876543 2344566666555 899999999999876
Q ss_pred ----CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CceecCCCCCCeEecCC
Q 008012 360 ----NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST--------PVVHCDLKPSNILLDEN 427 (581)
Q Consensus 360 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~--------~i~H~dikp~Nill~~~ 427 (581)
...++||||+++|+|.+++.... +++..++.++.|++.||+||| +. ||+||||||+||+++.+
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCCCCceEEEEeccCCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCC
Confidence 68899999999999999997653 789999999999999999999 66 99999999999999999
Q ss_pred CcEEEeeccCceecCCCCCcc--eeeccccCccccCCCCCCCCCCCcc------ccHHHHHHHHHHHHhC----------
Q 008012 428 MVAHVSDFGISKLLGEGDDSV--IQTMTIATIGYMAPEFGSEGNVSSK------CDVYSYGILLLETFTR---------- 489 (581)
Q Consensus 428 ~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~------~Dv~slG~vl~el~tg---------- 489 (581)
+.+||+|||++.......... ......||+.|+|||++.+...+.+ +|||||||++|||+||
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999998764332221 1224578999999999887766665 9999999999999999
Q ss_pred CCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 490 KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 490 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
+.||............................ .....++++.+.+++.+||+.||++|||+.|++++|+++.
T Consensus 259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN--------RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG--------GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccHhhhcCCCCchhhhHHHHhhhccCccccc--------cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 67776654444444333332222221111111 1122367888999999999999999999999999999987
Q ss_pred HH
Q 008012 570 DK 571 (581)
Q Consensus 570 ~~ 571 (581)
+.
T Consensus 331 ~~ 332 (337)
T 3mdy_A 331 ES 332 (337)
T ss_dssp HT
T ss_pred hh
Confidence 64
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=347.85 Aligned_cols=258 Identities=27% Similarity=0.394 Sum_probs=214.2
Q ss_pred hhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
..++|++.+.||+|+||.||+|...+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 34678999999999999999999888899999999765422 25688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++++|.+++......+++..++.++.|++.||+||| +.|++||||||+||+++.++.+||+|||.+....... ..
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 160 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 160 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence 9999999999987777899999999999999999999 8999999999999999999999999999998653211 11
Q ss_pred eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
......++..|+|||++.+..++.++||||||+++|+|++ |+.||..... ......+........+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~i~~~~~~~~~----------- 227 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFRLYKP----------- 227 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCCCCCC-----------
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--HHHHHHHhcCCcCCCC-----------
Confidence 1223456788999999988899999999999999999999 8999976321 1122222222111111
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
..++..+.+++.+||+.||++|||++|++++|+++.+
T Consensus 228 ------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 ------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp ------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1234568899999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=350.40 Aligned_cols=266 Identities=14% Similarity=0.129 Sum_probs=217.6
Q ss_pred hhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
..++|++.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+.+++++ +|++++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 457899999999999999999995 4799999999865532 24577899999999 8999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc-----EEEeeccCceec
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV-----AHVSDFGISKLL 441 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~-----~kl~Dfg~a~~~ 441 (581)
||+ +++|.+++...+..+++..++.++.||+.||+||| ++||+||||||+||+++.++. +||+|||++...
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999 99999999987767899999999999999999999 899999999999999987765 999999999877
Q ss_pred CCCCCc-----ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccc-c-HHHHHHhhCCCC
Q 008012 442 GEGDDS-----VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM-N-LKNWVKESLPHG 514 (581)
Q Consensus 442 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~-~-~~~~~~~~~~~~ 514 (581)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ . ...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 240 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST- 240 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc-
Confidence 543321 123445789999999999999999999999999999999999999987432211 1 11111111000
Q ss_pred CCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 515 LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
........+++.+.+++.+||+.||++|||++++++.|+++.++...
T Consensus 241 -------------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 241 -------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp -------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -------------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 00111124567899999999999999999999999999999887654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=350.02 Aligned_cols=253 Identities=30% Similarity=0.471 Sum_probs=207.6
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH----HH---HHHHHHHHHHHHhcCCCccceEeeeeecCC
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE----QA---FRSFNSECEVLRNVRHRNLIKILSSCCNTN 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~----~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 360 (581)
..++|++.+.||+|+||.||+|... +++.||+|++..... .. .+.+.+|++++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3578999999999999999999964 899999999865421 11 157889999999999999999999987665
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeEecCCCc-----EEEe
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP--VVHCDLKPSNILLDENMV-----AHVS 433 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dikp~Nill~~~~~-----~kl~ 433 (581)
++||||+++++|.+++.+....+++..++.++.|++.||+||| +.| |+||||||+||+++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 6999999999999999887777899999999999999999999 888 999999999999987776 9999
Q ss_pred eccCceecCCCCCcceeeccccCccccCCCCC--CCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 008012 434 DFGISKLLGEGDDSVIQTMTIATIGYMAPEFG--SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESL 511 (581)
Q Consensus 434 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 511 (581)
|||++..... ......|++.|+|||++ ....++.++|||||||++|+|++|+.||.............+....
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 9999985432 23445789999999988 4556789999999999999999999999865433332222222211
Q ss_pred -CCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 512 -PHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 512 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
....+ ..+++.+.+++.+||+.||++|||++|+++.|+++
T Consensus 247 ~~~~~~-----------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 LRPTIP-----------------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCCC-----------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCCC-----------------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111 13455788999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=354.35 Aligned_cols=274 Identities=21% Similarity=0.283 Sum_probs=213.2
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC--eeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN--FKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 365 (581)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999966 68999999997643 233466789999999999999999999987755 78999
Q ss_pred EeccCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe----cCCCcEEEeeccCce
Q 008012 366 LEFMPNGSLDKWLYSHNY--FQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL----DENMVAHVSDFGISK 439 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill----~~~~~~kl~Dfg~a~ 439 (581)
|||+++++|.+++..... .+++..++.++.||+.||+||| +.||+||||||+||++ +.++.+||+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999986432 3799999999999999999999 8999999999999999 788899999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCC--------CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccH--HHHHHh
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGS--------EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNL--KNWVKE 509 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~--~~~~~~ 509 (581)
....... .....|++.|+|||++. +..++.++|||||||++|||++|+.||.......... ...+..
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 7754332 23456899999999875 5788999999999999999999999997543222211 111222
Q ss_pred hCCCC-CCccccc---cc--hhh-hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 510 SLPHG-LPKIADA---NL--LRE-ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 510 ~~~~~-~~~~~~~---~~--~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
..+.. +..+... .+ ... .........++..+.+++.+||+.||++|||++|++++..+..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 22211 1111100 00 000 0011223466778999999999999999999999999988653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=356.09 Aligned_cols=272 Identities=25% Similarity=0.373 Sum_probs=222.2
Q ss_pred chhhhHHHhhcCCCcCCeecccccccEEEEEe------CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceE
Q 008012 281 TSYLDLERATDGFNECNLLGSGGFGSVYKGIL------SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKI 352 (581)
Q Consensus 281 ~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~ 352 (581)
.....+....++|++.+.||+|+||.||+|.+ .+++.||+|+++... ....+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455666778999999999999999999984 256889999997653 34556789999999999 79999999
Q ss_pred eeeeecCC-eeeEEEeccCCCCHHHHHhhCCCC---------------CCHHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 008012 353 LSSCCNTN-FKALVLEFMPNGSLDKWLYSHNYF---------------QDIPDRLNIMIDVALALEYLHHGHSTPVVHCD 416 (581)
Q Consensus 353 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~---------------~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~d 416 (581)
++++...+ ..++||||+++++|.+++...... +++..++.++.|++.||.||| +.||+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence 99987654 589999999999999999865432 688999999999999999999 89999999
Q ss_pred CCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCc
Q 008012 417 LKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDE 495 (581)
Q Consensus 417 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~ 495 (581)
|||+||+++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|+| |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987755444444455678899999999988899999999999999999998 9999976
Q ss_pred cccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 496 MFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
..... .....+........+. .+++.+.+++.+||+.||++|||+.|++++|+++.+...
T Consensus 254 ~~~~~-~~~~~~~~~~~~~~~~-----------------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 254 VKIDE-EFCRRLKEGTRMRAPD-----------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CCCSH-HHHHHHHHTCCCCCCT-----------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cchhH-HHHHHhccCccCCCCC-----------------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 43222 2222222222111111 234568899999999999999999999999999986543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=358.90 Aligned_cols=250 Identities=25% Similarity=0.326 Sum_probs=205.6
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3478999999999999999999965 78999999997653 2234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||++||+|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 93 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 999999999999998754 4789999999999999999999 899999999999999999999999999999876433
Q ss_pred CCcceeeccccCccccCCCCCCC---CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhh--CCCCCCccc
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSE---GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES--LPHGLPKIA 519 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~ 519 (581)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ......... .....+
T Consensus 169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~p--- 240 (384)
T 4fr4_A 169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVHTFETTVVTYP--- 240 (384)
T ss_dssp C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHHHHHHHHCCCCCC---
T ss_pred C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhhcccCCC---
Confidence 2 2345679999999998864 46899999999999999999999999753222 222222211 111111
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-HHHHHHH
Q 008012 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLY-MKDAATK 564 (581)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~ 564 (581)
..++..+.++|.+||+.||++||+ ++++++|
T Consensus 241 --------------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 241 --------------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp --------------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred --------------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 123456889999999999999998 7777653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=361.54 Aligned_cols=251 Identities=22% Similarity=0.248 Sum_probs=202.4
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 362 (581)
...++|++.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+.+|.++++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999965 78999999998653 23345678899999998 799999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
|+||||++||+|.+++...+. +++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999999987644 789999999999999999999 8999999999999999999999999999998543
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... .++.
T Consensus 176 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~~~-~~p~----- 245 (353)
T 3txo_A 176 CNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--DDLFEAILNDEV-VYPT----- 245 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC-CCCT-----
T ss_pred cCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCC-CCCC-----
Confidence 222 223455799999999999988999999999999999999999999976422 122222221111 1111
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCH------HHHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYM------KDAATK 564 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~ 564 (581)
.++..+.+++.+||..||++||++ +|+++|
T Consensus 246 ------------~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 246 ------------WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ------------TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ------------CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 133457899999999999999998 777765
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=356.27 Aligned_cols=253 Identities=20% Similarity=0.263 Sum_probs=208.2
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHH------HHHHHHHHHHHHHhcCCCccceEeeeeecCCe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQ------AFRSFNSECEVLRNVRHRNLIKILSSCCNTNF 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 361 (581)
..+.|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4467899999999999999999965 7999999998764311 24678899999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC----cEEEeeccC
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM----VAHVSDFGI 437 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~----~~kl~Dfg~ 437 (581)
.++||||+++++|.+++.... .+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 999999999999999997654 4789999999999999999999 89999999999999999877 899999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+..... ..+
T Consensus 165 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~-~~~- 237 (326)
T 2y0a_A 165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSAVNY-EFE- 237 (326)
T ss_dssp CEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHTCC-CCC-
T ss_pred CeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHHhcCC-CcC-
Confidence 987753322 23456899999999999999999999999999999999999999763221 11111111110 000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
......++..+.++|.+||..||++|||+.|+++|
T Consensus 238 ------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 238 ------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01122345678899999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=349.97 Aligned_cols=264 Identities=23% Similarity=0.411 Sum_probs=217.0
Q ss_pred hhcCCCcCC-eecccccccEEEEEeC---CCcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 289 ATDGFNECN-LLGSGGFGSVYKGILS---DGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 289 ~~~~y~~~~-~lg~G~~~~v~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
..++|.+.+ .||+|+||.||+|.+. ++..||+|+++.. .....+.+.+|++++++++||||+++++++ ..+..+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 345677776 8999999999999853 6788999999764 345567899999999999999999999999 456689
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+++++|.+++......+++..++.++.|++.||.||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999999877677899999999999999999999 89999999999999999999999999999988754
Q ss_pred CCCcc-eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 444 GDDSV-IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 444 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+........+
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i~~~~~~~~~----- 235 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKRMECP----- 235 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTTCCCCCC-----
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHhcCCcCCCC-----
Confidence 33221 1223356889999999988889999999999999999999 9999976422 2222223222111111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHhh
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLED 575 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 575 (581)
..+++.+.++|.+||..||++|||+.|++++|+++......+
T Consensus 236 ------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 236 ------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp ------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ------------CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 134567889999999999999999999999999998877654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=355.95 Aligned_cols=265 Identities=17% Similarity=0.162 Sum_probs=214.1
Q ss_pred hhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
..++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 347899999999999999999996 4799999999875532 23578899999999 9999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc-----EEEeeccCceec
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV-----AHVSDFGISKLL 441 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~-----~kl~Dfg~a~~~ 441 (581)
||+ +++|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++. +||+|||++..+
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999 99999999976667899999999999999999999 889999999999999998887 999999999976
Q ss_pred CCCCCcc-----eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCC
Q 008012 442 GEGDDSV-----IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP 516 (581)
Q Consensus 442 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 516 (581)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~~~-- 236 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TLKERYQKIGDTK-- 236 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SHHHHHHHHHHHH--
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--cHHHHHHHHHhhh--
Confidence 4433211 123557999999999999999999999999999999999999999874322 1111111110000
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
...+.......++ ++.+++..||+.||.+||+++++.+.|+++.++.
T Consensus 237 --------~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 237 --------RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp --------HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --------ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0000000111244 7899999999999999999999999999887765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=352.15 Aligned_cols=258 Identities=28% Similarity=0.404 Sum_probs=203.9
Q ss_pred hcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
.++|++.+.||+|+||.||+|... ++.||+|++.... ..+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 467889999999999999999986 7899999997653 34678899999999999999999998874 478999999
Q ss_pred CCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc-EEEeeccCceecCCCCC
Q 008012 370 PNGSLDKWLYSHNY--FQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV-AHVSDFGISKLLGEGDD 446 (581)
Q Consensus 370 ~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~-~kl~Dfg~a~~~~~~~~ 446 (581)
++++|.+++..... ..++..++.++.|+++||+|||+.+.+||+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999986543 4688899999999999999999433389999999999999998886 799999999765322
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||.............+........
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 225 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL----------- 225 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC-----------
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc-----------
Confidence 223468999999999999999999999999999999999999997643222111111111111111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
...++..+.+++.+||+.||++|||++|++++|+.+...+..
T Consensus 226 ------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 226 ------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp ------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 112345688999999999999999999999999999876654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=353.30 Aligned_cols=270 Identities=26% Similarity=0.425 Sum_probs=206.5
Q ss_pred hhhHHHhhcCCCcCCeecccccccEEEEEeC----CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeee
Q 008012 283 YLDLERATDGFNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSC 356 (581)
Q Consensus 283 ~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 356 (581)
..++....++|.+.+.||+|+||.||+|... +++.||+|+++.. .....+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3445556788999999999999999999854 3458999998754 345567789999999999999999999998
Q ss_pred ecCC-----eeeEEEeccCCCCHHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC
Q 008012 357 CNTN-----FKALVLEFMPNGSLDKWLYS-----HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE 426 (581)
Q Consensus 357 ~~~~-----~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~ 426 (581)
.+.+ ..++||||+++++|.+++.. ....+++..++.++.||+.||.||| +.||+||||||+||+++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcC
Confidence 7755 35999999999999999953 2345899999999999999999999 899999999999999999
Q ss_pred CCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHH
Q 008012 427 NMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKN 505 (581)
Q Consensus 427 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~ 505 (581)
++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~ 260 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYD 260 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHH
Confidence 99999999999987654433333344567889999999999999999999999999999999 88998764222 2222
Q ss_pred HHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 506 WVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
.+........+ ..+++.+.+++.+||..||++|||+.+++++|+++.+..++
T Consensus 261 ~~~~~~~~~~~-----------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 261 YLLHGHRLKQP-----------------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp HHHTTCCCCCB-----------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HHHcCCCCCCC-----------------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 22222111111 13445688999999999999999999999999999887653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=358.31 Aligned_cols=260 Identities=24% Similarity=0.416 Sum_probs=208.6
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcE----EEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTT----VAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+.... ......+.+|+.++++++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 467899999999999999999964 4554 7788775432 222345678999999999999999999986 45689
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+++|+|.+++......+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999999877666889999999999999999999 88999999999999999999999999999998765
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
...........++..|+|||++.+..++.++|||||||++|+|+| |+.||..... ......+........+..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~---- 241 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLEKGERLAQPQI---- 241 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--THHHHHHHTTCBCCCCTT----
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--HHHHHHHHcCCCCCCCCc----
Confidence 544444455678889999999998899999999999999999999 9999986422 223333332222111111
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
++..+.+++.+||..||++|||+.|++++|+++....
T Consensus 242 -------------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 242 -------------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp -------------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred -------------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 2334668999999999999999999999999886543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=350.67 Aligned_cols=267 Identities=24% Similarity=0.377 Sum_probs=221.9
Q ss_pred hhhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe
Q 008012 283 YLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF 361 (581)
Q Consensus 283 ~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 361 (581)
+.+++...++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3455567788999999999999999999976 588999999976543 34678899999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 362 KALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
.++||||+++++|.+++... ...+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+..
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999999864 345789999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
..... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ......+........+
T Consensus 161 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--~~~~~~~~~~~~~~~~--- 234 (288)
T 3kfa_A 161 MTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKDYRMERP--- 234 (288)
T ss_dssp SCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCCCCCC---
T ss_pred ccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhccCCCCCC---
Confidence 64332 223344457889999999988899999999999999999999 9999976322 2233333322221111
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
..+++.+.+++.+||..||++|||++|+++.|+++..+..
T Consensus 235 --------------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 235 --------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp --------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --------------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1344568899999999999999999999999999887654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=359.24 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=201.2
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCC--CccceEeeeeecCCeee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRH--RNLIKILSSCCNTNFKA 363 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~ 363 (581)
...++|++.+.||+|+||.||+|...+++.||+|++... .....+.+.+|++++++++| |||+++++++.+.+..+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 345679999999999999999999888999999998754 34556788999999999976 99999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+|||+ .+++|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++ ++.+||+|||++.....
T Consensus 86 lv~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99995 5789999998765 4788999999999999999999 88999999999999997 67899999999987754
Q ss_pred CCCcceeeccccCccccCCCCCCC-----------CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSE-----------GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLP 512 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 512 (581)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............+.....
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 443333445679999999998754 678999999999999999999999997643322222222222221
Q ss_pred CCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 513 HGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
...+.. .+..+.+++.+||+.||++|||+.|+++|-
T Consensus 240 ~~~~~~-----------------~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 240 IEFPDI-----------------PEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CCCCCC-----------------SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCccc-----------------CCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 111111 124577999999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=358.15 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=204.2
Q ss_pred hhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHH---HHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQ---AFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|.+.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+++++.++||||+++++++.+.+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 357899999999999999999996 48999999999765322 23478899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+ +|+|.+++...+. +++..++.++.||+.||+||| +.||+||||||+||++++++.+||+|||++......
T Consensus 87 v~E~~-~g~l~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EECCC-CEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEECC-CCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 99999 7799998876544 789999999999999999999 889999999999999999999999999999876433
Q ss_pred CCcceeeccccCccccCCCCCCCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNV-SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
.. .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ...+....
T Consensus 162 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------~~~i~~~~- 224 (336)
T 3h4j_B 162 NF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------FKKVNSCV- 224 (336)
T ss_dssp BT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------BCCCCSSC-
T ss_pred cc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------HHHHHcCC-
Confidence 21 234579999999999988776 7899999999999999999999976322111 00000000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+..+++.+.++|.+||..||++|||++|++++
T Consensus 225 ------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 ------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00111234568899999999999999999999886
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=350.37 Aligned_cols=246 Identities=26% Similarity=0.326 Sum_probs=206.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH---HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
.++|++.+.||+|+||.||+|+.+ +|+.||+|+++.... ...+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999965 799999999976532 2345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+++|+|.+++..... +++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++......
T Consensus 85 ~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999999999999987654 788999999999999999999 899999999999999999999999999999876432
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ..++.
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~--~~~p~-------- 224 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNAE--LRFPP-------- 224 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHCC--CCCCT--------
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC--CCCCC--------
Confidence 23457899999999999999999999999999999999999999763211 1111111111 11111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
.++.++.+++.+||..||++|| +++|+++|
T Consensus 225 ---------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 225 ---------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 2334678999999999999999 89999876
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=370.20 Aligned_cols=256 Identities=28% Similarity=0.410 Sum_probs=212.5
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC-eeeE
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN-FKAL 364 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~l 364 (581)
++...++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||+++++++...+ ..++
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 4455678999999999999999999986 7899999998664 3467899999999999999999999987655 7899
Q ss_pred EEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 365 VLEFMPNGSLDKWLYSHNY-FQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
||||+++|+|.+++...+. .+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999986544 3688999999999999999999 89999999999999999999999999999986432
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
.. ....++..|+|||++.+..++.++|||||||++|||+| |+.||...... .....+.......
T Consensus 342 ~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~~-------- 406 (450)
T 1k9a_A 342 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMD-------- 406 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHHHHTTCCCC--------
T ss_pred cc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCC--------
Confidence 21 22356889999999999999999999999999999998 99999764322 2222232221111
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
.+..+++.+.++|.+||+.||++|||+.++++.|+++...
T Consensus 407 ---------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 407 ---------APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1124566789999999999999999999999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=359.93 Aligned_cols=252 Identities=20% Similarity=0.272 Sum_probs=204.0
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeee
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 363 (581)
..++|++.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+.+|..+++++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4568999999999999999999965 68899999997653 33345678899999887 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+++|+|.+++...+. +++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++....
T Consensus 130 lV~E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEcCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999987544 789999999999999999999 89999999999999999999999999999985322
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc----cc---HHHHHHhhCCCCCC
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE----MN---LKNWVKESLPHGLP 516 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~----~~---~~~~~~~~~~~~~~ 516 (581)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. +.+.+... ...++
T Consensus 206 ~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p 282 (396)
T 4dc2_A 206 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIP 282 (396)
T ss_dssp TT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-CCCCC
T ss_pred CC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-ccCCC
Confidence 22 22345679999999999999999999999999999999999999996432111 01 11111111 11111
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCH------HHHHHH
Q 008012 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYM------KDAATK 564 (581)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~ 564 (581)
..++..+.++|.+||+.||++||++ +|+++|
T Consensus 283 -----------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 283 -----------------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred -----------------CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1234568899999999999999996 566665
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=351.12 Aligned_cols=267 Identities=22% Similarity=0.286 Sum_probs=204.7
Q ss_pred cCCCcCCeecccccccEEEEEeCCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 291 DGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
++|++.+.||+|+||.||+|...+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999998889999999986543 22235678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+++ +|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence 976 999999877667899999999999999999999 89999999999999999999999999999987643221
Q ss_pred eeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---CCccc-----
Q 008012 449 IQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---LPKIA----- 519 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~----- 519 (581)
......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+........... .+...
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHCCCChhhchhhhccccc
Confidence 2234568999999998865 46899999999999999999999999764222 12222222111110 11100
Q ss_pred cccch--hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 DANLL--REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 ~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
++... ...+.......+++.+.+++.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 0000001112355678899999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=360.68 Aligned_cols=247 Identities=22% Similarity=0.289 Sum_probs=201.7
Q ss_pred CCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCCCCH
Q 008012 296 CNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSL 374 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 374 (581)
.+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999964 7999999999877666667899999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe--cCCCcEEEeeccCceecCCCCCcceeec
Q 008012 375 DKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL--DENMVAHVSDFGISKLLGEGDDSVIQTM 452 (581)
Q Consensus 375 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 452 (581)
.+++......+++..++.++.||+.||+||| +.||+||||||+||++ +.++.+||+|||++........ ...
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~ 247 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKV 247 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---ccc
Confidence 9999877666899999999999999999999 8999999999999999 5678999999999997754332 234
Q ss_pred cccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhH
Q 008012 453 TIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSA 532 (581)
Q Consensus 453 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (581)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+...... .+ . ..
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~--~~---~----------~~ 311 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AETLNNILACRWD--LE---D----------EE 311 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCC--SC---S----------GG
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCC--CC---h----------hh
Confidence 4689999999999999999999999999999999999999976422 1122222221111 00 0 01
Q ss_pred HHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 533 RMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 533 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+++.+.++|.+||..||++|||+.|+++|
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 12345678899999999999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=359.36 Aligned_cols=253 Identities=23% Similarity=0.288 Sum_probs=193.3
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
...++|++.+.||+|+||.||+|... +++.||+|+++... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 45678999999999999999999976 68899999998654 2356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC---CCcEEEeeccCceecCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGE 443 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~~~~ 443 (581)
||+++++|.+++...+. +++..++.++.||+.||+||| +.||+||||||+||+++. ++.+||+|||++.....
T Consensus 128 e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKGY-YSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCCSCBHHHHHTTCSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EeCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999986543 789999999999999999999 889999999999999975 88999999999986543
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||................... ....
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-~~~~------ 273 (349)
T 2w4o_A 204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-FISP------ 273 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-CCTT------
T ss_pred cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-cCCc------
Confidence 22 2234568999999999999999999999999999999999999997643222122222111110 0000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+++..+.++|.+||..||++|||+.|++++
T Consensus 274 --------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 274 --------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp --------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011345568899999999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=360.39 Aligned_cols=278 Identities=20% Similarity=0.179 Sum_probs=216.0
Q ss_pred hhccccchhhhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-----CCc
Q 008012 275 LATWRRTSYLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-----HRN 348 (581)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~ 348 (581)
......+++.+.....++|++.+.||+|+||.||+|... +++.||+|+++... .....+..|+++++.+. |||
T Consensus 19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCC
Confidence 345566777777888899999999999999999999964 78999999997543 33456778999999996 999
Q ss_pred cceEeeeeecCCeeeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-
Q 008012 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE- 426 (581)
Q Consensus 349 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~- 426 (581)
|+++++++...+..++||||+ +++|.+++.... ..+++..++.++.||+.||+||| +.||+||||||+||+++.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDP 173 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCT
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccc
Confidence 999999999999999999999 889999998654 34789999999999999999999 899999999999999975
Q ss_pred ------------------------CCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHH
Q 008012 427 ------------------------NMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGIL 482 (581)
Q Consensus 427 ------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~v 482 (581)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 7899999999998754322 34568999999999999999999999999999
Q ss_pred HHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc-----------------chhhhhh-----------hhHHH
Q 008012 483 LLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN-----------------LLREENF-----------FSARM 534 (581)
Q Consensus 483 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~-----------~~~~~ 534 (581)
+|+|++|+.||..... ......+............... +...... .....
T Consensus 249 l~ell~g~~pf~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 326 (360)
T 3llt_A 249 LAELYTGSLLFRTHEH--MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326 (360)
T ss_dssp HHHHHHSSCSCCCSSH--HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred HHHHHHCCCCCCCCcH--HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence 9999999999976322 1222222222111110000000 0000000 00001
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 535 DCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 535 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+.+.+++.+||+.||++|||++|+++|
T Consensus 327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 327 IKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred chHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 122568899999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=363.72 Aligned_cols=274 Identities=15% Similarity=0.150 Sum_probs=211.3
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCC------CcEEEEEEeccchHHHH-----------HHHHHHHHHHHhcCCCccc
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSD------GTTVAIKIFNLQLEQAF-----------RSFNSECEVLRNVRHRNLI 350 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv 350 (581)
...++|++.+.||+|+||.||+|.+.+ ++.||+|++........ .....|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 345689999999999999999999753 47899999876542111 1233456667777899999
Q ss_pred eEeeeeecC----CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec-
Q 008012 351 KILSSCCNT----NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD- 425 (581)
Q Consensus 351 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~- 425 (581)
++++++... ...++||||+ +++|.+++......+++..++.++.||+.||+||| +.||+||||||+|||++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence 999998764 4589999999 99999999987777899999999999999999999 88999999999999999
Q ss_pred -CCCcEEEeeccCceecCCCCCcc-----eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Q 008012 426 -ENMVAHVSDFGISKLLGEGDDSV-----IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG 499 (581)
Q Consensus 426 -~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~ 499 (581)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999998764322111 113345999999999999999999999999999999999999999864332
Q ss_pred cccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 500 EMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
. .............+..+.+..+ ....++.++.+++..||..||++||+++++++.|+++.++...
T Consensus 268 ~-~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 268 P-KYVRDSKIRYRENIASLMDKCF--------PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp H-HHHHHHHHHHHHCHHHHHHHHS--------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred H-HHHHHHHHHhhhhHHHHHHHhc--------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 2 1121122111111111111100 0023467899999999999999999999999999999876543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=357.73 Aligned_cols=269 Identities=25% Similarity=0.323 Sum_probs=214.4
Q ss_pred hcCCCcCCeecccccccEEEEEe-----CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeee--cCCee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGIL-----SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC--NTNFK 362 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 362 (581)
.++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++. +.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36789999999999999999984 368899999998877777788999999999999999999999886 45678
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+++++|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999999876556899999999999999999999 8999999999999999999999999999999875
Q ss_pred CCCCcc-eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc----------ccHHHHHHhhC
Q 008012 443 EGDDSV-IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE----------MNLKNWVKESL 511 (581)
Q Consensus 443 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~----------~~~~~~~~~~~ 511 (581)
...... ......++..|+|||++.+..++.++||||||+++|+|++|+.||....... ...........
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 433322 2233467888999999988889999999999999999999999986532110 00001000000
Q ss_pred CCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHhh
Q 008012 512 PHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLED 575 (581)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 575 (581)
.. .....+..+++.+.+++.+||+.||++|||++|++++|+.+.......
T Consensus 259 ~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 259 EG--------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp TT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred cc--------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 00 001112245667899999999999999999999999999997765543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=357.22 Aligned_cols=252 Identities=24% Similarity=0.309 Sum_probs=206.0
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCe
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNF 361 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 361 (581)
....++|++.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+..|..+++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445688999999999999999999975 78999999997653 22345678899999887 99999999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
.|+||||++||+|.+++...+. +++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999999987543 789999999999999999999 899999999999999999999999999999864
Q ss_pred CCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ..++.
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~-~~~p~---- 239 (345)
T 1xjd_A 169 MLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDN-PFYPR---- 239 (345)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC-CCCCT----
T ss_pred ccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHhCC-CCCCc----
Confidence 32221 23456799999999999999999999999999999999999999976322 11222222111 11111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHH-HHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMK-DAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 564 (581)
.++..+.++|.+||..||++||++. |+++|
T Consensus 240 -------------~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 240 -------------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp -------------TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -------------ccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 1345678999999999999999998 77654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=343.31 Aligned_cols=263 Identities=21% Similarity=0.334 Sum_probs=212.3
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCC----CcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSD----GTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
...++|++.+.||+|+||.||+|.+.. +..||+|++... .....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence 346789999999999999999998542 346999998765 344567899999999999999999999998654 56
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+++++|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+....
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 8999999999999999877666899999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
.... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... .....+........+
T Consensus 165 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~~~~~~~~----- 236 (281)
T 3cc6_A 165 DEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEKGDRLPKP----- 236 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHHTCCCCCC-----
T ss_pred cccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhcCCCCCCC-----
Confidence 3221 12234457889999999988899999999999999999998 99999753222 223333322211111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
..+++.+.+++.+||+.||++|||+.|++++|+++.+...+
T Consensus 237 ------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 237 ------------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp ------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ------------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 12345688999999999999999999999999999876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=362.84 Aligned_cols=269 Identities=19% Similarity=0.240 Sum_probs=208.8
Q ss_pred HhhcCCCcCCeeccc--ccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 288 RATDGFNECNLLGSG--GFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G--~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
...++|++.+.||+| +||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 446789999999999 99999999976 79999999997653 45567888999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 363 ALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
++||||+++|+|.+++... ...+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||.+...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999999865 345799999999999999999999 899999999999999999999999999998754
Q ss_pred CCCCC-----cceeeccccCccccCCCCCCC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC
Q 008012 442 GEGDD-----SVIQTMTIATIGYMAPEFGSE--GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG 514 (581)
Q Consensus 442 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 514 (581)
..... ........|++.|+|||++.+ ..++.++|||||||++|||++|+.||........ .........+
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~-- 255 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVP-- 255 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH-HHHC--------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHhcCCCC--
Confidence 32211 111223468899999998887 6799999999999999999999999976432221 1111111110
Q ss_pred CCcccccc-------------------------------chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 008012 515 LPKIADAN-------------------------------LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAAT 563 (581)
Q Consensus 515 ~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 563 (581)
...+.. ........+....+++.+.+||.+||+.||++|||++|+++
T Consensus 256 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 256 --CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000000 00000111223345677999999999999999999999998
Q ss_pred H
Q 008012 564 K 564 (581)
Q Consensus 564 ~ 564 (581)
|
T Consensus 334 h 334 (389)
T 3gni_B 334 H 334 (389)
T ss_dssp S
T ss_pred C
Confidence 7
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=348.45 Aligned_cols=267 Identities=22% Similarity=0.311 Sum_probs=205.5
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3467999999999999999999964 7999999998753 34556788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 365 VLEFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
||||+++++|.+++.. ....+++..++.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999974 3455789999999999999999999 899999999999999999999999999999866
Q ss_pred CCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
..... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.............+.. ...+....
T Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~- 260 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ---CDYPPLPS- 260 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT---TCSCCCCT-
T ss_pred cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc---ccCCCCcc-
Confidence 43221 2234468999999999999999999999999999999999999997532222222222221 11111110
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHhhc
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDA 576 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~ 576 (581)
..++..+.+++.+||+.||++|||+.++++.|+++.+...++-
T Consensus 261 ------------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 261 ------------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp ------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred ------------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 1234568899999999999999999999999999998876653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=352.30 Aligned_cols=265 Identities=25% Similarity=0.418 Sum_probs=214.4
Q ss_pred hcCC-CcCCeecccccccEEEEEeC-----CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeec--CC
Q 008012 290 TDGF-NECNLLGSGGFGSVYKGILS-----DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCN--TN 360 (581)
Q Consensus 290 ~~~y-~~~~~lg~G~~~~v~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 360 (581)
.++| ++++.||+|+||.||++.+. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+ ..
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 3455 89999999999999988642 68899999998653 4556779999999999999999999999987 46
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..++||||+++++|.+++.... +++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++..
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred eEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 7899999999999999998764 789999999999999999999 89999999999999999999999999999998
Q ss_pred cCCCCCc-ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccc----------c---HHHH
Q 008012 441 LGEGDDS-VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM----------N---LKNW 506 (581)
Q Consensus 441 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~----------~---~~~~ 506 (581)
....... .......++..|+|||++.+..++.++||||||+++|+|++|+.||........ . ....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 7544322 123345678889999999988999999999999999999999999865321100 0 0001
Q ss_pred HHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHhhc
Q 008012 507 VKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDA 576 (581)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~ 576 (581)
+..... ...+..++..+.++|.+||+.||++|||++|+++.|+++.+++..+.
T Consensus 264 ~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 264 LERGER-----------------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp HHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred HhcccC-----------------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 111100 01122355678999999999999999999999999999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=354.88 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=204.5
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcE----EEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTT----VAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.++|++.+.||+|+||.||+|.+. +++. |++|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 468999999999999999999954 5554 467766433 2234467889999999999999999999998765 78
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+|+||+++|+|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999999987777899999999999999999999 89999999999999999999999999999987754
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
...........+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+........+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~~~~~~~~~------ 241 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP------ 241 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCCCCCC------
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCCCCC------
Confidence 444333444567889999999999999999999999999999999 9999976422 2333333332211111
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
..++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 242 -----------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 242 -----------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 12345688999999999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=361.16 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=200.5
Q ss_pred hcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcC--CCccceEeeeeecCCeeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVR--HRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv 365 (581)
.++|++.+.||+|+||.||+|...+++.||||++... .....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 4569999999999999999999888999999998654 3455678999999999996 59999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|| +.+++|.+++.... .+++..++.++.||+.||.||| +.||+||||||+|||++ ++.+||+|||++..+....
T Consensus 135 ~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred Ee-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 99 56889999998765 4788899999999999999999 89999999999999995 5899999999998765443
Q ss_pred CcceeeccccCccccCCCCCCC-----------CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC
Q 008012 446 DSVIQTMTIATIGYMAPEFGSE-----------GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG 514 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 514 (581)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+...+.......
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 3333445679999999998754 46889999999999999999999999764322222222222111111
Q ss_pred CCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 515 LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+.. .+..+.++|.+||..||++|||+.|++++
T Consensus 289 ~~~~-----------------~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 289 FPDI-----------------PEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCC-----------------SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCcc-----------------chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111 13457899999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=351.47 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=205.1
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc---hHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 364 (581)
.++|++.+.||+|+||.||+|+.+ +++.||+|+++.. .....+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467899999999999999999965 7899999999765 244556788999999998 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+++|+|.+++...+ .+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999999998654 3789999999999999999999 899999999999999999999999999999864322
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc----cc---HHHHHHhhCCCCCCc
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE----MN---LKNWVKESLPHGLPK 517 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~----~~---~~~~~~~~~~~~~~~ 517 (581)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ....+... ...++
T Consensus 164 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p- 239 (345)
T 3a8x_A 164 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIP- 239 (345)
T ss_dssp TC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CCCCC-
T ss_pred CC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CCCCC-
Confidence 21 2345579999999999999999999999999999999999999996532111 11 11111111 11111
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCH------HHHHHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYM------KDAATK 564 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~ 564 (581)
..++..+.++|.+||+.||++||++ +|+++|
T Consensus 240 ----------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 240 ----------------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ----------------TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ----------------CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1234568899999999999999996 677665
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=346.89 Aligned_cols=252 Identities=26% Similarity=0.410 Sum_probs=195.7
Q ss_pred hhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchH----HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLE----QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|++.+.||+|+||.||+|.+. ++.||+|+++.... ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 3568999999999999999999986 89999999876532 224678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---ceecCCCCCCeEecC--------CCcEEEe
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP---VVHCDLKPSNILLDE--------NMVAHVS 433 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~---i~H~dikp~Nill~~--------~~~~kl~ 433 (581)
||||+++++|.+++... .+++..++.++.|++.||+||| +.| |+||||||+||+++. ++.+||+
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 99999999999998643 4789999999999999999999 677 999999999999986 7789999
Q ss_pred eccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 008012 434 DFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH 513 (581)
Q Consensus 434 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 513 (581)
|||.+....... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||........ ...........
T Consensus 159 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~ 233 (271)
T 3dtc_A 159 DFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-AYGVAMNKLAL 233 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-HHHHHTSCCCC
T ss_pred cCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHhhhcCCCCC
Confidence 999998654322 2244689999999999888999999999999999999999999976422111 11111111111
Q ss_pred CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 514 GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
.. +..+++.+.+++.+||+.||++|||+.|++++|+++
T Consensus 234 ~~-----------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 234 PI-----------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CC-----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CC-----------------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11 113345688999999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=358.50 Aligned_cols=268 Identities=24% Similarity=0.382 Sum_probs=217.4
Q ss_pred hhhhHHHhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEee
Q 008012 282 SYLDLERATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILS 354 (581)
Q Consensus 282 ~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~ 354 (581)
...+++...++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|++++++++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 34456677889999999999999999999854 46889999997553 344567889999999999999999999
Q ss_pred eeecCCeeeEEEeccCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec
Q 008012 355 SCCNTNFKALVLEFMPNGSLDKWLYSHN---------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD 425 (581)
Q Consensus 355 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~ 425 (581)
++.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||+||| ++||+||||||+||+++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEc
Confidence 9999999999999999999999998532 34688999999999999999999 88999999999999999
Q ss_pred CCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHH
Q 008012 426 ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLK 504 (581)
Q Consensus 426 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~ 504 (581)
.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... ...
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~ 250 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVL 250 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HHH
Confidence 999999999999986643332222233456889999999988899999999999999999999 89998763221 122
Q ss_pred HHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 505 NWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
..+... .... .+..++..+.+++.+||+.||++|||+.|++++|+++...
T Consensus 251 ~~~~~~---~~~~--------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 251 RFVMEG---GLLD--------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHHHTT---CCCC--------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHcC---CcCC--------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 222211 1111 0113455688999999999999999999999999887543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=352.74 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=206.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CC-------cEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DG-------TTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF 361 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 361 (581)
.++|++.+.||+|+||.||+|... ++ ..||+|++........+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467899999999999999999855 33 4799999987766666789999999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc--------EEEe
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV--------AHVS 433 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~--------~kl~ 433 (581)
.++||||+++++|.+++......+++..++.++.||+.||+||| ++||+||||||+||+++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999999987766899999999999999999999 899999999999999998876 9999
Q ss_pred eccCceecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 008012 434 DFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLP 512 (581)
Q Consensus 434 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 512 (581)
|||.+..... .....+++.|+|||++.+ ..++.++||||||+++|||++|..|+........ ....... .
T Consensus 164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~--~ 234 (289)
T 4fvq_A 164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYED--R 234 (289)
T ss_dssp CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHT--T
T ss_pred cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhc--c
Confidence 9999875422 123457889999998877 6799999999999999999996555433222111 1111111 1
Q ss_pred CCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 513 HGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
...+.. .+..+.+++.+||+.||++|||++|++++|+++....
T Consensus 235 ~~~~~~-----------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 235 HQLPAP-----------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp CCCCCC-----------------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred CCCCCC-----------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 111111 1234679999999999999999999999999886543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=362.88 Aligned_cols=264 Identities=23% Similarity=0.280 Sum_probs=212.5
Q ss_pred chhhhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH---HHHHHHHHHHHHHHhcCCCccceEeeee
Q 008012 281 TSYLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVRHRNLIKILSSC 356 (581)
Q Consensus 281 ~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 356 (581)
..+.+.+...++|++.+.||+|+||.||+|+.+ +|+.||+|++++... ...+.+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345566677899999999999999999999975 799999999976432 2234578899999999999999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeecc
Q 008012 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 357 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
.+.+..|+||||++||+|.+++.+.+..+++..++.++.||+.||+||| +.||+||||||+|||++.++.+||+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999999876666899999999999999999999 8999999999999999999999999999
Q ss_pred CceecCCCCCcceeeccccCccccCCCCCC-------CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 008012 437 ISKLLGEGDDSVIQTMTIATIGYMAPEFGS-------EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKE 509 (581)
Q Consensus 437 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~ 509 (581)
+++....... .......||+.|+|||++. +..++.++|||||||++|||++|+.||...... ..+...+..
T Consensus 208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~ 285 (412)
T 2vd5_A 208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-ETYGKIVHY 285 (412)
T ss_dssp TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTH
T ss_pred hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhc
Confidence 9987644322 2223457999999999876 457899999999999999999999999763221 112222211
Q ss_pred hCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCC---CCHHHHHHH
Q 008012 510 SLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQR---LYMKDAATK 564 (581)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~evl~~ 564 (581)
.....++. ....++.++.++|.+||. +|++| |+++|+++|
T Consensus 286 ~~~~~~p~--------------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 286 KEHLSLPL--------------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHCCCC------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ccCcCCCc--------------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 10001110 011345678899999999 99998 589999876
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=349.89 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=198.3
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH--------------------------HHHHHHHHHHHHHH
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE--------------------------QAFRSFNSECEVLR 342 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 342 (581)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999965 789999999865431 12356889999999
Q ss_pred hcCCCccceEeeeeec--CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 008012 343 NVRHRNLIKILSSCCN--TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPS 420 (581)
Q Consensus 343 ~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~ 420 (581)
+++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..++.++.||+.||+||| +.||+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence 9999999999999986 5688999999999999886543 34799999999999999999999 889999999999
Q ss_pred CeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCC---CCccccHHHHHHHHHHHHhCCCCCCccc
Q 008012 421 NILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGN---VSSKCDVYSYGILLLETFTRKKPTDEMF 497 (581)
Q Consensus 421 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~vl~el~tg~~Pf~~~~ 497 (581)
||+++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999987653322 234457999999999987765 4788999999999999999999997532
Q ss_pred cccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 498 TGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
. ......+..... ..+. ...+++.+.++|.+||+.||++|||++|+++|
T Consensus 245 ~--~~~~~~~~~~~~-~~~~---------------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 I--MCLHSKIKSQAL-EFPD---------------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp H--HHHHHHHHHCCC-CCCS---------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred H--HHHHHHHhcccC-CCCC---------------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1 111111111110 1110 01234568899999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=351.23 Aligned_cols=264 Identities=27% Similarity=0.440 Sum_probs=208.9
Q ss_pred hhcCCCcCCeecccccccEEEEEeCC-----CcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILSD-----GTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
..++|++.+.||+|+||.||+|.... +..||+|+++... ......+.+|++++++++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 34677888999999999999998542 2359999997653 34456789999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+++++|.+++......+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999999987677899999999999999999999 8899999999999999999999999999998764
Q ss_pred CCCCc-ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 443 EGDDS-VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 443 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
..... .......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+........
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~~~~~~~~----- 271 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAINDGFRLPT----- 271 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCCCC-----
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHCCCcCCC-----
Confidence 33221 11223346788999999998899999999999999999999 99999764221 12222222111110
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
+..++..+.+++.+||+.||++||++.|++++|+++......
T Consensus 272 ------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 272 ------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp ------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred ------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 113455688999999999999999999999999998875543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=348.08 Aligned_cols=265 Identities=23% Similarity=0.392 Sum_probs=211.3
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCC----CcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeee-cCCe
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSD----GTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCC-NTNF 361 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 361 (581)
....+|++.+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.++++++||||+++++++. ..+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 345678899999999999999998542 235899998754 3455678999999999999999999999864 5567
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
.++||||+++++|.+++......+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++...
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 89999999999999999887777899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCC--cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 442 GEGDD--SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 442 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
..... ........+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.... . ......+........+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~-- 254 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-T-FDITVYLLQGRRLLQP-- 254 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-T-TTHHHHHHTTCCCCCC--
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC-H-HHHHHHHhcCCCCCCC--
Confidence 43221 112334467889999999998899999999999999999999 556665432 2 2222222222211111
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
..++..+.+++.+||+.||++|||++|+++.|+++.+.+..
T Consensus 255 ---------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 255 ---------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp ---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred ---------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 12345688999999999999999999999999999887654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=375.26 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=216.0
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.++...++|++.+.||+|+||.||+|.++ ++..||||+++.... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 34445677899999999999999999976 588999999976532 2467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 364 LVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
+||||+++|+|.+++... ...+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||++....
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999999864 345789999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
... ........++..|+|||++.+..++.++|||||||++|||+| |..||..... ......+.......
T Consensus 370 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~------- 439 (495)
T 1opk_A 370 GDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKDYRME------- 439 (495)
T ss_dssp TCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCCCC-------
T ss_pred CCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCC-------
Confidence 322 112233446788999999998899999999999999999999 9999976432 22333333222111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
.+..+++.+.++|.+||+.||++|||+.++++.|+.+.
T Consensus 440 ----------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 440 ----------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11234567889999999999999999999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=353.90 Aligned_cols=246 Identities=22% Similarity=0.272 Sum_probs=206.8
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH---HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
.++|++.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999965 799999999976532 2345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+++|+|.+++.+.+. +++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EcCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999999999999987554 789999999999999999999 899999999999999999999999999999876432
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ..++
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~-~~~p--------- 258 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSGK-VRFP--------- 258 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC-CCCC---------
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--HHHHHHHHcCC-CCCC---------
Confidence 2345689999999999999999999999999999999999999976321 11222122111 1111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLY-----MKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 564 (581)
..++..+.++|.+||+.||++||+ ++|+++|
T Consensus 259 --------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 259 --------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 123456889999999999999998 8888876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=363.59 Aligned_cols=261 Identities=19% Similarity=0.261 Sum_probs=211.2
Q ss_pred hhhhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHH---HHHHHHHHHHHHHhcCCCccceEeeeee
Q 008012 282 SYLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQ---AFRSFNSECEVLRNVRHRNLIKILSSCC 357 (581)
Q Consensus 282 ~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 357 (581)
...+++...++|++.+.||+|+||.||+|+.+ +++.||+|+++..... ..+.+.+|+.+++.++||||+++++++.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34566677889999999999999999999966 7899999999764321 1234778999999999999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccC
Q 008012 358 NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGI 437 (581)
Q Consensus 358 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 437 (581)
+.+..|+||||++||+|.+++.... +++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~~--~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999999998653 688999999999999999999 89999999999999999999999999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCC----CCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGN----VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH 513 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 513 (581)
++...... ........||+.|+|||++.+.. ++.++|||||||++|||++|++||...... .....+.......
T Consensus 215 a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 215 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHKNSL 292 (410)
T ss_dssp CEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHHHC
T ss_pred eEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-hHHHHHHhccccc
Confidence 98764332 22234567999999999887655 789999999999999999999999763211 1122222111111
Q ss_pred CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 008012 514 GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQ--RLYMKDAATK 564 (581)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 564 (581)
..+. ...++..+.+||.+||..+|++ ||+++||++|
T Consensus 293 ~~p~---------------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 TFPD---------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCT---------------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cCCC---------------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1111 1123456889999999999998 9999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=342.29 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=208.5
Q ss_pred hhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecC--CeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT--NFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 364 (581)
..++|++.+.||+|+||.||+|.+. ++.||+|+++... ....+.+.+|+.++++++||||+++++++.+. +..++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 3567999999999999999999986 8999999997653 44557799999999999999999999999887 78899
Q ss_pred EEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 365 VLEFMPNGSLDKWLYSHNY-FQDIPDRLNIMIDVALALEYLHHGHSTP--VVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
||||+++|+|.+++..... .+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999987653 4799999999999999999999 888 999999999999999999999999987643
Q ss_pred CCCCCcceeeccccCccccCCCCCCCCCCCc---cccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSEGNVSS---KCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
.. ....+|+.|+|||++.+..++. ++||||||+++|||++|+.||....... ..............+
T Consensus 164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~-- 233 (271)
T 3kmu_A 164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-IGMKVALEGLRPTIP-- 233 (271)
T ss_dssp SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-HHHHHHHSCCCCCCC--
T ss_pred cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-HHHHHHhcCCCCCCC--
Confidence 22 2346799999999988765554 7999999999999999999997642221 111111111111111
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
..+++.+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 234 ---------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 234 ---------------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1234568899999999999999999999999998864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=374.56 Aligned_cols=264 Identities=23% Similarity=0.405 Sum_probs=215.7
Q ss_pred hhHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 284 LDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 284 ~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
..++...++|++.+.||+|+||.||+|.++++..||||+++.... ..+.+.+|++++++++||||+++++++. .+..+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 344566788999999999999999999998889999999986532 3467899999999999999999999986 56789
Q ss_pred EEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 364 LVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
+||||+++|+|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 9999999999999998542 34788999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
... ........++..|+|||++.+..++.++|||||||++|||+| |+.||...... .....+.......
T Consensus 336 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~~------- 405 (454)
T 1qcf_A 336 DNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRMP------- 405 (454)
T ss_dssp CHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHTCCCC-------
T ss_pred CCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCC-------
Confidence 221 111223346788999999988899999999999999999999 99999764221 2222222221111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
.+..+++.+.++|.+||+.||++|||+++|++.|+++....
T Consensus 406 ----------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 406 ----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred ----------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 11235667899999999999999999999999999886543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=356.85 Aligned_cols=255 Identities=21% Similarity=0.256 Sum_probs=198.0
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
...++|++.+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 34578999999999999999999976 899999999976432 1246789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc--EEEeeccCceecCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV--AHVSDFGISKLLGEG 444 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~--~kl~Dfg~a~~~~~~ 444 (581)
||+++|+|.+++...+. +++..++.++.|++.||+||| ++||+||||||+||+++.++. +||+|||+++.....
T Consensus 96 e~~~~~~L~~~l~~~~~-~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 96 EYASGGELYERICNAGR-FSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp ECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EeCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999999976543 789999999999999999999 899999999999999987765 999999999753222
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSK-CDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... ......+..........
T Consensus 172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~------ 241 (361)
T 3uc3_A 172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-RDYRKTIQRILSVKYSI------ 241 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C-CCHHHHHHHHHTTCCCC------
T ss_pred C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-HHHHHHHHHHhcCCCCC------
Confidence 1 2234569999999999888777655 89999999999999999999864322 23333333322211110
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+....+++.+.+||.+||..||++|||+.|+++|
T Consensus 242 -------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 -------PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0001234567899999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=349.66 Aligned_cols=266 Identities=23% Similarity=0.272 Sum_probs=212.6
Q ss_pred HhhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeee----cCCee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC----NTNFK 362 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~ 362 (581)
...++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++. .....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 4457899999999999999999996 479999999997776667788999999999999999999999986 34478
Q ss_pred eEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 363 ALVLEFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
++||||+++++|.+++.. .+..+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 999999999999999985 3556899999999999999999999 8899999999999999999999999999987
Q ss_pred ecCCCCCcc-------eeeccccCccccCCCCCCCCC---CCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 008012 440 LLGEGDDSV-------IQTMTIATIGYMAPEFGSEGN---VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKE 509 (581)
Q Consensus 440 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~ 509 (581)
......... ......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||.............+..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 262 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence 653211100 012335799999999887654 6889999999999999999999997543333333332222
Q ss_pred hCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 510 SLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
... .+. ...++..+.+++.+||+.||++|||++|++++|+++....+
T Consensus 263 ~~~--~~~---------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 263 QLS--IPQ---------------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp C----CCC---------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred cCC--CCc---------------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 111 000 11234568899999999999999999999999998864433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=353.44 Aligned_cols=275 Identities=26% Similarity=0.424 Sum_probs=216.0
Q ss_pred hcCCCcCCeecccccccEEEEEe-----CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC--ee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGIL-----SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN--FK 362 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 362 (581)
.++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46788999999999999999983 368999999998776666778999999999999999999999986644 78
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+++++|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999999987767899999999999999999999 8999999999999999999999999999998875
Q ss_pred CCCCcc-eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 443 EGDDSV-IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 443 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
...... ......++..|+|||.+.+..++.++||||||+++|||+||..||...... +...............
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~------~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------FMRMIGNDKQGQMIVF 270 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH------HHHHHCTTCCTHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH------HHHhhccccchhhhHH
Confidence 443221 122345677899999998888999999999999999999999997642110 0000000000000000
Q ss_pred cc---hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 522 NL---LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 522 ~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
.+ .......+.+..++..+.++|.+||+.||++|||+.|+++.|+++++++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 00 00000001122456678999999999999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=352.14 Aligned_cols=267 Identities=23% Similarity=0.314 Sum_probs=192.3
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.++|++.+.||+|+||.||+|..+ +|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999965 78999999987553 2223567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 368 FMPNGSLDKWLYSHN-----YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
|++ ++|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999987532 34789999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC--C-CCcc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH--G-LPKI 518 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--~-~~~~ 518 (581)
.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+.......... . .+..
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCTTTCGGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHhhhh
Confidence 3322 1234568999999998876 46899999999999999999999999764322 1222222111100 0 0000
Q ss_pred cc-------------ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 AD-------------ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.. ..+.. .........++..+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQ-VLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHH-HHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhcccccccccchhHHH-hhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00 00000 00000111345678999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=350.30 Aligned_cols=263 Identities=23% Similarity=0.395 Sum_probs=209.5
Q ss_pred hcCCCcCCeecccccccEEEEEe-----CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecC--Ce
Q 008012 290 TDGFNECNLLGSGGFGSVYKGIL-----SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT--NF 361 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 361 (581)
.+.|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+. +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35588899999999999999983 368999999997553 22346788999999999999999999999876 66
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
.++||||+++++|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 89999999999999999876666899999999999999999999 899999999999999999999999999999887
Q ss_pred CCCCCc-ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccc----------ccccHHHHHHhh
Q 008012 442 GEGDDS-VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFT----------GEMNLKNWVKES 510 (581)
Q Consensus 442 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~----------~~~~~~~~~~~~ 510 (581)
...... .......++..|+|||++.+..++.++||||||+++|+|++|..|+..... ............
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 544322 223345678889999999888999999999999999999999998654211 011111111111
Q ss_pred CCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 511 LPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
.... ....+..+++.+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 257 ~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEGK--------------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTC--------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccC--------------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000 00111245567899999999999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=352.42 Aligned_cols=264 Identities=22% Similarity=0.353 Sum_probs=210.7
Q ss_pred HhhcCCCcCCeecccccccEEEEEe------CCCcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGIL------SDGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN 360 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 360 (581)
...++|++.+.||+|+||.||+|.+ .+++.||+|++... .......+.+|+.++++++||||+++++++.+.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 3457899999999999999999983 25778999999654 3445567889999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC---CCcEE
Q 008012 361 FKALVLEFMPNGSLDKWLYSHN------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE---NMVAH 431 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~---~~~~k 431 (581)
..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.||+||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999998654 34788999999999999999999 899999999999999984 45699
Q ss_pred EeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhh
Q 008012 432 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKES 510 (581)
Q Consensus 432 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 510 (581)
|+|||++................+++.|+|||++.+..++.++||||||+++|+|+| |+.||..... ......+...
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~ 261 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSG 261 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTT
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHHHhcC
Confidence 999999986543333333345567899999999988899999999999999999998 9999876321 1222222222
Q ss_pred CCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 511 LPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
.....+ ..++..+.+++.+||+.||++|||+.|++++|+.+.....
T Consensus 262 ~~~~~~-----------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 262 GRMDPP-----------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp CCCCCC-----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred CCCCCC-----------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 111111 1234568899999999999999999999999999876554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=342.95 Aligned_cols=254 Identities=22% Similarity=0.353 Sum_probs=209.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999975 78999999987543 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++++|.+++.... .+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+.........
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999999987654 3789999999999999999999 899999999999999999999999999999876433322
Q ss_pred ceeeccccCccccCCCCCCCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNV-SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.......|++.|+|||++.+..+ +.++||||||+++|+|++|+.||............+...... .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~----------- 228 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--L----------- 228 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--S-----------
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--c-----------
Confidence 22345578999999999887665 779999999999999999999998754333333332221100 0
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.....++..+.+++.+||+.||++|||++|++++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0112345568899999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=340.99 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=208.5
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999965 78999999996653 44557788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc---EEEeeccCceecC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV---AHVSDFGISKLLG 442 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~---~kl~Dfg~a~~~~ 442 (581)
|||+++++|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++. +||+|||.+....
T Consensus 84 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999999888664 3789999999999999999999 899999999999999986655 9999999998764
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
.... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+....... +.
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~-~~----- 228 (284)
T 3kk8_A 160 DSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDY-PS----- 228 (284)
T ss_dssp SSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCC-CT-----
T ss_pred cCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--hHHHHHHHhccccC-Cc-----
Confidence 3322 2345789999999999999999999999999999999999999976322 11222222211111 00
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+....+++.+.+++.+||+.||++|||+.|++++
T Consensus 229 --------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 229 --------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp --------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0011334568899999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=346.08 Aligned_cols=266 Identities=23% Similarity=0.386 Sum_probs=214.6
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
+++...++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+ +..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 34555678999999999999999999988888999999876532 23578899999999999999999999864 56899
Q ss_pred EEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 365 VLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
||||+++++|.+++.... ..+++..++.++.|++.||+||| +.||+||||||+||++++++.+||+|||.+.....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999999997542 24789999999999999999999 89999999999999999999999999999987754
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
... .......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+........
T Consensus 162 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~------- 231 (279)
T 1qpc_A 162 NEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRMVR------- 231 (279)
T ss_dssp SCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCCCC-------
T ss_pred ccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcccCCCC-------
Confidence 321 12233456788999999988889999999999999999999 99999763221 12222222111111
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHhh
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLED 575 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 575 (581)
+..++..+.+++.+||+.||++|||++++++.|+++.......
T Consensus 232 ----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 232 ----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred ----------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 1134457889999999999999999999999999998765543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=359.95 Aligned_cols=263 Identities=23% Similarity=0.385 Sum_probs=203.4
Q ss_pred cCCCcCCeecccccccEEEEEeC--C--CcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeec-CCeeeE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS--D--GTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCN-TNFKAL 364 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 364 (581)
..|++.+.||+|+||.||+|.+. + +..||+|.++.. .....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34677789999999999999853 2 246899998654 34556789999999999999999999998754 567899
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+++|+|.+++......+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999999987777899999999999999999999 899999999999999999999999999999866432
Q ss_pred CCc--ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 445 DDS--VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 445 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
... .......+++.|+|||++.+..++.++|||||||++|||+| |.+||..... ......+........
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~--~~~~~~~~~~~~~~~------ 317 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGRRLLQ------ 317 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS--SCHHHHHHTTCCCCC------
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH--HHHHHHHHcCCCCCC------
Confidence 211 12233457789999999999999999999999999999999 6777765322 222222222211111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHhh
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLED 575 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 575 (581)
+..++..+.+++.+||+.||++|||++|++++|+++...+...
T Consensus 318 -----------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 318 -----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp -----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred -----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 1134557889999999999999999999999999998877644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=350.40 Aligned_cols=246 Identities=22% Similarity=0.219 Sum_probs=198.2
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 365 (581)
.++|++.++||+|+||+||+|... +++.||||++... ..........|+..+.++ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 467999999999999999999976 7999999998653 233334555666666665 899999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+ +++|.+++...+..+++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999 67999999887777899999999999999999999 8899999999999999999999999999998764322
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
......||+.|+|||++.+ .++.++|||||||++|||++|..|+... ..... ......+.
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~----~~~~~~~~-------- 271 (311)
T 3p1a_A 212 ---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQ----LRQGYLPP-------- 271 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHH----HTTTCCCH--------
T ss_pred ---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHH----HhccCCCc--------
Confidence 2334568999999998876 7999999999999999999997766432 11111 11111110
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.....+++.+.+++.+||+.||++|||++|++++
T Consensus 272 -----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 272 -----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1122456678999999999999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=356.01 Aligned_cols=260 Identities=21% Similarity=0.348 Sum_probs=200.0
Q ss_pred hhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe---
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF--- 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 361 (581)
..++|++.+.||+|+||.||+|.+ .+++.||+|+++.. .......+.+|++++++++||||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 467899999999999999999996 47899999999765 34455678999999999999999999999876543
Q ss_pred -eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 362 -KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 362 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
.++||||+++++|.+++...+. +++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++..
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred ccEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 4999999999999999986553 789999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCc-ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 441 LGEGDDS-VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 441 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
....... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||........ ....... ...+
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~---~~~~--- 238 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVRE---DPIP--- 238 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHC---CCCC---
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhcC---CCCC---
Confidence 6543222 223345689999999999999999999999999999999999999976422111 1111111 0000
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHH-HHHHh
Q 008012 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAAT-KLKKI 568 (581)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~-~L~~~ 568 (581)
.......++..+.+++.+||+.||++||++.++++ .+.+.
T Consensus 239 ---------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 ---------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ---------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 01111235667889999999999999997776654 44444
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=349.41 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=196.8
Q ss_pred hhcCCCcCCeecccccccEEEEEe----CCCcEEEEEEeccch----HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL----SDGTTVAIKIFNLQL----EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 360 (581)
..++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++++++||||+++++++.+.+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 357899999999999999999996 478999999997652 233456788999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..++||||+++++|.+++...+. +++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++..
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREGI-FMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEEeCCCCCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999986543 688999999999999999999 88999999999999999999999999999975
Q ss_pred cCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+.... ..++
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~-~~~p---- 241 (327)
T 3a62_A 171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--KTIDKILKCK-LNLP---- 241 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHTC-CCCC----
T ss_pred cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCC-CCCC----
Confidence 43222 1233457899999999999989999999999999999999999999763221 1111111111 1111
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
..++..+.++|.+||..||++|| ++.|+++|
T Consensus 242 -------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 242 -------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 12345688999999999999999 78888876
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=342.50 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=208.1
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
..++|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4567999999999999999999965 678999999977654455788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe---cCCCcEEEeeccCceecCCC
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~~~~~ 444 (581)
|+++++|.+++..... +++..++.++.|++.||+||| +.||+||||||+||++ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 87 LCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred ccCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999999987544 789999999999999999999 8999999999999999 78899999999999876543
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
. ......+++.|+|||++.+. ++.++||||||+++|+|++|+.||...... .....+...... .+
T Consensus 163 ~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~-~~-------- 227 (277)
T 3f3z_A 163 K---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EVMLKIREGTFT-FP-------- 227 (277)
T ss_dssp S---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCC-CC--------
T ss_pred c---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCCCC-CC--------
Confidence 2 22345689999999988764 899999999999999999999999764221 111111111110 00
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
......+++.+.+++.+||+.||++|||+.|++++
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 228 -----EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp -----HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -----chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112345678899999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=349.00 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=184.0
Q ss_pred CCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-CCccceEeeeeecCCeeeEEEeccCCCC
Q 008012 296 CNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKALVLEFMPNGS 373 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 373 (581)
.+.||+|+||.||+|..+ +++.||+|++..... ..+.+|+.+++.+. ||||+++++++.+.+..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME---ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGH---HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhhh---hhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999975 789999999976543 45678999999996 9999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC---cEEEeeccCceecCCCCCccee
Q 008012 374 LDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM---VAHVSDFGISKLLGEGDDSVIQ 450 (581)
Q Consensus 374 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~ 450 (581)
|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++ .+||+|||++........ ..
T Consensus 93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~ 166 (325)
T 3kn6_A 93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PL 166 (325)
T ss_dssp HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cc
Confidence 999998764 4799999999999999999999 89999999999999998665 899999999987643322 23
Q ss_pred eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHhhCCCCCCccccccchhhhh
Q 008012 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG--EMNLKNWVKESLPHGLPKIADANLLREEN 528 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 528 (581)
....+|+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+........... .
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-~---------- 235 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-F---------- 235 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-C----------
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-C----------
Confidence 3456899999999999999999999999999999999999999764321 11222222222221111 0
Q ss_pred hhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 529 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.......+++++.++|.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 011223456778999999999999999999999865
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=362.57 Aligned_cols=248 Identities=26% Similarity=0.379 Sum_probs=207.3
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH---HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 478999999999999999999976 899999999976532 2346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+++|+|.+++.+.+ .+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 99999999999998654 4799999999999999999999 8999999999999999999999999999998765432
Q ss_pred CcceeeccccCccccCCCCCCCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNV-SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ......+..... ..+
T Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~-~~p-------- 236 (476)
T 2y94_A 171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--PTLFKKICDGIF-YTP-------- 236 (476)
T ss_dssp ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--HHHHHHHHTTCC-CCC--------
T ss_pred ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--HHHHHHHhcCCc-CCC--------
Confidence 2234579999999999888765 6899999999999999999999976321 112222221111 011
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+++.+.++|.+||..||++|||++|+++|
T Consensus 237 ---------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 237 ---------QYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1234567899999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=343.42 Aligned_cols=263 Identities=24% Similarity=0.367 Sum_probs=212.3
Q ss_pred CCCcCCeecccccccEEEEEeC-CC---cEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee-eEE
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DG---TTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK-ALV 365 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv 365 (581)
.|...+.||+|+||.||+|.+. ++ ..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4566789999999999999853 22 379999987543 45567889999999999999999999999876655 999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+.+++|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999987777899999999999999999999 8899999999999999999999999999998654322
Q ss_pred C--cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 446 D--SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 446 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
. ........+++.|+|||.+.+..++.++||||||+++|+|++|..|+.... ........+........+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~------- 250 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLAQGRRLPQP------- 250 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHHHHTTCCCCCC-------
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHHhhcCCCCCCC-------
Confidence 1 112234467889999999999999999999999999999999665544322 222333333332221111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHhh
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLED 575 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 575 (581)
..+++.+.+++.+||+.||++|||++++++.|+++.+.+...
T Consensus 251 ----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 251 ----------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp ----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred ----------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 123456889999999999999999999999999998877544
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=353.33 Aligned_cols=250 Identities=22% Similarity=0.259 Sum_probs=205.6
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeee
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 363 (581)
..++|++.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4578999999999999999999976 58899999997653 22345678899999988 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||++||+|.+++...+. +++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999987544 789999999999999999999 89999999999999999999999999999986432
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... .++
T Consensus 174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~~~-~~p------- 241 (353)
T 2i0e_A 174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIMEHNV-AYP------- 241 (353)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC-CCC-------
T ss_pred CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHHHHHHHhCCC-CCC-------
Confidence 22 123455799999999999999999999999999999999999999976321 112222221111 111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLY-----MKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 564 (581)
..++.++.++|.+||..||++||+ ++|+++|
T Consensus 242 ----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 242 ----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ----------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ----------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 123456889999999999999995 5777765
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=356.18 Aligned_cols=261 Identities=23% Similarity=0.287 Sum_probs=205.5
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-----HHHHHHHHHHHHHHHhcCCCccceEeeeeec
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-----EQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 358 (581)
++....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45667788999999999999999999965 78899999987542 3445688999999999999999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHHhhC---------------------------------------CCCCCHHHHHHHHHHHHH
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSH---------------------------------------NYFQDIPDRLNIMIDVAL 399 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~ 399 (581)
.+..++||||+++|+|.+++... ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521 111256778899999999
Q ss_pred HHHHHhcCCCCCceecCCCCCCeEecCCC--cEEEeeccCceecCCCCC--cceeeccccCccccCCCCCCC--CCCCcc
Q 008012 400 ALEYLHHGHSTPVVHCDLKPSNILLDENM--VAHVSDFGISKLLGEGDD--SVIQTMTIATIGYMAPEFGSE--GNVSSK 473 (581)
Q Consensus 400 ~L~~LH~~~~~~i~H~dikp~Nill~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~ 473 (581)
||+||| +.||+||||||+||+++.++ .+||+|||++..+..... ........|++.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999 88999999999999998766 899999999987643221 122345579999999998865 678999
Q ss_pred ccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCC
Q 008012 474 CDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPD 553 (581)
Q Consensus 474 ~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 553 (581)
+|||||||++|||++|+.||...... .............. . +....+++.+.++|.+||..||+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~-----~----------~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA-DTISQVLNKKLCFE-----N----------PNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCTT-----S----------GGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHhcccccC-----C----------cccccCCHHHHHHHHHHcCCChh
Confidence 99999999999999999999764222 11222222111100 0 11123456788999999999999
Q ss_pred CCCCHHHHHHH
Q 008012 554 QRLYMKDAATK 564 (581)
Q Consensus 554 ~Rps~~evl~~ 564 (581)
+|||+.|++++
T Consensus 321 ~Rps~~~~l~h 331 (345)
T 3hko_A 321 ERFDAMRALQH 331 (345)
T ss_dssp TSCCHHHHHHS
T ss_pred HCCCHHHHhcC
Confidence 99999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=357.84 Aligned_cols=276 Identities=24% Similarity=0.327 Sum_probs=202.8
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeec-----CCee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN-----TNFK 362 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 362 (581)
...++|++.+.||+|+||.||+|+. +++.||||++........ ....|+..+..++||||+++++.+.. ....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~-~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNF-INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHH-HHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhH-HHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 3457899999999999999999987 489999999976543321 12234444455799999999985532 3367
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CceecCCCCCCeEecCCCcEEEe
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST---------PVVHCDLKPSNILLDENMVAHVS 433 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~---------~i~H~dikp~Nill~~~~~~kl~ 433 (581)
++||||+++|+|.+++..... ++..++.++.||+.||+||| +. ||+||||||+||+++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHTS--DWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCCB--CHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhhccc--chhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 899999999999999987654 88899999999999999999 77 99999999999999999999999
Q ss_pred eccCceecCCCCC------cceeeccccCccccCCCCCCC-------CCCCccccHHHHHHHHHHHHhCCCCCCcccccc
Q 008012 434 DFGISKLLGEGDD------SVIQTMTIATIGYMAPEFGSE-------GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500 (581)
Q Consensus 434 Dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~ 500 (581)
|||++..+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987653221 112234469999999998876 456778999999999999999977764422211
Q ss_pred cc-------------HHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 501 MN-------------LKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 501 ~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
.. ...+............... .......+++.+.++|.+||+.||++|||++|+++.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE-------AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT-------TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCc-------ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 10 0000000000000000000 011123466789999999999999999999999999999
Q ss_pred hHHHHHhhcc
Q 008012 568 IRDKFLEDAN 577 (581)
Q Consensus 568 ~~~~~~~~~~ 577 (581)
+...+....+
T Consensus 316 ll~~~~~~~~ 325 (336)
T 3g2f_A 316 LMMIWERNKS 325 (336)
T ss_dssp HHHCCCC---
T ss_pred HHHHHHhccc
Confidence 9988776554
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=347.08 Aligned_cols=277 Identities=22% Similarity=0.350 Sum_probs=219.8
Q ss_pred hhhhHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHh--cCCCccceEeeeeecC
Q 008012 282 SYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRN--VRHRNLIKILSSCCNT 359 (581)
Q Consensus 282 ~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~ 359 (581)
+........++|++.+.||+|+||.||+|... ++.||+|++..... ..+.+|.++++. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGGH---HHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchhH---HHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 34445566789999999999999999999985 89999999976543 456788999888 6899999999999877
Q ss_pred C----eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCCeEecCCCcE
Q 008012 360 N----FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG-----HSTPVVHCDLKPSNILLDENMVA 430 (581)
Q Consensus 360 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~i~H~dikp~Nill~~~~~~ 430 (581)
+ ..++||||+++|+|.+++.+.. +++..++.++.|++.||+|||.. ++.+|+||||||+||+++.++.+
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred CCccceeEEEEeecCCCcHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence 5 7899999999999999998753 68999999999999999999932 14789999999999999999999
Q ss_pred EEeeccCceecCCCCCcc--eeeccccCccccCCCCCCCC------CCCccccHHHHHHHHHHHHhC----------CCC
Q 008012 431 HVSDFGISKLLGEGDDSV--IQTMTIATIGYMAPEFGSEG------NVSSKCDVYSYGILLLETFTR----------KKP 492 (581)
Q Consensus 431 kl~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~vl~el~tg----------~~P 492 (581)
||+|||++.......... ......|++.|+|||++.+. .++.++|||||||++|||+|| ..|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765433221 22345789999999988765 334689999999999999999 788
Q ss_pred CCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 493 TDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 493 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
|............+................ ....+++..+.+++.+||+.||++|||+.|++++|+++.++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNR--------WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGG--------GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccccCcCcccHHHHHHHHHHHHhCCCCccc--------ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 877554444444444433222211111111 112356778999999999999999999999999999997653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=354.25 Aligned_cols=266 Identities=20% Similarity=0.288 Sum_probs=202.1
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHH-HHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQ-AFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999976 7899999999765432 122456799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
++ ++|.+++...+..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K 155 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence 97 5999999987777899999999999999999999 8999999999999999999999999999998654322 2
Q ss_pred eeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC----CCccccccc
Q 008012 449 IQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG----LPKIADANL 523 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 523 (581)
......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+....... ++.......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHhchhhhcchh
Confidence 2234568999999998776 57899999999999999999999999764222 2222222222111 111111100
Q ss_pred hh--------hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 524 LR--------EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 524 ~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.. ..........++..+.+++.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 000112223456778899999999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=344.81 Aligned_cols=269 Identities=23% Similarity=0.278 Sum_probs=202.0
Q ss_pred HhhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchH-----HHHHHHHHHHHHHHhc---CCCccceEeeeeec
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLE-----QAFRSFNSECEVLRNV---RHRNLIKILSSCCN 358 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~ 358 (581)
...++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+++++++ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467999999999999999999996 4799999999874321 1123455677777666 59999999999977
Q ss_pred CC-----eeeEEEeccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEE
Q 008012 359 TN-----FKALVLEFMPNGSLDKWLYSHNY-FQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHV 432 (581)
Q Consensus 359 ~~-----~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl 432 (581)
.. ..++||||++ ++|.+++..... .+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence 54 5799999997 599999986643 3799999999999999999999 899999999999999999999999
Q ss_pred eeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 008012 433 SDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLP 512 (581)
Q Consensus 433 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 512 (581)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|++||...... ............
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~ 237 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGL 237 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHHHHHHHCC
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence 9999998664322 234557899999999998899999999999999999999999999764222 222222222111
Q ss_pred CC---CCcccc---ccch--hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 513 HG---LPKIAD---ANLL--REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 513 ~~---~~~~~~---~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.. ++.... .... ..........++++.+.++|.+||+.||++|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 11 110000 0000 0000111223456778899999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=344.75 Aligned_cols=265 Identities=25% Similarity=0.385 Sum_probs=213.1
Q ss_pred HHhhcCCCcCC-eecccccccEEEEEe---CCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC
Q 008012 287 ERATDGFNECN-LLGSGGFGSVYKGIL---SDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN 360 (581)
Q Consensus 287 ~~~~~~y~~~~-~lg~G~~~~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 360 (581)
....++|.+.+ .||+|+||.||+|.+ .+++.||+|+++... ....+.+.+|++++++++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 33456788888 999999999999964 257889999997653 23456799999999999999999999999 566
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..++||||+++++|.+++..... +++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCcC-CCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 78999999999999999987643 789999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCCcc-eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 441 LGEGDDSV-IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 441 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ......+........+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~-- 242 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCP-- 242 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCCCCC--
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCCCC--
Confidence 75443322 1223346788999999988889999999999999999999 9999976422 2222222222111111
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHhh
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLED 575 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 575 (581)
..+++.+.+++.+||+.||++|||+.++++.|+++.......
T Consensus 243 ---------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 243 ---------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp ---------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred ---------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 134567889999999999999999999999999998877654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=343.45 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=187.6
Q ss_pred hhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHH---HHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQ---AFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|++.+.||+|+||.||+|.. .+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346799999999999999999996 47999999999765322 23678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+++++|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999999987677899999999999999999999 899999999999999999999999999999876432
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
.. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||........ ........ . .
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~---~---~-- 230 (278)
T 3cok_A 166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LNKVVLAD---Y---E-- 230 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCSSC---C---C--
T ss_pred CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HHHHhhcc---c---C--
Confidence 22 12335689999999999998999999999999999999999999976322110 11110000 0 0
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+..++..+.+++.+||+.||++|||+++++++
T Consensus 231 -------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 231 -------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -------CccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 011234568899999999999999999999885
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=342.30 Aligned_cols=267 Identities=17% Similarity=0.213 Sum_probs=209.9
Q ss_pred HhhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeee-ecCCeeeEE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC-CNTNFKALV 365 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv 365 (581)
...++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+|+++++.++|++++..+..+ ...+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3467899999999999999999996 4789999998765432 24578899999999888777666655 667788999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe---cCCCcEEEeeccCceecC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLG 442 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~~~ 442 (581)
|||+ +++|.+++......+++..++.++.||+.||+||| +.||+||||||+||++ +.++.+||+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 99999999976667899999999999999999999 8999999999999999 788999999999998775
Q ss_pred CCCCc-----ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccc--cHHHHHHhhCCCCC
Q 008012 443 EGDDS-----VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM--NLKNWVKESLPHGL 515 (581)
Q Consensus 443 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~~~~ 515 (581)
..... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||........ .............
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-
Confidence 43321 122345789999999999999999999999999999999999999976432211 1111111111000
Q ss_pred CccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
.......+++.+.+++.+||+.||++|||++++++.|+++..+...
T Consensus 239 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 239 -------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp -------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred -------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 0011123467799999999999999999999999999999887653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=346.51 Aligned_cols=265 Identities=22% Similarity=0.269 Sum_probs=202.6
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999975 69999999886543 344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++++|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+........
T Consensus 82 e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp ECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 9999999998887554 4789999999999999999999 89999999999999999999999999999987643322
Q ss_pred cceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc--------
Q 008012 447 SVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK-------- 517 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 517 (581)
......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||......+ ....+........+.
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 158 --YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD--QLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHTC
T ss_pred --ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhcccccccccccccc
Confidence 2234578999999998865 678999999999999999999999997643221 111111111110000
Q ss_pred -------cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 -------IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..++. ...........++..+.+++.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPE--DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCS--SCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCcc--ccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0000011112456678899999999999999999999976
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=357.98 Aligned_cols=269 Identities=23% Similarity=0.292 Sum_probs=197.0
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcC-CCccceEeeeeecCC--e
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVR-HRNLIKILSSCCNTN--F 361 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~ 361 (581)
...++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45688999999999999999999965 7999999998543 3445567889999999996 999999999997544 7
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
.|+||||++ ++|.+++... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+|+.+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 899999997 5999999874 4788999999999999999999 899999999999999999999999999999876
Q ss_pred CCCC-------------------CcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccc
Q 008012 442 GEGD-------------------DSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM 501 (581)
Q Consensus 442 ~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~ 501 (581)
.... .........||+.|+|||++.+ ..++.++|||||||++|||++|++||..... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~ 238 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST-MN 238 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-HH
Confidence 4311 1112334579999999998876 6789999999999999999999999976422 11
Q ss_pred cHHHHHHhhCCCCCCccc----cc---cchh---------------hh-------hhhhHHHHHHHHHHHHHHhccCcCC
Q 008012 502 NLKNWVKESLPHGLPKIA----DA---NLLR---------------EE-------NFFSARMDCLLSIFHLALDCCAELP 552 (581)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~----~~---~~~~---------------~~-------~~~~~~~~~~~~l~~li~~cl~~dP 552 (581)
.+...+ ........... .+ .... .. ........+++.+.+|+.+||..||
T Consensus 239 ~~~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 239 QLERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 222222 11111100000 00 0000 00 0000011346678999999999999
Q ss_pred CCCCCHHHHHHH
Q 008012 553 DQRLYMKDAATK 564 (581)
Q Consensus 553 ~~Rps~~evl~~ 564 (581)
++|||++|+++|
T Consensus 318 ~~R~t~~e~l~H 329 (388)
T 3oz6_A 318 NKRISANDALKH 329 (388)
T ss_dssp GGSCCHHHHTTS
T ss_pred ccCCCHHHHhCC
Confidence 999999999988
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=369.59 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=209.3
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
.++...++|++.+.||+|+||.||+|.++++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 34456678999999999999999999988778899999986532 23578999999999999999999999876 67899
Q ss_pred EEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 365 VLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
||||+++|+|.+++... +..+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 99999999999999853 345789999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+.......
T Consensus 333 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~~-------- 401 (452)
T 1fmk_A 333 NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYRMP-------- 401 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCCC--------
T ss_pred Cce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCC--------
Confidence 221 12233456789999999988899999999999999999999 99999764221 1222222211111
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
.+..+++.+.++|.+||+.||++|||++++++.|+.+...
T Consensus 402 ---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 402 ---------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1123556788999999999999999999999999987643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=338.72 Aligned_cols=249 Identities=24% Similarity=0.313 Sum_probs=203.9
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH---HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4578999999999999999999965 678999999866532 224568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+++++|.+++..... +++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 9999999999999986543 788999999999999999999 899999999999999999999999999998654322
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+.... ...+.
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~-~~~~~------- 228 (279)
T 3fdn_A 163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRISRVE-FTFPD------- 228 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTC-CCCCT-------
T ss_pred ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHHHHHHhCC-CCCCC-------
Confidence 123457899999999999999999999999999999999999999753211 1111111111 11111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
.++..+.+++.+||+.||++|||++|+++|-
T Consensus 229 ----------~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 229 ----------FVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp ----------TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred ----------cCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 2345678999999999999999999999973
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=350.29 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=200.4
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC------
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN------ 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 360 (581)
..++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467899999999999999999976 89999999997543 334577899999999999999999999985543
Q ss_pred ---------------------------------------------------eeeEEEeccCCCCHHHHHhhCCC--CCCH
Q 008012 361 ---------------------------------------------------FKALVLEFMPNGSLDKWLYSHNY--FQDI 387 (581)
Q Consensus 361 ---------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~--~~~~ 387 (581)
..++||||+++++|.+++..... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 37999999999999999986543 2355
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc----------ceeeccccCc
Q 008012 388 PDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS----------VIQTMTIATI 457 (581)
Q Consensus 388 ~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~~~~ 457 (581)
..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||++......... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 678999999999999999 899999999999999999999999999999987543221 1223456999
Q ss_pred cccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHH
Q 008012 458 GYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCL 537 (581)
Q Consensus 458 ~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (581)
.|+|||++.+..++.++|||||||++|||++|..|+... ............+ ......+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~~~~~~~~--------------~~~~~~~ 299 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITDVRNLKFP--------------LLFTQKY 299 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHHHHTTCCC--------------HHHHHHC
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHHhhccCCC--------------cccccCC
Confidence 999999999999999999999999999999998774321 1111111111111 1223445
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 538 LSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 538 ~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+.+.+++.+||+.||++|||++|++++
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 667899999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=345.61 Aligned_cols=264 Identities=20% Similarity=0.262 Sum_probs=203.3
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
...++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34578999999999999999999965 78999999997652 344577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+++++|.+++...+ .+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 111 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999999998754 3789999999999999999999 89999999999999999999999999999986643
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
... .......+++.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+....+. +.
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~--~~------ 255 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR--PS------ 255 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC--GG------
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC--cc------
Confidence 221 1223456899999999999999999999999999999999999999763221 111212111110 00
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-CHHHHHHHHHHhHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRL-YMKDAATKLKKIRDKFL 573 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~~~~~~~ 573 (581)
.....++..+.+++.+||+.||++|| +++++++.|+++.+...
T Consensus 256 -------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 256 -------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp -------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred -------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 01123455688999999999999999 99999999998865544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=347.89 Aligned_cols=253 Identities=20% Similarity=0.257 Sum_probs=208.0
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHH------HHHHHHHHHHHHHhcCCCccceEeeeeecCCe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQ------AFRSFNSECEVLRNVRHRNLIKILSSCCNTNF 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 361 (581)
..++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4567999999999999999999965 7899999998764311 24678899999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC----cEEEeeccC
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM----VAHVSDFGI 437 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~----~~kl~Dfg~ 437 (581)
.++||||+++++|.+++.... .+++..++.++.|++.||+||| +.||+||||||+||+++.++ .+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 999999999999999998654 4789999999999999999999 89999999999999999887 799999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
+........ .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+..... ..+
T Consensus 166 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~-~~~- 238 (321)
T 2a2a_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANITSVSY-DFD- 238 (321)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTCC-CCC-
T ss_pred ceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhccc-ccC-
Confidence 987654322 23456899999999999999999999999999999999999999763221 11111111110 000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
. .....++..+.+++.+||..||++|||+.|+++|
T Consensus 239 ---~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 239 ---E---------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ---H---------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ---h---------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 1112345678899999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=350.04 Aligned_cols=247 Identities=26% Similarity=0.344 Sum_probs=203.3
Q ss_pred cCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
+.|+..+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999996 47999999998643 3445567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||++ |+|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 5888888766667899999999999999999999 889999999999999999999999999999865432
Q ss_pred cceeeccccCccccCCCCC---CCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 447 SVIQTMTIATIGYMAPEFG---SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
....||+.|+|||++ .+..++.++|||||||++|||++|+.||...... ........... +....
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~----~~~~~--- 275 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNES----PALQS--- 275 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCC----CCCCC---
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCC----CCCCC---
Confidence 234689999999987 3568899999999999999999999999763221 11111111111 11111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
..++..+.++|.+||+.||++|||+++++++-
T Consensus 276 ----------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 276 ----------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp ----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred ----------CCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 12345688999999999999999999998763
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=354.31 Aligned_cols=252 Identities=20% Similarity=0.286 Sum_probs=195.7
Q ss_pred hhcCCCcC-CeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeec----CCe
Q 008012 289 ATDGFNEC-NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCN----TNF 361 (581)
Q Consensus 289 ~~~~y~~~-~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~ 361 (581)
..++|.+. +.||+|+||.||+|..+ +++.||||+++.. ..+.+|++++.++ +||||+++++++.. .+.
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 34567776 68999999999999965 7899999999754 2456788887554 89999999999865 567
Q ss_pred eeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC---CCcEEEeeccC
Q 008012 362 KALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE---NMVAHVSDFGI 437 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~ 437 (581)
.++||||+++|+|.+++.... ..+++..+..++.||+.||.||| +.||+||||||+||+++. ++.+||+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 899999999999999998753 45899999999999999999999 899999999999999997 78999999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccc--cHHHHHHhhCCCCC
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM--NLKNWVKESLPHGL 515 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~~~~ 515 (581)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+...... .
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~-~ 286 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE-F 286 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC-C
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc-C
Confidence 98764322 22345789999999999999999999999999999999999999976432221 122222211110 0
Q ss_pred CccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
+. .....++.++.+||.+||..||++|||+.|+++|-
T Consensus 287 ~~-------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 287 PN-------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp CT-------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CC-------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00 01123456788999999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=343.24 Aligned_cols=252 Identities=25% Similarity=0.327 Sum_probs=205.4
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
..++|.+.+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4567999999999999999999965 799999999987655455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe---cCCCcEEEeeccCceecCCC
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~~~~~ 444 (581)
|+++++|.+++...+ .+++..++.++.|++.||+||| +.||+||||||+||++ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 87 LVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred cCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 999999999997654 3789999999999999999999 8999999999999999 78889999999999764322
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+....... +.
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~-~~------- 228 (304)
T 2jam_A 163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEKIKEGYYEF-ES------- 228 (304)
T ss_dssp ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHCCCCC-CT-------
T ss_pred ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCCCC-Cc-------
Confidence 12334689999999999999999999999999999999999999976322 12222222211110 00
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+....++..+.+++.+||..||++|||++|++++
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 229 ------PFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111345678899999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=342.33 Aligned_cols=266 Identities=17% Similarity=0.211 Sum_probs=213.5
Q ss_pred hhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeee-ecCCeeeEEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC-CNTNFKALVL 366 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~ 366 (581)
..++|++.+.||+|+||.||+|.. .+++.||+|++...... +.+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 457899999999999999999996 48999999998655322 3578899999999988766666555 5677889999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe---cCCCcEEEeeccCceecCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~~~~ 443 (581)
||+ +++|.+++......+++..++.++.|++.||+||| ++||+||||||+||++ +.++.+||+|||++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999 89999999876667899999999999999999999 8999999999999999 4888999999999987754
Q ss_pred CCCcc-----eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--ccHHHHHHhhCCCCCC
Q 008012 444 GDDSV-----IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE--MNLKNWVKESLPHGLP 516 (581)
Q Consensus 444 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~ 516 (581)
..... ......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ..............
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 238 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 238 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc--
Confidence 33211 1234578999999999999999999999999999999999999998643221 11111111111000
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
.......+++.+.+++.+||+.||++|||++++++.|+++..+...
T Consensus 239 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 239 ------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0011123567799999999999999999999999999999877654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.53 Aligned_cols=264 Identities=20% Similarity=0.206 Sum_probs=199.5
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecC------
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT------ 359 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 359 (581)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4578999999999999999999965 7899999999754 344567788999999999999999999998654
Q ss_pred CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 360 NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 360 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
...|+||||+++ ++.+.+.. .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred CeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 457999999976 57676643 3788999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
...... ......||+.|+|||++.+..++.++||||+||++|||++|++||..... ...+...+. ......+...
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-~~~~~~i~~-~lg~p~~~~~ 287 (464)
T 3ttj_A 213 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIE-QLGTPCPEFM 287 (464)
T ss_dssp ----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH-HHCSCCHHHH
T ss_pred ecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH-hcCCCCHHHH
Confidence 764322 23456789999999999999999999999999999999999999976321 111222111 1111111100
Q ss_pred cc------------------cchhhh------hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 DA------------------NLLREE------NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 ~~------------------~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.. .+.... .........++.+.+|+.+||..||++|||++|+++|
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000000 0011122336678999999999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=346.89 Aligned_cols=257 Identities=23% Similarity=0.273 Sum_probs=200.3
Q ss_pred hcCCCcC-CeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEE
Q 008012 290 TDGFNEC-NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 290 ~~~y~~~-~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
.+.|++. +.||+|+||.||+|... +++.||||++..........+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678885 78999999999999954 7999999999766544456788999999995 7999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc---EEEeeccCceecCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV---AHVSDFGISKLLGE 443 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~---~kl~Dfg~a~~~~~ 443 (581)
||+++++|.+++.... .+++..++.++.||+.||+||| +.||+||||||+||+++.++. +||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 9999999999998754 3789999999999999999999 889999999999999997765 99999999986542
Q ss_pred CCC-----cceeeccccCccccCCCCCCC-----CCCCccccHHHHHHHHHHHHhCCCCCCcccccccc-----------
Q 008012 444 GDD-----SVIQTMTIATIGYMAPEFGSE-----GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMN----------- 502 (581)
Q Consensus 444 ~~~-----~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~----------- 502 (581)
... ........|++.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 211 111223458999999998765 56889999999999999999999999764332210
Q ss_pred --HHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 503 --LKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 503 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+...+..... .++ ......++..+.+++.+||+.||++|||++|+++|
T Consensus 247 ~~~~~~i~~~~~-~~~-------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEGKY-EFP-------------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHCCC-CCC-------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhccCc-ccC-------------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111111100 000 01112355678899999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=343.24 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=203.2
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecC-CeeeEEE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT-NFKALVL 366 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 366 (581)
...++|++.+.||+|+||.||+|... |+.||+|+++... ..+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 34578999999999999999999885 8999999997654 346788999999999999999999987554 5789999
Q ss_pred eccCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 367 EFMPNGSLDKWLYSHNY-FQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
||+++++|.+++..... .+++..++.++.|++.||+||| +.|++||||||+||+++.++.+||+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999999986532 3688899999999999999999 8999999999999999999999999999998653321
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ......+........
T Consensus 172 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~~~--------- 235 (278)
T 1byg_A 172 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKMDA--------- 235 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTTCCCCC---------
T ss_pred -----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCCCCC---------
Confidence 23357889999999988899999999999999999998 9999976422 122222221111111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
+..+++.+.+++.+||+.||++|||+.|+++.|++++..
T Consensus 236 --------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 236 --------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 113456788999999999999999999999999999765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=348.61 Aligned_cols=259 Identities=28% Similarity=0.435 Sum_probs=207.5
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEE--EEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTV--AIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~v--avK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 364 (581)
.++|++.+.||+|+||.||+|+.. ++..+ |+|.++... ....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367899999999999999999965 56654 999887542 34456788999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc
Q 008012 365 VLEFMPNGSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV 429 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~ 429 (581)
||||+++++|.+++.... ..+++..++.++.||+.||+||| +.||+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence 999999999999998654 35799999999999999999999 899999999999999999999
Q ss_pred EEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHH
Q 008012 430 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVK 508 (581)
Q Consensus 430 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~ 508 (581)
+||+|||++..... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.
T Consensus 181 ~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~ 255 (327)
T 1fvr_A 181 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLP 255 (327)
T ss_dssp EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHGG
T ss_pred EEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--HHHHHhh
Confidence 99999999974321 112233456889999999988889999999999999999998 99999763221 1111111
Q ss_pred hhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 509 ESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
...... .+..+++.+.+++.+||..||++|||++|++++|+++.++..
T Consensus 256 ~~~~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 256 QGYRLE-----------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp GTCCCC-----------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred cCCCCC-----------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111100 011344568899999999999999999999999999877544
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=359.54 Aligned_cols=276 Identities=21% Similarity=0.296 Sum_probs=213.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC--eeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN--FKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 365 (581)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999976 69999999997643 233456789999999999999999999988755 78999
Q ss_pred EeccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe----cCCCcEEEeeccCce
Q 008012 366 LEFMPNGSLDKWLYSHN--YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL----DENMVAHVSDFGISK 439 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill----~~~~~~kl~Dfg~a~ 439 (581)
|||+++|+|.+++.... ..+++..++.++.||+.||+||| +.||+||||||+||++ +.++.+||+|||++.
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999998643 23799999999999999999999 8999999999999999 778889999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCC--------CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHH--HHh
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSE--------GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNW--VKE 509 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~--~~~ 509 (581)
...... ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||............. +..
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 764322 2234568999999998764 567889999999999999999999997543322222111 111
Q ss_pred hCCCC-CCccccc---cc--hhh-hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 510 SLPHG-LPKIADA---NL--LRE-ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 510 ~~~~~-~~~~~~~---~~--~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
..+.. +...... .+ ... .........++..+.+++.+||+.||++|||++|+++.++++.++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11111 1111000 00 000 001112246777899999999999999999999999999887653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=351.38 Aligned_cols=272 Identities=24% Similarity=0.288 Sum_probs=203.4
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHH-----HHHHHHHHHHHHHhcCCCccceEeeeeecC
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQ-----AFRSFNSECEVLRNVRHRNLIKILSSCCNT 359 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 359 (581)
+....++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 4455688999999999999999999965 7899999999754321 124678999999999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 360 NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 360 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
+..++||||+++ +|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999999976 899999887767889999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---C
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---L 515 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~ 515 (581)
....... ......+|+.|+|||++.+. .++.++|||||||++|||++|.+||..... ...+........... .
T Consensus 161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTS
T ss_pred eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHcCCCChhhh
Confidence 7643322 23345789999999988654 589999999999999999999999876422 122222222211111 1
Q ss_pred Ccccc---c---cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 516 PKIAD---A---NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 516 ~~~~~---~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+.... . ......+.......++..+.++|.+||..||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 11000 0 0000000011123455778999999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=358.36 Aligned_cols=254 Identities=25% Similarity=0.347 Sum_probs=197.5
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--------HHHHHHHHHHHHHHHhcCCCccceEeeeeec
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--------EQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 358 (581)
...++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45688999999999999999999965 78999999987542 1222357899999999999999999999754
Q ss_pred CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC---cEEEeec
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM---VAHVSDF 435 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~---~~kl~Df 435 (581)
+..++||||+++|+|.+++.... .+++..++.++.|++.||+||| +.||+||||||+||+++.++ .+||+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence 55799999999999999887654 4789999999999999999999 88999999999999997544 5999999
Q ss_pred cCceecCCCCCcceeeccccCccccCCCCCCC---CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 008012 436 GISKLLGEGDDSVIQTMTIATIGYMAPEFGSE---GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLP 512 (581)
Q Consensus 436 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 512 (581)
|+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+...+.....
T Consensus 287 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 287 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQITSGKY 362 (419)
T ss_dssp STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS-SCCHHHHHHTTCC
T ss_pred ccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc-hHHHHHHHhcCCC
Confidence 9998764322 2334578999999998753 6788899999999999999999999976432 2233333332221
Q ss_pred CCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 513 HGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+ .....+++.+.+++.+||+.||++|||++|+++|
T Consensus 363 ~~~~--------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 363 NFIP--------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CCCH--------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCc--------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111 1122345678899999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=364.73 Aligned_cols=250 Identities=24% Similarity=0.263 Sum_probs=198.4
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|++.+.||+|+||.||+|... +|+.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 4578999999999999999999965 79999999997652 3344567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS-TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
||||+++|+|.+++.... .+++..+..++.||+.||+||| + .||+||||||+|||++.++.+||+|||++.....
T Consensus 226 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999998654 4789999999999999999999 6 8999999999999999999999999999985432
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ..++
T Consensus 302 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~-~~~p------- 369 (446)
T 4ejn_A 302 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILMEE-IRFP------- 369 (446)
T ss_dssp -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC-CCCC-------
T ss_pred CC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHHHHhCC-CCCC-------
Confidence 22 223446799999999999999999999999999999999999999976322 11222222111 1111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
..+++.+.++|.+||+.||++|| +++|+++|
T Consensus 370 ----------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 370 ----------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ----------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 12345688999999999999999 99999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=354.39 Aligned_cols=267 Identities=11% Similarity=0.105 Sum_probs=211.2
Q ss_pred hcCCCcCCeecccccccEEEEEeCC---------CcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccce---------
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSD---------GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIK--------- 351 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~--------- 351 (581)
.++|++.+.||+|+||.||+|.... ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999999763 789999998765 35778999999999999988
Q ss_pred ------Eeeeeec-CCeeeEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeE
Q 008012 352 ------ILSSCCN-TNFKALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNIL 423 (581)
Q Consensus 352 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nil 423 (581)
+++++.. .+..++||||+ +++|.+++... ...+++..++.++.||+.||+||| +.||+||||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence 5666665 67889999999 99999999875 355899999999999999999999 889999999999999
Q ss_pred ecCCC--cEEEeeccCceecCCCCCc-----ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Q 008012 424 LDENM--VAHVSDFGISKLLGEGDDS-----VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEM 496 (581)
Q Consensus 424 l~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~ 496 (581)
++.++ .+||+|||++..+...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999876432211 1123347899999999999999999999999999999999999999875
Q ss_pred ccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 497 FTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
............... .......+... ....++..+.+++.+||+.||++|||++++++.|+++.++...
T Consensus 272 ~~~~~~~~~~~~~~~-~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 272 LPNTEDIMKQKQKFV-DKPGPFVGPCG--------HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp TTCHHHHHHHHHHHH-HSCCCEECTTS--------CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CcCHHHHHHHHHhcc-CChhhhhhhcc--------ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 433322322222111 11111111100 0012345788999999999999999999999999999877653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=354.33 Aligned_cols=260 Identities=16% Similarity=0.139 Sum_probs=212.3
Q ss_pred hhHHHhhcCCCcCCeecccccccEEEEE------eCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcC---CCccceEee
Q 008012 284 LDLERATDGFNECNLLGSGGFGSVYKGI------LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR---HRNLIKILS 354 (581)
Q Consensus 284 ~~~~~~~~~y~~~~~lg~G~~~~v~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~ 354 (581)
.+++...++|.+.+.||+|+||.||+|. ..+++.||+|+++..... .+.+|++++++++ |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHH---HHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChh---HHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3445567889999999999999999994 447899999999876543 5677888888886 999999999
Q ss_pred eeecCCeeeEEEeccCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC----
Q 008012 355 SCCNTNFKALVLEFMPNGSLDKWLYS----HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE---- 426 (581)
Q Consensus 355 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~---- 426 (581)
++...+..++||||+++|+|.+++.. ....+++..++.++.||+.||+||| +.||+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccC
Confidence 99999999999999999999999985 3455899999999999999999999 899999999999999998
Q ss_pred -------CCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Q 008012 427 -------NMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG 499 (581)
Q Consensus 427 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~ 499 (581)
++.+||+|||+|..+.............||+.|+|||++.+..++.++|||||||++|||+||+.||.....+
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 8999999999998765434444455667999999999999999999999999999999999999998653222
Q ss_pred cccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCC-CCHHHHHHHHHHhHHHHH
Q 008012 500 EMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQR-LYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-ps~~evl~~L~~~~~~~~ 573 (581)
.... ...+... ..++.+.+++..|++.+|.+| |+++++.+.|+++..+..
T Consensus 292 ~~~~--------~~~~~~~----------------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 292 ECKP--------EGLFRRL----------------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp EEEE--------CSCCTTC----------------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ceee--------chhcccc----------------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 1110 0000000 113456789999999999998 578888888888876643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=340.48 Aligned_cols=252 Identities=26% Similarity=0.306 Sum_probs=199.6
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
..++|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3467899999999999999999965 78999999987654 223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe---cCCCcEEEeeccCcee
Q 008012 367 EFMPNGSLDKWLYSH---NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKL 440 (581)
Q Consensus 367 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~ 440 (581)
||+++++|.+++... +..+++..++.++.|++.||+||| +.||+||||||+||++ +.++.+||+|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999998643 355899999999999999999999 8999999999999999 4567899999999986
Q ss_pred cCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
..... ......|++.|+|||++. ..++.++||||||+++|+|++|+.||...... ..........+ ....
T Consensus 177 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~-~~~~--- 246 (285)
T 3is5_A 177 FKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQKATYKEP-NYAV--- 246 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC-CCCC---
T ss_pred cCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHhhhccCCc-cccc---
Confidence 64322 233456899999999876 47899999999999999999999999764221 11111111111 1000
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....+++.+.+++.+||+.||++|||+.|++++
T Consensus 247 -----------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 247 -----------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -----------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000124567899999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=351.84 Aligned_cols=254 Identities=23% Similarity=0.311 Sum_probs=203.1
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
..++|++.+.||+|+||.||+|..+ +++.||+|++..... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4577999999999999999999975 789999999976532 234688888888 7999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC----CcEEEeeccCceecC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN----MVAHVSDFGISKLLG 442 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~----~~~kl~Dfg~a~~~~ 442 (581)
||++||+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||++.++ +.+||+|||++....
T Consensus 96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999998765 4799999999999999999999 8999999999999998533 359999999998764
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+........... ...
T Consensus 172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~~i~~~~~~-~~~-- 244 (342)
T 2qr7_A 172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILARIGSGKFS-LSG-- 244 (342)
T ss_dssp CTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHHHHHHHHCCCC-CCS--
T ss_pred CCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHHHHHHccCCcc-cCc--
Confidence 4322 22345789999999999888899999999999999999999999975322 1222222211111100 000
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
..+..+++.+.++|.+||..||++|||+.|+++|-
T Consensus 245 --------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 245 --------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp --------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred --------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 00113456788999999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=351.92 Aligned_cols=246 Identities=27% Similarity=0.298 Sum_probs=193.1
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHH-HHhcCCCccceEeeeeecCCeee
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEV-LRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
..++|++.+.||+|+||.||+|+.+ +++.||+|+++... ......+.+|..+ ++.++||||+++++++.+.+..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3467999999999999999999976 68899999997653 2334456677776 46679999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||++||+|.+++.+.+. +++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 116 lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERC-FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999999987543 688899999999999999999 89999999999999999999999999999986432
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... ...++
T Consensus 192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~--~~~~~------- 259 (373)
T 2r5t_A 192 HN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNILNK--PLQLK------- 259 (373)
T ss_dssp CC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-HHHHHHHHS--CCCCC-------
T ss_pred CC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhc--ccCCC-------
Confidence 22 1234567999999999999999999999999999999999999999763221 111121111 11111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKD 560 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 560 (581)
..++..+.++|.+||+.||++||++.+
T Consensus 260 ----------~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 260 ----------PNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ----------SSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ----------CCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 123446789999999999999999853
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=353.40 Aligned_cols=266 Identities=17% Similarity=0.184 Sum_probs=202.9
Q ss_pred hcCCCcCCeecccccccEEEEEeC----CCcEEEEEEeccchHH-----------HHHHHHHHHHHHHhcCCCccceEee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQLEQ-----------AFRSFNSECEVLRNVRHRNLIKILS 354 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~ 354 (581)
.++|++.+.||+|+||.||+|... ++..||+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999965 5788999998764311 1123667889999999999999999
Q ss_pred eeec----CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC--
Q 008012 355 SCCN----TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM-- 428 (581)
Q Consensus 355 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~-- 428 (581)
++.. ....++||||+ +++|.+++...+ .+++..++.++.||+.||+||| +.||+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence 9887 67899999999 999999998765 5799999999999999999999 88999999999999999877
Q ss_pred cEEEeeccCceecCCCCCc-----ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccH
Q 008012 429 VAHVSDFGISKLLGEGDDS-----VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNL 503 (581)
Q Consensus 429 ~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~ 503 (581)
.+||+|||+++.+...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 9999999999876432211 11134578999999999999899999999999999999999999996533332222
Q ss_pred HHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 504 KNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
........ ..++..... ......++..+.+++.+||..||++|||++++++.|+++.
T Consensus 271 ~~~~~~~~-~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 QTAKTNLL-DELPQSVLK--------WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHH-HTTTHHHHH--------HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHhhc-ccccHHHHh--------hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 22111111 111110000 0000145667999999999999999999999999998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=348.51 Aligned_cols=269 Identities=23% Similarity=0.300 Sum_probs=204.3
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 3568999999999999999999965 68999999985542 34456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+++++|.++..... .+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 103 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99999988888766544 4799999999999999999999 8999999999999999999999999999998664322
Q ss_pred CcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC-----------
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH----------- 513 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~----------- 513 (581)
. ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||......+ ............
T Consensus 179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHHC
T ss_pred c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhhc
Confidence 2 22345689999999988775 78999999999999999999999997643221 111111110000
Q ss_pred -CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 514 -GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 514 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.......+..............+++.+.+++.+||+.||++|||++|+++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000011111111112223456789999999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=374.32 Aligned_cols=261 Identities=23% Similarity=0.398 Sum_probs=208.5
Q ss_pred cCCCcCC-eecccccccEEEEEeC---CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 291 DGFNECN-LLGSGGFGSVYKGILS---DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 291 ~~y~~~~-~lg~G~~~~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
+++.+.+ .||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999854 56679999997653 2345678999999999999999999999976 568999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+++|+|.+++......+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999999999877777899999999999999999999 8999999999999999999999999999998764332
Q ss_pred Ccc-eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 446 DSV-IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 446 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+........
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~~~~~~-------- 560 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKRMEC-------- 560 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHHHHHHHTTCCCCC--------
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCCCC--------
Confidence 211 1222345688999999998999999999999999999998 9999986432 222333332221111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
+..+++.+.++|.+||+.||++||++.++++.|+.+......
T Consensus 561 ---------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 561 ---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp ---------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred ---------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 123566789999999999999999999999999998776643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=363.39 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=209.4
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH---HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|++.+.||+|+||.||+|..+ +|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4577999999999999999999965 799999999976532 234567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 365 VLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
||||++||+|.+++...+ ..+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999998654 34799999999999999999999 89999999999999999999999999999987653
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccc--cHHHHHHhhCCCCCCccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM--NLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 521 (581)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+...+.. .+..++
T Consensus 339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~p----- 409 (576)
T 2acx_A 339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEEYS----- 409 (576)
T ss_dssp TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCCCCC-----
T ss_pred Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-ccccCC-----
Confidence 322 2345799999999999999999999999999999999999999986432211 12222221 111111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
..++..+.++|.+||..||++|| +++|+++|
T Consensus 410 ------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 410 ------------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ------------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ------------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 12345688999999999999999 78999876
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=336.84 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=200.8
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeec----CCeee
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCN----TNFKA 363 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~ 363 (581)
..|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 44788889999999999999965 78899999987543 4556788999999999999999999998865 45689
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeEec-CCCcEEEeeccCcee
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP--VVHCDLKPSNILLD-ENMVAHVSDFGISKL 440 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dikp~Nill~-~~~~~kl~Dfg~a~~ 440 (581)
+||||+++++|.+++..... +++..++.++.|++.||+||| +.+ |+||||||+||+++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHccC-CCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999987543 788999999999999999999 788 99999999999998 789999999999975
Q ss_pred cCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
.... ......|++.|+|||++.+ .++.++||||||+++|+|++|+.||...... ............+...+
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~ 252 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVTSGVKPASFD 252 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHTTTCCCGGGG
T ss_pred cccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH----HHHHHHHhccCCccccC
Confidence 4322 2234568999999998774 5999999999999999999999999763222 22222222111111111
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...++.+.++|.+||+.||++|||++|+++|
T Consensus 253 -------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 253 -------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------------CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1223468899999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=351.97 Aligned_cols=243 Identities=23% Similarity=0.340 Sum_probs=203.5
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH--------HHHHHHHHHHHHHHhcCCCccceEeeeeecC
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE--------QAFRSFNSECEVLRNVRHRNLIKILSSCCNT 359 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 359 (581)
..++|++.+.||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999954 789999999876521 1233567899999999999999999999999
Q ss_pred CeeeEEEeccCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 360 NFKALVLEFMPNG-SLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 360 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
+..++||||+.+| +|.+++..... +++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999776 99999987654 799999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSEGNV-SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
........ .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ......
T Consensus 178 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------~~~~~~- 242 (335)
T 3dls_A 178 AYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------VEAAIH- 242 (335)
T ss_dssp EECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------TTTCCC-
T ss_pred eECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------HhhccC-
Confidence 87754332 234568999999999888776 78999999999999999999999753111 000000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+..+++.+.+++.+||+.||++|||++|++++
T Consensus 243 --------------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 243 --------------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --------------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001134568899999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=338.12 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=207.4
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeec--------
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN-------- 358 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 358 (581)
...++|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34567999999999999999999976 79999999997654 246689999999999999999998854
Q ss_pred --------CCeeeEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc
Q 008012 359 --------TNFKALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV 429 (581)
Q Consensus 359 --------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~ 429 (581)
....++||||+++++|.+++... ...+++..++.++.|++.||.||| +.||+||||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCC
Confidence 44579999999999999999854 345789999999999999999999 889999999999999999999
Q ss_pred EEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHh
Q 008012 430 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKE 509 (581)
Q Consensus 430 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~ 509 (581)
+||+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++|..||... ......
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~~ 230 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFTD 230 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHHH
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHHH
Confidence 99999999987654322 23446899999999999889999999999999999999999987431 111111
Q ss_pred hCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHhh
Q 008012 510 SLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLED 575 (581)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 575 (581)
.....++. .++..+.+++.+||+.||++|||+.|++++|+.+.+.....
T Consensus 231 ~~~~~~~~-----------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 231 LRDGIISD-----------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp HHTTCCCT-----------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred hhcccccc-----------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 11111111 12345779999999999999999999999999988665543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=337.44 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=201.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
.++|.....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 345666679999999999999964 7899999999876656667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-CCcEEEeeccCceecCCCC
Q 008012 369 MPNGSLDKWLYSHN--YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE-NMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 369 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~ 445 (581)
+++++|.+++.... ...++..+..++.|++.||+||| +.||+||||||+||+++. ++.+||+|||.+.......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999998653 23568889999999999999999 889999999999999987 8999999999998764322
Q ss_pred CcceeeccccCccccCCCCCCCCC--CCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGN--VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
.......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||.....................++
T Consensus 178 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------- 248 (295)
T 2clq_A 178 --PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP------- 248 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC-------
T ss_pred --CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc-------
Confidence 1223456899999999886643 78999999999999999999999975322211111111111111111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..++..+.+++.+||+.||++|||+.|++++
T Consensus 249 ----------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 249 ----------ESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ----------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ----------ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1234568899999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=348.09 Aligned_cols=269 Identities=23% Similarity=0.265 Sum_probs=198.7
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
...++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 45578999999999999999999955 79999999997553 2334567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec-----CCCcEEEeeccCce
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD-----ENMVAHVSDFGISK 439 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~-----~~~~~kl~Dfg~a~ 439 (581)
||||+++ +|.+++..... +++..++.++.||+.||+||| +.||+||||||+||+++ .++.+||+|||++.
T Consensus 111 v~e~~~~-~L~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEECCSE-EHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEecCCC-CHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9999975 99999987654 789999999999999999999 89999999999999994 55569999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---C
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---L 515 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~ 515 (581)
....... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+........... .
T Consensus 186 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 186 AFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTS
T ss_pred ccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHHHHHhCCCchhhh
Confidence 7643221 22345679999999988774 5899999999999999999999999764222 12222222111110 0
Q ss_pred Ccccc--------ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 516 PKIAD--------ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 516 ~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+.... +..............+++++.++|.+||+.||++|||++|+++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00000 00000000011112255678899999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.16 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=209.7
Q ss_pred hhhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--------HHHHHHHHHHHHHHHhc-CCCccceE
Q 008012 283 YLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--------EQAFRSFNSECEVLRNV-RHRNLIKI 352 (581)
Q Consensus 283 ~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~iv~~ 352 (581)
+.......++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3344556678999999999999999999975 79999999986542 23346788999999999 89999999
Q ss_pred eeeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEE
Q 008012 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHV 432 (581)
Q Consensus 353 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl 432 (581)
++++...+..++||||+++++|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999999998654 3789999999999999999999 889999999999999999999999
Q ss_pred eeccCceecCCCCCcceeeccccCccccCCCCCC------CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHH
Q 008012 433 SDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGS------EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNW 506 (581)
Q Consensus 433 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~ 506 (581)
+|||++..+..... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||..... ......
T Consensus 242 ~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~ 316 (365)
T 2y7j_A 242 SDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLRM 316 (365)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH
T ss_pred EecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHHH
Confidence 99999987754322 23457899999999875 33688999999999999999999999976321 111121
Q ss_pred HHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 507 VKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+....... . .+....++..+.+++.+||..||++|||+.|++++
T Consensus 317 i~~~~~~~-~-------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 317 IMEGQYQF-S-------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHTCCCC-C-------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhCCCCC-C-------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 21111100 0 01112345678899999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=340.57 Aligned_cols=253 Identities=25% Similarity=0.274 Sum_probs=191.9
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
...++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.++...++.++||||+++++++.+.+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 44678999999999999999999964 79999999997652 2333445555566788899999999999999999999
Q ss_pred EEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 365 VLEFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGHST-PVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
||||+++ +|.+++.. .+..+++..++.++.|++.||+||| +. ||+||||||+||+++.++.+||+|||++..
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999975 88887764 4556899999999999999999999 76 999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCccccCCCCC----CCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCC
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFG----SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP 516 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 516 (581)
..... ......|++.|+|||++ .+..++.++||||||+++|+|++|+.||.............+....+....
T Consensus 160 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T 3fme_A 160 LVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred ccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence 64322 22334689999999985 566789999999999999999999999976433322233322222111110
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..++..+.+++.+||+.||++|||+.|+++|
T Consensus 237 -----------------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 237 -----------------DKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -----------------ccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1234568899999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=339.27 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=205.3
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeee--cCCeeeE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCC--NTNFKAL 364 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~l 364 (581)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++. ..+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999975 7899999999754 2445678999999999999999999999874 4668899
Q ss_pred EEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----ceecCCCCCCeEecCCCcEEEeecc
Q 008012 365 VLEFMPNGSLDKWLYSH---NYFQDIPDRLNIMIDVALALEYLHHGHSTP-----VVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-----i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
||||+++++|.+++... ...+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999999853 344799999999999999999999 677 9999999999999999999999999
Q ss_pred CceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCC
Q 008012 437 ISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP 516 (581)
Q Consensus 437 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 516 (581)
.+........ ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+.......++
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~~~~~~ 237 (279)
T 2w5a_A 162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFRRIP 237 (279)
T ss_dssp HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCCCC
T ss_pred hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHHhhcccccCC
Confidence 9987643221 12344689999999999888999999999999999999999999976422 2222222222211111
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
..++..+.+++.+||+.||++|||++|+++++.
T Consensus 238 -----------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 238 -----------------YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -----------------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 123456889999999999999999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=334.28 Aligned_cols=247 Identities=25% Similarity=0.310 Sum_probs=205.9
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH---HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999965 688999999876532 2235788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+++++|.+++...+. +++..++.++.|++.||.||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp ECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 999999999999987643 789999999999999999999 8999999999999999999999999999997654322
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
.....|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+.... ..++
T Consensus 169 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~-~~~~--------- 232 (284)
T 2vgo_A 169 ----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ETHRRIVNVD-LKFP--------- 232 (284)
T ss_dssp ----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTTC-CCCC---------
T ss_pred ----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--HHHHHHhccc-cCCC---------
Confidence 23456899999999999999999999999999999999999999763221 1111111110 0111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..++..+.++|.+||+.||++|||++|+++|
T Consensus 233 --------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 233 --------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1234567899999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=337.03 Aligned_cols=257 Identities=21% Similarity=0.282 Sum_probs=206.5
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH------HHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE------QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
.++|++.+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467899999999999999999976 799999999875421 1246788999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC----cEEEeeccCc
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM----VAHVSDFGIS 438 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~----~~kl~Dfg~a 438 (581)
++||||+++++|.+++.... .+++..++.++.|++.||.||| +.||+||||||+||+++.++ .+||+|||.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 99999999999999998654 3789999999999999999999 89999999999999998877 8999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
........ .....+++.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+..... ..+
T Consensus 160 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~-~~~-- 231 (283)
T 3bhy_A 160 HKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLTNISAVNY-DFD-- 231 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTTCC-CCC--
T ss_pred eeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHHHhHhccc-CCc--
Confidence 87643321 23456899999999999999999999999999999999999999763221 11111111100 000
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHHhH
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK--LKKIR 569 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~~ 569 (581)
......++..+.+++.+||..||++|||+.|++++ ++.++
T Consensus 232 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 232 -----------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp -----------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred -----------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 01112345678899999999999999999999985 45544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=342.06 Aligned_cols=262 Identities=21% Similarity=0.239 Sum_probs=194.9
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-CCccceEeeeee------
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSSCC------ 357 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~------ 357 (581)
++....+|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3444568999999999999999999965 78999999997776666778999999999995 999999999983
Q ss_pred --cCCeeeEEEeccCCCCHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeEecCCCcEE
Q 008012 358 --NTNFKALVLEFMPNGSLDKWLYS--HNYFQDIPDRLNIMIDVALALEYLHHGHSTP--VVHCDLKPSNILLDENMVAH 431 (581)
Q Consensus 358 --~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dikp~Nill~~~~~~k 431 (581)
.....++||||++ |+|.+++.. ....+++..++.++.||+.||+||| +.| |+||||||+||+++.++.+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEE
Confidence 3446899999996 699998874 3445899999999999999999999 888 99999999999999999999
Q ss_pred EeeccCceecCCCCCcc----------eeeccccCccccCCCCC---CCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Q 008012 432 VSDFGISKLLGEGDDSV----------IQTMTIATIGYMAPEFG---SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFT 498 (581)
Q Consensus 432 l~Dfg~a~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~ 498 (581)
|+|||++.......... ......+++.|+|||++ .+..++.++|||||||++|+|++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999998765432211 11134589999999988 567789999999999999999999999975321
Q ss_pred ccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 499 GEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
. ............ ..++..+.+++.+||+.||++|||+.|++++|+++.....
T Consensus 259 ~-----~~~~~~~~~~~~-----------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 259 L-----RIVNGKYSIPPH-----------------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ------------CCCCTT-----------------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred H-----HhhcCcccCCcc-----------------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 1 111111111100 0112346789999999999999999999999999987543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=352.11 Aligned_cols=267 Identities=23% Similarity=0.289 Sum_probs=206.8
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 3578999999999999999999966 7899999999765 3445578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST-PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
||+++++|.+++...+. +++..+..++.|++.||+||| +. ||+||||||+||+++.++.+||+|||++......
T Consensus 111 e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred ECCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999999987543 788999999999999999999 64 8999999999999999999999999999755321
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCC---------
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP--------- 516 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------- 516 (581)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+.........
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE--LELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH--HHHHHC-----------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccCCCCCCCcccC
Confidence 1234578999999999999999999999999999999999999997632221 11111000000000
Q ss_pred -----cc-ccc----cc-------hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 517 -----KI-ADA----NL-------LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 517 -----~~-~~~----~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
.. .+. .. ............++..+.++|.+||+.||++|||++|+++|-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 00 000 00 000000000112456789999999999999999999999873
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=344.97 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=202.6
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999976 689999999987655556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++++|.+++......+++..++.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...... .
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L 171 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence 99999999999876666899999999999999999999 889999999999999999999999999987543111 1
Q ss_pred ceeeccccCccccCCCCC-----CCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 448 VIQTMTIATIGYMAPEFG-----SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
.......|++.|+|||++ .+..++.++||||||+++|+|++|+.||....... ......... . +...
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-~---~~~~--- 243 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSD-P---PTLL--- 243 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSC-C---CCCS---
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccC-C---cccC---
Confidence 112334689999999987 46788999999999999999999999997642211 111111111 1 1100
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....++..+.+++.+||+.||++|||+.|+++|
T Consensus 244 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 244 ---------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ---------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ---------CccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 112345568899999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=360.25 Aligned_cols=271 Identities=20% Similarity=0.251 Sum_probs=189.3
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeec-----CC
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCN-----TN 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 360 (581)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3578999999999999999999965 7999999998653 34455788999999999999999999999844 35
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..|+||||+ +++|.+++.... .+++..++.++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred eEEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 789999998 569999997654 4799999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCc-------------------------ceeeccccCccccCCCCC-CCCCCCccccHHHHHHHHHHHHh------
Q 008012 441 LGEGDDS-------------------------VIQTMTIATIGYMAPEFG-SEGNVSSKCDVYSYGILLLETFT------ 488 (581)
Q Consensus 441 ~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~vl~el~t------ 488 (581)
....... .......||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 6432211 122345789999999965 56779999999999999999999
Q ss_pred -----CCCCCCcccccc------------------ccHHHHHHhhCCCCCCccccccch-------------hhhhhhhH
Q 008012 489 -----RKKPTDEMFTGE------------------MNLKNWVKESLPHGLPKIADANLL-------------REENFFSA 532 (581)
Q Consensus 489 -----g~~Pf~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~ 532 (581)
|+++|.....-. ......+.........+....... ........
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 556654421100 000011111111000000000000 00000111
Q ss_pred HHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 533 RMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 533 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...++..+.+||.+||..||++|||++|+++|
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 12345678899999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=356.15 Aligned_cols=271 Identities=20% Similarity=0.263 Sum_probs=200.7
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecC-----C
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT-----N 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 360 (581)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4678999999999999999999965 7899999999753 344557889999999999999999999998766 5
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..|+||||++ ++|.+++.... .+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 7899999996 59999997654 4799999999999999999999 89999999999999999999999999999997
Q ss_pred cCCCCCc--------------------ceeeccccCccccCCCCC-CCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Q 008012 441 LGEGDDS--------------------VIQTMTIATIGYMAPEFG-SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG 499 (581)
Q Consensus 441 ~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~ 499 (581)
....... .......||+.|+|||++ .+..++.++||||+||++|||++|..||.....+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 6543221 123456789999999975 5667999999999999999999866555432111
Q ss_pred c--------------------------ccHHHHHHhhCCCCCCcc----ccccchh---------hhhhhhHHHHHHHHH
Q 008012 500 E--------------------------MNLKNWVKESLPHGLPKI----ADANLLR---------EENFFSARMDCLLSI 540 (581)
Q Consensus 500 ~--------------------------~~~~~~~~~~~~~~~~~~----~~~~~~~---------~~~~~~~~~~~~~~l 540 (581)
. ......+.+.......+. ....... ..........+++.+
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 0 000001111111100000 0000000 000001112356778
Q ss_pred HHHHHhccCcCCCCCCCHHHHHHH
Q 008012 541 FHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 541 ~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+|+.+||..||++|||++|+++|
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=336.19 Aligned_cols=251 Identities=21% Similarity=0.301 Sum_probs=208.3
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 4567999999999999999999976 68899999987652 4456778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+++++|.+++.... .+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+......
T Consensus 93 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 999999999999987654 3789999999999999999999 899999999999999999999999999999876433
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......+ .... +.... ..++
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~-~~~~~-~~~~-------- 235 (294)
T 2rku_A 169 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLR-IKKNE-YSIP-------- 235 (294)
T ss_dssp TC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH-HHTTC-CCCC--------
T ss_pred cc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-Hhhcc-CCCc--------
Confidence 22 2234568999999999998899999999999999999999999997642211 1111 11110 0111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
..++..+.+++.+||+.||++|||++|++++-
T Consensus 236 ---------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 236 ---------KHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp ---------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ---------cccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 12334678999999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=346.22 Aligned_cols=269 Identities=19% Similarity=0.264 Sum_probs=205.3
Q ss_pred hcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeec--------
Q 008012 290 TDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCN-------- 358 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 358 (581)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999997 489999999986543 2223467789999999999999999999876
Q ss_pred CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
.+..++||||+++ +|.+.+......+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 3468999999975 888888877667899999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCC--cceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC-
Q 008012 439 KLLGEGDD--SVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG- 514 (581)
Q Consensus 439 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~- 514 (581)
..+..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||...... .....+.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGSIT 249 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCC
Confidence 87653222 122344578999999998776 56899999999999999999999999864222 2222222221111
Q ss_pred ---CCccccccchhh-------h---hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 515 ---LPKIADANLLRE-------E---NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 515 ---~~~~~~~~~~~~-------~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+.......... . .........++.+.+||.+||..||++|||++|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 111111000000 0 0000111124568899999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=341.14 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=200.7
Q ss_pred hcCCCcCCeecccccccEEEEEeC--CCc--EEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS--DGT--TVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
.++|++.+.||+|+||.||+|.+. +++ .||+|+++... ....+.+.+|++++++++||||+++++++.+.+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467999999999999999999853 333 68999987642 345678899999999999999999999998765 8
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+++++|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 8999999999999999876666899999999999999999999 8899999999999999999999999999998875
Q ss_pred CCCCcc-eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 443 EGDDSV-IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 443 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
...... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... +............
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~--- 244 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILHKIDKEGERL--- 244 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTSCCCC---
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HHHHHHHccCCCC---
Confidence 433222 2234457788999999988889999999999999999999 99999764221 1111111111000
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
.....++..+.+++.+||+.||++|||+.+++++|+++...
T Consensus 245 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 245 ----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ----------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 00113456788999999999999999999999999988643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=345.50 Aligned_cols=250 Identities=21% Similarity=0.297 Sum_probs=208.0
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3467999999999999999999965 6889999998765 24456778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+++++|.+++.... .+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 119 v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 999999999999988654 4789999999999999999999 899999999999999999999999999999876433
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......+ .... +.... ..++
T Consensus 195 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~-~~~~~-~~~~-------- 261 (335)
T 2owb_A 195 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLR-IKKNE-YSIP-------- 261 (335)
T ss_dssp TC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH-HHHTC-CCCC--------
T ss_pred cc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHH-HhcCC-CCCC--------
Confidence 22 2234568999999999988899999999999999999999999997632211 1111 11111 1111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..++..+.++|.+||+.||++|||++|++++
T Consensus 262 ---------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 262 ---------KHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1233467899999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=362.34 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=205.1
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4577999999999999999999965 79999999986542 22346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec---CCCcEEEeeccCceecC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD---ENMVAHVSDFGISKLLG 442 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a~~~~ 442 (581)
|||+++++|.+++..... +++..+..++.||+.||.||| +.||+||||||+||+++ .++.+||+|||++....
T Consensus 100 ~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp ECCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEcCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999999876543 789999999999999999999 89999999999999995 45689999999998664
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhh-CCCCCCccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES-LPHGLPKIADA 521 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 521 (581)
... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||...... .....+... .....
T Consensus 176 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~------ 243 (486)
T 3mwu_A 176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVETGKYAFDL------ 243 (486)
T ss_dssp CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCSCS------
T ss_pred CCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCCCCC------
Confidence 332 2334579999999999876 5999999999999999999999999763221 112222211 11111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+....+++.+.++|.+||..||++|||+.|+++|
T Consensus 244 ---------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 ---------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1122345678899999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=337.58 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=208.2
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.+.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 456899999999999999999964 78999999997553 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++++|.+++... .+++..++.++.|++.||.||| +.||+||||||+||+++.++.+||+|||.+.......
T Consensus 101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 173 (303)
T ss_dssp CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence 99999999999753 4789999999999999999999 8999999999999999999999999999998764332
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+.......++
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~----------- 240 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNPPTLE----------- 240 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCCCC-----------
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCCCCCc-----------
Confidence 1223456899999999999999999999999999999999999999763221 122222222111111
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
..++..+.+++.+||+.||++|||+.|++++.
T Consensus 241 ------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 241 ------GNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ------cccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 12345688999999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=346.45 Aligned_cols=263 Identities=20% Similarity=0.270 Sum_probs=203.6
Q ss_pred hhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-CCccceEeeeeec--CCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSSCCN--TNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~l 364 (581)
..++|++.+.||+|+||.||+|.. .+++.||+|+++.... +.+.+|++++++++ ||||+++++++.+ ....++
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH---HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch---HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 347899999999999999999995 4799999999986543 46789999999996 9999999999987 667899
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC-cEEEeeccCceecCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM-VAHVSDFGISKLLGE 443 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~ 443 (581)
||||+++++|.+++.. +++..+..++.||+.||+||| +.||+||||||+||+++.++ .+||+|||++.....
T Consensus 111 v~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999998854 688899999999999999999 89999999999999999776 899999999987654
Q ss_pred CCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHH------------hh
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVK------------ES 510 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~------------~~ 510 (581)
... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.........+..... ..
T Consensus 184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 332 234578999999998876 67899999999999999999999999653332222222111 10
Q ss_pred CCCCCCcc---cc---ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 511 LPHGLPKI---AD---ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 511 ~~~~~~~~---~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.....+.. .. ...............+++.+.++|.+||+.||++|||++|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000 00 00000000011122356778999999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=347.56 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=198.7
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC-----
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN----- 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 360 (581)
..++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4578999999999999999999964 7999999998543 3445567889999999999999999999987653
Q ss_pred -eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 361 -FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 361 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
..++||||+ +++|.+++... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 78999999874 3789999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+...+. .........
T Consensus 177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~-~~g~~~~~~ 249 (367)
T 1cm8_A 177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMK-VTGTPPAEF 249 (367)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH-HHCCCCHHH
T ss_pred ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-hcCCCCHHH
Confidence 76432 234568999999998776 68999999999999999999999999763221 11222211 111110000
Q ss_pred ccc----c---ch------hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 ADA----N---LL------REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ~~~----~---~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
... . .. ...........+++.+.+|+.+||..||++|||++|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000 0 00 0000001112345678899999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=340.70 Aligned_cols=253 Identities=24% Similarity=0.325 Sum_probs=203.3
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
...++|++.+.||+|+||.||+|... +|+.||+|++..... .+.+.+|+.++++++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC--CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH--HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34678999999999999999999965 689999999976532 356888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||.+........
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999999866666899999999999999999999 89999999999999999999999999999987643221
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+........
T Consensus 181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~----------- 245 (314)
T 3com_A 181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPPPTF----------- 245 (314)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCCC-----------
T ss_pred --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCCccc-----------
Confidence 2234568999999999999899999999999999999999999997632211 1111111111111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+..++..+.+++.+||..||++|||+.+++++
T Consensus 246 ----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 ----RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ----SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111234568899999999999999999999885
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=342.25 Aligned_cols=263 Identities=22% Similarity=0.347 Sum_probs=203.9
Q ss_pred cchhhhHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcC--CCccceEeee
Q 008012 280 RTSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVR--HRNLIKILSS 355 (581)
Q Consensus 280 ~~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~ 355 (581)
.+.+..+....++|++.+.||+|+||.||+|...+++.||+|++... .....+.+.+|++++++++ ||||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 34455566677889999999999999999999888999999998654 3455678899999999996 5999999999
Q ss_pred eecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeec
Q 008012 356 CCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDF 435 (581)
Q Consensus 356 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 435 (581)
+.+.+..++||| +.+++|.+++.... .+++..++.++.|+++||.||| +.||+||||||+||++++ +.+||+||
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCC
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeec
Confidence 999999999999 55789999998765 4788999999999999999999 889999999999999964 89999999
Q ss_pred cCceecCCCCCcceeeccccCccccCCCCCCC-----------CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHH
Q 008012 436 GISKLLGEGDDSVIQTMTIATIGYMAPEFGSE-----------GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLK 504 (581)
Q Consensus 436 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~ 504 (581)
|++................|++.|+|||++.+ ..++.++||||||+++|+|++|+.||...........
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence 99987654433333345578999999998765 4788899999999999999999999976433222222
Q ss_pred HHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 505 NWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
...........+. .++..+.+++.+||+.||++|||+.|++++-
T Consensus 251 ~~~~~~~~~~~~~-----------------~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 251 AIIDPNHEIEFPD-----------------IPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HHHCTTSCCCCCC-----------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHhcccccCCcc-----------------cchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 2222111111111 1234678999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=372.29 Aligned_cols=262 Identities=26% Similarity=0.424 Sum_probs=213.8
Q ss_pred hhHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 284 LDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 284 ~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
..++...++|++.+.||+|+||.||+|.++++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 345566788999999999999999999988778899999976532 23578999999999999999999999876 6789
Q ss_pred EEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 364 LVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
+||||+++|+|.+++... +..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||++....
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 999999999999999853 345789999999999999999999 8999999999999999999999999999998653
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+.......
T Consensus 415 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~~------- 484 (535)
T 2h8h_A 415 DNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYRMP------- 484 (535)
T ss_dssp CHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHHHHHTTCCCC-------
T ss_pred CCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCC-------
Confidence 211 111223346788999999988899999999999999999999 99999764221 1222222221111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
.+..++..+.++|.+||+.||++|||+++|++.|+.+..
T Consensus 485 ----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 485 ----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 112345678899999999999999999999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=358.50 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=208.0
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH---HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|++.+.||+|+||.||+|+.+ +|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3478999999999999999999975 799999999976532 224578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 365 VLEFMPNGSLDKWLYSH---NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
||||++||+|.+++... ...+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||++...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999864 345789999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+......... .
T Consensus 340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~~~~i~~~~~-~---- 411 (543)
T 3c4z_A 340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAV-T---- 411 (543)
T ss_dssp CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHHHHHHHHCCC-C----
T ss_pred cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHHHHHHhhccc-C----
Confidence 54332 123457999999999999999999999999999999999999999764221 112222221111100 0
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCH-----HHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYM-----KDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 564 (581)
.+..++..+.++|.+||..||++||++ +++++|
T Consensus 412 ----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 412 ----------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp ----------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred ----------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 011234568899999999999999965 677654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=349.68 Aligned_cols=266 Identities=22% Similarity=0.282 Sum_probs=208.4
Q ss_pred hhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHH-----------------HHHHHHHHHHHHhcCCCccce
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQA-----------------FRSFNSECEVLRNVRHRNLIK 351 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~iv~ 351 (581)
..++|++.+.||+|+||.||+|.. +++.||+|++....... .+.+.+|++++++++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999999999 89999999997653221 167889999999999999999
Q ss_pred EeeeeecCCeeeEEEeccCCCCHHHH------HhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceecCCCCCCeE
Q 008012 352 ILSSCCNTNFKALVLEFMPNGSLDKW------LYSH-NYFQDIPDRLNIMIDVALALEYLHHGHS-TPVVHCDLKPSNIL 423 (581)
Q Consensus 352 ~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dikp~Nil 423 (581)
+++++.+.+..++||||+++++|.++ +... ...+++..++.++.|++.||+||| + .||+||||||+||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence 99999999999999999999999998 5542 456899999999999999999999 6 99999999999999
Q ss_pred ecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCC-CCCc-cccHHHHHHHHHHHHhCCCCCCccccccc
Q 008012 424 LDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG-NVSS-KCDVYSYGILLLETFTRKKPTDEMFTGEM 501 (581)
Q Consensus 424 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Dv~slG~vl~el~tg~~Pf~~~~~~~~ 501 (581)
++.++.+||+|||.+...... ......++..|+|||++.+. .++. ++||||||+++|||++|+.||...... .
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~ 259 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-V 259 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-H
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-H
Confidence 999999999999999876432 23456789999999998887 6666 999999999999999999999764332 1
Q ss_pred cHHHHHHhhCCCCCCccccccch--hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 502 NLKNWVKESLPHGLPKIADANLL--REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.....+..... ..+........ ...........++..+.+++.+||+.||++|||+.|+++|
T Consensus 260 ~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 260 ELFNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 12222211111 11110000000 0000011113456678999999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=334.20 Aligned_cols=245 Identities=19% Similarity=0.275 Sum_probs=200.7
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4577999999999999999999976 7999999998754 233456788999999999 99999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC--------------
Q 008012 365 VLEFMPNGSLDKWLYSH---NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN-------------- 427 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~-------------- 427 (581)
||||+++++|.+++... ...+++..++.++.||+.||+||| +.||+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999854 245799999999999999999999 8999999999999999844
Q ss_pred -----CcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccc
Q 008012 428 -----MVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM 501 (581)
Q Consensus 428 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~ 501 (581)
..+||+|||.+....... ...|++.|+|||++.+. .++.++|||||||++|+|++|.+|+... .
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----D 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----H
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----h
Confidence 479999999998764322 23589999999988765 6678999999999999999999876432 1
Q ss_pred cHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 502 NLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.... +.......++. .+++.+.+++.+||+.||++|||+.|+++|
T Consensus 236 ~~~~-~~~~~~~~~~~-----------------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 QWHE-IRQGRLPRIPQ-----------------VLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHH-HHTTCCCCCSS-----------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHH-HHcCCCCCCCc-----------------ccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1112 22111111111 234568899999999999999999999876
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=330.72 Aligned_cols=249 Identities=26% Similarity=0.389 Sum_probs=198.7
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH---HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4578999999999999999999976 799999999976532 234578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||+++++|.+++..... +++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+......
T Consensus 89 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEECCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEeccCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999999987644 788999999999999999999 889999999999999999999999999999876432
Q ss_pred CCcceeeccccCccccCCCCCCCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNV-SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
. ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ......+..... ..+
T Consensus 165 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~-~~~------- 231 (276)
T 2h6d_A 165 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTLFKKIRGGVF-YIP------- 231 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC-CCC-------
T ss_pred c---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhcCcc-cCc-------
Confidence 2 1234468999999999887765 6899999999999999999999976321 111222221111 011
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..++..+.+++.+||+.||++|||+.|++++
T Consensus 232 ----------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 232 ----------EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----------hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1234567899999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=360.58 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=204.9
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH-------------HHHHHHHHHHHHHHhcCCCccceEe
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE-------------QAFRSFNSECEVLRNVRHRNLIKIL 353 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~ 353 (581)
...++|++++.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35678999999999999999999965 789999999875431 2245788999999999999999999
Q ss_pred eeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC---cE
Q 008012 354 SSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM---VA 430 (581)
Q Consensus 354 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~---~~ 430 (581)
+++.+.+..++||||+++|+|.+++..... +++..++.++.||+.||+||| +.||+||||||+||+++.++ .+
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHK-FDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999999999986543 799999999999999999999 89999999999999998775 69
Q ss_pred EEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 008012 431 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES 510 (581)
Q Consensus 431 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~ 510 (581)
||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|.+||...... .....+...
T Consensus 189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~ 262 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKVEKG 262 (504)
T ss_dssp EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC
T ss_pred EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcC
Confidence 999999998775432 2334579999999998774 6999999999999999999999999763221 122222211
Q ss_pred CCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 511 LPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
... . .......+++.+.++|.+||..||++|||++|+++|
T Consensus 263 ~~~-~-------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 263 KYY-F-------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCC-C-------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCC-C-------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 100 0 011223456678999999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=345.23 Aligned_cols=264 Identities=20% Similarity=0.195 Sum_probs=196.6
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC-----
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN----- 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 360 (581)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3578999999999999999999965 7899999998753 3445567889999999999999999999987654
Q ss_pred -eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 361 -FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 361 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
..++||||+++ +|.+++.. .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred cceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 78999999975 78888863 3788999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..+.. +........+...
T Consensus 176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~-i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 176 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNK-VIEQLGTPCPEFM 250 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH-HHC-CCCCCHHHH
T ss_pred cccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHHHhCCCCHHHH
Confidence 654321 233457899999999999999999999999999999999999999763211 11111 1111111111000
Q ss_pred cc------------------cchhh------hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 DA------------------NLLRE------ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 ~~------------------~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.. .+... ..........+..+.+|+.+||..||++|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00 00000 00011223456789999999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=344.11 Aligned_cols=262 Identities=20% Similarity=0.237 Sum_probs=208.3
Q ss_pred chhhhHHHhhcCCCcC-CeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhc-CCCccceEeee
Q 008012 281 TSYLDLERATDGFNEC-NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNV-RHRNLIKILSS 355 (581)
Q Consensus 281 ~~~~~~~~~~~~y~~~-~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 355 (581)
..+...+...+.|.+. +.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++++ .||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3455566777888887 88999999999999966 79999999987643 22245788999999999 57999999999
Q ss_pred eecCCeeeEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC---CCcEE
Q 008012 356 CCNTNFKALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE---NMVAH 431 (581)
Q Consensus 356 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~---~~~~k 431 (581)
+.+.+..++||||+++|+|.+++... ...+++..++.++.|++.||+||| +.||+||||||+||+++. ++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999998643 355799999999999999999999 899999999999999987 78999
Q ss_pred EeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 008012 432 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESL 511 (581)
Q Consensus 432 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 511 (581)
|+|||++........ .....|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+....
T Consensus 175 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~ 249 (327)
T 3lm5_A 175 IVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYLNISQVN 249 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTC
T ss_pred EeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHHHhcc
Confidence 999999987643322 234578999999999999999999999999999999999999997632211 111111111
Q ss_pred CCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 512 PHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
... +. .....+++.+.++|.+||..||++|||++|++++
T Consensus 250 ~~~-~~-------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 250 VDY-SE-------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCC-CT-------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccc-Cc-------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 111 10 0111345568899999999999999999999886
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.23 Aligned_cols=277 Identities=21% Similarity=0.244 Sum_probs=206.5
Q ss_pred cchhhhHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccc-----------hHHHHHHHHHHHHHHHhcCCCc
Q 008012 280 RTSYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQ-----------LEQAFRSFNSECEVLRNVRHRN 348 (581)
Q Consensus 280 ~~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~ 348 (581)
+....++....++|++.+.||+|+||.||+|...+|+.||||++... .....+.+.+|++++++++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 34566788899999999999999999999999888999999998543 2233478899999999999999
Q ss_pred cceEeeeeec-----CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeE
Q 008012 349 LIKILSSCCN-----TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNIL 423 (581)
Q Consensus 349 iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nil 423 (581)
|+++++++.. ....++||||++ |+|.+++......+++..++.++.||+.||+||| +.||+||||||+||+
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNIL 166 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEE
Confidence 9999999843 346899999997 5999999877777899999999999999999999 889999999999999
Q ss_pred ecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCcccccccc
Q 008012 424 LDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMN 502 (581)
Q Consensus 424 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~ 502 (581)
++.++.+||+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~ 242 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQ 242 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 9999999999999998543222 2344578999999998776 67899999999999999999999999764221 11
Q ss_pred HHHHHHhhCCCCCCccc-----------cccch--hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 503 LKNWVKESLPHGLPKIA-----------DANLL--REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 503 ~~~~~~~~~~~~~~~~~-----------~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....+............ ..... ...........+++.+.+++.+||+.||++|||+.|+++|
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 22221111111000000 00000 0000011122345678899999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=334.06 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=201.5
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch----HHHHHHHHHHHHHHHhcCCCccceEeeeee--cCCe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL----EQAFRSFNSECEVLRNVRHRNLIKILSSCC--NTNF 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~ 361 (581)
..++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4578999999999999999999964 78999999997653 234567899999999999999999999984 4568
Q ss_pred eeEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 362 KALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
.++||||++++ |.+++... ...+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||.+..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999876 77777653 445799999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCccccCCCCCCCCC--CCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSEGN--VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
..............|++.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ......+..... .++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~~-~~~-- 233 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YKLFENIGKGSY-AIP-- 233 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHCCC-CCC--
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHHhcCCC-CCC--
Confidence 75443333444567899999999887644 47799999999999999999999976321 111111111110 011
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..++..+.+++.+||+.||++|||++|++++
T Consensus 234 ---------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 234 ---------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---------------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------------CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1234568899999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=369.54 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=202.6
Q ss_pred CeecccccccEEEEEeC---CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS---DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999643 56789999997653 2335679999999999999999999999964 457899999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc-cee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-VIQ 450 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~ 450 (581)
|+|.+++.... .+++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus 454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999998654 4789999999999999999999 899999999999999999999999999999876543322 122
Q ss_pred eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+........+
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~~~~p------------- 594 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERMGCP------------- 594 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCCCCC-------------
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCC-------------
Confidence 33456788999999999999999999999999999998 99999764222 222333222211111
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
..+++++.++|.+||+.||++|||+++|++.|+++..+.
T Consensus 595 ----~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 595 ----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp ----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 234567889999999999999999999999999987654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=343.84 Aligned_cols=265 Identities=24% Similarity=0.338 Sum_probs=189.1
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3455689999999999999999999954 78999999987653 334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeecc
Q 008012 364 LVLEFMPNGSLDKWLYS-------HNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
+||||+++++|.+++.. ....+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999999974 2345789999999999999999999 8899999999999999999999999999
Q ss_pred CceecCCCCC---cceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 008012 437 ISKLLGEGDD---SVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLP 512 (581)
Q Consensus 437 ~a~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 512 (581)
.+........ ........|++.|+|||++.+ ..++.++||||||+++|+|++|+.||........ ... ......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~-~~~~~~ 244 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LML-TLQNDP 244 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHH-HHTSSC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-HHH-HhccCC
Confidence 9976643221 112234568999999998765 5689999999999999999999999976432211 111 111111
Q ss_pred CCCCc-cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 513 HGLPK-IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 513 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..... ..+... ...++..+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 245 PSLETGVQDKEM---------LKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CCTTC-----CC---------CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred Cccccccccchh---------hhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11111 111111 11234568899999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.08 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=201.7
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
..++|++++.||+|+||.||+|..+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999975 78999999997653 22345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC---CCcEEEeeccCceecC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE---NMVAHVSDFGISKLLG 442 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~~~ 442 (581)
|||+++|+|.+++..... +++..++.++.||+.||+||| +.||+||||||+||+++. ++.+||+|||++....
T Consensus 115 ~e~~~~g~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999998876543 788999999999999999999 899999999999999975 4559999999998765
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
... ......||+.|+|||++. ..++.++||||+||++|+|++|++||...... .....+....... + .
T Consensus 191 ~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~-~---~-- 258 (494)
T 3lij_A 191 NQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEKGKYTF-D---S-- 258 (494)
T ss_dssp TTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCC-C---S--
T ss_pred CCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCCC-C---c--
Confidence 332 233457999999999876 46999999999999999999999999764221 1222222211110 0 0
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+....+++.+.++|.+||..||++|||+.|+++|
T Consensus 259 --------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 259 --------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp --------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1112345678899999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=340.99 Aligned_cols=254 Identities=26% Similarity=0.348 Sum_probs=201.7
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--------HHHHHHHHHHHHHHHhcCCCccceEeeeeec
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--------EQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 358 (581)
...++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34578999999999999999999965 68999999986542 1223457899999999999999999999876
Q ss_pred CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc---EEEeec
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV---AHVSDF 435 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~---~kl~Df 435 (581)
.+ .++||||+++++|.+++.... .+++..++.++.||+.||+||| +.||+||||||+||+++.++. +||+||
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred Cc-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 65 899999999999999987654 4789999999999999999999 899999999999999987654 999999
Q ss_pred cCceecCCCCCcceeeccccCccccCCCCC---CCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 008012 436 GISKLLGEGDDSVIQTMTIATIGYMAPEFG---SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLP 512 (581)
Q Consensus 436 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 512 (581)
|++....... ......|++.|+|||++ ....++.++|||||||++|+|++|+.||...... ..+...+.....
T Consensus 162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~ 237 (322)
T 2ycf_A 162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQITSGKY 237 (322)
T ss_dssp TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-SCHHHHHHHTCC
T ss_pred ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-HHHHHHHHhCcc
Confidence 9998764321 12345689999999986 3567899999999999999999999999764332 233333332221
Q ss_pred CCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 513 HGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+ .....++..+.+++.+||..||++|||+.|++++
T Consensus 238 ~~~~--------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 238 NFIP--------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CCCH--------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCc--------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1111 1112345678899999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=356.68 Aligned_cols=251 Identities=15% Similarity=0.176 Sum_probs=195.7
Q ss_pred HhhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccc---hHHHHHHHHHHHH---HHHhcCCCccceEe-------
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQ---LEQAFRSFNSECE---VLRNVRHRNLIKIL------- 353 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~iv~~~------- 353 (581)
...++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+. .+++++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3457899999999999999999995 47999999999743 3345577889994 55555899999998
Q ss_pred eeeecCC-----------------eeeEEEeccCCCCHHHHHhhCCCCCC------HHHHHHHHHHHHHHHHHHhcCCCC
Q 008012 354 SSCCNTN-----------------FKALVLEFMPNGSLDKWLYSHNYFQD------IPDRLNIMIDVALALEYLHHGHST 410 (581)
Q Consensus 354 ~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~~------~~~~~~i~~~i~~~L~~LH~~~~~ 410 (581)
+++.+.+ ..++||||+ +|+|.+++...+.... +..++.++.||+.||+||| +.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~ 225 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HY 225 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hC
Confidence 5555443 278999999 6799999986533222 5788899999999999999 89
Q ss_pred CceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCC-----------CCCccccHHHH
Q 008012 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG-----------NVSSKCDVYSY 479 (581)
Q Consensus 411 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~sl 479 (581)
||+||||||+|||++.++.+||+|||++...+. ......| +.|+|||++.+. .++.++|||||
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 999999999999999999999999999986422 2334567 999999998877 89999999999
Q ss_pred HHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHH
Q 008012 480 GILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMK 559 (581)
Q Consensus 480 G~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 559 (581)
||++|||++|+.||........ ...+.. ....+++.+.++|.+||+.||++|||+.
T Consensus 300 G~il~elltg~~Pf~~~~~~~~-------------~~~~~~-----------~~~~~~~~~~~li~~~L~~dp~~Rpt~~ 355 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGG-------------SEWIFR-----------SCKNIPQPVRALLEGFLRYPKEDRLLPL 355 (377)
T ss_dssp HHHHHHHHHSSCCC------CC-------------SGGGGS-----------SCCCCCHHHHHHHHHHTCSSGGGCCCHH
T ss_pred HHHHHHHHHCCCCCcccccccc-------------hhhhhh-----------hccCCCHHHHHHHHHHcCCCchhCCCHH
Confidence 9999999999999975322111 000000 0013355788999999999999999999
Q ss_pred HHHHH--HHHhHHHH
Q 008012 560 DAATK--LKKIRDKF 572 (581)
Q Consensus 560 evl~~--L~~~~~~~ 572 (581)
|++++ ++++.+..
T Consensus 356 e~l~hp~f~~~~~~~ 370 (377)
T 3byv_A 356 QAMETPEYEQLRTEL 370 (377)
T ss_dssp HHHTSHHHHHHHHHH
T ss_pred HHhhChHHHHHHHHH
Confidence 99974 55555544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=353.05 Aligned_cols=265 Identities=11% Similarity=0.072 Sum_probs=191.1
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc--CCCccceEe-------ee
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV--RHRNLIKIL-------SS 355 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~h~~iv~~~-------~~ 355 (581)
...+|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.+ +||||++++ ++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 3456899999999999999999965 78999999998743 34456778886555555 699988755 34
Q ss_pred eecC-----------------CeeeEEEeccCCCCHHHHHhhCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCc
Q 008012 356 CCNT-----------------NFKALVLEFMPNGSLDKWLYSHNYFQDIPDR------LNIMIDVALALEYLHHGHSTPV 412 (581)
Q Consensus 356 ~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~------~~i~~~i~~~L~~LH~~~~~~i 412 (581)
+... ...++||||++ |+|.+++...+...++..+ ..++.||+.||+||| ++||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~i 215 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGL 215 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCC
Confidence 4322 34799999998 7999999875444566666 788899999999999 8999
Q ss_pred eecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCC--CCCCccccHHHHHHHHHHHHhCC
Q 008012 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE--GNVSSKCDVYSYGILLLETFTRK 490 (581)
Q Consensus 413 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~ 490 (581)
+||||||+|||++.++.+||+|||++...+. ......+++.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987632 1224567799999999987 68999999999999999999999
Q ss_pred CCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHHh
Q 008012 491 KPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK--LKKI 568 (581)
Q Consensus 491 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~ 568 (581)
.||............ ........... ...+....+++.+.++|.+||+.||++|||+.|+++| ++++
T Consensus 291 ~Pf~~~~~~~~~~~~------~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 291 LPFGLVTPGIKGSWK------RPSLRVPGTDS-----LAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CSTTBCCTTCTTCCC------BCCTTSCCCCS-----CCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CCCCCcCcccccchh------hhhhhhccccc-----cchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 999875332111000 00000000000 0011112456678899999999999999999999875 4555
Q ss_pred HHHHH
Q 008012 569 RDKFL 573 (581)
Q Consensus 569 ~~~~~ 573 (581)
.....
T Consensus 360 ~~~~~ 364 (371)
T 3q60_A 360 QNEIS 364 (371)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 44433
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=333.46 Aligned_cols=254 Identities=23% Similarity=0.305 Sum_probs=206.7
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---------HHHHHHHHHHHHHHHhcC-CCccceEeeee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---------EQAFRSFNSECEVLRNVR-HRNLIKILSSC 356 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 356 (581)
...++|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45678999999999999999999975 78999999986432 234567889999999995 99999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeecc
Q 008012 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 357 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
.+.+..++||||+++++|.+++.... .+++..++.++.||+.||+||| +.|++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999998654 4789999999999999999999 8999999999999999999999999999
Q ss_pred CceecCCCCCcceeeccccCccccCCCCCC------CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 008012 437 ISKLLGEGDDSVIQTMTIATIGYMAPEFGS------EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES 510 (581)
Q Consensus 437 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~ 510 (581)
.+........ .....+++.|+|||++. ...++.++||||||+++|+|++|+.||..... ......+...
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~ 244 (298)
T 1phk_A 170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMIMSG 244 (298)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHT
T ss_pred chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHHHHHHhcC
Confidence 9987654322 23456899999999774 55788999999999999999999999976321 1111212211
Q ss_pred CCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 511 LPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.... + . +....++..+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~-~---~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 245 NYQF-G---S----------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp CCCC-C---T----------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred Cccc-C---c----------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 1110 0 0 0112345678899999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=363.55 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=207.3
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4567999999999999999999976 89999999986542 2334678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe---cCCCcEEEeeccCceec
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLL 441 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~~ 441 (581)
||||+.+++|.+++..... +++..++.++.||+.||+||| ++||+||||||+||++ +.++.+||+|||++..+
T Consensus 104 v~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EECCCCSCBHHHHHHTCSC-CBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999999986654 789999999999999999999 8999999999999999 46789999999999876
Q ss_pred CCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
..... .....||+.|+|||++.+ .++.++||||+||++|+|++|++||..... ......+....... +
T Consensus 180 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~-~----- 247 (484)
T 3nyv_A 180 EASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVEKGKYTF-E----- 247 (484)
T ss_dssp CCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCC-C-----
T ss_pred ccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCCCC-C-----
Confidence 44322 234579999999998876 699999999999999999999999976322 11222222211100 0
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+....+++.+.++|.+||..||++|||+.|+++|
T Consensus 248 --------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 --------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 01122345678899999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=351.88 Aligned_cols=264 Identities=17% Similarity=0.211 Sum_probs=212.6
Q ss_pred hhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCC-CccceEeeeeecCCeeeEEE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRH-RNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 366 (581)
..++|++.+.||+|+||.||+|.+ .+++.||||++...... ..+.+|+++++.++| +++..+..++...+..++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 457899999999999999999996 47999999988655322 357789999999976 56666666777888899999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe---cCCCcEEEeeccCceecCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL---DENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~~~~ 443 (581)
||+ +++|.+++......+++..++.|+.||+.||+||| ++||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999 89999999976667899999999999999999999 8999999999999999 6889999999999988754
Q ss_pred CCCcc-----eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccc--cHHHHHHhhCCCCCC
Q 008012 444 GDDSV-----IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM--NLKNWVKESLPHGLP 516 (581)
Q Consensus 444 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~ 516 (581)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||........ .+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~--- 235 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT--- 235 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS---
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc---
Confidence 33211 12355799999999999999999999999999999999999999987433211 111111111000
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
........++.++.+++..||+.||++||++++|++.|+++....
T Consensus 236 -----------~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 236 -----------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp -----------CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----------cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 001112345678999999999999999999999999999987644
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=367.95 Aligned_cols=264 Identities=23% Similarity=0.369 Sum_probs=212.6
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC----CCcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecC
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT 359 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 359 (581)
+.+...++|++.+.||+|+||.||+|.+. .+..||+|.++.. .....+.+.+|+.++++++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 44455678899999999999999999864 2467999998764 3445578999999999999999999999985 4
Q ss_pred CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 360 NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 360 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
+..++||||+++|+|.+++......+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 5689999999999999999977767899999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||...... .....+........+
T Consensus 540 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~~~~~~~-- 614 (656)
T 2j0j_A 540 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERLPMP-- 614 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHTCCCCCC--
T ss_pred ecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCCCCCC--
Confidence 7643322 22233456789999999988899999999999999999997 99999764221 222222222111111
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
..+++.+.++|.+||+.||++|||+.|+++.|+++.++.
T Consensus 615 ---------------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 615 ---------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 134567889999999999999999999999999997654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=346.34 Aligned_cols=264 Identities=21% Similarity=0.265 Sum_probs=187.6
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecC-----
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT----- 359 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 359 (581)
...++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 34588999999999999999999954 7899999998653 334556788999999999999999999998654
Q ss_pred -CeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 360 -NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 360 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
...++|||++ +++|.+++... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCCCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred CCeEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 5679999999 78999988763 4789999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+.. +.........+
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~-i~~~~g~p~~~ 252 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKL-ILRLVGTPGAE 252 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHH-HHHHHCSCCHH
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH-HHHHhCCCCHH
Confidence 865322 234578999999998876 6889999999999999999999999976322 111222 21111111000
Q ss_pred cc----cccch---------hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IA----DANLL---------REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~----~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.. ..... ...........+++.+.+|+.+||..||++|||+.|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00 00000 0000001112345678899999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=344.15 Aligned_cols=269 Identities=21% Similarity=0.245 Sum_probs=205.8
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecC-----C
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT-----N 360 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 360 (581)
...++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 44578999999999999999999965 78899999997543 44457789999999999999999999998654 3
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..++||||+++ +|.+++.... +++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||++..
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEcccCc-CHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 68999999974 9999997653 789999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCcc-eeeccccCccccCCCCCC-CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 441 LGEGDDSV-IQTMTIATIGYMAPEFGS-EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 441 ~~~~~~~~-~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
........ ......||+.|+|||++. +..++.++|||||||++|+|++|+.||...... ..+.... ........+.
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~-~~~~~~~~~~ 255 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-DQLNHIL-GILGSPSQED 255 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG-GHHHHHH-HHHCSCCHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHH-HHhCCCCHHH
Confidence 64332211 123457899999999754 456899999999999999999999999764222 1222222 1111111100
Q ss_pred ccccch-------------hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 ADANLL-------------REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...... ...+.......++..+.+++.+||+.||++|||+.|+++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000011112345678899999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=351.42 Aligned_cols=198 Identities=24% Similarity=0.310 Sum_probs=173.5
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhc------CCCccceEeeeeecCCe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV------RHRNLIKILSSCCNTNF 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~ 361 (581)
...+|++.+.||+|+||.||+|... +++.||||+++... ...+.+.+|+++++.+ .|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4568999999999999999999865 68999999997653 3345677888888887 57799999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc--EEEeeccCc
Q 008012 362 KALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV--AHVSDFGIS 438 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~--~kl~Dfg~a 438 (581)
.++||||+. ++|.+++.... ..+++..++.++.||+.||+||| +.||+||||||+|||++.++. +||+|||++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999996 59999998654 34799999999999999999999 889999999999999999887 999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEM 496 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~ 496 (581)
...... .....||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 865432 23457899999999999999999999999999999999999999764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=348.38 Aligned_cols=267 Identities=20% Similarity=0.266 Sum_probs=202.2
Q ss_pred HHhhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeec-------
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN------- 358 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 358 (581)
+...++|++.+.||+|+||.||+|.. .+|+.||+|++..... ...+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45678899999999999999999996 4899999999875532 23469999999999999999999843
Q ss_pred -------------------------------CCeeeEEEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHH
Q 008012 359 -------------------------------TNFKALVLEFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYL 404 (581)
Q Consensus 359 -------------------------------~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~L 404 (581)
....++||||+++ +|.+.+.. .+..+++..++.++.||+.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3348899999985 88877763 455689999999999999999999
Q ss_pred hcCCCCCceecCCCCCCeEec-CCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCC-CCCccccHHHHHHH
Q 008012 405 HHGHSTPVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGIL 482 (581)
Q Consensus 405 H~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~v 482 (581)
| +.||+||||||+||+++ .++.+||+|||++........ .....+++.|+|||++.+. .++.++||||+||+
T Consensus 158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9 89999999999999998 688999999999987644332 2345689999999987764 58999999999999
Q ss_pred HHHHHhCCCCCCccccccccHHHHHHhhCCC---------------CCCccccccchhhhhhhhHHHHHHHHHHHHHHhc
Q 008012 483 LLETFTRKKPTDEMFTGEMNLKNWVKESLPH---------------GLPKIADANLLREENFFSARMDCLLSIFHLALDC 547 (581)
Q Consensus 483 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 547 (581)
+|||++|++||..... ...+...+...-.. .++......+. ...+..++..+.+++.+|
T Consensus 232 l~ell~g~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~ 305 (383)
T 3eb0_A 232 FGELILGKPLFSGETS-IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR-----KILPEGTPSLAIDLLEQI 305 (383)
T ss_dssp HHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHH-----HHSCTTCCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHH-----hhCCCCCCHHHHHHHHHH
Confidence 9999999999986422 22222222211110 01111111110 011123566789999999
Q ss_pred cCcCCCCCCCHHHHHHH--HHHhHH
Q 008012 548 CAELPDQRLYMKDAATK--LKKIRD 570 (581)
Q Consensus 548 l~~dP~~Rps~~evl~~--L~~~~~ 570 (581)
|..||++|||+.|+++| ++++++
T Consensus 306 L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 306 LRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp CCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred ccCChhhCCCHHHHhcCHHHHHHHh
Confidence 99999999999999976 555544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=347.87 Aligned_cols=255 Identities=22% Similarity=0.273 Sum_probs=203.4
Q ss_pred hcCCCcCCeecccccccEEEEEe----CCCcEEEEEEeccch----HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCC
Q 008012 290 TDGFNECNLLGSGGFGSVYKGIL----SDGTTVAIKIFNLQL----EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTN 360 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 360 (581)
.++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999996 378999999986532 12234567899999999 7999999999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..++||||+++++|.+++.... .+++..++.++.||+.||.||| +.||+||||||+||+++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 9999999999999999998654 3789999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCccccCCCCCCC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSE--GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+........ +.
T Consensus 209 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~-~~- 284 (355)
T 1vzo_A 209 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSE-PP- 284 (355)
T ss_dssp CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHHHHHHHHHHCC-CC-
T ss_pred cccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc-chHHHHHHHHhccC-CC-
Confidence 643221 22334579999999998875 35789999999999999999999999753222 12222222211110 00
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHHH
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATKL 565 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~L 565 (581)
.+..++..+.++|.+||..||++|| |++|++++.
T Consensus 285 -------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 285 -------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0112345678999999999999999 999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=339.98 Aligned_cols=262 Identities=23% Similarity=0.306 Sum_probs=201.7
Q ss_pred ccchhhhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeee
Q 008012 279 RRTSYLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSC 356 (581)
Q Consensus 279 ~~~~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 356 (581)
......++....++|++.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 33455566677899999999999999999999964 789999999875432 235688999999999 899999999999
Q ss_pred ec------CCeeeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc
Q 008012 357 CN------TNFKALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV 429 (581)
Q Consensus 357 ~~------~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~ 429 (581)
.. .+..++||||+++++|.+++.... ..+++..++.++.||+.||+||| +.||+||||||+||+++.++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCC
Confidence 76 467899999999999999998653 45789999999999999999999 889999999999999999999
Q ss_pred EEEeeccCceecCCCCCcceeeccccCccccCCCCCC-----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHH
Q 008012 430 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGS-----EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLK 504 (581)
Q Consensus 430 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~ 504 (581)
+||+|||++....... .......|++.|+|||++. +..++.++|||||||++|+|++|+.||....... ..
T Consensus 168 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~ 243 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--AL 243 (326)
T ss_dssp EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH
T ss_pred EEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HH
Confidence 9999999998664321 1223456899999999876 5678999999999999999999999997632211 11
Q ss_pred HHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 505 NWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+..... +.... ..++..+.++|.+||..||++|||+.|++++
T Consensus 244 ~~~~~~~~---~~~~~-------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 244 FLIPRNPA---PRLKS-------------KKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHSCC---CCCSC-------------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhcCcc---ccCCc-------------cccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111111 11111 1234568899999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=367.30 Aligned_cols=251 Identities=21% Similarity=0.249 Sum_probs=206.5
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 362 (581)
...++|++.+.||+|+||.||+|+.+ +++.||||+++... ....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34678999999999999999999965 78899999998653 22345678899999988 799999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
|+||||+++|+|.+++...+. +++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||+++...
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEeCcCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999987654 789999999999999999999 8999999999999999999999999999998643
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+.+..... .++
T Consensus 494 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~~~~~i~~~~~-~~p------ 562 (674)
T 3pfq_A 494 WDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIMEHNV-AYP------ 562 (674)
T ss_dssp CTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHSSCC-CCC------
T ss_pred cCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HHHHHHHHhCCC-CCC------
Confidence 2222 23456799999999999999999999999999999999999999976321 122222221110 111
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCH-----HHHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYM-----KDAATK 564 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 564 (581)
..++.++.+||.+||..||++||++ +||++|
T Consensus 563 -----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 563 -----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp -----------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred -----------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1234568899999999999999998 777664
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=348.91 Aligned_cols=266 Identities=20% Similarity=0.232 Sum_probs=203.9
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcC--------CCccceEeeeee--
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR--------HRNLIKILSSCC-- 357 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~-- 357 (581)
..++|++.+.||+|+||.||+|+.. +++.||+|+++... ...+.+.+|++++++++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 3578999999999999999999954 78999999997653 34567889999999995 788999999987
Q ss_pred --cCCeeeEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeEecCCC-----
Q 008012 358 --NTNFKALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHST-PVVHCDLKPSNILLDENM----- 428 (581)
Q Consensus 358 --~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dikp~Nill~~~~----- 428 (581)
.....++||||+ ++++.+++... ...+++..++.++.||+.||+||| ++ ||+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhh
Confidence 566899999999 55666666644 356899999999999999999999 77 999999999999998775
Q ss_pred --------------------------------------------cEEEeeccCceecCCCCCcceeeccccCccccCCCC
Q 008012 429 --------------------------------------------VAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF 464 (581)
Q Consensus 429 --------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 464 (581)
.+||+|||.+...... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999876432 234468999999999
Q ss_pred CCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccccc----HHHHHHhhCCCCCC--------------------cccc
Q 008012 465 GSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMN----LKNWVKESLPHGLP--------------------KIAD 520 (581)
Q Consensus 465 ~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~--------------------~~~~ 520 (581)
+.+..++.++|||||||++|||++|+.||......... ....+......... .+.+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99989999999999999999999999999764332211 11111111110000 0000
Q ss_pred ccchh----hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ANLLR----EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..... ...........+..+.+||.+||+.||++|||++|+++|
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00000 000111234567789999999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=336.44 Aligned_cols=268 Identities=21% Similarity=0.272 Sum_probs=199.1
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeee----------
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCC---------- 357 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---------- 357 (581)
..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3578999999999999999999976 68999999998777777788999999999999999999999873
Q ss_pred ----cCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec-CCCcEEE
Q 008012 358 ----NTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD-ENMVAHV 432 (581)
Q Consensus 358 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl 432 (581)
+.+..++||||++ |+|.+++... .+++..++.++.|++.||+||| +.||+||||||+||+++ +++.+||
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999997 5999999753 4788999999999999999999 89999999999999997 5679999
Q ss_pred eeccCceecCCCCC-cceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 008012 433 SDFGISKLLGEGDD-SVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES 510 (581)
Q Consensus 433 ~Dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~ 510 (581)
+|||++........ ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+...
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~ 240 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLILES 240 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHh
Confidence 99999987643211 112234467899999997754 67899999999999999999999999764321 111112222
Q ss_pred CCCCCCc-----------cccccchh-hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 511 LPHGLPK-----------IADANLLR-EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 511 ~~~~~~~-----------~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+..... ........ ..+.......++..+.++|.+||+.||++|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 1111000 00000000 000011122456789999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=334.79 Aligned_cols=254 Identities=25% Similarity=0.329 Sum_probs=196.3
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeec---------
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN--------- 358 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------- 358 (581)
..++|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3567999999999999999999965 79999999997543 445778999999999999999999998754
Q ss_pred ----CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEee
Q 008012 359 ----TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSD 434 (581)
Q Consensus 359 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~D 434 (581)
.+..++||||+++++|.+++.......++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence 45789999999999999999977766788999999999999999999 88999999999999999999999999
Q ss_pred ccCceecCCCCC------------cceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccc
Q 008012 435 FGISKLLGEGDD------------SVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM 501 (581)
Q Consensus 435 fg~a~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~ 501 (581)
||.+........ ........|++.|+|||++.+. .++.++|||||||++|+|++ ||.......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~- 235 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV- 235 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH-
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH-
Confidence 999986642211 1122345689999999988764 78999999999999999998 554321111
Q ss_pred cHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 502 NLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.....+.... ..++.... ..++..+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~-------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 236 NILKKLRSVS-IEFPPDFD-------------DNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHSTT-CCCCTTCC-------------TTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHhccccc-cccCcccc-------------ccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111111111 11111111 1234567899999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.57 Aligned_cols=264 Identities=22% Similarity=0.273 Sum_probs=205.8
Q ss_pred hhcCCCcCCeecccccccEEEEEe-C-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCC------ccceEeeeeecCC
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-S-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHR------NLIKILSSCCNTN 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~ 360 (581)
..++|++.+.||+|+||.||+|.. . +++.||+|+++... ...+.+.+|+++++.++|+ +++++++++.+.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 457899999999999999999986 3 68899999997653 3456788999999998655 4999999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-------------
Q 008012 361 FKALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE------------- 426 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~------------- 426 (581)
..++||||+ +++|.+++...+ ..+++..++.++.||+.||+||| ++||+||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 889999998664 35789999999999999999999 899999999999999987
Q ss_pred ------CCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc
Q 008012 427 ------NMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500 (581)
Q Consensus 427 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~ 500 (581)
++.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~- 240 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK- 240 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH-
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-
Confidence 668999999999875432 23456899999999999999999999999999999999999999764221
Q ss_pred ccHHHHHHhhCCCCCCccccc------------cch--------------hhhhhhhHHHHHHHHHHHHHHhccCcCCCC
Q 008012 501 MNLKNWVKESLPHGLPKIADA------------NLL--------------REENFFSARMDCLLSIFHLALDCCAELPDQ 554 (581)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~------------~~~--------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 554 (581)
.....+.............. ... ...........+++.+.+++.+||+.||++
T Consensus 241 -~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 241 -EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp -HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred -HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 11111221111100000000 000 000001112345678999999999999999
Q ss_pred CCCHHHHHHH
Q 008012 555 RLYMKDAATK 564 (581)
Q Consensus 555 Rps~~evl~~ 564 (581)
|||++|+++|
T Consensus 320 Rpt~~ell~h 329 (339)
T 1z57_A 320 RITLREALKH 329 (339)
T ss_dssp SCCHHHHTTS
T ss_pred ccCHHHHhcC
Confidence 9999999976
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=337.22 Aligned_cols=269 Identities=23% Similarity=0.234 Sum_probs=203.5
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecC-----Ce
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT-----NF 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 361 (581)
..++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4678999999999999999999965 78999999997543 44456788999999999999999999987654 67
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceec
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
.++||||++ ++|.+++... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++...
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 899999997 5999999874 4789999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCcc--------eeeccccCccccCCCCCC-CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 008012 442 GEGDDSV--------IQTMTIATIGYMAPEFGS-EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLP 512 (581)
Q Consensus 442 ~~~~~~~--------~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 512 (581)
....... ......||+.|+|||++. +..++.++|||||||++|+|++|++||...... ..+.........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~ 241 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR-HQLLLIFGIIGT 241 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCC
Confidence 5322111 112346899999999765 477899999999999999999999999764221 111111111110
Q ss_pred CC----CCccccccchh---------hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 513 HG----LPKIADANLLR---------EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 513 ~~----~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.. ........... ..........+++.+.+++.+||+.||++|||++|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00000000000 000011123456788999999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=347.66 Aligned_cols=262 Identities=23% Similarity=0.281 Sum_probs=195.9
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecC------Ceee
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNT------NFKA 363 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~ 363 (581)
.+|++.+.||+|+||.||+|++. +|+.||||++..... ...+|++++++++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46889999999999999999975 699999999865432 234699999999999999999988532 2467
Q ss_pred EEEeccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC-CcEEEeeccCce
Q 008012 364 LVLEFMPNGSLDKWLY---SHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN-MVAHVSDFGISK 439 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~ 439 (581)
+||||+++ ++.+.+. .....+++..++.++.||+.||+||| +.||+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999976 6666655 34556899999999999999999999 8999999999999999955 678999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC-----
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH----- 513 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~----- 513 (581)
.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|++||..... ...+..++...-..
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence 7643322 2345789999999988664 799999999999999999999999976422 22222322211100
Q ss_pred -----CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 514 -----GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 514 -----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
......-+.+....-........+.++.+||.+||..||++|||+.|+++|
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000000000000000000012345678899999999999999999999976
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=339.97 Aligned_cols=267 Identities=21% Similarity=0.337 Sum_probs=205.2
Q ss_pred hhhHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC
Q 008012 283 YLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN 360 (581)
Q Consensus 283 ~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 360 (581)
..+++...++|++.+.||+|+||.||+|..++ .+|+|+++... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34455667899999999999999999999763 59999986542 222345778999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..++||||+++++|.+++...+..+++..++.++.||+.||+||| +.||+||||||+||+++ ++.+||+|||++..
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999999887767899999999999999999999 89999999999999998 67999999999876
Q ss_pred cCCCC---CcceeeccccCccccCCCCCCC---------CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHH
Q 008012 441 LGEGD---DSVIQTMTIATIGYMAPEFGSE---------GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVK 508 (581)
Q Consensus 441 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~ 508 (581)
..... .........|++.|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+.
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~ 256 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--AIIWQMG 256 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--HHHHHHH
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhc
Confidence 53211 1112233458999999998764 45788999999999999999999999763221 1111111
Q ss_pred hhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 509 ESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
.... +..... .++..+.+++.+||..||++|||+.++++.|+++.++..
T Consensus 257 ~~~~---~~~~~~-------------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 257 TGMK---PNLSQI-------------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp TTCC---CCCCCS-------------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred cCCC---CCCCcC-------------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111 111111 123457899999999999999999999999999886643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=338.20 Aligned_cols=204 Identities=26% Similarity=0.318 Sum_probs=174.9
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-CC-----ccceEeeeee
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HR-----NLIKILSSCC 357 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~ 357 (581)
..+...++|++.+.||+|+||.||+|... +++.||||+++... .....+.+|+.+++.++ |+ +|+++++++.
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 34455789999999999999999999965 78899999997553 33456778999988884 55 4999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec--CCCcEEEee
Q 008012 358 NTNFKALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD--ENMVAHVSD 434 (581)
Q Consensus 358 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~--~~~~~kl~D 434 (581)
..+..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||. ++.||+||||||+||+++ .++.+||+|
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999999964 9999998654 457999999999999999999993 247899999999999995 478899999
Q ss_pred ccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Q 008012 435 FGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEM 496 (581)
Q Consensus 435 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~ 496 (581)
||++...... .....||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 205 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 205 FGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999876432 23457899999999999999999999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=339.79 Aligned_cols=262 Identities=24% Similarity=0.255 Sum_probs=200.2
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee---
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK--- 362 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--- 362 (581)
..++|.+.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4578999999999999999999965 7999999999764 344457788999999999999999999999877654
Q ss_pred ---eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 363 ---ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 363 ---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
++||||++ ++|.+++.. .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eeEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 588887743 3789999999999999999999 8899999999999999999999999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+........... ...
T Consensus 193 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~-~~~ 265 (371)
T 4exu_A 193 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPG-TEF 265 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC-HHH
T ss_pred ccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCc-HHH
Confidence 65322 234568999999998877 78899999999999999999999999763211 11222221111100 000
Q ss_pred ccc---cch----------hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 ADA---NLL----------REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ~~~---~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
... ... ...........+++.+.+||.+||+.||++|||++|+++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000 000 0000011112346778999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=327.35 Aligned_cols=254 Identities=23% Similarity=0.290 Sum_probs=205.4
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 445678999999999999999999975 78999999986543 233467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC---CcEEEeeccCcee
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN---MVAHVSDFGISKL 440 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~---~~~kl~Dfg~a~~ 440 (581)
+||||+++++|.+++.... .+++..++.++.||+.||+||| +.|++||||||+||+++.+ +.+||+|||++..
T Consensus 98 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999999987654 3789999999999999999999 8999999999999999754 4799999999986
Q ss_pred cCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
...... .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||...... .....+....... +
T Consensus 174 ~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~-~---- 242 (287)
T 2wei_A 174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVETGKYAF-D---- 242 (287)
T ss_dssp BCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCC-C----
T ss_pred ecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCCC-C----
Confidence 643321 233458899999998776 4899999999999999999999999764221 1222221111100 0
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+....++..+.+++.+||..||++|||+.|++++
T Consensus 243 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 243 ---------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ---------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 01112345678899999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=346.46 Aligned_cols=270 Identities=20% Similarity=0.213 Sum_probs=185.6
Q ss_pred hhcCCCc-CCeecccccccEEEEEeC---CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeec--CCee
Q 008012 289 ATDGFNE-CNLLGSGGFGSVYKGILS---DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN--TNFK 362 (581)
Q Consensus 289 ~~~~y~~-~~~lg~G~~~~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 362 (581)
..+.|++ .++||+|+||.||+|..+ +++.||+|++...... ..+.+|++++++++||||+++++++.. ....
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 3445666 458999999999999965 5789999999765322 357789999999999999999999954 6789
Q ss_pred eEEEeccCCCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe----cCCCcE
Q 008012 363 ALVLEFMPNGSLDKWLYSH--------NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL----DENMVA 430 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill----~~~~~~ 430 (581)
++||||+++ +|.+++... ...+++..++.++.||+.||+||| +.||+||||||+|||+ +.++.+
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 999999965 888887632 224789999999999999999999 8999999999999999 677899
Q ss_pred EEeeccCceecCCCCCc-ceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCcccccc--------
Q 008012 431 HVSDFGISKLLGEGDDS-VIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE-------- 500 (581)
Q Consensus 431 kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~-------- 500 (581)
||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||.......
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 99999999876432211 22344578999999998877 458999999999999999999999997543210
Q ss_pred ccHHHHHHhhCCCC---CCcccccc--------chhhh-hh-------hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHH
Q 008012 501 MNLKNWVKESLPHG---LPKIADAN--------LLREE-NF-------FSARMDCLLSIFHLALDCCAELPDQRLYMKDA 561 (581)
Q Consensus 501 ~~~~~~~~~~~~~~---~~~~~~~~--------~~~~~-~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 561 (581)
..+...+...-... +..+.... +.... .. .......+..+.+||.+||..||++|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 11222221111111 11000000 00000 00 00000114568899999999999999999999
Q ss_pred HHH
Q 008012 562 ATK 564 (581)
Q Consensus 562 l~~ 564 (581)
++|
T Consensus 332 L~h 334 (405)
T 3rgf_A 332 MQD 334 (405)
T ss_dssp HTS
T ss_pred hcC
Confidence 986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=346.18 Aligned_cols=260 Identities=24% Similarity=0.305 Sum_probs=196.4
Q ss_pred hhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC------ee
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN------FK 362 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~ 362 (581)
...+|++.+.||+|+||.||+|+...+..||+|.+..... ...+|+++++.++||||+++++++...+ ..
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3467999999999999999999987667799998765432 2236999999999999999999985533 37
Q ss_pred eEEEeccCCCCHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec-CCCcEEEeeccCce
Q 008012 363 ALVLEFMPNGSLDKWLY--SHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD-ENMVAHVSDFGISK 439 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~ 439 (581)
++||||++++.+..... .....+++..++.++.||+.||+||| +.||+||||||+||+++ .++.+||+|||+++
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 89999998754333322 33456899999999999999999999 89999999999999999 79999999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCC-----
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH----- 513 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~----- 513 (581)
....... .....+|+.|+|||++.+. .++.++||||+||++|||++|++||..... ...+...+...-..
T Consensus 191 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 191 ILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-IDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp ECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHH
T ss_pred cccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence 7643332 2345689999999987664 589999999999999999999999976422 12222222211100
Q ss_pred ----------CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 514 ----------GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 514 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.++......+. ......+++++.+|+.+||..||++|||+.|+++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFS-----KVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHH-----HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccccccCCcHH-----HhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 01111110000 00112355678999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=334.05 Aligned_cols=257 Identities=23% Similarity=0.297 Sum_probs=182.0
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHH-HHHhcCCCccceEeeeeecCCeee
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECE-VLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
....++|++.+.||+|+||.||+|... +|+.||+|+++... ......+..|+. +++.++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 344688999999999999999999975 79999999997653 333445556666 666779999999999999999999
Q ss_pred EEEeccCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 364 LVLEFMPNGSLDKWLYS----HNYFQDIPDRLNIMIDVALALEYLHHGHST-PVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
+||||+++ +|.+++.. ....+++..+..++.|++.||.||| +. ||+||||||+||+++.++.+||+|||++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999975 88887763 2455789999999999999999999 67 9999999999999999999999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCC----CCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFG----SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG 514 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 514 (581)
....... ......|++.|+|||++ .+..++.++||||||+++|+|++|+.||....... ..+.......
T Consensus 174 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~ 246 (327)
T 3aln_A 174 GQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----DQLTQVVKGD 246 (327)
T ss_dssp CC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSC
T ss_pred eeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----HHHHHHhcCC
Confidence 8664322 12334689999999998 56678999999999999999999999997532111 1111111111
Q ss_pred CCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 515 LPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+..... ....++..+.+++.+||..||++|||+.|++++
T Consensus 247 ~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 247 PPQLSNS----------EEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCCC----------SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCCc----------ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 1111100 011234578899999999999999999999886
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=333.99 Aligned_cols=269 Identities=25% Similarity=0.309 Sum_probs=203.5
Q ss_pred HhhcCCCcCCeecccccccEEEEEe--CCCcEEEEEEeccchH--HHHHHHHHHHHHHHhc---CCCccceEeeeee---
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGIL--SDGTTVAIKIFNLQLE--QAFRSFNSECEVLRNV---RHRNLIKILSSCC--- 357 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~--- 357 (581)
...++|++.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4568899999999999999999997 3688999999865431 1122455677777766 8999999999987
Q ss_pred --cCCeeeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEee
Q 008012 358 --NTNFKALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSD 434 (581)
Q Consensus 358 --~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~D 434 (581)
.....++||||++ |+|.+++.... ..+++..++.++.|++.||.||| +.||+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999997 59999998653 34789999999999999999999 89999999999999999999999999
Q ss_pred ccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC
Q 008012 435 FGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG 514 (581)
Q Consensus 435 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 514 (581)
||++....... ......++..|+|||++.+..++.++||||||+++|+|++|+.||...... ..+...+.......
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPG 239 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCC
Confidence 99998654221 223456899999999999999999999999999999999999999764221 12222222111110
Q ss_pred ---CCcccc---ccch--hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 515 ---LPKIAD---ANLL--REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 515 ---~~~~~~---~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+.... .... ...........++..+.+++.+||..||++|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 0000 0000011122456678899999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=332.19 Aligned_cols=254 Identities=24% Similarity=0.273 Sum_probs=186.1
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
...++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+..+..+++.++||||+++++++.+.+..++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 34578899999999999999999975 79999999997653 2333445555667888899999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST-PVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
||||+ ++.+..+.......+++..++.++.|++.||.||| +. ||+||||||+||+++.++.+||+|||++.....
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999 55666666655566899999999999999999999 64 999999999999999999999999999976543
Q ss_pred CCCcceeeccccCccccCCCCCC-----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGS-----EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
.. ......+++.|+|||++. +..++.++||||||+++|+|++|+.||................ .....+.
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~- 252 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPG- 252 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-CCCCCCS-
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc-CCCCCCc-
Confidence 22 223456899999999884 5578899999999999999999999997643222222222221 1111111
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...++..+.+++.+||+.||++|||++|++++
T Consensus 253 --------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 253 --------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01234568899999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=334.05 Aligned_cols=264 Identities=22% Similarity=0.287 Sum_probs=202.9
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CC-cEEEEEEeccchHHHHHHHHHHHHHHHhcCCCc------cceEeeeeecCC
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DG-TTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRN------LIKILSSCCNTN 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~ 360 (581)
..++|++.+.||+|+||.||+|... ++ +.||+|+++... ...+.+.+|++++++++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 4578999999999999999999965 44 789999997653 34467888999999997655 899999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEe---------------
Q 008012 361 FKALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILL--------------- 424 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill--------------- 424 (581)
..++||||+ ++++.+++.... ..+++..++.++.||+.||+||| +.||+||||||+||++
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999 667777776553 45899999999999999999999 8999999999999999
Q ss_pred ----cCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc
Q 008012 425 ----DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE 500 (581)
Q Consensus 425 ----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~ 500 (581)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~- 245 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR- 245 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 567899999999998754322 3456899999999999999999999999999999999999999764221
Q ss_pred ccHHHHHHhhCCCCCCccc----------------cccchhh----------hhhhhHHHHHHHHHHHHHHhccCcCCCC
Q 008012 501 MNLKNWVKESLPHGLPKIA----------------DANLLRE----------ENFFSARMDCLLSIFHLALDCCAELPDQ 554 (581)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~----------------~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~ 554 (581)
.....+............ +...... ..........+..+.++|.+||+.||++
T Consensus 246 -~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 246 -EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp -HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred -HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 111112111111100000 0000000 0000111234567899999999999999
Q ss_pred CCCHHHHHHH
Q 008012 555 RLYMKDAATK 564 (581)
Q Consensus 555 Rps~~evl~~ 564 (581)
|||+.|+++|
T Consensus 325 Rpt~~e~l~h 334 (355)
T 2eu9_A 325 RITLAEALLH 334 (355)
T ss_dssp SCCHHHHTTS
T ss_pred CcCHHHHhcC
Confidence 9999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=332.54 Aligned_cols=255 Identities=20% Similarity=0.253 Sum_probs=176.4
Q ss_pred HhhcCCCcCC-eecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeec----CCe
Q 008012 288 RATDGFNECN-LLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN----TNF 361 (581)
Q Consensus 288 ~~~~~y~~~~-~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~ 361 (581)
...++|.+.+ .||+|+||.||+|... +++.||+|++...... .......++.+.||||+++++++.. ...
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 4567888865 6999999999999976 7999999999765321 1222334566799999999999876 446
Q ss_pred eeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC---CCcEEEeeccC
Q 008012 362 KALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE---NMVAHVSDFGI 437 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~ 437 (581)
.++||||+++|+|.+++.... ..+++..++.++.||+.||+||| +.||+||||||+||+++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 899999999999999998764 45899999999999999999999 889999999999999986 45699999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
+....... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||.......... . ...........
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~-~~~~~~~~~~~ 251 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-G-MKRRIRLGQYG 251 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------C
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-h-HHHhhhccccc
Confidence 98764322 234567999999999998899999999999999999999999997643221100 0 00000000000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
.. ......++..+.+++.+||+.||++|||++|++++-
T Consensus 252 ~~----------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 252 FP----------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp CC----------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred cC----------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00 001123456788999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=334.68 Aligned_cols=274 Identities=20% Similarity=0.225 Sum_probs=192.3
Q ss_pred hhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe-
Q 008012 284 LDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF- 361 (581)
Q Consensus 284 ~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 361 (581)
.......++|++.+.||+|+||.||+|... +++.||||++..... ......+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345567789999999999999999999975 789999998865432 12345678888889999999999999865332
Q ss_pred ------eeEEEeccCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-CCcEE
Q 008012 362 ------KALVLEFMPNGSLDKWLY---SHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE-NMVAH 431 (581)
Q Consensus 362 ------~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~-~~~~k 431 (581)
.++||||+++ +|.+.+. .....+++..+..++.|++.||.||| .|+.||+||||||+||+++. ++.+|
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEE
Confidence 7899999986 5555444 24455788999999999999999999 34689999999999999996 89999
Q ss_pred EeeccCceecCCCCCcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 008012 432 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES 510 (581)
Q Consensus 432 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~ 510 (581)
|+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+.......
T Consensus 173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~ 248 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRVL 248 (360)
T ss_dssp ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHHc
Confidence 999999987653322 2345689999999987654 4899999999999999999999999764221 2222222211
Q ss_pred CCCC-----------C-Cccccc-cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 511 LPHG-----------L-PKIADA-NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 511 ~~~~-----------~-~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.... . ....+. ..............++..+.+++.+||+.||++|||+.|+++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1100 0 000000 0000000001111246789999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=340.23 Aligned_cols=252 Identities=23% Similarity=0.293 Sum_probs=189.4
Q ss_pred cCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEEecc
Q 008012 291 DGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
+.|...+.||+|+||+||.+...+|+.||||++..... +.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGH---HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 34455678999999999877666799999999876543 3567899999987 8999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCC------CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCC-------------CcE
Q 008012 370 PNGSLDKWLYSHNYFQ------DIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDEN-------------MVA 430 (581)
Q Consensus 370 ~~~~L~~~l~~~~~~~------~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~-------------~~~ 430 (581)
+ |+|.+++....... ++..++.++.||+.||+||| +.||+||||||+||+++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 59999998654311 22345789999999999999 8999999999999999754 489
Q ss_pred EEeeccCceecCCCCCcc--eeeccccCccccCCCCCCC-------CCCCccccHHHHHHHHHHHHh-CCCCCCcccccc
Q 008012 431 HVSDFGISKLLGEGDDSV--IQTMTIATIGYMAPEFGSE-------GNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGE 500 (581)
Q Consensus 431 kl~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~ 500 (581)
||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999999875433221 1234579999999998865 678999999999999999999 999997643221
Q ss_pred ccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 501 MNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+...... +.... .....++.++.++|.+||+.||++|||+.|+++|
T Consensus 248 ---~~i~~~~~~~--~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 ---SNIIRGIFSL--DEMKC----------LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp ---HHHHHTCCCC--CCCTT----------CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---HHHhcCCCCc--ccccc----------cccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 2222221111 11000 0112456788999999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=335.49 Aligned_cols=262 Identities=24% Similarity=0.254 Sum_probs=198.6
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe----
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF---- 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 361 (581)
..++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 3578999999999999999999965 7999999998654 34445678899999999999999999999987654
Q ss_pred --eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 362 --KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 362 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
.++||||++ ++|.+++.. .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 588887743 3789999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+....... .......
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~-~~~~~~~ 247 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVT-GVPGTEF 247 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHH-CBCCHHH
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh-CCCCHHH
Confidence 65322 234568999999998776 67899999999999999999999999763221 1111111111 0000000
Q ss_pred ----ccccc---hh------hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 519 ----ADANL---LR------EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 519 ----~~~~~---~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+... .. ..........++..+.+++.+||..||++|||++|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 00 000001112346678999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.77 Aligned_cols=263 Identities=19% Similarity=0.226 Sum_probs=201.1
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-----------CCccceEeeeee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-----------HRNLIKILSSCC 357 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~ 357 (581)
.++|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999964 78999999997653 33456788999999885 899999999987
Q ss_pred cCC----eeeEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeEec------
Q 008012 358 NTN----FKALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHST-PVVHCDLKPSNILLD------ 425 (581)
Q Consensus 358 ~~~----~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dikp~Nill~------ 425 (581)
..+ ..++||||+ +++|.+++... ...+++..++.++.||+.||+||| ++ ||+||||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence 654 789999999 88999999864 344799999999999999999999 77 999999999999995
Q ss_pred CCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-----
Q 008012 426 ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE----- 500 (581)
Q Consensus 426 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~----- 500 (581)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 3448999999999876432 233468999999999999999999999999999999999999997642211
Q ss_pred ccHHHHHHhhCCCCCCc---------------------cccccchh----hhhhhhHHHHHHHHHHHHHHhccCcCCCCC
Q 008012 501 MNLKNWVKESLPHGLPK---------------------IADANLLR----EENFFSARMDCLLSIFHLALDCCAELPDQR 555 (581)
Q Consensus 501 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 555 (581)
..+...+.. ... ++. +....... .......+..++..+.+||.+||+.||++|
T Consensus 248 ~~~~~~~~~-~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 248 DHIAQIIEL-LGE-LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHH-HCS-CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHh-cCC-CCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 111111111 110 000 00000000 000111234677889999999999999999
Q ss_pred CCHHHHHHH
Q 008012 556 LYMKDAATK 564 (581)
Q Consensus 556 ps~~evl~~ 564 (581)
||++|+++|
T Consensus 326 pt~~ell~h 334 (373)
T 1q8y_A 326 ADAGGLVNH 334 (373)
T ss_dssp BCHHHHHTC
T ss_pred CCHHHHhhC
Confidence 999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.50 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=191.1
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEEE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
....+|.+.+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34456889999999999997655556799999999865432 2355799999999 8999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-----CCcEEEeeccCceec
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE-----NMVAHVSDFGISKLL 441 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~-----~~~~kl~Dfg~a~~~ 441 (581)
||++ |+|.+++...........++.++.||+.||+||| +.||+||||||+||+++. ...+||+|||++...
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 9996 5999999877655566677899999999999999 899999999999999953 336889999999876
Q ss_pred CCCCCc-ceeeccccCccccCCCCCC---CCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCC
Q 008012 442 GEGDDS-VIQTMTIATIGYMAPEFGS---EGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLP 516 (581)
Q Consensus 442 ~~~~~~-~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 516 (581)
...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||...... ..... ......
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~~~~~---~~~~~~ 247 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---QANIL---LGACSL 247 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---HHHHH---TTCCCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---HHHHH---hccCCc
Confidence 533221 2234457999999999987 4577889999999999999999 99998643211 11111 111100
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.... .....+..+.++|.+||+.||++|||++|+++|
T Consensus 248 ~~~~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 DCLH-----------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTSC-----------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccC-----------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0000 011334557899999999999999999999965
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=331.43 Aligned_cols=247 Identities=25% Similarity=0.268 Sum_probs=200.9
Q ss_pred hhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHH------HHHHHHHHHHHHHhcC--CCccceEee
Q 008012 284 LDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQ------AFRSFNSECEVLRNVR--HRNLIKILS 354 (581)
Q Consensus 284 ~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~iv~~~~ 354 (581)
.+.+...++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.++++++ ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 344556788999999999999999999954 7899999998765311 1235667999999996 599999999
Q ss_pred eeecCCeeeEEEeccCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec-CCCcEEE
Q 008012 355 SCCNTNFKALVLEFMPN-GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD-ENMVAHV 432 (581)
Q Consensus 355 ~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl 432 (581)
++...+..++|||++.+ ++|.+++...+ .+++..++.++.||+.||+||| +.||+||||||+||+++ +++.+||
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999999976 89999998754 3788999999999999999999 89999999999999999 7899999
Q ss_pred eeccCceecCCCCCcceeeccccCccccCCCCCCCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhC
Q 008012 433 SDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNV-SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESL 511 (581)
Q Consensus 433 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 511 (581)
+|||++....... .....|++.|+|||++.+..+ +.++||||||+++|||++|+.||.... .......
T Consensus 192 ~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~~ 260 (320)
T 3a99_A 192 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV 260 (320)
T ss_dssp CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC
T ss_pred eeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhcccc
Confidence 9999998765322 234568999999998876665 678999999999999999999996521 1111110
Q ss_pred CCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 512 PHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+ ..+++.+.++|.+||+.||++|||++|++++
T Consensus 261 --~~~-----------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 --FFR-----------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --CCS-----------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --ccc-----------------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 1234568899999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=328.09 Aligned_cols=246 Identities=27% Similarity=0.306 Sum_probs=192.8
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH------HHHHHHHHHHHHHHhc----CCCccceEe
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE------QAFRSFNSECEVLRNV----RHRNLIKIL 353 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~~iv~~~ 353 (581)
+.+...++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 44556788999999999999999999964 789999999975532 1233466799999999 899999999
Q ss_pred eeeecCCeeeEEEec-cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec-CCCcEE
Q 008012 354 SSCCNTNFKALVLEF-MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD-ENMVAH 431 (581)
Q Consensus 354 ~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~-~~~~~k 431 (581)
+++...+..++|||| +.+++|.+++...+. +++..++.++.||+.||+||| +.||+||||||+||+++ .++.+|
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence 999999999999999 789999999987553 789999999999999999999 88999999999999999 889999
Q ss_pred EeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhh
Q 008012 432 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVS-SKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES 510 (581)
Q Consensus 432 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~ 510 (581)
|+|||++....... .....|+..|+|||++.+..+. .++||||||+++|+|++|+.||.... ......
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~ 249 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEAE 249 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHTC
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhhhc
Confidence 99999998765432 2345689999999988766664 58999999999999999999997521 111111
Q ss_pred CCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 511 LPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..++ ..++..+.++|.+||+.||++|||++|++++
T Consensus 250 --~~~~-----------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 250 --LHFP-----------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --CCCC-----------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --cCCc-----------------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111 1234568899999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.43 Aligned_cols=264 Identities=22% Similarity=0.271 Sum_probs=198.7
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeec------CC
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCN------TN 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 360 (581)
..++|++.+.||+|+||.||+|... +|+.||+|+++.. .....+.+.+|++++++++||||+++++++.. .+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3478999999999999999999964 7899999998765 34556779999999999999999999998765 66
Q ss_pred eeeEEEeccCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc---EEEeec
Q 008012 361 FKALVLEFMPNGSLDKWLYSHN--YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV---AHVSDF 435 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~---~kl~Df 435 (581)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.||+||||||+||+++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 7899999999999999998643 25788999999999999999999 899999999999999997664 999999
Q ss_pred cCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC-
Q 008012 436 GISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG- 514 (581)
Q Consensus 436 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~- 514 (581)
|.+........ .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ..|........
T Consensus 169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~~~~~ 241 (676)
T 3qa8_A 169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVREKSN 241 (676)
T ss_dssp CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC----
T ss_pred ccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhhcccc
Confidence 99987654322 23457899999999999999999999999999999999999999753211 11100000000
Q ss_pred ----CCccccccc--hhh-hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHH
Q 008012 515 ----LPKIADANL--LRE-ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAA 562 (581)
Q Consensus 515 ----~~~~~~~~~--~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 562 (581)
......... ... .........++..+.+++.+||..||++|||+.|++
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000000000 000 000011224667899999999999999999999854
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.35 Aligned_cols=235 Identities=13% Similarity=0.051 Sum_probs=188.0
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+..+++++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3478999999999999999999975 68999999997652 4455788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
||||++|++|.+++... ....++..++.|++.||+||| +.||+||||||+||+++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999999643 355678899999999999999 8999999999999999999999998544
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
|++ .++.++|||||||++|||+||+.||............ . .......
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---------~-~~~~~~~- 222 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---------E-RDTAGQP- 222 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---------C-BCTTSCB-
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---------H-HHhccCC-
Confidence 222 3688999999999999999999999864322110000 0 0000000
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
.........+++.+.+++.+||+.||++| |+.|+++.|+++....
T Consensus 223 --~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 223 --IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp --CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred --CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 00011223456778999999999999999 9999999999987543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=309.35 Aligned_cols=232 Identities=19% Similarity=0.270 Sum_probs=182.1
Q ss_pred hhcCCCcC-CeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHH-HhcCCCccceEeeeeec----CCe
Q 008012 289 ATDGFNEC-NLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVL-RNVRHRNLIKILSSCCN----TNF 361 (581)
Q Consensus 289 ~~~~y~~~-~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~ 361 (581)
..++|.+. +.||+|+||.||+|... +++.||+|+++.. ..+.+|+.++ +..+||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 34667777 77999999999999964 7899999999754 3456788888 55599999999999876 677
Q ss_pred eeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC---CCcEEEeeccC
Q 008012 362 KALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE---NMVAHVSDFGI 437 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~ 437 (581)
.++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.||+||||||+||+++. ++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 899999999999999998754 35899999999999999999999 899999999999999997 78999999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
+.... +..++.++|||||||++|||++|+.||........ .... ...
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------~~~~---~~~ 213 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------SPGM---KTR 213 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------CCS---CCS
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------hHHH---HHH
Confidence 87542 23567899999999999999999999976322110 0000 000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+...... ........+++++.+++.+||+.||++|||+.|+++|
T Consensus 214 ~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 214 IRMGQYE---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCTTCCS---SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Hhhcccc---CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000 0011223456789999999999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=348.01 Aligned_cols=244 Identities=22% Similarity=0.298 Sum_probs=198.1
Q ss_pred hhcCCCcCCeecccccccEEEEEeC--CCcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe----
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS--DGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF---- 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 361 (581)
..++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|++++++++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3478999999999999999999975 6899999998644 34555678999999999999999999999987655
Q ss_pred -eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 362 -KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 362 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
.|+||||++|++|.+++.. .+++..++.++.||+.||.||| ++||+||||||+||+++.+ .+||+|||++..
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999999999998765 4799999999999999999999 8999999999999999885 899999999987
Q ss_pred cCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
.... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||....... ++.
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------~~~--- 286 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------LPE--- 286 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------CCT---
T ss_pred cccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--------------ccc---
Confidence 6432 345689999999988765 4889999999999999999999876532111 000
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-HHHHHHHHHHhHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLY-MKDAATKLKKIRDKF 572 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~L~~~~~~~ 572 (581)
.......++.+.++|.+||+.||++||+ ++++.+.|..+..+.
T Consensus 287 ---------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 287 ---------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp ---------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred ---------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 0111234467889999999999999995 666677777665443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.02 Aligned_cols=251 Identities=16% Similarity=0.151 Sum_probs=186.4
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCC-CccceEe---------
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRH-RNLIKIL--------- 353 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~iv~~~--------- 353 (581)
.....|...+.||+|+||.||+|.+. +|+.||||+++... ....+.+.+|+.+++.++| ++...+.
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34455778889999999999999954 79999999987432 2235678899999999976 3221111
Q ss_pred ------------eeeec-----CCeeeEEEeccCCCCHHHHHh------hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 008012 354 ------------SSCCN-----TNFKALVLEFMPNGSLDKWLY------SHNYFQDIPDRLNIMIDVALALEYLHHGHST 410 (581)
Q Consensus 354 ------------~~~~~-----~~~~~lv~e~~~~~~L~~~l~------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~ 410 (581)
.++.. ....+++|+++ +++|.+++. ..+..+++..++.++.||++||+||| ++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~ 230 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HY 230 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 11111 12456777766 679999985 22344677889999999999999999 89
Q ss_pred CceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCC----------CCCCCCccccHHHHH
Q 008012 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFG----------SEGNVSSKCDVYSYG 480 (581)
Q Consensus 411 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Dv~slG 480 (581)
||+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 9999999999999999999999999999865322 334467 999999988 666788999999999
Q ss_pred HHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHH
Q 008012 481 ILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKD 560 (581)
Q Consensus 481 ~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 560 (581)
|++|||++|+.||........ ...+.. ....+++.+.++|.+||+.||++|||+.|
T Consensus 305 vil~elltg~~Pf~~~~~~~~-------------~~~~~~-----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ 360 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGG-------------SEWIFR-----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQ 360 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSC-------------SGGGGS-----------SCCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHCCCCCCCcchhhh-------------HHHHHh-----------hcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999999999976422111 000000 00123466889999999999999999998
Q ss_pred HHHH--HHHhHHHH
Q 008012 561 AATK--LKKIRDKF 572 (581)
Q Consensus 561 vl~~--L~~~~~~~ 572 (581)
++++ ++++.+..
T Consensus 361 ~l~~~~~~~~~~~~ 374 (413)
T 3dzo_A 361 AMETPEYEQLRTEL 374 (413)
T ss_dssp HTTSHHHHHHHHHH
T ss_pred HHhCHHHHHHHHHH
Confidence 8765 44444433
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=317.47 Aligned_cols=245 Identities=18% Similarity=0.218 Sum_probs=184.9
Q ss_pred hcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccch--------HHHHHHHHHHHHHHHhcC---------CCccceE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--------EQAFRSFNSECEVLRNVR---------HRNLIKI 352 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~iv~~ 352 (581)
.++|++.+.||+|+||.||+|++ +|+.||||++.... ....+.+.+|++++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 58999999997652 122357888999998886 5555555
Q ss_pred eee-----------------eec-------------CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q 008012 353 LSS-----------------CCN-------------TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALE 402 (581)
Q Consensus 353 ~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~ 402 (581)
.++ +.+ .+..++||||+++|++.+.+.+ ..+++..++.++.||+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 554 433 6789999999999977666644 34789999999999999999
Q ss_pred HHhcCCCCCceecCCCCCCeEecCCC--------------------cEEEeeccCceecCCCCCcceeeccccCccccCC
Q 008012 403 YLHHGHSTPVVHCDLKPSNILLDENM--------------------VAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462 (581)
Q Consensus 403 ~LH~~~~~~i~H~dikp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 462 (581)
|||+ +.||+||||||+|||++.++ .+||+|||+|+..... ...||+.|+||
T Consensus 176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDE 246 (336)
T ss_dssp HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCS
T ss_pred HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccCh
Confidence 9993 47899999999999999887 9999999999876422 34789999999
Q ss_pred CCCCCCCCCccccHHHHHHH-HHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHH
Q 008012 463 EFGSEGNVSSKCDVYSYGIL-LLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIF 541 (581)
Q Consensus 463 E~~~~~~~~~~~Dv~slG~v-l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 541 (581)
|++.+.. +.++||||+|++ .+++++|..||....... .....+...... .. .........+++++.
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~-~~~~~~~~~~~~--~~---------~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH-YLTDKMLKQMTF--KT---------KCNTPAMKQIKRKIQ 313 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH-HHHHHHHHTCCC--SS---------CCCSHHHHHHHHHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh-HHHHhhhhhhcc--Cc---------ccchhhhhhcCHHHH
Confidence 9998766 889999998777 788999999985310000 011111111000 00 001123346788899
Q ss_pred HHHHhccCcCCCCCCCHHHHH-HH
Q 008012 542 HLALDCCAELPDQRLYMKDAA-TK 564 (581)
Q Consensus 542 ~li~~cl~~dP~~Rps~~evl-~~ 564 (581)
+||.+||+.| |++|++ +|
T Consensus 314 dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHhccC-----CHHHHHhcC
Confidence 9999999976 999998 54
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=266.25 Aligned_cols=209 Identities=31% Similarity=0.514 Sum_probs=141.0
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCC-CCcE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALE-YILY 81 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~ 81 (581)
++++|++|+|++|++++.+|..|.++++|++|+|++|.|++..|..|..+++|++|+|++|++++.+|..+..++ +|++
T Consensus 99 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~ 178 (313)
T 1ogq_A 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178 (313)
T ss_dssp GCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCE
T ss_pred cCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcE
Confidence 344455555555555444444455555555555555555544445555555555555555555444454555544 5555
Q ss_pred EecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeecccccc
Q 008012 82 VNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNL 161 (581)
Q Consensus 82 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l 161 (581)
|++++|++++..|..+..++ |++|++++|.+++..|..|.++++|+.|+|++|.+++..|. +..+++|++|+|++|.+
T Consensus 179 L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l 256 (313)
T 1ogq_A 179 MTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRI 256 (313)
T ss_dssp EECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCC
T ss_pred EECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcc
Confidence 55555555544455555444 55555555555555666667777777777777777755544 77788899999999999
Q ss_pred CCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCCC
Q 008012 162 SEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 162 ~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 213 (581)
++..|..+..+++|+.|++++|++++.+|....+..+..+.+.+|++.|+.|
T Consensus 257 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp EECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred cCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCC
Confidence 8889999999999999999999999999998889999999999999999975
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=293.97 Aligned_cols=230 Identities=34% Similarity=0.577 Sum_probs=191.9
Q ss_pred CCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcE
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILY 81 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 81 (581)
+.+++|++|+|++|++++.+|..+.++++|++|+|++|++++..|..|..+++|++|+|++|++++.+|..+..+++|+.
T Consensus 463 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 542 (768)
T 3rgz_A 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIW 542 (768)
T ss_dssp GGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCE
T ss_pred cCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCE
Confidence 35677788888888887777888888888888888888888778888888888888888888888788888888888888
Q ss_pred EecccCcCCCCCCccc----------------------------------------------------------------
Q 008012 82 VNLSSNYLTGSLTSDI---------------------------------------------------------------- 97 (581)
Q Consensus 82 L~l~~n~l~~~~~~~~---------------------------------------------------------------- 97 (581)
|++++|.+++.+|..+
T Consensus 543 L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g 622 (768)
T 3rgz_A 543 LDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG 622 (768)
T ss_dssp EECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEE
T ss_pred EECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecc
Confidence 8888888776665433
Q ss_pred ------cCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhc
Q 008012 98 ------QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVA 171 (581)
Q Consensus 98 ------~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 171 (581)
..++.|++|+|++|++++.+|..++++++|+.|+|++|+++|.+|..|+.+++|+.|+|++|++++.+|..+..
T Consensus 623 ~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~ 702 (768)
T 3rgz_A 623 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 702 (768)
T ss_dssp ECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGG
T ss_pred cCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhC
Confidence 33577889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCCCCCCCCCCCcccccccchheee
Q 008012 172 LSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCKEDKNKGFKKVALL 234 (581)
Q Consensus 172 l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~~p~c~~~~~~~~~~~~~~ 234 (581)
+++|+.|++++|+++|.+|..+.+..+....+.+||+.||++ .++|......++.++...
T Consensus 703 l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~---l~~C~~~~~~~~~~~~~~ 762 (768)
T 3rgz_A 703 LTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNADGYAHHQRS 762 (768)
T ss_dssp CCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT---SCCCCSCC----------
T ss_pred CCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC---CcCCCCCccCCCCCCCCc
Confidence 999999999999999999999889999999999999999986 348988888777665443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-31 Score=286.30 Aligned_cols=186 Identities=18% Similarity=0.080 Sum_probs=132.8
Q ss_pred eecccccccEEEEE-eCCCcEEEEEEeccc----------hHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEE
Q 008012 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQ----------LEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 298 ~lg~G~~~~v~~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 365 (581)
..+.|++|.+..++ .-.|+.+++|++... .+...+.+.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35666777666655 336899999999653 234456799999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||++|++|.+++.+.+. ++.. +|+.||+.||+|+| ++||+||||||+|||++++|++||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~~~-l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE-IDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTTCC-CCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhCCC-CCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 999999999999987654 4543 58999999999999 8999999999999999999999999999998764332
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCC
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPT 493 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf 493 (581)
. ......||+.|+|||++.+ .+..++|+||+|++++++.++..|+
T Consensus 394 ~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 S--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred c--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 2 2345679999999999876 5677899999999998887765543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-28 Score=239.31 Aligned_cols=210 Identities=23% Similarity=0.227 Sum_probs=194.3
Q ss_pred CCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCc-ccCCCCcccccCCCCcEE
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNK-LTSSIPSALWALEYILYV 82 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L 82 (581)
.++|++|+|++|+|+++.+..|..+++|++|+|++|.|++..+..|.++++|++|+|++|+ +++..|..|..+++|++|
T Consensus 31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 4689999999999998888889999999999999999998889999999999999999997 887778999999999999
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
++++|.+++..+..+..+++|++|++++|.+++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|.++
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccc
Confidence 99999999888889999999999999999999777777999999999999999999877778999999999999999999
Q ss_pred CCCchhhhcccccCeeEccCCCCCCCCCC-CCCCcCCccccccccccccCCC
Q 008012 163 EGIPKSLVALSHLKQFNVSHNRLEGEIPT-EGPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 163 ~~~~~~~~~l~~L~~l~l~~n~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~~ 213 (581)
+..|..+..+++|+.|++++|++++.++. ...+..+..+++.+|++.|+-.
T Consensus 191 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred ccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 98899999999999999999999976654 4678889999999999999754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=244.59 Aligned_cols=205 Identities=23% Similarity=0.444 Sum_probs=107.0
Q ss_pred CCCCCcEEEeec-CcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcE
Q 008012 3 RMQQLQGIGLAD-NHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILY 81 (581)
Q Consensus 3 ~~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 81 (581)
++++|++|+|++ |++++.+|..|+++++|++|+|++|.|++..|..|.++++|++|+|++|++++..|..+..+++|++
T Consensus 74 ~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 153 (313)
T 1ogq_A 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153 (313)
T ss_dssp GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred CCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCe
Confidence 344555555553 5555455555555555555555555555445555555555555555555555455555555555555
Q ss_pred EecccCcCCCCCCccccCCc-cCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccc
Q 008012 82 VNLSSNYLTGSLTSDIQNMK-VLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNN 160 (581)
Q Consensus 82 L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~ 160 (581)
|++++|++++..|..+..++ .|++|++++|++++..|..+..++ |+.|+|++|.+++..|..|..+++|+.|+|++|.
T Consensus 154 L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 232 (313)
T 1ogq_A 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232 (313)
T ss_dssp EECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSE
T ss_pred EECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCc
Confidence 55555555544555555554 555555555555545555555544 5555555555555555555555555555555555
Q ss_pred cCCCCchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCccccccccccc
Q 008012 161 LSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNYAL 209 (581)
Q Consensus 161 l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~ 209 (581)
+++..|. +..+++|+.|++++|++++.+|.. ..+..+..+++.+|...
T Consensus 233 l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 281 (313)
T 1ogq_A 233 LAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281 (313)
T ss_dssp ECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred eeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccc
Confidence 5543332 445555555555555555444432 34445555555555433
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=251.22 Aligned_cols=211 Identities=23% Similarity=0.289 Sum_probs=174.0
Q ss_pred CCCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCc
Q 008012 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYIL 80 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 80 (581)
|+++++|++|+|++|+|+++.+..|.++++|++|+|++|+|+...+..|.++++|++|+|++|+|++..+..|..+++|+
T Consensus 84 ~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 163 (440)
T 3zyj_A 84 FKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLR 163 (440)
T ss_dssp TSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCC
T ss_pred hhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccC
Confidence 45677778888888887776667777788888888888888766666777788888888888887766666777788888
Q ss_pred EEecccC-cCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeecccc
Q 008012 81 YVNLSSN-YLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSN 159 (581)
Q Consensus 81 ~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N 159 (581)
+|++++| .+....+..|.++++|++|+|++|.++ .+| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 164 ~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n 241 (440)
T 3zyj_A 164 RLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241 (440)
T ss_dssp EEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTC
T ss_pred EeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCC
Confidence 8888774 455444457888999999999999998 455 4888999999999999999888999999999999999999
Q ss_pred ccCCCCchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCccccccccccccCCC
Q 008012 160 NLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~ 213 (581)
.+++..+..|..+++|+.|+|++|++++..+.. ..+..+..+++.+|||.|+-.
T Consensus 242 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 242 QIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp CCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred ceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence 999988999999999999999999999776654 678889999999999999743
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=250.80 Aligned_cols=210 Identities=24% Similarity=0.279 Sum_probs=149.3
Q ss_pred CCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcE
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILY 81 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 81 (581)
+++++|++|+|++|+|+++.+..|.++++|++|+|++|+|+...+..|.++++|++|+|++|+|++..+..|.++++|++
T Consensus 96 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 175 (452)
T 3zyi_A 96 RHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMR 175 (452)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCE
T ss_pred CCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccE
Confidence 34555555555555555555555555555555555555555444445555555555555555555444445555555555
Q ss_pred Eeccc-CcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccc
Q 008012 82 VNLSS-NYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNN 160 (581)
Q Consensus 82 L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~ 160 (581)
|++++ |.+....+..|.++++|++|+|++|.+++ +| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|.
T Consensus 176 L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~ 253 (452)
T 3zyi_A 176 LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253 (452)
T ss_dssp EECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSC
T ss_pred EeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCc
Confidence 55555 23333333457778888888888888874 44 47888899999999999998888899999999999999999
Q ss_pred cCCCCchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCccccccccccccCCC
Q 008012 161 LSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 161 l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~ 213 (581)
+++..+..|..+++|+.|+|++|++++.++.. ..+..+..+++.+|||.|+-.
T Consensus 254 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 254 VSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred CceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 99888888999999999999999999766654 667888999999999999854
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=238.38 Aligned_cols=214 Identities=22% Similarity=0.229 Sum_probs=191.4
Q ss_pred CCCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCc-ccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCC
Q 008012 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNK-LNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYI 79 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 79 (581)
|+.+++|++|+|++|+++++.|..|.++++|++|+|++|. ++...+..|..+++|++|+|++|++++..|..+.++++|
T Consensus 52 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 131 (285)
T 1ozn_A 52 FRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131 (285)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred cccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCC
Confidence 4678999999999999998889999999999999999998 887779999999999999999999998889999999999
Q ss_pred cEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeecccc
Q 008012 80 LYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSN 159 (581)
Q Consensus 80 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N 159 (581)
++|++++|++++..+..|..+++|++|++++|.+++..+..|.++++|+.|+|++|.+++..|..|..+++|+.|++++|
T Consensus 132 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 211 (285)
T 1ozn_A 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211 (285)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCC
Confidence 99999999999777778999999999999999999666667999999999999999999988999999999999999999
Q ss_pred ccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCCCC
Q 008012 160 NLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQR 214 (581)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~ 214 (581)
.+++..+..+..+++|+.|++++|++++..+....+..+.......+...|..|.
T Consensus 212 ~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp CCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESG
T ss_pred cCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCch
Confidence 9999777889999999999999999998665443334455555666777777653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=232.75 Aligned_cols=205 Identities=27% Similarity=0.225 Sum_probs=185.6
Q ss_pred CCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcE
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILY 81 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 81 (581)
+++++|++|++++|+++ .+|..+. ++|++|+|++|.|++..+..|.++++|++|+|++|+|++..+ ...+++|++
T Consensus 7 ~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~ 81 (290)
T 1p9a_G 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGT 81 (290)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCE
T ss_pred cccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCE
Confidence 56889999999999999 5776665 899999999999998888999999999999999999985433 378999999
Q ss_pred EecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeecccccc
Q 008012 82 VNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNL 161 (581)
Q Consensus 82 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l 161 (581)
|++++|+|+ .+|..+..+++|++|++++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++
T Consensus 82 L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 160 (290)
T 1p9a_G 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (290)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence 999999999 7788899999999999999999977778899999999999999999988888899999999999999999
Q ss_pred CCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCC
Q 008012 162 SEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGP 212 (581)
Q Consensus 162 ~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~ 212 (581)
+...+..|..+++|+.|+|++|+++..++.......+..+.+.+|||.|+-
T Consensus 161 ~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 161 TELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 987777788999999999999999976666667778899999999999973
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.9e-27 Score=226.41 Aligned_cols=205 Identities=26% Similarity=0.290 Sum_probs=186.4
Q ss_pred CCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecc
Q 008012 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85 (581)
Q Consensus 6 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 85 (581)
+++.+++++++++ .+|..+. ++|++|+|++|+|+...+..|.++++|++|+|++|+|++..+..|..+++|++|+++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 5789999999999 5777666 789999999999998878899999999999999999997777778999999999999
Q ss_pred cCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCC
Q 008012 86 SNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGI 165 (581)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 165 (581)
+|.+++..+..|..+++|++|++++|.+++..+..|.++++|+.|+|++|.|++..+..|..+++|+.|+|++|.+++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 99999877788899999999999999999888888999999999999999999877777999999999999999999887
Q ss_pred chhhhcccccCeeEccCCCCCCCCCC-CCCCcCCccccccccccccCCC
Q 008012 166 PKSLVALSHLKQFNVSHNRLEGEIPT-EGPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 166 ~~~~~~l~~L~~l~l~~n~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~~ 213 (581)
+..|..+++|+.|++++|++++..+. ...+..+..+.+.+|||.|+-.
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 78899999999999999999976665 3667889999999999999854
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-27 Score=235.97 Aligned_cols=201 Identities=17% Similarity=0.269 Sum_probs=141.4
Q ss_pred CCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEe
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 83 (581)
.++|+.|+|++|+++ .+|..++++++|++|+|++|.|+ .+|..|.++++|++|+|++|+++ .+|..+.++++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 356777777777777 56666777777777777777777 66777777777777777777776 6677777777777777
Q ss_pred cccCcCCCCCCccccC---------CccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCcccccee
Q 008012 84 LSSNYLTGSLTSDIQN---------MKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESL 154 (581)
Q Consensus 84 l~~n~l~~~~~~~~~~---------l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L 154 (581)
+++|++.+.+|..+.. +++|++|++++|.++ .+|..+.++++|+.|+|++|++++ +|..+..+++|++|
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEE
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEE
Confidence 7777666666665543 777777777777777 666677777777777777777774 44557777777777
Q ss_pred eccccccCCCCchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCccccccccccc
Q 008012 155 DLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNYAL 209 (581)
Q Consensus 155 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~ 209 (581)
+|++|.+.+.+|..+..+++|+.|++++|++.+.+|.. ..+..+..+++.+|+..
T Consensus 235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 77777777777777777777777777777766666643 55666666677666543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-27 Score=263.79 Aligned_cols=207 Identities=31% Similarity=0.485 Sum_probs=125.8
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
.+++|++|+|++|++++.+|..+..+++|++|+|++|++++..|..|.++++|++|+|++|++++.+|.+++.+++|++|
T Consensus 440 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 519 (768)
T 3rgz_A 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL 519 (768)
T ss_dssp GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEE
T ss_pred cCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEE
Confidence 34455555555555555555555555555555555555555555555555555555565555555555555556666666
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccc-----------------------------------------
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI----------------------------------------- 121 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~----------------------------------------- 121 (581)
++++|++++.+|..+..+++|++|++++|.+++.+|..+
T Consensus 520 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (768)
T 3rgz_A 520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGI 599 (768)
T ss_dssp ECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTC
T ss_pred ECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccc
Confidence 666666555555556666666666666665554444332
Q ss_pred -----------------------------cCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcc
Q 008012 122 -----------------------------AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVAL 172 (581)
Q Consensus 122 -----------------------------~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 172 (581)
..+++|+.|+|++|+++|.+|..|+.+++|+.|+|++|.+++.+|..++.+
T Consensus 600 ~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L 679 (768)
T 3rgz_A 600 RSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDL 679 (768)
T ss_dssp CGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred cchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCC
Confidence 223455666666666666666666667777777777777776677777777
Q ss_pred cccCeeEccCCCCCCCCCCC-CCCcCCccccccccccc
Q 008012 173 SHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNYAL 209 (581)
Q Consensus 173 ~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~ 209 (581)
++|+.|+|++|++++.+|.. ..+..+..+++++|+..
T Consensus 680 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~ 717 (768)
T 3rgz_A 680 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717 (768)
T ss_dssp TTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence 77777777777777666654 55566666667666544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.3e-28 Score=254.48 Aligned_cols=206 Identities=22% Similarity=0.169 Sum_probs=161.4
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCc-----------
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS----------- 71 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----------- 71 (581)
.+++|++|+|++|+|++..|..|+.+++|++|+|++|.|++..| |..+++|++|+|++|.|++..+.
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N 109 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANN 109 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSS
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCC
Confidence 35689999999999998888899999999999999999996655 89999999999999988743211
Q ss_pred -----ccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCccccc-CcccccceeccccccccccCccc
Q 008012 72 -----ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIA-GLKDLTNLSLAGNQFQGPIPESF 145 (581)
Q Consensus 72 -----~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~l~~N~i~~~~~~~~ 145 (581)
....+++|+.|+|++|.|++..|..+..+++|++|+|++|.+++..|..+. .+++|+.|+|++|.|++..+ +
T Consensus 110 ~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~ 187 (487)
T 3oja_A 110 NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--Q 187 (487)
T ss_dssp CCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--C
T ss_pred cCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--c
Confidence 112356777777888887777777777888888888888888876777665 67888888888888876522 3
Q ss_pred cCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCCC
Q 008012 146 GSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 146 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 213 (581)
..+++|+.|+|++|.+++. |..+..+++|+.|+|++|++++.++....+..+..+++.+|++.|+..
T Consensus 188 ~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~~ 254 (487)
T 3oja_A 188 VVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTL 254 (487)
T ss_dssp CCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHHH
T ss_pred ccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcch
Confidence 3578888888888888874 445888888888888888888755555677788888888888887744
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.5e-27 Score=228.16 Aligned_cols=208 Identities=21% Similarity=0.228 Sum_probs=187.5
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 35999999999999887779999999999999999999888889999999999999999999888899999999999999
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCCCC-CcccccCcccccceeccccccccccCccccCccccc----eeecccc
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGD-IPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLE----SLDLSSN 159 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~----~L~l~~N 159 (581)
++|.+.+..+..+..+++|++|++++|.+++. +|..+.++++|+.|+|++|++++..+..|..+++|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 99999987777899999999999999999864 589999999999999999999988888888888887 8999999
Q ss_pred ccCCCCchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCccccccccccccCCC
Q 008012 160 NLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~ 213 (581)
.+++..+..+ ...+|+.|++++|++++.++.. ..+..+..+.+.+|++.|+-+
T Consensus 188 ~l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 188 PMNFIQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCCEECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred cccccCcccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 9997655544 4458999999999999776654 678899999999999999754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=233.78 Aligned_cols=208 Identities=22% Similarity=0.277 Sum_probs=112.3
Q ss_pred CCCCCcEEEeecCccccc--CCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCC-cccccCCCC
Q 008012 3 RMQQLQGIGLADNHLQGS--IPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIP-SALWALEYI 79 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L 79 (581)
++++|++|+|++|+++.. .+..+..+++|++|+|++|.|+ .+|..|..+++|++|+|++|++++..+ ..+..+++|
T Consensus 50 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 128 (306)
T 2z66_A 50 KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 128 (306)
T ss_dssp TCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTC
T ss_pred ccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCC
Confidence 344444444444444411 1333334444444444444444 234445555555555555555553333 345555566
Q ss_pred cEEecccCcCCCCCCccccCCccCcEEeCCCCcCCC-CCcccccCcccccceeccccccccccCccccCccccceeeccc
Q 008012 80 LYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSG-DIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSS 158 (581)
Q Consensus 80 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~ 158 (581)
++|++++|.+.+..+..+..+++|++|++++|.+++ ..|..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++
T Consensus 129 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 208 (306)
T 2z66_A 129 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 208 (306)
T ss_dssp CEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred CEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCC
Confidence 666666666555555555556666666666666553 3455556666666666666666655555566666666666666
Q ss_pred cccCCCCchhhhcccccCeeEccCCCCCCCCCCC-CCC-cCCccccccccccccC
Q 008012 159 NNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPF-RNFSAQSFHWNYALCG 211 (581)
Q Consensus 159 N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~-~~~~~~~~~~n~~~c~ 211 (581)
|.+++..+..+..+++|+.|++++|++++..+.. ..+ ..+..+++.+|++.|+
T Consensus 209 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp SCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred CccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 6665555555556666666666666665554433 233 2555566666666555
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=241.71 Aligned_cols=213 Identities=23% Similarity=0.248 Sum_probs=131.0
Q ss_pred CCCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCcc--ccCCCCCCEEEccCCcccCCCCcc-cccCC
Q 008012 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTC--LASLTSLRELRLNSNKLTSSIPSA-LWALE 77 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~ 77 (581)
|+.+++|++|+|++|++++..|..|+++++|++|+|++|.|++..+.. |.++++|++|+|++|++++..|.. +.+++
T Consensus 75 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~ 154 (455)
T 3v47_A 75 FRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMR 154 (455)
T ss_dssp TTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCT
T ss_pred ccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCC
Confidence 345667777777777777666666777777777777777766533333 666666666666666666554544 55666
Q ss_pred CCcEEecccCcCCCCC----------------------------------------------------------------
Q 008012 78 YILYVNLSSNYLTGSL---------------------------------------------------------------- 93 (581)
Q Consensus 78 ~L~~L~l~~n~l~~~~---------------------------------------------------------------- 93 (581)
+|++|++++|.+++..
T Consensus 155 ~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~ 234 (455)
T 3v47_A 155 RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD 234 (455)
T ss_dssp TCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHH
T ss_pred cccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhc
Confidence 6666666666555433
Q ss_pred ---------------------------------------------------------CccccCCccCcEEeCCCCcCCCC
Q 008012 94 ---------------------------------------------------------TSDIQNMKVLIDLDLSRNQLSGD 116 (581)
Q Consensus 94 ---------------------------------------------------------~~~~~~l~~L~~L~l~~N~l~~~ 116 (581)
+..+..+++|++|++++|.+++.
T Consensus 235 ~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 314 (455)
T 3v47_A 235 AIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKI 314 (455)
T ss_dssp HTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEE
T ss_pred cccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCccccc
Confidence 33344455566666666666555
Q ss_pred CcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCC-CCC
Q 008012 117 IPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPF 195 (581)
Q Consensus 117 ~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~ 195 (581)
.|..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++|.+++..|..+..+++|+.|++++|++++.++.. ..+
T Consensus 315 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 394 (455)
T 3v47_A 315 DDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL 394 (455)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred ChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccC
Confidence 5555666666666666666666555566666666666666666666655666666666666666666666544433 455
Q ss_pred cCCccccccccccccCCC
Q 008012 196 RNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 196 ~~~~~~~~~~n~~~c~~~ 213 (581)
..+..+++.+|++.|+-+
T Consensus 395 ~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 395 TSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTCCEEECCSSCBCCCTT
T ss_pred CcccEEEccCCCcccCCC
Confidence 666666666666666644
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=254.48 Aligned_cols=186 Identities=17% Similarity=0.177 Sum_probs=146.5
Q ss_pred CcCCeecccccccEEEEEeCCCcEEEEEEeccch--------HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 294 NECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--------EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 294 ~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
...+.||+|+||.||+|... ++.+++|...... ....+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 34578999999999999654 7889999764321 12245689999999999999999666665677778999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+++++|.+++.. +..++.|+++||+||| ++||+||||||+|||++. .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999876 4579999999999999 899999999999999998 99999999999875432
Q ss_pred Ccc-----eeeccccCccccCCCCCCC--CCCCccccHHHHHHHHHHHHhCCCCCC
Q 008012 446 DSV-----IQTMTIATIGYMAPEFGSE--GNVSSKCDVYSYGILLLETFTRKKPTD 494 (581)
Q Consensus 446 ~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~Pf~ 494 (581)
... ......||+.|+|||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 211 1235579999999999877 568888999999999999888887764
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.8e-26 Score=219.68 Aligned_cols=187 Identities=22% Similarity=0.240 Sum_probs=173.0
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
++|++|+|++|+|+++.+..|.++++|++|+|++|.|+...+..|.++++|++|+|++|++++..+..|..+++|++|++
T Consensus 37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 46999999999999877789999999999999999999877788899999999999999999887888999999999999
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEG 164 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~ 164 (581)
++|.+++..+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|.|++..+..|..+++|+.|+|++|.+++.
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRV 196 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcC
Confidence 99999988888899999999999999999976666789999999999999999988788899999999999999999987
Q ss_pred CchhhhcccccCeeEccCCCCCCCCCC
Q 008012 165 IPKSLVALSHLKQFNVSHNRLEGEIPT 191 (581)
Q Consensus 165 ~~~~~~~l~~L~~l~l~~n~l~~~~~~ 191 (581)
.+..+..+++|+.|++++|++.+..+.
T Consensus 197 ~~~~~~~l~~L~~L~l~~N~~~c~c~~ 223 (270)
T 2o6q_A 197 PEGAFDSLEKLKMLQLQENPWDCTCNG 223 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred CHHHhccccCCCEEEecCCCeeCCCcc
Confidence 777799999999999999999876653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-26 Score=228.90 Aligned_cols=201 Identities=23% Similarity=0.309 Sum_probs=184.7
Q ss_pred CCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCccccc------
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWA------ 75 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------ 75 (581)
+++++|++|+|++|+++ .+|..++++++|++|+|++|.|+ .+|..|.++++|++|+|++|++.+.+|..+..
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 45889999999999999 89999999999999999999999 77999999999999999999888888887665
Q ss_pred ---CCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccc
Q 008012 76 ---LEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLE 152 (581)
Q Consensus 76 ---l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~ 152 (581)
+++|++|++++|+++ .+|..+..+++|++|+|++|.++ .+|..+.++++|+.|+|++|++.+.+|..|..+++|+
T Consensus 179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~ 256 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256 (328)
T ss_dssp EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence 999999999999999 78888999999999999999999 5777899999999999999999999999999999999
Q ss_pred eeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCcccccccc
Q 008012 153 SLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWN 206 (581)
Q Consensus 153 ~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n 206 (581)
.|+|++|.+.+.+|..+..+++|+.|++++|++.+.+|.. ..+..+....+..+
T Consensus 257 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~ 311 (328)
T 4fcg_A 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311 (328)
T ss_dssp EEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGG
T ss_pred EEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHH
Confidence 9999999999999999999999999999999999988875 56666666666544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-26 Score=242.45 Aligned_cols=211 Identities=20% Similarity=0.225 Sum_probs=122.0
Q ss_pred CCCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCc
Q 008012 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYIL 80 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 80 (581)
|+++++|++|+|++|+|+++.|..|.++++|++|+|++|+|+...+..|.++++|++|+|++|++++..+..|..+++|+
T Consensus 52 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~ 131 (477)
T 2id5_A 52 FASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLK 131 (477)
T ss_dssp TTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred ccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCC
Confidence 34566666777776666666666666666666666666666655555566666666666666666655555555666666
Q ss_pred EEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcc-----------------------------------------
Q 008012 81 YVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPK----------------------------------------- 119 (581)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~----------------------------------------- 119 (581)
+|++++|.+++..+..|..+++|++|+|++|.+++..+.
T Consensus 132 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~ 211 (477)
T 2id5_A 132 SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP 211 (477)
T ss_dssp EEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCT
T ss_pred EEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCc
Confidence 666666655544444555555555555555544432222
Q ss_pred -------------------------------cccCcccccceeccccccccccCccccCccccceeeccccccCCCCchh
Q 008012 120 -------------------------------TIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKS 168 (581)
Q Consensus 120 -------------------------------~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 168 (581)
.+.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+++..|..
T Consensus 212 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 291 (477)
T 2id5_A 212 YLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYA 291 (477)
T ss_dssp TCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTT
T ss_pred cccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHH
Confidence 2333444445555555555444444555555555555555555555555
Q ss_pred hhcccccCeeEccCCCCCCCCCCC-CCCcCCccccccccccccC
Q 008012 169 LVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNYALCG 211 (581)
Q Consensus 169 ~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~ 211 (581)
|..+++|+.|++++|++++..+.. ..+..+..+.+.+|++.|+
T Consensus 292 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~ 335 (477)
T 2id5_A 292 FRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACD 335 (477)
T ss_dssp BTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECS
T ss_pred hcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCc
Confidence 666666666666666666544432 4455566666666666665
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.5e-27 Score=235.91 Aligned_cols=208 Identities=23% Similarity=0.205 Sum_probs=141.6
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|++
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 46778888888887666667777888888888888887777777778888888888888887555555777788888888
Q ss_pred ccCcCCCCCC-ccccCCccCcEEeCCCC-cCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 85 SSNYLTGSLT-SDIQNMKVLIDLDLSRN-QLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 85 ~~n~l~~~~~-~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
++|+++...+ ..+..+++|++|++++| .+++..+..|.++++|+.|++++|.+++..|..|..+++|++|++++|.++
T Consensus 132 ~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred CCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 8887774443 36777778888888777 355555566777777777777777777766777766666666666555554
Q ss_pred CCC-------------------------------------------------------chhhhcccccCeeEccCCCCCC
Q 008012 163 EGI-------------------------------------------------------PKSLVALSHLKQFNVSHNRLEG 187 (581)
Q Consensus 163 ~~~-------------------------------------------------------~~~~~~l~~L~~l~l~~n~l~~ 187 (581)
... |..+..+++|+.|++++|+++.
T Consensus 212 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~ 291 (353)
T 2z80_A 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS 291 (353)
T ss_dssp THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC
T ss_pred cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc
Confidence 321 2234455666666666666664
Q ss_pred CCCCC-CCCcCCccccccccccccCC
Q 008012 188 EIPTE-GPFRNFSAQSFHWNYALCGP 212 (581)
Q Consensus 188 ~~~~~-~~~~~~~~~~~~~n~~~c~~ 212 (581)
.++.. ..+..+..+++.+|++.|+.
T Consensus 292 i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 292 VPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 33332 45566666666666666654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-25 Score=212.87 Aligned_cols=183 Identities=23% Similarity=0.240 Sum_probs=169.1
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
...+++++++++++ .+|..+. ++|+.|+|++|.|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 35689999999999 6777776 79999999999999988889999999999999999999888888999999999999
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEG 164 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~ 164 (581)
++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 99999988888899999999999999999977777789999999999999999988777899999999999999999988
Q ss_pred CchhhhcccccCeeEccCCCCCCCCC
Q 008012 165 IPKSLVALSHLKQFNVSHNRLEGEIP 190 (581)
Q Consensus 165 ~~~~~~~l~~L~~l~l~~n~l~~~~~ 190 (581)
.+..+..+++|+.|++++|++++...
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred CHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 88889999999999999999997643
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-25 Score=228.09 Aligned_cols=88 Identities=22% Similarity=0.187 Sum_probs=41.7
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
.+++|++|+|++|++++..|..|+++++|++|+|++|+|+...+..|.++++|++|+|++|++++..+..+..+++|++|
T Consensus 91 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 170 (390)
T 3o6n_A 91 YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 170 (390)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEE
T ss_pred CCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEE
Confidence 34444445554444444444444444555555555554443333334444555555555555444444444444444444
Q ss_pred ecccCcCC
Q 008012 83 NLSSNYLT 90 (581)
Q Consensus 83 ~l~~n~l~ 90 (581)
++++|.++
T Consensus 171 ~l~~n~l~ 178 (390)
T 3o6n_A 171 QLSSNRLT 178 (390)
T ss_dssp ECCSSCCS
T ss_pred ECCCCcCC
Confidence 44444443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-25 Score=240.48 Aligned_cols=107 Identities=20% Similarity=0.274 Sum_probs=51.5
Q ss_pred ccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEc
Q 008012 101 KVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180 (581)
Q Consensus 101 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 180 (581)
++|++|+|++|.+++..|..|.++++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++. +|..+..+++|+.|+|
T Consensus 254 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~l~~L~~L~L 331 (597)
T 3oja_B 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYL 331 (597)
T ss_dssp TTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEEC
T ss_pred CCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCc-cCcccccCCCCCEEEC
Confidence 334444444444443334444444444444444444442 23333344455555555555542 4444555555555555
Q ss_pred cCCCCCCCCCCCCCCcCCccccccccccccC
Q 008012 181 SHNRLEGEIPTEGPFRNFSAQSFHWNYALCG 211 (581)
Q Consensus 181 ~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~ 211 (581)
++|++++.. ...+..+..+++.+|++.|.
T Consensus 332 ~~N~l~~~~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 332 DHNSIVTLK--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CSSCCCCCC--CCTTCCCSEEECCSSCEEHH
T ss_pred CCCCCCCcC--hhhcCCCCEEEeeCCCCCCh
Confidence 555555432 23345566666666666665
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.9e-26 Score=245.93 Aligned_cols=212 Identities=22% Similarity=0.219 Sum_probs=193.0
Q ss_pred CCCCCCCcEEEeecCccccc--CCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCC-cccccCC
Q 008012 1 MGRMQQLQGIGLADNHLQGS--IPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIP-SALWALE 77 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~ 77 (581)
++.+++|++|+|++|++++. .|..+..+++|++|+|++|.+++ .|..|.++++|++|+|++|++++..| ..+..++
T Consensus 346 ~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~ 424 (606)
T 3vq2_A 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE 424 (606)
T ss_dssp CCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCT
T ss_pred hccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccc
Confidence 35688999999999999866 38889999999999999999995 66899999999999999999998777 6899999
Q ss_pred CCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCC-CCcccccCcccccceeccccccccccCccccCccccceeec
Q 008012 78 YILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSG-DIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDL 156 (581)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l 156 (581)
+|++|++++|.+.+..|..+..+++|++|++++|.+++ ..|..+.++++|+.|+|++|++++..|..|..+++|+.|+|
T Consensus 425 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 504 (606)
T 3vq2_A 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504 (606)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEEC
Confidence 99999999999998889999999999999999999987 47889999999999999999999988999999999999999
Q ss_pred cccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCc-CCccccccccccccCCC
Q 008012 157 SSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFR-NFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 157 ~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~-~~~~~~~~~n~~~c~~~ 213 (581)
++|++++..|..+..+++|+.|++++|+++..++....+. .+..+++.+||+.|+-+
T Consensus 505 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 9999999889999999999999999999996555555554 58899999999999765
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-25 Score=232.95 Aligned_cols=121 Identities=20% Similarity=0.186 Sum_probs=106.0
Q ss_pred CCCCCCCcEEEeecCccccc-CCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcc--cccCC
Q 008012 1 MGRMQQLQGIGLADNHLQGS-IPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSA--LWALE 77 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~ 77 (581)
|+++++|++|+|++|.+.+. .+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..+.. |..++
T Consensus 50 ~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~ 129 (455)
T 3v47_A 50 FSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT 129 (455)
T ss_dssp TSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCT
T ss_pred hccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcc
Confidence 56899999999999999744 4678999999999999999999888999999999999999999998755544 99999
Q ss_pred CCcEEecccCcCCCCCCcc-ccCCccCcEEeCCCCcCCCCCcccc
Q 008012 78 YILYVNLSSNYLTGSLTSD-IQNMKVLIDLDLSRNQLSGDIPKTI 121 (581)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~l~~N~l~~~~~~~~ 121 (581)
+|++|+|++|.+++..|.. +..+++|++|++++|.+++..+..+
T Consensus 130 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l 174 (455)
T 3v47_A 130 SLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDL 174 (455)
T ss_dssp TCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTS
T ss_pred cCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhh
Confidence 9999999999999877776 7889999999999998876555433
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-25 Score=215.75 Aligned_cols=191 Identities=23% Similarity=0.238 Sum_probs=172.7
Q ss_pred CCCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCc
Q 008012 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYIL 80 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 80 (581)
|+.+++|++|+|++|+++++.+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..+..+++|+
T Consensus 48 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 127 (276)
T 2z62_A 48 FFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127 (276)
T ss_dssp TTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCC
T ss_pred hccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCC
Confidence 46789999999999999988888999999999999999999988889999999999999999999987777899999999
Q ss_pred EEecccCcCCCC-CCccccCCccCcEEeCCCCcCCCCCcccccCccccc----ceeccccccccccCccccCccccceee
Q 008012 81 YVNLSSNYLTGS-LTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLT----NLSLAGNQFQGPIPESFGSLISLESLD 155 (581)
Q Consensus 81 ~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~----~L~l~~N~i~~~~~~~~~~l~~L~~L~ 155 (581)
+|++++|.+++. +|..+..+++|++|++++|++++..+..+..+++|+ .|++++|++++..+..+. ..+|+.|+
T Consensus 128 ~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~ 206 (276)
T 2z62_A 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELA 206 (276)
T ss_dssp EEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEE
T ss_pred EEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEE
Confidence 999999999864 588999999999999999999977778888888887 899999999976666554 45899999
Q ss_pred ccccccCCCCchhhhcccccCeeEccCCCCCCCCCCC
Q 008012 156 LSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE 192 (581)
Q Consensus 156 l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~ 192 (581)
|++|.+++..+..+..+++|+.|++++|++++..+..
T Consensus 207 L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 207 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp CCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred CCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 9999999877777899999999999999999877653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=243.28 Aligned_cols=211 Identities=20% Similarity=0.225 Sum_probs=168.3
Q ss_pred CCCCCCcEEEeecCcccccC--CccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCc-ccccCCC
Q 008012 2 GRMQQLQGIGLADNHLQGSI--PYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS-ALWALEY 78 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~ 78 (581)
+.+++|++|+|++|++++.. +..+..+++|++|++++|++++..|..|..+++|++|+|++|++++..+. .+..+++
T Consensus 347 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 426 (606)
T 3t6q_A 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426 (606)
T ss_dssp TTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTT
T ss_pred hccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCccc
Confidence 45677788888888777654 66777888888888888888877778888888888888888888766544 4778888
Q ss_pred CcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCC---CcccccCcccccceeccccccccccCccccCccccceee
Q 008012 79 ILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGD---IPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLD 155 (581)
Q Consensus 79 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~---~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~ 155 (581)
|++|++++|.+++..+..+..+++|++|++++|.+++. .+..+..+++|+.|+|++|++++..|..|..+++|+.|+
T Consensus 427 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 506 (606)
T 3t6q_A 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506 (606)
T ss_dssp CCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEE
Confidence 88888888888877777888888888888888888752 235678888888888888888887788888888888888
Q ss_pred ccccccCCCCchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCccccccccccccCCC
Q 008012 156 LSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 156 l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~ 213 (581)
|++|++++..|..+..+++| .|++++|++++.+|.. ..+..+..+++.+||+.|+-+
T Consensus 507 Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 507 LSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred CCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 88888888888888888888 8888888888776654 566778888889999888643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-26 Score=225.00 Aligned_cols=203 Identities=24% Similarity=0.258 Sum_probs=174.3
Q ss_pred CCCCCcEEEeecCcccccCCccc--cCCCCCCEEEccCCcccccCCccccCC-----CCCCEEEccCCcccCCCCccccc
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDL--CQLKRLNSLSLQGNKLNGSIPTCLASL-----TSLRELRLNSNKLTSSIPSALWA 75 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~l~~n~i~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~ 75 (581)
++++|++|+|++|++++..|..+ ..+++|++|+|++|+|++. |..|..+ ++|++|+|++|+|++..|..|..
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence 58899999999999998888876 8999999999999999976 8888877 99999999999999888899999
Q ss_pred CCCCcEEecccCcCCCC--CCccc--cCCccCcEEeCCCCcCCCC--Cc-ccccCcccccceeccccccccccC-ccccC
Q 008012 76 LEYILYVNLSSNYLTGS--LTSDI--QNMKVLIDLDLSRNQLSGD--IP-KTIAGLKDLTNLSLAGNQFQGPIP-ESFGS 147 (581)
Q Consensus 76 l~~L~~L~l~~n~l~~~--~~~~~--~~l~~L~~L~l~~N~l~~~--~~-~~~~~l~~L~~L~l~~N~i~~~~~-~~~~~ 147 (581)
+++|++|++++|++.+. .+..+ ..+++|++|++++|++++. .+ ..+.++++|+.|+|++|+|++..| ..+..
T Consensus 172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 251 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251 (312)
T ss_dssp CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence 99999999999998754 23344 8899999999999999831 12 334678999999999999998765 55677
Q ss_pred ccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCcccccccccccc
Q 008012 148 LISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALC 210 (581)
Q Consensus 148 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c 210 (581)
+++|+.|+|++|.++ .+|..+. ++|+.|++++|++++. |....+..++.+++.+|++..
T Consensus 252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTTC
T ss_pred cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCCC
Confidence 899999999999998 5777666 8999999999999976 557788889999999997653
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=212.39 Aligned_cols=185 Identities=25% Similarity=0.269 Sum_probs=165.9
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
.+++|+.|++++|.++. + ..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++..+..|..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 114 (272)
T 3rfs_A 39 ELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKEL 114 (272)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred cccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEE
Confidence 46789999999999983 3 3588899999999999999953 578999999999999999998888888999999999
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
++++|++++..+..|..+++|++|++++|.+++..+..+.++++|+.|++++|++++..+..|..+++|+.|++++|.++
T Consensus 115 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 115 VLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence 99999999888788899999999999999999777777899999999999999999888888899999999999999999
Q ss_pred CCCchhhhcccccCeeEccCCCCCCCCCC
Q 008012 163 EGIPKSLVALSHLKQFNVSHNRLEGEIPT 191 (581)
Q Consensus 163 ~~~~~~~~~l~~L~~l~l~~n~l~~~~~~ 191 (581)
+..+..+..+++|+.|++++|++.+..|.
T Consensus 195 ~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 223 (272)
T 3rfs_A 195 SVPDGVFDRLTSLQYIWLHDNPWDCTCPG 223 (272)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence 98888889999999999999999987664
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=218.18 Aligned_cols=206 Identities=25% Similarity=0.294 Sum_probs=131.4
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCccc------------------
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLT------------------ 66 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~------------------ 66 (581)
++|++|+|++|+|++..+..|+++++|++|+|++|.|++..|..|.++++|++|+|++|+++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~~L~~L~l~~n 131 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHEN 131 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSS
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChhhcccccEEECCCC
Confidence 34566666666666554555666666666666666666555566666666666666666555
Q ss_pred ---CCCCcccccCCCCcEEecccCcCCC--CCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceecccccccccc
Q 008012 67 ---SSIPSALWALEYILYVNLSSNYLTG--SLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPI 141 (581)
Q Consensus 67 ---~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~ 141 (581)
+..+..|.++++|++|++++|.+.. ..+..+..+++|++|++++|.++ .+|..+. ++|+.|++++|.+++..
T Consensus 132 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~ 208 (330)
T 1xku_A 132 EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVD 208 (330)
T ss_dssp CCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEEC
T ss_pred cccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccC
Confidence 3333345555556666666665542 34455556666666666666665 3444332 56777777777777666
Q ss_pred CccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCCC
Q 008012 142 PESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 142 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 213 (581)
+..|..+++|+.|+|++|.+++..+..+..+++|+.|++++|+++..+.....+..+..+++.+|+....+.
T Consensus 209 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~~~~ 280 (330)
T 1xku_A 209 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGS 280 (330)
T ss_dssp TGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred HHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCCccCh
Confidence 777778888888888888887766667778888888888888887444445667777777787776655443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.3e-26 Score=223.88 Aligned_cols=210 Identities=19% Similarity=0.223 Sum_probs=183.2
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCC-ccccCCCCCCEEEccCCcccCCCCcccccCCCCcE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIP-TCLASLTSLRELRLNSNKLTSSIPSALWALEYILY 81 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 81 (581)
.+++|++|+|++|.++ .+|..+..+++|++|+|++|+|++..+ ..|.++++|++|+|++|.+++..+..+..+++|++
T Consensus 76 ~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 154 (306)
T 2z66_A 76 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 154 (306)
T ss_dssp SCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCE
T ss_pred cccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCE
Confidence 4789999999999999 577889999999999999999996655 68999999999999999999888999999999999
Q ss_pred EecccCcCCC-CCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccc
Q 008012 82 VNLSSNYLTG-SLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNN 160 (581)
Q Consensus 82 L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~ 160 (581)
|++++|.+++ ..|..+..+++|++|++++|.+++..|..+.++++|+.|+|++|++++..+..+..+++|+.|+|++|.
T Consensus 155 L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 234 (306)
T 2z66_A 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 234 (306)
T ss_dssp EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSC
T ss_pred EECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCC
Confidence 9999999986 578899999999999999999998778999999999999999999998888889999999999999999
Q ss_pred cCCCCchhhhccc-ccCeeEccCCCCCCCCCCC---CCCcCCccccccccccccCCC
Q 008012 161 LSEGIPKSLVALS-HLKQFNVSHNRLEGEIPTE---GPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 161 l~~~~~~~~~~l~-~L~~l~l~~n~l~~~~~~~---~~~~~~~~~~~~~n~~~c~~~ 213 (581)
+++..|..+..++ +|+.|++++|++++..+.. .-+.......+..+...|..|
T Consensus 235 l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p 291 (306)
T 2z66_A 235 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 291 (306)
T ss_dssp CCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred CcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCc
Confidence 9999999999985 9999999999999764421 111222333445566677655
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-25 Score=230.35 Aligned_cols=206 Identities=23% Similarity=0.235 Sum_probs=186.0
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
++|++|+|++|+|+++.+..|.++++|++|+|++|.|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 57999999999999988999999999999999999999998999999999999999999999887888999999999999
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCC-CcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSR-NQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 163 (581)
++|+|+...+..|..+++|++|++++ |.+....+..|.++++|+.|+|++|++++. | .+..+++|+.|+|++|.+++
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~ 232 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPE 232 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSE
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcc
Confidence 99999977777899999999999999 455544445789999999999999999964 4 58899999999999999999
Q ss_pred CCchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCccccccccccccCC
Q 008012 164 GIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNYALCGP 212 (581)
Q Consensus 164 ~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~ 212 (581)
..|..|..+++|+.|++++|++++..+.. ..+..+..+++.+|.....+
T Consensus 233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 282 (452)
T 3zyi_A 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLP 282 (452)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccC
Confidence 99999999999999999999999876654 67788999999999766433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=250.26 Aligned_cols=206 Identities=24% Similarity=0.256 Sum_probs=136.9
Q ss_pred CCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcE
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILY 81 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 81 (581)
+.+++|++|+|++|+|++..|..|.++++|++|+|++|.|++..|..|.++++|+.|+|++|+|++..+..|..+++|++
T Consensus 287 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 366 (844)
T 3j0a_A 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366 (844)
T ss_dssp SSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCE
T ss_pred hcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCE
Confidence 45667777777777777666667777777777777777777666677777777777777777776666666666777777
Q ss_pred EecccCcCCCCCC----------------------------------------ccccCCccCcEEeCCCCcCCCC-----
Q 008012 82 VNLSSNYLTGSLT----------------------------------------SDIQNMKVLIDLDLSRNQLSGD----- 116 (581)
Q Consensus 82 L~l~~n~l~~~~~----------------------------------------~~~~~l~~L~~L~l~~N~l~~~----- 116 (581)
|+|++|.+++... ..+..+++|++|+|++|++++.
T Consensus 367 L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 446 (844)
T 3j0a_A 367 LDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQT 446 (844)
T ss_dssp EEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSS
T ss_pred EECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccc
Confidence 7777666653110 0012445555555555555421
Q ss_pred -------------------------CcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhc
Q 008012 117 -------------------------IPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVA 171 (581)
Q Consensus 117 -------------------------~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 171 (581)
.+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+..+.
T Consensus 447 ~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~- 525 (844)
T 3j0a_A 447 PSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP- 525 (844)
T ss_dssp SCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-
T ss_pred cccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-
Confidence 123355666777777777777766666677777777777777777765555444
Q ss_pred ccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccC
Q 008012 172 LSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCG 211 (581)
Q Consensus 172 l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~ 211 (581)
++|+.|+|++|++++.+|.. +..+..+++.+|||.|+
T Consensus 526 -~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 526 -ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICE 562 (844)
T ss_dssp -SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCS
T ss_pred -ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccc
Confidence 66777777777777766654 55788899999999995
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=213.19 Aligned_cols=182 Identities=25% Similarity=0.221 Sum_probs=167.1
Q ss_pred CCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEe
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 83 (581)
.++|++|+|++|+|++..+..|..+++|++|+|++|.|++..+ ...+++|++|+|++|+|+ .+|..+..+++|++|+
T Consensus 30 ~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~ 106 (290)
T 1p9a_G 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLD 106 (290)
T ss_dssp CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEE
T ss_pred CCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEE
Confidence 3579999999999998888999999999999999999996544 388999999999999998 7788899999999999
Q ss_pred cccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCC
Q 008012 84 LSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 163 (581)
+++|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++.
T Consensus 107 l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ 186 (290)
T 1p9a_G 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT 186 (290)
T ss_dssp CCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCc
Confidence 99999998888899999999999999999997777778999999999999999998777788999999999999999985
Q ss_pred CCchhhhcccccCeeEccCCCCCCCC
Q 008012 164 GIPKSLVALSHLKQFNVSHNRLEGEI 189 (581)
Q Consensus 164 ~~~~~~~~l~~L~~l~l~~n~l~~~~ 189 (581)
+|..+..+++|+.|+|++|++.+..
T Consensus 187 -ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 187 -IPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp -CCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred -cChhhcccccCCeEEeCCCCccCcC
Confidence 7888888899999999999998743
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-25 Score=213.79 Aligned_cols=182 Identities=26% Similarity=0.292 Sum_probs=167.7
Q ss_pred CCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcE
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILY 81 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 81 (581)
+.+++|++|+|++|++++. ..+..+++|++|+|++|.|++..+..|.++++|++|+|++|++++..+..|..+++|++
T Consensus 60 ~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 137 (272)
T 3rfs_A 60 QYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTY 137 (272)
T ss_dssp GGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCE
Confidence 5689999999999999953 48999999999999999999888888999999999999999999888888999999999
Q ss_pred EecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeecccccc
Q 008012 82 VNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNL 161 (581)
Q Consensus 82 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l 161 (581)
|++++|++++..+..|..+++|++|++++|++++..+..+.++++|+.|+|++|++++..+..|..+++|+.|++++|.+
T Consensus 138 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (272)
T 3rfs_A 138 LNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW 217 (272)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred EECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCc
Confidence 99999999988888889999999999999999987777789999999999999999988888899999999999999999
Q ss_pred CCCCchhhhcccccCeeEccCCCCCCCCCCC
Q 008012 162 SEGIPKSLVALSHLKQFNVSHNRLEGEIPTE 192 (581)
Q Consensus 162 ~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~ 192 (581)
.+. +++|+.|+++.|.++|.+|..
T Consensus 218 ~~~-------~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 218 DCT-------CPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp CCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred ccc-------CcHHHHHHHHHHhCCCcccCc
Confidence 863 457889999999999998875
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.8e-25 Score=227.85 Aligned_cols=207 Identities=24% Similarity=0.269 Sum_probs=185.8
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
++++.|+|++|+|+++.+..|.++++|++|+|++|.|+.+.+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 57999999999999888899999999999999999999888899999999999999999999777778999999999999
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCC-cCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRN-QLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 163 (581)
++|.|+...+..|..+++|++|++++| .+....+..|.++++|+.|+|++|+|+. +| .+..+++|+.|+|++|.+++
T Consensus 144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~ 221 (440)
T 3zyj_A 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSA 221 (440)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCE
T ss_pred CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCc
Confidence 999999777779999999999999995 5554444578999999999999999994 44 48899999999999999999
Q ss_pred CCchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCccccccccccccCCC
Q 008012 164 GIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 164 ~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~ 213 (581)
..|..|..+++|+.|+|++|++++..+.. ..+..+..+++.+|.....++
T Consensus 222 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 272 (440)
T 3zyj_A 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPH 272 (440)
T ss_dssp ECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCT
T ss_pred cChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccCh
Confidence 88999999999999999999999876654 677889999999997664443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-24 Score=216.11 Aligned_cols=206 Identities=20% Similarity=0.221 Sum_probs=143.0
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+++ .+|..+. ++|++|++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence 46777777777777666667777777777777777777666777777777777777777776 4444333 56677777
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCCC--CCcccccCc--------------------ccccceeccccccccccC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSG--DIPKTIAGL--------------------KDLTNLSLAGNQFQGPIP 142 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l--------------------~~L~~L~l~~N~i~~~~~ 142 (581)
++|++++..+..|..+++|++|++++|.++. ..+..+..+ ++|+.|++++|.+++..+
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~ 210 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIEL 210 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCT
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCH
Confidence 7776665555556666666666666666642 333333332 467777777777776666
Q ss_pred ccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCCC
Q 008012 143 ESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 143 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 213 (581)
..|..+++|+.|+|++|.+++..+..+..+++|+.|++++|+++..++....+..+..+++.+|.....+.
T Consensus 211 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~l~~~~~ 281 (332)
T 2ft3_A 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITKVGV 281 (332)
T ss_dssp TSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSCCCBCCT
T ss_pred HHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCCCCccCh
Confidence 77778888888888888888777777888888888888888888444444667777788888777665544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-25 Score=209.55 Aligned_cols=197 Identities=16% Similarity=0.181 Sum_probs=171.6
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCc-ccccCCccccCCCCCCEEEccC-CcccCCCCcccccCCCCcEE
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNK-LNGSIPTCLASLTSLRELRLNS-NKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L 82 (581)
++|++|+|++|+|+++.+..|.++++|++|+|++|+ |+.+.+..|.++++|++|+|++ |+|++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 379999999999998777799999999999999997 9988888999999999999998 99997777899999999999
Q ss_pred ecccCcCCCCCCccccCCccCc---EEeCCCC-cCCCCCcccccCccccc-ceeccccccccccCccccCccccceeecc
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLI---DLDLSRN-QLSGDIPKTIAGLKDLT-NLSLAGNQFQGPIPESFGSLISLESLDLS 157 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~---~L~l~~N-~l~~~~~~~~~~l~~L~-~L~l~~N~i~~~~~~~~~~l~~L~~L~l~ 157 (581)
++++|++++ +|. |..+++|+ +|++++| .+++..+..|.++++|+ .|++++|+++.+.+..|.. ++|+.|+|+
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~ 187 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN 187 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence 999999995 565 88888888 9999999 99866667799999999 9999999999555555555 899999999
Q ss_pred ccc-cCCCCchhhhcc-cccCeeEccCCCCCCCCCCCCCCcCCcccccccc
Q 008012 158 SNN-LSEGIPKSLVAL-SHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWN 206 (581)
Q Consensus 158 ~N~-l~~~~~~~~~~l-~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n 206 (581)
+|+ +++..+..|..+ ++|+.|++++|++++.++. .+..+..+.+.++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence 995 988778889999 9999999999999965444 5666776666544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=240.75 Aligned_cols=211 Identities=25% Similarity=0.287 Sum_probs=146.3
Q ss_pred CCCCCcEEEeecCcccccCC-ccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCccc--CCCCcccccCCCC
Q 008012 3 RMQQLQGIGLADNHLQGSIP-YDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLT--SSIPSALWALEYI 79 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L 79 (581)
.+++|++|+|++|.+++.+| ..|.++++|++|+|++|++++..+..|..+++|+.|++++|.++ +..|..|.++++|
T Consensus 403 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L 482 (680)
T 1ziw_A 403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482 (680)
T ss_dssp TCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC
T ss_pred CCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC
Confidence 34455555555555543333 34555555555555555555455555555555555555555554 3556777778888
Q ss_pred cEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCC--------cccccCcccccceeccccccccccCccccCcccc
Q 008012 80 LYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDI--------PKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISL 151 (581)
Q Consensus 80 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--------~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L 151 (581)
+.|++++|+|++..+..|..+++|++|++++|.+++.. +..|.++++|+.|+|++|+|+.+.+..|.++++|
T Consensus 483 ~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L 562 (680)
T 1ziw_A 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCc
Confidence 88888888888766677788888888888888876431 1236778888888888888885555668888888
Q ss_pred ceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCC-C-CCcCCccccccccccccCCC
Q 008012 152 ESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-G-PFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 152 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~-~~~~~~~~~~~~n~~~c~~~ 213 (581)
+.|+|++|+++++.+..|..+++|+.|++++|++++..+.. . .+..+..+++.+|||.|+-.
T Consensus 563 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred ceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 88888888888766777788888888888888888766543 2 46778889999999999844
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=222.92 Aligned_cols=203 Identities=22% Similarity=0.231 Sum_probs=109.2
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
.+++|++|+|++|+|+++.+..|..+++|++|+|++|.|++..|..|.++++|++|+|++|++++..+..|.++++|++|
T Consensus 67 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L 146 (390)
T 3o6n_A 67 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTL 146 (390)
T ss_dssp HCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEE
Confidence 35566666666666665555566666666666666666665555666666666666666666664444445666666666
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCc-------------------------------------c
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGL-------------------------------------K 125 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-------------------------------------~ 125 (581)
++++|.+++..+..|..+++|++|++++|.+++.....+.++ +
T Consensus 147 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 226 (390)
T 3o6n_A 147 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNV 226 (390)
T ss_dssp ECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCS
T ss_pred ECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeeccccccc
Confidence 666666665555556666666666666666653321111111 1
Q ss_pred cccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccc
Q 008012 126 DLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHW 205 (581)
Q Consensus 126 ~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~ 205 (581)
+|+.|++++|.+++. ..+..+++|+.|+|++|.+++..|..+..+++|+.|++++|++++.......+..+..+++.+
T Consensus 227 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~ 304 (390)
T 3o6n_A 227 ELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSH 304 (390)
T ss_dssp SCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCS
T ss_pred cccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCC
Confidence 122222222222211 234444555555555555555445555555555555555555554333334444555555555
Q ss_pred cc
Q 008012 206 NY 207 (581)
Q Consensus 206 n~ 207 (581)
|.
T Consensus 305 n~ 306 (390)
T 3o6n_A 305 NH 306 (390)
T ss_dssp SC
T ss_pred Cc
Confidence 43
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=236.10 Aligned_cols=205 Identities=22% Similarity=0.234 Sum_probs=132.8
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
.+++|++|+|++|.|+++.|..|+.+++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|.++++|++|
T Consensus 73 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L 152 (597)
T 3oja_B 73 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTL 152 (597)
T ss_dssp HCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEE
Confidence 46677777777777776666677777777777777777777767777777777777777777775555556777777777
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCc-------------------------------------c
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGL-------------------------------------K 125 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-------------------------------------~ 125 (581)
+|++|.+++..|..|..+++|++|++++|.+++..+..+.++ +
T Consensus 153 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~ 232 (597)
T 3oja_B 153 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNV 232 (597)
T ss_dssp ECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCS
T ss_pred EeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCC
Confidence 777777776666677777777777777777764322222111 1
Q ss_pred cccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccc
Q 008012 126 DLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHW 205 (581)
Q Consensus 126 ~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~ 205 (581)
+|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++.++....+..+..+++.+
T Consensus 233 ~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~ 310 (597)
T 3oja_B 233 ELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSH 310 (597)
T ss_dssp CCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCS
T ss_pred CCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEECCC
Confidence 23333333333332 2345556666666666666666666666666666666666666665444444555666666666
Q ss_pred cccc
Q 008012 206 NYAL 209 (581)
Q Consensus 206 n~~~ 209 (581)
|...
T Consensus 311 N~l~ 314 (597)
T 3oja_B 311 NHLL 314 (597)
T ss_dssp SCCC
T ss_pred CCCC
Confidence 6544
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-25 Score=219.76 Aligned_cols=205 Identities=22% Similarity=0.188 Sum_probs=153.4
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCc-----------
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS----------- 71 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----------- 71 (581)
.+++|++|+|++|+|++..|..|.++++|++|+|++|.|++..+ |..+++|++|+|++|+|++..+.
T Consensus 32 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n 109 (317)
T 3o53_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANN 109 (317)
T ss_dssp TGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSS
T ss_pred cCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEECCCC
Confidence 46789999999999998777899999999999999999986544 88999999999999988743211
Q ss_pred -----ccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccc-cCcccccceeccccccccccCccc
Q 008012 72 -----ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTI-AGLKDLTNLSLAGNQFQGPIPESF 145 (581)
Q Consensus 72 -----~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~l~~N~i~~~~~~~~ 145 (581)
....+++|++|++++|++++..+..+..+++|++|++++|.+++..+..+ ..+++|+.|+|++|.|++. + ..
T Consensus 110 ~l~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~ 187 (317)
T 3o53_A 110 NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQ 187 (317)
T ss_dssp CCSEEEECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CC
T ss_pred ccCCcCccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cc
Confidence 11234567777777777776666677777788888888888776555555 3677788888888887754 2 23
Q ss_pred cCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCC
Q 008012 146 GSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGP 212 (581)
Q Consensus 146 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~ 212 (581)
..+++|+.|+|++|.+++ +|..+..+++|+.|++++|++++.++....+..+..+++.+|++.|+.
T Consensus 188 ~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~~ 253 (317)
T 3o53_A 188 VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGT 253 (317)
T ss_dssp CCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHHH
T ss_pred cccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCcC
Confidence 347788888888888876 444577888888888888888865555566777888888888887763
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.3e-24 Score=213.05 Aligned_cols=207 Identities=19% Similarity=0.269 Sum_probs=176.3
Q ss_pred CCCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCccccc---------------------CCccccCCCCCCEEE
Q 008012 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGS---------------------IPTCLASLTSLRELR 59 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~---------------------~~~~~~~l~~L~~L~ 59 (581)
|+++++|++|+|++|+++++.|..|.++++|++|+|++|+|+.. .+..|.++++|++|+
T Consensus 72 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 151 (330)
T 1xku_A 72 FKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 151 (330)
T ss_dssp TTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEE
T ss_pred hccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChhhcccccEEECCCCcccccCHhHhcCCccccEEE
Confidence 46788888999999888877788888888888888888877632 233478899999999
Q ss_pred ccCCcccC--CCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceecccccc
Q 008012 60 LNSNKLTS--SIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQF 137 (581)
Q Consensus 60 L~~N~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i 137 (581)
|++|.++. ..+..+.++++|++|++++|.++ .+|..+. ++|++|++++|.+++..|..|.++++|+.|+|++|.+
T Consensus 152 l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 228 (330)
T 1xku_A 152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 228 (330)
T ss_dssp CCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCC
T ss_pred CCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcC
Confidence 99999964 67888999999999999999999 4555544 8999999999999988889999999999999999999
Q ss_pred ccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCC-------CCcCCcccccccccccc
Q 008012 138 QGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEG-------PFRNFSAQSFHWNYALC 210 (581)
Q Consensus 138 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~-------~~~~~~~~~~~~n~~~c 210 (581)
++..+..|..+++|+.|+|++|.++ .+|..+..+++|+.|++++|++++..+... ....+..+++.+||+.+
T Consensus 229 ~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 229 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp CEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred ceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccc
Confidence 9888888999999999999999998 588889999999999999999997655431 23556678888999876
Q ss_pred C
Q 008012 211 G 211 (581)
Q Consensus 211 ~ 211 (581)
.
T Consensus 308 ~ 308 (330)
T 1xku_A 308 W 308 (330)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=227.46 Aligned_cols=203 Identities=21% Similarity=0.214 Sum_probs=162.7
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
++|++|+|++|+|+++.+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence 46888888888888777888888888888888888888877888888888888888888888666667888888888888
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEG 164 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~ 164 (581)
++|++++..+..|..+++|++|++++|.+++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|.+++.
T Consensus 112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~ 191 (477)
T 2id5_A 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI 191 (477)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEE
T ss_pred CCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEe
Confidence 88888877778888888888888888888877777888888888888888888876667788888888888888888877
Q ss_pred CchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCccccccccc
Q 008012 165 IPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNY 207 (581)
Q Consensus 165 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~ 207 (581)
.+..+..+++|+.|++++|++.+.++.. .....+..+++.+|.
T Consensus 192 ~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~ 235 (477)
T 2id5_A 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235 (477)
T ss_dssp CTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSC
T ss_pred ChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCc
Confidence 7777888888888888887665555443 222345555555553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-23 Score=210.83 Aligned_cols=207 Identities=22% Similarity=0.257 Sum_probs=171.9
Q ss_pred CCCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCc
Q 008012 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYIL 80 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 80 (581)
|+++++|++|+|++|+|++..|..|+++++|++|+|++|+|+ .+|..+. ++|++|+|++|++++..+..|.++++|+
T Consensus 74 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~ 150 (332)
T 2ft3_A 74 FKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMN 150 (332)
T ss_dssp TTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCC
T ss_pred hhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCC
Confidence 467899999999999999888999999999999999999999 4454443 7888888888888876667788888888
Q ss_pred EEecccCcCCC--CCCccccCC--------------------ccCcEEeCCCCcCCCCCcccccCcccccceeccccccc
Q 008012 81 YVNLSSNYLTG--SLTSDIQNM--------------------KVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQ 138 (581)
Q Consensus 81 ~L~l~~n~l~~--~~~~~~~~l--------------------~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~ 138 (581)
+|++++|.++. ..+..+..+ ++|++|++++|.+++..+..+.++++|+.|+|++|+++
T Consensus 151 ~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~ 230 (332)
T 2ft3_A 151 CIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR 230 (332)
T ss_dssp EEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCC
T ss_pred EEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCC
Confidence 88888888752 444444433 57888888888888777788999999999999999999
Q ss_pred cccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCC-------CCcCCccccccccccccC
Q 008012 139 GPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEG-------PFRNFSAQSFHWNYALCG 211 (581)
Q Consensus 139 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~-------~~~~~~~~~~~~n~~~c~ 211 (581)
+..+..|..+++|+.|+|++|.++ .+|..+..+++|+.|++++|++++..+... ....+..+.+.+||+.+.
T Consensus 231 ~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~ 309 (332)
T 2ft3_A 231 MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309 (332)
T ss_dssp CCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGG
T ss_pred cCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccc
Confidence 888889999999999999999998 588889999999999999999997655431 134567788899998754
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=213.56 Aligned_cols=202 Identities=20% Similarity=0.213 Sum_probs=171.9
Q ss_pred CCCCcEEEeecCcccccCCccc--cCCCCCCEEEccCCcccccCC----ccccCCCCCCEEEccCCcccCCCCcccccCC
Q 008012 4 MQQLQGIGLADNHLQGSIPYDL--CQLKRLNSLSLQGNKLNGSIP----TCLASLTSLRELRLNSNKLTSSIPSALWALE 77 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~l~~n~i~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 77 (581)
+++|++|+|++|++++..|..+ ..+++|++|+|++|.|++..+ ..+..+++|++|+|++|++++..+..|..++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 3569999999999999999888 899999999999999997554 4456799999999999999988889999999
Q ss_pred CCcEEecccCcCCCC--C--CccccCCccCcEEeCCCCcCCCCCcc----cccCcccccceeccccccccccCccccCc-
Q 008012 78 YILYVNLSSNYLTGS--L--TSDIQNMKVLIDLDLSRNQLSGDIPK----TIAGLKDLTNLSLAGNQFQGPIPESFGSL- 148 (581)
Q Consensus 78 ~L~~L~l~~n~l~~~--~--~~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~L~l~~N~i~~~~~~~~~~l- 148 (581)
+|++|+|++|++.+. . +..+..+++|++|+|++|+++ .++. .+.++++|+.|+|++|+|++..|..+..+
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 248 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM 248 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence 999999999998642 2 223478999999999999997 4444 25788999999999999998878777776
Q ss_pred --cccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCcccccccccccc
Q 008012 149 --ISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALC 210 (581)
Q Consensus 149 --~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c 210 (581)
++|+.|+|++|+++. +|..+. ++|+.|+|++|++++. |....+..+..+.+.+|++..
T Consensus 249 ~~~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 249 WSSALNSLNLSFAGLEQ-VPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCTTCCCEECCSSCCCS-CCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSCEECSSTTTSC
T ss_pred CcCcCCEEECCCCCCCc-hhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccEEECcCCCCCC
Confidence 699999999999985 676664 8999999999999964 445677889999999998653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=218.56 Aligned_cols=180 Identities=22% Similarity=0.230 Sum_probs=159.6
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
+.....++++|+++ .+|..+. ++|++|+|++|.|++..+..|.++++|++|+|++|++++..|..|.++++|++|++
T Consensus 31 ~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 31 DRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp CTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 44556899999999 6777666 69999999999999887779999999999999999999888889999999999999
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCCCCCc-ccccCcccccceecccc-ccccccCccccCccccceeeccccccC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIP-KTIAGLKDLTNLSLAGN-QFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N-~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
++|++++..+..|..+++|++|++++|++++..+ ..+.++++|+.|++++| .++...+..|..+++|+.|++++|.++
T Consensus 108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~ 187 (353)
T 2z80_A 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187 (353)
T ss_dssp CSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcC
Confidence 9999997666669999999999999999995433 37899999999999999 578777889999999999999999999
Q ss_pred CCCchhhhcccccCeeEccCCCCCC
Q 008012 163 EGIPKSLVALSHLKQFNVSHNRLEG 187 (581)
Q Consensus 163 ~~~~~~~~~l~~L~~l~l~~n~l~~ 187 (581)
+..|..+..+++|+.|++++|+++.
T Consensus 188 ~~~~~~l~~l~~L~~L~l~~n~l~~ 212 (353)
T 2z80_A 188 SYEPKSLKSIQNVSHLILHMKQHIL 212 (353)
T ss_dssp EECTTTTTTCSEEEEEEEECSCSTT
T ss_pred ccCHHHHhccccCCeecCCCCcccc
Confidence 9889999888888888888887753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-24 Score=235.79 Aligned_cols=205 Identities=24% Similarity=0.307 Sum_probs=184.4
Q ss_pred CCCCCCCcEEEeecCccccc-----------------CCcccc--CCCCCCEEEccCCcccccCCccccCCCCCCEEEcc
Q 008012 1 MGRMQQLQGIGLADNHLQGS-----------------IPYDLC--QLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~-----------------~~~~~~--~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~ 61 (581)
|+++++|++|+|++|++++. +|..++ ++++|++|+|++|.+.+.+|..|.++++|++|+|+
T Consensus 202 l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 281 (636)
T 4eco_A 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281 (636)
T ss_dssp GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECT
T ss_pred HhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECc
Confidence 46789999999999999975 899999 99999999999999999999999999999999999
Q ss_pred CCc-ccC-CCCcccccC------CCCcEEecccCcCCCCCCc--cccCCccCcEEeCCCCcCCCCCcccccCccccccee
Q 008012 62 SNK-LTS-SIPSALWAL------EYILYVNLSSNYLTGSLTS--DIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLS 131 (581)
Q Consensus 62 ~N~-l~~-~~~~~~~~l------~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 131 (581)
+|+ +++ .+|..++.+ ++|++|++++|+++ .+|. .++.+++|++|++++|.+++.+| .+.++++|+.|+
T Consensus 282 ~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~ 359 (636)
T 4eco_A 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN 359 (636)
T ss_dssp TCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEE
T ss_pred CCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEE
Confidence 998 987 789888887 99999999999999 7888 89999999999999999998888 899999999999
Q ss_pred ccccccccccCccccCccc-cceeeccccccCCCCchhhhccc--ccCeeEccCCCCCCCCCCC-C-------CCcCCcc
Q 008012 132 LAGNQFQGPIPESFGSLIS-LESLDLSSNNLSEGIPKSLVALS--HLKQFNVSHNRLEGEIPTE-G-------PFRNFSA 200 (581)
Q Consensus 132 l~~N~i~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~--~L~~l~l~~n~l~~~~~~~-~-------~~~~~~~ 200 (581)
|++|+++ .+|..+..+++ |+.|++++|.++ .+|..+..+. +|+.|++++|++++.+|.. . ....+..
T Consensus 360 L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~ 437 (636)
T 4eco_A 360 LAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437 (636)
T ss_dssp CCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEE
T ss_pred CCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCE
Confidence 9999999 78888999999 999999999998 5787777655 8999999999999877754 2 4456777
Q ss_pred ccccccccc
Q 008012 201 QSFHWNYAL 209 (581)
Q Consensus 201 ~~~~~n~~~ 209 (581)
+++.+|...
T Consensus 438 L~Ls~N~l~ 446 (636)
T 4eco_A 438 INLSNNQIS 446 (636)
T ss_dssp EECCSSCCC
T ss_pred EECcCCccC
Confidence 778777554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=207.68 Aligned_cols=196 Identities=26% Similarity=0.352 Sum_probs=171.3
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
++++|++|++++|+++. ++ .+..+++|++|+|++|.|++..+ +..+++|++|+|++|++++. ..+..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L 112 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTL 112 (308)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEE
T ss_pred HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEE
Confidence 46789999999999984 55 68999999999999999996544 99999999999999999853 369999999999
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
++++|++++. + .+..+++|++|++++|.+++..+ +..+++|+.|+|++|.+++..+ +..+++|+.|++++|.++
T Consensus 113 ~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 113 DLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp ECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence 9999999964 3 38999999999999999995433 8999999999999999996544 899999999999999998
Q ss_pred CCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCCC
Q 008012 163 EGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 163 ~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 213 (581)
+..+ +..+++|+.|++++|++++..+ ...+..+..+.+.+|++.+.+.
T Consensus 187 ~~~~--l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i~~~~~ 234 (308)
T 1h6u_A 187 DISP--LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTITNQPV 234 (308)
T ss_dssp CCGG--GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEEECCCE
T ss_pred cChh--hcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCeeecCCe
Confidence 7443 8899999999999999996654 6778889999999999877554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3e-23 Score=199.40 Aligned_cols=182 Identities=23% Similarity=0.288 Sum_probs=165.8
Q ss_pred CCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeC
Q 008012 29 KRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDL 108 (581)
Q Consensus 29 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 108 (581)
...+++++++|.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 46789999999999 5666665 68999999999999888889999999999999999999888888999999999999
Q ss_pred CCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCC
Q 008012 109 SRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGE 188 (581)
Q Consensus 109 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~ 188 (581)
++|.+++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 99999987778899999999999999999988778889999999999999999987777899999999999999999987
Q ss_pred CCC-CCCCcCCccccccccccccCCC
Q 008012 189 IPT-EGPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 189 ~~~-~~~~~~~~~~~~~~n~~~c~~~ 213 (581)
++. ...+..+..+.+.+|++.|...
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred CHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 764 4678899999999999999743
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-24 Score=213.30 Aligned_cols=180 Identities=20% Similarity=0.188 Sum_probs=157.7
Q ss_pred CCCCCCcEEEeecCcccccCCccccCC-----CCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCC--CCccc-
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQL-----KRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSS--IPSAL- 73 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~- 73 (581)
+.+++|++|+|++|++++. |..++.+ ++|++|+|++|+|++..+..|.++++|++|+|++|++.+. .+..+
T Consensus 118 ~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 196 (312)
T 1wwl_A 118 ATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC 196 (312)
T ss_dssp CCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSC
T ss_pred hcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHH
Confidence 6789999999999999976 8888887 9999999999999988889999999999999999998754 23334
Q ss_pred -ccCCCCcEEecccCcCCCC---CCccccCCccCcEEeCCCCcCCCCCc-ccccCcccccceeccccccccccCccccCc
Q 008012 74 -WALEYILYVNLSSNYLTGS---LTSDIQNMKVLIDLDLSRNQLSGDIP-KTIAGLKDLTNLSLAGNQFQGPIPESFGSL 148 (581)
Q Consensus 74 -~~l~~L~~L~l~~n~l~~~---~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l 148 (581)
..+++|++|+|++|+|++. ....+..+++|++|++++|.+++..| ..+..+++|+.|+|++|.|+ .+|..+.
T Consensus 197 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-- 273 (312)
T 1wwl_A 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-- 273 (312)
T ss_dssp TTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--
T ss_pred hccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--
Confidence 8899999999999999832 22345688999999999999997664 56677899999999999999 6777776
Q ss_pred cccceeeccccccCCCCchhhhcccccCeeEccCCCCCC
Q 008012 149 ISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEG 187 (581)
Q Consensus 149 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~ 187 (581)
++|+.|+|++|++++. |. +..+++|+.|++++|++++
T Consensus 274 ~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 274 AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 8999999999999985 66 8999999999999999985
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-24 Score=210.91 Aligned_cols=151 Identities=17% Similarity=0.140 Sum_probs=120.8
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchH------------------HHHHHHHHHHHHHHhcCC
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLE------------------QAFRSFNSECEVLRNVRH 346 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h 346 (581)
.+......|.+.+.||+|+||.||+|.+.+|+.||+|+++.... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34444556777799999999999999997799999999965321 23467889999999999
Q ss_pred CccceEeeeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC
Q 008012 347 RNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE 426 (581)
Q Consensus 347 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~ 426 (581)
| +++.+++.. +..++||||++|++|.+ +.. .....++.|++.||+||| +.||+||||||+|||++
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~- 227 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS- 227 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-
Confidence 4 566665543 55699999999999988 421 234579999999999999 89999999999999999
Q ss_pred CCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCC
Q 008012 427 NMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGS 466 (581)
Q Consensus 427 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 466 (581)
++.+||+|||+|... ..+.|||++.
T Consensus 228 ~~~vkl~DFG~a~~~---------------~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVEV---------------GEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred CCcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence 999999999999743 3467788654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=229.19 Aligned_cols=188 Identities=21% Similarity=0.206 Sum_probs=175.0
Q ss_pred CCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCC-ccccCCCCCCEEEccCCcccCCCCcccccCCCCc
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIP-TCLASLTSLRELRLNSNKLTSSIPSALWALEYIL 80 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 80 (581)
+.+++|++|+|++|.++ .+|..|..+++|++|++++|++++..+ ..|.++++|++|+|++|++++..|..+.++++|+
T Consensus 373 ~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 451 (606)
T 3vq2_A 373 LGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN 451 (606)
T ss_dssp HCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred ccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCC
Confidence 46789999999999998 477899999999999999999998777 7899999999999999999998999999999999
Q ss_pred EEecccCcCCC-CCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeecccc
Q 008012 81 YVNLSSNYLTG-SLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSN 159 (581)
Q Consensus 81 ~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N 159 (581)
+|++++|.+++ ..|..+..+++|++|++++|.+++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|
T Consensus 452 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 531 (606)
T 3vq2_A 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531 (606)
T ss_dssp EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTS
T ss_pred EEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCC
Confidence 99999999997 47889999999999999999999888899999999999999999999988999999999999999999
Q ss_pred ccCCCCchhhhccc-ccCeeEccCCCCCCCCCC
Q 008012 160 NLSEGIPKSLVALS-HLKQFNVSHNRLEGEIPT 191 (581)
Q Consensus 160 ~l~~~~~~~~~~l~-~L~~l~l~~n~l~~~~~~ 191 (581)
+++. +|..+..++ +|+.|++++|++.+..+.
T Consensus 532 ~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 532 RIET-SKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CCCC-EESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred cCcc-cCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 9985 777798987 699999999999986664
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3e-23 Score=225.96 Aligned_cols=160 Identities=19% Similarity=0.107 Sum_probs=101.8
Q ss_pred CCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecc
Q 008012 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85 (581)
Q Consensus 6 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 85 (581)
++++|+|++|+|+++.|..|+++++|++|+|++|+|++..|.+|.++++|++|+|++|++++..|..|.++++|++|+++
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 113 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence 46666777777666666666666777777777776666666666666677777777666666666666666666666666
Q ss_pred cCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccc--eeeccccccCC
Q 008012 86 SNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLE--SLDLSSNNLSE 163 (581)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~--~L~l~~N~l~~ 163 (581)
+|.+++..+..+.++++|++|++++|.+++..+..+.++++|+.|++++|.+++..+..|+.+++|+ .|++++|.+++
T Consensus 114 ~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~ 193 (606)
T 3t6q_A 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193 (606)
T ss_dssp TSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCE
T ss_pred ccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCc
Confidence 6666655555666666666666666666643333344466666666666666655555555555555 55555555544
Q ss_pred CC
Q 008012 164 GI 165 (581)
Q Consensus 164 ~~ 165 (581)
..
T Consensus 194 ~~ 195 (606)
T 3t6q_A 194 IE 195 (606)
T ss_dssp EC
T ss_pred cC
Confidence 33
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.8e-24 Score=234.88 Aligned_cols=185 Identities=20% Similarity=0.343 Sum_probs=161.9
Q ss_pred CCccccCCCCCCEEEccCCcccc-----------------cCCcccc--CCCCCCEEEccCCcccCCCCcccccCCCCcE
Q 008012 21 IPYDLCQLKRLNSLSLQGNKLNG-----------------SIPTCLA--SLTSLRELRLNSNKLTSSIPSALWALEYILY 81 (581)
Q Consensus 21 ~~~~~~~l~~L~~L~l~~n~i~~-----------------~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 81 (581)
+|..|+++++|++|+|++|+|++ .+|..++ ++++|++|+|++|++.+.+|..+.++++|++
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 78889999999999999999997 3788877 9999999999999999999999999999999
Q ss_pred EecccCc-CCC-CCCccccCCc-------cCcEEeCCCCcCCCCCcc--cccCcccccceeccccccccccCccccCccc
Q 008012 82 VNLSSNY-LTG-SLTSDIQNMK-------VLIDLDLSRNQLSGDIPK--TIAGLKDLTNLSLAGNQFQGPIPESFGSLIS 150 (581)
Q Consensus 82 L~l~~n~-l~~-~~~~~~~~l~-------~L~~L~l~~N~l~~~~~~--~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~ 150 (581)
|+|++|+ +++ .+|..+..++ +|++|+|++|.++ .+|. .|.++++|+.|+|++|+|+ .+| .|+.+++
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~ 596 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVK 596 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSE
T ss_pred EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCc
Confidence 9999998 887 6787666655 9999999999999 8888 8999999999999999999 677 8999999
Q ss_pred cceeeccccccCCCCchhhhcccc-cCeeEccCCCCCCCCCCC-CCC--cCCcccccccccccc
Q 008012 151 LESLDLSSNNLSEGIPKSLVALSH-LKQFNVSHNRLEGEIPTE-GPF--RNFSAQSFHWNYALC 210 (581)
Q Consensus 151 L~~L~l~~N~l~~~~~~~~~~l~~-L~~l~l~~n~l~~~~~~~-~~~--~~~~~~~~~~n~~~c 210 (581)
|+.|+|++|.++ .+|..+..+++ |+.|+|++|+++ .+|.. ... ..+..+++.+|...-
T Consensus 597 L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g 658 (876)
T 4ecn_A 597 LTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS 658 (876)
T ss_dssp ESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTT
T ss_pred ceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCC
Confidence 999999999998 68888999999 999999999999 55543 333 237778888876543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-23 Score=225.84 Aligned_cols=206 Identities=16% Similarity=0.219 Sum_probs=147.1
Q ss_pred CCCC-CcEEEeecCcccccCCccccCCC--CCCEEEccCCcccccCCcccc-------CCCCCCEEEccCCcccCCCCcc
Q 008012 3 RMQQ-LQGIGLADNHLQGSIPYDLCQLK--RLNSLSLQGNKLNGSIPTCLA-------SLTSLRELRLNSNKLTSSIPSA 72 (581)
Q Consensus 3 ~~~~-L~~L~l~~n~l~~~~~~~~~~l~--~L~~L~l~~n~i~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~ 72 (581)
.+++ |++|+|++|+++ .+|..+..++ +|++|+|++|.|++..|..|. .+++|++|+|++|++++..+..
T Consensus 374 ~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~ 452 (636)
T 4eco_A 374 GFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL 452 (636)
T ss_dssp EECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHH
T ss_pred hhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHH
Confidence 4555 777777777776 5666665544 677777777777766676666 6667777777777777444444
Q ss_pred cccCCCCcEEecccCcCCCCCCccccCC-------ccCcEEeCCCCcCCCCCccccc--CcccccceeccccccccccCc
Q 008012 73 LWALEYILYVNLSSNYLTGSLTSDIQNM-------KVLIDLDLSRNQLSGDIPKTIA--GLKDLTNLSLAGNQFQGPIPE 143 (581)
Q Consensus 73 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l-------~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~l~~N~i~~~~~~ 143 (581)
+..+++|++|+|++|+++...+..+..+ ++|++|+|++|.++ .+|..+. .+++|+.|+|++|+|++ +|.
T Consensus 453 ~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~ 530 (636)
T 4eco_A 453 FSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPT 530 (636)
T ss_dssp HHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCC
T ss_pred HccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cCh
Confidence 5567788888888888773333333322 27888888888887 6777776 78888888888888886 777
Q ss_pred cccCccccceeec------cccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCCC
Q 008012 144 SFGSLISLESLDL------SSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 144 ~~~~l~~L~~L~l------~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 213 (581)
.+..+++|+.|+| ++|.+.+.+|..+..+++|+.|++++|+++ .+|.... ..+..+++.+|++.|...
T Consensus 531 ~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~~-~~L~~L~Ls~N~l~~~~~ 604 (636)
T 4eco_A 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT-PNISVLDIKDNPNISIDL 604 (636)
T ss_dssp GGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCCC-TTCCEEECCSCTTCEEEC
T ss_pred hhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhHh-CcCCEEECcCCCCccccH
Confidence 7778888888888 456677778888888888888888888884 5555422 677888888888877654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.89 E-value=9.3e-24 Score=234.71 Aligned_cols=204 Identities=25% Similarity=0.292 Sum_probs=180.0
Q ss_pred CCCCCCCcEEEeecCcccc-----------------cCCcccc--CCCCCCEEEccCCcccccCCccccCCCCCCEEEcc
Q 008012 1 MGRMQQLQGIGLADNHLQG-----------------SIPYDLC--QLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN 61 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~-----------------~~~~~~~--~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~ 61 (581)
|+++++|++|+|++|+|++ .+|..++ ++++|++|+|++|.+.+.+|..|.++++|+.|+|+
T Consensus 444 l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls 523 (876)
T 4ecn_A 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA 523 (876)
T ss_dssp GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECT
T ss_pred HhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECc
Confidence 4678999999999999997 3888877 99999999999999999999999999999999999
Q ss_pred CCc-ccC-CCCcccccCC-------CCcEEecccCcCCCCCCc--cccCCccCcEEeCCCCcCCCCCcccccCcccccce
Q 008012 62 SNK-LTS-SIPSALWALE-------YILYVNLSSNYLTGSLTS--DIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNL 130 (581)
Q Consensus 62 ~N~-l~~-~~~~~~~~l~-------~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 130 (581)
+|+ +++ .+|..+..++ +|+.|+|++|+++ .+|. .+.++++|++|+|++|.++ .+| .|.++++|+.|
T Consensus 524 ~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L 600 (876)
T 4ecn_A 524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDL 600 (876)
T ss_dssp TCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEE
T ss_pred CCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEE
Confidence 998 987 7887776665 9999999999999 7888 8999999999999999999 788 89999999999
Q ss_pred eccccccccccCccccCccc-cceeeccccccCCCCchhhhcccc--cCeeEccCCCCCCCCCCCC------CCcCCccc
Q 008012 131 SLAGNQFQGPIPESFGSLIS-LESLDLSSNNLSEGIPKSLVALSH--LKQFNVSHNRLEGEIPTEG------PFRNFSAQ 201 (581)
Q Consensus 131 ~l~~N~i~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~~--L~~l~l~~n~l~~~~~~~~------~~~~~~~~ 201 (581)
+|++|+|+ .+|..+..+++ |+.|+|++|.++ .+|..+..+.. |+.|++++|++++.+|... ....+..+
T Consensus 601 ~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L 678 (876)
T 4ecn_A 601 KLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTV 678 (876)
T ss_dssp ECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEE
T ss_pred ECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEE
Confidence 99999999 78888999999 999999999998 57887777654 9999999999998776542 23356777
Q ss_pred cccccccc
Q 008012 202 SFHWNYAL 209 (581)
Q Consensus 202 ~~~~n~~~ 209 (581)
++.+|...
T Consensus 679 ~Ls~N~L~ 686 (876)
T 4ecn_A 679 TLSYNEIQ 686 (876)
T ss_dssp ECCSSCCC
T ss_pred EccCCcCC
Confidence 77777544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=225.67 Aligned_cols=208 Identities=25% Similarity=0.284 Sum_probs=177.6
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccC--CccccCCCCCCEEEccCCcccCCCCcccccCCCCc
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSI--PTCLASLTSLRELRLNSNKLTSSIPSALWALEYIL 80 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 80 (581)
.+++|++|++++|.+.+..+. ..+++|++|++++|.+++.. +..+.++++|++|+|++|.+++.. ..+..+++|+
T Consensus 323 ~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~-~~~~~l~~L~ 399 (570)
T 2z63_A 323 KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMS-SNFLGLEQLE 399 (570)
T ss_dssp BCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEE-EEEETCTTCC
T ss_pred cccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccc-ccccccCCCC
Confidence 345666666666666544443 67889999999999998554 677889999999999999998554 4499999999
Q ss_pred EEecccCcCCCCCC-ccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccc-cccCccccCccccceeeccc
Q 008012 81 YVNLSSNYLTGSLT-SDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQ-GPIPESFGSLISLESLDLSS 158 (581)
Q Consensus 81 ~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~-~~~~~~~~~l~~L~~L~l~~ 158 (581)
+|++++|.+.+..+ ..+..+++|++|++++|.+.+..|..+.++++|+.|+|++|.++ +.+|..|..+++|+.|++++
T Consensus 400 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~ 479 (570)
T 2z63_A 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479 (570)
T ss_dssp EEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred EEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCC
Confidence 99999999987655 57889999999999999999888889999999999999999997 57889999999999999999
Q ss_pred cccCCCCchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCccccccccccccCCC
Q 008012 159 NNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 159 N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~ 213 (581)
|.+++..|..+..+++|+.|++++|++++.++.. ..+..+..+++.+|++.|.-+
T Consensus 480 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 480 CQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 9999988999999999999999999999877764 678889999999999998755
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.8e-23 Score=219.40 Aligned_cols=203 Identities=24% Similarity=0.313 Sum_probs=162.2
Q ss_pred CCCcEEEeecCcccccCCccc-----cCCCCCCEEEccCCcccccCC-c-------------------------cccCCC
Q 008012 5 QQLQGIGLADNHLQGSIPYDL-----CQLKRLNSLSLQGNKLNGSIP-T-------------------------CLASLT 53 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~l~~n~i~~~~~-~-------------------------~~~~l~ 53 (581)
++|++|+|++|++++.+|..+ +.+++|+.|++++|.+. .| . .+..++
T Consensus 247 ~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~--~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~ 324 (520)
T 2z7x_B 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG--FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324 (520)
T ss_dssp SSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCC--SCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCC
T ss_pred CcccEEEeecccccCccccchhhcccccCceeEecccccccee--cchhhhhcccccCceeEEEcCCCccccccchhhCC
Confidence 367777777777776777766 66666555555555551 22 1 126788
Q ss_pred CCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCC--CCCccccCCccCcEEeCCCCcCCCCCccc-ccCcccccce
Q 008012 54 SLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTG--SLTSDIQNMKVLIDLDLSRNQLSGDIPKT-IAGLKDLTNL 130 (581)
Q Consensus 54 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~L 130 (581)
+|++|+|++|++++..|..+..+++|++|++++|++++ ..|..+..+++|++|++++|.+++.+|.. +..+++|+.|
T Consensus 325 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L 404 (520)
T 2z7x_B 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404 (520)
T ss_dssp CCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEE
T ss_pred cccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEE
Confidence 99999999999998888899999999999999999985 44567889999999999999998756654 7888999999
Q ss_pred eccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCC-CCCCcCCccccccccccc
Q 008012 131 SLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPT-EGPFRNFSAQSFHWNYAL 209 (581)
Q Consensus 131 ~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~-~~~~~~~~~~~~~~n~~~ 209 (581)
++++|++++..|..+. ++|+.|+|++|+++ .+|..+..+++|+.|++++|+++..++. ...+..+..+++.+|++.
T Consensus 405 ~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~ 481 (520)
T 2z7x_B 405 NMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481 (520)
T ss_dssp ECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCc
Confidence 9999999877777664 78999999999998 5787777999999999999999965554 467888999999999998
Q ss_pred cCC
Q 008012 210 CGP 212 (581)
Q Consensus 210 c~~ 212 (581)
|+-
T Consensus 482 c~c 484 (520)
T 2z7x_B 482 CSC 484 (520)
T ss_dssp CCH
T ss_pred ccC
Confidence 863
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=226.94 Aligned_cols=190 Identities=21% Similarity=0.250 Sum_probs=175.4
Q ss_pred CCCCCCcEEEeecCcccccC--CccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCC-cccccCCC
Q 008012 2 GRMQQLQGIGLADNHLQGSI--PYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIP-SALWALEY 78 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~ 78 (581)
..+++|++|+|++|++++.. |..+..+++|++|++++|.+++..+. |.++++|++|+|++|.+++..+ ..+.++++
T Consensus 344 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 422 (570)
T 2z63_A 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422 (570)
T ss_dssp CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTT
T ss_pred ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCC
Confidence 46899999999999999654 78899999999999999999965444 9999999999999999997766 57899999
Q ss_pred CcEEecccCcCCCCCCccccCCccCcEEeCCCCcCC-CCCcccccCcccccceeccccccccccCccccCccccceeecc
Q 008012 79 ILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLS-GDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLS 157 (581)
Q Consensus 79 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~ 157 (581)
|++|++++|.+.+..+..+..+++|++|++++|.++ +.+|..+..+++|+.|+|++|++++..|..|..+++|+.|+++
T Consensus 423 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 502 (570)
T 2z63_A 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMA 502 (570)
T ss_dssp CCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCC
Confidence 999999999999888999999999999999999997 5788999999999999999999999889999999999999999
Q ss_pred ccccCCCCchhhhcccccCeeEccCCCCCCCCCCC
Q 008012 158 SNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE 192 (581)
Q Consensus 158 ~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~ 192 (581)
+|++++..|..+..+++|+.|++++|++++..|..
T Consensus 503 ~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 503 SNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred CCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 99999988888999999999999999999988765
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.5e-23 Score=221.04 Aligned_cols=160 Identities=25% Similarity=0.258 Sum_probs=132.7
Q ss_pred cCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCC--CccccCCccCcEEeCCCCcCCCCCcc-cccCccc
Q 008012 50 ASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSL--TSDIQNMKVLIDLDLSRNQLSGDIPK-TIAGLKD 126 (581)
Q Consensus 50 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~ 126 (581)
..+++|++|+|++|++++..|..+.++++|++|++++|++++.. |..+..+++|++|++++|.+++.+|. .+..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 67788999999999998878888899999999999999988532 45688889999999999999874554 4788899
Q ss_pred ccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCC-CCCCcCCccccccc
Q 008012 127 LTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPT-EGPFRNFSAQSFHW 205 (581)
Q Consensus 127 L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~-~~~~~~~~~~~~~~ 205 (581)
|+.|+|++|++++..|..+. ++|+.|+|++|+++. +|..+..+++|+.|++++|++++.++. ...+..+..+++.+
T Consensus 430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~ 506 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHD 506 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCC-CCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCS
T ss_pred CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcc-cChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecC
Confidence 99999999999876666554 689999999999984 676677999999999999999965555 57788888999999
Q ss_pred cccccCC
Q 008012 206 NYALCGP 212 (581)
Q Consensus 206 n~~~c~~ 212 (581)
|||.|+-
T Consensus 507 N~~~c~c 513 (562)
T 3a79_B 507 NPWDCTC 513 (562)
T ss_dssp CCBCCCH
T ss_pred CCcCCCc
Confidence 9998863
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7e-23 Score=226.13 Aligned_cols=159 Identities=27% Similarity=0.290 Sum_probs=79.5
Q ss_pred CCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecc
Q 008012 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85 (581)
Q Consensus 6 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 85 (581)
+|++|+|++|+|+++.+..|+++++|++|+|++|.|++..|++|.++++|++|+|++|++++..+..|.++++|++|+++
T Consensus 26 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~ 105 (680)
T 1ziw_A 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105 (680)
T ss_dssp TCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred CCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECC
Confidence 45555555555554444445555555555555555555545555555555555555555553333345555555555555
Q ss_pred cCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCcccc--CccccceeeccccccCC
Q 008012 86 SNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFG--SLISLESLDLSSNNLSE 163 (581)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~--~l~~L~~L~l~~N~l~~ 163 (581)
+|++++..+..|.++++|++|++++|.+++..|..+.++++|+.|++++|.+++..+..+. .+++|+.|++++|.+++
T Consensus 106 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~ 185 (680)
T 1ziw_A 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185 (680)
T ss_dssp SSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCC
T ss_pred CCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccc
Confidence 5555544444555555555555555555544444455555555555555555443333322 22444444444444443
Q ss_pred C
Q 008012 164 G 164 (581)
Q Consensus 164 ~ 164 (581)
.
T Consensus 186 ~ 186 (680)
T 1ziw_A 186 F 186 (680)
T ss_dssp B
T ss_pred c
Confidence 3
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.3e-23 Score=230.80 Aligned_cols=90 Identities=20% Similarity=0.180 Sum_probs=47.4
Q ss_pred CCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCcc--ccCCCCCCEEEccCCcccCCCC-cccccCCC
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTC--LASLTSLRELRLNSNKLTSSIP-SALWALEY 78 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~ 78 (581)
+++++|++|+|++|+|++..|+.|+++++|++|+|++|.+++..|.. |.++++|++|+|++|.+++..+ ..|.++++
T Consensus 70 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~ 149 (844)
T 3j0a_A 70 RNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNS 149 (844)
T ss_dssp SSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSS
T ss_pred cCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCC
Confidence 34555555555555555555555555555555555555555433332 5555555555555555554332 34555555
Q ss_pred CcEEecccCcCCC
Q 008012 79 ILYVNLSSNYLTG 91 (581)
Q Consensus 79 L~~L~l~~n~l~~ 91 (581)
|++|+|++|.+++
T Consensus 150 L~~L~Ls~N~i~~ 162 (844)
T 3j0a_A 150 LKSIDFSSNQIFL 162 (844)
T ss_dssp CCEEEEESSCCCC
T ss_pred CCEEECCCCcCCe
Confidence 5555555555543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=8.9e-23 Score=190.24 Aligned_cols=175 Identities=25% Similarity=0.261 Sum_probs=156.0
Q ss_pred cEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccC
Q 008012 8 QGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSN 87 (581)
Q Consensus 8 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n 87 (581)
+.+++++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCCC--CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 67899999998 5665554 79999999999999887888999999999999999999777778899999999999999
Q ss_pred cCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCch
Q 008012 88 YLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPK 167 (581)
Q Consensus 88 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 167 (581)
++++..+..|..+++|++|++++|++++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 9997777778999999999999999997777778999999999999999998777778999999999999998875
Q ss_pred hhhcccccCeeEccCCCCCCCCCCC
Q 008012 168 SLVALSHLKQFNVSHNRLEGEIPTE 192 (581)
Q Consensus 168 ~~~~l~~L~~l~l~~n~l~~~~~~~ 192 (581)
.+++|+.|+++.|++++.+|..
T Consensus 163 ---~~~~l~~L~~~~n~~~g~ip~~ 184 (208)
T 2o6s_A 163 ---TCPGIRYLSEWINKHSGVVRNS 184 (208)
T ss_dssp ---CTTTTHHHHHHHHHCTTTBBCT
T ss_pred ---CCCCHHHHHHHHHhCCceeecc
Confidence 3467899999999999988874
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.5e-23 Score=194.44 Aligned_cols=177 Identities=19% Similarity=0.247 Sum_probs=156.9
Q ss_pred CCCCCCCcEEEeecCc-ccccCCccccCCCCCCEEEccC-CcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCC
Q 008012 1 MGRMQQLQGIGLADNH-LQGSIPYDLCQLKRLNSLSLQG-NKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEY 78 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 78 (581)
|+.+++|++|+|++|+ ++++.+..|.++++|++|+|++ |+|+...+..|.++++|++|+|++|++++ +|. |..+++
T Consensus 51 ~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~ 128 (239)
T 2xwt_C 51 FSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYS 128 (239)
T ss_dssp TTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCB
T ss_pred ccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccc
Confidence 4678999999999997 9877778999999999999999 99998888899999999999999999995 666 889999
Q ss_pred Cc---EEecccC-cCCCCCCccccCCccCc-EEeCCCCcCCCCCcccccCcccccceeccccc-cccccCccccCc-ccc
Q 008012 79 IL---YVNLSSN-YLTGSLTSDIQNMKVLI-DLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQ-FQGPIPESFGSL-ISL 151 (581)
Q Consensus 79 L~---~L~l~~n-~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~-i~~~~~~~~~~l-~~L 151 (581)
|+ +|++++| .+++..+..|..+++|+ +|++++|.++ .+|......++|+.|+|++|+ +++..+..|..+ ++|
T Consensus 129 L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L 207 (239)
T 2xwt_C 129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207 (239)
T ss_dssp CCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCC
T ss_pred cccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCC
Confidence 98 9999999 99977777899999999 9999999999 555544444899999999995 997778889999 999
Q ss_pred ceeeccccccCCCCchhhhcccccCeeEccCC
Q 008012 152 ESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183 (581)
Q Consensus 152 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n 183 (581)
+.|++++|++++. |.. .+++|+.|+++++
T Consensus 208 ~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 208 SLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp SEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred cEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 9999999999874 433 6788999999876
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=201.31 Aligned_cols=174 Identities=25% Similarity=0.352 Sum_probs=153.9
Q ss_pred CCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcE
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILY 81 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 81 (581)
..+++|++|+|++|++++.. . +..+++|++|+|++|+|++. ..+..+++|++|+|++|++++. +. +..+++|++
T Consensus 60 ~~l~~L~~L~L~~n~i~~~~-~-~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~ 133 (308)
T 1h6u_A 60 QYLNNLIGLELKDNQITDLA-P-LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQV 133 (308)
T ss_dssp GGCTTCCEEECCSSCCCCCG-G-GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCE
T ss_pred hccCCCCEEEccCCcCCCCh-h-HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCE
Confidence 46899999999999999544 4 99999999999999999953 4799999999999999999854 43 999999999
Q ss_pred EecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeecccccc
Q 008012 82 VNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNL 161 (581)
Q Consensus 82 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l 161 (581)
|++++|.+++..+ +..+++|++|++++|.+++. +. +.++++|+.|++++|.+++..+ +..+++|+.|+|++|.+
T Consensus 134 L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l 207 (308)
T 1h6u_A 134 LYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQI 207 (308)
T ss_dssp EECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCC
T ss_pred EECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCcc
Confidence 9999999996544 88999999999999999954 44 8999999999999999996544 88999999999999999
Q ss_pred CCCCchhhhcccccCeeEccCCCCCCCC
Q 008012 162 SEGIPKSLVALSHLKQFNVSHNRLEGEI 189 (581)
Q Consensus 162 ~~~~~~~~~~l~~L~~l~l~~n~l~~~~ 189 (581)
++.. .+..+++|+.|++++|++++..
T Consensus 208 ~~~~--~l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 208 SDVS--PLANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp CBCG--GGTTCTTCCEEEEEEEEEECCC
T ss_pred Cccc--cccCCCCCCEEEccCCeeecCC
Confidence 8744 3889999999999999998643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.88 E-value=7.7e-23 Score=207.53 Aligned_cols=178 Identities=25% Similarity=0.220 Sum_probs=154.2
Q ss_pred cEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCcccc-CCCCCCEEEccCCcccCCCCcccccCCCCcEEeccc
Q 008012 8 QGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLA-SLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSS 86 (581)
Q Consensus 8 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 86 (581)
+.+++++|+|+ .+|..+. +.+++|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 57899999998 5777665 6789999999999988888888 999999999999999988888899999999999999
Q ss_pred CcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccc---cCccccceeeccccccCC
Q 008012 87 NYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESF---GSLISLESLDLSSNNLSE 163 (581)
Q Consensus 87 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~---~~l~~L~~L~l~~N~l~~ 163 (581)
|+|+...+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|+.
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99997777789999999999999999997778889999999999999999997555555 568999999999999998
Q ss_pred CCchhhhcccc--cCeeEccCCCCCCC
Q 008012 164 GIPKSLVALSH--LKQFNVSHNRLEGE 188 (581)
Q Consensus 164 ~~~~~~~~l~~--L~~l~l~~n~l~~~ 188 (581)
..+..+..++. ++.|+|++|++.+.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred cCHHHhhhccHhhcceEEecCCCccCC
Confidence 77778888877 48899999988763
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.9e-23 Score=220.87 Aligned_cols=202 Identities=21% Similarity=0.219 Sum_probs=170.9
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|++|.++++|++|+|++|++++..|..|.++++|++|++
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 57999999999999888889999999999999999999888899999999999999999999877778999999999999
Q ss_pred ccCcCCCC-CCccccCCccCcEEeCCCCcCCCCCc-ccccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 85 SSNYLTGS-LTSDIQNMKVLIDLDLSRNQLSGDIP-KTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 85 ~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
++|.+++. .+..+.++++|++|++++|.+.+.+| ..|.++++|+.|++++|.+++..|..+..+++|+.|+++.|.+.
T Consensus 106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~ 185 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185 (549)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST
T ss_pred CCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc
Confidence 99999863 46788999999999999998444554 67999999999999999999889999999999999999999987
Q ss_pred CCCchh-hhcccccCeeEccCCCCCCCC----CCCCCCcCCccccccccc
Q 008012 163 EGIPKS-LVALSHLKQFNVSHNRLEGEI----PTEGPFRNFSAQSFHWNY 207 (581)
Q Consensus 163 ~~~~~~-~~~l~~L~~l~l~~n~l~~~~----~~~~~~~~~~~~~~~~n~ 207 (581)
. .|.. +..+++|+.|++++|++++.. +.......+..+.+.+|.
T Consensus 186 ~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~ 234 (549)
T 2z81_A 186 F-LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234 (549)
T ss_dssp T-HHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCE
T ss_pred c-cchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccc
Confidence 5 4444 456899999999999998742 222334555666665554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.88 E-value=8.1e-24 Score=223.10 Aligned_cols=207 Identities=19% Similarity=0.200 Sum_probs=164.2
Q ss_pred CCCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCc----------------cccCCCCCCEEEccCCc
Q 008012 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPT----------------CLASLTSLRELRLNSNK 64 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~----------------~~~~l~~L~~L~L~~N~ 64 (581)
|+.+++|++|+|++|.|++..| |..+++|++|+|++|.|++..+. ....+++|++|+|++|+
T Consensus 54 ~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~ 131 (487)
T 3oja_A 54 LAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNK 131 (487)
T ss_dssp GTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSC
T ss_pred HhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCC
Confidence 4567888888888888886555 88888888888888877743211 12346789999999999
Q ss_pred ccCCCCcccccCCCCcEEecccCcCCCCCCcccc-CCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCc
Q 008012 65 LTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQ-NMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPE 143 (581)
Q Consensus 65 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~ 143 (581)
|++..|..+..+++|++|+|++|.+++..|..+. .+++|++|+|++|.|++. |. +..+++|+.|+|++|.|++.+|
T Consensus 132 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~- 208 (487)
T 3oja_A 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGP- 208 (487)
T ss_dssp CCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECG-
T ss_pred CCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCH-
Confidence 9988888999999999999999999988888886 799999999999999954 33 4569999999999999997544
Q ss_pred cccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCC-CCCC-CCCCcCCcccccc-------ccccccCCC
Q 008012 144 SFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEG-EIPT-EGPFRNFSAQSFH-------WNYALCGPQ 213 (581)
Q Consensus 144 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~-~~~~-~~~~~~~~~~~~~-------~n~~~c~~~ 213 (581)
.|..+++|+.|+|++|.+++ +|..+..+++|+.|++++|++.+ .+|. ...+..+..+... .+++.|..+
T Consensus 209 ~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~~~~~~~~~~~~c~~~ 286 (487)
T 3oja_A 209 EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286 (487)
T ss_dssp GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHHHHHHTSSSSCCCSST
T ss_pred hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEeccccccccCCCcccccCC
Confidence 58899999999999999986 77789999999999999999983 3322 2344444444443 455555443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-22 Score=202.58 Aligned_cols=191 Identities=25% Similarity=0.338 Sum_probs=97.3
Q ss_pred CCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEe
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 83 (581)
+++|++|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|++|+
T Consensus 154 l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~ 227 (347)
T 4fmz_A 154 MTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEE
T ss_pred CCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEE
Confidence 3344444444444442211 4444444444444444442211 4444444444444444442222 55555555555
Q ss_pred cccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCC
Q 008012 84 LSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 163 (581)
+++|.+++..+ +..+++|++|++++|.+++. +.+..+++|+.|++++|++++. ..+..+++|+.|++++|.+++
T Consensus 228 l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~ 301 (347)
T 4fmz_A 228 IGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGN 301 (347)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCG
T ss_pred ccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCC
Confidence 55555553322 55556666666666655532 3455556666666666666543 235555666666666666655
Q ss_pred CCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccc
Q 008012 164 GIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNY 207 (581)
Q Consensus 164 ~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~ 207 (581)
..+..+..+++|+.|++++|++++..| ...+..+..+++.+|+
T Consensus 302 ~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 302 EDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQV 344 (347)
T ss_dssp GGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC-
T ss_pred cChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhhc
Confidence 555556666666666666666665444 4445555555555554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.3e-22 Score=187.44 Aligned_cols=164 Identities=24% Similarity=0.196 Sum_probs=149.2
Q ss_pred CCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEe
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 83 (581)
.++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+
T Consensus 27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 106 (208)
T 2o6s_A 27 PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELA 106 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEE
Confidence 46799999999999987777899999999999999999988778899999999999999999977777889999999999
Q ss_pred cccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCC
Q 008012 84 LSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 163 (581)
+++|+|++..+..|..+++|++|++++|.+++..+..+..+++|+.|+|++|++.+ .+++|++|+++.|.+++
T Consensus 107 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g 179 (208)
T 2o6s_A 107 LNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSG 179 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTT
T ss_pred cCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCc
Confidence 99999998777789999999999999999997766678999999999999998774 46789999999999999
Q ss_pred CCchhhhcccc
Q 008012 164 GIPKSLVALSH 174 (581)
Q Consensus 164 ~~~~~~~~l~~ 174 (581)
.+|..++.++.
T Consensus 180 ~ip~~~~~l~~ 190 (208)
T 2o6s_A 180 VVRNSAGSVAP 190 (208)
T ss_dssp TBBCTTSSBCT
T ss_pred eeeccCccccC
Confidence 99988876654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-22 Score=216.07 Aligned_cols=65 Identities=17% Similarity=0.241 Sum_probs=45.2
Q ss_pred cCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCC--CCCC-CCCCcCCcccccccccccc
Q 008012 146 GSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEG--EIPT-EGPFRNFSAQSFHWNYALC 210 (581)
Q Consensus 146 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~--~~~~-~~~~~~~~~~~~~~n~~~c 210 (581)
..+++|++|++++|.+++..|..+..+++|+.|++++|++++ .+|. ...+..+..+++.+|...-
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~ 388 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSY 388 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBC
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCc
Confidence 456777788888888877777777778888888888887775 2222 3456667777777766543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-22 Score=200.90 Aligned_cols=180 Identities=18% Similarity=0.166 Sum_probs=154.9
Q ss_pred CCCCCCcEEEeecCcccccCC----ccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCC----CCccc
Q 008012 2 GRMQQLQGIGLADNHLQGSIP----YDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSS----IPSAL 73 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~ 73 (581)
+.+++|++|+|++|++++..+ ..+..+++|++|+|++|+|++..+..|.++++|++|+|++|++.+. .+..+
T Consensus 114 ~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 193 (310)
T 4glp_A 114 ATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCP 193 (310)
T ss_dssp CCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCT
T ss_pred ccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhh
Confidence 678999999999999997555 4456799999999999999988889999999999999999998642 13345
Q ss_pred ccCCCCcEEecccCcCCCCCCc----cccCCccCcEEeCCCCcCCCCCcccccCc---ccccceeccccccccccCcccc
Q 008012 74 WALEYILYVNLSSNYLTGSLTS----DIQNMKVLIDLDLSRNQLSGDIPKTIAGL---KDLTNLSLAGNQFQGPIPESFG 146 (581)
Q Consensus 74 ~~l~~L~~L~l~~n~l~~~~~~----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l---~~L~~L~l~~N~i~~~~~~~~~ 146 (581)
..+++|++|+|++|+++ .++. .+..+++|++|+|++|++++..|..+..+ ++|+.|+|++|+|+ .+|..+.
T Consensus 194 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~ 271 (310)
T 4glp_A 194 HKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP 271 (310)
T ss_dssp TSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC
T ss_pred hcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc
Confidence 78999999999999998 3333 35788999999999999998878888777 69999999999999 5677664
Q ss_pred CccccceeeccccccCCCCchhhhcccccCeeEccCCCCCC
Q 008012 147 SLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEG 187 (581)
Q Consensus 147 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~ 187 (581)
++|+.|+|++|++++. |. +..+++|+.|++++|+++.
T Consensus 272 --~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 272 --AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp --SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred --CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 7999999999999974 44 6788999999999999974
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.87 E-value=7e-22 Score=207.83 Aligned_cols=198 Identities=26% Similarity=0.384 Sum_probs=110.8
Q ss_pred CCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCC--------------------ccccCCCCCCEEEcc
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIP--------------------TCLASLTSLRELRLN 61 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~--------------------~~~~~l~~L~~L~L~ 61 (581)
+++++|++|++++|.+++. ..+..+++|++|++++|.+++..+ +.+..+++|++|+|+
T Consensus 174 ~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~ 251 (466)
T 1o6v_A 174 ANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLA 251 (466)
T ss_dssp TTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECC
T ss_pred ccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccccccccccCCCCEEECCCCCcccchhhhcCCCCCEEECC
Confidence 3455555555555555532 234555555555555555553322 234445555555555
Q ss_pred CCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceecccccccccc
Q 008012 62 SNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPI 141 (581)
Q Consensus 62 ~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~ 141 (581)
+|.+++..+ +..+++|++|++++|.+++..+ +..+++|++|++++|++++..+ +..+++|+.|+|++|++++..
T Consensus 252 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~ 325 (466)
T 1o6v_A 252 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS 325 (466)
T ss_dssp SSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCG
T ss_pred CCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCch
Confidence 555543322 5555555555555555553322 5555666666666666654322 555666666666666666544
Q ss_pred CccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCC
Q 008012 142 PESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGP 212 (581)
Q Consensus 142 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~ 212 (581)
| +..+++|+.|++++|.+++. ..+..+++|+.|++++|++++..| ...+..+..+.+.+|++...+
T Consensus 326 ~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~~p 391 (466)
T 1o6v_A 326 P--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTNAP 391 (466)
T ss_dssp G--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEECCC
T ss_pred h--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccCCc
Confidence 3 55666666666666666553 356666677777777777766555 555666666777777666543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.2e-22 Score=187.13 Aligned_cols=153 Identities=22% Similarity=0.274 Sum_probs=127.4
Q ss_pred cEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccC
Q 008012 8 QGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSN 87 (581)
Q Consensus 8 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n 87 (581)
+.+++++++++ .+|..+. ++|+.|+|++|+|+++.+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 56888888888 5676665 78888888888888777778888888888888888888777888888888888888888
Q ss_pred cCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCC
Q 008012 88 YLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 88 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 163 (581)
+|+...+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 8886666677888888888888888887777888888888888888888887777778888888888888888865
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.9e-22 Score=213.00 Aligned_cols=108 Identities=19% Similarity=0.219 Sum_probs=84.5
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|++|.++++|++|+|++|+|+ .+|.. .+++|++|++
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 56888888888888777778888888888888888888777888888888888888888887 45554 7788888888
Q ss_pred ccCcCCCC-CCccccCCccCcEEeCCCCcCCC
Q 008012 85 SSNYLTGS-LTSDIQNMKVLIDLDLSRNQLSG 115 (581)
Q Consensus 85 ~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~ 115 (581)
++|++++. .|..|.++++|++|++++|.+++
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~ 160 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT
T ss_pred CCCCccccCchHhhcccCcccEEecCCCcccc
Confidence 88888753 34677788888888888887764
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.8e-22 Score=185.69 Aligned_cols=153 Identities=24% Similarity=0.284 Sum_probs=103.6
Q ss_pred cEEEeecCcccccCCccccCCCCCCEEEccCCcccccCC-ccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEeccc
Q 008012 8 QGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIP-TCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSS 86 (581)
Q Consensus 8 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 86 (581)
+.+++++|+++ .+|..+. +.+++|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 46777777776 4555544 455677777777775533 4466777777777777777766666677777777777777
Q ss_pred CcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCC
Q 008012 87 NYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 87 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 163 (581)
|.|++..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|.+++
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 77776666666777777777777777776666666677777777777777766666666666777777777776665
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.87 E-value=7.8e-22 Score=193.67 Aligned_cols=171 Identities=25% Similarity=0.375 Sum_probs=143.6
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
.+++|++|++++|.++.. + .+..+++|++|+|++|+|++..+ +.++++|++|+|++|++++ ++ .+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence 467889999999999844 4 48889999999999999996544 8899999999999999984 33 48889999999
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
++++|++++. ..+..+++|++|++++|.+++. ..+..+++|+.|++++|+|++..+ +..+++|+.|++++|.++
T Consensus 118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence 9999999853 4688899999999999999854 578889999999999999987654 888999999999999998
Q ss_pred CCCchhhhcccccCeeEccCCCCCC
Q 008012 163 EGIPKSLVALSHLKQFNVSHNRLEG 187 (581)
Q Consensus 163 ~~~~~~~~~l~~L~~l~l~~n~l~~ 187 (581)
+ ++ .+..+++|+.|++++|+++.
T Consensus 192 ~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 192 D-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp B-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred C-Ch-hhccCCCCCEEECcCCcccC
Confidence 6 44 48889999999999998875
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.2e-22 Score=187.91 Aligned_cols=157 Identities=25% Similarity=0.285 Sum_probs=142.9
Q ss_pred CCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCC-cccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCC
Q 008012 31 LNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIP-SALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLS 109 (581)
Q Consensus 31 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 109 (581)
-+.+++++|.++. +|..+. ..+++|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 13 ~~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 13 GTTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TTEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 3589999999994 676554 467999999999997744 568999999999999999998888899999999999999
Q ss_pred CCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCC
Q 008012 110 RNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEI 189 (581)
Q Consensus 110 ~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~ 189 (581)
+|.+++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|.+++..|..|..+++|+.|++++|++++..
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 99999888888999999999999999999988999999999999999999999988999999999999999999999765
Q ss_pred C
Q 008012 190 P 190 (581)
Q Consensus 190 ~ 190 (581)
+
T Consensus 170 ~ 170 (220)
T 2v70_A 170 Y 170 (220)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.6e-22 Score=212.69 Aligned_cols=198 Identities=21% Similarity=0.254 Sum_probs=168.2
Q ss_pred CCCcEEEeecCcccccCCccc-cCCCCCCEEEccCCcccccCC---ccccCCCCCCEEEccCCcccCCCC--cccccCCC
Q 008012 5 QQLQGIGLADNHLQGSIPYDL-CQLKRLNSLSLQGNKLNGSIP---TCLASLTSLRELRLNSNKLTSSIP--SALWALEY 78 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~i~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~ 78 (581)
++|++|++++|+++ .+|..+ .++++|++|+|++|+|++..| ..+..+++|++|+|++|++++..+ ..+..+++
T Consensus 310 ~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~ 388 (549)
T 2z81_A 310 EKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388 (549)
T ss_dssp TTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTT
T ss_pred ccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCC
Confidence 57899999999998 667665 679999999999999997653 347889999999999999985432 56889999
Q ss_pred CcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccc
Q 008012 79 ILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSS 158 (581)
Q Consensus 79 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~ 158 (581)
|++|++++|+++ .+|..+..+++|++|++++|+++ .+|..+ .++|+.|+|++|+|++.+ ..+++|++|+|++
T Consensus 389 L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~ 460 (549)
T 2z81_A 389 LTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISR 460 (549)
T ss_dssp CCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCS
T ss_pred CCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCC
Confidence 999999999999 67888899999999999999998 455443 368999999999998643 5789999999999
Q ss_pred cccCCCCchhhhcccccCeeEccCCCCCCCCCC-CCCCcCCccccccccccccCCC
Q 008012 159 NNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPT-EGPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 159 N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~~ 213 (581)
|+++. +|. ...+++|+.|++++|++++.+|. ...+..++.+++.+|++.|+-+
T Consensus 461 N~l~~-ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 461 NKLKT-LPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp SCCSS-CCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CccCc-CCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 99985 665 56799999999999999988876 3778889999999999988743
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.86 E-value=4.1e-22 Score=187.17 Aligned_cols=155 Identities=23% Similarity=0.316 Sum_probs=142.5
Q ss_pred CEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCC
Q 008012 32 NSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRN 111 (581)
Q Consensus 32 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 111 (581)
+.+++++|.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 68999999999 5666554 68999999999999888889999999999999999999888999999999999999999
Q ss_pred cCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCC
Q 008012 112 QLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEI 189 (581)
Q Consensus 112 ~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~ 189 (581)
.|+...+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++.+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 999666666899999999999999999988999999999999999999999988888999999999999999998743
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8.8e-22 Score=215.42 Aligned_cols=181 Identities=24% Similarity=0.228 Sum_probs=128.7
Q ss_pred EEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCc
Q 008012 9 GIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNY 88 (581)
Q Consensus 9 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~ 88 (581)
..+.++.+++ .+|..+. +++++|||++|+|+.+.+.+|.++++|++|+|++|+|++..|++|.++++|++|+|++|+
T Consensus 35 ~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~ 111 (635)
T 4g8a_A 35 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 111 (635)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence 4566666776 5665554 577777777777776666777777777777777777776666677777777777777777
Q ss_pred CCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccc-cCccccCccccceeeccccccCCCCch
Q 008012 89 LTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGP-IPESFGSLISLESLDLSSNNLSEGIPK 167 (581)
Q Consensus 89 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~ 167 (581)
|++..+.+|.++++|++|+|++|++++..+..|+++++|+.|+|++|.|++. .|..++.+++|++|+|++|++++..+.
T Consensus 112 l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 191 (635)
T 4g8a_A 112 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 191 (635)
T ss_dssp CCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred CCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccc
Confidence 7766666777777777777777777765555677777777777777777653 456677777777777777777776676
Q ss_pred hhhcccccC----eeEccCCCCCCCCCCC
Q 008012 168 SLVALSHLK----QFNVSHNRLEGEIPTE 192 (581)
Q Consensus 168 ~~~~l~~L~----~l~l~~n~l~~~~~~~ 192 (581)
.+..+.+++ .++++.|.++...+..
T Consensus 192 ~l~~L~~l~~~~~~~~ls~n~l~~i~~~~ 220 (635)
T 4g8a_A 192 DLRVLHQMPLLNLSLDLSLNPMNFIQPGA 220 (635)
T ss_dssp GGHHHHTCTTCCCEEECTTCCCCEECTTT
T ss_pred cccchhhhhhhhhhhhcccCcccccCccc
Confidence 666665543 5667777776555443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.86 E-value=4e-22 Score=198.56 Aligned_cols=200 Identities=19% Similarity=0.190 Sum_probs=158.7
Q ss_pred CCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCC----------------ccccCCCCCCEEEccCCcc
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIP----------------TCLASLTSLRELRLNSNKL 65 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~----------------~~~~~l~~L~~L~L~~N~l 65 (581)
+.+++|++|+|++|++++..+ |..+++|++|+|++|+|++..+ .....+++|++|+|++|++
T Consensus 55 ~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~N~l 132 (317)
T 3o53_A 55 APFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKI 132 (317)
T ss_dssp TTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECCCSSCEEEECCSSCC
T ss_pred hCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccccCCCCEEECCCCCC
Confidence 567888888888888886544 7888888888888888774321 0123457789999999999
Q ss_pred cCCCCcccccCCCCcEEecccCcCCCCCCccc-cCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCcc
Q 008012 66 TSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPES 144 (581)
Q Consensus 66 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~ 144 (581)
++..+..+..+++|++|++++|.+++..+..+ ..+++|++|++++|.+++. +. ...+++|+.|+|++|+|++. |..
T Consensus 133 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l-~~~ 209 (317)
T 3o53_A 133 TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFM-GPE 209 (317)
T ss_dssp CSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEE-CGG
T ss_pred CCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcc-hhh
Confidence 98778889999999999999999997777776 4789999999999999854 43 44599999999999999964 555
Q ss_pred ccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCC-CCCCCC-CCCcCCccccccccc
Q 008012 145 FGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE-GEIPTE-GPFRNFSAQSFHWNY 207 (581)
Q Consensus 145 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~-~~~~~~-~~~~~~~~~~~~~n~ 207 (581)
+..+++|+.|+|++|.++. +|..+..+++|+.|++++|+++ +.++.. ..+..+..+.+.++.
T Consensus 210 ~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~ 273 (317)
T 3o53_A 210 FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273 (317)
T ss_dssp GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHH
T ss_pred hcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCch
Confidence 8899999999999999985 6778999999999999999998 333322 344555566665443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.86 E-value=3.7e-21 Score=181.92 Aligned_cols=154 Identities=25% Similarity=0.289 Sum_probs=120.7
Q ss_pred CcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEeccc
Q 008012 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSS 86 (581)
Q Consensus 7 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 86 (581)
.+.+++++++++ .+|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|+|+...+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 356788888887 5666555 7888888888888877788888888888888888888766666778888888888888
Q ss_pred CcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCC
Q 008012 87 NYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEG 164 (581)
Q Consensus 87 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~ 164 (581)
|+|++..+..|..+++|++|+|++|+|+ .+|..+.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+++.
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 8888666667778888888888888887 6777778888888888888888866666777788888888888887753
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.85 E-value=6.6e-21 Score=200.38 Aligned_cols=194 Identities=27% Similarity=0.405 Sum_probs=149.0
Q ss_pred CCCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCc
Q 008012 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYIL 80 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 80 (581)
++.+++|++|+++ |.+.+.. .+.++++|++|++++|.+++. ..+..+++|++|++++|++++..| +..+++|+
T Consensus 152 ~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~ 224 (466)
T 1o6v_A 152 LSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLD 224 (466)
T ss_dssp GTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCC
T ss_pred hccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCC
Confidence 4678999999997 5565443 399999999999999999954 458999999999999999986655 77788899
Q ss_pred EEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccc
Q 008012 81 YVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNN 160 (581)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~ 160 (581)
+|++++|.+++. ..+..+++|++|++++|.+++..+ +.++++|+.|++++|.+++..+ +..+++|+.|++++|.
T Consensus 225 ~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~ 298 (466)
T 1o6v_A 225 ELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 298 (466)
T ss_dssp EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSC
T ss_pred EEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCc
Confidence 999998888853 357788888888888888875443 7778888888888888876543 7777888888888888
Q ss_pred cCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCcccccccccccc
Q 008012 161 LSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALC 210 (581)
Q Consensus 161 l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c 210 (581)
+++..+ +..+++|+.|++++|++++..| ...+..+..+.+.+|....
T Consensus 299 l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 299 LEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp CSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCC
T ss_pred ccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCC
Confidence 776433 6677777777777777776555 4456666666666665443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.3e-21 Score=210.83 Aligned_cols=208 Identities=21% Similarity=0.255 Sum_probs=178.8
Q ss_pred CCCCCcEEEeecCcccc--cCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCC-CcccccCCCC
Q 008012 3 RMQQLQGIGLADNHLQG--SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSI-PSALWALEYI 79 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L 79 (581)
.+++|+.|++++|.+.. ..+..+..+.+|++|+++.|.+. ..+..+..+++|+.+++..|++.... +..|..+++|
T Consensus 369 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l 447 (635)
T 4g8a_A 369 DLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 447 (635)
T ss_dssp BCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTC
T ss_pred cccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhcccccccccccccccccc
Confidence 46777888888887752 34556667788888888888877 35667888999999999988776544 4568899999
Q ss_pred cEEecccCcCCCCCCccccCCccCcEEeCCCCcC-CCCCcccccCcccccceeccccccccccCccccCccccceeeccc
Q 008012 80 LYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQL-SGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSS 158 (581)
Q Consensus 80 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l-~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~ 158 (581)
+.+++++|.+.+..+..+..++.|+.|++++|.+ .+..|..|..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 448 ~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~ 527 (635)
T 4g8a_A 448 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 527 (635)
T ss_dssp CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred ccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCC
Confidence 9999999999988888999999999999999985 445788899999999999999999999999999999999999999
Q ss_pred cccCCCCchhhhcccccCeeEccCCCCCCCCCCC-CCC-cCCccccccccccccC
Q 008012 159 NNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPF-RNFSAQSFHWNYALCG 211 (581)
Q Consensus 159 N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~-~~~~~~~~~~n~~~c~ 211 (581)
|+|++..|..|..+++|+.|+|++|++++.+|.. ..+ ..+..+++.+|||.|+
T Consensus 528 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 528 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp SCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred CcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 9999988999999999999999999999888875 344 5789999999999997
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.85 E-value=9.8e-21 Score=191.16 Aligned_cols=170 Identities=24% Similarity=0.407 Sum_probs=77.8
Q ss_pred CCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEe
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 83 (581)
+++|++|++++|.++. ++ .+..+++|++|++++|.|++. +. |..+++|++|+|++|.+++ + ..+..+++|++|+
T Consensus 43 l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L~~L~ 116 (347)
T 4fmz_A 43 LESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-I-SALQNLTNLRELY 116 (347)
T ss_dssp HTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCSEEE
T ss_pred cccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-c-hHHcCCCcCCEEE
Confidence 3445555555555542 22 245555555555555555532 22 5555555555555555542 2 2355555555555
Q ss_pred cccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCC
Q 008012 84 LSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 163 (581)
+++|.+++..+ +..+++|++|++++|...... ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++
T Consensus 117 l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~ 191 (347)
T 4fmz_A 117 LNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191 (347)
T ss_dssp CTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC
T ss_pred CcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc
Confidence 55555553221 444555555555555333222 224444444444444444443222 4444444444444444443
Q ss_pred CCchhhhcccccCeeEccCCCCC
Q 008012 164 GIPKSLVALSHLKQFNVSHNRLE 186 (581)
Q Consensus 164 ~~~~~~~~l~~L~~l~l~~n~l~ 186 (581)
..+ +..+++|+.|++++|.++
T Consensus 192 ~~~--~~~l~~L~~L~l~~n~l~ 212 (347)
T 4fmz_A 192 ISP--LASLTSLHYFTAYVNQIT 212 (347)
T ss_dssp CGG--GGGCTTCCEEECCSSCCC
T ss_pred ccc--ccCCCccceeecccCCCC
Confidence 211 334444444444444444
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.7e-21 Score=197.66 Aligned_cols=179 Identities=24% Similarity=0.172 Sum_probs=153.1
Q ss_pred CCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccc-cCCCCcEEecccCcCCCCCCccccCCccCcEEeCC
Q 008012 31 LNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALW-ALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLS 109 (581)
Q Consensus 31 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 109 (581)
-+.+++++|.|+ .+|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 20 ~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 20 SNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 368999999999 5676554 4699999999999988888887 99999999999999998888899999999999999
Q ss_pred CCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhh---hcccccCeeEccCCCCC
Q 008012 110 RNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSL---VALSHLKQFNVSHNRLE 186 (581)
Q Consensus 110 ~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~---~~l~~L~~l~l~~n~l~ 186 (581)
+|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.|+...+..| ..+++|+.|+|++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 999997777789999999999999999998889999999999999999999998555555 57999999999999999
Q ss_pred CCCCCC-CCCcC--CccccccccccccCC
Q 008012 187 GEIPTE-GPFRN--FSAQSFHWNYALCGP 212 (581)
Q Consensus 187 ~~~~~~-~~~~~--~~~~~~~~n~~~c~~ 212 (581)
+..+.. ..+.. +..+.+.+|||.|+-
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred ccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 654332 22332 356889999999973
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-20 Score=178.43 Aligned_cols=157 Identities=23% Similarity=0.240 Sum_probs=142.8
Q ss_pred CCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCC
Q 008012 30 RLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLS 109 (581)
Q Consensus 30 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 109 (581)
.-+.++++++.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|++|+|+
T Consensus 20 s~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 20 SGTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred eCCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence 4578999999999 5665554 899999999999998889999999999999999999997777788999999999999
Q ss_pred CCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCC
Q 008012 110 RNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEI 189 (581)
Q Consensus 110 ~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~ 189 (581)
+|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|++++..
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 99999777777899999999999999999 67888999999999999999999877788999999999999999999866
Q ss_pred C
Q 008012 190 P 190 (581)
Q Consensus 190 ~ 190 (581)
+
T Consensus 176 ~ 176 (229)
T 3e6j_A 176 R 176 (229)
T ss_dssp G
T ss_pred c
Confidence 5
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-20 Score=194.44 Aligned_cols=187 Identities=22% Similarity=0.238 Sum_probs=110.5
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
++++|++|+|++|++++. | .++.+++|++|+|++|.|++. | ++.+++|++|+|++|+|++. + +..+++|++|
T Consensus 40 ~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L 111 (457)
T 3bz5_A 40 QLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYL 111 (457)
T ss_dssp HHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEE
T ss_pred HcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEE
Confidence 356677777777777643 4 466677777777777777643 3 66666677777777766643 2 6666666666
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCc--------------------ccccCcccccceeccccccccccC
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIP--------------------KTIAGLKDLTNLSLAGNQFQGPIP 142 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~--------------------~~~~~l~~L~~L~l~~N~i~~~~~ 142 (581)
++++|++++. + +..+++|++|++++|++++. + -.+..+++|+.|++++|++++. |
T Consensus 112 ~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~l-~ 186 (457)
T 3bz5_A 112 NCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-DVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITEL-D 186 (457)
T ss_dssp ECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-CCTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCCC-C
T ss_pred ECCCCcCCee-c--CCCCCcCCEEECCCCcccee-ccccCCcCCEEECCCCCcccccccccCCcCCEEECCCCcccee-c
Confidence 6666666642 2 56666666666666666542 2 0234445555555555555542 2
Q ss_pred ccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccc
Q 008012 143 ESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYAL 209 (581)
Q Consensus 143 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~ 209 (581)
+..+++|+.|++++|.+++. .+..+++|+.|++++|++++ +| ...+..+..+++.+|...
T Consensus 187 --l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip-~~~l~~L~~L~l~~N~l~ 246 (457)
T 3bz5_A 187 --VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID-VTPLTQLTYFDCSVNPLT 246 (457)
T ss_dssp --CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC-CTTCTTCSEEECCSSCCS
T ss_pred --cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC-ccccCCCCEEEeeCCcCC
Confidence 45555566666666655543 25556666666666666665 33 445556666666666443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.84 E-value=7.1e-21 Score=204.61 Aligned_cols=173 Identities=24% Similarity=0.360 Sum_probs=151.6
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
.+++|+.|+|++|.|+. ++ .+..|++|+.|+|++|+|++..+ |..+++|+.|+|++|+|++ +| .+..+++|+.|
T Consensus 41 ~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L 114 (605)
T 1m9s_A 41 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSL 114 (605)
T ss_dssp HHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEE
T ss_pred cCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEE
Confidence 46789999999999984 44 58999999999999999996544 8999999999999999984 34 68999999999
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
+|++|.|++. ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.|++..| +..+++|+.|+|++|.|+
T Consensus 115 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 115 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp ECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred EecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCC
Confidence 9999999953 4688999999999999999954 678999999999999999997666 889999999999999998
Q ss_pred CCCchhhhcccccCeeEccCCCCCCCC
Q 008012 163 EGIPKSLVALSHLKQFNVSHNRLEGEI 189 (581)
Q Consensus 163 ~~~~~~~~~l~~L~~l~l~~n~l~~~~ 189 (581)
+. + .+..+++|+.|+|++|+++..+
T Consensus 189 ~l-~-~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 189 DL-R-ALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp BC-G-GGTTCTTCSEEECCSEEEECCC
T ss_pred CC-h-HHccCCCCCEEEccCCcCcCCc
Confidence 74 4 6889999999999999998653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.84 E-value=5.9e-21 Score=176.17 Aligned_cols=154 Identities=16% Similarity=0.249 Sum_probs=116.8
Q ss_pred ccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCc
Q 008012 25 LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLI 104 (581)
Q Consensus 25 ~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 104 (581)
...+++|++|++++|.|+ .+| .+..+++|++|+|++|.++ .+..+..+++|++|++++|++++..+..+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 356678888888888888 444 5778888888888888765 334677788888888888888866777788888888
Q ss_pred EEeCCCCcCCCCCcccccCcccccceeccccc-cccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCC
Q 008012 105 DLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQ-FQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183 (581)
Q Consensus 105 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~-i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n 183 (581)
+|++++|.+++..|..+..+++|+.|++++|. ++. ++ .+..+++|+.|++++|.+++ ++ .+..+++|+.|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 88888888886677778888888888888887 663 34 57778888888888888876 33 6778888888888888
Q ss_pred CCC
Q 008012 184 RLE 186 (581)
Q Consensus 184 ~l~ 186 (581)
++.
T Consensus 192 ~i~ 194 (197)
T 4ezg_A 192 TIG 194 (197)
T ss_dssp ---
T ss_pred ccC
Confidence 875
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.84 E-value=3.9e-21 Score=188.66 Aligned_cols=192 Identities=22% Similarity=0.347 Sum_probs=163.3
Q ss_pred CcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEeccc
Q 008012 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSS 86 (581)
Q Consensus 7 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 86 (581)
+..+.+..+.+++.. .+..+++|++|++++|.|+.. + .+..+++|++|+|++|++++..+ +..+++|++|++++
T Consensus 26 ~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence 344566677776443 356789999999999999954 3 48999999999999999996544 99999999999999
Q ss_pred CcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCc
Q 008012 87 NYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIP 166 (581)
Q Consensus 87 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 166 (581)
|.+++ ++ .+..+++|++|++++|++++. +.+..+++|+.|++++|++++. ..+..+++|+.|++++|.+++..+
T Consensus 100 n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 100 NKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp SCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 99995 33 499999999999999999953 5689999999999999999965 678999999999999999987554
Q ss_pred hhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCCC
Q 008012 167 KSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 167 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 213 (581)
+..+++|+.|++++|+++. ++....+..+..+++.+|+..+.+.
T Consensus 174 --l~~l~~L~~L~L~~N~i~~-l~~l~~l~~L~~L~l~~n~i~~~~~ 217 (291)
T 1h6t_A 174 --LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLNKPI 217 (291)
T ss_dssp --GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEEEEEECCCE
T ss_pred --hcCCCccCEEECCCCcCCC-ChhhccCCCCCEEECcCCcccCCcc
Confidence 8999999999999999995 4557788899999999998766543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.83 E-value=7.4e-20 Score=191.08 Aligned_cols=171 Identities=25% Similarity=0.241 Sum_probs=149.5
Q ss_pred CCCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCc
Q 008012 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYIL 80 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 80 (581)
++.+++|++|+|++|+|++. + ++++++|++|+|++|+|++. + +.++++|++|+|++|++++. + +..+++|+
T Consensus 81 ~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~ 151 (457)
T 3bz5_A 81 LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLT 151 (457)
T ss_dssp CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCC
T ss_pred cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCC
Confidence 46789999999999999964 4 89999999999999999964 4 89999999999999999964 3 88999999
Q ss_pred EEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccc
Q 008012 81 YVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNN 160 (581)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~ 160 (581)
+|++++|...+.+ .+..+++|++|++++|++++ +| +..+++|+.|++++|++++. .++.+++|+.|++++|+
T Consensus 152 ~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~ 223 (457)
T 3bz5_A 152 ELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNK 223 (457)
T ss_dssp EEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSC
T ss_pred EEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCc
Confidence 9999999655444 58889999999999999995 55 88899999999999999975 48889999999999999
Q ss_pred cCCCCchhhhcccccCeeEccCCCCCCCCCC
Q 008012 161 LSEGIPKSLVALSHLKQFNVSHNRLEGEIPT 191 (581)
Q Consensus 161 l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~ 191 (581)
+++ +| +..+++|+.|++++|++++.++.
T Consensus 224 l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~ 251 (457)
T 3bz5_A 224 LTE-ID--VTPLTQLTYFDCSVNPLTELDVS 251 (457)
T ss_dssp CSC-CC--CTTCTTCSEEECCSSCCSCCCCT
T ss_pred ccc-cC--ccccCCCCEEEeeCCcCCCcCHH
Confidence 988 55 88899999999999999976543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.6e-20 Score=188.03 Aligned_cols=197 Identities=17% Similarity=0.139 Sum_probs=156.3
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccc-cCCccccCCCCCCE-EEccCCcccCCCCcccccCCCCcEE
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNG-SIPTCLASLTSLRE-LRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
++|++|+|++|+|+++.++.|.++++|++|+|++|+|.+ +.+++|.++++|.+ +.+++|+|+...|..|..+++|++|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 578999999999997666789999999999999999864 44568899999876 5677899998888899999999999
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCC-CcCCCCCcccccCcc-cccceeccccccccccCccccCccccceeeccc-c
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSR-NQLSGDIPKTIAGLK-DLTNLSLAGNQFQGPIPESFGSLISLESLDLSS-N 159 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~-~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~-N 159 (581)
++++|+|+...+..+....++..|++++ |.+....+..|..+. .++.|+|++|+|+.+.+..| ...+|+.|++++ |
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n 188 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNN 188 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCT
T ss_pred cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCC
Confidence 9999999977777777788888999865 567755555677665 68899999999996544444 567899999974 7
Q ss_pred ccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCcccccc
Q 008012 160 NLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFH 204 (581)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~ 204 (581)
.++.+.+..|..+++|+.|++++|+|+..++.. +..+..+...
T Consensus 189 ~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~--~~~L~~L~~l 231 (350)
T 4ay9_X 189 NLEELPNDVFHGASGPVILDISRTRIHSLPSYG--LENLKKLRAR 231 (350)
T ss_dssp TCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS--CTTCCEEECT
T ss_pred cccCCCHHHhccCcccchhhcCCCCcCccChhh--hccchHhhhc
Confidence 787666677899999999999999999655432 4444444433
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.83 E-value=2.7e-22 Score=205.74 Aligned_cols=207 Identities=17% Similarity=0.216 Sum_probs=123.6
Q ss_pred CCCCCcEEEeecCcccccCC----ccccCCCCCCEEEccCCcc---cccCCccc-------cCCCCCCEEEccCCcccC-
Q 008012 3 RMQQLQGIGLADNHLQGSIP----YDLCQLKRLNSLSLQGNKL---NGSIPTCL-------ASLTSLRELRLNSNKLTS- 67 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~l~~n~i---~~~~~~~~-------~~l~~L~~L~L~~N~l~~- 67 (581)
.+++|++|+|++|+|+...+ ..+..+++|++|+|++|.+ ++..|..+ ..+++|++|+|++|.+++
T Consensus 30 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 109 (386)
T 2ca6_A 30 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 109 (386)
T ss_dssp HCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTT
T ss_pred cCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHH
Confidence 35667777777777765433 3355677777777777533 33334333 566777777777777765
Q ss_pred ---CCCcccccCCCCcEEecccCcCCCCCCcccc----CC---------ccCcEEeCCCCcCC-CCCc---ccccCcccc
Q 008012 68 ---SIPSALWALEYILYVNLSSNYLTGSLTSDIQ----NM---------KVLIDLDLSRNQLS-GDIP---KTIAGLKDL 127 (581)
Q Consensus 68 ---~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~----~l---------~~L~~L~l~~N~l~-~~~~---~~~~~l~~L 127 (581)
.+|..+..+++|++|+|++|.++...+..+. .+ ++|++|++++|+++ +..+ ..+..+++|
T Consensus 110 ~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L 189 (386)
T 2ca6_A 110 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 189 (386)
T ss_dssp THHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTC
T ss_pred HHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCc
Confidence 3555666777777777777776533333232 22 67777777777765 2333 345566677
Q ss_pred cceecccccccc-----ccCccccCccccceeeccccccC----CCCchhhhcccccCeeEccCCCCCCC----CCCC--
Q 008012 128 TNLSLAGNQFQG-----PIPESFGSLISLESLDLSSNNLS----EGIPKSLVALSHLKQFNVSHNRLEGE----IPTE-- 192 (581)
Q Consensus 128 ~~L~l~~N~i~~-----~~~~~~~~l~~L~~L~l~~N~l~----~~~~~~~~~l~~L~~l~l~~n~l~~~----~~~~-- 192 (581)
+.|+|++|+|+. ..+..+..+++|+.|+|++|.++ ..+|..+..+++|+.|+|++|++++. ++..
T Consensus 190 ~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~ 269 (386)
T 2ca6_A 190 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 269 (386)
T ss_dssp CEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHH
T ss_pred CEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHh
Confidence 777777776652 23335666667777777777764 34555666667777777777766643 1211
Q ss_pred -CCCcCCccccccccccc
Q 008012 193 -GPFRNFSAQSFHWNYAL 209 (581)
Q Consensus 193 -~~~~~~~~~~~~~n~~~ 209 (581)
..+..+..+++.+|...
T Consensus 270 ~~~~~~L~~L~L~~n~i~ 287 (386)
T 2ca6_A 270 KLENIGLQTLRLQYNEIE 287 (386)
T ss_dssp TCSSCCCCEEECCSSCCB
T ss_pred hccCCCeEEEECcCCcCC
Confidence 22455666666665433
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.8e-20 Score=195.98 Aligned_cols=180 Identities=26% Similarity=0.283 Sum_probs=143.0
Q ss_pred CCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecc
Q 008012 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85 (581)
Q Consensus 6 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 85 (581)
+|+.|+|++|+|++ +|..+. ++|++|+|++|.|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 78999999999986 676554 88999999999999 566 457899999999999985 666 555 89999999
Q ss_pred cCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCC
Q 008012 86 SNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGI 165 (581)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 165 (581)
+|+|++ +|. .+++|++|+|++|.|++ +|. .+++|+.|+|++|+|++ +|. |. ++|+.|+|++|.|+. +
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~-l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLES-L 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSS-C
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCc-h
Confidence 999986 554 67899999999999985 665 57889999999999986 555 65 899999999999984 5
Q ss_pred chhhhccccc-------CeeEccCCCCCCCCCCCCCCcCCccccccccccccCC
Q 008012 166 PKSLVALSHL-------KQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGP 212 (581)
Q Consensus 166 ~~~~~~l~~L-------~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~ 212 (581)
|. +.. +| +.|+|++|+|+..++....+..+..+++.+|+..+..
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~L~~N~l~~~~ 246 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRI 246 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCCCCCGGGGGSCTTEEEECCSSSCCHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcceecCHHHhcCCCCCEEEeeCCcCCCcC
Confidence 55 544 67 8999999999865444566888888888888876643
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.2e-21 Score=184.81 Aligned_cols=171 Identities=21% Similarity=0.305 Sum_probs=146.0
Q ss_pred CCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEe
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 83 (581)
+.++..++|++|.+++. + .+..+++|++|++++|.|+. ++ .+..+++|++|+|++|+|++..+ +..+++|++|+
T Consensus 18 l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 45677888999999854 3 68889999999999999994 45 78999999999999999996544 99999999999
Q ss_pred cccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCC
Q 008012 84 LSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 163 (581)
+++|++++. +. +.. ++|++|++++|++++ + +.+.++++|+.|+|++|+|++. + .+..+++|+.|++++|.+++
T Consensus 92 L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~-~-~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 92 VNRNRLKNL-NG-IPS-ACLSRLFLDNNELRD-T-DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CCSSCCSCC-TT-CCC-SSCCEEECCSSCCSB-S-GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred CCCCccCCc-Cc-ccc-CcccEEEccCCccCC-C-hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence 999999954 33 333 999999999999985 3 3689999999999999999965 3 68889999999999999987
Q ss_pred CCchhhhcccccCeeEccCCCCCCCC
Q 008012 164 GIPKSLVALSHLKQFNVSHNRLEGEI 189 (581)
Q Consensus 164 ~~~~~~~~l~~L~~l~l~~n~l~~~~ 189 (581)
. ..+..+++|+.|++++|++++..
T Consensus 165 ~--~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred h--HHhccCCCCCEEeCCCCcccCCc
Confidence 5 67889999999999999998653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=172.27 Aligned_cols=153 Identities=19% Similarity=0.262 Sum_probs=131.9
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
.+++|++|++++|+|+ .+| .+..+++|++|++++|.++ .+..+..+++|++|+|++|++++..+..+..+++|++|
T Consensus 42 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 117 (197)
T 4ezg_A 42 QMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117 (197)
T ss_dssp HHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred hcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence 4678999999999998 556 6899999999999999887 34578999999999999999998788889999999999
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCc-CCCCCcccccCcccccceeccccccccccCccccCccccceeecccccc
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQ-LSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNL 161 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l 161 (581)
++++|++++..+..+..+++|++|++++|. ++ .+| .+.++++|+.|++++|++++. + .+..+++|+.|++++|++
T Consensus 118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC--
T ss_pred EecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCccc
Confidence 999999997788889999999999999998 66 555 689999999999999999864 3 788899999999999998
Q ss_pred CC
Q 008012 162 SE 163 (581)
Q Consensus 162 ~~ 163 (581)
.+
T Consensus 194 ~~ 195 (197)
T 4ezg_A 194 GG 195 (197)
T ss_dssp --
T ss_pred CC
Confidence 64
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.6e-21 Score=194.42 Aligned_cols=181 Identities=22% Similarity=0.246 Sum_probs=106.7
Q ss_pred CCCCCcEEEeecCccccc-CCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCC-cccCC-CCcccccCCCC
Q 008012 3 RMQQLQGIGLADNHLQGS-IPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN-KLTSS-IPSALWALEYI 79 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L 79 (581)
.+++|++|+|++|.+++. ++..+..+++|++|+|++|.+++..+..++.+++|++|+|++| .+++. ++..+.++++|
T Consensus 91 ~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L 170 (336)
T 2ast_B 91 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 170 (336)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCC
Confidence 355666666666666544 5555666666666666666666555566666666666666666 45532 44555666666
Q ss_pred cEEecccC-cCCCC-CCccccCCc-cCcEEeCCCC--cCC-CCCcccccCcccccceeccccc-cccccCccccCccccc
Q 008012 80 LYVNLSSN-YLTGS-LTSDIQNMK-VLIDLDLSRN--QLS-GDIPKTIAGLKDLTNLSLAGNQ-FQGPIPESFGSLISLE 152 (581)
Q Consensus 80 ~~L~l~~n-~l~~~-~~~~~~~l~-~L~~L~l~~N--~l~-~~~~~~~~~l~~L~~L~l~~N~-i~~~~~~~~~~l~~L~ 152 (581)
++|++++| .+++. .+..+..++ +|++|++++| .++ +.+|..+.++++|+.|++++|. +++..+..+..+++|+
T Consensus 171 ~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~ 250 (336)
T 2ast_B 171 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 250 (336)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred CEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCC
Confidence 66666666 66532 344455666 6666666666 333 2344555566666666666666 5555555666666666
Q ss_pred eeeccccc-cCCCCchhhhcccccCeeEccCC
Q 008012 153 SLDLSSNN-LSEGIPKSLVALSHLKQFNVSHN 183 (581)
Q Consensus 153 ~L~l~~N~-l~~~~~~~~~~l~~L~~l~l~~n 183 (581)
.|++++|. ++......+..+++|+.|++++|
T Consensus 251 ~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 251 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp EEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred EeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 66666664 22111124556666666666666
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.8e-20 Score=201.43 Aligned_cols=194 Identities=22% Similarity=0.352 Sum_probs=167.1
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
..+..+.|.++.++...+ +..|++|+.|+|++|.|... + .|..+++|+.|+|++|+|++..+ +..+++|+.|+|
T Consensus 21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 94 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL 94 (605)
T ss_dssp HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence 345566778888875544 57789999999999999954 4 59999999999999999996554 999999999999
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEG 164 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~ 164 (581)
++|.|++ ++ .+..+++|++|+|++|.|++ + +.+..+++|+.|+|++|.|++. ..|..+++|+.|+|++|.+++.
T Consensus 95 s~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 95 DENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp CSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred cCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence 9999995 33 78999999999999999995 3 4689999999999999999975 6789999999999999999986
Q ss_pred CchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCCC
Q 008012 165 IPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 165 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 213 (581)
.| +..+++|+.|+|++|++++. +....+..+..+.+.+|+....+.
T Consensus 169 ~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 169 VP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp GG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECCCC
T ss_pred hh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCCcc
Confidence 55 99999999999999999964 667788899999999998765543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.81 E-value=7.5e-22 Score=202.37 Aligned_cols=212 Identities=19% Similarity=0.228 Sum_probs=171.8
Q ss_pred CCCCCCCcEEEeecC---cccccCCccc-------cCCCCCCEEEccCCcccc----cCCccccCCCCCCEEEccCCccc
Q 008012 1 MGRMQQLQGIGLADN---HLQGSIPYDL-------CQLKRLNSLSLQGNKLNG----SIPTCLASLTSLRELRLNSNKLT 66 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n---~l~~~~~~~~-------~~l~~L~~L~l~~n~i~~----~~~~~~~~l~~L~~L~L~~N~l~ 66 (581)
|..+++|++|+|++| ++++.+|..+ ..+++|++|+|++|.|+. .++..+.++++|++|+|++|.|+
T Consensus 56 l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 135 (386)
T 2ca6_A 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 135 (386)
T ss_dssp TTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred HHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCC
Confidence 457899999999996 4445556555 789999999999999996 46778899999999999999997
Q ss_pred CCCCccc----ccC---------CCCcEEecccCcCC-CCCC---ccccCCccCcEEeCCCCcCCC-----CCcccccCc
Q 008012 67 SSIPSAL----WAL---------EYILYVNLSSNYLT-GSLT---SDIQNMKVLIDLDLSRNQLSG-----DIPKTIAGL 124 (581)
Q Consensus 67 ~~~~~~~----~~l---------~~L~~L~l~~n~l~-~~~~---~~~~~l~~L~~L~l~~N~l~~-----~~~~~~~~l 124 (581)
+..+..+ ..+ ++|++|+|++|+++ ...+ ..+..+++|++|++++|+++. ..+..+..+
T Consensus 136 ~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~ 215 (386)
T 2ca6_A 136 PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 215 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGC
T ss_pred HHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcC
Confidence 5444433 344 89999999999997 3344 467789999999999999973 344478899
Q ss_pred ccccceeccccccc----cccCccccCccccceeeccccccCCC----Cchhhhc--ccccCeeEccCCCCCC----CCC
Q 008012 125 KDLTNLSLAGNQFQ----GPIPESFGSLISLESLDLSSNNLSEG----IPKSLVA--LSHLKQFNVSHNRLEG----EIP 190 (581)
Q Consensus 125 ~~L~~L~l~~N~i~----~~~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~--l~~L~~l~l~~n~l~~----~~~ 190 (581)
++|+.|+|++|.|+ ..+|..+..+++|+.|+|++|.+++. ++..+.. +++|+.|+|++|+++. .+|
T Consensus 216 ~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~ 295 (386)
T 2ca6_A 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 295 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred CCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHH
Confidence 99999999999996 56788899999999999999999875 4556643 8999999999999997 244
Q ss_pred CC--CCCcCCccccccccccccCC
Q 008012 191 TE--GPFRNFSAQSFHWNYALCGP 212 (581)
Q Consensus 191 ~~--~~~~~~~~~~~~~n~~~c~~ 212 (581)
.. ..+..+..+++.+|+.....
T Consensus 296 ~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 296 TVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHhcCCCceEEEccCCcCCcch
Confidence 43 34678889999988766444
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-19 Score=166.45 Aligned_cols=176 Identities=24% Similarity=0.318 Sum_probs=92.8
Q ss_pred CEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCc-ccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCC
Q 008012 32 NSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS-ALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSR 110 (581)
Q Consensus 32 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 110 (581)
++|++++|.|+ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45555555555 33433322 555555555555544332 355555666666666666555555566666666666666
Q ss_pred CcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCC
Q 008012 111 NQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIP 190 (581)
Q Consensus 111 N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 190 (581)
|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|.+++..+... -...++...+.++...+..|
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~-~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchH-HHHHHHHcCCCCCCCCCCCC
Confidence 66665555555666666666666666665556666666666666666666655332110 01112222334444444444
Q ss_pred CCCCCcCCccccccccccccCCC
Q 008012 191 TEGPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 191 ~~~~~~~~~~~~~~~n~~~c~~~ 213 (581)
.. +......++..+...|...
T Consensus 167 ~~--l~~~~l~~l~~~~~~C~~~ 187 (192)
T 1w8a_A 167 SK--VRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp TT--TTTSBGGGSCTTTCCCCCC
T ss_pred hH--HcCCChhhCcHhhcCcCCC
Confidence 32 3344555555566666644
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-19 Score=192.34 Aligned_cols=163 Identities=25% Similarity=0.374 Sum_probs=140.4
Q ss_pred CCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEe
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 83 (581)
+++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. |.+ +|++|+|++|+|++ +|. .+++|+.|+
T Consensus 79 ~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~ 146 (571)
T 3cvr_A 79 PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYIN 146 (571)
T ss_dssp CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEe
Confidence 467999999999999 677 457999999999999996 666 665 99999999999996 565 689999999
Q ss_pred cccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCcccc-------ceeec
Q 008012 84 LSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISL-------ESLDL 156 (581)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L-------~~L~l 156 (581)
|++|.|++ +|. .+++|++|+|++|.|++ +|. |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|
T Consensus 147 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~L 214 (571)
T 3cvr_A 147 ADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRC 214 (571)
T ss_dssp CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEEC
T ss_pred CCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEec
Confidence 99999995 555 57899999999999995 777 66 89999999999999 5666 654 77 99999
Q ss_pred cccccCCCCchhhhcccccCeeEccCCCCCCCCCC
Q 008012 157 SSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPT 191 (581)
Q Consensus 157 ~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~ 191 (581)
++|.|+. +|..+..+++|+.|+|++|++++.+|.
T Consensus 215 s~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 215 RENRITH-IPENILSLDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp CSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred CCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence 9999985 788888899999999999999987664
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.81 E-value=8e-20 Score=184.51 Aligned_cols=206 Identities=15% Similarity=0.151 Sum_probs=164.2
Q ss_pred CCCCCCCcEEEeecCcccccCC-ccccCCCCCCE-EEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCC
Q 008012 1 MGRMQQLQGIGLADNHLQGSIP-YDLCQLKRLNS-LSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEY 78 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~-L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 78 (581)
|+.+++|++|+|++|++.+.+| +.|.++++|.. ++++.|+|+.+.|+.|.++++|++|++++|+|+...+..+....+
T Consensus 50 f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~ 129 (350)
T 4ay9_X 50 FSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 129 (350)
T ss_dssp STTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSS
T ss_pred HcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccch
Confidence 5789999999999999865555 57899998775 777889999888999999999999999999999777777888889
Q ss_pred CcEEeccc-CcCCCCCCccccCCc-cCcEEeCCCCcCCCCCcccccCcccccceeccc-cccccccCccccCccccceee
Q 008012 79 ILYVNLSS-NYLTGSLTSDIQNMK-VLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAG-NQFQGPIPESFGSLISLESLD 155 (581)
Q Consensus 79 L~~L~l~~-n~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~-N~i~~~~~~~~~~l~~L~~L~ 155 (581)
+..|++.+ |++....+..|..+. .|+.|++++|+|+ .+|.......+|+.|++++ |.++.+.+..|..+++|+.|+
T Consensus 130 l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~Ld 208 (350)
T 4ay9_X 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILD 208 (350)
T ss_dssp CEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEE
T ss_pred hhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhh
Confidence 99999966 578766667787765 6999999999999 5666666678999999975 778866667899999999999
Q ss_pred ccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccC
Q 008012 156 LSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCG 211 (581)
Q Consensus 156 l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~ 211 (581)
|++|+|+.+.+..+. +|+.|.+.++.--..+|....+..+..+.+. +++.|.
T Consensus 209 Ls~N~l~~lp~~~~~---~L~~L~~l~~~~l~~lP~l~~l~~L~~l~l~-~~~~c~ 260 (350)
T 4ay9_X 209 ISRTRIHSLPSYGLE---NLKKLRARSTYNLKKLPTLEKLVALMEASLT-YPSHCC 260 (350)
T ss_dssp CTTSCCCCCCSSSCT---TCCEEECTTCTTCCCCCCTTTCCSCCEEECS-CHHHHH
T ss_pred cCCCCcCccChhhhc---cchHhhhccCCCcCcCCCchhCcChhhCcCC-CCcccc
Confidence 999999975555554 4555555444323366767778888877775 556664
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.81 E-value=4e-21 Score=195.09 Aligned_cols=204 Identities=22% Similarity=0.290 Sum_probs=149.5
Q ss_pred CCCCcEEEeecCcccccCC----ccccCCC-CCCEEEccCCcccccCCccccCC-----CCCCEEEccCCcccCCCCccc
Q 008012 4 MQQLQGIGLADNHLQGSIP----YDLCQLK-RLNSLSLQGNKLNGSIPTCLASL-----TSLRELRLNSNKLTSSIPSAL 73 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~----~~~~~l~-~L~~L~l~~n~i~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~ 73 (581)
.++|++|+|++|+|++..+ ..|.+++ +|++|+|++|.|++..+..|..+ ++|++|+|++|++++..+..+
T Consensus 21 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l 100 (362)
T 3goz_A 21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL 100 (362)
T ss_dssp CTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred CCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHH
Confidence 3458999999999886666 7788888 89999999999987777777665 889999999999886666544
Q ss_pred c----cC-CCCcEEecccCcCCCCCCcccc----C-CccCcEEeCCCCcCCCCCcc----cccCcc-cccceeccccccc
Q 008012 74 W----AL-EYILYVNLSSNYLTGSLTSDIQ----N-MKVLIDLDLSRNQLSGDIPK----TIAGLK-DLTNLSLAGNQFQ 138 (581)
Q Consensus 74 ~----~l-~~L~~L~l~~n~l~~~~~~~~~----~-l~~L~~L~l~~N~l~~~~~~----~~~~l~-~L~~L~l~~N~i~ 138 (581)
. .+ ++|++|+|++|.|++..+..+. . .++|++|+|++|.+++..+. .+..++ +|+.|+|++|+|+
T Consensus 101 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~ 180 (362)
T 3goz_A 101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180 (362)
T ss_dssp HHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred HHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCc
Confidence 3 34 7899999999998866554443 3 36899999999988854433 334554 8899999999888
Q ss_pred cccCcccc----Cc-cccceeeccccccCCC----Cchhhhc-ccccCeeEccCCCCCCCCCC-----CCCCcCCccccc
Q 008012 139 GPIPESFG----SL-ISLESLDLSSNNLSEG----IPKSLVA-LSHLKQFNVSHNRLEGEIPT-----EGPFRNFSAQSF 203 (581)
Q Consensus 139 ~~~~~~~~----~l-~~L~~L~l~~N~l~~~----~~~~~~~-l~~L~~l~l~~n~l~~~~~~-----~~~~~~~~~~~~ 203 (581)
+..+..+. .+ ++|+.|+|++|.+++. ++..+.. .++|+.|+|++|+++...+. ...+..++.+.+
T Consensus 181 ~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L 260 (362)
T 3goz_A 181 SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYL 260 (362)
T ss_dssp GSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEE
T ss_pred hhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEe
Confidence 76664443 44 5899999999988764 3444544 35899999999988864431 244566777777
Q ss_pred cccc
Q 008012 204 HWNY 207 (581)
Q Consensus 204 ~~n~ 207 (581)
.+|.
T Consensus 261 ~~n~ 264 (362)
T 3goz_A 261 DYDI 264 (362)
T ss_dssp EHHH
T ss_pred ccCC
Confidence 7765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=174.97 Aligned_cols=137 Identities=20% Similarity=0.236 Sum_probs=107.9
Q ss_pred CCcCCeecccccccEEEEEe-CCCcE--EEEEEeccchH------------------------HHHHHHHHHHHHHHhcC
Q 008012 293 FNECNLLGSGGFGSVYKGIL-SDGTT--VAIKIFNLQLE------------------------QAFRSFNSECEVLRNVR 345 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~e~~~l~~l~ 345 (581)
|++.+.||+|+||.||+|.. .+|+. ||||+++.... .....+.+|+++++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999997 67899 99998754321 11236789999999998
Q ss_pred CCcc--ceEeeeeecCCeeeEEEeccCC-C----CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCC
Q 008012 346 HRNL--IKILSSCCNTNFKALVLEFMPN-G----SLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLK 418 (581)
Q Consensus 346 h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dik 418 (581)
|+++ ..++++ +..++||||+.+ | +|.++.... ++..+..++.|++.||.|||. +.||+|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~----~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGREL----KELDVEGIFNDVVENVKRLYQ--EAELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGG----GGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhcc----ChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence 7754 344432 356899999942 3 777765431 345678899999999999995 5789999999
Q ss_pred CCCeEecCCCcEEEeeccCceec
Q 008012 419 PSNILLDENMVAHVSDFGISKLL 441 (581)
Q Consensus 419 p~Nill~~~~~~kl~Dfg~a~~~ 441 (581)
|+|||++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999988 9999999999865
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.80 E-value=4.7e-21 Score=192.59 Aligned_cols=179 Identities=19% Similarity=0.253 Sum_probs=119.6
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCccccc-CCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEe
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGS-IPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 83 (581)
++++.|++++|.+++..+. +..+++|++|+|++|.+++. .+..+.++++|++|+|++|++++..+..+..+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 5667777777777754444 44577777777777777644 566677777777777777777666666677777777777
Q ss_pred cccC-cCCC-CCCccccCCccCcEEeCCCC-cCCCC-CcccccCcc-cccceecccc--ccc-cccCccccCccccceee
Q 008012 84 LSSN-YLTG-SLTSDIQNMKVLIDLDLSRN-QLSGD-IPKTIAGLK-DLTNLSLAGN--QFQ-GPIPESFGSLISLESLD 155 (581)
Q Consensus 84 l~~n-~l~~-~~~~~~~~l~~L~~L~l~~N-~l~~~-~~~~~~~l~-~L~~L~l~~N--~i~-~~~~~~~~~l~~L~~L~ 155 (581)
+++| .+++ .++..+..+++|++|++++| .+++. ++..+..++ +|+.|+|++| .++ +.++..+..+++|+.|+
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~ 228 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence 7777 4553 24445666777777777777 66643 455566677 7777777777 343 23455566677777777
Q ss_pred ccccc-cCCCCchhhhcccccCeeEccCCC
Q 008012 156 LSSNN-LSEGIPKSLVALSHLKQFNVSHNR 184 (581)
Q Consensus 156 l~~N~-l~~~~~~~~~~l~~L~~l~l~~n~ 184 (581)
+++|. +++..+..+..+++|+.|++++|.
T Consensus 229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred CCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 77777 555566667777777777777774
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=175.48 Aligned_cols=149 Identities=23% Similarity=0.336 Sum_probs=131.9
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
.+++|++|++++|+|+. ++ .+..+++|++|+|++|+|++..+ |.++++|++|+|++|++++ +|.... ++|++|
T Consensus 39 ~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L 111 (263)
T 1xeu_A 39 ELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRL 111 (263)
T ss_dssp HHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEE
T ss_pred hcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcccc--CcccEE
Confidence 57899999999999994 55 78999999999999999996544 9999999999999999985 444333 999999
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
++++|+|++. ..+..+++|++|++++|++++ ++ .+..+++|+.|+|++|+|++. ..+..+++|+.|++++|.++
T Consensus 112 ~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 112 FLDNNELRDT--DSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp ECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEE
T ss_pred EccCCccCCC--hhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCccc
Confidence 9999999953 369999999999999999995 44 689999999999999999976 77899999999999999998
Q ss_pred CC
Q 008012 163 EG 164 (581)
Q Consensus 163 ~~ 164 (581)
+.
T Consensus 186 ~~ 187 (263)
T 1xeu_A 186 NE 187 (263)
T ss_dssp CC
T ss_pred CC
Confidence 75
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.80 E-value=1.5e-19 Score=165.81 Aligned_cols=175 Identities=23% Similarity=0.274 Sum_probs=143.4
Q ss_pred cEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCc-cccCCCCCCEEEccCCcccCCCCcccccCCCCcEEeccc
Q 008012 8 QGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPT-CLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSS 86 (581)
Q Consensus 8 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 86 (581)
+.|++++|+++ .+|..+. .+|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 78999999998 6787666 4999999999999977664 599999999999999999988899999999999999999
Q ss_pred CcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCc-cccCccccceeeccccccCCCC
Q 008012 87 NYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPE-SFGSLISLESLDLSSNNLSEGI 165 (581)
Q Consensus 87 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~-~~~~l~~L~~L~l~~N~l~~~~ 165 (581)
|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+- ++ ...|+...+..+......
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~--~~~l~~~~~~~~~~~C~~ 165 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF--AEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH--HHHHHHHCCSGGGCBBCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHH--HHHHHHcCCCCCCCCCCC
Confidence 999988888899999999999999999988899999999999999999999864331 11 112334445556565556
Q ss_pred chhhhcccccCeeEccCCCCCCCCC
Q 008012 166 PKSLVALSHLKQFNVSHNRLEGEIP 190 (581)
Q Consensus 166 ~~~~~~l~~L~~l~l~~n~l~~~~~ 190 (581)
|..+.+ ....++..+.+++..+
T Consensus 166 P~~l~~---~~l~~l~~~~~~C~~~ 187 (192)
T 1w8a_A 166 PSKVRD---VQIKDLPHSEFKCSSE 187 (192)
T ss_dssp STTTTT---SBGGGSCTTTCCCCCC
T ss_pred ChHHcC---CChhhCcHhhcCcCCC
Confidence 665544 4455667777766543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=4.7e-22 Score=212.52 Aligned_cols=184 Identities=22% Similarity=0.266 Sum_probs=157.2
Q ss_pred CCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCc-------------ccccCCccccCCCCCCEEE-ccCCcccC
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNK-------------LNGSIPTCLASLTSLRELR-LNSNKLTS 67 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-------------i~~~~~~~~~~l~~L~~L~-L~~N~l~~ 67 (581)
...++|+.|+|++|+|+ .+|..+++|++|+.|++++|. +.+..|..++++++|+.|+ ++.|.+..
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~ 424 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD 424 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccch
Confidence 45788999999999998 789999999999999998875 4567788889999999998 66665441
Q ss_pred CCCc------cccc--CCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceecccccccc
Q 008012 68 SIPS------ALWA--LEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQG 139 (581)
Q Consensus 68 ~~~~------~~~~--l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~ 139 (581)
++. .+.. ...|+.|+|++|+|++ +|. ++.+++|+.|+|++|.|+ .+|..|+++++|+.|+|++|+|++
T Consensus 425 -L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~ 500 (567)
T 1dce_A 425 -LRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN 500 (567)
T ss_dssp -HHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC
T ss_pred -hhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC
Confidence 111 1111 1359999999999995 565 999999999999999999 789999999999999999999996
Q ss_pred ccCccccCccccceeeccccccCCCC-chhhhcccccCeeEccCCCCCCCCCCC
Q 008012 140 PIPESFGSLISLESLDLSSNNLSEGI-PKSLVALSHLKQFNVSHNRLEGEIPTE 192 (581)
Q Consensus 140 ~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~n~l~~~~~~~ 192 (581)
+| .|+.+++|+.|+|++|.|++.. |..+..+++|+.|+|++|++++.+|..
T Consensus 501 -lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 501 -VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp -CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred -Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 56 8999999999999999999876 999999999999999999999877654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-18 Score=187.35 Aligned_cols=54 Identities=33% Similarity=0.362 Sum_probs=28.8
Q ss_pred cccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccc
Q 008012 149 ISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYAL 209 (581)
Q Consensus 149 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~ 209 (581)
++|+.|+|++|.+++ +| ..+++|+.|++++|+++. +|. .+..+..+++.+|...
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~--~~~~L~~L~Ls~N~L~ 274 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM--LPSGLLSLSVYRNQLT 274 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc--ccccCcEEeCCCCCCC
Confidence 456666666666654 33 334556666666666663 222 3344555555555433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.3e-20 Score=189.50 Aligned_cols=201 Identities=19% Similarity=0.200 Sum_probs=162.2
Q ss_pred EEEeecCcccccCCccccCCCCCCEEEccCCcccccCC----ccccCCC-CCCEEEccCCcccCCCCcccccC-----CC
Q 008012 9 GIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIP----TCLASLT-SLRELRLNSNKLTSSIPSALWAL-----EY 78 (581)
Q Consensus 9 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~ 78 (581)
.++|+.|++++.+|..+...++|++|+|++|.|++..+ +.|.+++ +|++|+|++|+|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 57899999999888888877889999999999997766 7889999 99999999999998878777775 99
Q ss_pred CcEEecccCcCCCCCCccc----cCC-ccCcEEeCCCCcCCCCCcccccC-----cccccceeccccccccccC----cc
Q 008012 79 ILYVNLSSNYLTGSLTSDI----QNM-KVLIDLDLSRNQLSGDIPKTIAG-----LKDLTNLSLAGNQFQGPIP----ES 144 (581)
Q Consensus 79 L~~L~l~~n~l~~~~~~~~----~~l-~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~l~~N~i~~~~~----~~ 144 (581)
|++|+|++|.+++..+..+ ..+ ++|++|+|++|.+++..+..+.. .++|+.|+|++|.|++... ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999997666644 444 89999999999999766655543 3699999999999996443 34
Q ss_pred ccCcc-ccceeeccccccCCCCchhhhcc-----cccCeeEccCCCCCCCC----CC-CCC-CcCCccccccccccc
Q 008012 145 FGSLI-SLESLDLSSNNLSEGIPKSLVAL-----SHLKQFNVSHNRLEGEI----PT-EGP-FRNFSAQSFHWNYAL 209 (581)
Q Consensus 145 ~~~l~-~L~~L~l~~N~l~~~~~~~~~~l-----~~L~~l~l~~n~l~~~~----~~-~~~-~~~~~~~~~~~n~~~ 209 (581)
+..++ +|++|+|++|.+++..+..+... ++|+.|+|++|+++... +. ... ...+..+++.+|...
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 238 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCC
Confidence 45565 99999999999998777666544 69999999999998622 11 111 236778888887543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.77 E-value=9.7e-19 Score=156.85 Aligned_cols=133 Identities=27% Similarity=0.227 Sum_probs=87.0
Q ss_pred CCCCEEEccCCccc-ccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEe
Q 008012 29 KRLNSLSLQGNKLN-GSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLD 107 (581)
Q Consensus 29 ~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 107 (581)
++|++|+|++|.|+ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 66667777777666 45566666666777777777766643 5566666777777777776655666666667777777
Q ss_pred CCCCcCCCCC-cccccCcccccceeccccccccccC---ccccCccccceeeccccccCC
Q 008012 108 LSRNQLSGDI-PKTIAGLKDLTNLSLAGNQFQGPIP---ESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 108 l~~N~l~~~~-~~~~~~l~~L~~L~l~~N~i~~~~~---~~~~~l~~L~~L~l~~N~l~~ 163 (581)
+++|.+++.. +..+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+..
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 7777776421 1566667777777777777765443 356667777777777777654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.1e-18 Score=182.14 Aligned_cols=78 Identities=28% Similarity=0.408 Sum_probs=36.7
Q ss_pred ccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEc
Q 008012 101 KVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180 (581)
Q Consensus 101 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 180 (581)
++|++|++++|.+++ +| .|+++++|++|++++|++++ +|..+ ++|++|++++|.+++ +| .+..+++|+.|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 345555555555553 34 35555555555555555543 23221 245555555555544 33 3444444555555
Q ss_pred cCCCCC
Q 008012 181 SHNRLE 186 (581)
Q Consensus 181 ~~n~l~ 186 (581)
++|+++
T Consensus 203 ~~N~l~ 208 (454)
T 1jl5_A 203 DNNSLK 208 (454)
T ss_dssp CSSCCS
T ss_pred CCCcCC
Confidence 544444
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.6e-19 Score=197.28 Aligned_cols=182 Identities=25% Similarity=0.290 Sum_probs=117.8
Q ss_pred CCCcEEEeecCcccccCCccccCCCCC-----CEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCC
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRL-----NSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYI 79 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L-----~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 79 (581)
+.++.|+|.+|.++. .+..+.....| ..++++.|++. ..++.|..+++|+.|+|++|.|. .+|..+.++++|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L 249 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL 249 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence 457888898888885 44433222222 23344445555 56888899999999999999998 677777789999
Q ss_pred cEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeecccc
Q 008012 80 LYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSN 159 (581)
Q Consensus 80 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N 159 (581)
++|+|++|.|+ .+|..|.++++|++|+|++|.|+ .+|..|++|++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|
T Consensus 250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N 326 (727)
T 4b8c_D 250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGN 326 (727)
T ss_dssp SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTS
T ss_pred CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCC
Confidence 99999999998 77888899999999999999998 77888999999999999999998 66777999999999999999
Q ss_pred ccCCCCchhhhcccc-cCeeEccCCCCCCCCCCC
Q 008012 160 NLSEGIPKSLVALSH-LKQFNVSHNRLEGEIPTE 192 (581)
Q Consensus 160 ~l~~~~~~~~~~l~~-L~~l~l~~n~l~~~~~~~ 192 (581)
.|++..|..+..+.. +..++|++|.+++.+|..
T Consensus 327 ~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~ 360 (727)
T 4b8c_D 327 PLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE 360 (727)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred ccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence 998888877765432 234788899998888764
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-17 Score=179.16 Aligned_cols=176 Identities=29% Similarity=0.338 Sum_probs=79.7
Q ss_pred CCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecc
Q 008012 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85 (581)
Q Consensus 6 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 85 (581)
+|++|+|++|+|+ .+|. .+++|++|+|++|+|+. +|. .+++|++|+|++|+|++ +|. .+++|+.|+++
T Consensus 62 ~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~ 129 (622)
T 3g06_A 62 HITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIF 129 (622)
T ss_dssp TCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECC
T ss_pred CCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECC
Confidence 4555555555555 2333 34555555555555552 332 34555555555555542 222 33444444444
Q ss_pred cCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccC-----------------cccccceeccccccccccCccccCc
Q 008012 86 SNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG-----------------LKDLTNLSLAGNQFQGPIPESFGSL 148 (581)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-----------------l~~L~~L~l~~N~i~~~~~~~~~~l 148 (581)
+|+|++ +|.. +++|++|++++|.+++ +|..+.+ +++|+.|++++|.|++ +|. .+
T Consensus 130 ~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l~~---~~ 200 (622)
T 3g06_A 130 GNQLTS-LPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPT---LP 200 (622)
T ss_dssp SSCCSC-CCCC---CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCC---CC
T ss_pred CCCCCc-CCCC---CCCCCEEECcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-CCC---cc
Confidence 444442 2221 2444444555544442 2221111 1334444444444442 111 12
Q ss_pred cccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccc
Q 008012 149 ISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYAL 209 (581)
Q Consensus 149 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~ 209 (581)
++|+.|++++|.++. +|. .+++|+.|++++|++++ +| ..+..+..+++.+|...
T Consensus 201 ~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~-lp--~~l~~L~~L~Ls~N~L~ 254 (622)
T 3g06_A 201 SELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTS-LP--VLPSELKELMVSGNRLT 254 (622)
T ss_dssp TTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSC-CC--CCCTTCCEEECCSSCCS
T ss_pred chhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCc-CC--CCCCcCcEEECCCCCCC
Confidence 344444444444432 221 12566777777777765 33 23455666666666544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.9e-18 Score=153.69 Aligned_cols=132 Identities=23% Similarity=0.212 Sum_probs=60.8
Q ss_pred CCCcEEEeecCccc-ccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEe
Q 008012 5 QQLQGIGLADNHLQ-GSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83 (581)
Q Consensus 5 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 83 (581)
++|++|+|++|+++ +.+|..+..+++|++|+|++|.|++. ..|..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 34445555555444 33444444444555555555544432 4444444555555555554433444444444555555
Q ss_pred cccCcCCCCCC-ccccCCccCcEEeCCCCcCCCCCc---ccccCcccccceeccccccc
Q 008012 84 LSSNYLTGSLT-SDIQNMKVLIDLDLSRNQLSGDIP---KTIAGLKDLTNLSLAGNQFQ 138 (581)
Q Consensus 84 l~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~l~~N~i~ 138 (581)
+++|.|++... ..+..+++|++|++++|.+++..+ ..+..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 55554443211 344444445555555554443222 24444444555555544444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.6e-18 Score=155.31 Aligned_cols=128 Identities=29% Similarity=0.395 Sum_probs=77.3
Q ss_pred CEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCC
Q 008012 32 NSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRN 111 (581)
Q Consensus 32 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 111 (581)
+++++++|.|+ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|.|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45566666665 3343332 35666666666665 44555666666666666666666555555666666666666666
Q ss_pred cCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCC
Q 008012 112 QLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 112 ~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 163 (581)
+|++..|..|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|.+..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 6665555556666666666666666665545556666666666666666654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.75 E-value=3e-17 Score=171.22 Aligned_cols=161 Identities=25% Similarity=0.401 Sum_probs=110.4
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
++|++|+|++|++++ +| .|+++++|++|++++|+|++ +|..+ ++|++|+|++|++++ +| .+.++++|++|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 578899999999985 66 58888999999999998885 55433 588888888888875 45 5788888888888
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEG 164 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~ 164 (581)
++|++++ +|... ++|++|++++|.++ .+|. +.++++|+.|++++|++++ +|.. +++|+.|++++|.+++
T Consensus 203 ~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~- 271 (454)
T 1jl5_A 203 DNNSLKK-LPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD- 271 (454)
T ss_dssp CSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-
T ss_pred CCCcCCc-CCCCc---CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-
Confidence 8888874 33322 47777777777777 5553 6777777777777777774 3332 3566666666666654
Q ss_pred CchhhhcccccCeeEccCCCCCC
Q 008012 165 IPKSLVALSHLKQFNVSHNRLEG 187 (581)
Q Consensus 165 ~~~~~~~l~~L~~l~l~~n~l~~ 187 (581)
+|.. +++|+.|++++|++++
T Consensus 272 l~~~---~~~L~~L~ls~N~l~~ 291 (454)
T 1jl5_A 272 LPEL---PQSLTFLDVSENIFSG 291 (454)
T ss_dssp CCCC---CTTCCEEECCSSCCSE
T ss_pred cCcc---cCcCCEEECcCCccCc
Confidence 3322 2445555555555543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=9.5e-19 Score=192.78 Aligned_cols=161 Identities=19% Similarity=0.215 Sum_probs=125.5
Q ss_pred eecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCC
Q 008012 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTG 91 (581)
Q Consensus 12 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 91 (581)
+..|.+. ..++.|..+++|+.|+|++|.|. .+|..+.++++|++|+|++|.|+ .+|..|.++++|++|+|++|.|+
T Consensus 208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 3334444 55788999999999999999999 67777779999999999999999 88999999999999999999999
Q ss_pred CCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccc-cceeeccccccCCCCchhhh
Q 008012 92 SLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLIS-LESLDLSSNNLSEGIPKSLV 170 (581)
Q Consensus 92 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~~~ 170 (581)
.+|..|..|++|++|+|++|.|+ .+|..|+++++|+.|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|..
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~-- 360 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE-- 360 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--
T ss_pred ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc--
Confidence 77999999999999999999998 78888999999999999999999988888765532 345889999999887764
Q ss_pred cccccCeeEccCC
Q 008012 171 ALSHLKQFNVSHN 183 (581)
Q Consensus 171 ~l~~L~~l~l~~n 183 (581)
|..|+++.|
T Consensus 361 ----l~~l~l~~n 369 (727)
T 4b8c_D 361 ----RRFIEINTD 369 (727)
T ss_dssp -------------
T ss_pred ----cceeEeecc
Confidence 455666666
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.6e-18 Score=150.68 Aligned_cols=127 Identities=24% Similarity=0.237 Sum_probs=72.9
Q ss_pred CCCCEEEccCCccc-ccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEe
Q 008012 29 KRLNSLSLQGNKLN-GSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLD 107 (581)
Q Consensus 29 ~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 107 (581)
++|+.|++++|.|+ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|++++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45556666666655 44555555566666666666665533 4455566666666666666544555555566666666
Q ss_pred CCCCcCCCC-CcccccCcccccceeccccccccccC---ccccCccccceeecc
Q 008012 108 LSRNQLSGD-IPKTIAGLKDLTNLSLAGNQFQGPIP---ESFGSLISLESLDLS 157 (581)
Q Consensus 108 l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~i~~~~~---~~~~~l~~L~~L~l~ 157 (581)
+++|.+++. .+..+.++++|+.|++++|++++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 666666532 22555666666666666666665443 345566666666654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.8e-17 Score=151.88 Aligned_cols=127 Identities=20% Similarity=0.295 Sum_probs=91.0
Q ss_pred cEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccC
Q 008012 8 QGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSN 87 (581)
Q Consensus 8 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n 87 (581)
+.+++++|+|+ .+|..+. ++|++|+|++|.|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 46777777777 4555544 57777777777777 55677777777777777777777666667777777777777777
Q ss_pred cCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccc
Q 008012 88 YLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQ 138 (581)
Q Consensus 88 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~ 138 (581)
+|++..+..|..+++|++|+|++|.|+...+..|..+++|+.|+|++|++.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 777666667777777777777777777544445777777777777777765
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.73 E-value=5.3e-18 Score=148.73 Aligned_cols=127 Identities=19% Similarity=0.198 Sum_probs=68.5
Q ss_pred CCCcEEEeecCccc-ccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEe
Q 008012 5 QQLQGIGLADNHLQ-GSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83 (581)
Q Consensus 5 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 83 (581)
++|++|++++|+++ +.+|..+..+++|++|+|++|.|++. ..|.++++|++|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 44555555555555 44555555555555555555555533 4455555555555555555544555555555555555
Q ss_pred cccCcCCCC-CCccccCCccCcEEeCCCCcCCCCCc---ccccCcccccceecc
Q 008012 84 LSSNYLTGS-LTSDIQNMKVLIDLDLSRNQLSGDIP---KTIAGLKDLTNLSLA 133 (581)
Q Consensus 84 l~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~l~ 133 (581)
+++|.+++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555555532 12445555555555555555553332 245555555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.3e-17 Score=149.16 Aligned_cols=111 Identities=26% Similarity=0.238 Sum_probs=56.1
Q ss_pred CCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceec
Q 008012 53 TSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSL 132 (581)
Q Consensus 53 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 132 (581)
++|++|+|++|++++..+..|..+++|++|++++|+|++..+..|..+++|++|++++|.+++..+..+.++++|+.|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 34445555555544433344444555555555555554444444455555555555555555444444455555555555
Q ss_pred cccccccccCccccCccccceeeccccccCC
Q 008012 133 AGNQFQGPIPESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 133 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 163 (581)
++|+|++..+..|..+++|+.|+|++|.+++
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 5555554444444555555555555555554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.72 E-value=2.4e-19 Score=188.25 Aligned_cols=206 Identities=19% Similarity=0.211 Sum_probs=125.5
Q ss_pred CCCCCcEEEeecCcccccCCcccc-----CCCCCCEEEccCCccccc----CCccccCCCCCCEEEccCCcccCCC----
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLC-----QLKRLNSLSLQGNKLNGS----IPTCLASLTSLRELRLNSNKLTSSI---- 69 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~-----~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~---- 69 (581)
.+++|++|+|++|.++...+..+. .+++|++|+|++|.|+.. ++..+..+++|++|+|++|++++..
T Consensus 168 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l 247 (461)
T 1z7x_W 168 AKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAEL 247 (461)
T ss_dssp HCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHH
T ss_pred hCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHH
Confidence 356777777777777654444433 255777777777777743 3556666777777777777776432
Q ss_pred -CcccccCCCCcEEecccCcCCCC----CCccccCCccCcEEeCCCCcCCCCCcccccCc-----ccccceecccccccc
Q 008012 70 -PSALWALEYILYVNLSSNYLTGS----LTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGL-----KDLTNLSLAGNQFQG 139 (581)
Q Consensus 70 -~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-----~~L~~L~l~~N~i~~ 139 (581)
+..+..+++|++|++++|.++.. ++..+..+++|++|++++|.+++..+..+... ++|+.|+|++|.+++
T Consensus 248 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~ 327 (461)
T 1z7x_W 248 CPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTA 327 (461)
T ss_dssp HHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBG
T ss_pred HHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCch
Confidence 22233567777777777777642 45556667777777777777654433333322 567777777777765
Q ss_pred c----cCccccCccccceeeccccccCCCCchhhhc-----ccccCeeEccCCCCCC----CCCCC-CCCcCCccccccc
Q 008012 140 P----IPESFGSLISLESLDLSSNNLSEGIPKSLVA-----LSHLKQFNVSHNRLEG----EIPTE-GPFRNFSAQSFHW 205 (581)
Q Consensus 140 ~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~l~l~~n~l~~----~~~~~-~~~~~~~~~~~~~ 205 (581)
. ++..+..+++|+.|+|++|.+++..+..+.. .++|+.|++++|+++. .++.. ..+..+..+++.+
T Consensus 328 ~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~ 407 (461)
T 1z7x_W 328 ACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 407 (461)
T ss_dssp GGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCS
T ss_pred HHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCC
Confidence 4 3444555677777777777766544444432 4567777777777663 22221 3345566666666
Q ss_pred ccc
Q 008012 206 NYA 208 (581)
Q Consensus 206 n~~ 208 (581)
|+.
T Consensus 408 N~i 410 (461)
T 1z7x_W 408 NCL 410 (461)
T ss_dssp SSC
T ss_pred CCC
Confidence 643
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.72 E-value=4.5e-20 Score=193.84 Aligned_cols=206 Identities=20% Similarity=0.156 Sum_probs=162.5
Q ss_pred CCCCcEEEeecCcccccC----CccccCCCCCCEEEccCCcccccCCcccc-----CCCCCCEEEccCCcccCC----CC
Q 008012 4 MQQLQGIGLADNHLQGSI----PYDLCQLKRLNSLSLQGNKLNGSIPTCLA-----SLTSLRELRLNSNKLTSS----IP 70 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~i~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~~ 70 (581)
.++|++|+|++|++++.. +..+..+++|++|+|++|.|+...+..+. ..++|++|+|++|.+++. ++
T Consensus 141 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 220 (461)
T 1z7x_W 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC 220 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHH
T ss_pred CCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHH
Confidence 567999999999999643 56777889999999999999865444443 367999999999999864 57
Q ss_pred cccccCCCCcEEecccCcCCCCC-----CccccCCccCcEEeCCCCcCCCC----CcccccCcccccceecccccccccc
Q 008012 71 SALWALEYILYVNLSSNYLTGSL-----TSDIQNMKVLIDLDLSRNQLSGD----IPKTIAGLKDLTNLSLAGNQFQGPI 141 (581)
Q Consensus 71 ~~~~~l~~L~~L~l~~n~l~~~~-----~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~i~~~~ 141 (581)
..+..+++|++|++++|.+++.. +..+..+++|++|++++|.+++. ++..+.++++|+.|+|++|.+++..
T Consensus 221 ~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~ 300 (461)
T 1z7x_W 221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 300 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHH
T ss_pred HHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHH
Confidence 77889999999999999987432 22334689999999999999853 5777888999999999999998655
Q ss_pred CccccC-----ccccceeeccccccCCC----CchhhhcccccCeeEccCCCCCCCCCCC------CCCcCCcccccccc
Q 008012 142 PESFGS-----LISLESLDLSSNNLSEG----IPKSLVALSHLKQFNVSHNRLEGEIPTE------GPFRNFSAQSFHWN 206 (581)
Q Consensus 142 ~~~~~~-----l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~n~l~~~~~~~------~~~~~~~~~~~~~n 206 (581)
+..+.. .++|+.|++++|.+++. ++..+..+++|+.|++++|+++...+.. .....+..+++.+|
T Consensus 301 ~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n 380 (461)
T 1z7x_W 301 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCC
Confidence 544443 36999999999999875 4566778899999999999987643221 11457788888877
Q ss_pred ccc
Q 008012 207 YAL 209 (581)
Q Consensus 207 ~~~ 209 (581)
...
T Consensus 381 ~i~ 383 (461)
T 1z7x_W 381 DVS 383 (461)
T ss_dssp CCC
T ss_pred CCC
Confidence 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=2.7e-19 Score=191.13 Aligned_cols=174 Identities=21% Similarity=0.211 Sum_probs=140.6
Q ss_pred CCCCCCcEEEeecCc-------------ccccCCccccCCCCCCEEE-ccCCcccccCCc-----cccC--CCCCCEEEc
Q 008012 2 GRMQQLQGIGLADNH-------------LQGSIPYDLCQLKRLNSLS-LQGNKLNGSIPT-----CLAS--LTSLRELRL 60 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~-------------l~~~~~~~~~~l~~L~~L~-l~~n~i~~~~~~-----~~~~--l~~L~~L~L 60 (581)
+++++|+.|++++|. +.+..|..++++++|+.|+ ++.|.+.....- .+.. ...|+.|+|
T Consensus 369 ~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~~l~l~~n~i~~l~~~~L~~L~L 448 (567)
T 1dce_A 369 ESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHL 448 (567)
T ss_dssp HHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHHHHHHHHTTCSEEEC
T ss_pred HHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhhhhhhhcccccccCccCceEEEe
Confidence 346678888887664 5567788888899999988 666654321100 0111 135999999
Q ss_pred cCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccc
Q 008012 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGP 140 (581)
Q Consensus 61 ~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~ 140 (581)
++|+|++ +|. +..+++|+.|+|++|+|+ .+|..++.+++|++|+|++|.|++ +| .++++++|+.|+|++|+|++.
T Consensus 449 s~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~ 523 (567)
T 1dce_A 449 AHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQS 523 (567)
T ss_dssp TTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSS
T ss_pred cCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCC
Confidence 9999995 676 999999999999999999 788899999999999999999995 67 899999999999999999987
Q ss_pred c-CccccCccccceeeccccccCCCCch---hhhcccccCeeEc
Q 008012 141 I-PESFGSLISLESLDLSSNNLSEGIPK---SLVALSHLKQFNV 180 (581)
Q Consensus 141 ~-~~~~~~l~~L~~L~l~~N~l~~~~~~---~~~~l~~L~~l~l 180 (581)
. |..|+.+++|+.|+|++|.+++..|. .+..+++|+.|++
T Consensus 524 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 524 AAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp STTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 6 99999999999999999999985442 2345788998864
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=6.1e-17 Score=146.41 Aligned_cols=131 Identities=23% Similarity=0.239 Sum_probs=97.2
Q ss_pred CcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEeccc
Q 008012 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSS 86 (581)
Q Consensus 7 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 86 (581)
.+.+++++|+++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|++++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 467778888877 4554443 6788888888888866666777788888888888888766666677788888888888
Q ss_pred CcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccc
Q 008012 87 NYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGP 140 (581)
Q Consensus 87 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~ 140 (581)
|+|++..+..|..+++|++|++++|.+++..+..+..+++|+.|+|++|++.+.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 888766666677778888888888888755555567778888888888877753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.8e-17 Score=165.45 Aligned_cols=136 Identities=14% Similarity=0.194 Sum_probs=101.6
Q ss_pred CCcCCeecccccccEEEEEeCCCcEEEEEEeccch------------------HH----HHHHHHHHHHHHHhcCCCccc
Q 008012 293 FNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL------------------EQ----AFRSFNSECEVLRNVRHRNLI 350 (581)
Q Consensus 293 y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~------------------~~----~~~~~~~e~~~l~~l~h~~iv 350 (581)
|++.+.||+|++|.||+|...+|+.||||+++... .. ......+|...+.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 89999999999999999998899999999875321 00 011124567777777444332
Q ss_pred --eEeeeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC
Q 008012 351 --KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM 428 (581)
Q Consensus 351 --~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~ 428 (581)
..+++ ...++||||++|++|.++.. .+....++.|++.+|.+|| +.|||||||||.|||+++++
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEE
T ss_pred CCeeeec----cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCC
Confidence 22222 12379999999988865432 2234568899999999999 88999999999999998776
Q ss_pred ----------cEEEeeccCceecC
Q 008012 429 ----------VAHVSDFGISKLLG 442 (581)
Q Consensus 429 ----------~~kl~Dfg~a~~~~ 442 (581)
.+.|+||+-+....
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETT
T ss_pred CcccccccccceEEEEeCCcccCC
Confidence 48999999887654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=149.50 Aligned_cols=135 Identities=21% Similarity=0.224 Sum_probs=96.5
Q ss_pred cccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccC
Q 008012 24 DLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVL 103 (581)
Q Consensus 24 ~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 103 (581)
.+.++.+|++|+|++|.|+. ++......++|++|+|++|+|++. ..+..+++|++|++++|.|++..+..+..+++|
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hcCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 45667778888888888874 344333334788888888888754 567777888888888888875544555777888
Q ss_pred cEEeCCCCcCCCCCcc--cccCcccccceeccccccccccCc----cccCccccceeeccccccCC
Q 008012 104 IDLDLSRNQLSGDIPK--TIAGLKDLTNLSLAGNQFQGPIPE----SFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 104 ~~L~l~~N~l~~~~~~--~~~~l~~L~~L~l~~N~i~~~~~~----~~~~l~~L~~L~l~~N~l~~ 163 (581)
++|++++|.|+ .+|. .+.++++|+.|++++|+++. .|. .+..+++|+.|++++|.+..
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 88888888886 4555 67778888888888888873 444 37778888888888887653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=6.6e-17 Score=161.63 Aligned_cols=185 Identities=15% Similarity=0.167 Sum_probs=151.7
Q ss_pred CCCCcEEEeecCccc--------------------ccCCccccC--------CCCCCEEEccCCcccccCCccccCCCCC
Q 008012 4 MQQLQGIGLADNHLQ--------------------GSIPYDLCQ--------LKRLNSLSLQGNKLNGSIPTCLASLTSL 55 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~--------------------~~~~~~~~~--------l~~L~~L~l~~n~i~~~~~~~~~~l~~L 55 (581)
+++|+.|||++|+|. .+.+..|.+ +++|+.|+|.+ .|+.+.+.+|.++++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 678999999999998 445567888 99999999999 8888888999999999
Q ss_pred CEEEccCCcccCCCCcccccCCCCcEEecccCcC----CCCCCccc----------------------------------
Q 008012 56 RELRLNSNKLTSSIPSALWALEYILYVNLSSNYL----TGSLTSDI---------------------------------- 97 (581)
Q Consensus 56 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l----~~~~~~~~---------------------------------- 97 (581)
+.|+|++|.++...+.+|.++.++..+.+..+.. ..+...+|
T Consensus 127 ~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~ 206 (329)
T 3sb4_A 127 KICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINF 206 (329)
T ss_dssp CEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSE
T ss_pred ceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccce
Confidence 9999999999877888888888888777666321 10111111
Q ss_pred ----------------cCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccc-eeeccccc
Q 008012 98 ----------------QNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLE-SLDLSSNN 160 (581)
Q Consensus 98 ----------------~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~-~L~l~~N~ 160 (581)
..+++|++|+|++|+++...+..|.++++|+.|+|.+| ++.+.+..|.++++|+ .|++.+ .
T Consensus 207 l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~ 284 (329)
T 3sb4_A 207 LTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-S 284 (329)
T ss_dssp EEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-T
T ss_pred EEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-c
Confidence 12789999999999999666678999999999999998 8777788899999999 999998 7
Q ss_pred cCCCCchhhhcccccCeeEccCCCCCCCCCC
Q 008012 161 LSEGIPKSLVALSHLKQFNVSHNRLEGEIPT 191 (581)
Q Consensus 161 l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~ 191 (581)
++.+.+.+|.++++|+.|++++|+++...+.
T Consensus 285 l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~ 315 (329)
T 3sb4_A 285 VTAIEFGAFMGCDNLRYVLATGDKITTLGDE 315 (329)
T ss_dssp CCEECTTTTTTCTTEEEEEECSSCCCEECTT
T ss_pred ceEEchhhhhCCccCCEEEeCCCccCccchh
Confidence 7778889999999999999999999855443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.68 E-value=3e-19 Score=164.82 Aligned_cols=152 Identities=23% Similarity=0.317 Sum_probs=73.4
Q ss_pred CCCCCEEEccCCcccccCCc------cccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCc
Q 008012 28 LKRLNSLSLQGNKLNGSIPT------CLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMK 101 (581)
Q Consensus 28 l~~L~~L~l~~n~i~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 101 (581)
...++.++++.|.+++..|. .|..+++|++|+|++|+|++ +| .+..+++|++|++++|.++ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 34444444444444443333 44455555555555555543 33 4455555555555555554 3344444445
Q ss_pred cCcEEeCCCCcCCCCCcccccCcccccceeccccccccccC-ccccCccccceeeccccccCCCCch----------hhh
Q 008012 102 VLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIP-ESFGSLISLESLDLSSNNLSEGIPK----------SLV 170 (581)
Q Consensus 102 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~----------~~~ 170 (581)
+|++|++++|++++ +| .+.++++|+.|++++|+|++..+ ..+..+++|++|++++|.+++..|. .+.
T Consensus 94 ~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 171 (198)
T 1ds9_A 94 TLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171 (198)
T ss_dssp HCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHH
T ss_pred cCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHH
Confidence 55555555555552 23 34455555555555555553222 2445555555555555555443322 245
Q ss_pred cccccCeeEccCCCCC
Q 008012 171 ALSHLKQFNVSHNRLE 186 (581)
Q Consensus 171 ~l~~L~~l~l~~n~l~ 186 (581)
.+++|+.|| +|.++
T Consensus 172 ~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 172 RLPNLKKLD--GMPVD 185 (198)
T ss_dssp HCSSCSEEC--CGGGT
T ss_pred hCCCcEEEC--CcccC
Confidence 556666554 44444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.68 E-value=5.2e-17 Score=146.67 Aligned_cols=129 Identities=17% Similarity=0.191 Sum_probs=56.5
Q ss_pred CCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEe
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 83 (581)
+++|++|+|++|+++. +|......++|++|+|++|.|++. ..|..+++|++|+|++|+|++..+..|..+++|++|+
T Consensus 18 ~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 3344444444444442 232111122444444444444432 3444444444444444444433333334444444444
Q ss_pred cccCcCCCCCCc--cccCCccCcEEeCCCCcCCCCCccc----ccCcccccceecccccc
Q 008012 84 LSSNYLTGSLTS--DIQNMKVLIDLDLSRNQLSGDIPKT----IAGLKDLTNLSLAGNQF 137 (581)
Q Consensus 84 l~~n~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~----~~~l~~L~~L~l~~N~i 137 (581)
+++|+|+ .+|. .+..+++|++|++++|.++ ..|.. +..+++|+.|++++|.+
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 4444444 2222 3444444444444444444 23332 44444444444444444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.66 E-value=8.5e-19 Score=161.75 Aligned_cols=153 Identities=25% Similarity=0.309 Sum_probs=131.3
Q ss_pred CCCCcEEEeecCcccccCCc------cccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCC
Q 008012 4 MQQLQGIGLADNHLQGSIPY------DLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALE 77 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 77 (581)
...++.++++++.+++..|. .|+.+++|++|+|++|.|++ +| .+.++++|++|+|++|+|+ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 46778888888888887776 89999999999999999996 56 8999999999999999998 6788888899
Q ss_pred CCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCc-ccccCcccccceeccccccccccCcc----------cc
Q 008012 78 YILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIP-KTIAGLKDLTNLSLAGNQFQGPIPES----------FG 146 (581)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~i~~~~~~~----------~~ 146 (581)
+|++|++++|++++ +| .+..+++|++|++++|.+++..+ ..+..+++|+.|++++|++++..|.. +.
T Consensus 94 ~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 171 (198)
T 1ds9_A 94 TLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171 (198)
T ss_dssp HCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHH
T ss_pred cCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHH
Confidence 99999999999995 44 68899999999999999984332 47889999999999999998765543 77
Q ss_pred CccccceeeccccccCC
Q 008012 147 SLISLESLDLSSNNLSE 163 (581)
Q Consensus 147 ~l~~L~~L~l~~N~l~~ 163 (581)
.+++|+.|+ +|.++.
T Consensus 172 ~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 172 RLPNLKKLD--GMPVDV 186 (198)
T ss_dssp HCSSCSEEC--CGGGTT
T ss_pred hCCCcEEEC--CcccCH
Confidence 899999887 777764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.62 E-value=3e-16 Score=156.80 Aligned_cols=205 Identities=10% Similarity=0.034 Sum_probs=156.8
Q ss_pred CCCCcEEEeecCcccccCCccccC-CCCCCEEEccCCccc--------------------ccCCccccC--------CCC
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQ-LKRLNSLSLQGNKLN--------------------GSIPTCLAS--------LTS 54 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~n~i~--------------------~~~~~~~~~--------l~~ 54 (581)
+++|+.|.++++ +...--..+.. +++|++|||++|+|. .+.+.+|.+ +++
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~ 102 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQT 102 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTT
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCC
Confidence 456889999875 22222233444 899999999999999 455677888 999
Q ss_pred CCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcC----CCCCcccc---------
Q 008012 55 LRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQL----SGDIPKTI--------- 121 (581)
Q Consensus 55 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l----~~~~~~~~--------- 121 (581)
|+.|+|.+ .++...+.+|.++++|++|++++|.+....+.+|.++.++..+.+..+.. .......|
T Consensus 103 L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~ 181 (329)
T 3sb4_A 103 LEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETT 181 (329)
T ss_dssp CCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEE
T ss_pred CcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccccee
Confidence 99999998 88877788899999999999999999878888999988888888766321 10000001
Q ss_pred -----------------------------------------cCcccccceeccccccccccCccccCccccceeeccccc
Q 008012 122 -----------------------------------------AGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNN 160 (581)
Q Consensus 122 -----------------------------------------~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~ 160 (581)
..+++|+.|+|++|+++.+.+..|.++.+|+.|+|++|
T Consensus 182 i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n- 260 (329)
T 3sb4_A 182 IQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN- 260 (329)
T ss_dssp EEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-
T ss_pred EEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-
Confidence 13789999999999999888888999999999999998
Q ss_pred cCCCCchhhhcccccC-eeEccCCCCCCCCCC-CCCCcCCccccccccccccCC
Q 008012 161 LSEGIPKSLVALSHLK-QFNVSHNRLEGEIPT-EGPFRNFSAQSFHWNYALCGP 212 (581)
Q Consensus 161 l~~~~~~~~~~l~~L~-~l~l~~n~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~ 212 (581)
++.+.+.+|.++++|+ .+++.+ .++...+. +..+..+..+.+.+|....-+
T Consensus 261 i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~ 313 (329)
T 3sb4_A 261 LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLG 313 (329)
T ss_dssp CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEEC
T ss_pred cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccc
Confidence 8788889999999999 999998 66644333 355667777777666444333
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.4e-15 Score=134.13 Aligned_cols=104 Identities=24% Similarity=0.288 Sum_probs=56.7
Q ss_pred cEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccC
Q 008012 8 QGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSN 87 (581)
Q Consensus 8 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n 87 (581)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45555555554 4444443 55555555555555555555555555555555555555444444555555555555555
Q ss_pred cCCCCCCccccCCccCcEEeCCCCcCC
Q 008012 88 YLTGSLTSDIQNMKVLIDLDLSRNQLS 114 (581)
Q Consensus 88 ~l~~~~~~~~~~l~~L~~L~l~~N~l~ 114 (581)
+|++..+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555444444555555555555555554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.60 E-value=4.4e-15 Score=133.00 Aligned_cols=104 Identities=23% Similarity=0.276 Sum_probs=52.3
Q ss_pred cEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccC
Q 008012 8 QGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSN 87 (581)
Q Consensus 8 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n 87 (581)
+.|++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 44555555555 3443332 45555555555555444555555555555555555555444444455555555555555
Q ss_pred cCCCCCCccccCCccCcEEeCCCCcCC
Q 008012 88 YLTGSLTSDIQNMKVLIDLDLSRNQLS 114 (581)
Q Consensus 88 ~l~~~~~~~~~~l~~L~~L~l~~N~l~ 114 (581)
+|++..+..|..+++|++|+|++|.++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 555444444445555555555555444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.57 E-value=8.3e-15 Score=131.16 Aligned_cols=105 Identities=27% Similarity=0.327 Sum_probs=59.0
Q ss_pred CCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCC
Q 008012 31 LNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSR 110 (581)
Q Consensus 31 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 110 (581)
.+.|++++|.|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 456666666666 3444332 5566666666666655555566666666666666666554444555555555555555
Q ss_pred CcCCCCCcccccCcccccceeccccccc
Q 008012 111 NQLSGDIPKTIAGLKDLTNLSLAGNQFQ 138 (581)
Q Consensus 111 N~l~~~~~~~~~~l~~L~~L~l~~N~i~ 138 (581)
|+|++..+..|.++++|+.|+|++|+++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 5555443344555555555555555554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.6e-14 Score=129.81 Aligned_cols=104 Identities=28% Similarity=0.342 Sum_probs=61.3
Q ss_pred CEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCC
Q 008012 32 NSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRN 111 (581)
Q Consensus 32 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 111 (581)
+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56666776666 4454443 56666666666666555666666666666666666666544444556666666666666
Q ss_pred cCCCCCcccccCcccccceeccccccc
Q 008012 112 QLSGDIPKTIAGLKDLTNLSLAGNQFQ 138 (581)
Q Consensus 112 ~l~~~~~~~~~~l~~L~~L~l~~N~i~ 138 (581)
+|++..+..|.++++|+.|+|++|++.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 665433334555555555555555554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.49 E-value=1.6e-13 Score=140.12 Aligned_cols=192 Identities=11% Similarity=0.084 Sum_probs=131.7
Q ss_pred CCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecc
Q 008012 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85 (581)
Q Consensus 6 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 85 (581)
+|+.+.|.+ .++.+.+..|.++++|+.++|++|.++.+...+|. .++|+.+.|..| ++.....+|.++++|+.+.+.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence 578888875 67767777888888888888888888876666776 578888888744 665667778888888888887
Q ss_pred cCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccc-----cccCccccCccccceeeccccc
Q 008012 86 SNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQ-----GPIPESFGSLISLESLDLSSNN 160 (581)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~-----~~~~~~~~~l~~L~~L~l~~N~ 160 (581)
+| ++.....+|.+ .+|+.+.| .|.++......|.++++|+.+++.+|.+. .+.+..|.++++|+.++|.+ .
T Consensus 235 ~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~ 310 (401)
T 4fdw_A 235 EN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-S 310 (401)
T ss_dssp TT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-T
T ss_pred CC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-c
Confidence 65 45455566766 67777777 34455455667777777777777776654 35556677777777777773 4
Q ss_pred cCCCCchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCcccccccc
Q 008012 161 LSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWN 206 (581)
Q Consensus 161 l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n 206 (581)
++.+....|.++++|+.+.+..| ++...... ... .+..+.+.+|
T Consensus 311 i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n 355 (401)
T 4fdw_A 311 IRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGT 355 (401)
T ss_dssp CCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCS
T ss_pred eEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCC
Confidence 66666677777777777777544 44222222 233 5566666555
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.5e-16 Score=159.39 Aligned_cols=158 Identities=21% Similarity=0.238 Sum_probs=79.7
Q ss_pred CCCCEEEccCCcccccCCccccC-----CCCCCEEEccCCcccCCCCcc-cccCCCCcEEecccCcCCCCCCccc-----
Q 008012 29 KRLNSLSLQGNKLNGSIPTCLAS-----LTSLRELRLNSNKLTSSIPSA-LWALEYILYVNLSSNYLTGSLTSDI----- 97 (581)
Q Consensus 29 ~~L~~L~l~~n~i~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~----- 97 (581)
++|+.|+|++|.|+......|.. .++|++|+|++|.|++..... ...+++|++|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 45556666666655332222222 145666666666554322211 2234456666666666553222222
Q ss_pred cCCccCcEEeCCCCcCCCC----CcccccCcccccceecccccccccc----CccccCccccceeeccccccCCC----C
Q 008012 98 QNMKVLIDLDLSRNQLSGD----IPKTIAGLKDLTNLSLAGNQFQGPI----PESFGSLISLESLDLSSNNLSEG----I 165 (581)
Q Consensus 98 ~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~i~~~~----~~~~~~l~~L~~L~l~~N~l~~~----~ 165 (581)
...++|++|+|++|.|+.. ++..+..+++|+.|+|++|.|++.. +..+..+++|+.|+|++|.|++. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 2345566666666665421 2223345556666666666665422 33444555666666666666542 2
Q ss_pred chhhhcccccCeeEccCCCCC
Q 008012 166 PKSLVALSHLKQFNVSHNRLE 186 (581)
Q Consensus 166 ~~~~~~l~~L~~l~l~~n~l~ 186 (581)
...+...++|+.|+|++|+|+
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCC
T ss_pred HHHHHhCCCCCEEeccCCCCC
Confidence 223334566666666666655
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.6e-15 Score=164.35 Aligned_cols=184 Identities=15% Similarity=0.094 Sum_probs=94.2
Q ss_pred CCCCCcEEEeecCcccccCC-ccccCCCCCCEEEccCCcccc-cCCccccCCCCCCEEEcc-----------CCcccCC-
Q 008012 3 RMQQLQGIGLADNHLQGSIP-YDLCQLKRLNSLSLQGNKLNG-SIPTCLASLTSLRELRLN-----------SNKLTSS- 68 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~-----------~N~l~~~- 68 (581)
.+++|++|+|++|.+++... ..+..+++|++|+++ |.+.. ..+..+..+++|++|+|+ .|.+++.
T Consensus 291 ~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~ 369 (592)
T 3ogk_B 291 FAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRG 369 (592)
T ss_dssp GGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHH
T ss_pred hcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHH
Confidence 45677888888777654332 334666666666666 33331 222223445555555555 2344321
Q ss_pred CCcccccCCCCcEEecccCcCCCCCCcc----------------------------------ccCCccCcEEeCCCCc--
Q 008012 69 IPSALWALEYILYVNLSSNYLTGSLTSD----------------------------------IQNMKVLIDLDLSRNQ-- 112 (581)
Q Consensus 69 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~----------------------------------~~~l~~L~~L~l~~N~-- 112 (581)
++..+..+++|++|+++.|.+++..+.. +.++++|++|++++|.
T Consensus 370 ~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~ 449 (592)
T 3ogk_B 370 LIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGG 449 (592)
T ss_dssp HHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGG
T ss_pred HHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCC
Confidence 1112233445555555444444333333 3344555555554222
Q ss_pred CCCCCccccc-Ccccccceeccccccccc-cCccccCccccceeeccccccCCC-CchhhhcccccCeeEccCCCCCC
Q 008012 113 LSGDIPKTIA-GLKDLTNLSLAGNQFQGP-IPESFGSLISLESLDLSSNNLSEG-IPKSLVALSHLKQFNVSHNRLEG 187 (581)
Q Consensus 113 l~~~~~~~~~-~l~~L~~L~l~~N~i~~~-~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~n~l~~ 187 (581)
+++..+..+. .+++|+.|+|++|++++. .+..+..+++|+.|+|++|.+++. .+..+..+++|+.|++++|+++.
T Consensus 450 l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 450 LTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp CCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred ccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence 3322222222 256666666666666542 233445666777777777776543 23334556777777777777654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.45 E-value=2.3e-13 Score=136.91 Aligned_cols=104 Identities=26% Similarity=0.261 Sum_probs=77.1
Q ss_pred cEEEeecC-cccccCCccccCCCCCCEEEccC-CcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecc
Q 008012 8 QGIGLADN-HLQGSIPYDLCQLKRLNSLSLQG-NKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85 (581)
Q Consensus 8 ~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 85 (581)
..++++++ +|+ .+|. +..+++|++|+|++ |.|+++.+..|.+|++|+.|+|++|+|++..|..|.++++|++|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35677777 777 4666 77777788888875 78877766777778888888888888877777777777788888888
Q ss_pred cCcCCCCCCccccCCccCcEEeCCCCcCC
Q 008012 86 SNYLTGSLTSDIQNMKVLIDLDLSRNQLS 114 (581)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 114 (581)
+|+|++..+..|..++ |+.|+|.+|.+.
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 8877765555565555 777777777776
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.44 E-value=1.6e-13 Score=138.19 Aligned_cols=104 Identities=25% Similarity=0.260 Sum_probs=76.5
Q ss_pred CEEEccCC-cccccCCccccCCCCCCEEEccC-CcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCC
Q 008012 32 NSLSLQGN-KLNGSIPTCLASLTSLRELRLNS-NKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLS 109 (581)
Q Consensus 32 ~~L~l~~n-~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 109 (581)
..++++++ +|+ .+|. |..+++|++|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35678887 787 4566 88888888888875 88876666778888888888888888877777777778888888888
Q ss_pred CCcCCCCCcccccCcccccceeccccccc
Q 008012 110 RNQLSGDIPKTIAGLKDLTNLSLAGNQFQ 138 (581)
Q Consensus 110 ~N~l~~~~~~~~~~l~~L~~L~l~~N~i~ 138 (581)
+|+|++..+..|..++ |+.|+|++|+|.
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 8887754444455444 777777777765
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.43 E-value=3.2e-14 Score=154.09 Aligned_cols=173 Identities=12% Similarity=0.089 Sum_probs=82.2
Q ss_pred CcEEEeecCc-ccc-cCCccccCCCCCCEEEccCCccccc----CCccccCCCCCCEEEccCCccc----CCCCcccccC
Q 008012 7 LQGIGLADNH-LQG-SIPYDLCQLKRLNSLSLQGNKLNGS----IPTCLASLTSLRELRLNSNKLT----SSIPSALWAL 76 (581)
Q Consensus 7 L~~L~l~~n~-l~~-~~~~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l 76 (581)
|++|+|++|. ++. .++....++++|++|+|++|.+++. ++..+.++++|++|+|++|.++ +.++..+.++
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~ 219 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC
Confidence 6666666664 211 1122233566666666666666543 2223445566666666666665 2233344556
Q ss_pred CCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCC---CCCcccccCcccccceeccccccccccCccccCccccce
Q 008012 77 EYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLS---GDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLES 153 (581)
Q Consensus 77 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~---~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~ 153 (581)
++|++|++++|.+.+ ++..+..+++|++|+++++... ...+..+..+++|+.|+++++... .+|..+..+++|++
T Consensus 220 ~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~ 297 (592)
T 3ogk_B 220 RSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRK 297 (592)
T ss_dssp TTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCE
T ss_pred CCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcE
Confidence 666666666666652 4455555555555555532211 122223344444444444443222 23334444444444
Q ss_pred eeccccccCCCCc-hhhhcccccCeeEcc
Q 008012 154 LDLSSNNLSEGIP-KSLVALSHLKQFNVS 181 (581)
Q Consensus 154 L~l~~N~l~~~~~-~~~~~l~~L~~l~l~ 181 (581)
|+|++|.+++... ..+..+++|+.|+++
T Consensus 298 L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~ 326 (592)
T 3ogk_B 298 LDLLYALLETEDHCTLIQKCPNLEVLETR 326 (592)
T ss_dssp EEETTCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred EecCCCcCCHHHHHHHHHhCcCCCEEecc
Confidence 4444444332111 123344444444444
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.4e-15 Score=151.05 Aligned_cols=169 Identities=22% Similarity=0.191 Sum_probs=125.5
Q ss_pred CCCCcEEEeecCcccccCCccccCC-----CCCCEEEccCCcccccCCccc-cCCCCCCEEEccCCcccCCCCccc----
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQL-----KRLNSLSLQGNKLNGSIPTCL-ASLTSLRELRLNSNKLTSSIPSAL---- 73 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~l~~n~i~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~---- 73 (581)
+++|++|+|++|.|+......+..+ ++|++|+|++|.|+......+ ..+++|+.|+|++|+|++.....+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 3678999999999986544444333 799999999999985433333 346789999999999985444443
Q ss_pred -ccCCCCcEEecccCcCCCC----CCccccCCccCcEEeCCCCcCCCCC----cccccCcccccceecccccccccc---
Q 008012 74 -WALEYILYVNLSSNYLTGS----LTSDIQNMKVLIDLDLSRNQLSGDI----PKTIAGLKDLTNLSLAGNQFQGPI--- 141 (581)
Q Consensus 74 -~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~~N~i~~~~--- 141 (581)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|++.. +..+...++|+.|+|++|.|++..
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 2468899999999998742 3345577899999999999987432 456677889999999999998643
Q ss_pred -CccccCccccceeeccccccCCCCchhhhcc
Q 008012 142 -PESFGSLISLESLDLSSNNLSEGIPKSLVAL 172 (581)
Q Consensus 142 -~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 172 (581)
+..+...++|++|+|++|.|++.....+..+
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 262 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSSEGRQVLRDL 262 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCHHHHHHHHHC
T ss_pred HHHHHHhCCCCCEEeccCCCCCHHHHHHHHHH
Confidence 3345567899999999999986555555443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.41 E-value=1.3e-12 Score=133.26 Aligned_cols=172 Identities=15% Similarity=0.136 Sum_probs=110.7
Q ss_pred CCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecc
Q 008012 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85 (581)
Q Consensus 6 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 85 (581)
+|+.+.|.++ ++.+...+|.++ +|+.++|.. .++.+.+.+|.++++|+.++|++|+++......|. ..+|+.+.+.
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp 211 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLP 211 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECC
T ss_pred CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeC
Confidence 5777777655 655666666663 577777765 56656667777777777777777777644444444 5677777776
Q ss_pred cCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccC---
Q 008012 86 SNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS--- 162 (581)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~--- 162 (581)
.| ++.....+|.+|++|+.+++.+| ++......|.+ .+|+.++| .|.++.+....|.++++|+.+++.+|.+.
T Consensus 212 ~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~ 287 (401)
T 4fdw_A 212 VT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDP 287 (401)
T ss_dssp TT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCT
T ss_pred Cc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCc
Confidence 44 55455667777777777777664 44344455555 56777777 34455555666777777777777776654
Q ss_pred --CCCchhhhcccccCeeEccCCCCC
Q 008012 163 --EGIPKSLVALSHLKQFNVSHNRLE 186 (581)
Q Consensus 163 --~~~~~~~~~l~~L~~l~l~~n~l~ 186 (581)
.+.+..|.++++|+.+++.+ .++
T Consensus 288 ~~~I~~~aF~~c~~L~~l~l~~-~i~ 312 (401)
T 4fdw_A 288 EAMIHPYCLEGCPKLARFEIPE-SIR 312 (401)
T ss_dssp TCEECTTTTTTCTTCCEECCCT-TCC
T ss_pred ccEECHHHhhCCccCCeEEeCC-ceE
Confidence 34556677777777777763 344
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=6.3e-13 Score=128.09 Aligned_cols=147 Identities=15% Similarity=0.114 Sum_probs=115.7
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-CCccceEeeeeecCCeeeEE
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 365 (581)
....++|++...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++.+.+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 345567888888898999999999865 6899999987532222245888999999994 67788999999888899999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH------------------------------------- 408 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------------------------------------- 408 (581)
|||++|.+|.+.+. +......++.+++++++.||...
T Consensus 89 ~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 89 MSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 99999999987632 12234478899999999999510
Q ss_pred -------------------CCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 409 -------------------STPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 409 -------------------~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
...++|||++|.||+++++..+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14589999999999998766677999997753
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.33 E-value=4.8e-14 Score=152.80 Aligned_cols=204 Identities=17% Similarity=0.153 Sum_probs=139.2
Q ss_pred CCCCCcEEEeecCcccccCC-ccccCCCCCCEEEccCCccccc-CCccccCCCCCCEEEc---------cCCcccCCCCc
Q 008012 3 RMQQLQGIGLADNHLQGSIP-YDLCQLKRLNSLSLQGNKLNGS-IPTCLASLTSLRELRL---------NSNKLTSSIPS 71 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~i~~~-~~~~~~~l~~L~~L~L---------~~N~l~~~~~~ 71 (581)
.+++|++|+|++|.++.... ..+..+++|++|++++| ++.. .+.....+++|++|+| +.|.+++....
T Consensus 287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~ 365 (594)
T 2p1m_B 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLV 365 (594)
T ss_dssp HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHH
T ss_pred hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHH
Confidence 46889999999999875432 33668899999999998 5522 2223345889999988 34555533222
Q ss_pred cc-ccCCCCcEEecccCcCCCCCCcccc-CCccCcEEeCC--C----CcCCCCC-----cccccCcccccceeccccccc
Q 008012 72 AL-WALEYILYVNLSSNYLTGSLTSDIQ-NMKVLIDLDLS--R----NQLSGDI-----PKTIAGLKDLTNLSLAGNQFQ 138 (581)
Q Consensus 72 ~~-~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~--~----N~l~~~~-----~~~~~~l~~L~~L~l~~N~i~ 138 (581)
.+ .++++|++|.++.|.+++.....+. .+++|++|+++ + |.+++.. +..+.++++|+.|+|++ .++
T Consensus 366 ~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~ 444 (594)
T 2p1m_B 366 SVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLT 444 (594)
T ss_dssp HHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCC
T ss_pred HHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-ccc
Confidence 23 3488899998888888855555554 58889999998 4 5565211 12256778899999977 666
Q ss_pred cccCccccC-ccccceeeccccccCCCCchhh-hcccccCeeEccCCCCCCCCCC--CCCCcCCcccccccccc
Q 008012 139 GPIPESFGS-LISLESLDLSSNNLSEGIPKSL-VALSHLKQFNVSHNRLEGEIPT--EGPFRNFSAQSFHWNYA 208 (581)
Q Consensus 139 ~~~~~~~~~-l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~l~l~~n~l~~~~~~--~~~~~~~~~~~~~~n~~ 208 (581)
+..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|+++..... ...+..++.+.+.+|+.
T Consensus 445 ~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 445 DKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 555555554 7889999999998876544444 6688899999999988532221 13456777777776643
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.30 E-value=1.7e-13 Score=148.47 Aligned_cols=154 Identities=14% Similarity=0.177 Sum_probs=85.2
Q ss_pred CCCCCcEEEeecCcccc---cCC------------ccccCCCCCCEEEccCCcccccCCcccc-CCCCCCEEEccCC-cc
Q 008012 3 RMQQLQGIGLADNHLQG---SIP------------YDLCQLKRLNSLSLQGNKLNGSIPTCLA-SLTSLRELRLNSN-KL 65 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~---~~~------------~~~~~l~~L~~L~l~~n~i~~~~~~~~~-~l~~L~~L~L~~N-~l 65 (581)
++++|++|+|++|.... ..| ..+..+++|++|+|++|.+++..+..+. .+++|++|+|++| .+
T Consensus 64 ~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~ 143 (594)
T 2p1m_B 64 RFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGF 143 (594)
T ss_dssp HCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEE
T ss_pred hCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCC
Confidence 46677777777764211 111 1134566777777777776655555554 5677777777766 44
Q ss_pred cCC-CCcccccCCCCcEEecccCcCCCCCCcccc----CCccCcEEeCCCCc--CCC-CCcccccCcccccceecccc-c
Q 008012 66 TSS-IPSALWALEYILYVNLSSNYLTGSLTSDIQ----NMKVLIDLDLSRNQ--LSG-DIPKTIAGLKDLTNLSLAGN-Q 136 (581)
Q Consensus 66 ~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~----~l~~L~~L~l~~N~--l~~-~~~~~~~~l~~L~~L~l~~N-~ 136 (581)
++. ++..+.++++|++|++++|.+++..+..+. .+++|++|++++|. +.. .++..+.++++|+.|+|++| .
T Consensus 144 ~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~ 223 (594)
T 2p1m_B 144 STDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVP 223 (594)
T ss_dssp EHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSC
T ss_pred CHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCc
Confidence 422 334444677777777777776644433332 45577777777765 210 01111234567777777766 3
Q ss_pred cccccCccccCccccceeecc
Q 008012 137 FQGPIPESFGSLISLESLDLS 157 (581)
Q Consensus 137 i~~~~~~~~~~l~~L~~L~l~ 157 (581)
+++ ++..+..+++|+.|+++
T Consensus 224 ~~~-l~~~~~~~~~L~~L~l~ 243 (594)
T 2p1m_B 224 LEK-LATLLQRAPQLEELGTG 243 (594)
T ss_dssp HHH-HHHHHHHCTTCSEEECS
T ss_pred HHH-HHHHHhcCCcceEcccc
Confidence 333 44445555555555543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.27 E-value=5.1e-12 Score=121.51 Aligned_cols=142 Identities=15% Similarity=0.072 Sum_probs=103.6
Q ss_pred HHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCc--cceEeeeeecCCeeeE
Q 008012 287 ERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRN--LIKILSSCCNTNFKAL 364 (581)
Q Consensus 287 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~l 364 (581)
.....+|.+....+.|..+.||++...+|+.+++|+..... ...+.+|+++++.+.+.+ +.+++++....+..++
T Consensus 16 ~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 16 VERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred HHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 33445555533334566699999987778889999976542 245678999999985434 5568888888888999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH------------------------------------ 408 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------------------------------------ 408 (581)
||||++|.++. ... .+ ...++.++++.|..||...
T Consensus 93 v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 99999998884 211 11 2357788888888888421
Q ss_pred -------------------CCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 409 -------------------STPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 409 -------------------~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..+++|+|++|.||++++++.+.|+|||.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999998764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.1e-11 Score=124.31 Aligned_cols=63 Identities=27% Similarity=0.384 Sum_probs=28.5
Q ss_pred cccccceeccccccccccCccc---cCccccceeeccccccCCC----CchhhhcccccCeeEccCCCCC
Q 008012 124 LKDLTNLSLAGNQFQGPIPESF---GSLISLESLDLSSNNLSEG----IPKSLVALSHLKQFNVSHNRLE 186 (581)
Q Consensus 124 l~~L~~L~l~~N~i~~~~~~~~---~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~n~l~ 186 (581)
+++|+.|+|.+|.+++..+..+ ..+++|+.|+|+.|.+++. ++..+..+++|+.|++++|.++
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 4455555555555543222221 1345555555555555432 1222234455555555555443
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=3.2e-10 Score=114.45 Aligned_cols=143 Identities=16% Similarity=0.192 Sum_probs=107.0
Q ss_pred CcCCeecccccccEEEEEeCCCcEEEEEEec--cch-HHHHHHHHHHHHHHHhcC--CCccceEeeeeecC---CeeeEE
Q 008012 294 NECNLLGSGGFGSVYKGILSDGTTVAIKIFN--LQL-EQAFRSFNSECEVLRNVR--HRNLIKILSSCCNT---NFKALV 365 (581)
Q Consensus 294 ~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv 365 (581)
..++.++.|.++.||++... +..+++|+.. ... ......+.+|+++++.+. +..+.+++.++.+. +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34578999999999999876 4678899876 332 122356888999999996 45678889888776 458999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH------------------------------------- 408 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------------------------------------- 408 (581)
|||++|..+.+.. -..++......++.+++++|+.||...
T Consensus 120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999998774311 122467788889999999999999520
Q ss_pred ------------------CCCceecCCCCCCeEecCCCc--EEEeeccCcee
Q 008012 409 ------------------STPVVHCDLKPSNILLDENMV--AHVSDFGISKL 440 (581)
Q Consensus 409 ------------------~~~i~H~dikp~Nill~~~~~--~kl~Dfg~a~~ 440 (581)
...++|||+++.||+++.++. +.++||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997653 68999998875
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.08 E-value=5.1e-11 Score=119.36 Aligned_cols=177 Identities=16% Similarity=0.188 Sum_probs=119.2
Q ss_pred CCCCCcEEEeecCccc---------ccCCccccCCCCCCEEEccCCc-ccccCCccccCCCCCCEEEccCCcccCCCCcc
Q 008012 3 RMQQLQGIGLADNHLQ---------GSIPYDLCQLKRLNSLSLQGNK-LNGSIPTCLASLTSLRELRLNSNKLTSSIPSA 72 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~---------~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 72 (581)
+|++|+.|.+.++... +.+...+..+|+|+.|+|++|. ++ .+. +. +++|+.|+|..|.++......
T Consensus 137 ~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~ 212 (362)
T 2ra8_A 137 KFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSVVED 212 (362)
T ss_dssp HHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHHHHH
T ss_pred hcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHHHHH
Confidence 4678999998765432 1244556778999999999884 33 233 43 789999999988886443333
Q ss_pred cc--cCCCCcEEeccc--CcCCCC-----CCccc--cCCccCcEEeCCCCcCCCCCccccc---Ccccccceeccccccc
Q 008012 73 LW--ALEYILYVNLSS--NYLTGS-----LTSDI--QNMKVLIDLDLSRNQLSGDIPKTIA---GLKDLTNLSLAGNQFQ 138 (581)
Q Consensus 73 ~~--~l~~L~~L~l~~--n~l~~~-----~~~~~--~~l~~L~~L~l~~N~l~~~~~~~~~---~l~~L~~L~l~~N~i~ 138 (581)
+. .+|+|+.|+|+. |...+. +...+ ..+++|++|+|++|.+.+..+..+. .+++|+.|+|+.|.|+
T Consensus 213 l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~ 292 (362)
T 2ra8_A 213 ILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292 (362)
T ss_dssp HHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCB
T ss_pred HHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCC
Confidence 43 689999999863 222111 11122 2478999999999998744433343 5789999999999998
Q ss_pred ccc----CccccCccccceeeccccccCCCCchhhhcccccCeeEccCCC
Q 008012 139 GPI----PESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNR 184 (581)
Q Consensus 139 ~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~ 184 (581)
+.. +..+..+++|+.|+|++|.+++..-..+...- ...+++++++
T Consensus 293 d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al-g~~~~~~~~~ 341 (362)
T 2ra8_A 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL-PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC-CSEEECCSBC
T ss_pred hHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc-CCEEEecCCc
Confidence 643 33345678999999999988754444444311 3568888877
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.03 E-value=1e-10 Score=115.11 Aligned_cols=188 Identities=14% Similarity=0.139 Sum_probs=123.1
Q ss_pred CCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCc--cceEeeeeecCC---eeeEEEecc
Q 008012 296 CNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRN--LIKILSSCCNTN---FKALVLEFM 369 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~--iv~~~~~~~~~~---~~~lv~e~~ 369 (581)
++.++.|.+..||++. ..+++|+.... .....+.+|+++++.+ .+.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4678999999999863 56899986543 3346788999999988 3332 345555543333 358999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 008012 370 PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH----------------------------------------- 408 (581)
Q Consensus 370 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------- 408 (581)
+|.++.+.... .++.+++..++.+++..++.||...
T Consensus 99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99988764332 2466777888888888888888410
Q ss_pred --------------CCCceecCCCCCCeEecC--CCcEEEeeccCceecCCCCCcceeecc---ccC-------ccc--c
Q 008012 409 --------------STPVVHCDLKPSNILLDE--NMVAHVSDFGISKLLGEGDDSVIQTMT---IAT-------IGY--M 460 (581)
Q Consensus 409 --------------~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~---~~~-------~~y--~ 460 (581)
...++|+|++|.||++++ +..+.++||+.+..-.+..+-...... .+. ..| .
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 135799999999999998 566889999998754221110000000 000 001 1
Q ss_pred C-CCCCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Q 008012 461 A-PEFGSEGNVSSKCDVYSYGILLLETFTRKKPTD 494 (581)
Q Consensus 461 a-PE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~ 494 (581)
. |+... ......+.|++|.++|.+.+|..+|.
T Consensus 256 ~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 256 DIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 11110 01123689999999999999988753
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.77 E-value=4.7e-08 Score=99.77 Aligned_cols=106 Identities=11% Similarity=0.243 Sum_probs=63.1
Q ss_pred cccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhccccc
Q 008012 96 DIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHL 175 (581)
Q Consensus 96 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 175 (581)
+|.++..|+.+.+.++..+ .....|.++++|+.+.+. +.++.+....|.++.+|+.++|..+ ++.+...+|.++.+|
T Consensus 260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L 336 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQL 336 (394)
T ss_dssp TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred eeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCC
Confidence 5666777888887665543 445566677777777775 3455455566777777777777654 444556667777777
Q ss_pred CeeEccCCCCCCCCCCC--CCCcCCcccccccc
Q 008012 176 KQFNVSHNRLEGEIPTE--GPFRNFSAQSFHWN 206 (581)
Q Consensus 176 ~~l~l~~n~l~~~~~~~--~~~~~~~~~~~~~n 206 (581)
+.+.+..+ ++ .+... .....|..+.+.++
T Consensus 337 ~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~ 367 (394)
T 4gt6_A 337 ERIAIPSS-VT-KIPESAFSNCTALNNIEYSGS 367 (394)
T ss_dssp CEEEECTT-CC-BCCGGGGTTCTTCCEEEESSC
T ss_pred CEEEECcc-cC-EEhHhHhhCCCCCCEEEECCc
Confidence 77776443 43 22221 33344555555443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.77 E-value=2.1e-08 Score=102.32 Aligned_cols=175 Identities=21% Similarity=0.151 Sum_probs=119.7
Q ss_pred CCCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcc---------------
Q 008012 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKL--------------- 65 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l--------------- 65 (581)
|.++++|+.+.+.++-. .+....|.++.+|+.+++..| ++.+...+|.++..|+.+.+..+..
T Consensus 158 F~~c~~L~~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~~~~~~~~l~~i 235 (394)
T 4fs7_A 158 FATCESLEYVSLPDSME-TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGDFALSKTGVKNI 235 (394)
T ss_dssp TTTCTTCCEEECCTTCC-EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCCCCEE
T ss_pred hcccCCCcEEecCCccc-eeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEeehhhcccCCCceE
Confidence 45678899999986644 477788999999999999876 5556667777777777666554321
Q ss_pred ------cCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceecccccccc
Q 008012 66 ------TSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQG 139 (581)
Q Consensus 66 ------~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~ 139 (581)
+......|..+..|+.+.+..+... .....|..+..|+.+.+..+.+. ...|.++.+|+.+.+.++ ++.
T Consensus 236 ~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~ 310 (394)
T 4fs7_A 236 IIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKF 310 (394)
T ss_dssp EECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCE
T ss_pred EECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cce
Confidence 1123456778888999998887654 55667777777777777665543 235666777777777654 554
Q ss_pred ccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCC
Q 008012 140 PIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHN 183 (581)
Q Consensus 140 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n 183 (581)
+....|.++.+|+.++|.++ ++.+...+|.++++|+.+.+..|
T Consensus 311 I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 311 IGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp ECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred echhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 55566777777777777644 55556666777777777777655
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.74 E-value=1.1e-09 Score=99.01 Aligned_cols=92 Identities=17% Similarity=0.252 Sum_probs=46.6
Q ss_pred ccccCCCCCCEEEccCC-ccccc----CCccccCCCCCCEEEccCCcccCC----CCcccccCCCCcEEecccCcCCCC-
Q 008012 23 YDLCQLKRLNSLSLQGN-KLNGS----IPTCLASLTSLRELRLNSNKLTSS----IPSALWALEYILYVNLSSNYLTGS- 92 (581)
Q Consensus 23 ~~~~~l~~L~~L~l~~n-~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~- 92 (581)
..+...+.|++|+|++| .|+.. +...+...++|++|+|++|+|.+. +...+...+.|++|+|++|.|...
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 34455566666666666 65522 233444555666666666666532 222333445555555555555521
Q ss_pred ---CCccccCCccCcEEeC--CCCcCC
Q 008012 93 ---LTSDIQNMKVLIDLDL--SRNQLS 114 (581)
Q Consensus 93 ---~~~~~~~l~~L~~L~l--~~N~l~ 114 (581)
+..++...+.|++|+| ++|.|.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 2233444455555555 445554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.74 E-value=5.1e-08 Score=99.47 Aligned_cols=159 Identities=12% Similarity=0.045 Sum_probs=106.5
Q ss_pred cCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCc-----------
Q 008012 20 SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNY----------- 88 (581)
Q Consensus 20 ~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~----------- 88 (581)
+....|.++.+|+.+.+.++-.+ +...+|.++++|+.+.+..| ++......|.++..|+.+.+..+.
T Consensus 153 i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~~~~~~~ 230 (394)
T 4fs7_A 153 IGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGDFALSKT 230 (394)
T ss_dssp ECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTC
T ss_pred cchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEeehhhcccC
Confidence 45567888888888888765433 66778888888888888766 444455566666666665554432
Q ss_pred ----------CCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccc
Q 008012 89 ----------LTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSS 158 (581)
Q Consensus 89 ----------l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~ 158 (581)
++.....+|..+..|+.+.+..+... .....|.++..|+.+.+..+.+. ...|..+.+|+.+.+.+
T Consensus 231 ~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~ 306 (394)
T 4fs7_A 231 GVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLD 306 (394)
T ss_dssp CCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECT
T ss_pred CCceEEECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---ccccccccccccccccc
Confidence 11122345667788888888777554 55567777888887777665433 34677788888888866
Q ss_pred cccCCCCchhhhcccccCeeEccCCCCC
Q 008012 159 NNLSEGIPKSLVALSHLKQFNVSHNRLE 186 (581)
Q Consensus 159 N~l~~~~~~~~~~l~~L~~l~l~~n~l~ 186 (581)
+ ++.+...+|.++.+|+.+++..+ ++
T Consensus 307 ~-i~~I~~~aF~~c~~L~~i~lp~~-v~ 332 (394)
T 4fs7_A 307 S-VKFIGEEAFESCTSLVSIDLPYL-VE 332 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEECCCTT-CC
T ss_pred c-cceechhhhcCCCCCCEEEeCCc-cc
Confidence 5 55566677888888888887544 44
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.73 E-value=1.4e-09 Score=98.24 Aligned_cols=113 Identities=16% Similarity=0.224 Sum_probs=89.2
Q ss_pred CCCCCCcEEEeecC-ccccc----CCccccCCCCCCEEEccCCccccc----CCccccCCCCCCEEEccCCcccCC----
Q 008012 2 GRMQQLQGIGLADN-HLQGS----IPYDLCQLKRLNSLSLQGNKLNGS----IPTCLASLTSLRELRLNSNKLTSS---- 68 (581)
Q Consensus 2 ~~~~~L~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~---- 68 (581)
...+.|++|+|++| .|+.. +...+...++|++|+|++|.|+.. +...+...++|++|+|++|.|++.
T Consensus 33 ~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~ 112 (185)
T 1io0_A 33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 112 (185)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHH
Confidence 45688999999999 88743 345677789999999999999843 345566678999999999999853
Q ss_pred CCcccccCCCCcEEec--ccCcCCCCC----CccccCCccCcEEeCCCCcCC
Q 008012 69 IPSALWALEYILYVNL--SSNYLTGSL----TSDIQNMKVLIDLDLSRNQLS 114 (581)
Q Consensus 69 ~~~~~~~l~~L~~L~l--~~n~l~~~~----~~~~~~l~~L~~L~l~~N~l~ 114 (581)
+...+...+.|++|+| ++|.|.... ...+...+.|++|+|++|.+.
T Consensus 113 l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 113 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4566778889999999 889998432 334556688888888888875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=2.2e-07 Score=89.43 Aligned_cols=136 Identities=18% Similarity=0.125 Sum_probs=102.3
Q ss_pred Ceecccccc-cEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-CCccceEeeeeecCCeeeEEEeccCCCC
Q 008012 297 NLLGSGGFG-SVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKALVLEFMPNGS 373 (581)
Q Consensus 297 ~~lg~G~~~-~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 373 (581)
+.+..|..+ .||+.... ++..+++|+-.... ...+.+|...++.+. +--+.++++++.+.+..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~---~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGSV---ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETHH---HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCCC---HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345566665 58988754 56789999866543 346778999999883 3346788899988899999999999998
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 008012 374 LDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG---------------------------------------------- 407 (581)
Q Consensus 374 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~---------------------------------------------- 407 (581)
+.+..... ......+..+++..|..||..
T Consensus 107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 88766542 123446778888888888831
Q ss_pred ---------CCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 408 ---------HSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 408 ---------~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
....++|+|+.+.||++++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999887778999998764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.66 E-value=1.9e-09 Score=102.32 Aligned_cols=79 Identities=25% Similarity=0.405 Sum_probs=40.4
Q ss_pred CCccCcEEeCCCCcCCC--CCcccccCcccccceeccccccccccCccccCcc--ccceeeccccccCCCCc-------h
Q 008012 99 NMKVLIDLDLSRNQLSG--DIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLI--SLESLDLSSNNLSEGIP-------K 167 (581)
Q Consensus 99 ~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~-------~ 167 (581)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++..| .
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 34555555555555554 2223444555555555555555543 1222222 56666666666654333 2
Q ss_pred hhhcccccCeeE
Q 008012 168 SLVALSHLKQFN 179 (581)
Q Consensus 168 ~~~~l~~L~~l~ 179 (581)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 245566666654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.65 E-value=2.5e-09 Score=101.57 Aligned_cols=105 Identities=26% Similarity=0.277 Sum_probs=69.1
Q ss_pred ccCCCCCCE--EEccCCccc---CCCCcccccCCCCcEEecccCcCCC--CCCccccCCccCcEEeCCCCcCCCCCcccc
Q 008012 49 LASLTSLRE--LRLNSNKLT---SSIPSALWALEYILYVNLSSNYLTG--SLTSDIQNMKVLIDLDLSRNQLSGDIPKTI 121 (581)
Q Consensus 49 ~~~l~~L~~--L~L~~N~l~---~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 121 (581)
|...+.|.. ++++.|+.. ...+-...++++|++|+|++|+|++ .++..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 444455555 566677443 1122223567788888888888886 3345566788888888888888753 334
Q ss_pred cCcc--cccceeccccccccccC-------ccccCccccceee
Q 008012 122 AGLK--DLTNLSLAGNQFQGPIP-------ESFGSLISLESLD 155 (581)
Q Consensus 122 ~~l~--~L~~L~l~~N~i~~~~~-------~~~~~l~~L~~L~ 155 (581)
..+. +|+.|+|++|++.+..| ..+..+|+|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 4444 78888888888876554 2356778888776
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.62 E-value=1.5e-07 Score=95.93 Aligned_cols=111 Identities=16% Similarity=0.246 Sum_probs=93.0
Q ss_pred cccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccc
Q 008012 71 SALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLIS 150 (581)
Q Consensus 71 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~ 150 (581)
.+|.++.+|+.+.+.++..+ ....+|.+++.|+.+.+. +.++......|.++.+|+.++|..+ ++.+....|.++.+
T Consensus 259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~ 335 (394)
T 4gt6_A 259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ 335 (394)
T ss_dssp TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred ceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC
Confidence 46778899999999877655 667889999999999996 4566466678999999999999865 66567788999999
Q ss_pred cceeeccccccCCCCchhhhcccccCeeEccCCCC
Q 008012 151 LESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRL 185 (581)
Q Consensus 151 L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l 185 (581)
|+.+.|..+ ++.+...+|.++++|+.+++.+|..
T Consensus 336 L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 336 LERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp CCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred CCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 999999765 7777888999999999999998854
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=4.1e-07 Score=89.19 Aligned_cols=136 Identities=14% Similarity=0.078 Sum_probs=95.8
Q ss_pred CCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCC---ccceEeeeee-cCCeeeEEEeccCC
Q 008012 296 CNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHR---NLIKILSSCC-NTNFKALVLEFMPN 371 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~ 371 (581)
++.++.|....||+. +..+++|+... ......+.+|+++++.+.+. .+.+++.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899988 57788998543 23446788999999999642 3556666664 45567899999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG-------------------------------------------- 407 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------------------------------------------- 407 (581)
.++.+..... ++......++.++++.|+.||..
T Consensus 98 ~~l~~~~~~~---l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGMAV---LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHHTT---SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhhhh---CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 8887632211 24445555666666666666632
Q ss_pred -------------CCCCceecCCCCCCeEecC---CCc-EEEeeccCcee
Q 008012 408 -------------HSTPVVHCDLKPSNILLDE---NMV-AHVSDFGISKL 440 (581)
Q Consensus 408 -------------~~~~i~H~dikp~Nill~~---~~~-~kl~Dfg~a~~ 440 (581)
....++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1335699999999999987 455 58999998764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.52 E-value=6e-07 Score=90.96 Aligned_cols=153 Identities=14% Similarity=0.139 Sum_probs=94.2
Q ss_pred ccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCc
Q 008012 25 LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLI 104 (581)
Q Consensus 25 ~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 104 (581)
+.....+..+.+..+.-. ....+|....+|+.+.+..+ ++......|.++..|+.+.+..+ ++.....+|.++..|+
T Consensus 190 ~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~ 266 (379)
T 4h09_A 190 YPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALK 266 (379)
T ss_dssp CCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred ccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhc
Confidence 444555555555543333 45566666777777776544 33345556667777777777655 4434555667777777
Q ss_pred EEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccC
Q 008012 105 DLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSH 182 (581)
Q Consensus 105 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~ 182 (581)
.+.+..+ ++......|.++++|+.+.+.++.++.+....|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..
T Consensus 267 ~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 267 TLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp EEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred ccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 7777544 44344455667777777777777666555666777777777777654 5555566677777777766643
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.50 E-value=6.3e-07 Score=90.81 Aligned_cols=162 Identities=10% Similarity=0.081 Sum_probs=118.6
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
..+..+.+....- ......+..+.+|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++.....+|.++.+|+.+.+
T Consensus 194 ~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l 270 (379)
T 4h09_A 194 KTGTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNF 270 (379)
T ss_dssp CCCSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEE
T ss_pred cccccccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccc
Confidence 3445555544333 255667777888888888765 45467788888888998888766 65566778888888888888
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEG 164 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~ 164 (581)
..+ +......+|.+|++|+.+.+.++.++......|.++.+|+.++|..+ ++.+....|.++.+|+.+.+..+ ++.+
T Consensus 271 ~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I 347 (379)
T 4h09_A 271 YAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLI 347 (379)
T ss_dssp CCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEE
T ss_pred ccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEE
Confidence 654 55455668888889999998888887566677888888988888755 66566678888888988888765 5555
Q ss_pred Cchhhhcc
Q 008012 165 IPKSLVAL 172 (581)
Q Consensus 165 ~~~~~~~l 172 (581)
...+|.+.
T Consensus 348 ~~~aF~~c 355 (379)
T 4h09_A 348 ESGAFEGS 355 (379)
T ss_dssp CTTTTTTS
T ss_pred chhHhhCC
Confidence 56666554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=5.8e-07 Score=90.29 Aligned_cols=80 Identities=6% Similarity=-0.033 Sum_probs=55.5
Q ss_pred CCee-cccccccEEEEEeC-------CCcEEEEEEeccchH---HHHHHHHHHHHHHHhcC-C--CccceEeeeeecC--
Q 008012 296 CNLL-GSGGFGSVYKGILS-------DGTTVAIKIFNLQLE---QAFRSFNSECEVLRNVR-H--RNLIKILSSCCNT-- 359 (581)
Q Consensus 296 ~~~l-g~G~~~~v~~~~~~-------~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~-- 359 (581)
.+.| +.|....+|+.... +++.+++|+...... .....+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88888999998754 267899998754320 01135677888888883 2 3567788877655
Q ss_pred -CeeeEEEeccCCCCHH
Q 008012 360 -NFKALVLEFMPNGSLD 375 (581)
Q Consensus 360 -~~~~lv~e~~~~~~L~ 375 (581)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.11 E-value=2.2e-05 Score=78.03 Aligned_cols=138 Identities=18% Similarity=0.173 Sum_probs=79.0
Q ss_pred CeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcC--CCccceEee------eeecCCeeeEEEec
Q 008012 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR--HRNLIKILS------SCCNTNFKALVLEF 368 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~------~~~~~~~~~lv~e~ 368 (581)
+.|+.|..+.||++...+| .+++|+..... ..+..|..+++.+. .-.+.+++. +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987644 58999987632 22334555555542 112333332 12345678999999
Q ss_pred cCCCCHH-----------H---HHhh--CCC--C---------CCHHHH-------------------------------
Q 008012 369 MPNGSLD-----------K---WLYS--HNY--F---------QDIPDR------------------------------- 390 (581)
Q Consensus 369 ~~~~~L~-----------~---~l~~--~~~--~---------~~~~~~------------------------------- 390 (581)
++|.++. . .++. ... . ..|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 1 1111 100 0 112110
Q ss_pred HHHHHHHHHHHHHHhc----------CCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 391 LNIMIDVALALEYLHH----------GHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 391 ~~i~~~i~~~L~~LH~----------~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
..+..++..++++|+. .....++|||+++.||+++.++.+.++||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223345666652 025789999999999999888899999999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=8.2e-06 Score=83.08 Aligned_cols=75 Identities=17% Similarity=0.220 Sum_probs=49.6
Q ss_pred CCeecccccccEEEEEeC-CCcEEEEEEeccchH-------HHHHHHHHHHHHHHhcC-C-Cc-cceEeeeeecCCeeeE
Q 008012 296 CNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE-------QAFRSFNSECEVLRNVR-H-RN-LIKILSSCCNTNFKAL 364 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~-h-~~-iv~~~~~~~~~~~~~l 364 (581)
.+.+|.|..+.||++... +++.+++|....... ....++..|.++++.+. + |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 578899998654321 01235677999988873 2 33 4455544 3445689
Q ss_pred EEeccCCC
Q 008012 365 VLEFMPNG 372 (581)
Q Consensus 365 v~e~~~~~ 372 (581)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999774
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.10 E-value=6.5e-07 Score=78.71 Aligned_cols=83 Identities=10% Similarity=0.128 Sum_probs=39.8
Q ss_pred CCcEEecccCcCCCCCCccccCCccCcEEeCCCCc-CCCCCcccccCc----ccccceecccc-ccccccCccccCcccc
Q 008012 78 YILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQ-LSGDIPKTIAGL----KDLTNLSLAGN-QFQGPIPESFGSLISL 151 (581)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l----~~L~~L~l~~N-~i~~~~~~~~~~l~~L 151 (581)
+|+.|+++++.|+...-..+..|++|++|+|++|. |++..-..++.+ ++|+.|+|++| +|++..-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 35555555555443333344455555555555553 443222333332 24555555555 2544333444555556
Q ss_pred ceeeccccc
Q 008012 152 ESLDLSSNN 160 (581)
Q Consensus 152 ~~L~l~~N~ 160 (581)
+.|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666655553
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.08 E-value=8.5e-07 Score=77.96 Aligned_cols=93 Identities=13% Similarity=0.128 Sum_probs=74.6
Q ss_pred CccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccc-cccccCccccCc----cccceeeccccc-cCCCCch
Q 008012 94 TSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQ-FQGPIPESFGSL----ISLESLDLSSNN-LSEGIPK 167 (581)
Q Consensus 94 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~-i~~~~~~~~~~l----~~L~~L~l~~N~-l~~~~~~ 167 (581)
|.....-..|++||++++.|+...-..+.++++|+.|+|++|. |++..-..++.+ ++|++|+|++|. +++..-.
T Consensus 54 P~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~ 133 (176)
T 3e4g_A 54 PTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGII 133 (176)
T ss_dssp CCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHH
T ss_pred CcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHH
Confidence 3333334679999999999987767778899999999999994 876555667664 479999999985 8876566
Q ss_pred hhhcccccCeeEccCCC-CC
Q 008012 168 SLVALSHLKQFNVSHNR-LE 186 (581)
Q Consensus 168 ~~~~l~~L~~l~l~~n~-l~ 186 (581)
.+..+++|+.|+++++. ++
T Consensus 134 ~L~~~~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 134 ALHHFRNLKYLFLSDLPGVK 153 (176)
T ss_dssp HGGGCTTCCEEEEESCTTCC
T ss_pred HHhcCCCCCEEECCCCCCCC
Confidence 78889999999999985 44
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.90 E-value=0.00011 Score=71.62 Aligned_cols=137 Identities=15% Similarity=0.078 Sum_probs=92.0
Q ss_pred cCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcC---CCccceEeeeeecCCeeeEEEeccCC
Q 008012 295 ECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR---HRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 295 ~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
..+.|+.|....+|+.... +..+++|+..... ...+..|++.++.+. ...+.+++++....+..++||||++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~~---~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERSY---RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGGG---HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCccc---HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3467899999999999864 6788999876543 356788999998883 36788889888888889999999998
Q ss_pred CCHH--------H---HHhhCCC---------------------CCCHHHHH---HHH----------------HHHHHH
Q 008012 372 GSLD--------K---WLYSHNY---------------------FQDIPDRL---NIM----------------IDVALA 400 (581)
Q Consensus 372 ~~L~--------~---~l~~~~~---------------------~~~~~~~~---~i~----------------~~i~~~ 400 (581)
..+. + .++.... .-+|.... ++. ..++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7642 1 1222111 01333221 011 112222
Q ss_pred H-HHHhc-CCCCCceecCCCCCCeEecCCCcEEEeecc
Q 008012 401 L-EYLHH-GHSTPVVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 401 L-~~LH~-~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
+ ..|.. .....++|+|+.+.|++++.++ +.++|++
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 23321 2246799999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.81 E-value=7.9e-05 Score=76.34 Aligned_cols=80 Identities=14% Similarity=0.112 Sum_probs=49.2
Q ss_pred CCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCC---CCCccccHHHHHHHHHH
Q 008012 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG---NVSSKCDVYSYGILLLE 485 (581)
Q Consensus 409 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~vl~e 485 (581)
...++|||++|.||+++.++ ++++||+.+..-.+..+-... ...-...|++|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 67899999999999998776 999999988753211110000 00001345666543311 11224566688888888
Q ss_pred HHhCC
Q 008012 486 TFTRK 490 (581)
Q Consensus 486 l~tg~ 490 (581)
.+++.
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.75 E-value=6.7e-05 Score=72.57 Aligned_cols=79 Identities=15% Similarity=0.105 Sum_probs=57.0
Q ss_pred CCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCC---CccceEeeeeecCCeeeEEEec
Q 008012 292 GFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRH---RNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
+...++.+|.|..+.||+++..+|+.|++|+...........+..|++.|+.+.. --+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 3445678999999999999999999999998765432223457789999998842 2345555542 24789999
Q ss_pred cCCCCH
Q 008012 369 MPNGSL 374 (581)
Q Consensus 369 ~~~~~L 374 (581)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00019 Score=70.89 Aligned_cols=139 Identities=12% Similarity=0.052 Sum_probs=74.3
Q ss_pred Ceeccccccc-EEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-C-CccceEeeeeecCCeeeEEEeccCCCC
Q 008012 297 NLLGSGGFGS-VYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-H-RNLIKILSSCCNTNFKALVLEFMPNGS 373 (581)
Q Consensus 297 ~~lg~G~~~~-v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~~iv~~~~~~~~~~~~~lv~e~~~~~~ 373 (581)
+.|+.|+... +|+....+++.+++|....... ..+..|+.+++.+. + -.+.+++.+....+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4566665554 6777654467788886544321 23445677776663 2 23556666543333 78999998777
Q ss_pred HHHHHhhCC-------------------------CCCCHHHHH-------HHH-------------HHHHHHHHHHh---
Q 008012 374 LDKWLYSHN-------------------------YFQDIPDRL-------NIM-------------IDVALALEYLH--- 405 (581)
Q Consensus 374 L~~~l~~~~-------------------------~~~~~~~~~-------~i~-------------~~i~~~L~~LH--- 405 (581)
+.+++.... ...+..... .+. ..+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 655443210 001111100 000 01111222221
Q ss_pred cCCCCCceecCCCCCCeEecCC----CcEEEeeccCcee
Q 008012 406 HGHSTPVVHCDLKPSNILLDEN----MVAHVSDFGISKL 440 (581)
Q Consensus 406 ~~~~~~i~H~dikp~Nill~~~----~~~kl~Dfg~a~~ 440 (581)
......++|||+.+.||+++.+ +.+.++||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1125679999999999999874 6899999998875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00023 Score=63.99 Aligned_cols=103 Identities=12% Similarity=0.026 Sum_probs=70.1
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 451 (581)
-+|.+.+...+.+++++++|.++.|.+.+|.-+-. .+.-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence 38999999999999999999999999999887721 11111333457899999999887763 1110
Q ss_pred ccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCC
Q 008012 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKP 492 (581)
Q Consensus 452 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~P 492 (581)
.....+.|||... ...+.+.=|||||+++|..+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1233566888763 3556788999999999999875554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00013 Score=71.15 Aligned_cols=129 Identities=16% Similarity=0.159 Sum_probs=76.6
Q ss_pred cCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCcc-ceEeeeeecCCeeeEEEecc-CCC
Q 008012 295 ECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNL-IKILSSCCNTNFKALVLEFM-PNG 372 (581)
Q Consensus 295 ~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~~~ 372 (581)
-++.|+.|....+|++ +.+++|+....... .....+|+.+++.+....+ .+++++. .+.-++++||+ +|.
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 3688999999999998 56889987654211 1123468887777732222 4555543 33457899999 665
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 008012 373 SLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHH---------------------------------------------- 406 (581)
Q Consensus 373 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~---------------------------------------------- 406 (581)
++....... ...+..++++.|+.||.
T Consensus 94 ~l~~~~~~~--------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 165 (301)
T 3dxq_A 94 TMSPEKFKT--------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSA 165 (301)
T ss_dssp ECCHHHHHH--------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHH
T ss_pred cCCHhhHhh--------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHH
Confidence 543210000 00012222222222221
Q ss_pred ----CCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 407 ----GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 407 ----~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
.....++|+|+.+.||+ ..++.+.++||..+..
T Consensus 166 l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 166 LAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 11345899999999999 5667889999998864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=8.5e-05 Score=62.14 Aligned_cols=36 Identities=33% Similarity=0.296 Sum_probs=18.4
Q ss_pred CCCEEEccCCcccCCCCcccccCCCCcEEecccCcC
Q 008012 54 SLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYL 89 (581)
Q Consensus 54 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l 89 (581)
+|+.|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 355555555555544444455555555555555544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.60 E-value=1.5e-05 Score=71.43 Aligned_cols=64 Identities=13% Similarity=0.239 Sum_probs=29.1
Q ss_pred CCCCCCEEEccCC-ccccc----CCccccCCCCCCEEEccCCcccCC----CCcccccCCCCcEEecccCcCC
Q 008012 27 QLKRLNSLSLQGN-KLNGS----IPTCLASLTSLRELRLNSNKLTSS----IPSALWALEYILYVNLSSNYLT 90 (581)
Q Consensus 27 ~l~~L~~L~l~~n-~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~ 90 (581)
+-+.|+.|+|++| .|... +.+++..-+.|+.|+|++|+|.+. +...+..-+.|++|+|++|.|.
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 3455555555553 44421 223344444555555555555422 1222223344555555555554
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.56 E-value=2.3e-05 Score=70.17 Aligned_cols=109 Identities=15% Similarity=0.096 Sum_probs=52.1
Q ss_pred CCCCcEEecccC-cCCC----CCCccccCCccCcEEeCCCCcCCCCC----cccccCcccccceecccccccccc----C
Q 008012 76 LEYILYVNLSSN-YLTG----SLTSDIQNMKVLIDLDLSRNQLSGDI----PKTIAGLKDLTNLSLAGNQFQGPI----P 142 (581)
Q Consensus 76 l~~L~~L~l~~n-~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~~N~i~~~~----~ 142 (581)
-+.|++|+|++| +|.. .+.+++..-+.|+.|+|++|.|.+.. .+.+..-+.|+.|+|+.|.|+... .
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 344555555543 4431 12233344455666666666554221 222333455666666666665322 2
Q ss_pred ccccCccccceeecccccc---CCC----CchhhhcccccCeeEccCCC
Q 008012 143 ESFGSLISLESLDLSSNNL---SEG----IPKSLVALSHLKQFNVSHNR 184 (581)
Q Consensus 143 ~~~~~l~~L~~L~l~~N~l---~~~----~~~~~~~l~~L~~l~l~~n~ 184 (581)
+.+..-+.|++|+|++|.. ... +...+..-+.|..|+++.|.
T Consensus 120 ~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 3344455677777765432 211 22334455666667665543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00012 Score=73.34 Aligned_cols=140 Identities=14% Similarity=0.148 Sum_probs=82.7
Q ss_pred CCeecccccccEEEEEeC--------CCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-CCccceEeeeeecCCeeeEEE
Q 008012 296 CNLLGSGGFGSVYKGILS--------DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++.+..|-...+|++... +++.+++|+..... .......+|.++++.+. +.-..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 467888889999999864 25789999864321 12345568999998883 3333566666543 2999
Q ss_pred eccCCCCHHH--------------HHh---hC----CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 008012 367 EFMPNGSLDK--------------WLY---SH----NYFQD--IPDRLNIMIDVAL-------------------ALEYL 404 (581)
Q Consensus 367 e~~~~~~L~~--------------~l~---~~----~~~~~--~~~~~~i~~~i~~-------------------~L~~L 404 (581)
||++|.++.. .+. .. +.... +.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9999865431 111 11 11112 3444445444322 12222
Q ss_pred h----c-CCCCCceecCCCCCCeEecCC----CcEEEeeccCcee
Q 008012 405 H----H-GHSTPVVHCDLKPSNILLDEN----MVAHVSDFGISKL 440 (581)
Q Consensus 405 H----~-~~~~~i~H~dikp~Nill~~~----~~~kl~Dfg~a~~ 440 (581)
. . .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 1 123568999999999999876 7899999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00094 Score=65.49 Aligned_cols=154 Identities=11% Similarity=0.096 Sum_probs=83.8
Q ss_pred hhHHHhhcCCCc-----CCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCc--cceEeee-
Q 008012 284 LDLERATDGFNE-----CNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRN--LIKILSS- 355 (581)
Q Consensus 284 ~~~~~~~~~y~~-----~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~- 355 (581)
.++.....+|.. .+.|+.|....+|++...+| .+++|+..... ....+..|+.+++.+.... +.+++..
T Consensus 10 ~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~ 86 (322)
T 2ppq_A 10 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRK 86 (322)
T ss_dssp HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred HHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCC
Confidence 344444444544 34566788889999987655 68899887631 1134556777777763111 2333321
Q ss_pred -----eecCCeeeEEEeccCCCCHHH--------------HHhhC--C--CC----CC---HHHHHH------------H
Q 008012 356 -----CCNTNFKALVLEFMPNGSLDK--------------WLYSH--N--YF----QD---IPDRLN------------I 393 (581)
Q Consensus 356 -----~~~~~~~~lv~e~~~~~~L~~--------------~l~~~--~--~~----~~---~~~~~~------------i 393 (581)
....+..+++|+|++|..+.. .++.. . .. .. |..... +
T Consensus 87 ~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l 166 (322)
T 2ppq_A 87 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 166 (322)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence 122456789999998865310 01110 0 00 01 111000 0
Q ss_pred HHHHHHHHHHHhcC----CCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 394 MIDVALALEYLHHG----HSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 394 ~~~i~~~L~~LH~~----~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
...+...++++++. ...+++|+|+++.||++++++.+.++||+.+..
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 01133445555421 235799999999999999876668999997763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00017 Score=73.92 Aligned_cols=73 Identities=12% Similarity=0.147 Sum_probs=49.3
Q ss_pred CCeecccccccEEEEEeCC--------CcEEEEEEeccchHHHHHHHHHHHHHHHhcC-CCccceEeeeeecCCeeeEEE
Q 008012 296 CNLLGSGGFGSVYKGILSD--------GTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++.|+.|....+|++...+ ++.+++|+...... ...+.+|..+++.+. +.-..++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3578888889999998653 57899999854211 123447888888884 3223566766542 3899
Q ss_pred eccCCCCH
Q 008012 367 EFMPNGSL 374 (581)
Q Consensus 367 e~~~~~~L 374 (581)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0011 Score=65.16 Aligned_cols=140 Identities=11% Similarity=0.068 Sum_probs=80.4
Q ss_pred CeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCC--CccceEeee-----eecCCeeeEEEecc
Q 008012 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRH--RNLIKILSS-----CCNTNFKALVLEFM 369 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~-----~~~~~~~~lv~e~~ 369 (581)
..++ |....||++...+|+.+++|+...... ....+..|..+++.+.. -.+.+++.. ....+..+++|+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 888899998877777899999874311 12355668888777731 123444433 12245668899999
Q ss_pred CCCCHH-----H------H---Hhh----CC----CCCCHHHH----------------------HHHHHHHHHHHHHHh
Q 008012 370 PNGSLD-----K------W---LYS----HN----YFQDIPDR----------------------LNIMIDVALALEYLH 405 (581)
Q Consensus 370 ~~~~L~-----~------~---l~~----~~----~~~~~~~~----------------------~~i~~~i~~~L~~LH 405 (581)
+|..+. . . ++. .. ...++... ...+..++..+..+-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 1 1 110 00 01121111 111112222222221
Q ss_pred c-CCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 406 H-GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 406 ~-~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
. .....++|||+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1246689999999999998 4 899999987764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00038 Score=71.69 Aligned_cols=74 Identities=16% Similarity=0.169 Sum_probs=48.0
Q ss_pred CCeecccccccEEEEEeCC-CcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCcc-ceEeeeeecCCeeeEEEeccCCCC
Q 008012 296 CNLLGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNL-IKILSSCCNTNFKALVLEFMPNGS 373 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~ 373 (581)
++.|+.|-...+|++...+ +..+++|+....... .-...+|..+++.+...++ .++++.+. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3578888889999998764 478999987543211 0112478999999854444 56777663 2 35999998754
Q ss_pred H
Q 008012 374 L 374 (581)
Q Consensus 374 L 374 (581)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0019 Score=63.83 Aligned_cols=71 Identities=13% Similarity=0.143 Sum_probs=45.1
Q ss_pred Ceeccc--ccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcC---CCccceEeee------eecCCeeeEE
Q 008012 297 NLLGSG--GFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR---HRNLIKILSS------CCNTNFKALV 365 (581)
Q Consensus 297 ~~lg~G--~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~------~~~~~~~~lv 365 (581)
+.+..| ....||++...+| .+++|+...... ..|+.+++.+. -|.+.+.+.. ....+..+++
T Consensus 27 ~~l~~G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l 99 (339)
T 3i1a_A 27 QFIQGGADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIA 99 (339)
T ss_dssp EEETTTSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEE
T ss_pred EEeeccCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEE
Confidence 445333 3678999987766 899998765431 34566665552 2324444432 2335678999
Q ss_pred EeccCCCCH
Q 008012 366 LEFMPNGSL 374 (581)
Q Consensus 366 ~e~~~~~~L 374 (581)
|+|++|..+
T Consensus 100 ~~~i~G~~~ 108 (339)
T 3i1a_A 100 YPFIHAPNG 108 (339)
T ss_dssp EECCCCCBT
T ss_pred EeccCCCcC
Confidence 999998765
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00071 Score=56.45 Aligned_cols=36 Identities=19% Similarity=0.121 Sum_probs=18.2
Q ss_pred CCcEEecccCcCCCCCCccccCCccCcEEeCCCCcC
Q 008012 78 YILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQL 113 (581)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 113 (581)
+|++|+|++|+|+...+..|..+++|++|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 355555555555544444445555555555555544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00048 Score=69.14 Aligned_cols=74 Identities=18% Similarity=0.262 Sum_probs=44.8
Q ss_pred CCeecccccccEEEEEeCC---------CcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCc-cceEeeeeecCCeeeEE
Q 008012 296 CNLLGSGGFGSVYKGILSD---------GTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRN-LIKILSSCCNTNFKALV 365 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv 365 (581)
.+.++.|....+|++...+ ++.+++|+....... ......|.++++.+...+ +.++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3567888889999998653 268999987653221 112356888888874223 44666544 2 3689
Q ss_pred EeccCCCCH
Q 008012 366 LEFMPNGSL 374 (581)
Q Consensus 366 ~e~~~~~~L 374 (581)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0035 Score=63.61 Aligned_cols=74 Identities=15% Similarity=0.217 Sum_probs=48.5
Q ss_pred CCeecccccccEEEEEeCC--------CcEEEEEEeccchHHHHHHHHHHHHHHHhcC-CCccceEeeeeecCCeeeEEE
Q 008012 296 CNLLGSGGFGSVYKGILSD--------GTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++.+..|-...+|++...+ ++.+++|+...... ..-...+|..+++.+. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3567788889999998653 58899998754321 1112356888888873 322445555432 27899
Q ss_pred eccCCCCH
Q 008012 367 EFMPNGSL 374 (581)
Q Consensus 367 e~~~~~~L 374 (581)
||++|.++
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.41 E-value=0.04 Score=55.62 Aligned_cols=30 Identities=33% Similarity=0.391 Sum_probs=25.3
Q ss_pred CceecCCCCCCeEe------cCCCcEEEeeccCcee
Q 008012 411 PVVHCDLKPSNILL------DENMVAHVSDFGISKL 440 (581)
Q Consensus 411 ~i~H~dikp~Nill------~~~~~~kl~Dfg~a~~ 440 (581)
.++|+|+.+.||++ +++..+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999998864
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=91.20 E-value=0.11 Score=33.04 Aligned_cols=27 Identities=26% Similarity=0.544 Sum_probs=15.6
Q ss_pred eeeccchhhHHHHHHHHHHHHHHhccCC
Q 008012 237 KYIFPPIICVVLIALVFIFFLRRRNRST 264 (581)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~rr~~~~ 264 (581)
.++++ +++++++++++++|.|||+.+.
T Consensus 16 ~~vVG-vll~vi~~l~~~~~~RRR~~~~ 42 (44)
T 2jwa_A 16 SAVVG-ILLVVVLGVVFGILIKRRQQKI 42 (44)
T ss_dssp HHHHH-HHHHHHHHHHHHHHHHHHCSCC
T ss_pred HHHHH-HHHHHHHHHHHHhheehhhhhc
Confidence 34444 5566666666666666666543
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.66 E-value=0.12 Score=33.00 Aligned_cols=26 Identities=23% Similarity=0.441 Sum_probs=13.2
Q ss_pred eeeccchhhHHHHHHHHHHHHHHhcc
Q 008012 237 KYIFPPIICVVLIALVFIFFLRRRNR 262 (581)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~rr~~ 262 (581)
..+++.++++++++.++++++|||+.
T Consensus 15 ~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 15 TGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred eehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 34444445555555555555555544
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.72 E-value=0.16 Score=32.46 Aligned_cols=29 Identities=17% Similarity=0.433 Sum_probs=15.5
Q ss_pred eeeeccchhhHHHHHHHHHHHHHHhccCC
Q 008012 236 LKYIFPPIICVVLIALVFIFFLRRRNRST 264 (581)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~rr~~~~ 264 (581)
...+++.++++++++.++++++|||+++.
T Consensus 13 A~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 13 AAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred EEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 34444445555555555556666655543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.51 E-value=1.5 Score=39.19 Aligned_cols=120 Identities=15% Similarity=0.206 Sum_probs=80.3
Q ss_pred CCCccceEeeeeecCCeeeEEEeccCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeE
Q 008012 345 RHRNLIKILSSCCNTNFKALVLEFMPNG-SLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNIL 423 (581)
Q Consensus 345 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nil 423 (581)
.||+.++. .+-.+.+.+.+.++.-+.+ +... +.+ .+...+++++.+|+....+++ .-+|--++|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~----~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS----FTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG----SCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh----cCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence 68888866 4556666655555544322 2222 322 477899999999998886655 2578889999999
Q ss_pred ecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Q 008012 424 LDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTG 499 (581)
Q Consensus 424 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~ 499 (581)
++.++.+++.-.|+-..+ +|. ..+...=.-.+=|++..+++++..|+....+
T Consensus 112 f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G 163 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEG 163 (215)
T ss_dssp ECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHS
T ss_pred EcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcC
Confidence 999999999877754322 222 1222233446778899999999988764443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.95 E-value=4.4 Score=36.36 Aligned_cols=116 Identities=9% Similarity=0.044 Sum_probs=77.0
Q ss_pred CCCccceEeeeeecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCceecCCCCCCeE
Q 008012 345 RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALE-YLHHGHSTPVVHCDLKPSNIL 423 (581)
Q Consensus 345 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~-~LH~~~~~~i~H~dikp~Nil 423 (581)
.||++ -...-.+.+.+.+.++.-+++.=...+.+ .+...+++++.+|+.... +++ .-+|--++|+|++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~----~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK----TTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT----SCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh----cCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence 67887 34444667777776666544433334432 477889999988887766 444 4678889999999
Q ss_pred ecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCc
Q 008012 424 LDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDE 495 (581)
Q Consensus 424 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~ 495 (581)
++.++.+++.-.|.-.. ++|.- .+..-=.-++=|++..++.++..|+.
T Consensus 117 f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 117 FNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp ECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred EeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999987775332 22321 12222234667888889998887654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 581 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-66 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.002 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 5e-66
Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 25/278 (8%)
Query: 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILS 354
+GSG FG+VYKG VA+K+ N+ Q ++F +E VLR RH N++ +
Sbjct: 14 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
A+V ++ SL L+ ++ ++I A ++YLH ++H
Sbjct: 72 -YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF---GSEGNVS 471
DLK +NI L E++ + DFG++ + S +I +MAPE + S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 472 SKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFS 531
+ DVY++GI+L E T + P + + + + L L K+
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS----------- 236
Query: 532 ARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569
+C ++ L +C + D+R ++ +
Sbjct: 237 ---NCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (499), Expect = 6e-59
Identities = 78/316 (24%), Positives = 131/316 (41%), Gaps = 42/316 (13%)
Query: 282 SYLDLERATDGFNEC---------NLLGSGGFGSVYKGIL----SDGTTVAIKIFNLQL- 327
++ D A F + ++G+G FG V G L VAIK
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 328 EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDI 387
E+ R F SE ++ H N+I + + ++ EFM NGSLD +L ++ +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127
Query: 388 PDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447
+ ++ +A ++YL + VH DL NIL++ N+V VSDFG+S+ L +
Sbjct: 128 IQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 448 VIQTMTI---ATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLK 504
T + I + APE +S DV+SYGI++ E + + T ++
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-NQDVI 243
Query: 505 NWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564
N +++ P MDC ++ L LDC + + R
Sbjct: 244 NAIEQDYRLPPP-----------------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 565 LKKIRDKFLEDANTLR 580
L K+ + + N+L+
Sbjct: 287 LDKM----IRNPNSLK 298
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-58
Identities = 71/278 (25%), Positives = 113/278 (40%), Gaps = 23/278 (8%)
Query: 293 FNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
+GSG FG V+ G + VAIK + F E EV+ + H L+++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
C LV EFM +G L +L + L + +DV + YL V
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
+H DL N L+ EN V VSDFG+++ + + D T T + + +PE S SS
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 473 KCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSA 532
K DV+S+G+L+ E F+ K E + + + P++A ++
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKPRLASTHVY-------- 232
Query: 533 RMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570
+ C E P+ R +L +I +
Sbjct: 233 ---------QIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 6e-58
Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 9/271 (3%)
Query: 286 LERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRS-FNSECEVLRN 343
+E D F + + LG+G G V+K G +A K+ +L+++ A R+ E +VL
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 344 VRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEY 403
++ + + ++ +E M GSLD+ L + + I V L Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSIAVIKGLTY 119
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 463
L H ++H D+KPSNIL++ + DFG+S L + + + T YM+PE
Sbjct: 120 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPE 173
Query: 464 FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523
+ S + D++S G+ L+E + P E+ L +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 524 LREENFFSARMDCLLSIFHLALDCCAELPDQ 554
R + + ++IF L E P +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 2e-56
Identities = 59/291 (20%), Positives = 112/291 (38%), Gaps = 23/291 (7%)
Query: 299 LGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358
+G G FG V++G G VA+KIF+ + E+++ +E +RH N++ +++
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 359 TNFKA----LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHH-----GHS 409
N LV ++ +GSL +L + Y + + + + A L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGYMAPEF--- 464
+ H DLK NIL+ +N ++D G++ D++ + T YMAPE
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 465 ---GSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKE--SLPHGLPKIA 519
+ D+Y+ G++ E R ++ + V S+ +
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570
+ L + L + + +C RL L ++
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 5e-56
Identities = 61/275 (22%), Positives = 110/275 (40%), Gaps = 27/275 (9%)
Query: 299 LGSGGFGSVYKGIL---SDGTTVAIKIFNLQLEQAFR-SFNSECEVLRNVRHRNLIKILS 354
LG G FGSV +G+ VAIK+ E+A E +++ + + +++++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 355 SCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVH 414
C LV+E G L K+L + + ++ V++ ++YL VH
Sbjct: 77 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 132
Query: 415 CDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEFGSEGNVSSK 473
DL N+LL A +SDFG+SK LG D + + APE + SS+
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192
Query: 474 CDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSAR 533
DV+SYG+ + E + + + G + ++++ P
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGKRMECPP---------------- 235
Query: 534 MDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
+C ++ L DC + R +++
Sbjct: 236 -ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 6e-56
Identities = 61/279 (21%), Positives = 124/279 (44%), Gaps = 25/279 (8%)
Query: 291 DGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLI 350
+ LG+G FG V+ G + T VA+K + +F +E +++ ++H+ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ-DIPDRLNIMIDVALALEYLHHGHS 409
++ + ++ E+M NGSL +L + + + I L++ +A + ++ +
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGN 469
+H DL+ +NIL+ + + ++DFG+++L+ E ++ + I + APE + G
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 470 VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529
+ K DV+S+GILL E T + T ++N ++ P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPD------------ 233
Query: 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
+C ++ L C E P+ R + L+
Sbjct: 234 -----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-55
Identities = 64/276 (23%), Positives = 109/276 (39%), Gaps = 23/276 (8%)
Query: 293 FNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
LG+G FG V G VAIK+ + F E +V+ N+ H L+++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
C ++ E+M NG L +L + L + DV A+EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
+H DL N L+++ V VSDFG+S+ + + D+ + + + PE SS
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 473 KCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSA 532
K D++++G+L+ E ++ K E FT + + L P
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQGLRLYRPH--------------- 224
Query: 533 RMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
++ + C E D+R K + + +
Sbjct: 225 --LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-55
Identities = 68/288 (23%), Positives = 123/288 (42%), Gaps = 25/288 (8%)
Query: 282 SYLDLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVL 341
+ E + LG G FG V+ G + T VAIK + +F E +V+
Sbjct: 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVM 66
Query: 342 RNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNY-FQDIPDRLNIMIDVALA 400
+ +RH L+++ + +V E+M GSL +L + +P +++ +A
Sbjct: 67 KKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 401 LEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460
+ Y+ + VH DL+ +NIL+ EN+V V+DFG+++L+ + + + + I +
Sbjct: 126 MAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWT 181
Query: 461 APEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520
APE G + K DV+S+GILL E T+ + + + V+ P
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPP--- 237
Query: 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
+C S+ L C + P++R + L+
Sbjct: 238 --------------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 8e-55
Identities = 70/279 (25%), Positives = 114/279 (40%), Gaps = 31/279 (11%)
Query: 293 FNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKI 352
+G G FG V G G VA+K ++ + ++F +E V+ +RH NL+++
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 353 LSSCCNTNFK-ALVLEFMPNGSLDKWLYSHNYFQ-DIPDRLNIMIDVALALEYLHHGHST 410
L +V E+M GSL +L S L +DV A+EYL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GN 122
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNV 470
VH DL N+L+ E+ VA VSDFG++K D+ + + APE E
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKF 177
Query: 471 SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFF 530
S+K DV+S+GILL E ++ + ++ V++ P
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPD------------- 223
Query: 531 SARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569
C +++ + +C R +L+ I+
Sbjct: 224 ----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-54
Identities = 65/300 (21%), Positives = 122/300 (40%), Gaps = 31/300 (10%)
Query: 284 LDLERATDGFNECNLLGSGGFGSVYKGILSD----GTTVAIKIFNLQLEQAFRS-FNSEC 338
+ FNE ++G G FG VY G L D A+K N + S F +E
Sbjct: 22 IGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG 79
Query: 339 EVLRNVRHRNLIKILSSCCNTNFKA-LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDV 397
++++ H N++ +L C + +VL +M +G L ++ + + + D + + V
Sbjct: 80 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 139
Query: 398 ALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IA 455
A + S VH DL N +LDE V+DFG+++ + + + + T
Sbjct: 140 AKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 456 TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGL 515
+ +MA E ++K DV+S+G+LL E TR P ++N +
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITV------- 245
Query: 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLED 575
+ L + + + + + L C + R + +++ I F+ +
Sbjct: 246 -YLLQGRRLLQPEYCPDPL------YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-53
Identities = 70/295 (23%), Positives = 126/295 (42%), Gaps = 32/295 (10%)
Query: 293 FNECNLLGSGGFGSVYKGILSDGT-----TVAIKIFNLQLEQAFR-SFNSECEVLRNVRH 346
++G+G FG VYKG+L + VAIK + R F E ++ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 347 RNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHH 406
N+I++ ++ E+M NG+LDK+L + + + ++ +A + +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA---AGMKY 125
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEFG 465
+ VH DL NIL++ N+V VSDFG+S++L + ++ T I + APE
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 466 SEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525
S +S DV+S+GI++ E T + + + + + P
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAINDGFRLPTP--------- 235
Query: 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDANTLR 580
MDC +I+ L + C + +R D + L K+ + ++L+
Sbjct: 236 --------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL----IRAPDSLK 278
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 5e-53
Identities = 66/289 (22%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 295 ECNLLGSGGFGSVYKGILSD---GTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNL 349
E LGSG FG+V KG TVA+KI + +E V++ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS 409
++++ C ++ LV+E G L+K+L + + +D + + ++ V++ ++YL +
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLEESN- 127
Query: 410 TPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAPEFGSEG 468
VH DL N+LL A +SDFG+SK L ++ + + APE +
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 469 NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528
SSK DV+S+G+L+ E F+ + G + +++ G P
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SEVTAMLEKGERMGCPA----------- 233
Query: 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDAN 577
C ++ L C + R +L+ + + N
Sbjct: 234 ------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY---YYDVVN 273
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (457), Expect = 6e-53
Identities = 67/295 (22%), Positives = 114/295 (38%), Gaps = 25/295 (8%)
Query: 279 RRTSYLDLERATDGFNECNLLGSGGFGSVYKGILSD-GTTVAIKIFNLQLEQAFRSFNSE 337
+Y E + LG G +G VY+G+ TVA+K + F E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKE 63
Query: 338 CEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ-DIPDRLNIMID 396
V++ ++H NL+++L C ++ EFM G+L +L N + L +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 397 VALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIAT 456
++ A+EYL +H DL N L+ EN + V+DFG+S+L+ GD
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFP 179
Query: 457 IGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP 516
I + APE + S K DV+++G+LL E T + +++ P
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERP 238
Query: 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571
+ C ++ L C P R + + + +
Sbjct: 239 E-----------------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (456), Expect = 1e-52
Identities = 67/317 (21%), Positives = 120/317 (37%), Gaps = 51/317 (16%)
Query: 282 SYLDLERATDGFNECNLLGSGGFGSVYKGIL------SDGTTVAIKIFNLQLEQAFRS-F 334
L LE + +G G FG V++ T VA+K+ + ++ F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 335 NSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ--------- 385
E ++ + N++K+L C L+ E+M G L+++L S +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 386 --------------DIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAH 431
++L I VA + YL VH DL N L+ ENMV
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 432 VSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKK 491
++DFG+S+ + D I +M PE +++ DV++YG++L E F+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 492 PTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAEL 551
+ +V++ P+ +C L +++L C ++L
Sbjct: 241 QPYYGMA-HEEVIYYVRDGNILACPE-----------------NCPLELYNLMRLCWSKL 282
Query: 552 PDQRLYMKDAATKLKKI 568
P R L+++
Sbjct: 283 PADRPSFCSIHRILQRM 299
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 3e-52
Identities = 63/284 (22%), Positives = 111/284 (39%), Gaps = 32/284 (11%)
Query: 288 RATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNV 344
RA D + +G+G +G K SDG + K + E + SE +LR +
Sbjct: 2 RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 345 RHRNLIKILSSCCNTNFKAL--VLEFMPNGSLDKWLYSHNYFQ---DIPDRLNIMIDVAL 399
+H N+++ + L V+E+ G L + + D L +M + L
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 400 ALEYLH--HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATI 457
AL+ H V+H DLKP+N+ LD + DFG++++L D+ + T
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTP 178
Query: 458 GYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517
YM+PE + + + K D++S G LL E P E+ K
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------------AGK 225
Query: 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDA 561
I + R +S ++ +++ R +++
Sbjct: 226 IREGKFRRIPYRYSDELNEIIT------RMLNLKDYHRPSVEEI 263
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-51
Identities = 61/297 (20%), Positives = 106/297 (35%), Gaps = 45/297 (15%)
Query: 297 NLLGSGGFGSVYKGIL------SDGTTVAIKIFNLQLEQAFR-SFNSECEVLRNV-RHRN 348
LG+G FG V + TVA+K+ R + SE +VL + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ-----------------DIPDRL 391
++ +L +C ++ E+ G L +L D+ D L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 392 NIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQT 451
+ VA + +L + +H DL NILL + + DFG+++ + + V++
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 452 MTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESL 511
+ +MAPE + + DV+SYGI L E F+ + +KE
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 265
Query: 512 PHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
P+ ++ + C P +R K ++K
Sbjct: 266 RMLSPE-----------------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-51
Identities = 62/271 (22%), Positives = 106/271 (39%), Gaps = 32/271 (11%)
Query: 299 LGSGGFGSVYKGILSD-GTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSS 355
+G G F +VYKG+ ++ VA + + + F E E+L+ ++H N+++ S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 356 CCNT----NFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP 411
+T LV E M +G+L +L I + + L++LH + P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM-KIKVLRSWCRQILKGLQFLHT-RTPP 134
Query: 412 VVHCDLKPSNILL-DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNV 470
++H DLK NI + + D G++ L + I T +MAPE E
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEM-YEEKY 189
Query: 471 SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFF 530
DVY++G+ +LE T + P E + P K+A +
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK------ 243
Query: 531 SARMDCLLSIFHLALDCCAELPDQRLYMKDA 561
+ C + D+R +KD
Sbjct: 244 -----------EIIEGCIRQNKDERYSIKDL 263
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-51
Identities = 59/274 (21%), Positives = 101/274 (36%), Gaps = 24/274 (8%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNL-QLEQAFRSFNSECEVLRNVRHRN 348
+ ++ LG G +G V + VA+KI ++ + + E + + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH 408
++K N + L LE+ G L + PD + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM-PEPDAQRFFHQLMAGVVYLHGIG 123
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-FGSE 467
+ H D+KP N+LLDE +SDFG++ + + + T+ Y+APE
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 468 GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527
+ DV+S GI+L + P D+ +W ++ K D+ L
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL--- 237
Query: 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDA 561
L E P R+ + D
Sbjct: 238 --------------ALLHKILVENPSARITIPDI 257
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (446), Expect = 5e-51
Identities = 62/279 (22%), Positives = 100/279 (35%), Gaps = 35/279 (12%)
Query: 290 TDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNL---QLEQAFRSFNSECEVLRNVR 345
F++ +G G FG+VY + + VAIK + Q + ++ E L+ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 346 HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH 405
H N I+ + LV+E+ + D Q+ + + L YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE-VEIAAVTHGALQGLAYLH 132
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF- 464
S ++H D+K NILL E + + DFG + ++ + T +MAPE
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVI 183
Query: 465 --GSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522
EG K DV+S GI +E RK P M L + + P
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSEY 242
Query: 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDA 561
+ C ++P R +
Sbjct: 243 FR-----------------NFVDSCLQKIPQDRPTSEVL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-50
Identities = 65/287 (22%), Positives = 121/287 (42%), Gaps = 29/287 (10%)
Query: 288 RATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL-----EQAFRSFNSECEVL 341
+ T+ F + +LGSG FG+VYKG+ + +G V I + +L +A + E V+
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 342 RNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALAL 401
+V + ++ ++L C + + L+ + MP G L ++ H LN + +A +
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 461
YL +VH DL N+L+ ++DFG++KLLG + I +MA
Sbjct: 125 NYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 462 PEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521
E + + DV+SYG+ + E T G+P +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDGIPASEIS 223
Query: 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
++L + C + ++ + + C D R ++ + K+
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-50
Identities = 64/278 (23%), Positives = 103/278 (37%), Gaps = 28/278 (10%)
Query: 290 TDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRN 348
D + LG G FG VYK A K+ + + E+ + E ++L + H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH 408
++K+L + N +++EF G++D + + AL YL H
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL---H 127
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEF---- 464
++H DLK NIL + ++DFG+S + I T +MAPE
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCE 185
Query: 465 -GSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523
+ K DV+S GI L+E + P E+ + L K P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPPT---------- 234
Query: 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDA 561
L + + +S+ L C + D R
Sbjct: 235 LAQPSRWSSNFKDFLK------KCLEKNVDARWTTSQL 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 3e-50
Identities = 64/299 (21%), Positives = 108/299 (36%), Gaps = 50/299 (16%)
Query: 298 LLGSGGFGSVYKGILSD------GTTVAIKIFNLQLEQAFR-SFNSECEVLRNV-RHRNL 349
+LGSG FG V VA+K+ + + + R + SE +++ + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ----------------------DI 387
+ +L +C + L+ E+ G L +L S
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 388 PDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447
D L VA +E+L VH DL N+L+ V + DFG+++ + +
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWV 507
V++ + +MAPE EG + K DV+SYGILL E F+ + N +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280
Query: 508 KESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566
+ P I+ + C A +R + + L
Sbjct: 281 QNGFKMDQPF-----------------YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 3e-50
Identities = 67/287 (23%), Positives = 102/287 (35%), Gaps = 29/287 (10%)
Query: 291 DGFNECNLLGSGGFGSVYKGIL----SDGTTVAIKIFNLQL---EQAFRSFNSECEVLRN 343
LG G FG V +G +VA+K + +A F E + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 344 VRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEY 403
+ HRNLI++ K +V E P GSL L H + + VA + Y
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYMAP 462
L S +H DL N+LL + + DFG+ + L + DD + + AP
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 463 EFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522
E S D + +G+ L E FT + G L KE P+
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE----- 238
Query: 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569
DC I+++ + C A P+ R L + +
Sbjct: 239 ------------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 7e-49
Identities = 62/273 (22%), Positives = 106/273 (38%), Gaps = 25/273 (9%)
Query: 290 TDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRN 348
+ +G G G+VY + ++ G VAI+ NLQ + +E V+R ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH 408
++ L S + +V+E++ GSL + D + + ALE+L H
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFL---H 133
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG 468
S V+H D+K NILL + ++DFG + ++ + T +MAPE +
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRK 191
Query: 469 NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREEN 528
K D++S GI+ +E + P L P L+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPE----------LQNPE 240
Query: 529 FFSARMDCLLSIFHLALDCCAELPDQRLYMKDA 561
SA L+ C ++R K+
Sbjct: 241 KLSAIFRDFLN------RCLDMDVEKRGSAKEL 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-48
Identities = 62/295 (21%), Positives = 109/295 (36%), Gaps = 28/295 (9%)
Query: 287 ERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL---EQAFRSFNSECEVLR 342
++ + F +LG G F +V L+ AIKI + E E +V+
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 343 NVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALE 402
+ H +K+ + + L + NG L K++ F D ++ +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEI---VS 119
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
L + H ++H DLKP NILL+E+M ++DFG +K+L + T Y++P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 463 EFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522
E +E + D+++ G ++ + P + + KI
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-------------FRAGNEYLIFQKIIKLE 226
Query: 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDAN 577
E FF D + + L LD +RL ++ F E
Sbjct: 227 YDFPEKFFPKARDLVEKL--LVLD-----ATKRLGCEEMEGYGPLKAHPFFESVT 274
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 6e-48
Identities = 61/275 (22%), Positives = 103/275 (37%), Gaps = 32/275 (11%)
Query: 291 DGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFN---LQLEQAFRSFNSECEVLRNVRH 346
+ F LG G FG+VY +A+K+ L+ E E+ ++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 347 RNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHH 406
N++++ + L+LE+ P G++ + L + F D + ++A AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCH- 123
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGS 466
S V+H D+KP N+LL ++DFG S +T T+ Y+ PE
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIE 177
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526
K D++S G+L E K P + + +I+
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP-------------FEANTYQETYKRISRVEFTFP 224
Query: 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDA 561
+ D L P QR +++
Sbjct: 225 DFVTEGARD-------LISRLLKHNPSQRPMLREV 252
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 7e-48
Identities = 57/279 (20%), Positives = 106/279 (37%), Gaps = 28/279 (10%)
Query: 298 LLGSGGFGSVYKGILSD----GTTVAIKIFNLQLEQAFRS-FNSECEVLRNVRHRNLIKI 352
+G G FG V++GI VAIK + R F E +R H +++K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 353 LSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPV 412
+ N +++E G L +L Y D+ + ++ AL + S
Sbjct: 74 IG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL---AYLESKRF 129
Query: 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSS 472
VH D+ N+L+ N + DFG+S+ + E + I +MAPE + +S
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 473 KCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSA 532
DV+ +G+ + E + ++ ++ +P
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERLPMPP--------------- 232
Query: 533 RMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571
+C +++ L C A P +R + +L I ++
Sbjct: 233 --NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-47
Identities = 70/301 (23%), Positives = 118/301 (39%), Gaps = 44/301 (14%)
Query: 291 DGFNECNLLGSGGFGSVYKGILSDG---TTVAIKIFNLQL-EQAFRSFNSECEVLRNV-R 345
+ +++G G FG V K + AIK + R F E EVL +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 346 HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIP---------------DR 390
H N+I +L +C + + L +E+ P+G+L +L + P
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 391 LNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450
L+ DVA ++YL +H DL NIL+ EN VA ++DFG+S+ + V +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKK 183
Query: 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKES 510
TM + +MA E + ++ DV+SYG+LL E + M +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC----GMTCAELYE-- 237
Query: 511 LPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570
L + ++C ++ L C E P +R L ++ +
Sbjct: 238 ------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
Query: 571 K 571
+
Sbjct: 286 E 286
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 62/309 (20%), Positives = 119/309 (38%), Gaps = 37/309 (11%)
Query: 285 DLERATDGFNECNLLGSGGFGSVYKGIL------SDGTTVAIKIFNLQLEQAFR-SFNSE 337
+ E A + LG G FG VY+G+ T VAIK N R F +E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 338 CEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ---------DIP 388
V++ +++++L +++E M G L +L S +
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 389 DRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448
+ + ++A + YL+ + VH DL N ++ E+ + DFG+++ + E D
Sbjct: 134 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 449 IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVK 508
+ + +M+PE +G ++ DV+S+G++L E T + + + E L+ ++
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
Query: 509 ESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568
L D +F L C P R + + +K+
Sbjct: 251 GGLLDKPDNCPDM------------------LFELMRMCWQYNPKMRPSFLEIISSIKEE 292
Query: 569 RDKFLEDAN 577
+ + +
Sbjct: 293 MEPGFREVS 301
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 162 bits (412), Expect = 9e-46
Identities = 55/274 (20%), Positives = 100/274 (36%), Gaps = 25/274 (9%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNL 349
D ++ LG+G FG V++ + G A K E + E + + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS 409
+ + + + N ++ EFM G L + + + + + M V L ++H +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144
Query: 410 TPVVHCDLKPSNILL--DENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE 467
VH DLKP NI+ + + DFG++ L +T T + APE
Sbjct: 145 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEG 199
Query: 468 GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527
V D++S G+L + P + E+ L + + ++
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSP-------------FGGENDDETLRNVKSCDWNMDD 246
Query: 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDA 561
+ FS P+ R+ + A
Sbjct: 247 SAFS---GISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 158 bits (401), Expect = 3e-44
Identities = 63/274 (22%), Positives = 112/274 (40%), Gaps = 25/274 (9%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNL 349
D ++ LGSG FG V++ + + G K N + +E ++ + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 350 IKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHS 409
I + + + L+LEF+ G L + + +Y + +N M L+++ H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HE 145
Query: 410 TPVVHCDLKPSNILLDENMVAHV--SDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE 467
+VH D+KP NI+ + + V DFG++ L + I +T AT + APE
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDR 202
Query: 468 GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527
V D+++ G+L + P F GE +L+ L + + +E
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLET---------LQNVKRCDWEFDE 249
Query: 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDA 561
+ FS + + P +RL + DA
Sbjct: 250 DAFS---SVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 8e-44
Identities = 69/303 (22%), Positives = 118/303 (38%), Gaps = 46/303 (15%)
Query: 291 DGFNECNLLGSGGFGSVYKGIL--------SDGTTVAIKIFNLQL-EQAFRSFNSECEVL 341
D LG G FG V + T VA+K+ E+ SE E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 342 RNV-RHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQ--------------- 385
+ + +H+N+I +L +C +++E+ G+L ++L +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 386 DIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445
D ++ VA +EYL S +H DL N+L+ E+ V ++DFG+++ + D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKN 505
T + +MAPE + + + DV+S+G+LL E FT L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFK 248
Query: 506 WVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565
+KE P +C ++ + DC +P QR K L
Sbjct: 249 LLKEGHRMDKPS-----------------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
Query: 566 KKI 568
+I
Sbjct: 292 DRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-43
Identities = 66/302 (21%), Positives = 108/302 (35%), Gaps = 44/302 (14%)
Query: 291 DGFNECNLLGSGGFGSVYKGI------LSDGTTVAIKIFNL-QLEQAFRSFNSECEVLRN 343
D LG G FG V + + TVA+K+ R+ SE ++L +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 344 VRHRNLIKILSSCCNT--NFKALVLEFMPNGSLDKWLYSHNY---------------FQD 386
+ H + L C +++EF G+L +L S F
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 387 IPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446
+ + VA +E+L S +H DL NILL E V + DFG+++ + + D
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNW 506
V + + +MAPE + + + DV+S+G+LL E F+ +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 507 VKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566
+KE P ++ LDC P QR + L
Sbjct: 250 LKEGTRMRAPD-----------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
Query: 567 KI 568
+
Sbjct: 293 NL 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (383), Expect = 1e-42
Identities = 63/292 (21%), Positives = 121/292 (41%), Gaps = 32/292 (10%)
Query: 290 TDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVR 345
+D + +LG GG V+ L VA+K+ L + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 346 HRNLIKILSSCCNTNFKA----LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALAL 401
H ++ + + +V+E++ +L +++ + ++ D AL
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKRAIEVIADACQAL 124
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA-TIGYM 460
+ H ++H D+KP+NI++ V DFGI++ + + +SV QT + T Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 461 APEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520
+PE +V ++ DVYS G +L E T + P FTG+ +A
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSP-------------VSVAY 224
Query: 521 ANLLREENFFSARMDCLLSIF-HLALDCCAELPDQRLY-MKDAATKLKKIRD 570
++ + SAR + L + + L A+ P+ R + L ++ +
Sbjct: 225 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 1e-41
Identities = 57/286 (19%), Positives = 105/286 (36%), Gaps = 27/286 (9%)
Query: 278 WRRTSYLDLERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQ-LEQAFRSFN 335
W++ E D ++ ++LG+G F V VAIK + LE S
Sbjct: 1 WKQA-----EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME 55
Query: 336 SECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI 395
+E VL ++H N++ + + L+++ + G L + ++ D ++
Sbjct: 56 NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY-TERDASRLIF 114
Query: 396 DVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA 455
V A++YLH LDE+ +SDFG+SK+ G + +
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACG 171
Query: 456 TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGL 515
T GY+APE ++ S D +S G++ P + ++ + +K
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-FEQILKAEYEFDS 230
Query: 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDA 561
P D S + + P++R + A
Sbjct: 231 PYWDD---------ISDSAKDFIR------HLMEKDPEKRFTCEQA 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 151 bits (381), Expect = 2e-41
Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 16/235 (6%)
Query: 291 DGFNECNLLGSGGFGSVYKGILSD-GTTVAIKIFNL------QLEQAFRSFNSECEVLRN 343
+ F+ ++G GGFG VY +D G A+K + Q E + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 344 VRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEY 403
++ + + + + +L+ M G L L H F + D ++ L LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-ADMRFYAAEIILGLEH 122
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 463
+H+ VV+ DLKP+NILLDE+ +SD G++ + ++ T GYMAPE
Sbjct: 123 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPE 175
Query: 464 FGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517
+G S D +S G +L + P + T + + + + ++ LP
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 55/292 (18%), Positives = 112/292 (38%), Gaps = 32/292 (10%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
LG G FG V++ + S T K ++ E +L RHRN++ + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESF 70
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCD 416
+ ++ EF+ + + + + + + + ++ + V AL++L HS + H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFD 127
Query: 417 LKPSNILLDENMVAHV--SDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKC 474
++P NI+ + + +FG ++ L GD+ + Y APE VS+
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 475 DVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARM 534
D++S G L+ + P ++ E+ + I +A +E F
Sbjct: 185 DMWSLGTLVYVLLSGINP-------------FLAETNQQIIENIMNAEYTFDEEAFK--- 228
Query: 535 DCLLSIFHLALDCCAELPDQRLYMKDA------ATKLKKIRDKFLEDANTLR 580
+ + + R+ +A K++++ K + R
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRR 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (371), Expect = 2e-40
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 13/215 (6%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRH 346
F LG+G FG V+ +G A+K+ ++ + N E +L V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 347 RNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHH 406
+I++ + + ++++++ G L + P +V L L +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCL---ALEY 119
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGS 466
HS +++ DLKP NILLD+N ++DFG +K + + ++ T Y+APE S
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVS 174
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM 501
+ D +S+GIL+ E P + T +
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 145 bits (366), Expect = 4e-40
Identities = 63/288 (21%), Positives = 112/288 (38%), Gaps = 40/288 (13%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNL---------QLEQAFRSFNSECEV 340
+ + +LG G V + I A+KI ++ ++++ + E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 341 LRNVR-HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVAL 399
LR V H N+I++ + F LV + M G L +L + IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL-SEKETRKIMRALLE 121
Query: 400 ALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGY 459
+ LH + +VH DLKP NILLD++M ++DFG S L G+ T Y
Sbjct: 122 VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSY 175
Query: 460 MAPEF------GSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPH 513
+APE + + D++S G+++ P + L+ + +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQF 234
Query: 514 GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDA 561
G P+ D +S + L+S P +R ++A
Sbjct: 235 GSPEWDD---------YSDTVKDLVS------RFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-39
Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 11/207 (5%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFN---LQLEQAFRSFNSECEVL-RNVR 345
+ F +LG G FG V+ AIK + ++ E VL
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 346 HRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLH 405
H L + + V+E++ G L + S + F D+ ++ L L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLH 120
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFG 465
+V+ DLK NILLD++ ++DFG+ K GD T Y+APE
Sbjct: 121 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEIL 175
Query: 466 SEGNVSSKCDVYSYGILLLETFTRKKP 492
+ D +S+G+LL E + P
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-38
Identities = 70/280 (25%), Positives = 111/280 (39%), Gaps = 21/280 (7%)
Query: 297 NLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL-----EQAFRSFNSECEVLRNVRHRNLI 350
+ LG G F +VYK + VAIK L + R+ E ++L+ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 351 KILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHST 410
+L + + + +LV +FM + ++ M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 411 PVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-FGSEGN 469
++H DLKP+N+LLDEN V ++DFG++K G + + T + T Y APE
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARM 177
Query: 470 VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529
D+++ G +L E R + + + P +L F
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 530 FSARMDCLLSIFHLALDCCAEL--------PDQRLYMKDA 561
S L IF A D +L P R+ A
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-37
Identities = 57/302 (18%), Positives = 119/302 (39%), Gaps = 40/302 (13%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRS------FNSECEVLRN 343
D ++ LGSG F V K S G A K + ++ R E +L+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 344 VRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEY 403
++H N+I + N L+LE + G L +L + + + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNG--- 125
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVA----HVSDFGISKLLGEGDDSVIQTMTIATIGY 459
+++ HS + H DLKP NI+L + V + DFG++ + G++ T +
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 182
Query: 460 MAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519
+APE + + + D++S G++ + P ++ ++ L ++
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDTKQETLANVS 229
Query: 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLEDANTL 579
N E+ +FS + + P +R+ ++D+ ++ +++ +T
Sbjct: 230 AVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDS------LQHPWIKPKDTQ 280
Query: 580 RL 581
+
Sbjct: 281 QA 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 6e-37
Identities = 64/294 (21%), Positives = 109/294 (37%), Gaps = 27/294 (9%)
Query: 288 RATDGFNECNLLGSGGFGSVYKG--ILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLR- 342
RA + +G G +G V+K + + G VA+K +Q E S E VLR
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 343 --NVRHRNLIKILSSCCNTNFKA-----LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMI 395
H N++++ C + LV E + ++M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 396 DVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIA 455
+ L++LH S VVH DLKP NIL+ + ++DFG++++ + T +
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 177
Query: 456 TIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGL 515
T+ Y APE + + ++ D++S G + E F RK + L + G
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGE 236
Query: 516 PKIADANLLREENFFSARMDCLLSIFHLALDCCAEL--------PDQRLYMKDA 561
L + F S + + +L P +R+ A
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 136 bits (343), Expect = 7e-37
Identities = 56/283 (19%), Positives = 105/283 (37%), Gaps = 18/283 (6%)
Query: 291 DGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRN 348
+ ++ +G G +G VYK + G T A+K L+ E + E +L+ ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH 408
++K+ LV E + + + ++ + + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGL-ESVTAKSFLLQLLNGIAYCH--- 117
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-FGSE 467
V+H DLKP N+L++ ++DFG+++ G T I T+ Y AP+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGS 175
Query: 468 GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527
S+ D++S G + E + + ++ + P+ L + +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 528 NFFSARMDCLLSIFHLALD---------CCAELPDQRLYMKDA 561
F+ F LD P+QR+ K A
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 7e-37
Identities = 61/293 (20%), Positives = 107/293 (36%), Gaps = 28/293 (9%)
Query: 290 TDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFR-SFNSECEVLRNVRHR 347
+ + +G G +G V + VAIK + Q + E ++L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 348 NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIP--DRLNIMIDVALALEYLH 405
N+I I + + ++ + LY Q + + + L+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 406 HGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT-IATIGYMAPE- 463
S V+H DLKPSN+LL+ + DFG++++ D +AT Y APE
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 464 FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523
+ + D++S G +L E + + F G+ L G P D N
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPI----FPGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 524 LREENFFSARMDC-------LLSIFHLALDCCAEL--------PDQRLYMKDA 561
+ + + +F A +L P +R+ ++ A
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-36
Identities = 59/228 (25%), Positives = 85/228 (37%), Gaps = 21/228 (9%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRS------FNSECEVLRNVR--HRN 348
LLGSGGFGSVY GI +SD VAIK + E +L+ V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 349 LIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH 408
+I++L + L+LE + + V A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---H 127
Query: 409 STPVVHCDLKPSNILLDEN-MVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-FGS 466
+ V+H D+K NIL+D N + DFG LL + T T Y PE
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRY 183
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKP---TDEMFTGEMNLKNWVKESL 511
V+S GILL + P +E+ G++ + V
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 231
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-36
Identities = 66/284 (23%), Positives = 109/284 (38%), Gaps = 18/284 (6%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHR 347
+ F + +G G +G VYK G VA+K L E + E +L+ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 348 NLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG 407
N++K+L N LV EF+ S +P + + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 408 HSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE-FGS 466
V+H DLKP N+L++ ++DFG+++ G T + T+ Y APE
Sbjct: 122 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 176
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKP------TDEMFTGEMNLKNWVKESLP--HGLPKI 518
S+ D++S G + E TR+ D++F L + P +P
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 519 ADANLLREENFFSARMDCLLSIFHLALDCCAEL-PDQRLYMKDA 561
+ FS + L L P++R+ K A
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (342), Expect = 2e-36
Identities = 44/291 (15%), Positives = 96/291 (32%), Gaps = 32/291 (10%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
+GSG FG +Y G ++ G VAIK+ ++ + + E ++ + ++ I + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCD 416
+++ + SL+ + + L + + +EY+H + +H D
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 128
Query: 417 LKPSNIL---LDENMVAHVSDFGISKLLGEGDDSVIQ-----TMTIATIGYMAPEFGSEG 468
+KP N L + + ++ DFG++K + T Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 469 NVSSKCDVYSYGILLLETFTRKKPTDEMFTGE--MNLKNWVKESLPHGLPKIADANLLRE 526
S + D+ S G +L+ P + + ++ + + +
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK------ 242
Query: 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI--RDKFLED 575
C + D + + + R F D
Sbjct: 243 --------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 5e-36
Identities = 56/234 (23%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 293 FNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIK 351
+ + ++G+G FG VY+ L G VAIK + Q R N E +++R + H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 352 ILSSCC------NTNFKALVLEFMPNGSLDKWLYSHNYFQDIP--DRLNIMIDVALALEY 403
+ + + LVL+++P + Q +P M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 404 LHHGHSTPVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
+H + H D+KP N+LLD + V + DFG +K L G+ + +
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPE 192
Query: 463 EFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLP 516
+ +S DV+S G +L E + F G+ + V+ G P
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVEIIKVLGTP 242
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 6e-36
Identities = 52/290 (17%), Positives = 110/290 (37%), Gaps = 24/290 (8%)
Query: 286 LERATDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLR 342
+++ + + +G G +G+V+K VA+K L E S E +L+
Sbjct: 1 MQK----YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK 56
Query: 343 NVRHRNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALE 402
++H+N++++ + LV EF + + + + + L
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLG 115
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
+ H + V+H DLKP N+L++ N +++FG+++ G + + T+ Y P
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPP 170
Query: 463 E-FGSEGNVSSKCDVYSYGILLLETFTRKKP------TDEMFTGEMNLKNWVKESLPHGL 515
+ S+ D++S G + E +P D+ L E +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 516 PKIADANLLREENFFSARMDCLLSIFHLALD----CCAELPDQRLYMKDA 561
K+ D ++ ++ + + D P QR+ ++A
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 2e-35
Identities = 56/295 (18%), Positives = 109/295 (36%), Gaps = 30/295 (10%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNL 349
+ + +G G FG V+K G VA+K ++ E + E ++L+ ++H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 350 IKILSSCCNTNFKA--------LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALAL 401
+ ++ C LV +F + F + + +M + L
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRVMQML---L 127
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMT--IATIGY 459
L++ H ++H D+K +N+L+ + V ++DFG+++ +S T + T+ Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 460 MAPEF-GSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEM--NLKNWVKESLPHGLP 516
PE E + D++ G ++ E +TR + P P
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 517 KIADANLLREENFFSARMDCLLSIFH------LALD----CCAELPDQRLYMKDA 561
+ + L + + + ALD P QR+ DA
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 131 bits (330), Expect = 6e-35
Identities = 40/291 (13%), Positives = 81/291 (27%), Gaps = 30/291 (10%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
+G G FG +++G L + VAIK + + E + + I +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 357 CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCD 416
+++ + SL+ L + + ++ +H +V+ D
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 126
Query: 417 LKPSNILLDENMVAH-----VSDFGISKLLGEGDDSVIQ-----TMTIATIGYMAPEFGS 466
+KP N L+ + V DFG+ K + T YM+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526
S + D+ + G + + G + + + +I + +
Sbjct: 187 GREQSRRDDLEALGHVFM----------YFLRGSLPWQGLKAATNKQKYERIGEKK--QS 234
Query: 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI--RDKFLED 575
+ D K+ R ED
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-34
Identities = 52/274 (18%), Positives = 99/274 (36%), Gaps = 33/274 (12%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVL-RNVRHRNLIKILSS 355
+LG G G V + A+K+ E E+ R + ++++I+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73
Query: 356 CCNT----NFKALVLEFMPNGSLDKWLYSHNYFQ-DIPDRLNIMIDVALALEYLHHGHST 410
N +V+E + G L + + IM + A++YLH +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 131
Query: 411 PVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSE 467
+ H D+KP N+L N + ++DFG +K + T T Y+APE
Sbjct: 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGP 187
Query: 468 GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527
CD++S G+++ P + + +K + G + + E
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSN--HGLAISPGMKTRIRMGQYEFPN----PEW 241
Query: 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDA 561
+ S + L+ + P QR+ + +
Sbjct: 242 SEVSEEVKMLIR------NLLKTEPTQRMTITEF 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 10/206 (4%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRH 346
+ F+ LLG G FG V + G A+KI ++ + +E VL+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 347 RNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHH 406
L + + + V+E+ G L L F ++ AL +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSAL---EY 120
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGS 466
HS VV+ D+K N++LD++ ++DFG+ K ++ T Y+APE
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLE 178
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKP 492
+ + D + G+++ E + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (325), Expect = 9e-34
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 13/206 (6%)
Query: 291 DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRH 346
D F+ LG+G FG V G A+KI + Q + +E +L+ V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 347 RNLIKILSSCCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHH 406
L+K+ S + + +V+E++ G + L F P + L EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLH- 158
Query: 407 GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGS 466
S +++ DLKP N+L+D+ V+DFG +K + ++ T +APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIIL 211
Query: 467 EGNVSSKCDVYSYGILLLETFTRKKP 492
+ D ++ G+L+ E P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-31
Identities = 59/239 (24%), Positives = 96/239 (40%), Gaps = 18/239 (7%)
Query: 291 DGFNECNLLGSGGFGSVYKGIL----SDGTTVAIKIFN----LQLEQAFRSFNSECEVLR 342
+ F +LG+G +G V+ G A+K+ +Q + +E +VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 343 NVRHRNLIKILSSCCNTNFK-ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALAL 401
++R + L T K L+L+++ G L L F + + I V +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIV 139
Query: 402 EYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMA 461
L H H +++ D+K NILLD N ++DFG+SK + TI YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMA 198
Query: 462 PEF--GSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518
P+ G + D +S G+L+ E T P GE N + + + P
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD--GEKNSQAEISRRILKSEPPY 255
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 120 bits (301), Expect = 1e-30
Identities = 63/302 (20%), Positives = 115/302 (38%), Gaps = 28/302 (9%)
Query: 279 RRTSYLDLERAT------DGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAF 331
R Y D E D + LG G + V++ I +++ V +KI ++
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI 76
Query: 332 RSFNSECEVLRNVR-HRNLIKILSSCCNTNFK--ALVLEFMPNGSLDKWLYSHNYFQDIP 388
+ E ++L N+R N+I + + + ALV E + N + +
Sbjct: 77 KR---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT----DY 129
Query: 389 DRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDS 447
D M ++ AL+Y H ++H D+KP N+++D E+ + D+G+++ G +
Sbjct: 130 DIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 185
Query: 448 VIQTMTIATIGYMAPE-FGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNW 506
+ +A+ + PE D++S G +L RK+P F G N
Sbjct: 186 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQL 240
Query: 507 VKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566
V+ + G + D D L + +Q L +A L
Sbjct: 241 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 300
Query: 567 KI 568
K+
Sbjct: 301 KL 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 5e-30
Identities = 56/289 (19%), Positives = 100/289 (34%), Gaps = 30/289 (10%)
Query: 293 FNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNL 349
+ + +GSG +G+V + G VAIK E + E +L+++RH N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 350 IKILSSCCNTNFKA------LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEY 403
I +L LV+ FM G+ L H ++ + L Y
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKL-GEDRIQFLVYQMLKGLRY 136
Query: 404 LHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPE 463
+H H DLKP N+ ++E+ + DFG+++ DS + +
Sbjct: 137 IHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEV 189
Query: 464 FGSEGNVSSKCDVYSYGILLLETFTRKKP---TDEMFTGEMNLKNWVKESLPHGLPKIAD 520
+ + D++S G ++ E T K +D + + +K +D
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249
Query: 521 ANLLREENFFSARMDCLLSIFHLALDCCAEL--------PDQRLYMKDA 561
+ SI A L +QR+ +A
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 4e-28
Identities = 49/290 (16%), Positives = 103/290 (35%), Gaps = 26/290 (8%)
Query: 290 TDGFNECNLLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRH 346
+ + + +GSG +GSV G VA+K + + E +L++++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 347 RNLIKILSSC----CNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALE 402
N+I +L F + L G+ + D ++ + L+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD-DHVQFLIYQILRGLK 135
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
Y+H H DLKPSN+ ++E+ + DFG+++ D +
Sbjct: 136 YIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAPE 188
Query: 463 EFGSEGNVSSKCDVYSYGILLLETFTRKKP---TDEMFTGEMNLKNWVKESLPHGLPKIA 519
+ + + D++S G ++ E T + TD + ++ L+ +
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 520 DANLLREENFFSARMDCLLSIFHLALDCCAEL--------PDQRLYMKDA 561
++ ++ ++F A +L D+R+ A
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-27
Identities = 49/220 (22%), Positives = 83/220 (37%), Gaps = 23/220 (10%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILS 354
+GSG G V VAIK + + + E +++ V H+N+I +L+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 355 SCCNTNFK------ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGH 408
LV+E M D ++ + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 409 STPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEG 468
++H DLKPSNI++ + + DFG+++ G + T + T Y APE
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM 193
Query: 469 NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVK 508
D++S G ++ E K F G + W K
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNK 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 7e-27
Identities = 44/212 (20%), Positives = 76/212 (35%), Gaps = 20/212 (9%)
Query: 298 LLGSGGFGSVYKGI-LSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSC 356
LG G F +V+ + + T VA+KI + E ++L+ V + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 357 CNTNFK---------------ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALAL 401
N K +V E + L + + I + L L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 402 EYLHHGHSTPVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYM 460
+Y+H ++H D+KP N+L++ + ++ I+ L T +I T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 461 APEFGSEGNVSSKCDVYSYGILLLETFTRKKP 492
+PE D++S L+ E T
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.8 bits (214), Expect = 3e-20
Identities = 29/203 (14%), Positives = 63/203 (31%), Gaps = 31/203 (15%)
Query: 297 NLLGSGGFGSVYKGILSDGTTVAIKIFNLQL----------EQAFRSFNSECEVLRNVRH 346
L+G G +V+ +K + + F+
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 347 RNLIKILSSCCNTNF----KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALE 402
R L K+ + A+++E + Y + + ++ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK--------ELYRVRVENPDEVLDMILEEVA 117
Query: 403 YLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAP 462
+H +VH DL N+L+ E + + DF S +GE + + + +
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGW---REILERDVRNIIT 170
Query: 463 EFGSEGNVSSKCDVYSYGILLLE 485
F + D+ S +L+
Sbjct: 171 YFSRTYRT--EKDINSAIDRILQ 191
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.9 bits (219), Expect = 1e-19
Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 14/183 (7%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+G + L + L N L+ L L L L L N+++ P L+ LT L EL+L
Sbjct: 215 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+N++++ P L L + + L+ N L S I N+K L L L N +S P
Sbjct: 271 GANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP-- 324
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
++ L L L A N+ S +L ++ L N +S+ P L L+ + Q +
Sbjct: 325 VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 380
Query: 181 SHN 183
+
Sbjct: 381 NDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.5 bits (192), Expect = 3e-16
Identities = 50/177 (28%), Positives = 87/177 (49%), Gaps = 14/177 (7%)
Query: 14 DNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSAL 73
+N + P + L+ LSL GN+L LASLT+L +L L +N++++ P L
Sbjct: 206 NNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--L 259
Query: 74 WALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLA 133
L + + L +N ++ S + + L +L+L+ NQ + I+ LK+LT L+L
Sbjct: 260 SGLTKLTELKLGANQISNI--SPLAGLTALTNLELNENQ--LEDISPISNLKNLTYLTLY 315
Query: 134 GNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIP 190
N P SL L+ L ++N +S+ SL L+++ + HN++ P
Sbjct: 316 FNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 9e-05
Identities = 16/109 (14%), Positives = 39/109 (35%), Gaps = 6/109 (5%)
Query: 99 NMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSS 158
+ + L + ++ + + L +T L + + L +L ++ S+
Sbjct: 20 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 159 NNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNY 207
N L++ P L L+ L +++N++ P F+
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI 122
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 81.2 bits (199), Expect = 2e-17
Identities = 44/204 (21%), Positives = 78/204 (38%), Gaps = 4/204 (1%)
Query: 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLT 66
+ L +N + D LK L++L L NK++ P A L L L L+ N+L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 67 SSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKD 126
+P + L V+ + + N ++++L + + SG G+K
Sbjct: 93 -ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151
Query: 127 LTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLE 186
L+ + +A IP+ SL L L N +++ SL L++L + +S N +
Sbjct: 152 LSYIRIADTNIT-TIPQGLPP--SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 187 GEIPTEGPFRNFSAQSFHWNYALC 210
+ N L
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLV 232
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 61.6 bits (148), Expect = 6e-11
Identities = 35/154 (22%), Positives = 60/154 (38%), Gaps = 10/154 (6%)
Query: 15 NHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALW 74
G +K+L+ + + + +IP L SL EL L+ NK+T ++L
Sbjct: 136 LKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLK 192
Query: 75 ALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAG 134
L + + LS N ++ + N L +L L+ N+L +P +A K + + L
Sbjct: 193 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 251
Query: 135 NQFQGPIPESF------GSLISLESLDLSSNNLS 162
N F S + L SN +
Sbjct: 252 NNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 29/153 (18%), Positives = 53/153 (34%), Gaps = 3/153 (1%)
Query: 54 SLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQL 113
LR ++ + L +P L ++L +N +T D +N+K L L L N++
Sbjct: 11 HLRVVQCSDLGLEK-VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 114 SGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALS 173
S P A L L L L+ NQ + + +L L + + + + L +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 174 HLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWN 206
++ E + S
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.8 bits (120), Expect = 2e-07
Identities = 21/105 (20%), Positives = 39/105 (37%), Gaps = 3/105 (2%)
Query: 106 LDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGI 165
+ S L +PK + D L L N+ F +L +L +L L +N +S+
Sbjct: 15 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 166 PKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALC 210
P + L L++ +S N+L+ + +
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVR 116
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.4 bits (173), Expect = 3e-14
Identities = 37/162 (22%), Positives = 63/162 (38%), Gaps = 4/162 (2%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+ LQ + L DN LQ L L L L GN+++ L SL L L
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+ N++ P A L ++ + L +N L+ T + ++ L L L+ N D
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-A 243
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162
L + ++ +P+ L + L++N+L
Sbjct: 244 RPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.4 bits (155), Expect = 6e-12
Identities = 38/178 (21%), Positives = 67/178 (37%), Gaps = 1/178 (0%)
Query: 15 NHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALW 74
L+ P L RL++L L L P L +L+ L L N L +
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 75 ALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAG 134
L + ++ L N ++ + + L L L +N+++ P L L L L
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 135 NQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE 192
N E+ L +L+ L L+ N ++ + L++F S + + +P
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWV-CDCRARPLWAWLQKFRGSSSEVPCSLPQR 267
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (153), Expect = 1e-11
Identities = 42/187 (22%), Positives = 71/187 (37%), Gaps = 4/187 (2%)
Query: 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRL 60
+ +L + L LQ P L L L LQ N L L +L L L
Sbjct: 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160
Query: 61 NSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT 120
+ N+++S A L + + L N + +++ L+ L L N LS +
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+A L+ L L L N + + L+ SS+ + +P+ L+ +
Sbjct: 221 LAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQR---LAGRDLKRL 276
Query: 181 SHNRLEG 187
+ N L+G
Sbjct: 277 AANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.4 bits (129), Expect = 1e-08
Identities = 44/204 (21%), Positives = 69/204 (33%), Gaps = 4/204 (1%)
Query: 20 SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYI 79
++P + + L GN+++ + +L L L+SN L +A L +
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 80 LYVNLSSNYLTGSLTS-DIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQ 138
++LS N S+ + L L L R L P GL L L L N Q
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 139 GPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRN 197
++F L +L L L N +S ++ L L + + NR+ P
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 198 FSAQSFHWNYALCGPQRLQVPPCK 221
N P P
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRA 226
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.5 bits (163), Expect = 6e-13
Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 27/244 (11%)
Query: 1 MGRMQQLQGIGLADNH-LQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELR 59
+ + L + + + L G IP + +L +L+ L + ++G+IP L+ + +L L
Sbjct: 72 LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131
Query: 60 LNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLI-DLDLSRNQLSGDIP 118
+ N L+ ++P ++ +L ++ + N ++G++ + L + +SRN+L+G IP
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
Query: 119 KTIAGLKDLTNLSLAGNQFQGPIPESFGSLI----------------------SLESLDL 156
T A L +L LDL
Sbjct: 192 PTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDL 251
Query: 157 SSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQ 216
+N + +P+ L L L NVS N L GEIP G + F ++ N LCG
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS---P 308
Query: 217 VPPC 220
+P C
Sbjct: 309 LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.0 bits (115), Expect = 7e-07
Identities = 45/137 (32%), Positives = 72/137 (52%), Gaps = 3/137 (2%)
Query: 27 QLKRLNSLSLQGNKLNG--SIPTCLASLTSLRELRLNSN-KLTSSIPSALWALEYILYVN 83
Q R+N+L L G L IP+ LA+L L L + L IP A+ L + Y+
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 84 LSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPE 143
++ ++G++ + +K L+ LD S N LSG +P +I+ L +L ++ GN+ G IP+
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 144 SFGSLISLESLDLSSNN 160
S+GS L + S N
Sbjct: 168 SYGSFSKLFTSMTISRN 184
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 38.2 bits (87), Expect = 0.002
Identities = 18/60 (30%), Positives = 27/60 (45%), Gaps = 3/60 (5%)
Query: 127 LTNLSLAGNQFQG--PIPESFGSLISLESLDLSSN-NLSEGIPKSLVALSHLKQFNVSHN 183
+ NL L+G PIP S +L L L + NL IP ++ L+ L ++H
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 2e-08
Identities = 44/187 (23%), Positives = 64/187 (34%), Gaps = 24/187 (12%)
Query: 20 SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSI---------- 69
++P DL K L L N L L T L +L L+ +LT
Sbjct: 24 ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81
Query: 70 -----------PSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIP 118
P L + +++S N LT ++ + L +L L N+L P
Sbjct: 82 LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141
Query: 119 KTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQF 178
+ L LSLA N L +L++L L N+L IPK L
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFA 200
Query: 179 NVSHNRL 185
+ N
Sbjct: 201 FLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 3e-05
Identities = 11/65 (16%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 96 DIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLD 155
++ + ++++ + L+ +P + KD T L L+ N + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 156 LSSNN 160
L
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 21/76 (27%), Positives = 32/76 (42%), Gaps = 1/76 (1%)
Query: 63 NKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIA 122
N+L + P L + ++L++N LT + ++ L L L N L IPK
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192
Query: 123 GLKDLTNLSLAGNQFQ 138
G L L GN +
Sbjct: 193 GSHLLPFAFLHGNPWL 208
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 5e-08
Identities = 18/86 (20%), Positives = 34/86 (39%), Gaps = 3/86 (3%)
Query: 106 LDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS-EG 164
LDL+ L D+ + + + P+ E F S ++ +DLS++ +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVST 62
Query: 165 IPKSLVALSHLKQFNVSHNRLEGEIP 190
+ L S L+ ++ RL I
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIV 88
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 2e-05
Identities = 36/234 (15%), Positives = 69/234 (29%), Gaps = 7/234 (2%)
Query: 56 RELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSG 115
+ L L L + L + ++ +++ L + + +DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 116 D-IPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLS--SNNLSEGIPKSLVAL 172
+ ++ L NLSL G + PI + +L L+LS S + L +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 173 SHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQVPPCKEDKNKGFKKVA 232
S L + N+S E + + S N + + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 233 LLVLKYIFPPIICVVLIALVFIFFLRRRNRSTKSPDDEELFSLATWRRTSYLDL 286
L + L ++ L E L L L +
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSR--CYDIIPETLLELGEIPTLKTLQV 232
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.001
Identities = 37/210 (17%), Positives = 78/210 (37%), Gaps = 35/210 (16%)
Query: 2 GRMQQLQGIGLADNHLQG-SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLREL-- 58
++Q + L+++ ++ ++ L Q +L +LSL+G +L+ I LA ++L L
Sbjct: 43 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 102
Query: 59 RLNSNKLTSSIPSALWALEYILYVN------------------------------LSSNY 88
S ++ + L + + +N N
Sbjct: 103 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNL 162
Query: 89 LTGSLTSDIQNMKVLIDLDLSRNQLSGD-IPKTIAGLKDLTNLSLAG-NQFQGPIPESFG 146
L++ ++ L+ LDLS + + + + L L +LSL+ G
Sbjct: 163 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 222
Query: 147 SLISLESLDLSSNNLSEGIPKSLVALSHLK 176
+ +L++L + + AL HL+
Sbjct: 223 EIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 252
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 1e-07
Identities = 22/103 (21%), Positives = 39/103 (37%), Gaps = 9/103 (8%)
Query: 74 WALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLA 133
L + N + + S L +L++S N+L ++P A L L +
Sbjct: 257 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIAS 312
Query: 134 GNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLK 176
N +PE +L + L + N L E P ++ L+
Sbjct: 313 FNHLAE-VPELPQNL---KQLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 2e-07
Identities = 24/92 (26%), Positives = 38/92 (41%), Gaps = 9/92 (9%)
Query: 36 LQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTS 95
N + I + SL EL +++NKL +P+ LE + S N+L +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPE 321
Query: 96 DIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDL 127
QN+K L + N L P ++DL
Sbjct: 322 LPQNLKQ---LHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 3e-06
Identities = 23/83 (27%), Positives = 36/83 (43%), Gaps = 9/83 (10%)
Query: 108 LSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPK 167
N S +I L L+++ N+ +P L E L S N+L+E +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASFNHLAE-VPE 321
Query: 168 SLVALSHLKQFNVSHNRLEGEIP 190
+LKQ +V +N L E P
Sbjct: 322 LP---QNLKQLHVEYNPLR-EFP 340
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 8e-06
Identities = 17/90 (18%), Positives = 33/90 (36%), Gaps = 10/90 (11%)
Query: 15 NHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALW 74
N I L L++ NKL +P A L L + N L +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPELPQ 324
Query: 75 ALEYILYVNLSSNYLTG--SLTSDIQNMKV 102
L+ + ++ N L + ++++++
Sbjct: 325 NLKQL---HVEYNPLREFPDIPESVEDLRM 351
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 1e-07
Identities = 16/107 (14%), Positives = 31/107 (28%), Gaps = 5/107 (4%)
Query: 106 LDLSRNQLS-GDIPKTIAGLKDLTNLSLAGNQFQG----PIPESFGSLISLESLDLSSNN 160
LD+ +LS + + L+ + L I + +L L+L SN
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 161 LSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNY 207
L + ++ + L+ T S+
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPT 113
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 3e-07
Identities = 20/87 (22%), Positives = 27/87 (31%), Gaps = 9/87 (10%)
Query: 95 SDIQNMKVLIDLDLSRNQLSGD----IPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLI- 149
Q VL L L+ +S + T+ L L L+ N +
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422
Query: 150 ----SLESLDLSSNNLSEGIPKSLVAL 172
LE L L SE + L AL
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 7e-06
Identities = 18/89 (20%), Positives = 34/89 (38%), Gaps = 9/89 (10%)
Query: 46 PTCLASLTSLRELRLNSNKLT----SSIPSALWALEYILYVNLSSNYLTGSLTSDI---- 97
+ LR L L ++ SS+ + L A + ++LS+N L + +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 98 -QNMKVLIDLDLSRNQLSGDIPKTIAGLK 125
Q +L L L S ++ + L+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 20/90 (22%), Positives = 33/90 (36%), Gaps = 5/90 (5%)
Query: 31 LNSLSLQGNKLNGS-IPTCLASLTSLRELRLNSNKLT----SSIPSALWALEYILYVNLS 85
+ SL +Q +L+ + L L + +RL+ LT I SAL + +NL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 86 SNYLTGSLTSDIQNMKVLIDLDLSRNQLSG 115
SN L + + + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 3e-05
Identities = 14/84 (16%), Positives = 32/84 (38%), Gaps = 5/84 (5%)
Query: 54 SLRELRLNSNKLTSSIPSALW-ALEYILYVNLSSNYLTG----SLTSDIQNMKVLIDLDL 108
++ L + +L+ + + L L+ V L LT ++S ++ L +L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 109 SRNQLSGDIPKTIAGLKDLTNLSL 132
N+L + + +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 3e-05
Identities = 11/89 (12%), Positives = 27/89 (30%), Gaps = 5/89 (5%)
Query: 79 ILYVNLSSNYLTGS-LTSDIQNMKVLIDLDLSRNQLSGD----IPKTIAGLKDLTNLSLA 133
I +++ L+ + + ++ + L L+ I + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 134 GNQFQGPIPESFGSLISLESLDLSSNNLS 162
N+ + S + +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 4e-05
Identities = 15/72 (20%), Positives = 27/72 (37%), Gaps = 5/72 (6%)
Query: 7 LQGIGLADNHLQGSIPYDLC-QLKRLNSLSLQGNKLNG----SIPTCLASLTSLRELRLN 61
+Q + + L + +L L++ + L L I + L +L EL L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 62 SNKLTSSIPSAL 73
SN+L +
Sbjct: 64 SNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 3e-04
Identities = 19/83 (22%), Positives = 27/83 (32%), Gaps = 9/83 (10%)
Query: 4 MQQLQGIGLADNHLQG----SIPYDLCQLKRLNSLSLQGNKLNGSIPTCLAS-----LTS 54
L+ + LAD + S+ L L L L N L + L
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 55 LRELRLNSNKLTSSIPSALWALE 77
L +L L + + L ALE
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 1e-07
Identities = 31/120 (25%), Positives = 44/120 (36%), Gaps = 8/120 (6%)
Query: 56 RELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSG 115
R L L LT L L + +++LS N L + ++ L L S N L
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALEN 57
Query: 116 DIPKTIAGLKDLTNLSLAGNQFQG-PIPESFGSLISLESLDLSSNNLS--EGIPKSLVAL 172
L L L N+ Q + S L L+L N+L EGI + L +
Sbjct: 58 VDGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 2e-05
Identities = 26/123 (21%), Positives = 48/123 (39%), Gaps = 9/123 (7%)
Query: 12 LADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS 71
LA L ++ L QL + L L N+L P LA+L L L ++
Sbjct: 5 LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALENVD 59
Query: 72 ALWALEYILYVNLSSNYLTG-SLTSDIQNMKVLIDLDLSRNQLSGD---IPKTIAGLKDL 127
+ L + + L +N L + + + L+ L+L N L + + L +
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119
Query: 128 TNL 130
+++
Sbjct: 120 SSI 122
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 2e-05
Identities = 25/160 (15%), Positives = 51/160 (31%), Gaps = 25/160 (15%)
Query: 44 SIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVL 103
+ ++ + L+ L S L A + +N S+ +L +N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 104 IDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163
+ L+LS N+L + +L+ L+LS N L
Sbjct: 68 LSLNLSNNRLYR----------------------LDDMSSIVQKAPNLKILNLSGNELKS 105
Query: 164 GIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSF 203
+ L++ + N L + + + + F
Sbjct: 106 ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERF 145
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 37/165 (22%), Positives = 65/165 (39%), Gaps = 5/165 (3%)
Query: 54 SLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDI-QNMKVLIDLDLSRNQ 112
+ L IP + + + L+ N L + + + L+ L+L RNQ
Sbjct: 9 EGTTVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 113 LSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVAL 172
L+G P G + L L N+ + + F L L++L+L N +S +P S L
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125
Query: 173 SHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCG-PQRLQ 216
+ L N++ N +S + A CG P +++
Sbjct: 126 NSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVR 170
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 1e-04
Identities = 27/192 (14%), Positives = 61/192 (31%), Gaps = 20/192 (10%)
Query: 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN 63
+ L + ++ +L ++ + + + + L ++ +L LN N
Sbjct: 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 64 KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAG 123
KLT P A L+++ + SL + + ++ + + +
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138
Query: 124 LKDLTNLSLAGNQFQG--------------PIPESFGSLISLESLDLSSNNLSEGIPKSL 169
L N L L++L LS N++S+ ++L
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRAL 196
Query: 170 VALSHLKQFNVS 181
L +L +
Sbjct: 197 AGLKNLDVLELF 208
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 3e-04
Identities = 22/148 (14%), Positives = 37/148 (25%), Gaps = 4/148 (2%)
Query: 24 DLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWA-LEYILYV 82
D C + L + L +L EL + + + + L + +
Sbjct: 3 DACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPI- 141
+ + L L L+LS N L + L L L+GN
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCA 120
Query: 142 PESFGSLISLESLDLSSNNLSEGIPKSL 169
+ L L
Sbjct: 121 LRWLQRWEEEGLGGVPEQKLQCHGQGPL 148
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 5e-04
Identities = 17/62 (27%), Positives = 28/62 (45%), Gaps = 4/62 (6%)
Query: 121 IAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNV 180
+A L LT L N+ P SL +L + L +N +S+ P L S+L +
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 181 SH 182
++
Sbjct: 225 TN 226
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 7e-04
Identities = 11/59 (18%), Positives = 21/59 (35%), Gaps = 4/59 (6%)
Query: 14 DNHLQGSIPYD-LCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPS 71
DN+ +P D L + +++ L +L LR + K +P+
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 7e-04
Identities = 9/51 (17%), Positives = 18/51 (35%), Gaps = 3/51 (5%)
Query: 141 IPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPT 191
+ F LD+S + L L L+ + + + ++PT
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.002
Identities = 6/47 (12%), Positives = 12/47 (25%), Gaps = 2/47 (4%)
Query: 117 IPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163
G L ++ + +L L + NL +
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKK 237
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.002
Identities = 22/124 (17%), Positives = 49/124 (39%), Gaps = 6/124 (4%)
Query: 82 VNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPI 141
V L++ + + N +LDL ++ I A L + + N+ +
Sbjct: 1 VKLTAELIEQAAQ--YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--K 55
Query: 142 PESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQ 201
+ F L L++L +++N + AL L + +++N L E+ P + +
Sbjct: 56 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSL 114
Query: 202 SFHW 205
++
Sbjct: 115 TYLC 118
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.003
Identities = 12/66 (18%), Positives = 21/66 (31%), Gaps = 5/66 (7%)
Query: 144 SFGSLISLESLDLSSNNLSEGIPKSLVA-----LSHLKQFNVSHNRLEGEIPTEGPFRNF 198
S I L++L L N + ++L + L ++ NR E R
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327
Query: 199 SAQSFH 204
+
Sbjct: 328 FSTRGR 333
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 581 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.89 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.85 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.83 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.83 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.7 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.67 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.67 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.66 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.65 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.58 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.54 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.52 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.51 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.49 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.48 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.48 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.39 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.38 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.31 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.91 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.9 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.84 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.83 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.78 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.37 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.11 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.07 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.79 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.69 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.6 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.25 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.22 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.14 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=426.59 Aligned_cols=267 Identities=25% Similarity=0.380 Sum_probs=212.7
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
++...++|++.+.||+|+||+||+|+++ ..||||+++.. .....+.+.+|++++++++||||+++++++.+ +..+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 3455688999999999999999999875 36999998654 34456789999999999999999999998754 5689
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+++|+|.+++...+..+++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999999999887777899999999999999999999 89999999999999999999999999999987754
Q ss_pred CCCcceeeccccCccccCCCCCCC---CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSE---GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
...........||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ......+.........
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-~~~~~~~~~~~~~p~~---- 231 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGYLSPDL---- 231 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHHHHTSCCCCG----
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-HHHHHHHhcCCCCCcc----
Confidence 444444455679999999998764 35899999999999999999999999764222 2222223222211100
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
.....++++++.++|.+||+.||++|||++|++++|+.+.+..
T Consensus 232 ---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 232 ---------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp ---------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ---------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 0112245677999999999999999999999999999987643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=419.16 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=208.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.++|++.+.||+|+||+||+|+.+ +|+.||||+++... .+..+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999975 79999999997653 3344678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+++|+|.+++.... .+++..+..++.||++||+||| ++||+||||||+|||+++++.+||+|||+|+........
T Consensus 84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999997654 4799999999999999999999 899999999999999999999999999999987544443
Q ss_pred ceeeccccCccccCCCCCCCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNV-SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.......||+.|+|||++.+..+ +.++||||+||++|||+||++||............+......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------------- 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Confidence 34455689999999999988776 578999999999999999999997643332222222111100
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
......+++++.+|+.+||+.||++|||++|+++|
T Consensus 226 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01112345568899999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=413.98 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=205.4
Q ss_pred cCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccC
Q 008012 291 DGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMP 370 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 370 (581)
++|++.+.||+|+||.||+|.+.+++.||||+++.... ..+.+.+|++++++++||||++++|++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 57889999999999999999998888999999976542 23578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCccee
Q 008012 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 450 (581)
+|+|.+++......+++..++.++.||+.||+||| +++|+||||||+||++++++.+||+|||+++....... ...
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence 99999999888777899999999999999999999 89999999999999999999999999999987644332 223
Q ss_pred eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhC-CCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTR-KKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
....||+.|+|||++.+..++.++|||||||++|||+|+ ++||... ........+........+
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~~~~p------------- 224 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKP------------- 224 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHHTCCCCCC-------------
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHHHhcCCCCCc-------------
Confidence 345789999999999999999999999999999999995 5555432 222233333332222111
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
..+++++.++|.+||+.||++|||++||+++|+++.+
T Consensus 225 ----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 ----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1234568899999999999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-54 Score=416.81 Aligned_cols=250 Identities=24% Similarity=0.310 Sum_probs=210.8
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
++|++.+.||+|+||+||+|... +|+.||||+++.......+.+.+|++++++++||||+++++++.+.+..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999964 79999999997665444567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce
Q 008012 370 PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI 449 (581)
Q Consensus 370 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 449 (581)
+||+|.+++.+. .+++.++..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172 (293)
T ss_dssp TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--c
Confidence 999999988765 3799999999999999999999 89999999999999999999999999999998754332 2
Q ss_pred eeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 450 QTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 450 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
.....||+.|+|||++.+..++.++||||+||++|+|+||+.||...... ..+........+ .+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~~~~~~~~-~~-------------- 236 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIATNGTP-EL-------------- 236 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHHCSC-CC--------------
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCCC-CC--------------
Confidence 34567999999999999999999999999999999999999999763221 112222221111 11
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+..+++.+.++|.+||+.||++|||++|+++|
T Consensus 237 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred -CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112345678899999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=406.77 Aligned_cols=246 Identities=24% Similarity=0.323 Sum_probs=207.6
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 78999999987543 223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+++|+|.+++...+. +++..+..++.||++||+||| ++||+||||||+|||++.++.+||+|||+|.......
T Consensus 86 Ey~~~g~L~~~l~~~~~-l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp ECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred eecCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 99999999999987554 799999999999999999999 8999999999999999999999999999998664322
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ..++
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~-~~~p---------- 224 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETYKRISRVE-FTFP---------- 224 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHTTC-CCCC----------
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--HHHHHHHHcCC-CCCC----------
Confidence 2445799999999999999999999999999999999999999976321 11111111111 1111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+++++.+++.+||+.||++|||++|+++|
T Consensus 225 -------~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 225 -------DFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------ccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1234568899999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=416.10 Aligned_cols=252 Identities=25% Similarity=0.314 Sum_probs=210.1
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEecc
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFM 369 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 369 (581)
+.|++++.||+|+||.||+|++. +++.||+|+++.......+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999965 79999999998766555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcce
Q 008012 370 PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVI 449 (581)
Q Consensus 370 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 449 (581)
++|+|.+++.+....+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|...... ...
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence 999999998876667899999999999999999999 899999999999999999999999999999865321 112
Q ss_pred eeccccCccccCCCCCC-----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 450 QTMTIATIGYMAPEFGS-----EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 450 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
.....||+.|+|||++. +..|+.++|||||||++|||+||+.||...... ..+..... ..+..+
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-~~~~~i~~-~~~~~~--------- 235 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-RVLLKIAK-SEPPTL--------- 235 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GHHHHHHH-SCCCCC---------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHc-CCCCCC---------
Confidence 23457999999999873 456899999999999999999999999764322 12222222 111111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+..+++++.+||.+||+.||++|||++|+++|
T Consensus 236 ------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 ------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112345678899999999999999999999885
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-53 Score=413.94 Aligned_cols=265 Identities=24% Similarity=0.370 Sum_probs=219.1
Q ss_pred hhhhHHHhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC
Q 008012 282 SYLDLERATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN 360 (581)
Q Consensus 282 ~~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 360 (581)
.|.+++...++|++.+.||+|+||+||+|.++ +++.||||+++.... ..+.+.+|++++++++|||||++++++.+.+
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 44455666788999999999999999999975 689999999876532 2457899999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 361 FKALVLEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
..++||||+++|+|.+++... ...+++..+..++.||++||+||| ++||+||||||+|||+++++.+||+|||+|+
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999999854 456799999999999999999999 8899999999999999999999999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
...... ........|++.|+|||++.+..++.++|||||||++|||++|..||....+ .....+.+........+
T Consensus 164 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~i~~~~~~~~~--- 238 (287)
T d1opja_ 164 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERP--- 238 (287)
T ss_dssp TCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCCCCCC---
T ss_pred ecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHHHhcCCCCCCC---
Confidence 764432 2233445688999999999999999999999999999999997777644222 22233333332222111
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
..+++++.+||.+||+.||++|||++|+++.|+.+.
T Consensus 239 --------------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 239 --------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp --------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --------------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 234567889999999999999999999999998874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.6e-53 Score=412.99 Aligned_cols=259 Identities=28% Similarity=0.438 Sum_probs=204.3
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CC---cEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DG---TTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
.++|++.+.||+|+||+||+|.++ ++ ..||||.+... .....+.+.+|++++++++|||||+++|++.+.+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 356788899999999999999965 33 35889988654 34556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
|||||++|+|.+++......+++.++..++.||++||+||| +++|+||||||+|||++.++++||+|||+|+.+...
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999999987777899999999999999999999 899999999999999999999999999999876543
Q ss_pred CCcc---eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 445 DDSV---IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 445 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
.... ......+|+.|+|||++.++.++.++|||||||++|||+| |++||..... ......+.......
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i~~~~~~~------ 253 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAIEQDYRLP------ 253 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCCCC------
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCC------
Confidence 2221 1223457899999999999999999999999999999998 8999976422 22223333222111
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
.+.+++..+.+||.+||+.||++|||++||++.|+++.+
T Consensus 254 -----------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 254 -----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 112355678899999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=410.22 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=196.7
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeec--CCeeeE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCN--TNFKAL 364 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 364 (581)
.++|++.+.||+|+||.||+|+.+ +|+.||+|+++.. .+...+.+.+|++++++++||||+++++++.+ .+..|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 467999999999999999999965 7999999998665 34456778999999999999999999999865 456899
Q ss_pred EEeccCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 365 VLEFMPNGSLDKWLYS---HNYFQDIPDRLNIMIDVALALEYLHHGH--STPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
||||+++|+|.+++.+ .+..+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999874 3456899999999999999999999421 1349999999999999999999999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
.+..... ......||+.|+|||++.+..++.++|||||||++|||+||++||..... ..+...+.......++
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~i~~~~~~~~~--- 235 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFRRIP--- 235 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCCCCC---
T ss_pred ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHHHHHcCCCCCCC---
Confidence 7653322 23456799999999999999999999999999999999999999976322 2222222222211111
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+++++.+||.+||+.||++|||++|+++|
T Consensus 236 --------------~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 236 --------------YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------------cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1244568899999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=401.61 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=215.6
Q ss_pred cCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccC
Q 008012 291 DGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMP 370 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 370 (581)
++|++.++||+|+||+||+|++++++.||||+++..... .+.+.+|+.++++++||||++++|++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 689999999999999999999988889999999765422 3578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCccee
Q 008012 371 NGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQ 450 (581)
Q Consensus 371 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 450 (581)
+|+|.+++......+++..+++++.|+++||+||| +.||+||||||+||++++++.+||+|||+++....... ...
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSS 158 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eee
Confidence 99999998877777899999999999999999999 89999999999999999999999999999987654332 233
Q ss_pred eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
....+|+.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+........+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i~~~~~~~~p------------- 223 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLYRP------------- 223 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCCCCCC-------------
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHHHhCCCCCCc-------------
Confidence 44678999999999999999999999999999999998 89999875322 223333332221111
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHH
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKK 567 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 567 (581)
..+++++.++|.+||+.||++|||++|++++|.+
T Consensus 224 ----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 ----HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1234568899999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=406.33 Aligned_cols=261 Identities=23% Similarity=0.402 Sum_probs=215.0
Q ss_pred cCCCcCC-eecccccccEEEEEeC---CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 291 DGFNECN-LLGSGGFGSVYKGILS---DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 291 ~~y~~~~-~lg~G~~~~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
++|.+.+ +||+|+||.||+|.++ ++..||||+++... ....+.+.+|++++++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999854 45579999997653 4556789999999999999999999999865 467999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+++|+|.+++...+..+++..+..++.||++||+||| +++|+||||||+||+++.++.+||+|||+|+.+....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999999877777899999999999999999999 8999999999999999999999999999999875443
Q ss_pred Ccc-eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 446 DSV-IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 446 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ......+........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i~~~~~~~~-------- 233 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKRMEC-------- 233 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTTCCCCC--------
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCC--------
Confidence 222 2334468899999999999999999999999999999998 9999986432 223333333222111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHh
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLE 574 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~ 574 (581)
+..+++++.+||.+||+.||++|||+.+|.+.|+.+.....+
T Consensus 234 ---------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 234 ---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp ---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred ---------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 123556788999999999999999999999999887655443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-53 Score=407.29 Aligned_cols=261 Identities=23% Similarity=0.395 Sum_probs=212.0
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
++...++|++.+.||+|+||.||+|.+++++.||||+++.... ..+.+.+|++++++++|||||++++++.+ +..++|
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 3445678999999999999999999998889999999976532 23578999999999999999999998754 567999
Q ss_pred EeccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 366 LEFMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
|||+++|+|.+++... ...+++..++.|+.||++||+||| +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 9999999999988643 334799999999999999999999 899999999999999999999999999999987543
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
. ........|++.|+|||++.++.++.++|||||||++|||+||..|+...... ......+........+
T Consensus 163 ~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~~i~~~~~~~~p-------- 232 (272)
T d1qpca_ 163 E-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLERGYRMVRP-------- 232 (272)
T ss_dssp C-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCCCCCC--------
T ss_pred c-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCCCCCc--------
Confidence 2 22334457899999999999899999999999999999999966655432222 1222222222211111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
..+++++.+||.+||+.||++|||++||++.|+.+..
T Consensus 233 ---------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 233 ---------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1345678899999999999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=408.22 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=206.1
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++.+.||+|+||.||+|+.+ +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999975 79999999997543 233467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||++||+|.+++...+. +++..++.++.|++.||+||| +.||+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 88 Ey~~gg~L~~~~~~~~~-l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccCC-CCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999999887654 789999999999999999999 89999999999999999999999999999998765444
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.... ..++
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i~~~~-~~~p---------- 230 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIFQKIIKLE-YDFP---------- 230 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHTTC-CCCC----------
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--HHHHHHHHcCC-CCCC----------
Confidence 4444556799999999999999999999999999999999999999976321 11111111111 1111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKL 565 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 565 (581)
..+++++.+||.+||+.||++|||++|++++-
T Consensus 231 -------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 231 -------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp -------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred -------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 12345688999999999999999999986653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-52 Score=410.39 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=194.6
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
...+.|++.+.||+|+||+||+|+.+ +|+.||||++.... ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34577999999999999999999965 78999999997654 23345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec---CCCcEEEeeccCceecC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD---ENMVAHVSDFGISKLLG 442 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a~~~~ 442 (581)
||||+||+|.+++.+.+ .+++..+..++.||+.||+||| ++||+||||||+||++. +++.+||+|||+|+...
T Consensus 86 mE~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp ECCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EeccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999998754 4899999999999999999999 89999999999999995 57899999999998764
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
... ......||+.|+|||++.+..++.++|||||||++|||++|++||.+.... .....+...... .+.
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~~~~~-~~~----- 230 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFEQILKAEYE-FDS----- 230 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHTTCCC-CCT-----
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCC-CCC-----
Confidence 332 233457999999999999999999999999999999999999999763221 122222221111 000
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+....+++++.+||.+||+.||++|||++|+++|
T Consensus 231 --------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 231 --------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0112345678899999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-52 Score=398.55 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=198.4
Q ss_pred CcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeec----CCeeeEEE
Q 008012 294 NECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCN----TNFKALVL 366 (581)
Q Consensus 294 ~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~ 366 (581)
++.++||+|+||+||+|.+. +++.||+|.+... .....+.+.+|++++++++||||+++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999965 7899999998654 34556789999999999999999999999865 34689999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeEec-CCCcEEEeeccCceecCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTP--VVHCDLKPSNILLD-ENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~ 443 (581)
||+++|+|.+++.+.. .+++..+..++.||++||+||| +++ |+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999998754 3789999999999999999999 777 99999999999997 578999999999986432
Q ss_pred CCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 444 GDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 444 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
. ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ............+...
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~----~~~~~~i~~~~~~~~~---- 234 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVTSGVKPASF---- 234 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHTTTCCCGGG----
T ss_pred C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH----HHHHHHHHcCCCCccc----
Confidence 2 2245679999999998876 6999999999999999999999999753222 2222221111111111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+++++.++|.+||+.||++|||++|+++|
T Consensus 235 ---------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 235 ---------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ---------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---------CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11234568899999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-51 Score=412.54 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=213.3
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999965 7999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec--CCCcEEEeeccCceecCCCCC
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD--ENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~--~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|+||+|.+++.+....+++..+..++.||+.||+||| ++||+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 9999999999876666899999999999999999999 89999999999999996 46799999999999875433
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.. +..... ..+.
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~-i~~~~~-~~~~--------- 246 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRN-VKSCDW-NMDD--------- 246 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH-HHHTCC-CSCC---------
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHH-HHhCCC-CCCc---------
Confidence 234567999999999999999999999999999999999999999763211 11212 211111 1110
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.....+++.+.+||.+||..||++|||++|+++|
T Consensus 247 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 ----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ----GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112345678899999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-53 Score=418.35 Aligned_cols=270 Identities=23% Similarity=0.275 Sum_probs=207.4
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
...++|++++.||+|+||+||+|+.. +|+.||+|+++... ......+.+|+.++++++|||||+++++|.+.+..++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678999999999999999999965 78999999997652 34456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||++||+|.+++.+.+. +++..+..++.|++.||+|||+ ..||+||||||+|||++.++++||+|||+|......
T Consensus 83 mEy~~gg~L~~~l~~~~~-l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EECCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEcCCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 999999999999987654 7999999999999999999993 248999999999999999999999999999866322
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHH--HhhCCCCCC-------
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWV--KESLPHGLP------- 516 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~--~~~~~~~~~------- 516 (581)
......||+.|+|||++.+..|+.++||||+||++|||++|+.||.............. .........
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 12345799999999999999999999999999999999999999976322211100000 000000000
Q ss_pred ----ccccc----cchhhh-------hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 517 ----KIADA----NLLREE-------NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 517 ----~~~~~----~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
...+. ...... +........+.++.+++.+||..||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000 000000 0000001234678899999999999999999999997
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-52 Score=412.89 Aligned_cols=258 Identities=25% Similarity=0.384 Sum_probs=212.6
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC-CC-----cEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeecC
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS-DG-----TTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNT 359 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 359 (581)
...++|++.+.||+|+||+||+|++. .+ ..||+|.+.... ......+.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 44578999999999999999999964 22 369999986543 34456788999999998 899999999999999
Q ss_pred CeeeEEEeccCCCCHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 008012 360 NFKALVLEFMPNGSLDKWLYSHN----------------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDL 417 (581)
Q Consensus 360 ~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~di 417 (581)
+..++|||||++|+|.+++.... ..+++..++.++.||++||+||| +++|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccC
Confidence 99999999999999999998643 24688999999999999999999 899999999
Q ss_pred CCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCcc
Q 008012 418 KPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEM 496 (581)
Q Consensus 418 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~ 496 (581)
||+||+++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |++||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987765554444556678999999999999999999999999999999998 89999764
Q ss_pred ccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 008012 497 FTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLK 566 (581)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 566 (581)
... ..+...+........+ ..+++++.+||.+||+.||++|||++||+++|.
T Consensus 271 ~~~-~~~~~~~~~~~~~~~p-----------------~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVD-ANFYKLIQNGFKMDQP-----------------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCS-HHHHHHHHTTCCCCCC-----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHH-HHHHHHHhcCCCCCCC-----------------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 322 2333444433222111 234567889999999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-51 Score=412.05 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=213.7
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
.++|++++.||+|+||.||+|... +|+.||||+++.........+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999964 7999999999877666667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec--CCCcEEEeeccCceecCCCCC
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD--ENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~--~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|+||+|.+++...+..+++.+++.++.||+.||+||| ++||+||||||+|||++ .++.+||+|||+|..+....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 9999999998877777899999999999999999999 89999999999999998 67899999999999875432
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
......||+.|+|||++.+..++.++||||+||++|||+||+.||.+.... .....+...... ++..
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~~~-~~~~-------- 250 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKRCDWE-FDED-------- 250 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHCCCC-CCSS--------
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCC-CCcc--------
Confidence 234567899999999999999999999999999999999999999763221 122222221111 1110
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....+++++.+||.+||+.||++|||++|+++|
T Consensus 251 -----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 251 -----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111345568899999999999999999999886
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=399.75 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=204.8
Q ss_pred CeecccccccEEEEEeC---CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEeccCC
Q 008012 297 NLLGSGGFGSVYKGILS---DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEFMPN 371 (581)
Q Consensus 297 ~~lg~G~~~~v~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 371 (581)
++||+|+||.||+|.++ +++.||||+++... ....+.+.+|++++++++|||||++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999854 35689999996543 3445689999999999999999999999865 457899999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc-ee
Q 008012 372 GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV-IQ 450 (581)
Q Consensus 372 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~ 450 (581)
|+|.+++.+... +++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.+....... ..
T Consensus 92 g~L~~~l~~~~~-l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhccC-CCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 999999987654 789999999999999999999 8999999999999999999999999999999775443322 23
Q ss_pred eccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchhhhhh
Q 008012 451 TMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENF 529 (581)
Q Consensus 451 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (581)
....||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ......+........+
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i~~~~~~~~p------------- 232 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCP------------- 232 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCCCCC-------------
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHHHHHcCCCCCCC-------------
Confidence 34578999999999999999999999999999999998 8999986422 2233333322211111
Q ss_pred hhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 530 FSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 530 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
..+++++.+||.+||+.||++|||+++|++.|+....+..
T Consensus 233 ----~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 233 ----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp ----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred ----cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 2345678899999999999999999999999988765443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=400.95 Aligned_cols=261 Identities=26% Similarity=0.439 Sum_probs=206.9
Q ss_pred hcCCCcCCeecccccccEEEEEeCC-C----cEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSD-G----TTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 363 (581)
.+.|+..+.||+|+||.||+|.+++ + ..||||+++... ......+.+|++++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 3568888999999999999999653 2 469999986543 444567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCC
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGE 443 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~ 443 (581)
+||||+.++++.+++......+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999999888777899999999999999999999 89999999999999999999999999999987654
Q ss_pred CCC-cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccccc
Q 008012 444 GDD-SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADAN 522 (581)
Q Consensus 444 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (581)
... ........||+.|+|||++.+..++.++|||||||++|||++|..|+...... ......+........
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~~~~~------- 234 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFRLPT------- 234 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTCCCCC-------
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHhccCCCCC-------
Confidence 322 22233456899999999999999999999999999999999976665443222 222233332222111
Q ss_pred chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 523 LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
+.+++.++.+||.+||+.||++|||++||++.|+++.+.
T Consensus 235 ----------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 235 ----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 123456788999999999999999999999999988753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=398.07 Aligned_cols=261 Identities=22% Similarity=0.352 Sum_probs=205.7
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC----CCcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
...++|++.+.||+|+||.||+|.+. .+..||||.++.. .....+.+.+|++++++++||||+++++++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 34578999999999999999999864 2356889988654 3445678999999999999999999999986 4678
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+++|+|.+++......+++..++.++.||++||+||| +++|+||||||+||+++.++.+||+|||+|+...
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999999998887777899999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
... ........||+.|+|||++.+..++.++|||||||++|||+| |.+||..... ......+........
T Consensus 160 ~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~i~~~~~~~~------ 230 (273)
T d1mp8a_ 160 DST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGERLPM------ 230 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCCCCC------
T ss_pred CCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCCC------
Confidence 332 223344568999999999999999999999999999999998 8999876432 223333333222111
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
+..+++++.+||.+||+.||++|||++||+++|+++.++-
T Consensus 231 -----------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 231 -----------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp -----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1234567889999999999999999999999999987663
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-51 Score=402.47 Aligned_cols=245 Identities=24% Similarity=0.321 Sum_probs=202.5
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
.|+.++.||+|+||.||+|+.. +|+.||||+++.. .....+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4889999999999999999965 7899999998654 24455678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
||++|++..++...+ .+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+|||+|......
T Consensus 96 ~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp CCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 999999977666544 4799999999999999999999 899999999999999999999999999999865332
Q ss_pred ceeeccccCccccCCCCCCC---CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccch
Q 008012 448 VIQTMTIATIGYMAPEFGSE---GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLL 524 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (581)
....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||.+.... ..+........ +....
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~~~i~~~~~----~~~~~---- 236 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNES----PALQS---- 236 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCC----CCCSC----
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCC----CCCCC----
Confidence 33569999999998754 46899999999999999999999999763221 11111111111 11111
Q ss_pred hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 525 REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+++.+.+||.+||+.||++|||++|+++|
T Consensus 237 ---------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 237 ---------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---------CCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1234568899999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=397.28 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=209.1
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch------HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL------EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNF 361 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 361 (581)
..++|++.+.||+|+||.||+|+.+ +|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3468999999999999999999965 79999999986542 1234678999999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC----cEEEeeccC
Q 008012 362 KALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM----VAHVSDFGI 437 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~----~~kl~Dfg~ 437 (581)
.|+|||||++|+|.+++.+.+ .+++..++.++.|++.||+||| +.+|+||||||+||+++.++ .+|++|||+
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999998765 4799999999999999999999 89999999999999998776 599999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
|........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+..... ..+
T Consensus 164 a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~~~~-~~~- 236 (293)
T d1jksa_ 164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSAVNY-EFE- 236 (293)
T ss_dssp CEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHTTCC-CCC-
T ss_pred hhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--HHHHHHHhcCC-CCC-
Confidence 988754332 33457899999999999999999999999999999999999999763211 11111111110 000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
......++..+.+||.+||+.||++|||++|+++|
T Consensus 237 ------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 237 ------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122456678899999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-51 Score=402.12 Aligned_cols=265 Identities=26% Similarity=0.417 Sum_probs=217.3
Q ss_pred hhhHHHhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeee
Q 008012 283 YLDLERATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSS 355 (581)
Q Consensus 283 ~~~~~~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 355 (581)
+.+++...++|++.+.||+|+||+||+|+++ +++.||||+++... .+..+.+.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3456666789999999999999999999864 35789999997653 3445779999999999999999999999
Q ss_pred eecCCeeeEEEeccCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 008012 356 CCNTNFKALVLEFMPNGSLDKWLYSHN-----------------------YFQDIPDRLNIMIDVALALEYLHHGHSTPV 412 (581)
Q Consensus 356 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i 412 (581)
+.+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +++|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCe
Confidence 999999999999999999999997432 23688899999999999999999 8999
Q ss_pred eecCCCCCCeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCC-C
Q 008012 413 VHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRK-K 491 (581)
Q Consensus 413 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~-~ 491 (581)
+||||||+|||++.++.+||+|||+|+...........+...+++.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998765544444445667899999999999999999999999999999999985 5
Q ss_pred CCCccccccccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 492 PTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 492 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
||...... .....+........ +..+++++.+||.+||+.||++||||.||++.|+++.
T Consensus 242 p~~~~~~~--e~~~~v~~~~~~~~-----------------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHE--EVIYYVRDGNILAC-----------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHH--HHHHHHHTTCCCCC-----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHH--HHHHHHHcCCCCCC-----------------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 67653222 22222322221111 1234557889999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=401.59 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=209.2
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCc----EEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGT----TVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 364 (581)
++|++++.||+|+||+||+|.+. +|+ .||+|.++... ....+.+.+|++++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999964 444 58888886543 33456799999999999999999999999865 4678
Q ss_pred EEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCC
Q 008012 365 VLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 365 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 444 (581)
++||+.+|+|.+++......+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 89999999999999988888999999999999999999999 899999999999999999999999999999987655
Q ss_pred CCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccc
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANL 523 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 523 (581)
..........||+.|+|||++.++.++.++|||||||++|||+| |++||..... ..+...+........+
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~~~~~~~p------- 235 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP------- 235 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHHTCCCCCC-------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCCCCC-------
Confidence 54444455578999999999999999999999999999999999 7888876432 2334444433222111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 524 LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
..+++.+.+++.+||+.||++|||+.|++++|+++...
T Consensus 236 ----------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 236 ----------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ----------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 23456788999999999999999999999999988653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=392.56 Aligned_cols=253 Identities=28% Similarity=0.423 Sum_probs=203.4
Q ss_pred hhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeec-CCeeeEEEe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN-TNFKALVLE 367 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 367 (581)
..++|++.+.||+|+||.||+|+++ |+.||||+++... ..+.+.+|++++++++||||++++|++.+ .+..++|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 3567888999999999999999986 7899999997654 33678999999999999999999999865 456899999
Q ss_pred ccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 368 FMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|+++|+|.+++.+.+ ..+++..++.|+.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 999999999997543 34789999999999999999999 899999999999999999999999999999865432
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
.....++..|+|||++.++.++.++|||||||++|||+| |++||... ........+........+
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~~~~~~~--------- 222 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKMDAP--------- 222 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTCCCCCC---------
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCCCCCC---------
Confidence 233467889999999999999999999999999999998 68887653 222333444332222211
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
..+++++.++|.+||+.||++|||+.|++++|++++..
T Consensus 223 --------~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 223 --------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp --------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 12345688999999999999999999999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=397.09 Aligned_cols=265 Identities=26% Similarity=0.396 Sum_probs=206.6
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeee
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSC 356 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 356 (581)
.++...++|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 34445678999999999999999999853 34689999997543 34456788888888887 789999999987
Q ss_pred ecC-CeeeEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 008012 357 CNT-NFKALVLEFMPNGSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPS 420 (581)
Q Consensus 357 ~~~-~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~ 420 (581)
... +..++|||||++|+|.+++.... ..+++..+..++.||++||+||| +++|+||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCcc
Confidence 654 46899999999999999997532 34788999999999999999999 899999999999
Q ss_pred CeEecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCC-CCCCccccc
Q 008012 421 NILLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRK-KPTDEMFTG 499 (581)
Q Consensus 421 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~-~Pf~~~~~~ 499 (581)
|||+++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. +||... ..
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~-~~ 242 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KI 242 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CC
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC-CH
Confidence 9999999999999999998765554444445567999999999999999999999999999999999975 567653 22
Q ss_pred cccHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 500 EMNLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
...+...+........++ .+++++.++|.+||+.||++|||++|++++|+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~-----------------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 243 DEEFCRRLKEGTRMRAPD-----------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp SHHHHHHHHHTCCCCCCT-----------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCc-----------------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 223333344333222221 234568899999999999999999999999998853
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=397.55 Aligned_cols=249 Identities=24% Similarity=0.267 Sum_probs=209.3
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
.++|++++.||+|+||.||+|+.+ +|+.||+|++++.. ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999965 89999999997653 22356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||++||+|.+++.+.+. +++..++.++.||+.||+||| ++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhcccC-CcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999999987654 688999999999999999999 8999999999999999999999999999998754322
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
. ......||+.|+|||++.+..|+.++||||+||++|||++|++||..... ..+...+.... ..++
T Consensus 160 ~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~~~~~~i~~~~-~~~p--------- 225 (337)
T d1o6la_ 160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILMEE-IRFP--------- 225 (337)
T ss_dssp C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC-CCCC---------
T ss_pred c--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--HHHHHHHhcCC-CCCC---------
Confidence 2 23456799999999999999999999999999999999999999976422 12222222211 1111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLY-----MKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 564 (581)
..+++++.+||.+||++||++||+ ++|+++|
T Consensus 226 --------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 226 --------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 123456789999999999999995 8888876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-51 Score=394.95 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=205.1
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
...++|++.+.||+|+||.||+|++++++.||||+++.... ..+.+.+|+.++++++|||||++++++.+ +..++|||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 34578999999999999999999998888899999976543 23578999999999999999999999854 56789999
Q ss_pred ccCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 368 FMPNGSLDKWLYSH-NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 368 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
|+++|+|..++... ...+++.+++.++.||+.||+||| +.||+||||||+|||+++++.+||+|||+|+.......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 99999999988743 345899999999999999999999 88999999999999999999999999999987643332
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.......||+.|+|||++.++.++.++|||||||++|||++|..||...... ......+........+
T Consensus 169 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~~~~~~---------- 236 (285)
T d1fmka3 169 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCP---------- 236 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCCCCCC----------
T ss_pred -eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCCCCCC----------
Confidence 2334457899999999999999999999999999999999976665443222 2222223322211111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIR 569 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~ 569 (581)
..+++++.++|.+||+.||++|||+++|++.|+...
T Consensus 237 -------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 237 -------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -------cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 234567889999999999999999999999888754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=395.97 Aligned_cols=253 Identities=19% Similarity=0.264 Sum_probs=211.2
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
..++|++.+.||+|+||+||+|.++ +++.||+|+++....+ ...+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4578999999999999999999975 7899999999876533 3568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC--CCcEEEeeccCceecCCCC
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE--NMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~~~~~~ 445 (581)
||+||+|.+++.+.+..+++.+++.++.||+.||+||| ++||+||||||+|||++. ...+||+|||++.......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999999887767899999999999999999999 899999999999999985 4589999999998764332
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
......+++.|+|||...+..++.++||||+||++|+|++|+.||...... .....+..... .++
T Consensus 159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~i~~~~~-~~~--------- 223 (321)
T d1tkia_ 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNAEY-TFD--------- 223 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCC-CCC---------
T ss_pred ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC-CCC---------
Confidence 234557899999999999999999999999999999999999999764221 11111111110 011
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
......+++++.+||.+||..||++|||++|+++|
T Consensus 224 ----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 224 ----EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01122345678899999999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-49 Score=390.55 Aligned_cols=245 Identities=26% Similarity=0.318 Sum_probs=206.5
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++++.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999965 79999999997653 223567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||++||+|..++..... .++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCcccccccccccc-ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 99999999998887654 688888999999999999999 899999999999999999999999999999986432
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||...... .....+.... ..++.
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~~~~-~~~p~--------- 222 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYEKILNAE-LRFPP--------- 222 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHCC-CCCCT---------
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--HHHHHHHcCC-CCCCC---------
Confidence 23457999999999999999999999999999999999999999763211 1111111111 11111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
.+++++.+++.+||..||++|| |++|+++|
T Consensus 223 --------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 223 --------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 2345678999999999999996 89999886
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.6e-50 Score=390.87 Aligned_cols=261 Identities=20% Similarity=0.331 Sum_probs=205.7
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC----
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ---LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN---- 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 360 (581)
..++|++.+.||+|+||.||+|... +|+.||||+++.. .....+.+.+|++++++++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 3578999999999999999999964 8999999999754 2445668999999999999999999999987644
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..|+||||++|++|.+++...+. +++.+++.++.||+.||+||| ++||+||||||+||+++.++..+++|||.+..
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~-l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred eEEEEEECCCCCEehhhhcccCC-CCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence 47899999999999999887654 789999999999999999999 89999999999999999999999999999886
Q ss_pred cCCCCC-cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 441 LGEGDD-SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 441 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
...... ........||+.|+|||++.+..++.++|||||||++|||+||++||......+ .....+.... ..+.
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~~~~~~~--~~~~-- 235 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-VAYQHVREDP--IPPS-- 235 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHCCC--CCGG--
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-HHHHHHhcCC--CCCc--
Confidence 643322 223345579999999999999999999999999999999999999997632211 1111111110 0111
Q ss_pred cccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-CHHHHHHHHHHhH
Q 008012 520 DANLLREENFFSARMDCLLSIFHLALDCCAELPDQRL-YMKDAATKLKKIR 569 (581)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~~~ 569 (581)
....++++++.++|.+||+.||++|| |++++++.|.+++
T Consensus 236 -----------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 236 -----------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -----------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 11123456788999999999999999 8999999998875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=389.46 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=200.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC--CC--cEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS--DG--TTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
.++|++.+.||+|+||.||+|+.. ++ ..||||+++... .+..+.+.+|++++++++||||++++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 357899999999999999999853 22 368999987642 3445689999999999999999999999976 467
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
++||||+++|++.+++......+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 8999999999999998877667899999999999999999999 8999999999999999999999999999999875
Q ss_pred CCCCcc-eeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 443 EGDDSV-IQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 443 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
...... ......++..|+|||++.+..++.++|||||||++|||+| |+.||...... .....+.. .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~~---~~~~~--- 234 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDK---EGERL--- 234 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHT---SCCCC---
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHHHh---CCCCC---
Confidence 543322 2334467889999999999999999999999999999998 89999763222 12122211 11000
Q ss_pred ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHh
Q 008012 521 ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKI 568 (581)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~ 568 (581)
+.+..++..+.+||.+||+.||++|||++||.+.|+++
T Consensus 235 ----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 ----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 01123456788999999999999999999999998875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-49 Score=384.24 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=207.8
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---------HHHHHHHHHHHHHHHhcC-CCccceEeeeeec
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---------EQAFRSFNSECEVLRNVR-HRNLIKILSSCCN 358 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 358 (581)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999964 79999999986532 233456889999999996 9999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
.+..|+||||+++|+|.+++...+ .+++..+..++.||++||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhe
Confidence 999999999999999999998765 4799999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCC------CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCC
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGS------EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLP 512 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 512 (581)
+.+..... .....||+.|+|||.+. ...++.++||||+||++|||++|+.||...... ............
T Consensus 158 ~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-~~~~~i~~~~~~ 233 (277)
T d1phka_ 158 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMSGNYQ 233 (277)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCC
T ss_pred eEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-HHHHHHHhCCCC
Confidence 98754332 34467999999999764 345788999999999999999999999864221 112222222111
Q ss_pred CCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 513 HGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
. +. +....+++++.+++.+||+.||++|||++||++|
T Consensus 234 ~--~~-------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 234 F--GS-------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp C--CT-------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred C--CC-------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 10 1112455678899999999999999999999876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.9e-49 Score=396.58 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=202.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH------HHHHHHHHHHHHHHhcCCCccceEeeeeecCCee
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE------QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFK 362 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 362 (581)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... .......+|+++++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999965 799999999865421 1122233456677777899999999999999999
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
|+||||++||+|.+++.+... +++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHhccc-ccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999987654 688999999999999999999 8999999999999999999999999999999775
Q ss_pred CCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccc
Q 008012 443 EGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADA 521 (581)
Q Consensus 443 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (581)
... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... .............. ..
T Consensus 159 ~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~~~~~~-~~--- 228 (364)
T d1omwa3 159 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTMAV-EL--- 228 (364)
T ss_dssp SSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHHHHSSSCCC-CC---
T ss_pred CCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcccCCC-CC---
Confidence 432 234579999999998864 56899999999999999999999999764222 22222222221111 00
Q ss_pred cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 008012 522 NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLY-----MKDAATK 564 (581)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 564 (581)
+..+++++.+||.+||+.||++||| ++|+++|
T Consensus 229 -----------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 229 -----------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -----------CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -----------CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0123456889999999999999999 7888876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=391.63 Aligned_cols=263 Identities=24% Similarity=0.367 Sum_probs=220.1
Q ss_pred HhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeeecC
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCCNT 359 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 359 (581)
...++|++.+.||+|+||.||+|++. +++.||||+++... ......+.+|+.+++++ +|||||++++++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 44578999999999999999999852 46789999997653 44556789999999999 699999999999999
Q ss_pred CeeeEEEeccCCCCHHHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCe
Q 008012 360 NFKALVLEFMPNGSLDKWLYSHN-----------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNI 422 (581)
Q Consensus 360 ~~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Ni 422 (581)
+..++|||||++|+|.+++.... ..+++..+..++.||+.||+||| +++++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccc
Confidence 99999999999999999998543 24788999999999999999999 89999999999999
Q ss_pred EecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhC-CCCCCccccccc
Q 008012 423 LLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTR-KKPTDEMFTGEM 501 (581)
Q Consensus 423 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg-~~Pf~~~~~~~~ 501 (581)
+++.++.+|++|||.++...............||+.|+|||++.++.++.++|||||||++|||+|+ .+||.. .....
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~-~~~~~ 255 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-MPVDS 255 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCSSH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC-CCHHH
Confidence 9999999999999999987665555555667899999999999999999999999999999999995 555544 33334
Q ss_pred cHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 502 NLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
.+...+........+. .++..+.+||.+||+.||++|||++||++.|+++..+
T Consensus 256 ~~~~~i~~~~~~~~~~-----------------~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 256 KFYKMIKEGFRMLSPE-----------------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHHTCCCCCCT-----------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCcc-----------------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 4455555544332221 2345688999999999999999999999999887554
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=388.53 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=212.5
Q ss_pred HhhcCCCcCCeecccccccEEEEEeCC--------CcEEEEEEeccch-HHHHHHHHHHHHHHHhc-CCCccceEeeeee
Q 008012 288 RATDGFNECNLLGSGGFGSVYKGILSD--------GTTVAIKIFNLQL-EQAFRSFNSECEVLRNV-RHRNLIKILSSCC 357 (581)
Q Consensus 288 ~~~~~y~~~~~lg~G~~~~v~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 357 (581)
...++|++.+.||+|+||.||+|+... +..||||+++.+. ......+.+|...+.++ +||||+++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 445789999999999999999998531 2479999997664 34557788999999998 8999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCe
Q 008012 358 NTNFKALVLEFMPNGSLDKWLYSHN---------------YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNI 422 (581)
Q Consensus 358 ~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Ni 422 (581)
+.+..++||||+++|+|.+++.... ..+++.+++.++.||+.||+||| +.+|+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccce
Confidence 9999999999999999999997553 34799999999999999999999 89999999999999
Q ss_pred EecCCCcEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHh-CCCCCCccccccc
Q 008012 423 LLDENMVAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFT-RKKPTDEMFTGEM 501 (581)
Q Consensus 423 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~Pf~~~~~~~~ 501 (581)
|++.++.+||+|||++................+++.|+|||.+.++.|+.++|||||||++|||++ |.+||......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-- 244 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 244 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--
Confidence 999999999999999998765554444556678999999999999999999999999999999998 68888653222
Q ss_pred cHHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 502 NLKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
.....+........+ ..+++.+.+||.+||+.||++|||+.||++.|+++.+
T Consensus 245 ~~~~~i~~~~~~~~p-----------------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 ELFKLLKEGHRMDKP-----------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHHTTCCCCCC-----------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCC-----------------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 223333332222111 1234568899999999999999999999999998854
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=387.25 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=210.8
Q ss_pred CCeecccccccEEEEEeCC----CcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeec-CCeeeEEEecc
Q 008012 296 CNLLGSGGFGSVYKGILSD----GTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCN-TNFKALVLEFM 369 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 369 (581)
.++||+|+||+||+|++.+ ...||||.++.. .....+.+.+|++++++++||||++++|++.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999999642 235899998753 45566889999999999999999999999865 56889999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc--
Q 008012 370 PNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS-- 447 (581)
Q Consensus 370 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-- 447 (581)
++|+|.+++.......++..++.++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999988777888999999999999999999 899999999999999999999999999999876543322
Q ss_pred ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhhh
Q 008012 448 VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLREE 527 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (581)
.......||+.|+|||.+.+..++.++||||||+++|||+||+.||....... .....+........+
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~~~~p----------- 256 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRRLLQP----------- 256 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCCCCC-----------
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCCCCCc-----------
Confidence 12234568999999999999999999999999999999999888876543332 223333322221111
Q ss_pred hhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHHhh
Q 008012 528 NFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFLED 575 (581)
Q Consensus 528 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~ 575 (581)
..+++++.+||.+||+.||++|||+.||+++|+++.+.+...
T Consensus 257 ------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 257 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 124457889999999999999999999999999998776543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=391.97 Aligned_cols=253 Identities=20% Similarity=0.267 Sum_probs=201.8
Q ss_pred hhcCCCcCC-eecccccccEEEEEe-CCCcEEEEEEeccchHHHHHHHHHHHHHHHhc-CCCccceEeeeeec----CCe
Q 008012 289 ATDGFNECN-LLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLEQAFRSFNSECEVLRNV-RHRNLIKILSSCCN----TNF 361 (581)
Q Consensus 289 ~~~~y~~~~-~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~ 361 (581)
..++|.+.+ .||+|+||.||+|++ .+++.||||+++.. ..+.+|++++.++ +||||++++++|.+ ...
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 356898875 599999999999996 47999999999754 3466799987665 89999999999865 467
Q ss_pred eeEEEeccCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC---CCcEEEeeccC
Q 008012 362 KALVLEFMPNGSLDKWLYSHN-YFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE---NMVAHVSDFGI 437 (581)
Q Consensus 362 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~ 437 (581)
.|+|||||+||+|.+++.+.+ ..+++.+++.++.||+.||+||| +.||+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccce
Confidence 899999999999999998653 45899999999999999999999 899999999999999985 56799999999
Q ss_pred ceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 438 SKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 438 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
|+....... .....||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.... .....+.......-..
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~--~~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKTRIRMGQYE 235 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCSSS
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH--HHHHHHHHHHhcCCCC
Confidence 987654332 34557999999999999999999999999999999999999999763221 1111111111110000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
. .......+++++.+||.+||+.||++|||+.|+++|
T Consensus 236 ~----------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 236 F----------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp C----------CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C----------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 011233567789999999999999999999999886
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-49 Score=394.43 Aligned_cols=245 Identities=22% Similarity=0.273 Sum_probs=207.2
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++|++++.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 67999999999999999999965 79999999997543 223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCC
Q 008012 367 EFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDD 446 (581)
Q Consensus 367 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 446 (581)
||+.+|+|.+++.+.+. +++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~~-l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 99999999999987654 799999999999999999999 899999999999999999999999999999987432
Q ss_pred cceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchhh
Q 008012 447 SVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLRE 526 (581)
Q Consensus 447 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (581)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+..... ..+
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~~~~-~~p---------- 258 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSGKV-RFP---------- 258 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCC-CCC----------
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHHHHHHHhcCCC-CCC----------
Confidence 234579999999999999999999999999999999999999997632 1112222221111 111
Q ss_pred hhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 527 ENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 527 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
..+++++.++|.+||..||++|+ |++|+++|
T Consensus 259 -------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 259 -------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 12345688999999999999994 89999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=388.94 Aligned_cols=248 Identities=25% Similarity=0.323 Sum_probs=204.6
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch---HHHHHHHHHHHHHHH-hcCCCccceEeeeeecCCeeeEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL---EQAFRSFNSECEVLR-NVRHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 365 (581)
++|++.+.||+|+||+||+|+.+ +|+.||||++++.. ....+.+..|..++. .++||||+++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999965 79999999997643 223445667777665 68999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGD 445 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 445 (581)
|||+++|+|.+++..... +++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999999999987654 688999999999999999999 8999999999999999999999999999998654332
Q ss_pred CcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccccccchh
Q 008012 446 DSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIADANLLR 525 (581)
Q Consensus 446 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 525 (581)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||.+... ..+...+....+ .++
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~~-~~p--------- 223 (320)
T d1xjda_ 158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDNP-FYP--------- 223 (320)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC-CCC---------
T ss_pred --ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCC-CCC---------
Confidence 223456799999999999999999999999999999999999999976322 222222222111 111
Q ss_pred hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHH-HHHHH
Q 008012 526 EENFFSARMDCLLSIFHLALDCCAELPDQRLYMK-DAATK 564 (581)
Q Consensus 526 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 564 (581)
..+++++.+||.+||..||++|||+. |+++|
T Consensus 224 --------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 224 --------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp --------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred --------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 12345688999999999999999995 77653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=387.94 Aligned_cols=270 Identities=21% Similarity=0.295 Sum_probs=204.7
Q ss_pred hcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC----eeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN----FKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 365 (581)
+++|...+.||+|+||.||+|+.. |+.||||+++..... ......|+..+.+++||||+++++++.+.+ ..++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 456778899999999999999974 899999999765432 222334555666789999999999997643 67999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG-----HSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
|||+++|+|.+++++.. +++..++.++.|++.||+|||.. +++||+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999999998764 68999999999999999999942 247999999999999999999999999999998
Q ss_pred cCCCCCcc--eeeccccCccccCCCCCCCC------CCCccccHHHHHHHHHHHHhCCCCCCcccccc----------cc
Q 008012 441 LGEGDDSV--IQTMTIATIGYMAPEFGSEG------NVSSKCDVYSYGILLLETFTRKKPTDEMFTGE----------MN 502 (581)
Q Consensus 441 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~----------~~ 502 (581)
........ ......||+.|+|||++.+. .++.++|||||||++|||+||..||....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 75443322 23456799999999987764 36778999999999999999998875432221 11
Q ss_pred HHHHHHhhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHH
Q 008012 503 LKNWVKESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDK 571 (581)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 571 (581)
.............. +.+ +......+++..+.+++.+||+.||++|||+.||+++|+++.++
T Consensus 238 ~~~~~~~~~~~~~~----p~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 238 VEEMRKVVCEQKLR----PNI----PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTTSCCC----CCC----CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccccC----CCC----CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 11111111111111 111 11112234566789999999999999999999999999998754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=387.73 Aligned_cols=268 Identities=23% Similarity=0.278 Sum_probs=204.0
Q ss_pred cCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccchH--HHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 291 DGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQLE--QAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
++|++++.||+|+||+||+|.+ .+|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999996 4799999999976532 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
|+.++.+..........+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 99765444444455666899999999999999999999 89999999999999999999999999999987643322
Q ss_pred ceeeccccCccccCCCCCCCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---CCcccc-cc
Q 008012 448 VIQTMTIATIGYMAPEFGSEGN-VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---LPKIAD-AN 522 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~-~~ 522 (581)
......||+.|+|||++.... ++.++||||+||++|+|++|+.||...... ..+........... .+.... +.
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-HHHHHHHHhcCCCchhhccccccccc
Confidence 234457999999999776655 578999999999999999999999764221 12222222111110 000000 00
Q ss_pred c------hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 523 L------LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 523 ~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
. ............++.++.+|+.+||..||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 00000111122345678899999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-49 Score=386.53 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=205.7
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCc--EEEEEEeccc-hHHHHHHHHHHHHHHHhc-CCCccceEeeeeecCCeeeEE
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGT--TVAIKIFNLQ-LEQAFRSFNSECEVLRNV-RHRNLIKILSSCCNTNFKALV 365 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 365 (581)
++|++.+.||+|+||.||+|.++ +|. .||||.++.. ..+..+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67888999999999999999965 454 4778877544 344556799999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcE
Q 008012 366 LEFMPNGSLDKWLYSH---------------NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVA 430 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~ 430 (581)
|||+++|+|.+++... ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 9999999999999754 356799999999999999999999 8999999999999999999999
Q ss_pred EEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCC-CCCccccccccHHHHHHh
Q 008012 431 HVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKK-PTDEMFTGEMNLKNWVKE 509 (581)
Q Consensus 431 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~-Pf~~~~~~~~~~~~~~~~ 509 (581)
||+|||+|+...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||... ....+...+..
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--~~~~~~~~i~~ 241 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYEKLPQ 241 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHGGG
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--CHHHHHHHHHh
Confidence 999999998653222 2234468999999999999999999999999999999999764 56542 11222222222
Q ss_pred hCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 510 SLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
..... .+..+++++.+||.+||+.||++||||+||+++|+++.++.
T Consensus 242 ~~~~~-----------------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 242 GYRLE-----------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp TCCCC-----------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cCCCC-----------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 11111 11234567889999999999999999999999999987543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=383.89 Aligned_cols=263 Identities=24% Similarity=0.258 Sum_probs=197.2
Q ss_pred cCCeecccccccEEEEEeC-CCcEEEEEEeccchHH-----HHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 295 ECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQ-----AFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 295 ~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
.+++||+|+||+||+|+++ +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4578999999999999965 7999999998755321 234688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
++++++..+. ..+..+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence 9887666554 44455788999999999999999999 89999999999999999999999999999987644322
Q ss_pred eeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---CCccccc---
Q 008012 449 IQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---LPKIADA--- 521 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--- 521 (581)
......||+.|+|||++.+ ..++.++||||+||++|||+||++||...... ..+........... .+.....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHhcCCCChhhccchhccchh
Confidence 2234578999999998765 46799999999999999999999999764221 11222221111100 1100000
Q ss_pred c---chhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 N---LLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 ~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
. .....+........++.+.+|+.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 000000111112345678899999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=388.04 Aligned_cols=265 Identities=23% Similarity=0.358 Sum_probs=215.3
Q ss_pred HHHhhcCCCcCCeecccccccEEEEEeC------CCcEEEEEEeccc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeec
Q 008012 286 LERATDGFNECNLLGSGGFGSVYKGILS------DGTTVAIKIFNLQ-LEQAFRSFNSECEVLRNVRHRNLIKILSSCCN 358 (581)
Q Consensus 286 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 358 (581)
++...++|++.+.||+|+||.||+|.++ +++.||||+++.. .......+.+|++++++++||||+++++++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 4455688999999999999999999863 3578999999754 34455678999999999999999999999999
Q ss_pred CCeeeEEEeccCCCCHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCc
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSH---------NYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMV 429 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~ 429 (581)
.+..++||||+++|+|.+++... ....++..+..++.|+++||.||| +++|+||||||+|||++++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCce
Confidence 99999999999999999998742 134688899999999999999999 889999999999999999999
Q ss_pred EEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCC-CCCCccccccccHHHHHH
Q 008012 430 AHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRK-KPTDEMFTGEMNLKNWVK 508 (581)
Q Consensus 430 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~-~Pf~~~~~~~~~~~~~~~ 508 (581)
+||+|||+|+...............+++.|+|||.+.+..++.++|||||||++|||+||. +||.... .. .....+.
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-~~-~~~~~i~ 249 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NE-QVLRFVM 249 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-HH-HHHHHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-HH-HHHHHHH
Confidence 9999999998775444433344456899999999999999999999999999999999985 6665431 11 1122222
Q ss_pred hhCCCCCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHH
Q 008012 509 ESLPHGLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKF 572 (581)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 572 (581)
....... +..++..+.++|.+||+.||++|||++||+++|++..+..
T Consensus 250 ~~~~~~~-----------------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 250 EGGLLDK-----------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp TTCCCCC-----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred hCCCCCC-----------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 2111111 1134567899999999999999999999999998775433
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-47 Score=375.62 Aligned_cols=267 Identities=21% Similarity=0.267 Sum_probs=202.7
Q ss_pred cCCCcCCeecccccccEEEEEeCCCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEec
Q 008012 291 DGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLEF 368 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 368 (581)
++|++++.||+|+||+||+|++++|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999899999999996653 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCcc
Q 008012 369 MPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDSV 448 (581)
Q Consensus 369 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 448 (581)
+.++.+..+. .....+++..+..++.||+.||+||| +.||+||||||+|||++.++.+|++|||.|........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 155 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence 9776555554 44456899999999999999999999 89999999999999999999999999999987643322
Q ss_pred eeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---CCccccc---
Q 008012 449 IQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---LPKIADA--- 521 (581)
Q Consensus 449 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--- 521 (581)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+........... .+.....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhccchhhhhhc
Confidence 2344568999999998765 456899999999999999999999997642221 1222222111111 1100000
Q ss_pred --cc--hhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 522 --NL--LREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 522 --~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.. ....+........++.+.+++.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00000111122345678899999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=375.30 Aligned_cols=241 Identities=25% Similarity=0.269 Sum_probs=198.0
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchH------HHHHHHHHHHHHHHhcC--CCccceEeeeeecCC
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE------QAFRSFNSECEVLRNVR--HRNLIKILSSCCNTN 360 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 360 (581)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.... .....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 467999999999999999999965 799999999875421 11234668999999996 899999999999999
Q ss_pred eeeEEEeccCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-CCcEEEeeccCc
Q 008012 361 FKALVLEFMPN-GSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE-NMVAHVSDFGIS 438 (581)
Q Consensus 361 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a 438 (581)
..++||||+.+ +++.+++.... .+++.+++.++.||++||+||| ++||+||||||+||+++. ++.+||+|||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence 99999999976 57888887654 4789999999999999999999 899999999999999985 579999999999
Q ss_pred eecCCCCCcceeeccccCccccCCCCCCCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCc
Q 008012 439 KLLGEGDDSVIQTMTIATIGYMAPEFGSEGNV-SSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPK 517 (581)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 517 (581)
....... .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... +...... .++
T Consensus 159 ~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~~~--~~~- 224 (273)
T d1xwsa_ 159 ALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV--FFR- 224 (273)
T ss_dssp EECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC--CCS-
T ss_pred eeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhccc--CCC-
Confidence 8754322 344679999999999887665 567999999999999999999997521 1111110 111
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
..+++++.++|.+||+.||++|||++|+++|
T Consensus 225 ----------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 225 ----------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------------CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1234568899999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=378.18 Aligned_cols=269 Identities=23% Similarity=0.283 Sum_probs=202.8
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-C-CcEEEEEEeccchH--HHHHHHHHHHHHHHhc---CCCccceEeeeeec---
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-D-GTTVAIKIFNLQLE--QAFRSFNSECEVLRNV---RHRNLIKILSSCCN--- 358 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~--- 358 (581)
..++|++++.||+|+||+||+|++. + ++.||||+++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3578999999999999999999964 4 66799999865421 1223455777777666 79999999999853
Q ss_pred --CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeecc
Q 008012 359 --TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFG 436 (581)
Q Consensus 359 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 436 (581)
....+++|||++++++..........+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence 34789999999988777666666667899999999999999999999 8999999999999999999999999999
Q ss_pred CceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC--
Q 008012 437 ISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG-- 514 (581)
Q Consensus 437 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~-- 514 (581)
.+...... .......||+.|+|||++.+..|+.++||||+||++|||++|++||..... ...+...........
T Consensus 162 ~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCGG
T ss_pred hhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCchh
Confidence 98865322 233456799999999999999999999999999999999999999976422 122222222111110
Q ss_pred -CCccc---cccch--hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 515 -LPKIA---DANLL--REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 515 -~~~~~---~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.+... ..... ...+........++.+.+|+.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 00000 0000111122345678899999999999999999999886
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=370.10 Aligned_cols=269 Identities=20% Similarity=0.234 Sum_probs=200.0
Q ss_pred hhcCCCcCCeecccccccEEEEEe-CCCcEEEEEEeccch-HHHHHHHHHHHHHHHhcCCCccceEeeeeecCC----ee
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGIL-SDGTTVAIKIFNLQL-EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN----FK 362 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~ 362 (581)
..++|++++.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 456799999999999999999996 489999999997543 445678899999999999999999999986643 23
Q ss_pred eEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecC
Q 008012 363 ALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLG 442 (581)
Q Consensus 363 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~ 442 (581)
+++++|+.+|+|.+++...+ +++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~--l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeecCCchhhhhhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 45556677999999998653 799999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCCc-ceeeccccCccccCCCCCC-CCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 443 EGDDS-VIQTMTIATIGYMAPEFGS-EGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 443 ~~~~~-~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
..... .......|++.|+|||++. +..++.++||||+||++|||++|+.||......+ ..................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQEDLN 238 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH--HHHHHhhhccCCChhhhh
Confidence 33221 1234457899999999874 4567899999999999999999999997642211 111111111110000000
Q ss_pred ccch-------------hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ANLL-------------REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.... ...+........+.++.+|+.+||+.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 0000001112334578899999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.3e-45 Score=357.23 Aligned_cols=265 Identities=14% Similarity=0.135 Sum_probs=213.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCC-CccceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRH-RNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 367 (581)
.++|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+|++.++.+.| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999965 789999999865432 2356789999999965 899999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecC-----CCcEEEeeccCceecC
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDE-----NMVAHVSDFGISKLLG 442 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~-----~~~~kl~Dfg~a~~~~ 442 (581)
|+ +++|.+++...+..++..++..++.|++.||+||| +.||+||||||+||+++. ++.+||+|||+|+.+.
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 68999999887777899999999999999999999 899999999999999974 5789999999999875
Q ss_pred CCCCc-----ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHhhCCCCCC
Q 008012 443 EGDDS-----VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMN-LKNWVKESLPHGLP 516 (581)
Q Consensus 443 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~ 516 (581)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......... ....+......
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~--- 234 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS--- 234 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH---
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC---
Confidence 43221 1233457999999999999999999999999999999999999999764322111 11111111000
Q ss_pred ccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHHHHH
Q 008012 517 KIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRDKFL 573 (581)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 573 (581)
.+.......+|+++.+++..|+..+|++||+++.+.+.|+++.++..
T Consensus 235 ----------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 235 ----------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp ----------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ----------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 00011123456789999999999999999999999999988876554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=365.63 Aligned_cols=269 Identities=19% Similarity=0.255 Sum_probs=198.2
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeec--------
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCN-------- 358 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 358 (581)
.++|++++.||+|+||+||+|++. +|+.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999964 89999999986542 2334568899999999999999999998754
Q ss_pred CCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCc
Q 008012 359 TNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGIS 438 (581)
Q Consensus 359 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 438 (581)
.+..++||||+.++.+. ........+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence 34689999999876555 44444556789999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcc--eeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCC
Q 008012 439 KLLGEGDDSV--IQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGL 515 (581)
Q Consensus 439 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 515 (581)
..+....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLCGSIT 242 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH--HHHHHHHHHhcCCCC
Confidence 8765433221 22334689999999987654 689999999999999999999999976322 122222222211111
Q ss_pred Cc----cccccchh----------hhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 516 PK----IADANLLR----------EENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 516 ~~----~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+. ........ ............+.+.+||.+||+.||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 10 00000000 000011112234567899999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-45 Score=361.19 Aligned_cols=261 Identities=16% Similarity=0.202 Sum_probs=204.7
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCc-cceEeeeeecCCeeeEEEe
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRN-LIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e 367 (581)
.++|++.+.||+|+||.||+|++. +|+.||||++...... ..+.+|+++++.++|++ |+.+.+++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 467999999999999999999964 7899999998765322 35778999999997666 4555566677888999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEec---CCCcEEEeeccCceecCCC
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGEG 444 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a~~~~~~ 444 (581)
|+ ++++.+.+......+++..+..++.|++.||+||| ++||+||||||+||+++ .+..+||+|||+|+.+...
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99 56888888777777899999999999999999999 89999999999999986 4557999999999987543
Q ss_pred CCc-----ceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccH--HHHHHhhCCCCCCc
Q 008012 445 DDS-----VIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNL--KNWVKESLPHGLPK 517 (581)
Q Consensus 445 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~--~~~~~~~~~~~~~~ 517 (581)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......... ..........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~---- 235 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---- 235 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS----
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC----
Confidence 321 12334579999999999999999999999999999999999999997643322111 1111100000
Q ss_pred cccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHHhHH
Q 008012 518 IADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATKLKKIRD 570 (581)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 570 (581)
+.......+++++.++|..||+.||++||+++++.+.|+.+..
T Consensus 236 ----------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 236 ----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ----------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0011123466789999999999999999999999998887754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=361.19 Aligned_cols=268 Identities=20% Similarity=0.244 Sum_probs=207.7
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecCCeeeEEEe
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNTNFKALVLE 367 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 367 (581)
++|++++.||+|+||+||+|++. +++.||||+++... ......+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999965 88999999986543 3456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCceecCCCCCc
Q 008012 368 FMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKLLGEGDDS 447 (581)
Q Consensus 368 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 447 (581)
++.++++..++...+ ..++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||.|........
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred ecccccccccccccc-ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence 999988888776554 4788999999999999999999 89999999999999999999999999999998754332
Q ss_pred ceeeccccCccccCCCCCCCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCC---CCccc---c
Q 008012 448 VIQTMTIATIGYMAPEFGSEGN-VSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHG---LPKIA---D 520 (581)
Q Consensus 448 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~---~ 520 (581)
......++..|+|||.+.+.. ++.++||||+||++|||++|+.||....+....+........... .+... +
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 233446788999999877654 689999999999999999999997543222222222222111110 00000 0
Q ss_pred ----ccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ----ANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
................++.+.+|+.+||+.||++||||+|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000001111222345678899999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=368.66 Aligned_cols=268 Identities=22% Similarity=0.273 Sum_probs=200.0
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeecCC-----
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCNTN----- 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 360 (581)
..++|++++.||+|+||+||+|.+. +|+.||||+++.. .....+.+.+|++++++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3578999999999999999999965 7999999999754 3455678899999999999999999999997654
Q ss_pred -eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCce
Q 008012 361 -FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISK 439 (581)
Q Consensus 361 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 439 (581)
+.|+||||+ +.+|..++... .+++..++.++.||+.||+||| ++||+||||||+|||++.++.+|++|||.|.
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence 579999999 66888877654 3799999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 440 LLGEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
..... .+...||+.|+|||++.+ ..++.++||||+||++|+|++|++||..... ...+........... ...
T Consensus 170 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~-~~~ 242 (346)
T d1cm8a_ 170 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPP-AEF 242 (346)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCC-HHH
T ss_pred ccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-HHHHHHHHhccCCCc-HHH
Confidence 76432 234578999999998765 4578999999999999999999999976421 111111111111100 000
Q ss_pred cccc---c----h------hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHHhH
Q 008012 519 ADAN---L----L------REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK--LKKIR 569 (581)
Q Consensus 519 ~~~~---~----~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~~ 569 (581)
.... . . ...........+++.+.+||.+||..||++|||++|+++| ++.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000 0 0 0000001112345668899999999999999999999997 65554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=370.74 Aligned_cols=261 Identities=25% Similarity=0.319 Sum_probs=196.6
Q ss_pred CCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCccceEeeeeec------CCeeeE
Q 008012 292 GFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRNLIKILSSCCN------TNFKAL 364 (581)
Q Consensus 292 ~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~l 364 (581)
+|+.+++||+|+||+||+|++. +|+.||||+++.... ...+|++++++++||||+++++++.. ..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999975 799999999976532 23479999999999999999999854 235789
Q ss_pred EEeccCCCCHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC-cEEEeeccCceec
Q 008012 365 VLEFMPNGSLDKWLY--SHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM-VAHVSDFGISKLL 441 (581)
Q Consensus 365 v~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~ 441 (581)
||||++++.+..... .....+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998754433332 34556899999999999999999999 89999999999999999765 8999999999877
Q ss_pred CCCCCcceeeccccCccccCCCCCCC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHH-----------h
Q 008012 442 GEGDDSVIQTMTIATIGYMAPEFGSE-GNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVK-----------E 509 (581)
Q Consensus 442 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~-----------~ 509 (581)
..... .....|++.|+|||.+.+ ..++.++||||+||++|||++|++||...... ..+...+. .
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHHhhhh
Confidence 54332 234579999999997654 57899999999999999999999999764221 11222211 1
Q ss_pred hCCC----CCCccccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHHh
Q 008012 510 SLPH----GLPKIADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK--LKKI 568 (581)
Q Consensus 510 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~~ 568 (581)
.... .++........ .......++++.+|+.+||..||++|||+.|+++| ++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWT-----KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGG-----GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccchhhccccccccCchh-----hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 1100 01111110000 00112345678899999999999999999999986 4444
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.7e-45 Score=362.34 Aligned_cols=262 Identities=19% Similarity=0.259 Sum_probs=199.9
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-CCccceEeeeeec--CCeeeEE
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSSCCN--TNFKALV 365 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv 365 (581)
.++|+++++||+|+||+||+|+.. +|+.||||+++.... +.+.+|++++++++ ||||+++++++.. ....++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCH---HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHH---HHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 367999999999999999999964 799999999976543 46788999999995 9999999999874 4568999
Q ss_pred EeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC-cEEEeeccCceecCCC
Q 008012 366 LEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM-VAHVSDFGISKLLGEG 444 (581)
Q Consensus 366 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~ 444 (581)
|||+++++|..+. ..+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|......
T Consensus 111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999987653 34789999999999999999999 89999999999999998654 6999999999877543
Q ss_pred CCcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHH------------HHhhC
Q 008012 445 DDSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNW------------VKESL 511 (581)
Q Consensus 445 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~------------~~~~~ 511 (581)
.. .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....+........ .....
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 32 3455789999999987664 57999999999999999999999997643221111111 11100
Q ss_pred CCCCCcc---ccc---cchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 512 PHGLPKI---ADA---NLLREENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 512 ~~~~~~~---~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
....... ... ..............+++++.+||.+||..||++|||++|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 000 0000011111223456678899999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=363.18 Aligned_cols=263 Identities=21% Similarity=0.199 Sum_probs=194.1
Q ss_pred hcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeec------CC
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQ--LEQAFRSFNSECEVLRNVRHRNLIKILSSCCN------TN 360 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 360 (581)
.++|+++++||+|+||+||+|.+. +|+.||||+++.. .......+.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 468999999999999999999965 7999999999754 24455678999999999999999999999854 46
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
+.|+||||+.++ +.+.+. ..+++..++.++.||+.||+||| +.||+||||||+|||++.++.+|++|||.++.
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eeEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhc
Confidence 889999999765 444443 24789999999999999999999 89999999999999999999999999999886
Q ss_pred cCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcccc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIAD 520 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (581)
..... ......+|+.|+|||++.+..++.++||||+||++|+|++|++||...... ......+.... ...++...
T Consensus 169 ~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~-~~~~~~~~ 243 (355)
T d2b1pa1 169 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLG-TPCPEFMK 243 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC-CCCHHHHT
T ss_pred ccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhcc-CCCHHHHH
Confidence 54322 334557899999999999999999999999999999999999999753211 11111111111 10000000
Q ss_pred ---------------------ccch---hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 521 ---------------------ANLL---REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 521 ---------------------~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
+... ............+..+.+|+.+||..||++||||+|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0001112334567789999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=364.31 Aligned_cols=254 Identities=23% Similarity=0.283 Sum_probs=203.4
Q ss_pred hcCCCcCCeecccccccEEEEEeC----CCcEEEEEEeccch----HHHHHHHHHHHHHHHhcCC-CccceEeeeeecCC
Q 008012 290 TDGFNECNLLGSGGFGSVYKGILS----DGTTVAIKIFNLQL----EQAFRSFNSECEVLRNVRH-RNLIKILSSCCNTN 360 (581)
Q Consensus 290 ~~~y~~~~~lg~G~~~~v~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~ 360 (581)
.++|++++.||+|+||+||+|... +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 367999999999999999999842 58899999986532 2234567889999999966 89999999999999
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..++||||+.+|+|.+++...+. .++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999987665 577889999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCcceeeccccCccccCCCCCCCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCcc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSEG--NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKI 518 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (581)
+..... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||....... ..............+
T Consensus 179 ~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-~~~~i~~~~~~~~~~-- 254 (322)
T d1vzoa_ 179 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSEPP-- 254 (322)
T ss_dssp CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHCCCC--
T ss_pred hccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcccCCCC--
Confidence 643322 223456799999999987654 57889999999999999999999997653322 222222222111100
Q ss_pred ccccchhhhhhhhHHHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 008012 519 ADANLLREENFFSARMDCLLSIFHLALDCCAELPDQRL-----YMKDAATK 564 (581)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 564 (581)
.+..+++++.+++.+||++||++|| |++|+++|
T Consensus 255 -------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 255 -------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0113456788999999999999999 48899875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=360.22 Aligned_cols=264 Identities=19% Similarity=0.252 Sum_probs=198.4
Q ss_pred hhcCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccch--HHHHHHHHHHHHHHHhcCCCccceEeeeeecC-----C
Q 008012 289 ATDGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQL--EQAFRSFNSECEVLRNVRHRNLIKILSSCCNT-----N 360 (581)
Q Consensus 289 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 360 (581)
..++|++++.||+|+||+||+|++. +|+.||||+++... ....+.+.+|++++++++||||+++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 4678999999999999999999964 89999999997543 34556788999999999999999999998643 3
Q ss_pred eeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 361 FKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 361 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
..+++|+|+.+|+|.+++..+ .+++.++..++.||+.||+||| ++||+||||||+|||++.++.+|++|||.+..
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred ceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcc
Confidence 446777888899999999654 4799999999999999999999 89999999999999999999999999999976
Q ss_pred cCCCCCcceeeccccCccccCCCCCCCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccccHHHHHHhhCCCCCCccc
Q 008012 441 LGEGDDSVIQTMTIATIGYMAPEFGSEG-NVSSKCDVYSYGILLLETFTRKKPTDEMFTGEMNLKNWVKESLPHGLPKIA 519 (581)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (581)
... ......|++.|+|||...+. .++.++||||+||++|+|++|++||.... .......+............
T Consensus 171 ~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~--~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 171 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp CTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCHHHH
T ss_pred cCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCChHHh
Confidence 532 22345789999999976654 56889999999999999999999997632 11111122111111100000
Q ss_pred cccc---h----------hhhhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 008012 520 DANL---L----------REENFFSARMDCLLSIFHLALDCCAELPDQRLYMKDAATK 564 (581)
Q Consensus 520 ~~~~---~----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 564 (581)
.... . ...........+++.+.+||.+||..||++|||++|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000 0 0000011112345678899999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.9e-39 Score=323.28 Aligned_cols=266 Identities=19% Similarity=0.157 Sum_probs=191.3
Q ss_pred cCCCcCCeecccccccEEEEEeC-CCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-----------CCccceEeeeeec
Q 008012 291 DGFNECNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-----------HRNLIKILSSCCN 358 (581)
Q Consensus 291 ~~y~~~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~ 358 (581)
++|+++++||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999964 899999999987643 2356788999888874 5789999998754
Q ss_pred --CCeeeEEEeccCCCCHHHH--HhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCC------
Q 008012 359 --TNFKALVLEFMPNGSLDKW--LYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENM------ 428 (581)
Q Consensus 359 --~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~------ 428 (581)
....+++++++..+..... ........++..+..++.||+.||+|||+ ..||+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence 3456677776655443322 22444567889999999999999999994 48999999999999998654
Q ss_pred cEEEeeccCceecCCCCCcceeeccccCccccCCCCCCCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-----ccH
Q 008012 429 VAHVSDFGISKLLGEGDDSVIQTMTIATIGYMAPEFGSEGNVSSKCDVYSYGILLLETFTRKKPTDEMFTGE-----MNL 503 (581)
Q Consensus 429 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~Pf~~~~~~~-----~~~ 503 (581)
.++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||....... ..+
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 4999999999865332 234579999999999999999999999999999999999999997532211 011
Q ss_pred HHHHHhhCC----------------------CCCCccccccchhh-hhhhhHHHHHHHHHHHHHHhccCcCCCCCCCHHH
Q 008012 504 KNWVKESLP----------------------HGLPKIADANLLRE-ENFFSARMDCLLSIFHLALDCCAELPDQRLYMKD 560 (581)
Q Consensus 504 ~~~~~~~~~----------------------~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 560 (581)
...+...-. ..+........... ..........++.+.+|+.+||..||++||||+|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 111110000 00000000000000 0011123456778999999999999999999999
Q ss_pred HHHH
Q 008012 561 AATK 564 (581)
Q Consensus 561 vl~~ 564 (581)
+++|
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9876
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=3.5e-28 Score=239.76 Aligned_cols=215 Identities=27% Similarity=0.505 Sum_probs=143.3
Q ss_pred CCCCCcEEEeec-CcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcE
Q 008012 3 RMQQLQGIGLAD-NHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILY 81 (581)
Q Consensus 3 ~~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 81 (581)
++++|++|+|++ |+++|.+|..|++|++|++|+|++|+|.+..+..+..+.+|+.+++++|.+.+.+|..+.++++|+.
T Consensus 74 ~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~ 153 (313)
T d1ogqa_ 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153 (313)
T ss_dssp GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred cCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccce
Confidence 455555555554 4555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred EecccCcCCCCCCccccCCccC-cEEeCCCCcCCCC-----------------------CcccccCcccccceecccccc
Q 008012 82 VNLSSNYLTGSLTSDIQNMKVL-IDLDLSRNQLSGD-----------------------IPKTIAGLKDLTNLSLAGNQF 137 (581)
Q Consensus 82 L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~N~l~~~-----------------------~~~~~~~l~~L~~L~l~~N~i 137 (581)
+++++|.+++.+|..+..+..+ +.+++++|++++. .|..+..+++|+.|++++|.+
T Consensus 154 l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l 233 (313)
T d1ogqa_ 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233 (313)
T ss_dssp EECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEE
T ss_pred eecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 5555555555555555444443 4444444444322 222333445666677777777
Q ss_pred ccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCCCCCCC
Q 008012 138 QGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGPQRLQV 217 (581)
Q Consensus 138 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~~ 217 (581)
++.+ ..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++|+|+|.+|....+..+..+.+.+|+..||.| +
T Consensus 234 ~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p---l 309 (313)
T d1ogqa_ 234 AFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---L 309 (313)
T ss_dssp CCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT---S
T ss_pred cccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC---C
Confidence 6543 35777899999999999999999999999999999999999999999998889999999999999999976 4
Q ss_pred CCCC
Q 008012 218 PPCK 221 (581)
Q Consensus 218 p~c~ 221 (581)
|+|.
T Consensus 310 p~c~ 313 (313)
T d1ogqa_ 310 PACT 313 (313)
T ss_dssp SCCC
T ss_pred CCCC
Confidence 6773
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1e-26 Score=223.23 Aligned_cols=203 Identities=27% Similarity=0.246 Sum_probs=183.6
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
++..+.++++++++|+ .+|..+. ++|++|+|++|+|+++.+++|.++++|++|+|++|+|+ .+| .+..+++|++|
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccc
Confidence 4566788999999999 5787776 78999999999999877889999999999999999998 444 36789999999
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
+|++|+++ ..+..+..+++|++|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+++
T Consensus 83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 99999999 56778999999999999999999888888899999999999999999888888899999999999999999
Q ss_pred CCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccC
Q 008012 163 EGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCG 211 (581)
Q Consensus 163 ~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~ 211 (581)
+..+..|..+++|+.|+|++|+|+..+++...+..++.+.+.+|||.|+
T Consensus 162 ~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 162 ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred ccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCC
Confidence 9888889999999999999999996555667788899999999999997
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.1e-25 Score=216.41 Aligned_cols=207 Identities=23% Similarity=0.238 Sum_probs=190.0
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEcc-CCcccCCCCcccccCCCCcEEe
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLN-SNKLTSSIPSALWALEYILYVN 83 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~ 83 (581)
+++++|+|++|+|+++.+..|.++++|++|++++|.|..+.+..+.+++.++.+... .|.++...+..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 368999999999997777889999999999999999999999999999999999764 6788877788999999999999
Q ss_pred cccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCC
Q 008012 84 LSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 163 (581)
+++|.+....+..+..+++|+.+++++|.|++..+..|..+++|+.|++++|+|+++.+..|.++++|+.+++++|++++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 99999987778889999999999999999997777889999999999999999998888999999999999999999999
Q ss_pred CCchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCccccccccccccC
Q 008012 164 GIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNYALCG 211 (581)
Q Consensus 164 ~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~ 211 (581)
..|..|..+++|+.|++++|++++..+.. ..+..+..+.+.+|||.|+
T Consensus 192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 99999999999999999999999877653 6778899999999999996
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.7e-24 Score=206.16 Aligned_cols=180 Identities=25% Similarity=0.234 Sum_probs=166.0
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
++|++|+|++|+|+++.++.|.++++|++|+|++|+|+.. + .++.+++|++|+|++|+++ ..+..+.++++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccccccccccc-ccccccccccccccccc
Confidence 4799999999999987778999999999999999999954 3 4688999999999999998 56778999999999999
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEG 164 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~ 164 (581)
++|.+....+..+..+.+|++|++++|.++...+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 999999888888999999999999999999777788889999999999999999888888999999999999999998 5
Q ss_pred CchhhhcccccCeeEccCCCCCCC
Q 008012 165 IPKSLVALSHLKQFNVSHNRLEGE 188 (581)
Q Consensus 165 ~~~~~~~l~~L~~l~l~~n~l~~~ 188 (581)
+|..+..+++|+.|+|++|++.+.
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cChhHCCCCCCCEEEecCCCCCCC
Confidence 888888999999999999999864
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=4.5e-24 Score=206.91 Aligned_cols=211 Identities=22% Similarity=0.231 Sum_probs=186.2
Q ss_pred CCCCCCCcEEEeecCcccccCCccccCCCCCCEEEcc-CCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCC
Q 008012 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQ-GNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYI 79 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~-~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 79 (581)
|..+++|++|++++|+|..+.+..+.++..++.++.+ .|.++...+..|.++++|++|+|++|.+....+..+..+++|
T Consensus 52 f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L 131 (284)
T d1ozna_ 52 FRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred hhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhccc
Confidence 5678999999999999999888999999999998765 678888889999999999999999999987778889999999
Q ss_pred cEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeecccc
Q 008012 80 LYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSN 159 (581)
Q Consensus 80 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N 159 (581)
+.+++++|+|++..+..|..+++|++|++++|++++..+..|.++++|+.|++++|++++..|..|.++++|++|++++|
T Consensus 132 ~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 211 (284)
T d1ozna_ 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211 (284)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred chhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccc
Confidence 99999999999877889999999999999999999888889999999999999999999999999999999999999999
Q ss_pred ccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccC
Q 008012 160 NLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCG 211 (581)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~ 211 (581)
.+++..+..|..+++|+.|++++|++++..+...-..+++......+...|.
T Consensus 212 ~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~ 263 (284)
T d1ozna_ 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263 (284)
T ss_dssp CCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEE
T ss_pred ccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeC
Confidence 9999888999999999999999999998654322222344444444555564
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=2.8e-24 Score=195.09 Aligned_cols=168 Identities=18% Similarity=0.175 Sum_probs=122.3
Q ss_pred CcCCeecccccccEEEEEeCCCcEEEEEEeccch------------------HHHHHHHHHHHHHHHhcCCCccceEeee
Q 008012 294 NECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQL------------------EQAFRSFNSECEVLRNVRHRNLIKILSS 355 (581)
Q Consensus 294 ~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 355 (581)
.+.++||+|+||+||+|...+|+.||||+++... ........+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4678999999999999998889999999875321 1112345678999999999999988866
Q ss_pred eecCCeeeEEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeEecCCCcEEEeec
Q 008012 356 CCNTNFKALVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHGHSTPVVHCDLKPSNILLDENMVAHVSDF 435 (581)
Q Consensus 356 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df 435 (581)
.. .+++|||+++..+.+ ++......++.|++.+++||| +.||+||||||+|||++++ .++|+||
T Consensus 83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence 32 379999998866543 344556789999999999999 8999999999999999865 5899999
Q ss_pred cCceecCCCCCcceeec-cccCccccCCCCCCCCCCCccccHHHHHHHH
Q 008012 436 GISKLLGEGDDSVIQTM-TIATIGYMAPEFGSEGNVSSKCDVYSYGILL 483 (581)
Q Consensus 436 g~a~~~~~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~Dv~slG~vl 483 (581)
|.|.....+........ ..... |. ..+.|+.++|+||..--+
T Consensus 147 G~a~~~~~~~~~~~l~rd~~~~~-----~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWREILERDVRNII-----TY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHHHHHHHHHHHHH-----HH-HHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcHHHHHHHHHHHH-----HH-HcCCCCCcccHHHHHHHH
Confidence 99987643321110000 00000 11 125678899999976443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.89 E-value=1.6e-22 Score=198.05 Aligned_cols=205 Identities=21% Similarity=0.276 Sum_probs=170.7
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCC---------------
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSI--------------- 69 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~--------------- 69 (581)
++|++|+|++|+|+.+.+..|.++++|++|++++|.+....|..|.++++|++|+|++|+|+...
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~~~~~l~~L~~~~n 110 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHEN 110 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSS
T ss_pred CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCccchhhhhhhhhcccc
Confidence 67999999999999666678999999999999999999888999999999999999999886211
Q ss_pred --------------------------------CcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCC
Q 008012 70 --------------------------------PSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDI 117 (581)
Q Consensus 70 --------------------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 117 (581)
+..+..+++|+.+++++|.+. .++..+ +++|++|++++|.+++..
T Consensus 111 ~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~ 187 (305)
T d1xkua_ 111 EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVD 187 (305)
T ss_dssp CCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEEC
T ss_pred chhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCC
Confidence 123456677888888888887 344333 578899999999988888
Q ss_pred cccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCC------
Q 008012 118 PKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPT------ 191 (581)
Q Consensus 118 ~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~------ 191 (581)
+..|.+++.++.|++++|.+++..+..|.++++|++|+|++|+|+. +|..+..+++|+.|+|++|+|+.....
T Consensus 188 ~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~ 266 (305)
T d1xkua_ 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266 (305)
T ss_dssp TGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS
T ss_pred hhHhhccccccccccccccccccccccccccccceeeecccccccc-cccccccccCCCEEECCCCccCccChhhccCcc
Confidence 8889999999999999999998888899999999999999999985 678899999999999999999864322
Q ss_pred -CCCCcCCccccccccccccCCC
Q 008012 192 -EGPFRNFSAQSFHWNYALCGPQ 213 (581)
Q Consensus 192 -~~~~~~~~~~~~~~n~~~c~~~ 213 (581)
......+..+.+.+|||.+..-
T Consensus 267 ~~~~~~~L~~L~L~~N~~~~~~~ 289 (305)
T d1xkua_ 267 YNTKKASYSGVSLFSNPVQYWEI 289 (305)
T ss_dssp CCTTSCCCSEEECCSSSSCGGGS
T ss_pred hhcccCCCCEEECCCCcCccCcC
Confidence 1345667788899999887644
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.88 E-value=5.5e-23 Score=202.16 Aligned_cols=203 Identities=26% Similarity=0.469 Sum_probs=173.9
Q ss_pred CCcEEEeecCcccc--cCCccccCCCCCCEEEccC-CcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 6 QLQGIGLADNHLQG--SIPYDLCQLKRLNSLSLQG-NKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 6 ~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
+++.|+|++|++++ .+|..+++|++|++|+|++ |.+++.+|..|+++++|++|+|++|++.+..+..+..+++|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 68999999999987 4789999999999999997 89999999999999999999999999999999999999999999
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccc-cceeccccccccccCc------------------
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDL-TNLSLAGNQFQGPIPE------------------ 143 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-~~L~l~~N~i~~~~~~------------------ 143 (581)
++++|.+.+.+|..+.+++.|+++++++|.+.+.+|..+..+.++ +.+++++|++++..|.
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~ 210 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLE 210 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999999999999998888776 7788888877765543
Q ss_pred -----cccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCC-CCCcCCccccccccccc
Q 008012 144 -----SFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTE-GPFRNFSAQSFHWNYAL 209 (581)
Q Consensus 144 -----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~ 209 (581)
.+..+++|+.+++++|.+++. +..+..+++|+.|+|++|++++.+|.. ..+..++.+++++|...
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~-~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~ 281 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFD-LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCB-GGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred cccccccccccccccccccccccccc-ccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCccc
Confidence 344566777788888887764 345777788888888888888777654 66777888888877544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.85 E-value=1.6e-21 Score=176.83 Aligned_cols=173 Identities=24% Similarity=0.269 Sum_probs=92.8
Q ss_pred cEEEeecCcccccCCccccCCCCCCEEEccCCcccc-cCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEeccc
Q 008012 8 QGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNG-SIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSS 86 (581)
Q Consensus 8 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 86 (581)
+.+++++++++ .+|..+. +++++|+|++|+|+. ..+..|.++++|++|+|++|+++...+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 45666666666 4554443 566666666666653 3345556666666666666666655556666666666666666
Q ss_pred CcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCc
Q 008012 87 NYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIP 166 (581)
Q Consensus 87 n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 166 (581)
|+|+...+.+|.++++|++|+|++|+|++..+..|.++++|++|+|++|++.... ....-...++.+.+..|.++...|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~-~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC-HLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG-GGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc-chHHHhhhhhhhcccCCCeEeCCC
Confidence 6666555555666666666666666666544555555666666666666554211 111111234444444555444444
Q ss_pred hhhhcccccCeeEccCCCCCC
Q 008012 167 KSLVALSHLKQFNVSHNRLEG 187 (581)
Q Consensus 167 ~~~~~l~~L~~l~l~~n~l~~ 187 (581)
..+ ..++.++|+.|.+++
T Consensus 167 ~~l---~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 167 SKV---RDVQIKDLPHSEFKC 184 (192)
T ss_dssp TTT---TTSBGGGSCTTTCCC
T ss_pred hhh---cCCEeeecCHhhCcC
Confidence 332 223344445555443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.83 E-value=8.8e-21 Score=171.85 Aligned_cols=178 Identities=24% Similarity=0.306 Sum_probs=151.2
Q ss_pred CCEEEccCCcccccCCccccCCCCCCEEEccCCcccC-CCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCC
Q 008012 31 LNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTS-SIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLS 109 (581)
Q Consensus 31 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 109 (581)
.+++++++|+++ .+|..+. +++++|+|++|+|++ ..+..|.++++|++|+|++|.+....+..|..++.|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 468999999999 5676553 689999999999986 446778999999999999999998999999999999999999
Q ss_pred CCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCC
Q 008012 110 RNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEI 189 (581)
Q Consensus 110 ~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~ 189 (581)
+|+|++..+..|.++++|+.|+|++|+|+++.+..|..+++|++|+|++|.+..... ...-...++.+.+..|.+++..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCC
Confidence 999998778889999999999999999998888999999999999999999986332 2222345677788889888777
Q ss_pred CCCCCCcCCccccccccccccCCCC
Q 008012 190 PTEGPFRNFSAQSFHWNYALCGPQR 214 (581)
Q Consensus 190 ~~~~~~~~~~~~~~~~n~~~c~~~~ 214 (581)
|.. +..+...++..|...|..+.
T Consensus 166 p~~--l~~~~l~~L~~n~l~C~~~~ 188 (192)
T d1w8aa_ 166 PSK--VRDVQIKDLPHSEFKCSSEN 188 (192)
T ss_dssp STT--TTTSBGGGSCTTTCCCCCC-
T ss_pred Chh--hcCCEeeecCHhhCcCCCCC
Confidence 653 56677888888988897763
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.83 E-value=1e-19 Score=177.85 Aligned_cols=199 Identities=27% Similarity=0.296 Sum_probs=165.7
Q ss_pred CCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecc
Q 008012 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85 (581)
Q Consensus 6 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 85 (581)
.++.++.++++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 3578999999999 6787775 799999999999997777789999999999999999998888999999999999999
Q ss_pred cCcCCCCCCcc------------------------------------------------ccCCccCcEEeCCCCcCCCCC
Q 008012 86 SNYLTGSLTSD------------------------------------------------IQNMKVLIDLDLSRNQLSGDI 117 (581)
Q Consensus 86 ~n~l~~~~~~~------------------------------------------------~~~l~~L~~L~l~~N~l~~~~ 117 (581)
+|+|+. +|.. +..+++|+.+++++|.++ .+
T Consensus 88 ~n~l~~-l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l 165 (305)
T d1xkua_ 88 KNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TI 165 (305)
T ss_dssp SSCCSB-CCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SC
T ss_pred CCccCc-CccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-cc
Confidence 998773 2221 222355777777777776 34
Q ss_pred cccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcC
Q 008012 118 PKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRN 197 (581)
Q Consensus 118 ~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~ 197 (581)
|..+ +++|+.|++++|.+++..+..|..++.++.|++++|.+++..+..+.++++|+.|+|++|+|+..++....+..
T Consensus 166 ~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~ 243 (305)
T d1xkua_ 166 PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243 (305)
T ss_dssp CSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSS
T ss_pred Cccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccC
Confidence 4433 56788888888888888888899999999999999999998899999999999999999999966555677889
Q ss_pred CccccccccccccC
Q 008012 198 FSAQSFHWNYALCG 211 (581)
Q Consensus 198 ~~~~~~~~n~~~c~ 211 (581)
++.+++.+|....-
T Consensus 244 L~~L~Ls~N~i~~i 257 (305)
T d1xkua_ 244 IQVVYLHNNNISAI 257 (305)
T ss_dssp CCEEECCSSCCCCC
T ss_pred CCEEECCCCccCcc
Confidence 99999999876543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=1.5e-19 Score=166.01 Aligned_cols=165 Identities=25% Similarity=0.369 Sum_probs=114.2
Q ss_pred CCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEe
Q 008012 4 MQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVN 83 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 83 (581)
+..|++|++++|.|++. + .+..+++|++|+|++|+|++.. .++.+++|++|++++|+|++ +| .+..+++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccc
Confidence 45677777777777743 3 3667777777777777777432 36677777777777777763 33 467777777777
Q ss_pred cccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCC
Q 008012 84 LSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSE 163 (581)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 163 (581)
+++|.+.. + ..+..++.|+.+++++|.+++ +..+..+++|+.+++++|++++.. .+.++++|+.|+|++|++++
T Consensus 119 l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~ 192 (210)
T d1h6ta2 119 LEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD 192 (210)
T ss_dssp CTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB
T ss_pred cccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC
Confidence 77777663 2 346677777777777777763 335667777777777777777532 36777777777777777765
Q ss_pred CCchhhhcccccCeeEccC
Q 008012 164 GIPKSLVALSHLKQFNVSH 182 (581)
Q Consensus 164 ~~~~~~~~l~~L~~l~l~~ 182 (581)
++ .+.++++|+.|+|++
T Consensus 193 -l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 193 -LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp -CG-GGTTCTTCSEEEEEE
T ss_pred -Ch-hhcCCCCCCEEEccC
Confidence 34 477777777777753
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=2.8e-19 Score=162.80 Aligned_cols=165 Identities=22% Similarity=0.380 Sum_probs=105.4
Q ss_pred EEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCc
Q 008012 9 GIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNY 88 (581)
Q Consensus 9 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~ 88 (581)
.+.++.+.+++.++ ...+++|++|++++|.|+.. +.+..+++|++|+|++|+|++..| +.++++|++|++++|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence 34455566654332 24456777777777777733 346667777777777777764322 6677777777777777
Q ss_pred CCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchh
Q 008012 89 LTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKS 168 (581)
Q Consensus 89 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 168 (581)
+.. ++ .+.+++.|++|++++|.+... ..+.++++|+.|++++|++... ..+..+++|+.|++++|++++. + .
T Consensus 96 ~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l-~-~ 167 (199)
T d2omxa2 96 IAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL-K-P 167 (199)
T ss_dssp CCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-G-G
T ss_pred ccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCC-c-c
Confidence 663 22 366777777777777776532 3466677777777777777632 2466677777777777777653 2 3
Q ss_pred hhcccccCeeEccCCCCCC
Q 008012 169 LVALSHLKQFNVSHNRLEG 187 (581)
Q Consensus 169 ~~~l~~L~~l~l~~n~l~~ 187 (581)
+.++++|+.|++++|+++.
T Consensus 168 l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 168 LANLTTLERLDISSNKVSD 186 (199)
T ss_dssp GTTCTTCCEEECCSSCCCC
T ss_pred ccCCCCCCEEECCCCCCCC
Confidence 6677777777777777764
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=1.4e-18 Score=161.74 Aligned_cols=187 Identities=24% Similarity=0.333 Sum_probs=155.6
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
.+.+|++|++.+|+|++ + ..+..+++|++|++++|.|++.. .|..+++|+.|++++|.++. + ..+.++++|+.+
T Consensus 39 ~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l 112 (227)
T d1h6ua2 39 DLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLKN-V-SAIAGLQSIKTL 112 (227)
T ss_dssp HHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEE
T ss_pred HcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeeccc--cccccccccccccccccccc-c-cccccccccccc
Confidence 46789999999999995 4 45899999999999999999543 38999999999999999983 3 458899999999
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
++++|...+. ..+...+.++.+.++++.+... ..+.++++|+.|++++|.+++. ..+.++++|+.|+|++|+++
T Consensus 113 ~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~ 186 (227)
T d1h6ua2 113 DLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS 186 (227)
T ss_dssp ECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCC
T ss_pred cccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCccC
Confidence 9999998743 3467789999999999998743 3478889999999999999854 34889999999999999998
Q ss_pred CCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCcccccc
Q 008012 163 EGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFH 204 (581)
Q Consensus 163 ~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~ 204 (581)
+ ++ .+..+++|+.|++++|++++. +....+..+..+++.
T Consensus 187 ~-l~-~l~~l~~L~~L~Ls~N~lt~i-~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 187 D-IS-PLASLPNLIEVHLKNNQISDV-SPLANTSNLFIVTLT 225 (227)
T ss_dssp C-CG-GGGGCTTCCEEECTTSCCCBC-GGGTTCTTCCEEEEE
T ss_pred C-Ch-hhcCCCCCCEEECcCCcCCCC-cccccCCCCCEEEee
Confidence 6 43 488999999999999999954 445566666666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=2.9e-19 Score=162.69 Aligned_cols=162 Identities=28% Similarity=0.444 Sum_probs=139.3
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
.+++|++|++++|+|+. + +.+..+++|++|+|++|+|++..+ +.++++|++|++++|.+.. ++ .+.++++|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccc
Confidence 36789999999999985 3 458899999999999999996433 9999999999999999984 44 48899999999
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
++++|.+... ..+..+++|+.|++++|++.. + +.+..+++|+.|++++|++++.. .++++++|+.|++++|+++
T Consensus 112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred cccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCC
Confidence 9999998843 358889999999999999983 4 46889999999999999999653 4889999999999999998
Q ss_pred CCCchhhhcccccCee
Q 008012 163 EGIPKSLVALSHLKQF 178 (581)
Q Consensus 163 ~~~~~~~~~l~~L~~l 178 (581)
+ ++ .+.++++|+.|
T Consensus 186 ~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 186 D-IS-VLAKLTNLESL 199 (199)
T ss_dssp C-CG-GGGGCTTCSEE
T ss_pred C-Cc-cccCCCCCCcC
Confidence 6 43 58888888875
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=2.9e-18 Score=172.91 Aligned_cols=190 Identities=27% Similarity=0.407 Sum_probs=161.5
Q ss_pred CCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcE
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILY 81 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 81 (581)
..+++++.+++++|.+++..| +..+++|++|++++|+++. .+.+..+++|+.|++++|++++.. .+..+++|++
T Consensus 194 ~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~ 267 (384)
T d2omza2 194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA--PLSGLTKLTE 267 (384)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSE
T ss_pred ccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC--cchhhcccccchhccccCccCCCC--cccccccCCE
Confidence 357889999999999997654 4667999999999999994 357889999999999999998543 3888999999
Q ss_pred EecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeecccccc
Q 008012 82 VNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNL 161 (581)
Q Consensus 82 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l 161 (581)
|++++|.+++.. .+..++.++.+++++|.+++ ...+..+++++.|++++|+|++.. .+..+++|+.|++++|++
T Consensus 268 L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l 341 (384)
T d2omza2 268 LKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKV 341 (384)
T ss_dssp EECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCC
T ss_pred eeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCC
Confidence 999999998543 47889999999999999984 345888999999999999999754 388899999999999999
Q ss_pred CCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCcccccccc
Q 008012 162 SEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWN 206 (581)
Q Consensus 162 ~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n 206 (581)
++ ++ .+..+++|+.|++++|++++.+| ...+..++.+++++|
T Consensus 342 ~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 342 SD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp CC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 86 44 68999999999999999997655 566778888888776
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=3e-18 Score=161.18 Aligned_cols=185 Identities=16% Similarity=0.130 Sum_probs=141.1
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccc-cCCccccCCCCCCEEEcc-CCcccCCCCcccccCCCCcEE
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNG-SIPTCLASLTSLRELRLN-SNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L 82 (581)
+++++|+|++|+|+++.+..|.++++|++|+|++|.+.. ..+.+|.+++++++|.+. .|++....+..|.++++|+.|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 478899999999986666678889999999999998875 346678888999988775 467777778888889999999
Q ss_pred ecccCcCCCCCCc-cccCCccCcEEeCCCCcCCCCCcccccCcc-cccceeccccccccccCccccCccccc-eeecccc
Q 008012 83 NLSSNYLTGSLTS-DIQNMKVLIDLDLSRNQLSGDIPKTIAGLK-DLTNLSLAGNQFQGPIPESFGSLISLE-SLDLSSN 159 (581)
Q Consensus 83 ~l~~n~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~l~~N~i~~~~~~~~~~l~~L~-~L~l~~N 159 (581)
++++|++....+. .+..+..|..+..+++.+....+..|.+++ .++.|++++|+++.+.+..|. .++++ .+++++|
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n 187 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNN 187 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCT
T ss_pred ccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccccccccc-chhhhcccccccc
Confidence 9999988743332 234556666677778788755566676665 788899999999865555554 44544 4467888
Q ss_pred ccCCCCchhhhcccccCeeEccCCCCCCCCC
Q 008012 160 NLSEGIPKSLVALSHLKQFNVSHNRLEGEIP 190 (581)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 190 (581)
.++.+.+..|.++++|+.|++++|+++..++
T Consensus 188 ~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~ 218 (242)
T d1xwdc1 188 NLEELPNDVFHGASGPVILDISRTRIHSLPS 218 (242)
T ss_dssp TCCCCCTTTTTTSCCCSEEECTTSCCCCCCS
T ss_pred ccccccHHHhcCCCCCCEEECCCCcCCccCH
Confidence 8987666678999999999999999985444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=2e-18 Score=158.47 Aligned_cols=181 Identities=22% Similarity=0.348 Sum_probs=148.6
Q ss_pred EEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCc
Q 008012 9 GIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNY 88 (581)
Q Consensus 9 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~ 88 (581)
...+.++.+++.++. ..+.+|+.|++++|.|+... .+..+++|++|+|++|+|++. + .+..+++|++|++++|+
T Consensus 28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~ 101 (210)
T d1h6ta2 28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENK 101 (210)
T ss_dssp HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSC
T ss_pred HHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCcccccccccccc
Confidence 345666777755543 35689999999999999543 488999999999999999854 3 36889999999999999
Q ss_pred CCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccCCCCchh
Q 008012 89 LTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLSEGIPKS 168 (581)
Q Consensus 89 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 168 (581)
|++ ++ .+..+++|+.|++++|.+.. + ..+.++++|+.+++++|.+++ +..+..+++|+.+++++|++++. + .
T Consensus 102 i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~ 173 (210)
T d1h6ta2 102 VKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-P 173 (210)
T ss_dssp CCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-G
T ss_pred ccc-cc-cccccccccccccccccccc-c-ccccccccccccccccccccc--ccccccccccccccccccccccc-c-c
Confidence 994 44 58899999999999999873 3 468899999999999999985 34677899999999999999863 3 4
Q ss_pred hhcccccCeeEccCCCCCCCCCCCCCCcCCcccccc
Q 008012 169 LVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFH 204 (581)
Q Consensus 169 ~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~ 204 (581)
+..+++|+.|+|++|+++. ++....+..++.+++.
T Consensus 174 l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 174 LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELF 208 (210)
T ss_dssp GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEE
T ss_pred ccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEcc
Confidence 8899999999999999984 5555666677766654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=5.5e-18 Score=157.65 Aligned_cols=168 Identities=27% Similarity=0.388 Sum_probs=143.8
Q ss_pred CCCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCc
Q 008012 1 MGRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYIL 80 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 80 (581)
+..+++|++|+|++|+|++..| +..+++|++|++++|.++.. +.+.++++|+.|++++|.+.+. ..+...+.++
T Consensus 59 l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~ 132 (227)
T d1h6ua2 59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQ 132 (227)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCC
T ss_pred HhcCCCCcEeecCCceeecccc--cccccccccccccccccccc--cccccccccccccccccccccc--chhccccchh
Confidence 3578999999999999996543 89999999999999999843 4688999999999999998743 4477889999
Q ss_pred EEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccc
Q 008012 81 YVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNN 160 (581)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~ 160 (581)
.+.++++.+... ..+..+++|++|++++|.+.+. ..+.++++|+.|+|++|++++. + .++.+++|++|+|++|+
T Consensus 133 ~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 133 VLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQ 206 (227)
T ss_dssp EEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSC
T ss_pred hhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCc
Confidence 999999998843 3478889999999999999843 3489999999999999999964 3 48899999999999999
Q ss_pred cCCCCchhhhcccccCeeEccC
Q 008012 161 LSEGIPKSLVALSHLKQFNVSH 182 (581)
Q Consensus 161 l~~~~~~~~~~l~~L~~l~l~~ 182 (581)
++++ + .+..+++|+.|++++
T Consensus 207 lt~i-~-~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 207 ISDV-S-PLANTSNLFIVTLTN 226 (227)
T ss_dssp CCBC-G-GGTTCTTCCEEEEEE
T ss_pred CCCC-c-ccccCCCCCEEEeeC
Confidence 9874 3 388999999999873
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=9.2e-18 Score=169.17 Aligned_cols=167 Identities=28% Similarity=0.396 Sum_probs=146.1
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 3 RMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
.+++|++|++++|+++. + +.+..+++|+.|++++|.+++.. .+..+++|++|++++|++++.. .+..++.++.+
T Consensus 217 ~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l 290 (384)
T d2omza2 217 ILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNL 290 (384)
T ss_dssp GCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEE
T ss_pred ccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--ccccccccccc
Confidence 46789999999999984 3 46889999999999999999643 4889999999999999998543 48889999999
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcccccceeccccccccccCccccCccccceeeccccccC
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQGPIPESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 162 (581)
.+++|.+++. ..+..++++++|++++|++++.. .+..+++|+.|++++|+|++. + .|.++++|++|++++|+++
T Consensus 291 ~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 291 ELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp ECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCCC
T ss_pred cccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCcCC
Confidence 9999999852 35888999999999999999643 388999999999999999953 3 6899999999999999999
Q ss_pred CCCchhhhcccccCeeEccCC
Q 008012 163 EGIPKSLVALSHLKQFNVSHN 183 (581)
Q Consensus 163 ~~~~~~~~~l~~L~~l~l~~n 183 (581)
+..| +.++++|+.|++++|
T Consensus 365 ~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 365 DLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp BCGG--GTTCTTCSEEECCCE
T ss_pred CChh--hccCCCCCEeeCCCC
Confidence 8544 889999999999987
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=1.3e-17 Score=145.47 Aligned_cols=128 Identities=20% Similarity=0.201 Sum_probs=94.4
Q ss_pred cccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccC
Q 008012 24 DLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVL 103 (581)
Q Consensus 24 ~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 103 (581)
.|.+..+|++|+|++|+|+. +++.+..+++|+.|+|++|+|+. ++ .|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 35677788888888888884 46666778888888888888873 33 47788888888888888885555556678888
Q ss_pred cEEeCCCCcCCCCCc--ccccCcccccceecccccccccc---CccccCccccceee
Q 008012 104 IDLDLSRNQLSGDIP--KTIAGLKDLTNLSLAGNQFQGPI---PESFGSLISLESLD 155 (581)
Q Consensus 104 ~~L~l~~N~l~~~~~--~~~~~l~~L~~L~l~~N~i~~~~---~~~~~~l~~L~~L~ 155 (581)
++|++++|+|+. .+ ..+..+++|+.|++++|+++... +..+..+|+|++||
T Consensus 90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccc-cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 888888888874 33 35777888888888888887432 12466788888876
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=1e-16 Score=150.56 Aligned_cols=181 Identities=15% Similarity=0.142 Sum_probs=145.8
Q ss_pred CCCCCCCcEEEeecCcccccC-CccccCCCCCCEEEccC-CcccccCCccccCCCCCCEEEccCCcccCCCC-cccccCC
Q 008012 1 MGRMQQLQGIGLADNHLQGSI-PYDLCQLKRLNSLSLQG-NKLNGSIPTCLASLTSLRELRLNSNKLTSSIP-SALWALE 77 (581)
Q Consensus 1 ~~~~~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~ 77 (581)
|.++++|++|+|++|.+...+ +..|.+++++++|++.. |.+....++.|.++++|++|++++|++....+ ..+..+.
T Consensus 49 f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~ 128 (242)
T d1xwdc1 49 FSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128 (242)
T ss_dssp TTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSS
T ss_pred hhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhhhccccccccccccc
Confidence 567899999999999987544 56799999999999864 78888889999999999999999999974433 2345567
Q ss_pred CCcEEecccCcCCCCCCccccCCc-cCcEEeCCCCcCCCCCcccccCcccc-cceeccccccccccCccccCccccceee
Q 008012 78 YILYVNLSSNYLTGSLTSDIQNMK-VLIDLDLSRNQLSGDIPKTIAGLKDL-TNLSLAGNQFQGPIPESFGSLISLESLD 155 (581)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L-~~L~l~~N~i~~~~~~~~~~l~~L~~L~ 155 (581)
.+..+..+++.+....+..|..++ .++.|++++|+++. ++.......++ +.+++++|+|+.+.+..|.++++|++|+
T Consensus 129 ~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~-i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~ 207 (242)
T d1xwdc1 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILD 207 (242)
T ss_dssp CEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEE
T ss_pred ccccccccccccccccccccccccccceeeecccccccc-cccccccchhhhccccccccccccccHHHhcCCCCCCEEE
Confidence 777778888888866677777765 89999999999995 44444445555 4456788999976667799999999999
Q ss_pred ccccccCCCCchhhhcccccCeeEccC
Q 008012 156 LSSNNLSEGIPKSLVALSHLKQFNVSH 182 (581)
Q Consensus 156 l~~N~l~~~~~~~~~~l~~L~~l~l~~ 182 (581)
|++|+|+...+..|..+++|+.+++.+
T Consensus 208 Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 208 ISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred CCCCcCCccCHHHHcCCcccccCcCCC
Confidence 999999987677788888888877654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=3.5e-17 Score=142.82 Aligned_cols=128 Identities=20% Similarity=0.191 Sum_probs=65.9
Q ss_pred ccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCccccc
Q 008012 49 LASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLKDLT 128 (581)
Q Consensus 49 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 128 (581)
|.++.+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+. + +.|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 445555555666655555 334444555555666666665552 2 2355555556666666655533333344555555
Q ss_pred ceeccccccccccC-ccccCccccceeeccccccCCCC---chhhhcccccCeeE
Q 008012 129 NLSLAGNQFQGPIP-ESFGSLISLESLDLSSNNLSEGI---PKSLVALSHLKQFN 179 (581)
Q Consensus 129 ~L~l~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~---~~~~~~l~~L~~l~ 179 (581)
.|++++|+|+.... ..+..+++|++|++++|.++... +..+..+++|+.||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 56666555553211 34555555555666655554321 12344555555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.66 E-value=1.8e-16 Score=131.36 Aligned_cols=100 Identities=28% Similarity=0.344 Sum_probs=45.2
Q ss_pred EEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCc
Q 008012 9 GIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNY 88 (581)
Q Consensus 9 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~ 88 (581)
.|+|++|+|+ .++ .+.++++|++|++++|+|+ .+|+.|+.+++|++|++++|+|++ +| .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 4455555554 222 2444555555555555554 234444445555555555555542 22 24444444444444444
Q ss_pred CCCCCC-ccccCCccCcEEeCCCCcC
Q 008012 89 LTGSLT-SDIQNMKVLIDLDLSRNQL 113 (581)
Q Consensus 89 l~~~~~-~~~~~l~~L~~L~l~~N~l 113 (581)
|++... ..+..+++|++|++++|.+
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcC
Confidence 442221 2344444444444444444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.65 E-value=2.4e-16 Score=130.66 Aligned_cols=103 Identities=27% Similarity=0.347 Sum_probs=74.9
Q ss_pred CEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCC
Q 008012 32 NSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRN 111 (581)
Q Consensus 32 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 111 (581)
++|+|++|+|+. ++ .+.++++|++|+|++|+|+ .+|..++.+++|+.|++++|.|++ ++ .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 468888888883 33 3778888888888888887 556677788888888888888874 33 4777888888888888
Q ss_pred cCCCCC-cccccCcccccceecccccccc
Q 008012 112 QLSGDI-PKTIAGLKDLTNLSLAGNQFQG 139 (581)
Q Consensus 112 ~l~~~~-~~~~~~l~~L~~L~l~~N~i~~ 139 (581)
+|++.. ...+..+++|+.|++++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 877432 2456777777777777777763
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.58 E-value=3.2e-17 Score=148.26 Aligned_cols=112 Identities=24% Similarity=0.312 Sum_probs=51.4
Q ss_pred CccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCcccccCcc
Q 008012 46 PTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKTIAGLK 125 (581)
Q Consensus 46 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 125 (581)
+..++.+++|++|+|++|+|+. ++ .+.++++|++|+|++|.|+ .++..+..+++|++|++++|.++. + +.+.+++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHH
T ss_pred hhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccc
Confidence 3444445555555555555542 22 2444555555555555544 233333333445555555555542 2 2244455
Q ss_pred cccceeccccccccccC-ccccCccccceeeccccccC
Q 008012 126 DLTNLSLAGNQFQGPIP-ESFGSLISLESLDLSSNNLS 162 (581)
Q Consensus 126 ~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~ 162 (581)
+|+.|++++|+|+.... ..|..+++|+.|+|++|++.
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccc
Confidence 55555555555543211 23445555555555555543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.54 E-value=1.2e-16 Score=144.35 Aligned_cols=131 Identities=24% Similarity=0.300 Sum_probs=106.8
Q ss_pred CCCcEEEeecC--cccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEE
Q 008012 5 QQLQGIGLADN--HLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYV 82 (581)
Q Consensus 5 ~~L~~L~l~~n--~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 82 (581)
..++.+++.++ .++ .++..+..+++|++|+|++|+|+.+ + .|.++++|++|+|++|+|+ .+|..+..+++|++|
T Consensus 23 ~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L 98 (198)
T d1m9la_ 23 TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEEL 98 (198)
T ss_dssp TTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEE
T ss_pred cccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccc
Confidence 34566777665 454 5677899999999999999999954 3 5889999999999999998 567777777889999
Q ss_pred ecccCcCCCCCCccccCCccCcEEeCCCCcCCCCCc--ccccCcccccceeccccccccccC
Q 008012 83 NLSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIP--KTIAGLKDLTNLSLAGNQFQGPIP 142 (581)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L~l~~N~i~~~~~ 142 (581)
++++|+|+. + ..+..+++|+.|++++|+|+. ++ ..+.++++|+.|+|++|++....+
T Consensus 99 ~l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 99 WISYNQIAS-L-SGIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp ECSEEECCC-H-HHHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccccccccc-c-ccccccccccccccccchhcc-ccccccccCCCccceeecCCCccccCcc
Confidence 999999984 3 357889999999999999984 33 468899999999999999875443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=3.2e-14 Score=122.83 Aligned_cols=106 Identities=24% Similarity=0.183 Sum_probs=60.8
Q ss_pred CcEEEeecCcccccCCccccCCCCCCEEEccCC-cccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecc
Q 008012 7 LQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGN-KLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLS 85 (581)
Q Consensus 7 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 85 (581)
...++++++++. ..|..+..+++|++|++++| .|+.+.+++|.++++|+.|+|++|+|+...+.+|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 445666666665 45555666666666666544 3665555556666666666666666665555556666666666666
Q ss_pred cCcCCCCCCccccCCccCcEEeCCCCcCC
Q 008012 86 SNYLTGSLTSDIQNMKVLIDLDLSRNQLS 114 (581)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 114 (581)
+|+|+...+..|.. ..|++|+|++|.+.
T Consensus 89 ~N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred CCCCcccChhhhcc-ccccccccCCCccc
Confidence 66666333333433 24666666666553
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=1.8e-14 Score=124.43 Aligned_cols=110 Identities=20% Similarity=0.114 Sum_probs=81.4
Q ss_pred CCCCCCEEEccCCcccccCCccccCCCCCCEEEccCC-cccCCCCcccccCCCCcEEecccCcCCCCCCccccCCccCcE
Q 008012 27 QLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN-KLTSSIPSALWALEYILYVNLSSNYLTGSLTSDIQNMKVLID 105 (581)
Q Consensus 27 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 105 (581)
.+...+.++++++.+. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...+.+|..+++|++
T Consensus 6 ~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (156)
T ss_dssp CCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence 3455667888888887 46777888888888888655 477666677888888888888888888777777888888888
Q ss_pred EeCCCCcCCCCCcccccCcccccceeccccccc
Q 008012 106 LDLSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQ 138 (581)
Q Consensus 106 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~ 138 (581)
|+|++|+|+...+..|. ..+|+.|+|++|++.
T Consensus 85 L~Ls~N~l~~l~~~~~~-~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 85 LNLSFNALESLSWKTVQ-GLSLQELVLSGNPLH 116 (156)
T ss_dssp EECCSSCCSCCCSTTTC-SCCCCEEECCSSCCC
T ss_pred eeccCCCCcccChhhhc-cccccccccCCCccc
Confidence 88888888843333343 346777888888774
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=3.6e-15 Score=143.04 Aligned_cols=181 Identities=22% Similarity=0.252 Sum_probs=139.1
Q ss_pred CCCCCcEEEeecCccccc-CCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCC-cccCC-CCcccccCCCC
Q 008012 3 RMQQLQGIGLADNHLQGS-IPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSN-KLTSS-IPSALWALEYI 79 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L 79 (581)
...+|++|||++|.++.. +...+..+++|++|+|++|.+++..+..+..+++|++|+|+++ .+++. +...+.++++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 356799999999998744 4456788999999999999998777888999999999999985 56532 22335678999
Q ss_pred cEEecccCc-CCCC-CCccc-cCCccCcEEeCCCCc--CCCC-CcccccCcccccceecccc-ccccccCccccCccccc
Q 008012 80 LYVNLSSNY-LTGS-LTSDI-QNMKVLIDLDLSRNQ--LSGD-IPKTIAGLKDLTNLSLAGN-QFQGPIPESFGSLISLE 152 (581)
Q Consensus 80 ~~L~l~~n~-l~~~-~~~~~-~~l~~L~~L~l~~N~--l~~~-~~~~~~~l~~L~~L~l~~N-~i~~~~~~~~~~l~~L~ 152 (581)
++|+++++. +++. ....+ ..++.|+.|+++++. ++.. +.....++++|+.|++++| .+++.....+..+++|+
T Consensus 124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~ 203 (284)
T d2astb2 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203 (284)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred cccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCC
Confidence 999999864 5421 11223 335789999998753 4322 2233456899999999986 57777778888999999
Q ss_pred eeecccc-ccCCCCchhhhcccccCeeEccCC
Q 008012 153 SLDLSSN-NLSEGIPKSLVALSHLKQFNVSHN 183 (581)
Q Consensus 153 ~L~l~~N-~l~~~~~~~~~~l~~L~~l~l~~n 183 (581)
+|+|++| .+++.....++.+++|+.|+++++
T Consensus 204 ~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp EEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred EEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 9999995 677666677888999999999887
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.48 E-value=5.4e-13 Score=131.77 Aligned_cols=58 Identities=31% Similarity=0.369 Sum_probs=45.4
Q ss_pred ccccceeeccccccCCCCchhhhcccccCeeEccCCCCCCCCCCCCCCcCCccccccccccccCC
Q 008012 148 LISLESLDLSSNNLSEGIPKSLVALSHLKQFNVSHNRLEGEIPTEGPFRNFSAQSFHWNYALCGP 212 (581)
Q Consensus 148 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~ 212 (581)
+++|++|+|++|+|+. +|.. +++|+.|++++|+|+ .+|.. ...++.+++.+|+...-|
T Consensus 283 ~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~L~-~l~~~--~~~L~~L~L~~N~L~~lp 340 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPEL--PQNLKQLHVEYNPLREFP 340 (353)
T ss_dssp CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCCC--CTTCCEEECCSSCCSSCC
T ss_pred CCCCCEEECCCCccCc-cccc---cCCCCEEECCCCcCC-ccccc--cCCCCEEECcCCcCCCCC
Confidence 4689999999999985 6643 678999999999999 45543 456888899999866543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.48 E-value=7.1e-13 Score=130.89 Aligned_cols=96 Identities=28% Similarity=0.390 Sum_probs=65.3
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEec
Q 008012 5 QQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNL 84 (581)
Q Consensus 5 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 84 (581)
.+|++|+|++|+|+ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 35788888888887 56643 467888888888888 556543 56777777777776 33322 135777777
Q ss_pred ccCcCCCCCCccccCCccCcEEeCCCCcCC
Q 008012 85 SSNYLTGSLTSDIQNMKVLIDLDLSRNQLS 114 (581)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 114 (581)
++|.++ .+|. ++.+++|++|++++|.+.
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred cccccc-cccc-hhhhccceeecccccccc
Confidence 777777 3443 466777777777777655
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=5.3e-14 Score=134.76 Aligned_cols=184 Identities=24% Similarity=0.270 Sum_probs=136.2
Q ss_pred CCCCCCcEEEeecCcccccCCccccCCCCCCEEEccCC-ccccc-CCccccCCCCCCEEEccCC-cccCC-CCcccc-cC
Q 008012 2 GRMQQLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGN-KLNGS-IPTCLASLTSLRELRLNSN-KLTSS-IPSALW-AL 76 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~i~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~-~l 76 (581)
.++++|++|+|++|.++...+..++.+++|++|+|+++ .+++. ....+.++++|++|+|+++ .+++. ....+. ..
T Consensus 68 ~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~ 147 (284)
T d2astb2 68 SQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVS 147 (284)
T ss_dssp TTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSC
T ss_pred HhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccc
Confidence 56899999999999999888889999999999999994 67632 2233467899999999986 45422 122233 35
Q ss_pred CCCcEEecccC--cCCCC-CCccccCCccCcEEeCCCC-cCCCCCcccccCcccccceecccc-ccccccCccccCcccc
Q 008012 77 EYILYVNLSSN--YLTGS-LTSDIQNMKVLIDLDLSRN-QLSGDIPKTIAGLKDLTNLSLAGN-QFQGPIPESFGSLISL 151 (581)
Q Consensus 77 ~~L~~L~l~~n--~l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l~~N-~i~~~~~~~~~~l~~L 151 (581)
++|+.|+++++ .++.. +...+..+++|++|++++| .+++.....+.++++|++|+|++| .+++.....++.+++|
T Consensus 148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 78999999975 34422 2223467899999999986 477777788999999999999995 7887667778899999
Q ss_pred ceeeccccccCC-CCchhhhcccccCeeEccCCCCCCCC
Q 008012 152 ESLDLSSNNLSE-GIPKSLVALSHLKQFNVSHNRLEGEI 189 (581)
Q Consensus 152 ~~L~l~~N~l~~-~~~~~~~~l~~L~~l~l~~n~l~~~~ 189 (581)
+.|+++++ ++. ..+..... +..|.+..+.++...
T Consensus 228 ~~L~l~~~-~~d~~l~~l~~~---lp~L~i~~~~ls~~~ 262 (284)
T d2astb2 228 KTLQVFGI-VPDGTLQLLKEA---LPHLQINCSHFTTIA 262 (284)
T ss_dssp CEEECTTS-SCTTCHHHHHHH---STTSEESCCCSCCTT
T ss_pred CEEeeeCC-CCHHHHHHHHHh---CccccccCccCCCCC
Confidence 99999988 333 22222233 444556777777543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.38 E-value=2.3e-14 Score=141.66 Aligned_cols=209 Identities=17% Similarity=0.156 Sum_probs=141.7
Q ss_pred CCCCCCcEEEeecCccccc----------CCccccCCCCCCEEEccCCccccc----CCccccCCCCCCEEEccCCcccC
Q 008012 2 GRMQQLQGIGLADNHLQGS----------IPYDLCQLKRLNSLSLQGNKLNGS----IPTCLASLTSLRELRLNSNKLTS 67 (581)
Q Consensus 2 ~~~~~L~~L~l~~n~l~~~----------~~~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~ 67 (581)
...++|+.|+++++.+... +...+..+++|+.|+|++|.|+.. +...+...++|+.|+|++|.++.
T Consensus 56 ~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~ 135 (344)
T d2ca6a1 56 ASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGP 135 (344)
T ss_dssp TTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHH
T ss_pred HhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccc
Confidence 4678899999988765422 123456678999999999998854 23345567899999999998752
Q ss_pred CCCc-------------ccccCCCCcEEecccCcCCCCCC----ccccCCccCcEEeCCCCcCCCC-----CcccccCcc
Q 008012 68 SIPS-------------ALWALEYILYVNLSSNYLTGSLT----SDIQNMKVLIDLDLSRNQLSGD-----IPKTIAGLK 125 (581)
Q Consensus 68 ~~~~-------------~~~~l~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~l~~N~l~~~-----~~~~~~~l~ 125 (581)
.... .....+.|+.+.+++|.++.... ..+..++.|++|+|++|.+... +...+..++
T Consensus 136 ~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~ 215 (344)
T d2ca6a1 136 QAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ 215 (344)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCT
T ss_pred cccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchh
Confidence 2111 12356788999999998873222 2345678899999999988632 234466788
Q ss_pred cccceeccccccccc----cCccccCccccceeeccccccCCCCchhh----hc--ccccCeeEccCCCCCCCC----CC
Q 008012 126 DLTNLSLAGNQFQGP----IPESFGSLISLESLDLSSNNLSEGIPKSL----VA--LSHLKQFNVSHNRLEGEI----PT 191 (581)
Q Consensus 126 ~L~~L~l~~N~i~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~----~~--l~~L~~l~l~~n~l~~~~----~~ 191 (581)
+|+.|+|++|.|+.. +...+..+++|++|+|++|.|++.....+ .. .+.|++|++++|+++..- ..
T Consensus 216 ~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~ 295 (344)
T d2ca6a1 216 ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 295 (344)
T ss_dssp TCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHH
T ss_pred hhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHH
Confidence 899999999988643 33556778889999999998876433333 22 357889999999876411 00
Q ss_pred C--CCCcCCcccccccccccc
Q 008012 192 E--GPFRNFSAQSFHWNYALC 210 (581)
Q Consensus 192 ~--~~~~~~~~~~~~~n~~~c 210 (581)
. .....+..+++.+|....
T Consensus 296 ~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 296 VIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHCTTCCEEECTTSBSCT
T ss_pred HHHccCCCCCEEECCCCcCCC
Confidence 0 123456777777776543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.31 E-value=1.4e-13 Score=135.92 Aligned_cols=205 Identities=16% Similarity=0.176 Sum_probs=147.9
Q ss_pred CCCCCcEEEeecCccccc----CCccccCCCCCCEEEccCCccccc----------CCccccCCCCCCEEEccCCcccCC
Q 008012 3 RMQQLQGIGLADNHLQGS----IPYDLCQLKRLNSLSLQGNKLNGS----------IPTCLASLTSLRELRLNSNKLTSS 68 (581)
Q Consensus 3 ~~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~i~~~----------~~~~~~~l~~L~~L~L~~N~l~~~ 68 (581)
....|+.|+|++|.|... +-..+..+++|+.|+++++.+... +...+..+++|+.|+|++|.++..
T Consensus 29 ~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 108 (344)
T d2ca6a1 29 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 108 (344)
T ss_dssp HCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTT
T ss_pred hCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccc
Confidence 357899999999998643 334567789999999998765522 123456788999999999999854
Q ss_pred ----CCcccccCCCCcEEecccCcCCCCCCcc-------------ccCCccCcEEeCCCCcCCCCC----cccccCcccc
Q 008012 69 ----IPSALWALEYILYVNLSSNYLTGSLTSD-------------IQNMKVLIDLDLSRNQLSGDI----PKTIAGLKDL 127 (581)
Q Consensus 69 ----~~~~~~~l~~L~~L~l~~n~l~~~~~~~-------------~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L 127 (581)
+...+...++|+.|++++|.+....... ....+.|+.|++++|.++... ...+..++.|
T Consensus 109 ~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L 188 (344)
T d2ca6a1 109 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188 (344)
T ss_dssp THHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTC
T ss_pred cccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhh
Confidence 3344567899999999999876211111 134678999999999987332 2335567899
Q ss_pred cceeccccccccc-----cCccccCccccceeeccccccCCC----CchhhhcccccCeeEccCCCCCCCCCC-------
Q 008012 128 TNLSLAGNQFQGP-----IPESFGSLISLESLDLSSNNLSEG----IPKSLVALSHLKQFNVSHNRLEGEIPT------- 191 (581)
Q Consensus 128 ~~L~l~~N~i~~~-----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~n~l~~~~~~------- 191 (581)
+.|+|++|.|+.. +...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|.++..-..
T Consensus 189 ~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~ 268 (344)
T d2ca6a1 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 268 (344)
T ss_dssp CEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhh
Confidence 9999999998642 334577889999999999998643 345567889999999999998752110
Q ss_pred CCCCcCCccccccccc
Q 008012 192 EGPFRNFSAQSFHWNY 207 (581)
Q Consensus 192 ~~~~~~~~~~~~~~n~ 207 (581)
......+..+++.+|.
T Consensus 269 ~~~~~~L~~L~ls~N~ 284 (344)
T d2ca6a1 269 KLENIGLQTLRLQYNE 284 (344)
T ss_dssp TCSSCCCCEEECCSSC
T ss_pred hccCCCCCEEECCCCc
Confidence 1123456667777663
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.91 E-value=4.1e-11 Score=122.34 Aligned_cols=180 Identities=21% Similarity=0.221 Sum_probs=89.1
Q ss_pred CcEEEeecCccccc----CCccccCCCCCCEEEccCCcccc-----cCCccccCCCCCCEEEccCCcccCC----CCccc
Q 008012 7 LQGIGLADNHLQGS----IPYDLCQLKRLNSLSLQGNKLNG-----SIPTCLASLTSLRELRLNSNKLTSS----IPSAL 73 (581)
Q Consensus 7 L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~i~~-----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~ 73 (581)
...+++.++.+... ....+...+.++.+++++|.+.. .....+.....|+.|++++|.+... ....+
T Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l 279 (460)
T d1z7xw1 200 LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVL 279 (460)
T ss_dssp CCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHH
T ss_pred ccccccccccccchhhhcccccccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccc
Confidence 34455555544421 11223445666666666666542 1223334455666666666665522 12233
Q ss_pred ccCCCCcEEecccCcCCCCCCccc-----cCCccCcEEeCCCCcCCCCCcccc----cCcccccceeccccccccc----
Q 008012 74 WALEYILYVNLSSNYLTGSLTSDI-----QNMKVLIDLDLSRNQLSGDIPKTI----AGLKDLTNLSLAGNQFQGP---- 140 (581)
Q Consensus 74 ~~l~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~~~~~~~----~~l~~L~~L~l~~N~i~~~---- 140 (581)
...+.++.+++++|.++......+ .....|+.+++++|.++......+ ...++|+.|+|++|+|++.
T Consensus 280 ~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~ 359 (460)
T d1z7xw1 280 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRE 359 (460)
T ss_dssp HHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHH
T ss_pred cccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccch
Confidence 455666666666666542111111 123456666666666553322222 2344566666666666532
Q ss_pred cCcccc-CccccceeeccccccCCC----CchhhhcccccCeeEccCCCCC
Q 008012 141 IPESFG-SLISLESLDLSSNNLSEG----IPKSLVALSHLKQFNVSHNRLE 186 (581)
Q Consensus 141 ~~~~~~-~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~n~l~ 186 (581)
++..+. ..+.|++|+|++|.|+.. +...+..+++|++|++++|+++
T Consensus 360 l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred hhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 122222 244566666666666532 2233444566666666666664
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.90 E-value=5.1e-11 Score=121.62 Aligned_cols=184 Identities=23% Similarity=0.192 Sum_probs=131.2
Q ss_pred CCCCcEEEeecCcccc-----cCCccccCCCCCCEEEccCCccccc----CCccccCCCCCCEEEccCCcccCCCCccc-
Q 008012 4 MQQLQGIGLADNHLQG-----SIPYDLCQLKRLNSLSLQGNKLNGS----IPTCLASLTSLRELRLNSNKLTSSIPSAL- 73 (581)
Q Consensus 4 ~~~L~~L~l~~n~l~~-----~~~~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~- 73 (581)
.+.++.+++++|++.. ...........|+.|++++|.+... ....+...+.++.+++++|.+++.....+
T Consensus 225 ~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~ 304 (460)
T d1z7xw1 225 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC 304 (460)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred cccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhh
Confidence 4678899999998753 2334455678999999999998733 22345667899999999999874322221
Q ss_pred ----ccCCCCcEEecccCcCCCCCCc----cccCCccCcEEeCCCCcCCCC----Cccccc-Ccccccceeccccccccc
Q 008012 74 ----WALEYILYVNLSSNYLTGSLTS----DIQNMKVLIDLDLSRNQLSGD----IPKTIA-GLKDLTNLSLAGNQFQGP 140 (581)
Q Consensus 74 ----~~l~~L~~L~l~~n~l~~~~~~----~~~~l~~L~~L~l~~N~l~~~----~~~~~~-~l~~L~~L~l~~N~i~~~ 140 (581)
.....|+.+++++|.++..... .+..+++|++|+|++|.|++. +++.+. ..+.|+.|+|++|+|+..
T Consensus 305 ~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~ 384 (460)
T d1z7xw1 305 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 384 (460)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred ccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChH
Confidence 2346799999999998854333 334567899999999998643 233333 456799999999999753
Q ss_pred ----cCccccCccccceeeccccccCCCCchhhh-----cccccCeeEccCCCCCC
Q 008012 141 ----IPESFGSLISLESLDLSSNNLSEGIPKSLV-----ALSHLKQFNVSHNRLEG 187 (581)
Q Consensus 141 ----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-----~l~~L~~l~l~~n~l~~ 187 (581)
++..+..+++|++|+|++|+|+......+. ....|+.|++.+|.+..
T Consensus 385 ~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 385 SCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp HHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred HHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 344566678999999999999764333332 23469999999998874
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.84 E-value=1.3e-10 Score=100.51 Aligned_cols=105 Identities=24% Similarity=0.164 Sum_probs=52.4
Q ss_pred CCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCCCcccccCCCCcEEecccCcCCCCC--CccccCCccCcEEe
Q 008012 30 RLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSIPSALWALEYILYVNLSSNYLTGSL--TSDIQNMKVLIDLD 107 (581)
Q Consensus 30 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~ 107 (581)
..+.|++++++.. ..+..+..+..|++.+|.+. .++..+..+++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 4455565554432 12333444444444444443 33444455666666666666666432 23345566666666
Q ss_pred CCCCcCCCCCcccccCcccccceecccccccc
Q 008012 108 LSRNQLSGDIPKTIAGLKDLTNLSLAGNQFQG 139 (581)
Q Consensus 108 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~ 139 (581)
|++|.|+...+-.+.+..+|+.|++++|++..
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCc
Confidence 66666653222122233455566666665553
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.83 E-value=9.2e-11 Score=101.42 Aligned_cols=121 Identities=21% Similarity=0.135 Sum_probs=87.4
Q ss_pred CCcEEEeecCcccccCCccccCCCCCCEEEccCCcccccCCccccCCCCCCEEEccCCcccCCC--CcccccCCCCcEEe
Q 008012 6 QLQGIGLADNHLQGSIPYDLCQLKRLNSLSLQGNKLNGSIPTCLASLTSLRELRLNSNKLTSSI--PSALWALEYILYVN 83 (581)
Q Consensus 6 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~ 83 (581)
..+.|+++++... ..+..+..+..|+...|.+. .++..+..+++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 4566777766543 23555666666777666665 45666778999999999999998543 45678899999999
Q ss_pred cccCcCCCCCCccccCCccCcEEeCCCCcCCCCCccc-------ccCccccccee
Q 008012 84 LSSNYLTGSLTSDIQNMKVLIDLDLSRNQLSGDIPKT-------IAGLKDLTNLS 131 (581)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-------~~~l~~L~~L~ 131 (581)
|++|.|+...+-.+....+|+.|++++|.+....... +..+++|+.||
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 9999999655444555678999999999998543322 44566666554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.78 E-value=1.1e-08 Score=95.94 Aligned_cols=149 Identities=15% Similarity=0.125 Sum_probs=106.5
Q ss_pred hHHHhhcCCCcCCeecccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-CCccceEeeeeecCCeee
Q 008012 285 DLERATDGFNECNLLGSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKA 363 (581)
Q Consensus 285 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 363 (581)
++......|+.++..+.++.+.||+.... ++.+++|+...........+.+|...++.+. +--+.+++++..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 55666677877666555555789998754 6778889887654433445678888888773 434667788888888899
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 008012 364 LVLEFMPNGSLDKWLYSHNYFQDIPDRLNIMIDVALALEYLHHG------------------------------------ 407 (581)
Q Consensus 364 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~------------------------------------ 407 (581)
+||++++|.++.+..... .....++.++++.++.||+.
T Consensus 87 lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999998886654321 12334566777777777731
Q ss_pred --------------------CCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 408 --------------------HSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 408 --------------------~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
....++|+|+.|.||++++++.+-|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 022379999999999999877777999997763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.37 E-value=3.1e-07 Score=85.18 Aligned_cols=131 Identities=17% Similarity=0.095 Sum_probs=89.5
Q ss_pred eeccccc-ccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcC--CCccceEeeeeecCCeeeEEEeccCCCCH
Q 008012 298 LLGSGGF-GSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR--HRNLIKILSSCCNTNFKALVLEFMPNGSL 374 (581)
Q Consensus 298 ~lg~G~~-~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 374 (581)
.+..|.. +.||+....++..+++|....... ..+..|...++.+. .-.+.+++++..+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555554 678999988788899998765532 24667888887773 23366778888888889999999998765
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc------------------------------------------------
Q 008012 375 DKWLYSHNYFQDIPDRLNIMIDVALALEYLHH------------------------------------------------ 406 (581)
Q Consensus 375 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~------------------------------------------------ 406 (581)
.+.. .. ....+.++...|+.||.
T Consensus 94 ~~~~------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccc------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 3210 11 11223344445555552
Q ss_pred -------CCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 407 -------GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 407 -------~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
.....++|+|+.|.||+++++..+-|+||+.+..
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 0123479999999999999877778999997763
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.11 E-value=4.8e-07 Score=77.82 Aligned_cols=88 Identities=11% Similarity=0.215 Sum_probs=46.4
Q ss_pred CCCCCCEEEccCC-ccccc----CCccccCCCCCCEEEccCCcccCC----CCcccccCCCCcEEecccCcCCCC----C
Q 008012 27 QLKRLNSLSLQGN-KLNGS----IPTCLASLTSLRELRLNSNKLTSS----IPSALWALEYILYVNLSSNYLTGS----L 93 (581)
Q Consensus 27 ~l~~L~~L~l~~n-~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~ 93 (581)
+.+.|+.|+|+++ .|+.. +..++...++|++|+|++|.++.. +...+...+.|++|+|++|.|+.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 3466666666653 34421 223445556666666666666522 222334455666666666666531 1
Q ss_pred CccccCCccCcEEeCCCCcCC
Q 008012 94 TSDIQNMKVLIDLDLSRNQLS 114 (581)
Q Consensus 94 ~~~~~~l~~L~~L~l~~N~l~ 114 (581)
..++...+.|++|+|++|.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHhCCcCCEEECCCCcCC
Confidence 123445566666666666544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.07 E-value=6.5e-07 Score=76.97 Aligned_cols=111 Identities=16% Similarity=0.237 Sum_probs=81.6
Q ss_pred CCCCCcEEEeecC-ccccc----CCccccCCCCCCEEEccCCccccc----CCccccCCCCCCEEEccCCcccCC----C
Q 008012 3 RMQQLQGIGLADN-HLQGS----IPYDLCQLKRLNSLSLQGNKLNGS----IPTCLASLTSLRELRLNSNKLTSS----I 69 (581)
Q Consensus 3 ~~~~L~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~ 69 (581)
+.++|++|+|+++ .++.. +-..+...+.|++|+|++|.|+.. +.+.+...+.|++|+|++|.|++. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4688999999984 57632 234577789999999999999843 234556678999999999999843 2
Q ss_pred CcccccCCCCcEEecccCcCCCC-------CCccccCCccCcEEeCCCCcC
Q 008012 70 PSALWALEYILYVNLSSNYLTGS-------LTSDIQNMKVLIDLDLSRNQL 113 (581)
Q Consensus 70 ~~~~~~l~~L~~L~l~~n~l~~~-------~~~~~~~l~~L~~L~l~~N~l 113 (581)
..++...+.|++|++++|.+... +...+...+.|+.|+++.+..
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 33466678899999999987632 223445568888888876643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.79 E-value=3.9e-05 Score=75.31 Aligned_cols=76 Identities=17% Similarity=0.212 Sum_probs=49.1
Q ss_pred CCeecccccccEEEEEeC-CCcEEEEEEeccchH-------HHHHHHHHHHHHHHhc-CC--CccceEeeeeecCCeeeE
Q 008012 296 CNLLGSGGFGSVYKGILS-DGTTVAIKIFNLQLE-------QAFRSFNSECEVLRNV-RH--RNLIKILSSCCNTNFKAL 364 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l-~h--~~iv~~~~~~~~~~~~~l 364 (581)
.+.||.|....||++... +++.++||.-..... ....+...|++.++.+ .+ ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 357899999999999865 477899997543210 1123455688888777 22 345556654 4455679
Q ss_pred EEeccCCCC
Q 008012 365 VLEFMPNGS 373 (581)
Q Consensus 365 v~e~~~~~~ 373 (581)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.69 E-value=1.5e-06 Score=74.51 Aligned_cols=85 Identities=18% Similarity=0.263 Sum_probs=43.8
Q ss_pred cccCCCCCCEEEccC-Cccccc----CCccccCCCCCCEEEccCCcccCC----CCcccccCCCCcEEecccCcCCCC--
Q 008012 24 DLCQLKRLNSLSLQG-NKLNGS----IPTCLASLTSLRELRLNSNKLTSS----IPSALWALEYILYVNLSSNYLTGS-- 92 (581)
Q Consensus 24 ~~~~l~~L~~L~l~~-n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~-- 92 (581)
...+.+.|++|+|++ |.|+.. +..++...++|++|+|++|.++.. +...+...+.|+.+++++|.+...
T Consensus 12 ~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~ 91 (166)
T d1io0a_ 12 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 91 (166)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhH
Confidence 344556677777765 445421 223344566666777766666532 222344455666666666665421
Q ss_pred --CCccccCCccCcEEeC
Q 008012 93 --LTSDIQNMKVLIDLDL 108 (581)
Q Consensus 93 --~~~~~~~l~~L~~L~l 108 (581)
+...+...++|+.++|
T Consensus 92 ~~l~~~l~~~~~L~~l~L 109 (166)
T d1io0a_ 92 LALVEALQSNTSLIELRI 109 (166)
T ss_dssp HHHHHGGGGCSSCCEEEC
T ss_pred HHHHHHHHhCccccEEee
Confidence 1123344555554333
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.60 E-value=5.2e-06 Score=71.07 Aligned_cols=111 Identities=16% Similarity=0.228 Sum_probs=81.4
Q ss_pred CCCCCcEEEeec-Cccccc----CCccccCCCCCCEEEccCCccccc----CCccccCCCCCCEEEccCCcccCC----C
Q 008012 3 RMQQLQGIGLAD-NHLQGS----IPYDLCQLKRLNSLSLQGNKLNGS----IPTCLASLTSLRELRLNSNKLTSS----I 69 (581)
Q Consensus 3 ~~~~L~~L~l~~-n~l~~~----~~~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~ 69 (581)
+.+.|++|+|++ +.|+.. +-..+...++|+.|+|++|.|+.. +...+...+.|+.|++++|.++.. +
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l 94 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 94 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence 568999999998 567632 234567889999999999999843 334566789999999999998743 3
Q ss_pred CcccccCCCCcEEec--ccCcCCC----CCCccccCCccCcEEeCCCCcC
Q 008012 70 PSALWALEYILYVNL--SSNYLTG----SLTSDIQNMKVLIDLDLSRNQL 113 (581)
Q Consensus 70 ~~~~~~l~~L~~L~l--~~n~l~~----~~~~~~~~l~~L~~L~l~~N~l 113 (581)
...+...++|+.++| ++|.+.. .+...+...++|+.|+++.+..
T Consensus 95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 356677889998666 5667763 2334456778899998877654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.25 E-value=0.00038 Score=66.08 Aligned_cols=134 Identities=12% Similarity=0.084 Sum_probs=77.0
Q ss_pred cccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcCCCc--cceEee-----eeecCCeeeEEEeccCCCCHH-
Q 008012 304 FGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVRHRN--LIKILS-----SCCNTNFKALVLEFMPNGSLD- 375 (581)
Q Consensus 304 ~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~-----~~~~~~~~~lv~e~~~~~~L~- 375 (581)
--.||++..++|+.+++|+.+.... ..+.+..|.+.+..+.... ++..+. .+...+..+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 3689999998999999999876521 2245677888888873211 111111 223456678899998765321
Q ss_pred ----HH------H---h----hC----CCCCCH----------------------HHHHHHHHHHHHHHHHHh-cCCCCC
Q 008012 376 ----KW------L---Y----SH----NYFQDI----------------------PDRLNIMIDVALALEYLH-HGHSTP 411 (581)
Q Consensus 376 ----~~------l---~----~~----~~~~~~----------------------~~~~~i~~~i~~~L~~LH-~~~~~~ 411 (581)
.+ + + .. ....+. ......+.++...+...- .....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 10 0 0 00 000111 111223333333333221 122467
Q ss_pred ceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 412 VVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 412 i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
++|+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999743 45899997763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.22 E-value=0.00078 Score=63.55 Aligned_cols=156 Identities=10% Similarity=0.012 Sum_probs=83.4
Q ss_pred hhhhHHHhhcCCCcCCee-----cccccccEEEEEeCCCcEEEEEEeccchHHHHHHHHHHHHHHHhcC-----CCccce
Q 008012 282 SYLDLERATDGFNECNLL-----GSGGFGSVYKGILSDGTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-----HRNLIK 351 (581)
Q Consensus 282 ~~~~~~~~~~~y~~~~~l-----g~G~~~~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~ 351 (581)
+..+++....+|.+.+.. ..|---+.|+....+| .+++|++..... .+.+..|++++..+. .|..+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccce
Confidence 345677777788775544 3555678899987755 589999865421 234455666776663 222222
Q ss_pred Eee---eeecCCeeeEEEeccCCCCHH--------------HHHhh----CC----C------------------CCCHH
Q 008012 352 ILS---SCCNTNFKALVLEFMPNGSLD--------------KWLYS----HN----Y------------------FQDIP 388 (581)
Q Consensus 352 ~~~---~~~~~~~~~lv~e~~~~~~L~--------------~~l~~----~~----~------------------~~~~~ 388 (581)
..+ +.........++.+..+.... ..++. .. . .....
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 110 112234556667776654221 00000 00 0 00001
Q ss_pred HHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCCeEecCCCcEEEeeccCcee
Q 008012 389 DRLNIMIDVALALEYLHH-GHSTPVVHCDLKPSNILLDENMVAHVSDFGISKL 440 (581)
Q Consensus 389 ~~~~i~~~i~~~L~~LH~-~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 440 (581)
.....+..+...+...+. .-..|+||+|+.++||+++.+...-++||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 112222223333333321 2357899999999999999888778999998863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.14 E-value=0.00046 Score=67.51 Aligned_cols=73 Identities=12% Similarity=0.147 Sum_probs=49.8
Q ss_pred CCeecccccccEEEEEeCC--------CcEEEEEEeccchHHHHHHHHHHHHHHHhcC-CCccceEeeeeecCCeeeEEE
Q 008012 296 CNLLGSGGFGSVYKGILSD--------GTTVAIKIFNLQLEQAFRSFNSECEVLRNVR-HRNLIKILSSCCNTNFKALVL 366 (581)
Q Consensus 296 ~~~lg~G~~~~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 366 (581)
++.|+.|-.-.+|++...+ .+.|++++.-.... .....+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3678888899999998643 35677887653322 124457888888884 4334577777643 5899
Q ss_pred eccCCCCH
Q 008012 367 EFMPNGSL 374 (581)
Q Consensus 367 e~~~~~~L 374 (581)
||++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|